ITEM DESCRIPTION_START Description LATEST 00001 01FEB1984 Professional attendance at consulting rooms of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 2-- each attendance N 00001 01NOV1996 EMERGENCY ATTENDANCEAFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance being an attendance at other than consulting rooms, by a general practitioner on not more than 1 patient on 1 occasion. Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatmenteach attendance N 00001 01NOV1997 EMERGENCY ATTENDANCEAFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday N 00001 01MAR2007 URGENT ATTENDANCEAFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment Y 00002 01FEB1984 Professional attendance at consulting rooms of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday N 00002 01NOV1996 Professional attendance being an attendance at consulting rooms, by a general practitioner on not more than 1 patient on 1 occasion Professional attendance after hours AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period, where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendanceeach attendance N 00002 01NOV1997 Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday N 00002 01MAR2007 Professional attendance AT CONSULTING ROOMS,by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment; and `)it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance Y 00003 01DEC1989 Professional attendance at consulting rooms (not being an attendance covered by any other item in this Part) by a vocationally registered general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management each attendance N 00003 01DEC1991 NOTE: Professional attendances by general practitioners cover consultations during which the general practitioner evaluates the patient's problem (which may include certain health screening services - see paragraph 12.3 of the General Explanatory Notes) and formulates a management plan, in relation to one or more conditions present in the patient. The service also includes advice to the patient and/or relatives and the recording of appropriate detail of the particular services - (see paragraphs A.4.6 - A.4.7 of Explanatory Notes to this Category) LEVEL 'A' Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00003 01NOV1993 LEVEL 'A' Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00003 01MAY2010 Professional attendance at consulting rooms (other than a service to which another item applies) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-each attendance Y 00004 01DEC1989 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00004 01NOV1993 HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution) N 00004 01NOV1997 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00004 01NOV2000 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution) N 00004 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00004 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00004 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies) that requires a short patient history and, if necessary, limited examination and management-an attendance on one or more patients at one place on one occasion-each patient Y 00005 01FEB1984 Professional attendance at consulting rooms of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 6-- each attendance Y 00006 01FEB1984 Professional attendance at consulting rooms of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00007 01FEB1984 Professional attendance at consulting rooms of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 8-- each attendance Y 00008 01FEB1984 Professional attendance at consulting rooms of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00009 01FEB1984 Professional attendance at consulting rooms of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 10-- each attendance Y 00010 01FEB1984 Professional attendance at consulting rooms of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00011 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-at a time other than a time covered by Item 12-- each attendance Y 00012 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00013 01NOV1990 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00013 01NOV1993 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00013 01NOV2000 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient Y 00014 01DEC1989 LEVEL A Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management.CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT Y 00015 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 16-- each attendance Y 00016 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00017 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 18-- each attendance Y 00018 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00019 01NOV1990 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient N 00019 01NOV1993 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient Y 00020 01NOV1990 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a selfcontained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00020 01NOV1993 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a selfcontained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00020 01NOV2000 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion)each patient N 00020 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient. N 00020 01JAN2013 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in a residential aged care facility (other than accommodation in a self-contained unit) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 00021 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 22-- each attendance Y 00022 01FEB1984 Professional attendance, not being an attendance at consulting rooms, a hospital or a nursing home or an attendance that is one of 2 or more attendances on the one occasion at an institution, of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday Y 00023 01DEC1989 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of an attendance of the type otherwise covered by Item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00023 01NOV1990 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00023 01NOV1993 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00023 01MAY2010 Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance Y 00024 01DEC1989 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00024 01NOV1993 HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution) N 00024 01NOV1997 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00024 01NOV2000 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution) N 00024 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00024 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00024 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient Y 00025 01NOV1990 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00025 01NOV1993 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00025 01NOV2000 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient Y 00026 01DEC1989 LEVEL B Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of an attendance of the type otherwise covered by Items 36, 37, 39, 44, 47 or 49.CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT Y 00027 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 28-- each attendance where only one in-patient is seen Y 00028 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-- each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday, where only one in-patient is seen Y 00029 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-- an attendance on each of two in-patients in the one hospital on the one occasion at a time other than a time covered by Item 30-- each patient who is not a nursing-home type patient Y 00030 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of two in-patients in the one hospital on the one occasion-each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-each patient who is not a nursing-home type patient Y 00031 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of three or more in-patients in the one hospital on the one occasion-each patient who is not a nursing-home type patient Y 00032 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of two in-patients in the one hospital on the one occasion where at least one of those in-patients is a nursing-home type patient-each nursing-home type patient Y 00033 01NOV1990 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient N 00033 01NOV1993 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient Y 00034 01FEB1984 Professional attendance at a hospital (not being an attendance covered by any other item in this Part)-an attendance on each of three or more in-patients in the one hospital on the one occasion where at least one of those in-patients is a nursing-home type patient-each nursing-home type patient Y 00035 01NOV1990 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00035 01NOV1993 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00035 01NOV2000 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient N 00035 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient. N 00035 01JAN2013 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 00036 01DEC1989 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of an attendance of the type otherwise covered by Items 44, 47, 48, 50 or 51 SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00036 01NOV1990 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00036 01NOV1993 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00036 01MAY2010 Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance Y 00037 01DEC1989 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00037 01NOV1993 HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution) N 00037 01NOV1997 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00037 01NOV2000 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution) N 00037 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00037 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00037 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient Y 00038 01NOV1990 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00038 01NOV1993 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00038 01NOV2000 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient Y 00039 01DEC1989 LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of an attendance of the type otherwise covered by Items 44, 47 or 49 . CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT Y 00040 01NOV1990 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient N 00040 01NOV1993 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion) each patient Y 00041 01FEB1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 42-each attendance where only one patient is seen N 00041 01MAR1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - each in hours attendance where only one patient is seen Y 00042 01FEB1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part)-each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday, where only one patient is seen N 00042 01MAR1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - each after hours attendance where only one patient is seen Y 00043 01NOV1990 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00043 01NOV1993 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00043 01NOV2000 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion)each patient N 00043 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient. N 00043 01JAN2013 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 00044 01DEC1989 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00044 01NOV1993 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan SURGERY CONSULTATION (Professional attendance at consulting rooms) N 00044 01MAY2010 Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance Y 00045 01FEB1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part)-an attendance on two patients in the one nursing home or aged persons' accommodation on the one occasion-each patient N 00045 01MAR1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - an attendance on two patients in the one nursing home or aged persons' accommodation on the one occasion - each patient Y 00046 01FEB1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a nursing home complex (not being an attendance covered by any other item in this Part)-an attendance on three or more patients in the one nursing home or aged persons' accommodation on the one occasion-each patient N 00046 01MAR1984 Professional attendance at a nursing home, including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (other than a professional attendance at a selfcontained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (not being accommodation in a self-contained unit) - an attendance on three or more patients in the one nursing home or aged persons' accommodation on the one occasion - each patient Y 00047 01DEC1989 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00047 01NOV1993 HOME VISIT (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution) N 00047 01NOV1997 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) N 00047 01NOV2000 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution) N 00047 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (INCLUDING A HOSPITAL) OTHER THAN A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00047 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility. N 00047 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms or a residential aged care facility or a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one place on one occasion-each patient Y 00048 01NOV1990 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00048 01NOV1993 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient N 00048 01NOV2000 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient Y 00049 01DEC1989 LEVEL D Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems, and lasting atast 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan. CONSULTATION AT AN INSTITUTION - OTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on two or more patients in the one INSTITUTION on the one occasion) - EACH PATIENT Y 00050 01NOV1990 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient N 00050 01NOV1993 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient Y 00051 01NOV1990 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00051 01NOV1993 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion)each patient N 00051 01NOV2000 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion)each patient N 00051 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion each patient. N 00051 01JAN2013 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 00052 01DEC1989 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration N 00052 01NOV1993 Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00052 01NOV2019 Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00053 01DEC1989 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration N 00053 01NOV1993 Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00053 01NOV2019 Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00054 01DEC1989 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration N 00054 01NOV1993 Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00054 01NOV2019 Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00055 01FEB1984 Professional attendance at an institution of not more than 5 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 56-an attendance on each of two or more patients at the one institution on the one occasion-each patient Y 00056 01FEB1984 Professional attendance at an institution of not more than 5 minutes duration (not being an attendance covered by any other item in this Part)-an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-each patient Y 00057 01DEC1989 PROLONGED CONSULTATION of more than 45 minutes duration N 00057 01NOV1993 Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00057 01NOV2019 Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which any other item applies)-each attendance, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00058 01DEC1989 HOME VISITS (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) BRIEF HOME VISIT of not more than 5 minutes duration N 00058 01NOV1993 HOME VISITS (Professional attendance at a place other than consulting rooms, hospital, nursing home or institution) BRIEF HOME VISIT of not more than 5 minutes duration N 00058 01NOV1997 HOME VISITS (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, nursing home or institution) BRIEF HOME VISIT of not more than 5 minutes duration N 00058 01NOV2000 HOME VISITS Professional attendance by a medical practitioner (other than a general practitioner) on 1 or more patients on 1 occasion at a place other than consulting rooms or a residential aged care facility BRIEF HOME VISIT of not more than 5 minutes duration N 00058 01MAY2010 BRIEF CONSULTATION of not more than 5 minutes duration N 00058 01JAN2013 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies), not more than 5 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00058 01NOV2019 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies), not more than 5 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00059 01DEC1989 STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration N 00059 01NOV1993 STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration N 00059 01NOV1997 STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration N 00059 01MAY2010 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration N 00059 01JAN2013 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00059 01NOV2019 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00060 01DEC1989 LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration N 00060 01NOV1993 LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration N 00060 01NOV1997 LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration N 00060 01MAY2010 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration N 00060 01JAN2013 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00060 01NOV2019 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00061 01FEB1984 Professional attendance at an institution of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 62-- an attendance on each of two or more patients at the one institution on the one occasion-- each patient Y 00062 01FEB1984 Professional attendance at an institution of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part)-- an attendance on each of two or more patients at at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-- each patient N 00062 01MAR1984 Professional attendance at an institution of more than 5 minutes duration but not more than 25 minutes duration (not being an attendance covered by any other item in this Part) - an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday - each patient Y 00063 01FEB1984 Professional attendance at an institution of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 64-- an attendance on each of two or more patients at the one institution on the one occasion-- each patient Y 00064 01FEB1984 Professional attendance at an institution of more than 25 minutes duration but not more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-- each patient Y 00065 01DEC1989 PROLONGED HOME VISIT of more than 45 minutes duration N 00065 01NOV1993 PROLONGED HOME VISIT of more than 45 minutes duration N 00065 01NOV1997 PROLONGED HOME VISIT of more than 45 minutes duration N 00065 01MAY2010 PROLONGED CONSULTATION of more than 45 minutes duration N 00065 01JAN2013 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 45 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies N 00065 01NOV2019 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 45 minutes in duration-an attendance on one or more patients at one place on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a Group A1 disqualified general practitioner, as defined in the dictionary of the General Medical Services Table (GMST). Y 00066 01DEC1989 CONSULTATION AT AN INSTITUTION- Professional attendance on two or more patients in the one INSTITUTION on the one occasion - BRIEF CONSULTATION of not more than 5 minutes duration - EACH PATIENT Y 00067 01FEB1984 Professional attendance at an institution of more than 45 minutes duration (not being an attendance covered by any other item in this Part) at a time other than a time covered by Item 68-- an attendance on each of two or more patients at the one institution on the one occasion-- each patient Y 00068 01FEB1984 Professional attendance at an institution of more than 45 minutes duration (not being an attendance covered by any other item in this Part)-- an attendance on each of two or more patients at the one institution on the one occasion on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday-- each patient Y 00069 01DEC1989 CONSULTATION AT AN INSTITUTION- Professional attendance on two or more patients in the one INSTITUTION on the one occasion - STANDARD CONSULTATION, of more than 5 minutes duration but not more than 25 minutes duration - EACH PATIENT Y 00070 01AUG1987 GENERAL PRACTITIONER-EMERGENCY ATTENDANCE-AFTER HOURS (on not more than one patient on the one occasion). Professional attendance after hours AT A PLACE OTHER THAN SURGERY on not more than one patient on the one occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment-each attendance N 00070 01SEP1989 Professional attendance, being an attendance at other than consulting rooms, on not more than one patient on the one occasion-each attendance on a public holiday, on a Sunday, before 8 a.m. or after 1 p.m. on a Saturday or at any time other than between 8 a.m. and 8 p.m. on a day not being a Saturday, Sunday or public holiday, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment Y 00071 01DEC1989 CONSULTATION AT AN INSTITUTION-Professional attendance on two or more patients in the one INSTITUTION on the one occasion - LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration - EACH PATIENT Y 00072 01DEC1989 CONSULTATION AT AN INSTITUTION- Professional attendance on two or more patients in the one INSTITUTION on the one occasion - PROLONGED CONSULTATION of more than 45 minutes duration - EACH PATIENT Y 00073 01DEC1989 CONSULTATION AT HOSPITAL (one in-patient) - Professional attendance at a HOSPITAL where only one in-patient is seen - EACH ATTENDANCE Y 00074 01DEC1989 CONSULTATION AT HOSPITAL (two or more in-patients) - Professional attendance on two or more in-patients in the one HOSPITAL on the one occasion - EACH PATIENT who is not a nursing-home type patient Y 00075 01DEC1989 CONSULTATION AT HOSPITAL (two in-patients where at least one is a nursing-home type patient) - Professional attendance on two in-patients in the one HOSPITAL on the one occasion where at least one of those in-patients IS a nursing-home type patient - EACH NURSING-HOME TYPE PATIENT Y 00076 01DEC1989 CONSULTATION AT HOSPITAL (three or more in-patients where at least one is a nursing-home type patient) - Professional attendance on three or more in-patients in the one HOSPITAL on the one occasion where at least one of those in-patients is a nursing-home type patient - EACH NURSING-HOME TYPE PATIENT Y 00077 01DEC1989 CONSULTATION AT NURSING HOME (one patient) - Professional attendance at a NURSING HOME, including AGED PERSONS' ACCOMMODATION attached to a nursing home or aged persons' accommodation SITUATED WITHIN A COMPLEX THAT INCLUDES A NURSINGHOME (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a self-contained unit) where only ONE PATIENT is seen - EACH ATTENDANCE Y 00078 01DEC1989 CONSULTATION AT NURSING HOME (two patients) - Professional attendance at a NURSING HOME, including AGED PERSONS' ACCOMMODATION attached to a nursing home or aged persons' accommodation SITUATED WITHIN A COMPLEX THAT INCLUDES A NURSING HOME (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a self-contained unit) - an attendance on TWO PATIENTS in the one nursing home or aged persons' accommodation ON THE ONE OCCASION - EACH PATIENT Y 00079 01DEC1989 CONSULTATION AT NURSING HOME (three or more patients) - Professional attendance at a NURSING HOME, including AGED PERSONS' ACCOMMODATION attached to a nursing home or aged persons' accommodation SITUATED WITHIN A COMPLEX THAT INCLUDES A NURSING HOME (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a self-contained unit) - an attendance on THREE OR MORE PATIENTS in the one nursing home or aged persons' accommodation ON THE ONE OCCASION - EACH PATIENT Y 00080 01DEC1989 EMERGENCY ATTENDANCE - AFTER HOURS (on not more than one patient on the one occasion) -Professional attendance after hours AT A PLACE OTHER THAN SURGERY on not more than one patient on the one occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - EACH ATTENDANCE Y 00081 01NOV1990 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient BRIEF CONSULTATION of not more than 5 minutes duration N 00081 01NOV1993 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR NURSING HOME (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient BRIEF CONSULTATION of not more than 5 minutes duration N 00081 01NOV2000 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient BRIEF CONSULTATION of not more than 5 minutes duration Y 00082 01FEB1984 Pre-operative examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (G) N 00082 01NOV1986 PRE-OPERATIVE EXAMINATION OF A PATIENT IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at an attendance other than at which the anaesthetic is administered (G) N 00082 01SEP1989 Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (G) Y 00083 01NOV1990 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration N 00083 01NOV1993 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration Y 00084 01NOV1990 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration N 00084 01NOV1993 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration Y 00085 01FEB1984 Pre-operative examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (S) N 00085 01NOV1986 PRE-OPERATIVE EXAMINATION OF A PATIENT IN PREPARATION FOR THE ADMINISTRATION OF AN ANAESTHETIC, being an examination carried out at an attendance other than at which the anaesthetic is administered (S) N 00085 01SEP1989 Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (S) Y 00086 01NOV1990 PROLONGED CONSULTATION of more than 45 minutes duration N 00086 01NOV1993 PROLONGED CONSULTATION of more than 45 minutes duration Y 00087 01NOV1990 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient BRIEF CONSULTATION of not more than 5 minutes duration N 00087 01NOV1993 CONSULTATION AT A HOSPITAL (Professional attendance on 1 or more patients in 1 hospital on 1 occasion)each patient BRIEF CONSULTATION of not more than 5 minutes duration Y 00088 01FEB1984 Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at consulting rooms, hospital or nursing home Y 00089 01NOV1990 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration N 00089 01NOV1993 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration Y 00090 01NOV1990 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration N 00090 01NOV1993 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration Y 00091 01NOV1990 PROLONGED CONSULTATION of more than 45 minutes duration N 00091 01NOV1993 PROLONGED CONSULTATION of more than 45 minutes duration Y 00092 01NOV1990 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) - each patient BRIEF CONSULTATION of not more than 5 minutes duration N 00092 01NOV1993 CONSULTATION AT A NURSING HOME (Professional attendance on 1 or more patients in 1 nursing home including aged persons' accommodation attached to a nursing home or aged persons' accommodation situated within a complex that includes a nursing home (but excluding a professional attendance at a self contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the nursing home or aged persons' accommodation (excluding accommodation in a selfcontained unit) on 1 occasion) - each patient BRIEF CONSULTATION of not more than 5 minutes duration N 00092 01NOV2000 BRIEF CONSULTATION of not more than 5 minutes duration N 00092 01JAN2013 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of not more than 5 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies Y 00093 01NOV1990 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration N 00093 01NOV1993 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration N 00093 01JAN2013 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies Y 00094 01FEB1984 Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- each attendance subsequent to the first in a single course of treatment where that attendance is at consulting rooms, hospital or nursing home Y 00095 01NOV1990 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration N 00095 01NOV1993 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration N 00095 01JAN2013 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies Y 00096 01NOV1990 PROLONGED CONSULTATION of more than 45 minutes duration N 00096 01NOV1993 PROLONGED CONSULTATION of more than 45 minutes duration N 00096 01JAN2013 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self-contained unit) of more than 45 minutes in duration-an attendance on one or more patients at one residential aged care facility on one occasion-each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause 2.3.1 applies Y 00097 01NOV1990 EMERGENCY ATTENDANCEAFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatmenteach attendance N 00097 01NOV1996 EMERGENCY ATTENDANCEAFTER HOURS (on not more than 1 patient on 1 occasion) Professional attendance being an attendance at other than consulting rooms, by a medical practitioner (other than general practitioner) on not more than 1 patient on 1 occasion. Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatmenteach attendance N 00097 01NOV1997 (on not more than 1 patient on 1 occasion) Professional attendance after hours AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatmenteach attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday N 00097 01MAR2007 Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment Y 00098 01NOV1990 Professional attendance after hours AT CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period, where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendanceeach attendance N 00098 01NOV1996 Professional attendance being an attendance at consulting rooms, by a medical practitioner (other than a general practitioner) on not more than 1 patient on 1 occasion Professional attendance after hours AT CONSULTING ROOMS on not more than 1 patient on 1 occasion where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period, where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendanceeach attendance N 00098 01NOV1997 Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday N 00098 01MAR2007 Professional attendance AT CONSULTING ROOMS, by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment; and `)it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance Y 00099 01JUL2011 The initiation of a professional attendance via video conference by a specialist in the practice of his or her specialty, rendered to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 104 or 105. N 00099 01NOV2012 Professional attendance on a patient by a specialist practising in his or her specialty if: (a)the attendance is by video conference; and (b)the attendance is for a service: (i)provided with item 104 lasting more than 10 minutes; or (ii)provided with item 105; and (c)the patient is not an admitted patient; and (d)the patient: (i)is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii)is a care recipient in a residential care service; or (iii)is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 00099 01JAN2013 Professional attendance on a patient by a specialist practising in his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 104 lasting more than 10 minutes; or (ii) provided with item 105; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 00099 01NOV2019 Professional attendance on a patient by a specialist practising in the specialist's specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 104 lasting more than 10 minutes; or (ii) provided with item 105; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 00100 01FEB1984 Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at a place other than consulting rooms, hospital or nursing home Y 00101 01NOV1990 Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (G) Y 00102 01NOV1990 Examination of a patient in preparation for the administration of an anaesthetic, being an examination carried out at an attendance other than that at which the anaesthetic is administered (S) Y 00103 01FEB1984 Professional attendance by a specialist in the practice of his specialty where the patient is referred to him-- each attendance subsequent to the first in a single course of treatment where that attendance is at a place other than consulting rooms, hospital or nursing home Y 00104 01NOV1990 SPECIALIST, REFERRED CONSULTATIONSURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a specialist in the practice of his or her specialty where the patient is referred to him or her) INITIAL attendance in a single course of treatment N 00104 01DEC1991 SPECIALIST, REFERRED CONSULTATIONSURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment, not being a service to which item 106 applies N 00104 01NOV2000 SPECIALIST, REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment, not being a service to which item 106 applies N 00104 01MAY2006 SPECIALIST, REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment, not being a service to which item 106 or 109 apply N 00104 01JAN2010 Professional attendance at consulting rooms or hospital by a specialist in the practice of his or her specialty after referral of the patient to him or her-each attendance, other than a second or subsequent attendance, in a single course of treatment, other than a service to which item 106, 109 or 16401 applies N 00104 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist in the practice of the specialist's specialty after referral of the patient to the specialist-each attendance, other than a second or subsequent attendance, in a single course of treatment, other than a service to which item 106, 109 or 16401 applies Y 00105 01NOV1990 Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-an attendance after the first in a single course of treatment, if that attendance is at consulting rooms or hospital N 00105 01NOV2017 Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-an attendance after the first in a single course of treatment, if that attendance is at consulting rooms or hospital, other than a service to which item 16404 applies N 00105 01NOV2019 Professional attendance by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist-an attendance after the first in a single course of treatment, if that attendance is at consulting rooms or hospital, other than a service to which item 16404 applies Y 00106 01DEC1991 - INITIAL ATTENDANCE in a single course of treatment, being an attendance at which refraction is performed by a specialist ophthalmologist, and the attendance results in the issuing of a prescription for spectacles or contact lenses, including any consultation on the same occasion and any other attendance on the same day (other than a service to which items 10801 to 10816 apply) N 00106 01NOV2005 - INITIAL SPECIALIST OPHTHALMOLOGIST ATTENDANCE in a single course of treatment, being an attendance at which the sole service provided is refraction testing for the issue of a prescription for spectacles or contact lenses not being a service to which items 104 or 10801 to 10816 apply N 00106 01MAY2006 - INITIAL SPECIALIST OPHTHALMOLOGIST ATTENDANCE in a single course of treatment, being an attendance at which the sole service provided is refraction testing for the issue of a prescription for spectacles or contact lenses not being a service to which items 104, 109 or 10801 to 10816 apply N 00106 01MAY2009 Professional attendance by a specialist in the practice of his or her specialty of ophthalmology and following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment) at which the only service provided is refraction testing for the issue of a prescription for spectacles or contact lenses, if that attendance is at consulting rooms or hospital (other than a service to which any of items 104, 109 and 10801 to 10816 applies) N 00106 01NOV2019 Professional attendance by a specialist in the practice of the specialist's specialty of ophthalmology and following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment) at which the only service provided is refraction testing for the issue of a prescription for spectacles or contact lenses, if that attendance is at consulting rooms or hospital (other than a service to which any of items 104, 109 and 10801 to 10816 applies) Y 00107 01NOV1990 SPECIALIST, REFERRED CONSULTATIONHOME VISITS (Professional attendance at a place other than consulting rooms, hospital or nursing home by a specialist in the practice of his or her specialty where the patient is referred to him or her) - INITIAL attendance in a single course of treatment N 00107 01NOV2000 Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment), if that attendance is at a place other than consulting rooms or hospital N 00107 01NOV2019 Professional attendance by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment), if that attendance is at a place other than consulting rooms or hospital Y 00108 01NOV1990 Professional attendance by a specialist in the practice of his or her specialty following referral of the patient to him or her-each attendance after the first in a single course of treatment, if that attendance is at a place other than consulting rooms or hospital N 00108 01NOV2019 Professional attendance by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist-each attendance after the first in a single course of treatment, if that attendance is at a place other than consulting rooms or hospital Y 00109 01MAY2006 INITIAL SPECIALIST OPHTHALMOLOGIST PAEDIATRIC ATTENDANCE in a single course of treatment, being an attendance at which a comprehensive eye examination is performed on a child aged 8 years or under, or on a child aged 14 years or under with developmental delay, not being a service to which item 104, 106 or any of items 10801 to 10816 applies N 00109 01MAY2009 INITIAL SPECIALIST OPHTHALMOLOGIST PAEDIATRIC ATTENDANCE, REFERRED CONSULTATION in a single course of treatment, being an attendance at which a comprehensive eye examination is performed on a child aged 8 years or under, or on a child aged 14 years or under with developmental delay, not being a service to which item 104, 106 or any of items 10801 to 10816 applies N 00109 01MAR2012 Professional attendance by a specialist in the practice of his or her specialty of ophthalmology following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment) at which a comprehensive eye examination, including pupil dilation, is performed on: (a) a patient aged 9 years or younger; or (b) a patient aged 14 years or younger with developmental delay; (other than a service to which any of items 104, 106 and 10801 to 10816 applies) N 00109 01NOV2019 Professional attendance by a specialist in the practice of the specialist's specialty of ophthalmology following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment) at which a comprehensive eye examination, including pupil dilation, is performed on: (a) a patient aged 9 years or younger; or (b) a patient aged 14 years or younger with developmental delay; (other than a service to which any of items 104, 106 and 10801 to 10816 applies) Y 00110 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at consulting rooms, hospital or nursing home N 00110 01MAR1987 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment N 00110 01SEP1989 Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his/her specialty (other than psychiatry) where the patient is referred to him by a medical practitioner-initial attendance in a single course of treatment. N 00110 01NOV2000 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment N 00110 01NOV2011 Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 00110 01NOV2019 Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-initial attendance in a single course of treatment Y 00111 01NOV2017 Professional attendance at consulting rooms or in hospital by a specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $300 or more For any particular patient, once only on the same day N 00111 01JUL2019 Professional attendance at consulting rooms or in hospital by a specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day N 00111 01NOV2019 Professional attendance at consulting rooms or in hospital by a specialist in the practice of the specialist's specialty following referral of the patient to the specialist by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) during the attendance, the specialist determines the need to perform an operation on the patient that had not otherwise been scheduled; and (b) the specialist subsequently performs the operation on the patient, on the same day; and (c) the operation is a service to which an item in Group T8 applies; and (d) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day Y 00112 01JUL2011 The initiation of a professional attendance via video conference by a consultant physician in the practice of his or her specialty, rendered to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 110, 116, 119, 132 or 133. N 00112 01NOV2012 Professional attendance on a patient by a consultant physician practising in his or her specialty if: (a) the attendance is by video conference; and (b) item 110, 116, 119, 132 or 133 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 00112 01JAN2013 Professional attendance on a patient by a consultant physician practising in his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 110 lasting more than 10 minutes; or (ii) provided with item 116, 119, 132 or 133; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 00112 01NOV2019 Professional attendance on a patient by a consultant physician practising in the consultant physician's specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 110 lasting more than 10 minutes; or (ii) provided with item 116, 119, 132 or 133; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 00113 01JAN2013 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist in the practice of his or her speciality if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 00113 01NOV2019 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist in the practice of the specialist's speciality if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 00114 01JAN2013 Initial professional attendance of 10 minutes or less in duration on a patient by a consultant physician practising in his or her specialty if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 00114 01NOV2019 Initial professional attendance of 10 minutes or less in duration on a patient by a consultant physician practising in the consultant physician's specialty if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 00115 01APR2019 Professional attendance at consulting rooms or in hospital by a specialist or consultant physician in the practice of the medical practitioner's specialty after referral of the patient to the specialist or consultant physician by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) the specialist or consultant physician performs a scheduled operation on that patient on the same day; and (b) the operation is one to which an item in Group T8 of the general medical service table applies; and (c) the amount as the fee for service is the amount specified in subclause 1.2.3(2)(c) of the general medical services table; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later date. For any particular patient, once only on the same day. N 00115 01JUL2019 Professional attendance at consulting rooms or in hospital by a specialist or consultant physician in the practice of the medical practitioner's specialty after referral of the patient to the specialist or consultant physician by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) the specialist or consultant physician performs a scheduled operation on that patient on the same day; and (b) the operation is one to which an item in Group T8 applies; and (c) the amount specified in the item in Group T8 as the fee for a service to which the item applies is $304.80 or more; and (d) the attendance is unrelated to the scheduled operation; and (e) it is considered a clinical risk to defer the attendance to a later date. For any particular patient, once only on the same day. Y 00116 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- each attendance subsequent to the first in a single course of treatment where that attendance is at consulting rooms, hospital or nursing home N 00116 01MAR1987 Each attendance (other than an attendance covered by Item 119) SUBSEQUENT to the first in a single course of treatment N 00116 22DEC1987 Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 119 applies) after the first in a single course of treatment N 00116 01SEP1989 Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his/her specialty (other than psychiatry) where the patient is referred to him by a medical practitioner-each attendance (other than an attendance covered by item 119) subsequent to the first in a single course of treatment. N 00116 01NOV2019 Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each attendance (other than a service to which item 119 applies) after the first in a single course of treatment Y 00117 01NOV2017 Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $300 or more For any particular patient, once only on the same day N 00117 01JUL2019 Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day N 00117 01NOV2019 Professional attendance at consulting rooms or in hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is not a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day Y 00118 01AUG1987 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION-SURGERY, HOSPITAL OR NURSING HOME Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his speciality (other than in psychiatry) where the patient is referred to him by a medical practitioner - FOURTH OR SUBSEQUENT attendance in a single course of treatment - EACH ATTENDANCE Y 00119 22DEC1987 Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each minor attendance after the first in a single course of treatment N 00119 01SEP1989 Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his/her specialty (other than psychiatry) where the patient is referred to him by a medical practitioner-each minor attendance subsequent to the first in a single course of treatment. N 00119 01NOV2019 Professional attendance at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each minor attendance after the first in a single course of treatment Y 00120 01NOV2017 Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $300 or more For any particular patient, once only on the same day N 00120 01JUL2019 Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner - an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day N 00120 01NOV2019 Professional attendance at consulting rooms or in hospital by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-an attendance after the first attendance in a single course of treatment, if: (a) the attendance is a minor attendance; and (b) during the attendance, the consultant physician determines the need to perform an operation on the patient that had not otherwise been scheduled; and (c) the consultant physician subsequently performs the operation on the patient, on the same day; and (d) the operation is a service to which an item in Group T8 applies; and (e) the amount specified in the item in Group T8 as the fee for a service to which that item applies is $304.80 or more For any particular patient, once only on the same day Y 00122 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- an attendance (other than a second or subsequent attendance in a single course of treatment) where that attendance is at a place other than consulting rooms, hospital or nursing home N 00122 01MAR1987 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY, REFERRED CONSULTATIONHOME VISITS (Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment N 00122 01SEP1989 Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner-initial attendance in a single course of treatment. N 00122 01NOV2000 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION - HOME VISITS (Professional attendance at a place other than consulting rooms or hospital by a consultant physician in the practice of his or her specialty (other than in psychiatry) where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment N 00122 01NOV2011 Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 00122 01NOV2019 Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-initial attendance in a single course of treatment Y 00128 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty (not being psychiatry) where the patient is referred to him by a medical practitioner-- each attendance subsequent to the first in a single course of treatment where that attendance is at a place other than consulting rooms, hospital or nursing home N 00128 01MAR1987 Each attendance (other than an attendance covered by Item 131) SUBSEQUENT to the first in a single course of treatment N 00128 22DEC1987 Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 131 applies) after the first in a single course of treatment N 00128 01SEP1989 Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner-each attendance (other than an attendance covered by item 131) subsequent to the first in a single course of treatment. N 00128 01NOV2019 Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each attendance (other than a service to which item 131 applies) after the first in a single course of treatment Y 00130 01AUG1987 "CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY), REFERRED CONSULTATION - ""HOME VISITS "" Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner - FOURTH OR SUBSEQUENT attendance in a single course of treatment - EACH ATTENDANCE" Y 00131 22DEC1987 Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of his or her specialty (other than psychiatry) following referral of the patient to him or her by a referring practitioner-each minor attendance after the first in a single course of treatment N 00131 01SEP1989 Professional attendance at a place other than consulting rooms, hospital or nursing home by a consultant physician in the practice of his specialty (other than in psychiatry) where the patient is referred to him by a medical practitioner-each minor attendance subsequent to the * first in a single course of treatment. N 00131 01NOV2019 Professional attendance at a place other than consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) following referral of the patient to the consultant physician by a referring practitioner-each minor attendance after the first in a single course of treatment Y 00132 01NOV2007 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY) REFERRED PATIENT TREATMENT AND MANAGEMENT PLAN - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration for an initial assessment of a patient with at least two morbidities (this can include complex congenital, developmental and behavioural disorders), where the patient is referred by a medical practitioner, and where a) assessment is undertaken that covers: -a comprehensive history, including psychosocial history and medication review; -comprehensive multi or detailed single organ system assessment; -the formulation of differential diagnoses; and b) a consultant physician treatment and management plan of significant complexity is developed and provided to the referring practitioner that involves: -an opinion on diagnosis and risk assessment -treatment options and decisions -medication recommendations Not being an attendance on a patient in respect of whom, an attendance under items 110, 116 and 119 has been received on the same day by the same consultant physician. Not being an attendance on the patient in respect of whom, in the preceding 12 months, payment has been made under this item for attendance by the same consultant physician. N 00132 01NOV2011 Professional attendance by a consultant physician in the practice of his or her specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to him or her by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116 or 119 applies did not take place on the same day by the same consultant physician; and (d) this item has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician Not being an attendance on the patient in respect of whom, in the preceding 12 months, payment has been made under this item for attendance by the same consultant physician. N 00132 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) of at least 45 minutes in duration for an initial assessment of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) following referral of the patient to the consultant physician by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a consultant physician treatment and management plan of significant complexity is prepared and provided to the referring practitioner, which involves: (i) an opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) medication recommendations; and (c) an attendance on the patient to which item 110, 116 or 119 applies did not take place on the same day by the same consultant physician; and (d) this item has not applied to an attendance on the patient in the preceding 12 months by the same consultant physician Y 00133 01NOV2007 CONSULTANT PHYSICIAN (OTHER THAN IN PSYCHIATRY) REVIEW OF REFERRED PATIENT TREATMENT AND MANAGEMENT PLAN - SURGERY OR HOSPITAL Professional attendance of at least 20 minutes duration subsequent to the first attendance in a single course of treatment for a review of a patient with at least two morbidities (this can include complex congenital, developmental and behavioural disorders), where a) a review is undertaken that covers: - review of initial presenting problem/s and results of diagnostic investigations - review of responses to treatment and medication plans initiated at time of initial consultation comprehensive multi or detailed single organ system assessment, - review of original and differential diagnoses; and b) a modified consultant physician treatment and management plan is provided to the referring practitioner that involves, where appropriate: - a revised opinion on the diagnosis and risk assessment - treatment options and decisions - revised medication recommendations Not being an attendance on a patient in respect of whom, an attendance under item 110, 116 and 119 has been received on the same day by the same consultant physician. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 132 by the same consultant physician, payable no more than twice in any 12 month period. N 00133 01MAR2013 Professional attendance of at least 20 minutes duration subsequent to the first attendance in a single course of treatment for a review of a patient with at least two morbidities (this can include complex congenital, developmental and behavioural disorders), wherea) a review is undertaken that covers: - review of initial presenting problem/s and results of diagnostic investigations - review of responses to treatment and medication plans initiated at time of initial consultation - comprehensive multi or detailed single organ system assessment, - review of original and differential diagnoses; and b) a modified consultant physician treatment and management plan is provided to the referring practitioner that involves, where appropriate: - a revised opinion on the diagnosis and risk assessment - treatment options and decisions - revised medication recommendations   Not being an attendance on a patient in respect of whom, an attendance under item 110, 116 and 119 has been received on the same day by the same consultant physician or locum tenens.   Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 132.  Item 133 can be provided by either the same consultant physician or a locum tenens.     Payable no more than twice in any 12 month period. N 00133 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty (other than psychiatry) of at least 20 minutes in duration after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities (which may include complex congenital, developmental and behavioural disorders) if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified consultant physician treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on the diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 110, 116 or 119 applies did not take place on the same day by the same consultant physician; and (d) item 132 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same consultant physician who claimed item 132 or a locum tenens; and (f) this item has not applied more than twice in any 12 month period Y 00134 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of not more than 15 minutes duration where that attendance is at consulting rooms, hospital or nursing home N 00134 01MAR1987 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by a consultant physician in the practice of his or her specialty of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) An attendance of not more than 15 minutes duration Y 00135 01JUL2008 CONSULTANT PAEDIATRICIAN, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration by a consultant physician in his or her specialty of paediatrics, for assessment, diagnosis and the preparation of a treatment and management plan for a patient aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant paediatrician by a medical practitioner, where the consultant paediatrician: (a)undertakes a comprehensive assessment of the patient and forms a diagnosis (using theassistance of one or more allied health providers where appropriate) (b)develops a treatment and management plan that contains: (i)the outcomes of the assessment; (ii)the diagnosis or diagnoses; (iii)opinion on risk assessment; (iv)treatment options and decisions; (v)appropriate care pathways; and (vi)appropriate medication recommendations, where necessary. (c)provides a copy of the treatment and management plan to the: (i)referring practitioner; and (ii)relevant allied health providers (where appropriate). Not being an attendance on a patient in respect of whom payment has previously been made under this item or item 289. N 00135 01JUL2011 CONSULTANT PAEDIATRICIAN, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration at consulting rooms or hospital, by a consultant physician in his or her specialty of paediatrics, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant paediatrician by a medical practitioner, if the consultant paediatrician does the following: (a)undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b)develops a treatment and management plan which must include the following: (i)the outcomes of the assessment; (ii)the diagnosis or diagnoses; (iii)opinion on risk assessment; (iv)treatment options and decisions; (v)appropriate medication recommendations, where necessary. (c)provides a copy of the treatment and management plan to the: (i)referring practitioner; and (ii)relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 137, 139 or 289. N 00135 01NOV2011 Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 137, 139 or 289) N 00135 01NOV2019 Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of the consultant physician's specialty of paediatrics, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient aged under 13 years with autism or another pervasive developmental disorder, if the consultant paediatrician does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medical recommendations; (c) provides a copy of the treatment and management plan to: (i) the referring practitioner; and (ii) one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 137, 139 or 289) Y 00136 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 15 minutes duration but not more than 30 minutes duration where that attendance is at consulting rooms, hospital or nursing home N 00136 01MAR1987 An attendance of more than 15 minutes duration but not more than 30 minutes duration Y 00137 01JUL2011 SPECIALIST OR CONSULTANT PHYSICIAN, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR A CHILD WITH AN ELIGIBLE DISABILITY - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration, at consulting rooms or hospital, by a specialist or consultant physician, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with an eligible disability, who has been referred to the specialist or consultant physician by a medical practitioner, if the specialist or consultant physician does the following: (a)undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b)develops a treatment and management plan which must include the following: (i)the outcomes of the assessment; (ii)the diagnosis or diagnoses; (iii)opinion on risk assessment; (iv)treatment options and decisions; (v)appropriate medication recommendations, where necessary. (c)provides a copy of the treatment and management plan to the: (i)referring practitioner; and (ii)relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 135, 139 or 289. N 00137 01NOV2011 Professional attendance of at least 45 minutes duration, at consulting rooms or hospital, by a specialist or consultant physician, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with an eligible disability, who has been referred to the specialist or consultant physician by a referring practitioner, if the specialist or consultant physician does the following: (a)undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b)develops a treatment and management plan which must include the following: (i)the outcomes of the assessment; (ii)the diagnosis or diagnoses; (iii)opinion on risk assessment; (iv)treatment options and decisions; (v)appropriate medication recommendations, where necessary. (c)provides a copy of the treatment and management plan to the: (i)referring practitioner; and (ii)relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 135, 139 or 289. Y 00138 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 30 minutes duration but not more than 45 minutes duration where that attendance is at consulting rooms, hospital or nursing home N 00138 01MAR1987 An attendance of more than 30 minutes duration but not more than 45 minutes duration Y 00139 01JUL2011 Professional attendance of at least 45 minutes in duration at consulting rooms only, by a general practitioner (not including a specialist or consultant physician) for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with an eligible disability if the general practitioner does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan, which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137 or 289) Y 00140 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 45 minutes duration but not more than 75 minutes duration where that attendance is at consulting rooms, hospital or nursing home N 00140 01MAR1987 An attendance of more than 45 minutes duration but not more than 75 minutes duration Y 00141 01NOV2007 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician), where the attendance is initiated by the medical practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at consulting rooms or hospital during which: (*)the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriately validated assessment tools where indicated ('assessment'), (*)the patient's various health problems and care needs are identified and prioritised ('formulation'), (*)a detailed management plan is developed ('management plan'), (*)the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, and (*)the management plan is communicated in writing to the referring medical practitioner. The management plan should include: (*)the prioritised list of health problems and care needs, (*)short and longer term management goals, (*)recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: -likely to improve or maintain health status, -readily available, and -acceptable to the patient, their family and carer(s). Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or item 145 by the same practitioner. N 00141 01NOV2011 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner, where the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at consulting rooms or hospital during which: (*)the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriately validated assessment tools where indicated ('assessment'), (*)the patient's various health problems and care needs are identified and prioritised ('formulation'), (*)a detailed management plan is developed ('management plan'), (*)the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, and (*)the management plan is communicated in writing to the referring practitioner. The management plan should include: (*)the prioritised list of health problems and care needs, (*)short and longer term management goals, (*)recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: -likely to improve or maintain health status, -readily available, and -acceptable to the patient, their family and carer(s). Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or item 145 by the same practitioner. N 00141 01JUL2013 Professional attendance of more than 60 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patient's family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months N 00141 01NOV2019 Professional attendance of more than 60 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail using appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient and the patient's family and carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 145 applies has not been provided to the patient by the same practitioner in the preceding 12 months Y 00142 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-- an attendance of more than 75 minutes duration where that attendance is at consulting rooms, hospital or nursing home N 00142 01MAR1987 An attendance of more than 75 minutes duration Y 00143 01NOV2007 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under item 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes duration at consulting rooms or hospital where that attendance follows item 141 or 145 and during which: (*)the patient's health status is reassessed, (*)a management plan provided under items 141 or 145 is reviewed and revised, (*)the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the referring medical practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review. N 00143 01NOV2011 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under item 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice or participating practice nurse. An attendance of more than 30 minutes duration at consulting rooms or hospital where that attendance follows item 141 or 145 and during which: (*)the patient's health status is reassessed, (*)a management plan provided under items 141 or 145 is reviewed and revised, (*)the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the referring practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review. N 00143 01JUL2013 Professional attendance of more than 30 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review N 00143 01NOV2019 Professional attendance of more than 30 minutes in duration at consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under item 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies was not provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or item 147 applies has not been provided to the patient in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review Y 00144 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of not more than 15 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home N 00144 01MAR1987 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATIONHOME VISITS (Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY where the patient is referred to him or her by a medical practitionerwhere that attendance is at a place other than consulting rooms, hospital or nursing home) An attendance of not more than 15 minutes duration Y 00145 01NOV2007 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and has been referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician), where the attendance is initiated by the medical practitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at a place other than consulting rooms or hospital during which: (*)the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriatelyvalidated assessment tools where indicated ('assessment'), (*)the patient's various health problems and care needs are identified and prioritised ('formulation'), (*)a detailed management plan is developed ('management plan'), (*)the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, (*)the management plan is communicated in writing to the referring medical practitioner. The management plan should include: (*)the prioritised list of health problems and care needs, (*)short and longer term management goals, (*)recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: -likely to improve or maintain health status -readily available -acceptable to the patient, their family and carer(s) Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or 141 by the same practitioner. N 00145 01NOV2011 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, where the patient is at least 65 years old and has been referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or participating nurse practitioner, where the attendance is initiated by thepractitioner for the provision of a comprehensive assessment and management plan. An attendance of more than 60 minutes at a place other than consulting rooms or hospital during which: (*)the medical, physical, psychological and social aspects of the patient's health are evaluated in detail, utilising appropriatelyvalidated assessment tools where indicated ('assessment'), (*)the patient's various health problems and care needs are identified and prioritised ('formulation'), (*)a detailed management plan is developed ('management plan'), (*)the management plan is explained and discussed with the patient and/or their family and carer(s) where appropriate, (*)the management plan is communicated in writing to the referring practitioner. The management plan should include: (*)the prioritised list of health problems and care needs, (*)short and longer term management goals, (*)recommended actions or intervention strategies to be undertaken by the patient's general practitioner or other relevant health care providers that are: -likely to improve or maintain health status -readily available -acceptable to the patient, their family and carer(s) Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item or 141 by the same practitioner. N 00145 01JUL2013 Professional attendance of more than 60 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail utilising appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies, to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient, the patient's family and any carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 141 applies has not been provided to the patient by the same practitioner in the preceding 12 months N 00145 01NOV2019 Professional attendance of more than 60 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine, if: (a) the patient is at least 65 years old and referred by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or a participating nurse practitioner; and (b) the attendance is initiated by the referring practitioner for the provision of a comprehensive assessment and management plan; and (c) during the attendance: (i) the medical, physical, psychological and social aspects of the patient's health are evaluated in detail utilising appropriately validated assessment tools if indicated (the assessment); and (ii) the patient's various health problems and care needs are identified and prioritised (the formulation); and (iii) a detailed management plan is prepared (the management plan) setting out: (A) the prioritised list of health problems and care needs; and (B) short and longer term management goals; and (C) recommended actions or intervention strategies, to be undertaken by the patient's general practitioner or another relevant health care provider that are likely to improve or maintain health status and are readily available and acceptable to the patient, the patient's family and any carers; and (iv) the management plan is explained and discussed with the patient and, if appropriate, the patient's family and any carers; and (v) the management plan is communicated in writing to the referring practitioner; and (d) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (e) an attendance to which this item or item 141 applies has not been provided to the patient by the same practitioner in the preceding 12 months Y 00146 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 15 minutes duration but not more than 30 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home N 00146 01MAR1987 An attendance of more than 15 minutes duration but not more than 30 minutes duration Y 00147 01NOV2007 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under items 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes duration at a place other than consulting rooms or hospital where that attendance follows items 141 or 145 and during which: (*)the patient's health status is reassessed, (*)a management plan provided under items 141 or 145 is reviewed and revised, (*)the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the medical practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review. N 00147 01NOV2011 CONSULTANT PHYSICIAN OR SPECIALIST IN GERIATRIC MEDICINE, REVIEW OF REFERRED PATIENT, INITIAL COMPREHENSIVE ASSESSMENT AND MANAGEMENT - HOME VISITS Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist in geriatric medicine and claimed under items 141 or 145, where the review is initiated by the referring medical practitioner practising in general practice or participating practice nurse. An attendance of more than 30 minutes duration at a place other than consulting rooms or hospital where that attendance follows items 141 or 145 and during which: (*)the patient's health status is reassessed, (*)a management plan provided under items 141 or 145 is reviewed and revised, (*)the revised management plan is explained to the patient and/or their family and carer(s) and communicated in writing to the referring practitioner. Not being an attendance on a patient in respect of whom, an attendance under items 104, 105, 107, 108, 110, 116 and 119 has been received on the same day by the same practitioner. Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under items 141 or 145 by the same practitioner, payable no more than once in any 12 month period, except for where there has been a significant change in the patient's clinical condition or care circumstances that requires a further review. N 00147 01JUL2013 Professional attendance of more than 30 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of his or her specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under items 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan that was prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or 143 applies has not been provided by the same practitioner in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review N 00147 01NOV2019 Professional attendance of more than 30 minutes in duration at a place other than consulting rooms or hospital by a consultant physician or specialist in the practice of the consultant physician's or specialist's specialty of geriatric medicine to review a management plan previously prepared by that consultant physician or specialist under items 141 or 145, if: (a) the review is initiated by the referring medical practitioner practising in general practice or a participating nurse practitioner; and (b) during the attendance: (i) the patient's health status is reassessed; and (ii) a management plan that was prepared under item 141 or 145 is reviewed and revised; and (iii) the revised management plan is explained to the patient and (if appropriate) the patient's family and any carers and communicated in writing to the referring practitioner; and (c) an attendance to which item 104, 105, 107, 108, 110, 116 or 119 applies has not been provided to the patient on the same day by the same practitioner; and (d) an attendance to which item 141 or 145 applies has been provided to the patient by the same practitioner in the preceding 12 months; and (e) an attendance to which this item or 143 applies has not been provided by the same practitioner in the preceding 12 months, unless there has been a significant change in the patient's clinical condition or care circumstances that requires a further review Y 00148 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 30 minutes duration but not more than 45 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home N 00148 01MAR1987 An attendance of more than 30 minutes duration but not more than 45 minutes duration Y 00149 01JUL2011 The initiation of a professional attendance via video conference rendered by a consultant physician or specialist practising in the specialty of geriatric medicine to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 141 or 143. N 00149 01NOV2012 Professional attendance on a patient by a consultant physician or specialist practising in his or her specialty of geriatric medicine if: (a) the attendance is by video conference; and (b) item 141 or 143 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the physician or specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 00149 01JAN2013 Professional attendance on a patient by a consultant physician or specialist practising in his or her specialty of geriatric medicine if: (a) the attendance is by video conference; and (b) item 141 or 143 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician or specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies N 00149 01NOV2019 Professional attendance on a patient by a consultant physician or specialist practising in the consultant physician's or specialist's specialty of geriatric medicine if: (a) the attendance is by video conference; and (b) item 141 or 143 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician or specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies Y 00150 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 45 minutes duration but not more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home N 00150 01MAR1987 An attendance of more than 45 minutes duration but not more than 75 minutes duration Y 00152 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner-an attendance of more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home Y 00153 01DEC1991 ELECTROCONVULSIVE THERAPY, including associated consultation (AU 3 - 17903) Y 00154 01DEC1991 CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including associated consultation) of not less than ONE hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. -GROUP PSYCHOTHERAPY on a group of 2-9 patients OR FAMILY GROUP psychotherapy on a group of more than THREE patients, EACH PATIENT Y 00155 01DEC1991 CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including associated consultation) of not less than ONE hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. - FAMILY GROUP PSYCHOTHERAPY on a group of three patients, EACH PATIENT Y 00156 01DEC1991 CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including associated consultation) of not less than ONE hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. - FAMILY GROUP PSYCHOTHERAPY on a group of two patients, EACH PATIENT Y 00157 01DEC1991 CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR NURSING HOME Professional attendance by a consultant psychiatrist in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or nursing home Y 00158 01DEC1991 CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR NURSING HOME Professional attendance by a consultant psychiatrist in the practice of his or her recognised specialty of psychiatry where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of notless than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or nursing home Y 00159 01NOV1992 CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT. Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration, in the course of continuing management of a patient - payable not more than twice in any twelve month period. Y 00160 01FEB1984 Professional attendance for a period of not less than 1 hour but less than 2 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients N 00160 01MAR1987 PROLONGED PROFESSIONAL ATTENDANCES (Professional attendance (not being a service to which another item in this Category applies) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients) For a period of not less than 1 hour but less than 2 hours N 00160 01SEP1989 Professional attendance for a period of not less than 1 hour but less than 2 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients N 00160 01MAY1997 Professional attendance for a period of not less than 1 hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death N 00160 01JUL2018 Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 1 hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00161 01FEB1984 Professional attendance for a period of not less than 2 hours but less than 3 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients N 00161 01MAR1987 For a period of not less than 2 hours but less than 3 hours N 00161 01SEP1989 Professional attendance for a period of not less than 2 hours but less than 3 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients N 00161 01MAY1997 Professional attendance for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death N 00161 01JUL2018 Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00162 01FEB1984 Professional attendance for a period of not less than 3 hours but less than 4 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients N 00162 01MAR1987 For a period of not less than 3 hours but less than 4 hours N 00162 01SEP1989 Professional attendance for a period of not less than 3 hours but less than 4 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients N 00162 01MAY1997 Professional attendance for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death N 00162 01JUL2018 Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00163 01FEB1984 Professional attendance for a period of not less than 4 hours but less than 5 hours on a patient in a critical condition that requires constant attention to the exclusion of all other patients N 00163 01MAR1987 For a period of not less than 4 hours but less than 5 hours N 00163 01SEP1989 Professional attendance for a period of not less than 4 hours but less than 5 hours (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients N 00163 01MAY1997 Professional attendance for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death N 00163 01JUL2018 Professional attendance by a general practitioner, specialist or consultant physician for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00164 01FEB1984 Professional attendance for a period of 5 hours or more on a patient in a critical condition that requires constant attention to the exclusion of all other patients N 00164 01MAR1987 For a period of 5 hours or more N 00164 01SEP1989 Professional attendance for a period of 5 hours or more (not being an attendance covered by any other item in this Part) on a patient in imminent danger of death requiring continuous life saving emergency treatment (not being treatment of a counselling nature) to the exclusion of all other patients N 00164 01MAY1997 Professional attendance for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death N 00164 01JUL2018 Professional attendance by a general practitioner, specialist or consultant physician for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death Y 00170 01AUG1987 Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 2 patients N 00170 01SEP1989 Professional attendance for the purpose of group therapy of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family-each group of two patients N 00170 01JUL2018 Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of his or her speciality of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 2 patients N 00170 01NOV2019 Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of the consultant physician's specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each group of 2 patients Y 00171 01AUG1987 Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 3 patients N 00171 01SEP1989 Professional attendance for the purpose of group therapy of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family-each group of three patients N 00171 01JUL2018 Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 3 patients N 00171 01NOV2019 Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of the consultant physician's specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each group of 3 patients Y 00172 01AUG1987 Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 4 or more patients N 00172 01SEP1989 Professional attendance for the purpose of group therapy of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family-each group of four or more patients N 00172 01JUL2018 Professional attendance for the purpose of Group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of his or her specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each Group of 4 or more patients N 00172 01NOV2019 Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a general practitioner, specialist or consultant physician (other than a consultant physician in the practice of the consultant physician's specialty of psychiatry) involving members of a family and persons with close personal relationships with that family-each group of 4 or more patients Y 00173 01DEC1991 ATTENDANCE at which ACUPUNCTURE is performed by a medical practitioner by application of stimuli on or through the surface of the skin by any means, including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00173 01MAY2010 Professional attendance at which acupuncture is performed by a medical practitioner by application of stimuli on or through the surface of the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture was performed Y 00177 01APR2019 Professional attendance for a heart health assessment by a medical practitioner (other than a specialist or consultant physician) at consulting rooms lasting at least 20 minutes and must include:(a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status, cholesterol status (if not performed within the last 12 months) and blood glucose;(b) a physical examination, which must include recording of blood pressure;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors;with appropriate documentation.   N 00177 01NOV2019 Professional attendance for a heart health assessment by amedical practitioner (other than a specialist or consultant physician)at consulting rooms lasting at least 20 minutes and must include:(a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status and blood glucose;(b) a physical examination, which must include recording of blood pressure and cholesterol status;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors; with appropriate documentation. Claimable once only in a 12 month period.The heart health assessment item cannot be claimed if a patient has had a health assessment service(items 224, 225, 226, 227, 228) in the previous 12 months. Y 00179 01JUL2018 Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which any other item applies) - each attendance, by a medical practitioner in an eligible area. Y 00180 01FEB1984 Professional attendance by a participating optometrist-an attendance that is the sole or first attendance in a single course of attention that commenced on or after the proclaimed date, being-(a) the first or only course of attention of the patient by a participating optometrist since the proclaimed date; or (b) the second or a subsequent course of attention of the patient by a participating optometrist since the proclaimed date, being a course of attention commencing not earlier than 12 months after the commencement of the preceding course of attention N 00180 01MAR1984 Professional attendance by a participating optometrist - an attendance that is the sole or first attendance in a single course of attention that commenced on or after 1 July 1975, being - (a) the first or only course of attention of the patient by a participating optometrist since 1 July 1975; or (b) the second or a subsequent course of attention of the patient by a participating optometrist since 1 July 1975, being the sole course of attention in any calender year N 00180 01SEP1989 Professional attendance by a participating optometrist that is the sole or first attendance in a single course of attention of a patient. The Medicare benefit is payable in respect of attendances by a participating optometrist at, or operating from, the same practice location, only once in a period of twenty four consecutive months unless the examining optometrist has certified that, in his professional opinion, the patient had an ocular condition which necessitated a further course of attention being commenced within twenty four months of the previous initial consultation Y 00181 01JUL2018 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies), not more than 5 minutes in duration - an attendance on one or more patients at one place on one occasion - each patient, by a medical practitioner in an eligible area Y 00182 01FEB1984 Professional attendance by a participating optometrist-- an attendance (not being an attendance covered by Item 186) that is the second attendance in a single course of attention in respect of which the first attendance is covered by Item 180 N 00182 01SEP1989 Professional attendance by a participating optometrist (not being an attendance relating to the prescription and fitting of contact lenses) that is the second attendance in a single course of attention in respect of which the first attendance is covered by item 180 Y 00183 01JUL2018 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of not more than 5 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by medical practitioner in an eligible area Y 00184 01FEB1984 Professional attendance by a participating optometrist-- an attendance (not being an attendance covered by Item 186) that is the third or a subsequent attendance in a single course of attention of a patient, who, in the professional opinion of the attending optometrist, has a need for that attendance, being a course of attention in respect of which the first attendance is covered by Item 180 N 00184 01SEP1989 Professional attendance by a participating optometrist (not being an attendance relating to the prescription and fitting of contact lenses) that is the third or a subsequent attendance in a single course of attention of a patient in respect of whom the attending optometrist has certified on the patient's account that, in his professional opinion, there is a need for that attendance, being a course of attention in respect of which the first attendance is covered by item 180 Y 00185 01JUL2018 Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes (other than a service to which any other item applies) - each attendance, by a medical practitioner in an eligible area Y 00186 01FEB1984 Professional attendance by a participating optometrist-- all attendances after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is covered by Item 180 N 00186 01SEP1989 Professional attendances by a participating optometrist after the first, being those attendances regarded as a single service, in a single course of attention involving the prescription and fitting of contact lenses, being a course of attention in respect of which the first attendance is covered by Item 180. The Medicare benefit is payable only once in a period of thirty six consecutive months unless the examining optometrist has certified on the patient's account that, in his professional opinion, the patient had an ocular condition which necessitated a further course of attention being commenced within thirty six months of the previous initial consultation Y 00187 01JUL2018 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 5 minutes in duration but not more than 25 minutes - an attendance on one or more patients at one place on one occasion - each patient, by a medical practitioner in an eligible area Y 00188 01JUL2018 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of more than 5 minutes in duration but not more than 25 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner in an eligible area Y 00189 01JUL2018 Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes (other than a service to which any other item applies) - each attendance, by a medical practitioner in an eligible area Y 00190 01FEB1984 Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the attendances do not exceed ten-- each attendance N 00190 01MAR1984 Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the attendances do not exceed ten - each attendance N 00190 01MAR1987 ANTENATAL CARE (not including any service or services covered by Item 204 or 205) where the attendances do not exceed teneach attendance Y 00191 01JUL2018 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 25 minutes in duration but not more than 45 minutes - an attendance on one or more patients at one place on one occasion - each patient, by a medical practitioner in an eligible area Y 00192 01FEB1984 Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the attendances exceed ten N 00192 01MAR1984 Antenatal care (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the attendances exceed ten N 00192 01MAR1987 ANTENATAL CARE (not including any service or services covered by Item 204 or 205) where attendances exceed ten Y 00193 01NOV1998 Professional attendance by a general practitioner at a place other than a hospital, involving either: (i)taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii)a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00193 01NOV2003 Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, involving either: (i)taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii)a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00193 01MAY2010 Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed Y 00194 01FEB1984 Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the medical practitioner has not given the antenatal care (G) N 00194 01MAR1984 Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the medical practitioner has not given the antenatal care (G) N 00194 01NOV1986 CONFINEMENT AND POSTNATAL CARE for nine days (not including any service or services covered by Item 204 or 205 or by any item in Division 2 of this Part) where the medical practitioner has not given the antenatal care (G) N 00194 01SEP1989 Confinement and postnatal care for nine days where the medical practitioner has not given the antenatal care (G) Y 00195 01NOV1998 Professional attendance by a general practitioner on 1 or more patients at a hospital, on one occasion, involving either: (i)taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii)a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00195 01NOV2003 Professional attendance by a general practitioner who is a qualified medical acupuncturist, on 1 or more patients at a hospital, on one occasion, involving either: (i)taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems; OR (ii)a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00195 01MAY2010 CONSULTATION AT A HOSPITAL Consultation by a general practitioner, who is a qualified medical acupuncturist at a hospital on one or more patients on one occasion at which ACUPUNCTURE is performed by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed. N 00195 01JAN2013 Professional attendance by a general practitioner who is a qualified medical acupuncturist, on one or more patients at a hospital, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed Y 00196 01FEB1984 Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2) where the medical practitioner has not given the antenatal care (S) N 00196 01MAR1984 Confinement and postnatal care for nine days (not including any service or services covered by Item 200 or 207 or by any item in Division 2 of this Part) where the medical practitioner has not given the antenatal care (S) N 00196 01SEP1989 Confinement and postnatal care for nine days where the medical practitioner has not given the antenatal care (S) Y 00197 01MAY2003 Professional attendance by a general practitioner at a place other than a hospital, involving either: (i)taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes; OR (ii)a professional attendance of at least 20 minutes but less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00197 01NOV2003 Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, involving either: (i)taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes; OR (ii)a professional attendance of at least 20 minutes but less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00197 01MAY2010 Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed Y 00198 01FEB1984 Confinement as an independent procedure, including all related attendances (S) Y 00199 01MAY2003 Professional attendance by a general practitioner at a place other than a hospital, involving either: (i)taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems and lasting a least 40 minutes; OR (ii)a professional attendance of at least 40 minutes duration for implementation of a management plan AND at which ACUPUNCTURE is performed by the medical practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00199 01NOV2003 Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, involving either: (i)taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems and lasting a least 40 minutes; OR (ii)a professional attendance of at least 40 minutes duration for implementation of a management plan AND at which ACUPUNCTURE is performed by the general practitioner by the application of stimuli on or through the surface of the skin by any means; including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed N 00199 01MAY2010 Professional attendance by a general practitioner who is a qualified medical acupuncturist, at a place other than a hospital, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, at which acupuncture is performed by the qualified medical acupuncturist by the application of stimuli on or through the skin by any means, including any consultation on the same occasion and another attendance on the same day related to the condition for which the acupuncture is performed Y 00200 01FEB1984 Antenatal care, confinement and postnatal care for nine days (not including services covered by Division 2) (G) N 00200 01MAR1984 Antenatal care, confinement and postnatal care for nine days(not including services covered by Division 2 of this Part) (G) Y 00201 01AUG1987 CONFINEMENT, incomplete, with or without postnatal care for nine-days where the patient is referred to a specialist for completion of the confinement N 00201 01SEP1989 Confinement, incomplete, with or without postnatal care for nine days where the patient is referred to a specialist in the practice of his or her specialty or the patient's care is transferred to another medical practitioner for completion of the delivery Y 00202 01JUL2018 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of more than 25 minutes in duration but not more than 45 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner in an eligible area Y 00203 01JUL2018 Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which any other item applies) - each attendance, by a medical practitioner in an eligible area Y 00204 01AUG1987 ANTENATAL CARE, CONFINEMENT AND POSTNATAL CARE for nine days (G) N 00204 01SEP1989 Antenatal care, confinement with delivery by any means (including Caesarean section) and postnatal care for nine days (G) Y 00205 01AUG1987 ANTENATAL CARE, CONFINEMENT AND POSTNATAL CARE for nine days (S) N 00205 01SEP1989 Antenatal care, confinement with delivery by any means (including Caesarean section) and postnatal care for nine days (S) Y 00206 01JUL2018 Professional attendance (other than an attendance at consulting rooms or a residential aged care facility or a service to which any other item in the table applies) of more than 45 minutes in duration - an attendance on one or more patients at one place on one occasion - each patient, by a medical practitioner in an eligible area Y 00207 01FEB1984 Antenatal care, confinement and postnatal care for nine days (not including services covered by Division 2) (S) N 00207 01MAR1984 Antenatal care, confinement and postnatal care for nine days(not including services covered by Division 2 of this Part) (S) Y 00208 01FEB1984 Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2) (G) N 00208 01MAR1984 Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2 of this Part) (G) Y 00209 01FEB1984 Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2) (S) N 00209 01MAR1984 Antenatal care, confinement and postnatal care for nine days with mid-cavity forceps or vacuum extraction, breech delivery or management of multiple delivery (including any service or services covered by Item 295, 298 or 360 where performed at the time of delivery but not including any other service or services covered by Division 2 of this Part) (S) Y 00210 01AUG1987 CAESAREAN SECTION and postnatal care for nine days where the patient has been referred for management of the confinement and the practitioner does not provide the antenatal care N 00210 01SEP1989 Caesarean section and postnatal care for nine days where the patient has been referred to a specialist in the practice of his or her specialty or the patient's care has been transferred to another medical practitioner for management of the confinement and the practitioner who performed the Caesarean section did not provide the antenatal care Y 00211 01FEB1984 Antenatal care, confinement and postnatal care for nine days with surgical induction of labour (G) Y 00212 01JUL2018 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self contained unit) of more than 45 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner in an eligible area Y 00213 01FEB1984 Antenatal care, confinement and postnatal care for nine days with surgical induction of labour (S) Y 00214 01JUL2018 Professional attendance by a medical practitioner for a period of not less than 1 hour but less than 2 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00215 01JUL2018 Professional attendance by a medical practitioner for a period of not less than 2 hours but less than 3 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00216 01FEB1984 Antenatal care, confinement and postnatal care for nine days with surgical induction of labour; including major regional or field block (G) Y 00217 01FEB1984 Antenatal care, confinement and postnatal care for nine days with surgical induction of labour; including major regional or field block (S) Y 00218 01JUL2018 Professional attendance by a medical practitioner for a period of not less than 3 hours but less than 4 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00219 01JUL2018 Professional attendance by a medical practitioner for a period of not less than 4 hours but less than 5 hours (other than a service to which another item applies) on a patient in imminent danger of death Y 00220 01JUL2018 Professional attendance by a medical practitioner for a period of 5 hours or more (other than a service to which another item applies) on a patient in imminent danger of death Y 00221 01JUL2018 Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner involving members of a family and persons with close personal relationships with that family - each Group of 2 patients Y 00222 01JUL2018 Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner involving members of a family and persons with close personal relationships with that family - each Group of 3 patients Y 00223 01JUL2018 Professional attendance for the purpose of group therapy of not less than 1 hour in duration given under the direct continuous supervision of a medical practitioner involving members of a family and persons with close personal relationships with that family - each Group of 4 or more patients Y 00224 01JUL2018 Professional attendance by a medical practitioner to perform a brief health assessment, lasting not more than 30 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing the patient with preventive health care advice and information Y 00225 01JUL2018 Professional attendance by a medical practitioner to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including: (a) detailed information collection, including taking a patient history; and (b) an extensive physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing a preventive health care strategy for the patient Y 00226 01JUL2018 Professional attendance by a medical practitioner to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition and physical function; and (c) initiating interventions and referrals as indicated; and (d) providing a basic preventive health care management plan for the patient Y 00227 01JUL2018 Professional attendance by a medical practitioner to perform a prolonged health assessment (lasting at least 60 minutes) including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition, and physical, psychological and social function; and (c) initiating interventions or referrals as indicated; and (d) providing a comprehensive preventive health care management plan for the patient Y 00228 01JUL2018 Professional attendance by a medical practitioner at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent - this item or item 715 not more than once in a 9 month period Y 00229 01JUL2018 Attendance by a medical practitioner, for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items735 to 758 and items 235 to 240 apply) Y 00230 01JUL2018 Attendance by a medical practitioner, to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 and items 235 to 240 apply) Y 00231 01JUL2018 Contribution by a medical practitioner, to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 and items 235 to 240 apply) Y 00232 01JUL2018 Contribution by a medical practitioner, to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items735 to 758 and items 235 to 240 apply) Y 00233 01JUL2018 Attendance by a medical practitioner to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item721 or item 229 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item723 or item 230 applies Y 00234 01FEB1984 Caesarean section and postnatal care for nine days (G) (AU 10) Y 00235 01JUL2018 Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items721 to 732 or items 229 to 233 apply) Y 00236 01JUL2018 Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items721 to 732 or items 229 to 233 apply) Y 00237 01JUL2018 Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items721 to 732 or items 229 to 233 apply) Y 00238 01JUL2018 Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items721 to 732 or items 229 to 233 apply) Y 00239 01JUL2018 Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items721 to 732 or items 229 to 233 apply) Y 00240 01JUL2018 Attendance by a medical practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items721 to 732 or items 229 to 233 apply) Y 00241 01FEB1984 Caesarean section and postnatal care for nine days (S) (AU 10) Y 00242 01FEB1984 Treatment of habitual miscarriage by injection of hormones-- each injection up to a maximum of twelve injections, where the injection is not administered during a routine antenatal attendance Y 00243 01JUL2018 Attendance by a medical practitioner, as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers Y 00244 01JUL2018 Attendance by a medical practitioner, as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers Y 00245 01JUL2018 Participation by a medical practitioner in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the medical practitioner, with the patient's consent: (a) assesses the patient as: (i) having a chronic medical condition or a complex medication regimen; and (ii) not having their therapeutic goals met; and (b) following that assessment: (i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and (ii) provides relevant clinical information required for the DMMR; and (c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and (d) develops a written medication management plan following discussion with the patient; and (e) provides the written medication management plan to a community pharmacy chosen by the patient For any particular patient - this item or item 900 is applicable not more than once in each 12 month period, except if there has been a significant change in the patient's condition or medication regimen requiring a new DMMR Y 00246 01FEB1984 Threatened abortion, threatened miscarriage or hyperemesis gravidarum, requiring admission to hospital, treatment of-- each attendance that is not a routine antenatal attendance Y 00247 01AUG1987 Intra-uterine growth retardation, polyhydramnios, unstable lie, multiple pregnancy, pregnancy complicated by diabetes or anaemia, threatened premature labour treated by bed rest only or oral medication, requiring admission to hospital - each attendance that is not a routine antenatal attendance, to a maximum of two attendances in any seven day period N 00247 01SEP1989 Polyhydramnios, unstable lie, multiple pregnancy, pregnancy complicated by diabetes or anaemia, threatened premature labour treated by bed rest only or oral medication, requiring admission to hospital-each attendance that is not a routine antenatal attendance, to a maximum of two attendances in any seven day period Y 00248 01AUG1987 Pregnancy complicated by acute intercurrent infection, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital - each attendance that is not a routine antenatal attendance, to a maximum of one visit per day N 00248 01SEP1989 Pregnancy complicated by acute intercurrent infection, intrauterine growth retardation, threatened premature labour with ruptured membranes or threatened premature labour treated by intravenous therapy, requiring admission to hospital-each attendance that is not a routine antenatal attendance, to a maximum of one visit per day Y 00249 01JUL2018 Participation by a medical practitioner in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility - other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item or item 903 has applied, unless there has been a significant change in the resident's medical condition or medication management plan requiring a new RMMR Y 00250 01FEB1984 Cervix, purse string ligation of, for threatened miscarriage (G) (AU 6) Y 00251 01JUL2018 Professional attendance at consulting rooms of less than 5 minutes in duration by a medical practitioner in an eligible area at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00252 01JUL2018 Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00253 01JUL2018 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00254 01JUL2018 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00255 01JUL2018 Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00256 01JUL2018 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00257 01JUL2018 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 00258 01FEB1984 Cervix, purse string ligation of, for threatened miscarriage (S) (AU 6) Y 00259 01JUL2018 Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 00260 01JUL2018 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 00261 01JUL2018 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the requirements for a cycle of care of a patient with established diabetes mellitus Y 00262 01JUL2018 Professional attendance at a place other than consulting rooms of more than 25 minutes but not more than 45 minutes, in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 00263 01JUL2018 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 00264 01JUL2018 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 00265 01JUL2018 Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care Y 00266 01JUL2018 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care Y 00267 01FEB1984 Cervix, removal of purse string ligature of, under general anaesthesia (AU 5) Y 00268 01JUL2018 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care Y 00269 01JUL2018 Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care Y 00270 01JUL2018 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care Y 00271 01JUL2018 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner in an eligible area, that completes the minimum requirements of the Asthma Cycle of Care Y 00272 01JUL2018 Professional attendance by a medical practitioner (who has not undertaken mental health skills training) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 00273 01FEB1984 Pre-eclampsia, eclampsia or antepartum haemorrhage, treatment of-- each attendance that is not a routine antenatal attendance Y 00274 01FEB1984 Induction and management of second trimester labour (G) N 00274 01SEP1989 Management of second trimester labour, with or without induction (G) Y 00275 01FEB1984 Induction and management of second trimester labour (S) N 00275 01SEP1989 Management of second trimester labour, with or without induction (S) Y 00276 01JUL2018 Professional attendance by a medical practitioner (who has not undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 00277 01JUL2018 Professional attendance by a medical practitioner to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan Y 00278 01FEB1984 Amnioscopy or amniocentesis Y 00279 01JUL2018 Professional attendance by a medical practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation Y 00280 01AUG1988 Chorionic villus sampling including any associated imaging Y 00281 01JUL2018 Professional attendance by a medical practitioner (who has undertaken mental health skills training) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 00282 01JUL2018 Professional attendance by a medical practitioner (who has undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 00283 01JUL2018 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes Y 00284 01FEB1984 Amnioscopy with surgical induction of labour (AU 6) Y 00285 01JUL2018 Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes Y 00286 01JUL2018 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes Y 00287 01JUL2018 Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes Y 00288 01JUL2011 The initiation of a professional attendance via video conference rendered by a consultant physician practising in the specialty of psychiatry to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352. N 00288 01NOV2012 Professional attendance on a patient by a consultant physician practising in his or her specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 00288 01JAN2013 Professional attendance on a patient by a consultant physician practising in his or her specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 00288 01NOV2019 Professional attendance on a patient by a consultant physician practising inthe consultant physician's specialty of psychiatry if: (a) the attendance is by video conference; and (b) item 291, 293, 296, 300, 302, 304, 306, 308, 310, 312, 314, 316, 318, 319, 348, 350 or 352 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 00289 01JUL2008 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration by a consultant physician in his or her specialty of psychiatry, for assessment, diagnosis and the preparation of a treatment and management plan for a patient aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant psychiatrist by a medical practitioner, where the consultant psychiatrist: (a)undertakes a comprehensive assessment of the patient and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b)develops a treatment and management plan that contains: (i)the outcomes of the assessment; (ii)the diagnosis or diagnoses; (iii)opinion on risk assessment; (iv)treatment options and decisions; (v)appropriate care pathways; and (vi)appropriate medication recommendations, where necessary. (c)provides a copy of the treatment and management plan to the: (i)referring practitioner; and (ii)relevant allied health providers (where appropriate). Not being an attendance on a patient in respect of whom payment has previously been made under this item or item 135. N 00289 01JUL2011 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND DEVELOPMENT OF A TREATMENT AND MANAGEMENT PLAN FOR AUTISM OR ANY OTHER PERVASIVE DEVELOPMENTAL DISORDER - SURGERY OR HOSPITAL Professional attendance of at least 45 minutes duration, at consulting rooms or hospital, by a consultant physician in his or her specialty of psychiatry, for assessment, diagnosis and the preparation of a treatment and management plan for a child aged under 13 years, with autism or any other pervasive developmental disorder, who has been referred to the consultant psychiatrist by a medical practitioner, if the consultant psychiatrist does the following: (a)undertakes a comprehensive assessment of the child and forms a diagnosis (using the assistance of one or more allied health providers where appropriate) (b)develops a treatment and management plan which must include the following: (i)the outcomes of the assessment; (ii)the diagnosis or diagnoses; (iii)opinion on risk assessment; (iv)treatment options and decisions; (v)appropriate medication recommendations, where necessary. (c)provides a copy of the treatment and management plan to the: (i)referring practitioner; and (ii)relevant allied health providers (where appropriate). Not being an attendance on a child in respect of whom payment has previously been made under this item or items 135, 137 or 139. N 00289 01NOV2011 Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice of his or her specialty of psychiatry, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant psychiatrist does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137 or 139) N 00289 01NOV2019 Professional attendance of at least 45 minutes in duration at consulting rooms or hospital, by a consultant physician in the practice ofthe consultant physician's specialty of psychiatry, following referral of the patient to the consultant by a referring practitioner, for assessment, diagnosis and preparation of a treatment and management plan for a patient under 13 years with autism or another pervasive developmental disorder, if the consultant psychiatrist does all of the following: (a) undertakes a comprehensive assessment and makes a diagnosis (if appropriate, using information provided by an eligible allied health provider); (b) develops a treatment and management plan which must include the following: (i) an assessment and diagnosis of the patient's condition; (ii) a risk assessment; (iii) treatment options and decisions; (iv) if necessary-medication recommendations; (c) provides a copy of the treatment and management plan to the referring practitioner; (d) provides a copy of the treatment and management plan to one or more allied health providers, if appropriate, for the treatment of the patient; (other than attendance on a patient for whom payment has previously been made under this item or item 135, 137 or 139) Y 00290 01AUG1986 ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (not during the course of the confinement) Y 00291 01MAY2005 CONSULTANT PSYCHIATRIST, REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred for the provision of an assessment and management plan by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) where the attendance is initiated by that medical practitioner and where the consultant psychiatrist provides the referring medical practitioner with an assessment and management plan to be undertaken by that medical practitioner in general practice for the patient, where clinically appropriate. An attendance of more than 45 minutes duration at consulting rooms during which: -An outcome tool is used where clinically appropriate -A mental state examination is conducted -A psychiatric diagnosis is made -The consultant psychiatrist decides that the patient can be appropriately managed by the referring medical practitioner without the need for ongoing treatment by the psychiatrist -A 12 month management plan, appropriate to the diagnosis, is provided to the referring medical practitioner which must: a)comprehensively evaluate biological, psychological and social issues; b)address diagnostic psychiatric issues; c)make management recommendations addressing biological, psychological and social issues; and d)be provided to the medical practitioner within two weeks of completing the assessment of the patient. -The diagnosis and management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -The diagnosis and management plan is communicated in writing to the referring medical practitioner Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item N 00291 01NOV2011 CONSULTANT PSYCHIATRIST, REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred for the provision of an assessment and management plan by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or participating nurse practitioner,where the attendance is initiated by the referring practitioner and where the consultant psychiatrist provides the referring practitioner with an assessment and management plan to be undertaken by that practitioner for the patient, where clinically appropriate. An attendance of more than 45 minutes duration at consulting rooms during which: -An outcome tool is used where clinically appropriate -A mental state examination is conducted -A psychiatric diagnosis is made -The consultant psychiatrist decides that the patient can be appropriately managed by the referring practitioner without the need for ongoing treatment by the psychiatrist -A 12 month management plan, appropriate to the diagnosis, is provided to the referring practitioner which must: a)comprehensively evaluate biological, psychological and social issues; b)address diagnostic psychiatric issues; c)make management recommendations addressing biological, psychological and social issues; and d)be provided to the referring practitioner within two weeks of completing the assessment of the patient. -The diagnosis and management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -The diagnosis and management plan is communicated in writing to the referring practitioner Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item N 00291 01NOV2015 Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred for the provision of an assessment and management plan by a medical practitioner practising in general practice (including a general practitioner, but not including a specialist or consultant physician) or participating nurse practitioner,where the attendance is initiated by the referring practitioner and where the consultant psychiatrist provides the referring practitioner with an assessment and management plan to be undertaken by that practitioner for the patient, where clinically appropriate. An attendance of more than 45 minutes duration at consulting rooms during which: -An outcome tool is used where clinically appropriate -A mental state examination is conducted -A psychiatric diagnosis is made -The consultant psychiatrist decides that the patient can be appropriately managed by the referring practitioner without the need for ongoing treatment by the psychiatrist -A 12 month management plan, appropriate to the diagnosis, is provided to the referring practitioner which must: a)comprehensively evaluate biological, psychological and social issues; b)address diagnostic psychiatric issues; c)make management recommendations addressing biological, psychological and social issues; and d)be provided to the referring practitioner within two weeks of completing the assessment of the patient. -The diagnosis and management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -The diagnosis and management plan is communicated in writing to the referring practitioner Not being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under this item N 00291 01NOV2019 Professional attendance of more than 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry, if: (a) the attendance follows referral of the patient to the consultant for an assessment or management by a medical practitioner in general practice (including a general practitioner, but not a specialist or consultant physician) or a participating nurse practitioner; and (b) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) the consultant decides that it is clinically appropriate for the patient to be managed by the referring practitioner without ongoing treatment by the consultant; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patient's diagnosis; and (C) comprehensively evaluates the patient's biological, psychological and social issues; and (D) addresses the patient's diagnostic psychiatric issues; and (E) makes management recommendations addressing the patient's biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees Y 00293 01MAY2005 CONSULTANT PSYCHIATRIST, REVIEW OF REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY to review a management plan previously prepared by that consultant psychiatrist for a patient and claimed under item 291, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms where that attendance follows item 291 and during which: -An outcome tool is used where clinically appropriate -A mental state examination is conducted -A psychiatric diagnosis is made -A management plan provided under Item 291 is reviewed and revised -The reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -The reviewed management plan is communicated in writing to the referring medical practitioner Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 291, payable no more than once in any 12 month period N 00293 01NOV2007 CONSULTANT PSYCHIATRIST, REVIEW OF REFERRED PATIENT ASSESSMENT AND MANAGEMENT Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY to review a management plan previously prepared by that consultant psychiatrist for a patient and claimed under item 291, where the review is initiated by the referring medical practitioner practising in general practice. An attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms where that attendance follows item 291 and during which: -An outcome tool is used where clinically appropriate -A mental state examination is conducted -A psychiatric diagnosis is made -A management plan provided under Item 291 is reviewed and revised -The reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -The reviewed management plan is communicated in writing to the referring medical practitioner Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 291, and no payment has been made under item 359, payable no more than once in any 12 month period. N 00293 01NOV2011 Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY to review a management plan previously prepared by that consultant psychiatrist for a patient and claimed under item 291, where the review is initiated by the referring medical practitioner practising in general practice or participating nurse practitioner. An attendance of more than 30 minutes but not more than 45 minutes duration at consulting rooms where that attendance follows item 291 and during which: -An outcome tool is used where clinically appropriate -A mental state examination is conducted -A psychiatric diagnosis is made -A management plan provided under Item 291 is reviewed and revised -The reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -The reviewed management plan is communicated in writing to the referring medical practitioner or participating nurse practitioner Being an attendance on a patient in respect of whom, in the preceding 12 months, payment has been made under item 291, and no payment has been made under item 359, payable no more than once in any 12 month period. N 00293 01NOV2019 Professional attendance of more than 30 minutes but not more than 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant in accordance with item 291; and (b) the attendance follows referral of the patient to the consultant for review of the management plan by the medical practitioner or a participating nurse practitioner managing the patient; and (c) during the attendance, the consultant: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees; and (e) in the preceding 12 months, a service to which item 291 applies has been provided; and (f) in the preceding 12 months, a service to which this item or item 293 applies has not been provided Y 00295 01FEB1984 Version, external, under general anaesthesia (AU 6) Y 00296 01NOV2006 CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, CONSULTING ROOMS Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: -is a new patient for this consultant psychiatrist; or -is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 297 or 299, or any of items 300 to 346 or 353 to 370 in the preceding 24 month period N 00296 01NOV2007 CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, CONSULTING ROOMS Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: -is a new patient for this consultant psychiatrist; or -is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 297 or 299, or any of items 300 to 346 or 353 to 358 or 361 to 370 in the preceding 24 month period N 00296 01NOV2011 Professional attendance of more than 45 minutes in duration by a consultant physician in the practice of his or her speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at consulting rooms if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 297 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months N 00296 01NOV2019 Professional attendance of more than 45 minutes in duration by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at consulting rooms if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 297 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months Y 00297 01NOV2006 CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, HOSPITAL Professional attendance of more than 45 minutes at hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: -is a new patient for this consultant psychiatrist; or -is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 299 or any of items 300 to 346 or 353 to 370 in the preceding 24 month period N 00297 01NOV2007 CONSULTANT PSYCHIATRIST, INITIAL CONSULTATION ON A NEW PATIENT, HOSPITAL Professional attendance of more than 45 minutes at hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a referring practitioner, and where the patient: -is a new patient for this consultant psychiatrist; or -is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 299 or any of items 300 to 346 or 353 to 358 or 361 to 370 in the preceding 24 month period N 00297 01NOV2011 Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months (H) N 00297 01NOV2019 Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 299, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months (H) Y 00298 01FEB1984 Version, internal, under general anaesthesia (AU 6) Y 00299 01NOV2006 CONSULTANT PSYCHIATRIST,INITIAL CONSULTATION ON A NEW PATIENT, HOME VISITS Professional attendance of more than 45 minutes at a place other than consulting rooms or hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: -is a new patient for this consultant psychiatrist; or -is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 297, or any of items 300 to 346 or 353 to 370 in the preceding 24 month period N 00299 01NOV2007 CONSULTANT PSYCHIATRIST,INITIAL CONSULTATION ON A NEW PATIENT, HOME VISITS Professional attendance of more than 45 minutes at a place other than consulting rooms or hospital by a consultant physician in the practice of his or her speciality of PSYCHIATRY where a patient is referred to him or her by a medical practitioner, and where the patient: -is a new patient for this consultant psychiatrist; or -is a patient who has not received a professional attendance from this consultant psychiatrist in the preceding 24 months. Not being an attendance on a patient in respect of whom payment has been made under this item, items 296 or 297, or any of items 300 to 346 or 353 to 358 or 361 to 370 in the preceding 24 month period N 00299 01NOV2011 Professional attendance of more than 45 minutes by a consultant physician in the practice of his or her speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 297, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months N 00299 01NOV2019 Professional attendance of more than 45 minutes by a consultant physician in the practice of the consultant physician's speciality of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance at a place other than consulting rooms or a hospital if the patient: (a) is a new patient for this consultant psychiatrist; or (b) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; other than attendance on a patient in relation to whom this item, item 296 or 297, or any of items 300 to 346, 353 to 358 and 361 to 370, has applied in the preceding 24 months Y 00300 01NOV1996 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) An attendance of not more than 15 minutes durationat consulting rooms, where that attendance and any other attendance to which items 302, 304, 306 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period. N 00300 01JUL1998 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes durationat consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00300 01NOV2006 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes durationat consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00300 01NOV2007 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, CONSULTING ROOMS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes durationat consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 358 or 361 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00300 01NOV2011 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient N 00300 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00302 01NOV1996 An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 304, 306 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period. N 00302 01JUL1998 - An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00302 01NOV2006 - An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00302 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient N 00302 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00304 01NOV1996 An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 302, 306 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period. N 00304 01JUL1998 - An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00304 01NOV2006 - An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00304 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient N 00304 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00306 01NOV1996 An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 302, 304 or 308 apply have not exceeded the sum of 50 attendances in a 12 month period. N 00306 01JUL1998 - An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00306 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient N 00306 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00308 01NOV1996 An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300, 302, 304 or 306 apply have not exceeded the sum of 50 attendances in a 12 month period. N 00308 01JUL1998 - An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00308 01NOV2006 - An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply have not exceeded the sum of 50 attendances in a calendar year. N 00308 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient N 00308 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms), if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00310 01NOV1996 An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 312, 314, 316 or 318 apply exceed 50 attendances in a 12 month period. N 00310 01JUL1998 - An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00310 01NOV2006 - An attendance of not more than 15 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00310 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient N 00310 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient Y 00312 01NOV1996 An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 314, 316 or 318 apply exceed 50 attendances in a 12 month period. N 00312 01JUL1998 - An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00312 01NOV2006 - An attendance of more than 15 minutes duration but not more than 30 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00312 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient N 00312 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient Y 00314 01NOV1996 An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 312, 316 or 318 apply exceed 50 attendances in a 12 month period. N 00314 01JUL1998 - An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00314 01NOV2006 - An attendance of more than 30 minutes duration but not more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00314 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient N 00314 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient Y 00316 01NOV1996 An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 312, 314 or 318 apply exceed 50 attendances in a 12 month period. N 00316 01JUL1998 - An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00316 01NOV2006 - An attendance of more than 45 minutes duration but not more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00316 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient N 00316 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient Y 00318 01NOV1996 An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 302, 304, 306, 308, 310, 312, 314 or 316 apply exceed 50 attendances in a 12 month period. N 00318 01JUL1998 - An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00318 01NOV2006 - An attendance of more than 75 minutes duration at consulting rooms, where that attendance and any other attendance to which items 296, 300 to 318 and items 353 to 370 apply exceed 50 attendances in a calendar year. N 00318 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient N 00318 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration at consulting rooms, if that attendance and another attendance to which any of items 296, 300 to 308, 353 to 358 and 361 to 370 applies exceed 50 attendances in a calendar year for the patient Y 00319 01JAN1997 - An attendance of more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 or 319 apply exceed 50 but not more than 160 attendances in a 12 month period and where the patient has: (i)a history of severe sexual or physical abuse which has led to psychiatric illness, or has been diagnosed as suffering from borderline personality disorder or anorexia nervosa or bulimia nervosa; and (ii)been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; and (iii)a history of failed related psychiatric treatment. N 00319 01MAY1997 - An attendance of more than 45 minutes duration at consulting rooms, where that attendance and any other attendance to which items 300 to 308 or 319 apply exceed 50 but not more than 160 attendances in a 12 month period and where the patient has: (i)a history of severe sexual or physical abuse which has led to psychiatric illness, or has been diagnosed as suffering from borderline personality disorder or anorexia nervosa or bulimia nervosa; and (ii)been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; and (iii)a history of failed related psychiatric treatment. N 00319 01NOV1997 - An attendance of more than 45 minutes duration at consulting rooms, where the patient has: (i)been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (ii)for persons 18 years and over, been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale where that attendance and any other attendance to which items 300 to 308 apply do not exceed 160 attendances in a 12 month period. N 00319 01JUL1998 - An attendance of more than 45 minutes duration at consulting rooms, where the patient has: (i)been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (ii)for persons 18 years and over, been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale where that attendance and any other attendance to which items 300 to 308 and items 353 to 370 apply do not exceed 160 attendances in a calendar year. N 00319 01NOV2006 - An attendance of more than 45 minutes duration at consulting rooms, where the patient has: (i)been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (ii)for persons 18 years and over, been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale where that attendance and any other attendance to which items 296, 300 to 308 and items 353 to 370 apply do not exceed 160 attendances in a calendar year. N 00319 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes in duration at consulting rooms, if the patient has: (a) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (b) for persons 18 years and over-been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; if that attendance and another attendance to which any of items 296, 300 to 319, 353 to 358 and 361 to 370 applies have not exceeded 160 attendances in a calendar year for the patient N 00319 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes in duration at consulting rooms, if the patient has: (a) been diagnosed as suffering severe personality disorder, anorexia nervosa, bulimia nervosa, dysthymic disorder, substance-related disorder, somatoform disorder or a pervasive development disorder; and (b) for persons 18 years and over-been rated with a level of functional impairment within the range 1 to 50 according to the Global Assessment of Functioning Scale; if that attendance and another attendance to which any of items 296, 300 to 319, 353 to 358 and 361 to 370 applies have not exceeded 160 attendances in a calendar year for the patient Y 00320 01NOV1996 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOSPITAL OR NURSING HOME (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at hospital or nursing home. N 00320 01NOV2000 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOSPITAL (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes duration at hospital. N 00320 01NOV2011 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration at hospital N 00320 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration at hospital Y 00322 01NOV1996 - An attendance of more than 15 minutes duration but not more than 30 minutes duration at hospital or nursing home. N 00322 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at hospital N 00322 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration at hospital Y 00324 01NOV1996 - An attendance of more than 30 minutes duration but not more than 45 minutes duration at hospital or nursing home. N 00324 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at hospital N 00324 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration at hospital Y 00326 01NOV1996 - An attendance of more than 45 minutes duration but not more than 75 minutes duration at hospital or nursing home. N 00326 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at hospital N 00326 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration at hospital Y 00328 01NOV1996 - An attendance of more than 75 minutes duration at hospital or nursing home. N 00328 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration at hospital N 00328 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration at hospital Y 00330 01NOV1996 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOME VISITS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes durationwhere that attendance is at a place other than consulting rooms, hospital or nursing home. N 00330 01NOV2000 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION, HOME VISITS (Professional attendance by a consultant physician in the practice of his or her speciality of PSYCHIATRY where the patient is referred to him or her by a medical practitioner) - An attendance of not more than 15 minutes durationwhere that attendance is at a place other than consulting rooms or hospital N 00330 01NOV2011 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of not more than 15 minutes in duration if that attendance is at a place other than consulting rooms or hospital N 00330 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of not more than 15 minutes in duration if that attendance is at a place other than consulting rooms or hospital Y 00332 01NOV1996 - An attendance of more than 15 minutes duration but not more than 30 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home. N 00332 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration if that attendance is at a place other than consulting rooms or hospital N 00332 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 15 minutes, but not more than 30 minutes, in duration if that attendance is at a place other than consulting rooms or hospital Y 00334 01NOV1996 - An attendance of more than 30 minutes duration but not more than 45 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home N 00334 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration if that attendance is at a place other than consulting rooms or hospital N 00334 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 30 minutes, but not more than 45 minutes, in duration if that attendance is at a place other than consulting rooms or hospital Y 00336 01NOV1996 - An attendance of more than 45 minutes duration but not more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home. N 00336 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration if that attendance is at a place other than consulting rooms or hospital N 00336 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 45 minutes, but not more than 75 minutes, in duration if that attendance is at a place other than consulting rooms or hospital Y 00338 01NOV1996 - An attendance of more than 75 minutes duration where that attendance is at a place other than consulting rooms, hospital or nursing home. N 00338 01NOV2000 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-an attendance of more than 75 minutes in duration if that attendance is at a place other than consulting rooms or hospital N 00338 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-an attendance of more than 75 minutes in duration if that attendance is at a place other than consulting rooms or hospital Y 00340 01NOV1996 ELECTROCONVULSIVE THERAPY ATTENDANCE FOR ELECTROCONVULSIVE THERAPY, with or without the use of stimulus dosing techniques, including any electroencephalographic monitoring and associated consultation Y 00342 01NOV1996 CONSULTANT PSYCHIATRIST - GROUP PSYCHOTHERAPY Group psychotherapy (including any associated consultation with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hours duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry where the patients are referred to him or her by a medical practitioner. - GROUP PSYCHOTHERAPY on a group of 2 to 9 unrelated patients OR FAMILY GROUP psychotherapy on a group of more than 3 patients, EACH PATIENT N 00342 01NOV2011 Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which Group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry, involving a Group of 2 to 9 unrelated patients or a family Group of more than 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient N 00342 01NOV2019 Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of the consultant physician's specialty of psychiatry, involving a group of 2 to 9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient Y 00344 01NOV1996 Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which Group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry, involving a family Group of 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient N 00344 01NOV2019 Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of the consultant physician's specialty of psychiatry, involving a family group of 3 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient Y 00346 01NOV1996 Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which Group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of his or her specialty of psychiatry, involving a family Group of 2 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient N 00346 01NOV2019 Group psychotherapy (including any associated consultations with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour in duration given under the continuous direct supervision of a consultant physician in the practice of the consultant physician's specialty of psychiatry, involving a family group of 2 patients, each of whom is referred to the consultant physician by a referring practitioner-each patient Y 00348 01NOV1996 CONSULTANT PSYCHIATRISTINTERVIEW OF A PERSON OTHER THAN A PATIENTSURGERY, HOSPITAL OR NURSING HOME Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or nursing home N 00348 01NOV2000 CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a medical practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility N 00348 01NOV2010 CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a referring practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility N 00348 01NOV2011 Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a referring practitioner involving an interview of a person other than the patient of not less than 20 minutes duration but less than 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility N 00348 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes, but less than 45 minutes, in duration, in the course of initial diagnostic evaluation of a patient Y 00350 01NOV1996 Professional attendance by a consultant physician in the practice of his or her recognised specialty of psychiatry, where the patient is referred to him or her by a referring practitioner involving an interview of a person other than the patient of not less 45 minutes duration, in the course of initial diagnostic evaluation of a patient, where that interview is at consulting rooms, hospital or residential aged care facility N 00350 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 45 minutes in duration, in the course of initial diagnostic evaluation of a patient Y 00352 01NOV1996 CONSULTANT PSYCHIATRIST - INTERVIEW OF A PERSON OTHER THAN A PATIENT - IN THE COURSE OF CONTINUING MANAGEMENT OF A PATIENT Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry, where the patient is referred to him or her by a medical practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration, in the course of continuing management of a patient - payable not more than 4 times in any 12 month period N 00352 01NOV2011 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry, where the patient is referred to him or her by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration, in the course of continuing management of a patient - payable not more than 4 times in any 12 month period N 00352 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, following referral of the patient to the consultant physician by a referring practitioner, involving an interview of a person other than the patient of not less than 20 minutes in duration, in the course of continuing management of a patient-if that attendance and another attendance to which this item applies have not exceeded 4 in a calendar year for the patient Y 00353 01NOV2002 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR ASSESSMENT, DIAGNOSIS AND TREATMENT A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 300 to 319 apply), where: -the patient is referred to him or her by a medical practitioner for assessment, diagnosis and/or treatment, -that consultation and any other consultation to which items 353 to 358 apply, have not exceeded 12 consultations in a calendar year, -a minimum of one face-to-face consultation (items 364 to 370) is conducted with the patient after every fourth telepsychiatry consultation, and -any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration. N 00353 01MAY2007 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR ASSESSMENT, DIAGNOSIS AND TREATMENT A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 291 to 319 apply), where: -the patient is referred to him or her by a medical practitioner for assessment, diagnosis and/or treatment and is located in a regional, rural or remote area (RRMA3-7), -that consultation and any other consultation to which items 353 to 358 apply, have not exceeded 12 consultations in a calendar year, -any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration. N 00353 01NOV2007 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR ASSESSMENT, DIAGNOSIS AND TREATMENT A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 291 to 319 apply), where: -the patient is referred to him or her by a medical practitioner for assessment, diagnosis and/or treatment and is located in a regional, rural or remote area (RRMA3-7), -that consultation and any other consultation to which items 353 to 361 apply, have not exceeded 12 consultations in a calendar year, -any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration. N 00353 01NOV2011 A telepsychiatry consultation by a consultant physician in the practice of his or her specialty of PSYCHIATRY (not being an attendance to which items 291 to 319 apply), where: -the patient is referred to him or her by a referring practitioner for assessment, diagnosis and/or treatment and is located in a regional, rural or remote area (RRMA3-7), -that consultation and any other consultation to which items 353 to 361 apply, have not exceeded 12 consultations in a calendar year, -any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. A telepsychiatry consultation of not more than 15 minutes duration. N 00353 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of not more than 15 minutes in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00354 01FEB1984 Surgical induction of labour (AU 5) Y 00355 01NOV2002 A telepsychiatry consultation of more than 15 minutes duration but not more than 30 minutes duration. N 00355 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 15 minutes, but not more than 30 minutes, in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00356 01NOV2002 A telepsychiatry consultation of more than 30 minutes duration but not more than 45 minutes duration. N 00356 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 30 minutes, but not more than 45 minutes, in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00357 01NOV2002 A telepsychiatry consultation of more than 45 minutes duration but not more than 75 minutes duration N 00357 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 45 minutes, but not more than 75 minutes, in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00358 01NOV2002 A telepsychiatry consultation of more than 75 minutes duration N 00358 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 75 minutes in duration, if: (a) that attendance and another attendance to which any of items 353 to 358 and 361 applies have not exceeded 12 attendances in a calendar year for the patient; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00359 01NOV2007 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION VIA TELEPSYCHIATRY FOR REVIEW OF REFERRED PATIENT ASSESSMENT AND MANAGEMENT A telepsychiatry consultation of more than 30 minutes but not more than 45 minutes duration by a consultant physician in the practice of his or her specialty of PSYCHIATRY where: -the patient is located in a regional, rural or remote area (RRMA 3-7) -in the preceding 12 months, payment has been made under item 291 -an outcome tool is used where clinically appropriate -a mental state examination is conducted -a psychiatric diagnosis is made -a management plan provided under Item 291 is reviewed and revised -the reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -the reviewed management plan is communicated in writing to the referring medical practitioner Not being an attendance on a patient in respect of whom payment has been made under this item or item 293 in the preceding 12 month period. N 00359 01NOV2011 A telepsychiatry consultation of more than 30 minutes but not more than 45 minutes duration by a consultant physician in the practice of his or her specialty of PSYCHIATRY where: -the patient is located in a regional, rural or remote area (RRMA 3-7) -in the preceding 12 months, payment has been made under item 291 -an outcome tool is used where clinically appropriate -a mental state examination is conducted -a psychiatric diagnosis is made -a management plan provided under Item 291 is reviewed and revised -the reviewed management plan is explained and provided, unless clinically inappropriate, to the patient and/or the carer (with the patient's agreement) -the reviewed management plan is communicated in writing to the referring practitioner Not being an attendance on a patient in respect of whom payment has been made under this item or item 293 in the preceding 12 month period. N 00359 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry-a telepsychiatry consultation of more than 30 minutes but not more than 45 minutes in duration, if: (a) the patient is being managed by a medical practitioner or a participating nurse practitioner in accordance with a management plan prepared by the consultant physician in accordance with item 291; and (b) the attendance follows referral of the patient to the consultant physician for review of the management plan by the referring practitioner managing the patient; and (c) during the attendance, the consultant physician: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the management plan; and (d) within 2 weeks after the attendance, the consultant physician: (i) prepares a written diagnosis of the patient; and (ii) revises the management plan; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees; and (e) the patient is located in a regional, rural or remote area; and (f) in the preceding 12 months, a service to which item 291 applies has been performed; and (g) in the preceding 12 months, a service to which this item or item 293 applies has not been performed Y 00360 01FEB1984 Decapitation, craniotomy, cleidotomy or evisceration of foetus or any two or more of those services (AU 8) Y 00361 01NOV2007 Professional attendance by a consultant physician in the practice of his or her specialty of psychiatry following referral of the patient to him or her by a referring practitioner-a telepsychiatry consultation of more than 45 minutes in duration, if the patient: (a) either: (i) is a new patient for this consultant psychiatrist; or (ii) has not received a professional attendance from this consultant psychiatrist in the preceding 24 months; and (b) is located in a regional, rural or remote area; other than attendance on a patient in relation to whom this item, item 296, 297 or 299, or any of items 300 to 346 and 353 to 370, has applied in the preceding 24 month period N 00361 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a telepsychiatry consultation of more than 45 minutes in duration, if the patient: (a) either: (i) is a new patient for this consultant physician; or (ii) has not received a professional attendance from this consultant physician in the preceding 24 months; and (b) is located in a regional, rural or remote area; other than attendance on a patient in relation to whom this item, item 296, 297 or 299, or any of items 300 to 346 and 353 to 370, has applied in the preceding 24 month period Y 00362 01FEB1984 Evacuation of products of conception (such as retained foetus, placenta, membranes or mole) by intrauterine manual removal or treatment of postpartum haemorrhage by special procedures such as packing of uterus (AU 7) N 00362 01SEP1989 Evacuation of products of conception (such as retained foetus, placenta, membranes or mole) by intrauterine manual removal as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances Y 00363 01AUG1987 Treatment of post-partum haemorrhage by special procedures such as packing of uterus as an independent procedure where the patient has been referred by another medical practitioner for this procedure N 00363 01SEP1989 Treatment of post-partum haemorrhage by special procedures such as packing of uterus as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances Y 00364 01NOV2002 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND TREATMENT FOLLOWING TELEPSYCHIATRY Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: -the patient is referred to him or her by a medical practitioner, -that attendance occurs following four telepsychiatry consultations (items 353 to 358), - where that attendance and any other attendance to which items 364 to 370 apply does not exceed three consultations per patient in a calendar year. -any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after every fourth telepsychiatry consultation conducted in accordance with items 353 to 358. A face-to-face attendance of not more than 15 minutes duration. N 00364 01MAY2007 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND TREATMENT FOLLOWING TELEPSYCHIATRY Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: - the patient is referred to him or her by a medical practitioner, - that attendance occurs following a telepsychiatry consultation (items 353 to 358), - that attendance and any other attendance to which items 300 to 308 and 353 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after telepsychiatry consultation(s) have been conducted in accordance with items 353 to 358. A face-to-face attendance of not more than 15 minutes duration. N 00364 01NOV2007 CONSULTANT PSYCHIATRIST, REFERRED CONSULTATION FOR ASSESSMENT, DIAGNOSIS AND TREATMENT FOLLOWING TELEPSYCHIATRY Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: - the patient is referred to him or her by a medical practitioner, - that attendance occurs following a telepsychiatry consultation (items 353 to 361), - that attendance and any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after telepsychiatry consultation(s) have been conducted in accordance with items 353 to 361. A face-to-face attendance of not more than 15 minutes duration. N 00364 01NOV2011 Professional attendance by a consultant physician in the practice of his or her specialty of PSYCHIATRY, where: - the patient is referred to him or her by a referring practitioner, - that attendance occurs following a telepsychiatry consultation (items 353 to 361), - that attendance and any other attendance to which items 300 to 308 and 353 to 358 or 361 to 370 apply, have not exceeded the sum of 50 attendances in a calendar year. These items may only be used after telepsychiatry consultation(s) have been conducted in accordance with items 353 to 361. A face-to-face attendance of not more than 15 minutes duration. N 00364 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of not more than 15 minutes in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00365 01FEB1984 Manipulative correction of acute inversion of uterus, by vaginal approach, with or without incision of cervix (AU 8) N 00365 01SEP1989 Manipulative correction of acute inversion of uterus, by vaginal approach, with or without incision of cervix as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances Y 00366 01NOV2002 A face-to-face attendance of more than 15 minutes duration but not more than 30 minutes duration N 00366 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 15 minutes, but not more than 30 minutes, in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00367 01NOV2002 A face-to-face attendance of more than 30 minutes duration but not more than 45 minutes duration. N 00367 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 30 minutes, but not more than 45 minutes, in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00368 01FEB1984 Manipulative correction of acute inversion of uterus, by abdominal approach, with or without incision of cervix (AU 9) Y 00369 01NOV2002 A face-to-face attendance of more than 45 minutes duration but not more than 75 minutes duration N 00369 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 45 minutes, but not more than 75 minutes, in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00370 01NOV2002 A face-to-face attendance of more than 75 minutes duration. N 00370 01NOV2019 Professional attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry following referral of the patient to the consultant physician by a referring practitioner-a face-to-face consultation of more than 75 minutes in duration, if: (a) the patient has had a telepsychiatry consultation to which any of items 353 to 358 and 361 applies before that attendance; and (b) that attendance and another attendance to which any of items 296 to 308, 353 to 358 and 361 to 370 applies have not exceeded 50 attendances in a calendar year for the patient Y 00371 01NOV2018 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner. Y 00372 01NOV2018 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner. Y 00383 01FEB1984 Third degree tear, repair of, involving anal sphincter muscles (AU 7) N 00383 01SEP1989 Third degree tear, repair of, involving anal sphincter muscles as an independent procedure where the medical practitioner has not managed the confinement, including all associated attendances Y 00384 01JAN2013 Initial professional attendance of 10 minutes or less in duration on a patient by a consultant occupational physician practising in his or her specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 00384 01NOV2019 Initial professional attendance of 10 minutes or less in duration on a patient by a consultant occupational physician practising in the consultant occupational physician's specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 00385 01JUL1998 CONSULTANT OCCUPATIONAL PHYSICIAN, REFERRED CONSULTATION - SURGERY OR HOSPITAL (Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine where the patient is referred to him or her by a medical practitioner) -INITIAL attendance in a single course of treatment N 00385 01NOV2011 Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 00385 01NOV2019 Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-initial attendance in a single course of treatment Y 00386 01JUL1998 Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-each attendance after the first in a single course of treatment N 00386 01NOV2019 Professional attendance at consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-each attendance after the first in a single course of treatment Y 00387 01JUL1998 CONSULTANT OCCUPATIONAL PHYSICIAN, REFERRED CONSULTATION - HOME VISITS (Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine where the patient is referred to him or her by a medical practitioner) - INITIAL attendance in a single course of treatment N 00387 01NOV2011 Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 00387 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-initial attendance in a single course of treatment Y 00388 01JUL1998 Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of his or her specialty of occupational medicine following referral of the patient to him or her by a referring practitioner-each attendance after the first in a single course of treatment N 00388 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a consultant occupational physician in the practice of the consultant occupational physician's specialty of occupational medicine following referral of the patient to the consultant occupational physician by a referring practitioner-each attendance after the first in a single course of treatment Y 00389 01JUL2011 The initiation of a professional attendance via video conference rendered by a consultant occupational physician practising in the specialty of occupational medicine, to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 385 or 386. N 00389 01NOV2012 Professional attendance on a patient by a consultant occupational physician practising in his or her specialty of occupational medicine if: (a) the attendance is by video conference; and (b) item 385 or 386 applies to the attendance; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 00389 01JAN2013 Professional attendance on a patient by a consultant occupational physician practising in his or her specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 385 lasting more than 10 minutes; or (ii) provided with item 386; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 00389 01NOV2019 Professional attendance on a patient by a consultant occupational physician practising in the consultant occupational physician's specialty of occupational medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 385 lasting more than 10 minutes; or (ii) provided with item 386; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 00401 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 1) Y 00403 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 2) Y 00404 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 3) Y 00405 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 4) Y 00406 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 5) Y 00407 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 6) Y 00408 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 7) Y 00409 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 8) Y 00410 01NOV1999 PUBLIC HEALTH PHYSICIAN ATTENDANCES - SURGERY (Professional attendance at consulting rooms by a public health physician in the practice of his or her specialty of public health medicine) - Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management N 00410 01MAY2010 LEVEL AProfessional attendance at consulting rooms by a public health physician in the practice of his or her specialty of public health medicine for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management. Y 00411 01NOV1999 - Attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR an attendance of less than 20 minutes duration involving components of a service to which item 412 applies N 00411 01MAY2010 LEVEL BProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine at consulting rooms lasting less than 20 minutes, including any of the following that are clinically relevant: a)    taking a patient history; b)    performing a clinical examination; c)    arranging any necessary investigation; d)    implementing a management plan; e)    providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. Y 00412 01NOV1999 - Attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR an attendance of less than 40 minutes duration involving components of a service to which item 413 applies N 00412 01MAY2010 LEVEL CProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine at consulting rooms lasting at least 20 minutes, including any of the following that are clinically relevant: a)    taking a detailed patient history; b)    performing a clinical examination; c)    arranging any necessary investigation; d)    implementing a management plan; e)    providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. Y 00413 01NOV1999 - Attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR an attendance of at least 40 minutes duration for implementation of a management plan N 00413 01MAY2010 LEVEL DProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine at consulting rooms lasting at least 40 minutes, including any of the following that are clinically relevant: a)    taking an extensive patient history; b)    performing a clinical examination; c)    arranging any necessary investigation; d)    implementing a management plan; e)    providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. Y 00414 01NOV1999 PUBLIC HEALTH PHYSICIAN ATTENDANCES - OTHER THAN AT CONSULTING ROOMS (Professional attendance at other than consulting rooms by a public health physician in the practice of his or her specialty of public health medicine) - Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management N 00414 01MAY2010 LEVEL A Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management. N 00414 01JAN2013 LEVEL AProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management Y 00415 01NOV1999 - Attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR an attendance of less than 20 minutes duration involving components of a service to which item 416 applies N 00415 01MAY2010 LEVEL B Professional attendance by a general practitioner (not being a service to which any other item in this table applies) lasting less than 20 minutes, including any of the following that are clinically relevant: a)taking a patient history; b)performing a clinical examination; c)arranging any necessary investigation; d)implementing a management plan; e)providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. N 00415 01JAN2013 LEVEL BProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms, lasting less than 20 minutes, including any of the following that are clinically relevant: a)    taking a patient history; b)    performing a clinical examination; c)    arranging any necessary investigation; d)    implementing a management plan; e)    providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. Y 00416 01NOV1999 - Attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR an attendance of less than 40 minutes duration involving components of a service to which item 417 applies N 00416 01MAY2010 LEVEL C Professional attendance by a general practitioner (not being a service to which any other item in this table applies) lasting at least 20 minutes, including any of the following that are clinically relevant: a)taking a detailed patient history; b)performing a clinical examination; c)arranging any necessary investigation; d)implementing a management plan; e)providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. N 00416 01JAN2013 LEVEL CProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms lasting at least 20 minutes, including any of the following that are clinically relevant: a)    taking a detailed patient history; b)    performing a clinical examination; c)    arranging any necessary investigation; d)    implementing a management plan; e)    providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. Y 00417 01NOV1999 - Attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR an attendance of at least 40 minutes duration for implementation of a management plan N 00417 01MAY2010 LEVEL D Professional attendance by a general practitioner (not being a service to which any other item in this table applies) lasting at least 40 minutes, including any of the following that are clinically relevant: a)taking an extensive patient history; b)performing a clinical examination; c)arranging any necessary investigation; d)implementing a management plan; e)providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. N 00417 01JAN2013 LEVEL DProfessional attendance by a public health physician in the practice of his or her specialty of public health medicine other than at consulting rooms lasting at least 40 minutes, including any of the following that are clinically relevant: a)    taking an extensive patient history; b)    performing a clinical examination; c)    arranging any necessary investigation; d)    implementing a management plan; e)    providing appropriate preventive health care; in relation to 1 or more health-related issues, with appropriate documentation. Y 00443 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 9) Y 00444 01MAY2001 MEDICAL PRACTITIONER (SPORTS PHYSICIAN) ATTENDANCES - SURGERY LEVEL 1 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management Y 00445 01MAY2001 LEVEL 2 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, or an attendance of less than 20 minutes duration involving components of a service to which item 446 applies Y 00446 01MAY2001 LEVEL 3 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, or an attendance of less than 40 minutes duration involving components of a service to which item 447 applies Y 00447 01MAY2001 LEVEL 4 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine - Attendance involving taking an exhaustive history, an comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, or an attendance of at least 40 minutes duration for implementation of a management plan Y 00448 01MAY2001 MEDICAL PRACTITIONER (SPORTS PHYSICIAN) ATTENDANCES - EMERGENCY AFTER HOURS Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance other than an attendance between 11pm and 7am, on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or at any time other than between 8am and 8pm on a day not being a Saturday, Sunday or public holiday N 00448 01MAR2007 MEDICAL PRACTITIONER (SPORTS PHYSICIAN) ATTENDANCES - URGENT AFTER-HOURS (on not more than 1 patient on the 1 occasion) Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance AT CONSULTING ROOMS - each attendance (other than an attendance between 11pm and 7am) in an after-hours period, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment; and `)it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance Y 00449 01MAY2001 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance, AT CONSULTING ROOMS, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance on any day of the week between 11pm and 7am N 00449 01MAR2007 Professional attendance at consulting rooms by a medical practitioner who is a sports physician in the practice of sports medicine Professional attendance AT CONSULTING ROOMS - each attendance between 11pm and 7am if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment; and `)it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance Y 00450 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 10) Y 00453 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 11) Y 00454 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 12) Y 00457 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 13) Y 00458 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 14) Y 00459 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 15) Y 00460 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 16) Y 00461 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 17) Y 00462 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 18) Y 00463 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 19) Y 00464 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 20) Y 00465 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 21) Y 00466 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 22) Y 00467 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 23) Y 00468 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 24) Y 00469 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 25) Y 00470 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 26) Y 00471 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 27) Y 00472 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 28) Y 00473 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 29) Y 00474 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 30) Y 00475 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 32) Y 00476 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 36) Y 00477 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 38) Y 00478 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 39) Y 00479 01FEB1984 Administration of an anaesthetic in connection with electroconvulsive therapy N 00479 01SEP1989 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 40) Y 00480 01FEB1984 Administration of an anaesthetic in connection with radio-therapy Y 00481 01FEB1984 Administration of an anaesthetic in connection with a forceps delivery of a foetus N 00481 01SEP1989 Administration of an anaesthetic in connection with forceps delivery, vacuum extraction delivery, breech delivery by manipulation, delivery of second twin by manipulation, rotation of head followed by delivery-where an epidural needle or catheter has not been inserted earlier in labour Y 00482 01FEB1984 Administration of an anaesthetic in connection with the treatment of a dislocation requiring open operation, being a dislocation referred to in Items 7397 to 7472 Y 00483 01FEB1984 Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in Items 7505 to 7798 Y 00484 01FEB1984 Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring internal fixation or in connection with the treatment of a compound fracture requiring open operation, being in either case a fracture referred to in Items 7505 to 7798 Y 00485 01FEB1984 Administration of an anaesthetic in connection with the treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Items 7505 to 7798 Y 00486 01NOV1984 Administration of an anaesthetic in connection with a medical service, being a medical service that does not contain a reference to a number of anaesthetic units Y 00487 01FEB1984 Administration of an anaesthetic where the anaesthetic is administered as a therapeutic procedure Y 00488 01NOV1986 Administration of an anaesthetic in connection with reamputation of amputation stump referred to in item 5057 Y 00489 01FEB1984 Administration of an anaesthetic in connection with computerised axial tomography-brain scan, plain study with or without contrast medium study Y 00490 01FEB1984 Administration of an anaesthetic in connection with computerised axial tomography-body scan, plain study with or without contrast medium study Y 00492 01APR1985 Administration of an anaesthetic in connection with a medical service which has been assigned an anaesthetic unit value of - THIRTY-FOUR UNITS N 00492 01SEP1989 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 34) Y 00493 01JUL1985 Administration of an anaesthetic in connection with a medical service which has been assigned an anaesthetic unit value of - THIRTY-FOUR UNITS N 00493 01SEP1989 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 35) Y 00497 01JUN1985 Administration of an anaesthetic in connection with a medical service which has been assigned an anaesthetic unit value of - FORTY-SEVEN UNITS N 00497 01SEP1989 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 47) Y 00500 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 1) Y 00501 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving straightforward medical decision making that requires: (a) taking a problem focussed history; and (b) limited examination; and (c) diagnosis; and (d) initiation of appropriate treatment interventions N 00501 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving straightforward medical decision making that requires: (a) taking a problem focussed history; and (b) limited examination; and (c) diagnosis; and (d) initiation of appropriate treatment interventions Y 00503 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of low complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (d) initiation of appropriate treatment interventions N 00503 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of low complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (d) initiation of appropriate treatment interventions Y 00505 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 2) Y 00506 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 3) Y 00507 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions N 00507 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking an expanded problem focussed history; and (b) expanded examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions Y 00509 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 4) Y 00510 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 5) Y 00511 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking a detailed history; and (b) detailed examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent N 00511 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of moderate complexity that requires: (a) taking a detailed history; and (b) detailed examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent Y 00513 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 6) Y 00514 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 7) Y 00515 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of high complexity that requires: (a) taking a comprehensive history; and (b) comprehensive examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent N 00515 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for the unscheduled evaluation and management of a patient, involving medical decision making of high complexity that requires: (a) taking a comprehensive history; and (b) comprehensive examination of one or more systems; and (c) ordering and evaluation of appropriate investigations; and (d) formulation and documentation of a diagnosis and management plan in relation to one or more problems; and (e) initiation of appropriate treatment interventions; and (f) liaison with relevant health care professionals and discussion with, as appropriate, the patient or the patient's relatives or agent Y 00517 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 8) Y 00518 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 9) Y 00519 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 30 minutes but less than 1 hour (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem N 00519 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 30 minutes but less than 1 hour (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem Y 00520 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 1 hour but less than 2 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem N 00520 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 1 hour but less than 2 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem Y 00521 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 10) Y 00522 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 11) Y 00523 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 12) Y 00524 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 13) Y 00525 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 14) Y 00526 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 15) Y 00527 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 16) Y 00528 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 17) Y 00529 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 18) Y 00530 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 2 hours but less than 3 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem N 00530 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 2 hours but less than 3 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem Y 00531 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 19) Y 00532 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 3 hours but less than 4 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem N 00532 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 3 hours but less than 4 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem Y 00533 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 20) Y 00534 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 4 hours but less than 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem N 00534 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 4 hours but less than 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem Y 00535 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 21) Y 00536 01NOV2002 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of his or her specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem N 00536 01NOV2019 Professional attendance at a recognised emergency department of a private hospital by a specialist in the practice of the specialist's specialty of emergency medicine-attendance for a total period (whether or not continuous) of at least 5 hours (before the patient's admission to an in-patient hospital bed) for emergency evaluation of a critically ill patient with an immediately life threatening problem Y 00537 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 22) Y 00538 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 23) Y 00539 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 24) Y 00540 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 25) Y 00541 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 26) Y 00542 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 27) Y 00543 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 28) Y 00544 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 29) Y 00545 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 30) Y 00546 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 32) Y 00547 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 36) Y 00548 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 38) Y 00549 01FEB1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 39) Y 00550 01FEB1984 Administration of an anaesthetic in connection with electroconvulsive therapy N 00550 01SEP1989 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 40) Y 00551 01FEB1984 Administration of an anaesthetic in connection with radio-therapy Y 00552 01FEB1984 Administration of an anaesthetic in connection with a forceps delivery of a foetus N 00552 01SEP1989 Administration of an anaesthetic in connection with forceps delivery, vacuum extraction delivery, breech delivery by manipulation, delivery of second twin by manipulation, rotation of head followed by delivery- where an epidural needle or catheter has not been inserted earlier in labour Y 00553 01FEB1984 Administration of an anaesthetic in connection with the treatment of a dislocation requiring open operation, being a dislocation referred to in Items 7397 to 7472 Y 00554 01FEB1984 Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in Items 7505 to 7798 Y 00556 01FEB1984 Administration of an anaesthetic in connection with the treatment of a simple and uncomplicated fracture requiring internal fixation or in connection with the treatment of a compound fracture requiring open operation, being in either case a fracture referred to in Items 7505 to 7798 Y 00557 01FEB1984 Administration of an anaesthetic in connection with the treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Items 7505 to 7798 Y 00558 01NOV1984 Administration of an anaesthetic in connection with a medical service, being a medical service that does not contain a reference to a number of anaesthetic units Y 00559 01FEB1984 Administration of an anaesthetic where the anaesthetic is administered as a therapeutic procedure Y 00560 01OCT1986 - In connection with reamputation of amputation stump referred to in item 5057 DERIVED FEE - 85% of the fee specified for the anaesthetic for the amputation N 00560 01SEP1989 Administration of an anaesthetic in connection with reamputation of amputation stump referred to in item 5057 Y 00561 01FEB1984 Administration of an anaesthetic in connection with computerised axial tomography-brain scan, plain study with or without contrast medium study Y 00562 01FEB1984 Administration of an anaesthetic in connection with computerised axial tomography-body scan, plain study with or without contrast medium study Y 00563 01NOV1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 34) Y 00564 01NOV1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 35) Y 00565 01DEC1984 Administration of an anaesthetic in connection with a medical service, being a medical service which contains the reference (AU 47) Y 00566 01FEB1984 Administration by a medical practitioner of an anaesthetic, other than an endotracheal anaesthetic, in connection with a dental operation (G) Y 00567 01FEB1984 Administration by a medical practitioner of an anaesthetic, other than an endotracheal anaesthetic, in connection with a dental operation (S) Y 00568 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for extraction of a tooth or teeth, not being a service covered by Item 570 (G) Y 00569 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for extraction of a tooth or teeth, not being a service covered by Item 571 (S) Y 00570 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for removal of a tooth or teeth requiring incision of soft tissue and removal of bone (G) Y 00571 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for removal of a tooth or teeth requiring incision of soft tissue and removal of bone (S) Y 00572 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of not more than 30 minutes duration (G) Y 00573 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of not more than 30 minutes duration (S) Y 00574 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of more than 30 minutes duration (G) Y 00575 01FEB1984 Administration by a medical practitioner of an endotracheal anaesthetic for restorative dental work where the procedure is of more than 30 minutes duration (S) Y 00576 01JUL1985 ADMINISTRATION BY A MEDICAL PRACTITIONER OF AN ENDOTRACHEAL ANAESTHETIC in connection with a dental operation, not covered by any other item in this Part. Anaesthetic 7 units (G) N 00576 01SEP1989 Administration by a medical practitioner of an endotracheal anaesthetic in connection with a dental operation, not covered by any other item in this Part (G) Y 00577 01JUL1985 ADMINISTRATION BY A MEDICAL PRACTITIONER OF AN ENDOTRACHEAL ANAESTHETIC in connection with a dental operation, not covered by any other item in this Part. Anaesthetic 7 units (S) N 00577 01SEP1989 Administration by a medical practitioner of an endotracheal anaesthetic in connection with a dental operation, not covered by any other item in this Part (S) Y 00585 01MAR2018 Professional attendance by a general practitioner on one patient on one occasion - each attendance (other than an attendance in unsociable hours) in an after-hours period if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patient's medical condition requires urgent assessment; and (c) if the attendance is at consulting rooms - it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00588 01MAR2018 Professional attendance by a medical practitioner (other than a general practitioner) on one patient on one occasion - each attendance (other than an attendance in unsociable hours) in an after-hours period if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patient's medical condition requires urgent assessment; and (c) the attendance is in an after-hours rural area; and (d) if the attendance is at consulting rooms - it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00591 01MAR2018 Professional attendance by a medical practitioner (other than a general practitioner) on one patient on one occasion - each attendance (other than an attendance in unsociable hours) in an after-hours period if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patient's medical condition requires urgent assessment; and (c) the attendance is not in an after-hours rural area; and (d) if the attendance is at consulting rooms - it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00594 01MAR2018 Professional attendance by a medical practitioner - each additional patient at an attendance that qualifies for item 585, 588 or 591 in relation to the first patient Y 00597 01MAY2010 Professional attendance by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period if: a)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken urgent after-hours period; b)the patient's condition requires urgent medical treatment; and c)if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00598 01MAY2010 Professional attendance by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance (other than an attendance between 11pm and 7am) in an after-hours period if: a)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken urgent after-hours period; b)the patient's condition requires urgent medical treatment; and c)if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00599 01MAY2010 Professional attendance, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: a)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b)the patient's condition requires urgent medical treatment; and c)if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to and specially open, the consulting rooms for the attendance. N 00599 01MAR2018 Professional attendance by a general practitioner on not more than one patient on one occasion - each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patient's medical condition requires urgent assessment; and (c) if the attendance is at consulting rooms - it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00600 01MAY2010 Professional attendance, by a medical practitioner, (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: a)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b)the patient's condition requires urgent medical treatment; and c)if the attendance is undertaken at consulting rooms, it is necessary for the practitioner to return to and specially open, the consulting rooms for the attendance N 00600 01MAR2018 Professional attendance by a medical practitioner (other than a general practitioner) on not more than one patient on one occasion - each attendance in unsociable hours if: (a) the attendance is requested by the patient or a responsible person in the same unbroken after-hours period; and (b) the patient's medical condition requires urgent assessment; and (c) if the attendance is at consulting rooms - it is necessary for the practitioner to return to, and specially open, the consulting rooms for the attendance Y 00601 01NOV1997 Professional attendance, at a place OTHER THAN CONSULTING ROOMS, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - each attendance on any day of the week between 11pm and 7am N 00601 01MAR2007 Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment Y 00602 01NOV1997 Professional attendance, AT CONSULTING ROOMS, where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance on any day of the week between 11pm and 7am N 00602 01MAR2007 Professional attendance AT CONSULTING ROOMS,by a general practitioner on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment; and `)it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance Y 00603 01NOV2008 GENERAL PRACTITIONER URGENT ATTENDANCES - TRANSITIONAL HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a general practitioner on not more than 1 patient on the 1 occasion - each attendance (between 6pm and 8pm weekdays excluding public holidays and 12pm and 1pm on a Saturday) in a transitional hours, if: a)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b)the patient's medical condition requires urgent treatment Y 00696 01NOV2008 OTHER NON-REFERRED URGENT ATTENDANCES - TRANSITIONAL HOURS (on not more than 1 patient on 1 occasion) Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a medical practitioner, other than a general practitioner on not more than 1 patient on the 1 occasion - each attendance (between 6pm and 8pm weekdays excluding public holidays and 12pm and 1pm on a Saturday) in a transitional hours, if: a)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and b)the patient's medical condition requires urgent treatment Y 00697 01NOV1997 Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment - each attendance on any day of the week between 11pm and 7am N 00697 01MAR2007 Professional attendance AT A PLACE OTHER THAN CONSULTING ROOMS, by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment Y 00698 01NOV1997 Professional attendance AT CONSULTING ROOMS where the attendance is initiated by or on behalf of the patient in the same unbroken after hours period and where the patient's medical condition requires immediate treatment and where it is necessary for the doctor to return to, and specially open, consulting rooms for the attendance - each attendance on any day of the week between 11pm and 7am N 00698 01MAR2007 Professional attendance AT CONSULTING ROOMS,by a medical practitioner (other than a general practitioner) on not more than 1 patient on the 1 occasion - each attendance between 11pm and 7am, if: `)the attendance is requested by the patient or a responsible person in, or not more than 2 hours before the start of, the same unbroken after-hours period; and `)the patient's medical condition requires urgent treatment; and `)it is necessary for the practitioner to return to, and specially open, consulting rooms for the attendance Y 00699 01APR2019 Professional attendance for a heart health assessment by a general practitioner at consulting rooms lasting at least 20 minutes and must include:(a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status, cholesterol status (if not performed within the last 12 months) and blood glucose;(b) a physical examination, which must include recording of blood pressure;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors; with appropriate documentation. N 00699 01NOV2019 Professional attendance for a heart health assessment by a general practitioner at consulting roomslasting at least 20 minutes and must include: (a) collection of relevant information, including taking a patient history that is aimed at identifying cardiovascular disease risk factors, including diabetes status, alcohol intake, smoking status and blood glucose;(b) a physical examination, which must include recording of blood pressure and cholesterol status;(c) initiating interventions and referrals to address the identified risk factors;(d) implementing a management plan for appropriate treatment of identified risk factors;(e) providing the patient with preventative health care advice and information, including modifiable lifestyle factors; with appropriate documentation. Claimable once only in a 12 month period.The heart health assessment item cannot be claimed if a patient has had a health assessment service(items 701, 703, 705, 707, 715) in the previous 12 months. Y 00700 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 702, 704 or 706 N 00700 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 702, 704 or 706 Y 00701 01MAY2010 Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a brief health assessment, lasting not more than 30 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing the patient with preventive health care advice and information N 00701 01JUL2018 Professional attendance by a general practitioner to perform a brief health assessment, lasting not more than 30 minutes and including: (a) collection of relevant information, including taking a patient history; and (b) a basic physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing the patient with preventive health care advice and information Y 00702 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A NURSING HOME, for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 704 or 706 N 00702 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY for a health assessment - of a patient who is at least 75 years old - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 704 or 706 Y 00703 01MAY2010 Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including: (a) detailed information collection, including taking a patient history; and (b) an extensive physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing a preventive health care strategy for the patient N 00703 01JUL2018 Professional attendance by a general practitioner to perform a standard health assessment, lasting more than 30 minutes but less than 45 minutes, including: (a) detailed information collection, including taking a patient history; and (b) an extensive physical examination; and (c) initiating interventions and referrals as indicated; and (d) providing a preventive health care strategy for the patient Y 00704 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 706 N 00704 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 706 Y 00705 01MAY2010 Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition and physical function; and (c) initiating interventions and referrals as indicated; and (d) providing a basic preventive health care management plan for the patient N 00705 01JUL2018 Professional attendance by a general practitioner to perform a long health assessment, lasting at least 45 minutes but less than 60 minutes, including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition and physical function; and (c) initiating interventions and referrals as indicated; and (d) providing a basic preventive health care management plan for the patient Y 00706 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A NURSING HOME, for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 704 N 00706 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY, for a health assessment - of a patient who is at least 55 years old and of Aboriginal or Torres Strait Islander descent - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 700, 702 or 704 Y 00707 01MAY2010 Professional attendance by a medical practitioner (other than a specialist or consultant physician) to perform a prolonged health assessment (lasting at least 60 minutes) including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition, and physical, psychological and social function; and (c) initiating interventions or referrals as indicated; and (d) providing a comprehensive preventive health care management plan for the patient N 00707 01JUL2018 Professional attendance by a general practitioner to perform a prolonged health assessment (lasting at least 60 minutes) including: (a) comprehensive information collection, including taking a patient history; and (b) an extensive examination of the patient's medical condition, and physical, psychological and social function; and (c) initiating interventions or referrals as indicated; and (d) providing a comprehensive preventive health care management plan for the patient Y 00708 01MAY2006 ABORIGINAL AND TORRES STRAIT ISLANDER CHILD HEALTH CHECK Attendance by a medical practitioner, other than a specialist or a consultant physician, at consulting rooms or in another place other than a hospital or Residential Aged Care Facility, for a child health check of a patient who is of Aboriginal or Torres Strait Islander descent and aged 0 to 14 years inclusive - not being a child health check of a patient in respect of whom, in the preceding 9 months, a payment has been made under this item Y 00709 01JUL2008 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS to undertake a health check for a patient who is receiving or has received their four year old immunisation. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 711. Benefits are payable on one occasion only for each eligible patient. Y 00710 01MAY2004 ABORIGINAL AND TORRES STRAIT ISLANDER ADULT HEALTH CHECK Attendance by a medical practitioner, other than a specialist or a consultant physician, at consulting rooms or in another place other than a hospital or Residential Aged Care Facility, for an adult health check of a patient who is of Aboriginal or Torres Strait Islander descent and aged at least 15 years old and less than 55 years old - not being an adult health check of a patient in respect of whom, in the preceding 18 months, a payment has been made under this item Y 00711 01JUL2008 Service provided by a practice nurse being the provision of a health check for a patient who is receiving or has received their four year old immunisation, if : (a)the service is provided on behalf of, and under the supervision of, a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), and (b)the person is not an admitted patient of a hospital. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 709. Benefits are payable on one occasion only for each eligible patient. N 00711 01NOV2008 Service provided by a practice nurse or registered Aboriginal Health Worker being the provision of a health check for a patient who is receiving or has received their four year old immunisation, if : (a)the service is provided on behalf of, and under the supervision of, a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), and (b)the person is not an admitted patient of a hospital. Not being an attendance on a patient in respect of whom a payment has already been made under this item or item 709. Benefits are payable on one occasion only for each eligible patient. Y 00712 01JUL2004 Attendance by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) AT A RESIDENTIAL AGED CARE FACILITY OR AT CONSULTING ROOMS for a Comprehensive Medical Assessment (CMA) of a permanent resident of a residential aged care facility - not being a CMA of a resident in respect of whom, in the preceding 12 months, a payment has been made under this item. Benefits under this item are payable in respect of one CMA for new residents on admission to a Residential Aged Care Facility and for continuing residents on an as required basis, with a maximum of one CMA for a resident in any twelve month period. Y 00713 01JUL2008 Attendance by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) AT A PLACE OTHER THAN A HOSPITAL to undertake a type 2 diabetes risk evaluation for a patient who is 40 to 49 years of age (inclusive) with a high risk of developing type 2 diabetes as determined by the Australian Type 2 Diabetes Risk Assessment Tool - not being a type 2 diabetes risk evaluation of a patient in respect of whom, in the preceding 3 years, a payment has been made under this item or item 717. Y 00714 01MAY2006 HEALTH ASSESSMENT FOR REFUGEES AND OTHER HUMANITARIAN ENTRANTS Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment of a patient that has been granted residency in Australia under the Humanitarian Program, not being a health assessment of a patient in respect of whom, a payment has been made under this item or item 700, 702, 712 or 716. Benefits are payable for a service provided to a patient within 12 months of them arriving in Australia or receiving residency (whichever is the later) Note: Benefits are payable on one occasion only for a service included in this item or item716 Y 00715 01MAY2010 Professional attendance by a medical practitioner (other than a specialist or consultant physician) at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-not more than once in a 9 month period N 00715 01JUL2018 Professional attendance by a general practitioner at consulting rooms or in another place other than a hospital or residential aged care facility, for a health assessment of a patient who is of Aboriginal or Torres Strait Islander descent-not more than once in a 9 month period Y 00716 01MAY2006 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) NOT BEING AN ATTENDANCE AT CONSULTING ROOMS, A HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY for a health assessment of a patient that has been granted residency in Australia under the Humanitarian Program, not being a health assessment of a patient in respect of whom, a payment has been made under this item or item 700, 702, 712 or 714. Benefits are payable for a service provided to a patient within 12 months of them arriving in Australia or receiving residency (whichever is the later) Note: Benefits are payable on one occasion only for a service included in this item or item 714 Y 00717 01NOV2006 45 YEAR OLD HEALTH CHECK Attendance by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) AT A PLACE OTHER THAN A HOSPITAL to undertake a health check for a patient between the age of 45 and 49 (inclusive) at risk of developing a chronic disease. Benefits are payable on one occasion only for each eligible patient. Y 00718 01JUL2007 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) AT CONSULTING ROOMS for a health assessment - of a patient with an intellectual disability - not being a health assessment of a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 719. Y 00719 01JUL2007 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) not being an attendance at consulting rooms, a hospital or residential aged care facility for a health assessment - of a patient with an intellectual disability - not being a health assessment for a patient in respect of whom, in the preceding 12 months, a payment has been made under this item or item 718. Y 00720 01NOV1999 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary CARE PLAN for a patient (not being a service associated with a service to which items 740 to 773 apply) - payable not more than once in any 6 month period N 00720 01MAY2000 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary COMMUNITY CARE PLAN for a patient (not being a service associated with a service to which items 740 to 773 apply) - payable not more than once in any 6 month period N 00720 01NOV2000 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary COMMUNITY CARE PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply) - payable not more than once in any 6 month period Y 00721 01JUL2005 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MANAGEMENT PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or former item 720, or within three months of a claim for items 725, 727, 729 or 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Management Plan. N 00721 01NOV2006 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MANAGEMENT PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, or within three months of a claim for items 725, 727, 729 or 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Management Plan. N 00721 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 apply) N 00721 01JUL2018 Attendance by a general practitioner for preparation of a GP management plan for a patient (other than a service associated with a service to which any of items 735 to 758 apply) Y 00722 01NOV1999 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary CARE PLAN for a patient (not being a service associated with a service to which items 740 to 773 apply) - payable not more than once for each HOSPITAL ADMISSION N 00722 01NOV2000 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), in consultation with a multidisciplinary care plan team, of a multidisciplinary DISCHARGE CARE PLAN for a patient (not being a service associated with a service to which items 734 to 779 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00723 01JUL2005 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to COORDINATE the development of TEAM CARE ARRANGEMENTS for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or former item 720, or within three months of a claim for item 727, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the coordination of new Team Care Arrangements. N 00723 01NOV2006 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to COORDINATE the development of TEAM CARE ARRANGEMENTS for a patient (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, or within three months of a claim for item 727, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the coordination of new Team Care Arrangements. N 00723 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 apply) N 00723 01JUL2018 Attendance by a general practitioner to coordinate the development of team care arrangements for a patient (other than a service associated with a service to which any of items 735 to 758 apply) Y 00724 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to REVIEW a multidisciplinary CARE PLAN prepared by that medical practitioner for a patient (not being a payment in respect of a service to which items 740 to 773 apply) - payable not more than once in any 3 month period, and not being an attendance in relation to a patient: (a)in respect of whom, in the preceding 3 months, a payment has been made under item 720; or (b)in respect of whom, in the preceding month, a payment has been made under item 722 N 00724 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to REVIEW a multidisciplinary COMMUNITY CARE PLAN or a DISCHARGE CARE PLAN prepared by that medical practitioner for a patient and claimed for under item 720 or 722 (not being a payment for a service to which items 740 to 773 apply) - payable not more than once in any 3 month period, and not being an attendance in relation to a patient: (a)for whom, in the preceding 3 months, a payment has been made under item 720; or (b)for whom, in the preceding month, a payment has been made under item 722 N 00724 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to REVIEW a multidisciplinary COMMUNITY CARE PLAN or a DISCHARGE CARE PLAN prepared by that medical practitioner for a patient and claimed for under item 720 or 722 (not being a payment for a service to which items 734 to 779 apply) - payable not more than once in any 3 month period, and not being an attendance in relation to a patient: (a)for whom, in the preceding 3 months, a payment has been made under item 720; or (b)for whom, in the preceding month, a payment has been made under item 722 Y 00725 01JUL2005 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW: (a) a GP MANAGEMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 721 applies; or (b) a multidisciplinary community care plan to which former item 720 applied, or a multidisciplinary discharge care plan to which former item 722 applied, prepared by that medical practitioner (or an associated medical practitioner); (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 721, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Management Plan. Y 00726 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to make a CONTRIBUTION to a multidisciplinary CARE PLAN (not being a payment in respect of a service to which items 740 to 773 apply) - not being an attendance in relation to a patient in respect of whom, in the preceding 6 months, a payment has been made under item 720 N 00726 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to contribute to a multidisciplinary COMMUNITY CARE PLAN or to a REVIEW of a multidisciplinary COMMUNITY CARE PLAN prepared by another provider (not being a payment for a service to which items 740 to 773 apply) - not being an attendance in relation to a patient for whom, in the preceding 6 months, a payment has been made under item 720 N 00726 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to contribute to a multidisciplinary COMMUNITY CARE PLAN or to a REVIEW of a multidisciplinary COMMUNITY CARE PLAN prepared by another provider (not being a payment for a service to which items 734 to 779 apply) - not being an attendance in relation to a patient for whom, in the preceding 6 months, a payment has been made under item 720 Y 00727 01JUL2005 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to COORDINATE a REVIEW of (a) TEAM CARE ARRANGEMENTS coordinated by that medical practitioner (or an associated medical practitioner) to which item 723 applies; or (b) a multidisciplinary community care plan to which former item 720 applied or a multidisciplinary discharge care plan to which former item 722 applied, prepared by that medical practitioner (or an associated medical practitioner); (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 723, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the coordination of a new review of Team Care Arrangements. Y 00728 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to make a CONTRIBUTION to a multidisciplinary DISCHARGE CARE PLAN (not being a service associated with a service to which items 722, 740 to 773 apply) N 00728 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to CONTRIBUTE to a multidisciplinary DISCHARGE CARE PLAN or to a REVIEW of a multidisciplinary DISCHARGE CARE PLAN prepared by another provider (not being a service associated with a service to which items 722, 734 to 779 apply) Y 00729 01JUL2005 CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to a multidisciplinary care plan prepared by another provider or to a REVIEW of a multidisciplinary care plan prepared by another provider (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a claim by the same practitioner for item 721 or 723, within three months of a claim for the same item or within three months of a claim for item 725, former item 726, item 727, former item 728 or item 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan. N 00729 01NOV2006 CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to a multidisciplinary care plan prepared by another provider or to a REVIEW of a multidisciplinary care plan prepared by another provider (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within twelve months of a claim by the same practitioner for item 721 or 723, within three months of a claim for the same item or within three months of a claim for item 725, item 727, or item 731, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan. N 00729 01MAY2010 Contribution by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 apply) N 00729 01JUL2018 Contribution by a general practitioner to a multidisciplinary care plan prepared by another provider or a review of a multidisciplinary care plan prepared by another provider (other than a service associated with a service to which any of items 735 to 758 apply) Y 00730 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary care plan team, to make a CONTRIBUTION to a multidisciplinary CARE PLAN IN A RESIDENTIAL AGED CARE FACILITY or to a REVIEW of a multidisciplinary CARE PLAN IN A RESIDENTIAL AGED CARE FACILITY prepared by the residential aged care facility (not being a payment in respect of a service to which items 734 to 779 apply) Y 00731 01JUL2005 CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to: (a) a multidisciplinary care plan for a patient in A RESIDENTIAL AGED CARE FACILITY, prepared by that facility, or to a REVIEW of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a resident by another provider before the resident is discharged from a hospital or an approved day-hospital facility, or to a review of such a plan prepared by another provider; (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 721, 723, 725, 727, 729 or former item 730, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan. N 00731 01NOV2006 CONTRIBUTION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to: (a) a multidisciplinary care plan for a patient in A RESIDENTIAL AGED CARE FACILITY, prepared by that facility, or to a REVIEW of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a resident by another provider before the resident is discharged from a hospital or an approved day-hospital facility, or to a review of such a plan prepared by another provider; (not being a service associated with a service to which items 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within three months of a claim for item 721, 723, 725, 727, 729, except where there has been a significant change in the patient's clinical condition or care circumstances that requires a new contribution to the multidisciplinary care plan. N 00731 01MAY2010 Contribution by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 apply) N 00731 01JUL2018 Contribution by a general practitioner to: (a) a multidisciplinary care plan for a patient in a residential aged care facility, prepared by that facility, or to a review of such a plan prepared by such a facility; or (b) a multidisciplinary care plan prepared for a patient by another provider before the patient is discharged from a hospital, or to a review of such a plan prepared by another provider (other than a service associated with a service to which items 735 to 758 apply) Y 00732 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to review or coordinate a review of: (a) a GP management plan prepared by a medical practitioner (or an associated medical practitioner) to which item 721 applies; or (b) team care arrangements which have been coordinated by the medical practitioner (or an associated medical practitioner) to which item 723 applies N 00732 01JUL2018 Attendance by a general practitioner to review or coordinate a review of: (a) a GP management plan prepared by a general practitioner (or an associated general practitioner) to which item 721 applies; or (b) team care arrangements which have been coordinated by the general practitioner (or an associated general practitioner) to which item 723 applies Y 00733 01JUL2018 Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which another item applies) by a medical practitioner - each attendance Y 00734 01NOV2000 CASE CONFERENCE - MEDICAL PRACTITIONER (OTHER THAN A SPECIALIST OR CONSULTANT PHYSICIAN) Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which item 731 applies) Y 00735 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply) N 00735 01JUL2018 Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply) Y 00736 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which item 731 applies) Y 00737 01JUL2018 Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes in duration (other than a service to which another item applies) by a medical practitioner - each attendance Y 00738 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, where the conference time is at least 45 minutes, (not being a service associated with a service to which item 731 applies) Y 00739 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply) N 00739 01JUL2018 Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply) Y 00740 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00740 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00740 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply) Y 00741 01JUL2018 Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner - each attendance Y 00742 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00742 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00742 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply) Y 00743 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply) N 00743 01JUL2018 Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to organise and coordinate: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply) Y 00744 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00744 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00744 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply) Y 00745 01JUL2018 Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner - each attendance Y 00746 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION N 00746 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00747 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply) N 00747 01JUL2018 Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 15 minutes, but for less than 20 minutes (other than a service associated with a service to which items 721 to 732 apply) Y 00748 01FEB1984 Initial major regional or field block, including abdominal; brachial plexus; caudal; cervical plexus (not including the uterine cervix); epidural (peridural) ; paravertebral (thoracic or lumbar); pudendal; sacral; spinal N 00748 01NOV1986 REGIONAL OR FIELD NERVE BLOCK, being one of the following nerve blocks — abdominal (in association with an intra-peritoneal operation), brachial plexus, caudal, cervical plexus (not including the uterine cervix), epidural (peridural), ilio inguinal-ilio hypogastric-genitofemoral, intercostal (involving any four or more nerves, one or both sides), paravertebral (thoracic or lumbar), pudendal; retrobulbar with facial nerve; sacral or spinal (intrathecal) N 00748 01SEP1989 Regional or field nerve block, being one of the following nerve blocks-abdominal (in association with an intraperitoneal operation); brachial plexus, cervical plexus (not including the uterine cervix); epidural (peridural); ilio-inguinal, ilio-hypogastric, genito-femoral, (involving all three nerves); intercostal (involving any four or more nerves, one or both sides); paravertebral (thoracic or lumbar); pudendal; retrobulbar with facial nerve; sacral or spinal (intrathecal) Y 00749 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION N 00749 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00750 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply) N 00750 01JUL2018 Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 20 minutes, but for less than 40 minutes (other than a service associated with a service to which items 721 to 732 apply) Y 00751 01MAR1987 MAINTENANCE OF A REGIONAL OR FIELD NERVE BLOCK referred to in Item 748 by the administration of local anaesthetic through an in situ needle or catheter when performed other than by the operating surgeon Y 00752 01FEB1984 Subsequent major regional or field block, including abdominal; brachial plexus; caudal; cervical plexus (not including the uterine cervix); epidural (peridural) ; paravertebral (thoracic or lumbar); pudendal; sacral; spinal N 00752 01AUG1987 INTRODUCTION OF A NARCOTIC, for the control of post-operative pain, into the epidural or intrathecal space in association with an operation Y 00753 01FEB1984 Epidural injection in lumbar or thoracic region for the control of post-operative pain, in association with general anaesthesia N 00753 01MAR1984 Introduction at the end of an operation of a narcotic or local anaesthetic into the lumbar or thoracic epidural space for the control of post-operative pain, in association with general anaesthesia N 00753 01NOV1986 INTRODUCTION at the end of an operation OF A NARCOTIC OR LOCAL ANAESTHETIC into the caudal,lumbar or thoracic epidural space for the control of post-operative pain,in association with general anaesthesia N 00753 01SEP1989 Introduction at the end of an operation of a local anaesthetic into the caudal, lumbar or thoracic epidural space for the control of post-operative pain, in association with general anaesthesia Y 00754 01AUG1987 MAINTENANCE of narcotic analgesia referred to in Item 752 by the administration of a narcotic through an in situ needle or catheter, when performed other than by the operating surgeon Y 00755 01FEB1984 Nerve block with local anaesthetic agent of the coeliac plexus, the lumbar sympathetic chain, the thoracic sympathetic chain, the glossopharyngeal nerve or the obturator nerve, with or without X-ray control N 00755 01NOV1986 NERVE BLOCK with local anaesthetic agent of the coeliac plexus, lumbar sympathetic chain, thoracic sympathetic chain glossopharyngeal nerve or obturator nerve, with or without x-ray control N 00755 01SEP1989 Nerve block with local anaesthetic agent of the coeliac plexus, the lumbar sympathetic chain, the thoracic sympathetic chain, the glossopharyngeal nerve or the obturator nerve, with or without X-ray control (AU 8) Y 00756 01FEB1984 Nerve block with alcohol, phenol or other neurolytic agent of the coeliac plexus, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain or a cranial nerve (other than the trigeminal nerve) or an epidural or caudal block with or without X-ray control, localization by electrical stimulator or preliminary block with local anaesthetic N 00756 01NOV1986 NERVE BLOCK with alcohol, phenol or other neurolytic agent of the coeliac plexus nerve, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain, or cranial nerve (other than the trigeminal nerve) or an epidural or caudal block With or without x-ray control, localisation by electrical stimulator or preliminary block with local anaesthetic N 00756 01SEP1989 Nerve block with alcohol, phenol or other neurolytic agent of the coeliac plexus, the splanchnic nerves, the lumbar sympathetic chain, the thoracic sympathetic chain or a cranial nerve (other than the trigeminal nerve) or an epidural or caudal block with or without X-ray control, localization by electrical stimulator or preliminary block with local anaesthetic (AU 8) Y 00757 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND CO-ORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION N 00757 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE, where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00758 01MAY2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply) N 00758 01JUL2018 Attendance by a general practitioner, as a member of a multidisciplinary case conference team, to participate in: (a) a community case conference; or (b) a multidisciplinary case conference in a residential aged care facility; or (c) a multidisciplinary discharge case conference; if the conference lasts for at least 40 minutes (other than a service associated with a service to which items 721 to 732 apply) Y 00759 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE, (other than to organise and co-ordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00759 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE, (other than to organise and co-ordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00759 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE, (other than to organise and coordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply) Y 00760 01FEB1984 Intravenous regional anaesthesia of limb by retrograde perfusion (G) N 00760 01MAR1987 Intravenous regional anaesthesia of limb by retrograde perfusion (G) Y 00761 01JUL2018 Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting not more than 5 minutes - an attendance on one or more patients on one occasion - each patient Y 00762 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00762 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00762 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply) Y 00763 01JUL2018 Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 5 minutes, but not more than 25 minutes - an attendance on one or more patients on one occasion - each patient Y 00764 01FEB1984 Intravenous regional anaesthesia of limb by retrograde perfusion (S) N 00764 01MAR1987 Intravenous regional anaesthesia of limb by retrograde perfusion (S) Y 00765 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00765 01MAY2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) N 00765 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply) Y 00766 01JUL2018 Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 25 minutes, but not more than 45 minutes - an attendance on one or more patients on one occasion - each patient Y 00767 01FEB1984 Assistance in the administration of an anaesthetic where the administration of the anaesthetic is in connection with a medical service which contains the reference (AU 21), (AU 22), (AU 23), (AU 24), (AU 25), (AU 26), (AU 27), (AU 28), (AU 29), (AU 30), (AU 32), (AU 36), (AU 38) or (AU 39) N 00767 01NOV1986 Assistance in the administration of an anaesthetic for which the anaesthetic unit value is not less than 21 units N 00767 01SEP1989 Assistance in the administration of an anaesthetic where the administration of the anaesthetic is in connection with a medical service which contains the reference (AU 21), (AU 22), (AU 23), (AU 24), (AU 25), (AU 26), (AU 27), (AU 28), (AU 29), (AU 30), (AU 32), (AU 34), (AU 35), (AU 36), (AU 38), (AU 39), (AU 40) or (AU 47) Y 00768 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION N 00768 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00769 01JUL2018 Professional attendance by a medical practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 45 minutes - an attendance on one or more patients on one occasion - each patient Y 00770 01FEB1984 Blood pressure recording by intravascular cannula (AU 4) N 00770 01NOV1986 BLOOD PRESSURE RECORDING by intravascular cannula N 00770 01MAR1987 BLOOD PRESSURE RECORDING by intravascular cannula Y 00771 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION N 00771 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00772 01JUL2018 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of not more than 5 minutes in duration by a medical practitioner - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 00773 01NOV1999 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and co-ordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 720 to 728 apply) - payable not more than once for each HOSPITAL ADMISSION N 00773 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE (other than to organise and coordinate the conference), where the conference time is at least 45 minutes (not being a service associated with a service to which items 721 to 731 apply) - payable not more than once for each HOSPITAL ADMISSION Y 00774 01FEB1984 Hyperbaric oxygen therapy where the medical practitioner is not in the chamber N 00774 01MAR1987 Hyperbaric oxygen therapy where the medical practitioner is not in the chamber Y 00775 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, (other than to organise and coordinate the conference), where the conference time is at least 15 minutes, but less than 30 minutes (not being a service associated with a service to which item 731 applies) Y 00776 01JUL2018 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of more than 5 minutes in duration but not more than 25 minutes in duration by a medical practitioner - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 00777 01FEB1984 Hyperbaric oxygen therapy where the medical practitioner is confined in the chamber N 00777 01MAR1987 Hyperbaric oxygen therapy where the medical practitioner is confined in the chamber Y 00778 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, (other than to organise and coordinate the conference), where the conference time is at least 30 minutes, but less than 45 minutes (not being a service associated with a service to which item 731 applies) Y 00779 01NOV2000 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician), as a member of a case conference team, to PARTICIPATE IN A CASE CONFERENCE IN A RESIDENTIAL AGED CARE FACILITY, (other than to organise and coordinate the conference), where the conference time is at least 45 minutes, (not being a service associated with a service to which item 731 applies) Y 00780 01MAY1990 URINE FLOW STUDY including peak urine flow measurement, not associated with Item 786 Y 00781 01MAY1990 CYSTOMETROGRAPHY, not associated with Items 784, 785, 786, 810817, 839, 5840 or any item in Part 8 Y 00782 01MAY1990 URETHRAL PRESSURE PROFILOMETRY, not associated with Items 783, 786, 810817, 839, 5840 or any item in Part 8 Y 00783 01MAY1990 URETHRAL PRESSURE PROFILOMETRY WITH simultaneous measurement of urethral sphincter electromyography, not associated with Items 782, 785, 786, 5840 or any item in Part 8 Y 00784 01MAY1990 CYSTOMETROGRAPHY with simultaneous measurement of rectal pressure, not associated with Items 781, 785, 786, 810817, 839, 5840 or any item in Part 8 Y 00785 01MAY1990 CYSTOMETROGRAPHY with simultaneous measurement of urethral sphincter electromyography, not associated with Items 781, 783, 784, 786, 810817, 839, 5840 or any item in Part 8 Y 00786 01MAY1990 CYSTOMETROGRAPHY with simultaneous measurement of any one or more of urine flow rate, urethral pressure profile, rectal pressure, urethral sphincter electromyography; and all associated fluoroscopic imaging, not associated with Items 780785, 810817, 839 and 5840 Y 00787 01FEB1984 Administration of a general anaesthetic (including the administration of oxygen) during hyperbaric therapy where the medical practitioner is not confined in the chamber N 00787 01NOV1986 ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practioner is NOT confined in the chamber N 00787 01MAR1987 ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practitioner is NOT confined in the chamber Y 00788 01JUL2018 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of more than 25 minutes in duration but not more than 45 minutes by a medical practitioner - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 00789 01JUL2018 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self contained unit) of more than 45 minutes in duration by a medical practitioner - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 00790 01FEB1984 Administration of a general anaesthetic (including the administration of oxygen) during hyperbaric therapy where the medical practitioner is confined in the chamber N 00790 01NOV1986 ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practioner is confined in the chamber N 00790 01MAR1987 ADMINISTRATION OF A GENERAL ANAESTHETIC (including the administration of oxygen) during HYPERBARIC THERAPY where the medical practitioner is confined in the chamber Y 00791 01FEB1984 Ultrasonic cross-sectional echography, not associated with Item 793, 794 or 913, where the patient is not referred by a medical practitioner for ultrasonic examination each ultrasonic examination not exceeding two examinations in any one pregnancy N 00791 01MAR1987 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, not associated with Item 793, 794 or 913 where the patient is not referred by a medical practitioner for ultrasonic examinationeach ultrasonic examination not exceeding two examinations in any one pregnancy Y 00792 01JUL2018 Professional attendance of at least 20 minutes in duration at consulting rooms by a medical practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non?directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or items 4001, 81000, 81005 or 81010 applies in relation to that pregnancy Y 00793 01FEB1984 Ultrasonic cross-sectional echography performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not associated with Item 791, 794 or 913 and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member N 00793 01MAR1987 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not associated with Item 791, 794 or 913 and where the referring medical practitioner is not a member of a group of practitioners of which the firstmentioned practitioner is a member Y 00794 01FEB1984 Ultrasonic echography, unidimensional, not associated with Item 792, 797 or 913 N 00794 01MAR1984 Ultrasonic echography, unidimensional not associated with Item 791, 793 or 913 N 00794 01MAR1987 ULTRASONIC ECHOGRAPHY, UNIDIMENSIONAL, not associated with Item 791, 793 or 913 Y 00795 01AUG1988 EXAMINATION OF PERIPHERAL VESSELS AT REST (unilateral or bilateral) with hard copy recordings of wave forms, involving one of the following techniquesDoppler recordings (pulsed, continuous wave, or both) of blood flow velocity with or without pulse volume recordings; Doppler recordings involving real time fast fourier transform analysis; venous occlusion plethysmography; air plethysmography; straingauge plethysmography; impedance plethysmography; or photo plethysmography; (not associated with Items 798 or 799) one examination and report Y 00796 01AUG1988 - two examinations of the kind referred to in Item 795 and report (not associated with Item 798 or 799) Y 00797 01FEB1984 Ultrasonic cross-sectional echography, bidimensional (excluding real-time scanning covered by Item 792), not associated with Item 792, 794 or 913 N 00797 01AUG1988 - three or more examinations of the kind referred to in Item 795 and report (not associated with Item 798 or 799) Y 00798 01AUG1988 EXAMINATION OF PERIPHERAL VESSELS and report, involving any of the techniques referred to in Item 795, with hard copy recording of wave forms before measured exercise using a treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral) Y 00799 01AUG1988 Measurement of digital temperature, one or more digits, (unilateral or bilateral) and report, with hard copy recording of temperature before and for 10 minutes or more after cold stress testing Y 00800 01AUG1988 Examination of carotid vessels (unilateral or bilateral) with hard copy recordings of wave forms, involving one of the following techniques-Doppler real time fast fourier transform analysis; oculoplethysmography, phonoangiography or both; or periorbital Doppler examination (not associated with item 990, 991, 992 or 993)-one examination and report Y 00801 01AUG1988 -two examinations of the kind referred to in item 800, and report (not associated with item 990, 991, 992 or 993) N 00801 01NOV2000 CASE CONFERENCE - CONSULTANT PHYSICIAN Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00802 01AUG1988 - threeor more examinations of the kind referred to in Item 795 and report (not associated with Item 990, 991 or 993) N 00802 01SEP1989 -three examinations of the kind referred to in item 800, and report (not associated with item 990, 991, 992 or 993) Y 00803 01FEB1984 Electroencephalography, not covered by Item 794, 797, 806 or 809 (AU 6) N 00803 01MAR1984 Electroencephalography, not associated with Item 793, 794,806 or 809 (AU 6) N 00803 01SEP1989 Electroencephalography, not associated with item 804, 806 or 809 (AU 6) N 00803 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A COMMUNITY CASE CONFERENCE of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00804 01AUG1988 Electroencephalography, prolonged recording of at least three hours duration, not associated with item 803, 806 or 809 Y 00805 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and to coordinate the conference) of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00806 01FEB1984 Electroencephalography, temporosphenoidal Y 00807 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A COMMUNITY CASE CONFERENCE (other than to organise and to coordinate the conference) of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00809 01FEB1984 Electrocorticography N 00809 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00810 01FEB1984 Neuromuscular electrodiagnosis-- conduction studies on one nerve or electromyography of one or more muscles using concentric needle electrodes or both these examinations (not associated with Item 811 or 813) Y 00811 01FEB1984 Neuromuscular electrodiagnosis-- conduction studies on two or three nerves with or without electromyography (not associated with Item 810 or 813) N 00811 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to ORGANISE AND COORDINATE A DISCHARGE CASE CONFERENCE of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00812 01JUL2018 Professional attendance at consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection19(2) of the Act applies Y 00813 01FEB1984 Neuromuscular electrodiagnosis-- conduction studies on four or more nerves with or without electromyography or recordings from single fibres of nerves and muscles or both of these examinations (not associated with Item 810 or 811) N 00813 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE of at least 30 minutes but less than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00814 01FEB1984 Neuromuscular electrodiagnosis-- repetitive stimulation for study of neuromuscular conduction or electromyography with quantitative computerised analysis or both of these examinations Y 00815 01NOV2000 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to PARTICIPATE IN A DISCHARGE CASE CONFERENCE of more than 60 minutes, with a multidisciplinary team of at least three other formal care providers of different disciplines (see note A24.6 on permissible combinations) Y 00816 01FEB1984 Investigation of cortical evoked responses-- 1 or 2 studies N 00816 01SEP1989 Investigation of central nervous system evoked responses by computerised averaging techniques-one or two studies Y 00817 01FEB1984 Investigation of cortical evoked responses-- 3 or more studies N 00817 01SEP1989 Investigation of central nervous system evoked responses by computerised averaging techniques-three or more studies Y 00818 01JAN1986 BRAIN stem evoked response audiometry ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S N 00818 01SEP1989 Brain stem evoked response audiometry (AU 6) Y 00819 01AUG1987 INSERTION OF ELECTRODES FOR THE PURPOSE OF ELECTROCOCHLEOGRAPHY Y 00820 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines N 00820 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines Y 00821 01FEB1984 Haemodialysis in hospital, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist exceeds 45 minutes in the one day N 00821 01SEP1989 Supervision in hospital by a medical specialist of-haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist exceeds 45 minutes in the one day Y 00822 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines N 00822 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines Y 00823 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines N 00823 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a community case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines Y 00824 01FEB1984 Haemodialysis in hospital, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist does not exceed 45 minutes in the one day N 00824 01SEP1989 Supervision in hospital by a medical specialist of-haemodialysis, haemofiltration, haemoperfusion or peritoneal dialysis, including all professional attendances, where the total attendance time on the patient by the supervising medical specialist does not exceed 45 minutes in the one day Y 00825 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team N 00825 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team Y 00826 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team N 00826 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team Y 00827 01JUL2018 Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); for an attendance on one or more patients at one place on one occasion - each patient Y 00828 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team N 00828 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team Y 00829 01JUL2018 Professional attendance of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self?contained unit; for an attendance on one or more patients at one place on one occasion - each patient Y 00830 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines N 00830 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines Y 00831 01FEB1984 Declotting of an arteriovenous shunt Y 00832 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines N 00832 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines Y 00833 01FEB1984 Indwelling peritoneal catheter (Tenckhoff or similar) for dialysis-- insertion and fixation of N 00833 01SEP1989 Indwelling peritoneal catheter (Tenckhoff or similar) for dialysis-insertion and fixation of (AU 8) Y 00834 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines N 00834 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 3 other formal care providers of different disciplines Y 00835 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 00835 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 00836 01FEB1984 Peritoneal dialysis, establishment of by abdominal puncture and insertion of temporary catheter (including associated consultation) Y 00837 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 00837 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 00838 01MAY2002 Attendance by a consultant physician in the practice of his or her specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 00838 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 00839 01FEB1984 Bladder washout test for localization of urinary infection not including bacterial counts for organisms in specimens Y 00840 01NOV1990 Assisted reproductive services (such as in vitro fertilisation, gamete intra-fallopian transfer or similar procedures) involving the use of drugs to induce superovulation, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services - but excluding services for treatment involving surrogacy arrangements, transfer of frozen embryos or donated embryos or ova - all such services rendered during the one treatment cycle, where the duration of the treatment cycle is at least nine days from commencement - a maximum of six claims per patient (not associated with item 104, 105, 791, 793, 794, 841, 842, 847, 960, 963, 2021, 2024-2034 or 4194). Y 00841 01FEB1984 Urinary flow study Y 00842 01NOV1990 Assisted reproductive services (such as in vitro fertilisation, gamete intra-fallopian transfer or similar procedures), using natural (unstimulated) ovulation or ovulation stimulated only by clomiphene citrate, and including quantitative estimation of hormones, ultrasound examinations, all treatment counselling and embryology laboratory services - but excluding services for treatment involving surrogacy arrangements, frozen embryo transfer or donated embryos or ova or involving the use of drugs to induce superovulation - all such services rendered during the one treatment cycle - only where rendered in conjunction with item 845 (not associated with item 791, 793, 794, 840, 841, 847, 960, 963, 2021 or 2024-2034) Y 00843 01FEB1984 Cystometrography Y 00844 01FEB1984 Tonography-- in the investigation or management of glaucoma N 00844 01MAR1984 Tonography - in the investigation or management of glaucoma, of one or both eyes - using an electrical tonography machine producing a directly recorded tracing Y 00845 01NOV1990 Oocyte retrieval by any means including laparoscopy or ultrasound-guided ova flushing, for the purposes of assisted reproductive technologies including in vitro fertilisation, gamete intra-fallopian transfer and similar procedures, excluding services related to surrogacy arrangements - where rendered in conjunction with item 840 or 842 (not associated with item 104, 105, 841 or 4194) (AU 9) Y 00846 01NOV1990 Transfer of embryos or both ova and sperm to the female reproductive system, by any means (including laparoscopy and gamete intra-fallopian transfer) excluding services related to: the transfer of frozen or donated embryos; artificial insemination; or surrogacy arrangements - where rendered in conjunction with item 840 or 842 - all such services rendered in the one treatment cycle (not associated with item 104, 105, 841, 960, 963 or 4194 ). (AU 9) Y 00847 01NOV1990 Preparation and transfer of frozen or donated embryos or both ova and sperm, to the female reproductive system, by any means (including laparoscopy) and including quantitative estimation of hormones and all treatment counselling but excluding services provided for the purposes of artificial insemination or surrogacy arrangements - all such services rendered in the one treatment cycle (not associated with item 104, 105, 840, 841, 842, 845, 846, 960, 963, 2021, 2024-2034 or 4194). (AU 9) Y 00848 01NOV1990 Preparation of semen for the purposes of assisted reproductive technologies including in vitro fertilisation and gamete intra-fallopian transfer or for artificial insemination using donated or husband's sperm, but excluding services related to surrogacy arrangements (not associated with item 2370-2373, 2377 or 2378). Y 00849 01FEB1984 Provocative test or tests for glaucoma, including water drinking Y 00850 01NOV1990 Tonography - in the investigation or management of glaucoma, one or both eyes - using an electrical tonography machine producing a directly recorded tracing Y 00851 01FEB1984 Attendance by a medical practitioner for the investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-- one attendance in any period of thirtysix consecutive months N 00851 01SEP1989 Investigation and evaluation of a patient for the fitting of contact lenses, with keratometry and testing with trial lenses and the issue of a prescription-one service in any period of thirty six consecutive months Y 00852 01AUG1987 REFITTING OF CONTACT LENSES with keratometry and testing with trial lenses and the issue of a prescription being a subsequent fitting of CONTACT LENSES WITHIN A PERIOD OF THIRTY-SIX MONTHS OF THE INITIAL FITTING WHICH IS COVERED BY ITEM 851 Y 00853 01FEB1984 Electroretinography N 00853 01MAR1984 Electroretinography of one or both eyes or electro-oculography of one or both eyes Y 00854 01FEB1984 Electroretinography of one or both eyes and electro-oculography of one or both eyes Y 00855 01NOV2002 Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team N 00855 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team Y 00856 01FEB1984 Optic fundi, examination of following intravenous dye injection Y 00857 01NOV2002 Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team N 00857 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team Y 00858 01NOV2002 Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team N 00858 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team Y 00859 01FEB1984 Retinal photography, multiple exposures, of one eye with intravenous dye injection Y 00860 01FEB1984 Retinal photography, multiple exposures of both eyes with intravenous dye injection Y 00861 01NOV2002 Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 00861 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 00862 01AUG1986 Non-determinate AUDIOMETRY Y 00863 01FEB1984 Audiogram, air conduction Y 00864 01NOV2002 Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 00864 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 00865 01FEB1984 Audiogram, air and bone conduction N 00865 01SEP1989 Audiogram, air and bone conduction or air conduction and speech discrimination Y 00866 01NOV2002 Attendance by a consultant physician in the practice of his or her specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 00866 01NOV2019 Attendance by a consultant physician in the practice of the consultant physician's specialty of psychiatry, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 00867 01JUL2018 Professional attendance at consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection19(2) of the Act applies Y 00868 01JUL2018 Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); for an attendance on one or more patients at one place on one occasion - each patient Y 00869 01JUL2018 Professional attendance of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self?contained unit; for an attendance on one or more patients at one place on one occasion - each patient Y 00870 01FEB1984 Audiogram, air and bone conduction and speech Y 00871 01NOV2006 Attendance by a medical practitioner (including a specialist or consultant physician in the practice of his or her specialty or a general practitioner), as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers N 00871 01JUL2018 Attendance by a general practitioner, specialist or consultant physician as a member of a case conference team, to lead and coordinate a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 3 other medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers Y 00872 01NOV2006 Attendance by a medical practitioner (including a specialist or consultant physician in the practice of his or her specialty or a general practitioner), as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers N 00872 01JUL2018 Attendance by a general practitioner, specialist or consultant physician as a member of a case conference team, to participate in a multidisciplinary case conference on a patient with cancer to develop a multidisciplinary treatment plan, if the case conference is of at least 10 minutes, with a multidisciplinary team of at least 4 medical practitioners from different areas of medical practice (which may include general practice), and, in addition, allied health providers Y 00873 01JUL2018 Professional attendance at consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner who provides clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection19(2) of the Act applies Y 00874 01FEB1984 Audiogram, air and bone conduction and speech, with other cochlear tests Y 00875 01AUG1986 GLYCEROL INDUCED COCHLEAR FUNCTION CHANGES assessed by a minimum of four air conduction and speech discrimination tests (Klockoff's tests) N 00875 01SEP1989 Glycerol induced cochlear function changes assessed by a minimum of four air conduction and speech discrimination tests (Klockoff's test) Y 00876 01JUL2018 Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); for an attendance on one or more patients at one place on one occasion - each patient Y 00877 01FEB1984 Impedance audiogram not associated with a service covered by Item 863, 865, 870 or 874 Y 00878 01FEB1984 Impedance audiogram in association with a service covered by Item 863, 865, 870 or 874 Y 00879 01NOV1990 Impedance audiogram where the patient is not referred by a medical practitioner - one examination in any four week period Y 00880 01MAY2006 CASE CONFERENCE - CONSULTANT PHYSICIAN IN GERIATRIC OR REHABILITATION MEDICINE Attendance by a consultant physician in the practice of his or her specialty of GERIATRIC OR REHABILITATION MEDICINE, as a member of a case conference team, to COORDINATE A CASE CONFERENCE ON AN ADMITTED HOSPITAL PATIENT of at least 10 minutes but less than 30 minutes, with a multidisciplinary team of at least two other formal care providers of different disciplines N 00880 01SEP2015 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of geriatric or rehabilitation medicine, as a member of a case conference team, to coordinate a case conference of at least 10 minutes but less than 30 minutes-for any particular patient, one attendance only in a 7 day period (other than attendance on the same day as an attendance for which item 832, 834, 835, 837 or 838 was applicable in relation to the patient) (H) N 00880 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of geriatric or rehabilitation medicine, as a member of a case conference team, to coordinate a case conference of at least 10 minutes but less than 30 minutes-for any particular patient, one attendance only in a 7 day period (other than attendance on the same day as an attendance for which item 832, 834, 835, 837 or 838 was applicable in relation to the patient) (H) Y 00881 01JUL2018 Professional attendance of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self?contained unit; for an attendance on one or more patients at one place on one occasion - each patient Y 00882 01FEB1984 Caloric test of labyrinth or labyrinths Y 00883 01AUG1986 SIMULTANEOUS BITHERMAL CALORIC TEST OF LABYRINTHS Y 00884 01FEB1984 Electronystagmography Y 00885 01JUL2018 Professional attendance at consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection19(2) of the Act applies Y 00886 01FEB1984 Electroconvulsive therapy, including associated consultation N 00886 01SEP1989 Electroconvulsive therapy, including associated consultation (AU 3) Y 00887 01FEB1984 Group psychotherapy (including associated consultations) of not less than 1 hour's duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a group of 2-9 unrelated patients or a family group of more than 3 patients, each of whom is referred to the consultant physician by a medical practitioner-- each patient Y 00888 01FEB1984 Group psychotherapy (including associated consultations) of not less than 1 hour's duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a family group of 3 patients, each of whom is referred to the consultant physician by a medical practitioner-- each patient Y 00889 01FEB1984 Group psychotherapy (including associated consultations) of not less than 1 hour's duration given under the continuous direct supervision of a consultant physician in the practice of his specialty of psychiatry, involving a family group of 2 patients, each of whom is referred to the consultant physician by a medical practitioner-- each patient Y 00890 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner, involving an interview of a person other than the patient of not less than 20 minutes duration in the course of initial diagnostic evaluation of the patient, where that interview is at consulting rooms, hospital or nursing home Y 00891 01JUL2018 Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist or physician mentioned in paragraph(a); for an attendance on one or more patients at one place on one occasion - each patient Y 00892 01JUL2018 Professional attendance of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self?contained unit; for an attendance on one or more patients at one place on one occasion - each patient Y 00893 01FEB1984 Professional attendance by a consultant physician in the practice of his specialty of psychiatry where the patient is referred to him by a medical practitioner, involving an interview of a person other than the patient of not less than 45 minutes duration in the course of initial diagnostic evaluation of the patient, where that interview is at consulting rooms, hospital or nursing home Y 00894 01NOV2018 Professional attendance at consulting rooms by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the medical practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (e) the patient has an existing relationship with the medical practitioner. N 00894 10JAN2020 Professional attendance by video conference by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the medical practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (ii) the patient has an existing relationship with the medical practitioner Y 00895 01FEB1984 Umbilical or scalp vein catheterisation with or without infusion N 00895 01SEP1989 Umbilical or scalp vein catheterisation with or without infusion; or cannulation of a vein in a neonate Y 00896 01NOV2018 Professional attendance at consulting rooms by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the medical practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (e) the patient has an existing relationship with the medical practitioner. N 00896 10JAN2020 Professional attendance by video conference by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the medical practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (ii) the patient has an existing relationship with the medical practitioner. Y 00897 01FEB1984 Umbilical artery catheterisation with or without infusion Y 00898 01NOV2018 Professional attendance at consulting rooms by a medical practitioner, lasting more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the medical practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (e) the patient has an existing relationship with the medical practitioner. N 00898 10JAN2020 Professional attendance by video conference by a medical practitioner, lasting more than 45 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the medical practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner; and (ii) the patient has an existing relationship with the medical practitioner Y 00899 02MAR2019 Professional attendance at consulting rooms by a medical practitioner, lasting not more than 5 minutes in duration, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 00900 01OCT2001 Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for patients living in the community setting, where the medical practitioner: -assesses a patient's medication management needs, and following that assessment, refers the patient to a community pharmacy for a DMMR, and provides relevant clinical information required for the review, with the patient's consent; and -discusses with the reviewing pharmacist the results of that review including suggested medication management strategies; and -develops a written medication management plan following discussion with the patient. Benefits under this item are payable not more than once in each 12 month period, except where there has been a significant change in the patient's condition or medication regimen requiring a new DMMR. N 00900 01NOV2002 Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for patients living in the community setting, where the medical practitioner: -assesses a patient's medication management needs, and following that assessment, refers the patient to a community pharmacy for a DMMR, and provides relevant clinical information required for the review, with the patient's consent; and -discusses with the reviewing pharmacist the results of that review including suggested medication management strategies; and -develops a written medication management plan following discussion with the patient. Benefits under this item are payable not more than once in each 12 month period, except where there has been a significant change in the patient's condition or medication regimen requiring a new DMMR. N 00900 01OCT2011 Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for patients living in a community setting, in which the medical practitioner: (a) assesses a patient's medication management needs and, following that assessment, refers the patient to a community pharmacy or an accredited pharmacist for a DMMR and, with the patient's consent, provides relevant clinical information required for the review; and (b) discusses with the reviewing pharmacist the results of that review including suggested medication management strategies; and (c) develops a written medication management plan following discussion with the patient For any particular patient-applicable not more than once in each 12 month period, except if there has been a significant change in the patient's condition or medication regimen requiring a new DMMR N 00900 01FEB2018 Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the medical practitioner, with the patient's consent: (a) assesses the patient as: (i) having a chronic medical condition or a complex medication regimen; and (ii) not having their therapeutic goals met; and (b) following that assessment: (i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and (ii) provides relevant clinical information required for the DMMR; and (c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and (d) develops a written medication management plan following discussion with the patient; and (e) provides the written medication management plan to a community pharmacy chosen by the patient For any particular patient - applicable not more than once in each 12 month period, except if there has been a significant change in the patient's condition or medication regimen requiring a new DMMR N 00900 01JUL2018 Participation by a general practitioner in a Domiciliary Medication Management Review (DMMR) for a patient living in a community setting, in which the general practitioner, with the patient's consent: (a) assesses the patient as: (i) having a chronic medical condition or a complex medication regimen; and (ii) not having their therapeutic goals met; and (b) following that assessment: (i) refers the patient to a community pharmacy or an accredited pharmacist for the DMMR; and (ii) provides relevant clinical information required for the DMMR; and (c) discusses with the reviewing pharmacist the results of the DMMR including suggested medication management strategies; and (d) develops a written medication management plan following discussion with the patient; and (e) provides the written medication management plan to a community pharmacy chosen by the patient For any particular patient - applicable not more than once in each 12 month period, except if there has been a significant change in the patient's condition or medication regimen requiring a new DMMR Y 00901 02MAR2019 Professional attendance at consulting rooms by a medical practitioner, lasting more than 5 minutes but not more than 25 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 00902 01FEB1984 Blood transfusion with venesection and complete replacement of blood, including collection from donor N 00902 01MAR1984 Blood transfusion with venesection and complete replacement of blood, including collection from donor 904 Y 00903 01NOV2004 Participation by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) in a collaborative Residential Medication Management Review (RMMR) for a permanent resident of a residential aged care facility, where the medical practitioner: -discusses and seeks consent for an RMMR from the new or existing resident; -initiates the RMMR and collaborates with the reviewing pharmacist regarding the pharmacy component of the review; -provides input from the resident's Comprehensive Medical Assessment (CMA), or if a CMA has not been undertaken, provides relevant clinical information for the resident's RMMR; -discusses findings of the pharmacist review and proposed medication management strategies with the reviewing pharmacist (unless exceptions apply); -develops and/or revises a written medication plan for the resident; and -consults with the resident to discuss the medication mangement plan and its implementation. Benefits under this item are payable for one RMMR service for new residents on admission to a Residential Aged Care Facility and for continuing residents on an as required basis, with a maximum of one RMMR for a resident in any 12 month period, except where there has been a significant change in medical condition or medication regimen requiring a new RMMR. N 00903 01NOV2005 Participation by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item has applied, unless there has been a significant change in the resident's medical condition or medication management plan requiring a new RMMR N 00903 01JUL2018 Participation by a general practitioner in a residential medication management review (RMMR) for a patient who is a permanent resident of a residential aged care facility-other than an RMMR for a resident in relation to whom, in the preceding 12 months, this item has applied, unless there has been a significant change in the resident's medical condition or medication management plan requiring a new RMMR Y 00904 01FEB1984 Blood transfusion with venesection and complete replacement of blood, using blood already collected Y 00905 02MAR2019 Professional attendance at consulting rooms by a medical practitioner, lasting more than 25 minutes but not more than 45 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 00906 02MAR2019 Professional attendance at consulting rooms by a medical practitioner, lasting more than 45 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 00907 01FEB1984 Blood for pathology test, collection of, by femoral or external jugular vein puncture in infants Y 00908 01FEB1984 Electrocardiography, tracing and report, with or without implanted pacemaker testing N 00908 01MAR1984 Twelve-lead electrocardiography, tracing and report Y 00909 01FEB1984 Electrocardiography, tracing or report only N 00909 01MAR1984 Twelve-lead electrocardiography, tracing only, or twelve-lead electrocardiography, report only where the tracing has been forwarded to another medical practitioner, not associated with an attendance item in Part N 00909 01SEP1989 Twelve-lead electrocardiography, report only where the tracing has been forwarded to another medical practitioner, not associated with an attendance item in Part 1, or twelve-lead electrocardiography, tracing only Y 00910 01NOV1990 Two Dimensional real time transoesophageal echocardiographic examination of the heart, not associated with any other echocardiographic examination Y 00911 01NOV1990 Two Dimensional real time transoesophageal echocardiographic examination of the heart, associated with another echocardiographic examination Y 00912 01FEB1984 Phonocardiography N 00912 01SEP1989 Phonocardiography with electrocardiograph lead with indirect arterial or venous pulse tracing, with or without apex cardiogram-interpretation and report Y 00913 01FEB1984 Echocardiography, not covered by Item 792 N 00913 01MAR1984 Echocardiography, not covered by Item 791 or 793 Y 00915 01FEB1984 Electrocardiographic monitoring (continuous) of ambulatory patient including resting electrocardiography and the recording of other parameters N 00915 01MAR1984 Continuous ECG monitoring(Holter) of an ambulatory patient for twelve or more hours involving recording, scanning analysis, interpretation and report, including resting ECG and the recording of other parameters Y 00916 01FEB1984 Electrocardiographic monitoring during exercise with apparatus such as bicycle ergometer or treadmill including resting electrocardiography and the recording of other parameters N 00916 01SEP1989 Electrocardiographic monitoring during exercise, with apparatus such as bicycle ergometer or treadmill, involving the continuous attendance of a medical practitioner for not less than 20 minutes, including resting electrocardiography and with or without recording of other parameters, on premises equipped with mechanical respirator and defibrillator Y 00917 01FEB1984 Restoration of cardiac rhythm by electrical stimulation (cardioversion), other than in the course of cardiac surgery (AU4) Y 00918 01FEB1984 Bronchospirometry, including gas analysis Y 00920 01FEB1984 Estimation of respiratory function requiring complicated techniques-- each attendance at which one or more tests are performed Y 00921 01FEB1984 Estimation of respiratory function involving a directly recorded tracing, performed before and after inhalation of a bronchodilator, a cholinergic substance or a sensitising agent, or before and after exercise-- one or more such tests performed on the one occasion Y 00922 01FEB1984 Perfusion of limb or organ using heart-lung machine or equivalent Y 00923 01FEB1984 Whole body perfusion, cardiac bypass, using heart-lung machine or equivalent Y 00924 01SEP1989 Hyperthermic isolated limb perfusion including vascular cannulation by open operation and subsequent removal of catheters (AU 30) Y 00925 01FEB1984 Induced controlled hypothermia-- total body Y 00926 01MAY1990 MEASUREMENT OF RESPIRATORY FUNCTION involving a permanently recorded tracing and written report, performed before and after inhalation of bronchodilator, with continuous technician attendance in a laboratory equipped to perform complex respiratory function tests; the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital - each occasion at which one or more such tests are performed Y 00927 01FEB1984 Fluids, intravenous infusion of-- percutaneous N 00927 01MAR1984 Fluids, intravenous drip infusion of - percutaneous Y 00928 01MAY1990 CONTINUOUS MEASUREMENT OF THE RELATIONSHIP BETWEEN FLOW AND VOLUME DURING EXPIRATION OR INSPIRATION involving a permanently recorded tracing and written report, performed before and after inhalation of bronchodilator, with continuous technician attendance in a laboratory equipped to perform complex lung function tests; the tests being performed under the supervision of a specialist or consultant physician or in the respiratory laboratory of a hospital - each occasion at which one or more such tests are performed Y 00929 01FEB1984 Fluids, intravenous infusion of-- by open exposure N 00929 01MAR1984 Fluids, intravenous drip infusion of - by open exposure Y 00931 01JAN1986 INTRA-ARTERIAL INFUSION or retrograde intra-venous perfusion of a sympatholytic agent Y 00932 01FEB1984 Intravenous infusion or injection of a substance incorporating a cytotoxic agent N 00932 01SEP1989 Administration of a cytotoxic agent by intravenous drip infusion or by introduction into the bladder Y 00934 01FEB1984 Intra-arterial infusion or injection of a substance incorporating a cytotoxic agent, preparation for N 00934 01MAR1984 Intra-arterial infusion or injection of a substance incorporating a cytotoxic agent, preparation for 936 N 00934 01SEP1989 Intra-arterial infusion or intra-arterial injection of a substance incorporating a cytotoxic agent, preparation for Y 00936 01FEB1984 Intralymphatic infusion or injection of a fluid containing a cytotoxic agent, with or without the incorporation of an opaque medium N 00936 01SEP1989 Intralymphatic infusion or intralymphatic injection of a fluid containing a cytotoxic agent, with or without the incorporation of an opaque medium Y 00938 01FEB1984 Intralymphatic insertion of needle or cannula for the introduction of radio-active material Y 00939 01FEB1986 HARVESTING OF HOMOLOGOUS (including allogeneic) bone marrow for the purpose of transplantation ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 00939 01SEP1989 Harvesting of homologous (including allogeneic) or autologous bone marrow for the purpose of transplantation (AU 10) Y 00940 01FEB1984 Administration of blood including collection from donor N 00940 01MAR1984 Administration of blood including collection from donor 944 Y 00944 01FEB1984 Administration of blood already collected N 00944 01SEP1989 Administration of blood or bone marrow already collected Y 00947 01FEB1984 Intra-uterine foetal blood transfusion using blood already collected, including necessary amniocentesis Y 00949 01FEB1984 Collection of blood for purposes of transfusion N 00949 01SEP1989 Collection of blood for autologous transfusion or when homologous blood is required for immediate transfusion in emergency situation Y 00950 01FEB1984 Central vein catheterisation (via jugular or subclavian vein) by open exposure for parenteral alimentation in a person under twelve years of age (AU 12) N 00950 01SEP1989 Central vein catheterisation (via jugular or subclavian vein) by open exposure, in a person under twelve years of age (AU 12) Y 00951 01FEB1984 Central vein catheterisation (via jugular or subclavian vein) by percutaneous or open exposure for parenteral alimentation not covered by Item 950 (AU 6) N 00951 01SEP1989 Central vein catheterisation (via jugular or subclavian vein) by percutaneous or open exposure, not covered by Item 950 (AU 6) Y 00952 01FEB1984 Blood dye-- dilution indicator test Y 00953 01JAN1986 RIGHT HEART BALLOON FLOTATION (Swann-Ganz) catheterisation, insertion of catheter and monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry ~ management on the first day Y 00954 01JAN1986 RIGHT HEART BALLOON FLOTATION (Swann-Ganz) catheterisation, monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry - management on each day subsequent to the first N 00954 01SEP1989 Right heart balloon flotation (Swann-Ganz) catheterisation, monitoring of right heart and pulmonary wedge pressures, cardiac output and blood oximetry-management on each day subsequent to the first Y 00955 01NOV1979 Venepuncture and the collection of blood for the performance by an approved pathology practitioner of a pathology service-- one or more such procedures during the one attendance N 00955 01MAR1984 Venepuncture and the collection of blood for forwarding to an approved pathology practitioner for the performance of a pathology service, where the referring medical practitioner is not a member of a group of practitioners of which the approved pathology practitioner is a member - one or more such procedures during the one attendance Y 00956 01FEB1984 Arterial puncture and collection of blood for diagnostic purposes Y 00957 01FEB1984 Intra-arterial cannulisation for purpose of taking multiple arterial blood samples for blood gas analysis Y 00958 01FEB1984 Collection of specimen of sweat by iontophoresis Y 00960 01FEB1984 Hormone or living tissue implantation-- by incision Y 00963 01FEB1984 Hormone or living tissue implantation-- by cannula Y 00966 01FEB1984 Oesophageal motility test, manometric Y 00968 01FEB1984 Gastric hypothermia by closed circuit circulation of refrigerant in the absence of gastrointestinal haemorrhage Y 00970 01FEB1984 Gastric hypothermia by closed circuit circulation of refrigerant for upper gastrointestinal haemorrhage Y 00974 01FEB1984 Gastric lavage in the treatment of ingested poison Y 00976 01FEB1984 Counterpulsation by intra-aortic balloon-- management on the first day, including initial and subsequent consultations and monitoring of parameters N 00976 01SEP1989 Counterpulsation by intra-aortic balloon-management on the first day, including percutaneous insertion, initial and subsequent consultations and monitoring of parameters Y 00977 01FEB1984 Counterpulsation by intra-aortic balloon-- management on each day subsequent to the first, including associated consultations and monitoring of parameters Y 00978 01AUG1987 PUVA THERAPY or UVB THERAPY administered in whole body cabinet, not associated with Item 979 including associated consultations other than an initial consultation Y 00979 01AUG1987 PUVA THERAPY or UVB THERAPY administered to localised body areas in a hand and foot cabinet not associated with item 978 including associated consultations other than an initial consultation Y 00980 01FEB1984 Attendance by a medical practitioner at which acupuncture is performed by application of stimuli on or through the surface of the skin by any means, including any associated consultation on the same day N 00980 01MAR1984 Attendance at which acupuncture is performed by a medical practitioner by application of stimuli on or through the surface of the skin by any means, including any consultation on the same occasion and any other attendance on the same day related to the condition for which the acupuncture was performed Y 00981 01JUL1985 URINARY FLOW STUDY N 00981 01SEP1989 Urine flow study Y 00982 01JUL1985 CYSTOMETROGRAPHY Y 00983 01JUL1985 URETHRAL PRESSURE PROFILE MEASUREMENT N 00983 01SEP1989 Urethral pressure profile Y 00984 01JUL1985 CYSTOMETROGRAPHY with rectal pressure measurement or bladder sphincter electromyography ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S N 00984 01SEP1989 Cystometrography with rectal pressure measurement or bladder sphincter electromyography (AU 6) Y 00985 01JAN1986 CYSTOMETROGRAPHY, rectal pressure measurement or sphincter electromyography, urinary flow and retrograde micturating cystourethrography including all associated radiological services N 00985 01SEP1989 Cystometrography, rectal pressure measurement or sphincter electromyography and urine flow study including all associated imaging procedures Y 00987 01FEB1984 Skin sensitivity testing for allergens, using one to twenty allergens Y 00989 01FEB1984 Skin sensitivity testing for allergens, using more than twenty allergens Y 00990 01AUG1988 Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries), peripheral vessels, or intra-thoracic or intra-abdominal vascular vessels (excluding cardiac and pregnancy related studies) (not associated with item 793)-one examination and report-two or more examinations of the kind referred to in item 990 and report (not associated with item 793) Y 00991 01AUG1988 - two or more examinations of the kind referred to in item 990 and report (not associated with Item 793) Y 00992 01AUG1988 Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography (not associated with item 793)-examination and report Y 00993 01AUG1988 Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels and carotid vessels, with oculoplethysmography (not associated with item 793)-examination and report Y 00994 01FEB1984 Multiphasic health screening service involving the performance of ten or more medical services specified in items in Parts 6, 7 and 8 (including any associated consultation) Y 00995 01AUG1988 Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including any of the investigations covered by item 795, 796 or 797 (not associated with item 793)-examination and report Y 00996 01FEB1984 Family group therapy (including associated consultation) of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family, where the group consists of two patients-- each patient Y 00997 01FEB1984 Family group therapy (including associated consultation) of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family, where the group consists of three patients-- each patient Y 00998 01FEB1984 Family group therapy (including associated consultation) of not less than one hour's duration given under the direct continuous supervision of a medical practitioner, other than a consultant physician in the practice of his specialty of psychiatry, involving members of a family and persons with close personal relationships with that family, where the group consists of four to six patients-- each patient Y 00999 01AUG1988 Duplex scanning (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels, including any of the investigations covered by item 798 (not associated with item 793-examination and report Y 01001 01NOV1988 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (SP) Y 01002 01NOV1988 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (PP) Y 01003 01NOV1988 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (OP) Y 01004 01NOV1988 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haemoglobin, platelet count, leucocyte count - one or two procedures when requested by another medical practitioner. (RP) Y 01005 01NOV1988 Three or more procedures to which item 1001 applies, including any calculation or measurement of erythrocyte or other indices (SP) Y 01006 01JUL1982 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count-- one procedure (SP) Y 01007 01JUL1982 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count-- one procedure (excluding blood count consisting of haemoglobin estimation or erthrocyte sedimentation rate when not referred by another medical practitioner) (OP) Y 01008 01FEB1984 Two procedures to which Item 1006 applies (SP) Y 01009 01FEB1984 Two procedures to which Item 1007 applies (OP) Y 01010 01JUL1982 Blood count consisting of erythrocyte count, erythrocyte sedimentation rate, haematocrit estimation, haemoglobin estimation, platelet count or leucocyte count-- 2 procedures (excluding blood count consisting of haemoglobin estimation or erythrocyte sedimentation rate when not referred by another medical practitioner) (HP) Y 01011 01FEB1984 Three or more procedures to which Item 1006 applies including calculation of erythrocyte indices where done (SP) Y 01012 01FEB1984 Three or more procedures to which Item 1007 applies including calculation of erythrocyte indices where done (OP) Y 01013 01JUL1982 Three or more procedures to which Item 1010 applies including calculation of erythrocyte indices where done (HP) Y 01014 01FEB1984 Blood film, examination of-- including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (SP) Y 01015 01FEB1984 Blood film, examination of-- including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (OP) Y 01016 01JUL1982 Blood film, examination of-- including erythrocyte morphology, differential count by one or more methods and the qualitative estimation of platelets (HP) Y 01017 01NOV1988 Three or more procedures to which item 1002 applies, including any calculation or measurement of erythrocyte or other indices (PP) Y 01018 01NOV1988 Three or more procedures to which item 1003 applies, including any calculation or measurement of erythrocyte or other indices (OP) Y 01019 01JUL1982 Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances-- one procedure (SP) Y 01020 01JUL1982 Blood film, examination by special stains to demonstrate the presence of basophilic stippling, eosinophils (where wet preparation or film is used), haemoglobin H, reticulocytes, or similar conditions, cells or substances-- one procedure (OP) Y 01021 01JUL1982 Two or more procedures to which Item 1019 applies (SP) Y 01022 01JUL1982 Two or more procedures to which Item 1020 applies (OP) Y 01023 01NOV1988 Three or more procedures to which item 1004 applies, including any calculation or measurement of erythrocyte or other indices (RP) Y 01024 01NOV1988 Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1041 or 1091 (SP) Y 01025 01NOV1988 Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1042 or 1092 (PP) Y 01026 01NOV1988 Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1043 or 1093 (OP) Y 01027 01NOV1988 Examination of blood film by a person, with or without differential cell count, or differential cell count by a counting instrument with or without examination of blood film by a person, including any services specified in items 1046 or 1094 (RP) Y 01028 01JUL1982 Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-- one procedure (SP) Y 01029 01JUL1982 Blood film, examination by special stains to demonstrate the presence of foetal haemoglobin, Heinz bodies, iron, malarial or other parasites, neutrophil alkaline phosphatase, PAS, Sudan black positive granules, sickle cells, or any similar cells, substances or parasites-- one procedure (OP) Y 01030 01JUL1982 Two or more procedures to which Item 1028 applies (SP) Y 01032 01JUL1982 Two or more procedures to which Item 1029 applies (OP) Y 01033 01NOV1988 Full blood examination, consisting of items 1005 and 1024. (SP) Y 01034 01NOV1988 Full blood examination, consisting of items 1017 and 1025. (PP) Y 01035 01NOV1988 Full blood examination, consisting of items 1018 and 1026. (OP) Y 01036 01JUL1982 Erythrocytes, qualitative assessment of metabolism or haemolysis by-- erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical) , glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria-- one procedure (SP) Y 01037 01JUL1982 Erythrocytes, qualitative assessment of metabolism or haemolysis by-- erythrocyte autohaemolysis test, erythrocyte fragility test (mechanical) , glucose-6-phosphate dehydrogenase estimation, glutathione deficiencies test, pyruvate kinase estimation or sugar water test (or similar) for paroxysmal nocturnal haemoglobinuria-- one procedure (OP) Y 01038 01JUL1982 Two or more procedures to which Item 1036 applies (SP) Y 01039 01NOV1988 Full blood examination, consisting of items 1023 and 1027. (RP) Y 01040 01JUL1982 Two or more procedures to which Item 1037 applies (OP) Y 01041 01NOV1988 Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (SP) Y 01042 01NOV1988 Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (PP) Y 01043 01NOV1988 Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (OP) Y 01044 01JUL1982 Erythrocytes, quantitative assessment of metabolism or haemolysis by-- acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation, or pyruvate kinase estimation-- one procedure (SP) Y 01045 01JUL1982 Erythrocytes, quantitative assessment of metabolism or haemolysis by-- acid haemolysis test (or similar) for paroxysmal nocturnal haemoglobinuria, erythrocyte fragility to hypotonic saline test without incubation, erythrocyte fragility to hypotonic saline test after incubation, glutathione stability test, glucose-6-phosphate dehydrogenase estimation, or pyruvate kinase estimation-- one procedure (OP) Y 01046 01NOV1988 Blood film, examination by special stains to demonstrate reticulocytes, haemoglobin H, fetal haemoglobin, Heinz bodies, iron, parasites, sickle cells or examination by the following techniques - alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff or Sudan black - one or more of these procedures. (RP) Y 01047 01NOV1988 Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (SP) Y 01048 01JUL1982 Two or more procedures to which Item 1044 applies (SP) Y 01049 01JUL1982 Two or more procedures to which Item 1045 applies (OP) Y 01050 01NOV1988 Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (PP) Y 01051 01NOV1988 Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (OP) Y 01052 01JUL1985 Viscosity of plasma or whole blood, estimation of - each procedure. (SP) Y 01053 01JUL1985 Viscosity of plasma or whole blood, estimation of - each procedure. (OP) Y 01054 01NOV1988 Erythrocytes, qualitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test - one or more of these procedures. (RP) Y 01055 01NOV1988 Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1001, 1005, 1024 and 1033 . (SP) Y 01056 01NOV1988 Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1002, 1017, 1025 and 1034 . (PP) Y 01057 01NOV1988 Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1003, 1018, 1026 and 1035 . (OP) Y 01058 01NOV1988 Haemoglobin electrophoresis for diagnosis of haemoglobinopathy including qualitative and quantative tests and direct or indirect measurement of any haemoglobin fraction by any method and any services specified in items 1004, 1023, 1027 and 1039 . (RP) Y 01059 01NOV1988 Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1001, 1005, 1024 and 1033, performed on the same day as the biopsy. (SP) Y 01060 01NOV1988 Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1002, 1017, 1025 and 1034, performed on the same day as the biopsy. (PP) Y 01061 01NOV1988 Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1003, 1018, 1026 and 1035, performed on the same day as the biopsy. (OP) Y 01062 01JUL1982 Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-- one procedure (SP) Y 01063 01JUL1982 Bone marrow examination (including use of special stains where indicated) of bone marrow aspirate, clot section or trephine section-- one procedure (OP) Y 01064 01JUL1982 Two or more procedures to which Item 1062 applies (SP) Y 01065 01JUL1982 Two or more procedures to which Item 1063 applies (OP) Y 01066 01NOV1988 Bone marrow examination, including histopathology examination of sections or examination of smears using any special stains and immuno-chemical techniques which may be necessary, and including any services specified in items 1004, 1023, 1027 and 1039, performed on the same day as the biopsy. (RP) Y 01067 01NOV1988 Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (SP) Y 01068 01NOV1988 Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (PP) Y 01069 01NOV1988 Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (OP) Y 01070 01NOV1988 Blood grouping, including back-grouping when performed - ABO and Rh (D antigen). (RP) Y 01071 01NOV1988 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1067. (SP) Y 01072 01NOV1988 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1068. (PP) Y 01073 01NOV1988 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1069. (OP) Y 01074 01NOV1988 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any services specified in item 1070. (RP) Y 01075 01NOV1988 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1001, 1005, 1024 and 1033. (SP) Y 01076 01NOV1988 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1002, 1017, 1025 and 1034. (PP) Y 01077 01NOV1988 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1003, 1018, 1026 and 1035. (OP) Y 01078 01NOV1988 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1004, 1023, 1027 and 1039. (RP) Y 01079 01NOV1988 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1001, 1005, 1024, 1033, 1067 and 1075 including all testing performed on any one day. (SP) Y 01080 01JUL1982 Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) (not covered by Item 1089) (SP) Y 01081 01JUL1982 Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) (not covered by Item 1090) (OP) Y 01082 01NOV1988 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1002, 1017, 1025, 1034, 1068, and 1076 including all testing performed on any one day. (PP) Y 01083 01NOV1988 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1003, 1018, 1026, 1035, 1069 and 1077 including all testing performed on any one day. (OP) Y 01084 01NOV1988 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and quantitative estimation of any antibodies detected and any services specified in items 1004, 1023, 1027, 1039, 1070 and 1078 including all testing performed on any one day. (RP) Y 01085 01NOV1988 Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (SP) Y 01086 01NOV1988 Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (PP) Y 01087 01NOV1988 Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (OP) Y 01088 01NOV1988 Examination of serum for blood group antibodies - initial test or tests, including identification and quantitative estimation of any antibodies detected. (RP) Y 01089 01JUL1982 Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) when performed in association with the compatibility testing covered by Item 1112 or 1114 (SP) Y 01090 01JUL1982 Blood grouping (including back grouping when performed)-- ABO and Rh (D antigen) when performed in association with the compatibility testing covered by Item 1113 or 1116 (OP) Y 01091 01NOV1988 Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1024 or 1033. (SP) Y 01092 01NOV1988 Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1025 or 1034. (PP) Y 01093 01NOV1988 Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1026 or 1035. (OP) Y 01094 01NOV1988 Direct Coombs test, test for cold agglutinins, tests for heterophile antibodies or EB virus antibodies - one or more tests when performed other than as specified in items 1027 or 1039. (RP) Y 01095 01NOV1988 Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (SP) Y 01096 01NOV1988 Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (PP) Y 01097 01NOV1988 Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (OP) Y 01098 01NOV1988 Spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins - one or more examinations or tests. (RP) Y 01099 01NOV1988 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (SP) Y 01100 01NOV1988 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (PP) Y 01101 01JUL1982 Blood grouping-- Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system-- one system (SP) Y 01102 01JUL1982 Blood grouping-- Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system-- one system (OP) Y 01103 01NOV1988 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (OP) Y 01104 01JUL1982 Two procedures to which Item 1101 applies (SP) Y 01105 01JUL1982 Two procedures to which Item 1102 applies (OP) Y 01106 01JUL1982 Each procedure to which Item N 01106 01MAR1984 Each procedure to which Item 1101 applies in excess of two (SP) Y 01107 01NOV1988 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), heparin, heparin cofactor II, lupus anticoagulant, antithrombin III, protein C, protein S - one estimation. (RP) Y 01108 01JUL1982 Each procedure to which Item N 01108 01MAR1984 Each procedure to which Item 1102 applies in excess of two (OP) Y 01109 01NOV1988 Two estimations specified in item 1099. (SP) Y 01110 01NOV1988 Two estimations specified in item 1100. (PP) Y 01111 01FEB1984 Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- testing involving one or two units of blood (SP) Y 01112 01FEB1984 Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- testing involving one or two units of blood (OP) Y 01113 01JUL1982 Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- testing involving one or two units of blood (HP) Y 01114 01FEB1984 Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- each unit of blood tested in excess of two (SP) Y 01115 01NOV1988 Two estimations specified in item 1103. (OP) Y 01116 01FEB1984 Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- each unit of blood tested in excess of two (OP) Y 01117 01JUL1982 Compatibility testing by saline, papain, albumin or indirect Coombs techniques (by one or more of those techniques), including auto-cross-match and donor group check where performed-- each unit of blood tested in excess of two (HP) Y 01118 01NOV1988 Two estimations specified in item 1107. (RP) Y 01119 01NOV1988 Three estimations specified in item 1099. (SP) Y 01120 01NOV1988 Three estimations specified in item 1100. (PP) Y 01121 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) (SP) Y 01122 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) (OP) Y 01123 01NOV1988 Three estimations specified in item 1103. (OP) Y 01124 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) and quantitative estimation of one antibody (SP) Y 01125 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- screening test (by one or more of those techniques) and quantitative estimation of one antibody (OP) Y 01126 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of one antibody (SP) Y 01127 01NOV1988 Three estimations specified in item 1107. (RP) Y 01128 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of one antibody (OP) Y 01129 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of each antibody in excess of one (SP) Y 01130 01JUL1982 Examination of serum for Rh antibodies or other blood group antibodies or both Rh antibodies and other blood group antibodies-- quantitative estimation of each antibody in excess of one (OP) Y 01131 01NOV1988 Four estimations specified in item 1099. (SP) Y 01132 01NOV1988 Four estimations specified in item 1100. (PP) Y 01133 01NOV1988 Four estimations specified in item 1103. (OP) Y 01134 01NOV1988 Four estimations specified in item 1107. (RP) Y 01135 01NOV1988 Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (SP) Y 01136 01JUL1982 Coombs test, direct (SP) Y 01137 01JUL1982 Coombs test, direct (OP) Y 01138 01NOV1988 Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (PP) Y 01139 01NOV1988 Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (OP) Y 01140 01NOV1988 Fibrinogen, fibrinogen degradation products, fibrin monomer, D-dimer - one or more estimations. (RP) Y 01141 01NOV1988 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (SP) Y 01142 01NOV1988 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (PP) Y 01143 01NOV1988 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (OP) Y 01144 01JUL1982 Coombs test, indirect (not associated with Item 1112, 1114, 1121, 1124, 1126 or 1129, except where part of neo-natal screening or in investigation of haemolytic anaemia) (SP) Y 01145 01JUL1982 Coombs test, indirect (not associated with Item 1113, 1116, 1122, 1125, 1128 or 1130, except where part of neo-natal screening or in investigation of haemolytic anaemia) (OP) Y 01146 01NOV1988 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - one or more estimations. (RP) Y 01147 01NOV1988 Platelet antibodies - one or more estimations. (SP) Y 01148 01NOV1988 Platelet antibodies - one or more estimations. (PP) Y 01149 01NOV1988 Platelet antibodies - one or more estimations. (OP) Y 01150 01NOV1988 Platelet antibodies - one or more estimations. (RP) Y 01151 01NOV1988 Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (SP) Y 01152 01JUL1982 Examination of serum for blood group haemolysins (SP) Y 01153 01JUL1982 Examination of serum for blood group haemolysins (OP) Y 01154 01NOV1988 Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (PP) Y 01155 01NOV1988 Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (OP) Y 01156 01NOV1988 Von Willebrand 's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, facto r VII, factor VIII, factor IX, factor X, factor X I, factor XII, factor X III, plasminogen, Fletcher factor, Fitzgerald factor, Passovy factor - one or more estimations. (RP) Y 01157 01NOV1988 Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1001, 1005, 1024, 1033, 1099, 1135, 1141, 1147 and 1151. (SP) Y 01158 01NOV1988 Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1002, 1017, 1025, 1034, 1100, 1138, 1142, 1148 and 1154. (PP) Y 01159 01JUL1982 Leucocyte agglutinins, detection of (SP) Y 01160 01JUL1982 Leucocyte agglutinins, detection of (OP) Y 01161 01NOV1988 Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1003, 1018, 1026, 1035, 1103, 1139, 1143, 1149 and 1155 (OP) Y 01162 01NOV1988 Coagulation studies involving platelet count, two or more services specified in item 1099 and any medically indicated additional services specified in items 1004, 1023, 1027, 1039, 1107, 1140, 1146, 1150 and 1156. (RP) Y 01163 01AUG1989 Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count - 1 or 2 procedures (SP) Y 01164 01AUG1989 Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count - 1 or 2 procedures (OP) Y 01166 01JUL1982 Platelet agglutinins, detection of (SP) Y 01167 01JUL1982 Platelet agglutinins, detection of (OP) Y 01168 01AUG1989 3 or more procedures to which item 1163 applies, including any calculation or measurement of erythrocyte or other indices(SP) Y 01169 01AUG1989 3 or more procedures to which item 1164 applies, including any calculation or measurement of erythrocyte or other indices(OP) Y 01170 01AUG1989 Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and if performed, any of these additional services - Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 1419 (SP) Y 01171 01AUG1989 Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and if performed, any of these additional services - Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, inlcuding any services specified in item 1420 (OP) Y 01172 01AUG1989 Full blood examination consisting of items 1168 and 1170 (SP) Y 01173 01AUG1989 Full blood examination consisting of items 1169 and 1171 (OP) Y 01176 01AUG1989 Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - 1 or more procedures (SP) Y 01177 01AUG1989 Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by - erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine - 1 or more procedures (OP) Y 01179 01AUG1989 Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following - examination for HbH, quantitation of HbA2 or HbF, including any service specified in item 1163, 1168, 1170 or 1172 (SP) Y 01180 01AUG1989 Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the following - examination for HbH, quantitation of HbA2 or HbF, including any service specified in item 1164, 1169, 1171 or 1173 (OP) Y 01181 01AUG1989 Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any service specified in item 1163, 1168, 1170, 1172 or 1183 (SP) Y 01182 01AUG1989 Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any service specified in item 1164, 1169, 1171, 1173 or 1184 (OP) Y 01183 01AUG1989 Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any service specified in, item 1163, 1168, 1170 or 1172 (SP) Y 01184 01AUG1989 Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any service specified in item 1164, 1169, 1171 or 1173 (OP) Y 01187 01AUG1989 Blood grouping, including back-grouping when performed - ABO and Rh (D antigen) (SP) Y 01188 01AUG1989 Blood grouping, including back-grouping when performed - ABO and Rh (D antigen) (OP) Y 01190 01JUL1982 Heterophile antibodies-- qualitative estimation of (test for infectious mononucleosis) (SP) Y 01191 01JUL1982 Heterophile antibodies-- qualitative estimation of (test for infectious mononucleosis) (OP) Y 01192 01AUG1989 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any service specified in item 1187 (SP) Y 01193 01AUG1989 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - one or more systems, including any service specified in item 1188 (OP) Y 01194 01JUL1982 Heterophile antibodies-- quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by Item 1190 where performed) (SP) Y 01195 01JUL1982 Heterophile antibodies-- quantitative estimation of by serial dilutions with specific absorption (including qualitative estimation covered by Item 1191 where performed) (OP) Y 01196 01AUG1989 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any service specified in item 1163, 1168, 1170 or 1172 (SP) Y 01197 01AUG1989 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any service specified in item 1164, 1169, 1171 or 1173 (OP) Y 01198 01AUG1989 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any service specified in item 1163, 1168, 1170, 1172, 1187 or 1196 including all testing performed on any 1 day (SP) Y 01199 01AUG1989 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any service specified in item 1164, 1169, 1171, 1173, 1188 or 1197 including all testing performed on any 1 day (OP) Y 01201 01NOV1988 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (SP) Y 01202 01JUL1982 Cold agglutinins, qualitative estimation of (SP) Y 01203 01JUL1982 Cold agglutinins, qualitative estimation of (OP) Y 01204 01NOV1988 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (PP) Y 01205 01NOV1988 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (OP) Y 01206 01JUL1982 Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by Item 1202 where performed) (SP) Y 01207 01JUL1982 Cold agglutinins, quantitative estimation of by serial dilutions (including qualitative estimation covered by Item 1203 where performed) (OP) Y 01208 01NOV1988 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter of, - acid phosphatase (one or more fractions) alanine amino-transferase, albumin, alkaline phosphatase, alkaline phosphatase isoenzymes, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, C-reactive protein, creatine kinase, creatine kinase isoenzymes, creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, glycosylated haemoglobin, HDL cholesterol, iron, lactate dehydrogenase, lactate dehydrogenase isoenzymes, lipase, magnesium, phosphate, potassium, total protein, sodium, total thyroxine, triglycerides, urate, urea - one estimation. (RP) Y 01209 01NOV1988 Two estimations specified in item 1201 (SP) Y 01210 01NOV1988 Two estimations specified in item 1204 (PP) Y 01211 01JUL1982 Blood volume, estimation of by dye method (SP) Y 01212 01JUL1982 Blood volume, estimation of by dye method (OP) Y 01213 01NOV1988 Two estimations specified in item 1205 (OP) Y 01214 01NOV1988 Two estimations specified in item 1208 (RP) Y 01215 01JUL1982 Blood, spectroscopic examination of (SP) Y 01216 01JUL1982 Blood, spectroscopic examination of (OP) Y 01217 01NOV1988 Three estimations specified in item 1201 (SP) Y 01218 01NOV1988 Three estimations specified in item 1204 (PP) Y 01219 01NOV1988 Three estimations specified in item 1205 (OP) Y 01220 01NOV1988 Three estimations specified in item 1208 (RP) Y 01221 01NOV1988 Four estimations specified in item 1201 (SP) Y 01222 01NOV1988 Four estimations specified in item 1204 (PP) Y 01223 01NOV1988 Four estimations specified in item 1205 (OP) Y 01224 01NOV1988 Four estimations specified in item 1208 (RP) Y 01225 01NOV1988 Five estimations specified in item 1201 (SP) Y 01226 01NOV1988 Five estimations specified in item 1204 (PP) Y 01227 01NOV1988 Five estimations specified in item 1205 (OP) Y 01228 01NOV1988 Five estimations specified in item 1208 (RP) Y 01229 01NOV1988 Six estimations specified in item 1201 (SP) Y 01230 01NOV1988 Six estimations specified in item 1204 (PP) Y 01231 01NOV1988 Six estimations specified in item 1205 (OP) Y 01232 01NOV1988 Six estimations specified in item 1208 (RP) Y 01234 01JUL1982 Estimation of-- bleeding time; coagulation time (including clot retraction); prothrombin time (one stage); thromboplastin time (partial) with or without kaolin and with or without kaolin clotting time; or thrombotest (Owren)-- one procedure (SP) Y 01235 01JUL1982 Estimation of-- bleeding time; coagulation time (including clot retraction); prothrombin time (one stage); thromboplastin time (partial) with or without kaolin and with or without kaolin clotting time; or thrombotest (Owren)-- one procedure (OP) Y 01236 01JUL1982 Two procedures to which Item 1234 applies (SP) Y 01237 01JUL1982 Two procedures to which Item 1235 applies (OP) Y 01238 01JUL1982 Three or more procedures to which Item 1234 applies (SP) Y 01239 01JUL1982 Three or more procedures to which Item 1235 applies (OP) Y 01242 01JUL1982 Platelet aggregation, qualitative test for (SP) Y 01243 01JUL1982 Platelet aggregation, qualitative test for (OP) Y 01244 01JUL1982 Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time-- each procedure (SP) Y 01246 01JUL1982 Estimation of thrombin time (including test for presence of an inhibitor and serial test for fibrinogenolysis) or recalcified plasma clotting time-- each procedure (OP) Y 01247 01JUL1982 Fibrinogen titre, determination of (SP) Y 01248 01JUL1982 Fibrinogen titre, determination of (OP) Y 01249 01NOV1988 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (SP) Y 01250 01NOV1988 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (PP) Y 01251 01JUL1982 Factor 13, test for presence of (SP) Y 01252 01JUL1982 Factor 13, test for presence of (OP) Y 01253 01NOV1988 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (OP) Y 01254 01NOV1988 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum - one or more estimations. (RP) Y 01255 01JUL1982 Thromboplastin generation screening test (SP) Y 01256 01JUL1982 Thromboplastin generation screening test (OP) Y 01257 01NOV1988 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (SP) Y 01258 01NOV1988 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (PP) Y 01259 01JUL1982 Prothrombin time, estimation of (two stage) (SP) Y 01260 01JUL1982 Prothrombin time, estimation of (two stage) (OP) Y 01261 01JUL1982 Qualitative, quantitative or qualitative and quantitative estimation of fibrin degeneration products (SP) Y 01262 01JUL1982 Qualitative, quantitative or qualitative and quantitative estimation of fibrin degeneration products (OP) Y 01263 01JUL1982 Quantitative estimation of-- platelet adhesion, prothrombin consumption or protamine sulphate-- each procedure (SP) Y 01264 01JUL1982 Quantitative estimation of-- platelet adhesion, prothrombin consumption or protamine sulphate-- each procedure (OP) Y 01265 01NOV1988 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (OP) Y 01266 01NOV1988 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances estimations - one or more estimations, including all estimations within any twenty eight day period. (RP) Y 01267 01JUL1982 Euglobulin lysis time, estimation of (SP) Y 01268 01JUL1982 Euglobulin lysis time, estimation of (OP) Y 01269 01NOV1988 Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (SP) Y 01270 01NOV1988 Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (PP) Y 01271 01JUL1982 Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)-- each procedure (SP) Y 01272 01JUL1982 Quantitative estimation of platelet antibodies (by one or more techniques), platelet Factor III availability or one or more blood coagulation factors (including antihaemophilic globulin)-- each procedure (OP) Y 01273 01NOV1988 Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (OP) Y 01274 01NOV1988 Immunological test for human haemoglobin in faeces, including chemical tests if performed - one or more specimens received separately or together within any twenty eight day period. (RP) Y 01275 01NOV1988 Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (SP) Y 01276 01NOV1988 Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (PP) Y 01277 01JUL1982 Platelet aggregation test using-- ADP, collagen, 5HT, ristocetin, or similar substance-- one procedure (SP) Y 01278 01JUL1982 Platelet aggregation test using-- ADP, collagen, 5HT, ristocetin, or similar substance-- one procedure (OP) Y 01279 01JUL1982 Two or more procedures to which Item 1277 applies (SP) Y 01280 01JUL1982 Two or more procedures to which Item 1278 applies (OP) Y 01281 01NOV1988 Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (OP) Y 01282 01NOV1988 Osmolality, estimation by osmometer, in serum or in urine - one or more estimations. (RP) Y 01283 01NOV1988 Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (SP) Y 01284 01NOV1988 Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (PP) Y 01285 01NOV1988 Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (OP) Y 01286 01NOV1988 Quantitative estimation of blood gases including tests performed from - p02, oxygen saturation, pC02, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments - one or more estimation on one specimen. (RP) Y 01287 01NOV1988 One or more estimations of blood gases as specified in item 1283 on two or more specimens within any one day. (SP) Y 01288 01NOV1988 One or more estimations of blood gases as specified in item 1284 on two or more specimens within any one day. (PP) Y 01289 01NOV1988 One or more estimations of blood gases as specified in item 1285 on two or more specimens within any one day. (OP) Y 01290 01NOV1988 One or more estimations of blood gases as specified in item 1286 on two or more specimens within any one day. (RP) Y 01291 01NOV1988 Calculus, analysis of one or more. (SP) Y 01292 01NOV1988 Calculus, analysis of one or more. (PP) Y 01293 01NOV1988 Calculus, analysis of one or more. (OP) Y 01294 01NOV1988 Calculus, analysis of one or more. (RP) Y 01295 01NOV1988 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1329, 134 1 and 1353 - one or more assays within any twenty eight day period. (SP) Y 01296 01FEB1984 Quantitative estimation of any substance by reagent strip with reflectance meter (not associated with Items 1301 to1312) by or on behalf of an approved pathology practitioner where the patient is referred by a medical practitioner for the estimation and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member - one or more estimations (SP) Y 01297 01FEB1984 Quantitative estimation of any substance by reagent strip with reflectance meter (not associated with Items 1301 to 1312) by or on behalf of an approved pathology practitioner where the patient is referred by a medical practitioner for the estimation and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member - one or more estimations (OP) Y 01298 01NOV1983 Quantitative estimation of any substance by reagent strip with reflectance meter (not associated with Items 1301 to 1312) by or on behalf of an approved pathology practitioner where the patient is referred by a medical practitioner for the estimation and where the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member - one or more estimations (HP) Y 01299 01NOV1988 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1332, 1344 and 1356 - one or more assays within any twenty eight day period. (PP) Y 01300 01NOV1988 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1335, 1347 and 1359 - one or more assays within any twenty eight day period. (OP) Y 01301 01FEB1984 Estimation by any method of-- albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct) , bilirubin (indirect), calcium, chloride, cholesterol, CK, CK isoenzymes, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1302 and 1303 where the estimation is performed on a multichannel analyser-- one estimation (SP) N 01301 01MAR1984 Estimation by any method, except by reagent strip with or without reflectance meter, of - albumin; alkaline phosphatase; ALT; AST; bicarbonate; bilirubin (direct); bilirubin(indirect); calcium (including serum ionized calcium); chloride; cholesterol; CK; CK isoenzymes; creatinine; GGTP; globulin; glucose; HBD; LD; phosphate; potassium; protein (total) ; sodium; triglycerides; urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1302 and 1303 where the estimation is performed on a multichannel analyser - one estimation (SP) Y 01302 01FEB1984 Estimation by any method of-- albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct) , bilirubin (indirect), calcium, chloride, cholesterol, CK, CK isoenzymes, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1303 where the estimation is performed on a multichannel analyser-- one estimation (OP) N 01302 01MAR1984 Estimation by any method, except by reagent strip with or without reflectance meter, of - albumin; alkaline phosphatase; ALT; AST; bicarbonate; bilirubin (direct); bilirubin(indirect); calcium (including serum ionized calcium); chloride; cholesterol; CK; CK isoenzymes; creatinine; GGTP; globulin; glucose; HBD; LD; phosphate; potassium; protein (total) ; sodium; triglycerides; urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1303 where the estimation is performed on a multichannel analyser - one estimation (OP) Y 01303 01JUL1982 Estimation by any method of-- albumin, alkaline phosphatase, ALT, AST, bicarbonate, bilirubin (direct) , bilirubin (indirect), calcium, chloride, cholesterol, CK, CK isoenzymes, creatinine, GGTP, globulin, glucose, HBD, LD, phosphate, potassium, protein (total), sodium, triglycerides, urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1302 where the estimation is performed on a multichannel analyser-- one estimation (HP) N 01303 01MAR1984 Estimation by any method, except by reagent strip with or without reflectance meter, of - albumin; alkaline phosphatase; ALT; AST; bicarbonate; bilirubin (direct); bilirubin(indirect); calcium (including serum ionized calcium); chloride; cholesterol; CK; CK isoenzymes; creatinine; GGTP; globulin; glucose; HBD; LD; phosphate; potassium; protein (total) ; sodium; triglycerides; urate or urea or estimation of a substance referred to in any other item in this Division other than Items 1301 and 1302 where the estimation is performed on a multichannel analyser - one estimation (HP) 7.70 Y 01304 01FEB1984 Two estimations of a kind specified in Item 1301 (SP) Y 01305 01FEB1984 Two estimations of a kind specified in Item 1302 (OP) Y 01306 01JUL1982 Two estimations of a kind specified in Item 1303 (HP) Y 01307 01FEB1984 Three to five estimations of a kind specified in Item 1301 (SP) Y 01308 01FEB1984 Three to five estimations of a kind specified in Item 1302 (OP) Y 01309 01JUL1982 Three to five estimations of a kind specified in Item 1303 (HP) Y 01310 01FEB1984 Six or more estimations of a kind specified in Item 1301 (SP) Y 01311 01FEB1984 Six or more estimations of a kind specified in Item 1302 (OP) Y 01312 01JUL1982 Six or more estimations of a kind specified in Item 1303 (HP) Y 01313 01JUL1982 Glycosylated haemoglobin, estimation of, in the management of established diabetes, with a maximum of three estimations in any twelve month period (SP) Y 01314 01JUL1982 Glycosylated haemoglobin, estimation of, in the management of established diabetes, with a maximum of three estimations in any twelve month period (OP) Y 01315 01NOV1988 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, be ingested or absorbed toxic chemicals including any services specified in items 1338, 1350 and 1361 - one or more assays within any twenty eight day period. (RP) Y 01316 01NOV1988 Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (SP) Y 01317 01NOV1988 Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (PP) Y 01318 01NOV1988 Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (OP) Y 01319 01JUL1982 Qualitative estimation of-- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-- one estimation (SP) Y 01320 01JUL1982 Qualitative estimation of-- acidity (by pH meter or titration), blood in faeces (occult blood), cryoglobulins, cryoproteins, euglobulins, macroglobulins (Sia test), PBG, UBG or any other substance not specified in any other item in this Division-- one estimation (OP) Y 01321 01NOV1988 Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects - one or more assays within any seven day period. (RP) Y 01322 01JUL1982 Two or more estimations to which Item 1319 applies (SP) Y 01323 01JUL1982 Two or more estimations to which Item 1320 applies (OP) Y 01324 01FEB1984 Quantitative estimation of blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH) (SP) Y 01325 01FEB1984 Quantitative estimation of blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH) (OP) Y 01326 01JUL1982 Quantitative estimation of blood gases (including pO2, oxygen saturation, pCO2 and estimation of bicarbonate and pH) (HP) Y 01327 01JUL1982 Qualitative estimation of-- foetoprotein, gastric acidity (by dye method) or porphyrins-- each estimation (SP) Y 01328 01JUL1982 Qualitative estimation of-- foetoprotein, gastric acidity (by dye method) or porphyrins-- each estimation (OP) Y 01329 01NOV1988 Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (SP) Y 01330 01JUL1982 Chromatography, qualitative estimation of a substance not specified in any other item in this Division (SP) Y 01331 01JUL1982 Chromatography, qualitative estimation of a substance not specified in any other item in this Division (OP) Y 01332 01NOV1988 Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (PP) Y 01333 01JUL1982 Electrophoresis, qualitative (SP) Y 01334 01JUL1982 Electrophoresis, qualitative (OP) Y 01335 01NOV1988 Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (OP) Y 01336 01JUL1982 Australia antigen or similar antigen, detection of by any method including radioimmunoassay (SP) Y 01337 01JUL1982 Australia antigen or similar antigen, detection of by any method including radioimmunoassay (OP) Y 01338 01NOV1988 Drug assay - quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents) - one estimation. (RP) Y 01339 01JUL1982 Osmolality, estimation of in serum or urine (SP) Y 01340 01JUL1982 Osmolality, estimation of in serum or urine (OP) Y 01341 01NOV1988 Two estimations specified in item 1329. (SP) Y 01342 01JUL1982 Quantitative estimation of-- acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement (total or fraction), any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose-- each estimation (SP) Y 01343 01JUL1982 Quantitative estimation of-- acid phosphatase, aldolase, amylase, lipase, amylase and lipase, bromide, BSP, caeruloplasmin, carotene, complement (total or fraction), any other specific protein (excluding immunoglobulins) (where estimated by immunodiffusion, nephelometry, Laurell rocket or similar technique), creatine, hexosamine, lactate, lithium, magnesium, pyruvate, salicylate or xylose-- each estimation (OP) Y 01344 01NOV1988 Two estimations specified in item 1332. (PP) Y 01345 01JUL1982 Quantitative estimation of-- arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin (direct and indirect) cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin, or any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase, urinary or serum HCG (other than in diagnosis of pregnancy), or any other substance not specified in any other item in this Division-- each estimation (SP) N 01345 01MAR1984 Quantitative estimation of - arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin(direct and indirect), cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin or any other porphyrin factor, delta ALA, 5HIAA, iron(including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any other substance not specified in any other item in this Division - each estimation (SP) Y 01346 01JUL1982 Quantitative estimation of-- arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin (direct and indirect) cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin, or any other porphyrin factor, delta ALA, 5HIAA, iron (including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase, urinary or serum HCG (other than in diagnosis of pregnancy), or any other substance not specified in any other item in this Division-- each estimation (OP) N 01346 01MAR1984 Quantitative estimation of - arsenic, copper, gold, lead, mercury, strontium, zinc, any other element not specified in any other item in this Division, folic acid, vitamin B12, any other vitamin not specified in any other item in this Division, alcohol, ammonia, neo-natal bilirubin(direct and indirect) cholinesterase, coproporphyrin, erythroporphyrin, uroporphyrin or any other porphyrin factor, delta ALA, 5HIAA, iron(including iron-binding capacity), oxalate, oxosteroids, oxogenic steroids, PBG, urine oestriol, transketolase or any other substance not specified in any other item in this Division - each estimation (OP) Y 01347 01NOV1988 Two estimations specified in item 1335. (OP) Y 01348 01JUL1982 Dibucaine number or similar, determination of (SP) Y 01349 01JUL1982 Dibucaine number or similar, determination of (OP) Y 01350 01NOV1988 Two estimations specified in item 1338. (RP) Y 01351 01JUL1982 Indican, qualitative test for (SP) Y 01352 01JUL1982 Indican, qualitative test for (OP) Y 01353 01NOV1988 Three or more estimations specified in item 1329. (SP) Y 01354 01JUL1982 Calculus, analysis of (SP) Y 01355 01JUL1982 Calculus, analysis of (OP) Y 01356 01NOV1988 Three or more estimations specified in item 1332. (PP) Y 01357 01JUL1982 Amniotic fluid, spectrophotometric analysis of (SP) Y 01358 01JUL1982 Amniotic fluid, spectrophotometric analysis of (OP) Y 01359 01NOV1988 Three or more estimations specified in item 1335. (OP) Y 01360 01JUL1982 Electrophoresis, quantitative (including qualitative test) (SP) Y 01361 01NOV1988 Three or more estimations specified in item 1338. (RP) Y 01362 01JUL1982 Electrophoresis, quantitative (including qualitative test) (OP) Y 01363 01NOV1988 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (SP) Y 01364 01JUL1982 Quantitative estimation of-- catecholamines (each component), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process-- each estimation (SP) N 01364 01MAR1984 Quantitative estimation of - catecholamines (one or more components), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process - each estimation (SP) Y 01365 01NOV1988 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (PP) Y 01366 01JUL1982 Quantitative estimation of-- catecholamines (each component), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process-- each estimation (OP) N 01366 01MAR1984 Quantitative estimation of - catecholamines (one or more components), faecal fat, HMMA, hydroxyproline, non-pregnancy oestrogens, pregnanediol, pregnanetriol, any other steroid fraction (where not estimated in the same process as another steroid fraction) or multiple steroid fractions estimated in the same process - each estimation (OP) Y 01367 01NOV1988 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (OP) Y 01368 01JUL1982 Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (SP) Y 01369 01NOV1988 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid - one or more examinations or estimations. (RP) Y 01370 01JUL1982 Chromatography, quantitative estimation (including qualitative test) of any substance not specified in any other item in this Division (OP) Y 01371 01NOV1988 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1379, but excluding lipoprotein electrophoresis - one or more examinations. (SP) Y 01372 01JUL1982 Lechithin/sphingomyelin ratio of amniotic fluid, determination of (SP) N 01372 01MAR1984 Lecithin/sphingomyelin ratio of amniotic fluid, determination of (SP) Y 01373 01NOV1988 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amo unt of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1383, but excluding lipoprotein electrophoresis - one or more examinations. (PP) Y 01374 01JUL1982 Lechithin/sphingomyelin ratio of amniotic fluid, determination of (OP) N 01374 01MAR1984 Lecithin/sphingomyelin ratio of amniotic fluid, determination of (OP) Y 01375 01NOV1988 Electrophoresis, q uantitative or qualitative of serum, unne or other body fluid to demonstrate protein classes or presence and amo unt of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1386, but excluding lipoprotein electrophoresis - one or more examinations. (OP) Y 01376 01JUL1982 Drug assays-- qualitative estimations or screening procedures, by colorimetric methods-- one or more estimations or procedures on each specimen (SP) Y 01377 01NOV1988 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amo unt of para protein, including any measurement of albumin, globulin, total protein and any protein specified in item 1388, but excluding lipoprotein electrophoresis - one or more examinations. (RP) Y 01378 01JUL1982 Drug assays-- qualitative estimations or screening procedures, by colorimetric methods-- one or more estimations or procedures on each specimen (OP) Y 01379 01NOV1988 Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (SP) Y 01380 01JUL1982 Assay by radioimmmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin-- estimation of one substance by one or more methods (SP) N 01380 01MAR1984 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin - estimation of one substance by one or more methods (SP) Y 01381 01JUL1982 Assay by radioimmmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin-- estimation of one substance by one or more methods (OP) N 01381 01MAR1984 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of barbiturates, carbamazepine, digoxin or phenytoin - estimation of one substance by one or more methods (OP) Y 01382 01JUL1982 Estimation of two substances referred to in Item 1380 by using one or more of the methods specified in that item in relation to each (SP) Y 01383 01NOV1988 Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (PP) Y 01384 01JUL1982 Estimation of two substances referred to in Item 1381 by using one or more of the methods specified in that item in relation to each (OP) Y 01385 01JUL1982 Estimation of three or more substances referred to in Item 1380 by using one or more of the methods specified in that item in relation to each (SP) Y 01386 01NOV1988 Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (OP) Y 01387 01JUL1982 Estimation of three or more substances referred to in Item 1381 by using one or more of the methods specified in that item in relation to each (OP) Y 01388 01NOV1988 Alpha-feta protein, Alpha-1 antitrypsin, Alpha-2 microglobulin, beta-2 microglobulin, CA-1 25 antigen, C- l esterase inhibitor, Caeruloplasmin, Carcinoembryonic antigen, Ferritin, Haptoglobins, Microalbumin, Prostate specific antigen, Transferrin - quantitative estimation in serum, urine or other body fluid - one estimation. (RP) Y 01389 01NOV1988 Quantitative estimation of two or more proteins specified in item 1379. (SP) Y 01390 01NOV1988 Quantitative estimation of two or more proteins specified in item 1383. (PP) Y 01391 01NOV1988 Quantitative estimation of two or more proteins specified in item 1386. (OP) Y 01392 01JUL1982 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and Item 1393-- estimation of one substance by one or more methods (SP) Y 01393 01JUL1982 Assay by radioimmunoassay, enzyme linked immunoassay, gas liquid chromatography or any other method of diazepam, ethosuximide, methotrexate, morphine, procainamide, quinidine or a similar substance not referred to in any item in this Division other than this item and Item 1392-- estimation of one substance by one or more methods (OP) Y 01394 01JUL1982 Estimation of two substances referred to in Item 1392 by using one or more of the methods specified in that item in relation to each (SP) Y 01395 01JUL1982 Estimation of two substances referred to in Item 1393 by using one or more of the methods specified in that item in relation to each (OP) Y 01396 01NOV1988 Quantitative estimation of two or more proteins specified in item 1388. (RP) Y 01397 01JUL1982 Estimation of three or more substances referred to in Item 1392 by using one or more of the methods specified in that item in relation to each (SP) Y 01398 01JUL1982 Estimation of three or more substances referred to in Item 1393 by using one or more of the methods specified in that item in relation to each (OP) Y 01399 01NOV1988 Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (SP) Y 01400 01NOV1988 Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (PP) Y 01401 01JUL1982 HDL cholesterol, estimation of, in proven cases of hyperlipidaemia-- one estimation in any twelve month period (SP) Y 01402 01JUL1982 HDL cholesterol, estimation of, in proven cases of hyperlipidaemia-- one estimation in any twelve month period (OP) Y 01403 01NOV1988 Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (OP) Y 01404 01NOV1988 Iron studies involving quantitative analysis of iron, transferrin and ferritin, including iron binding capacity if performed. (RP) Y 01405 01NOV1988 Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (SP) Y 01406 01NOV1988 Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (PP) Y 01407 01NOV1988 Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (OP) Y 01408 01NOV1988 Serum B12, scrum folate, red cell folate, one or more quantitative estimations, including all estimations within any twenty eight day period. (RP) Y 01409 01NOV1988 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (SP) Y 01410 01NOV1988 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (PP) Y 01411 01NOV1988 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (OP) Y 01412 01NOV1988 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - one or more estimations within any six month period. (RP) Y 01413 01NOV1988 Vitamin D or D fractions - one or more estimations. (SP) Y 01414 01NOV1988 Vitamin D or D fractions - one or more estimations. (PP) Y 01415 01NOV1988 Vitamin D or D fractions - one or more estimations. (OP) Y 01416 01NOV1988 Vitamin D or D fractions - one or more estimations. (RP) Y 01417 01AUG1989 Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected (SP) Y 01418 01AUG1989 Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected (OP) Y 01419 01AUG1989 Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) including service specified in item 1170 or 1172 - 1 or more tests (SP) Y 01420 01AUG1989 Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) including service specified in item 1171 or 1173 - 1 or more tests (OP) Y 01421 01JUL1982 Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- one estimation (SP) Y 01422 01JUL1982 Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- one estimation (OP) Y 01424 01JUL1982 Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- two or more estimations (SP) Y 01425 01JUL1982 Assay of T3 resin uptake, thyroxine (T4) or normalised thyroxine (effective thyroxine ratio)-- using any technique-- two or more estimations (OP) Y 01429 01NOV1988 Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (SP) Y 01430 01NOV1988 Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (PP) Y 01431 01NOV1988 Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (OP) Y 01432 01NOV1988 Alcohol, ammonia, angiotensin converting enzyme, bilirubin (neonatal, one or more fractions), cholinesterase, cystine ( cysteine), hydroxy indoleacetic acid, hydroxyproline, lactate, lead, pyruvate, oxalate, xylose, zinc - one quantitative estimation. (RP) Y 01433 01NOV1988 Two or more estimations specified in item 1429. (SP) Y 01434 01NOV1988 Two or more estimations specified in item 1430. (PP) Y 01435 01NOV1988 Two or more estimations specified in item 1431. (OP) Y 01436 01NOV1988 Two or more estimations specified in item 1432. (RP) Y 01437 01NOV1988 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (SP) Y 01438 01NOV1988 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (PP) Y 01439 01NOV1988 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (OP) Y 01440 01NOV1988 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six month period. (RP) Y 01445 01NOV1988 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (SP) Y 01446 01NOV1988 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (PP) Y 01447 01NOV1988 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (OP) Y 01448 01NOV1988 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - one or more estimations. (RP) Y 01449 01NOV1988 Faecal fat - one or more quantitative estimations within any twenty eight day period. (SP) Y 01450 01NOV1988 Faecal fat - one or more quantitative estimations within any twenty eight day period. (PP) Y 01451 01NOV1988 Faecal fat - one or more quantitative estimations within any twenty eight day period. (OP) Y 01452 01JUL1982 Hormone assays (including assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH or HPL but not including assay of a thyroid hormone covered by Item 1421 or 1424) using gamma emitting labels or any other unspecified technique-- one estimation of any one hormone (SP) N 01452 01MAR1984 Hormone assays - assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH, HPL but not including assay of a thyroid hormone covered by Item 1421 or 1424, using gamma emitting labels or other unspecified technique - one estimation of any one hormone (SP) Y 01453 01JUL1982 Hormone assays (including assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH or HPL but not including assay of a thyroid hormone covered by Item 1422 or 1425) using gamma emitting labels or any other unspecified technique-- one estimation of any one hormone (OP) N 01453 01MAR1984 Hormone assays - assay of insulin, growth hormone, TSH, LH, FSH, T3, prolactin, renin, gastrin, cortisol (selenium labelled), ACTH, HPL but not including assay of a thyroid hormone covered by Item 1422 or 1425, using gamma emitting labels or other unspecified technique - one estimation of any one hormone (OP) Y 01454 01NOV1988 Faecal fat - one or more quantitative estimations within any twenty eight day period. (RP) Y 01455 01JUL1982 Two estimations of any one hormone using any technique referred to in Item 1452 (SP) Y 01456 01JUL1982 Two estimations of any one hormone using any technique referred to in Item 1453 (OP) Y 01457 01NOV1988 Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (SP) Y 01458 01JUL1982 Three estimations of any one hormone using any technique referred to in Item 1452 (SP) Y 01459 01JUL1982 Three estimations of any one hormone using any technique referred to in Item 1453 (OP) Y 01460 01NOV1988 Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (PP) Y 01461 01JUL1982 Each estimation of any one hormone in excess of three estimations using any technique referred to in Item 1452 (SP) Y 01462 01JUL1982 Each estimation of any one hormone in excess of three estimations using any technique referred to in Item 1453 (OP) Y 01463 01NOV1988 Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (OP) Y 01464 01NOV1988 Solid tissue or tissues excluding blood elements- assay of one or more enzymes, excluding assays performed in association with items 200 l, 2005, 20 11 and 20 17 including any assays performed within any 28 day period. (RP) Y 01465 01NOV1988 Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (SP) Y 01466 01NOV1988 Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (PP) Y 01467 01NOV1988 Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (OP) Y 01468 01NOV1988 Thyroid function tests, total thyroxine and T3 resin uptake or equivalent test, thyroxine binding globulin, free thyroxine, free T3, total T3, thyrotrophin (TSH) - an initial test or tests, and any indicated additional test or tests, performed within any twenty eight day period. (RP) Y 01469 01NOV1984 Hormone receptor assay on proven primary breast carcinoma or in subsequent lesion in the breast - one or more assays (SP) Y 01470 01NOV1984 Hormone receptor assay on proven primary breast carcinoma or in subsequent lesion in the breast - one or more assays (OP) Y 01471 01NOV1988 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (SP) Y 01472 01NOV1988 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (PP) Y 01473 01NOV1988 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (OP) Y 01474 01NOV1988 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. (RP) Y 01475 01JUL1982 Hormone assays (including assay of progesterone, testosterone, cortisol (tritium labelled), 17-hydroxyprogesterone, oestradiol or aldosterone) using beta emitting labels or bioassay techniques-- one estimation of any one hormone (SP) Y 01476 01JUL1982 Hormone assays (including assay of progesterone, testosterone, cortisol (tritium labelled), 17-hydroxyprogesterone, oestradiol or aldosterone) using beta emitting labels or bioassay techniques-- one estimation of any one hormone (OP) Y 01477 01NOV1988 Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (SP) Y 01478 01JUL1982 Hormone assay using beta emitting labels or bioassay techniques-- two estimations of any one hormone (SP) Y 01479 01JUL1982 Hormone assay using beta emitting labels or bioassay techniques-- two estimations of any one hormone (OP) Y 01480 01NOV1988 Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (PP) Y 01481 01JUL1982 Hormone assay using beta emitting labels or bioassay techniques-- three estimations of any one hormone (SP) Y 01482 01JUL1982 Hormone assay using beta emitting labels or bioassay techniques-- three estimations of any one hormone (OP) Y 01483 01NOV1988 Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (OP) Y 01484 01JUL1982 Hormone assay using beta emitting labels or bioassay techniques-- each estimation of any one hormone in excess of three (SP) Y 01485 01JUL1982 Hormone assay using beta emitting labels or bioassay techniques-- each estimation of any one hormone in excess of three (OP) Y 01486 01NOV1988 Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, excluding services specified in item 1515 - one estimation. (RP) Y 01487 01NOV1988 Two estimations specified in item 1477. (SP) Y 01488 01NOV1988 Two estimations specified in item 1480. (PP) Y 01489 01NOV1988 Two estimations specified in item 1483. (OP) Y 01490 01NOV1988 Two estimations specified in item 1486. (RP) Y 01491 01NOV1988 Three estimations specified in item 1477. (SP) Y 01492 01NOV1988 Three estimations specified in item 1480. (PP) Y 01493 01NOV1988 Three estimations specified in item 1483. (OP) Y 01494 01NOV1988 Three estimations specified in item 1486. (RP) Y 01495 01NOV1988 Four estimations specified in item 1477 . (SP) Y 01496 01NOV1988 Four estimations specified in item 1480 . (PP) Y 01497 01NOV1988 Four estimations specified in item 1483 . (OP) Y 01498 01NOV1988 Four estimations specified in item 1486 . (RP) Y 01499 01NOV1988 Five estimations specified in item 1477. (SP) Y 01500 01NOV1988 Five estimations specified in item 1480. (PP) Y 01501 01NOV1988 Five estimations specified in item 1483. (OP) Y 01502 01NOV1988 Five estimations specified in item 1486. (RP) Y 01503 01NOV1988 Six or more estimations specified in item 1477. (SP) Y 01504 01JUL1982 Procedural service associated with -ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, L-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (SP) Y 01505 01JUL1982 Procedural service associated with -ACTH stimulation test, adrenaline tolerance test, arginine infusion test, bromsulphthalein test, carbohydrate tolerance test, creatinine clearance test, gastric function test requiring intubation, glucagon tolerance test, histidine loaded FIGLU test, L-dopa stimulation test, phenolsulphthalein excretion test, TSH stimulation test (other than the administration of TSH), urea clearance test, urea concentration test, vasopressin stimulation test, xylose absorption test, or any similar test (OP) Y 01506 01NOV1988 Six or more estimations specified in item 1480. (PP) Y 01507 01NOV1988 Six or more estimations specified in item 1483. (OP) Y 01508 01NOV1988 Six or more estimations specified in item 1486. (RP) Y 01509 01NOV1988 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (SP) Y 01510 01NOV1988 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (PP) Y 01511 01JUL1982 Procedural services associated with -tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (SP) Y 01512 01JUL1982 Procedural services associated with -tolbutamide test, insulin hypoglycaemia stimulation test, gonadotrophin releasing hormone stimulation test (other than the administration of gonadotrophin releasing hormone), thyrotrophin releasing hormone stimulation test (other than the administration of thyroid stimulating hormone), urine acidification test, or any similar test (OP) Y 01513 01NOV1988 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (OP) Y 01514 01NOV1988 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - one or more assays. (RP) Y 01516 01JUL1982 Procedural services associated with the administration of -thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (SP) Y 01517 01JUL1982 Procedural services associated with the administration of -thyrotrophin releasing hormone, gonadotrophin releasing hormone or thyroid stimulating hormone (OP) Y 01521 01AUG1989 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of - fibrinogen degradation products, fibrin monomer or D-dimer - 1 estimation (SP) Y 01522 01AUG1989 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of - fibrinogen degradation products, fibrin monomer or D-dimer - 1 estimation (OP) Y 01523 01AUG1989 2 estimations specified in item 1521 (SP) Y 01524 01AUG1989 2 estimations specified in item 1522 (OP) Y 01525 01AUG1989 3 estimations specified in item 1521 (SP) Y 01526 01AUG1989 3 estimations specified in item 1522 (OP) Y 01527 01AUG1989 4 or more estimations specified in item 1521 (SP) Y 01528 01AUG1989 4 or more estimations specified in item 1522 (OP) Y 01529 01JUL1982 Microscopical examination, wet film, not covered by Item 1536 (SP) Y 01530 01JUL1982 Microscopical examination, wet film, not covered by Item 1537 (OP) Y 01531 01AUG1989 Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant - 1 estimation (SP) Y 01532 01AUG1989 Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant - 1 estimation (OP) Y 01533 01AUG1989 4 or more estimations specified in item 1531 (SP) Y 01534 01AUG1989 4 or more estimations specified in item 1532 (OP) Y 01535 01AUG1989 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - 1 or more estimations (SP) Y 01536 01JUL1982 Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP) Y 01537 01JUL1982 Microscopical examination of urine and examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (where the patient is referred by another medical practitioner) (OP) Y 01538 01AUG1989 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance - 1 or more estimations (OP) Y 01539 01AUG1989 Heperin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin - 1 or more estimations (SP) Y 01540 01AUG1989 Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin - 1 or more estimations (OP) Y 01541 01AUG1989 Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor - 1 estimation (SP) Y 01542 01AUG1989 Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor - 1 estimation (OP) Y 01543 01AUG1989 2 estimations as specified in item 1541 (SP) Y 01544 01AUG1989 2 estimations as specified in item 1542 (OP) Y 01545 01JUL1982 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- one stain (SP) Y 01546 01JUL1982 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- one stain (OP) Y 01548 01JUL1982 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- two or more stains (SP) Y 01549 01JUL1982 Microscopical examination using gram or similar stain (e.g. Loeffler, methylene blue, Giemsa)-- two or more stains (OP) Y 01550 01AUG1989 3 or more estimations as specified in item 1541 (SP) Y 01551 01AUG1989 3 or more estimations as specified in item 1542 (OP) Y 01556 01JUL1982 Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)-- one stain (SP) Y 01557 01JUL1982 Microscopical examination using special stain (e.g. Ziehl-Neelsen or similar stain)-- one stain (OP) Y 01558 01AUG1989 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of - alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 1734), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - 1 estimation (SP) Y 01559 01AUG1989 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of - alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 1735), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea - 1 estimation (OP) Y 01560 01AUG1989 2 estimations specified in item 1558 (SP) Y 01561 01AUG1989 2 estimations specified in item 1559 (OP) Y 01562 01AUG1989 3 estimations specified in item 1558 (SP) Y 01563 01AUG1989 3 estimations specified in item 1559 (OP) Y 01564 01AUG1989 4 estimations specified in item 1558 (SP) Y 01565 01AUG1989 4 estimations specified in item 1559 (OP) Y 01566 01JUL1982 Microscopical examination using two or more stains, one or more of which is a special stain referred to in Item 1556 (SP) Y 01567 01JUL1982 Microscopical examination using two or more stains, one or more of which is a special stain referred to in Item 1557 (OP) Y 01569 01AUG1989 5 estimations specified in item 1558 (SP) Y 01570 01AUG1989 5 estimations specified in item 1559 (OP) Y 01571 01AUG1989 6 or more estimations specified in item 1558 (SP) Y 01572 01AUG1989 6 or more estimations specified in item 1559 (OP) Y 01575 01AUG1989 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations (SP) Y 01576 01AUG1989 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations (OP) Y 01577 01AUG1989 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances - each estimation, to a maximum of 3 estimations, taken on separate days (SP) Y 01578 01AUG1989 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents - haemoglobin, porphyrins, reducing substances - each estimation, to a maximum of 3 estimations, taken on separate days (OP) Y 01579 01AUG1989 Immunological tests for human haemoglobin in faeces performed in any 28 day period, including chemical test if performed - 1 estimation (SP) Y 01580 01AUG1989 Immunological tests for human haemoglobin in faeces performed in any 28 day period, including chemical test if performed - 1 estimation (OP) Y 01581 01AUG1989 2 or more estimations specified in item 1579 (SP) Y 01582 01AUG1989 2 or more estimations specified in item, 1580 (OP) Y 01583 01AUG1989 Osmolality, estimation by osmometer, in serum or in urine - 1 or more estimations (SP) Y 01584 01AUG1989 Osmolality, estimation by osmometer, in serum or in urine - 1 or more estimations (OP) Y 01586 01JUL1982 Microscopical examination for dermatophytes-- examination of material from one site (SP) Y 01587 01JUL1982 Microscopical examination for dermatophytes-- examination of material from one site (OP) Y 01588 01JUL1982 Microscopical examination for dermatophytes-- examination of material from two or more sites (SP) Y 01589 01JUL1982 Microscopical examination for dermatophytes-- examination of material from two or more sites (OP) Y 01590 01AUG1989 Quantitative estimation of blood gases including tests performed from - pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (e.g. haemoglobin, potassium) or calculation performed on the same specimen - 1 or more estimation on 1 specimen (SP) Y 01591 01AUG1989 Quantitative estimation of blood gases including tests performed from - pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (e.g. haemoglobin, potassium) or calculation performed on the same specimen - 1 or more estimation on 1 specimen (OP) Y 01592 01AUG1989 1 or more estimations of blood gases as specified in item 1590 on 2 or more specimens within any 1 day (SP) Y 01593 01AUG1989 1 or more estimations of blood gases as specified in item 1591 on 2 or more specimens within any 1 day (OP) Y 01595 01AUG1989 Calculus, analysis of 1 or more (SP) Y 01596 01AUG1989 Calculus, analysis of 1 or more (OP) 30.90 1598 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any service specified in item 1712, 1714 or 1716, but excluding the surveillance of sports people and athletes for performance improving substances - 1 or more assays (SP) Y 01598 01AUG1989 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 1712, 1714 and 1716, but excluding the surveillance of sports people and athletes for performance improving substances - one or more assays.(S) Y 01599 01AUG1989 Drug or chemical assays - including all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any service specified in item 1713, 1715 or 1717, but excluding the surveillance of sports people and athletes for performance improving substances - 1 or more assays (OP) Y 01601 01NOV1988 Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (SP) Y 01602 01NOV1988 Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (PP) Y 01603 01NOV1988 Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (OP) Y 01604 01JUL1982 Microscopical examination of exudate by dark ground illumination for Treponema pallidum (SP) Y 01605 01NOV1988 Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient, and excluding material from cultures, wet film, including differential cell count if performed - one or more examinations when requested by another practitioner. (RP) Y 01606 01JUL1982 Microscopical examination of exudate by dark ground illumination for Treponema pallidum (OP) Y 01607 01NOV1988 Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1629, 1635 or 1671, and including any services specified in item 1601 - one or more examinations. (SP) Y 01608 01NOV1988 Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1630, 1639 or 1672, and including any services specified in item 1602 - one or more examinations. (PP) Y 01609 01FEB1984 Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (SP) Y 01610 01FEB1984 Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (OP) Y 01611 01JUL1982 Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (HP) Y 01612 01FEB1984 Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (SP) Y 01613 01FEB1984 Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (OP) Y 01614 01JUL1982 Cultural examination of material other than urine for aerobic micro-organisms (including fungi) with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (HP) Y 01615 01FEB1984 Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (SP) Y 01616 01FEB1984 Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (OP) Y 01617 01NOV1988 Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1631, 1642 or 1675, and including any services specified in item 1603 - one or more examinations. (OP) Y 01618 01JUL1982 Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from one site (HP) Y 01619 01FEB1984 Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (SP) Y 01620 01FEB1984 Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (OP) Y 01621 01JUL1982 Cultural examination of material other than blood or urine for aerobic and anaerobic microorganisms using an anaerobic atmosphere for the culture of anaerobes, with, where indicated, the use of relevant stains, selective media or sensitivity testing or any two or more of those procedures-- examination of material from two or more sites where processed independently (HP) Y 01622 01JUL1982 Cultural examination for mycobacteria-- each specimen (SP) Y 01623 01JUL1982 Cultural examination for mycobacteria-- each specimen (OP) Y 01624 01NOV1988 Microscopic examination including serial examinations of material from one or more sites, other than blood, obtained directly from a patient and excluding material from cultures - examination for dermatophytes or parasites or dark ground illumination, or stained preparation or preparations using any relevant stain or stains excluding services specified in items 1632, 1643 or 1677, and including any services specified in item 1605 - one or more examinations. (RP) Y 01627 01AUG1989 Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes - each assay to a maximum of 4 assays within any 28 day period (SP) Y 01628 01AUG1989 Drug assays - including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmes - each assay to a maximum of 4 assays within any 28 day period (OP) Y 01629 01NOV1988 Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (SP) Y 01630 01NOV1988 Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (PP) Y 01631 01NOV1988 Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (OP) Y 01632 01NOV1988 Microbial (including fungal and parasitic) antigens not elsewhere specified in an item in the Schedule, identification by immunological method or methods of presence or absence in material obtained directly from a patient, excluding urine and material from cultures - identification of one antigen. (RP) Y 01633 01FEB1984 Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-- each set of cultures to a maximum of three sets (SP) Y 01634 01FEB1984 Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-- each set of cultures to a maximum of three sets (OP) Y 01635 01NOV1988 Identification of two or more antigens specified in item 1629. (SP) Y 01636 01JUL1982 Blood culture, including sub-culture, using both aerobic and anaerobic media, with, where indicated, the use of relevant stains or sensitivity testing or relevant stains and sensitivity testing, but not involving organism identification-- each set of cultures to a maximum of three sets (HP) Y 01637 01JUL1982 Screening test for mycoplasma or ureaplasma or both (SP) Y 01638 01JUL1982 Screening test for mycoplasma or ureaplasma or both (OP) Y 01639 01NOV1988 Identification of two or more antigens specified in item 1630. (PP) Y 01640 01JUL1982 Coagulase test for organism identification by slide or tube method, not being a test conducted in conjunction with a service specified in Item 1644, 1647, 1661 or 1664 that is performed for the purpose of identifying the same organism (SP) Y 01641 01JUL1982 Coagulase test for organism identification by slide or tube method, not being a test conducted in conjunction with a service specified in Item 1645, 1648, 1662 or 1665 that is performed for the purpose of identifying the same organism (OP) Y 01642 01NOV1988 Identification of two or more antigens specified in item 1631. (OP) Y 01643 01NOV1988 Identification of two or more antigens specified in item 1632. (RP) Y 01644 01JUL1982 Identification of pathogenic microorganisms other than M tuberculosis, using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture-- identification of one organism (SP) Y 01645 01JUL1982 Identification of pathogenic microorganisms other than M tuberculosis, using biochemical tests or other special techniques involving sub-culture or biochemical tests and other special techniques involving sub-culture-- identification of one organism (OP) Y 01646 01NOV1988 Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1629 and 1635 - examination of material from one or more sites.(SP) Y 01647 01JUL1982 Identification of two or more organisms, excluding M tuberculosis, by the method referred to in Item 1644 (SP) Y 01648 01JUL1982 Identification of two or more organisms, excluding M tuberculosis, by the method referred to in Item 1645 (OP) Y 01649 01NOV1988 Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1630 and 1639 - examination of material from one or more sites.(PP) Y 01650 01NOV1988 Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1631 and 1642 - examination of material from one or more sites.(OP) Y 01651 01NOV1988 Cultural examination including serial cultures (eg of faeces or sputum) to determine the presence or absence of pathogenic micro-organisms, including fungi but excluding viruses, in material obtained directly from a patient, other than blood or urine, including all tests necessary to identify any cultured pathogen, and necessary antibiotic sensitivity testing and including any services specified in items 1632 and 1643 - examination of material from one or more sites.(RP) Y 01652 01NOV1988 Microbiological examination consisting of items 1607 and 1646. (SP) Y 01653 01NOV1988 Microbiological examination consisting of items 1608 and 1649. (PP) Y 01654 01NOV1988 Microbiological examination consisting of items 16 17 and 1650. (OP) Y 01655 01NOV1988 Microbiological examination consisting of items 1624 and 1651. (RP) Y 01656 01NOV1988 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (SP) Y 01657 01NOV1988 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (PP) Y 01658 01NOV1988 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (OP) Y 01659 01NOV1988 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - all cultures performed within any three day period. (RP) Y 01661 01JUL1982 Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic method)- a procedure involving one technique (SP) Y 01662 01JUL1982 Identification of pathogenic microorganisms using a serological technique (including the immunofluorescent or immunoenzymic method)- a procedure involving one technique (OP) Y 01664 01JUL1982 Two or more of any procedures of a kind referred to in Item 1661 using different techniques (SP) Y 01665 01JUL1982 Two or more of any procedures of a kind referred to in Item 1662 using different techniques (OP) Y 01668 01FEB1984 Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (SP) Y 01669 01FEB1984 Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (OP) Y 01670 01JUL1982 Anaerobic culture of urine obtained by suprapubic aspiration of the bladder where previous aerobic urine culture is negative, plus microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (not covered by Item 1673, 1674 or 1676) (HP) Y 01671 01NOV1988 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (SP) Y 01672 01NOV1988 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (PP) Y 01673 01FEB1984 Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (SP) Y 01674 01FEB1984 Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (OP) Y 01675 01NOV1988 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (OP) Y 01676 01JUL1982 Microscopical examination of urine, with cell count, relevant stains (if indicated), aerobic cultural examination and colony count of micro-organisms (not being a service to which Item 1682 or 1683 applies), together with sensitivity testing (where indicated) and general examination for one or more of pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone and bile pigments (HP) Y 01677 01NOV1988 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). (RP) Y 01678 01NOV1988 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (SP) Y 01679 01NOV1988 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (PP) Y 01680 01NOV1988 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (OP) Y 01681 01NOV1988 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of one antibody. (RP) Y 01682 01JUL1982 Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (SP) Y 01683 01JUL1982 Microscopical examination of urine and simple culture by means of dip slide or microbiological kit test (where the patient is referred by another medical practitioner) (OP) Y 01684 01NOV1988 Two estimations specified in item 1678. (SP) Y 01685 01NOV1988 Two estimations specified in item 1679. (PP) Y 01686 01NOV1988 Two estimations specified in item 1680. (OP) Y 01687 01JUL1982 Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (SP) Y 01688 01JUL1982 Microscopical examination of faeces or body fluids for parasites, cysts or ova, with or without simple stains or concentration techniques (OP) Y 01689 01NOV1988 Two estimations specified in item 1681. (RP) Y 01690 01NOV1988 Three estimations specified in item 1678. (SP) Y 01691 01NOV1988 Three estimations specified in item 1679. (PP) Y 01692 01NOV1988 Three estimations specified in item 1680. (OP) Y 01693 01JUL1982 Identification of helminths (SP) Y 01694 01JUL1982 Identification of helminths (OP) Y 01695 01NOV1988 Three estimations specified in item 1681. (RP) Y 01696 01NOV1988 Four estimations specified in item 1678. (SP) Y 01697 01NOV1988 Four estimations specified in item 1679. (PP) Y 01698 01NOV1988 Four estimations specified in item 1680. (OP) Y 01699 01NOV1988 Four estimations specified in item 1681. (RP) Y 01700 01NOV1988 Five estimations specified in item 1678 . (SP) Y 01701 01NOV1988 Five estimations specified in item 1679 . (PP) Y 01702 01JUL1982 Cultural examination for parasites, other than trichomonas-- culture of one parasite (SP) Y 01703 01JUL1982 Cultural examination for parasites, other than trichomonas-- culture of one parasite (OP) Y 01704 01NOV1988 Five estimations specified in item 1680 . (OP) Y 01705 01JUL1982 Cultural examination for parasites, other than trichomonas-- culture of two or more parasites (SP) Y 01706 01JUL1982 Cultural examination for parasites, other than trichomonas-- culture of two or more parasites (OP) Y 01707 01NOV1988 Five estimations specified in item 1681 . (RP) Y 01708 01NOV1988 Six or more estimations specified in item 1678 . (SP) Y 01709 01NOV1988 Six or more estimations specified in item 1679 . (PP) Y 01710 01NOV1988 Six or more estimations specified in item 1680 . (OP) Y 01711 01NOV1988 Six or more estimations specified in item 1681 . (RP) Y 01712 01AUG1989 Drug assay - quantitative estimation on blood or other body fluid by any method of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule - 1 estimation (SP) Y 01713 01AUG1989 Drug assay - quantitative estimation on blood or other body fluid by any method of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule - 1 estimation (OP) Y 01714 01AUG1989 2 estimations specified in item 1712 (SP) Y 01715 01AUG1989 2 estimations specified in item 1713 (OP) Y 01716 01AUG1989 3 or more estimations specified in item 1712 (SP) Y 01717 01AUG1989 3 or more estimations specified in item 1713 (OP) Y 01721 01JUL1982 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- one organism (SP) Y 01722 01JUL1982 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- one organism (OP) Y 01724 01JUL1982 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- two or more organisms (SP) Y 01725 01JUL1982 Determination of the minimum inhibitory concentration of an antibiotic or chemotherapeutic agent by tube technique or by agar plate dilution-- two or more organisms (OP) Y 01726 01AUG1989 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid - 1 or more examinations or estimations (SP) Y 01727 01AUG1989 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid - 1 or more examinations or estimations (OP) Y 01728 01NOV1988 Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1629 and 1635. (SP) Y 01729 01NOV1988 Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1630 and 1639. (PP) Y 01730 01NOV1988 Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1631 and 1642. (OP) Y 01731 01NOV1988 Herpes simplex virus, one or more types, investigation for, in material obtained directly from a patient, by one or more cultural methods, including any immuno-logical tests for herpes infection on serum or other body fluid, or on other material obtained directly from a patient, and including any services specified in items 1632 and 1642. (RP) Y 01732 01JUL1982 Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (SP) Y 01733 01JUL1982 Detection of substances inhibitory to micro-organisms in a body fluid (including urine) (OP) Y 01734 01AUG1989 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5mmol/l and Triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity - 1 examination to a maximum of 2 examinations in any 12 month period (SP) Y 01735 01AUG1989 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5 mmol/l and Triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity - 1 examination to a maximum of 2 examinations in any 12 month period (OP) Y 01736 01AUG1989 Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity - 2 or more examinations (SP) Y 01737 01AUG1989 Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin, or of total relevant enzyme activity - 2 or more examinations (OP) Y 01738 01AUG1989 Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1752), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphatase, Transferrin (unless specified in item 1752) and, in the follow-up of proven malignancy, Mucin-like carcinoma associated antigen, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, SCC Related antigen, Thyroglobulin - quantitative estimation in serum, urine or other body fluid - 1 estimation (SP) Y 01739 01AUG1989 Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1753), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphatase, Transferrin (unless specified in item 1753) and, in the follow up of proven malignancy, Mucin-like carcinoma associated antigen, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, SCC Related antigen, Thyroglobulin - quantitative estimation in serum, urine or other body fluid - 1 estimation (OP) Y 01740 01AUG1989 2 or more estimations specified in item 1738 (SP) Y 01741 01AUG1989 2 or more estimations specified in item 1739 (OP) Y 01742 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (SP) Y 01743 01JUL1982 Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (SP) Y 01744 01JUL1982 Quantitative assay of an antibiotic or a chemotherapeutic agent in a body fluid (including urine) (OP) Y 01745 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (PP) Y 01746 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (OP) Y 01747 01NOV1984 Serological tests for Hepatitis A and Hepatitis B. Each test to a maximum of two tests. (SP) Y 01748 01NOV1984 Serological tests for Hepatitis A and Hepatitis B. Each test to a maximum of two tests. (OP) Y 01749 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - one or more estimations. (RP) Y 01752 01AUG1989 Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin (SP) Y 01753 01AUG1989 Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin (OP) Y 01754 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1742 - one or more estimations. (SP) Y 01755 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1745 - one or more estimations. (PP) Y 01756 01JUL1982 Agglutination tests (screening)-- one test (SP) Y 01757 01JUL1982 Agglutination tests (screening)-- one test (OP) Y 01758 01JUL1982 Agglutination tests (screening) -- two or more tests (SP) Y 01759 01JUL1982 Agglutination tests (screening) -- two or more tests (OP) Y 01760 01JUL1982 Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- one antigen (SP) Y 01761 01JUL1982 Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- one antigen (OP) Y 01762 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1746 - one or more estimations. (OP) Y 01763 01JUL1982 Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- second to sixth antigen-- each antigen (SP) Y 01764 01JUL1982 Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- second to sixth antigen-- each antigen (OP) Y 01765 01NOV1988 Antibiotics or anti-microbial chemo-therapeutic agents, in serum, urine or either body fluid, estimation of inhibitory concentration or bactericidal titre including any services specified in item 1749 - one or more estimations. (RP) Y 01766 01JUL1982 Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- each antigen in excess of six (SP) Y 01767 01JUL1982 Agglutination tests (quantitative) , including those for enteric fever and brucellosis-- each antigen in excess of six (OP) Y 01768 01AUG1989 Serum B12, serum folate - 1 or more estimations within any 28 day period (SP) Y 01769 01AUG1989 Serum B12, serum folate - 1 or more estimations within any 28 day period (OP) Y 01770 01AUG1989 Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period (SP) Y 01771 01AUG1989 Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period (OP) Y 01772 01JUL1982 Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- one test (SP) Y 01773 01JUL1982 Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- one test (OP) Y 01775 01JUL1982 Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- two or more tests (SP) Y 01776 01JUL1982 Flocculation test, including V.D.R.L., Kahn, Kline or similar tests-- two or more tests (OP) Y 01780 01AUG1989 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - 1 or more estimations within any 6 month period (SP) Y 01781 01JUL1982 Complement fixation tests-- one test (SP) Y 01782 01JUL1982 Complement fixation tests-- one test (OP) Y 01783 01AUG1989 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E - 1 or more estimations within any 6 month period (OP) Y 01784 01JUL1982 Complement fixation tests-- each test in excess of one (SP) N 01784 01MAR1984 Complement fixation tests - each test in excess of one (SP) 5.10 Y 01785 01JUL1982 Complement fixation tests-- each test in excess of one (OP) N 01785 01MAR1984 Complement fixation tests - each test in excess of one (OP) 3.85 Y 01786 01AUG1989 Vitamin D or D fractions - 1 or more estimations (SP) Y 01787 01AUG1989 Vitamin D or D fractions - 1 or more estimations (OP) Y 01791 01AUG1989 Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc - 1 quantitative estimation (SP) Y 01792 01AUG1989 Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc - 1 quantitative estimation (OP) Y 01793 01JUL1982 Fluorescent serum antibody test (FTA test, FTA-- absorbed test or similar)-- one test (SP) Y 01794 01JUL1982 Fluorescent serum antibody test (FTA test, FTA-- absorbed test or similar)-- one test (OP) Y 01795 01AUG1989 2 or more estimations specified in item 1791 (SP) Y 01796 01JUL1982 Each test referred to in Item 1793 in excess of one (SP) Y 01797 01JUL1982 Each test referred to in Item 1794 in excess of one (OP) Y 01798 01AUG1989 2 or more estimations specified in item 1792 (OP) Y 01801 01NOV1988 Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1371 or 1807), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (SP) Y 01802 01NOV1988 Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1373 or 1810), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (PP) Y 01803 01NOV1988 Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1375 or 1811), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (OP) Y 01804 01NOV1988 Identification of paraprotein or suspected paraprotein, the presence of which is suggested by other tests (eg item 1377 or 1812), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - one or more procedures. (RP) Y 01805 01JUL1982 Haemagglutination tests-- one test (SP) Y 01806 01JUL1982 Haemagglutination tests-- one test (OP) Y 01807 01NOV1988 Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (SP) Y 01808 01JUL1982 Haemagglutination tests-- each test in excess of one (SP) Y 01809 01JUL1982 Haemagglutination tests-- each test in excess of one (OP) Y 01810 01NOV1988 Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (PP) Y 01811 01NOV1988 Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (OP) Y 01812 01NOV1988 Immunoglobulins G, A, M, D or sub-classes thereof, quantitative estimation in serum, urine or other body fluid, by any method - estimation of one immunoglobin. (RP) Y 01813 01NOV1988 Two estimations specified in item 1807. (SP) Y 01814 01NOV1988 Two estimations specified in item 1810. (PP) Y 01815 01NOV1988 Two estimations specified in item 1811. (OP) Y 01816 01NOV1988 Two estimations specified in item 1812. (RP) Y 01817 01NOV1988 Three or more estimations specified in item 1807. (SP) Y 01818 01NOV1988 Three or more estimations specified in item 181. (PP) Y 01819 01NOV1988 Three or more estimations specified in item 1811. (OP) Y 01820 01NOV1988 Three or more estimations specified in item 1812. (RP) Y 01821 01NOV1988 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (SP) Y 01822 01NOV1988 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (PP) Y 01823 01JUL1982 Haemagglutination inhibition tests-- one test (SP) Y 01824 01JUL1982 Haemagglutination inhibition tests-- one test (OP) Y 01825 01NOV1988 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (OP) Y 01826 01JUL1982 Haemagglutination inhibition tests-- each test in excess of one (SP) Y 01827 01JUL1982 Haemagglutination inhibition tests-- each test in excess of one (OP) Y 01828 01NOV1988 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. (RP) Y 01829 01NOV1988 Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (SP) Y 01830 01NOV1988 Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (PP) Y 01831 01NOV1988 Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (OP) Y 01832 01NOV1988 Specific IgG or IgE antibodies to potential allergens - one test for single or multiple allergens with a maximum of two estimations in any twelve month period. (RP) Y 01833 01NOV1988 Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1829, with a maximum of three estimations in any twelve month period. (SP) Y 01834 01NOV1988 Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1830, with a maximum of three estimations in any twelve month period. (PP) Y 01835 01NOV1988 Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1831, with a maximum of three estimations in any twelve month period. (OP) Y 01836 01NOV1988 Specific IgG or IgE antibodies to potential allergens - more than one test for single or multiple allergens, including any services specified in item 1832, with a maximum of three estimations in any twelve month period. (RP) Y 01837 01NOV1988 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (SP) Y 01838 01NOV1988 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (PP) Y 01839 01JUL1982 Antistreptolysin O titre or similar test, qualitative, not associated with Item 1843 or 1846 (SP) Y 01840 01JUL1982 Antistreptolysin O titre or similar test, qualitative, not associated with Item 1844 or 1847 (OP) Y 01841 01NOV1988 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (OP) Y 01842 01NOV1988 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of one antibody. (RP) Y 01843 01JUL1982 Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- one test (SP) Y 01844 01JUL1982 Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- one test (OP) Y 01845 01NOV1988 Two estimations specified in item 1837. (SP) Y 01846 01JUL1982 Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- two or more tests (SP) Y 01847 01JUL1982 Antistreptolysin O titre test, anti-desoxyribonuclease B titre test or similar test (quantitative) -- two or more tests (OP) Y 01848 01NOV1988 Two estimations specified in item 1838. (PP) Y 01849 01NOV1988 Two estimations specified in item 1841. (OP) Y 01850 01NOV1988 Two estimations specified in item 1842. (RP) Y 01851 01JUL1982 Total and differential cell count on any body fluid (SP) Y 01852 01JUL1982 Total and differential cell count on any body fluid (OP) Y 01853 01NOV1988 Three estimations specified in item 1837. (SP) Y 01854 01NOV1988 Three estimations specified in item 1838. (PP) Y 01855 01NOV1988 Three estimations specified in item 1841. (OP) Y 01856 01NOV1988 Three estimations specified in item 1842. (RP) Y 01857 01NOV1988 Four estimations specified in item 1837. (SP) Y 01858 01JUL1982 Autogenous vaccine, preparation of-- each organism (SP) Y 01859 01JUL1982 Autogenous vaccine, preparation of-- each organism (OP) Y 01860 01NOV1988 Four estimations specified in item 1838. (PP) Y 01861 01NOV1988 Four estimations specified in item 1841. (OP) Y 01862 01NOV1988 Four estimations specified in item 1842. (RP) Y 01863 01NOV1988 Five estimations specified in item 1837. (SP) Y 01864 01NOV1988 Five estimations specified in item 1838. (PP) Y 01865 01NOV1988 Five estimations specified in item 1841. (OP) Y 01866 01NOV1988 Five estimations specified in item 1842. (RP) Y 01867 01NOV1988 Six or more estimations specified in item 1837. (SP) Y 01868 01NOV1988 Six or more estimations specified in item 1838. (PP) Y 01869 01NOV1988 Six or more estimations specified in item 1841. (OP) Y 01870 01NOV1988 Six or more estimations specified in item 1842. (RP) Y 01871 01AUG1989 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - 1 or more estimations within any 6 month period (SP) Y 01872 01AUG1989 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - 1 or more estimations within any 6 month period (OP) Y 01875 01NOV1988 Complement - total and components - one or two quantitative estimations. (SP) Y 01876 01NOV1988 Complement - total and components - one or two quantitative estimations. (PP) Y 01877 01JUL1982 Immunoelectrophoresis using polyvalent antisera (SP) Y 01878 01JUL1982 Immunoelectrophoresis using polyvalent antisera (OP) Y 01879 01NOV1988 Complement - total and components - one or two quantitative estimations. (OP) Y 01880 01NOV1988 Complement - total and components - one or two quantitative estimations. (RP) Y 01881 01NOV1988 Three or four estimations specified in item 1875. (SP) Y 01882 01NOV1988 Three or four estimations specified in item 1876. (PP) Y 01883 01NOV1988 Three or four estimations specified in item 1879. (OP) Y 01884 01JUL1982 Immunoelectrophoresis using monovalent antiserum-- each antiserum (SP) Y 01885 01JUL1982 Immunoelectrophoresis using monovalent antiserum-- each antiserum (OP) Y 01886 01NOV1988 Three or four estimations specified in item 1880. (RP) Y 01887 01NOV1988 Five or more estimations specified in item 1875. (SP) Y 01888 01JUL1982 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of one immunoglobulin (SP) Y 01889 01JUL1982 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of one immunoglobulin (OP) Y 01890 01NOV1988 Five or more estimations specified in item 1876. (PP) Y 01891 01JUL1982 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of each immunoglobulin in excess of one (SP) Y 01892 01JUL1982 Immunoglobulins G, A, M or D, quantitative estimation of by immunodiffusion or any other method-- estimation of each immunoglobulin in excess of one (OP) Y 01893 01NOV1988 Five or more estimations specified in item 1879. (OP) Y 01894 01NOV1988 Five or more estimations specified in item 1880. (RP) Y 01895 01AUG1989 Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period - each estimation (SP) Y 01896 01AUG1989 Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month period - each estimation (OP) Y 01897 01JUL1982 Immunoglobulin E, quantitative estimation of (SP) Y 01898 01JUL1982 Immunoglobulin E, quantitative estimation of (OP) Y 01901 01NOV1988 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (SP) Y 01902 01NOV1988 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (PP) Y 01903 01JUL1982 Radioallergosorbent tests for allergen identification-- identification of one to four allergens-- each allergen (SP) Y 01904 01JUL1982 Radioallergosorbent tests for allergen identification-- identification of one to four allergens-- each allergen (OP) N 01904 01MAR1984 Radioallergosorbent tests for allergen identification - identification of one to four allergens - each allergen (OP) 7.65 Y 01905 01JUL1982 Radioallergosorbent tests for allergen identification-- identification of each allergen in excess of four (SP) Y 01906 01JUL1982 Radioallergosorbent tests for allergen identification-- identification of each allergen in excess of four (OP) Y 01907 01NOV1988 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (OP) Y 01908 01NOV1988 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. (RP) Y 01909 01NOV1988 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (SP) Y 01910 01NOV1988 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (PP) Y 01911 01JUL1982 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1918), detection of one antibody (SP) Y 01912 01JUL1982 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1919), detection of one antibody (OP) Y 01913 01JUL1982 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1918), detection of each antibody in excess of one (SP) Y 01914 01JUL1982 Immunofluorescent detection of tissue antibodies, qualitative (not associated with the service specified in Item 1919), detection of each antibody in excess of one (OP) N 01914 01MAR1984 Immunofluorescent detection of tissue antibodies, qualitative(not associated with the service specified in Item 1919), detection of each antibody in excess of one (OP) 7.65 Y 01915 01NOV1988 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (OP) Y 01916 01NOV1988 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). (RP) Y 01917 01NOV1988 Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (SP) Y 01918 01JUL1982 Immunofluorescent detection of tissue antibodies, qualitative and quantitative-- detection and estimation of each antibody (SP) Y 01919 01JUL1982 Immunofluorescent detection of tissue antibodies, qualitative and quantitative-- detection and estimation of each antibody (OP) Y 01920 01NOV1988 Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (PP) Y 01921 01NOV1988 Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (OP) Y 01922 01NOV1988 Leucocyte surface marker characterisation by irnmunofluorescence or immunoenzyme techniques - one to three subset markers. (RP) Y 01923 01NOV1988 Leucocyte surface markers as specified in item 1917 - four or more subset markers. (SP) Y 01924 01JUL1982 Complement fixation tests on human tissue antibodies-- one antibody (SP) Y 01925 01JUL1982 Complement fixation tests on human tissue antibodies-- one antibody (OP) Y 01926 01JUL1982 Complement fixation tests on human tissue antibodies-- each antibody in excess of one (SP) Y 01927 01JUL1982 Complement fixation tests on human tissue antibodies-- each antibody in excess of one (OP) N 01927 01MAR1984 Complement fixation tests on human tissue antibodies - each antibody in excess of one (OP) 7.65 Y 01928 01NOV1988 Leucocyte surface markers as specified in item 1920 - four or more subset markers. (PP) Y 01929 01NOV1988 Leucocyte surface markers as specified in item 1921 - four or more subset markers. (OP) Y 01930 01NOV1988 Leucocyte surface markers as specified in item 1922 - four or more subset markers. (RP) Y 01931 01NOV1988 HLA typing comprising A, B and C phenotypes. (SP) Y 01932 01NOV1988 HLA typing comprising A, B and C phenotypes. (PP) Y 01933 01NOV1988 HLA typing comprising A, B and C phenotypes. (OP) Y 01934 01NOV1988 HLA typing comprising A, B and C phenotypes. (RP) Y 01935 01JUL1982 Latex flocculation test-- qualitative, quantitative or qualitative and quantitative (SP) Y 01936 01JUL1982 Latex flocculation test-- qualitative, quantitative or qualitative and quantitative (OP) Y 01937 01NOV1988 HLA typing, DR phenotype. (SP) Y 01938 01NOV1988 HLA typing, DR phenotype. (PP) Y 01939 01NOV1988 HLA typing, DR phenotype. (OP) Y 01940 01NOV1988 HLA typing, DR phenotype. (RP) Y 01941 01JUL1982 Rose Waaler test, quantitative, using sheep cells (SP) Y 01942 01JUL1982 Rose Waaler test, quantitative, using sheep cells (OP) Y 01943 01JUL1982 Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1941 (SP) Y 01944 01JUL1982 Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1942 (OP) N 01944 01MAR1984 Modified Rose Waaler test using stabilised sheep cells, not associated with Item 1942 (OP) 7.65 Y 01945 01NOV1988 IILA typing, one or more antigens. (SP) Y 01946 01NOV1988 IILA typing, one or more antigens. (PP) Y 01947 01NOV1988 IILA typing, one or more antigens. (OP) Y 01948 01JUL1982 Lupus erythematosus cells, preparation and examination of film for (SP) Y 01949 01JUL1982 Lupus erythematosus cells, preparation and examination of film for (OP) Y 01950 01NOV1988 IILA typing, one or more antigens. (RP) Y 01951 01NOV1988 Mantoux test. (SP) Y 01952 01NOV1988 Mantoux test. (PP) Y 01953 01NOV1988 Mantoux test. (OP) Y 01954 01NOV1988 Mantoux test. (RP) Y 01955 01JUL1982 Tanned erythrocyte haemagglutination test for tissue antibodies-- one antibody (SP) Y 01956 01JUL1982 Tanned erythrocyte haemagglutination test for tissue antibodies-- one antibody (OP) Y 01957 01JUL1982 Tanned erythrocyte haemagglutination test for tissue antibodies-- each antibody in excess of one (SP) Y 01958 01JUL1982 Tanned erythrocyte haemagglutination test for tissue antibodies-- each antibody in excess of one (OP) Y 01959 01AUG1989 Porphyrins (1 or more fractions), Catecholamines (1 or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - 1 or more estimations (SP) Y 01960 01AUG1989 Porphyrins (1 or more fractions), Catecholamines (1 or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA) - quantitative including any qualitative estimations - 1 or more estimations (OP) Y 01963 01AUG1989 Faecal fat, Breath Hydrogen measurements in response to loading with disaccharides - 1 or more quantitative estimations within any 28 day period (SP) Y 01964 01AUG1989 Faecal fat, Breath Hydrogen measurements in response to loading with disaccharides - 1 or more quantitative estimations within any 28 day period (OP) Y 01965 01JUL1982 Leucocyte fractionation as preliminary test to specific tests of leucocyte function-- by density gradient centrifugation or any other method (SP) Y 01966 01JUL1982 Leucocyte fractionation as preliminary test to specific tests of leucocyte function-- by density gradient centrifugation or any other method (OP) Y 01969 01AUG1989 Solid tissue or tissues excluding blood elements - assay of 1 or 2 enzymes (SP) Y 01970 01AUG1989 Solid tissue or tissues excluding blood elements - assay of 1 or 2 enzymes (OP) Y 01971 01JUL1982 Neutrophil or monocyte tests for phagocytic activity-- visual techniques (SP) Y 01972 01JUL1982 Neutrophil or monocyte tests for phagocytic activity-- visual techniques (OP) Y 01973 01JUL1982 Neutrophil or monocyte function tests for phagocytic activity-- radioactive techniques (SP) Y 01974 01JUL1982 Neutrophil or monocyte function tests for phagocytic activity-- radioactive techniques (OP) Y 01975 01AUG1989 Assay of 3 to 5 enzymes as specified in item 1969 (SP) Y 01976 01AUG1989 Assay of 3 to 5 enzymes as specified in item 1970 (OP) Y 01977 01AUG1989 Assay of 6 or more enzymes as specified in item 1969 (SP) Y 01978 01AUG1989 Assay of 6 or more enzymes as specified in item 1970 (OP) Y 01981 01JUL1982 Lymphocyte cell count-- E. rosette technique or similar (SP) Y 01982 01JUL1982 Lymphocyte cell count-- E. rosette technique or similar (OP) Y 01983 01AUG1989 Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests - free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin (SP) Y 01984 01AUG1989 Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following tests - free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin (OP) Y 01985 01AUG1989 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones (SP) Y 01986 01AUG1989 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones (OP) Y 01987 01JUL1982 B lymphocyte cell count-- by immunofluorescence or immunoperoxidase (SP) Y 01988 01JUL1982 B lymphocyte cell count-- by immunofluorescence or immunoperoxidase (OP) Y 01989 01NOV1990 Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, L-Dopa stimulation of growth hormone, where physically performed by a recognised pathologist - 1 or more procedures (SP) Y 01990 01NOV1990 Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, L-Dopa stimulation of growth hormone, where physically performed by a recognised pathologist - one or more procedures. (GP) Y 01991 01NOV1990 Gonadotrophin releasing hormone stimulation test, Synacthen stimulation test, Glucagon stimulation test with C-peptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist - 1 procedure (SP) Y 01992 01NOV1990 Gonadotrophin releasing hormone stimulation test, Synacthen stimulation test, Glucagon stimulation test with C-peptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologist - one procedure. (GP) Y 01993 01NOV1990 Two or more procedures specified in item 1991. (SP) Y 01994 01NOV1990 Two or more procedures specified in item 1992. (GP) Y 01995 01JUL1982 Lymphocyte function test-- visual transformation (SP) Y 01996 01JUL1982 Lymphocyte function test-- visual transformation (OP) Y 01997 01JUL1982 Lymphocyte function test-- radioactive techniques (SP) Y 01998 01JUL1982 Lymphocyte function test-- radioactive techniques (OP) Y 02001 01NOV1988 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (SP) Y 02002 01NOV1988 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (PP) Y 02003 01NOV1988 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (OP) Y 02004 01NOV1988 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. (RP) Y 02005 01NOV1988 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (SP) Y 02006 01JUL1982 Tissue group typing (HLA phenotyping) (SP) Y 02007 01JUL1982 Tissue group typing (HLA phenotyping) (OP) Y 02008 01NOV1988 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (PP) Y 02009 01NOV1988 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (OP) Y 02010 01NOV1988 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. (RP) Y 02011 01NOV1988 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (SP) Y 02012 01NOV1988 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (PP) Y 02013 01JUL1982 Mantoux, Schick, Casoni or similar test, not being a test covered by Item 987 or 989 (SP) Y 02014 01JUL1982 Mantoux, Schick, Casoni or similar test, not being a test covered by Item 987 or 989 (OP) N 02014 01MAR1984 Mantoux, Schick, Casoni or similar test, not being a test covered by Item 987 or 989 (OP) 7.65 Y 02015 01NOV1988 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (OP) Y 02016 01NOV1988 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. (RP) Y 02017 01NOV1988 Electron microscopy of biopsy material including any other histopathology examination. (SP) Y 02018 01NOV1988 Electron microscopy of biopsy material including any other histopathology examination. (PP) Y 02019 01NOV1988 Electron microscopy of biopsy material including any other histopathology examination. (OP) Y 02020 01NOV1988 Electron microscopy of biopsy material including any other histopathology examination. (RP) Y 02021 01AUG1989 Hormones and hormone binding proteins, quantitative estimation by any method of: ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti-diuretic hormone) - 1 estimation (SP) Y 02022 01JUL1982 Skin sensitivity-- induction and detection of sensitivity to chemical antigens (SP) Y 02023 01JUL1982 Skin sensitivity-- induction and detection of sensitivity to chemical antigens (OP) Y 02024 01AUG1989 Hormones and hormone binding proteins, quantitative estimation by any method of: ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti-diuretic hormone) - 1 estimation (OP) Y 02025 01AUG1989 2 estimations specified in item 2021 (SP) Y 02026 01AUG1989 2 estimations specified in item 2024 (OP) Y 02027 01AUG1989 3 estimations specified in item 2021 (SP) Y 02028 01AUG1989 3 estimations specified in item 2024 (OP) Y 02029 01AUG1989 4 estimations specified in item 2021 (SP) Y 02030 01AUG1989 4 estimations specified in item 2024 (OP) Y 02031 01AUG1989 5 estimations specified in item 2021 (SP) Y 02032 01AUG1989 5 estimations specified in item 2024 (OP) Y 02033 01AUG1989 6 or more estimations specified in item 2021 (SP) Y 02034 01AUG1989 6 or more estimations specified in item 2024 (OP) Y 02037 01AUG1989 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - 1 or more assays (SP) Y 02038 01AUG1989 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma - 1 or more assays (OP) Y 02039 01AUG1989 HDL Cholesterol, estimation of, in patients with serum cholesterol 5.5mmol/l or those on prescribed lipid lowering drugs - each estimation to a maximum of 4 estimations in any 12 month period (SP) Y 02040 01AUG1989 HDL cholesterol, estimation of, in patients with serum cholesterol 5.5mmol/l or those on prescribed lipid lowering drugs - each estimation to a maximum of 4 estimations in any 12 month period (OP) Y 02041 01JUL1982 Histopathology examination of biopsy material-- processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (SP) Y 02042 01JUL1982 Histopathology examination of biopsy material-- processing of one or more paraffin blocks, with all appropriate stains and provision of professional opinion (OP) Y 02043 01AUG1989 Glycosylated haemoglobin only when performed in the management of established diabetes - each estimation to a maximum of 4 estimations in any 12 month period (SP) Y 02044 01AUG1989 Glycosylated haemoglobin only when performed in the management of established diabetes - each estimation to a maximum of 4 estimations in any 12 month period (OP) Y 02048 01JUL1982 Immediate frozen section diagnosis of biopsy material performed at the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) Y 02049 01JUL1982 Immediate frozen section diagnosis of biopsy material performed at the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) Y 02051 01NOV1988 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (SP) Y 02052 01NOV1988 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (PP) Y 02053 01NOV1988 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (OP) Y 02054 01NOV1988 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - one or more examinations . (RP) Y 02055 01NOV1988 Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (SP) Y 02056 01JUL1982 Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (SP) Y 02057 01JUL1982 Immediate frozen section diagnosis of biopsy material performed at a distance of one or more kilometres from the pathologist's laboratory and confirmatory histopathology examination of this material after the frozen section using all appropriate stains (OP) Y 02058 01NOV1988 Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (PP) Y 02059 01NOV1988 Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (OP) Y 02060 01JUL1982 Immunofluorescent investigation of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to immunofluorescent investigation was obtained (SP) Y 02061 01JUL1982 Immunofluorescent investigation of biopsy specimen, including any other histopathology examination of the biopsy specimen and any histopathology examination of tissue obtained from the patient at the time the tissue subject to immunofluorescent investigation was obtained (OP) Y 02062 01NOV1984 Electron microscopy examination of biopsy material including any other histopathology examination of that tissue obtained from the one patient at the one time. (SP) Y 02063 01NOV1984 Electron microscopy examination of biopsy material including any other histopathology examination of that tissue obtained from the one patient at the one time. (OP) Y 02064 01NOV1988 Cytological examination including serial examinations of smears from skin, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - one or more examinations. (RP) Y 02065 01NOV1988 Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2055 and any histopathological service performed - one or more examinations. (SP) Y 02066 01NOV1988 Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2058 and any histopathological service performed - one or more examinations. (PP) Y 02067 01NOV1988 Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2059 and any histopathological service performed - one or more examinations. (OP) Y 02068 01NOV1988 Cytological examination including serial examinations for malignant cells of body fluids, urine, washings or brushings not specified in item 2064 and any histopathological service performed - one or more examinations. (RP) Y 02069 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (SP) Y 02070 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (PP) Y 02071 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (OP) Y 02072 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. (RP) Y 02073 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (SP) Y 02074 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (PP) Y 02075 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (OP) Y 02076 01NOV1988 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. (RP) Y 02081 01JUL1982 Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane, excluding nasal smears for cell count covered by Item 1545, 1546, 1548 or 1549-- each examination (SP) Y 02082 01JUL1982 Cytological examination for pathological change of smears from cervix and vagina, skin or mucous membrane, excluding nasal smears for cell count covered by Item 1545, 1546, 1548 or 1549-- each examination (OP) Y 02083 01AUG1989 Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures - wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains - 1 or more examinations (SP) Y 02084 01AUG1989 Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultures - wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains - 1 or more examinations (OP) Y 02085 01AUG1989 Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any service specified in item 2083 - each estimation (SP) Y 02086 01AUG1989 Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any service specified in item 2084 - each estimation (OP) Y 02087 01AUG1989 The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2083 - 1 or more sites (SP) Y 02088 01AUG1989 The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2084 - 1 or more sites (OP) Y 02089 01AUG1989 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites - skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 2119), including pathogenic identification and antibiotic sensitivity testing, including any service specified in item 2083 or 2087 - 1 or more examinations on 1 or more specimens (SP) Y 02090 01AUG1989 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites: skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except where part of item 2120), including pathogenic identification and antibiotic sensitivity testing, including any service specified in item 2084 or 2088 - 1 or more examinations on 1 or more specimens (OP) Y 02091 01JUL1982 Cytological examination for malignant cells-- examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid-- each examination (SP) Y 02092 01JUL1982 Cytological examination for malignant cells-- examination of sputum, urine, bronchial secretion, cerebrospinal fluid, peritoneal fluid or any similar fluid-- each examination (OP) Y 02093 01JUL1985 Cytological examination for malignant cells of material obtained by fine needle aspiration ofsolid tissues. (SP) Y 02094 01JUL1985 Cytological examination for malignant cells of material obtained by fine needle aspiration ofsolid tissues. (OP) Y 02095 02MAR2019 Professional attendance at consulting rooms by a general practitioner, for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 02096 01JUL1982 Cytological examination for malignant cells-- examination of gastric washings, duodenal washings, oesophageal washings or colonic washings; including collection of specimen-- each examination (SP) Y 02097 01JUL1982 Cytological examination for malignant cells-- examination of gastric washings, duodenal washings, oesophageal washings or colonic washings; including collection of specimen-- each examination (OP) Y 02098 01AUG1989 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2083, 2087 or 2089 - 1 or more sites (SP) Y 02099 01AUG1989 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2084, 2088 or 2090 - 1 or more sites (OP) Y 02100 01JUL2011 Level A - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting at least 5 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, who is not an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician. N 02100 01NOV2012 Level A - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 02100 01MAR2013 Professional attendance at consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies Y 02101 01NOV1988 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (SP) Y 02102 01NOV1988 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (PP) Y 02103 01NOV1988 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (OP) Y 02104 01JUL1982 Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) Y 02105 01JUL1982 Hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) Y 02106 01NOV1988 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - one or more estimations. (RP) Y 02107 01NOV1988 Chromosome studies, including preparation, count and karyotyping of blood. (SP) Y 02108 01NOV1988 Chromosome studies, including preparation, count and karyotyping of blood. (PP) Y 02109 01NOV1988 Chromosome studies, including preparation, count and karyotyping of blood. (OP) Y 02110 01NOV1988 Chromosome studies, including preparation, count and karyotyping of blood. (RP) Y 02111 01JUL1982 Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (SP) Y 02112 01JUL1982 Cytological examination for pathological change of smears from cervix and vagina with hormonal assessment by cytological examination of vaginal epithelium involving cell count, index or both (OP) Y 02113 01NOV1988 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (SP) Y 02114 01NOV1988 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (PP) Y 02115 01NOV1988 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (OP) Y 02116 01NOV1988 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile X-site determination - one or more identifications. (RP) Y 02117 01AUG1989 Cultural examination (including the detection of Clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2083, to a maximum of 3 specimens in any 7 day period - each examination (SP) Y 02118 01AUG1989 Cultural examination (including the detection of Clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and including pathogen identification and antibiotic sensitivity testing, including any service specified in item 2084, to a maximum of 3 specimens in any 7 day period - each examination (OP) Y 02119 01AUG1989 Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any service specified in item 2083 (SP) Y 02120 01AUG1989 Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any service specified in item 2084 (OP) Y 02121 01NOV2018 Professional attendance at consulting rooms by a general practitioner, lasting less than 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the general practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (e) the patient has an existing relationship with the general practitioner. N 02121 10JAN2020 Professional attendance by video conference by a general practitioner, lasting less than 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the general practitioner are located within a drought affected eligible area, and: (i)the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (ii) the patient has an existing relationship with the general practitioner Y 02122 01JUL2011 Level A - Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other item applies) lasting at least 5 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02122 01NOV2012 Level A - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a)is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b)is not an admitted patient; and (c)is not a care recipient in a residential care service; and (d)is located both: (i)outside an inner metropolitan area; and (ii)at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient N 02122 01JAN2013 Level A - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a)is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b)is not an admitted patient; and (c)is not a care recipient in a residential care service; and (d)is located both: (i)within a telehealth eligible area; and (ii)at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02122 01MAR2013 Professional attendance not in consulting rooms of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Y 02123 01AUG1989 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of 3 sets (SP) Y 02124 01AUG1989 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of 3 sets (OP) Y 02125 01JUL2011 Level A - Telehealth attendance at a residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting at least 5 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit) and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02125 01JAN2013 Professional attendance of at least 5 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient N 02125 01JUL2018 Professional attendance of at least 5 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient Y 02126 01JUL2011 Level B - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting less than 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, who is not an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies and who is participating in a video consultation with a specialist or consultant physician. N 02126 01NOV2012 Level B - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 02126 01MAR2013 Professional attendance at consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 02127 01AUG1989 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item) (SP) Y 02128 01AUG1989 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item) (OP) Y 02129 01AUG1989 Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 2117 has been performed - 1 or more estimations (SP) Y 02130 01AUG1989 Direct detection of the antigens of Heamophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varcella zoster or detection of Clostridium difficile toxin except where item 2118 has been performed - 1 or more estimations (OP) Y 02131 01JUL1982 Cytological sex determination from blood film (SP) Y 02132 01JUL1982 Cytological sex determination from blood film (OP) Y 02133 01AUG1989 Direct detection of Chlamydia from clinical material, not cultures - 1 or more estimations (SP) Y 02134 01AUG1989 Direct detection of Chlamydia from clinical material, not cultures - 1 or more estimations (OP) Y 02135 01AUG1989 Direct detection of Herpes simplex from clinical material, not cultures - 1 or more estimations (SP) Y 02136 01AUG1989 Direct detection of Herpes simplex from clinical material, not cultures - 1 or more estimations (OP) Y 02137 01JUL2011 Level B - Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other item applies) lasting less than 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02137 01NOV2012 Level B - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a)is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b)is not an admitted patient; and (c)is not a care recipient in a residential care service; and (d)is located both: (i)outside an inner metropolitan area; and (ii)at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient N 02137 01JAN2013 Level B - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a)is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b)is not an admitted patient; and (c)is not a care recipient in a residential care service; and (d)is located both: (i)within a telehealth eligible area; and (ii)at the time of the attendance-at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02137 01MAR2013 Professional attendance not in consulting rooms of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Y 02138 01JUL2011 Level B - Telehealth attendance at residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting less than 20 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02138 01NOV2012 Level B - Telehealth attendance at residential aged care facility Professional attendance of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient N 02138 01JAN2013 Professional attendance of less than 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient N 02138 01JUL2018 Professional attendance of less than 20 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient Y 02139 01AUG1989 Investigation for Herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any service specified in item 2133 or 2135 (SP) Y 02140 01AUG1989 Investigation for Herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any service specified in item 2134 or 2136 (OP) Y 02141 01JUL1982 Cytological sex chromatin studies (Barr or Y bodies)-- other than from blood film-- each tissue examined (SP) Y 02142 01JUL1982 Cytological sex chromatin studies (Barr or Y bodies)-- other than from blood film-- each tissue examined (OP) Y 02143 01JUL2011 Level C - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting at least 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, who is not an admitted patient; b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician. N 02143 01NOV2012 Level C - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner who provides clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 02143 01MAR2013 Professional attendance at consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner who provides clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service: for which a direction made under subsection 19(2) of the Act applies Y 02144 02MAR2019 Professional attendance at consulting rooms by a general practitioner, lasting less than 20 minutes, if: (a)the attendance is by video conference; and (b) the patient is located within a flood affected eligible area. Y 02145 01AUG1989 Serology including IgG and IgM estimations of Rubella, toxoplasma or CMV when performed during pregnancy - 1 or more assays (SP) Y 02146 01AUG1989 Serology including IgG and IgM estimations of Rubella, toxoplasma or CMV when performed during pregnancy - 1 or more assays (OP) Y 02147 01JUL2011 Level C -Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other items applies) lasting at least 20 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02147 01NOV2012 Level C - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient N 02147 01JAN2013 Level C - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02147 01MAR2013 Professional attendance not in consulting rooms of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Y 02148 01JUL1982 Chromosome studies, including preparation, count and karyotyping of amniotic fluid (SP) Y 02149 01JUL1982 Chromosome studies, including preparation, count and karyotyping of amniotic fluid (OP) Y 02150 01NOV2018 Professional attendance at consulting rooms by a general practitioner, lasting at least 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the general practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (e) the patient has an existing relationship with the general practitioner. N 02150 10JAN2020 Professional attendance by video conference by a general practitioner, lasting at least 20 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the general practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (ii) the patient has an existing relationship with the general practitioner Y 02151 01NOV1988 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (SP) Y 02152 01NOV1988 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (PP) Y 02153 01NOV1988 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (OP) Y 02154 01NOV1988 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). (RP) Y 02155 01JUL1982 Chromosome studies, including preparation, count and karyotyping of bone marrow (SP) Y 02156 01JUL1982 Chromosome studies, including preparation, count and karyotyping of bone marrow (OP) Y 02157 01NOV1988 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (SP) Y 02158 01NOV1988 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (PP) Y 02159 01NOV1988 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (OP) Y 02160 01NOV1988 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month peri9d. (RP) Y 02161 01JUL1982 Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in Item 2148 or 2155-- each study (SP) Y 02162 01JUL1982 Chromosome studies, including preparation, count and karyotyping of blood, skin or any tissue or fluid not referred to in Item 2149 or 2156-- each study (OP) Y 02163 01NOV1988 Sperm antibodies, sperm penetrating ability - one or more tests. (SP) Y 02164 01NOV1988 Sperm antibodies, sperm penetrating ability - one or more tests. (PP) Y 02165 01NOV1988 Sperm antibodies, sperm penetrating ability - one or more tests. (OP) Y 02166 01NOV1988 Sperm antibodies, sperm penetrating ability - one or more tests. (RP) Y 02167 01NOV1988 Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (SP) Y 02168 01NOV1988 Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (PP) Y 02169 01NOV1988 Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (OP) Y 02170 01JUL1982 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- one method (SP) Y 02171 01JUL1982 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- one method (OP) Y 02172 01NOV1988 Chorionic gonadotrophin (beta - HCG), qualitative estimation in semen or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy - one or more estimations. (RP) Y 02173 01JUL1982 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- two or more methods (SP) Y 02174 01JUL1982 Chromosome identification by banding techniques (using fluorescein, Giemsa or centromeres staining)-- two or more methods (OP) Y 02175 01NOV1988 Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (SP) Y 02176 01NOV1988 Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (PP) Y 02177 01NOV1988 Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (OP) Y 02178 01NOV1988 Chorionic gonadotrophin (beta- IICG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion. (RP) Y 02179 01JUL2011 Level C - Telehealth attendance at residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting at least 20 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02179 01JAN2013 Professional attendance of at least 20 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient N 02179 01JUL2018 Professional attendance of at least 20 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient Y 02180 02MAR2019 Professional attendance at consulting rooms by a general practitioner, lasting at least 20 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 02181 01AUG1989 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of 1 antibody (SP) Y 02182 01AUG1989 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule - estimation of 1 antibody (OP) Y 02183 01AUG1989 2 estimations specified in item 2181 (SP) Y 02184 01AUG1989 2 estimations specified in item 2182 (OP) Y 02185 01AUG1989 3 estimations specified in item 2181 (SP) Y 02186 01AUG1989 3 estimations specified in item 2182 (OP) Y 02187 01AUG1989 4 estimations specified in item 2181 (SP) Y 02188 01AUG1989 4 estimations specified in item 2182 (OP) Y 02189 01AUG1989 5 estimations specified in item 2181 (SP) Y 02190 01AUG1989 5 estimations specified in item 2182 (OP) Y 02191 01AUG1989 6 or more estimations specified in item 2181 (SP) Y 02192 01AUG1989 6 or more estimations specified in item 2182 (OP) Y 02193 02MAR2019 Professional attendance at consulting rooms by a general practitioner, lasting at least 40 minutes, if: the attendance is by video conference; and the patient is located within a flood affected eligible area. Y 02195 01JUL2011 Level D - Telehealth attendance at consulting rooms A professional attendance at consulting rooms (not being a service to which any other item applies) lasting at least 40 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, who is not an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician. N 02195 01NOV2012 Level D - Telehealth attendance at consulting rooms Professional attendance at consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 02195 01MAR2013 Professional attendance at consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) either: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); or (ii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 02196 01NOV2018 Professional attendance at consulting rooms by a general practitioner, lasting at least 40 minutes, for providing mental health services to a patient with mental health issues, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient and the general practitioner are located within a drought affected eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (e) the patient has an existing relationship with the general practitioner. N 02196 10JAN2020 Professional attendance by video conference by a general practitioner, lasting at least 40 minutes, for providing mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; or (b) the patient and the general practitioner are located within a drought affected eligible area, and: (i) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner; and (ii) the patient has an existing relationship with the general practitioner Y 02199 01JUL2011 Level D - Telehealth attendance other than at consulting rooms A professional attendance other than at consulting rooms (not being a service to which any other item applies) lasting at least 40 minutes (whether or not continuous) by a medical practitioner that requires the provision of clinical support to a patient who is located outside an inner metropolitan area, not being an admitted patient, and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02199 01NOV2012 Level D - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) outside an inner metropolitan area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient N 02199 01JAN2013 Level D - Telehealth attendance other than at consulting rooms Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist, consultant physician or psychiatrist; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance - at least 15 kms by road from the specialist, physician or psychiatrist mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02199 01MAR2013 Professional attendance not in consulting rooms of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is not an admitted patient; and (c) is not a care recipient in a residential care service; and (d) is located both: (i) within a telehealth eligible area; and (ii) at the time of the attendance-at least 15 kms by road from the specialist or physician mentioned in paragraph (a); for an attendance on one or more patients at one place on one occasion-each patient Y 02201 01JUL1982 Examination of semen for presence of spermatozoa (SP) Y 02202 01JUL1982 Examination of semen for presence of spermatozoa (OP) Y 02203 01NOV1988 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - one procedure. Y 02204 01NOV1988 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - two procedures. Y 02205 01NOV1988 13lood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - three or more procedures. Y 02206 01NOV1988 Microscopical examination of urine. Y 02207 01NOV1988 Pregnancy test by one or more imnmunochemical methods. Y 02208 01NOV1988 Microscopical examination of wet film other than urine. Y 02209 01NOV1988 Microscopical examination of gram stained film. Y 02210 01NOV1988 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method. Y 02211 01JUL1982 Huhner's test (post-coital test)-- collection of sample and examination of wet preparation (SP) Y 02212 01JUL1982 Huhner's test (post-coital test)-- collection of sample and examination of wet preparation (OP) Y 02213 01NOV1988 Microscopical examination screening for fungi in skin, hair or nails - one or more sites. Y 02214 01NOV1988 Mantoux test. Y 02215 01JUL1982 Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (SP) Y 02216 01JUL1982 Examination of semen involving measurement of volume, sperm count, gram or similar stain, morphology by differential count and motility (including duration) or viability or both (OP) Y 02217 01NOV1988 Casoni test for hydatid disease. Y 02218 01NOV1988 Schick test. Y 02219 01NOV1988 Seminal examination for presence of spermatozoa. Y 02220 01JUL2011 Level D - Telehealth attendance at residential aged care facility A professional attendance by a medical practitioner (not being a service to which any other item applies) lasting at least 40 minutes (whether or not continuous) that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex where the patient is a resident of the aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician, on 1 occasion - each patient. N 02220 01JAN2013 Professional attendance of at least 40 minutes in duration (whether or not continuous) by a medical practitioner providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient N 02220 01JUL2018 Professional attendance of at least 40 minutes in duration (whether or not continuous) by a general practitioner, specialist or consultant physician providing clinical support to a patient who: (a) is participating in a video conferencing consultation with a specialist or consultant physician; and (b) is a care recipient in a residential care service; and (c) is not a resident of a self-contained unit; for an attendance on one or more patients at one place on one occasion-each patient Y 02221 01AUG1989 Hepatitis B surface antigen test (SP) Y 02222 01AUG1989 Hepatitis B surface antigen test (OP) Y 02223 01AUG1989 Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including service specified in item 2221, 2229 or 2231 (SP) Y 02224 01AUG1989 Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including service specified in item 2222, 2230 or 2232 (OP) Y 02225 01JUL1982 Chemical analysis of semen-- analysis of one substance (SP) Y 02226 01JUL1982 Chemical analysis of semen-- analysis of one substance (OP) Y 02227 01JUL1982 Chemical analysis of semen-- analysis of two or more substances (SP) Y 02228 01JUL1982 Chemical analysis of semen-- analysis of two or more substances (OP) Y 02229 01AUG1989 All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those service specified in item 2221, 2223 or 2231 (SP) Y 02230 01AUG1989 All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in item 2222, 2224 or 2232 (OP) Y 02231 01AUG1989 All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in item 2221 or 2223 (SP) Y 02232 01AUG1989 All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in item 2222 or 2224 (OP) Y 02235 01AUG1989 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - 1 or more estimations (SP) Y 02236 01AUG1989 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent - 1 or more estimations (OP) 25.00 Y 02239 01AUG1989 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1734, 1736 or 2245), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation - 1 or more procedures (SP) Y 02240 01AUG1989 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1735, 1737 or 2246), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresi or immunofixation - 1 or more procedures (OP) Y 02241 01AUG1989 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1734, 1736 or 2245) on serum and urine concurrently collected - 2 or more procedures (SP) Y 02242 01AUG1989 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1735, 1737 or 2246) on serum and urine concurrently collected - 2 or more procedures (OP) Y 02245 01AUG1989 Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method - estimation of 1 immunoglobin (SP) Y 02246 01AUG1989 Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method - estimation of 1 immunoglobin (OP) Y 02247 01JUL1982 Spermagglutinating and immobilising antibodies, test for-- one test (SP) Y 02248 01JUL1982 Spermagglutinating and immobilising antibodies, test for-- one test (OP) Y 02249 01JUL1982 Two or more tests referred to in Item 2247 (SP) Y 02250 01JUL1982 Two or more tests referred to in Item 2248 (OP) Y 02251 01AUG1989 2 estimations specified in item 2245 (SP) Y 02252 01AUG1989 2 estimations specified in item 2246 (OP) Y 02253 01AUG1989 3 or more estimations specified in item 2245 (SP) Y 02254 01AUG1989 3 or more estimations specified in item 2246 (OP) Y 02255 01AUG1989 Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA - 1 or more estimation (SP) Y 02256 01AUG1989 Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA - 1 or more estimation (OP) Y 02257 01AUG1989 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of 2 estimations in any 12 month period (SP) Y 02258 01AUG1989 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of 2 estimations in any 12 month period (OP) Y 02259 01AUG1989 Specific IgG or IgE antibodies to potential allergens - 1 or more tests for single or multiple allergens with a maximum of 4 estimations in any 12 month period (SP) Y 02260 01AUG1989 Specific IgG or IgE antibodies to potential allergens - 1 or more tests for single or multiple allergens with a maximum of 4 estimations in any 12 month period (SP) Y 02261 01AUG1989 Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required (SP) Y 02262 01AUG1989 Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required (OP) Y 02263 01AUG1989 Measurment of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained (SP) Y 02264 01JUL1982 Sperm penetrability, one or more tests for-- not associated with Item 2211 (SP) Y 02265 01JUL1982 Sperm penetrability, one or more tests for-- not associated with Item 2212 (OP) Y 02266 01AUG1989 Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained (OP) Y 02267 01AUG1989 Antibodies to extractable nuclear antigens, detection of in serum or other body fluids (SP) Y 02268 01AUG1989 Antibodies to extractable nuclear antigens, detection of in serum or other body fluids (OP) Y 02269 01AUG1989 Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 2267 (SP) Y 02270 01AUG1989 Charaterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 2268 (OP) Y 02271 01AUG1989 Antibodies to tissue antigens that are not elsewhere specified in an item in the Schedule - estimation of 1 antibody (SP) Y 02272 01JUL1982 Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods including estimation of beta-HCG in serum or urine (SP) N 02272 01MAR1984 Chorionic gonadotrophin(beta-HCG), qualitative estimation or quantitative estimation or qualitative and quantitative estimation by one or more methods for any purpose not covered by Item 2285 or 2286 (SP) Y 02273 01JUL1982 Chorionic gonadotrophin, qualitative estimation of for diagnosis of pregnancy or hormone producing neoplasm by one or more methods including estimation of beta-HCG in serum or urine (OP) N 02273 01MAR1984 Chorionic gonadotrophin(beta-HCG), qualitative estimation or quantitative estimation or qualitative and quantitative estimation by one or more methods for any purpose not covered by Item 2285 or 2286 (OP) Y 02274 01AUG1989 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule - estimation of 1 antibody (OP) Y 02275 01AUG1989 2 estimations specified in item 2271 (SP) Y 02276 01AUG1989 2 estimations specified in item 2274 (OP) Y 02277 01AUG1989 3 estimations specified in item 2271 (SP) Y 02278 01AUG1989 3 estimations specified in item 2274 (OP) Y 02279 01AUG1989 4 or more estimations specified in item 2271 (SP) Y 02280 01AUG1989 4 or more estimations specified in item 2274 (OP) Y 02281 01AUG1989 Rheumatoid factor, detection of by any technique (SP) Y 02282 01AUG1989 Rheumatoid factor, detection of by any technique (OP) Y 02283 01AUG1989 Quantitation of Rheumatoid factor where detected, including services specified in item 2281 (SP) Y 02284 01AUG1989 Quantitation of Rheumatoid factor where detected, including services specified in item 2282 (OP) Y 02285 01JUL1982 Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in Item 2272) (SP) N 02285 01MAR1984 Chorionic gonadotrophin quantitative estimation of(including serial dilutions) for assessments of hormone levels in the case of proven hormone producing neoplasms by one or more methods (SP) Y 02286 01JUL1982 Chorionic gonadotrophin, quantitative estimation of by serial dilution for assessment of hormone producing neoplasm by one or more methods (not associated with the service specified in Item 2273) (OP) N 02286 01MAR1984 Chorionic gonadotrophin quantitative estimation of(including serial dilutions) for assessments of hormone levels in the case of proven hormone producing neoplasms by one or more methods (OP) Y 02287 01JUL1985 PREGNANCY PATHOLOGY ASSESSMENT - comprising haemoglobin estimation, calculation of red cell indices, blood film examination, blood grouping, examination for blood group antibodies, test for syphillis, test for rubella antibodies, microscopic examination of uring and culture - one assessment in any one pregnancy. (SP) Y 02288 01JUL1985 PREGNANCY PATHOLOGY ASSESSMENT - comprising haemoglobin estimation, calculation of red cell indices, blood film examination, blood grouping, examination for blood group antibodies, test for syphillis, test for rubella antibodies, microscopic examination of uring and culture - one assessment in any one pregnancy. (OP) Y 02289 01AUG1989 Complement - total and components - 1 quantitative estimation (SP) Y 02290 01AUG1989 Complement - total and components - 1 quantitative estimation (OP) Y 02291 01AUG1989 2 estimations as specified in item 2289 (SP) Y 02292 01AUG1989 2 estimations as specified in item 2290 (OP) Y 02293 01AUG1989 3 or more estimations as specified in item 2289 (SP) Y 02294 01NOV1983 Pathology examination of any body fluid or tissue not covered by any other item in this Part (SP) Y 02295 01NOV1983 Pathology examination of any body fluid or tissue not covered by any other item in this Part (OP) Y 02296 01DEC1987 [Unidentified item - pathology] Y 02297 01DEC1987 [Unidentified item - pathology] Y 02298 01DEC1987 [Unidentified item - pathology] Y 02299 01DEC1987 [Unidentified item - pathology] Y 02300 01DEC1987 [Unidentified item - pathology] Y 02301 01DEC1987 [Unidentified item - pathology] Y 02302 01DEC1987 [Unidentified item - pathology] Y 02303 01DEC1987 [Unidentified item - pathology] Y 02304 01DEC1987 [Unidentified item - pathology] Y 02305 01DEC1987 [Unidentified item - pathology] Y 02306 01DEC1987 [Unidentified item - pathology] Y 02307 01DEC1987 [Unidentified item - pathology] Y 02308 01DEC1987 [Unidentified item - pathology] Y 02310 01DEC1987 [Unidentified item - pathology] Y 02312 01AUG1989 3 or more estimations as specified in item 2290 (OP) Y 02313 01AUG1989 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests (SP) Y 02314 01AUG1989 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests (OP) Y 02315 01AUG1989 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Division 1 - Haematology in the Schedule (SP) Y 02316 01AUG1989 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Division 1 - Haematology in the Schedule (OP) Y 02317 01AUG1989 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of 3 monoclonal antibodies, including any services in item 2319 - 1 or more estimations (SP) Y 02318 01AUG1989 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of 3 monoclonal antibodies, including any service in item 2320 - 1 or more estimations (OP) Y 02319 01AUG1989 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques in the investigation of a probable haematological malignancy using a minimum of 7 monoclonal antibodies, including any services in item 2317 - 1 or more estimations (SP) Y 02320 01AUG1989 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques in the investigation of a probable haematological malignancy using a minimum of 7 monoclonal antibodies, including any service in item 2318 - 1 or more estimations (OP) Y 02321 01AUG1989 HLA typing comprising A, B, C and DR phenotypes (SP) Y 02322 01AUG1989 HLA typing comprising A, B, C and DR phenotypes (OP) Y 02323 01AUG1989 HLA typing, excluding any service specified in item 2321 - 1 or more antigens (SP) Y 02324 01AUG1989 HLA typing, excluding any service specified in item 2322 - 1 or more antigens (OP) Y 02325 01AUG1989 Mantoux test (SP) Y 02326 01AUG1989 Mantoux test (OP) Y 02327 01AUG1989 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions (SP) Y 02328 01AUG1989 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions (OP) Y 02329 01AUG1989 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination (SP) Y 02330 01AUG1989 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination (OP) Y 02331 01AUG1989 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination (SP) Y 02332 01AUG1989 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination (OP) Y 02333 01AUG1989 Electron microscopy of biopsy material including any other histopathology examination (SP) 141.40 Y 02334 01JUL1982 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-- one procedure Y 02335 01JUL1982 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-- two procedures Y 02336 01JUL1982 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-- three or more procedures Y 02337 01AUG1989 Electron microscopy of biopsy material including any other histopathology examination (OP) 106.05 Y 02338 01AUG1989 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - 1 or more examinations (SP) 20.50 Y 02339 01AUG1989 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes - 1 or more examinations (OP) Y 02340 01AUG1989 Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - 1 or more examinations (SP) Y 02341 01AUG1989 Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes - 1 or more examinations (OP) Y 02342 01JUL1982 Microscopical examination of urine Y 02343 01AUG1989 Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 2340 and any histopathological service performed on that cytology specimen - 1 or more examinations (SP) 40.10 Y 02344 01AUG1989 Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 2341 and any histopathological service performed on that cytology specimen - 1 or more examinations (OP) Y 02346 01JUL1982 Pregnancy test by one or more immunochemical methods Y 02348 01AUG1989 Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells (SP) Y 02349 01AUG1989 Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells (OP) Y 02350 01AUG1989 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues (SP) Y 02351 01AUG1989 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues (OP) Y 02352 01JUL1982 Microscopical examination of wet film other than urine Y 02355 01AUG1989 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance (SP) Y 02356 01AUG1989 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance (OP) Y 02357 01JUL1982 Microscopical examination of gram stained film Y 02360 01AUG1989 Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - 1 or more estimations (SP) 181.50 Y 02361 01AUG1989 Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood - 1 or more estimations (OP) Y 02362 01JUL1982 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method Y 02363 01AUG1989 Chromosome studies, including preparation, count and karyotyping of blood (SP) Y 02364 01AUG1989 Chromosome studies, including preparation, count and karyotyping of blood (OP) Y 02365 01AUG1989 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis) or by fragile X-site determination - 1 or more identifications (SP) Y 02366 01AUG1989 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis) or by fragile X-site determination - 1 or more identifications (OP) Y 02369 01JUL1982 Microscopical examination screening for fungi in skin, hair or nails-- one or more sites Y 02370 01AUG1989 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) (SP) Y 02371 01AUG1989 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) (OP) Y 02372 01AUG1989 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period (SP) Y 02373 01AUG1989 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period (OP) Y 02374 01JUL1982 Mantoux test Y 02377 01AUG1989 Sperm antibodies, sperm penetrating ability - 1 or more tests (SP) Y 02378 01AUG1989 Sperm antibodies, sperm penetrating ability - 1 or more tests (OP) Y 02379 01AUG1989 Chorionic gonadotrophin (beta - HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy - 1 or more estimations (SP) Y 02380 01AUG1989 Chorionic gonadotrophin (beta - HCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy - 1 or more estimations (OP) Y 02382 01JUL1982 Casoni test for hydatid disease Y 02384 01AUG1989 Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion (SP) Y 02385 01AUG1989 Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCG - secreting neoplasm, threatened abortion or follow-up of abortion (OP) Y 02387 01AUG1989 Seminal examination for presence of spermatozoa Y 02388 01JUL1982 Schick test Y 02389 01AUG1989 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count - 1 procedure Y 02390 01AUG1989 2 procedures specified in item 2389 Y 02391 01AUG1989 3 or more procedures specified in item 2389 8.25 Y 02392 01JUL1982 Seminal examination for presence of spermatozoa Y 02393 01AUG1989 Microscopical examination of urine Y 02394 01AUG1989 Pregnancy test by 1 or more immunochemical methods Y 02395 01AUG1989 Microscopical examination of wet film other than urine Y 02396 01AUG1989 Microscopical examination of gram-stained film Y 02397 01AUG1989 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method Y 02398 01AUG1989 Microscopical examination screening for fungi in skin, hair or nails - 1 or more sites Y 02399 01AUG1989 Mantoux test 10.15 Y 02400 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with or without scan of internal auditory nneatus without intravenous contrast medium (not covered by item 2447 or 2450) N 02400 01SEP1989 Computerised tomography-scan of brain with or without scan of internal auditory meatus without intravenous contrast medium (not covered by item 2447 or 2450) Y 02401 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with or without scan of internal auditory meatus with intravenous contrast medium (not covered by item 2448 or 2451) N 02401 01SEP1989 Computerised tomography-scan of brain with or without scan of internal auditory meatus with intravenous contrast medium (not covered by item 2448 or 2451) Y 02402 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with or without scan of internal auditor/ meatus without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2449 or 2452) N 02402 01SEP1989 Computerised tomography-scan of brain with or without scan of internal auditory meatus without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2449 or 2452) Y 02403 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF PITUITARY FOSSA by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan N 02403 01SEP1989 Computerised tomography-scan of pituitary fossa by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan Y 02404 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF ORBITS by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain Scan N 02404 01SEP1989 Computerised tomography-scan of orbits by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan Y 02405 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF MIDDLE EAR AND TEMPORAL BONE, unilateral or bilateral, detailed study by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan N 02405 01SEP1989 Computerised tomography-scan of middle ear and temporal bone, unilateral or bilateral, detailed study by multiple thin slices (including reconstructions) without or with intravenous contrast medium and with or without brain scan Y 02406 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF TEMPORAL BONES WITH AIR STUDY (including reconstructions) and including intrathecal injection, not including an associated brain scan N 02406 01SEP1989 Computerised tomography-scan of temporal bones with air study (including reconstructions) and including intrathecal injection, not including an associated brain scan Y 02407 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF FACIAL BONES, sinuses and salivary glands-Scan of one or more regions without intravenous contrast medium N 02407 01SEP1989 Computerised tomography-scan of facial bones, sinuses and salivary glands-scan of one or more regions without intravenous contrast medium Y 02408 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF FACIAL BONES, sinuses and salivary glands-scan of one or more regions with intravenous contrast medium N 02408 01SEP1989 Computerised tomography-scan of facial bones, sinuses and salivary glands-scan of one or more regions with intravenous contrast medium Y 02409 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF FACIAL BONES, sinuses and salivary glands-scan of one or more regions without and with intravenous contrast medium N 02409 01SEP1989 Computerised tomography-scan of facial bones, sinuses and salivary glands-scan of one or more regions without and with intravenous contrast medium Y 02410 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without intravenous contrast medium (not covered by item 2444) N 02410 01SEP1989 Computerised tomography-scan of soft tissues of neck including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without intravenous contrast medium (not covered by item 2444) Y 02411 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SOFT TISSUES OF NECK including lan/nx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions with intravenous contrast medium (not covered by item 2445) N 02411 01SEP1989 Computerised tomography-scan of soft tissues of neck including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions with intravenous contrast medium (not covered by item 2445) Y 02412 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SOFT TISSUES OF NECK including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without and with intravenous contrast medium (not covered by item 2446) N 02412 01SEP1989 Computerised tomography-scan of soft tissues of neck including larynx, pharynx and upper oesophagus (not associated with cervical spine)-scan of one or more regions without and with intravenous contrast medium (not covered by item 2446) Y 02413 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-25 slices or less without intravenous contrast medium N 02413 01SEP1989 Computerised tomography-scan of spine, one or more regions-25 slices or less without intravenous contrast medium Y 02414 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-25 slices or less with intravenous contrast medium N 02414 01SEP1989 Computerised tomography-scan of spine, one or more regions-25 slices or less with intravenous contrast medium Y 02415 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF S.PINE,;one or more regions-25 slices Sr less without and with intravenous contrast medium N 02415 01SEP1989 Computerised tomography-scan of spine, one or more regions-25 slices or less without and with intravenous contrast medium Y 02416 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-26 or more slices without intravenous contrast medium N 02416 01SEP1989 Computerised tomography-scan of spine, one or more regions-26 or more slices without intravenous contrast medium Y 02417 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-26 or more slices with intravenous contrast medium N 02417 01SEP1989 Computerised tomography-scan of spine, one or more regions-26 or more slices with intravenous contrast medium Y 02418 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions-26 or more slices without and with intravenous contrast medium N 02418 01SEP1989 Computerised tomography-scan of spine, one or more regions-26 or more slices without and with intravenous contrast medium Y 02419 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF SPINE, one or more regions with intrathecal contrast medium (not including the preparation by intrathecal injection of contrast medium) N 02419 01SEP1989 Computerised tomography-scan of spine, one or more regions with intrathecal contrast medium (not including the preparation by intrathecal injection of contrast medium) Y 02420 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST (including lungs, mediastinum and pleura) with-out intravenous contrast medium (not covered by item 2438, 2441, 2444, 2447 or 2450) N 02420 01SEP1989 Computerised tomography-scan of chest (including lungs, mediastinum and pleura) without intravenous contrast medium (not covered by item 2438, 2441, 2444, 2447 or 2450) Y 02421 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST (irtcl.uding lungs, mediastinum and pleura) with intravenous contrast medium (not covered by item 2439, 2442, 2445, 2448 or 2451) N 02421 01SEP1989 Computerised tomography-scan of chest (including lungs, mediastinum and pleura) with intravenous contrast medium (not covered by item 2439, 2442, 2445, 2448 or 2451) Y 02422 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST (including lungs, mediastinum and pleura) with-out intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446, 2449 or 2452) N 02422 01SEP1989 Computerised tomography-scan of chest (including lungs, mediastinum and pleura) without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440 2443, 2446, 2449 or 2452) Y 02423 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451) N 02423 01SEP1989 Computerised tomography-scan of upper abdomen (diaphragm to iliac crest) or pelvis without intravenous contrast medium (not covered by item 2438, 2441, 2444 or 2450) Y 02424 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451) N 02424 01SEP1989 Computerised tomography-scan of upper abdomen (diaphragm to iliac crest) or pelvis with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451) Y 02425 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452) N 02425 01SEP1989 Computerised tomography-scan of upper abdomen (diaphragm to iliac crest) or pelvis without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452) Y 02426 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (not covered by item 2438, 2441, 2444 or 2450) N 02426 01SEP1989 Computerised tomography-scan of upper abdomen and pelvis without intravenous contrast medium (not covered by item 2438, 2441, 2444 or 2450) Y 02427 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN AND PELVIS with intravenous con-trast medium (not covered by item 2439, 2442, 2445 or 2451) N 02427 01SEP1989 Computerised tomography-scan of upper abdomen and pelvis with intravenous contrast medium (not covered by item 2439, 2442, 2445 or 2451) Y 02428 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452) N 02428 01SEP1989 Computerised tomography-scan of upper abdomen and pelvis without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not covered by item 2440, 2443, 2446 or 2452) Y 02429 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES. ONE OR MORE REGIONS involving up to 20 slices without intravenous contrast medium N 02429 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving up to 20 slices without intravenous contrast medium Y 02430 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving up to 20 slices with intravenous contrast medium N 02430 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving up to 20 slices with intravenous contrast medium Y 02431 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving up to 20 slices without and with intravenous contrast medium N 02431 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving up to 20 slices without and with intravenous contrast medium Y 02432 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 20 slices but not more than 40 slices without intravenous contrast medium N 02432 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving more than 20 slices but not more than 40 slices without intravenous contrast medium Y 02433 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES. ONE OR MORE REGIONS involving more than 20 slices but not more than 40 slices with intravenous contrast medium N 02433 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving more than 20 slices but not more than 40 slices with intravenous contrast medium Y 02434 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 20 slices but not more than 40 slices without and with intravenous contrast medium N 02434 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving more than 20 slices but not more than 40 slices without and with intravenous contrast medium Y 02435 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 40 slices without intravenous contrast medium N 02435 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving more than 40 slices without intravenous contrast medium Y 02436 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 40 slices with intravenous contrast medium N 02436 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving more than 40 slices with intravenous contrast medium Y 02437 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF EXTREMITIES, ONE OR MORE REGIONS involving more than 40 slices without and with intravenous contrast medium N 02437 01SEP1989 Computerised tomography-scan of extremities, one or more regions involving more than 40 slices without and with intravenous contrast medium Y 02438 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without intravenous contrast medium (not covered by item 2441, 2444 or 2450) N 02438 01SEP1989 Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) without intravenous contrast medium (not covered by item 2441, 2444 or 2450) Y 02439 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) with intravenous contrast medium (not covered by item 2442, 2445 or 2451) N 02439 01SEP1989 Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) with intravenous contrast medium (not covered by item 2442, 2445 or 2451) Y 02440 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without and with intravenous contrast medium (not covered by item 2443, 2446 or 2452) N 02440 01SEP1989 Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) without and with intravenous contrast medium (not covered by item 2443 2446 or 2452) Y 02441 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST, ABDOMEN AND PELVIS without intravenous contrast medium (not covered by item 2444) N 02441 01SEP1989 Computerised tomography-scan of chest, abdomen and pelvis without intravenous contrast medium (not covered by item 2444) Y 02442 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST, ABDOMEN AND PELVIS with intravenous contrast medium (not covered by item 2445) N 02442 01SEP1989 Computerised tomography-scan of chest, abdomen and pelvis with intravenous contrast medium (not covered by item 2445) Y 02443 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST, ABDOMEN AND PELVIS without and with intravenous contrast, medium (not covered by item 2446) N 02443 01SEP1989 Computerised tomography-scan of chest, abdomen and pelvis without and with intravenous contrast medium (not covered by item 2446) Y 02444 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF NECK, CHEST, ABDOMEN AND PELVIS without intra-venous contrast medium N 02444 01SEP1989 Computerised tomography-scan of neck, chest, abdomen and pelvis without intravenous contrast medium Y 02445 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF NECK. CHEST, ABDOMEN AND PELVIS with intrave-nous contrast medium N 02445 01SEP1989 Computerised tomography-scan of neck, chest, abdomen and pelvis with intravenous contrast medium Y 02446 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF NECK, CHEST, ABDOMEN AND PELVIS without and with intravenous contrast medium N 02446 01SEP1989 Computerised tomography-scan of neck, chest, abdomen and pelvis without and with intravenous contrast medium Y 02447 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN AND CHEST without intravenous contrast medium N 02447 01SEP1989 Computerised tomography-scan of brain and chest without intravenous contrast medium Y 02448 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN AND CHEST with intravenous contrast medium N 02448 01SEP1989 Computerised tomography-scan of brain and chest with intravenous contrast medium Y 02449 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN AND CHEST without and with intravenous contrast medium N 02449 01SEP1989 Computerised tomography-scan of brain and chest without and with intravenous contrast medium Y 02450 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without intravenous contrast medium N 02450 01SEP1989 Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) and scan of brain without intravenous contrast medium Y 02451 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER fBDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN with intravenous contrast mediuni . N 02451 01SEP1989 Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) and scan of brain with intravenous contrast medium Y 02452 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without and with intravenous contrast medium N 02452 01SEP1989 Computerised tomography-scan of chest and upper abdomen (from lung apices to iliac crest) and scan of brain without and with intravenous contrast medium Y 02453 01AUG1987 COMPUTERISED TOMOGRAPHY PELVIMETRY Y 02454 01AUG1987 COMPUTERISED TQMOGRAPHY-DYNAMIC SCAN OF REGION not associated with any other item in this part N 02454 01SEP1989 Computerised tomography-dynamic scan of region not associated with any other item in this part Y 02455 01AUG1987 COMPUTERISED TOMOGRAPHY-DYNAMIC SCAN OR REGION when associated with another itenn in this part DERIVED FEE-The fee for computerised tomography of the area and report plus an amount of $88 N 02455 01SEP1989 Computerised tomography-dynamic scan of region when associated with another item in this Part Y 02458 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN without intravenous contrast medium N 02458 01SEP1989 Computerised tomography-scan of brain without intravenous contrast medium Y 02459 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN with intravenous contrast medium N 02459 01SEP1989 Computerised tomography-scan of brain with intravenous contrast medium Y 02460 01AUG1987 COMPUTERISED TOMOGRAPHY-SCAN OF BRAIN without and with intravenous contrast medium N 02460 01SEP1989 Computerised tomography-scan of brain without and with intravenous contrast medium Y 02461 01NOV2019 Professional attendance by video conference by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management, only if: the patient is not an admitted patient; and the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months. Y 02463 01NOV2019 Professional attendance by video conference by a general practitioner (other than a service to which another item applies), lasting less than 20 minutes and including any of the following that are clinically relevant: taking a patient history; performing a clinical examination; (arranging any necessary investigation; implementing a management plan; providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation - only if: - the patient is not an admitted patient; and - the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and - at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and - the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months. Y 02464 01NOV2019 Professional attendance by video conference by a general practitioner (other than a service to which another item applies), lasting at least 20 minutes but less than 40 minutes and including any of the following that are clinically relevant: taking a patient history; performing a clinical examination; arranging any necessary investigation; implementing a management plan; providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation - only if: - the patient is not an admitted patient; and - the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and - at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and - the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months. Y 02465 01NOV2019 Professional attendance by video conference by a general practitioner (other than a service to which another item applies), lasting at least 40 minutes and including any of the following that are clinically relevant: taking a patient history; performing a clinical examination; arranging any necessary investigation; implementing a management plan; providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation - only if: - the patient is not an admitted patient; and - the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and - at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and - the patient has received 3 face-to-face professional attendances from that practitioner in the preceding 12 months. Y 02471 01NOV2019 Professional attendance by video conference of not more than 5 minutes in duration (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02472 01NOV2019 Professional attendance by video conference of more than 5 minutes in duration but not more than 25 minutes (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02475 01NOV2019 Professional attendance by video conference of more than 25 minutes in duration but not more than 45 minutes (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02478 01NOV2019 Professional attendance by video conference of more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner (who is not a general practitioner), only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02480 01NOV2019 Professional attendance by video conference of not more than 5 minutes in duration by a medical practitioner, only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02481 01NOV2019 Professional attendance by video conference of more than 5 minutes in duration but not more than 25 minutes by a medical practitioner, only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02482 01NOV2019 Professional attendance by video conference of more than 25 minutes in duration but not more than 45 minutes by a medical practitioner, only if: (a) the patient is not an admitted patient; and (b) the patient is located within a Modified Monash 6 area or a Modified Monash 7 area; and (c) at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d) the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02483 01NOV2019 Professional attendance by video conference of more than 45 minutes in duration by a medical practitioner, only if:(a)     the patient is not an admitted patient; and (b)     the patient is located within a Modified Monash 6 area or a Modified Monash 7 area;  and (c)      at the time of the attendance, the patient and the medical practitioner are at least 15 km by road from each other; and (d)     the patient has received 3 face?to?face professional attendances from that practitioner in the preceding 12 months. Y 02497 01MAY2005 LEVEL 'A' Professional attendance involving taking a short patient history and, if required, limited examination and management AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999 SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02497 01NOV2006 LEVEL 'A' Professional attendance involving taking a short patient history and, if required, limited examination and management AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999 SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02497 01MAY2010 Professional attendance at consulting rooms by a general practitioner: (a) involving taking a short patient history and, if required, limited examination and management; and (b) at which a cervical smear is taken from a person between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years N 02497 01DEC2017 Professional attendance at consulting rooms by a general practitioner: (a) involving taking a short patient history and, if required, limited examination and management; and (b) at which a specimen for a cervical screening service is collected from the patient; if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years. Y 02501 01NOV2001 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02501 01MAY2005 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02501 01NOV2006 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02501 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years N 02501 01DEC2017 Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, andat which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years. Y 02502 01FEB1984 Digits or phalanges-- all or any of either hand or either foot (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02503 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02503 01MAY2005 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with item 10999. N 02503 01NOV2006 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02503 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02503 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years N 02503 01DEC2017 Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, andat which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years. Y 02504 01NOV2001 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02504 01MAY2005 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02504 01NOV2006 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02504 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years N 02504 01DEC2017 Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, andat which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02505 01FEB1984 Digits or phalanges-- all or any of either hand or either foot (when the service is rendered by a specialist in the practice of his specialty) Y 02506 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02506 01MAY2005 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with item 10999. N 02506 01NOV2006 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02506 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02506 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years N 02506 01DEC2017 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, andat which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02507 01NOV2001 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02507 01MAY2005 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02507 01NOV2006 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02507 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years N 02507 01DEC2017 Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, andat which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02508 01FEB1984 Hand, wrist, forearm, elbow or arm (elbow to shoulder) (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02509 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with item 10999. N 02509 01NOV2006 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms). This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02509 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02509 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and at which a papanicolaou smear is taken from a person at least 20 years old and not older than 69 years old, who has not had a papanicolaou smear in the last 4 years N 02509 01DEC2017 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, andat which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02512 01FEB1984 Hand, wrist, forearm, elbow or arm (elbow to shoulder) (when the service is rendered by a specialist in the practice of his specialty) Y 02516 01FEB1984 Hand, wrist and lower forearm; upper forearm and elbow; or elbow and arm (elbow to shoulder) (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02517 01NOV2001 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01MAY2002 Note: Benefits are payable for only one service included in Subgroup 2 or A19, Subgroup 2 in a 12-month period The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once every year -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BM*I:At least once every six months -Measure blood pressure:At least once every six months -Examine feet:At least once every six months -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least once every year -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review * Initial visit: measure height wieght and calculate BMI as part of the initial assessment. Subsequent visits: measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01NOV2002 Note: Benefits are payable for only one service included in Subgroup 2 or A19, Subgroup 2 in a 12-month period The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI*:At least once every six months -Measure blood pressure:At least once every six months -Examine feet:At least once every six months -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least onceevery year -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review *Initial visit:measure height and weight and calculate BMI as part of the initial patient assessment.Subsequent visits:measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01MAY2005 The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI*:At least once every six months -Measure blood pressure:At least once every six months -Examine feet:At least once every six months -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least onceevery year -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review *Initial visit:measure height and weight and calculate BMI as part of the initial patient assessment.Subsequent visits:measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01NOV2005 The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI*:At least twice every cycle of care -Measure blood pressure:At least twice every cycle of care -Examine feet:At least twice every cycle of care -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least onceevery year -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review *Initial visit:measure height and weight and calculate BMI as part of the initial patient assessment.Subsequent visits:measure weight. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01NOV2006 The minimum requirements of care needed to be assessed to complete a cycle of care for patients with established diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out*At least once every two years -Measure weight and height and calculate BMI**At least twice every cycle of care -Measure blood pressureAt least twice every cycle of care -Examine feet***At least twice every cycle of care -Measure total cholesterol, triglycerides and HDL cholesterolAt least once every year -Test for microalbuminuriaAt least onceevery year -Provide self-care educationPatient education regarding diabetes management -Review dietReinforce information about appropriate dietary choices -Review levels of physical activityReinforce information about appropriate levels of physical activity -Check smoking statusEncourage cessation of smoking (if relevant) -Review of medicationMedication review *Not required if the patient is blind or does not have both eyes. **Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. ***Not required if the patient does not have both feet. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01JUL2009 The minimum requirements of care to complete an annual Diabetes Cycle of Care for patients with established diabetes mellitus must be completed over a period of at least 11 months and up to 13 months, and must include: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out*At least once every two years -Measure weight and height and calculate BMI**At least twice every cycle of care -Measure blood pressureAt least twice every cycle of care -Examine feet***At least twice every cycle of care -Measure total cholesterol, triglycerides and HDL cholesterolAt least once every year -Test for microalbuminuriaAt least onceevery year -Provide self-care educationPatient education regarding diabetes management -Review dietReinforce information about appropriate dietary choices -Review levels of physical activityReinforce information about appropriate levels of physical activity -Check smoking statusEncourage cessation of smoking (if relevant) -Review of medicationMedication review *Not required if the patient is blind or does not have both eyes. **Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. ***Not required if the patient does not have both feet. LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02517 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus Y 02518 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02518 01NOV2006 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus N 02518 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02518 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus Y 02520 01FEB1984 Hand, wrist and lower forearm; upper forearm and elbow; or elbow and arm (elbow to shoulder) (when the service is rendered by a specialist in the practice of his specialty) Y 02521 01NOV2001 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02521 01NOV2006 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02521 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus Y 02522 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02522 01NOV2006 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus N 02522 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02522 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus Y 02524 01FEB1984 Foot, ankle, lower leg, upper leg, knee or thigh (femur) (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02525 01NOV2001 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements for a full year of care of a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02525 01NOV2006 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02525 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus Y 02526 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02526 01NOV2006 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus N 02526 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02526 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus Y 02528 01FEB1984 Foot, ankle, lower leg, upper leg, knee or thigh (femur) (when the service is rendered by a specialist in the practice of his specialty) Y 02532 01FEB1984 Foot, ankle and lower leg; or upper leg and knee (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02537 01FEB1984 Foot, ankle and lower leg; or upper leg and knee (when the service is rendered by a specialist in the practice of his specialty) Y 02539 01FEB1984 Shoulder or scapula (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02541 01FEB1984 Shoulder or scapula (when the service is rendered by a specialist in the practice of his specialty) Y 02543 01FEB1984 Clavicle (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02545 01FEB1984 Clavicle (when the service is rendered by a specialist in the practice of his specialty) Y 02546 01NOV2001 At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - at least two of these consultations to have been planned recalls - diagnosis and assessment of severity - review of asthma related medication - provision of written asthma action plan and education to patient LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms N 02546 01MAY2002 Note: Benefits are payable for one service included in Subgroup 3 or A19, Subgroup 3 only in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - planned recalls for at least two of these consultations - documented diagnosis and assessment of severity - review of the patient's use of asthma related medication - provision of a written asthma action plan and self-management education to the patient - review of asthma action plan LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02546 01NOV2002 Note: Benefits are payable for only one service included in Subgroup 3 or A19, Subgroup 3 in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - documented diagnosis and assessment of severity - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - review of the patient's use of asthma related medication - planned recalls for at least two of these consultations - provision of a written asthma action plan and self-management education to the patient, (if the patient is unable to use a written action plan, alternative patient education may be provided and documented in the medical record). - review of asthma action plan LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02546 01NOV2006 Note: Benefits are payable for only one service included in Subgroup 3 or A19, Subgroup 3 in a 12-month period, unless a further Asthma Cycle of Care is clinically indicated. At a minimum the Asthma Cycle of Care must include: - at least 2 asthma related consultations within 12 months for a patient with moderate to severe asthma (at least 1 of which (the review consultation) is a consultation that was planned at a previous consultation) - documented diagnosis and assessment of level of asthma control and severity of asthma - review of the patient's use of and access to asthma related medication and devices - provision to the patient of a written asthma action plan (if the patient is unable to use a written asthma action plan - discussion with the patient about an alternative method of providing an asthma action plan, and documentation of the discussion in the patient's medical records) - provision of asthma self-management education to the patient - review of the written or documented asthma action plan LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with the implementation of a management plan in relation to one or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 36, 37, 38, 40, 43, 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma Cycle of Care. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02546 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care Y 02547 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02547 01NOV2006 OUT-OF-SURGERY CONSULTATION AND which completes the minimum requirements of the Asthma Cycle of Care. (Professional attendance at a place other than consulting rooms) N 02547 01MAY2010 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02547 01JAN2012 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02547 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care Y 02548 01FEB1984 Hip joint Y 02551 01FEB1984 Pelvic girdle Y 02552 01NOV2001 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02552 01MAY2002 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02552 01NOV2006 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the minimum requirements of the Asthma Cycle of Care. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02552 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care Y 02553 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02553 01NOV2006 OUT-OF-SURGERY CONSULTATION AND which completes the minimum requirements of the Asthma Cycle of Care. (Professional attendance at a place other than consulting rooms) N 02553 01MAY2010 CONSULTATION AT A PLACE OTHER CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02553 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care Y 02554 01FEB1984 Sacro-iliac joints Y 02557 01FEB1984 Smith-Petersen nail-- insertion or similar procedure N 02557 01SEP1989 Femur, internal fixation of neck or intertrochanteric (pertrochanteric) fracture Y 02558 01NOV2001 LEVEL 'D' Professional attendance involving taking a exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements of theAsthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02558 01MAY2002 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the minimum requirements of the Asthma 3+ Visit Plan. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02558 01NOV2006 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more complex problems and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the minimum requirements of the Asthma Cycle of Care. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02558 01MAY2010 Professional attendance by a general practitioner at consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care Y 02559 01NOV2001 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02559 01NOV2006 OUT-OF-SURGERY CONSULTATION AND which completes the minimum requirements of the Asthma Cycle of Care. (Professional attendance at a place other than consulting rooms) N 02559 01MAY2010 CONSULTATION AT A APLACE OTHER THAN CONSULTING ROOMS Professional attendance at a place other than consulting rooms. N 02559 01JAN2013 Professional attendance by a general practitioner at a place other than consulting rooms, lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation, and that completes the minimum requirements of the Asthma Cycle of Care Y 02560 01FEB1984 Skull (calvarium) Y 02563 01FEB1984 Sinuses Y 02566 01FEB1984 Mastoids Y 02569 01FEB1984 Petrous temporal bones Y 02573 01FEB1984 Facial bones-- orbit, maxilla or malar-- any or all Y 02574 30JUL2002 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least two of the consultations to have been planned visits; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2) LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02574 01NOV2002 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least two of the consultations to have been planned visits; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2) LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02574 01MAY2005 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 Step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least 2 of the consultations to have been planned visits; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials. LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02574 01NOV2005 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one 3 Step Mental Health Process per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least one of the consultations to have been a planned visit which must include the review step; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a general practitioner, who practices in general practice and has been notified to the HIC as having the required credentials. LEVEL C Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to one or more problems and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 44, 47, 48, 50 or 51 applies; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms) Y 02575 30JUL2002 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02575 01NOV2002 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) Y 02576 01FEB1984 Mandible Y 02577 30JUL2002 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02577 01NOV2002 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan; AND which completes the requirements of the 3 Step Mental Health Process. SURGERY CONSULTATION (Professional attendance at consulting rooms) Y 02578 30JUL2002 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02578 01NOV2002 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) Y 02579 01FEB1984 Salivary calculus Y 02581 01FEB1984 Nose Y 02583 01FEB1984 Eye Y 02585 01FEB1984 Temporo-mandibular joints Y 02587 01FEB1984 Teeth-- single area Y 02589 01FEB1984 Teeth-- full mouth Y 02590 01SEP1989 Teeth-orthopantomography Y 02591 01FEB1984 Palato-pharyngeal studies with fluoroscopic screening Y 02593 01FEB1984 Palato-pharyngeal studies without fluoroscopic screening Y 02595 01FEB1984 Larynx Y 02597 01FEB1984 Spine-- cervical Y 02598 01MAY2005 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999 N 02598 01NOV2006 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999 N 02598 01JAN2012 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) BRIEF CONSULTATION of not more than 5 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. N 02598 01JUL2013 Professional attendance at consulting rooms of less than 5 minutes in duration by a medical practitioner who practices in general practice (other than a general practitioner) at which a cervical smear is taken from a person between the ages of 20 and 69 years (inclusive) who has not had a cervical smear in the last 4 years N 02598 01DEC2017 Professional attendance at consulting rooms of less than 5 minutes in duration by a medical practitioner who practices in general practice (other than a general practitioner)at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02599 01FEB1984 Spine-- thoracic Y 02600 01NOV2001 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years N 02600 01MAY2005 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. N 02600 01NOV2006 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02600 01JAN2012 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. N 02600 01JUL2013 Professional attendance at consulting rooms of more than 5, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years N 02600 01DEC2017 Professional attendance at consulting rooms of more than 5, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner),at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02601 01FEB1984 Spine-- lumbo-sacral Y 02603 01NOV2001 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years N 02603 01MAY2005 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. N 02603 01NOV2006 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02603 01JAN2012 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. N 02603 01JUL2013 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years N 02603 01DEC2017 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02604 01FEB1984 Spine-- sacro-coccygeal Y 02606 01NOV2001 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive who has not had a cervical smear in the last 4 years N 02606 01MAY2005 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. N 02606 01NOV2006 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02606 01JAN2012 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. N 02606 01JUL2013 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years N 02606 01DEC2017 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02607 01FEB1984 Spine-- two regions Y 02609 01FEB1984 Spine-- three or more regions Y 02610 01NOV2001 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years N 02610 01MAY2005 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. N 02610 01NOV2006 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02610 01JAN2012 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. N 02610 01JAN2013 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02610 01JUL2013 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years N 02610 01DEC2017 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner),at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02611 01FEB1984 Spine-- functional views of one area Y 02613 01NOV2001 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive, who has not had a cervical smear in the last 4 years N 02613 01MAY2005 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. N 02613 01NOV2006 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02613 01JAN2012 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. N 02613 01JAN2013 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive, who has not had a cervical smear in the last 4 years. Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02613 01JUL2013 Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years N 02613 01DEC2017 Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02614 01FEB1984 Bone age study, wrist and knee Y 02616 01NOV2001 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 inclusive who has not had a cervical smear in the last 4 years N 02616 01MAY2005 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with item 10999. N 02616 01NOV2006 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. This item cannot be claimed in conjunction with items 10994, 10995, 10998 or 10999. N 02616 01JAN2012 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. N 02616 01JAN2013 PROLONGED CONSULTATION of more than 45 minutes duration AND at which a cervical smear is taken from a woman between the ages of 20 and 69 years inclusive who has not had a cervical smear in the last 4 years. Extended Medicare Safety Net Cap: 300% of the Derived fee for this item, or $500, whichever is the lesser amount N 02616 01JUL2013 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a cervical smear is taken from a person between the ages of 20 and 69 (inclusive) who has not had a cervical smear in the last 4 years N 02616 01DEC2017 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), at which a specimen for a cervical screening service is collected from the patient, if the patient is at least 24 years and 9 months of age but is less than 75 years of age and has not been provided with a cervical screening service or a cervical smear service in the last 4 years Y 02617 01FEB1984 Bone age study, wrist Y 02620 01NOV2001 SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02620 01MAY2002 Note: Benefits are payable for one service included in Subgroup 2 or A18, Subgroup 2 only in a 12-month period The minimum requirements of care needed to be assesed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once per year -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI:At least once every six months -Examine feet:At least once every six months -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least once per year -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02620 01NOV2002 Note: Benefits are payable for only one service included in Subgroup 2 or A18, Subgroup 2 in a 12-month period The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI*:At least once every six months -Measure blood pressure:At least once every six months -Examine feet:At least once every six months -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least once everyyear -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review *Initial visit:measure height and weight and calculate BMI as part of the initial patient assessment.Subsequent visits:measure weight. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02620 01MAY2005 The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI*:At least once every six months -Measure blood pressure:At least once every six months -Examine feet:At least once every six months -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least once everyyear -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review *Initial visit:measure height and weight and calculate BMI as part of the initial patient assessment.Subsequent visits:measure weight. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus. N 02620 01NOV2005 The minimum requirements of care needed to be assessed to complete an annual cycle of care for patients with diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out:At least once every two years -Measure weight and height and calculate BMI*:At least twice every cycle of care -Measure blood pressure:At least twice every cycle of care -Examine feet:At least twice every cycle of care -Measure total cholesterol, triglycerides and HDL cholesterol:At least once every year -Test for microalbuminuria:At least once everyyear -Provide self-care education:Patient education regarding diabetes management -Review diet:Reinforce information about appropriate dietary choices -Review levels of physical activity:Reinforce information about appropriate levels of physical activity -Check smoking status:Encourage cessation of smoking (if relevant) -Review of medication:Medication review *Initial visit:measure height and weight and calculate BMI as part of the initial patient assessment.Subsequent visits:measure weight. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus. N 02620 01NOV2006 The minimum requirements of care needed to be assessed to complete a cycle of care for patients with established diabetes mellitus are: -Assess diabetes control by measuring HbA1cAt least once everyyear -Ensure that a comprehensive eye examination is carried out*At least once every two years -Measure weight and height and calculate BMI**At least twice every cycle of care -Measure blood pressureAt least twice every cycle of care -Examine feet***At least twice every cycle of care -Measure total cholesterol, triglycerides and HDL cholesterolAt least once every year -Test for microalbuminuriaAt least once everyyear -Provide self-care educationPatient education regarding diabetes management -Review dietReinforce information about appropriate dietary choices -Review levels of physical activityReinforce information about appropriate levels of physical activity -Check smoking statusEncourage cessation of smoking (if relevant) -Review of medicationMedication review *Not required if the patient is blind or does not have both eyes. **Initial visit: measure height and weight and calculate BMI as part of the initial patient assessment. Subsequent visits: measure weight. ***Not required if the patient does not have both feet. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus. N 02620 01JUL2009 Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 02621 01FEB1984 Skeletal survey involving four or more regions Y 02622 01NOV2001 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02622 01NOV2006 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the requirements for a cycle of care of a patient with established diabetes mellitus Y 02624 01NOV2001 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02624 01NOV2006 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 02625 01FEB1984 Chest (lung fields) by direct radiography (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02627 01FEB1984 Chest (lung fields) by direct radiography (when the service is rendered by a specialist in the practice of his specialty) Y 02630 01FEB1984 Chest (lung fields) by direct radiography with fluoroscopic screening Y 02631 01NOV2001 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02631 01NOV2006 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus N 02631 01JAN2013 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 02633 01NOV2001 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02633 01NOV2006 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus N 02633 01JAN2013 Professional attendance at a place other than consulting rooms of more than 25 minutes but not more than 45 minutes, in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 02634 01FEB1984 Thoracic inlet or trachea Y 02635 01NOV2001 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements for a full year of care of a patient with established diabetes mellitus N 02635 01NOV2006 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of a cycle of care for a patient with established diabetes mellitus N 02635 01JAN2013 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements for a cycle of care of a patient with established diabetes mellitus Y 02638 01FEB1984 Chest by miniature radiography Y 02642 01FEB1984 Cardiac examination (including barium swallow) (when the service is rendered otherwise than by a specialist in the practice of his specialty) Y 02646 01FEB1984 Cardiac examination (including barium swallow) (when the service is rendered by a specialist in the practice of his specialty) Y 02655 01FEB1984 Sternum or ribs on one side Y 02656 01FEB1984 Sternum and ribs on one side, or ribs on both sides Y 02657 01FEB1984 Sternum and ribs on both sides Y 02664 01NOV2001 At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - at least two of these consultations to have been planned recalls - diagnosis and assessment of severity - review of asthma related medication - provision of written asthma action plan and education to patient SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATIONS of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements of theAsthma 3+ Visit Plan. N 02664 01MAY2002 Note: Benefits are payable for one service included in Subgroup 3 or A18, Subgroup 3 only in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - planned recalls for at least two of these consultations - documented diagnosis and assessment of severity - review of the patient's use of asthma related medication - provision of a written asthma action plan and self-management education to the patient - review of asthma action plan SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATIONS of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02664 01NOV2002 Note: Benefits are payable for only one service included in Subgroup 3 or A18, Subgroup 3 in a 12-month period, unless a further Asthma 3+ Visit Plan is clinically indicated. At a minimum the Asthma 3+ Visit Plan must include: - documented diagnosis and assessment of severity - at least 3 asthma related consultations in the previous 4 weeks (minimum) to 4 months (maximum) for a patient with moderate to severe asthma - review of the patient's use of asthma related medication - planned recalls for at least two of these consultations - provision of a written asthma action plan and self-management education to the patient, (if the patient is unable to use a written action plan, alternative patient education may be provided and documented in the medical record) - review of asthma action plan SURGERY CONSULTATIONS (Professional attendance at consulting rooms) STANDARD CONSULTATIONS of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02664 01NOV2006 Professional attendance at consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care Y 02665 01FEB1984 Plain renal only Y 02666 01NOV2001 LONG CONSULTATION or more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan. N 02666 01MAY2002 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02666 01NOV2006 Professional attendance at consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care Y 02668 01NOV2001 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan. N 02668 01MAY2002 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02668 01NOV2006 Professional attendance at consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care Y 02672 01FEB1984 Drip-infusion pyelography Y 02673 01NOV2001 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan. N 02673 01MAY2002 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02673 01NOV2006 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration AND which completes the minimum requirements of the Asthma Cycle of Care. N 02673 01JAN2013 Professional attendance at a place other than consulting rooms of more than 5 minutes, but not more than 25 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care Y 02675 01NOV2001 LONG CONSULTATION of more than 25 minutes duration but notmore than 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan. N 02675 01MAY2002 LONG CONSULTATION of more than 25 minutes duration but notmore than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02675 01NOV2006 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the minimum requirements of the Asthma Cycle of Care. N 02675 01JAN2013 Professional attendance at a place other than consulting rooms of more than 25 minutes, but not more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care Y 02676 01FEB1984 Intravenous pyelography, including preliminary plain film Y 02677 01NOV2001 PROLONGED CONSULTATION of more 45 minutes duration AND which completes the requirements of the Asthma 3+ Visit Plan. N 02677 01MAY2002 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of the Asthma 3+ Visit Plan. N 02677 01NOV2006 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the minimum requirements of the Asthma Cycle of Care. N 02677 01JAN2013 Professional attendance at a place other than consulting rooms of more than 45 minutes in duration by a medical practitioner who practises in general practice (other than a general practitioner), that completes the minimum requirements of the Asthma Cycle of Care Y 02678 01FEB1984 Intravenous pyelography, including preliminary plain film and limited tomography involving up to three tomographic cuts Y 02681 01FEB1984 Intravenous pyelography, including preliminary plain film with delayed examination for the cysto-ureteric reflex Y 02687 01FEB1984 Antegrade or retrograde pyelography including preliminary plain film Y 02690 01FEB1984 Retrograde cystography or retrograde urethrography Y 02694 01FEB1984 Retrograde micturating cysto-urethrography Y 02697 01FEB1984 Retro-peritoneal pneumogram Y 02699 01FEB1984 Plain abdominal only (when the service is rendered otherwise than by a specialist in the practice of his specialty) not associated with Item 2709, 2711, 2714 or 2720 Y 02700 01NOV2011 Professional attendance by a medical practitioner (including a general practitioner who has not undertaken mental health skills training, but not including a specialist or consultant physician) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient N 02700 01JUL2018 Professional attendance by a general practitioner (including a general practitioner who has not undertaken mental health skills training) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 02701 01NOV2011 Professional attendance by a medical practitioner (including a general practitioner who has not undertaken mental health skills training, but not including a specialist or consultant physician) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient N 02701 01JUL2018 Professional attendance by a general practitioner (including a general practitioner who has not undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 02702 01JAN2010 PREPARATION by a medical practitioner who has not undertaken mental health skills training (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH TREATMENT PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or item 2710 or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Treatment Plan. Y 02703 01FEB1984 Plain abdominal only (when the service is rendered by a specialist in the practice of his specialty) not associated with Item 2709, 2711, 2714 or 2720 Y 02704 30JUL2002 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least two of the consultations to have been planned visits; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2). SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. AND which completes the requirements of the 3 Step Mental Health Process. N 02704 01NOV2002 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 3 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least two of the consultations to have been planned visits; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to the HIC as having the required credentials (See Note A30.2). SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. N 02704 01MAY2005 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least 2 of the consultations to have been planned visits; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to the HIC as having the required credentials. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. N 02704 01NOV2005 Note: Benefits included in Subgroup 4, A18 or A19, are payable for one service per patient only in a 12-month period, unless a further 3 Step Mental Health Process is clinically indicated. At a minimum the 3 Step Mental Health Process must include: -at least 2 consultations of more than twenty minutes each for a patient with an assessed mental health disorder; -at least one of the consultations to have been a planned visit which must include the review step; -an assessment and formulation or diagnosis of the mental health disorder/s; -provision of a written mental health plan and appropriate education to the patient and/or the carer (with the patient's agreement); -a review of the patient's progress against the goals included in the mental health plan. This review to have been conducted a minimum of 4 weeks and a maximum of 6 months from the consultation in which the mental health plan was prepared; and -utilising an outcome tool in the assessment and review stages except where considered clinically inappropriate. The 3 Step Mental Health Process can only be provided by a medical practitioner (not including a general practitioner, a specialist or consultant physician), who practices in general practice and has been notified to Medicare Australia as having the required credentials. SURGERY CONSULTATIONS (Professional attendance at consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. Y 02705 30JUL2002 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. N 02705 01NOV2002 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. Y 02706 01FEB1984 Oesophagus, with or without examination for foreign body or barium swallow Y 02707 30JUL2002 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. N 02707 01NOV2002 OUT-OF-SURGERY CONSULTATIONS (Professional attendance at a place other than the consulting rooms) LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. Y 02708 30JUL2002 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. N 02708 01NOV2002 PROLONGED CONSULTATION of more than 45 minutes duration AND which completes the requirements of the 3 Step Mental Health Process. Y 02709 01FEB1984 Barium or other opaque meal of oesophagus, stomach and duodenum, with or without screening of chest and with or without preliminary plain film Y 02710 01NOV2006 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH CARE PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, within twelve months of a claim for a 3 Step Mental Health Process (items 2574, 2575, 2577, 2578 and 2704, 2705, 2707, 2708) or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Care Plan. N 02710 01MAY2007 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH CARE PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item, within twelve months of a claim for a former 3 Step Mental Health Process (items 2574, 2575, 2577, 2578 and 2704, 2705, 2707, 2708) or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Care Plan. N 02710 01JUL2009 PREPARATION by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH TREATMENT PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Treatment Plan. N 02710 01JAN2010 PREPARATION by a medical practitioner who has undertaken mental health skills training (including a general practitioner, but not including a specialist or consultant physician) of a GP MENTAL HEALTH TREATMENT PLAN for a patient (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within twelve months of a previous claim for the same item or item 2702 or within three months following a claim for item 2712, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new GP Mental Health Treatment Plan. Y 02711 01FEB1984 Barium or other opaque meal of oesophagus, stomach, duodenum and follow through to colon, with or without screening of chest and with or without preliminary plain film Y 02712 01NOV2006 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH CARE PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2710, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Care Plan. N 02712 01JUL2009 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2710, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan. N 02712 01JAN2010 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2702 or 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 734 to 779 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2702 or 2710, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan. N 02712 01NOV2011 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which item 2700, 2701, 2715 or 2717 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 735 to 758 apply). A rebate will not be paid within three months of a previous claim for the same item or within four weeks following a claim for item 2700, 2701, 2715 or 2717, except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan. N 02712 01MAR2012 Professional attendance by a medical practitioner (not including a specialist or consultant physician) to review a GP mental health treatment plan which he or she, or an associated medical practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan N 02712 01JUL2018 Professional attendance by a general practitioner to review a GP mental health treatment plan which he or she, or an associated general practitioner has prepared, or to review a Psychiatrist Assessment and Management Plan Y 02713 01NOV2006 Professional ATTENDANCE by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) involving taking relevant history, identifying presenting problem(s), providing treatment, advice and/or referral for other services or treatments and documenting the outcomes of the consultation, on a patient in relation to a mental disorder and lasting at least 20 minutes (not being a service associated with a service to which items 2710 or 2712 apply). SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02713 01JAN2010 Professional ATTENDANCE by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) involving taking relevant history, identifying presenting problem(s), providing treatment, advice and/or referral for other services or treatments and documenting the outcomes of the consultation, on a patient in relation to a mental disorder and lasting at least 20 minutes (not being a service associated with a service to which items 2702, 2710 or 2712 apply). SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02713 01NOV2011 Professional attendance by a medical practitioner (not including a specialist or consultant physician) in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation N 02713 01JUL2018 Professional attendance by a general practitioner in relation to a mental disorder and of at least 20 minutes in duration, involving taking relevant history and identifying the presenting problem (to the extent not previously recorded), providing treatment and advice and, if appropriate, referral for other services or treatments, and documenting the outcomes of the consultation Y 02714 01FEB1984 Barium or other opaque meal, small bowel series only, with or without preliminary plain film Y 02715 01NOV2011 Professional attendance by a medical practitioner (including a general practitioner who has undertaken mental health skills training, but not including a specialist or consultant physician) of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient N 02715 01JUL2018 Professional attendance by a general practitioner (including a general practitioner who has undertaken mental health skills training of at least 20 minutes but less than 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 02716 01FEB1984 Opaque enema Y 02717 01NOV2011 Professional attendance by a medical practitioner (including a general practitioner who has undertaken mental health skills training, but not including a specialist or consultant physician) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient N 02717 01JUL2018 Professional attendance by a general practitioner (including a general practitioner who has undertaken mental health skills training) of at least 40 minutes in duration for the preparation of a GP mental health treatment plan for a patient Y 02718 01FEB1984 Opaque enema, including air contrast study Y 02719 01NOV2011 Attendance by a medical practitioner (including a general practitioner, but not including a specialist or consultant physician) to REVIEW a GP MENTAL HEALTH TREATMENT PLAN prepared by that medical practitioner (or an associated medical practitioner) to which former items 2702 or 2710 applies or to REVIEW a PSYCHIATRIST ASSESSMENT AND MANAGEMENT PLAN to which item 291 applies (not being a service associated with a service to which items 2713 or 735 to 758 apply). A rebate will not be paid within three months of a previous claim for the same item, within three months following the review of a GP mental health treatment plan for the patient under item 2712 or within four weeks following a claim for item 2700, 2701, 2715, 2717, 2702 or 2710 except where there has been a significant change in the patient's clinical condition or care circumstances that requires the preparation of a new review of a GP Mental Health Treatment Plan. Y 02720 01FEB1984 Graham's test (cholecystography) , with or without preliminary abdominal radiograph Y 02721 01NOV2002 MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note:These services may only be provided by a medical practitioner who is registered with Medicare Australia as meeting the requirements to participate in the Better Outcomes in Mental Health Care Initiative.The medical practitioner must provide the service in a general practice participating in the PIP or which is accredited. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in general, in up to 6 planned sessions.In some instances, following review by the practitioner managing the 3 Step Mental Health Process, up to a further 6 sessions may be approved in any 12 month period to an individual patient.Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental health disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02721 01NOV2006 MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note:These services may only be provided by a medical practitioner who is registered with Medicare Australia as having satisfied the requirements for higher level mental health skills for the provision of the service.The medical practitioner must provide the service in a general practice participating in the PIP or which is accredited. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in general, in up to 12 planned sessions comprising two groups of up to six sessions.In exceptional circumstances, following review by the practitioner managing either the 3 Step Mental Health Process, the GP Mental Health Care Plan or the Psychiatric Assessment and Management Plan, up to a further 6 sessions may be approved in a calendar year to an individual patient.Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02721 01MAY2007 MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note:These services may only be provided by a medical practitioner who is registered with Medicare Australia as having satisfied the requirements for higher level mental health skills for the provision of the service. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in general, in up to 12 planned sessions comprising two groups of up to six sessions.In exceptional circumstances, following review by the practitioner managing either the former 3 Step Mental Health Process, the GP Mental Health Care Plan or the Psychiatric Assessment and Management Plan, up to a further 6 sessions may be approved in a calendar year to an individual patient.Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02721 01NOV2011 MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF FOCUSSED PSYCHOLOGICAL STRATEGIES Note:These services may only be provided by a medical practitioner who is registered with Medicare Australia as having satisfied the requirements for higher level mental health skills for the provision of the service. Focussed psychological strategies are specific mental health care management strategies, derived from evidence based psychological therapies, that have been shown to integrate the best external evidence of clinical effectiveness with general practice clinical expertise. These strategies are required to be provided to patients by a credentialled medical practitioner and are time limited; being deliverable, in up to ten planned sessions per calendar year. Medical practitioners must be notified to Medicare Australia by the General Practice Mental Health Standards Collaboration that they have met the required standards for higher level mental health skills. A session should last for a minimum of 30 minutes. FPS ATTENDANCE Professional attendance for the purpose of providing focussed psychological strategies (from the list included in the Explanatory Notes) for assessed mental disorders by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes to less than 40 minutes. SURGERY CONSULTATION (Professional attendance at consulting rooms) N 02721 01MAR2012 Professional attendance at consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes N 02721 01JUL2018 Professional attendance at consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes Y 02722 01FEB1984 Cholegraphy direct-operative or post-operative Y 02723 01NOV2002 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02723 01JAN2013 Professional attendance at a place other than consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes N 02723 01JUL2018 Professional attendance at a place other than consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes Y 02724 01FEB1984 Cholegraphy-intravenous Y 02725 01NOV2002 Professional attendance at consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes N 02725 01JUL2018 Professional attendance at consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes Y 02726 01FEB1984 Cholegraphy-percutaneous transhepatic Y 02727 01NOV2002 OUT-OF-SURGERY CONSULTATION (Professional attendance at a place other than consulting rooms) N 02727 01JAN2013 Professional attendance at a place other than consulting rooms by a medical practitioner who practises in general practice (other than a specialist or a consultant physician), for providing focussed psychological strategies for assessed mental disorders by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes N 02727 01JUL2018 Professional attendance at a place other than consulting rooms by a general practitioner, for providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes Y 02728 01FEB1984 Cholegraphy-drip infusion Y 02729 01NOV2018 Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 30 minutes, but less than 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner. Y 02730 01FEB1984 Foreign body in eye (special method, Sweet's or other) Y 02731 01NOV2018 Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for assessed mental disorders by a general practitioner registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service, and lasting at least 40 minutes if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner Y 02732 01FEB1984 Foreign body, localization of and report, not covered by any other item in this Part Y 02734 01FEB1984 Radiographic examination of both breasts (with or without thermography) and report where the patient is referred with a specific request for this procedure and there is reason to suspect the presence of malignancy in the breasts because of the past occurrence of breast malignancy in the patient or members of the patient's family or because symptoms or indications of malignancy were found on an examination of the patient by a medical practitioner (S) Y 02736 01FEB1984 Radiographic examination of one breast (with or without thermography) and report where the patient is referred with a specific request for this procedure and there is reason to suspect the presence of malignancy in the breast because of the past occurrence of breast malignancy in the patient or members of the patient's family or because symptoms or indications of malignancy were found on an examination of the patient by a medical practitioner (S) Y 02738 01FEB1984 Pregnant uterus Y 02740 01FEB1984 Pelvimetry or placentography Y 02742 01FEB1984 Control X-rays associated with intrauterine foetal blood transfusion Y 02744 01FEB1984 Serial angiocardiography (rapid cassette changing)-each series (AU 8) Y 02746 01FEB1984 Serial angiocardiography (single plane-direct roll-film method)-each series (AU 8) Y 02748 01FEB1984 Serial angiocardiography (bi-plane-direct roll-film method)-each series (AU 8) Y 02750 01FEB1984 Serial angiocardiography (indirect roll-film method)-each series (AU 8) Y 02751 01FEB1984 Selective coronary arteriography Y 02752 01FEB1984 Discography-one disc Y 02754 01FEB1984 Dacryocystography-one side Y 02756 01FEB1984 Encephalography Y 02758 01FEB1984 Cerebral angiography-one side Y 02760 01FEB1984 Cerebral ventriculography Y 02762 01FEB1984 Hysterosalpingography Y 02764 01FEB1984 Bronchography-one side Y 02766 01FEB1984 Arteriography, peripheral-one side Y 02768 01FEB1984 Phlebography-one side Y 02770 01FEB1984 Aortography Y 02772 01FEB1984 Splenography Y 02773 01FEB1984 Myelography, one region Y 02774 01FEB1984 Myelography, two regions Y 02775 01FEB1984 Myelography, three regions Y 02776 01FEB1984 Selective arteriography per injection and film run Y 02778 01FEB1984 Sialography-one side Y 02780 01FEB1984 Vasoepididymography-one side Y 02782 01FEB1984 Sinuses and fistulae Y 02784 01FEB1984 Laryngography with contrast media Y 02786 01FEB1984 Pneumarthrography N 02786 01SEP1989 Pneumoarthrography Y 02788 01FEB1984 Arthrography-contrast Y 02790 01FEB1984 Arthrography-double contrast Y 02792 01FEB1984 Lymphangiography, including follow up radiography Y 02794 01FEB1984 Pneumomediastinum Y 02796 01FEB1984 Tomography, any part and report Y 02798 01FEB1984 Stereoscopic examination of any area and report Y 02799 01JAN2013 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in his or her specialty of pain medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 02799 01NOV2019 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of pain medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 02800 01FEB1984 Examination with general anaesthesia (AU 7) N 02800 01SEP1989 Examination with general anaesthesia (not associated with a radiographic examination) (AU 7) Y 02801 01MAY2006 MEDICAL PRACTITIONER (PAIN MEDICINE SPECIALIST) ATTENDANCE - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist practising in the specialty of pain medicine, where the patient was referred to him or her by a medical practitioner - INITIAL attendance in a single course of treatment N 02801 01NOV2011 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 02801 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment Y 02802 01FEB1984 Examination without general anaesthesia N 02802 01SEP1989 Examination without general anaesthesia (not associated with a radiographic examination) Y 02804 01FEB1984 Radiographic examination of any part and report not covered by any item in this Part Y 02805 01FEB1984 Encephalography (AU 10) Y 02806 01MAY2006 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 2814 applies) after the first in a single course of treatment N 02806 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 2814 applies) after the first in a single course of treatment Y 02807 01FEB1984 Cerebral angiography, one side-percutaneous, catheter or open exposure (AU 10) Y 02811 01FEB1984 Cerebral ventriculography (AU 10) Y 02813 01FEB1984 Dacryocystography-one side Y 02814 01MAY2006 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment N 02814 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment Y 02815 01FEB1984 Bronchography-one or both sides (AU 8) Y 02817 01FEB1984 Aortography (AU 8) Y 02819 01FEB1984 Arteriography (peripheral) or phlebography-one vessel (AU 6) Y 02820 01JUL2011 The initiation of a professional attendance via video conference rendered by a consultant physician or specialist practising in the specialty of pain medicine to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 2801, 2806 or 2814. N 02820 01NOV2012 Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of pain medicine if: (a)the attendance is by video conference; and (b)item 2801, 2806 or 2814 applies to the attendance; and (c)the patient is not an admitted patient; and (d)the patient: (i) is located both: (A) outside an inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 02820 01JAN2013 Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of pain medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 2801 lasting more than 10 minutes; or (ii) provided with item 2806 or 2814; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 02820 01NOV2019 Professional attendance on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of pain medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 2801 lasting more than 10 minutes; or (ii) provided with item 2806 or 2814; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 02823 01FEB1984 Splenography (AU 6) Y 02824 01MAY2006 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 02824 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment Y 02825 01FEB1984 Retroperitoneal pneumogram Y 02827 01FEB1984 Selective arteriogram or phlebogram (AU 6) Y 02831 01FEB1984 Percutaneous injection of radioopaque material into renal pelvis or into a renal cyst (including aspiration of the cyst) for antegrade pyelography Y 02832 01MAY2006 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 2840 applies) after the first in a single course of treatment N 02832 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 2840 applies) after the first in a single course of treatment Y 02833 01FEB1984 Pneumoarthrography or pneumoperitoneum Y 02834 01SEP1989 Preparation for contrast arthrography or double contrast arthrography excluding arthrography of the joints between articular processes of the vertebrae Y 02837 01FEB1984 Drip-infusion pyelography or dripinfusion cholegraphy Y 02839 01FEB1984 Retrograde micturating cystourethrography Y 02840 01MAY2006 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment N 02840 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment Y 02841 01FEB1984 Hysterosalpingography (AU 6) Y 02843 01FEB1984 Discography-one disc (AU 5) Y 02844 01SEP1989 Preparation for discography using Metrizamide contrast medium Y 02845 01FEB1984 Intraosseous venography Y 02847 01FEB1984 Myelography (AU 11) N 02847 01SEP1989 Myelography, not covered by item 2848 (AU 11) Y 02848 01NOV1984 Myelography, using Metrizamide (Amipaque) contrast medium (AU 11) Y 02849 01FEB1984 Cisternal puncture Y 02851 01FEB1984 Sinus or fistula injection into Y 02852 01SEP1989 Preparation for sialography Y 02853 01FEB1984 Lymphangiography-one side Y 02855 01FEB1984 Laryngography Y 02857 01FEB1984 Pneumomediastinum Y 02859 01FEB1984 Cholegram, percutaneous transhepatic N 02859 01SEP1989 Cholegram, percutaneous transhepatic (AU 11) Y 02861 01FEB1984 Radiotherapy, superficial-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given to one field only N 02861 01SEP1989 Radiotherapy, superficial (including treatment with x-rays, radium rays or other radioactive substances) not covered by any other item in this Part-each attendance at which fractionated treatment is given-one field Y 02863 01FEB1984 Radiotherapy, superficial-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields Y 02865 01FEB1984 Radiotherapy, superficial-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given to one field only Y 02867 01FEB1984 Radiotherapy, superficial-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields Y 02869 01FEB1984 Radiotherapy, superficial-attendance in relation to a condition for the treatment of which a single dose to one field only is given Y 02871 01FEB1984 Radiotherapy, superficial-attendance in relation to a condition for the treatment of which a single dose is given separately to each of two or more fields Y 02873 01FEB1984 Radiotherapy, superficial-each attendance at which treatment is given to an eye Y 02875 01FEB1984 Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given to one field only Y 02877 01FEB1984 Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields Y 02879 01FEB1984 Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given to one field only Y 02881 01FEB1984 Radiotherapy, deep or orthovoltage-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields Y 02883 01FEB1984 Radiotherapy, deep or orthovoltage-attendance in relation to a condition for the treatment of which a single dose to one field only is given (not being an attendance covered by any other item in this Part) Y 02885 01FEB1984 Radiotherapy, deep or orthovoltage-attendance in relation to a condition for the treatment of which only a single dose is separately given to each of two or more fields (not being an attendance covered by any other item in this Part) Y 02887 01FEB1984 Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given to one field only N 02887 01SEP1989 Radiation oncology treatment, using a linear accelerator-each attendance at which treatment is given-one field Y 02889 01FEB1984 Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves three or more radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields N 02889 01SEP1989 -two or more fields up to a maximum of five additional fields (rotational therapy being three fields) Y 02891 01FEB1984 Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given to one field only N 02891 01SEP1989 Radiation oncology treatment, using cobalt unit or caesium teletherapy unit-each attendance at which treatment is given-one field Y 02893 01FEB1984 Radiotherapy, megavoltage or teletherapy-each attendance in a course of treatment where the course involves not more than two radiotherapy treatments per week at which fractionated treatment is given separately to each of two or more fields N 02893 01SEP1989 -two or more fields up to a maximum of five additional fields (rotational therapy being three fields) Y 02894 01SEP1989 Intrauterine insertion alone (AU 5) Y 02895 01FEB1984 Radiotherapy, megavoltage or teletherapy ( not covered by any other item in this Part)-attendance in relation to a condition for the treatment of which a single dose to one field only is given Y 02896 01SEP1989 Intravaginal insertion alone (AU 4) Y 02897 01FEB1984 Radiotherapy, megavoltage or teletherapy (not covered by any other item in this Part)-attendance in relation to a condition for the treatment of which only a single dose is given separately to each of two or more fields Y 02898 01SEP1989 Combined intrauterine and intravaginal insertion (AU 5) Y 02899 01FEB1984 Intrauterine insertion alone (AU 5) Y 02900 01SEP1989 Implantation of a region necessitating a major anaesthetic and surgical exposure (including implantation in an eye or in an intra-abdominal organ, bladder or prostate) (AU 7) Y 02901 01FEB1984 Intravaginal insertion alone (AU 4) Y 02902 01SEP1989 Complex implantation of a site not requiring separate surgical exposure but necessitating a major anaesthetic (including implantation in the mouth, in the tongue, in a salivary gland, in the neck, in the axilla, in the groin or in any subcutaneous region) (AU 6) Y 02903 01SEP1989 Simple implantation of a site not requiring separate surgical exposure, but necessitating a major anaesthetic (AU 5) Y 02904 01FEB1984 Combined intrauterine and intravaginal insertion (AU 5) Y 02905 01SEP1989 Implantation of a site not requiring separate surgical exposure or a major anaesthetic (including implantation in skin and implantation in a lip) (AU 4) Y 02906 01SEP1989 Preparation of a patient to receive sources for gynaecological irradiation and supervision of the patient during the subsequent irradiation (but not including insertion of the radiation source) Y 02907 01FEB1984 Implantation of a region necessitating a major anaesthetic and surgical exposure (including implantation in an eye or in an intra-abdominal organ, bladder or prostate) (AU 7) Y 02908 01SEP1989 Removal of sealed radioactive sources under a major anaesthetic (AU 4) Y 02909 01SEP1989 Removal of sealed radioactive sources without a major anaesthetic Y 02910 01FEB1984 Complex implantation of a site not requiring separate surgical exposure but necessitating a major anaesthetic (including implantation in the mouth, in the tongue, in a salivary gland, in the neck, in the axilla, in the groin or in any subcutaneous region) (AU 6) Y 02911 01SEP1989 Construction and first application of a radioactive mould to an intracavitary, an intraoral or an intranasal site Y 02912 01SEP1989 Attendance upon a patient to apply a radioactive mould constructed for application to an intracavitary, intraoral or intranasal site other than an attendance which is the first attendance to apply the mould-each attendance Y 02913 01FEB1984 Simple implantation of a site not requiring separate surgical exposure, but necessitating a major anaesthetic (AU 5) Y 02914 01SEP1989 Construction and first application of a radioactive mould not exceeding 5 cm in diameter to an external surface Y 02915 01FEB1984 Implantation of a site not requiring separate surgical exposure or a major anaesthetic (including implantation in skin and implantation in a lip) (AU 4) Y 02916 01SEP1989 Construction and first application of a radioactive mould more than 5 cm in diameter to an external surface Y 02917 01FEB1984 Preparation of a patient to receive sources for gynaecological irradiation and supervision of the patient during the subsequent irradiation (but not including insertion of the radiation source) Y 02918 01SEP1989 Attendance upon a patient to apply a radioactive mould constructed for application to an external surface of the patient other than an attendance which is the first attendance to apply the mould-each attendance Y 02919 01FEB1984 Removal of sealed radioactive sources under a major anaesthetic (AU 4) Y 02920 01SEP1989 Oral administration of a therapeutic dose of a radioisotope, being an administration not covered by item 2937 Y 02921 01SEP1989 Oral administration of a therapeutic dose of radioiodine for hyperthyroidism or thyroid cancer by single dose technique Y 02922 01FEB1984 Removal of sealed radioactive sources without a major anaesthetic Y 02923 01SEP1989 Intravenous administration of a therapeutic dose of a radioisotope Y 02924 01FEB1984 Construction and first application of a radioactive mould to an intracavitary, an intraoral or an intranasal site Y 02925 01SEP1989 Intracavitary administration of a therapeutic dose of a radioisotope (not including preliminary paracentesis) (AU 5) Y 02926 01FEB1984 Attendance upon a patient to apply a radioactive mould constructed for application to an intracavitary, intraoral or intranasal site other than an attendance which is the first attendance to apply the mould-each attendance Y 02927 01SEP1989 Radiation field setting using a simulator or isocentric x-ray or megavoltage machine of a single area for treatment by a single field or parallel opposed fields (not associated with Item 2932) Y 02928 01FEB1984 Construction and first application of a radioactive mould not exceeding 5 cm in diameter to an external surface Y 02929 01SEP1989 Radiation field setting using a simulator or isocentric x-ray or megavoltage machine of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 2934) Y 02930 01SEP1989 Radiation field setting using a simulator or isocentric x-ray or megavoltage machine of three or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 2936) Y 02931 01FEB1984 Construction and first application of a radioactive mould more than 5 cm in diameter to an external surface Y 02932 01SEP1989 Radiation field setting using a diagnostic x-ray unit of a single area for treatment by a single field or parallel opposed fields (not associated with Item 2927) Y 02933 01FEB1984 Attendance upon a patient to apply a radioactive mould constructed for application to an external surface of the patient other than an attendance which is the first attendance to apply the mould-each attendance Y 02934 01SEP1989 Radiation field setting using a diagnostic x-ray unit of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 2929) Y 02935 01FEB1984 Oral administration of a therapeutic dose of a radioisotope, being an administration not covered by Item 2937 Y 02936 01SEP1989 Radiation field setting using a diagnostic x-ray unit of three or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 2930) Y 02937 01FEB1984 Oral administration of a therapeutic dose of radioiodine for hyperthyroidism or thyroid cancer by single dose technique Y 02938 01SEP1989 Radiation Dosimetry by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane Y 02939 01FEB1984 Intravenous administration of a therapeutic dose of a radioisotope Y 02940 01SEP1989 Radiation Dosimetry by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by three or more fields, or by a single field or parallel opposed fields to two areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons Y 02941 01FEB1984 Intracavitary administration of a therapeutic dose of a radioisotope (not including preliminary paracentesis) (AU 5) Y 02942 01SEP1989 Radiation Dosimetry by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy to three or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons Y 02943 01SEP1989 Radiation Dosimetry by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane Y 02944 01SEP1989 Radiation Dosimetry by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single area by three or more fields, or by a single field or parallel opposed fields to two areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons Y 02945 01SEP1989 Radiation Dosimetry by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy to three or more areas, or by mantle fields or inverted Y fields, or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons Y 02946 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes N 02946 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes Y 02949 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes N 02949 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes Y 02951 01FEB1984 Assistance at any operation, or series or combination of operations, for which the fee, or the aggregate of the fees exceeds $124.00 but does not exceed $ N 02951 01SEP1989 Assistance at any operation for which the fee exceeds $160 but does not exceed $285 or at a series or a combination of operations where the fee for at least one of the operations exceeds $160 but where the fee for the series or combination of operations does not exceed $285 Y 02953 01FEB1984 Assistance at any operation, or series or combination of operations, for which the fee, or the aggregate of the fees, specified is $118.00 or more N 02953 01MAR1984 Assistance at any operation, or series or combination of operations, for which the fee, or the aggregate of the fees, specified exceeds $ N 02953 01SEP1989 Assistance at any operation for which the fee exceeds $285 or at a combination of operations for which the aggregate fee exceeds $285 provided that the fee for at least one of the operations exceeds $160 Y 02954 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes N 02954 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes Y 02955 01AUG1988 Assistance at a delivery involving Caesarean section, not in association with item 201 when itemised by the same practitioner Y 02957 01AUG1988 Assistance at a series or combination of operations, one of which is a delivery involving Caesarean section, not in association with item 201 when itemised by the same practitioner Y 02958 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes N 02958 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes Y 02960 01FEB1984 Computerised axial tomography-brain scan on a brain scanner, plain study (OR) Y 02961 01FEB1984 Computerised axial tomography-brain scan on a brain scanner, plain study (HR) Y 02962 01FEB1984 Computerised axial tomography-brain scan on a brain scanner, plain study and contrast medium study (OR) Y 02963 01FEB1984 Computerised axial tomography-brain scan on a brain scanner, plain study and contrast medium study (HR) Y 02964 01FEB1984 Computerised axial tomography-brain scan on a body scanner, plain study (OR) Y 02965 01FEB1984 Computerised axial tomography-brain scan on a body scanner, plain study (HR) Y 02966 01FEB1984 Computerised axial tomography-brain scan on a body scanner, plain study and contrast medium study (OR) Y 02967 01FEB1984 Computerised axial tomography-brain scan on a body scanner, plain study and contrast medium study (HR) Y 02968 01FEB1984 Computerised axial tomography-body scan on a body scanner, plain study (OR) Y 02969 01FEB1984 Computerised axial tomography-body scan on a body scanner, plain study (HR) Y 02970 01FEB1984 Computerised axial tomography-body scan on a body scanner, plain study and intravenous contrast medium study (OR) Y 02971 01FEB1984 Computerised axial tomography-body scan on a body scanner, plain study and intravenous contrast medium study (HR) Y 02972 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes N 02972 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes Y 02974 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes N 02974 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes Y 02978 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) N 02978 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) Y 02980 01JUN1986 MAGNETIC RESONANCE IMAGING - examination of any parts or parts of the body (HR) N 02980 01SEP1989 Magnetic resonance imaging-examination of any part or parts of body (HR) Y 02981 01JUL1985 MAGNETIC RESONANCE IMAGING - examination of any part of parts of the body using a scanner with magnetic filed strength of one Tesla or less. (HR) Y 02984 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) N 02984 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) Y 02988 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H) N 02988 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H) Y 02992 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) N 02992 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) Y 02996 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) N 02996 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) Y 03000 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H) N 03000 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of pain medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H) Y 03003 01JAN2013 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in his or her specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 03003 01NOV2019 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 03004 01JAN1984 Operative procedure on tissue, organ or region not covered by any other item in this Part, including any consultation on the same occasion Y 03005 01MAY2006 MEDICAL PRACTITIONER (PALLIATIVE MEDICINE SPECIALIST) ATTENDANCE - SURGERY OR HOSPITAL Professional attendance at consulting rooms or hospital by a consultant physician or specialist practising in the specialty of palliative medicine, where the patient was referred to him or her by a medical practitioner - INITIAL attendance in a single course of treatment N 03005 01NOV2011 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 03005 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment Y 03006 01FEB1984 Dressing of localized burns (not involving grafting)-each attendance at which the procedure is performed, including any associated consultation Y 03010 01MAY2006 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 3014 applies) after the first in a single course of treatment N 03010 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 3014 applies) after the first in a single course of treatment Y 03012 01FEB1984 Dressing of burns, extensive, without anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation Y 03014 01MAY2006 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment N 03014 01NOV2019 Professional attendance at consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment Y 03015 01JUL2011 The initiation of a professional attendance via video conference rendered by a consultant physician or specialist practising in the specialty of palliative medicine to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or c)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 3005, 3010 or 3014. N 03015 01NOV2012 Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of palliative medicine if: (a)the attendance is by video conference; and (b)item 3005, 3010 or 3014 applies to the attendance; and (c)the patient is not an admitted patient; and (d)the patient: (i)is located both: (A) outside an inner metropolitan area; and (B)at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii)is a care recipient in a residential care service; or (iii)is a patient of: (A)an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 03015 01JAN2013 Professional attendance on a patient by a specialist or consultant physician practising in his or her specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 3005 lasting more than 10 minutes; or (ii) provided with item 3010 or 3014; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 03015 01NOV2019 Professional attendance on a patient by a specialist or consultant physician practising in the specialist's or consultant physician's specialty of palliative medicine if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 3005 lasting more than 10 minutes; or (ii) provided with item 3010 or 3014; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or physician; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 03016 01FEB1984 Dressing of localized burns under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (G) (AU 7) Y 03018 01MAY2006 MEDICAL PRACTITIONER (PALLIATIVE MEDICINE SPECIALIST) ATTENDANCE - HOME VISIT Professional attendance at a place other than consulting rooms or hospital by a consultant physician or specialist practising in the specialty of pallitive medicine, where the patient was referred to him or her by a medical practitioner - INITIAL attendance in a single course of treatment N 03018 01NOV2011 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 03018 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-initial attendance in a single course of treatment Y 03022 01FEB1984 Dressing of localized burns under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (S) (AU 7) Y 03023 01MAY2006 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each attendance (other than a service to which item 3028 applies) after the first in a single course of treatment N 03023 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each attendance (other than a service to which item 3028 applies) after the first in a single course of treatment Y 03027 01FEB1984 Dressing of burns, extensive, under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (G) (AU 10) Y 03028 01MAY2006 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine following referral of the patient to him or her by a referring practitioner-each minor attendance after the first attendance in a single course of treatment N 03028 01NOV2019 Professional attendance at a place other than consulting rooms or hospital by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine following referral of the patient to the specialist or consultant physician by a referring practitioner-each minor attendance after the first attendance in a single course of treatment Y 03032 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes N 03032 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes Y 03033 01FEB1984 Dressing of burns, extensive, under general anaesthesia (not involving grafting)-- each attendance at which the procedure is performed, including any associated consultation (S) (AU 10) Y 03038 01FEB1984 Excision, under general anaesthesia, of burns involving not more than 10 per cent of body surface, where grafting is not carried out during the same operation (AU 10) Y 03039 01FEB1984 Excision, under general anaesthesia, of burns involving more than 10 per cent of body surface, where grafting is not carried out during the same operation (AU 15) Y 03040 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes N 03040 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes Y 03041 01FEB1984 Debridement, under general anaesthesia, of deep or extensive contaminated wound of soft tissue (AU 10) N 03041 01MAR1984 Debridement, under general anaesthesia, of deep or extensive contaminated wound of soft tissue, including suturing of that wound when performed(AU 10) N 03041 01SEP1989 Debridement, under general anaesthesia or major regional or field block, of deep or extensive contaminated wound of soft tissue, including suturing of that wound when performed (AU 10) Y 03044 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes N 03044 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a community case conference of at least 45 minutes Y 03046 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, small (not more than 7 centimetres long), superficial, not covered by any item in Part 2 (AU 5) Y 03050 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, small (not more than 7 centimetres long), involving deeper tissue, not covered by any item in Part 2 (AU 6) Y 03051 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes N 03051 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes Y 03055 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines N 03055 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with a multidisciplinary team of at least 2 other formal care providers of different disciplines Y 03058 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), superficial (AU 7) Y 03059 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), superficial (D) (AU 7) Y 03062 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes N 03062 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes Y 03063 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), involving deeper tissue (AU 7) Y 03068 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, small (not more than 7 centimetres long), involving deeper tissue (D) (AU 7) Y 03069 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) N 03069 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) Y 03073 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, large (more than 7 centimetres long), superficial, not covered by any item in Part 2 (AU 6) Y 03074 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) N 03074 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a case conference team, to organise and coordinate a discharge case conference of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) Y 03078 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H) N 03078 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to organise and coordinate a discharge case conference of at least 45 minutes, before the patient is discharged from a hospital (H) Y 03082 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, large (more than 7 centimetres long), involving deeper tissue, not covered by any item in Part 2 (G) (AU 7) Y 03083 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) N 03083 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, before the patient is discharged from a hospital (H) Y 03087 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, other than on face or neck, large (more than 7 centimetres long), involving deeper tissue, not covered by any item in Part 2 (S) (AU 7) Y 03088 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) N 03088 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, before the patient is discharged from a hospital (H) Y 03092 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), superficial (AU 7) Y 03093 01MAY2006 Attendance by a specialist, or consultant physician, in the practice of his or her specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H) N 03093 01NOV2019 Attendance by a specialist, or consultant physician, in the practice of the specialist's or consultant physician's specialty of palliative medicine, as a member of a multidisciplinary case conference team, to participate in a discharge case conference (other than to organise and coordinate the conference) of at least 45 minutes, before the patient is discharged from a hospital (H) Y 03095 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), superficial (D) (AU 7) Y 03098 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), involving deeper tissue (G) (AU 8) Y 03101 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), involving deeper tissue (S) (AU 8) Y 03103 01FEB1984 Skin and subcutaneous tissue or mucous membrane, repair of recent wound of, on face or neck, large (more than 7 centimetres long), involving deeper tissue (D) (AU 8) Y 03104 01FEB1984 Repair of full thickness laceration of ear, eyelid or nose with accurate apposition of each layer of tissue (AU 10) Y 03106 01FEB1984 Dressing and removal of sutures requiring a general anaesthetic, not associated with any other item in this Part (AU 5) Y 03110 01FEB1984 Control of post-operative haemorrhage under general anaesthesia following perineal or vaginal operations (AU 6) Y 03113 01FEB1984 Superficial foreign body, removal of, as an independent procedure (AU 5) Y 03114 01FEB1984 Superficial foreign body, removal of, as an independent procedure (D) (AU 5) Y 03116 01FEB1984 Subcutaneous foreign body, removal of, requiring incision and suture, as an independent procedure (AU 6) Y 03117 01FEB1984 Subcutaneous foreign body, removal of, as an independent procedure (D) (AU 6) Y 03120 01FEB1984 Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (G) (AU 7) Y 03124 01FEB1984 Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (S) (AU 7) Y 03128 01FEB1984 Foreign body in muscle, tendon or other deep tissue, removal of, as an independent procedure (D) (AU 7) Y 03130 01FEB1984 Biopsy of skin or mucous membrane, as an independent procedure (AU 5) Y 03134 01FEB1984 Biopsy of skin or mucous membrane, as an independent procedure (D) (AU 5) Y 03135 01FEB1984 Biopsy of lymph gland, muscle or other deep tissue or organ, as an independent procedure (G) (AU 6) Y 03142 01FEB1984 Biopsy of lymph gland, muscle or other deep tissue or organ, as an independent procedure (S) (AU 6) Y 03147 01FEB1984 Biopsy of lymph gland, muscle or other deep tissue or organ, as an independent procedure (D) (AU 6) Y 03148 01FEB1984 Aspiration biopsy of lymph gland, deep tissue or organ, as an independent procedure (AU 5) N 03148 01SEP1989 Drill biopsy of lymph gland, deep tissue or organ, as an independent procedure (AU 5) Y 03157 01FEB1984 Biopsy of bone marrow by trephine using an open approach (AU 5) Y 03158 01FEB1984 Biopsy of bone marrow by trephine using a percutaneous approach with a Jamshidi needle or similar device (AU 5) Y 03159 01MAY1990 BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S Y 03160 01FEB1984 Biopsy of bone marrow by aspiration or punch biopsy of synovial membrane or pleura (AU 5) Y 03161 01MAY1990 BIOPSY OF PLEURA, PERCUTANEOUS - one or more biopsies on anyone occasion ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S Y 03162 01AUG1988 Needle biopsy of vertebra (AU 8) Y 03168 01FEB1984 Scalene node biopsy (AU 5) Y 03173 01FEB1984 Sinus, excision of, involving superficial tissue only (AU 6) Y 03175 01FEB1984 Sinus, excision of, involving superficial tissue only (D) (AU 6) Y 03178 01FEB1984 Sinus, excision of, involving muscle and deep tissue (G) (AU 7) Y 03183 01FEB1984 Sinus, excision of, involving muscle and deep tissue (S) (AU 7) Y 03187 01FEB1984 Sinus, excision of, involving muscle and deep tissue (D) (AU 7) Y 03194 01FEB1984 Ganglion or small bursa, excision of (G) (AU 6) Y 03199 01FEB1984 Ganglion or small bursa, excision of (S) (AU 6) Y 03208 01FEB1984 Bursa (large), including olecranon, calcaneum or patella, excision of (G) (AU 6) Y 03213 01FEB1984 Bursa (large), including olecranon, calcaneum or patella, excision of (S) (AU 6) Y 03217 01FEB1984 Bursa, semimembranosus (Baker's cyst), excision of (AU 7) Y 03219 01FEB1984 Tumour, cyst, ulcer or scar, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3221, 3223, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 6) N 03219 01MAR1984 Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3221, 3223, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 6) N 03219 01SEP1989 Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by item 3221, 3223, 3225, 3226 or 3349 (G) (AU 6) Y 03220 01FEB1984 Tumour, cyst, ulcer or scar, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3222, 3224, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 6) N 03220 01MAR1984 Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3222, 3224, 3225, 3226, 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 6) N 03220 01SEP1989 Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by item 3222, 3224, 3225, 3226 or 3349 (S) (AU 6) Y 03221 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 9) N 03221 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 9) N 03221 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by item 3349 (G) (AU 9) Y 03222 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 9) N 03222 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 9) N 03222 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by item 3349 (S) (AU 9) Y 03223 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 13) N 03223 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (G) (AU 13) N 03223 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by item 3349 (G) (AU 13) Y 03224 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 13) N 03224 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (S) (AU 13) N 03224 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 10 but not more than 20 lesions, not covered by item 3349 (S) (AU 13) Y 03225 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 20 but not more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 15) N 03225 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 20 but not more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 15) N 03225 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 20 but not more than 50 lesions, not covered by item 3349 (AU 15) Y 03226 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 17) N 03226 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 50 lesions, not covered by Item 3330, 3332, 3338, 3342, 3346 or 3349 (AU 17) N 03226 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 50 lesions, not covered by item 3349 (AU 17) Y 03229 01FEB1984 Tumour, cyst, ulcer or scar, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3230 or 3331 (D) (AU 6) N 03229 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by Item 3230 or 3331 (D) (AU 6) N 03229 01SEP1989 Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not covered by item 3230 (D) (AU 6) Y 03230 01FEB1984 Tumours, cysts, ulcers or scars, up to 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3331 (D) (AU 9) N 03230 01MAR1984 Tumours, cysts, ulcers or scars(other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions, not covered by Item 3331 (D) (AU 9) N 03230 01SEP1989 Tumours, cysts, ulcers or scars (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions (D) (AU 9) Y 03233 01FEB1984 Tumour, cyst, ulcer or scar, more than 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (G) (AU 6) N 03233 01MAR1984 Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (G) (AU 6) Y 03237 01FEB1984 Tumour, cyst, ulcer or scar, more than 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (S) (AU 6) N 03237 01MAR1984 Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (S) (AU 6) Y 03245 01FEB1984 Tumour, cyst, ulcer or scar, more than 3 centimeters in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (D) (AU 6) N 03245 01MAR1984 Tumour, cyst, ulcer or scar(other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane (D) (AU 6) Y 03247 01FEB1984 Tumour, cyst, ulcer or scar, removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (G) (AU 8) N 03247 01MAR1984 Tumour, cyst (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (G)(AU 8) Y 03253 01FEB1984 Tumour, cyst, ulcer or scar, removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (S) (AU 8) N 03253 01MAR1984 Tumour, cyst (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (S)(AU 8) Y 03258 01FEB1984 Tumour, cyst, ulcer or scar, removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (D) (AU 8) N 03258 01MAR1984 Tumour, cyst (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in this Part, involving muscle, bone or other deep tissue (D)(AU 8) Y 03261 01FEB1984 Tumour or deep cyst, removal of, not covered by any other item in this Part, requiring wide excision (G) (AU 8) N 03261 01MAR1984 Tumour or deep cyst (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in this Part (G) (AU 8) Y 03265 01FEB1984 Tumour or deep cyst, removal of, not covered by any other item in this Part, requiring wide excision (S) (AU 8) N 03265 01MAR1984 Tumour or deep cyst (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in this Part (S) (AU 8) Y 03268 01FEB1984 Tumour or deep cyst, removal of, not covered by any other item in this Part, requiring wide excision (D) (AU 8) N 03268 01MAR1984 Tumour or deep cyst (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in this Part (D) (AU 8) Y 03271 01FEB1984 Malignant tumour, removal of, from skin, requiring wide and deep excision (AU 8) N 03271 01MAR1984 Malignant tumour, removal of, from skin, requiring wide and deep excision, other than removal of basal cell carcinoma(AU 8) Y 03276 01FEB1984 Malignant tumour, removal of, from skin, requiring wide and deep excision with immediate block dissection of lymph glands (AU 13) Y 03281 01FEB1984 Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin graft (AU 8) Y 03284 01FEB1984 Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin graft (D) (AU 8) Y 03289 01FEB1984 Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin graft (AU 10) Y 03290 01FEB1984 Tumour, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin graft (D) (AU 10) Y 03295 01FEB1984 Malignant tumour, removal of, from any region involving a radical operation (not being an operation covered by any other item in this Part) (AU 13) Y 03301 01FEB1984 Malignant tumour, removal of, from any region involving a limited operation (not being an operation covered by any other item in this Part) (AU 8) N 03301 01MAR1984 Malignant tumour, removal of, from any region involving a limited operation, other than removal of basal cell carcinoma(not being an operation covered by any other item in this Part) (AU 8) Y 03306 01FEB1984 Lipectomy-- transverse wedge excision of abdominal apron (AU 10) Y 03307 01FEB1984 Lipectomy-- wedge excision of skin or fat not covered by Item 3306-- one excision (AU 10) Y 03308 01FEB1984 Lipectomy-- wedge excision of skin or fat not covered by Item 3306-- two or more excisions (AU 10) N 03308 01SEP1989 Lipectomy-wedge excision of skin or fat not covered by item 3306-two or more excisions (AU 12) Y 03310 01FEB1984 Lipectomy-- subumbilical excision with undermining of skin edges and strengthening of musculo-aponeurotic wall (AU 12) Y 03311 01FEB1984 Lipectomy-- radical abdominoplasty (Pitanguy type or similar) with excision of skin and subcutaneous tissue, repair of musculo-aponeurotic layer and transposition of umbilicus (AU 18) Y 03314 01FEB1984 Axillary hyperidrosis, wedge excision for (AU 7) Y 03315 01NOV1986 AXILLARY HYPERHIDROSIS, total excision of sweat gland bearing area ANAESTHETIC 10 UNITS-ITEM NOS 450G/521S N 03315 01SEP1989 Axillary hyperhidrosis, total excision of sweat gland bearing area (AU 10) Y 03320 01FEB1984 Plantar wart, removal of (AU 5) Y 03330 01FEB1984 Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on not more than 5 lesions (including any associated consultation) (AU 4) Y 03331 01FEB1984 Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on not more than 5 lesions (including any associated consultation) (D) (AU 4) Y 03332 01FEB1984 Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 5 but not more than 10 lesions (including any associated consultation) (AU 5) Y 03338 01FEB1984 Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 10 but not more than 15 lesions (including any associated consultation) (AU 6) Y 03342 01FEB1984 Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 15 but not more than 20 lesions (including any associated consultation) (AU 7) Y 03346 01FEB1984 Keratoses, warts or similar lesions, treatment by electrosurgical destruction, cryosurgery or surgical removal-- each attendance at which the procedure is performed on more than 20 lesions (including any associated consultation) (AU 8) Y 03347 01AUG1988 Warts, removal of, by any method (other than by chemical means) under general anaesthesia or under a regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved day hospital facility, not associated with any other item in this Part (AU 6) Y 03348 01NOV1990 Premalignant skin lesions, treatment of, by galvanocautery or electrodesiccation or cryocautery (10 or more lesions) (AU 4) Y 03349 01FEB1984 Cutaneous neoplastic lesions, treatment by electrosurgical destruction, chemotherapy, simple curettage or shaving-- one or more lesions (AU 4) Y 03350 01FEB1984 Cancer of skin or mucous membrane, removal by serial curettage excision or cryosurgery using liquid nitrogen (not covered by Item 3349) (AU 6) Y 03351 01FEB1984 Cancer of skin or mucous membrane, removal by serial curettage excision or cryosurgery using liquid nitrogen (not covered by Item 3349)-- more than 3 but not more than 10 lesions (AU 9) Y 03352 01FEB1984 Cancer of skin or mucous membrane, removal by serial curettage excision or cryosurgery using liquid nitrogen (not covered by Item 3349)-more than 10 lesions (AU 13) Y 03356 01FEB1984 Skin lesions, multiple injections with hydrocortisone or similar preparations Y 03363 01FEB1984 Keloid, extensive, multiple injections of hydrocortisone or similar preparations under general anaesthesia (AU 5) Y 03366 01FEB1984 Haematoma, aspiration of (AU 4) Y 03371 01FEB1984 Haematoma, furuncle, small abscess or similar lesion not requiring a general anaesthetic, incision with drainage of (excluding after-care) Y 03379 01FEB1984 Large haematoma, large abscess, (including ischio-rectal abscess), carbuncle, cellulitis or similar lesion requiring a general anaesthetic, incision with drainage of (excluding after-care) (G) (AU 5) Y 03384 01FEB1984 Large haematoma, large abscess, (including ischio-rectal abscess), carbuncle, cellulitis or similar lesion requiring a general anaesthetic, incision with drainage of (excluding after-care) (S) (AU 5) Y 03386 01FEB1984 Large haematoma, large abscess, carbuncle, cellulitis or similar lesion requiring a general anaesthetic, incision with drainage of (excluding after-care) (D) (AU 5) Y 03391 01FEB1984 Muscle, excision of (limited) (AU 6) N 03391 01SEP1989 Muscle, excision of (limited) or fasciotomy (AU 6) Y 03393 01FEB1984 Muscle, excision of (limited) (D) (AU 6) Y 03399 01FEB1984 Muscle, excision of (extensive) (AU 7) Y 03400 01FEB1984 Muscle, excision of (extensive) (D) (AU 7) Y 03404 01FEB1984 Muscle, ruptured, repair of (limited) , not associated with external wound (AU 7) Y 03407 01FEB1984 Muscle, ruptured, repair of (extensive) , not associated with external wound (AU 7) Y 03417 01FEB1984 Fascia, deep, repair of, for herniated muscle (AU 7) Y 03425 01FEB1984 Bone tumour, innocent, excision of, not covered by any other item in this Part (AU 7) Y 03427 01FEB1984 Bone tumour, innocent, excision of, not covered by any other item in this Part (D) (AU 7) Y 03431 01FEB1984 Styloid process of temporal bone, removal of (AU 7) Y 03437 01FEB1984 Parotid gland, total extirpation of (AU 15) Y 03444 01FEB1984 Parotid gland, total extirpation of with preservation of facial nerve (AU 18) Y 03450 01FEB1984 Parotid gland, superficial lobectomy or removal of tumour from, with exposure of facial nerve (AU 14) Y 03455 01FEB1984 Submandibular gland, extirpation of (AU 8) Y 03456 01FEB1984 Submandibular gland, extirpation of (D) (AU 8) Y 03459 01FEB1984 Sublingual gland, extirpation of (AU 7) Y 03462 01FEB1984 Sublingual gland, extirpation of (D) (AU 7) Y 03465 01FEB1984 Salivary gland, dilatation or diathermy of duct (AU 6) Y 03466 01FEB1984 Salivary gland, dilatation or diathermy of duct (D) (AU 6) Y 03468 01FEB1984 Salivary gland, removal of calculus from duct (G) (AU 7) N 03468 01SEP1989 Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one more such procedures (G) (AU 7) Y 03472 01FEB1984 Salivary gland, removal of calculus from duct (S) (AU 7) N 03472 01SEP1989 Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one or more such procedures (S) (AU 7) Y 03475 01FEB1984 Salivary gland, removal of calculus from duct (D) (AU 7) N 03475 01SEP1989 Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, one or more such procedures (D) (AU 7) Y 03477 01FEB1984 Salivary gland, repair of cutaneous fistula of (AU 7) Y 03480 01FEB1984 Tongue, partial excision of (AU 7) Y 03483 01FEB1984 Tongue, partial excision of (D) (AU 7) Y 03495 01FEB1984 Radical excision of intra-oral tumour involving resection of mandible and lymph glands of neck (commando-type operation) (AU 18) Y 03496 01FEB1984 Tongue tie, repair of, not covered by any other item in this Part (AU 6) Y 03500 01FEB1984 Tongue tie, repair of, not covered by any other item in this Part (D) (AU 6) Y 03505 01FEB1984 Tongue tie or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (AU 6) N 03505 01SEP1989 Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (AU 6) Y 03507 01FEB1984 Tongue tie or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (D) (AU 6) N 03507 01SEP1989 Tongue tie, mandibular frenulum or maxillary frenulum, repair of, in a person aged not less than 2 years, under general anaesthesia (D) (AU 6) Y 03509 01FEB1984 Ranula or mucous cyst of mouth, removal of (G) (AU 9) Y 03516 01FEB1984 Ranula or mucous cyst of mouth, removal of (S) (AU 9) Y 03521 01FEB1984 Ranula or mucous cyst of mouth, removal of (D) (AU 9) Y 03526 01FEB1984 Branchial cyst, removal of (AU 9) Y 03530 01FEB1984 Branchial fistula, removal of (AU 9) Y 03532 01FEB1984 Cystic hygroma, removal of massive lesion requiring extensive excision-- with or without thoracotomy (AU 11) Y 03542 01FEB1984 Thyroidectomy, total (AU 14) N 03542 01SEP1989 Thyroidectomy, total or thyroidectomy following previous hemithyroidectomy or following previous unilateral or bilateral sub-total thyroidectomy (AU 14) Y 03547 01FEB1984 Parathyroid tumour, removal of (AU 13) Y 03555 01FEB1984 Parathyroid glands, removal of, other than for tumour (AU 16) Y 03557 01AUG1987 CERVICAL RE-EXPLORATION for recurrent or persistent hyperparathyroidism ANAESTHETIC 20 UNITS-ITEM NOS 464G/533S N 03557 01SEP1989 Cervical re-exploration for recurrent or persistent hyperparathyroidism (AU 20) Y 03560 01DEC1991 [Unidentified item] Y 03563 01FEB1984 Hemithyroidectomy or sub-total thyroidectomy with or without exposure of recurrent laryngeal nerve (AU 12) N 03563 01SEP1989 Total hemithyroidectomy or bilateral sub-total thyroidectomy, with or without exposure of recurrent laryngeal nerve (AU 12) Y 03576 01FEB1984 Thyroid, excision of localized tumour of (AU 10) N 03576 01SEP1989 Thyroid, excision of localised tumour of, or unilateral sub-total thyroidectomy (AU 10) Y 03581 01FEB1984 Thyroglossal cyst, removal of (AU 10) Y 03591 01FEB1984 Thyroglossal cyst and fistula, removal of (AU 10) Y 03597 01FEB1984 Cervical oesophagostomy; or closure of cervical oesophagostomy with or without plastic repair (AU 13) Y 03616 01FEB1984 Cervical oesophagectomy with tracheostomy and oesophagostomy, with or without plastic reconstruction; or laryngopharyngectomy with tracheostomy and plastic reconstruction (AU 22) Y 03618 01FEB1984 Lymph glands of neck, limited excision of (AU 9) Y 03622 01FEB1984 Lymph glands of neck, radical excision of (AU 20) Y 03634 01FEB1984 Lymph glands of groin or axilla, limited excision of (AU 9) Y 03638 01FEB1984 Lymph glands of groin or axilla, radical excision of (AU 13) Y 03647 01FEB1984 Simple mastectomy with or without frozen section biopsy (G) (AU 9) Y 03652 01FEB1984 Simple mastectomy with or without frozen section biopsy (S) (AU 9) Y 03654 01FEB1984 Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason (G) (AU 7) Y 03664 01FEB1984 Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason (S) (AU 7) Y 03668 01FEB1984 Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed (G) (AU 8) N 03668 01SEP1989 Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used (G) (AU 8) Y 03673 01FEB1984 Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed (S) (AU 8) N 03673 01SEP1989 Breast, excision of cyst, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used (S) (AU 8) Y 03678 01FEB1984 Partial mastectomy involving more than one quarter of the breast tissue with or without frozen section biopsy (G) (AU 8) Y 03683 01FEB1984 Partial mastectomy involving more than one quarter of the breast tissue with or without frozen section biopsy (S) (AU 8) Y 03698 01FEB1984 Breast, extended simple mastectomy with or without frozen section biopsy (AU 12) Y 03700 01FEB1984 Subcutaneous mastectomy with or without frozen section biopsy (AU 12) Y 03702 01FEB1984 Breast, radical or modified radical mastectomy with or without frozen section biopsy (AU 16) Y 03707 01FEB1984 Nipple, inverted, surgical eversion of (AU 7) Y 03713 01FEB1984 Laparotomy (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed (G) (AU 9) Y 03718 01FEB1984 Laparotomy (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed (S) (AU 9) Y 03719 01NOV1990 Liver biopsy by wedge excision when performed in association with another intra-abdominal procedure (AU 11) Y 03722 01FEB1984 Laparotomy involving caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckel's diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus or pyloroplasty (adult) (AU 11) N 03722 01SEP1989 Laparotomy involving caecostomy, enterostomy, colostomy, enterotomy, colotomy, cholecystostomy, gastrostomy, gastrotomy, reduction of intussusception, removal of Meckel's diverticulum, suture of perforated peptic ulcer, simple repair of ruptured viscus, reduction of volvulus, pyloroplasty (adult) or drainage of pancreas (AU 11) Y 03726 01FEB1984 Laparotomy involving division of peritoneal adhesions (where no other listed intra abdominal procedure is performed) (AU 11) Y 03727 01NOV1990 Laparotomy involving division of adhesions in association with another intra-abdominal procedure where the time taken to divide the adhesions exceeds 45 minutes (AU 14) Y 03728 01NOV1990 Laparotomy with division of extensive adhesions (duration greater than 2 hours) with or without insertion of long intestinal tube (AU 20) Y 03730 01FEB1984 Laparotomy for grading of lymphoma, including splenectomy, liver biopsies, lymph node biopsies and oophoropexy (AU 14) Y 03734 01FEB1984 Laparotomy for control of postoperative haemorrhage, where no other procedure is performed (AU 11) Y 03739 01FEB1984 Laparotomy involving operation on abdominal viscera, not covered by any other item in this Part (G) (AU 12) Y 03745 01FEB1984 Laparotomy involving operation on abdominal viscera, not covered by any other item in this Part (S) (AU 12) Y 03750 01FEB1984 Subphrenic abscess, drainage of (AU 10) Y 03752 01FEB1984 Liver biopsy, percutaneous (AU 6) Y 03754 01FEB1984 Liver tumour, removal of other than by biopsy (AU 13) Y 03759 01FEB1984 Liver, massive resection of or lobectomy (AU 18) Y 03764 01FEB1984 Liver abscess, abdominal drainage of (AU 11) Y 03783 01FEB1984 Hydatid cyst of liver, peritoneum or viscus, drainage procedure for (AU 11) Y 03789 01FEB1984 Operative cholangiography (including one or more cholegrams performed during the one operation) or operative pancreatography (AU 10) Y 03793 01FEB1984 Cholecystectomy (G) (AU 11) Y 03798 01FEB1984 Cholecystectomy (S) (AU 11) Y 03818 01NOV1984 Choledochoscopy (AU 7) Y 03820 01FEB1984 Choledochotomy (with or without cholecystectomy), including dilatation of sphincter of Oddi and removal of calculi (AU 13) Y 03822 01FEB1984 Choledochotomy (with or without cholecystectomy), including dilatation of sphincter of Oddi and removal of calculi with choledochoduodenostomy, choledochogastrostomy or choledochoenterostomy (AU 18) Y 03825 01FEB1984 Transduodenal operation on sphincter of Oddi, including dilatation, removal of calculi, sphincterotomy and sphincteroplasty with or without choledochotomy, with or without cholecystectomy (AU 15) Y 03831 01FEB1984 Cholecystoduodenostomy, cholecystogastrostomy or cholecystoenterostomy with or without enteroenterostomy (AU 15) Y 03834 01FEB1984 Operation for reconstruction of hepatic duct or common bile duct for correction of strictures or atresia including all necessary anastomoses, not associated with Item 3793, 3798, 3820, 3822, 3825 or 3831 (AU 19) Y 03847 01FEB1984 Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) (AU 6) N 03847 01SEP1989 Oesophagoscopy (not covered by item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with or without biopsy (AU 6) Y 03849 01FEB1984 Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with biopsy or with endoscopic sclerosing injection of oesophageal or gastric varices (AU 7) N 03849 01SEP1989 Oesophagoscopy (not covered by item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with endoscopic sclerosing injection of oesophageal or gastric varices (AU 7) Y 03851 01FEB1984 Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy (one or more such procedures) with polypectomy, with or without removal of foreign body, with or without diathermy coagulation of bleeding oesophageal, gastric or duodenal lesions (AU 7) N 03851 01MAR1984 Oesophagoscopy (not covered by Item 5464), gastroscopy, duodenoscopy or panendoscopy(one or more such procedures) with one or more of the following procedures - polypectomy, removal of foreign body, diathermy coagulation of bleeding upper gastrointestinal lesions (AU 7) Y 03853 01NOV1990 Oesophageal prosthesis, insertion of, including endoscopy and dilatation (AU 9) Y 03860 01FEB1984 Endoscopic pancreatocholangiography (AU 8) Y 03862 01FEB1984 Endoscopic sphincterotomy with or without extraction of stones from common bile duct (AU 8) Y 03864 01NOV1990 Biliary manometry (AU 9) Y 03866 01NOV1990 Endoscopic biliary dilatation (AU 11) Y 03867 01NOV1990 Bile duct, endoscopic stenting of (including endoscopy and dilatation) (AU 11) Y 03868 01NOV1990 Percutaneous endoscopic gastrostomy (initial procedure) (AU 10) Y 03869 01NOV1990 Percutaneous endoscopic gastrostomy (repeat procedure) (AU 10) Y 03870 01NOV1990 Endoscopic laser therapy for malignancy of upper or lower gastrointestinal tract (AU 12) Y 03875 01FEB1984 Vagotomy-- trunkal (AU 11) Y 03882 01FEB1984 Vagotomy-- selective (AU 12) Y 03889 01FEB1984 Vagotomy, highly selective; or vagotomy, trunkal or selective, with pyloroplasty or gastroenterostomy (AU 13) Y 03891 01FEB1984 Vagotomy, highly selective with pyloroplasty or gastroenterostomy (AU 13) N 03891 01SEP1989 Vagotomy, highly selective, with pyloroplasty, gastroenterostomy or dilatation of pylorus (AU 13) Y 03892 01FEB1984 Gastric reduction or gastroplasty for obesity, by any method (AU 13) Y 03893 01FEB1984 Gastric by-pass for obesity, including an anastomosis, by any method (AU 21) Y 03894 01FEB1984 Gastro-enterostomy (including gastroduodenostomy) or enterocolostomy or entero-enterostomy (G) (AU 12) Y 03898 01FEB1984 Gastro-enterostomy (including gastroduodenostomy) or enterocolostomy or entero-enterostomy (S) (AU 12) Y 03900 01FEB1984 Gastro-enterostomy or gastroduodenostomy, reconstruction of (AU 14) Y 03902 01FEB1984 Pancreatic cyst-anastomosis to stomach or duodenum (AU 13) Y 03922 01FEB1984 Partial gastrectomy, with or without gastro-jejunostomy (AU 15) Y 03930 01FEB1984 Gastrectomy, total, for benign disease (AU 19) Y 03937 01NOV1986 GASTRECTOMY, RADICAL SUB-TOTAL, for carcinoma ANAESTHETIC 19 UNITS-ITEM NOS 463G/531S N 03937 01SEP1989 Gastrectomy, sub-total radical, for carcinoma (AU 19) Y 03938 01FEB1984 Gastrectomy, total radical, for carcinoma (AU 21) Y 03952 01FEB1984 Pyloroplasty, infant or pyloromyotomy (Ramstedt's operation) (AU 9) Y 03976 01FEB1984 Enterostomy or colostomy, extraperitoneal closure of (G) (AU 11) Y 03981 01FEB1984 Enterostomy or colostomy, extraperitoneal closure of (S) (AU 11) Y 03986 01FEB1984 Enterostomy or colostomy, intraperitoneal closure, not involving resection (AU 11) Y 03988 01SEP1989 Colostomy, refashioning of (AU 10) Y 04001 01NOV2006 MEDICAL PRACTITIONER ATTENDANCE (INCLUDING A GENERAL PRACTITIONER, BUT NOT INCLUDING A SPECIALIST OR CONSULTANT PHYSICIAN) ASSOCIATED WITH PROVISION OF NON-DIRECTIVE PREGNANCY SUPPORT COUNSELLING SERVICES Professional attendance for the purpose of providing non-directive pregnancy support counselling to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by a medical practitioner registered with Medicare Australia as meeting the credentialling requirements for provision of this service, and lasting at least 20 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may not be provided by a medical practitioner who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of 3 non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items - 4001, 81000, 81005 and 81010 (see Explanatory note M.8). SURGERY CONSULTATION (professional attendance at consulting rooms) N 04001 01JAN2014 Professional attendance of at least 20 minutes in duration at consulting rooms by a medical practitioner (including a general practitioner but not including a specialist or consultant physician) who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 81000, 81005 or 81010 applies in relation to that pregnancy Note:For items 81000, 81005 and 81010, see the determination about allied health services under subsection 3C(1) of the Act. N 04001 01JUL2018 Professional attendance of at least 20 minutes in duration at consulting rooms by a general practitioner who is registered with the Chief Executive Medicare as meeting the credentialing requirements for provision of this service for the purpose of providing non-directive pregnancy support counselling to a person who: (a) is currently pregnant; or (b) has been pregnant in the 12 months preceding the provision of the first service to which this item or item 81000, 81005 or 81010 applies in relation to that pregnancy Note:For items 81000, 81005 and 81010, see the determination about allied health services under subsection 3C(1) of the Act. Y 04003 01FEB1984 Intussusception, reduction of, by fluid Y 04012 01FEB1984 Intussusception, laparotomy and resection of (AU 14) Y 04018 01FEB1984 Transverse or sigmoid colectomy with or without anastomosis (AU 15) Y 04038 01NOV1990 Small intestine, resection of, without anastomosis (including formation of stoma) (AU 17) Y 04039 01FEB1984 Bowel, segmental resection of, with or without anastomosis, not covered by any other item in this Part (G) (AU 15) Y 04042 01NOV1990 Small intestine, resection of, with anastomosis (AU 18) Y 04043 01FEB1984 Bowel, segmental resection of, with or without anastomosis, not covered by any other item in this Part (S) (AU 15) Y 04044 01NOV1990 Large intestine, resection of, without anastomosis, including right hemicolectomy (including formation of stoma) (AU 18) Y 04045 01NOV1990 Large intestine, resection of, with anastomosis, including right hemicolectomy (AU 20) Y 04046 01FEB1984 Hemicolectomy, right or left (AU 15) Y 04047 01NOV1990 Total colectomy and ileostomy (AU 22) Y 04048 01FEB1984 Total colectomy with ileo-rectal anastomosis or ileostomy (AU 20) Y 04052 01FEB1984 Total colectomy with excision of rectum and ileostomy-one surgeon (AU 20) Y 04054 01FEB1984 Total colectomy with excision of rectum and ileostomy, combined synchronous operation; abdominal resection (including after-care) (AU 17) Y 04059 01FEB1984 Total colectomy with excision of rectum and ileostomy, combined synchronous operation; perineal resection Y 04065 01NOV1990 Rectum, high restorative anterior resection with intraperitoneal anastomosis (of the rectum) greater than 10 centimetres from the anal verge - excluding resection of sigmoid colon alone (AU 22) Y 04067 01NOV1990 Rectum, low restorative anterior resection with extraperitoneal anastomosis (of the rectum) less than 10 centimetres from the anal verge (AU 26) Y 04068 01FEB1984 Rectum, restorative anterior resection of, with rectosigmoidectomy (AU 16) Y 04070 01SEP1989 Rectosigmoidectomy, anterior (Hartman's operation) (AU 15) Y 04071 01SEP1989 Restoration of bowel continuity following Hartman's procedure, including dismantling of colostomy (AU 15) Y 04074 01FEB1984 Appendicectomy, not covered by Item 4084 (G) (AU 8) Y 04080 01FEB1984 Appendicectomy, not covered by Item 4084 (S) (AU 8) Y 04084 01FEB1984 Appendicectomy, when performed in conjunction with any other intra-abdominal procedure and through the same incision (AU 5) Y 04087 01FEB1984 Drainage of appendiceal abscess or for ruptured appendix or for peritonitis with or without appendicectomy (G) (AU 10) N 04087 01SEP1989 Laparotomy for drainage of pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause-with or without appendicectomy (G) (AU 10) Y 04093 01FEB1984 Drainage of appendiceal abscess or for ruptured appendix or for peritonitis with or without appendicectomy (S) (AU 10) N 04093 01SEP1989 Laparotomy for drainage of pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause-with or without appendicectomy (S) (AU 10) Y 04099 01FEB1984 Small bowel intubation with biopsy Y 04104 01FEB1984 Small bowel intubation, as an independent procedure Y 04109 01FEB1984 Pancreatectomy, partial (AU 15) Y 04115 01FEB1984 Pancreatico-duodenectomy, Whipple's operation (AU 30) Y 04130 01NOV1979 Pancreas, drainage of (AU 11) Y 04131 01JAN1986 PANCREATIC ABSCESS, drainage of, excluding after-care ANAESTHETIC 11 UNITS - ITEM NOS 453G / 522S N 04131 01SEP1989 Pancreatic abscess, drainage of, excluding after-care (AU 11) Y 04133 01FEB1984 Anastomosis of pancreatic duct to bowel (AU 18) Y 04139 01JAN1986 SPLENORRHAPHY OR PARTIAL SPLENECTOMY FOR TRAUMA ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S N 04139 01SEP1989 Splenorrhaphy or partial splenectomy for trauma (AU 13) Y 04141 01FEB1984 Splenectomy for trauma (AU 13) Y 04144 01FEB1984 Splenectomy, other than for trauma (AU 13) Y 04165 01FEB1984 Multiple ruptured viscera (including liver, kidney, spleen or hollow viscus) major repair or removal of (AU 18) Y 04173 01FEB1984 Retroperitoneal tumour, removal of (AU 15) Y 04179 01FEB1984 Sacrococcygeal and presacral tumour-- excision of (AU 13) Y 04185 01FEB1984 Retroperitoneal abscess, drainage of, not involving laparotomy (AU 9) Y 04191 01NOV1979 Peritoneoscopy (AU 6) Y 04192 01NOV1984 Laparoscopy, diagnostic (AU 7) Y 04193 01NOV1984 Laparoscopy, with biopsy (AU 7) Y 04194 01NOV1984 Laparoscopy, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other procedure-one or more procedures with or without biopsy-not associated with item 4193, 6611 or 6612 (AU 7) Y 04197 01FEB1984 Paracentesis abdominis Y 04202 01FEB1984 Rectum and anus, abdomino-perineal resection of-- one surgeon (AU 17) Y 04209 01FEB1984 Rectum and anus, abdomino-perineal resection of, combined synchronous operation-- abdominal resection (AU 16) Y 04214 01FEB1984 Rectum and anus, abdomino-perineal resection of, combined synchronous operation-- perineal resection Y 04217 01FEB1984 Abdomino-perineal pull through resection with colo-anal anastomosis (one or two stages), including associated colostomy (AU 30) Y 04218 01NOV1990 Total colectomy with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy - one surgeon (AU 36) Y 04219 01NOV1990 Total colectomy with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy - conjoint surgery, abdominal surgeon (including aftercare) (AU 30) Y 04220 01NOV1990 Total colectomy with excision of rectum and ileoanal anastomosis with formation of ileal reservoir - conjoint surgery, perineal surgeon Y 04222 01FEB1984 Femoral or inguinal hernia or infantile hydrocele, repair of, not covered by Item 4233, 4258 or 4262 (G) (AU 8) Y 04227 01FEB1984 Femoral or inguinal hernia or infantile hydrocele, repair of, not covered by Item 4233, 4258 or 4262 (S) (AU 8) Y 04228 01NOV1990 Ileostomy closure with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy - one surgeon (AU 30) Y 04229 01NOV1990 Ileostomy closure with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy - conjoint surgery, abdominal surgeon (including aftercare) (AU 26) Y 04230 01NOV1990 Ileostomy closure with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy - conjoint surgery, perineal surgeon Y 04231 01NOV1990 Ileostomy reservoir, continent type, creation of, including conversion of existing ileostomy where appropriate (AU 30) Y 04233 01FEB1984 Strangulated, incarcerated or obstructed hernia, repair of, without bowel resection (AU 10) Y 04238 01FEB1984 Diaphragmatic hernia, traumatic, repair of (AU 17) Y 04241 01FEB1984 Diaphragmatic hernia, other than traumatic, repair of (abdominal approach) (AU 14) N 04241 01SEP1989 Diaphragmatic hernia, congential, repair of, by thoracic or adbominal approach) (AU 14) Y 04242 01NOV1984 Antireflux operation involving insertion of prosthetic device-not associated with Item 4241, 4243, 4244 or 4245 (AU 11) Y 04243 01NOV1984 Antireflux operation by fundoplasty via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus-not covered by item 4241 or 4242 (AU 18) Y 04244 01DEC1984 Oesophagogastric myotomy (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus (AU 17) Y 04245 01DEC1984 Oesophagogastric myotomy (Heller's operation) via abdominal or thoracic approach, with fundoplasty, with or without closure of the diaphragmatic hiatus (AU 18) Y 04246 01FEB1984 Umbilical, epigastric or linea alba hernia, repair of, in a person under ten years of age (G) (AU 8) Y 04249 01FEB1984 Umbilical, epigastric or linea alba hernia, repair of, in a person under ten years of age (S) (AU 8) Y 04251 01FEB1984 Umbilical, epigastric or linea alba hernia, repair of, in a person ten years of age or over (G) (AU 8) Y 04254 01FEB1984 Umbilical, epigastric or linea alba hernia, repair of, in a person ten years of age or over (S) (AU 8) Y 04258 01FEB1984 Ventral, incisional, lumbar or recurrent hernia or burst abdomen, repair of (G) (AU 10) Y 04262 01FEB1984 Ventral, incisional, lumbar or recurrent hernia or burst abdomen, repair of (S) (AU 10) Y 04265 01FEB1984 Hydrocele, tapping of Y 04266 01SEP1989 Hydrocele, removal of (AU 7) Y 04269 01FEB1984 Varicocele or hydrocele, removal of (G) (AU 7) N 04269 01SEP1989 Varicocele, surgical correction of when not associated with items 4288, 4293 and 4296, one procedure (G) (AU 7) Y 04273 01FEB1984 Varicocele or hydrocele, removal of (S) (AU 7) N 04273 01SEP1989 Varicocele, surgical correction of when not associated with items 4288, 4293 and 4296 one procedure (S) (AU 7) Y 04288 01FEB1984 Orchidectomy (simple) (G) (AU 7) N 04288 01SEP1989 Orchidectomy, simple or subcapsular, unilateral with or without insertion of testicular prosthesis (G) (AU 7) Y 04293 01FEB1984 Orchidectomy (simple) (S) (AU 7) N 04293 01SEP1989 Orchidectomy, simple or subcapsular, unilateral with or without insertion of testicular prosthesis (S) (AU 7) Y 04296 01FEB1984 Orchidectomy and complete excision of spermatic cord (AU 8) N 04296 01SEP1989 Exploration of spermatic cord, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis (AU 8) Y 04307 01FEB1984 Undescended testis, orchidopexy or transplantation of, with or without associated hernial repair (AU 8) Y 04313 01FEB1984 Secondary detachment of testis from thigh (AU 6) Y 04319 01FEB1984 Circumcision of a person under four weeks of age (AU 6) N 04319 01SEP1989 Circumcision of a person under six months of age, where medically indicated (AU 6) Y 04327 01FEB1984 Circumcision of a person under ten years of age but not less than four weeks of age (AU 6) N 04327 01SEP1989 Circumcision of a person under ten years of age but not less than six months of age (AU 6) Y 04338 01FEB1984 Circumcision of a person ten years of age or over (G) (AU 6) Y 04345 01FEB1984 Circumcision of a person ten years of age or over (S) (AU 6) Y 04351 01FEB1984 Paraphimosis, reduction of, under anaesthesia, with or without dorsal incision, not associated with any other item in this Part (AU 5) N 04351 01SEP1989 Paraphimosis, reduction of, under general anaesthesia, with or without dorsal incision, not associated with any other item in this Part (AU 5) Y 04354 01FEB1984 Sigmoidoscopic examination (with rigid sigmoidoscope), with or without biopsy Y 04363 01FEB1984 Sigmoidoscopic examination (with rigid sigmoidoscope), under general anaesthesia, with or without biopsy, not associated with any other item in this Part (AU 5) Y 04365 01NOV1990 Sigmoidoscopic examination with diathermy or resection of one or more polyps where the time taken is less than or equal to 45 minutes (AU 7) Y 04366 01FEB1984 Sigmoidoscopic examination with diathermy or resection of one or more rectal polyps or tumours (G) (AU 7) Y 04367 01FEB1984 Sigmoidoscopic examination with diathermy or resection of one or more rectal polyps or tumours (S) (AU 7) Y 04368 01NOV1990 Sigmoidoscopic examination with diathermy or resection of one or more polyps where the time taken is greater than 45 minutes (AU 10) Y 04380 01FEB1984 Full or partial thickness rectal biopsy under general anaesthesia (AU 6) Y 04383 01FEB1984 Flexible fibreoptic sigmoidoscopy with or without short fibreoptic colonoscopy up to splenic flexure (AU 6) N 04383 01SEP1989 Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to hepatic flexure, with or without biopsy (AU 6) Y 04385 01NOV1979 Flexible fibreoptic sigmoidoscopy with or without short fibreoptic colonoscopy up to splenic flexure, with biopsy (AU 7) Y 04386 01FEB1984 Flexible fibreoptic sigmoidoscopy with or without short fibreoptic colonoscopy up to splenic flexure, with removal of one or more colonic polyps, not covered by Item 4366 or 4367 (AU 8) N 04386 01SEP1989 Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to the hepatic flexure with removal of one or more polyps, not covered by item 4366 or 4367 (AU 8) Y 04388 01FEB1984 Fibreoptic colonoscopy-- examination of colon up to and beyond splenic flexure (AU 8) N 04388 01MAR1984 Fibreoptic colonoscopy examination of colon up to and beyond splenic flexure (long colonoscopy) (AU 8) N 04388 01SEP1989 Fibreoptic colonoscopy-examination of colon beyond the hepatic flexure with or without biopsy (AU 8) Y 04389 01NOV1979 Fibreoptic colonoscopy-- examination of colon up to and beyond splenic flexure with biopsy (AU 9) N 04389 01MAR1984 Fibreoptic colonoscopy - examination of colon up to and beyond splenic flexure (long colonoscopy) with biopsy (AU 9) Y 04394 01FEB1984 Fibreoptic colonoscopy-- examination of colon up to and beyond splenic flexure (long colonoscopy) with removal of one or more colonic polyps (AU 10) N 04394 01SEP1989 Fibreoptic colonoscopy-examination of colon beyond the hepatic flexure with removal of one or more polyps (AU 10) Y 04395 01NOV1990 Rectal tumour of five centimetres or less in diameter, per anal submucosal excision of (excluding snare diathermy) (AU 10) Y 04397 01FEB1984 Villous tumour of rectum, greater than 3 centimetres in diameter, local excision (AU 9) Y 04398 01NOV1990 Anorectal carcinoma - per anal full thickness excision of (AU 13) Y 04399 01FEB1984 Rectal tumour, excision of, via trans-sphincteric approach (AU 12) N 04399 01MAR1984 Rectal tumour, excision of, via trans-sphincteric approach(AU 13) Y 04410 01SEP1989 Rectal prolapse, Delorme procedure for (AU 10) Y 04411 01NOV1990 Rectal stricture, per anal release of (AU 8) Y 04413 01FEB1984 Rectum, radical operation for prolapse of, involving laparotomy (AU 13) Y 04455 01FEB1984 Anus, dilatation of, under general anaesthesia, with or without disimpaction of faeces, not associated with any other item in this Part (AU 4) Y 04467 01FEB1984 Anal prolapse-- circum-anal suture (AU 6) Y 04482 01FEB1984 Anal stricture, repair of (AU 7) Y 04490 01FEB1984 Anal sphincterotomy as an independent procedure for Hirschsprung's disease (AU 6) Y 04492 01FEB1984 Anal incontinence, operation for, by Parkes intersphincteric procedure or by direct repair of anal sphincters, not covered by Item 383 in Part 2 (AU 11) N 04492 01MAR1984 Anal incontinence, operation for, by Parkes intersphincteric procedure or by direct repair of anal sphincters, not covered by Item 383 in Part 2 (AU 12) Y 04493 01NOV1990 Anal sphincter, direct repair of (AU 12) Y 04507 01NOV1990 Haemorrhoids or rectal prolapse - sclerotherapy for (AU 6) Y 04509 01FEB1984 Haemorrhoids, rubber band ligation of, or incision of thrombosed external haemorrhoids (AU 5) Y 04510 01SEP1989 Cryosurgery to haemorrhoids (AU 5) Y 04523 01FEB1984 Haemorrhoidectomy, radical (G) (AU 7) N 04523 01SEP1989 Haemorrhoidectomy, radical (G) (AU 8) Y 04527 01FEB1984 Haemorrhoidectomy, radical (S) (AU 7) N 04527 01SEP1989 Haemorrhoidectomy, radical (S) (AU 8) Y 04533 01NOV1990 Anal polyps, excision of one or more of (AU 5) Y 04534 01FEB1984 Removal of external haemorrhoids, removal of anal skin tags, injection of rectal prolapse or injection of anal prolapse-- under general anaesthesia-- one or more of these procedures (AU 5) Y 04535 01NOV1990 Anal skin tags, excision of one or more of (AU 7) Y 04536 01NOV1990 Perianal thrombosis, incision of (AU 7) Y 04537 01FEB1984 Operation for fissure-in-ano including excision, posterior sphincterotomy or lateral sphincterotomy but excluding dilatation only (G) (AU 6) Y 04544 01FEB1984 Operation for fissure-in-ano including excision, posterior sphincterotomy or lateral sphincterotomy but excluding dilatation only (S) (AU 6) Y 04552 01FEB1984 Fistula in ano, subcutaneous, excision of (G) (AU 7) Y 04557 01FEB1984 Fistula in ano, subcutaneous, excision of (S) (AU 7) Y 04568 01FEB1984 Fistula in ano, excision of (involving incision of external sphincter) (G) (AU 7) Y 04572 01NOV1990 Anal fistula, excision of, involving lower half of the anal sphincter mechanism (AU 7) Y 04573 01FEB1984 Fistula in ano, excision of (involving incision of external sphincter) (S) (AU 7) Y 04574 01NOV1990 Anal fistula, excision of, involving the upper half of the anal sphincter mechanism (AU 11) Y 04575 01NOV1990 Anal fistula, repair of by mucosal flap advancement (AU 15) Y 04576 01NOV1990 Fistula wound - review of, under general anaesthetic (AU 7) Y 04578 01NOV1990 Anorectal examination, with or without biopsy, under general anaesthetic, not associated with any other item in this Part (AU 6) Y 04580 01NOV1990 Intra-anal, perianal or ischio-rectal abscess, drainage of (excluding aftercare) (AU 8) Y 04583 01NOV1990 Anal warts, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved day-hospital facility, where the time taken is less than or equal to 45 minutes (AU 6) Y 04584 01NOV1990 Anal warts, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved day-hospital facility, where the time taken is greater than 45 minutes (AU 11) Y 04586 01NOV1990 Intestinal sling procedure prior to radiotherapy (AU 15) Y 04588 01NOV1990 Colonic lavage, total, intra operative (AU 12) Y 04590 01FEB1984 Faecal fistula, repair of (AU 12) Y 04606 01FEB1984 Coccyx, excision of (AU 8) Y 04611 01FEB1984 Pilonidal sinus or cyst or sacral sinus or cyst, excision of in a person ten years of age or over (G) (AU 8) Y 04617 01FEB1984 Pilonidal sinus or cyst or sacral sinus or cyst, excision of in a person ten years of age or over (S) (AU 8) Y 04618 01MAY1991 PILONIDAL SINUS, injection of sclerosant fluid under anaesthesia (AU 6 - 407/513) Y 04619 01MAY1991 TELANGIECTASES OR STARBURST VESSELS, diathenny or sclerosant injection of, including associated consultation Y 04620 01MAY1991 VARICOSE VEINS, multiple simultaneous injections by continuous compression techniques including associated consultation - ONE OR BOTH LEGS - not associated with any other varicose veins operation on the same leg (excluding after-care) Y 04621 01MAY1991 VARICOSE VEINS, multiple ligations, with or without local stripping or excision, including sub-fascial ligation of one or more deep perforating veins through separate incisions - ONE LEG - not associated with item 4624, 4625 or 4632 on the same leg (AU 7 - 408/514) Y 04622 01FEB1984 Pilonidal sinus, injection of sclerosant fluid under anaesthesia (AU 6) Y 04623 01MAY1991 VARICOSE VEINS, complete dissection at SAPHENO-FEMORAL JUNCTION, with or without ligation of long saphenous vein, with or without ligation of the major tributaries at sapheno-femoral junction - ONE LEG (AU 6 - 407/513) Y 04624 01MAY1991 VARICOSE VEINS, high ligation and complete or partial stripping or excision of long or short saphenous vein or its major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - one leg (AU 10 - 450/521) Y 04625 01MAY1991 VARICOSE VEINS, high ligation and stripping or excision of both long and short saphenous veins or their major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - one leg (AU 12 - 454/523) Y 04626 01MAY1991 LONG SAPHENOUS VEIN, complete dissection and ligation of, at the saphenofemoral junction, for migrating thrombosis of long saphenous vein (AU 11 - 453/522) Y 04627 01MAY1991 VARICOSE VEINS, complete dissection at sapheno-popliteal junction, with or without ligation of the short saphenous vein, with or without ligation of the major tributaries at the sapheno-popliteal junction - one leg (AU 6 - 407/513) Y 04628 01MAY1991 VARICOSE VEINS, sub-fascial ligation of single deep perforating vein not associated with any other varicose vein operation on the same leg - ONE LEG (AU 6 - 407/513) Y 04629 01FEB1984 Varicose veins, injection into-- one or more injections, including any associated consultation Y 04630 01AUG1988 Telangiectases or starburst vessels, subcutaneous diathermy or sclerosant injection of, including associated consultation Y 04631 01MAY1991 GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-popliteal incompetence - one leg (AU 12 - 454/523) Y 04632 01MAY1991 GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-femoral incompetence or recurrent sapheno-popliteal incompetence with one or more of the following - multiple ligations, local stripping or excision of minor veins or sclerotherapy of minor veins - one leg (AU 13 - 457/524) Y 04633 01FEB1984 Varicose veins, multiple simultaneous injections by continuous compression techniques (excluding after-care) N 04633 01SEP1989 Varicose veins, multiple simultaneous injections by continuous compression techniques including associated consultation-one or both legs-not associated with any other varicose veins operation on the same leg (excluding after-care) Y 04634 01MAY1991 BYPASS OR ANASTOMOSIS FOR OCCLUSIVE ARTERIAL DISEASE ARTERY OF NECK, bypass using vein or synthetic material (AU 19 - 463/531) Y 04636 01MAY1991 INTERNAL CAROTID ARTERY, transection and reanastomosis of, or resection of small length and reanastomosis of - with or without endarterectomy (AU 18 - 462/529) Y 04637 01FEB1984 Varicose veins, multiple ligations, with or without local stripping or excision, not covered by any other item in this Part (AU 8) N 04637 01SEP1989 Varicose veins, multiple ligations, with or without local stripping or excision, including sub-fascial ligation of one or or more deep perforating veins through separate incisions-one leg-not associated with item 4641, 4649 or 4664 on the same leg (AU 7) Y 04638 01MAY1991 INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with by-pass by graft of vein or synthetic material (AU 19 - 463/531) Y 04639 01MAY1991 AORTO-ILIAC OR AORTO-FEMORAL GRAFTING, straight or bifurcated (AU 21 - 465/535) Y 04640 01FEB1984 Varicose veins, high ligation and complete stripping or excision of long saphenous vein (AU 7) Y 04641 01JUL1985 VARICOSE VEINS, high ligation and stripping or excision of LONG OR SHORT saphenous vein or its major tributaries, WITH OR WITHOUT MULTIPLE LIGATIONS, local stripping or excision of minor veins - ONE LEG ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 04641 01SEP1989 Varicose veins, high ligation and stripping or excision of long or short saphenous vein or its major tributaries, with or without multiple ligations, local stripping or excision of minor veins-one leg (AU 10) Y 04642 01MAY1991 AXILLARY or SUBCLAVIAN TO FEMORAL BYPASS GRAFTING to one or both FEMORAL ARTERIES (AU 19 - 463/531) Y 04643 01FEB1984 Varicose veins, high ligation and complete stripping or excision of short saphenous vein (AU 7) Y 04644 01MAY1991 RENAL ARTERY, bypass grafting to (AU 22 - 466/537) Y 04645 01MAY1991 RENAL ARTERIES (both), bypass grafting to (AU 26- 470/541) Y 04646 01MAY1991 SPLENO-RENAL ARTERIAL BYPASS GRAFTING (AU 21- 465/535) Y 04647 01MAY1991 MESENTERIC VESSEL (single), bypass grafting to (AU 18 - 462/529) Y 04648 01MAY1991 MESENTERIC VESSELS (multiple), bypass grafting to (AU 21 - 465/535) Y 04649 01FEB1984 Varicose veins, high ligation and complete stripping or excision of both long and short saphenous systems (AU 10) N 04649 01SEP1989 Varicose veins, high ligation and stripping or excision of both long and short saphenous veins or their major tributaries, with or without multiple ligations, local stripping or excision of minor veins-one leg (AU 12) Y 04650 01MAY1991 INFERIOR MESENTERIC ARTERY, operation on, when performed in association with another intra-abdominal vascular operation (AU 17 - 461/528) Y 04651 01FEB1984 Varicose veins, high ligation of long saphenous vein at saphenous femoral junction (AU 6) N 04651 01SEP1989 Varicose veins, complete dissection at sapheno-femoral junction, with or without ligation of long saphenous vein, with or without ligation of the major tributaries at sapheno-femoral junction-one leg (AU 6) Y 04652 01MAY1991 FEMORAL ARTERY BYPASS GRAFfING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with above knee anastomosis (AU 19 - 463/531) Y 04653 01MAY1991 FEMORAL ARTERY BYPASS GRAFfING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to below knee popliteal artery (AU 20 - 464/533) Y 04654 01MAY1991 FEMORAL ARTERY BYPASS GRAFfING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to tibio peroneal trunk or tibial or peroneal artery (AU 21 - 465/535) Y 04655 01FEB1984 Varicose veins, high ligation of short saphenous vein at saphenous popliteal junction (AU 6) N 04655 01SEP1989 Varicose veins, high ligation of short saphenous vein at saphenous popliteal junction-one leg (AU 6) Y 04656 01MAY1991 FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis within 5cms of the ankle joint (AU 22 - 466/537) Y 04657 01MAY1991 FEMORAL ARTERY BYPASS GRAFTING using synthetic graft, with lower anastomosis above or below the knee (AU 18 - 462/529) Y 04658 01FEB1984 Varicose veins, sub-fascial ligation of single deep perforation (AU 6) N 04658 01SEP1989 Varicose veins, sub-fascial ligation of single deep perforating vein-one leg-not associated with any other varicose operation on the same leg (AU 6) Y 04659 01MAY1991 FEMORAL ARTERY BYPASS GRAFTING, using a composite graft (synthetic material and vein) with lower anastomosis above or below the knee, including use of a cuff or sleeve of vein at one or both anastomoses (AU 20 - 464/533) Y 04660 01MAY1991 FEMORAL ARTERY SEQUENTIAL BYPASS GRAFTING, (using a vein or synthetic materia\) where an additional anastomosis is made to separately revascularise more than one artery - each additional artery revascularised beyond a femoral bypass (AU 16 - 460/527) Y 04661 01MAY1991 VEIN, harvesting of from leg or arm for bypass or replacement graft when not performed through same incision as operation - each vein (AU 9 - 443/518) Y 04662 01FEB1984 Varicose veins, sub-fascial ligation of multiple deep perforating veins (Cockett's operation) (AU 7) Y 04663 01MAY1991 ARTERIAL BVP ASS GRAFTING, using vein or synthetic materia\, not covered by any other item in this Part (AU 18 - 462/529) Y 04664 01NOV1984 Re-operation for recurrent sapheno-femoral or sapheno-popliteal incompetence, with or without multiple ligations, local stripping or excision-one leg (AU 13) Y 04665 01FEB1984 Cross-leg by-pass graft-- saphenous to femoral vein (AU 11) Y 04666 01MAY1991 ARTERIAL OR VENOUS ANASTOMOSIS, not covered by any other item in this Part, as an independent procedure (AU 15 - 459/526) Y 04667 01MAY1991 ARTERIAL OR VENOUS ANASTOMOSIS not covered by any other item in this Part, when performed in combination with another vascular operation (including graft to graft anastomosis) (AU 15 - 459/526) Y 04668 01MAY1991 BYPASS, REPLACEMENT, LIGATION OF ANEURYSMS ANEURYSM OF COMMON OR INTERNAL CAROTID ARTERY, OR BOTH, replacement by graft of vein or synthetic material (AU 20 - 464/533) Y 04669 01MAY1991 THORACIC ANEURYSM, replacement by graft (AU 35 - 493/564) Y 04670 01FEB1984 Intra-arterial oxygen injection Y 04671 01MAY1991 SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft including re-implantation of arteries (AU 35 - 493/564) Y 04672 01MAY1991 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft (AU 26 - 470/541) Y 04673 01MAY1991 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision of common iliac aneurysms) (AU 29 - 473/544) Y 04674 01MAY1991 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both femoral arteries (with or without excision or bypass of common iliac aneurysms) (AU 29 - 473/544) Y 04675 01MAY1991 ANEURYSM OF ILIAC ARTERY (common, external or internal), replacement by graftunilateral (AU 18 - 462/529) Y 04676 01FEB1984 Ligation of medium artery, medium vein or medium artery and medium vein by elective operation (including repair of artifical arterio-venous fistula) (AU 6) N 04676 01MAR1984 Ligation of medium artery, medium vein or medium artery and medium vein by elective operation, or repair of artificial arterio-venous fistula (AU 6) Y 04677 01MAY1991 ANEURYSM OF VISCERAL ARTERY, excision and repair by direct anastomosis or replacement by graft (AU 18 - 462/529) Y 04678 01FEB1984 Ligation of large artery, large vein or large artery and large vein by elective operation (AU 7) Y 04679 01MAY1991 FALSE ANEURYSM, repair of, at aortic anastomosis following previous aortic surgery (AU 25 - 469/540) Y 04680 01MAY1991 FALSE ANEURYSM, repair of, in iliac artery and restoration of arterial continuity (AU 19 - 463/531) Y 04681 01MAY1991 FALSE ANEURYSM, repair of, in femoral artery and restoration of arterial continuity (AU 18 - 462/529) Y 04682 01MAY1991 RUPTURED THORACIC AORTIC ANEURYSM, replacement by graft (AU 38 - 477 /548) Y 04683 01MAY1991 RUPTURED THORACO-ABDOMINAL AORTIC ANEURYSM, replacement by graft (AU 40 - 479/550) Y 04684 01MAY1991 RUPTURED SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft (AU 38 - 477/548) Y 04685 01MAY1991 RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft (AU 28 - 472/543) Y 04686 01MAY1991 RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision or bypass of common iliac aneurysms) (AU 30 - 474/545) Y 04687 01MAY1991 RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both femoral arteries (AU 30 - 474/545) Y 04688 01JUL1985 ARTERY or VEIN or ARTERY AND VEIN (including brachial, radial, ulnar ortibial), ligation of, by elective operation OR repair of surgically created fistula ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S N 04688 01SEP1989 Artery or vein or artery and vein (including brachial, radial, ulnar or tibial), ligation of, by elective operation or repair of surgically created fistula (AU 7) Y 04689 01MAY1991 RUPTURED ILIAC ARTERY ANEURYSM, replacement by graft (AU 22 - 466/537) Y 04690 01FEB1984 Great artery or great vein (including jugular, subclavian, axillary, iliac, femoral or popliteal) ligation of (AU 8) Y 04691 01MAY1991 RUPTURED ANEURYSM OF VISCERAL ARTERY, replacement by anastomosis or graft (AU 22 - 466/537) Y 04692 01MAY1991 RUPTURED ANEURYSM OF VISCERAL ARTERY, simple ligation of (AU 18 - 462/529) Y 04693 01FEB1984 Major artery or vein of neck or extremity, repair of wound of, with restoration of continuity (AU 13) Y 04694 01MAY1991 ANEURYSM OF MAJOR ARTERY, replacement by graft, not covered by any other item in this Part (AU 21 - 465/535) Y 04695 01FEB1984 Microvascular repair using operating microscope with restoration of continuity of artery or vein of distal extremity or digit (AU 14) Y 04696 01FEB1984 Major artery or vein of abdomen including aorta and vena cava, repair of wound of, with restoration of continuity (AU 16) Y 04697 01MAY1991 ENDARTERECTOMY AND ARTERIAL PATCH ARTERY OR ARTERIES OF NECK, endarterectomy of, including closure by suture (where endarterectomy of one or more arteries is undertaken through one arteriotomy incision) (AU 17 - 461/528) Y 04698 01MAY1991 INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with endarterectomy and closure by suture (AU 19 - 463/531) Y 04699 01FEB1984 Arterio-venous fistula, dissection and repair of, with restoration of continuity (AU 10) N 04699 01SEP1989 Arterio-venous fistula, dissection and repair of, with restoration of continuity (not in association with haemodialysis) (AU 10) Y 04700 01MAY1991 INNOMINATE OR SUBCLAVIAN ARTERY, endarterectomy of, including closure by suture (AU 18 - 462/529) Y 04701 01MAY1991 AORTIC ENDARTERECTOMY, including closure by suture, not associated with another procedure on the aorta (AU 18 - 462/529) Y 04702 01FEB1984 Arterio-venous fistula, dissection and ligation of (AU 10) N 04702 01SEP1989 Arterio-venous fistula, dissection and ligation of (not in association with haemodialysis) (AU 10) Y 04703 01MAY1991 AORTD-ILIAC ENDARTERECTOMY (one or both iliac arteries), including closure by suture not associated with Item 4704 (AU 19 - 463/531) Y 04704 01MAY1991 AORTD-FEMORAL ENDARTERECTOMY (one or both femoral arteries) or BILATERAL ILID-FEMORAL ENDARTERECTOMY, including closure by suture, not in association with Item 4703 (AU 20 - 464/533) Y 04705 01FEB1984 Innominate, subclavian or any intraabdominal artery, endarterectomy of (AU 19) N 04705 01SEP1989 Innominate, subclavian or any intra-abdominal artery, endarterectomy of, with closure by simple suture or patch graft, including harvesting of vein (AU 19) Y 04706 01MAY1991 ILIAC ENDARTERECTOMY, including closure by suture, not associated with another procedure on the iliac artery (AU 17 - 461/528) Y 04707 01MAY1991 ILIO-FEMORAL ENDARTERECTOMY (one side), including closure by suture (AU 17 - 461/528) Y 04708 01MAY1991 RENAL ARTERY, endarterectomy of (AU 19 - 463/531) Y 04709 01FEB1984 Artery of neck or extremities, endarterectomy of (AU 15) N 04709 01SEP1989 Artery of neck or extremities, endarterectomy of, with closure by simple suture or patch graft, including harvesting of vein (AU 15) Y 04710 01MAY1991 RENAL ARTERIES (both), endarterectomy of (AU 21 - 465/535) Y 04711 01MAY1991 COELIAC OR SUPERIOR MESENTERIC ARTERY, endarterectomy of (AU 19 - 463/531) Y 04712 01MAY1991 COELIAC AND SUPERIOR MESENTERIC ARTERY, endarterectomy of (AU 20 - 464/533) Y 04713 01MAY1991 INFERIOR MESENTERIC ARTERY, endarterectomy of, not associated with any other item in this Part (AU 19 - 463/531) Y 04714 01MAY1991 ARTERY OF EXTREMmES, endarterectomy of, including closure by suture (AU 12 - 454/523) Y 04715 01FEB1984 Great artery or great vein (including carotid, jugular, subclavian, axillary, iliac, femoral or popliteal) ligation of involving gradual occlusion by mechanical device (AU 10) Y 04716 01MAY1991 EXTENDED DEEP FEMORAL ENDARTERECTOMY where the endarterectomy is at least 7cms long (AU 17 - 461/528) Y 04717 01MAY1991 ARTERY OR VEIN, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is less than 3cm long (AU 13 - 457/524) Y 04718 01MAY1991 ARTERY OR VEIN, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is 3cm long or greater (AU 14 - 458/525) Y 04719 01MAY1991 ARTERY OR VEIN BYPASS GRAFf, patch grafting to using vein or synthetic material, not associated with any other vascular operation (AU 14 - 458/525) Y 04720 01MAY1991 VEIN, harvesting of from leg or arm for patch when not performed through same incision as operation (AU 9 - 443/518) Y 04721 01FEB1984 Inferior vena cava, plication or ligation of (AU 12) Y 04722 01MAY1991 ENDARTERECTOMY, in association with an arterial bypass operation to prepare the site for anastomosis - each site (AU 16 - 460/527) Y 04723 01MAY1991 EMBOLECTOMY, THROMBECTOMY AND VASCULAR TRAUMA EMBOLUS, removal of, from artery of neck (AU 15 - 459/526) Y 04724 01MAY1991 EMBOLECTOMY or THROMBECTOMY, by abdominal approach, of an artery or bypass graft of trunk (AU 16 - 460/527) Y 04725 01MAY1991 EMBOLECTOMY OR THROMBECTOMY, from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery (AU 11 - 453/522) Y 04726 01MAY1991 INFERIOR VENA CAVA OR ILIAC VEIN, thrombectomy of (AU 12 - 454/523) Y 04727 01MAY1991 THROMBUS, removal of, from femoral or other similar large vein (AU 10 - 450/521) Y 04728 01MAY1991 MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by lateral suture (AU 12 - 454/523) Y 04729 01MAY1991 MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by direct anastomosis (AU 13 - 457/524) Y 04730 01MAY1991 MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein (AU 15 - 459/526) Y 04731 01MAY1991 MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by lateral suture (AU 13 - 457/524) Y 04732 01MAY1991 MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by direct anastomosis (AU 14 - 458/525) Y 04733 01FEB1984 Internal carotid artery, repositioning of (AU 13) Y 04734 01MAY1991 MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein (AU 16 - 460/527) Y 04735 01MAY1991 MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by lateral suture (AU 16 - 460/527) Y 04736 01MAY1991 MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by direct anastomosis (AU 17 - 461/528) Y 04737 01MAY1991 MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by means of interposition graft (AU 18 - 462/529) Y 04738 01FEB1984 Arterial patch graft (AU 12) N 04738 01SEP1989 Arterial patch graft including harvesting of vein (AU 12) Y 04739 01MAY1991 ARTERY OF NECK, re-operation for bleeding or thrombosis after carotid or vertebral artery surgery (AU 12 - 454/523) Y 04740 01MAY1991 LAPAROTOMY for control of post operative bleeding or thrombosis after intraabdominal vascular procedure, where no other procedure is performed (AU 14 - 458/525) Y 04741 01MAY1991 EXTREMITY, re-operation on, for control of bleeding or thrombosis after vascular procedure, where no other procedure is performed (AU 12 - 454/523) Y 04742 01MAY1991 LIGATION, EXCISION, ELECTIVE REPAffi, DECOMPRESSION OF VESISELS I MAJOR ARTERY OF NECK, elective ligation or exploration of, not associated o/ith any other vascular procedure (AU 11 - 453/522) Y 04743 01MAY1991 GREAT ARTERY OR GREAT VEIN (including subclavian, axillary, iliac, femoral or popliteal), ligation of, or exploration of, not associated with any other vascular procedure (AU 13 - 457/524) Y 04744 01FEB1984 Aorto-iliac or aorto-femoral bifurcate graft (AU 19) N 04744 01SEP1989 Aorto-iliac or aorto-femoral or other intra-abdominal straight or bifurcate graft, with or without local endarterectomy to prepare artery for anastomosis (AU 19) Y 04746 01MAY1991 ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by elective operation, or exploration of, not associated with any other vascular procedure (AU 9 - 443/518) Y 04747 01MAY1991 TEMPORAL ARTERY, biopsy of (AU 7 - 408/514) Y 04748 01MAY1991 ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and ligation (AU 14 - 458/525) 458/525) Y 04749 01FEB1984 Axillary-femoral by-pass graft or subclavian-femoral by-pass graft (AU 16) N 04749 01SEP1989 Axillary or subclavian to femoral by-pass graft or other extra-abdominal arterial by-pass graft, using a synthetic graft, with or without local endarterectomy to prepare artery for anastomosis (AU 16) Y 04750 01MAY1991 ARTERIO-VENOUS FISTULA OF THE NECK, dissection and ligation (AU 17 - 461/528) Y 04751 01MAY1991 ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and ligation (AU 19- 463/531) Y 04752 01MAY1991 ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and repair of, with restoration of continuity (AU 18 - 462/529) Y 04753 01MAY1991 ARTERIO-VENOUS FISTULA OF THE NECK, dissection and repair of, with restoration of continuity (AU 18 - 462/529) Y 04754 01FEB1984 Arterial or venous graft or by-pass not included in any other item (AU 20) N 04754 01SEP1989 Arterial by-pass graft using synthetic graft, with or without local endarterectomy (AU 16) Y 04755 01JUL1985 FEMORAL ARTERY BY-PASS GRAFT using synthetic or vein graft, including harvesting of vein, with below knee anastomosis ANAESTHETIC 20 UNITS - ITEM NOS 464G / 533S N 04755 01SEP1989 Femoral artery by-pass graft using synthetic or vein graft, including harvesting of vein, with below knee anastomosis (AU 20) Y 04756 01FEB1984 Micro-arterial or micro-venous graft using operating microscope (AU 22) Y 04757 01MAY1991 ARTERIO-VENOUS FISTULA OF THE ABOOMEN, dissection and repair of, with restoration of continuity (AU 22 - 466/537) Y 04758 01MAY1991 SURGICALLY CREATED ARTERIO-VENOUS FISTULA OF AN EXTREMITY, closure of (AU 10 - 450/521) Y 04759 01MAY1991 SCALENOTOMY (AU 10 - 450/521) Y 04760 01MAY1991 FIRST RIB, resection of portion of (AU 13 - 457/524) Y 04761 01MAY1991 CERVICAL RIB, removal of, or other operation for removal of thoracic outlet compression, not covered by any other item in this Part (AU 13 - 457/524) Y 04762 01FEB1984 Arterial anastomosis (AU 16) N 04762 01SEP1989 Arterial anastomosis not associated with any other arterial operation, with or without local endarterectomy to prepare artery for anastomosis (AU 16) Y 04763 01MAY1991 COELIAC ARTERY, decompression of, for coeliac artery compression syndrome, as an independent procedure (AU 19 - 463/531) Y 04764 01FEB1984 Microvascular anastomosis of artery or vein using operating microscope, for reimplantation of limb or digit or free transfer of tissue (AU 38) Y 04765 01MAY1991 POPLITEAL ARTERY, exploration of, for popliteal entrapment, with or without division of fibrous tissue and muscle (AU 13 - 457/524) Y 04766 01FEB1984 Portal hypertension, vascular anastomosis for (AU 21) Y 04767 01MAY1991 CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is less that 4cm in maximum diameter (AU 19 - 463/531) Y 04768 01MAY1991 CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is greater than 4cm in maximum diameter (AU 19 - 463/531) Y 04769 01MAY1991 RECURRENT CAROTID BODY TUMOUR, resection of, with or without repair or Y 04770 01MAY1991 NECK, excision of infected bypass graft, including closure of vessel or vessels (AU 15 - 459/526) Y 04771 01MAY1991 AORTO-DUODENAL FISTULA, repair of, by suture of aorta and repair of duodenum (AU 24 - 468/539) Y 04772 01MAY1991 AORTO-DUODENAL FISTULA, repair of, by insertion of aortic graft and repair of duodenum (AU 26 - 470/541) Y 04773 01MAY1991 AORTO-DUODENAL FISTULA, repair of, by oversewing of abdominal aorta, repair Y 04774 01MAY1991 lNFECTED BYPASS GRAFT FROM TRUNK, excision of, including closure of arteries (AU 20 - 464/533) Y 04775 01MAY1991 lNFECTED AXILLO-FEMORAL OR FEMORO-FEMORAL GRAFT, excision of, including closure of arteries (AU 15 - 459/526) Y 04776 01MAY1991 lNFECTED BYPASS GRAFT FROM EXTREMITIES, excision of including closure of arteries (AU 15 - 459/526) Y 04777 01MAY1991 OPERATIONS FOR VASCULAR DISEASE ARTERIOVENOUS SHUNT, EXTERNAL, insertion of (AU 9 - 443/518) Y 04778 01FEB1984 Embolus, removal of, from artery of neck or extremities (AU 12) N 04778 01SEP1989 Embolus, removal of, from an artery or by-pass graft of neck or extremities (AU 12) Y 04779 01MAY1991 ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, in association with another venous or arterial operation (AU 14 - 458/525) Y 04780 01MAY1991 ARTERIOVENOUS SHUNT, EXTERNAL, removal of (AU 5 - 406/510) Y 04781 01MAY1991 ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, not in association with another venous or arterial operation (AU 14 - 458/525) Y 04782 01MAY1991 ARTERIOVENOUS ACCESS DEVICE, insertion of (AU 14 - 458/525) Y 04783 01MAY1991 ARTERIOVENOUS ACCESS DEVICE, thrombectomy of (AU 11 - 453/522) Y 04784 01FEB1984 Embolus, removal of, from artery of trunk (AU 15) N 04784 01SEP1989 Embolus or thrombus, removal of, from artery or prosthetic graft of trunk (AU 15) Y 04785 01MAY1991 STENOSIS OF ARTERIOVENOUS FISTULA OR PROSTHETIC ARTERIOVENOUS ACCESS DEVICE, correction of (AU 14 - 458/525) Y 04786 01MAY1991 INTRA-ABDOMINAL ARTERY OR VEIN, cannulation of for infusion chemotherapy, by open operation (excluding aftercare) (AU 11 - 453/522) Y 04787 01MAY1991 ARTERIAL CANNULATION for infusion chemotherapy by open operation, not covered by Item 4786 (excluding after-care) (AU 10 - 450/521) Y 04788 01MAY1991 CENTRAL VEIN CATHETERISATION by open exposure, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device (AU 11 - 453/522) Y 04789 01FEB1984 Thrombus, removal of, from femoral, iliac or other similar large vein (AU 12) Y 04790 01MAY1991 HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of (AU 10 - 450/521) Y 04791 01FEB1984 Abdominal aortic aneurysm, excision of and insertion of graft (AU 26) Y 04792 01JUL1985 THORACO-ABDOMINAL ANEURYSM, excision of and insertion of graft, including reanastomosis of visceral vessels ANAESTHETIC 40 UNITS - ITEM NOS 479G / 550S N 04792 01SEP1989 Thoraco-abdominal aneurysm, excision of and insertion of graft, including reanastomosis of visceral vessels (AU 40) Y 04793 01MAY1991 ISOLA TED LIMB PERFUSION, including cannulation of artery and vein at commencement of procedure, regional perfusion for chemotherapy, or other therapy, repair of arteriotomy and venotomy at conclusion of procedure (excluding aftercare) (AU 18 - 462/529) Y 04794 01FEB1984 Ruptured abdominal aortic aneurysm, excision of and insertion of graft (AU 26) N 04794 01SEP1989 Ruptured abdominal aortic aneurysm, excision of and insertion of graft, or repair of aorto-duodenal fistula, including repair of aorta and duodenum (AU 26) Y 04795 01MAY1991 ENDOVASCULAR INTERVENTION PROCEDURES INFERIOR VENA CAVAL FILTER, insertion of, by percutaneous method using interventional imaging techniques (AU 11 - 453/522) Y 04796 01MAY1991 INFERIOR VENA CAVAL FILTER, insertion of, by open operation (AU 12 - 454/523) Y 04797 01MAY1991 INFERIOR VENA CAVA, plication, ligation, or application of caval clip (AU 13 - 457/524) Y 04798 01FEB1984 Aneurysm of major artery, excision of and insertion of graft (AU 18) Y 04799 01MAY1991 INFERIOR VENA CAVA, reconstruction of or bypass by vein or synthetic material (AU 24 - 468/539) Y 04800 01FEB1984 Transluminal arterioplasty including associated radiological services and preparation (AU 12) Y 04801 01JUL1985 EXCISION OF INFECTED PROSTHETIC BY-PASS GRAFT from NECK or EXTREMITIES, including closure of vessel or vessels ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S N 04801 01SEP1989 Excision of infected prosthetic by-pass graft from neck or extremities, including closure of vessel or vessels (AU 14) Y 04802 01AUG1985 EXCISION OF INFECTED PROSTHETIC BY-PASS GRAFT from TRUNK, including closure of vessel or vessels ANAESTHETIC 18 UNITS - ITEM NOS 462G / 529S N 04802 01SEP1989 Excision of infected prosthetic by-pass graft from trunk, including closure of vessel or vessels (AU 18) Y 04803 01MAY1991 CROSS LEG BYPASS GRAFTING, saphenous to iliac or femoral vein (AU 14 - 458/525) Y 04804 01MAY1991 SAPHENOUS VEIN ANASTOMOSIS to femoral or popliteal vein for femoral vein bypass (AU 14 - 458/525) Y 04805 01MAY1991 VENOUS STENOSIS OR OCCLUSION, vein bypass for, using vein or synthetic material, not associated with items 4803 or 4804 (AU 13 - 457/524) Y 04806 01FEB1984 Intra-aortic balloon for counterpulsation, operation for insertion by arteriotomy or removal of and arterioplasty (AU 14) N 04806 01SEP1989 Intra-aortic balloon for counterpulsation, operation for insertion by arteriotomy, or removal of and arterioplasty (excluding repair by patch graft) (AU 14) Y 04807 01MAY1991 VEIN STENOSIS, patch angioplasty for, (excluding vein graft stenosis)-using vein or synthetic material (AU 15 - 459/526) Y 04808 01FEB1984 Arteriovenous shunt, external, insertion of (AU 9) Y 04809 01MAY1991 VENOUS VALVE, plica tion or repair to restore valve competency (AU 25 - 469/540) Y 04810 01MAY1991 VEIN TRANSPLANT to restore valvular function (AU 15 - 459/526) Y 04811 01MAY1991 EXTERNAL STENT, application of, to restore venous valve competency to superficial vein - one stent (AU 10 - 450/521) Y 04812 01FEB1984 Arteriovenous shunt, external, removal of (AU 5) Y 04813 01MAY1990 TRANS LUMINAL BALLOON ANGIOPLASTY OF CORONORY ARTERY AND DILATATION OF VESSEL, using interventional imaging techniques ANAESTHETIC 12 UNITS - ITEM NOS 454G I 523S Y 04814 01MAY1990 TRANSLUMINAL BALLOON ANGIOPLASTY OF PERIPHERAL VESSEL AND DILATATION OF VESSEL, using interventional imaging techniques ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S Y 04815 01MAY1991 EXTERNAL STENTS, application of, to restore venous valve competency to superficial vein or veins - more than one stent (AU 11 - 453/522) Y 04816 01MAY1991 EXTERNAL STENT, application of, to restore venous valve competency to deep vein (one stent) (AU 11 - 453/522) Y 04817 01FEB1984 Arteriovenous anastomosis, direct, of upper or lower limb (AU 14) Y 04818 01MAY1991 EXTERNAL STENTS, application of, to restore venous valve competency to deep vein or veins (more than one stent) (AU 12 - 454/523) Y 04819 01MAY1991 PORTAL HYPERTENSION, vascular decompression operation for (including splenorenal, porto-caval and mesenterico-caval anastomosis) (AU 24 - 468/539) Y 04820 01MAY1991 SYMPATHECTOMY LUMBAR SYMPATHEOUMY (AU 11 - 453/522) Y 04821 01MAY1991 CERVICAL OR UPPER THORACIC SYMPATHECTOMY by any surgical approach (AU 16 - 460/527) Y 04822 01FEB1984 Intra-arterial infusion of arteries of neck, thorax or abdomen, including initial operation and all postoperative management (AU 13) N 04822 01SEP1989 Cannulation of intra-abdominal artery or vein for infusion chemotherapy, by open operation (excluding after-care) (AU 13) Y 04823 01NOV1985 ARTERIAL CANNULATION for infusion chemotherapy by open operation, not covered by Item 4822 (excluding after-care) ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 04823 01SEP1989 Arterial cannulation for infusion chemotherapy, by open operation, not covered by item 4822 (excluding after-care) (AU 10) Y 04824 01JUL1985 CENTRAL VEIN CATHETERISATION by open exposure, using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter not covered by item 4825 ANAESTHETIC 8 UNITS - ITEM NOS 409G / 514S N 04824 01SEP1989 Central vein catheterisation by open exposure, using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter, not covered by item 4825 (AU 8) Y 04825 01NOV1986 CENTRAL VEIN CATHETERISATION by open exposure using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter in children under the age of 12 years ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 04825 01SEP1989 Central vein catheterisation by open exposure, using subcutaneous tunnel with pump or access port as with a Hickman or Broviac catheter, in children under the age or 12 years (AU 12) Y 04826 01MAY1991 CERVICAL OR UPPER THORACIC SYMPATHECTOMY, where operation is a reoperation for previous incomplete sympathectomy by any surgical approach (AU 13 - 457/524) Y 04827 01MAY1991 LUMBAR SYMPATHECTOMY, where operation is following chemical sympathectomy or for previous incomplete surgical sympathectomy (AU 11 - 453/522) Y 04828 01MAY1991 DEBRIDEMENT AND AMPUTATIONS FOR VASCULAR DISEASE ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, slough in, in the operating theatre of a hospital, when debridement includes muscle, tendon or bone (AU 8 - 409/517) Y 04829 01SEP1989 Percutaneous epidural implant for chronic pain-insertion of (one or two stages), not involving laminectomy (AU 8) Y 04830 01SEP1989 Percutaneous epidural implant for chronic pain-removal of (AU 7) Y 04831 01MAY1991 ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough in, in the operating theatre of a hospital, superficial tissue only (AU 9 - 443/518) Y 04832 01FEB1984 Operation on phalanx (AU 7) Y 04834 01MAY1991 MISCELLANEOUS VASCULAR PROCEDURES OPERATIVE ARTERIOGRAPHY OR VENOGRAPHY, one or more of, performed during the course of an operative prodedure on an artery or vein on one leg (AU 8 - 409/517) Y 04835 01MAY1991 TRANSLUMINAL BALLOON ANGIOPLAS1Y OF CORONARY ARTERY AND DILATATION OF VESSEL, using interventionaI imaging techniques (AU 12 - 454/523) Y 04836 01MAY1991 TRANSLUMINAL BALLOON ANGIOPLAS1Y OF PERIPHERAL VESSEL AND DILATATION OF VESSEL, using interventionaI imaging techniques (AU 12 - 454/523) Y 04837 01MAY1991 OPERATIONS FOR ACUTE OSTEOMYELITIS OPERATION ON PHALANX (AU 7 - 408/514) Y 04838 01FEB1984 Operation on sternum, clavicle, rib, ulna, radius, carpus, tibia, fibula, tarsus, skull, mandible or maxilla (other than alveolar margins)-- one bone (AU 10) Y 04841 01FEB1984 Operation on mandible or maxilla (other than alveolar margins)-- one bone (D) (AU 10) Y 04844 01FEB1984 Operation on humerus or femur-- one bone (AU 10) Y 04853 01FEB1984 Operation on spine or pelvic bones-- one bone (AU 13) Y 04860 01FEB1984 Operation on scapula, sternum, clavicle, rib, ulna, radius, metacarpus, carpus, phalanx, tibia, fibula, metatarsus, tarsus, mandible or maxilla (other than alveolar margins)-- one bone or any combination of adjoining bones (AU 12) Y 04862 01FEB1984 Operation on mandible or maxilla or mandible and maxilla (other than alveolar margins) (D) (AU 12) Y 04864 01FEB1984 Operation on humerus or femur-- one bone (AU 11) Y 04867 01FEB1984 Operation on spine or pelvic bones-- one bone (AU 12) Y 04870 01FEB1984 Operation on skull (AU 12) Y 04877 01FEB1984 Operation on any combination of adjoining bones, being bones referred to in Item 4864, 4867 or 4870 (AU 12) Y 04927 01FEB1984 One digit of hand (G) (AU 6) Y 04930 01FEB1984 One digit of hand (S) (AU 6) Y 04934 01FEB1984 Two digits of one hand (G) (AU 7) Y 04940 01FEB1984 Two digits of one hand (S) (AU 7) Y 04943 01FEB1984 Three digits of one hand (G) (AU 8) Y 04948 01FEB1984 Three digits of one hand (S) (AU 8) Y 04950 01FEB1984 Four digits of one hand (G) (AU 9) Y 04954 01FEB1984 Four digits of one hand (S) (AU 9) Y 04957 01FEB1984 Five digits of one hand (G) (AU 10) Y 04961 01FEB1984 Five digits of one hand (S) (AU 10) Y 04965 01FEB1984 Finger or thumb, including metacarpal or part of metacarpal-- each digit (G) (AU 6) Y 04969 01FEB1984 Finger or thumb, including metacarpal or part of metacarpal-- each digit (S) (AU 6) Y 04972 01FEB1984 Hand, midcarpal or transmetacarpal (G) (AU 7) Y 04976 01FEB1984 Hand, midcarpal or transmetacarpal (S) (AU 7) N 04976 01MAR1985 HAND, MIDCARPAL OR TRANSMETACARPAL ANAESTHETIC 7 UNITS (S) - ITEM NOS 408G / 514S Y 04979 01FEB1984 Hand, forearm or through arm (AU 8) Y 04983 01FEB1984 At shoulder (AU 12) Y 04987 01FEB1984 Interscapulothoracic (AU 15) Y 04990 01FEB1984 One digit of foot (G) (AU 6) Y 04993 01FEB1984 One digit of foot (S) (AU 6) Y 04995 01FEB1984 Two digits of one foot (G) (AU 7) Y 04997 01FEB1984 Two digits of one foot (S) (AU 7) Y 04999 01FEB1984 Three digits of one foot (G) (AU 8) N 04999 01MAR1985 THREE DIGITS of one foot (G) ANAESTHETIC 8 UNITS - ITEM NOS 409G / 517S Y 05000 01JAN2005 LEVEL 'A' Professional attendance for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management SURGERY CONSULTATION Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05000 01MAY2010 Professional attendance at consulting rooms (other than a service to which another item applies) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-each attendance Y 05002 01FEB1984 Three digits of one foot (S) (AU 8) Y 05003 01JAN2005 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05003 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05003 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05003 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies) that requires a short patient history and, if necessary, limited examination and management-an attendance on one or more patients on one occasion-each patient Y 05006 01FEB1984 Four digits of one foot (G) (AU 9) Y 05007 01JAN2005 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) Y 05009 01FEB1984 Four digits of one foot (S) (AU 9) Y 05010 01JAN2005 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05010 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6 pm on any other day. N 05010 01JAN2013 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex, if the patient is accommodated in a residential aged care facility (other than accommodation in a self-contained unit) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05015 01FEB1984 Five digits of one foot (G) (AU 10) Y 05018 01FEB1984 Five digits of one foot (S) (AU 10) Y 05020 01JAN2005 LEVEL 'B' Professional attendance involving taking a selective history, examination of the patient with implementation of a management plan in relation to 1 or more problems, OR a professional attendance of less than 20 minutes duration involving components of a service to which item 5040, 5043, 5046, 5049, 5060, 5063, 5064 or 5067 applies SURGERY CONSULTATION (Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05020 01MAY2010 Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance Y 05023 01JAN2005 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05023 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05023 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05023 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient Y 05024 01FEB1984 Toe, including metatarsal or part of metatarsal-- each toe (G) (AU 7) Y 05026 01JAN2005 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) Y 05028 01JAN2005 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05028 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05028 01JAN2013 Professional attendance by a general practitioner (other than a service to which another item in the table applies), at a residential aged care facility to residents of the facility, lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05029 01FEB1984 Toe, including metatarsal or part of metatarsal-- each toe (S) (AU 7) Y 05034 01FEB1984 Foot at ankle (Syme, Pirogoff types) (AU 8) Y 05038 01FEB1984 Foot, midtarsal or transmetatarsal (AU 7) Y 05040 01JAN2005 LEVEL 'C' Professional attendance involving taking a detailed history, an examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more problems, and lasting at least 20 minutes, OR a professional attendance of less than 40 minutes duration involving components of a service to which item 5060, 5063, 5064 or 5067 applies. SURGERY CONSULTATION (Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05040 01MAY2010 Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance Y 05043 01JAN2005 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution). The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05043 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital or residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05043 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital or residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05043 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient Y 05045 01NOV1979 Through leg or at knee (AU 8) Y 05046 01JAN2005 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) Y 05048 01NOV1979 Through thigh (AU 10) Y 05049 01JAN2005 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05049 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05049 01JAN2013 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05050 01JUL1985 THROUGH THIGH, AT KNEE OR BELOW KNEE ANAESTHETIC 10 UNITS - ITEM NOS 450G / 5218 N 05050 01SEP1989 Through thigh, at knee or below knee (AU 10) Y 05051 01FEB1984 At hip (AU 14) Y 05055 01FEB1984 Hindquarter (AU 17) Y 05057 01NOV1986 AMPUTATION STUMP, reamputation of, to provide adequate skin and muscle cover DERIVED FEE - 75% of the original amputation fee ANAESTHETIC - ITEM NOS 488G / 5608 N 05057 01SEP1989 Amputation stump, reamputation of, to provide adequate skin and muscle cover Y 05059 01FEB1984 Ear, removal of foreign body in, otherwise than by simple syringing (AU 4) Y 05060 01JAN2005 LEVEL 'D' Professional attendance involving taking an exhaustive history, a comprehensive examination of multiple systems, arranging any necessary investigations and implementing a management plan in relation to 1 or more complex problems, and lasting at least 40 minutes, OR a professional attendance of at least 40 minutes duration for implementation of a management plan SURGERY CONSULTATION (Professional attendance at consulting rooms. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05060 01MAY2010 Professional attendance by a general practitioner at consulting rooms (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-each attendance Y 05062 01FEB1984 Ear, removal of foreign body in, involving incision of external auditory canal (AU 6) Y 05063 01JAN2005 HOME VISIT (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05063 01MAY2010 HOME VISIT OR CONSULTATION AT AN INSTITUTION (OTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY) Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05063 01NOV2011 CONSULTATION AT A PLACE OTHER THAN CONSULTING ROOMS, HOSPITAL OR A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05063 01JAN2013 Professional attendance by a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients on one occasion-each patient Y 05064 01JAN2005 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion) each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. Y 05066 01FEB1984 Aural polyp, removal of (AU 4) Y 05067 01JAN2005 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion)each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day.) N 05067 01MAY2010 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion)each patient. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05067 01JAN2013 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health-related issues, with appropriate documentation-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05068 01FEB1984 External auditory meatus, surgical removal of keratosis obturans from, not covered by any other item in this Part (AU 9) Y 05069 01AUG1986 MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone not covered by Item 5070 ANAESTHETIC 9 UNITS - ITEM NOS 443G / 5188 N 05069 01SEP1989 Meatoplasty involving removal of cartilage or bone or both cartilage and bone not covered by item 5070 (AU 9) Y 05070 01AUG1986 MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone associated with Items 5078, 5091, 5095, 5098 or 5100 ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S N 05070 01SEP1989 Meatoplasty involving removal of cartilage or bone or both cartilage and bone associated with items 5078, 5091, 5095, 5098 or 5100 (AU 7) Y 05072 01FEB1984 External auditory meatus, removal of exostoses in (AU 12) Y 05073 01SEP1986 Correction of AUDITORY CANAL STENOSIS, including meatoplasty, with or without grafting ANAESTHETIC 12 UNITS - ITEM NOS 454G / 5238 N 05073 01SEP1989 Correction of auditory canal stenosis, including meatoplasty, with or without grafting (AU 12) Y 05074 01OCT1986 RECONSTRUCTION OF EXTERNAL AUDITORY CANAL in association with Items 5095, 5098, 5100 ANAESTHETIC 9 UNITS - ITEM NOS 443G / 5188 N 05074 01SEP1989 Reconstruction of external auditory canal in association with items 5095, 5098, 5100 (AU 9) Y 05075 01FEB1984 Myringoplasty, trans-canal approach (Rosen incision) (AU 11) Y 05078 01FEB1984 Myringoplasty, post-aural or endaural approach with or without mastoid inspection (AU 12) Y 05079 01AUG1986 ATTICOTOMY without reconstruction of the bony defect, with or without myringoplasty ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 05079 01SEP1989 Atticotomy without reconstruction of the bony defect, with or without myringoplasty (AU 12) Y 05080 01AUG1986 ATTICOTOMY with reconstruction of the bony defect, with or without myringoplasty ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S N 05080 01SEP1989 Atticotomy with reconstruction of the bony defect with or without myringoplasty (AU 14) Y 05081 01FEB1984 Ossicular chain reconstruction (AU 12) Y 05085 01FEB1984 Ossicular chain reconstruction and myringoplasty (AU 13) Y 05087 01FEB1984 Mastoidectomy (cortical) (AU 12) Y 05091 01FEB1984 Obliteration of the mastoid cavity (AU 10) Y 05093 01AUG1986 MASTOIDECTOMY, intact wall technique, with myringoplasty ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S N 05093 01SEP1989 Mastoidectomy, intact wall technique, with myringoplasty (AU 16) Y 05094 01AUG1986 MASTOIDECTOMY, intact wall technique, with myringoplasty and ossicular chain reconstruction ANAESTHETIC 18 UNITS - ITEM NOS 462G / 529S N 05094 01SEP1989 Mastoidectomy, intact wall technique, with myringoplasty and ossicular chain reconstruction (AU 18) Y 05095 01FEB1984 Mastoidectomy (radical or modified radical) (AU 13) Y 05098 01FEB1984 Mastoidectomy ( radical or modified radical) and myringoplasty (AU 13) Y 05100 01FEB1984 Mastoidectomy (radical or modified radical), myringoplasty and ossicular chain reconstruction (AU 14) Y 05101 01AUG1986 REVISION OF MASTOIDECTOMY (radical, modified radical or intact wall), including myringoplasty ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S N 05101 01SEP1989 Revision of mastoidectomy (radical, modified radical or intact wall), including myringoplasty (AU 16) Y 05102 01FEB1984 Decompression of facial nerve in its mastoid portion (AU 13) Y 05104 01FEB1984 Decompression of facial nerve in its intracranial portion by intracranial or intrapetrous approach (AU 18) Y 05106 01FEB1984 Labyrinthotomy or destruction of labyrinth (AU 12) Y 05108 01FEB1984 Cerebello-pontine angle tumour, removal of by two surgeons operating conjointly, by transmastoid, translabyrinthine approach-- transmastoid, translabyrinthine procedure (including after-care) (AU 39) Y 05112 01FEB1984 Cerebello-pontine angle tumour, removal of by two surgeons operating conjointly, by transmastoid, translabyrinthine approach-- intracranial procedure (including aftercare) Y 05113 01AUG1987 SKULL BASE TUMOUR, removal of by infra-temporal approach ANAESTHETIC 40 UNITS-ITEM NOS 479G/550S N 05113 01SEP1989 Skull base tumour, removal of by infratemporal approach (AU 40) Y 05114 01AUG1987 PARTIAL TEMPORAL BONE RESECTION for removal of tumour involving mastoidectomy with or without decompression of facial nerve. ANAESTHETIC 28 UNITS-ITEM NOS 472G/543S N 05114 01SEP1989 Partial temporal bone resection for removal of tumour involving mastoidectomy with or without decompression of facial nerve (AU 28) Y 05115 01AUG1987 TOTAL TEMPORAL BONE RESECTION for removal of tumour ANAESTHETIC 32 UNITS-ITEM NOS 475G/546S N 05115 01SEP1989 Total temporal bone resection for removal of tumour (AU 32) Y 05116 01FEB1984 Endolymphatic sac, transmastoid decompression with or without drainage of (AU 12) Y 05117 01AUG1987 TRANSLABYRINTHINE VESTIBULAR NERVE SECTION ANAESTHETIC 22 UNITS-ITEM NOS 466G/537S N 05117 01SEP1989 Translabyrinthine vestibular nerve section (AU 22) Y 05118 01AUG1987 RETROLABYRINTHINE VESTIBULAR and/or COCHLEAR NERVE SECTION ANAESTHETIC 26 UNITS-ITEM NOS 470G/541S N 05118 01SEP1989 Retrolabyrinthine vestibular and/or cochlear nerve section (AU 26) Y 05119 01AUG1987 INTERNAL AUDITORY MEATUS, exploration by middle cranial fossa approach with cranial nerve decompression ANAESTHETIC 23 UNITS-ITEM NOS 467G/538S N 05119 01SEP1989 Internal auditory meatus, exploration by middle cranial fossa approach with cranial nerve decompression (AU 23) Y 05122 01FEB1984 Internal auditory meatus, exploration of, by middle cranial fossa approach with or without removal of tumour (AU 21) Y 05127 01FEB1984 Fenestration operation-- each ear (AU 11) Y 05131 01FEB1984 Venous graft to fenestration cavity (AU 12) Y 05138 01FEB1984 Stapedectomy (AU 11) Y 05143 01FEB1984 Stapes mobilisation (AU 10) Y 05147 01FEB1984 Repair of round window (AU11) N 05147 01SEP1989 Round window surgery including repair or cochleotomy (AU 11) Y 05148 01AUG1986 COCHLEAR IMPLANT, insertion of, including mastoidectomy ANAESTHETIC 23 UNITS-ITEM NOS 467G/538S N 05148 01SEP1989 Cochlear implant, insertion of, including mastoidectomy (AU 23) Y 05152 01FEB1984 Glomus tumour, transtympanic removal of (AU 12) Y 05158 01FEB1984 Glomus tumour, transmastoid removal of, including mastoidectomy (AU 13) Y 05162 01FEB1984 Abscess or inflammation of middle ear, operation for (excluding aftercare) (AU 7) Y 05166 01FEB1984 Middle ear, exploration of (AU 9) Y 05172 01FEB1984 Middle ear, insertion of tube for drainage of (including myringotomy) (AU 7) Y 05173 01AUG1986 CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, one or more, with or without myringoplasty ANAESTHETIC 10 UNITS-ITEM NOS 450G/521S N 05173 01SEP1989 Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, with or without myringoplasty (AU 10) Y 05174 01AUG1986 CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, one or more, with or without myringoplasty with ossicular chain reconstruction ANAESTHETIC 16 UNITS-ITEM NOS 460G/527S N 05174 01SEP1989 Clearance of middle ear for granuloma, cholesteatoma and polyp, one or more, with or without myringoplasty with ossicular chain reconstruction (AU 16) Y 05176 01FEB1984 Perforation of tympanum, cauterisation or diathermy of (AU 6) Y 05177 01AUG1986 EXCISION OF RIM OF EARDRUM PERFORATION, not associated with mynngoplasty ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S N 05177 01SEP1989 Excision of rim of eardrum perforation, not associated with myringoplasty (AU 6) Y 05182 01FEB1984 Ear toilet requiring use of operating microscope and microinspection of tympanic membrane with or without general anaesthesia (AU 7) Y 05186 01FEB1984 Tympanic membrane, microinspection of one or both ears under general anaesthesia, not associated with any other item in this Part (AU 7) Y 05192 01FEB1984 Examination of nasal cavity or postnasal space or nasal cavity and post-nasal space, under general anaesthesia, not associated with any other item in this Part (AU 6) Y 05196 01FEB1984 Nasal haemorrhage, posterior, arrest of, with posterior nasal packing with or without cauterisation and with or without anterior pack (excluding after-care) (AU 8) Y 05200 01JAN2005 Professional attendance at consulting rooms of not more than 5 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance Y 05201 01FEB1984 Nose, removal of foreign body in, other than by simple probing (AU 6) Y 05203 01JAN2005 Professional attendance at consulting rooms of more than 5 minutes in duration but not more than 25 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance Y 05205 01FEB1984 Nasal polyp or polypi (simple), removal of Y 05207 01JAN2005 Professional attendance at consulting rooms of more than 25 minutes in duration but not more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance Y 05208 01JAN2005 Professional attendance at consulting rooms of more than 45 minutes in duration (other than a service to which another item applies) by a medical practitioner (other than a general practitioner)-each attendance Y 05210 01FEB1984 Nasal polyp or polypi (requiring admission to hospital), removal of (G) (AU 7) Y 05214 01FEB1984 Nasal polyp or polypi (requiring admission to hospital), removal of (S) (AU 7) Y 05217 01FEB1984 Nasal septum, septoplasty or submucous resection of (AU 9) N 05217 01SEP1989 Nasal septum, septoplasty, submucous resection or closure of septal perforation (AU 9) Y 05220 01JAN2005 HOME VISITS (Professional attendance on 1 or more patients on 1 occasion at a place other than consulting rooms, hospital, residential aged care facility or institution) BRIEF HOME VISIT of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05220 01MAY2010 BRIEF CONSULTATION in an after hours period of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day N 05220 01JAN2013 Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting not more than 5 minutes-an attendance on one or more patients on one occasion-each patient Y 05223 01JAN2005 STANDARD HOME VISIT of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05223 01MAY2010 STANDARD CONSULTATION in an after hours period of more than 5 minutes duration but not more than 25 minutes duration.The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day. N 05223 01JAN2013 Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 5 minutes, but not more than 25 minutes-an attendance on one or more patients on one occasion-each patient Y 05227 01JAN2005 LONG HOME VISIT of more than 25 minutes duration but not more than 45 minutes duration The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05227 01MAY2010 LONG CONSULTATION in an after hours period of more than 25 minutes duration but not more than 45 minutes duration.The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day. N 05227 01JAN2013 Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 25 minutes, but not more than 45 minutes-an attendance on one or more patients on one occasion-each patient Y 05228 01JAN2005 PROLONGED HOME VISIT of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05228 01MAY2010 PROLONGED CONSULTATION in an after hours period of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12 noon on a Saturday, or before 8am or after 6pm on any other day. N 05228 01JAN2013 Professional attendance by a medical practitioner who is not a general practitioner (other than attendance at consulting rooms, a hospital or a residential aged care facility or a service to which another item in the table applies), lasting more than 45 minutes-an attendance on one or more patients on one occasion-each patient Y 05229 01FEB1984 Cauterisation or diathermy of any or all of septum, turbinates or pharynx -each attendance at which the procedure is performed, including any associated consultation (AU 6) N 05229 01MAR1984 Cauterisation (other than by chemical means) or diathermy of septum, turbinates or pharynx - one or more of these procedures (including any consultation on the same occasion) not associated with any other operation on the nose (AU 6) N 05229 01SEP1989 Cauterisation (other than by chemical means) or cauterisation by chemical means when performed under general anaesthesia or diathermy of septum, turbinates or pharynx-one or more of these procedures (including any consultation on the same occasion) not associated with any other operation on the nose (AU 6) Y 05230 01FEB1984 Cauterisation of blood vessels in nose during epistaxis (AU 7) N 05230 01MAR1984 Cauterisation (other than by chemical means) of blood vessels in nose during an episode of epistaxis, one or both sides (AU 7) N 05230 01SEP1989 Nasal haemorrhage, arrest of during an episode of epistaxis by cauterisation or nasal cavity packing or both (AU 7) Y 05233 01FEB1984 Cryotherapy to nose in the treatment of nasal haemorrhage (AU 7) Y 05234 01AUG1986 DIVISION OF NASAL ADHESIONS, with or without stenting not associated with any other operation on the nose and not perfornned during the post-operative period of a nasal operation ANAESTHETIC 6 UNITS-ITEM NOS 407G/513S N 05234 01SEP1989 Division of nasal adhesions, with or without stenting not associated with any other operation on the nose and not performed during the post-operative period of a nasal operation (AU 6) Y 05235 01FEB1984 Dislocation of turbinate or turbinates, one or both sides, not associated with any other item in this Part (AU 6) Y 05237 01FEB1984 Turbinectomy (AU 6) N 05237 01SEP1989 Turbinectomy or turbinectomies, partial or total, unilateral (AU 6) Y 05240 01JAN2005 CONSULTATION AT AN INSTITUTIONOTHER THAN A HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 institution on 1 occasion)each patient BRIEF CONSULTATION of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. Y 05241 01FEB1984 Turbinates, submucous resection of (AU 8) N 05241 01SEP1989 Turbinates, submucous resection of, unilateral (AU 8) Y 05242 01SEP1989 Nasal turbinates, cryotherapy to (AU 6) Y 05243 01JAN2005 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. Y 05245 01FEB1984 Maxillary antrum, proof puncture and lavage of (AU 6) Y 05247 01JAN2005 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. Y 05248 01JAN2005 PROLONGED CONSULTATION of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. Y 05249 01FEB1984 Maxillary antrum, proof puncture and lavage of (D) (AU 6) Y 05254 01FEB1984 Maxillary antrum, proof puncture and lavage of-- under general anaesthesia (requiring admission to hospital) (AU 6) N 05254 01SEP1989 Maxillary antrum, proof puncture and lavage of-under general anaesthesia (requiring admission to hospital), not associated with any other item in this Part (AU 6) Y 05259 01FEB1984 Maxillary antrum, proof puncture and lavage of-- under general anaesthesia (D) (AU 6) Y 05260 01JAN2005 CONSULTATION AT A RESIDENTIAL AGED CARE FACILITY (Professional attendance on 1 or more patients in 1 residential aged care facility (but excluding a professional attendance at a self-contained unit) or attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (excluding accommodation in a self-contained unit) on 1 occasion) - each patient BRIEF CONSULTATION of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05260 01MAY2010 BRIEF CONSULTATION of not more than 5 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05260 01JAN2013 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of not more than 5 minutes in duration by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05263 01JAN2005 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05263 01MAY2010 STANDARD CONSULTATION of more than 5 minutes duration but not more than 25 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05263 01JAN2013 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 5 minutes in duration but not more than 25 minutes in duration by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05264 01FEB1984 Maxillary antrum, lavage of-- each attendance at which the procedure is performed, including any associated consultation (AU 6) Y 05265 01JAN2005 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05265 01MAY2010 LONG CONSULTATION of more than 25 minutes duration but not more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05265 01JAN2013 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 25 minutes in duration but not more than 45 minutes by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05267 01JAN2005 PROLONGED CONSULTATION of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 1pm on a Saturday, or before 8am or after 8pm on any other day. N 05267 01MAY2010 PROLONGED CONSULTATION of more than 45 minutes duration. The attendance must be initiated either on a public holiday, on a Sunday, before 8am or after 12noon on a Saturday, or before 8am or after 6pm on any other day. N 05267 01JAN2013 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self-contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in the residential aged care facility (other than accommodation in a self-contained unit) of more than 45 minutes in duration by a medical practitioner (other than a general practitioner)-an attendance on one or more patients at one residential aged care facility on one occasion-each patient Y 05268 01FEB1984 Maxillary artery, transantral ligation of (AU 9) Y 05270 01FEB1984 Antrostomy (radical) (AU 9) Y 05274 01FEB1984 Antrostomy (radical) (D) (AU 9) Y 05277 01FEB1984 Antrostomy (radical) with transantral ethmoidectomy or transantral vidian neurectomy (AU 10) Y 05280 01FEB1984 Antrum, intranasal operation on or removal of foreign body from (AU 8) Y 05282 01FEB1984 Antrum, intranasal operation on or removal of foreign body from (D) (AU 8) Y 05284 01FEB1984 Antrum, drainage of, through tooth socket (AU 7) Y 05286 01FEB1984 Antrum, drainage of, through tooth socket (D) (AU 7) Y 05288 01FEB1984 Oro-antral fistula, plastic closure of (AU 11) Y 05291 01FEB1984 Oro-antral fistula, plastic closure of (D) (AU 11) Y 05292 01SEP1986 ETHMOIDAL ARTERY OR ARTERIES, transorbital ligation of (unilateral) ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 05292 01SEP1989 Ethmoidal artery or arteries, transorbital ligation of (unilateral) (AU 10) Y 05293 01AUG1986 LATERAL RHINOTOMY with removal of tumour ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 05293 01SEP1989 Lateral rhinotomy with removal of tumour (AU 12) Y 05295 01FEB1984 Fronto-nasal ethmoidectomy with or without sphenoidectomy (AU 9) Y 05298 01FEB1984 Radical fronto-ethmoidectomy with osteoplastic flap (AU 13) Y 05301 01FEB1984 Frontal sinus or ethmoidal sinuses, intranasal operation on (AU 9) Y 05305 01FEB1984 Frontal sinus, catheterisation of (AU 6) Y 05308 01FEB1984 Frontal sinus, trephine of (AU 6) Y 05318 01FEB1984 Frontal sinus, radical obliteration of (AU 10) Y 05320 01FEB1984 Ethmoidal sinuses, external operation on (AU 10) Y 05330 01FEB1984 Sphenoidal sinus, intranasal operation on (AU 10) Y 05343 01FEB1984 Eustachian tube, catheterisation of (AU 6) Y 05345 01FEB1984 Division of pharyngeal adhesions (AU 7) Y 05348 01FEB1984 Post-nasal spaces, direct examination of, with biopsy nasendoscopy or sinoscopy (unilateral) (AU 7) N 05348 01SEP1989 Post nasal space, direct examination of, with or without biopsy (AU 7) Y 05349 01AUG1986 NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S N 05349 01SEP1989 Nasendoscopy or sinoscopy or fibreoptic examination of nasopharynx and larynx (AU 7) Y 05350 01AUG1986 NASOPHARYNGEAL ANGIOFIBROMA, transpalatal removal ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 05350 01SEP1989 Nasopharyngeal angiofibroma, transpalatal removal (AU 12) Y 05354 01FEB1984 Pharyngeal pouch, removal of (AU 16) N 05354 01SEP1989 Pharyngeal pouch, removal of, with or without cricopharyngeal myotomy (AU 16) Y 05357 01FEB1984 Pharyngeal pouch, endoscopic resection of (Dohlman's operation) (AU 14) Y 05358 01AUG1986 CRICOPHARYNGEAL MYOTOMY with or without inversion of pharyngeal pouch ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 05358 01SEP1989 Cricopharyngeal myotomy with or without inversion of pharyngeal pouch (AU 10) Y 05360 01FEB1984 Pharyngotomy (lateral), with or without total excision of tongue (AU 6) Y 05361 01OCT1986 PARTIAL PHARYNGECTOMY via PHARYNGOTOMY ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 05361 01SEP1989 Partial pharyngectomy via pharyngotomy (AU 12) Y 05362 01SEP1986 PARTIAL PHARYNGECTOMY via PHARYNGOTOMY with partial or total glossectomy ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S N 05362 01SEP1989 Partial pharyngectomy via pharyngotomy with partial or total glossectomy (AU 14) Y 05363 01FEB1984 Tonsils or tonsils and adenoids, removal of, in a person aged less than twelve years (G) (AU 7) Y 05366 01FEB1984 Tonsils or tonsils and adenoids, removal of, in a person aged less than twelve years (S) (AU 7) Y 05389 01FEB1984 Tonsils or tonsils and adenoids, removal of, in a person twelve years of age or over (G) (AU 8) Y 05392 01FEB1984 Tonsils or tonsils and adenoids, removal of, in a person twelve years of age or over (S) (AU 8) Y 05396 01FEB1984 Tonsils or tonsils and adenoids, arrest of haemorrhage requiring general anaesthesia, following removal of (G) (AU 9) Y 05401 01FEB1984 Tonsils or tonsils and adenoids, arrest of haemorrhage requiring general anaesthesia, following removal of (S) (AU 9) Y 05407 01FEB1984 Adenoids, removal of (G) (AU 6) Y 05411 01FEB1984 Adenoids, removal of (S) (AU 6) Y 05431 01FEB1984 Lingual tonsil or lateral pharyngeal bands, removal of (AU 7) Y 05445 01FEB1984 Peritonsillar abscess (quinsy) , incision of (AU 7) Y 05449 01FEB1984 Uvulotomy (AU 6) Y 05456 01FEB1984 Vallecular or pharyngeal cysts, removal of (AU 8) Y 05464 01FEB1984 Oesophagoscopy (with rigid oesophagoscope) (AU 6) Y 05470 01FEB1984 Oesophagoscopy with dilatation or insertion of prosthesis-- each occasion (AU 7) Y 05480 01FEB1984 Oesophagoscopy (with rigid oesophagoscope) with biopsy (AU 7) Y 05486 01FEB1984 Oesophagoscopy (with rigid oesophagoscope) with removal of foreign body (AU 7) Y 05490 01FEB1984 Oesophageal stricture, dilatation of, without oesophagoscopy (AU 6) Y 05492 01FEB1984 Oesophagus, pneumatic dilatation of (AU 8) N 05492 01SEP1989 Oesophagus, endoscopic pneumatic dilatation of (AU 8) Y 05498 01FEB1984 Laryngectomy (total) (AU 20) Y 05499 01AUG1986 VERTICAL HEMI-LARYNGECTOMY including tracheostomy ANAESTHETIC 17 UNITS - ITEM NOS 461G / 528S N 05499 01SEP1989 Vertical hemi-laryngectomy including tracheostomy (AU 17) Y 05500 01DEC1986 SUPRAGLOTTIC LARYNGECTOMY including tracheostomy ANAESTHETIC 21 UNITS - ITEM NOS 465G / 535S N 05500 01SEP1989 Supraglottic laryngectomy including tracheostomy (AU 21) Y 05508 01FEB1984 Laryngopharyngectomy or primary restoration of alimentary continuity after laryngopharyngectomy using stomach or bowel (AU 20) Y 05520 01FEB1984 Larynx, direct examination of, as an independent procedure (AU 8) N 05520 01SEP1989 Larynx, direct examination of the supraglottic, glottic and subglottic regions, not associated with any other procedure on the larynx nor with the administration of a general anaesthetic (AU 8) Y 05524 01FEB1984 Larynx, direct examination of, with biopsy (AU 8) Y 05530 01FEB1984 Larynx, direct examination of, with removal of tumour (AU 9) Y 05534 01FEB1984 Microlaryngoscopy (AU 8) Y 05538 01AUG1986 MICROLARYNGOSCOPY with removal of juvenile papillomata ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 05538 01SEP1989 Microlaryngoscopy with removal of juvenile papillomata (AU 10) Y 05539 01AUG1986 MICROLARYNGOSCOPY with removal of papillomata by laser surgery ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S N 05539 01SEP1989 Microlaryngoscopy with removal of papillomata by laser surgery (AU 13) Y 05540 01FEB1984 Microlaryngoscopy with removal of tumour (AU 9) Y 05541 01AUG1986 MICROLARYNGOSCOPY with arytenoidectomy ANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S N 05541 01SEP1989 Microlaryngoscopy with arytenoidectomy (AU 13) Y 05542 01FEB1984 Teflon injection into vocal cord (AU 9) Y 05545 01FEB1984 Larynx, fractured, operation for (AU 15) Y 05556 01FEB1984 Larynx, external operation on or laryngofissure (AU 13) N 05556 01SEP1989 Larynx, external operation on, or laryngofissure, with or without cordectomy (AU 13) Y 05557 01OCT1986 LARYNGOPLASTY or TRACHEOPLASTY, including tracheostomy ANAESTHETIC 17 UNITS - ITEM NOS 461G / 528S N 05557 01SEP1989 Laryngoplasty or tracheoplasty, including tracheostomy (AU 17) Y 05572 01FEB1984 Tracheostomy (G) (AU 10) Y 05598 01FEB1984 Tracheostomy (S) (AU 10) Y 05601 01FEB1984 Trachea, removal of foreign body in (AU 7) Y 05605 01FEB1984 Bronchoscopy, as an independent procedure (AU 7) Y 05611 01FEB1984 Bronchoscopy with biopsy or other diagnostic or therapeutic procedure (AU 8) Y 05613 01FEB1984 Bronchus, removal of foreign body in (AU 9) Y 05615 01MAY1990 FIBREOPTIC BRONCHOSCOPY with one or more transbronchial lung biopsies, with or without bronchial or broncho- alveolar lavage, with or without the use of interventional imaging ANAESTHETIC 8 UNITS - ITEM NOS 409G / 517S Y 05617 01MAY1990 ENDOSCOPIC LASER RESECTION OF ENDOBRONCHIAL TUMOURS for relief of obstruction including any associated endoscopic procedures ANAESTHETIC 15 UNITS - ITEM NOS 459G / 526S Y 05619 01FEB1984 Bronchoscopy with dilatation of tracheal stricture (AU 7) Y 05636 01FEB1984 Adrenal gland, biopsy or removal of (AU 12) N 05636 01SEP1989 Adrenal gland, excision of-partial or total (AU 12) Y 05642 01FEB1984 Renal transplant, not covered by Items 5644 and 5645 (AU 24) Y 05644 01FEB1984 Renal transplant, performed by vascular surgeon and urologist operating together-- vascular anastomosis, including aftercare (AU 24) Y 05645 01FEB1984 Renal transplant, performed by vascular surgeon and urologist operating together-- ureterovesical anastomosis, including after-care Y 05647 01FEB1984 Donor nephrectomy (cadaver) N 05647 01MAR1984 Donor nephrectomy (cadaver) , one or both kidneys Y 05654 01FEB1984 Nephrectomy, complete (G) (AU 11) Y 05661 01FEB1984 Nephrectomy, complete (S) (AU 11) Y 05663 01FEB1989 Nephrectomy, complete, complicated by previous surgery on the same kidney (AU 13) Y 05665 01FEB1984 Partial nephrectomy, nephrectomy complicated by previous surgery on the same kidney or nephroureterectomy (AU 13) N 05665 01SEP1989 Nephrectomy, partial (AU 13) Y 05666 01FEB1989 Nephrectomy, partial, complicated by previous surgery on the same kidney (AU 15) Y 05667 01NOV1984 Nephrectomy, radical, with enbloc dissection of lymph nodes, with or without adrenalectomy (AU 17) Y 05675 01FEB1984 Nephro-ureterectomy, complete, with bladder repair (AU 17) N 05675 01SEP1989 Nephro-ureterectomy, complete, including associated bladder repair and any associated endoscopic procedure (AU 17) Y 05679 01FEB1984 Kidney, fused, symphysiotomy for (AU 14) N 05679 01JAN1985 KIDNEY, FUSED, symphysiotomy for ANAESTHETIC 14 UNITS - ITEM NOS 458G / 525S N 05679 01SEP1989 Kidney, fused, renal symphysiotomy for (AU 14) Y 05683 01FEB1984 Kidney, exploration of, with any procedure, not covered by any other item in this Part (AU 10) N 05683 01SEP1989 Kidney or perinephric area, exploration of, with or without drainage of, by open exposure, not covered by any other item in this Part (AU 10) Y 05691 01FEB1984 Nephrolithotomy or pyelolithotomy (AU 12) N 05691 01SEP1989 Nephrolithotomy or pyelolithotomy, or both, through the same skin incision, for one or two stones (AU 12) Y 05699 01FEB1984 Nephrolithotomy or pyelolithotomy, where complicated by previous surgery on the same kidney or for large staghorn calculus filling renal pelvis and calyces (AU 12) N 05699 01SEP1989 Nephrolithotomy or pyelolithotomy, or both, extended, for staghorn stone or 3 or more stones, including one or more of the following: nephrostomy, pyelostomy, pedicle control with or without freezing, calyorrhaphy or pyeloplasty (AU 12) Y 05700 01AUG1986 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY and post-operative care for three days, including pre-operative consultation In hospital for assessment for lithotripsy ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 05700 01SEP1989 Extracorporeal shock wave lithotripsy (ESWL) to urinary tract and post-treatment care for three days, including pre-treatment consultation (AU 12) Y 05705 01FEB1984 Ureterolithotomy (AU 11) Y 05715 01FEB1984 Nephrostomy, nephrotomy or pyelostomy with drainage (AU 11) N 05715 01SEP1989 Nephrostomy or pyelostomy, open, as an independent procedure (AU 11) Y 05721 01FEB1984 Nephropexy, as an independent procedure (AU 9) Y 05724 01FEB1984 Renal cyst or cysts, excision or unroofing of (AU 11) Y 05726 01FEB1984 Renal biopsy (closed) (AU 6) Y 05729 01FEB1984 Pyonephrosis, drainage of (AU 11) Y 05732 01FEB1984 Perinephric abscess, drainage of (AU 9) Y 05734 01FEB1984 Pyeloplasty (AU 14) N 05734 01SEP1989 Pyeloplasty,by open exposure (AU 14) Y 05737 01FEB1984 Pyeloplasty, complicated by previous surgery on same kidney or by congenital kidney abnormality or by the operation being on a solitary kidney (AU 14) N 05737 01SEP1989 Pyeloplasty in congenitally abnormal kidney or solitary kidney, by open exposure (AU 14) Y 05738 01FEB1989 Pyeloplasty, complicated by previous surgery on the same kidney, by open exposure (AU 15) Y 05741 01FEB1984 Divided ureter, repair of (AU 13) Y 05744 01FEB1984 Repair of kidney, wound or injury (AU 13) N 05744 01SEP1989 Kidney, exposure and exploration of, including repair or nephrectomy, for trauma, not associated with any other procedure performed on the kidney, renal pelvis or renal pedicle (AU 13) Y 05747 01FEB1984 Ureterectomy, complete or partial, with bladder repair (AU 12) N 05747 01SEP1989 Ureterectomy, complete or partial, with or without associated bladder repair, not associated with item 5889 (AU 12) Y 05753 01FEB1984 Replacement of ureter by bowel-- unilateral (AU 12) N 05753 01SEP1989 Ureter, replacement of, by bowel (AU 12) Y 05757 01FEB1984 Replacement of ureter by bowel-- bilateral (AU 17) Y 05763 01FEB1984 Ureter (unilateral), transplantation of, into skin (AU 10) N 05763 01SEP1989 Ureter, transplantation of, into skin (AU10) Y 05769 01FEB1984 Ureters (bilateral), transplantation of, into skin (AU 12) Y 05773 01FEB1984 Ureter (unilateral), transplantation of, into bladder (AU 12) N 05773 01SEP1989 Ureter, reimplantation into bladder (AU 12) Y 05777 01FEB1984 Ureters (bilateral), transplantation of, into bladder (AU 14) Y 05780 01FEB1984 Ureter, transplantation of, into bladder with bladder plastic procedure (Boari flap) (AU 12) N 05780 01SEP1989 Ureter, reimplantation into bladder with psoas hitch or Boari flap or both (AU 12) Y 05785 01FEB1984 Ureter (unilateral), transplantation of, into intestine (AU 12) N 05785 01SEP1989 Ureter, transplantation of, into intestine (AU 12) Y 05792 01FEB1984 Ureters (bilateral), transplantation of, into intestine (AU 14) Y 05799 01FEB1984 Ureter, transplantation of, into other ureter (AU 12) N 05799 01SEP1989 Ureter, transplantation of, into another ureter (AU 12) Y 05804 01FEB1984 Ureter (unilateral), transplantation of, into isolated intestinal loop (AU 14) N 05804 01SEP1989 Ureter, transplantation of, into isolated intestinal segment, unilateral (AU 14) Y 05807 01FEB1984 Ureters (bilateral), transplantation of, into isolated intestinal loop (AU 16) N 05807 01SEP1989 Ureters, transplantation of, into isolated intestinal segment, bilateral (AU 16) Y 05808 01FEB1989 Intestinal urinary reservoir, continent, formation of, including formation of nonreturn valves and implantation of ureters (one or both) into reservoir (AU 27) Y 05809 01FEB1989 Intestinal urinary conduit or ureterostomy, revision of (AU 13) Y 05812 01FEB1984 Ureterotomy, with exploration or drainage, as an independent procedure (AU 11) N 05812 01SEP1989 Ureter, exploration of, with or without drainage of, as an independent procedure (AU 11) Y 05816 01FEB1984 Ureterotomy, with exploration or drainage for tumour, as an independent procedure (AU 11) Y 05821 01FEB1984 Ureterolysis, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition-- unilateral (AU 11) N 05821 01SEP1989 Ureterolysis, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition (AU 11) Y 05827 01FEB1984 Ureterolysis, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition-- bilateral (AU 13) Y 05831 01FEB1984 Reduction ureteroplasty, unilateral (AU 14) N 05831 01SEP1989 Reduction ureteroplasty (AU 14) Y 05836 01FEB1984 Reduction ureteroplasty, bilateral (AU 17) Y 05837 01FEB1984 Closure of cutaneous ureterostomy-- unilateral (AU 9) N 05837 01SEP1989 Closure of cutaneous ureterostomy (AU 9) Y 05840 01FEB1984 Bladder, catheterisation of-- where no other surgical procedure is performed (AU 4) N 05840 01SEP1989 Bladder, catheterisation of , where no other procedure is performed (AU 4) Y 05841 01JAN1986 CYSTOSCOPY and URETEROSCOPY with or without PYELOSCOPY including, where performed, ureteric meatotomy or dilatation of the ureter (not associated with a service covered by Items 5842 to 5888) ANAESTHETIC 5 UNITS - ITEM NOS 406G / 51 OS N 05841 01SEP1989 Ureteroscopy, with or without any one or more of; cystoscopy, ureteric meatotomy, ureteric dilatation and pyeloscopy, not associated with item 5842, 5843, 5845, 5851, 5878 or 5885 (AU 7) Y 05842 01JAN1986 CYSTOSCOPY and URETEROSCOPY with or without PYELOSCOPY including, where performed, ureteric meatotomy or dilatation of the ureter with one or more of the following procedures in the ureter or renal pelvis - biopsy, diathermy, calculus extraction (not associated with a service covered by Item 5841 and Items 5843 to 5888) ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S N 05842 01SEP1989 Ureteroscopy as described in item 5841, plus one or more of extraction of stone, biopsy or diathermy (AU 9) Y 05843 01JAN1986 CYSTOSCOPY and URETEROSCOPY with or without PYELOSCOPY including, where performed, ureteric meatotomy or dilatation of the ureter with ultrasonic or electrohydraulic pulse disintegration of stone in the ureter or renal pelvis (not associated with Items 5841,5842 and 5845 to 5888) ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S N 05843 01SEP1989 Ureteroscopy as described in item 5841, plus destruction of stone with ultrasound, electrohydraulic shock waves, or laser, with extraction of fragments (AU 11) Y 05845 01FEB1984 Cystoscopy, with or without urethral dilatation (AU 5) N 05845 01SEP1989 Cystoscopy with urethroscopy, with or without urethral dilatation, not associated with any other urological endoscopic procedure on the lower urinary tract except item 6070 (AU 5) Y 05846 01DEC1989 CYSTOSCOPY, with or without urethroscopy, for the treatment of penile warts or uretheral warts, not associated with Item 3347 ANAESTHETIC 6 UNIITS - ITEM NOS 407G/513S Y 05847 01FEB1989 Cystoscopy with ureteric catheterisation including imaging of the upper urinary tract, unilateral or bilateral, not associated with item 5851 or 5855 (AU 6) Y 05849 01FEB1989 Cystoscopy with one or more of; ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter or of renal pelvis, unilateral, not associated with item 5851 or 5855 (AU 6) Y 05851 01FEB1984 Cystoscopy, with ureteric catheterisation, with or without introduction of opaque medium (AU 5) N 05851 01SEP1989 Cystoscopy with ureteric catheterisation, unilateral or bilateral, not associated with item 5847 or 5849 (AU 5) Y 05853 01FEB1984 Cystoscopy, with controlled hydrodilatation of the bladder (AU 5) Y 05855 01FEB1989 Cystoscopy, with ureteric meatotomy (AU 5) Y 05861 01FEB1984 Ascending cysto-urethrography (AU 5) Y 05864 01FEB1984 Cystoscopic removal of foreign body (AU 6) N 05864 01SEP1989 Cystoscopy with removal of foreign body (AU 6) Y 05868 01FEB1984 Cystoscopy, with biopsy of bladder tumours (AU 6) N 05868 01SEP1989 Cystoscopy with biopsy of bladder, not associated with item 5845, 5855, 5871, 5875, 5878, 5881, 6005, 6006 or 6027 (AU 6) Y 05871 01FEB1984 Cystoscopy, with diathermy or resection of superficial bladder tumours or with other diathermy of bladder or prostate (AU 6) N 05871 01SEP1989 Cystoscopy with resection or diathermy of bladder tumour or other lesion of the bladder or prostate, not associated with item 5875 (AU 6) Y 05872 01DEC1989 CYSTOSCOPY, with lavage of blood clots from bladder including any associated diathermy of prostate or bladder and not associated with Item 5845 and Items 5853 to 5888 and Items 6005 and 6006 ANAESTHETIC 8 UNITS - ITEM NOS 409G I 517S Y 05875 01FEB1984 Cystoscopy with diathermy or resection of invasive bladder tumours or solitary tumour over 2 centimetres in diameter (AU 6) N 05875 01SEP1989 Cystoscopy with diathermy or resection of multiple bladder tumours in more than two quadrants of the bladder or solitary tumour greater than 2 centimetres in diameter (AU 6) Y 05878 01FEB1984 Cystoscopy, with ureteric meatotomy or with resection of ureterocoele (AU 5) N 05878 01MAR1984 Cystoscopy, with ureteric meatotomy or with resection of ureterocele(AU 5) N 05878 01SEP1989 Cystoscopy with resection of ureterocele (AU 5) Y 05879 01FEB1989 Cystoscopy with injection into bladder wall (AU 5) Y 05881 01FEB1984 Cystoscopy with endoscopic resection bladder neck or cystoscopy with endoscopic incision of bladder neck or both of these procedures (AU 7) N 05881 01MAR1984 Cystoscopy with endoscopic resection of bladder neck or cystoscopy with endoscopic incision of bladder neck or both of these procedures (AU 7) N 05881 01SEP1989 Cystoscopy with endoscopic incision or resection of external sphincter, bladder neck or both (AU 7) Y 05883 01FEB1984 Endoscopic external sphincterotomy for neurogenic bladder neck obstruction not associated with Item 5881 (AU 7) Y 05885 01FEB1984 Cystoscopy, with endoscopic removal or manipulation of ureteric calculus (AU 6) N 05885 01SEP1989 Endoscopic manipulation or extraction of ureteric calculus (AU 6) Y 05886 01FEB1989 Endoscopic examination of intestinal conduit or reservoir (AU 5) Y 05888 01FEB1984 Litholapaxy, with or without cystoscopy (AU 7) N 05888 01MAR1984 Litholapaxy, with or without cystoscopy (AU 7) 235.00 235.00 235.00 235.00 235.00 235.00 Operations on the Bladder (Open) Y 05889 01FEB1989 Bladder, partial excision of (AU 13) Y 05891 01FEB1984 Bladder, repair of rupture of, or partial excision of, or plastic repair of (G) (AU 13) N 05891 01SEP1989 Bladder, repair of rupture (G) (AU 13) Y 05894 01FEB1984 Bladder, repair of rupture of, or partial excision of, or plastic repair of (S) (AU 13) N 05894 01SEP1989 Bladder, repair of rupture (S) (AU 13) Y 05897 01FEB1984 Cystostomy or cystotomy, suprapubic (not covered by Item 5903) (G) (AU 8) N 05897 01SEP1989 Cystostomy or cystotomy, suprapubic, not covered by item 5903 and not associated with other open bladder procedure (G) (AU 8) Y 05901 01FEB1984 Cystostomy or cystotomy, suprapubic (not covered by Item 5903) (S) (AU 8) N 05901 01SEP1989 Cystostomy or cystotomy, suprapubic, not covered by item 5903 and not associated with other open bladder procedure (S) (AU 8) Y 05903 01FEB1984 Suprapubic stab cystotomy (AU 6) Y 05905 01FEB1984 Bladder, total excision of (AU 29) Y 05906 01NOV2006 Professional attendance of not more than 5 minutes duration SURGERY CONSULTATION(Professional attendance at consulting rooms) Y 05908 01NOV2006 Professional attendance of more than 5 minutes duration but not more than 20 minutes duration SURGERY CONSULTATION (Professional attendance at consulting rooms) Y 05910 01NOV2006 Professional attendance of more than 20 minutes duration but not more than 40 minutes duration SURGERY CONSULTATION(Professional attendance at consulting rooms) Y 05912 01NOV2006 Professional attendance of more than 40 minutes duration SURGERY CONSULTATION (Professional attendance at consulting rooms) Y 05916 01FEB1984 Bladder neck contracture, operation for (AU 9) Y 05919 01FEB1984 Bladder tumours, suprapubic diathermy of (AU 10) Y 05929 01FEB1984 Diverticulum of bladder, excision or obliteration of (AU 10) N 05929 01SEP1989 Bladder diverticulum, excision or obliteration of (AU 10) Y 05935 01FEB1984 Vesical fistula, cutaneous, operation for (AU 12) Y 05936 01FEB1989 Cutaneous vesicostomy, establishment of (AU 9) Y 05941 01FEB1984 Vesico-vaginal fistula, closure of by abdominal approach (AU 12) Y 05942 01FEB1989 Vesico-vaginal fistula, closure of, synchronous combined approach, abdominal component, including aftercare (AU 12) Y 05943 01FEB1989 Vesico-vaginal fistula, closure of, synchronous combined approach, vaginal component, including aftercare Y 05947 01FEB1984 Vesico-colic fistula, closure of, excluding bowel resection (AU 11) N 05947 01SEP1989 Vesico-intestinal fistula, closure of, excluding bowel resection (AU 11) Y 05956 01FEB1984 Vesico-rectal fistula, closure of (AU 13) Y 05964 01FEB1984 Bladder aspiration, by needle Y 05968 01FEB1984 Cystotomy, with removal of calculus, as an independent procedure (AU 8) Y 05977 01FEB1984 Urethropexy (Marshall-Marchetti operation) (AU 9) N 05977 01SEP1989 Bladder stress incontinence, suprapubic procedure for, not covered by item 6406 (AU 9) Y 05981 01FEB1984 Bladder enlargement using intestine or segment of bowel (AU 23) N 05981 01SEP1989 Bladder enlargement using intestine (AU 23) Y 05982 01FEB1989 Bladder extrophy closure, not involving sphincter reconstruction (AU 14) Y 05984 01FEB1984 Correction of vesico-ureteric reflux-- operation for-- unilateral (AU 12) Y 05993 01FEB1984 Correction of vesico-ureteric reflux-- operation for-- bilateral (AU 14) Y 06001 01FEB1984 Prostatectomy (suprapubic, perineal or retropubic) (AU 13) N 06001 01SEP1989 Prostatectomy, open (AU13) Y 06004 01JAN2013 Initial professional attendance of 10 minutes or less in duration on a patient by a specialist practising in his or her specialty of neurosurgery if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 06005 01FEB1984 Prostatectomy (endoscopic), with or without cystoscopy (AU 10) N 06005 01SEP1989 Prostatectomy (endoscopic), with or without cystoscopy, and with or without urethroscopy, and including services covered by item 6039, 6066 or 6069 (AU 10) Y 06006 01FEB1989 Prostatectomy (endoscopic), with or without cystoscopy, and with or without urethroscopy, and including services covered by items 6039, 6066 and 6069, continuation of, within 10 days of initial procedure which had to be discontinued for medical reasons (AU 9) Y 06007 01NOV2006 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance (other than a second or subsequent attendance in a single course of treatment) at consulting rooms or hospital N 06007 01NOV2019 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance (other than a second or subsequent attendance in a single course of treatment) at consulting rooms or hospital Y 06009 01NOV2006 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-a minor attendance after the first in a single course of treatment at consulting rooms or hospital N 06009 01NOV2019 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-a minor attendance after the first in a single course of treatment at consulting rooms or hospital Y 06010 01FEB1984 Median bar, endoscopic resection of, with or without cystoscopy (AU 9) Y 06011 01NOV2006 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance after the first in a single course of treatment, involving an extensive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 15 minutes in duration but not more than 30 minutes in duration at consulting rooms or hospital N 06011 01NOV2019 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving an extensive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 15 minutes in duration but not more than 30 minutes in duration at consulting rooms or hospital Y 06013 01NOV2006 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance after the first in a single course of treatment, involving a detailed and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 30 minutes in duration but not more than 45 minutes in duration at consulting rooms or hospital N 06013 01NOV2019 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving a detailed and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 30 minutes in duration but not more than 45 minutes in duration at consulting rooms or hospital Y 06015 01NOV2006 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to him or her-an attendance after the first in a single course of treatment, involving an exhaustive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 45 minutes in duration at consulting rooms or hospital N 06015 01NOV2019 Professional attendance by a specialist in the practice of neurosurgery following referral of the patient to the specialist-an attendance after the first in a single course of treatment, involving an exhaustive and comprehensive examination, arranging any necessary investigations in relation to one or more complex problems and of more than 45 minutes in duration at consulting rooms or hospital Y 06016 01JUL2011 The initiation of a professional attendance via video conference rendered by a specialist practising in the specialty of neurosurgery to a patient who is: a)a care recipient receiving care in a residential aged care service; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; or b)located outside an inner metropolitan area, not being an admitted patient; being a service associated with item 6007, 6009, 6011, 6013 or 6015. N 06016 01NOV2012 Professional attendance on a patient by a specialist practising in his or her specialty of neurosurgery if: (a)the attendance is by video conference; and (b)item 6007, 6009, 6011, 6013 or 6015 applies to the attendance; and (c)the patient is not an admitted patient; and (d)the patient: (i)is located both: (A) outside an inner metropolitan area; and (B)at the time of the attendance-at least 15 kms by road from the specialist; or (ii)is a care recipient in a residential care service; or (iii)is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19 (2) of the Act applies N 06016 01JAN2013 Professional attendance on a patient by a specialist practising in his or her specialty of neurosurgery if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6007 lasting more than 10 minutes; or (ii) provided with item 6009, 6011, 6013 or 6015; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies N 06016 01NOV2019 Professional attendance on a patient by a specialist practising in the specialist's specialty of neurosurgery if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6007 lasting more than 10 minutes; or (ii) provided with item 6009, 6011, 6013 or 6015; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 kms by road from the specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies Y 06017 01FEB1984 Prostate, total excision of (AU 13) Y 06018 01NOV2016 Professional attendance by an addiction medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided N 06018 01NOV2019 Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty following referral of the patient to the addiction medicine specialist by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided Y 06019 01NOV2016 Professional attendance by an addiction medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6018 in a single course of treatment; or (b) that follows an initial assessment under item 6023 in a single course of treatment; or (c) that follows a review under item 6024 in a single course of treatment N 06019 01NOV2019 Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty following referral of the patient to the addiction medicine specialist by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6018 in a single course of treatment; or (b) that follows an initial assessment under item 6023 in a single course of treatment; or (c) that follows a review under item 6024 in a single course of treatment Y 06022 01FEB1984 Prostate, open perineal biopsy of (AU 6) N 06022 01SEP1989 Prostate, open perineal biopsy or open drainage of abscess (AU 6) Y 06023 01NOV2016 Professional attendance by an addiction medicine specialist in the practice of his or her specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to him or her by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) an addiction medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same addiction medicine specialist N 06023 01NOV2019 Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to the addiction medicine specialist by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) an addiction medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same addiction medicine specialist Y 06024 01NOV2016 Professional attendance by an addiction medicine specialist in the practice of his or her specialty of at least 20 minutes after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified addiction medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) item 6023 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same addiction medicine specialist who claimed item 6023 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period N 06024 01MAY2017 Professional attendance by an addiction medicine specialist in the practice of his or her specialty of at least 20 minutes, after the first attendance in a single course of treatment, for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified addiction medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) item 6023 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same addiction medicine specialist who claimed item 6023 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period N 06024 01NOV2019 Professional attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty of at least 20 minutes, after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified addiction medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6018 or 6019 applies did not take place on the same day by the same addiction medicine specialist; and (d) item 6023 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same addiction medicine specialist who claimed item 6023 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period Y 06025 01NOV2016 Initial professional attendance of 10 minutes or less, on a patient by an addiction medicine specialist in the practice of his or her specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 06025 01NOV2019 Initial professional attendance of 10 minutes or less, on a patient by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 06026 01NOV2016 Professional attendance on a patient by an addiction medicine specialist in the practice of his or her specialty, if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6018 or 6019 and lasting more than 10 minutes; or (ii) provided with item 6023 or 6024; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies N 06026 01NOV2019 Professional attendance on a patient by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6018 or 6019 and lasting more than 10 minutes; or (ii) provided with item 6023 or 6024; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the addiction medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies Y 06027 01FEB1984 Prostate, biopsy of, endoscopic, with or without cystoscopy (AU 6) Y 06028 01NOV2016 Group therapy (including any associated consultation with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour, given under the continuous direct supervision of an addiction medicine specialist in the practice of his or her specialty for a group of 2 to 9 unrelated patients, or a family group of more than 2 patients, each of whom is referred to the addiction medicine specialist by a referring practitioner-for each patient N 06028 01NOV2019 Group therapy (including any associated consultation with a patient taking place on the same occasion and relating to the condition for which group therapy is conducted) of not less than 1 hour, given under the continuous direct supervision of an addiction medicine specialist in the practice of the addiction medicine specialist's specialty for a group of 2 to 9 unrelated patients, or a family group of more than 2 patients, each of whom is referred to the addiction medicine specialist by a referring practitioner-for each patient Y 06029 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team N 06029 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team Y 06030 01FEB1984 Prostate, needle biopsy of, or injection into (AU 5) Y 06031 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team N 06031 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team Y 06032 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team N 06032 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team Y 06033 01FEB1984 Prostatic abscess, retropubic or endoscopic drainage of (AU 7) N 06033 01SEP1989 Prostatic abscess, endoscopic drainage of (AU 7) Y 06034 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate the multidisciplinary case conference of at least 45 minutes, with the multidisciplinary case conference team N 06034 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate the multidisciplinary case conference of at least 45 minutes, with the multidisciplinary case conference team Y 06035 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team N 06035 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team Y 06036 01FEB1984 Urethral sounds, passage of, as an independent procedure (AU 5) Y 06037 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team N 06037 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team Y 06038 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team N 06038 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team Y 06039 01FEB1984 Urethral stricture, dilatation of (AU 5) Y 06040 01FEB1989 Urethra, repair of rupture of distal section (AU 9) Y 06041 01FEB1984 Urethra, repair of rupture of (AU 10) N 06041 01SEP1989 Urethra, repair of rupture of prostatic or membranous segment (AU 10) Y 06042 01NOV2016 Attendance by an addiction medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team N 06042 01NOV2019 Attendance by an addiction medicine specialist in the practice of the addiction medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team Y 06044 01FEB1984 Urethral fistula, closure of (AU 8) Y 06047 01FEB1984 Urethroscopy, as an independent procedure (AU 5) Y 06050 01DEC1991 [Unidentified item] Y 06051 01NOV2016 Professional attendance by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided N 06051 01NOV2019 Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner, if the attendance: (a) includes a comprehensive assessment; and (b) is the first or only time in a single course of treatment that a comprehensive assessment is provided Y 06052 01NOV2016 Professional attendance by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6051 in a single course of treatment; or (b) that follows an initial assessment under item 6057 in a single course of treatment; or (c) that follows a review under item 6058 in a single course of treatment N 06052 01NOV2019 Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner, if the attendance is a patient assessment: (a) before or after a comprehensive assessment under item 6051 in a single course of treatment; or (b) that follows an initial assessment under item 6057 in a single course of treatment; or (c) that follows a review under item 6058 in a single course of treatment Y 06053 01FEB1984 Urethroscopy, with diathermy of tumour (AU 7) N 06053 01SEP1989 Urethroscopy, with any one or more of; biopsy, diathermy or removal of foreign body or stone (AU 7) Y 06056 01FEB1984 Urethroscopy, with removal of stone or foreign body (AU 6) Y 06057 01NOV2016 Professional attendance by a sexual health medicine specialist in the practice of his or her specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to him or her by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a sexual health medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same sexual health medicine specialist N 06057 01NOV2019 Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty of at least 45 minutes for an initial assessment of a patient with at least 2 morbidities, following referral of the patient to the sexual health medicine specialist by a referring practitioner, if: (a) an assessment is undertaken that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) a comprehensive multi or detailed single organ system assessment; and (iii) the formulation of differential diagnoses; and (b) a sexual health medicine specialist treatment and management plan of significant complexity that includes the following is prepared and provided to the referring practitioner: (i) an opinion on diagnosis and risk assessment; (ii) treatment options and decisions; (iii) medication recommendations; and (c) an attendance on the patient to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) neither this item nor item 132 has applied to an attendance on the patient in the preceding 12 months by the same sexual health medicine specialist Y 06058 01NOV2016 Professional attendance by sexual health medicine specialist in the practice of his or her specialty of at least 20 minutes after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified sexual health medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient, being an attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) item 6057 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same sexual health medicine specialist who claimed item 6057 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period N 06058 01MAY2017 Professional attendance by a sexual health medicine specialist in the practice of his or her specialty of at least 20 minutes, after the first attendance in a single course of treatment, for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified sexual health medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient, being an attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) item 6057 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same sexual health medicine specialist who claimed item 6057 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period N 06058 01NOV2019 Professional attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty of at least 20 minutes, after the first attendance in a single course of treatment for a review of a patient with at least 2 morbidities if: (a) a review is undertaken that covers: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv) review of original and differential diagnoses; and (b) the modified sexual health medicine specialist treatment and management plan is provided to the referring practitioner, which involves, if appropriate: (i) a revised opinion on diagnosis and risk assessment; and (ii) treatment options and decisions; and (iii) revised medication recommendations; and (c) an attendance on the patient, being an attendance to which item 104, 105, 110, 116, 119, 132, 133, 6051 or 6052 applies did not take place on the same day by the same sexual health medicine specialist; and (d) item 6057 applied to an attendance claimed in the preceding 12 months; and (e) the attendance under this item is claimed by the same sexual health medicine specialist who claimed item 6057 or by a locum tenens; and (f) this item has not applied more than twice in any 12 month period Y 06059 01NOV2016 Initial professional attendance of 10 minutes or less, on a patient by a sexual health medicine specialist in the practice of his or her specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment N 06059 01NOV2019 Initial professional attendance of 10 minutes or less, on a patient by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19(2) of the Act applies; and (d) no other initial consultation has taken place for a single course of treatment Y 06060 01NOV2016 Professional attendance on a patient by a sexual health medicine specialist in the practice of his or her specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6051 or 6052 and lasting more than 10 minutes; or (ii) provided with item 6057 or 6058; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies N 06060 01NOV2019 Professional attendance on a patient by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty if: (a) the attendance is by video conference; and (b) the attendance is for a service: (i) provided with item 6051 or 6052 and lasting more than 10 minutes; or (ii) provided with item 6057 or 6058; and (c) the patient is not an admitted patient; and (d) the patient: (i) is located both: (A) within a telehealth eligible area; and (B) at the time of the attendance-at least 15 km by road from the sexual health medicine specialist; or (ii) is a care recipient in a residential care service; or (iii) is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service; for which a direction made under subsection 19 (2) of the Act applies Y 06061 01FEB1984 Urethra, examination of, involving the use of urethroscope, with cystoscopy (AU 5) Y 06062 01NOV2016 Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner-initial attendance in a single course of treatment N 06062 01NOV2019 Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner-initial attendance in a single course of treatment Y 06063 01NOV2016 Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of his or her specialty following referral of the patient to him or her by a referring practitioner-each attendance after the attendance under item 6062 in a single course of treatment N 06063 01NOV2019 Professional attendance at a place other than consulting rooms or a hospital by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty following referral of the patient to the sexual health medicine specialist by a referring practitioner-each attendance after the attendance under item 6062 in a single course of treatment Y 06064 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team N 06064 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of less than 15 minutes, with the multidisciplinary case conference team Y 06065 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team N 06065 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team Y 06066 01FEB1984 Urethral meatotomy, external (AU 4) Y 06067 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team N 06067 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team Y 06068 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team N 06068 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to organise and coordinate a community case conference of at least 45 minutes, with the multidisciplinary case conference team Y 06069 01FEB1984 Urethrotomy, external or internal (AU 5) N 06069 01SEP1989 Urethrotomy or urethrostomy, internal or external (AU 5) Y 06070 01FEB1989 Urethrotomy, optical, for urethral stricture (AU 5) Y 06071 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team N 06071 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of less than 15 minutes, with the multidisciplinary case conference team Y 06072 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team N 06072 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 15 minutes but less than 30 minutes, with the multidisciplinary case conference team Y 06074 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team N 06074 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 30 minutes but less than 45 minutes, with the multidisciplinary case conference team Y 06075 01NOV2016 Attendance by a sexual health medicine specialist in the practice of his or her specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team N 06075 01NOV2019 Attendance by a sexual health medicine specialist in the practice of the sexual health medicine specialist's specialty, as a member of a multidisciplinary case conference team of at least 2 other formal care providers of different disciplines, to participate in a community case conference (other than to organise and coordinate the conference) of at least 45 minutes, with the multidisciplinary case conference team Y 06077 01FEB1984 Urethrectomy, partial or complete, for removal of tumour (AU 9) Y 06079 01FEB1984 Urethro-vaginal fistula, closure of (AU 9) Y 06080 01NOV2017 Coordination of a TAVI Case Conference by a TAVI Practitioner where the TAVI Case Conference has a duration of 10 minutes or more. (Not payable more than once per patient in a five year period.) Y 06081 01NOV2017 Attendance at a TAVI Case Conference by a specialist or consultant physician who does not also perform the service described in item 6080 for the same case conference where the TAVI Case Conference has a duration of 10 minutes or more. (Not payable more than twice per patient in a five year period.) Y 06083 01FEB1984 Urethro-rectal fistula, closure of (AU 10) Y 06085 01JUL1985 PERIURETHRAL TEFLON INJECTION for urinary incontinence including cystoscopy and urethroscopy ANAESTHETIC 5 UNITS - ITEM NOS 406G / 51 OS N 06085 01SEP1989 Peri-urethral injection of Teflon, including urethroscopy and cystoscopy (AU 5) Y 06086 01FEB1984 Urethroplasty-- single stage operation (AU 10) Y 06087 01OCT2017 A professional attendance, including by telephone or videoconference, on a patient participating in the Health Care Homes Program by or on behalf of a medical practitioner (including a general practitioner but not including a specialist or consultant physician) or participating nurse practitioner employed or otherwise engaged by the Health Care Home trial site at which the patient is enrolled - each patient. The service must be provided to the patient for the purposes of the Health Care Homes Program and the service may be provided to the patient individually or as part of a group. Y 06089 01FEB1984 Urethroplasty-- two stage operation-- first stage (AU 9) Y 06091 01DEC1991 [Unidentified item] Y 06092 01FEB1984 Urethroplasty-- two stage operation-- second stage (AU 9) Y 06093 01DEC1991 [Unidentified item] Y 06094 01DEC1991 [Unidentified item] Y 06095 01FEB1984 Urethroplasty, not covered by any other item in this Part (AU 9) Y 06098 01FEB1984 Hypospadias, meatotomy and hemicircumcision (AU 7) Y 06100 01FEB1989 Hypospadias, glanuloplasty incorporating meatal advancement (AU 8) Y 06105 01FEB1984 Hypospadias, correction of chordee (AU 10) Y 06107 01FEB1984 Hypospadias, correction of chordee with transplantation of prepuce (AU 10) N 06107 01SEP1989 Hypospadias or epispadias, with or without chordee, correction of, as a staged procedure, first stage (AU 10) Y 06110 01FEB1984 Hypospadias, urethral reconstruction for, with or without urinary diversion (AU 11) N 06110 01SEP1989 Hypospadias or epispadias, with or without chordee, correction of, as a staged procedure, second stage (AU 11) Y 06118 01FEB1984 Hypospadias, urethral reconstruction and correction of chordee, complete, one stage including urinary diversion (AU 13) N 06118 01SEP1989 Hypospadias or epispadias, with or without chordee, correction of, as one stage procedure, not covered by item 6100 (AU 13) Y 06122 01FEB1984 Hypospadias, secondary correction of (AU 9) Y 06130 01FEB1984 Epispadias, repair of, not involving sphincter-- each stage (AU 9) Y 06135 01FEB1984 Epispadias, repair of, including bladder neck closure (AU 10) Y 06140 01FEB1984 Urethra, diathermy of (AU 4) Y 06146 01FEB1984 Urethra, excision of prolapse of (AU 7) Y 06152 01FEB1984 Urethra, excision of diverticulum of (AU 8) N 06152 01SEP1989 Urethral diverticulum, excision of (AU 8) Y 06155 01FEB1989 Urethral sphincter, reconstruction by bladder tubularisation technique or similar procedure (AU 16) Y 06157 01FEB1984 Urethra, operation for correction of male urinary incontinence (AU 9) N 06157 01SEP1989 Urethra, operation for correction of male urinary incontinence, not covered by item 6158 or 6161 (AU 9) Y 06158 01FEB1989 Artificial urinary sphincter, insertion of cuff, perineal approach (AU 10) Y 06159 01FEB1989 Artificial urinary sphincter, insertion of cuff, abdominal approach (AU 16) Y 06160 01FEB1989 Artificial urinary sphincter, insertion of pressure regulating balloon and pump (AU 8) Y 06161 01FEB1989 Artificial urinary sphincter, revision or removal of, with or without replacement (AU 12) Y 06162 01FEB1984 Priapism, decompression operation for, under general anaesthesia (AU 7) N 06162 01SEP1989 Priapism, decompression by glanular stab cavernosospongiosum shunt (AU 7) Y 06166 01FEB1984 Priapism, decompression shunt operation for (AU 10) N 06166 01SEP1989 Priapism, shunt operation for, not covered by item 6162 (AU 10) Y 06175 01FEB1984 Urethral valves or urethral membrane, endoscopic resection of (AU 7) N 06175 01SEP1989 Urethral valve, destruction of, including cystoscopy and urethroscopy (AU 7) Y 06179 01FEB1984 Penis, partial amputation of (AU 8) Y 06184 01FEB1984 Penis, complete or radical amputation of (AU 12) Y 06189 01FEB1984 Penis, repair of laceration or fracture involving cavernous tissue (AU 8) N 06189 01SEP1989 Penis, repair of laceration of cavernous tissue, or fracture involving cavernous tissue (AU 8) Y 06194 01FEB1984 Penis, repair of avulsion (AU 12) N 06194 01DEC1985 PENIS, repair of avulsion ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S Y 06199 01FEB1984 Penis, Peyronie's disease, injection procedure for N 06199 01MAR1984 Penis, Peyronie's disease, injection procedure for 6204 N 06199 01SEP1989 Penis, injection of, for investigation or treatment of impotence, priapism or Peyronie's plaque Y 06204 01FEB1984 Penis, Peyronie's disease, operation for (AU 8) N 06204 01SEP1989 Penis, correction of chordee, with or without excision of fibrous plaque or plaques and with or without grafting (AU 8) Y 06205 01FEB1989 Penis, surgery to inhibit rapid penile drainage causing impotence, by ligation of deep veins to Bucks fascia including one or deep cavernosal veins, with or without pharmological test (AU 7) Y 06207 01FEB1989 Penis, lengthening by translocation of corpora (AU 14) Y 06208 01FEB1984 Penis, plastic implantion of (AU 8) N 06208 01SEP1989 Penis, artificial erection device, insertion of, into one or both corpora (AU 8) Y 06210 01FEB1984 Penis, lengthening of by translocation of corpora, as an independent procedure (AU 8) Y 06212 01FEB1984 Scrotum, partial excision of (AU 7) Y 06213 01FEB1989 Penis, artificial erection device, insertion of pump and pressure regulating reservoir (AU 11) Y 06214 01FEB1989 Penis, artificial erection device, complete or partial revision or removal of components, with or without replacement (AU 11) Y 06215 01FEB1989 Penis, frenuloplasty as an independent procedure (AU 5) Y 06216 01FEB1989 Scrotum, partial excision of (AU 7) Y 06218 01FEB1984 Testicular biopsy (AU 6) Y 06221 01FEB1984 Spermatocele or epididymal cysts, excision of (G) (AU 6) N 06221 01SEP1989 Spermatocele or epididymal cyst, excision of, one or both (G) (AU 6) Y 06224 01FEB1984 Spermatocele or epididymal cysts, excision of (S) (AU 6) N 06224 01SEP1989 Spermatocele or epididymal cyst, excision of, one or both (S) (AU 6) Y 06228 01FEB1984 Exploration of the testis, with or without fixation for torsion (AU 5) N 06228 01SEP1989 Exploration of scrotal contents, with or without fixation and with or without biopsy (AU 5) Y 06231 01FEB1984 Retroperitoneal lymph node dissection following orchidectomy (unilateral) (AU 12) N 06231 01SEP1989 Retroperitoneal lymph node dissection, unilateral, as an independent procedure (AU 12) Y 06232 01FEB1984 Retroperitoneal lymph node dissection following nephrectomy for tumour (AU 12) Y 06233 01NOV1979 Orchidoplasty (AU 8) Y 06234 01FEB1989 Retroperitoneal lymph node dissection, unilateral, as an independent procedure, following previous similar retroperitoneal dissection, retroperitoneal irradiation or chemotherapy (AU 24) Y 06236 01FEB1984 Epididymectomy (AU 8) Y 06245 01FEB1984 Vaso-vasostomy or vaso-epididymostomy, unilateral, using operating microscope (AU 14) N 06245 01MAR1984 Vaso-vasostomy or vaso-epididymostomy, unilateral, using the operating microscope(AU 14) Y 06246 01FEB1984 Vasoepididymography and vasovesiculography, preparation for, by open operation, as an independent procedure (AU 5) Y 06247 01FEB1984 Vaso-vasostomy or vaso-epididymostomy (unilateral) (AU 9) Y 06249 01FEB1984 Vasotomy or vasectomy (unilateral or bilateral) (G) (AU 5) Y 06253 01FEB1984 Vasotomy or vasectomy (unilateral or bilateral) (S) (AU 5) Y 06258 01FEB1984 Gynaecological examination under anaesthesia, not associated with any other item in this Part (AU 5) Y 06262 01FEB1984 Intra-uterine contraceptive device, introduction of, not associated with any other item in this Part, or removal of under general anaesthesia, not associated with any other item in this Part (AU 5) N 06262 01MAR1984 Intra-uterine contraceptive device, introduction of, not associated with any other item in this Part (AU 5) Y 06264 01FEB1984 Intra-uterine contraceptive device, removal of under general anaesthesia, not associated with any other item in this Part (AU 5) Y 06271 01FEB1984 Hymenectomy (AU 5) Y 06274 01FEB1984 Bartholin's cyst, excision of (G) (AU 7) Y 06277 01FEB1984 Bartholin's cyst, excision of (S) (AU 7) Y 06278 01FEB1984 Bartholin's cyst or gland, marsupialisation of (G) (AU 6) Y 06280 01FEB1984 Bartholin's cyst or gland, marsupialisation of (S) (AU 6) Y 06284 01FEB1984 Bartholin's abscess, incision of (AU 5) Y 06290 01FEB1984 Urethra or urethral caruncle, cauterisation of (AU 4) Y 06292 01FEB1984 Urethral caruncle, excision of (G) (AU 6) Y 06296 01FEB1984 Urethral caruncle, excision of (S) (AU 6) Y 06299 01FEB1984 Clitoris, amputation of (AU 7) N 06299 01SEP1989 Clitoris, amputation of, where medically indicated (AU 7) Y 06301 01SEP1989 Vulvoplasty or labioplasty, where medically indicated, not associated with Item 6302 (AU 9) Y 06302 01FEB1984 Vulvectomy (simple), vulvoplasty or labioplasty (AU 9) N 06302 01SEP1989 Vulva, wide local excision of suspected malignancy; or hemivulvecomy; or superficial vulvectomy, (including colposcopically directed CO2 laser), one or more procedures (AU 9) Y 06303 01AUG1988 Colposcopically directed CO2 laser therapy for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsies-one anatomical site (AU 5) Y 06304 01AUG1988 Colposcopically directed CO2 laser therapy for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsies-two or more anatomical sites (AU 6) Y 06305 01AUG1988 Colposcopically directed CO2 laser therapy for condylomata, unsuccessfully treated by other methods (AU 6) Y 06306 01FEB1984 Vulvectomy (radical) (AU 16) Y 06307 01SEP1989 Vulvectomy (radical) for malignancy (AU 17) Y 06308 01FEB1984 Pelvic lymph glands, excision of (radical) (AU 15) Y 06313 01FEB1984 Vagina, dilatation of, as an independent procedure including any associated consultation (AU 4) Y 06321 01FEB1984 Vagina, removal of simple tumour-- (including Gartner duct cyst) (AU 8) Y 06325 01FEB1984 Vagina, complete removal of (AU 13) N 06325 01MAR1984 Vagina, partial or complete removal of(AU 13) Y 06327 01FEB1984 Vaginal reconstruction for congenital absence, gynatresia or urogenital sinus (AU 18) Y 06332 01FEB1984 Vaginal septum, excision of, for correction of double vagina (AU 12) Y 06336 01FEB1984 Plastic repair to enlarge vaginal orifice (AU 9) Y 06342 01FEB1984 Colpotomy or colporrhaphy, not covered by any other item in this Part (AU 6) N 06342 01SEP1989 Colpotomy, not covered by any other item in this Part (AU 6) Y 06347 01FEB1984 Cystocele or rectocele, repair of, not covered by Item 6358, 6363, 6367 or 6373 (G) (AU 10) N 06347 01MAR1984 Anterior vaginal repair or posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6358, 6363, 6367 or 6373 (G)(AU 10) Y 06352 01FEB1984 Cystocele or rectocele, repair of, not covered by Item 6358, 6363, 6367 or 6373 (S) (AU 10) N 06352 01MAR1984 Anterior vaginal repair or posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6358, 6363, 6367 or 6373 (S)(AU 10) Y 06358 01FEB1984 Cystocele and rectocele, repair of, not covered by Item 6367 or 6373 (G) (AU 10) N 06358 01MAR1984 Anterior vaginal repair and posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6367 or 6373 (G) (AU 10) Y 06363 01FEB1984 Cystocele and rectocele, repair of, not covered by Item 6367 or 6373 (S) (AU 10) N 06363 01MAR1984 Anterior vaginal repair and posterior vaginal repair (involving repair of rectocele or enterocele or both) not covered by Item 6367 or 6373 (S) (AU 10) Y 06367 01FEB1984 Colpoplasty, Donald-Fothergill or Manchester operation (operation for genital prolapse) (G) (AU 10) N 06367 01MAR1984 Donald-Fothergill or Manchester operation for genital prolapse (G)(AU 10) Y 06373 01FEB1984 Colpoplasty, Donald-Fothergill or Manchester operation (operation for genital prolapse) (S) (AU 10) N 06373 01MAR1984 Donald-Fothergill or Manchester operation for genital prolapse (S)(AU 10) Y 06389 01FEB1984 Urethrocele, operation for (AU 9) Y 06396 01FEB1984 Operation involving abdominal approach for repair of enterocoele or suspension of vaginal vault or enterocoele and suspension of vaginal vault (AU 9) Y 06398 01FEB1989 Vaginal repair of enterocele with or without repair of rectocele, not associated with item 6347, 6352, 6358, 6363, 6367, 6373, 6396, 6518, 6519 or 6544, and where on a previous occasion there had been performed surgery reflected by a procedure in item 6347, 6352, 6458, 6363, 6367, 6373, 6396, 6518, 6519 or 6544 (AU 8) Y 06401 01FEB1984 Fistula between genital and urinary or alimentary tracts, repair of, not covered by Item 5941, 6079 or 6083 (AU 13) Y 06406 01FEB1984 Stress incontinence, sling operation for (AU 12) Y 06407 01FEB1984 Stress incontinence, combined synchronous abdomino-vaginal operation for; abdominal procedure (including after-care) (AU 12) Y 06408 01FEB1984 Stress incontinence, combined synchronous abdomino-vaginal operation for; vaginal procedure (including after-care) Y 06411 01FEB1984 Cervix, cauterisation, ionisation, diathermy or biopsy of, with or without removal of cervical polyp and with or without dilatation of cervix (AU 5) N 06411 01MAR1984 Cervix, cauterisation(other than by by chemical means) ionisation, diathermy or biopsy of, with or without removal of cervical polyp, and with or without dilatation of cervix (AU 5) N 06411 01SEP1989 Cervix, cauterisation (other than by chemical means), ionisation, diathermy or biopsy of, with or without dilatation of cervix (AU 5) Y 06413 01NOV1986 CERVIX, removal of polyp or polypi, with or without dilatation of cervix, not associated with item 6411 ANAESTHETIC 5 UNITS - ITEM NOS 406G / 5108 N 06413 01SEP1989 Cervix, removal of polyp or polypi, with or without dilatation of cervix, not associated with item 6411 (AU 5) Y 06415 01FEB1984 Examination of the uterine cervix by a magnifying colposcope of the Hinselmann type or similar instrument (AU 5) N 06415 01MAR1984 Examination of lower female genital tract by a Hinselmann-type colposcope in a patient with a previous abnormal cervical smear or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner (AU 5) Y 06430 01FEB1984 Cervix, cone biopsy, amputation or repair of, not covered by Item 6367 or 6373 (G) (AU 7) N 06430 01MAR1984 Cervix, cone biopsy, amputation or repair of, not covered by Item 6367 Y 06431 01FEB1984 Cervix, cone biopsy, amputation or repair of, not covered by Item 6367 or 6373 (S) (AU 7) Y 06446 01FEB1984 Cervix, dilatation of, under general anaesthesia, not covered by Item 6460,6464 or 6469 (AU 5) Y 06447 01SEP1989 Endometrial biopsy where malignancy is suspected in patients with abnormal uterine bleeding or post menopausal bleeding (AU 5) Y 06451 01FEB1984 Hysteroscopy under general anaesthesia or culdoscopy (AU 7) N 06451 01SEP1989 Hysteroscopy with dilatation of cervix under general anaesthesia (AU 7) Y 06452 01SEP1989 Hysteroscopy with endometrial biopsy or suction curettage, or both (AU 7) Y 06453 01SEP1989 Hysteroscopy with uterine adhesiolysis or polypectomy or tubal catheterization or removal of IUD which cannot be removed by other means, one or more of (AU 8) Y 06454 01SEP1989 Hysteroscopy and laparoscopy under general anaesthesia involving either myomectomy or resection of uterine septum, or both (AU 10) Y 06460 01FEB1984 Uterus, curettage of, under general anaesthesia, with or without dilatation (including curettage for incomplete miscarriage) (G) (AU 5) N 06460 01SEP1989 Uterus, curettage of, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day-hospital facility (G) (AU 5) Y 06464 01FEB1984 Uterus, curettage of, under general anaesthesia, with or without dilatation (including curettage for incomplete miscarriage) (S) (AU 5) N 06464 01SEP1989 Uterus, curettage of, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day-hospital facility (S) (AU 5) Y 06469 01FEB1984 Evacuation of the contents of the gravid uterus by curettage or suction curettage not covered by Item 6460 or 6464 (AU 5) Y 06483 01FEB1984 Uterus, curettage of, with colposcopy, cervical biopsy and radical diathermy (AU 8) N 06483 01SEP1989 Uterus-colposcopy, cervical biopsy and radical diathermy of (AU 8) Y 06508 01FEB1984 Hysterectomy or uterine myomectomy (AU 10) N 06508 01SEP1989 Hysterotomy or uterine myomectomy, abdominal (AU 10) Y 06513 01FEB1984 Hysterectomy, sub-total or total, by any route (G) (AU 11) N 06513 01SEP1989 Hysterectomy, abdominal, subtotal or total, with or without removal of uterine adnexae (G) (AU 11) Y 06517 01FEB1984 Hysterectomy, sub-total or total, by any route (S) (AU 11) N 06517 01SEP1989 Hysterectomy, vaginal, with or without uterine curettage, not covered by item 6544 (S) (AU 11) Y 06518 01FEB1989 HYSTERECTOMY, VAGINAL, with or without uterine curettage, not covered by Item 6544 ANAESTHETIC]] UNITS - ITEM NOS 453G / 522S (G) Y 06519 01FEB1989 HYSTERECTOMY, VAGINAL, with or without uterine curettage, not covered by Item 6544 ANAESTHETIC]] UNITS - ITEM NOS 453G / 522S (S) Y 06532 01FEB1984 Hysterectomy, abdominal, with enucleation of ovarian cyst, one or both sides (G) (AU 12) N 06532 01SEP1989 Hysterectomy, abdominal, with excision of ovarian, para-ovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries (G) (AU 12) Y 06533 01FEB1984 Hysterectomy, abdominal, with enucleation of ovarian cyst, one or both sides (S) (AU 12) N 06533 01SEP1989 Hysterectomy, abdominal, with excision of ovarian, para-ovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries (S) (AU 12) Y 06536 01FEB1984 Hysterectomy and dissection of pelvic glands (AU 17) N 06536 01SEP1989 Radical hysterectomy with radical excision of pelvic lymph glands (with or without excision of uterine adnexae) for proven malignancy including excision of any one more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum (AU 17) Y 06542 01FEB1984 Radical hysterectomy without gland dissection (AU 12) N 06542 01SEP1989 Radical hysterectomy without gland dissection (with or without excision of uterine adnexae) for proven malignancy including excision of any one or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum (AU 17) Y 06543 01SEP1989 Hysterectomy, abdominal, with radical excision of pelvic lymph glands, with or without removal of uterine adnexae (AU 19) Y 06544 01FEB1984 Hysterectomy, vaginal, with removal of uterine adnexae (AU 12) N 06544 01SEP1989 Hysterectomy, vaginal, (with or without uterine curettage) with salpingectomy, oophorectomy or excision of ovarian cyst, one or more, one or both sides (AU 12) Y 06553 01FEB1984 Ectopic gestation, removal of (G) (AU 9) Y 06557 01FEB1984 Ectopic gestation, removal of (S) (AU 9) Y 06570 01FEB1984 Bicornuate uterus, plastic reconstruction for (AU 14) Y 06585 01FEB1984 Uterus, suspension or fixation of, as an independent procedure (G) (AU 8) Y 06594 01FEB1984 Uterus, suspension or fixation of, as an independent procedure (S) (AU 8) Y 06604 01NOV1979 Laparoscopy, diagnostic, as a diagnostic procedure performed in gynaecology (AU 7) Y 06607 01NOV1979 Laparoscopy involving one or more of biopsy, puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other procedure-- not associated with Item 6611 or 6612 (AU 7) Y 06611 01FEB1984 Sterilisation by transection or resection of fallopian tubes, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method (G) (AU 8) Y 06612 01FEB1984 Sterilisation by transection or resection of fallopian tubes, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method (S) (AU 8) Y 06613 01MAY1990 STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in conjunction with Caesarean section ANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S Y 06631 01FEB1984 Tuboplasty (salpingostomy, salpingolysis, or tubal implantation into uterus), unilateral or bilateral (AU 11) N 06631 01SEP1989 Tuboplasty (salpingostomy, salpingolysis or tubal implantation into uterus), unilateral or bilateral, one or more procedures (AU 11) Y 06632 01AUG1987 MICROSURGICAL TUBOPLASTY (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, one or more procedures ANAESTHETIC 16 UNITS-ITEM NOS 460G/527S N 06632 01SEP1989 Microsurgical tuboplasty (salpingostomy, salpingolysis or tubal implantation into uterus), unilateral or bilateral, one or more procedures (AU 16) Y 06633 01FEB1984 Fallopian tubes, unilateral microsurgical anastomosis of, using operating microscope (AU 18) Y 06638 01FEB1984 Fallopian tubes, hydrotubation of, as an isolated procedure, or Rubin test for patency of (AU 7) N 06638 01MAR1984 Rubin test for patency of Fallopian tubes, or hydrotubation of Fallopian tubes, as a non-repetitive procedure not associated with any other item in this Part (AU 7) N 06638 01SEP1989 Hydrotubation of Fallopian tubes as a non-repetitive procedure not associated with any other item in this Part or Rubin test for patency of Fallopian tubes (AU 7) Y 06639 01MAY1990 RUBINS TEST FOR PATENCY OF FALLOPIAN TUBES ANAESTHETIC 7 UNITS - ITEM NOS 408G I 514S Y 06641 01FEB1984 Fallopian tubes, hydrotubation of, as a repetitive post-operative procedure (AU 7) Y 06643 01FEB1984 Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- one such procedure not associated with hysterectomy (G) (AU 9) N 06643 01MAR1984 Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - one such procedure not associated with hysterectomy (G) (AU 9) Y 06644 01FEB1984 Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- one such procedure not associated with hysterectomy (S) (AU 9) N 06644 01MAR1984 Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - one such procedure not associated with hysterectomy (S) (AU 9) Y 06648 01FEB1984 Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- two or more such procedures, unilateral or bilateral, not associated with hysterectomy (G) (AU 10) N 06648 01MAR1984 Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - two or more such procedures, unilateral or bilateral, not associated with hysterectomy (G) (AU 10) Y 06649 01FEB1984 Laparotomy, involving oophorectomy, salpingectomy, salpingooophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst-- two or more such procedures, unilateral or bilateral, not associated with hysterectomy (S) (AU 10) N 06649 01MAR1984 Laparotomy, involving oophorectomy, salpingectomy, salpingoophorectomy, removal of ovarian, parovarian, fimbrial or broad ligament cyst - two or more such procedures, unilateral or bilateral, not associated with hysterectomy (S) (AU 10) Y 06655 01FEB1984 Radical or debulking operation for ovarian tumour including omentectomy (AU 16) N 06655 01SEP1989 Radical or debulking operation for advanced gynaecological malignancy, with or without omentectomy (AU 16) Y 06657 01AUG1987 LAPAROTOMY, FOR REASSESSMENT ('second look') in the management of ovarian cancer, including associated biopsies and other procedures ANAESTHETIC 13 UNITS-ITEM NOS 457G/524S Y 06658 01SEP1989 Retro-peritoneal lymph node biopsies from above the level of the aortic bifurcation, for staging or restaging of gynaecological malignancy (AU 19) Y 06659 01SEP1989 Infra-colic omentectomy with multiple peritoneal biopsies for staging or restaging of gynaecological malignancy (AU 19) Y 06677 01NOV1979 Pelvic abscess, suprapubic drainage of (G) (AU 8) Y 06681 01NOV1979 Pelvic abscess, suprapubic drainage of (S) (AU 8) Y 06686 01FEB1984 Ophthalmological examination under general anaesthesia, not associated with any other item in this Part (AU 5) Y 06688 01FEB1984 Eye, enucleation of, with or without sphere implant (AU 8) Y 06692 01FEB1984 Eye, enucleation of, with insertion of integrated implant (AU 9) Y 06697 01FEB1984 Globe, evisceration of (AU 8) Y 06699 01FEB1984 Globe, evisceration of, and insertion of intrascleral ball or cartilage (AU 9) Y 06701 01FEB1984 Anophthalmic orbit, insertion of cartilage or artificial implant as a delayed procedure, or removal of implant from socket (AU 9) Y 06703 01FEB1984 Orbit, skin graft to, as a delayed procedure (AU 7) Y 06705 01FEB1984 Contracted socket, reconstruction including mucous membrane grafting and stent mould (AU 11) Y 06707 01FEB1984 Orbit, exploration with or without biopsy, requiring removal of bone (AU 9) Y 06709 01FEB1984 Orbit, exploration of, with drainage or biopsy not requiring removal of bone (AU 8) Y 06715 01FEB1984 Orbit, exenteration of, with or without skin graft and with or without temporalis muscle transplant (AU 11) Y 06722 01FEB1984 Orbit, exploration of, with removal of tumour or foreign body, requiring removal of bone (AU 12) Y 06724 01FEB1984 Orbit, exploration of, with removal of tumour or of foreign body (AU 10) Y 06728 01FEB1984 Eyeball, perforating wound of, not involving intraocular structures-- repair (AU 10) N 06728 01MAR1984 Eyeball, perforating wound of, not involving intraocular structures - repair involving suture of cornea or sclera, or both, not covered by Item 6807 (AU 10) Y 06730 01FEB1984 Eyeball, perforating wound of, with incarceration or prolapse of uveal tissue-- repair (AU 12) Y 06736 01FEB1984 Eyeball, perforating wound of, with incarceration of lens or vitreous-- repair (AU 12) Y 06740 01FEB1984 Intraocular foreign body, magnetic removal from anterior segment (AU 10) Y 06742 01FEB1984 Intraocular foreign body, nonmagnetic removal from anterior segment (AU 11) Y 06744 01FEB1984 Intraocular foreign body, magnetic removal from posterior segment (AU 10) Y 06747 01FEB1984 Intraocular foreign body, nonmagnetic removal from posterior segment (AU 12) Y 06752 01FEB1984 Abscess (intraorbital), drainage of (AU 6) Y 06754 01FEB1984 Tarsal cyst, extirpation of (AU 6) Y 06758 01FEB1984 Tarsal cartilage, excision of (AU 8) Y 06762 01FEB1984 Ectropion, tarsal cauterisation for N 06762 01MAR1984 Ectropion, tarsal cauterisation for 6766 Y 06766 01FEB1984 Tarsorrhaphy (AU 8) Y 06767 01FEB1984 Electrolysis epilation for trichiasis, each treatment (AU 6) N 06767 01SEP1989 Cryotherapy or electrolysis epilation for trichiasis-each treatment (AU 6) Y 06768 01FEB1984 Canthoplasty, medial or lateral (AU 9) Y 06772 01FEB1984 Lacrimal gland, excision of palpebral lobe (AU 8 ) Y 06774 01FEB1984 Lacrimal sac, excision of, or operation on (AU 8) Y 06778 01FEB1984 Dacryocystorhinostomy (AU 11) Y 06786 01FEB1984 Conjunctivorhinostomy including dacryocystorhinostomy and fashioning of conjunctival flaps (AU 12) Y 06792 01FEB1984 Lacrimal canalicular system, reconstruction of (AU 8) N 06792 01SEP1989 Lacrimal canalicular system, establishment of patency by open operation (AU 8) Y 06796 01FEB1984 Lacrimal canaliculus, immediate repair of (AU 8) Y 06799 01FEB1984 Naso-lacrimal duct, probing for obstruction, one or both ducts (AU 4) N 06799 01SEP1989 Nasolacrimal tube (unilateral) replacement of, under general anaesthesia, or lacrimal passages, probing for obstruction, unilateral or bilateral, with or without lavage (AU 4) Y 06802 01FEB1984 Lacrimal passages, lavage of (excluding after-care) (AU 4) N 06802 01SEP1989 Lacrimal passages, lavage of, unilateral, not associated with item 6799 (excluding after-care) (AU 4) Y 06805 01FEB1984 Punctum snip operation (AU 4) Y 06807 01FEB1984 Conjunctival peritomy or repair of corneal laceration by conjunctival flap (AU 6) Y 06810 01FEB1984 Conjunctival graft over cornea (AU 7) Y 06816 01NOV1979 Cornea or sclera, removal of superficial foreign body from (excluding after-care) (AU 6) Y 06818 01FEB1984 Cornea or sclera, removal of imbedded foreign body from (excluding after-care) (AU 8) Y 06820 01FEB1984 Corneal scars, removal of, by partial keratectomy (AU 8) Y 06824 01FEB1984 Cornea, epithelial debridement for dendritic ulcer (excluding after-care) (AU 8) N 06824 01SEP1989 Cornea, epithelial debridement for corneal ulcer or corneal erosion (excluding after-care) (AU 8) Y 06828 01FEB1984 Cornea, transplantation of, full thickness, including collection of implant (AU 13) Y 06832 01FEB1984 Cornea, transplantation of, superficial or lamellar, including collection of transplant (AU 11) Y 06833 01NOV1984 Refractive keratoplasty (excluding radial keratotomy) following corneal grafting or intraocular operation including any measurements and calculations associated with the procedure (AU 10) Y 06835 01FEB1984 Conjunctiva, cautery of, including treatment of pannus-- each attendance at which treatment is given including any associated consultation (AU 4) Y 06837 01FEB1984 Pterygium, removal of (AU 6) Y 06842 01FEB1984 Pinguecula, removal of (AU 6) Y 06846 01FEB1984 Limbic tumour, removal of (AU 7) Y 06848 01FEB1984 Lens extraction (AU 11) Y 06852 01FEB1984 Artificial lens, insertion of (AU 11) Y 06857 01FEB1984 Artificial lens, removal of (AU 9) N 06857 01SEP1989 Artificial lens, removal or repositioning of by open operation-not associated with item 6852 (AU 9) Y 06858 01NOV1984 Artificial lens, removal of and replacement with a different lens (AU 12) Y 06859 01FEB1984 Cataract, juvenile, removal of, including subsequent needlings (AU 11) Y 06861 01FEB1984 Capsulectomy, or removal of, vitreous via the anterior chamber (AU 9) N 06861 01SEP1989 Capsulectomy or removal of vitreous via the anterior chamber by any method, not associated with any other intraocular operation on that eye (AU 9) Y 06862 01JUL1985 CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation on that eye - one or both procedures. (See Explanatory Notes covering this Item) ANAESTHETIC 15 UNITS - ITEM NOS 459G / 526S N 06862 01SEP1989 Capsulectomy by posterior chamber sclerotomy or removal of vitreous or vitreous bands from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation on that eye-one or both procedures (AU 15) Y 06863 01FEB1984 Virectomy via posterior chamber sclerotomy with removal of vitreous by cutting and suction and replacement by saline, Hartmann's or similar solution (AU 25) N 06863 01MAR1984 Vitrectomy via posterior chamber sclerotomy with removal of vitreous by cutting and suction and replacement by saline, Hartmann's or similar solution (AU 25) N 06863 01SEP1989 Vitrectomy by posterior chamber sclerotomy-including the removal of vitreous, division of bands or removal of pre-retinal membranes by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation on that eye (AU 25) Y 06864 01JUL1985 CAPSULECTOMY or LENSECTOMY by posterior chamber sclerotomy associated with the removal of vitreous or division of vitreous bands or removal of pre-retinal membrane from the posterior chamber by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation. (See Explanatory Notes covering this Item) ANAESTHETIC 25 UNITS - ITEM NOS 469G / 540S N 06864 01SEP1989 Capsulectomy or lensectomy by posterior chamber sclerotomy associated with the removal of vitreous or division of vitreous bands or removal of pre-retinal membrane from the posterior chamber by cutting and suction and replacement by saline, Hartmann's or similar solution, not associated with any other intraocular operation (AU 25) Y 06865 01FEB1984 Capsulotomy, needling or paracentesis for diagnosis or relief of tension (AU 7) Y 06871 01FEB1984 Anterior chamber, irrigation of blood from, as an independent procedure (AU 7) Y 06873 01FEB1984 Glaucoma, filtering and allied operations in the treatment of (AU 10) Y 06879 01FEB1984 Goniotomy (AU 10) Y 06881 01FEB1984 Division of anterior or posterior synechiae, as an independent procedure (AU 9) Y 06885 01FEB1984 Iridectomy (including excision of tumour of iris) or iridotomy, as an independent procedure (AU 10) Y 06889 01FEB1984 Iris, light coagulation of (AU 6) Y 06894 01FEB1984 Tumour, involving ciliary body or ciliary body and iris, excision of (AU 12) Y 06898 01FEB1984 Cyclodiathermy or cyclocryotherapy (AU 8) Y 06900 01FEB1984 Detached retina, diathermy or cryotherapy for (AU 11) N 06900 01SEP1989 Detached retina, diathermy or cryotherapy for, not associated with item 6902 (AU 11) Y 06902 01FEB1984 Detached retina, resection of, or buckling operation for, or revision operation for (AU 15) Y 06904 01FEB1984 Photocoagulation, each attendance at which treatment is given (AU 10) N 06904 01SEP1989 Photocoagulation, treatment to one or both eyes (AU 10) Y 06906 01FEB1984 Detached retina, removal of encircling silicone band from (AU 8) Y 06908 01FEB1984 Retina, cryotherapy to, as an independent procedure (AU 13) Y 06914 01FEB1984 Retrobulbar transillumination, as an independent procedure (AU 5) Y 06918 01FEB1984 Retrobulbar injection of alcohol or other drug, as an independent procedure Y 06920 01SEP1989 Injection of botulinus toxin for blepharospasm or strabismus Y 06922 01FEB1984 Squint, operation for, on one or both eyes, the operation involving a total of one or two muscles (AU 8) Y 06924 01FEB1984 Squint, operation for, on one or both eyes, the operation involving a total of three or four muscles (AU 9) N 06924 01SEP1989 Squint, operation for, on one or both eyes, the operation involving a total of three or more muscles (AU 9) Y 06928 01NOV1979 Squint, operation for, on one or both eyes, the operation involving a total of more than four muscles (AU 10) Y 06929 01JUL1985 READJUSTMENT OF ADJUSTABLE SUTURES, one or both eyes, as an independent procedure following an operation for correction of squint ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S N 06929 01SEP1989 Readjustment of adjustable sutures, one or both eyes, as an independent procedure following an operation for correction of squint (AU 6) Y 06930 01FEB1984 Squint, muscle transplant for (Hummelsheim type, etc.) (AU 9) Y 06931 01JUL1985 RECURRENT SQUINT OPERATION, one or both eyes, being an operation referred to in Item 6922,6924 or 6930 where there has been two or more previous squint operations on the eye or eyes DERIVED FEE - The fee specified for Item 6922,6924 or 6930 plus one-quarter of that fee ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S N 06931 01SEP1989 Recurrent squint operation, one or both eyes, being an operation referred to in item 6922, 6924 or 6930 where there has been two or more previous squint operations on the eye or eyes (AU 10) Y 06932 01FEB1984 Ruptured medial palpebral ligament or ruptured extra-ocular muscle, repair of (AU 9) Y 06938 01FEB1984 Resuturing of wound following intraocular procedures with or without excision of prolapsed iris (AU 9) Y 06939 01MAY1990 THORACIC CAVITY, aspiration of, for diagnostic purposes, not associated with Item 6941 Y 06940 01FEB1984 Thoracic cavity, aspiration or paracentesis of, or both (excluding after-care) Y 06941 01MAY1990 THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with or without diagnostic sample Y 06942 01FEB1984 Pericardium, paracentesis of (excluding after-care) (AU 6) Y 06953 01FEB1984 Intercostal drain, insertion of, not involving resection of rib (excluding after-care) (AU 7) Y 06954 01SEP1989 Percutaneous needle biopsy of lung (AU 7) Y 06955 01FEB1984 Empyema, radical operation for, involving resection of rib (AU 13) Y 06958 01FEB1984 Thoracotomy, exploratory, with or without biopsy (AU 11) Y 06962 01FEB1984 Thoracotomy with pulmonary decortication (AU 17) Y 06964 01FEB1984 Thoracotomy for pleurectomy or pleurodesis; or enucleation of hydatid cysts (AU 16) Y 06966 01FEB1984 Thoracoplasty (complete) (AU 21) Y 06968 01FEB1984 Thoracoplasty (in stages)-- each stage (AU 14) Y 06972 01FEB1984 Pectus excavatum or pectus carinatum, radical correction of (AU 16) Y 06974 01FEB1984 Thoracoscopy, with or without division of pleural adhesions (AU 7) Y 06980 01FEB1984 Pneumonectomy or lobectomy (AU 18) Y 06986 01FEB1984 Oesophagectomy with direct anastomosis or with stomach transposition (AU 23) Y 06988 01FEB1984 Oesophagectomy with interposition of small or large bowel (AU 27) Y 06992 01FEB1984 Mediastinum, cervical exploration of, with or without biopsy (AU 10) Y 06995 01FEB1984 Pericardium, transthoracic drainage of (other than for treatment of constrictive pericarditis) (AU 14) Y 06997 01NOV1979 Hernia, hiatus or other diaphragmatic, transthoracic repair of (AU 15) Y 06999 01FEB1984 Intrathoracic operation on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum or on more than one of those organs, not covered by any other item in this Part (AU 28) Y 07001 01FEB1984 Right heart catheterisation-- including fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection and exercise stress test (AU 12) N 07001 01MAR1984 Measurement of intracardiac conduction times or right heart catheterisation, including fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection and exercise stress test(AU 12) Y 07002 01FEB1984 Intracardiac electrophysiological investigations not covered by Item 7001 (AU 16) Y 07003 01FEB1984 Left heart catheterisation by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular puncture-- including fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test (AU 12) Y 07006 01FEB1984 Right heart catheterisation with left heart catheterisation via the right heart or by any other procedure-- including fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test (AU 14) Y 07007 01DEC1989 CARDIAC ELECTRO PHYSIOLOGICAL STUDY - up to and including 3 catheter investigation of anyone or more of - syncope, atrioventricular conduction, sinus node function or simple ventricular tachycardia studies, not in association with Item 7008 ANAESTHETIC 19 UNITS - ITEM NOS 463G / 531S Y 07008 01DEC1989 CARDIAC ELECTRO PHYSIOLOGICAL STUDY - 4 or more catheter supraventricular tachycardia invcstigation; or complex ventricular tachycardia investigation involving multiple ventricular tachycardia inductions, multiple catheter mapping, or acute intravenous anti-arryhthmic drug testing with pre and post drug inductions; or catheter ablation; or intra-operative mapping; or clectrophysiological services during defibrillator implantation or testing - not in association with Item 7007 ANAESTHETIC 27 UNITS - ITEM NOS 471G / 542S Y 07011 01FEB1984 Selective coronary arteriography-- placement of catheters and injection of opaque material (AU 14) Y 07013 01FEB1984 Selective coronary arteriography-- placement of catheters and injection of opaque material with right or left heart catheterisation, or both (AU 16) Y 07015 01MAY1991 INTRA-AORTIC BALLOON FOR COUNTERPULSATION, operation for insertion by arteriotomy, or removal and arterioplasty (excluding repair by patch graft) (AU 14 - 458/525) Y 07021 01FEB1984 Permanent internal pacemaker and myocardial electrodes, insertion or replacement of by thoracotomy (AU 11) Y 07028 01FEB1984 Permanent transvenous electrode, insertion or replacement of (AU 12) Y 07033 01FEB1984 Permanent pacemaker, insertion or replacement of (AU 12) Y 07042 01FEB1984 Temporary transvenous pacemaking electrode, insertion of (AU 11) Y 07044 01FEB1984 Open heart surgery for congenital heart disease in children up to two years, excluding patent ductus arteriosus (AU 38) Y 07046 01FEB1984 Open heart surgery for single valve replacement, atrial septal defect, pulmonary valvotomy, congenital heart disease (not covered by Item 7044) or any other open heart operation not covered by any other item in this Part (AU 32) Y 07057 01FEB1984 Open heart surgery on more than one valve or involving more than one chamber (AU 38) Y 07066 01FEB1984 Coronary artery or arteries, direct surgery to, employing cardiopulmonary by-pass (AU 36) Y 07070 01MAY1991 LUMBAR PUNCTURE, or spinal or epidural injection not covered by Item 748 (AU 5 - 406/510) Y 07071 01MAY1991 CISTERNAL PUNCTURE Y 07072 01MAY1991 DIAGNOSTIC PROCEDURES VENTRICULAR PUNCfURE (not including burr-hole) Y 07073 01MAY1991 SUBDURAL HAEMORRHAGE, tap for, each tap (AU 6 - 407/513) Y 07074 01MAY1991 BURR-HOLE, single, preparatory to ventricular puncture or for inspection purpose - not included in any other Items (AU 11 - 453/522) Y 07075 01MAY1991 VENTRICULAR RESERVOIR or intracranial pressure monitoring device, insertion of - including burr-hole (excluding after-care) (AU 12 - 454/523) Y 07076 01MAY1991 CEREBROSPINAL FLUID reservoir, insertion of (AU 10 - 450/521) Y 07077 01MAY1991 PROCEDURES FOR PAIN RELIEF INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, phenol, or similar substance (AU 8 - 409/517) Y 07078 01MAY1991 INTRATHECAL INJECfION of alcohol or phenol Y 07079 01FEB1984 Injection into trigeminal ganglion or primary branch of trigeminal nerve with alcohol N 07079 01SEP1989 Injection into trigeminal ganglion or primary branch of trigeminal nerve with alcohol, cortisone, phenol, etc. (AU 8) Y 07080 01MAY1991 NEURECTOMY, INTRACRANIAL, for trigeminal neuralgia (AU 16 - 460/527) Y 07081 01FEB1984 Intrathecal injection of alcohol or phenol Y 07082 01MAY1991 TRIGEMINAL GANGLIOTOMY by radiofrequency, balloon or glycerol (AU 8 - 409/517) Y 07083 01MAY1991 CRANIAL NERVE, intracranial decompression of, using microsurgical techniques (AU 25 - 469/540) Y 07084 01MAY1991 PERCUTANEOUS NEUROTOMY of posterior divisions of spinal nerves by any method on one or more occasions within a thirty day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy (AU 6 - 407/513) Y 07085 01FEB1984 Lumbar puncture; or spinal or epidural injection not covered by Item 748 or 752 N 07085 01SEP1989 Lumbar puncture, or spinal or epidural injection not covered by item 748 or 752 (AU 5) Y 07086 01MAY1991 PERCUTANEOUS NEUROTOMY for facet joint denervation by radio-frequency probe or cryoprobe using radiological imaging control (AU 7 - 408/514) Y 07087 01MAY1991 PERCUTANEOUS CORDOTOMY (AU 9 - 443/518) Y 07088 01MAY1991 CORDOTMY OR MYELOTOMY, laminectomy for, or operation for dorsal root entry zone (Drez) lesion (AU 13 - 457/524) Y 07089 01FEB1984 Cisternal puncture Y 07090 01MAY1991 SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER FOR PAIN, insertion of (AU 8 - 409/517) Y 07091 01MAY1991 PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, insertion of (one or two stages), not involving laminectomy (AU 8 - 409/517) Y 07092 01MAY1991 EPIDURAL STIMULATOR or INTRATHECAL INFUSION DEVICE, revision of (AU 7 - 408/514) Y 07093 01MAY1991 PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, removal of (AU 7 - 408/514) Y 07094 01MAY1991 EPIDURAL IMPLANT FOR PAIN, laminectomy and insertion of, including implantation of pulse generator (one or two stages) (AU 18 - 462/529) Y 07095 01MAY1991 PERIPHERAL NERVES CUTANEOUS NERVE (including digi tal nerve), primary repair of, using microsurgical techniques (AU 9 - 443/518) Y 07096 01MAY1991 CUTANEOUS NERVE (including digital nerve), secondary repair of, using microsurgical techniques (AU 10 - 450/521) Y 07097 01MAY1991 NERVE 1RUNK, primary repair of, using microsurgical techniques (AU 11 - 453/522) Y 07098 01MAY1991 NERVE 1RUNK, secondary repair of, using microsurgical techniques (AU 12 - 454/523) Y 07099 01FEB1984 Ventricular puncture (not including burr-hole) Y 07100 01MAY1991 NERVE TRUNK, internal (interfasicular), neurolysis of, using microsurgical techniques (AU 11 - 453/522) Y 07101 01MAY1991 NERVE 1RUNK, nerve graft to, (cable graft) including harvesting of nerve graft using microsurgical techniques (AU 16 - 460/527) Y 07102 01MAY1991 CUTANEOUS NERVE (including digital nerve), nerve graft to, using microsurgical techniques (AU 12 - 454/523) Y 07103 01MAY1991 NERVE, transposition of (AU 8 - 409/517) Y 07104 01MAY1991 NEURECTOMY, NEUROTOMY or removal of tumour from superficial peripheral nerve (AU 8 - 409/517) Y 07105 01MAY1991 NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral nerve (AU 10 - 450/521) Y 07106 01FEB1984 Cutaneous or digital nerve, primary suture of (G) (AU 8) Y 07107 01MAY1991 BRACHIAL PLEXUS, exploration of not covered by any other item in this Part (AU 11 - 453/522) Y 07108 01MAY1991 CRANIAL NERVES VESTIBULAR NERVE, section of, via posterior fossa (AU 24 - 468/539) Y 07109 01MAY1991 FACIO-HYPOGLOSSAL nerve or FACIO-ACCESSORY nerve, anastomosis of (AU 28 - 472/543) Y 07110 01MAY1991 CRANIO-CEREBRAL INJURIES Intracranial haemorrhage, burr-hole craniotomy for - including burr holes (AU 11 - 453/522) Y 07111 01FEB1984 Cutaneous or digital nerve, primary suture of (S) (AU 8) Y 07112 01FEB1984 Cutaneous nerve (other than digital nerve) primary suture of by microsurgical techniques (AU 9) N 07112 01MAR1984 Cutaneous nerve (other than digital nerve), primary suture of, using the operating microscope(AU 9) Y 07113 01MAY1991 FRACTURED SKULL, compound, without dural penetration, operation for (AU 12 - 454/523) Y 07114 01MAY1991 FRACTURED SKULL, compound or complicated, with dural penetration and brain laceration, operation for (AU 14 - 458/525) Y 07115 01MAY1991 FRACTURED SKULL with rhinorrhoea or otorrhoea, cranioplasty and repair of (AU 16 - 460/527) Y 07116 01FEB1984 Repair of divided digital nerve to thumb or finger (G) (AU 8) Y 07117 01FEB1984 Repair of divided digital nerve to thumb or finger (S) (AU 8) Y 07118 01JAN1986 CUTANEOUS NERVE (including digital nerve), primary repair of ANAESTHETIC 8 UNITS - ITEM NOS 409G / 517S N 07118 01SEP1989 Cutaneous nerve (including digital nerve), primary repair of (AU 8) Y 07119 01JAN1986 CUTANEOUS NERVE (including digital nerve), secondary repair of ANAESTHETIC 9 UNITS - ITEM NOS 443G / 518S N 07119 01SEP1989 Cutaneous nerve (including digital nerve), secondary repair of (AU 9) Y 07120 01FEB1984 Repair of divided digital nerve to thumb or finger by microsurgical techniques, primary repair (AU 9) N 07120 01MAR1984 Repair of divided digital nerve to thumb or finger using the operating microscope - primary repair (AU 9) N 07120 01SEP1989 Cutaneous nerve (including digital nerve), primary repair of, using the operating microscope (AU 9) Y 07121 01FEB1984 Repair of divided digital nerve to thumb or finger by microsurgical techniques, secondary repair (AU 10) N 07121 01MAR1984 Repair of divided digital nerve to thumb or finger using the operating microscope - secondary repair (AU 10) N 07121 01SEP1989 Cutaneous nerve (including digital nerve), secondary repair of, using the operating microscope (AU 10) Y 07122 01MAY1991 INTRACRANIAL tumour, biopsy or decompression of via osteoplastic flap OR biopsy and decompression of via osteoplastic flap (AU 18 - 462/529) Y 07123 01MAY1991 CRANIOTOMY for removal of glioma, metastatic carcinoma or any other tumour in cerebrum, cerebellum or brain stem - not covered by any other Item in this Part (AU 25 - 469/540) Y 07124 01FEB1984 Nerve trunk, primary suture of (AU 8) N 07124 01SEP1989 Nerve trunk, primary repair of (AU 8) Y 07125 01MAY1991 CRANIOTOMY FOR REMOVAL OF MENINGIOMA, pinealoma, cranio-pharyngioma, intraventricular tumour or any other intracranial tumour not covered by any other item in this Part (AU 25 - 469/540) Y 07126 01MAY1991 PITUITARY TUMOUR, hypophysectomy or removal of by transcranial or transphenoidal approach (AU 25 - 469/540) Y 07128 01FEB1984 Nerve trunk, primary suture of (D) (AU 8) N 07128 01SEP1989 Nerve trunk, primary repair of (D) (AU 8) Y 07129 01FEB1984 Nerve trunk, primary suture of, by microsurgical techniques (AU 11) N 07129 01MAR1984 Nerve trunk, primary suture of, using the operating microscope (AU 11) N 07129 01SEP1989 Nerve trunk, primary repair of, using the operating microscope (AU 11) Y 07130 01MAY1991 ARACHNOIDAL CYST, craniotomy for (AU 15 - 459/526) Y 07132 01FEB1984 Nerve trunk, secondary suture of (AU 9) N 07132 01SEP1989 Nerve trunk, secondary repair of (AU 9) Y 07133 01FEB1984 Neurolysis of nerve trunk, internal(interfascicular), using the operating microscope (AU 11) Y 07134 01FEB1984 Nerve trunk, secondary suture of (D) (AU 9) N 07134 01SEP1989 Nerve trunk, secondary repair of (D) (AU 9) Y 07135 01MAY1991 CRANIOTOMY, involving osteoplastic flap, for re-opening post-operatively for haemorrhage, swelling, etc (AU 16 - 460/527) Y 07136 01MAY1991 CEREBROVASCULAR DISEASE ANEURYSM, clipping or reinforcement of sac (AU 28 - 472/543) Y 07137 01MAY1991 INTRACRANIAL ARTERIOVENOUS MALFORMATION, excision of (AU 32 - 475/546) Y 07138 01FEB1984 Nerve trunk, secondary suture of, by microsurgical techniques (AU 12) N 07138 01MAR1984 Nerve trunk, secondary suture of, using the operating microscope(AU 12) N 07138 01SEP1989 Nerve trunk, secondary repair of, using the operating microscope (AU 12) Y 07139 01FEB1984 Nerve graft performed with magnification (AU 9) N 07139 01SEP1989 Nerve graft to nerve trunk (cable graft) including harvesting of nerve graft (AU 9) Y 07140 01JUL1985 NERVE GRAFT to cutaneous nerve (including digital nerve) ANAESTHETIC 12 UNITS - ITEM NOS 454G / 523S N 07140 01SEP1989 Nerve graft to cutaneous nerve (including digital nerve) (AU 12) Y 07141 01NOV1986 NERVE GRAFT to nerve trunk (cable graft) including harvesting of nerve graft using microsurgical techniques ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S N 07141 01SEP1989 Nerve graft to nerve trunk (cable graft) including harvesting of nerve graft using microsurgical techniques (AU 16) Y 07143 01FEB1984 Nerve, transposition of (AU 8) Y 07146 01FEB1984 Nerve, transposition of (D) (AU 8) Y 07147 01MAY1991 ANEURYSM, or arteriovenous malformation, intracranial proximal artery clipping of (AU 24 - 468/539) Y 07148 01FEB1984 Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve, including multiple percutaneous neurotomy of posterior division of spinal nerves (G) (AU 8) N 07148 01SEP1989 Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve (G) (AU 8) Y 07149 01MAY1991 ARTERIOVENOUS MALFORMATION, craniotomy and direct embolisation of (AU 32 - 475/546) Y 07150 01MAY1991 INTRACRANIAL ANEURYSM or arteriovenous fistula, ligation of cervical vessel or vessels (AU 10 - 450/521) Y 07151 01MAY1991 CAROTID-CA VERNOUS FISTULA, obliteration of - combined cervical and intracranial procedure (AU 40 - 479/550) Y 07152 01FEB1984 Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve, including multiple percutaneous neurotomy of posterior division of spinal nerves (S) (AU 8) N 07152 01SEP1989 Neurectomy, neurotomy or removal of tumour from superficial peripheral nerve (S) (AU 8) Y 07153 01JUL1985 PERCUTANEOUS NEUROTOMY of posterior divisions of spinal nerves by any method on one or more occasions within a thirty day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy ANAESTHETIC 6 UNITS - ITEM NOS 407G / 513S N 07153 01SEP1989 Percutaneous neurotomy of posterior divisions of spinal nerves by any method on one or more occasions within a thirty day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy (AU 6) Y 07154 01MAY1991 EXTRACRANIAL TO INTRACRANIAL BYPASS using superficial temporal artery or saphenous vein graft (AU 32 - 475/546) Y 07155 01MAY1991 INFECTION INTRACRANIAL INFECfION, drainage of, via burr-hole - including burr-hole (AU 10 - 450/521) Y 07156 01FEB1984 Neurectomy, neurotomy or removal of tumour from deep peripheral nerve (AU 10) Y 07157 01FEB1984 Radiofrequency trigeminal gangliotomy (AU 8) Y 07158 01MAY1991 INTRACRANIAL ABSCESS, excision of (AU 17 - 461/528) Y 07159 01MAY1991 OSTEOMYELITIS OF SKULL or removal of infected bone flap, craniectomy for (AU 10 - 450/521) Y 07160 01MAY1991 CEREBRO-SPINAL FLUID CIRCULATION DISORDERS VENTRICULO-CISTERNOSTOMY (Torkildsen's operation) (AU 15 - 459/526) Y 07161 01MAY1991 CRANIAL OR CISTERNAL SHUNT DIVERSION, insertion of (AU 14 - 458/525) Y 07162 01MAY1991 LUMBAR SHUNT DIVERSION, insertion of (AU 13 - 457/524) Y 07163 01MAY1991 CRANIAL, CISTERNAL OR LUMBAR SHUNT, revision or removal of (AU 12 - 454/523) Y 07164 01MAY1991 THIRD VENTRICULOSTOMY (AU 15 - 459/526) Y 07165 01MAY1991 SUBTEMPORAL DECOMPRESSION (AU 26 - 470/541) Y 07166 01MAY1991 LUMBAR CEREBROSPINAL FLUID DRAIN, insertion of (AU 6 - 407/513) Y 07167 01MAY1991 CONGENITAL DISORDERS MENINGOCELE, excision and closure of (AU 13 - 457/524) Y 07168 01MAY1991 MYELOMENINGOCELE, excision and closure of, including skin flaps or Z plasty where performed (AU 15 - 459/526) Y 07169 01MAY1991 ARNOLD-CHIARI MALFORMATION, decompression of (AU 35 - 493/564) Y 07170 01FEB1984 Neurectomy, intracranial or radical as in tic douloureux (AU 16) Y 07171 01FEB1984 Intracranial microsurgical decompression of cranial nerve, posterior cranial fossa approach including Jannetta's operation (AU 25) Y 07172 01MAY1991 ENCEPHALOCOELE, excision and closure of (AU 34 - 492/563) Y 07173 01MAY1991 TETHERED CORD, release of, including lipomeningocoele or diastematomyelia (AU 35 - 493/564) Y 07174 01MAY1991 CRANIOSTENOSIS, operation for - single suture (AU 17 - 461/528) Y 07175 01FEB1984 Exploration of brachial plexus, not covered by any other item in this Part (AU 11) Y 07176 01MAY1991 CRANIOSTENOSIS, operation for - more than one suture (AU 20 - 464/533) Y 07177 01MAY1991 SPINAL DISORDERS INTERVERTEBRAL DISC OR DISCS, laminectomy for exploration or removal of (AU 12 - 454/523) Y 07178 01FEB1984 Neurolysis by open operation, without transposition (G) (AU 7) N 07178 01SEP1989 Neurolysis by open operation without transposition, not associated with item 7133 (G) (AU 7) Y 07179 01MAY1991 RECURRENT DISC LESION OR SPINAL STENOSIS, laminectomy for - one level (AU 13 - 457/524) Y 07180 01MAY1991 SPINAL CANAL STENOSIS, laminectomy (multi-level), for treatment of (AU 16- 460/527) Y 07181 01MAY1991 EXTRADURAL TUMOUR OR ABSCESS, laminectomy for (AU 12 - 454/523) Y 07182 01FEB1984 Neurolysis by open operation, without transposition (S) (AU 7) N 07182 01SEP1989 Neurolysis by open operation without transposition, not associated with item 7133 (S) (AU 7) Y 07183 01MAY1991 SPINAL RHIZOLYSIS involving exposure of spinal nerve roots, with or without laminectomy (AU 16 - 460/527) Y 07184 01FEB1984 Subdural haemorrhage, tap for, each tap (AU 6) Y 07185 01MAY1991 INTRADURAL LESION, laminectomy for, not covered by any other item in this Part (AU 13 - 457/524) Y 07186 01FEB1984 Burr-hole, single preparatory to ventricular puncture or for inspection purpose-- not included in any other items (AU 11) Y 07187 01MAY1991 CRANIOCERVICAL JUNCTION LESION, transoral approach for (AU 29 - 473/544) Y 07188 01MAY1991 INTRAMEDULLARY TUMOUR OR ARTERIOVENOUS MALFORMATION, laminectomy and radical excision of (AU 14 - 458/525) Y 07189 01MAY1991 POSTERIOR SPINAL FUSION, not covered by items 7191 and 7193 (AU 18 - 462/529) Y 07190 01FEB1984 Insertion of ventricular reservoir, or insertion of intracranial pressure monitoring device, including burr-hole, as an independent procedure(excluding after-care)(AU 12) Y 07191 01MAY1991 LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - laminectomy, including aftercare (AU 18 - 462/529) Y 07192 01FEB1984 Intracranial tumour, biopsy of, or intracranial cyst, drainage of via burr-hole-- including burr-hole (AU 10) Y 07193 01MAY1991 LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - posterior fusion, including aftercare Y 07194 01FEB1984 Intracranial tumour, biopsy or decompression of via osteoplastic flap or biopsy and decompression of via osteoplastic flap (AU 18) Y 07195 01MAY1991 ANTERIOR INTERBODY SPINAL FUSION TO CERVICAL SPINE - one level (AU 14 - 458/525) Y 07196 01MAY1991 CERVICAL DISCEcrOMY (ANTERIOR), without fusion (AU 19 - 463/531) Y 07197 01MAY1991 SPINE (EXCLUDING SACRUM), treatment of fracture of vertebral body, without involvement of cord, requiring immobilisation in plaster or traction by skull calipers (AU 9 - 443/518) Y 07198 01FEB1984 Intracerebral tumour, craniotomy and removal; or temporal lobectomy for any reason (AU 25) N 07198 01SEP1989 Craniotomy for removal of glioma, metastatic carcinoma or any other tumour in cerebrum, cerebellum or brain stem-not covered by any other item in this Part (AU 25) Y 07199 01MAY1991 SPINE (EXCLUDING SACRUM), treatment of fracture of vertebral body, with involvement of cord (AU 9 - 443/518) Y 07200 01MAY1991 INTRADISCAL INJECTION OF CHYMOPAPAIN (DISCASE) - one disc (AU 8- 409/517) (See para 10.33 of explanatory notes to this Part) Y 07203 01FEB1984 Intracranial extracerebral tumour, craniotomy and removal; or hemispherectomy for any reason (AU 25) N 07203 01MAR1984 Intracranial extracerebral tumour, craniotomy and removal; or hemispherectomy for any reason, not associated with Item 7204(AU 25) N 07203 01SEP1989 Craniotomy for removal of meningioma pinealoma, cranio-pharyngioma or any other intracranial tumour-not covered by any other item in this Part (AU 25) Y 07204 01FEB1984 Hypophysectomy or removal of pituitary tumour by transcranial or transphenoidal approach(AU 25) Y 07208 01MAY1991 BONE GRAFT TO SPINE with laminectomy and posterior interbody fusion - one level (AU 15 - 459/526) Y 07209 01MAY1991 BONE GRAFT TO SPINE with laminectomy and posterior interbody fusion - more than one level (AU 18 - 462/529) Y 07211 01MAY1991 BONE GRAFT TO SPINE, postero-lateral fusion (AU 14 - 458/525) Y 07212 01FEB1984 Intracranial haemorrhage, burr-hole craniotomy for-- including burrholes (AU 11) Y 07213 01MAY1991 ANTERIOR INTERBODY SPINAL FUSION TO LUMBAR OR THORACIC SPINE - one level (AU 15 - 459/526) Y 07214 01MAY1991 ANTERIOR INTERBODY SPINAL FUSION TO LUMBAR OR THORACIC SPINE - more than one level (AU 15 - 459/526) Y 07216 01FEB1984 Intracranial haemorrhage, osteoplastic craniotomy or extensive craniectomy and removal of haematoma (AU 18) Y 07217 01MAY1991 HYDROMELIA, plugging of obex for, with or without duroplasty (AU 25 - 469/540) Y 07218 01MAY1991 HYDROMELIA, craniotomy and laminectomy for, with cavity packing and CSF shunt (AU 25 - 469/540) Y 07219 01MAY1991 SKULL RECONSTRUCTION CRANIOPLASTY, reconstructive (AU 16 - 460/527) Y 07222 01MAY1991 EPILEPSY CORPUS CALLOSUM, anterior section of, for epilepsy (AU 25 - 469/540) Y 07223 01MAY1991 CORTICECfOMY, TOPECfOMY or PARTIAL LOBECTOMY for epilepsy (AU 23 - 467/538) Y 07224 01MAY1991 HEMISPHERECTOMY for intractible epilepsy (AU 40 - 479/550) Y 07225 01MAY1991 BURR-HOLE PLACEMENT of intracranial depth or surface electrodes (AU 15 - 459/526) Y 07226 01MAY1991 INTRACRANIAL ELECTRODE PLACEMENT via craniotomy (AU 21 - 465/535) Y 07227 01MAY1991 STEREOTACTIC PROCEDURES STEREOTACTIC ANATOMICAL LOCALISATION in association with an intracranial operative procedure (AU 17 - 461/528) Y 07228 01MAY1991 INTRACRANIAL STEREOTACTIC PROCEDURE BY ANY METHOD, not covered by any other item in this Part (AU 17 - 461/528) Y 07229 01MAY1991 MISCELLANEOUS LEUCOTOMY for psychiatric disorder (AU 15 - 459/526) Y 07231 01FEB1984 Fracture of skull, depressed or comminuted, operation for (AU 12) Y 07232 01MAY1991 OPTIC NERVE MENINGES, incision of (AU 14 - 458/525) Y 07240 01FEB1984 Fractured skull, compound, without dural penetration, operation for (AU 12) Y 07244 01FEB1984 Fractured skull, compound or complicated, with dural penetration and brain damage, operation for (AU 14) Y 07248 01FEB1984 Fractured skull with rhinorrhoea or otorrhea, cranioplasty and repair of (AU 16) Y 07251 01FEB1984 Reconstructive cranioplasty (AU 16) Y 07265 01FEB1984 Aneurysm or arteriovenous malformation, clipping or reinforcement of sac (AU 28) Y 07270 01FEB1984 Aneurysm or arteriovenous malformation, intracranial proximal artery clipping (AU 24) Y 07274 01FEB1984 Aneurysm or arteriovenous fistula, cervical carotid ligation for (AU 10) Y 07279 01FEB1984 Craniotomy involving osteoplastic flap, for re-opening post-operatively for haemorrhage, swelling, etc. (AU 16) Y 07283 01FEB1984 Intracranial abscess, excision of (AU 17) Y 07287 01FEB1984 Intracranial infection, drainage of, via burr-hole-- including burr-hole (AU 10) Y 07291 01FEB1984 Craniectomy for osteomyelitis of skull (AU 10) Y 07298 01FEB1984 Leucotomy or lobotomy for psychiatric causes (AU 15) Y 07312 01FEB1984 Chemopallidectomy or other stereotactic procedure including burrhole and air studies (AU 17) N 07312 01MAR1984 Intracranial stereotactic procedure by any method, including burr-holes, preparation for ventriculography and localisation of lesion(AU 17) Y 07314 01FEB1984 Ventriculo-cisternostomy (Torkildsen's operation) (AU 15) Y 07316 01FEB1984 Ventriculo-atrial or ventriculoperitoneal valvular shunt for hydrocephalus or other lesions (AU 14) Y 07318 01FEB1984 Ventriculo-atrial or ventriculoperitoneal valvular shunt, revision or removal of (AU 12) Y 07320 01FEB1984 Spino-ureteral, spino-peritoneal, spino-pleural or similar spinal shunt for hydrocephalus (AU 13) Y 07324 01FEB1984 Craniostenosis, operation for-- single suture (AU 17) Y 07326 01FEB1984 Craniostenosis, operation for-- more than one suture (AU 20) Y 07328 01FEB1984 Arachnoidal cyst, operation for (AU 15) Y 07331 01FEB1984 Laminectomy for exploration or removal of intervertebral disc or discs (AU 12) Y 07336 01FEB1984 Laminectomy for recurrent disc lesion or spinal stenosis (AU 13) Y 07338 01AUG1988 Laminectomy, multi-level, for the treatment of spinal canal stenosis (AU 16) Y 07341 01FEB1984 Laminectomy for extradural tumour or abscess (AU 12) Y 07346 01FEB1984 Laminectomy for intradural lesion or open cordotomy (AU 13) Y 07353 01FEB1984 Laminectomy and radical excision of intra-medullary tumour or arteriovenous malformation (AU 14) Y 07355 01FEB1984 Laminectomy followed by posterior fusion-- not covered by Items 7361 and 7365 (AU 18) Y 07361 01FEB1984 Laminectomy followed by posterior fusion performed by neuro-surgeon and orthopaedic surgeon operating together-- laminectomy including after-care (AU 18) Y 07365 01FEB1984 Laminectomy followed by posterior fusion performed by neuro-surgeon and orthopaedic surgeon operating together-- posterior fusion including after-care Y 07370 01FEB1984 Spinal rhizolysis involving exposure of spinal nerve roots, with or without laminectomy (AU 16) Y 07373 01AUG1987 INTRADISCAL INJECTION of chymopapain (DISCASE)-ONE DISC ANAESTHETIC 8 UNITS-ITEM NOS 409G/517S N 07373 01SEP1989 Intradiscal injection of chymopapain (Discase)-one disc (AU 8) Y 07376 01FEB1984 Sympathectomy (cervical, lumbar, thoracic, sacral or presacral) (AU 10) Y 07381 01FEB1984 Percutaneous cordotomy (AU 9) Y 07397 01FEB1984 Mandible (AU 4) Y 07402 01FEB1984 Mandible (D) (AU 4) Y 07410 01FEB1984 Clavicle (AU 4) Y 07412 01FEB1984 Shoulder-first or second dislocation (AU 4) Y 07416 01FEB1984 Shoulder-third or subsequent dislocation -requiring anaesthesia (AU 4) Y 07419 01FEB1984 Shoulder-third or subsequent dislocation-not requiring anaesthesia Y 07423 01FEB1984 Elbow (AU 4) Y 07426 01FEB1984 Carpus (AU 4) Y 07430 01FEB1984 Carpus on radius and ulna (G)(AU 4) Y 07432 01FEB1984 Carpus on radius and ulna (S) (AU 4) Y 07435 01FEB1984 Finger (AU 4) Y 07436 01FEB1984 Metacarpo-phalangeal joint of thumb (AU 4) Y 07440 01FEB1984 Hip (G) (AU 5) Y 07443 01FEB1984 Hip (S) (AU 5) Y 07446 01FEB1984 Knee (G) (AU 4) Y 07451 01FEB1984 Knee (S) (AU 4) Y 07457 01FEB1984 Patella (AU 4) Y 07461 01FEB1984 Ankle (AU 5) Y 07464 01FEB1984 Toe (AU 4) Y 07468 01FEB1984 Tarsus (AU 4) Y 07472 01FEB1984 Spine (cervical or lumbar), without fracture (AU 7) Y 07480 01FEB1984 Treatment of a dislocation requiring open operation, being a dislocation referred to in Item 7397, 7410, 7416, 7419, 7426, 7435, 7457 or 7464 Y 07483 01FEB1984 Treatment of a dislocation requiring open operation, being a dislocation referred to in an item (other than an item referred to in Item 7480 or an item that includes the symbol (D)) under the heading Dislocations not requiring Open Operation in this Division Y 07485 01FEB1984 Treatment of a dislocation of the mandible requiring open operation (D) Y 07505 01FEB1984 Terminal phalanx of finger or thumb (AU 4) Y 07508 01FEB1984 Proximal phalanx of finger or thumb (G) (AU 4) Y 07512 01FEB1984 Proximal phalanx of finger or thumb (S) (AU 4) Y 07516 01FEB1984 Middle phalanx of finger (AU 4) Y 07520 01FEB1984 One or more metacarpals, not involving base of first carpometacarpal joint (G) (AU 4) Y 07524 01FEB1984 One or more metacarpals, not involving base of first carpometacarpal joint (S) (AU 4) Y 07527 01FEB1984 First metacarpal involving carpometacarpal joint (Bennett's fracture) (G) (AU 4) Y 07530 01FEB1984 First metacarpal involving carpometacarpal joint (Bennett's fracture) (S) (AU 4) Y 07533 01FEB1984 Carpus (excluding navicular) (AU 5) Y 07535 01FEB1984 Navicular or carpal scaphoid (G) (AU 5) Y 07538 01FEB1984 Navicular or carpal scaphoid (S) (AU 5) Y 07539 01SEP1989 Carpal scaphoid, fracture of, reduction and screw fixation (AU 10) Y 07540 01FEB1984 Colles' fracture of wrist (G) (AU 5) Y 07544 01FEB1984 Colles' fracture of wrist (S) (AU 5) Y 07547 01FEB1984 Distal end of radius or ulna, involving wrist (AU 5) Y 07550 01FEB1984 Radius (G) (AU 5) Y 07552 01FEB1984 Radius (S) (AU 5) Y 07559 01FEB1984 Ulna (G) (AU 5) Y 07563 01FEB1984 Ulna (S) (AU 5) Y 07567 01FEB1984 Humerus or both shafts of forearm (G) (AU 6) Y 07572 01FEB1984 Humerus or both shafts of forearm (S) (AU 6) Y 07588 01FEB1984 Clavicle or sternum (G) (AU 6) Y 07593 01FEB1984 Clavicle or sternum (S) (AU 6) Y 07597 01FEB1984 Scapula (AU 6) Y 07601 01FEB1984 One or more ribs-- each attendance (G) (AU 7) Y 07605 01FEB1984 One or more ribs-- each attendance (S) (AU 7) Y 07608 01FEB1984 Pelvis (excluding symphysis pubis) or sacrum (G) (AU 8) Y 07610 01FEB1984 Pelvis (excluding symphysis pubis) or sacrum (S) (AU 8) Y 07615 01FEB1984 Symphysis pubis (G) (AU 7) Y 07619 01FEB1984 Symphysis pubis (S) (AU 7) Y 07624 01FEB1984 Femur (G) (AU 8) Y 07627 01FEB1984 Femur (S) (AU 8) Y 07632 01FEB1984 Fibula or tarsus (excepting os calcis or os talus) (G) (AU 6) Y 07637 01FEB1984 Fibula or tarsus (excepting os calcis or os talus) (S) (AU 6) Y 07641 01FEB1984 Tibia or patella (G) (AU 6) Y 07643 01FEB1984 Tibia or patella (S) (AU 6) Y 07647 01FEB1984 Ankle (Pott's fracture) with or without dislocation, os calcis (calcaneus), os talus or both shafts of leg (G) (AU 7) Y 07652 01FEB1984 Ankle (Pott's fracture) with or without dislocation, os calcis (calcaneus), os talus or both shafts of leg (S) (AU 7) Y 07673 01FEB1984 Metatarsals-- one or more (G) (AU 5) Y 07677 01FEB1984 Metatarsals-- one or more (S) (AU 5) Y 07681 01FEB1984 Phalanx of toe (other than great toe) (AU 4) Y 07683 01FEB1984 More than one phalanx of toe (other than great toe) (AU 4) Y 07687 01FEB1984 Distal phalanx of great toe (AU 4) Y 07691 01FEB1984 Proximal phalanx of great toe (AU 4) Y 07694 01FEB1984 Skull, not requiring operation-- each attendance (G) Y 07697 01FEB1984 Skull, not requiring operation-- each attendance (S) Y 07701 01FEB1984 Nasal bones, not requiring reduction-- each attendance (G) Y 07706 01FEB1984 Nasal bones, not requiring reduction-each attendance (S) Y 07709 01FEB1984 Nasal bones, requiring reduction (G) (AU 6) Y 07712 01FEB1984 Nasal bones, requiring reduction (S) (AU 6) Y 07715 01FEB1984 Nasal bones, requiring reduction and involving osteotomies (AU 8) Y 07718 01NOV1979 Maxilla-not requiring splinting (G) Y 07719 01NOV1984 Maxilla or mandible, unilateral or bilateral, not requiring splinting Y 07720 01NOV1984 Maxilla or mandible, unilateral or bilateral, not requiring splinting (D) Y 07721 01NOV1979 Maxilla-not requiring splinting (S) Y 07722 01NOV1984 Maxilla or mandible, requiring splinting or wiring of teeth, not associated with item 7725-each procedure to a maximum of three such procedures (AU 13) Y 07723 01NOV1984 Maxilla or mandible, requiring splinting or wiring of teeth, not associated with item 7726-each procedure to a maximum of three such procedures (D) (AU 13) Y 07724 01NOV1979 Maxilla-not requiring splinting (D) Y 07725 01NOV1984 Maxilla or mandible, circumosseous fixation of-each procedure to a maximum of three such procedures (AU 15) Y 07726 01NOV1984 Maxilla or mandible, circumosseous fixation of-each procedure to a maximum of three such procedures (D) (AU 15) Y 07727 01NOV1979 Maxilla-with external fixation, wiring of teeth or internal fixation (AU 11) Y 07728 01NOV1984 Maxilla or mandible, external skeletal fixation of-each procedure to a maximum of three such procedures (AU 15) Y 07729 01NOV1984 Maxilla or mandible, external skeletal fixation of-each procedure to a maximum of three such procedures (D) (AU 15) Y 07731 01NOV1979 Maxilla-with external fixation, wiring of teeth or internal fixation (D) (AU 11) Y 07739 01NOV1979 Mandible-not requiring splinting (G) Y 07743 01NOV1979 Mandible-not requiring splinting (S) Y 07745 01NOV1979 Mandible-not requiring splinting (D) Y 07749 01NOV1979 Mandible-with wiring of teeth, internal fixation or skeletal pinning with external fixation (AU 12) Y 07753 01NOV1979 Mandible-with wiring of teeth, internal fixation or skeletal pinning with external fixation (D) (AU 12) Y 07764 01FEB1984 Zygoma (G) (AU 7) Y 07766 01FEB1984 Zygoma (S) (AU 7) Y 07770 01FEB1984 Zygoma (D) (AU 7) Y 07774 01FEB1984 Spine (excluding sacrum), transverse process or bone other than vertebral body, not requiring immobilisation in plaster-each attendance (G) Y 07777 01FEB1984 Spine (excluding sacrum), transverse process or bone other than vertebral body, not requiring immobilisation in plaster-each attendance (S) Y 07781 01FEB1984 Spine (excluding sacrum), vertebral body, without involvement of cord, not requiring immobilisation in plaster-each attendance (G) Y 07785 01FEB1984 Spine (excluding sacrum), vertebral body, without involvement of cord, not requiring immobilisation in plaster-each attendance (S) Y 07789 01FEB1984 Spine (excluding sacrum), transverse process or bone other than vertebral body requiring immobilisation in plaster or traction by skull calipers (AU 9) Y 07793 01FEB1984 Spine (excluding sacrum), vertebral body, without involvement of cord, requiring immobilisation in plaster or traction by skull calipers (AU 9) Y 07798 01FEB1984 Spine (excluding sacrum), vertebral body, with involvement of cord (AU 9) Y 07802 01FEB1984 Treatment of a simple and uncomplicated fracture requiring open operation being a fracture referred to in Item 7505, 7508, 7516, 7533, 7601, 7605, 7681, 7683, 7687, 7691, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785 N 07802 01MAR1987 TREATMENT OF A SIMPLE AND UNCOMPLICATED FRACTURE REQUIRING OPEN OPERATION, being a fracture referred to in Item - 7505, 7508,7516,7533, 7601. 7605, 7681,7683,7687,7691,7694,7697, 7701, 7706, 7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 483G / 554S Y 07803 01FEB1984 Treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in an item (other than an item referred to in Item 7802 or an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07804 01FEB1984 Treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D) N 07804 01SEP1989 Treatment of a simple and uncomplicated fracture requiring open operation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D) Y 07808 01FEB1984 Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in Item 7505, 7516, 7533, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785 N 07808 01MAR1987 TREATMENT OF A SIMPLE AND UNCOMPLICATED FRACTURE REQUIRING INTERNAL FIXATION, being a fracture referred to in Item - 7505,7516,7533, 7601,7605,7681, 7683, 7694,7697, 7701,7706, 7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 484G / 556S Y 07809 01FEB1984 Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in an item (other than an item referred to in Item 7808 or an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07812 01FEB1984 Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D) N 07812 01SEP1989 Treatment of a simple and uncomplicated fracture requiring internal fixation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D) Y 07815 01FEB1984 Treatment of a compound fracture requiring open operation, being a fracture referred to in Item 7505, 7516, 7533, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785 N 07815 01MAR1987 TREATMENT OF A COMPOUND FRACTURE REQUIRING OPEN OPERATION, being a fracture referred to in Item - 7505,7516, 7533,7601,7605, 7681, 7683,7694, 7697,7701,7706,7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 484G / 556S Y 07817 01FEB1984 Treatment of a compound fracture requiring open operation, being a fracture referred to in an item (other than an item referred to in Item 7815 or an item that includes the symbol (D) ) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07818 01FEB1984 Treatment of a compound fracture requiring open operation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D) N 07818 01SEP1989 Treatment of a compound fracture requiring open operation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D) Y 07821 01FEB1984 Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Item 7505, 7516, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785 N 07821 01MAR1987 TREATMENT OF A COMPLICATED FRACTURE INVOLVING VISCERA, BLOOD VESSELS OR NERVES AND REQUIRING OPEN OPERATION, being a fracture referred to in Item - 7505, 7516, 7601, 7605, 7681, 7683, 7694, 7697, 7701, 7706, 7774, 7777, 7781 or 7785 ANAESTHETIC - ITEM NOS 485G / 557S Y 07823 01FEB1984 Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in an item (other than an item referred to in Item 7821 or an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07824 01FEB1984 Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D) N 07824 01SEP1989 Treatment of a complicated fracture involving viscera, blood vessels or nerves and requiring open operation, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D) Y 07828 01FEB1984 Initial reduction (without full postoperative treatment) in a series of two or more reductions of a fracture, being a reduction that would, but for this item, be covered by an item (other than an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07831 01FEB1984 Initial reduction (without full postoperative treatment) in a series of two or more reductions of a fracture, being a reduction that would, but for this item, be covered by Item 7724, 7731, 7745, 7753 or 7770 (D) N 07831 01SEP1989 Initial reduction (without full post-operative treatment) in a series of two or more reductions of a fracture, being a reduction that would, but for this item, be covered by item 7720, 7723, 7726, 7729 or 7770 (D) Y 07834 01FEB1984 Each subsequent reduction (without full post-operative treatment) in a series (other than the final reduction), being a reduction that would, but for this item, be covered by an item (other than an item that includes the symbol(D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07836 01FEB1984 Each subsequent reduction (without full post-operative treatment) in a series (other than the final reduction), being a reduction that would, but for this item, be covered by Item 7724, 7731, 7745, 7753 or 7770 (D) N 07836 01SEP1989 Each subsequent reduction (without full post-operative treatment) in a series (other than the final reduction), being a reduction that would, but for this item, be covered by item 7720, 7723, 7726, 7729 or 7770 (D) Y 07839 01FEB1984 Final reduction (including full postoperative treatment) in a series, being a reduction that would, but for this item, be covered by an item (other than an item that includes the symbol (D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division N 07839 01MAR1987 FINAL REDUCTION {including full post-operative treatment) in a series being a reduction that would, but for this item, be covered by an item under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division DERIVED FEE - The fee specified for the administration of the anaesthetic for the reduction of this fracture Y 07841 01FEB1984 Final reduction (including full post-operative treatment) in a series, being a reduction that would, but for this item, be covered by Item 7724, 7731, 7745, 7753 or 7770 (D) N 07841 01SEP1989 Final reduction (including full post-operative treatment) in a series, being a reduction that would, but for this item, be covered by item 7720, 7723, 7726, 7729 or 7770 (D) Y 07844 01FEB1984 Treatment of avulsion of epiphysis of any part referred to in an item under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07847 01FEB1984 Treatment of a closed fracture, involving a joint surface, being a fracture referred to in an item (other than an item that includes the symbol(D)) under the heading Simple and Uncomplicated Fractures Not Requiring Open Operation in this Division Y 07849 01FEB1984 Treatment of a closed fracture, involving a joint surface, being a fracture referred to in Item 7724, 7731, 7745, 7753 or 7770 (D) N 07849 01SEP1989 Treatment of a closed fracture, involving a joint surface, being a fracture referred to in item 7720, 7723, 7726, 7729 or 7770 (D) Y 07853 01FEB1984 Accessory or sesamoid bone, removal of (AU 6) Y 07855 01NOV1984 Bone cysts, injection of steroids into (AU 8) Y 07857 01FEB1984 Epicondylitis, open operation for (AU 6) Y 07861 01FEB1984 Digital nail, removal of (AU 5) Y 07864 01FEB1984 Incision for pulp space infection, paronychia or other acute infection of hands or feet, not covered by any other item in this Part (excluding after-care) (AU 5) Y 07868 01FEB1984 Middle palmar, thenar or hypothenar spaces, drainage of (AU 6) Y 07872 01FEB1984 Ingrowing toenail, excision of nail bed (G) (AU 6) Y 07874 01SEP1989 Nail bed, excision or wedge resection of (G) (AU 6) Y 07875 01SEP1989 Nail bed, excision or wedge resection of (S) (AU 6) Y 07878 01FEB1984 Ingrowing toenail, excision of nail bed (S) (AU 6) Y 07883 01FEB1984 Insertion of orthopaedic pin or wire, as an independent procedure (AU 5) Y 07886 01FEB1984 Removal of buried wire, pin, screw, rod, nail or plate requiring incision under regional or general anaesthesia (AU 8) Y 07888 01FEB1984 Insertion of orthopaedic pin or wire where no other surgical procedure is performed (D) (AU 5) Y 07898 01FEB1984 Osteosynthesis by Smith-Petersen nail (AU 11) N 07898 01SEP1989 Femur, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (AU 11) Y 07902 01FEB1984 Temporo-mandibular meniscectomy (AU 9) Y 07907 01FEB1984 Temporo-mandibular meniscectomy (D) (AU 9) Y 07911 01FEB1984 Manipulation of joint, joints, spine, joint and spine or joints and spine, under general anaesthesia, not associated with any other item in this Part (G) (AU 4) Y 07915 01FEB1984 Manipulation of joint, joints, spine, joint and spine or joints and spine, under general anaesthesia, not associated with any other item in this Part (S) (AU 4) Y 07926 01FEB1984 Spine, application of plaster jacket (AU 6) Y 07928 01FEB1984 Risser jacket, localizer or turn-buckle jacket, application of, body only Y 07932 01FEB1984 Risser jacket, localizer or turn-buckle jacket, application of, body and head Y 07934 01FEB1984 Scoliosis, spinal fusion for (AU 23) Y 07937 01FEB1984 Scoliosis, re-exploration for adjustment or removal of Harrington rods or similar devices (AU 12) Y 07938 01FEB1984 Spinal fusion for scoliosis or kyphosis by use of Harrington distraction rod or by anterior correction (Dwyer procedure) of not more than four spaces (AU 23) N 07938 01MAR1984 Anterior correction of scoliosis (Dwyer procedure) of not more than four spaces; or spinal fusion for scoliosis or kyphosis with use of Harrington distraction rod (AU 23) Y 07939 01FEB1984 Spinal fusion for scoliosis or kyphosis by use of Harrington distraction rod and compression rod or by anterior correction (Dwyer procedure) of more than four spaces (AU 29) N 07939 01MAR1984 Anterior correction of scoliosis (Dwyer procedure) of more than four spaces; or spinal fusion for scoliosis or kyphosis with use of Harrington distraction and compression rods(AU 29) Y 07940 01FEB1984 Application of halo for spinal fusion in the treatment of scoliosis, not covered by Item 7934 (AU 8) Y 07942 01FEB1984 Bone graft to spine, posterior, not covered by Item 7945, 7967 or 7969 (AU 14) Y 07945 01FEB1984 Bone graft to spine, postero-lateral fusion (AU 14) Y 07947 01FEB1984 Anterior interbody spinal fusion to cervical spine-- one level (AU 14) Y 07951 01FEB1984 Anterior interbody spinal fusion to cervical spine-- more than one level (AU 15) Y 07957 01FEB1984 Anterior interbody spinal fusion to lumbar or thoracic spine-- one level (AU 15) Y 07961 01FEB1984 Anterior interbody spinal fusion to lumbar or thoracic spine-- more than one level (AU 15) Y 07967 01FEB1984 Bone graft to spine with laminectomy and posterior interbody fusion-- one level (AU 15) Y 07969 01FEB1984 Bone graft to spine with laminectomy and posterior interbody fusion-- more than one level (AU 18) Y 07975 01FEB1984 Bone graft to femur (AU 11) Y 07977 01FEB1984 Bone graft to tibia (AU 10) Y 07980 01MAY1990 CARPAL SCAPHOID, fracture of, reduction and screw fixation ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S Y 07983 01FEB1984 Bone graft to humerus or to radius and ulna (AU 10) Y 07993 01FEB1984 Bone graft to radius or ulna (AU 8) Y 07999 01FEB1984 Bone graft to scaphoid (AU 9) Y 08001 01FEB1984 Bone graft to other bones, not covered by any other item in this Part (AU 8) Y 08003 01FEB1984 Carpal bone, replacement of, by silicone or other implant, including any necessary tendon transfers (AU 9) Y 08006 01FEB1984 Bone graft not covered by any other item in this Part (D) (AU 8) Y 08009 01FEB1984 Shoulder-- removal of calcium deposit from cuff (AU 8) Y 08014 01FEB1984 Shoulder-- arthrotomy (AU 7) Y 08017 01FEB1984 Shoulder-- arthroplasty or plastic reconstruction (AU 11) Y 08019 01FEB1984 Shoulder-- arthrodesis or arthrectomy (AU 11) Y 08022 01FEB1984 Finger or other small joint-- arthrodesis, arthrectomy or arthroplasty (AU 5) Y 08023 01SEP1989 Finger joint, prosthetic replacement of (AU 5) Y 08024 01FEB1984 Metacarpo-phalangeal joint, prosthetic athroplasty (AU 5) N 08024 01SEP1989 Metacarpo-phalangeal joint, prosthetic arthroplasty (AU 5) Y 08026 01FEB1984 Small joint-- arthrotomy (AU 5) Y 08028 01FEB1984 Zygapophyseal joints, arthrectomy (AU 8) Y 08032 01FEB1984 Sacro-iliac joint-- arthrodesis (AU 12) Y 08036 01FEB1984 Other large joint-- arthrodesis, arthrectomy, arthroplasty or total synovectomy of (AU 10) Y 08040 01FEB1984 Other large joint-- arthrotomy (AU 8) Y 08044 01FEB1984 Hip-- arthrodesis (AU 15) Y 08048 01FEB1984 Hip-- arthrectomy (AU 15) Y 08053 01FEB1984 Hip-- arthroplasty (Austin Moore, Girdlestone or similar procedure) (AU 10) Y 08064 01MAR1987 Historical item included for item mapping purposes Y 08069 01FEB1984 Joint-- arthroplasty, total replacement of hip (McKee-Farrer, Charnley or similar procedure), knee, elbow, shoulder or ankle (AU 17) N 08069 01SEP1989 Joint - arthroplasty, total replacement of hip (McKee-Farrer, Charnley or similar procedure), wrist, knee, elbow, shoulder or ankle (AU 17) Y 08070 01FEB1984 Joint-- arthroplasty, revision operation for total replacement of hip, knee, elbow, shoulder or ankle with removal of prosthesis and replacement with new prosthesis (AU 20) Y 08072 01AUG1988 Shoulder, elbow, wrist, hip or ankle-arthroscopic examination of (AU 6) Y 08074 01FEB1984 Hip-- arthrotomy including removal of prosthesis (AU 9) Y 08080 01FEB1984 Knee-- diagnostic arthroscopy not associated with a procedure performed through the arthroscope (AU 5) N 08080 01MAR1984 Knee - diagnostic arthroscopy not associated with a procedure performed through the arthroscope(AU 6) Y 08082 01FEB1984 Knee-- arthrotomy, including one or more of, removal of loose body, removal of foreign body, biopsy or lateral capsular release, not associated with Item 8085, 8088, 8090 or 8092 (AU 6) Y 08085 01FEB1984 Knee-- single meniscectomy, repair of one collateral ligament, patellectomy, operation for recurrent dislocation of patella, single transfer of ligament for rotary instablity, single transfer of tendon for rotary instability or any other single procedure not covered by any other item in this Part-- one procedure (AU 7) N 08085 01MAR1984 Knee - single meniscectomy, repair of one collateral ligament, patellectomy, operation for recurrent dislocation of patella, single transfer of ligament for rotary instability, single transfer of tendon for rotary instability or any other single procedure not covered by any other item in this Part - one procedure(AU 8) Y 08088 01FEB1984 Knee-- total synovectomy, arthrectomy, arthrodesis,repair of cruciate ligaments, replacement of cruciate ligaments, reconstruction of cruciate ligaments, arthroscopic surgery for meniscectomy, chondroplasty, removal of loose body or removal of foreign body-- one procedure (AU 9) Y 08090 01FEB1984 Knee-- operation comprising two or more procedures covered by Item 8082, 8085 or 8088, but not covered by Item 8092 (AU 11) Y 08092 01FEB1984 Knee-- three or more procedures for correction of rotary instability involving injury to cruciate ligaments, comprising as a minimum, medial, lateral and intra-articular procedures (AU 12) Y 08105 01FEB1984 Joint or other synovial cavity-- aspiration of, injection into, or both of these procedures (AU 5) Y 08113 01FEB1984 Joint, repair of capsule or ligament of, or internal fixation of to stabilize joint (AU 7) Y 08116 01FEB1984 Foot or ankle region-- triple arthrodesis (AU 9) Y 08120 01FEB1984 Calcanean spur, removal of (AU 6) Y 08131 01FEB1984 Hallux valgus or rigidus, correction of, with osteotomy or osteectomy of phalanx or metatarsal (Keller's arthroplasty); or total replacement of the first metatarsophalangeal joint (AU 7) Y 08135 01FEB1984 Hallux valgus, correction of, with osteotomy or osteectomy of phalanx or metatarsal and transplantation of adductor hallucis tendon (AU 8) Y 08151 01FEB1984 Hammer toe, correction of (G) (AU 6) Y 08153 01FEB1984 Hammer toe, correction of (S) (AU 6) Y 08158 01FEB1984 Cervical rib, removal of (AU 11) Y 08159 01JUL1985 REMOVAL OF FIRST RIB by axillary approach ANAESTHETIC 13 UNITS - ITEM NOS 457G / 5248 N 08159 01SEP1989 Removal of the first rib by axillary approach (AU 13) Y 08161 01FEB1984 Scalenotomy (AU 8) Y 08166 01FEB1984 Acromion or coraco-acromion ligament, removal of (AU 7) Y 08169 01FEB1984 Excision of exostosis of small bone including simple removal of bunion (G) (AU 6) Y 08173 01FEB1984 Excision of exostosis of small bone including simple removal of bunion (S) (AU 6) Y 08175 01FEB1984 Excision of exostosis of small bone (D) (AU 6) Y 08179 01FEB1984 Excision of exostosis of large bone (G) (AU 6) N 08179 01SEP1989 Excision of exostosis of large bone or excision of osteoma of palate (G) (AU 6) Y 08182 01FEB1984 Excision of exostosis of large bone (S) (AU 6) N 08182 01SEP1989 Excision of exostosis of large bone or excision of osteoma of palate (S) (AU 6) Y 08185 01FEB1984 Osteotomy or osteectomy of phalanx, metacarpal or metatarsal (AU 6) Y 08187 01FEB1984 Osteotomy of phalanx, metacarpal or metatarsal, with internal fixation (AU 6) Y 08190 01FEB1984 Osteotomy or osteectomy of fibula, radius, ulna, clavicle, scapula (other than acromion), rib, tarsus or carpus (AU 7) Y 08193 01FEB1984 Osteotomy of fibula, radius, ulna, clavicle, scapula (other than acromion), rib, tarsus or carpus, with internal fixation (AU 7) Y 08195 01FEB1984 Osteotomy or osteectomy of tibia or humerus (AU 7) Y 08198 01FEB1984 Osteotomy or osteectomy of femur or pelvic bone (AU 8) Y 08201 01FEB1984 Osteotomy of tibia, humerus, femur or pelvic bone, with internal fixation (AU 11) Y 08206 01FEB1984 Osteotomy of femur-- sub-trochanteric (AU 11) Y 08209 01FEB1984 Osteectomy of vertebral bodies (AU 10) N 08209 01SEP1989 Vertebral body, total or sub-total excision of, including bone graft or other form of fixation (AU 26) Y 08211 01FEB1984 Osteotomy and distraction for lengthening of limb (AU 8) Y 08214 01FEB1984 Removal of distracting apparatus from limb, without internal fixation (AU 6) Y 08217 01FEB1984 Removal of distracting apparatus from limb, with internal fixation (AU 7) Y 08219 01FEB1984 Flexor tendon of hand, primary suture of (G) (AU 8) Y 08222 01FEB1984 Flexor tendon of hand, primary suture of (S) (AU 8) Y 08225 01FEB1984 Flexor tendon of hand, secondary suture of (AU 9) Y 08227 01FEB1984 Extensor tendon of hand, primary suture of (G) (AU 8) Y 08230 01FEB1984 Extensor tendon of hand, primary suture of (S) (AU 8) Y 08233 01FEB1984 Extensor tendon of hand, secondary suture of (AU 9) Y 08235 01FEB1984 Achilles tendon or other large tendon, suture of (G) (AU 9) Y 08238 01FEB1984 Achilles tendon or other large tendon, suture of (S) (AU 9) Y 08241 01FEB1984 Tendon of foot, primary suture of (AU 8) Y 08243 01FEB1984 Tendon of foot, secondary suture of (AU 8) Y 08246 01FEB1984 Tenotomy, subcutaneous, one or more tendons (AU 4) Y 08249 01FEB1984 Tenotomy, open, with or without tenoplasty (AU 7) Y 08251 01FEB1984 Tendon or ligament transplantation, not covered by any other item in this Part (AU 8) Y 08257 01FEB1984 Tendon graft (AU 8) Y 08259 01FEB1984 Insertion of artificial tendon prosthesis in preparation for tendon grafting (AU 10) Y 08262 01FEB1984 Achilles tendon or other large tendon-- operation for lengthening (AU 9) Y 08267 01FEB1984 Tendon sheath, incision of, or open operation for stenosing tendovaginitis (AU 6) Y 08275 01FEB1984 Tenolysis of flexor tendon following tendon injury, repair or graft (AU 8) Y 08279 01FEB1984 Tenolysis of extensor tendon following tendon injury, repair or graft (AU 7) Y 08282 01FEB1984 Tendon sheath of finger or thumb, synovectomy of (AU 8) Y 08283 01FEB1984 Synovectomy of metacarpophalangeal joint (AU 8) N 08283 01SEP1989 Synovectomy of metacarpophalangeal or metatarsophalangeal joint (AU 8) Y 08287 01FEB1984 Synovectomy of interphalangeal joint (AU 8) Y 08290 01FEB1984 Synovectomy of wrist, extensor or flexor tendon of wrist, carpometacarpal joint or inferior radio ulnar joint (AU 11) Y 08294 01FEB1984 Cicatricial flexion contracture of joint, correction of, involving tissues deeper than skin and subcutaneous tissue (AU 9) Y 08296 01FEB1984 Dupuytren's contracture, subcutaneous fasciotomy (AU 8) Y 08298 01FEB1984 Dupuytren's contracture, radical operation for (AU 9) Y 08302 01FEB1984 Fragmentation and rodding in fragilitas ossium-- humerus, radius or ulna (AU 11) Y 08304 01FEB1984 Fragmentation and rodding in fragilitas ossium-- tibia (AU 10) Y 08306 01FEB1984 Fragmentation and rodding in fragilitas ossium-- femur (AU 12) Y 08310 01FEB1984 Epiphyseodesis-- femur (AU 7) Y 08312 01FEB1984 Epiphyseodesis-- tibia and fibula (AU 7) Y 08314 01FEB1984 Epiphyseodesis-- femur, tibia and fibula (AU 10) Y 08316 01FEB1984 Staple arrest of hemi-epiphysis (AU 7) Y 08318 01FEB1984 Operation for the prevention of closure of epiphysial plate (AU 8) Y 08320 01FEB1984 Radical plantar fasciotomy (Steindler's operation) (AU 7) Y 08322 01FEB1984 Talipes equinovarus-- posterior release procedure (AU 7) Y 08324 01FEB1984 Talipes equinovarus-- medial release procedure (AU 7) Y 08326 01FEB1984 Subtalar arthrodesis (extra-articular) (AU 10) Y 08328 01FEB1984 Calcaneal osteotomy (AU 8) Y 08330 01FEB1984 Calcaneal osteotomy with bone graft (AU 10) Y 08332 01FEB1984 Congenital dislocation of hip-- manipulation and plaster (one hip) (AU 6) Y 08334 01FEB1984 Talipes equinovarus, calcaneus valgus, pes planus, metatarsus varus, genu varum or genu valgum-- manipulation under general anaesthesia (AU 5) Y 08336 01FEB1984 Talipes equinovarus, calcaneus valgus, pes planus, metatarsus varus, genu varum or genu valgum-- manipulation and plaster under general anaesthesia (AU 6) Y 08349 01FEB1984 Epiphysitis (Perthes' Calve's or Scheuermann's) plaster for (AU 5) Y 08351 01FEB1984 Epiphysitis (Sever's, Kohler's, Keinbock's or Schlatter's) plaster for (AU 5) Y 08352 01FEB1984 Contractures, manipulation under general anaesthesia, not covered by any other item in this Part (AU 5) Y 08354 01FEB1984 Contractures, manipulation and plaster under general anaesthesia, not covered by any other item in this Part (AU 5) Y 08356 01FEB1984 Spastic paralysis-- manipulation and plaster (one limb) (AU 5) Y 08378 01FEB1984 Hypertelorism, correction of (AU 14) Y 08380 01FEB1984 Choanal atresia, plastic repair of (AU 16) Y 08382 01FEB1984 Choanal atresia, repair of by puncture and dilatation (AU 11) Y 08384 01FEB1984 Macrocheilia, macroglossia or macrostomia, operation for (AU 13) Y 08386 01FEB1984 Torticollis, operation for (AU 7) Y 08388 01FEB1984 Oesophagus, correction of congenital stenosis by oesophagectomy and anastomosis (AU 21) Y 08390 01FEB1984 Tracheo-oesophageal fistula (with or without atresia), ligation and division of (AU 20) Y 08392 01FEB1984 Oesophageal atresia, with or without fistula, correction of (AU 23) Y 08394 01FEB1984 Neonatal alimentary obstruction, laparotomy for, with or without resection, including reduction of volvulus (AU 15) Y 08397 01NOV1990 Anal sphincterotomy as an independent procedure for Hirchsprung's disease (AU 6) Y 08398 01FEB1984 Hirschsprung's disease, rectosigmoidectomy for (AU 22) Y 08400 01FEB1984 Exomphalos or gastroschisis, operation for (AU 13) Y 08402 01FEB1984 Exomphalos or gastroschisis, operaation for, by plastic flap (AU 14) N 08402 01MAR1984 Exomphalos or gastroschisis, operation for, by plastic flap(AU 14) Y 08406 01FEB1984 Ano-rectal malformation, perineal anoplasty, primary or secondary repair (AU 10) Y 08408 01FEB1984 Ano-rectal malformation, rectoplasty, primary or secondary repair, not covered by Item 8406 (AU 18) Y 08410 01FEB1984 Contracted bladder neck (congenital) , wedge excision or perurethral resection of (AU 11) Y 08412 01FEB1984 Urachal fistula, operation for (AU 11) Y 08414 01FEB1984 Sphincter reconstruction for ectopia vesicae, ectopia cloacae or congenital incontinence (AU 12) Y 08418 01FEB1984 Urethral valves or urethral membrane, open removal of (AU 12) Y 08422 01FEB1984 Lymphangiectasis of limb (Milroy's disease)-- limited excision of (AU 14) Y 08424 01FEB1984 Lymphangiectasis of limb (Milroy's disease)-- radical excision of (AU 18) Y 08428 01FEB1984 Extra digit, ligation of pedicle (AU 4) Y 08430 01FEB1984 Extra digit, amputation of (AU 6) Y 08432 01FEB1984 Dermoid, periorbital or superficial nasal, excision of (G) (AU 8) Y 08434 01FEB1984 Dermoid, periorbital or superficial nasal, excision of (S) (AU 8) Y 08436 01FEB1984 Dermoid, orbital, excision of (AU 8) Y 08440 01FEB1984 Dermoid of nose, excision of, with intranasal extension (AU 8) Y 08442 01FEB1984 Myelomeningocele-- excision of sac (AU 13) Y 08444 01FEB1984 Myelomeningocele, extensive, requiing formal repair with skin flaps or Z plasty (AU 15) N 08444 01MAR1984 Myelomeningocele, extensive, requiring formal repair with skin flaps or Z plasty(AU 15) Y 08445 01MAY1991 METICULOUS REPAIR DESIGNED TO OBTAIN MAXIMUM FUNCTIONAL AND AESTHETIC RESULTS INCLUDING THE PREPARATION OF THE DEFECT REQUIRING REPAIR SINGLE STAGE LOCAL MUSCLE FLAP REP AIR, on eyelid, nose, lip, neck, hand, thumb, finger or genitals (AU 7 - 408/514) Y 08446 01MAY1991 SINGLE STAGE LOCAL MYOCUT ANEOUS FLAP REP AIR to one defect, simple and small (AU 11 - 453/522) Y 08447 01MAY1991 SINGLE STAGE LARGE MYOCUT ANEOUS FLAP REP AIR to one defect, (pectoralis major, latissimus dorsi, or similar large muscle) (AU 16 - 460/527) Y 08448 01FEB1984 Single stage local muscle flap repair, simple, small (AU 11) Y 08449 01FEB1984 Single stage large muscle flap repair, (pectoralis major, gastrocnemius, gracilis or similar large muscle) (AU 17) Y 08450 01FEB1984 Dermo-fat or fascia graft (including transplant or muscle flap) (AU 12) Y 08451 01MAY1991 MUSCLE OR MYOCUTANEOUS FLAP, delay of (AU 8 - 409/517) Y 08452 01FEB1984 Abrasive therapy, limited area (AU 6) Y 08453 01MAY1991 DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) (AU 12 - 454/523) Y 08454 01FEB1984 Abrasive therapy, extensive area (AU 7) Y 08455 01MAY1991 ABRASIVE THERAPY, limited to one aesthetic area (AU 6 - 407/513) Y 08456 01MAY1991 ABRASIVE THERAPY to more than one aesthetic area (AU 7 - 408/514) Y 08458 01FEB1984 Angioma, cauterisation of or injection into, under general anaesthetic (AU 7) Y 08460 01FEB1984 Angioma, cauterisation of or injection into, under general anaesthetic (D) (AU 7) Y 08462 01FEB1984 Angioma of skin, and subcutaneous tissue or mucous surface, small, excision and repair of (AU 7) Y 08464 01FEB1984 Angioma of skin and subcutaneous tissue or mucous surface, small, excision and repair of (D) (AU 7) Y 08466 01FEB1984 Angioma of skin and subcutaneous tissue or mucous surface, large, excision and repair of (AU 9) Y 08467 01MAY1991 ANGIOMA OF NECK, deep, excision of (AU 10 - 450/521) Y 08468 01FEB1984 Angioma of skin and subcutaneous tissue or mucous surface, large, excision and repair of (D) (AU 9) Y 08470 01FEB1984 Angioma, involving deeper tissue, small, excision and repair of (AU 9) Y 08471 01MAY1991 ARTERIOVENOUS MALFORMATION (3 centimetres or less) of superficial tissue, excision of (AU 11 - 453/522) Y 08472 01FEB1984 Angioma, involving deeper tissue, large, excision and repair of (AU 10) Y 08473 01MAY1991 ARTERIOVENOUS MALFORMATION, (greater than 3 centimetres), excision of (AU 16 - 460/527) Y 08474 01FEB1984 Haemangioma of neck, deep-seated, excision of (AU 10) Y 08475 01MAY1991 ARTERIOVENOUS MALFORMATION on eyelid, nose, lip, neck,hand, thumb, finger or genitals, excision of (AU 16 - 460/527) Y 08476 01FEB1984 Major excision and grafting for lymphoedema (AU 15) Y 08478 01FEB1984 Foreign implants for contour reconstruction (AU 10) N 08478 01SEP1989 Foreign implants, insertion of, for contour reconstruction (AU 10) Y 08479 01FEB1984 Foreign implants for contour reconstruction (D) (AU 10) N 08479 01SEP1989 Foreign implants, insertion of, for contour reconstruction (D) (AU 10) Y 08480 01FEB1984 Single stage local flap repair, simple, small, excluding flap for male pattern baldness (AU 7) Y 08481 01MAY1991 SINGLE STAGE LOCAL FLAP, where indicated to repair one defect, complicated or large, excluding flap for male pattern baldness (AU 10 - 450/521) Y 08482 01FEB1984 Single stage local flap repair, simple, small (D) (AU 7) Y 08483 01MAY1991 SINGLE STAGE LOCAL FLAP where indicated to repair one defect, on eyelid, nose, lip, neck, hand, thumb, finger or genitals (AU 12 - 454/523) Y 08484 01FEB1984 Single stage local flap repair, complicated or large, excluding flap for male pattern baldness (AU 10) Y 08485 01FEB1984 Direct flap repair (cross arm, abdominal or similar), first stage (AU 11) Y 08486 01FEB1984 Direct flap repair (cross arm, abdominal or similar), second stage (AU 9) Y 08487 01FEB1984 Direct flap repair, cross leg, first stage (AU 13) Y 08488 01FEB1984 Direct flap repair, cross leg, second stage (AU 10) Y 08490 01FEB1984 Direct flap repair, small (cross finger or similar), first stage (AU 7) Y 08492 01FEB1984 Direct flap repair, small (cross finger or similar), second stage (AU 7) Y 08494 01FEB1984 Indirect flap or tubed pedicle, formation of (AU 10) Y 08496 01FEB1984 Indirect flap or tubed pedicle, delay of (AU 8) Y 08498 01FEB1984 Indirect flap or tubed pedicle, preparation of intermediate or final site and attachment to the site (AU 10) Y 08500 01FEB1984 Indirect flap or tubed pedicle, spreading of pedicle, as a separate procedure (AU 8) Y 08502 01FEB1984 Direct, indirect or local flap repair, revision of graft (AU 7) Y 08504 01FEB1984 Free grafts (split skin or pinch grafts) on granulating areas, small (AU 7) Y 08506 01FEB1984 Free grafts (split skin or pinch grafts) on granulating areas, small (D) (AU 7) Y 08508 01FEB1984 Free grafts (split skin) on granulating areas, extensive (AU 11) Y 08509 01FEB1984 Free grafts (split skin) to burns, including excision of burned tissue-- involving not more than 2.5 per centum of total body surface (AU 8) Y 08510 01FEB1984 Free grafts (split skin) to burns, including excision of burned tissue-- involving more than 2.5 per centum of total body surface (AU 14) Y 08511 01FEB1984 Free grafts (homograft split skin) to burns, including excision of burned tissue-- involving more than 2.5 per centum of total body surface (AU 13) Y 08512 01FEB1984 Free grafts (split skin) including elective dissection, small (AU 8) Y 08514 01FEB1984 Free grafts (split skin) including elective dissection, small (D) (AU 8) Y 08515 01MAY1991 FREE GRAFTING (split skin) to one defect, including elective dissection, extensive (AU 11 - 453/522) Y 08516 01FEB1984 Free grafts (split skin) including elective dissection, extensive; or inlay graft using a mould, insertion of and removal of mould (AU 11) Y 08517 01MAY1991 FREE GRAFTING (split skin) to one defect, including elective dissection on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, not covered by Items 8515 or 8516 (AU 8 - 409/517) Y 08518 01FEB1984 Free full thickness grafts, excluding grafts for male pattern baldness (AU 9) Y 08519 01MAY1991 MICROVASCULAR REPAIR using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit (AU 14 - 458/525) Y 08520 01FEB1984 Free full thickness grafts (D) (AU 9) Y 08521 01MAY1991 MICRO-ARTERIAL OR MICRO-VENOUS GRAFf using microsurgical techniques (AU 22 - 466/537) Y 08522 01FEB1984 Revision under general anaesthesia of facial or neck scar not more than 3 cm. in length (AU 8) Y 08523 01MAY1991 MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for reimplantation of limb or digit or free transfer of tissue (AU 38 - 477/548) Y 08524 01FEB1984 Revision under general anaesthesia of facial or neck scar more than 3 cm. in length (AU 9) Y 08525 01MAY1991 SCAR, other than on face or neck, not more than 7 centimetres in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure (AU 10 - 450/521) Y 08526 01MAY1991 SCAR, other than on face or neck, more than 7 centimetres in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure (AU 12 - 454/523) Y 08527 01MAY1991 BREAST PROSTHESIS, removal of, as an independent procedure (AU 11 - 453/522) Y 08528 01FEB1984 Mammaplasty, reduction including repositioning of nipple (unilateral) (AU 10) N 08528 01MAR1984 Mammaplasty, reduction (unilateral) , with or without repositioning of nipple (AU 10) Y 08529 01MAY1991 FIBROUS CAPSULE SURROUNDING BREAST PROSTHESIS, excision or multiple incisions to, as an independent procedure (AU 10 - 450/521) Y 08530 01FEB1984 Augumentation mammaplasty for significant breast asymmetry or following mastectomy, where the mammaplasty is limited to one breast (AU 10) N 08530 01MAR1984 Augmentation mammaplasty for significant breast asymmetry or following mastectomy, where the mammaplasty is limited to one breast (AU 10) N 08530 01SEP1989 Augmentation mammaplasty for significant breast asymmetry where the augmentation is limited to one breast (AU 10) Y 08531 01NOV1986 Augmentation mammoplasty following mastectomy-unilateral (AU 9) N 08531 01SEP1989 Augmentation mammaplasty (unilateral), following mastectomy (AU 9) Y 08532 01NOV1986 Breast reconstruction using a latissimus dorsi or other large myocutaneous flap,including repair of secondary skin defect (AU 20) N 08532 01SEP1989 Breast reconstruction (unilateral), using a latissimus dorsi or other large myocutaneous flap, including repair of secondary skin defect (AU 20) Y 08533 01FEB1987 Breast reconstruction using breast sharing technique(first stage)including breast reduction, transfer of complex skin and breast tissue flap,split skin graft to pedicle of flap or other similar procedure (AU 15) Y 08534 01NOV1986 Breast reconstruction using breast sharing technique (second stage) including division of pedicle, insetting of breast flap, with closure of donor site or other similar procedure (AU 12) Y 08535 01FEB1984 Hair transplantation for the treatment of alopecia of congenital or traumatic origin or due to disease, excluding male pattern baldness, not covered by any other item in this Part (AU 11) Y 08536 01NOV1986 Breast reconstruction using tissue expansion-insertion of tissue expansion unit and all attendances for subsequent expansion injections (AU 9) N 08536 01SEP1989 Breast reconstruction (unilateral), following mastectomy, using tissue expansion -insertion of tissue expansion unit and all attendances for subsequent expansion injections (AU 9) Y 08537 01NOV1986 Breast reconstruction using tissue expansion-removal of tissue expansion unit and insertion of permanent prosthesis (AU 9) N 08537 01SEP1989 Breast reconstruction (unilateral), following mastectomy, using tissue expansion-removal of tissue expansion unit and insertion of permanent prosthesis (AU 9) Y 08538 01NOV1986 Nipple or areola or both,reconstruction of by any technique (AU 10) Y 08539 01MAY1991 BREAST PROSTHESIS, replacement of, following medical complications, (including rupture, migration, or capsule formation) where new pocket is formed (AU 15 - 459/526) Y 08540 01FEB1984 Digit, transplantation of-- complete procedure (AU 16) Y 08541 01MAY1991 HAIR TRANSPLANTATION for the treatment of alopecia of congenital or traumatic origin or due to disease, excluding male pattern baldness, not covered by any other item in this Part (AU 11 - 453/522) Y 08542 01FEB1984 Neurovascular island flap, including repair of secondary defect, excluding flap for male pattern baldness (AU 15) N 08542 01SEP1989 Neurovascular island flap, or free transfer of tissue with vascular or neurovascular pedicle, including repair of secondary defect excluding flap for male pattern baldness (AU 15) Y 08543 01NOV1986 Tissue expansion not covered by Items 8536/8537-insertion of tissue expansion unit and all attendances for subsequent expansion injections (AU 10) Y 08544 01FEB1984 Macrodactyly, plastic reduction of, each finger (AU 8) Y 08545 01MAY1991 INTRA OPERATIVE TISSUE EXPANSION performed during an operation when combined with any other Item in Part 10 including expansion injections and excluding treatment of male pattern baldness (AU 13 - 457/524) Y 08546 01FEB1984 Facial nerve paralysis, free fascia graft for (AU 12) Y 08548 01FEB1984 Facial nerve paralysis, muscle transfer or graft for (AU 13) Y 08549 01MAY1991 FACIAL NERVE PALSY, excision of tissue for (AU 12 - 454/523) Y 08550 01MAY1991 LIPOSUCTION (suction assisted lipolysis) to one regional area (thigh, buttock, or similar), for treatment of post-traumatic pseudolipoma (AU 13 - 457/524) Y 08551 01FEB1984 Meloplasty for correction of facial asymmetry due to soft tissue abnormality where the meloplasty is limited to one side of the face (AU 14) Y 08552 01FEB1984 Orbital cavity, reconstruction of floor or roof of (AU 12) N 08552 01SEP1989 Orbital cavity, reconstruction of walls or floor or both walls and floor with or without foreign implant (AU 12) Y 08553 01AUG1987 Orbital cavity, bone or cartilage graft to orbital walls or floor or both walls and floor including reduction of prolapsed or entrapped orbital contents (AU 14) Y 08554 01FEB1984 Maxilla, resection of (AU 17) Y 08556 01FEB1984 Mandible, resection of (AU 15) Y 08557 01MAY1991 MANDIBLE, including lower border, OR MAXILLA, sub-total resection of (AU 19 - 463/531) Y 08558 01FEB1984 Mandible, resection of (D) (AU 15) Y 08560 01FEB1984 Mandible, segmental resection of, for tumours (AU 13) Y 08562 01FEB1984 Mandible, segmental resection of, for tumours (D) (AU 13) Y 08564 01NOV1979 Mandible, section-fixation for prognathism or retrognathism (AU 14) Y 08566 01NOV1979 Mandible, section-fixation for prognathism or retrognathism (D) (AU 14) Y 08568 01FEB1984 Mandible, hemi-mandibular reconstruction with bone graft, not associated with Item 8556 (AU 15) Y 08570 01FEB1984 Mandible, condylectomy (AU 11) Y 08572 01FEB1984 Mandible, condylectomy (D) (AU 11) Y 08574 01NOV1979 Osteotomy or osteectomy of mandible (other than alveolar margins) for congenital or post-traumatic malformation, not covered by any other item in this Part (AU 11) Y 08576 01NOV1979 Osteotomy or osteectomy of mandible (other than alveolar margins) for congenital or post-traumatic malformation, not covered by any other item in this Part (D) (AU 11) Y 08578 01NOV1979 Osteotomy or osteectomy of maxilla (other than alveolar margins) or zygoma or both for congenital or post-traumatic malformation, not covered by any other item in this Part (AU 11) Y 08580 01NOV1979 Osteotomy or osteectomy of maxilla (other than alveolar margins) or zygoma or both for congenital or post-traumatic malformation, not covered by any other item in this Part (D) (AU 11) Y 08582 01FEB1984 Whole thickness reconstruction of eyelid other than by direct suture only (AU 10) Y 08584 01FEB1984 Reduction of upper eyelid for skin redundancy obscuring vision, herniation of orbital fat in exophthalmos, facial nerve palsy or post traumatic scarring, or, in respect of one of these conditions, the restoration of symmetry of the contralateral upper eyelid (AU 7) Y 08585 01FEB1984 Reduction of lower eyelid for herniation of orbital fat in exophthalmos, facial nerve palsy or post traumatic scarring, or, in respect of one of these conditions, the restoration of symmetry of the contralateral lower eyelid (AU 8) Y 08586 01FEB1984 Correction of ptosis (unilateral) (AU 12) Y 08588 01FEB1984 Ectropion or entropion, correction of (unilateral) (AU 9) Y 08592 01FEB1984 Symblepharon, grafting for (AU 8) Y 08594 01FEB1984 Rhinoplasty, correction of lateral or alar cartilages or both (AU 10) N 08594 01SEP1989 Rhinoplasty, correction of lateral or alar cartilages or columella, one or more (AU 10) Y 08596 01FEB1984 Rhinoplasty, correction of bony vault only (AU 10) Y 08598 01FEB1984 Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose (AU 12) Y 08599 01MAY1991 RHINOPLASTY involving nasal or septal cartilage graft (AU 14 - 458/525) Y 08600 01FEB1984 Rhinoplasty or similar contour restoration of the face, involving autogenous bone or costal cartilage graft (AU 13) N 08600 01SEP1989 Rhinoplasty involving autogenous bone or cartilage graft (excluding nasal or septal cartilage) (AU 13) Y 08601 01NOV1986 Contour restoration of one region of face using autogenous bone or cartilage graft (not covered by item 8600) (AU 18) Y 08602 01FEB1984 Rhinoplasty, secondary revision of (AU 10) Y 08604 01FEB1984 Rhinophyma, correction of (AU 9) Y 08605 01MAY1991 FACE, contour restoration of one region, using autogenous bone or cartilage graft (not covered by Item 8600) (AU 18 - 462/529) Y 08606 01FEB1984 Composite graft (chondrocutaneous or chondro-mucosal) to nose, ear or eyelid (AU 11) Y 08608 01FEB1984 Lop ear, bat ear or similar deformity, correction of (AU 8) Y 08612 01FEB1984 Congenital atresia, reconstruction of external auditory canal (AU 11) Y 08614 01FEB1984 Full thickness wedge excision of lip or eyelid, with repair by direct sutures (AU 8) Y 08616 01FEB1984 Vermilionectomy (AU 8) Y 08618 01FEB1984 Lip or eyelid reconstruction using full thickness flap (Abbe or similar), first stage (AU 11) Y 08620 01FEB1984 Lip or eyelid reconstruction using full thickness flap (Abbe or similar), second stage (AU 4) Y 08622 01FEB1984 Cleft lip, unilateral-- primary repair, (AU 12) Y 08623 01MAY1991 CLEFT LIP, unilateral - primary repair, one stage, with anterior palate repair (AU 14 - 458/525) Y 08624 01FEB1984 Cleft lip, complete primary repair, one stage, bilateral (AU 14) Y 08625 01MAY1991 CLEFT LIP, bilateral - primary repair, one stage, with anterior palate repair (AU 16 - 460/527) Y 08627 01MAY1991 CLEFT LIP, lip adhesion procedure, unilateral or bilateral (AU 10 - 450/521) Y 08628 01FEB1984 Cleft lip, secondary correction, partial or incomplete (AU 10) Y 08630 01FEB1984 Cleft lip, secondary correction, complete revision (AU 12) Y 08631 01MAY1991 CLEFT LIP, primary columella lengthening procedure, bilateral (AU 10 - 450/521) Y 08632 01FEB1984 Cleft lip, secondary correction, Abbe flap (AU 12) Y 08633 01MAY1991 CLEFT LIP reconstruction using full thickness flap (Abbe or similar), second stage (AU 8 - 409/517) Y 08634 01FEB1984 Cleft lip, secondary correction of nostril or nasal tip (AU 10) Y 08636 01FEB1984 Cleft palate, primary repair, partial cleft (AU 13) Y 08638 01FEB1984 Cleft palate, primary repair, partial cleft (D) (AU 13) Y 08640 01FEB1984 Cleft palate, primary repair, complete cleft or cleft requiring major repair (AU 14) Y 08642 01FEB1984 Cleft palate, primary repair, complete cleft or cleft requiring major repair (D) (AU 14) Y 08644 01FEB1984 Cleft palate, secondary repair, closure of fistula (AU 13) Y 08646 01FEB1984 Cleft palate, secondary repair, closure of fistula (D) (AU 13) Y 08648 01FEB1984 Cleft palate, secondary repair, lengthening procedure (AU 12) Y 08650 01FEB1984 Cleft palate, secondary repair, lengthening procedure (D) (AU 12) Y 08652 01FEB1984 Cleft palate, partial repair, complex cleft (AU 13) Y 08654 01FEB1984 Cleft palate, partial repair, complex cleft (D) (AU 13) Y 08655 01MAY1991 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 16 - 460/527) Y 08656 01FEB1984 Pharyngeal flap or pharyngoplasty (AU 15) N 08656 01SEP1989 Pharyngeal flap or pharyngoplasty, with or without tonsillectomy (AU 15) Y 08657 01MAY1991 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 20 - 464/533) Y 08658 01NOV1984 Unilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (AU 14) Y 08659 01NOV1984 Unilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 14) Y 08660 01NOV1984 Bilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (AU 18) Y 08661 01NOV1984 Bilateral osteotomy or osteectomy of mandible or maxilla, including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 18) Y 08662 01DEC1984 Osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures on the one jaw, including transposition of nerves and vessels and bone grafts taken from the same site (AU 22) Y 08663 01NOV1984 Osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures on the one jaw, including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 22) Y 08664 01DEC1984 Bilateral osteotomies or osteectomies of mandible or maxilla involving two such procedures of each jaw including transposition of nerves and vessels and bone grafts taken from the same site (AU 26) Y 08665 01NOV1984 Bilateral osteotomies or osteectomies of mandible or maxilla involving two such procedures of each jaw including transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 26) Y 08666 01APR1985 Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of one jaw and two such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (AU 32) Y 08667 01NOV1984 Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of one jaw and two such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 32) Y 08668 01DEC1984 Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (AU 34) Y 08669 01NOV1984 Complex bilateral osteotomies or osteectomies of mandible or maxilla, involving three or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site (D) (AU 34) Y 08670 01NOV1984 Genioplasty not associated with item 8658, 8660, 8662, 8664, 8666, or 8668 including transposition of nerves and vessels and bone grafts taken from the site (AU 10) Y 08671 01NOV1984 Genioplasty not associated with item 8659, 8661, 8663, 8665, 8667 or 8669 including transposition of nerves and vessels and bone grafts taken from the site (D) (AU 10) Y 08672 01DEC1984 Genioplasty associated with item 8658, 8660, 8662 or 8664 (AU 8) Y 08673 01NOV1984 Genioplasty associated with item 8659, 8661, 8663 or 8665 (D) (AU 8) Y 08674 01MAY1991 MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving three or more such procedures on the ONE JAW, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 24 - 468/539) Y 08675 01NOV1984 Hypertelorism, correction of, intra-cranial (AU 47) Y 08676 01MAY1985 Hypertelorism, correction of, sub-cranial (AU 26) Y 08677 01APR1986 Peri-orbital correction of Treacher Collins Syndrome, with rib and iliac bone grafts (AU 30) Y 08678 01MAR1985 Correction of unilateral orbital dystopia - total repositioning of one orbit intra-cranial (AU 35) Y 08679 01NOV1984 Correction of unilateral orbital dystopia-sub-total repositioning of one orbit, extra-cranial (AU 18) Y 08680 01NOV1984 Unilateral fronto-orbital advancement (AU 19) Y 08681 01DEC1984 Cranial vault reconstruction for oxycephaly, brachycephaly, turricephaly or similar condition-(bilateral frontoorbital advancement) (AU 39) Y 08682 01APR1985 Reconstruction of glenoid fossa, zygomatic arch and temporal bone (Obwegeser technique) (AU 19) Y 08683 01MAR1987 Construction of absent condyle and ascending ramus in hemifacial microsomia (AU 15) Y 08684 01MAY1991 OSSEO-INTEGRA TION PROCEDURE - extra oral, implantation of titanium fixture (AU 20 - 464/533) Y 08685 01MAY1991 OSSEO-INTEGRATION PROCEDURE, fixation of transcutaneous abutment (AU 16- 460/527) Y 08686 01MAY1991 MANDIBLE OR MAXILLA, osteotomies or oteectomies of, involving TWO such procedures of EACH JAW, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 28 - 472/543) Y 08687 01MAY1991 MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving THREE or MORE such procedures of ONE JAW and TWO such procedures of the OTHER JAW, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid screws or both (AU 34 - 492/563)fixation by bone plates, Y 08688 01MAY1991 FREE GRAFTING (split skin) to bums, including excision of burnt tissue - involving not more than 3 per cent of total body surface (AU 8 - 409/517) Y 08689 01MAY1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent of total body surface (AU 10 - 450/521) Y 08690 01MAY1991 FREE GRAFTING (split skin) to bums, including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface (AU 12 - 454/523) Y 08691 01MAY1991 FREE GRAFTING (split skin) to bums, including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface (AU 14 - 458/525) Y 08692 01MAY1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 12 per cent or more of total body surface (AU 16 - 460/527) Y 08693 01MAY1991 FREE GRAFTING (split skin) to bums, including excision of burnt tissue, on eyelid, nose, lip, neck, hand, thumb, finger or genitals (AU 18 - 462/529) Y 08694 01MAY1991 FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving not more than 3 per cent of total body surface (AU 13 - 457/524) Y 08695 01MAY1991 FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent Qf total body surface (AU 15 - 459/526) Y 08696 01MAY1991 FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface (AU 17 - 461/528) Y 08697 01MAY1991 FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface (AU 19 - 463/531) Y 08698 01MAY1991 FREE GRAFTING (xenograft or homograft split skin) to bums including excision of burnt tissue - involving 12 per cent or more of total body surface (AU 21 - 465/535) Y 08699 01MAY1991 MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving THREE or MORE such procedures of EACH JAW, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both (AU 36 - 476/547) Y 08700 01FEB1984 Erythrocyte radioactive uptake survival time test Y 08701 01SEP1989 Blood volume estimation Y 08702 01FEB1984 Blood volume estimation using radioactive chromium Y 08703 01SEP1989 Erythrocyte radioactive uptake survival time test or iron kinetic test Y 08704 01FEB1984 Gastrointestinal blood loss estimation with radioactive chromium involving serial examinations of stool specimens Y 08705 01SEP1989 Gastrointestinal blood loss estimation involving examination of stool specimens Y 08706 01FEB1984 Radioiodine, urinary estimation Y 08707 01SEP1989 Gastrointestinal protein loss Y 08708 01FEB1984 Protein bound radioactive iodine test Y 08710 01FEB1984 Radioactive B12 absorption test (Schilling test)-- one isotope Y 08711 01FEB1984 Radioactive B12 absorption test (Schilling test)-- two isotopes Y 08712 01FEB1984 Thallium myocardial study or thallium myocardial redistribution study (C) Y 08713 01FEB1984 Thallium myocardial study or thallium myocardial redistribution study (NC) Y 08714 01SEP1989 Radioactive B12 absorption test-one isotope Y 08715 01SEP1989 Radioactive B12 absorption test-two isotopes Y 08716 01FEB1984 Myocardial infarct avid imaging study, cardiac blood pool study or cardiac output estimation (C) Y 08717 01FEB1984 Myocardial infarct avid imaging study, cardiac blood pool study or cardiac output estimation (NC) Y 08718 01SEP1989 Thyroid uptake (using probe) Y 08719 01SEP1989 Perchlorate discharge study Y 08720 01FEB1984 Gated cardiac blood pool (equilibrium) study (C) Y 08721 01FEB1984 Gated cardiac blood pool (equilibrium) study (NC) Y 08722 01SEP1989 Renal function test (without imaging procedure) Y 08723 01FEB1984 Gated cardiac blood pool study with intervention (C) Y 08724 01FEB1984 Cardiac first pass blood flow study (gated or ungated) or cardiac shunt study (C) Y 08725 01SEP1989 Renal function test (associated with imaging and at least 2 blood samples) Y 08726 01SEP1989 Whole body count-not associated with any other item Y 08727 01SEP1989 Myocardial perfusion study using thallium-single study for stress OR reperfusion (C) Y 08728 01SEP1989 Myocardial perfusion study using thallium-single study for stress OR reperfusion (NC) Y 08730 01FEB1984 Lung perfusion study, lung ventilation study or lung aerosol study (C) Y 08731 01FEB1984 Lung perfusion study, lung ventilation study or lung aerosol study (NC) Y 08732 01SEP1989 Myocardial perfusion study using thallium-combined study for stress AND reperfusion (C) Y 08733 01SEP1989 Myocardial perfusion study using thallium-combined study for stress AND reperfusion (NC) Y 08734 01SEP1989 Myocardial infarct-avid imaging study (C) Y 08735 01SEP1989 Myocardial infarct-avid imaging study (NC) Y 08736 01FEB1984 Liver and spleen study, hepato biliary study or Meckel's diverticulum study (C) Y 08737 01FEB1984 Liver and spleen study, hepato biliary study or Meckel's diverticulum study (NC) Y 08738 01FEB1984 Spleen study, red blood cell spleen study, pancreas study, gastrooesophageal reflux study, salivary study or bowel haemorrhage study (C) Y 08739 01FEB1984 Spleen study, red blood cell spleen study, pancreas study, gastrooesophageal reflux study, salivary study or bowel haemorrhage study (NC) Y 08740 01SEP1989 Gated cardiac blood pool (equilibrium) study (C) Y 08741 01SEP1989 Gated cardiac blood pool study with intervention (C) Y 08742 01FEB1984 Liver and lung study (C) Y 08743 01FEB1984 Liver and lung study (NC) Y 08744 01SEP1989 Cardiac first pass blood flow study, cardiac shunt study or cardiac output study (not part of other investigation) (C) Y 08745 01SEP1989 Cardiac first pass blood flow study, cardiac shunt study or cardiac output study (not part of other investigation) (NC) Y 08746 01FEB1984 Le Veen shunt study (C) Y 08747 01FEB1984 Le Veen shunt study (NC) Y 08748 01SEP1989 Cardiac first pass blood flow study, cardiac shunt study or cardiac output study when associated with another item in this Part (C) Y 08749 01SEP1989 Cardiac first pass blood flow study, cardiac shunt study or cardiac output study when associated with another item in this Part (NC) Y 08750 01FEB1984 Gastric emptying study Y 08751 01SEP1989 Lung perfusion study (C) Y 08752 01SEP1989 Lung perfusion study (NC) Y 08753 01SEP1989 Lung ventilation study using Xe127 gas (C) Y 08754 01SEP1989 Lung ventilation study using Xe127 gas (NC) Y 08755 01FEB1984 Renal study (static) or placental study (C) Y 08756 01FEB1984 Renal study (static) or placental study (NC) Y 08757 01SEP1989 Lung ventilation study using Xe133 gas (C) Y 08758 01SEP1989 Lung ventilation study using Xe133 gas (NC) Y 08759 01FEB1984 Cystoureterogram or quantitative renogram (C) Y 08760 01FEB1984 Cystoureterogram or quantitative renogram (NC) Y 08761 01SEP1989 Lung ventilation study using aerosol (C) Y 08762 01SEP1989 Lung ventilation study using aerosol (NC) Y 08763 01FEB1984 Testicular study (C) Y 08764 01FEB1984 Testicular study (NC) Y 08765 01SEP1989 Lung perfusion study and lung ventilation study using either Xe127 or Xe133 gas (C) Y 08766 01SEP1989 Lung perfusion study and lung ventilation study using either Xe127 or Xe133 gas (NC) Y 08767 01SEP1989 Lung perfusion study and lung ventilation study using aerosol (C) Y 08768 01SEP1989 Lung perfusion study and lung ventilation study using aerosol (NC) Y 08769 01FEB1984 Brain study (static) or cerebro spinal fluid study (static) (C) Y 08770 01FEB1984 Brain study (static) or cerebro spinal fluid study (static) (NC) Y 08771 01SEP1989 Liver and spleen study (colloid) (C) Y 08772 01SEP1989 Liver and spleen study (colloid) (NC) Y 08773 01FEB1984 Shunt patency study (C) Y 08774 01FEB1984 Shunt patency study (NC) Y 08775 01SEP1989 Red blood cell spleen study (C) Y 08776 01SEP1989 Red blood cell spleen study (NC) Y 08777 01SEP1989 Hepatobiliary study (C) Y 08778 01SEP1989 Hepatobiliary study (NC) Y 08779 01FEB1984 Dynamic flow study or regional blood volume quantitative study (C) Y 08780 01FEB1984 Dynamic flow study or regional blood volume quantitative study (NC) Y 08781 01SEP1989 Bowel haemorrhage study (C) Y 08782 01SEP1989 Bowel haemorrhage study (NC) Y 08783 01FEB1984 Venography, lymphoscintigraphy, labelled platelets thrombus study or labelled white cell study (C) Y 08784 01FEB1984 Venography, lymphoscintigraphy, labelled platelets thrombus study or labelled white cell study (NC) Y 08785 01SEP1989 Meckel's diverticulum study (C) Y 08786 01SEP1989 Meckel's diverticulum study (NC) Y 08787 01FEB1984 Peripheral perfusion study (C) Y 08788 01FEB1984 Peripheral perfusion study (NC) Y 08789 01SEP1989 Salivary study (C) Y 08790 01SEP1989 Salivary study (NC) Y 08791 01SEP1989 Gastro-oesophageal reflux study (C) Y 08792 01SEP1989 Gastro-oesophageal reflux study (NC) Y 08793 01FEB1984 Bone study-- 4 or more areas (C) Y 08794 01FEB1984 Bone study-- 4 or more areas (NC) Y 08795 01SEP1989 Oesophageal clearance study (C) Y 08796 01SEP1989 Oesophageal clearance study (NC) Y 08797 01FEB1984 Bone study-- less than 4 areas (C) Y 08798 01FEB1984 Bone study-- less than 4 areas (NC) Y 08799 01FEB1984 Joint study of two or more joints (C) Y 08800 01FEB1984 Joint study of two or more joints (NC) Y 08801 01SEP1989 Gastric emptying study using single tracer (C) Y 08802 01SEP1989 Gastric emptying study using dual tracer (C) Y 08803 01FEB1984 Tumour seeking study-- 3 or more areas (C) Y 08804 01FEB1984 Tumour seeking study-- 3 or more areas (NC) Y 08805 01SEP1989 Renal study involving dynamic flow study and computer extraction of functional parameters (C) Y 08807 01FEB1984 Tumour seeking study-- less than 3 areas (C) Y 08808 01FEB1984 Tumour seeking study-- less than 3 areas (NC) Y 08809 01SEP1989 Renal study with intervention (C) Y 08810 01SEP1989 Renal study with intervention (NC) Y 08811 01SEP1989 Cystoureterogram (C) Y 08812 01SEP1989 Cystoureterogram (NC) Y 08813 01FEB1984 Thyroid study (using technetium, iodine or caesium) perchlorate discharge study (C) N 08813 01MAR1984 Thyroid study (using technetium, iodine or caesium) or perchlorate discharge study (C) Y 08814 01FEB1984 Thyroid study (using technetium, iodine or caesium) perchlorate discharge study (NC) N 08814 01MAR1984 Thyroid study (using technetium, iodine or caesium) or perchlorate discharge study (NC) Y 08815 01SEP1989 Testicular study (C) Y 08816 01SEP1989 Testicular study (NC) Y 08817 01FEB1984 Thyroid uptake study (C) Y 08818 01FEB1984 Thyroid uptake study (NC) Y 08819 01SEP1989 Brain study with blood brain barrier agent (C) Y 08820 01SEP1989 Brain study with blood brain barrier agent (NC) Y 08821 01FEB1984 Parathyroid study Y 08822 01SEP1989 Cerebro-spinal fluid transport study (C) Y 08823 01SEP1989 Cerebro-spinal fluid transport study (NC) Y 08824 01FEB1984 Adrenal study (C) Y 08825 01FEB1984 Adrenal study (NC) Y 08826 01SEP1989 Cerebro-spinal fluid shunt patency study (C) Y 08827 01SEP1989 Cerebro-spinal fluid shunt patency study (NC) Y 08828 01FEB1984 Study of region or organ not covered by any other item in this Part (C) Y 08829 01FEB1984 Study of region or organ not covered by any other item in this Part (NC) Y 08830 01SEP1989 Dynamic blood flow study or regional blood volume quantitative study (not associated with any other item in this Part) (C) Y 08831 01SEP1989 Dynamic blood flow study or regional blood volume quantitative study (not associated with any other item in this Part) (NC) Y 08832 01SEP1989 Bone study-whole body (C) Y 08833 01SEP1989 Bone study-whole body (NC) Y 08834 01SEP1989 Bone study-whole body and dynamic blood flow or regional blood volume quantitative study (C) Y 08835 01SEP1989 Bone study-whole body and dynamic blood flow or regional blood volume quantitative study (NC) Y 08836 01SEP1989 Whole body study using iodine (C) Y 08837 01SEP1989 Whole body study using iodine (NC) Y 08838 01SEP1989 Whole body study using gallium (C) Y 08839 01SEP1989 Whole body study using gallium (NC) Y 08840 01SEP1989 Whole body study using cells labelled with technetium (C) Y 08841 01SEP1989 Whole body study using cells labelled with technetium (NC) Y 08842 01SEP1989 Bone marrow study-whole body (C) Y 08843 01SEP1989 Bone marrow study-whole body (NC) Y 08844 01SEP1989 Repeat whole body study on different occasion using same administration of radiopharmaceutical (C) Y 08845 01SEP1989 Repeat whole body study on different occasion using same administration of radiopharmaceutical (NC) Y 08846 01SEP1989 Localised bone or joint study including flow and blood pool studies (C) Y 08847 01SEP1989 Localised bone or joint study including flow and blood pool studies (NC) Y 08848 01SEP1989 Localised bone, joint, tumour, infection or inflammation seeking study using gallium (C) Y 08849 01SEP1989 Localised bone, joint, tumour, infection or inflammation seeking study using gallium (NC) Y 08850 01NOV1984 Procedure service associated with the administration of a radionucletide in relation to a service covered by an item in Part 8A or Part 11. Y 08851 01SEP1989 Localised bone, joint, tumour, infection or inflammation seeking study using technetium (C) Y 08852 01SEP1989 Localised bone, joint, tumour, infection or inflammation seeking study using technetium (NC) Y 08853 01SEP1989 Repeat localised bone, joint, tumour, infection or inflammation seeking study on different occasion using same administration of radiopharmaceutical (C) Y 08854 01SEP1989 Repeat localised bone, joint, tumour, infection or inflammation seeking study on different occasion using same administration of radiopharmaceutical (NC) Y 08855 01SEP1989 Venography (including blood pool study, active uptake study or dynamic blood flow study) (C) Y 08856 01SEP1989 Venography (including blood pool study, active uptake study or dynamic blood flow study) (NC) Y 08857 01SEP1989 Lymphoscintigraphy (C) Y 08858 01SEP1989 Lymphoscintigraphy (NC) Y 08859 01SEP1989 Thyroid Study (C) Y 08860 01SEP1989 Thyroid Study (NC) Y 08861 01SEP1989 Thyroid uptake study performed on gamma camera (C) Y 08862 01SEP1989 Thyroid uptake study performed on gamma camera (NC) Y 08863 01SEP1989 Parathyroid (C) Y 08864 01SEP1989 Adrenal Study using Selenocholesterol (C) Y 08865 01SEP1989 Adrenal Study using Selenocholesterol (NC) Y 08866 01SEP1989 Adrenal Study (not covered by Item 8864/8865) (C) Y 08867 01SEP1989 Adrenal Study (not covered by Item 8864/8865) (NC) Y 08868 01SEP1989 Single photon emission tomography when associated with another item in this Part (C) Y 08869 01SEP1989 Tear Duct Study (C) Y 08870 01SEP1989 Tear Duct Study (NC) Y 08871 01SEP1989 Particle perfusion study (intra-arterial) or Le Veen Shunt study (C) Y 08872 01SEP1989 Particle perfusion study (intra-arterial) or Le Veen Shunt study (NC) Y 08873 01SEP1989 Study of region or organ not covered by any other item in this Part (C) Y 08874 01SEP1989 Study of region or organ not covered by any other item in this Part (NC) Y 08875 01SEP1989 Procedural service associated with the administration of a radionuclide in relation to a service covered by any item in Part 8A or Part 11 Y 08878 01NOV1990 Administration of a therapeutic dose of a radioisotope - not covered by any other item in this Part Y 08880 01NOV1990 Intra-cavitary administration of a therapeutic dose of Yttrium 90 (not including preliminary paracentesis) (AU 5) Y 08882 01NOV1990 Administration of a therapeutic dose of Iodine 131 for thyroid cancer by single dose technique Y 08884 01NOV1990 Administration of a therapeutic dose of Iodine 131 for thyrotoxicosis by single dose technique Y 08886 01NOV1990 Intravenous administration of a therapeutic dose of Phosphorous 32 Y 08901 01FEB1984 Professional attendance not covered by Item 8902 (AO) Y 08902 01FEB1984 Professional attendance and treatmentplanning where treatment is deferred (AO) Y 08903 01FEB1984 Production of dental study models not associated with Item 8902 or with a service covered by Item 8914, 8915, 8917, 8918, 8919, 8922, 8923, 8924, 8925, or 8928 (AO) Y 08905 01FEB1984 Orthodontic radiography-- orthopantomography (AO) Y 08906 01FEB1984 Orthodontic radiography-- anteroposterior cephalometric radiography with cephalometric tracings or lateral cephalometric radiography with cephalometric tracings (AO) Y 08907 01FEB1984 Orthodontic radiography-- anteroposterior and lateral cephalometric radiography, with cephalometric tracings (AO) Y 08908 01FEB1984 Orthodontic radiography-- anteroposterior and lateral cephalometric radiography, with cephalometric tracings and orthopantomography (AO) Y 08909 01FEB1984 Orthodontic radiography-- anteroposterior and lateral cephalometric radiography, with cephalometric tracings, orthopantomography and hand-wrist studies (including growth prediction) (AO) Y 08914 01FEB1984 Pre-surgical infant maxillary arch repositioning, including supply of appliances and all associated consultations-- where one appliance is used (AO) Y 08915 01FEB1984 Pre-surgical infant maxillary arch repositioning, including supply of appliances and all associated consultations-- where two appliances are used (AO) Y 08917 01FEB1984 Deciduous dentition treatment-- maxillary arch expansion, including supply of appliances and all associated consultations, treatmentplanning and retention services beyond the period of active treatment (AO) Y 08918 01FEB1984 Deciduous and permanent dentition treatment-incisor alignment using fixed appliances in maxillary arch, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment (AO) Y 08919 01FEB1984 Deciduous and permanent dentition treatment (not being treatment associated with treatment covered by Item 8918)-- lateral arch expansion and incisor alignment using fixed appliances in maxillary arch, including supply of appliances and all associated attendances, treatment-planning and retention services beyond the period of active treatment (AO) Y 08922 01FEB1984 Permanent dentition treatment (not being treatment associated with treatment covered by Item 8924 or 8925)-- single arch (mandibular or maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- initial three months of active treatment (AO) Y 08923 01FEB1984 Permanent dentition treatment (not being treatment associated with treatment covered by Item 8924 or 8925)-- single arch (mandibular or maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- each three months of active treatment after the first for a maximum of a further 33 months (AO) Y 08924 01FEB1984 Permanent dentition treatment (not being treatment associated with treatment covered by Item 8922 or 8923)-- two-arch (mandibular and maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- initial three months of active treatment (AO) Y 08925 01FEB1984 Permanent dentition treatment (not being treatment associated with treatment covered by Item 8922 or 8923)-- two-arch (mandibular and maxillary) treatment (correction or alignment, or both) using fixed appliances, including supply of appliances and all associated consultations, treatment-planning and retention services beyond the period of active treatment-- each three months of active treatment after the first for a maximum of a further 33 months (AO) Y 08928 01FEB1984 Pre-sugical or post-sugrical jaw growth guidance using removable appliances, including supply of appliances and all associated consultations and treatment-planning (AO) N 08928 01MAR1984 Pre-surgical or post-surgical jaw growth guidance using removable appliances, including supply of appliances and all associated consultations and treatment-planning (AO) Y 08931 01FEB1984 Removal of tooth or tooth fragment (not being treatment covered by Item 8936, 8937, 8938, 8939, 8940 or 8941), where the patient is referred by a recognized orthodontist (AD) N 08931 01MAR1984 Removal of tooth or tooth fragment (not being treatment covered by Item 8936, 8937, 8938, 8939, 8940 or 8941), where the patient is referred by a recognized orthodonist (AD) Y 08932 01FEB1984 Removal of tooth or tooth fragment under general anaesthesia, where the patient is referred by a recognized orthodontist (AD) Y 08933 01FEB1984 Removal of each additional tooth or tooth fragment at the same attendance at which a service referred to in Item 8931 or 8932 is rendered (AD) Y 08936 01FEB1984 Surgical removal of erupted tooth, where the patient is referred by a recognized orthodontist (AOS) Y 08937 01FEB1984 Surgical removal of tooth with soft tissue impaction, where the patient is referred by a recognized orthodontist (AOS) Y 08938 01FEB1984 Surgical removal of tooth with partial bone impaction, where the patient is referred by a recognized orthodontist (AOS) Y 08939 01FEB1984 Surgical removal of tooth with complete bone impaction, where the patient is referred by a recognized orthodontist (AOS) Y 08940 01FEB1984 Surgical removal of tooth fragment requiring incision of soft tissue only, where the patient is referred by a recognized orthodontist (AOS) Y 08941 01FEB1984 Surgical removal of tooth fragment requiring removal of bone, where the patient is referred by a recognized orthodontist (AOS) Y 08945 01FEB1984 Surgical exposure, stimulation and packing of unerupted tooth, where the patient is referred by a recognized orthodontist (AOS) Y 08946 01FEB1984 Surgical exposure of unerupted tooth for the purpose of fitting a traction device, where the patient is referred by a recognized orthodontist (AOS) Y 08947 01FEB1984 Surgical repositioning of unerupted tooth, where the patient is referred by a recognized orthodontist (AOS) Y 08948 01FEB1984 Transplantation of tooth bud, where the patient is referred by a recognized orthodontist (AOS) Y 08960 01FEB1984 Attendance comprising consultation, preventive treatment and prophylaxis, of not more than thirty minutes duration-- each attendance to a maximum of three attendances in any period of twelve months (AD) N 08960 01SEP1989 Attendance comprising consultation, preventive treatment and prophylaxis, of not less than thirty minutes duration-each attendance to a maximum of three attendances in any period of twelve months (AD) Y 08961 01FEB1984 Provision and fitting of acrylic base partial denture, including retainers-- one tooth (AD) Y 08962 01FEB1984 Provision and fitting of acrylic base partial denture, including retainers-- two teeth (AD) Y 08963 01FEB1984 Provision and fitting of acrylic base partial denture, including retainers-- three teeth (AD) Y 08964 01FEB1984 Provision and fitting of acrylic base partial denture, including retainers-- four teeth (AD) Y 08965 01FEB1984 Provision and fitting of acrylic base partial denture, including retainers-- five to nine teeth (AD) Y 08966 01FEB1984 Provision and fitting of acrylic base partial denture, including retainers-- ten to twelve teeth (AD) Y 08971 01FEB1984 Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-- one tooth (AD) Y 08972 01FEB1984 Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-- two teeth (AD) Y 08973 01FEB1984 Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-three teeth (AD) Y 08974 01FEB1984 Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-four teeth (AD) Y 08975 01FEB1984 Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-five to nine teeth (AD) Y 08976 01FEB1984 Provision and fitting of cast metal base (cobalt chromium alloy) partial denture including casting and retainers-ten to twelve teeth (AD) Y 08980 01FEB1984 Provision and fitting of retainers (not being treatment associated with treatment covered by Item 8961, 8962, 8963, 8964, 8965, 8966, 8971, 8972, 8973, 8974, 8975 or 8976)-each retainer (AD) Y 08982 01FEB1984 Adjustment of partial denture (not being treatment associated with treatment covered by Item 8961, 8962, 8963, 8964, 8965, 8966, 8971, 8972, 8973, 8974, 8975 or 8976) (AD) Y 08984 01FEB1984 Relining of partial denture by laboratory process and associated fitting (AD) N 08984 01MAR1984 Reclining of partial denture by laboratory process and associated fitting (AD) Y 08986 01FEB1984 Remodelling and fitting of partial denture of more than four teeth (AD) Y 08988 01FEB1984 Repair to cast metal base of partial denture-one or more points (AD) Y 08990 01FEB1984 Addition of a tooth or teeth to a partial denture to replace extracted tooth or teeth, including taking of necessary impression (AD) Y 09011 01JUL1985 ANTENATAL CARDIOTOCOGRAPHY in the management of high risk pregnancy (for services from 1 July 1985 to 31 July 1986) Y 09021 01NOV1986 ANAESTHETICS ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with removal of phaeochromocytoma - SIXTEEN UNITS (G) Y 09022 01NOV1986 ANAESTHETICS ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with removal of phaeochromocytoma - SIXTEEN UNITS (S) Y 09023 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with insertion of peripheral venous cannula - FOUR UNITS (G) Y 09024 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with insertion of peripheral venous cannula - FOUR UNITS (S) Y 09025 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with peripheral venous cannulation by open exposure - FIVE UNITS (G) Y 09026 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with peripheral venous cannulation by open exposure - FIVE UNITS (S) Y 09027 01SEP1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation - FIVE UNITS (G) N 09027 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation — FIVE UNITS (G) Y 09028 01OCT1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation - FIVE UNITS (S) N 09028 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with percutaneous central venous cannulation — FIVE UNITS (S) Y 09029 01MAR1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation OVER TWELVE YEARS of age - EIGHT UNITS (G) Y 09030 01MAR1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation OVER TWELVE YEARS of age - EIGHT UNITS (S) Y 09031 01OCT1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation UNDER TWELVE YEARS of age - TWELVE UNITS (G) Y 09032 01NOV1986 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with open exposure central venous cannulation UNDER TWELVE YEARS of age - TWELVE UNITS (S) Y 09033 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with electrocochleography (insertion of electrodes and brain stem evoked response audiometry) - ELEVEN UNITS (G) Y 09034 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with electrocochleography (insertion of electrodes and brain stem evoked response audiometry) - ELEVEN UNITS (S) Y 09035 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manual removal of products of conception, treatment of postpartum haemorrhage or repair of third degree tear - SEVEN UNITS (G) Y 09036 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manual removal of products of conception, treatment of postpartum haemorrhage or repair of third degree tear - SEVEN UNITS (S) Y 09037 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manipulative correction of acute inversion of uterus - EIGHT UNITS (G) Y 09038 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with manipulative correction of acute inversion of uterus - EIGHT UNITS (S) Y 09039 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with caesarean section - TEN UNITS (G) Y 09040 01AUG1987 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with caesarean section - TEN UNITS (S) Y 09041 01AUG1988 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with repair of episiotomy - FIVE UNITS (G) Y 09042 01AUG1988 ADMINISTRATION OF AN ANAESTHETIC ASSOCIATED with repair of episiotomy - FIVE UNITS (S) Y 09061 01JUL1985 ADMINISTRATION OF CYTOTOXIC AGENT by intravenous drip infusion (for services from 1 July 1985 to 31 July 1986) Y 09062 01AUG1988 MISCELLANEOUS PROCEDURES PULMONARY ARTERY pressure monitoring during open heart surgery, in a person under 12 years of age Y 09063 01AUG1988 PULMONARY ARTERY pressure monitoring during open heart surgery, in a person over 12 years of age Y 09065 01AUG1989 ASSISTED REPRODUCTIVE TECHNOLOGIES involving handling of both human ova and sperm including invitro fertilisation or gamete intra-faiIopian transfer or similar !echniques, when rendered in conjunction with Y 09066 01DEC1989 M-MODE AND TWO DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST TWO THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not associated with Items 791, 793 or 913 Y 09067 01DEC1989 OVERNIGHT INVESTIGATION FOR SLEEP APNOEA FOR A PERIOD OF AT LEAST EIGHT HOURS DURATION, involving continuous morutoring of oxygen saturation and breathing using a multi-channel polygraph, and recordings of EEG, EOG, submental EMG, anterior tibial EMG, respiratory movement, airflow, oxygen saturation and ECG, with continuous technician attendance, under the supervision of a consultant physician in the practice of his or her specialty of thoracic medicine, where the patient is referred to him or her by a medical practitioner, including interpretation by physician of recordings; payable not more than three times in any twelve month period Y 09341 01AUG1988 ORTHOPANTOMOGRAPHY and report Y 09342 01AUG1988 PREPARATION FOR DISCOGRAPHY using Metrizarnide contrast medium Y 09343 01AUG1988 PREPARATION FOR CONTRAST ARTHROGRAPHY or double contrast arthrography excluding arthrography of the joints between articular processes of the vertebrae Y 09344 01AUG1988 PREPARATION FOR SIALOGRAPHY Y 09381 01FEB1988 RADIATION FIELD SETTING using a simulator or isocentric x-ray or megavoliage machine of a single area for treatment by a single field or parallel opposed fields (not associated with Item 9384) Y 09382 01FEB1988 RADIATION FIELD SETTING using a simulator or isocentric x-ray or megavolt age machine of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 9385) Y 09383 01MAR1988 RADIATION FIELD SETTING usining simulator or isocentric x-ray or megavoltage machine of three or more areas, or of total body or half body irradiatigrt, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 9386) Y 09384 01FEB1988 RADIATION FIELD SETTING using a diagnostic x-ray unit of a single area for treatment by a single field or parallel opposed fields (not associated with Item 9381) Y 09385 01FEB1988 RADIATION FIELD SETTING using a diagnostic x-ray unit of a single area, where views in more than one plane are required for treatment by multiple fields, or of two areas (not associated with Item 9382) Y 09386 01FEB1988 RADIATION FIELD SETTING using a diagnostic x-ray unit of three or more areas, or of total body or half body irradiation, or of mantle therapy or inverted Y fields, or of irregularly shaped fields using multiple blocks, or of off-axis fields or several joined fields (not associated with Item 9383) Y 09387 01FEB1988 "RADIATION DOSIMETRY by a CT interfacing computer for ""megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane" Y 09388 01FEB1988 RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy adiotherapy to a single area by three or more fields, or by a single field or parallel opposed fields to two areas, or here wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons Y 09389 01FEB1988 RADIATION DOSIMETRY by a CT interfacing planning computer for megavoltage or teletherapy radiotherapy o three or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane implants of more than 10 sources or ribbons Y 09390 01FEB1988 RADIATION DOSIMETRY by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy by a single field or parallel opposed fields to one area with up to two shielding blocks, or for brachytherapy with isodose calculations in a single plane Y 09391 01FEB1988 RADIATION DOSIMETRY by a non-CT interfacing planning computer for megavoltage or teletherapy radiotherapy to a single Ii area by three or more fields, or by a single field or parallel opposed fields to two areas, or where wedges are used, or for brachytherapy for multiplane implants of up to 10 sources or ribbons Y 09392 01FEB1988 RADIATION DOSIMETRY by a non-CT interfac planning computer for megavoltage or teletherapy radiotherapy to three or more areas, or by mantle fields or inverted Y fields or tangential fields or irregularly shaped fields using multiple blocks, or off-axis fields, or several joined fields, or for brachytherapy using multiplane of more than 10 sources or ribbons Y 09401 01SEP1986 OPERATIONS HAEMORRHAGE, arrest of, following circumcision requiring general anaes-thesia Y 09402 01MAR1987 AMPUTATION STUMP, reamputation of, to provide adequate skin and muscle cover. ANAESTHETIC - ITEM NOS 488G/560S (for services from 31 July 1986 to 31 October 1986) Y 09403 01OCT1986 NASAL SEPTUM BUTTON, insertion of Y 09404 01AUG1988 PERCUTANEOUS NEEDLE BIOPSY of lung ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S Y 09405 01AUG1988 NASAL TURBINATES, cryotherapy to ANAESTHETIC 6 UNIT - ITEM NOS 407G / 5I3S Y 09406 01AUG1988 PERCUTANEOUS EPIDURAL IMPLANCT FOR CHRONIC PAIN -insertion of (one or two stages), not involving laminectomy ANAESTHETIC 8 ITS - ITEM NOS 409G / 5l7S Y 09407 01AUG1988 PERCUTANEOUS EPIDURAL IMPLANCT FOR CHRONIC PAIN - removal of ANAESTHETIC 7 UNITS - ITEM NOS 408G / 514S Y 09408 01AUG1988 POSTERIOR MOBILISATION (release), operaiion for scoliosis ANAESTHETIC 21 UNITS - ITEM NOS 4650 / 535S Y 09409 01AUG1988 FINGER JOINT, prosthetic replacement of ANAETHETIC 5 UNITS - ITEM NOS 406G / 510S Y 09410 01AUG1988 ARGON LASER THERAPY for vascular lesions of the Skin - session up to one half hour Y 09411 01AUG1988 ARGON LASER THERAPY for vascular lesions of the skin- session taking more than one half hour but less than one hour Y 09412 01AUG1988 ARGON LASER THERAPY for vascular lesions of the skin - session taking more than one hour but less than two hours Y 09413 01AUG1988 ARGON LASER THERAPY for vascular lesions of the skin - session taking more than two hours but less than three hours Y 09414 01AUG1988 ARGON LASER THERAPY for vascular lesions of the skin - session taking more than three hours Y 09415 01AUG1988 CRYOSURGERY to haemorrhoidsANAESTHETIC 5 UNITS - ITEM NOS 406G / 510S Y 09416 01AUG1988 WRIST, total replacementANAESTHETIC 13 UNITS - ITEM NOS 457G / 524S Y 09417 01AUG1988 CARPAL SCAPHOID, internal fixation of ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S Y 09418 01AUG1988 HYPERTHERMIC ISOLATED LIMB PERFUSION including vascular cannulation by operation and subsequent removal of catheteters ANAESTHETIC 30 UNITS - ITEM NOS 474G / 545S Y 09419 01AUG1988 ARTERIAL BYPASS GRAFT USING SYNTHETIC GRAFT,with or without local endarterectomy ANAESTHETIC 16 UNITS - ITEM NOS 460G / 527S Y 09420 01AUG1988 LAPAROTOMY WITH INSERTION OF PORTACATH for administration of cytotoxic therapy including placement of reservoir ' ANAESTHETIC II UNITS - ITEM NOS 4530 / 522S Y 09421 01AUG1988 NAIL BED, excision or wedge resection of ANAETHETIC 5 UNITS - ITEM NOS 406G / 510S (G) Y 09422 01AUG1988 NAIL BED, excision or wedge resection of ANAETHETIC 5 UNITS - ITEM NOS 406G / 510S (S) Y 09423 01AUG1988 TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOANAL ANASTOMOSIS WITH ILEAL RESERVOIR, with or without creation of temporary ileostomy: one surgeon ANAESTHETIC 36 UNITS - ITEM NOS 4760 / 547S Y 09424 01AUG1988 TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOANAL ANASTOMOSIS WITH ILEAL RESERVOIR, with or without creation of temporary ileostomy: conjoint surgery abdominal surgeon (including after-care) ANAESTHETIC 30 UNITS - ITEM NOS 4740 / 545S Y 09425 01AUG1988 TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOANAL ANASTOMOSIS WITH ILEAL RESERVOIR: conjoint surgery perineal surgeon Y 09426 01AUG1988 ILEOSTOMY closure with rectal resection and mucosectomy and ileoanal anastomosis with ileal reservoir, with or without temporary loop ileostomy: one surgeon ANAESTHETIC 30 UNITS - ITEM NOS 4740 / 545S Y 09427 01AUG1988 ILEOSTOMY closure with rectal resection and mucoscctomy and ileoanal anastomosis with ileal reservoir, with or without temporary loop ileostomy: abdominal surgeon (including aftercare) ANAESTHETIC 26 UNITS - ITEM NOS 4700 /541S Y 09428 01AUG1988 ILEOSTOMY closure with rectal resection and mucoscctomy and ileoanal anastomosis with ileal reservoir, with or without temporary loop ileostomy: conjoint surgery perineal surgeon Y 09429 01AUG1988 ILEOSTOMY reservoir, continent type, creation of including conversion of existing ileostomy where appropriate ANAESTHETIC 30 UNITS - ITEM NOS 4740 / 545S Y 09430 01AUG1988 RECTOSIGMOIDECTOMY, anterior (Hartman's peration)ANAESTHETIC 15 UNITS - ITEM NOS 459G 526S Y 09431 01AUG1988 Restoration of bowel continuity following Hartman's procedure, including dismantling of colostomy ANAESTHETIC 15 UNITS - ITEM NO 459G / 526S Y 09432 01AUG1988 RECTAL PROLAPSE - Delorme procedure for ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S Y 09433 01AUG1988 COLOSTOMY, refashioning of ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S Y 09434 01AUG1988 Injection of botulinus toxin fo blepharospasm or strabismus Y 09435 01AUG1988 LAPAROTOMY with division of bowel adhesions and introduction of Dennis tube ANAESTHETIC 14 UNITS - ITEM NOS 4580 / 525S Y 09436 01AUG1988 CENTRAL VEIN ATHETERISATION (via jugular or subclavian vein) or by open exposure in a person under 12 years of age ANAESTHETI 12 UNITS - ITEM NOS 454G / 523S Y 09437 01AUG1988 CENTRAL VEIN CATHETERISATION (via jugular or subclavian vein) by percutaneous or open exposure, not covered by item 9430 ANAESTHETIC 6 UNITS - ITEM NOS 407G / 5l3S Y 09438 19OCT1988 TEMPORO-MANDIBULAR JOINT, arthroplasty ANAESTHETIC 6 UNITS - ITEM NOS 4070 / 513S Y 09439 19OCT1988 TEMPORO-MANDIBULAR JOINT, arthroplasty (D) ANAESTHETIC 6 UNITS - ITEM NOS 407G /513S Y 09441 01FEB1989 NEPHROSTOMY, percutaneous, including associated imaging ANAESTHETIC 9 UNITS - ITEM NOS 443G / 518S Y 09442 01FEB1989 NEPHROSCOPY, percutaneous, with or without anyone or more of; stone extraction, biopsy or diathermy, not covered by Items 9446, 9447, 9448 or 9449 ANAESTHETIC II UNITS - ITEM NOS 453G / 522S Y 09443 01FEB1989 The services covered by Item 9442 where, after a substantial portion of the procedure has been performed, it is necessary to discontinue the operation due to bleeding ANAESTHETIC 10 UNITS - ITEM NOS 450G / 521S Y 09444 01FEB1989 NEPHROSCOPY, percutaneous, with incision of anyone or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, not in association with Items 9442,9446, 9447, 9448 or 9449 ANAESTHETIC II UNITS - ITEM NOS 453G / 522S Y 09445 01FEB1989 NEPHROSCOPY, percutaneous, with incision of anyone or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, in association with Items 9442, 9446, 9447, 9448 or 9449 ANAESTHETIC 13 UNITS - ITEM N<-S 457G / 524S N 09445 01SEP1989 NEPHROSCOPY, percutaneous, with incision of anyone or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, in association with Items 9442, 9446, 9447, 9448 or 9449 ANAESTHETIC 13 UNITS - ITEM N 500mls) Y 21100 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the anterior pelvic region (anterior to iliac crest), except external genitalia Y 21110 01MAY2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its derivatives or subcutaneous tissue of the pelvic region (posterior to iliac crest), except perineum N 21110 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin, its derivatives or subcutaneous tissue of the pelvic region (posterior to iliac crest), except perineum Y 21112 01MAY2003 INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of the anterior iliac crest Y 21114 01MAY2003 INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow biopsy of the posterior iliac crest Y 21116 01MAY2003 INITIATION OF MANAGEMENT OF ANAESTHESIA for percutaneous bone marrow harvesting from the pelvis Y 21120 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the bony pelvis Y 21130 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for body cast application or revision when performed in the operating theatre of a hospital Y 21140 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for interpelviabdominal (hind-quarter) amputation Y 21150 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures for tumour of the pelvis, except hind-quarter amputation Y 21155 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the anterior or posterior pelvis Y 21160 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving symphysis pubis or sacroiliac joint when performed in the operating theatre of a hospital Y 21170 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving symphysis pubis or sacroiliac joint Y 21195 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper leg Y 21199 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of the upper leg Y 21200 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving hip joint when performed in the operating theatre of a hospital Y 21202 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of the hip joint Y 21210 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving hip joint, not being a service to which another item in this Subgroup applies Y 21212 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for hip disarticulation Y 21214 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for total hip replacement or revision Y 21216 01NOV2005 INITIATION OF MANAGEMENT OF ANAESTHESIA for bilateral total hip replacement Y 21220 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures involving upper 2/3 of femur when performed in the operating theatre of a hospital Y 21230 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures involving upper 2/3 of femur, not being a service to which another item in this Subgroup applies Y 21232 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for above knee amputation Y 21234 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection of the upper 2/3 of femur Y 21260 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures involving veins of upper leg, including exploration Y 21270 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures involving arteries of upper leg, including bypass graft, not being a service to which another item in this Subgroup applies Y 21272 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for femoral artery ligation Y 21274 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for femoral artery embolectomy Y 21275 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the upper leg Y 21280 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of upper leg Y 21300 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the knee and/or popliteal area Y 21321 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of knee and/or popliteal area Y 21340 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on lower 1/3 of femur when performed in the operating theatre of a hospital Y 21360 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on lower 1/3 of femur Y 21380 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on knee joint when performed in the operating theatre of a hospital Y 21382 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of knee joint Y 21390 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on upper ends of tibia, fibula, and/or patella when performed in the operating theatre of a hospital Y 21392 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on upper ends of tibia, fibula, and/or patella Y 21400 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on knee joint, not being a service to which another item in this Subgroup applies Y 21402 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for total knee replacement N 21402 01MAY2002 INITIATION OF MANAGEMENT OF ANAESTHESIA for knee replacement Y 21403 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for bilateral knee replacement Y 21404 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for disarticulation of knee Y 21420 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for cast application, removal, or repair involving knee joint, undertaken in a hospital Y 21430 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of knee or popliteal area, not being a service to which another item in this Subgroup applies Y 21432 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of arteriovenous fistula of knee or popliteal area Y 21440 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of knee or popliteal area, not being a service to which another item in this Subgroup applies Y 21445 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the knee and/or popliteal area Y 21460 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of lower leg, ankle, or foot Y 21461 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, or fascia of lower leg, ankle, or foot, not being a service to which another item in this Subgroup applies Y 21462 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on lower leg, ankle, or foot Y 21464 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedure of ankle joint Y 21472 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for repair of Achilles tendon Y 21474 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for gastrocnemius recession Y 21480 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on bones of lower leg, ankle, or foot, including amputation, not being a service to which another item in this Subgroup applies Y 21482 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection of bone involving lower leg, ankle or foot Y 21484 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for osteotomy or osteoplasty of tibia or fibula Y 21486 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for total ankle replacement Y 21490 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for lower leg cast application, removal or repair, undertaken in a hospital Y 21500 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of lower leg, including bypass graft, not being a service to which another item in this Subgroup applies Y 21502 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of the lower leg Y 21520 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of lower leg, not being a service to which another item in this Subgroup applies Y 21522 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for venous thrombectomy of the lower leg Y 21530 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of lower leg, ankle or foot Y 21532 01MAY2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of toe N 21532 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of toe Y 21535 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the lower leg Y 21600 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the shoulder or axilla Y 21610 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of shoulder or axilla including axillary dissection Y 21620 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint, or shoulder joint when performed in the operating theatre of a hospital Y 21622 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of shoulder joint Y 21630 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on humeral head and neck, sternoclavicular joint, acromioclavicular joint orshoulder joint, not being a service to which another item in this Subgroup applies Y 21632 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for radical resection involving humeral head and neck, sternoclavicular joint, acromioclavicular joint or shoulder joint Y 21634 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder disarticulation Y 21636 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for interthoracoscapular (forequarter) amputation Y 21638 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for total shoulder replacement Y 21650 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of shoulder or axilla, not being a service to which another item in this Subgroup applies Y 21652 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures for axillary-brachial aneurysm Y 21654 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for bypass graft of arteries of shoulder or axilla Y 21656 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for axillary-femoral bypass graft Y 21670 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of shoulder or axilla Y 21680 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder cast application, removal or repair, not being a service to which another item in this Subgroup applies, when undertaken in a hospital Y 21682 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for shoulder spica application when undertaken in a hospital Y 21685 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the shoulder or the axilla Y 21700 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the upper arm or elbow Y 21710 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on nerves, muscles, tendons, fascia or bursae of upper arm or elbow, not being a service to which another item in this Subgroup applies Y 21712 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open tenotomy of the upper arm orelbow Y 21714 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for tenoplasty of the upper arm orelbow Y 21716 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for tenodesis for rupture of long tendon of biceps Y 21730 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on the upper arm orelbow when performed in the operating theatre of a hospital Y 21732 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of elbow joint Y 21740 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the upper arm or elbow, not being a service to which another item in this Subgroup applies Y 21756 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for radical procedures on the upper arm or elbow Y 21760 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for total elbow replacement Y 21770 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on arteries of upper arm, not being a service to which another item in this Subgroup applies Y 21772 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of arteries of the upper arm Y 21780 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on veins of upper arm, not being a service to which another item in this Subgroup applies Y 21785 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the upper arm or elbow Y 21790 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of upper arm Y 21800 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the skin or subcutaneous tissue of the forearm, wrist or hand Y 21810 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the nerves, muscles, tendons, fascia, or bursae of the forearm, wrist or hand Y 21820 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for closed procedures on the radius, ulna, wrist, or hand bones when performed in the operating theatre of a hospital Y 21830 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for open procedures on the radius, ulna, wrist, or hand bones, not being a service to which another item in this Subgroup applies Y 21832 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for total wrist replacement Y 21834 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arthroscopic procedures of the wrist joint Y 21840 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the arteries of forearm, wrist or hand, not being a service to which another item in this Subgroup applies Y 21842 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for embolectomy of artery of forearm, wrist or hand Y 21850 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for procedures on the veins of forearm, wrist or hand, not being a service to which another item in this Subgroup applies Y 21860 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for forearm, wrist, or hand cast application, removal, or repair when undertaken in a hospital or approved day hospital facility N 21860 01DEC2007 INITIATION OF MANAGEMENT OF ANAESTHESIA for forearm, wrist, or hand cast application, removal, or repair when rendered to a patient as part of an episode of hospital treatment Y 21865 01JUL2008 INITIATION OF MANAGEMENT OF ANAESTHESIA for microvascular free tissue flap surgery involving the forearm, wrist or hand Y 21870 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of forearm, wrist or hand Y 21872 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for microsurgical reimplantation of a finger Y 21878 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting where the area of burn involves not more than 3% of total body surface Y 21879 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting,where the area of burn involves more than 3% but less than 10% of total body surface Y 21880 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 10% or more but less than 20% of total body surface Y 21881 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 20% or more but less than 30% of total body surface Y 21882 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 30% or more but less than 40% of total body surface Y 21883 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 40% or more but less than 50% of total body surface Y 21884 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 50% or more but less than 60% of total body surface Y 21885 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 60% or more but less than 70% of total body surface Y 21886 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 70% or more but less than 80% of total body surface Y 21887 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for excision or debridement of burns, with or without skin grafting, where the area of burn involves 80% or more of total body surface Y 21900 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for hysterosalpingography Y 21906 01MAY2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: lumbar or thoracic N 21906 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: lumbar or thoracic Y 21908 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: cervical Y 21910 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for myelography: posterior fossa Y 21912 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for discography: lumbar or thoracic Y 21914 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for injection procedure for discography: cervical Y 21915 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for peripheral arteriogram Y 21916 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for arteriograms: cerebral, carotid or vertebral Y 21918 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for retrograde arteriogram: brachial or femoral Y 21922 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for computerised axial tomography scanning, magnetic resonance scanning, digital subtraction angiography scanning Y 21925 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for retrograde cystography, retrograde urethrography or retrograde cystourethrography Y 21926 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for fluoroscopy Y 21927 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA forl barium enema or other opaque study of the small bowel N 21927 01NOV2012 INITIATION OF MANAGEMENT OF ANAESTHESIA for barium enema or other opaque study of the small bowel Y 21930 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for bronchography Y 21935 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for phlebography Y 21936 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for heart, 2 dimensional real time transoesophageal examination Y 21939 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for peripheral venous cannulation Y 21941 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac catheterisation including coronary arteriography, ventriculography, or cardiac mapping N 21941 01MAY2002 INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac catheterisation including coronary arteriography, ventriculography, cardiac mapping, insertion of automatic defibrillator or transvenous pacemaker Y 21942 01MAY2002 INITIATION OF MANAGEMENT OF ANAESTHESIA for cardiac electrophysiological procedures including radio frequency ablation Y 21943 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for central vein catheterisation or insertion of right heart balloon catheter (via jugular, subclavian or femoral vein) by percutaneous or open exposure Y 21945 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for lumbar puncture, cisternal puncture, or epidural injection Y 21949 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for harvesting of bone marrow for the purpose of transplantation Y 21952 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for muscle biopsy for malignant hyperpyrexia N 21952 01NOV2019 Initiation of the management of anaesthesia for diagnostic muscle biopsy to assess for malignant hyperpyrexia Y 21955 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for electroencephalography Y 21959 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for brain stem evoked response audiometry Y 21962 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for electrocochleography by extratympanic method or transtympanic membrane insertion method Y 21965 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure where it can be demonstrated that there is a clinical need for anaesthesia N 21965 01NOV2005 INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure where it can be demonstrated that there is a clinical need for anaesthesia, not for the treatment of headache of any etiology N 21965 01NOV2018 INITIATION OF MANAGEMENT OF ANAESTHESIA as a therapeutic procedure if there is a clinical need for anaesthesia, not for headache of any etiology Y 21969 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA during hyperbaric therapy where the medical practitioner is not confined in the chamber (including the administration of oxygen) Y 21970 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA during hyperbaric therapy where the medical practitioner is confined in the chamber (including the administration of oxygen) Y 21973 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for brachytherapy using radioactive sealed sources Y 21976 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for therapeutic nuclear medicine Y 21980 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for radiotherapy Y 21981 01JUL2008 ANAESTHETIC AGENT ALLERGY TESTING, using skin sensitivity methods in a patient with a history of prior anaphylactic or anaphylactoid reaction or cardiovascular collapse in association with the administration of anaesthesia agents N 21981 01JUL2011 ANAESTHETIC AGENT ALLERGY TESTING, using skin sensitivity methods in a patient with a history of prior anaphylactic or anaphylactoid reaction or cardiovascular collapse associated with the management of anaesthesia agents Y 21990 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA when no procedure ensues Y 21992 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA performed on a person under the age of 10 years in connection with a procedure covered by an item which has not been identified as attracting an anaesthetic Y 21997 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA in connection with a procedure covered by an item which has not been identified as attracting an anaesthetic rebate, not being a service to which item 21992 or 21965 applies where it can be demonstrated that there is a clinical need for anaesthesia N 21997 01NOV2018 "INITIATION OF MANAGEMENT OF ANAESTHESIA in connection with a procedure covered by an item that does not include the word ""(Anaes.)"", other than a service to which item 21965 or 21992 applies, if there is a clinical need for anaesthesia" Y 22001 01NOV2001 COLLECTION OF BLOOD FOR AUTOLOGOUS TRANSFUSION or when homologous blood is required for immediate transfusion in an emergency situation, when performed in association with the administration of anaesthesia Y 22002 01NOV2001 ADMINISTRATION OF BLOOD or bone marrow already collected when performed in association with the administration of anaesthesia N 22002 01NOV2019 Administration of homologous blood or bone marrow already collected, when performed in association with the management of anaesthesia Y 22007 01NOV2001 AWAKE ENDOTRACHEAL INTUBATION with flexible fibreoptic scope associated with difficult airway when performed in association with the administration of anaesthesia N 22007 01JUL2008 ENDOTRACHEAL INTUBATION with flexible fibreoptic scope associated with difficult airway when performed in association with the administration of anaesthesia Y 22008 01NOV2001 DOUBLE LUMEN ENDOBRONCHIAL TUBE OR BRONCHIAL BLOCKER, insertion of when performed in association with the administration of anaesthesia Y 22012 01NOV2001 BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - each day of monitoring for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia N 22012 01MAY2002 BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia N 22012 01NOV2008 BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - once only for each type of pressure on any calendar day, up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia N 22012 01NOV2019 Central venous, pulmonary arterial, systemic arterial or cardiac intracavity blood pressure monitoring by indwelling catheter - once per day for each type of pressure for a patient:(a) when performed in association with the management of anaesthesia for the patient; and(b) other than a service to which item 13876 applies(c) is categorised as having a high risk of complications or during the procedure develops either complications or a high risk of complications Y 22014 01NOV2001 BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - for each type of pressure up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia relating to another discrete operation on the same day N 22014 01NOV2008 BLOOD PRESSURE MONITORING (central venous, pulmonary arterial, systemic arterial or cardiac intracavity), by indwelling catheter - once only for each type of pressure on any calendar day, up to a maximum of 4 pressures (not being a service to which item 13876 applies) when performed in association with the administration of anaesthesia relating to another discrete operation on the same day N 22014 01NOV2019 Central venous, pulmonary arterial, systemic arterial or cardiac intracavity blood pressure monitoring by indwelling catheter - once per day for each type of pressure for a patient:(a) when performed in association with the management of anaesthesia for the patient; and(b) relating to another discrete operation on the same day for the patient; and(c) other than a service to which item 13876 applies(d) who is categorised as having a high risk of complications or develops during the current procedure either complications or a high risk of complications Y 22015 01NOV2001 RIGHT HEART BALLOON CATHETER, insertion of, including pulmonary wedge pressure and cardiac output measurement, when performed in association with the administration of anaesthesia Y 22018 01NOV2005 MEASUREMENT OF THE MECHANICAL OR GAS EXCHANGE FUNCTION OF THE RESPIRATORY SYSTEM, using measurements of parameters, including pressures, volumes, flow, gas concentrations in inspired or expired air, alveolar gas or blood and incorporating serial arterial blood gas analysis and a written record of the results, when performed in association with the administration of anaesthesia, not being a service associated with a service to which item 11503 applies Y 22020 01NOV2001 CENTRAL VEIN CATHETERISATION (via jugular, subclavian or femoral vein) by percutaneous or open exposure, not being a service to which item 13318 applies, when performed in association with the administration of anaesthesia N 22020 01JUL2012 CENTRAL VEIN CATHETERISATION by percutaneous or open exposure, not being a service to which item 13318 applies, when performed in association with the administration of anaesthesia Y 22025 01NOV2001 INTRAARTERIAL CANNULATION when performed in association with the administration of anaesthesia N 22025 01NOV2019 Intra-arterial cannulation when performed in association with the management of anaesthesia in a patient who:(a) is categorised as having a high risk of complications; or(b) develops a high risk of complications during the procedure Y 22030 01NOV2001 INTRODUCTION OF A NARCOTIC, for the control of postoperative pain, into the epidural or intrathecal space in conjunction with an operation Y 22031 01NOV2005 INTRATHECAL or EPIDURAL INJECTION (initial) of a therapeutic substance or substances, with or without insertion of a catheter, in association with anaesthesia and surgery, for postoperative pain management, not being a service associated with a service to which 22036 applies N 22031 01NOV2019 Intrathecal or epidural injection (initial) of a therapeutic substance or substances, with or without insertion of a catheter, in association with anaesthesia and surgery, for post-operative pain management, not being a service to which 22036 applies Y 22035 01NOV2001 INTRODUCTION OF A LOCAL ANAESTHETIC, for control of postoperative pain, into the epidural or intrathecal space, in conjunction with an operation Y 22036 01NOV2005 INTRATHECAL or EPIDURAL INJECTION (subsequent) of a therapeutic substance or substances, using an in-situ catheter, in association with anaesthesia and surgery, for postoperative pain management, not being a service associated with a service to which 22031 applies Y 22040 01NOV2001 INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room theatre or recovery room for the control of post operative pain via the femoral OR sciatic nerves, in conjunction with knee, ankle or foot surgery N 22040 01NOV2003 INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room theatre or recovery room for the control of post operative pain via the femoral OR sciatic nerves, in conjunction with hip, knee, ankle or foot surgery Y 22041 01NOV2019 Perioperative introduction of a plexus or nerve block proximal to the lower leg or forearm for post operative pain management Y 22042 01NOV2019 Introduction of a nerve block performed via a retrobulbar, peribulbar, or sub Tenon's approach, or other complex eye block, when administered by an anaesthetist perioperatively Y 22045 01NOV2001 INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral AND sciatic nerves, in conjunction with knee, ankle or foot surgery N 22045 01NOV2003 INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the femoral AND sciatic nerves, in conjunction with hip, knee, ankle or foot surgery Y 22050 01NOV2001 INTRODUCTION OF A REGIONAL OR FIELD NERVE BLOCK peri-operatively performed in the induction room, theatre or recovery room for the control of post operative pain via the brachial plexus in conjunction with shoulder surgery Y 22051 01NOV2008 INTRA-OPERATIVE TRANSOESOPHAGEAL ECHOCARDIOGRAPHY - Monitoring in real time of the structure and function of the heart chambers, valves and surrounding structures, including assessment of blood flow, with appropriate permanent recording during procedures on the heart, pericardium or great vessels of the chest (not in association with items 55130, 55135 or 21936) Y 22055 01NOV2001 PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent N 22055 01MAY2009 PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent, not being a service associated with a service to which an item in Subgroup 21 applies N 22055 01JUL2009 PERFUSION OF LIMB OR ORGAN using heart-lung machine or equivalent, not being a service associated with anaesthesia to which an item in Subgroup 21 applies Y 22060 01NOV2001 WHOLE BODY PERFUSION, CARDIAC BYPASS, using heart-lung machine or equivalent N 22060 01MAY2009 WHOLE BODY PERFUSION, CARDIAC BYPASS, using heart-lung machine or equivalent, not being a service associated with anaesthesia to which an item in Subgroup 21 applies N 22060 01NOV2015 WHOLE BODY PERFUSION, CARDIAC BYPASS, where the heart-lung machine or equivalent is continuously operated by a medical perfusionist, other than a service associated with anaesthesia to which an item in Subgroup 21 applies.(20 basic units) Y 22065 01NOV2001 INDUCED CONTROLLED HYPOTHERMIA total body N 22065 01MAY2009 INDUCED CONTROLLED HYPOTHERMIA total body, not being a service associated with a service to which an item in Subgroup 21 applies N 22065 01JUL2009 INDUCED CONTROLLED HYPOTHERMIA total body, being a service to which item 22060 applies, not being a service associated with anaesthesia to which an item in Subgroup 21 applies Y 22070 01NOV2001 CARDIOPLEGIA, blood or crystalloid, administration by any route N 22070 01MAY2009 CARDIOPLEGIA, blood or crystalloid, administration by any route, not being a service associated with a service to which an item in Subgroup 21 applies N 22070 01JUL2009 CARDIOPLEGIA, blood or crystalloid, administration by any route, being a service to which item 22060 applies, not being a service associated with anaesthesia to which an item in Subgroup 21 applies Y 22075 01NOV2001 DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22 Degrees Celsius, including management of retrograde cerebral perfusion if performed N 22075 01MAY2009 DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22 Degrees Celsius, including management of retrograde cerebral perfusion if performed, not being a service associated with a service to which an item in Subgroup 21 applies N 22075 01JUL2009 DEEP HYPOTHERMIC CIRCULATORY ARREST, with core temperature less than 22 Degrees Celsius, including management of retrograde cerebral perfusion if performed, not being a service associated with anaesthesia to which an item in Subgroup 21 applies Y 22900 01NOV2001 INITIATION OF MANAGEMENT BY A MEDICAL PRACTITIONER OF ANAESTHESIA for extraction of tooth or teeth with or without incision of soft tissue or removal of bone Y 22905 01NOV2001 INITIATION OF MANAGEMENT OF ANAESTHESIA for restorative dental work Y 23010 01MAY2001 ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 For a period of: (FIFTEEN MINUTES OR LESS) N 23010 01NOV2001 ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 For a period of: (FIFTEEN MINUTES OR LESS) N 23010 01JUL2008 ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA (a) administration of anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 For a period of: (FIFTEEN MINUTES OR LESS) Y 23021 01MAY2001 16 MINUTES TO 20 MINUTES N 23021 01NOV2001 16 MINUTES TO 20 MINUTES Y 23022 01MAY2001 21 MINUTES TO 25 MINUTES N 23022 01NOV2001 21 MINUTES TO 25 MINUTES Y 23023 01MAY2001 26 MINUTES TO 30 MINUTES N 23023 01NOV2001 26 MINUTES TO 30 MINUTES Y 23025 01NOV2019 16 MINUTES TO 30 MINUTES Y 23031 01MAY2001 31 MINUTES TO 35 MINUTES N 23031 01NOV2001 31 MINUTES TO 35 MINUTES Y 23032 01MAY2001 36 MINUTES TO 40 MINUTES N 23032 01NOV2001 36 MINUTES TO 40 MINUTES Y 23033 01MAY2001 41 MINUTES TO 45 MINUTES N 23033 01NOV2001 41 MINUTES TO 45 MINUTES Y 23035 01NOV2019 31 MINUTES to 45 MINUTES Y 23041 01MAY2001 46 MINUTES TO 50 MINUTES N 23041 01NOV2001 46 MINUTES TO 50 MINUTES Y 23042 01MAY2001 51 MINUTES TO 55 MINUTES N 23042 01NOV2001 51 MINUTES TO 55 MINUTES Y 23043 01MAY2001 56 MINUTES TO 1:00 HOUR N 23043 01NOV2001 56 MINUTES TO 1:00 HOUR Y 23045 01NOV2019 46 MINUTES to 1:00 HOUR Y 23051 01MAY2001 1:01 HOURS TO 1:05 HOURS N 23051 01NOV2001 1:01 HOURS TO 1:05 HOURS Y 23052 01MAY2001 1:06 HOURS TO 1:10 HOURS N 23052 01NOV2001 1:06 HOURS TO 1:10 HOURS Y 23053 01MAY2001 1:11 HOURS TO 1:15 HOURS N 23053 01NOV2001 1:11 HOURS TO 1:15 HOURS Y 23055 01NOV2019 1:01 HOURS to 1:15 HOURS Y 23061 01MAY2001 1:16 HOURS TO 1:20 HOURS N 23061 01NOV2001 1:16 HOURS TO 1:20 HOURS Y 23062 01MAY2001 1:21 HOURS TO 1:25 HOURS N 23062 01NOV2001 1:21 HOURS TO 1:25 HOURS Y 23063 01MAY2001 1:26 HOURS TO 1:30 HOURS N 23063 01NOV2001 1:26 HOURS TO 1:30 HOURS Y 23065 01NOV2019 1:16 HOURS to 1:30 HOURS Y 23071 01MAY2001 1:31 HOURS TO 1:35 HOURS N 23071 01NOV2001 1:31 HOURS TO 1:35 HOURS Y 23072 01MAY2001 1:36 HOURS TO 1:40 HOURS N 23072 01NOV2001 1:36 HOURS TO 1:40 HOURS Y 23073 01MAY2001 1:41 HOURS TO 1:45 HOURS N 23073 01NOV2001 1:41 HOURS TO 1:45 HOURS Y 23075 01NOV2019 1:31 HOURS to 1:45 HOURS Y 23081 01MAY2001 1:46 HOURS TO 1:50 HOURS N 23081 01NOV2001 1:46 HOURS TO 1:50 HOURS Y 23082 01MAY2001 1:51 HOURS TO 1:55 HOURS N 23082 01NOV2001 1:51 HOURS TO 1:55 HOURS Y 23083 01MAY2001 1:56 HOURS TO 2:00 HOURS N 23083 01NOV2001 1:56 HOURS TO 2:00 HOURS Y 23085 01NOV2019 1:46 HOURS to 2:00 HOURS Y 23090 01MAY2001 2:01 HOURS TO 2:15 HOURS N 23090 01NOV2001 2:01 HOURS TO 2:15 HOURS Y 23091 01NOV2005 2:01 HOURS TO 2:10 HOURS Y 23100 01MAY2001 2:16 HOURS TO 2:30 HOURS N 23100 01NOV2001 2:16 HOURS TO 2:30 HOURS Y 23101 01NOV2005 2:11 HOURS TO 2:20 HOURS Y 23110 01MAY2001 2:31 HOURS TO 2:45 HOURS N 23110 01NOV2001 2:31 HOURS TO 2:45 HOURS Y 23111 01NOV2005 2:21 HOURS TO 2:30 HOURS Y 23112 01NOV2005 2:31 HOURS TO 2:40 HOURS Y 23113 01NOV2005 2:41 HOURS TO 2:50 HOURS Y 23114 01NOV2005 2:51 HOURS TO 3:00 HOURS Y 23115 01NOV2005 3:01 HOURS TO 3:10 HOURS Y 23116 01NOV2005 3:11 HOURS TO 3:20 HOURS Y 23117 01NOV2005 3:21 HOURS TO 3:30 HOURS Y 23118 01NOV2005 3:31 HOURS TO 3:40 HOURS Y 23119 01NOV2005 3:41 HOURS TO 3:50 HOURS Y 23120 01MAY2001 2:46 HOURS TO 3:00 HOURS N 23120 01NOV2001 2:46 HOURS TO 3:00 HOURS Y 23121 01NOV2005 3:51 HOURS TO 4:00 HOURS Y 23130 01MAY2001 3:01 HOURS TO 3:15 HOURS N 23130 01NOV2001 3:01 HOURS TO 3:15 HOURS Y 23140 01MAY2001 3:16 HOURS TO 3:30 HOURS N 23140 01NOV2001 3:16 HOURS TO 3:30 HOURS Y 23150 01MAY2001 3:31 HOURS TO 3:45 HOURS N 23150 01NOV2001 3:31 HOURS TO 3:45 HOURS Y 23160 01MAY2001 3:46 HOURS TO 4:00 HOURS N 23160 01NOV2001 3:46 HOURS TO 4:00 HOURS Y 23170 01MAY2001 4:01 HOURS TO 4:10 HOURS N 23170 01NOV2001 4:01 HOURS TO 4:10 HOURS Y 23180 01MAY2001 4:11 HOURS TO 4:20 HOURS N 23180 01NOV2001 4:11 HOURS TO 4:20 HOURS Y 23190 01MAY2001 4:21 HOURS TO 4:30 HOURS N 23190 01NOV2001 4:21 HOURS TO 4:30 HOURS Y 23200 01MAY2001 4:31 HOURS TO 4:40 HOURS N 23200 01NOV2001 4:31 HOURS TO 4:40 HOURS Y 23210 01MAY2001 4:41 HOURS TO 4:50 HOURS N 23210 01NOV2001 4:41 HOURS TO 4:50 HOURS Y 23220 01MAY2001 4:51 HOURS TO 5:00 HOURS N 23220 01NOV2001 4:51 HOURS TO 5:00 HOURS Y 23230 01MAY2001 5:01 HOURS TO 5:10 HOURS N 23230 01NOV2001 5:01 HOURS TO 5:10 HOURS Y 23240 01MAY2001 5:11 HOURS TO 5:20 HOURS N 23240 01NOV2001 5:11 HOURS TO 5:20 HOURS Y 23250 01MAY2001 5:21 HOURS TO 5:30 HOURS N 23250 01NOV2001 5:21 HOURS TO 5:30 HOURS Y 23260 01MAY2001 5:31 HOURS TO 5:40 HOURS N 23260 01NOV2001 5:31 HOURS TO 5:40 HOURS Y 23270 01MAY2001 5:41 HOURS TO 5:50 HOURS N 23270 01NOV2001 5:41 HOURS TO 5:50 HOURS Y 23280 01MAY2001 (5:51 HOURS TO 6:00 HOURS N 23280 01NOV2001 (5:51 HOURS TO 6:00 HOURS Y 23290 01MAY2001 6:01 HOURS TO 6:10 HOURS N 23290 01NOV2001 6:01 HOURS TO 6:10 HOURS Y 23300 01MAY2001 6:11 HOURS TO 6:20 HOURS N 23300 01NOV2001 6:11 HOURS TO 6:20 HOURS Y 23310 01MAY2001 6:21 HOURS TO 6:30 HOURS N 23310 01NOV2001 6:21 HOURS TO 6:30 HOURS Y 23320 01MAY2001 6:31 HOURS TO 6:40 HOURS N 23320 01NOV2001 6:31 HOURS TO 6:40 HOURS Y 23330 01MAY2001 6:41 HOURS TO 6:50 HOURS N 23330 01NOV2001 6:41 HOURS TO 6:50 HOURS Y 23340 01MAY2001 6:51 HOURS TO 7:00 HOURS N 23340 01NOV2001 6:51 HOURS TO 7:00 HOURS Y 23350 01MAY2001 7:01 HOURS TO 7:10 HOURS N 23350 01NOV2001 7:01 HOURS TO 7:10 HOURS Y 23360 01MAY2001 7:11 HOURS TO 7:20 HOURS N 23360 01NOV2001 7:11 HOURS TO 7:20 HOURS Y 23370 01MAY2001 7:21 HOURS TO 7:30 HOURS N 23370 01NOV2001 7:21 HOURS TO 7:30 HOURS Y 23380 01MAY2001 7:31 HOURS TO 7:40 HOURS N 23380 01NOV2001 7:31 HOURS TO 7:40 HOURS Y 23390 01MAY2001 7:41 HOURS TO 7:50 HOURS N 23390 01NOV2001 7:41 HOURS TO 7:50 HOURS Y 23400 01MAY2001 7:51 HOURS TO 8:00 HOURS N 23400 01NOV2001 7:51 HOURS TO 8:00 HOURS Y 23410 01MAY2001 8:01 HOURS TO 8:10 HOURS N 23410 01NOV2001 8:01 HOURS TO 8:10 HOURS Y 23420 01MAY2001 8:11 HOURS TO 8:20 HOURS N 23420 01NOV2001 8:11 HOURS TO 8:20 HOURS Y 23430 01MAY2001 8:21 HOURS TO 8:30 HOURS N 23430 01NOV2001 8:21 HOURS TO 8:30 HOURS Y 23440 01MAY2001 8:31 HOURS TO 8:40 HOURS N 23440 01NOV2001 8:31 HOURS TO 8:40 HOURS Y 23450 26JAN2001 8:41 HOURS TO 8:50 HOURS N 23450 01NOV2001 8:41 HOURS TO 8:50 HOURS Y 23460 01MAY2001 8:51 HOURS TO 9:00 HOURS N 23460 01NOV2001 8:51 HOURS TO 9:00 HOURS Y 23470 01MAY2001 9:01 HOURS TO 9:10 HOURS N 23470 01NOV2001 9:01 HOURS TO 9:10 HOURS Y 23480 01MAY2001 9:11 HOURS TO 9:20 HOURS N 23480 01NOV2001 9:11 HOURS TO 9:20 HOURS Y 23490 01MAY2001 9:21 HOURS TO 9:30 HOURS N 23490 01NOV2001 9:21 HOURS TO 9:30 HOURS Y 23500 01MAY2001 9:31 HOURS TO 9:40 HOURS N 23500 01NOV2001 9:31 HOURS TO 9:40 HOURS Y 23510 01MAY2001 9:41 HOURS TO 9:50 HOURS N 23510 01NOV2001 9:41 HOURS TO 9:50 HOURS Y 23520 01MAY2001 9:51 HOURS TO 10:00 HOURS N 23520 01NOV2001 9:51 HOURS TO 10:00 HOURS Y 23530 01MAY2001 10:01 HOURS TO 10:10 HOURS N 23530 01NOV2001 10:01 HOURS TO 10:10 HOURS Y 23540 01MAY2001 10:11 HOURS TO 10:20 HOURS N 23540 01NOV2001 10:11 HOURS TO 10:20 HOURS Y 23550 01JAN2001 10:21 HOURS TO 10:30 HOURS N 23550 01NOV2001 10:21 HOURS TO 10:30 HOURS Y 23560 01MAY2001 10:31 HOURS TO 10:40 HOURS N 23560 01NOV2001 10:31 HOURS TO 10:40 HOURS Y 23570 01MAY2001 10:41 HOURS TO 10:50 HOURS N 23570 01NOV2001 10:41 HOURS TO 10:50 HOURS Y 23580 01JAN2001 10:51 HOURS TO 11:00 HOURS N 23580 01NOV2001 10:51 HOURS TO 11:00 HOURS Y 23590 01JAN2001 11:01 HOURS TO 11:10 HOURS N 23590 01NOV2001 11:01 HOURS TO 11:10 HOURS Y 23600 01MAY2001 11:11 HOURS TO 11:20 HOURS N 23600 01NOV2001 11:11 HOURS TO 11:20 HOURS Y 23610 01MAY2001 11:21 HOURS TO 11:30 HOURS N 23610 01NOV2001 11:21 HOURS TO 11:30 HOURS Y 23620 01MAY2001 11:31 HOURS TO 11:40 HOURS N 23620 01NOV2001 11:31 HOURS TO 11:40 HOURS Y 23630 01MAY2001 11:41 HOURS TO 11:50 HOURS N 23630 01NOV2001 11:41 HOURS TO 11:50 HOURS Y 23640 01MAY2001 11:51 HOURS TO 12:00 HOURS N 23640 01NOV2001 11:51 HOURS TO 12:00 HOURS Y 23650 01MAY2001 12:01 HOURS TO 12:10 HOURS N 23650 01NOV2001 12:01 HOURS TO 12:10 HOURS Y 23660 01MAY2001 12:11 HOURS TO 12:20 HOURS N 23660 01NOV2001 12:11 HOURS TO 12:20 HOURS Y 23670 01MAY2001 12:21 HOURS TO 12:30 HOURS N 23670 01NOV2001 12:21 HOURS TO 12:30 HOURS Y 23680 01MAY2001 12:31 HOURS TO 12:40 HOURS N 23680 01NOV2001 12:31 HOURS TO 12:40 HOURS Y 23690 01MAY2001 12:41 HOURS TO 12:50 HOURS N 23690 01NOV2001 12:41 HOURS TO 12:50 HOURS Y 23700 01MAY2001 12:51 HOURS TO 13:00 HOURS N 23700 01NOV2001 12:51 HOURS TO 13:00 HOURS Y 23710 01MAY2001 13:01 HOURS TO 13:10 HOURS N 23710 01NOV2001 13:01 HOURS TO 13:10 HOURS Y 23720 01MAY2001 13:11 HOURS TO 13:20 HOURS N 23720 01NOV2001 13:11 HOURS TO 13:20 HOURS Y 23730 01MAY2001 13:21 HOURS TO 13:30 HOURS N 23730 01NOV2001 13:21 HOURS TO 13:30 HOURS Y 23740 01MAY2001 13:31 HOURS TO 13:40 HOURS N 23740 01NOV2001 13:31 HOURS TO 13:40 HOURS Y 23750 01MAY2001 13:41 HOURS TO 13:50 HOURS N 23750 01NOV2001 13:41 HOURS TO 13:50 HOURS Y 23760 01MAY2001 13:51 HOURS TO 14:00 HOURS N 23760 01NOV2001 13:51 HOURS TO 14:00 HOURS Y 23770 01MAY2001 14:01 HOURS TO 14:10 HOURS N 23770 01NOV2001 14:01 HOURS TO 14:10 HOURS Y 23780 01MAY2001 14:11 HOURS TO 14:20 HOURS N 23780 01NOV2001 14:11 HOURS TO 14:20 HOURS Y 23790 01MAY2001 14:21 HOURS TO 14:30 HOURS N 23790 01NOV2001 14:21 HOURS TO 14:30 HOURS Y 23800 01MAY2001 14:31 HOURS TO 14:40 HOURS N 23800 01NOV2001 14:31 HOURS TO 14:40 HOURS Y 23810 01MAY2001 14:41 HOURS TO 14:50 HOURS N 23810 01NOV2001 14:41 HOURS TO 14:50 HOURS Y 23820 01MAY2001 14:51 HOURS TO 15:00 HOURS N 23820 01NOV2001 14:51 HOURS TO 15:00 HOURS Y 23830 01MAY2001 15:01 HOURS TO 15:10 HOURS N 23830 01NOV2001 15:01 HOURS TO 15:10 HOURS Y 23840 01MAY2001 15:11 HOURS TO 15:20 HOURS N 23840 01NOV2001 15:11 HOURS TO 15:20 HOURS Y 23850 01MAY2001 15:21 HOURS TO 15:30 HOURS N 23850 01NOV2001 15:21 HOURS TO 15:30 HOURS Y 23860 01MAY2001 15:31 HOURS TO 15:40 HOURS N 23860 01NOV2001 15:31 HOURS TO 15:40 HOURS Y 23870 01MAY2001 15:41 HOURS TO 15:50 HOURS N 23870 01NOV2001 15:41 HOURS TO 15:50 HOURS Y 23880 01MAY2001 15:51 HOURS TO 16:00 HOURS N 23880 01NOV2001 15:51 HOURS TO 16:00 HOURS Y 23890 01MAY2001 16:01 HOURS TO 16:10 HOURS N 23890 01NOV2001 16:01 HOURS TO 16:10 HOURS Y 23900 01MAY2001 16:11 HOURS TO 16:20 HOURS N 23900 01NOV2001 16:11 HOURS TO 16:20 HOURS Y 23910 01MAY2001 16:21 HOURS TO 16:30 HOURS N 23910 01NOV2001 16:21 HOURS TO 16:30 HOURS Y 23920 01MAY2001 16:31 HOURS TO 16:40 HOURS N 23920 01NOV2001 16:31 HOURS TO 16:40 HOURS Y 23930 01MAY2001 16:41 HOURS TO 16:50 HOURS N 23930 01NOV2001 16:41 HOURS TO 16:50 HOURS Y 23940 01MAY2001 16:51 HOURS TO 17:00 HOURS N 23940 01NOV2001 16:51 HOURS TO 17:00 HOURS Y 23950 01MAY2001 17:01 HOURS TO 17:10 HOURS N 23950 01NOV2001 17:01 HOURS TO 17:10 HOURS Y 23960 01MAY2001 17:11 HOURS TO 17:20 HOURS N 23960 01NOV2001 17:11 HOURS TO 17:20 HOURS Y 23970 01MAY2001 17:21 HOURS TO 17:30 HOURS N 23970 01NOV2001 17:21 HOURS TO 17:30 HOURS Y 23980 01MAY2001 17:31 HOURS TO 17:40 HOURS N 23980 01NOV2001 17:31 HOURS TO 17:40 HOURS Y 23990 01MAY2001 17:41 HOURS TO 17:50 HOURS N 23990 01NOV2001 17:41 HOURS TO 17:50 HOURS Y 24100 01MAY2001 17:51 HOURS TO 18:00 HOURS N 24100 01NOV2001 17:51 HOURS TO 18:00 HOURS Y 24101 01MAY2001 18:01 HOURS TO 18:10 HOURS N 24101 01NOV2001 18:01 HOURS TO 18:10 HOURS Y 24102 01MAY2001 18:11 HOURS TO 18:20 HOURS N 24102 01NOV2001 18:11 HOURS TO 18:20 HOURS Y 24103 01MAY2001 18:21 HOURS TO 18:30 HOURS N 24103 01NOV2001 18:21 HOURS TO 18:30 HOURS Y 24104 01MAY2001 18:31 HOURS TO 18:40 HOURS N 24104 01NOV2001 18:31 HOURS TO 18:40 HOURS Y 24105 01MAY2001 18:41 HOURS TO 18:50 HOURS N 24105 01NOV2001 18:41 HOURS TO 18:50 HOURS Y 24106 01MAY2001 18:51 HOURS TO 19:00 HOURS N 24106 01NOV2001 18:51 HOURS TO 19:00 HOURS Y 24107 01MAY2001 19:01 HOURS TO 19:10 HOURS N 24107 01NOV2001 19:01 HOURS TO 19:10 HOURS Y 24108 01MAY2001 19:11 HOURS TO 19:20 HOURS N 24108 01NOV2001 19:11 HOURS TO 19:20 HOURS Y 24109 01MAY2001 19:21 HOURS TO 19:30 HOURS N 24109 01NOV2001 19:21 HOURS TO 19:30 HOURS Y 24110 01MAY2001 19:31 HOURS TO 19:40 HOURS N 24110 01NOV2001 19:31 HOURS TO 19:40 HOURS Y 24111 01MAY2001 19:41 HOURS TO 19:50 HOURS N 24111 01NOV2001 19:41 HOURS TO 19:50 HOURS Y 24112 01MAY2001 19:51 HOURS TO 20:00 HOURS N 24112 01NOV2001 19:51 HOURS TO 20:00 HOURS Y 24113 01MAY2001 20:01 HOURS TO 20:10 HOURS N 24113 01NOV2001 20:01 HOURS TO 20:10 HOURS Y 24114 01MAY2001 20:11 HOURS TO 20:20 HOURS N 24114 01NOV2001 20:11 HOURS TO 20:20 HOURS Y 24115 01MAY2001 20:21 HOURS TO 20:30 HOURS N 24115 01NOV2001 20:21 HOURS TO 20:30 HOURS Y 24116 01MAY2001 20:31 HOURS TO 20:40 HOURS N 24116 01NOV2001 20:31 HOURS TO 20:40 HOURS Y 24117 01MAY2001 20:41 HOURS TO 20:50 HOURS N 24117 01NOV2001 20:41 HOURS TO 20:50 HOURS Y 24118 01MAY2001 20:51 HOURS TO 21:00 HOURS N 24118 01NOV2001 20:51 HOURS TO 21:00 HOURS Y 24119 01MAY2001 21:01 HOURS TO 21:10 HOURS N 24119 01NOV2001 21:01 HOURS TO 21:10 HOURS Y 24120 01MAY2001 21:11 HOURS TO 21:20 HOURS N 24120 01NOV2001 21:11 HOURS TO 21:20 HOURS Y 24121 01MAY2001 21:21 HOURS TO 21:30 HOURS N 24121 01NOV2001 21:21 HOURS TO 21:30 HOURS Y 24122 01MAY2001 21:31 HOURS TO 21:40 HOURS N 24122 01NOV2001 21:31 HOURS TO 21:40 HOURS Y 24123 01MAY2001 21:41 HOURS TO 21:50 HOURS N 24123 01NOV2001 21:41 HOURS TO 21:50 HOURS Y 24124 01MAY2001 21:51 HOURS TO 22:00 HOURS N 24124 01NOV2001 21:51 HOURS TO 22:00 HOURS Y 24125 01MAY2001 22:01 HOURS TO 22:10 HOURS N 24125 01NOV2001 22:01 HOURS TO 22:10 HOURS Y 24126 01MAY2001 22:11 HOURS TO 22:20 HOURS N 24126 01NOV2001 22:11 HOURS TO 22:20 HOURS Y 24127 01MAY2001 22:21 HOURS TO 22:30 HOURS N 24127 01NOV2001 22:21 HOURS TO 22:30 HOURS Y 24128 01MAY2001 22:31 HOURS TO 22:40 HOURS N 24128 01NOV2001 22:31 HOURS TO 22:40 HOURS Y 24129 01MAY2001 22:41 HOURS TO 22:50 HOURS N 24129 01NOV2001 22:41 HOURS TO 22:50 HOURS Y 24130 01MAY2001 22:51 HOURS TO 23:00 HOURS N 24130 01NOV2001 22:51 HOURS TO 23:00 HOURS Y 24131 01MAY2001 23:01 HOURS TO 23:10 HOURS N 24131 01NOV2001 23:01 HOURS TO 23:10 HOURS Y 24132 01MAY2001 23:11 HOURS TO 23:20 HOURS N 24132 01NOV2001 23:11 HOURS TO 23:20 HOURS Y 24133 01MAY2001 23:21 HOURS TO 23:30 HOURS N 24133 01NOV2001 23:21 HOURS TO 23:30 HOURS Y 24134 01MAY2001 23:31 HOURS TO 23:40 HOURS N 24134 01NOV2001 23:31 HOURS TO 23:40 HOURS Y 24135 01MAY2001 23:41 HOURS TO 23:50 HOURS N 24135 01NOV2001 23:41 HOURS TO 23:50 HOURS Y 24136 01MAY2001 23:51 HOURS TO 24:00 HOURS N 24136 01NOV2001 23:51 HOURS TO 24:00 HOURS Y 25000 01NOV2001 ANAESTHESIA, PERFUSION or ASSISTANCE AT ANAESTHESIA (a) for anaesthesia performed in association with an item in the range 20100 to 21997 or 22900 to 22905; or (b) for perfusion performed in association with item 22060; or (c) for assistance at anaesthesia performed in association with items 25200 to 25205 Where the patient has severe systemic disease equivalent to ASA physical status indicator 3 Y 25005 01NOV2001 Where the patient has severe systemic disease which is a constant threat to life equivalent to ASA physical status indicator 4 Y 25010 01MAY2001 For a patient who is not expected to survive for 24 hours with or without the operation, equivalent to ASA physical status indicator 5 N 25010 01NOV2001 For a patient who is not expected to survive for 24 hours with or without the operation, equivalent to ASA physical status indicator 5 Y 25012 01NOV2019 Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is over 3 years of age but under 4 years of age Y 25015 01NOV2001 ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient's age is one year or less or 70 years or greater N 25015 01MAY2002 ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient is less than 12 months of age or 70 years or greater N 25015 01NOV2019 Anaesthesia, perfusion or assistance in the management of anaesthesia, if the patient is aged not more than 3 years or at least 75 years Y 25020 01NOV2001 ANAESTHESIA, PERFUSION OR ASSISTANCE AT ANAESTHESIA - where the patient requires immediate treatment without which there would be significant threat to life or body part - not being a service associated with a service to which item 25025 or 25030 or 25050 applies Y 25025 01MAY2001 EMERGENCY ANAESTHESIA performed in the after hours period where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for the emergency anaesthesia service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25030 or 25050 applies Derived Fee: An additional amount of 50% of the fee for the anaesthetic service.That is: (a) an anaesthesia item/s in the range 20100 - 21997 or 22900, plus (b) an item in the range 23010 - 24136, plus (c) where applicable, an item in the range 25000-25015, plus (d) where performed, any associated therapeutic or diagnostic service/s in the range 22001-22050 N 25025 01NOV2001 EMERGENCY ANAESTHESIA performed in the after hours period where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for the emergency anaesthesia service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25030 or 25050 applies Derived Fee: An additional amount of 50% of the fee for the anaesthetic service. That is: (a) an anaesthesia item/s in the range 20100 - 21997 or 22900, plus (b) an item in the range 23010 - 24136, plus (c) where applicable, an item in the range 25000-25015, plus (d) where performed, any associated therapeutic or diagnostic service/s in the range 22001-22050 N 25025 01NOV2007 EMERGENCY ANAESTHESIA performed in the after hours period where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for the emergency anaesthesia service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25030 or 25050 applies Y 25030 01MAY2001 ASSISTANCE AT AFTER HOURS EMERGENCY ANAESTHESIA where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for which the assistant is in professional attendance on the patient is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25050 applies N 25030 01NOV2001 ASSISTANCE AT AFTER HOURS EMERGENCY ANAESTHESIA where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for which the assistant is in professional attendance on the patient is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25050 applies N 25030 01NOV2007 ASSISTANCE AT AFTER HOURS EMERGENCY ANAESTHESIA where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the time for which the assistant is in professional attendance on the patient is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25050 applies Y 25050 01NOV2001 AFTER HOURS EMERGENCY PERFUSION where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the perfusion service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25030 applies N 25050 01NOV2007 AFTER HOURS EMERGENCY PERFUSION where the patient requires immediate treatment without which there would be significant threat to life or body part and where more than 50% of the perfusion service is provided in the after hours period, being the period from 8pm to 8am on any weekday, or at any time on a Saturday, a Sunday or a public holiday - not being a service associated with a service to which item 25020, 25025 or 25030 applies Y 25200 01NOV2001 ASSISTANCE IN THE ADMINISTRATION OF ANAESTHESIA on a patient in imminent danger of death requiring continuous life saving emergency treatment, to the exclusion of all other patients Y 25205 01NOV2001 ASSISTANCE IN THE ADMINISTRATION OF ELECTIVE ANAESTHESIA where: (i)the patient has complex airway problems; or (ii)the patient is a neonate or a complex paediatric case; or (iii)there is anticipated to be massive blood loss (greater than 50% of blood volume) during the procedure; or (iv)the patient is critically ill, with multiple organ failure; or (v)where the anaesthesia time exceeds 6 hours and the assistance is provided to the exclusion of all other patients Y 30000 01DEC1991 Operative procedure on tissue, organ or region not being a service to which another item in this Group applies, including any consultation on the same occasion Y 30001 01NOV1997 OPERATIVE PROCEDURE, not being a service to which any other item in this Group applies, being a service to which an item in this Group would have applied had the procedure not been discontinued on medical grounds Y 30003 01DEC1991 DRESSING OF LOCALISED BURNS (not involving grafting)each attendance at which the procedure is performed, including any associated consultation N 30003 01NOV1995 LOCALISED BURNS, dressing of, (not involving grafting)each attendance at which the procedure is performed, including any associated consultation Y 30006 01DEC1991 DRESSING OF BURNS, EXTENSIVE, without anaesthesia (not involving grafting)each attendance at which the procedure is performed, including any associated consultation N 30006 01NOV1995 EXTENSIVE BURNS, dressing of, without anaesthesia (not involving grafting)each attendance at which the procedure is performed, including any associated consultation Y 30009 01DEC1991 DRESSING OF LOCALISED BURNS UNDER GENERAL ANAESTHESIA (not involving grafting)each attendance at which the procedure is performed, including any associated consultation N 30009 01NOV1995 LOCALISED BURNS, dressing of, under general anaesthesia (not involving grafting) Y 30010 01DEC1991 DRESSING OF LOCALISED BURNS UNDER GENERAL ANAESTHESIA (not involving grafting)each attendance at which the procedure is performed, including any associated consultation N 30010 01NOV1995 LOCALISED BURNS, dressing of, under general anaesthesia (not involving grafting) Y 30013 01DEC1991 DRESSING OF BURNS, EXTENSIVE, UNDER GENERAL ANAESTHESIA (not involving grafting)each attendance at which the procedure is performed, including any associated consultation N 30013 01NOV1995 EXTENSIVE BURNS, dressing of, under general anaesthesia (not involving grafting) Y 30014 01DEC1991 DRESSING OF BURNS, EXTENSIVE, UNDER GENERAL ANAESTHESIA (not involving grafting)each attendance at which the procedure is performed, including any associated consultation N 30014 01NOV1995 EXTENSIVE BURNS, dressing of, under general anaesthesia (not involving grafting) Y 30017 01DEC1991 EXCISION, under general anaesthesia, OF BURNS involving not more than 10 per cent of body surface, where grafting is not carried out during the same operation N 30017 01NOV1995 BURNS, excision of, under general anaesthesia, involving not more than 10 per cent of body surface, where grafting is not carried out during the same operation Y 30020 01DEC1991 EXCISION, under general anaesthesia, OF BURNS involving more than 10 per cent of body surface, where grafting is not carried out during the same operation N 30020 01NOV1995 BURNS, excision of, under general anaesthesia, involving more than 10 per cent of body surface, where grafting is not carried out during the same operation Y 30023 01DEC1991 DEBRIDEMENT, under general anaesthesia or major regional or field block, of deep or extensive contaminated wound of soft tissue, including suturing of that wound when performed N 30023 01NOV1995 WOUND OF SOFT TISSUE, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed N 30023 01NOV2005 WOUND OF SOFT TISSUE, traumatic, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed Y 30024 01NOV2005 WOUND OF SOFT TISSUE, debridement of extensively infected post-surgical incision or Fournier's Gangrene, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed Y 30026 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), superficial, not being a service to which another item in Group T4 applies N 30026 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, not on face or neck, small (NOT MORE THAN 7 CM LONG), superficial, not being a service to which another item in Group T4 applies Y 30029 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), involving deeper tissue, not being a service to which another item in Group T4 applies N 30029 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, not on face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue, not being a service to which another item in Group T4 applies Y 30032 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), superficial N 30032 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, on face or neck, small (NOT MORE THAN 7 CM LONG), superficial Y 30035 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CENTIMETRES LONG), involving deeper tissue N 30035 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, on face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue Y 30038 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, large (MORE THAN 7 CENTIMETRES LONG), superficial, not being a service to which another item in Group T4 applies N 30038 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, not on face or neck, large (MORE THAN 7 CM LONG), superficial, not being a service to which another item in Group T4 applies Y 30041 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue, not being a service to which another item in Group T4 applies N 30041 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, not on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue, not being a service to which another item in Group T4 applies Y 30042 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, other than on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue, not being a service to which another item in Group T4 applies N 30042 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, other than on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue, not being a service to which another item in Group T4 applies N 30042 01NOV2017 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, other than on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue, other than a service to which another item in Group T4 applies Y 30045 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CENTIMETRES LONG), superficial N 30045 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM LONG), superficial Y 30048 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue N 30048 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF WOUND OF, other than wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue Y 30049 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CENTIMETRES LONG), involving deeper tissue N 30049 01JUL1998 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OFWOUND OF, other than wound closure at time of surgery, on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue Y 30052 01DEC1991 REPAIR OF FULL THICKNESS LACERATION OF EAR, EYELID OR NOSE with accurate apposition of each layer of tissue N 30052 01NOV1995 FULL THICKNESS LACERATION OF EAR, EYELID, NOSE OR LIP, repair of, with accurate apposition of each layer of tissue Y 30055 01DEC1991 DRESSING AND REMOVAL OF SUTURES requiring a general anaesthetic, not being a service associated with a service to which another item in this Group applies N 30055 01NOV1995 WOUNDS, DRESSING OF, under general anaesthesia, with or without removal of sutures, not being a service associated with a service to which another item in this Group applies Y 30058 01DEC1991 CONTROL OF POSTOPERATIVE HAEMORRHAGE, under general anaesthesia following perineal or vaginal operations N 30058 01NOV1995 POSTOPERATIVE HAEMORRHAGE, control of, under general anaesthesia, as an independent procedure Y 30061 01DEC1991 SUPERFICIAL FOREIGN BODY, REMOVAL OF, (including from cornea or sclera), as an independent procedure Y 30062 01MAY2007 Etonogestrel subcutaneous implant, removal of, as an independent procedure Y 30064 01DEC1991 SUBCUTANEOUS FOREIGN BODY, REMOVAL OF, requiring incision and suture, as an independent procedure N 30064 01NOV1995 SUBCUTANEOUS FOREIGN BODY, removal of, requiring incision and exploration, including closure of wound if performed, as an independent procedure Y 30067 01DEC1991 FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure Y 30068 01DEC1991 FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure Y 30071 01DEC1991 BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure N 30071 01NOV2003 DIAGNOSTIC BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure, where the biopsy specimen is sent for pathological examination N 30071 01NOV2016 Diagnostic biopsy of skin, as an independent procedure, if the biopsy specimen is sent for pathological examination Y 30072 01NOV2016 Diagnostic biopsy of mucous membrane, as an independent procedure, if the biopsy specimen is sent for pathological examination Y 30074 01DEC1991 BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure N 30074 01NOV2003 DIAGNOSTIC BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination Y 30075 01DEC1991 BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure N 30075 01NOV2003 DIAGNOSTIC BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination N 30075 01NOV2017 DIAGNOSTIC BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure,if the biopsy specimen is sent for pathological examination N 30075 01NOV2019 DIAGNOSTIC BIOPSY OF LYMPH NODE, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure,if the biopsy specimen is sent for pathological examination Y 30078 01DEC1991 DRILL BIOPSY OF LYMPH GLAND, DEEP TISSUE OR ORGAN, as an independent procedure N 30078 01NOV2003 DIAGNOSTIC DRILL BIOPSY OF LYMPH GLAND, DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination N 30078 01NOV2019 DIAGNOSTIC DRILL BIOPSY OF LYMPH NODE, DEEP TISSUE OR ORGAN, as an independent procedure, where the biopsy specimen is sent for pathological examination Y 30081 01DEC1991 BIOPSY OF BONE MARROW by trephine using open approach N 30081 01NOV2003 DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using open approach, where the biopsy specimen is sent for pathological examination Y 30084 01DEC1991 BIOPSY OF BONE MARROW by trephine using percutaneous approach with a Jamshidi needle or similar device N 30084 01NOV2003 DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using percutaneous approach with a Jamshidi needle or similar device, where the biopsy is sent for pathological examination N 30084 01JAN2014 DIAGNOSTIC BIOPSY OF BONE MARROW by trephine using percutaneous approach where the biopsy is sent for pathological examination Y 30087 01DEC1991 BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL MEMBRANE N 30087 01NOV2003 DIAGNOSTIC BIOPSY OF BONE MARROW by aspiration or PUNCH BIOPSY OF SYNOVIAL MEMBRANE, where the biopsy is sent for pathological examination Y 30090 01DEC1991 BIOPSY OF PLEURA, PERCUTANEOUS1 or more biopsies on any 1 occasion N 30090 01NOV2003 DIAGNOSTIC BIOPSY OF PLEURA, PERCUTANEOUS 1 or more biopsies on any 1 occasion, where the biopsy is sent for pathological examination Y 30093 01DEC1991 NEEDLE BIOPSY OF VERTEBRA N 30093 01NOV2003 DIAGNOSTIC NEEDLE BIOPSY OF VERTEBRA, where the biopsy is sent for pathological examination Y 30094 01APR1992 PERCUTANEOUS ASPIRATION BIOPSY of deep organ using interventional imaging techniques - but not including imaging N 30094 01NOV2003 DIAGNOSTIC PERCUTANEOUS ASPIRATION BIOPSY of deep organ using interventional imaging techniques - but not including imaging, where the biopsy is sent for pathological examination Y 30096 01DEC1991 SCALENE NODE BIOPSY N 30096 01MAY2004 DIAGNOSTIC SCALENE NODE BIOPSY, by open procedure, where the specimen excised is sent for pathological examination Y 30097 01NOV2006 Personal performance of a Synacthen Stimulation Test, including associated consultation; by a medical practitioner with resuscitation training and access to facilities where life support procedures can be implemented. N 30097 01NOV2018 Personal performance of a Synacthen Stimulation Test, including associated consultation; by a medical practitioner with resuscitation training and access to facilities where life support procedures can be implemented, if: serum cortisol at 0830-0930 hours on any dayin the preceding month has been measured at greater than 100 nmol/L but less than 400 nmol/L; or in a patient who is acutely unwelland adrenal insufficiency is suspected. Y 30099 01DEC1991 SINUS, excision of, involving superficial tissue only Y 30102 01DEC1991 SINUS, excision of, involving muscle and deep tissue Y 30103 01DEC1991 SINUS, excision of, involving muscle and deep tissue Y 30104 01NOV1995 PRE-AURICULAR SINUS, excision of N 30104 01SEP2015 PRE-AURICULAR SINUS, on a person 10 years of age or over.Excision of, Y 30105 01SEP2015 PRE-AURICULAR SINUS, on a person under 10 years of age.Excision of, Y 30106 01DEC1991 GANGLION OR SMALL BURSA, excision of N 30106 01NOV1995 GANGLION OR SMALL BURSA, excision of, not being a service associated with a service to which another item in this Group applies Y 30107 01DEC1991 GANGLION OR SMALL BURSA, excision of N 30107 01NOV1995 GANGLION OR SMALL BURSA, excision of, not being a service associated with a service to which another item in this Group applies N 30107 01NOV2017 GANGLION OR SMALL BURSA, excision of,other thana service associated with a service to which another item in this Group applies Y 30110 01DEC1991 BURSA (LARGE), INCLUDING OLECRANON, CALCANEUM OR PATELLA, excision of Y 30111 01DEC1991 BURSA (LARGE), INCLUDING OLECRANON, CALCANEUM OR PATELLA, excision of Y 30114 01DEC1991 BURSA, SEMIMEMBRANOSUS (Baker's cyst), excision of Y 30116 01NOV1996 TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which items 30127, 30128, 30130, 30134, 30138, 30145, 30149, 30152, 30157 or 30195 apply) Y 30117 01DEC1991 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 30121/30122, 30125/30126, 30129, 30132 or 30195 applies Y 30118 01DEC1991 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removalis by surgical excision and suture, not being a service to which item 30121/30122, 30125/30126, 30129, 30132 or 30195 applies Y 30119 01NOV1996 TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which items 30127, 30130, 30137, 30141, 30146, 30151, 30154, 30158 or 30195 apply) Y 30120 01NOV1996 TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which items 30127, 30130, 30137, 30142, 30148, 30151, 30155, 30160 or 30195 apply) Y 30121 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 3 BUT NOT MORE THAN 10 LESIONS, not being a service to which item 30195 applies Y 30122 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 3 BUT NOT MORE THAN 10 LESIONS, not being a service to which item 30195 applies Y 30123 01NOV1996 TUMOURS,(other than viral verrucae[common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which item 30195 applies) Y 30124 01NOV1996 TUMOURS,(other than viral verrucae[common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions from cutaneous or subcutaneous tissue or from mucous membrane, where removal is by surgical excision and suture (not being a service to which item 30195 applies) Y 30125 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 10 BUT NOT MORE THAN 20 LESIONS, not being a service to which item 30195 applies Y 30126 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 10 BUT NOT MORE THAN 20 LESIONS, not being a service to which item 30195 applies Y 30127 01NOV1996 TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal from nose, eyelid, lip, ear, digit or genitalia - where removal is by surgical excision and suture (not being a service to which items 30134, 30137, 30149, 30151 or 30195 apply) Y 30128 01NOV1996 TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30127, lesion size up to 10mm in diameter - where removal is by surgical excision and suture (not being a service to which items 30138, 30141, 30142, 30152, 30154, 30155 or 30195 apply) Y 30129 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 20 BUT NOT MORE THAN 50 LESIONS, not being a service to which item 30195 applies Y 30130 01NOV1996 TUMOUR,(other than viral verrucae[common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30127, lesion size more than 10mm in diameter - where removal is by surgical excision and suture (not being a service to which items 30138, 30141, 30142, 30152, 30154, 30155 or 30195 apply) Y 30131 01NOV1996 SKIN AND SUBCUTANEOUS TISSUE, extensive excision of, in the treatment of suppurative hydradenitis (excision from axilla, groin or natal cleft) or sycosis barbae or nuchae (excision from face or neck) Y 30132 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on MORE THAN 50 LESIONS, not being a service to which item 30195 applies Y 30133 01NOV1996 GIANT HAIRY OR CONGENITAL PIGMENTED NAEVUS, excision of an area at least 1 percent of body surface where the specimen is sent for histological confirmation of diagnosis Y 30134 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30135 01DEC1991 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane Y 30136 01DEC1991 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 centimetres in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane Y 30137 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, lesion size more than 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30138 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from hand, lower leg (mid calf to ankle), foot or areas of the head and neck not covered by item 30134, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30139 01DEC1991 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in this Group applies, involving muscle, bone or other deep tissue Y 30140 01DEC1991 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in this Group applies, involving muscle, bone or other deep tissue Y 30141 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from hand, lower leg (mid calf to ankle), foot or areas of the head and neck not covered by item 30137, lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30142 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from hand, lower leg (mid calf to ankle), foot or areas of the head and neck not covered by item 30137, lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30143 01DEC1991 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not being a service to which another item in this Group applies Y 30144 01DEC1991 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not being a service to which another item in this Group applies Y 30145 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 30134 and 30138, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30146 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 30137 and 30141, lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30147 01DEC1991 MALIGNANT TUMOUR, removal of, from skin, requiring wide and deep excision, other than removal of basal cell carcinoma Y 30148 01NOV1996 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 30137 and 30142, lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30149 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30150 01DEC1991 MALIGNANT TUMOUR, removal of, from skin, requiring wide and deep excision with immediate block dissection of lymph glands Y 30151 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, lesion size more than 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30152 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30149, lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30153 01DEC1991 TUMOUR, removal of, from SOFT TISSUE (INCLUDING MUSCLE, FASCIA AND CONNECTIVE TISSUE), EXTENSIVE EXCISION OF, WITHOUT SKIN GRAFT Y 30154 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30151, lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30155 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from hand, foot, lower leg (mid calf to ankle) or areas of the head and neck not covered by item 30151, lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30156 01DEC1991 TUMOUR, removal of, from SOFT TISSUE (INCLUDING MUSCLE, FASCIA AND CONNECTIVE TISSUE), EXTENSIVE EXCISION OF, WITH SKIN GRAFT Y 30157 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 30149 and 30151 - lesion size up to 10mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30158 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 30149 and 30151 - lesion size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30159 01DEC1991 MALIGNANT TUMOUR, removal of, from any region involving a RADICAL OPERATION (not being an operation to which another item in this Group applies) Y 30160 01NOV1996 MALIGNANT MELANOMA, RESIDUAL OR RECURRENT BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen cryotherapy), APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN OR HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 30149 and 30151 - lesion size more than 20mm in diameter - where removal is by surgical excision and suture and specimen is sent for histological confirmation of diagnosis Y 30161 01NOV1996 NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, performed in association with excision of malignant tumour of skin covered by items 30134, 30137, 30138, 30141, 30142, 30145, 30146, 30148, 30149, 30151, 30152, 30154, 30155, 30157, 30158 or 30160 Y 30162 01DEC1991 MALIGNANT TUMOUR, removal of, from any region involving a LIMITED OPERATION, other than removal of basal cell carcinoma (not being an operation to which another item in this Group applies) Y 30165 01DEC1991 LIPECTOMYtransverse wedge excision of abdominal apron N 30165 01NOV2003 LIPECTOMY transverse wedge excision of abdominal apron, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45533 applies N 30165 01NOV2004 LIPECTOMY transverse wedge excision of abdominal apron, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45530 applies N 30165 01JAN2015 LIPECTOMY transverse wedge excision of abdominal apron, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45530 applies(H) N 30165 01JAN2016 Lipectomy, wedge excision of abdominal apron that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30168, 30171, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the abdominal apron interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H) Y 30168 01DEC1991 LIPECTOMYwedge excision of skin or fat not being a service to which item 30165 applies1 EXCISION N 30168 01NOV2003 LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45533 and not being a service to which item 30165 applies, 1 EXCISION N 30168 01NOV2004 LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 1 EXCISION N 30168 01JUL2009 LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 1 EXCISION N 30168 01JAN2015 LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 1 EXCISION (H) N 30168 01JAN2016 Lipectomy, wedge excision of redundant non abdominal skin and fat that is a direct consequence of significant weight loss,not being a service associated with a service to which item 30165, 30171, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy; and (d) the procedure involves 1 excision only (H) Y 30171 01DEC1991 LIPECTOMYwedge excision of skin or fat not being a service to which item 30165 applies2 OR MORE EXCISIONS N 30171 01NOV2003 LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45533 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS N 30171 01NOV2004 LIPECTOMY wedge excision of skin or fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS N 30171 01JUL2009 LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS N 30171 01JAN2015 LIPECTOMY wedge excision of skin and fat, not being a service associated with items 45564, 45565 or 45530 and not being a service to which item 30165 applies, 2 OR MORE EXCISIONS (H) N 30171 01JAN2016 Lipectomy, wedge excision of redundant non abdominal skin and fat that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30165, 30168, 30172, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy; and (d) the procedure involves 2 excisions only (H) Y 30172 01JAN2016 Lipectomy, wedge excision of redundant non abdominal skin and fat that is a direct consequence of significant weight loss, not being a service associated with a service to which item 30165, 30168, 30171, 30176, 30177, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy; and (d) the procedure involves 3 or more excisions (H) Y 30174 01DEC1991 LIPECTOMYsubumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall N 30174 01NOV2003 LIPECTOMYsubumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall, not being a service associated with items 45564 or 45565 or 45533 N 30174 01NOV2004 LIPECTOMYsubumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall, not being a service associated with items 45564 or 45565 or 45530 N 30174 01JAN2015 LIPECTOMYsubumbilical excision with undermining of skin edges and strengthening of musculoaponeurotic wall, not being a service associated with items 45564 or 45565 or 45530 (H) Y 30176 01JAN2016 Lipectomy, radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30177, 30179, 45530, 45564 or 45565 applies, if it can be demonstrated that there is an anterior abdominal wall defect that is a consequence of the surgical removal of large intra abdominal or pelvic tumours (H) N 30176 01NOV2018 Lipectomy, radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30177, 30179, 45530, 45564 or 45565 applies,if the patient has previously had a massive intra-abdominal or pelvic tumour surgically removed Y 30177 01DEC1991 LIPECTOMY radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus N 30177 01NOV2003 LIPECTOMY radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45533 applies N 30177 01NOV2004 LIPECTOMY radical abdominoplasty (Pitanguy type or similar), with excision of skin and subcutaneous tissue, repair of musculoaponeurotic layer and transposition of umbilicus, not being a service performed within 12 months after the end of a pregnancy and not being a service associated with a service to which item 45564, 45565 or 45530 applies N 30177 01JAN2016 Lipectomy, excision of skin and subcutaneous tissue associated with redundant abdominal skin and fat that is a direct consequence of significant weight loss, in conjunction with a radical abdominoplasty (Pitanguy type or similar), with or without repair of musculoaponeurotic layer and transposition of umbilicus, not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30179, 45530, 45564 or 45565 applies, if: (a) there is intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H) Y 30178 01NOV2003 CLOSURE OF ABDOMEN WITH RECONSTRUCTION OF UMBILICUS, with or without lipectomy, being a service associated with items 45564, 45565 or 45533 N 30178 01NOV2004 CLOSURE OF ABDOMEN WITH RECONSTRUCTION OF UMBILICUS, with or without lipectomy, being a service associated with items 45564, 45565 or 45530 Y 30179 01JAN2016 Circumferential lipectomy, as an independent procedure, to correct circumferential excess of redundant skin and fat that is a direct consequence of significant weight loss, with or without a radical abdominoplasty (Pitanguy type or similar),not being a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177, 45530, 45564 or 45565 applies, if: (a) the circumferential excess of redundant skin and fat is complicated by intertrigo or another skin condition that risks loss of skin integrity and has failed 3 months of conventional (or non surgical) treatment; and (b) the circumferential excess of redundant skin and fat interferes with the activities of daily living; and (c) the weight has been stable for at least 6 months following significant weight loss prior to the lipectomy (H) Y 30180 01DEC1991 AXILLARY HYPERHIDROSIS, wedge excision for N 30180 01NOV2003 AXILLARY HYPERHIDROSIS, partial excision for Y 30183 01DEC1991 AXILLARY HYPERHIDROSIS, total excision of sweat gland bearing area Y 30185 01NOV2003 PALMAR OR PLANTAR WARTS (10 or more), definitive removal of, excluding ablative methods alone, not being a service to which item 30186 or 30187 applies Y 30186 01DEC1991 PLANTAR WART, removal of N 30186 01NOV1995 PALMAR OR PLANTAR WARTS, removal of, not being a service to which item 30187 applies N 30186 01NOV2003 PALMAR OR PLANTAR WARTS (less than 10), definitive removal of, excluding ablative methods alone, not being a service to which item 30185 or 30187 applies Y 30187 01NOV1995 PALMAR OR PLANTAR WARTS, removal of, by carbon dioxide laser, requiring admission to a hospital or day-hospital facility, or when performed by a specialist in the practice of his/her specialty, where the time taken is greater than 45 minutes (5 or more warts) N 30187 01MAY2001 PALMAR OR PLANTAR WARTS, removal of, by carbon dioxide laser or erbium laser, requiring admission to a hospital, or when performed by a specialist in the practice of his/her specialty, (5 or more warts) Y 30189 01DEC1991 WARTS or MOLLUSCUM CONTAGIOSUM, removal of, by any method (other than by chemical means), where undertaken in the operating theatre of a hospital or approved day-hospital facility, not being a service associated with a service to which another item in this Group applies N 30189 01NOV2003 WARTS or MOLLUSCUM CONTAGIOSUM (one or more), removal of, by any method (other than by chemical means), where undertaken in the operating theatre of a hospital, not being a service associated with a service to which another item in this Group applies N 30189 01JAN2015 WARTS or MOLLUSCUM CONTAGIOSUM (one or more), removal of, by any method (other than by chemical means), where undertaken in the operating theatre of a hospital, not being a service associated with a service to which another item in this Group applies (H) Y 30190 01NOV1995 ANGIOFIBROMAS, TRICHOEPITHELIOMAS or other severely disfiguring tumours suitable for laser excision as confirmed by specialist opinion, of the face or neck, removal of, by carbon dioxide laser excision-ablation including associated resurfacing (10 or more tumours) N 30190 01MAY2001 ANGIOFIBROMAS, TRICHOEPITHELIOMAS or other severely disfiguring tumours suitable for laser excision as confirmed by specialist opinion, of the face or neck, removal of, by carbon dioxide laser or erbium laser excision-ablation including associated resurfacing (10 or more tumours) N 30190 01NOV2018 Angiofibromas, trichoepitheliomas or other severely disfiguring tumours of the face or neck (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), suitable for laser ablation as confirmed by the opinion of a specialist in the specialty of dermatology - removal of, by carbon dioxide laser or erbium laser ablation, including associated resurfacing (10 or more tumours) Y 30191 01NOV2018 Angiofibromas, trichoepithelioma, epidermal naevi, xanthelasma, pyogenic granuloma, genital angiokeratomas, hereditary haemorrhagic telangiectasia and other severely disfiguring or recurrently bleeding tumours (excluding melanocytic naevi, sebaceous hyperplasia, dermatosis papulosa nigra, Campbell De Morgan angiomas and seborrheic or viral warts), treatment of, with carbon dioxide/erbium or other appropriate laser (or curettage and fine point diathermy for pyogenic granuloma only), if confirmed by the opinion of a specialist in the specialty of dermatology, one or more lesions. Y 30192 01DEC1991 PREMALIGNANT SKIN LESIONS, treatment of, by galvanocautery or electrodesiccation or cryocautery (10 or more lesions) N 30192 01NOV2003 PREMALIGNANT SKIN LESIONS (including solar keratoses), treatment of, by ablative technique (10 or more lesions) Y 30195 01DEC1991 NEOPLASTIC SKIN LESIONS, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, not being a service to which item 30198, 30201 or 30204 applies(1 or more lesions) N 30195 01NOV1993 NEOPLASTIC SKIN LESIONS, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, not being a service associated with a service to which item 30196, 30197, 30202, 30203 or 30205 applies(1 or more lesions) N 30195 01NOV1995 NEOPLASTIC SKIN LESIONS, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which items 30196, 30197, 30202, 30203 or 30205 apply(1 or more lesions) N 30195 01MAY2003 BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which items 30196, 30197, 30202, 30203 or 30205 apply(1 or more lesions) N 30195 01NOV2003 BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) and seborrheic keratoses, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions) N 30195 01NOV2004 BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) seborrheic keratoses and skin tags, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions) N 30195 01MAY2005 BENIGN NEOPLASM OF SKIN, other than viral verrucae (common warts) seborrheic keratoses, cysts and skin tags, treatment by electrosurgical destruction, simple curettage or shave excision, or laser photocoagulation, not being a service to which item 30196, 30197, 30202, 30203 or 30205 applies (1 or more lesions) Y 30196 01NOV1993 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by a specialist opinion, removal of, BY SERIAL CURETTAGE, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies N 30196 01NOV1995 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser excision-ablation, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies N 30196 01MAY2001 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser or erbium laser excision-ablation, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies N 30196 01MAY2003 MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser or erbium laser excision-ablation, including any associated cryotherapy or diathermy, not being a service to which item 30197 applies N 30196 01NOV2018 Malignant neoplasm of skin or mucous membrane that has been:(a) proven by histopathology; or (b) confirmed by the opinion of a specialist in the specialty of dermatology where a specimen has been submitted for histologic confirmation; removal of, by serial curettage, or carbon dioxide laser or erbium laser excision?ablation, including any associated cryotherapy or diathermy Y 30197 01NOV1993 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by a specialist opinion, removal of, BY SERIAL CURETTAGE, including any associated cryotherapy or diathermy, (10 OR MORE LESIONS) N 30197 01NOV1995 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser excision-ablation, including any associated cryotherapy or diathermy, (10 or more lesions) N 30197 01MAY2003 MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, by serial curettage or carbon dioxide laser excision-ablation, including any associated cryotherapy or diathermy, (10 OR MORE LESIONS) Y 30198 01DEC1991 CANCER OF SKIN OR MUCOUS MEMBRANE, removal by serial curettage or liquid nitrogen cryosurgery using repeat freezethaw cycles, not being a service to which item 30201 or 30204 applies Y 30201 01DEC1991 CANCER OF SKIN OR MUCOUS MEMBRANE, removal by serial curettage or liquid nitrogen cryosurgery using repeat freezethaw cycles (more than 3 but not more than 10 lesions) Y 30202 01NOV1993 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles, not being a service to which item 30203 applies N 30202 01MAY2003 MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles, not being a service to which item 30203 applies N 30202 01NOV2018 Malignant neoplasm of skin or mucous membrane proven by histopathology or confirmed by the opinion of a specialist in the specialty of dermatology - removal of, by liquid nitrogen cryotherapy using repeat freeze thaw cycles Y 30203 01NOV1993 CANCER OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles (10 OR MORE LESIONS) N 30203 01MAY2003 MALIGNANT NEOPLASM OF SKIN OR MUCOUS MEMBRANE proven by histopathology or confirmed by specialist opinion, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles (10 OR MORE LESIONS) Y 30204 01DEC1991 CANCER OF SKIN OR MUCOUS MEMBRANE, removal by serial curettage or liquid nitrogen cryosurgery using repeat freezethaw cycles (more than 10 lesions) Y 30205 01NOV1993 CANCER OF SKIN proven by histopathology, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles WHERE CANCER EXTENDS INTO CARTILAGE N 30205 01MAY2003 MALIGNANT NEOPLASM OF SKIN proven by histopathology, removal of, BY LIQUID NITROGEN CRYOTHERAPY using repeat freeze-thaw cycles WHERE THE MALIGNANT NEOPLASM EXTENDS INTO CARTILAGE Y 30207 01DEC1991 SKIN LESIONS, multiple injections with hydrocortisone or similar preparations N 30207 01NOV2018 Skin lesions, multiple injections with glucocorticoid preparations Y 30210 01DEC1991 KELOID and other SKIN LESIONS, EXTENSIVE, MULTIPLE INJECTIONS OF HYDROCORTISONE or similar preparations where undertaken in the operating theatre of a hospital N 30210 01NOV2018 Keloid and other skin lesions, extensive, multiple injections of glucocorticoid preparations, if undertaken in the operating theatre of a hospital on a patient less than 16 years of age Y 30213 01DEC1991 TELANGIECTASES OR STARBURST VESSELS, diathermy or sclerosant injection of, including associated consultation - for a session of at least 20 minutes N 30213 01JUL1993 TELANGIECTASES OR STARBURST VESSELS on the head or neck, diathermy or sclerosant injection of, including associated consultation - for a session of at least 20 minutes duration N 30213 01NOV1995 TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 3 metres, diathermy or sclerosant injection of, including associated consultation - limited to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - for a session of at least 20 minutes duration N 30213 01NOV1996 TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 4 metres, diathermy or sclerosant injection of, including associated consultation - limited to a maximum of 6 sessions (including any sessions to which items 14100 to 14118 and 30213 apply) in any 12 month period - for a session of at least 20 minutes duration Y 30214 19JUN1997 TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 4 metres, diathermy or sclerosant injection of, including associated consultation - session of at least 20 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period N 30214 01NOV1997 TELANGIECTASES OR STARBURST VESSELS on the head or neck where lesions are visible from 4 metres, diathermy or sclerosant injection of, including associated consultation - session of at least 20 minutes duration - where it can be demonstrated that a 7th or subsequent session (including any sessions to which items 14100 to 14118 and 30213 apply) is indicated in a 12 month period Y 30216 01DEC1991 HAEMATOMA, aspiration of Y 30219 01DEC1991 HAEMATOMA, FURUNCLE, SMALL ABSCESS OR SIMILAR LESION not requiring a general anaesthetic, INCISION WITH DRAINAGE OF (excluding aftercare) N 30219 01MAY2000 HAEMATOMA, FURUNCLE, SMALL ABSCESS OR SIMILAR LESION not requiring admission to a hospital - INCISION WITH DRAINAGE OF (excluding aftercare) Y 30222 01DEC1991 LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion requiring a general anaesthetic, INCISION WITH DRAINAGE OF (excluding aftercare) Y 30223 01DEC1991 LARGE HAEMATOMA, LARGE ABSCESS (including ischiorectal abscess), CARBUNCLE, CELLULITIS or similar lesionrequiring a general anaesthetic, INCISION WITH DRAINAGE OF (excluding aftercare) N 30223 01MAY2000 LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding aftercare) Y 30224 01APR1992 PERCUTANEOUS DRAINAGE OF DEEP ABSCESS - but not including imaging N 30224 01NOV1992 PERCUTANEOUS DRAINAGE OF DEEP ABSCESS using interventional imaging techniques - but not including imaging Y 30225 01APR1992 ABSCESS DRAINAGE TUBE, exchange of - but not including imaging N 30225 01NOV1992 ABSCESS DRAINAGE TUBE, exchange of using interventional imaging techniques - but not including imaging Y 30226 01DEC1991 MUSCLE, excision of (LIMITED), or fasciotomy Y 30229 01DEC1991 MUSCLE, excision of (EXTENSIVE) Y 30232 01DEC1991 MUSCLE, RUPTURED, repair of (limited), not associated with external wound Y 30235 01DEC1991 MUSCLE, RUPTURED, repair of (extensive), not associated with external wound Y 30238 01DEC1991 FASCIA, DEEP, repair of, FOR HERNIATED MUSCLE Y 30241 01DEC1991 BONE TUMOUR, INNOCENT, excision of, not being a service to which another item in this Group applies Y 30244 01DEC1991 STYLOID PROCESS OF TEMPORAL BONE, removal of Y 30246 01JUL1998 PAROTID DUCT, repair of, using micro-surgical techniques Y 30247 01DEC1991 PAROTID GLAND, total extirpation of Y 30250 01DEC1991 PAROTID GLAND, total extirpation of, with preservation of facial nerve Y 30251 01JUL1998 RECURRENT PAROTID TUMOUR, excision of, withpreservation of facial nerve Y 30253 01DEC1991 PAROTID GLAND, SUPERFICIAL LOBECTOMY OR REMOVAL OF TUMOUR FROM, with exposure of facial nerve N 30253 01JUL1998 PAROTID GLAND, SUPERFICIAL LOBECTOMY OF, with exposure of facial nerve Y 30255 01MAY1997 SUBMANDIBULAR DUCTS, removal of, for surgical control of drooling N 30255 01JUL1998 SUBMANDIBULAR DUCTS, relocation of, for surgical control of drooling Y 30256 01DEC1991 SUBMANDIBULAR GLAND, extirpation of Y 30259 01DEC1991 SUBLINGUAL GLAND, extirpation of Y 30262 01DEC1991 SALIVARY GLAND, DILATATION OR DIATHERMY of duct Y 30265 01DEC1991 SALIVARY GLAND, removal of CALCULUS from duct or meatotomy or marsupialisation, 1 or more such procedures. Y 30266 01DEC1991 Salivary gland, removal of calculus from duct or meatotomy or marsupialisation, 1 or more such procedures. Y 30269 01DEC1991 SALIVARY GLAND, repair of CUTANEOUS FISTULA OF Y 30272 01DEC1991 TONGUE, partial excision of Y 30275 01DEC1991 RADICAL EXCISION OF INTRAORAL TUMOUR INVOLVING RESECTION OF MANDIBLE AND LYMPH GLANDS OF NECK (commandotype operation) N 30275 01NOV2019 RADICAL EXCISION OF INTRAORAL TUMOUR INVOLVING RESECTION OF MANDIBLE AND LYMPH NODES OF NECK (commandotype operation) Y 30278 01DEC1991 TONGUE TIE, repair of, not being a service to which another item in this Group applies Y 30281 01DEC1991 TONGUE TIE, MANDIBULAR FRENULUM or MAXILLARY FRENULUM, repair of, in a person aged 2 years and over, under general anaesthesia Y 30282 01DEC1991 RANULA OR MUCOUS CYST OF MOUTH, removal of Y 30283 01DEC1991 RANULA OR MUCOUS CYST OF MOUTH, removal of Y 30286 01DEC1991 BRANCHIAL CYST, removal of N 30286 01SEP2015 BRANCHIAL CYST, on a person 10 years of age or over.Removal of, Y 30287 01SEP2015 BRANCHIAL CYST, on a person under 10 years of age.Removal of, Y 30289 01DEC1991 BRANCHIAL FISTULA, removal of N 30289 01SEP2015 BRANCHIAL FISTULA, on a person 10 years of age or over.Removal of, Y 30292 01DEC1991 CYSTIC HYGROMA, removal of massive lesion requiring extensive excisionwith or without thoracotomy Y 30293 01NOV1992 CERVICAL OESOPHAGOSTOMY or CLOSURE OF CERVICAL OESOPHAGOSTOMY with or without plastic repair Y 30294 01NOV1992 CERVICAL OESOPHAGECTOMY with tracheostomy and oesophagostomy, with or without plastic reconstruction; or LARYNGOPHARYNGECTOMY with tracheostomy and plastic reconstruction Y 30295 01DEC1991 THYROIDECTOMY, total, or THYROIDECTOMY following previous total hemithyroidectomy or following previous unilateral or bilateral subtotal thyroidectomy Y 30296 01NOV1992 THYROIDECTOMY, total Y 30297 01NOV1992 THYROIDECTOMY following previous thyroid surgery Y 30298 01DEC1991 PARATHYROID TUMOUR, removal of Y 30299 01NOV2005 SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level I axilla, using preoperative lymphoscintigraphy and lymphotropic dye injection, not being a service associated with a service to which item 30300, 30302 or 30303 applies Y 30300 01NOV2005 SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level II/III axilla, using preoperative lymphoscintigraphy and lymphotropic dye injection, not being a service associated with a service to which item 30299, 30302 or 30303 applies Y 30301 01DEC1991 PARATHYROID GLANDS, removal of, other than for tumour Y 30302 01NOV2005 SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level I axilla, using lymphotropic dye injection, not being a service associated with a service to which item 30299, 30300 or 30303 applies Y 30303 01NOV2005 SENTINEL LYMPH NODE BIOPSY OR BIOPSIES for breast cancer, involving dissection in a level II/III axilla, using lymphotropic dye injection, not being a service associated with a service to which item 30299, 30300 or 30302 applies Y 30304 01DEC1991 CERVICAL REEXPLORATION for recurrent or persistent hyperparathyroidism Y 30306 01NOV1992 TOTAL HEMITHYROIDECTOMY Y 30307 01DEC1991 TOTAL HEMITHYROIDECTOMY or BILATERAL SUBTOTAL THYROIDECTOMY, with or without exposure of recurrent laryngeal nerve Y 30308 01NOV1992 BILATERAL SUBTOTAL THYROIDECTOMY Y 30309 01NOV1992 THYROIDECTOMY, SUBTOTAL for THYROTOXICOSIS Y 30310 01DEC1991 THYROID, excision of localised tumour of, or unilateral subtotal thyroidectomy N 30310 01NOV1992 THYROID, unilateral subtotal thyroidectomy or equivalent partial thyroidectomy N 30310 01NOV2018 Partial or subtotal thyroidectomy Y 30313 01DEC1991 THYROGLOSSAL CYST, removal of Y 30314 01NOV1992 THYROGLOSSAL CYST or FISTULA or both, radical removal of, including thyroglossal duct and portion of hyoid bone N 30314 01SEP2015 THYROGLOSSAL CYST or FISTULA or both, on a person 10 years of age or over.Radical removal of, including thyroglossal duct and portion of hyoid bone Y 30315 01NOV1992 PARATHYROID operation for hyperparathyroidism N 30315 01NOV2018 Minimally invasive parathyroidectomy. Removal of 1 or more parathyroid adenoma through a small cervical incision for an image localised adenoma, including thymectomy. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item30318, 30317 or 30320 applies. Y 30316 01DEC1991 THYROGLOSSAL CYST AND FISTULA, removal of Y 30317 01NOV1992 CERVICAL REEXPLORATION for recurrent or persistent hyperparathyroidism N 30317 01NOV2018 Redo parathyroidectomy. Cervical re-exploration for persistent or recurrent hyperparathyroidism, including thymectomy and cervical exploration of the mediastinum. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30315, 30318 or 30320 applies. Y 30318 01NOV1992 MEDIASTINUM, exploration of, via the cervical route, for hyperparathyroidism (including thymectomy) N 30318 01NOV2018 Open parathyroidectomy, exploration and removal of 1 or more adenoma or hyperplastic glands via a cervical incision including thymectomy and cervical exploration of the mediastinum when performed. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30315, 30317 or 30320 applies. Y 30319 01DEC1991 CERVICAL OESOPHAGOSTOMY or CLOSURE OF CERVICAL OESOPHAGOSTOMY with or without plastic repair Y 30320 01NOV1992 MEDIASTINUM, exploration of, via mediastinotomy, for hyperparathyroidism (including thymectomy) N 30320 01NOV2018 Removal of a mediastinal parathyroid adenoma via sternotomy or mediastinal thorascopic approach. For any particular patient - applicable only once per occasion on which the service is provided. Not in association with a service to which item 30315, 30317 or 30318 applies. Y 30321 01NOV1992 RETROPERITONEAL NEUROENDOCRINE TUMOUR, removal of Y 30322 01DEC1991 CERVICAL OESOPHAGECTOMY with tracheostomy and oesophagostomy, with or without plastic reconstruction; or LARYNGOPHARYNGECTOMY with tracheostomy and plastic reconstruction Y 30323 01NOV1992 RETROPERITONEAL NEUROENDOCRINE TUMOUR, removal of, requiring complex and extensive dissection N 30323 01NOV2018 Excision of phaeochromocytoma or extraadrenal paraganglioma via endoscopic or open approach. Y 30324 01NOV1992 ADRENAL GLAND TUMOUR, excision of N 30324 01NOV2018 Excision of an adrenocortical tumour or hyperplasia via endoscopic or open approach. Y 30325 01DEC1991 LYMPH GLANDS of NECK, limited excision of Y 30326 01SEP2015 THYROGLOSSAL CYST or FISTULA or both, radical removal of, including thyroglossal duct and portion of hyoid bone, on a person under 10 years of age Y 30328 01DEC1991 LYMPH GLANDS of NECK, radical excision of Y 30329 01NOV1992 LYMPH GLANDS of GROIN, limited excision of N 30329 01NOV2019 LYMPH NODES of GROIN, limited excision of Y 30330 01NOV1992 LYMPH GLANDS of GROIN, radical excision of N 30330 01NOV2019 LYMPH NODES of GROIN, radical excision of Y 30331 01DEC1991 LYMPH GLANDS OF GROIN OR AXILLA, limited excision of Y 30332 01NOV1992 LYMPH GLANDS of AXILLA, limited excision of N 30332 01MAY2000 LYMPH NODES of AXILLA, limited excision of (sampling) Y 30333 01NOV1992 LYMPH GLANDS of AXILLA, radical excision of Y 30334 01DEC1991 LYMPH GLANDS OF GROIN OR AXILLA, radical excision of Y 30335 01MAY2000 LYMPH NODES of AXILLA, complete excision of, to level I Y 30336 01MAY2000 LYMPH NODES of AXILLA, complete excision of, to level II or level III Y 30337 01DEC1991 SIMPLE MASTECTOMY with or without frozen section biopsy Y 30338 01DEC1991 SIMPLE MASTECTOMY with or without frozen section biopsy Y 30339 01MAY2000 BREAST, BENIGN LESION up to and including 50mm in diameter, including simple cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision of, with or without frozen section histology Y 30340 01MAY2000 BREAST, BENIGN LESION more than 50mm in diameter, excision of Y 30341 01DEC1991 BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason Y 30342 01DEC1991 BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason Y 30343 01MAY2000 BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or other localisation procedure is performed, excision biopsy of Y 30344 01MAY2000 BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen section histology Y 30345 01DEC1991 BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used Y 30346 01DEC1991 BREAST, excision of CYST, fibro adenoma or other local lesion or segmental resection for any other reason, where frozen section biopsy is performed or where specimen radiography is used Y 30347 01MAY2000 BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology Y 30348 01MAY2000 BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete excision of malignant tumour Y 30349 01DEC1991 PARTIAL MASTECTOMY, involving more than 25% of the breast tissue, with or without frozen section biopsy Y 30350 01DEC1991 PARTIAL MASTECTOMY, involving more than 25% of the breast tissue, with or without frozen section biopsy Y 30351 01MAY2000 BREAST (female), total mastectomy Y 30352 01MAY2000 BREAST (male), total mastectomy Y 30353 01DEC1991 BREAST, extended simple mastectomy with or without frozen section biopsy Y 30354 01MAY2000 BREAST (female), subcutaneous mastectomy Y 30355 01MAY2000 BREAST (male), subcutaneous mastectomy Y 30356 01DEC1991 SUBCUTANEOUS MASTECTOMY with or without frozen section biopsy Y 30358 01NOV2000 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a vacuum-assisted breast biopsy device under imaging guidance, for histological examination, where imaging has demonstrated: (a)microcalcification of lesion; or (b)impalpable lesion less than 1cm in diameter -including pre-operative localisation of lesion where performed, not being a service to which item 30363 applies Y 30359 01DEC1991 BREAST, radical or modified radical mastectomy with or without frozen section biopsy Y 30360 01APR1992 FINE NEEDLE ASPIRATION of an impalpable breast lesion defected by mammography or ultrasound, imaging guided - but not including imaging N 30360 01MAY2000 FINE NEEDLE ASPIRATION of an impalpable breast lesion detected by mammography or ultrasound, imaging guided - but not including imaging Y 30361 01APR1992 BREAST, preoperative localisation of lesion by hookwire or similar device - but not including imaging N 30361 01NOV1992 BREAST, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques - but not including imaging Y 30362 01DEC1991 NIPPLE, INVERTED, surgical eversion of N 30362 01NOV1992 INVERTED NIPPLE, surgical eversion of Y 30363 01NOV1992 BREAST, core biopsy of solid tumour or tissue of, using mechanical biopsy device, for histological examination N 30363 01NOV2000 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using mechanical biopsy device, for histological examination, not being a service to which item 30358 applies Y 30364 01NOV1992 BREAST, haematoma, seroma or inflammatory condition including abscess, granulomatous mastitis or similar, exploration and drainage of when undertaken in the operating theatre of a hospital or day-hospital facility, excluding aftercare N 30364 01MAY2000 BREAST, HAEMATOMA, SEROMA OR INFLAMMATORY CONDITION including abscess, granulomatous mastitis or similar, exploration and drainage of when undertaken in the operating theatre of a hospital or day-hospital facility, excluding aftercare Y 30365 01DEC1991 LAPAROTOMY (exploratory), including associated biopsies, where no other intraabdominal procedure is performed Y 30366 01NOV1992 BREAST, microdochotomy of, for benign or malignant condition Y 30367 01NOV1992 BREAST CENTRAL DUCTS, excision of, for benign condition Y 30368 01DEC1991 LAPAROTOMY involving Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas Y 30369 01NOV1992 ACCESSORY BREAST TISSUE, excision of Y 30370 01NOV1992 INVERTED NIPPLE, surgical eversion of Y 30371 01DEC1991 LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed) Y 30372 01NOV1992 ACCESSORY NIPPLE, excision of Y 30373 01NOV1992 LAPAROTOMY (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed Y 30374 01DEC1991 LAPAROTOMY INVOLVING DIVISION OF ADHESIONS in association with another intraabdominal procedure where the time taken to divide the adhesions exceeds 45 minutes Y 30375 01NOV1992 LAPAROTOMY involving Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas N 30375 01MAY2005 Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas N 30375 01SEP2015 Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, on a person 10 years of age or over. Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty (adult) or Drainage of pancreas Y 30376 01NOV1992 LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed) N 30376 01SEP2015 LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed) on a person 10 years of age or over Y 30377 01DEC1991 LAPAROTOMY WITH DIVISION OF EXTENSIVE ADHESIONS (duration greater than 2 hours) with or without insertion of long intestinal tube Y 30378 01NOV1992 LAPAROTOMY INVOLVING DIVISION OF ADHESIONS in conjunction with another intraabdominal procedure where the time taken to divide the adhesions exceeds 45 minutes N 30378 01JUL1996 LAPAROTOMY involving division of adhesions in conjunction with another intraabdominal procedure where the time taken to divide the adhesions is between 45 minutes and 2 hours N 30378 01SEP2015 LAPAROTOMY involving division of adhesions in conjunction with another intraabdominal procedure where the time taken to divide the adhesions is between 45 minutes and 2 hours, on a person 10 years of age or over Y 30379 01NOV1992 LAPAROTOMY WITH DIVISION OF EXTENSIVE ADHESIONS (duration greater than 2 hours) with or without insertion of long intestinal tube Y 30380 01DEC1991 LAPAROTOMY FOR GRADING OF LYMPHOMA, including splenectomy, liver biopsies, lymph node biopsies and oophoropexy Y 30381 01NOV1992 FAECAL FISTULA, abdominal repair of, by simple excision of bowel Y 30382 01NOV1992 ENTEROCUTANEOUS FISTULA, radical repair of involving extensive dissection and resection of bowel (Ministerial Determination) N 30382 01JUL1995 ENTEROCUTANEOUS FISTULA, radical repair of, involving extensive dissection and resection of bowel Y 30383 01DEC1991 LAPAROTOMY FOR CONTROL OF POSTOPERATIVE HAEMORRHAGE, where no other procedure is performed Y 30384 01NOV1992 LAPAROTOMY FOR GRADING OF LYMPHOMA, including splenectomy, liver biopsies, lymph node biopsies and oophoropexy Y 30385 01NOV1992 LAPAROTOMY FOR CONTROL OF POSTOPERATIVE HAEMORRHAGE, where no other procedure is performed Y 30386 01DEC1991 LAPAROTOMY for drainage of pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause; with or without appendicectomy Y 30387 01NOV1992 LAPAROTOMY INVOLVING OPERATION ON ABDOMINAL VISCERA (including pelvic viscera), not being a service to which another item in this Group applies Y 30388 01NOV1992 LAPAROTOMY for trauma involving 3 or more organs (Ministerial Determination) N 30388 01JUL1995 LAPAROTOMY for trauma involving 3 or more organs Y 30389 01DEC1991 LAPAROTOMY INVOLVING OPERATION ON ABDOMINAL VISCERA (including pelvic viscera), not covered by any other Item in this Group Y 30390 01NOV1992 LAPAROSCOPY, diagnostic N 30390 01NOV2010 LAPAROSCOPY, diagnostic, not being a service associated with any other laparoscopic procedure N 30390 01SEP2015 LAPAROSCOPY, diagnostic, not being a service associated with any other laparoscopic procedure, on a person 10 years of age or over Y 30391 01NOV1992 LAPAROSCOPY with biopsy Y 30392 01DEC1991 RADICAL OR DEBULKING OPERATION for advanced intra-abdominal malignancy, with or without omentectomy, as an independent procedure N 30392 01NOV1997 RADICAL OR DEBULKING OPERATION for advanced intra-abdominal malignancy, with or without omentectomy, as an independent procedure Y 30393 01MAY1997 LAPAROSCOPIC DIVISION OF ADHESIONS in association with another intra-abdominal procedure where the time taken to divide the adhesions exceeds 45 minutes Y 30394 01NOV1992 LAPAROTOMY for drainage of subphrenic abscess, pelvic abscess, appendiceal abscess, ruptured appendix or for peritonitis from any cause, with or without appendicectomy Y 30395 01DEC1991 SUBPHRENIC ABSCESS, drainage of Y 30396 01NOV1992 LAPAROTOMY for gross intra peritoneal sepsis requiring debridement of fibrin, with or without removal of foreign material or enteric contents, with lavage of the entire peritoneal cavity via a major abdominal incision, with or without closure of abdomen and with or without mesh or zipper insertion (Ministerial Determination) N 30396 01JUL1995 LAPAROTOMY for gross intra peritoneal sepsis requiring debridement of fibrin, with or without removal of foreign material or enteric contents, with lavage of the entire peritoneal cavity via a major abdominal incision, with or without closure of abdomen and with or without mesh or zipper insertion Y 30397 01NOV1992 LAPAROSTOMY, via wound previously made and left open or closed with zipper, involving change of dressings or packs, and with or without drainage of loculated collections (Ministerial Determination) N 30397 01JUL1995 LAPAROSTOMY, via wound previously made and left open or closed with zipper, involving change of dressings or packs, and with or without drainage of loculated collections Y 30398 01DEC1991 LIVER BIOPSY, percutaneous Y 30399 01NOV1992 LAPAROSTOMY, final closure of wound made at previous operation, after removal of dressings or packs and removal of mesh or zipper if previously inserted(Ministerial Determination) N 30399 01JUL1995 LAPAROSTOMY, final closure of wound made at previous operation, after removal of dressings or packs and removal of mesh or zipper if previously inserted Y 30400 01NOV1992 LAPAROTOMY WITH INSERTION OF PORTACATH for administration of cytotoxic therapy including placement of reservoir Y 30401 01DEC1991 LIVER BIOPSY by wedge excision when performed in association with another intraabdominal procedure Y 30402 01NOV1992 RETROPERITONEAL ABSCESS, drainage of, not involving laparotomy Y 30403 01NOV1992 VENTRAL, INCISIONAL, OR RECURRENT HERNIA OR BURST ABDOMEN, repair of N 30403 01MAY2005 VENTRAL, INCISIONAL, OR RECURRENT HERNIA OR BURST ABDOMEN, repair of with or without mesh Y 30404 01DEC1991 LIVER TUMOUR, removal of other than by biopsy Y 30405 01NOV1992 VENTRAL, or incisional hernia, repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel (Ministerial Determination) N 30405 01JUL1995 VENTRAL OR INCISIONAL HERNIA, repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel N 30405 01MAY2005 VENTRAL OR INCISIONAL HERNIA, (excluding recurrent inguinal or femoral hernia), repair of, requiring muscle transposition, mesh hernioplasty or resection of strangulated bowel Y 30406 01NOV1992 PARACENTESIS ABDOMINIS Y 30407 01DEC1991 LIVER, MASSIVE RESECTION OF, or LOBECTOMY Y 30408 01NOV1992 PERITONEO venous (Leveen) shunt, insertion of (Ministerial Determination) N 30408 01JUL1995 PERITONEO venous (Leveen) shunt, insertion of N 30408 01NOV2010 PERITONEOVENOUS shunt, insertion of Y 30409 01NOV1992 LIVER BIOPSY, percutaneous Y 30410 01DEC1991 LIVER ABSCESS, ABDOMINAL, drainage of Y 30411 01NOV1992 LIVER BIOPSY by wedge excision when performed in conjunction with another intraabdominal procedure Y 30412 01NOV1992 LIVER BIOPSY by core needle, when performed in conjunction with another intra-abdominal procedure (Ministerial Determination) N 30412 01JUL1995 LIVER BIOPSY by core needle, when performed in conjunction with another intra-abdominal procedure Y 30413 01DEC1991 HYDATID CYST OF LIVER, PERITONEUM OR VISCUS, drainage procedure for Y 30414 01NOV1992 LIVER, subsegmental resection of, (local excision), other than for trauma (Ministerial Determination) N 30414 01JUL1995 LIVER, subsegmental resection of, (local excision), other than for trauma Y 30415 01NOV1992 LIVER, segmental resection of, other than for trauma (Ministerial Determination) N 30415 01JUL1995 LIVER, segmental resection of, other than for trauma Y 30416 01DEC1991 LIVER CYST, laparoscopic marsupialisation of, where the size of the cyst is greater than 5cm in diameter N 30416 01NOV1996 LIVER CYST, laparoscopic marsupialisation of, where the size of the cyst is greater than 5cm in diameter Y 30417 01APR1992 LIVER CYSTS, laparoscopic marsupialisation of 5 or more, including any cyst greater than 5cm in diameter N 30417 01NOV1996 LIVER CYSTS, laparoscopic marsupialisation of 5 or more, including any cyst greater than 5cm in diameter Y 30418 01NOV1992 LIVER, lobectomy of, other than for trauma (Ministerial Determination) N 30418 01JUL1995 LIVER, lobectomy of, other than for trauma Y 30419 01DEC1991 LIVER TUMOURS, destruction of, by hepatic cryotherapy N 30419 01MAY1997 LIVER TUMOURS, destruction of, by hepatic cryotherapy N 30419 01MAY2004 LIVER TUMOURS, destruction of, by hepatic cryotherapy, not being a service associated with a service to which item 50950 or 50952 applies Y 30420 01DEC1991 CHOLECYSTECTOMY Y 30421 01NOV1992 LIVER, TRI-SEGMENTAL RESECTION (extended lobectomy) of, other than for trauma (Ministerial Determination) N 30421 01JUL1995 LIVER, TRI-SEGMENTAL RESECTION (extended lobectomy) of, other than for trauma Y 30422 01NOV1992 LIVER, repair of superficial laceration of, for trauma (Ministerial Determination) N 30422 01JUL1995 LIVER, repair of superficial laceration of, for trauma Y 30423 01DEC1991 CHOLEDOCHOSCOPY Y 30424 01APR1992 BILIARY DRAINAGE TUBE, exchange of - but not including imaging Y 30425 01NOV1992 LIVER, repair of deep multiple lacerations of, or requiring debridement, for trauma (Ministerial Determination) N 30425 01JUL1995 LIVER, repair of deep multiple lacerations of, or debridement of, for trauma Y 30426 01DEC1991 CHOLEDOCHOTOMY (WITH OR WITHOUT CHOLECYSTECTOMY), including dilatation of sphincter of Oddi and removal of calculi Y 30427 01NOV1992 LIVER, segmental resection of, for trauma (Ministerial Determination) N 30427 01JUL1995 LIVER, segmental resection of, for trauma Y 30428 01NOV1992 LIVER, lobectomy of, for trauma (Ministerial Determination) N 30428 01JUL1995 LIVER, lobectomy of, for trauma Y 30429 01DEC1991 CHOLEDOCHOTOMY (WITH OR WITHOUT CHOLECYSTECTOMY), including dilatation of sphincter of Oddi and removal of calculi WITH CHOLEDOCHODUODENOSTOMY, CHOLEDOCHOGASTROSTOMY OR CHOLEDOCHOENTEROSTOMY Y 30430 01NOV1992 LIVER, extended lobectomy (tri-segmental resection) of, for trauma (Ministerial Determination) N 30430 01JUL1995 LIVER, extended lobectomy (tri-segmental resection) of, for trauma Y 30431 01NOV1992 LIVER ABSCESS, open abdominal drainage of Y 30432 01DEC1991 TRANSDUODENAL OPERATION ON SPHINCTER OF ODDI, including dilatation, removal of calculi, sphincterotomy and sphincteroplasty with or without choledochotomy, with or without cholecystectomy Y 30433 01NOV1992 LIVER ABSCESS (multiple), open abdominal drainage of (Ministerial Determination) N 30433 01JUL1995 LIVER ABSCESS (multiple), open abdominal drainage of Y 30434 01NOV1992 HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles (Ministerial Determination) N 30434 01JUL1995 HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles Y 30435 01DEC1991 CHOLECYSTODUODENOSTOMY, CHOLECYSTOGASTROSTOMY or CHOLECYSTOENTEROSTOMY with or without enteroenterostomy Y 30436 01NOV1992 HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles, with omentoplasty or myeloplasty (Ministerial Determination) N 30436 01JUL1995 HYDATID CYST OF LIVER, peritoneum or viscus, complete removal of contents of, with or without suture of biliary radicles, with omentoplasty or myeloplasty Y 30437 01NOV1992 HYDATID CYST OF LIVER, total excision of, by cysto-pericystectomy (membrane plus fibrous wall) (Ministerial Determination) N 30437 01JUL1995 HYDATID CYST OF LIVER, total excision of, by cysto-pericystectomy (membrane plus fibrous wall) Y 30438 01DEC1991 HYDATID CYST OF LIVER, excision of, with drainage and excision of liver tissue N 30438 01NOV1996 HYDATID CYST OF LIVER, excision of, with drainage and excision of liver tissue Y 30439 01NOV1992 OPERATIVE CHOLANGIOGRAPHY or operative pancreatography or intra operative ultrasound (including 1 or more examinations performed during the 1 operation) N 30439 01NOV1996 OPERATIVE CHOLANGIOGRAPHY OR OPERATIVE PANCREATOGRAPHY OR INTRA OPERATIVE ULTRASOUND of the biliary tract (including 1 or more examinations performed during the 1 operation) Y 30440 01NOV1992 CHOLANGIOGRAM, percutaneous transhepatic, and biliary drainage, using interventional imaging techniques - but not including imaging N 30440 01MAY2005 CHOLANGIOGRAM, percutaneous transhepatic, and insertion of biliary drainage tube, using interventional imaging techniques - but not including imaging, not being a service associated with a service to which item 30451 applies Y 30441 01DEC1991 INTRA OPERATIVE ULTRASOUND for staging of intra abdominal tumours N 30441 01NOV1996 INTRA OPERATIVE ULTRASOUND for staging of intra abdominal tumours Y 30442 01NOV1992 CHOLEDOCHOSCOPY in conjunction with another procedure Y 30443 01NOV1992 CHOLECYSTECTOMY Y 30444 01DEC1991 OESOPHAGOSCOPY (not covered by Item 41816 or 41822), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (one or more such procedures), with endoscopic sclerosing injection of oesophageal or gastric varices, not associated with Item 30441 or 30447 Y 30445 01NOV1992 LAPAROSCOPIC CHOLECYSTECTOMY (Ministerial Determination) N 30445 01JUL1995 LAPAROSCOPIC CHOLECYSTECTOMY Y 30446 01NOV1992 LAPAROSCOPIC CHOLECYSTECTOMY when procedure is completed by laparotomy (Ministerial Determination) N 30446 01JUL1995 LAPAROSCOPIC CHOLECYSTECTOMY when procedure is completed by laparotomy Y 30447 01DEC1991 OESOPHAGOSCOPY (not covered by Item 41816, 41822 or 41825), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (one or more such procedures), with one or more of the following procedurespolypectomy, removal of foreign body, diathermy coagulation of bleeding upper gastrointestinal lesions, not associated with Item 30441 or 30444 Y 30448 01NOV1992 LAPAROSCOPIC CHOLECYSTECTOMY, involving removal of common duct calculi via the cystic duct (Ministerial Determination) N 30448 01JUL1995 LAPAROSCOPIC CHOLECYSTECTOMY, involving removal of common duct calculi via the cystic duct Y 30449 01NOV1992 LAPAROSCOPIC CHOLECYSTECTOMY with removal of common duct calculi via laparoscopic choledochotomy (Ministerial Determination) N 30449 01JUL1995 LAPAROSCOPIC CHOLECYSTECTOMY with removal of common duct calculi via laparoscopic choledochotomy Y 30450 01DEC1991 CALCULUS OF BILIARY OR RENAL TRACT, extraction of, using interventional imaging techniques - not being a service associated with a service to which items 36627, 36630, 36645 or 36648 applies N 30450 01NOV1996 CALCULUS OF BILIARY OR RENAL TRACT, extraction of, using interventional imaging techniques - not being a service associated with a service to which items 36627, 36630, 36645 or 36648 applies Y 30451 01NOV1992 BILIARY DRAINAGE TUBE, exchange of, using interventional imaging techniques - but not including imaging N 30451 01MAY2005 BILIARY DRAINAGE TUBE, exchange of, using interventional imaging techniques - but not including imaging, not being a service associated with a service to which item 30440 applies Y 30452 01NOV1992 CHOLEDOCHOSCOPY with balloon dilation of a stricture or passage of stent or extraction of calculi (Ministerial Determination) N 30452 01JUL1995 CHOLEDOCHOSCOPY with balloon dilation of a stricture or passage of stent or extraction of calculi Y 30453 01DEC1991 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Y 30454 01NOV1992 CHOLEDOCHOTOMY (with or without cholecystectomy), with or without removal of calculi Y 30455 01NOV1992 CHOLEDOCHOTOMY (with or without cholecystectomy), with removal of calculi including biliary intestinal anastomosis Y 30456 01DEC1991 ENDOSCOPIC SPHINCTEROTOMY with or without extraction of stones from common bile duct Y 30457 01NOV1992 CHOLEDOCHOTOMY, intrahepatic, involving removal of intrahepatic bile duct calculi (Ministerial Determination) N 30457 01JUL1995 CHOLEDOCHOTOMY, intrahepatic, involving removal of intrahepatic bile duct calculi Y 30458 01NOV1992 TRANSDUODENAL OPERATION ON SPHINCTER OF ODDI, involving 1 or more of, removal of calculi, sphincterotomy, sphincteroplasty, biopsy, local excision of peri-ampullary or duodenal tumour, sphincteroplasty of the pancreatic duct, pancreatic duct septoplasty, with or without choledochotomy Y 30459 01DEC1991 BILIARY MANOMETRY Y 30460 01NOV1992 CHOLECYSTODUODENOSTOMY, CHOLECYSTOENTEROSTOMY, CHOLEDOCHOJEJUNOSTOMY or Roux-en-Y as a bypass procedure when no prior biliary surgery performed Y 30461 01NOV1992 RADICAL RESECTION of porta hepatis for gall bladder or common bile duct carcinoma with biliary-enteric anastomoses, not being a service associated with a service to which item 30443, 30454, 30455, 30458 or 30460 applies N 30461 01NOV2000 RADICAL RESECTION of porta hepatis with biliary-enteric anastomoses, not being a service associated with a service to which item 30443, 30454, 30455, 30458 or 30460 applies Y 30462 01DEC1991 ENDOSCOPIC BILIARY DILATATION Y 30463 01NOV1992 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, with 2 duct anastomoses (Ministerial Determination) N 30463 01JUL1995 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, with 2 duct anastomoses N 30463 01NOV2000 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts, with 2 duct anastomoses Y 30464 01NOV1991 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, involving more than 2 anastomoses or resection of segment or major portion of segment of liver (Ministerial Determination) N 30464 31OCT1992 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts for carcinoma, involving more than 2 anastomoses or resection of segment or major portion of segment of liver (Ministerial Determination) N 30464 01JUL1995 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts, involving more than 2 anastomoses or resection of segment or major portion of segment of liver N 30464 01NOV2000 RADICAL RESECTION of common hepatic duct and right and left hepatic ducts, involving more than 2 anastomoses or resection of segment or major portion of segment of liver Y 30465 01DEC1991 BILE DUCT, ENDOSCOPIC STENTING OF (including endoscopy and dilatation) Y 30466 01NOV1992 INTRAHEPATIC biliary bypass of left hepatic ductal system by Roux-en-Y loop to peripheral ductal system (Ministerial Determination) N 30466 01JUL1995 INTRAHEPATIC biliary bypass of left hepatic ductal system by Roux-en-Y loop to peripheral ductal system Y 30467 01NOV1992 INTRAHEPATIC BYPASS of right hepatic ductal system by Roux-en-Y loop to peripheral ductal system (Ministerial Determination) N 30467 01JUL1995 INTRAHEPATIC BYPASS of right hepatic ductal system by Roux-en-Y loop to peripheral ductal system Y 30468 01DEC1991 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (initial procedure) Y 30469 01NOV1992 BILIARY STRICTURE, repair of, after 1 or more operations on the biliary tree (Ministerial Determination) N 30469 01JUL1995 BILIARY STRICTURE, repair of, after 1 or more operations on the biliary tree Y 30470 01NOV1992 BILE DUCT FISTULA, repair of, following previous bile duct surgery (Ministerial Determination) N 30470 01JUL1995 BILE DUCT FISTULA, repair of, following previous bile duct surgery Y 30471 01DEC1991 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (repeat procedure) Y 30472 01NOV1992 HEPATIC OR COMMON BILE DUCT, repair of, as the primary procedure subsequent to transection of bile duct or ducts (Ministerial Determination) N 30472 01JUL1995 HEPATIC OR COMMON BILE DUCT, repair of, as the primary procedure subsequent to transection of bile duct or ducts N 30472 01NOV2000 HEPATIC OR COMMON BILE DUCT, repair of, as the primary procedure subsequent to partial or total transection of bile duct or ducts Y 30473 01NOV1992 OESOPHAGOSCOPY (not being a service to which item 41816 or 41822 applies), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (1 or more such procedures), with or without biopsy, not being a service associated with a service to which item 30476 or 30478 applies N 30473 01NOV2017 Oesophagoscopy (not being a service to which item 41816 or 41822 applies), gastroscopy,duodenoscopy or panendoscopy (1 or more such procedures), with or without biopsy, not being a service associated with a service to which item 30478 or 30479 applies. Y 30474 01DEC1991 ENDOSCOPIC LASER THERAPY for malignancy of upper or lower gastrointestinal tract Y 30475 01NOV1992 ENDOSCOPY with balloon dilatation of gastric or gastroduodenal stricture N 30475 01NOV2017 Endoscopic dilatation of stricture of upper gastrointestinal tract (including the use of imaging intensification where clinically indicated) Y 30476 01NOV1992 OESOPHAGOSCOPY (not being a service to which item 41816 or 41822 applies), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (1 or more such procedures), with endoscopic sclerosing injection of oesophageal or gastric varices, not being a service associated with a service to which item 30473 or 30478 applies N 30476 01NOV1995 OESOPHAGOSCOPY (not being a service to which item 41816 or 41822 applies), GASTROSCOPY, DUODENOSCOPY or PANENDOSCOPY (1 or more such procedures), with endoscopic sclerosing injection or banding of oesophageal or gastric varices, not being a service associated with a service to which item 30473 or 30478 applies Y 30477 01DEC1991 VAGOTOMY - TRUNKAL Y 30478 01NOV1992 OESOPHAGOSCOPY (not being a service to which item 41816, 41822 or 41825 applies), gastroscopy, duodenoscopy or panendoscopy (1 or more such procedures), with 1 or more of the following endoscopic procedures - polypectomy, removal of foreign body, diathermy, heater probe or laser coagulation, or sclerosing injection of bleeding upper gastrointestinal lesions, not being a service associated with a service to which item 30473 or 30476 applies N 30478 01NOV2017 Oesophagoscopy (other than a service to which item41816, 41822 or 41825 applies), gastroscopy, duodenoscopy, panendoscopy or push enteroscopy, one or more such procedures, if: (a) the procedures are performed using one or more of the following endoscopic procedures: (i) polypectomy; (ii) sclerosing or adrenalin injections; (iii) banding; (iv) endoscopic clips; (v) haemostatic powders; (vi) diathermy; (vii) argon plasma coagulation; and (b) the procedures are for the treatment of one or more of the following: (i) upper gastrointestinal tract bleeding; (ii) polyps; (iii) removal of foreign body; (iv) oesophageal or gastric varices; (v) peptic ulcers; (vi) neoplasia; (vii) benign vascular lesions; (viii) strictures of the gastrointestinal tract; (ix) tumorous overgrowth through or over oesophageal stents; other than a service associated with a service to which item30473 or 30479 applies Y 30479 01NOV1992 ENDOSCOPIC LASER THERAPY for malignancy of upper or lower gastrointestinal tract N 30479 01JUL1993 ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions or strictures of the gastrointestinal tract N 30479 01MAY2010 ENDOSCOPY with LASER THERAPY or ARGON PLASMA COAGULATION, for the treatment of neoplasia, benign vascular lesions, strictures of the gastrointestinal tract, tumorous overgrowth through or over oesophageal stents, peptic ulcers, angiodysplasia, gastric antral vascular ectasia (GAVE) or post-polypectomy bleeding, 1 or more of N 30479 01NOV2017 Endoscopy with laser therapy, for the treatment of one or more of the following: (a) neoplasia; (b) benign vascular lesions; (c) strictures of the gastrointestinal tract; (d) tumorous overgrowth through or over oesophageal stents; (e) peptic ulcers; (f) angiodysplasia; (g) gastric antral vascular ectasia; (h) post-polypectomy bleeding; other than a service associated with a service to which item 30473 or 30478 applies Y 30480 01DEC1991 VAGOTOMYSELECTIVE Y 30481 01NOV1992 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (initial procedure) N 30481 01NOV1997 PERCUTANEOUS GASTROSTOMY (initial procedure), including any associated imaging services N 30481 01MAY2018 PERCUTANEOUS GASTROSTOMY (initial procedure): (a) including any associated imaging services; and (b) excluding the insertion of a device for the purpose of facilitating weight loss Y 30482 01NOV1992 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (repeat procedure) N 30482 01NOV1997 PERCUTANEOUS GASTROSTOMY (repeat procedure), including any associated imaging services N 30482 01MAY2018 PERCUTANEOUS GASTROSTOMY (repeat procedure): (a) including any associated imaging services; and (b) excluding the insertion of a device for the purpose of facilitating weight loss Y 30483 01DEC1991 GASTROSTOMY BUTTON, non-endoscopic insertion of, or non-endoscopic replacement of N 30483 01NOV1996 GASTROSTOMY BUTTON, non-endoscopic insertion of, or non-endoscopic replacement of N 30483 01SEP2015 GASTROSTOMY BUTTON, CAECOSTOMY ANTEGRADE ENEMA DEVICE (CHAIT etc) or STOMAL INDWELLING DEVICE non-endoscopic insertion of, or non-endoscopic replacement of, on a person 10 years of age or over N 30483 01MAY2018 GASTROSTOMY BUTTON, CAECOSTOMY ANTEGRADE ENEMA DEVICE (CHAIT etc.) or STOMAL INDWELLING DEVICE: (a) non-endoscopic insertion of; or (b)non-endoscopic replacement of; on a person 10 years of age or over, excluding the insertion of a device for the purpose of facilitating weight loss Y 30484 01NOV1992 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Y 30485 01NOV1992 ENDOSCOPIC SPHINCTEROTOMY with or without extraction of stones from common bile duct Y 30486 01DEC1991 VAGOTOMY, HIGHLY SELECTIVE with pyloroplasty or gastroenterostomy or dilatation of pylorus Y 30487 01NOV1992 SMALL BOWEL INTUBATION with biopsy N 30487 01JUL2008 SMALL BOWEL INTUBATION with biopsy, as an independent procedure Y 30488 01NOV1992 SMALL BOWEL INTUBATIONas an independent procedure Y 30489 01DEC1991 GASTRIC REDUCTION OR GASTROPLASTY for obesity, by any method Y 30490 01NOV1992 OESOPHAGEAL PROSTHESIS, insertion of, including endoscopy and dilatation Y 30491 01NOV1992 BILE DUCT, ENDOSCOPIC STENTING OF (including endoscopy and dilatation) Y 30492 01DEC1991 GASTRIC BYPASS FOR OBESITY, including anastomosis, by any method N 30492 01MAY2005 BILE DUCT, PERCUTANEOUS STENTING OF (including dilatation when performed), using interventional imaging techniques - but not including imaging Y 30493 01NOV1992 BILIARY MANOMETRY Y 30494 01NOV1992 ENDOSCOPIC BILIARY DILATATION Y 30495 01DEC1991 GASTROENTEROSTOMY (INCLUDING GASTRODUODENOSTOMY) OR ENTEROCOLOSTOMY OR ENTEROENTEROSTOMY N 30495 01MAY2005 PERCUTANEOUS BILIARY DILATATION for biliary stricture, using interventional imaging techniques - but not including imaging Y 30496 01NOV1992 VAGOTOMY, truncal or selective, with or without pyloroplasty or gastroenterostomy Y 30497 01NOV1992 VAGOTOMY and ANTRECTOMY Y 30498 01DEC1991 GASTROENTEROSTOMY or GASTRODUODENOSTOMY, reconstruction of Y 30499 01NOV1992 VAGOTOMY, highly selective Y 30500 01NOV1992 VAGOTOMY, highly selective with duodenoplasty for peptic stricture Y 30501 01DEC1991 PANCREATIC CYSTANASTOMOSIS TO STOMACH OR DUODENUM Y 30502 01NOV1992 VAGOTOMY, highly selective, with dilatation of pylorus Y 30503 01NOV1992 VAGOTOMY or ANTRECTOMY, or both, for peptic ulcer following previous operation for peptic ulcer Y 30504 01DEC1991 PARTIAL GASTRECTOMY, with or without gastrojejunostomy Y 30505 01NOV1992 BLEEDING PEPTIC ULCER, control of, involving suture of bleeding point or wedge excision Y 30506 01NOV1992 BLEEDING PEPTIC ULCER, control of, involving suture of bleeding point or wedge excision, and vagotomy and pyloroplasty or gastroenterostomy Y 30507 01DEC1991 GASTRECTOMY, TOTAL, FOR BENIGN DISEASE Y 30508 01NOV1992 BLEEDING PEPTIC ULCER, control of, involving suture of bleeding point or wedge excision, and highly selective vagotomy Y 30509 01NOV1992 BLEEDING PEPTIC ULCER, control of, involving gastric resection (other than wedge resection) Y 30510 01DEC1991 GASTRECTOMY, RADICAL SUBTOTAL, for carcinoma Y 30511 01NOV1992 (see Item 31441 for repair, revision or replacement of implanted reservoir associated with adjustable gastric band) (see Item 14215 for adding or removing fluid via the implanted reservoir to adjust the tightness of the gastric band) MORBID OBESITY, gastric reduction or gastroplasty for, by any method Y 30512 01NOV1992 MORBID OBESITY, gastric bypass for, by any method including anastomosis Y 30513 01DEC1991 GASTRECTOMY, RADICAL TOTAL, for carcinoma Y 30514 01NOV1992 MORBID OBESITY, reversal surgical procedure N 30514 01JUL1993 MORBID OBESITY, surgical reversal of procedure to which item 30511 or 30512 applies N 30514 01MAY2005 MORBID OBESITY, surgical reversal, by any method, of procedure to which item 30511 or 30512 applies Y 30515 01NOV1992 GASTROENTEROSTOMY (INCLUDING GASTRODUODENOSTOMY) OR ENTEROCOLOSTOMY OR ENTEROENTEROSTOMY N 30515 01JUL2013 Gastroenterostomy (including gastroduodenostomy) or enterocolostomy or enteroenterostomy, not being a service to which any of items 31569 to 31581 apply Y 30516 01DEC1991 PYLOROPLASTY, INFANT, OR PYLOROMYOTOMY (RAMSTEDT'S operation) Y 30517 01NOV1992 GASTROENTEROSTOMY, PYLOROPLASTY or GASTRODUODENOSTOMY, reconstruction of Y 30518 01NOV1992 PARTIAL GASTRECTOMY N 30518 01JUL2013 Partial gastrectomy, not being a service associated with a service to which any of items 31569 to 31581 apply Y 30519 01DEC1991 ENTEROSTOMY or COLOSTOMY, closure ofnot involving resection of bowel Y 30520 01NOV1992 GASTRIC TUMOUR, removal of, by local excision, not being a service to which item 30518 applies Y 30521 01NOV1992 GASTRECTOMY, TOTAL, for benign disease Y 30522 01DEC1991 COLOSTOMY OR ILEOSTOMY, refashioning of Y 30523 01NOV1992 GASTRECTOMY, SUBTOTAL RADICAL, for carcinoma, (including splenectomy when performed) Y 30524 01NOV1992 GASTRECTOMY, TOTAL RADICAL, for carcinoma (including extended node dissection and distal pancreatectomy and splenectomy when performed) Y 30525 01DEC1991 INTUSSUSCEPTION, reduction of, by fluid Y 30526 01NOV1992 GASTRECTOMY, TOTAL, and including lower oesophagus, performed by left thoraco-abdominal incision or opening of diaphragmatic hiatus, (including splenectomy when performed) Y 30527 01NOV1992 ANTIREFLUX OPERATION by fundoplasty, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatusnot being a service to which item 30601 applies Y 30528 01DEC1991 INTUSSUSCEPTION, LAPAROTOMY and resection of Y 30529 01NOV1992 ANTIREFLUX operation by fundoplasty, with OESOPHAGOPLASTY for stricture or short oesophagus Y 30530 01NOV1992 ANTIREFLUX operation by cardiopexy, with or without fundoplasty Y 30531 01DEC1991 SMALL INTESTINE, resection of, without anastomosis (including formation of stoma) Y 30532 01NOV1992 OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus N 30532 01NOV2000 OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus, by laparoscopy or open operation Y 30533 01NOV1992 OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic hiatus N 30533 01NOV2000 OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic hiatus, by laparoscopy or open operation Y 30534 01DEC1991 SMALL INTESTINE, resection of, with anastomosis Y 30535 01NOV1992 OESOPHAGECTOMY with gastric reconstruction by abdominal mobilisation and right thoracotomy N 30535 01JUL1993 OESOPHAGECTOMY with gastric reconstruction by abdominal mobilisation and thoracotomy Y 30536 01NOV1992 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, right thoracotomy and anastomosis in the neck - 1 surgeon N 30536 01JUL1993 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck- 1 surgeon N 30536 01NOV2000 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck or chest - 1 surgeon Y 30537 01DEC1991 APPENDICECTOMY, not covered by Item 30543 Y 30538 01NOV1992 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, right thoracotomy and anastomosis in the neck - conjoint surgery, principal surgeon (including aftercare) N 30538 01JUL1993 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck - conjoint surgery, principal surgeon (including aftercare) N 30538 01NOV2000 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck or chest- conjoint surgery, principal surgeon (including aftercare) Y 30539 01NOV1992 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, right thoracotomy and anastomosis in the neck - conjoint surgery, co-surgeon N 30539 01JUL1993 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck- conjoint surgery, co-surgeon N 30539 01NOV2000 OESOPHAGECTOMY involving gastric reconstruction by abdominal mobilisation, thoracotomy and anastomosis in the neck or chest - conjoint surgery, co-surgeon Y 30540 01DEC1991 APPENDICECTOMY, not covered by Item 30543 Y 30541 01NOV1992 OESOPHAGECTOMY, by trans-hiatal oesophagectomy (cervical and abdominal mobilisation, anastomosis) with posterior or anterior mediastinal placement - 1 surgeon Y 30542 01NOV1992 OESOPHAGECTOMY, by trans-hiatal oesophagectomy (cervical and abdominal mobilisation, anastomosis) with posterior or anterior mediastinal placement - conjoint surgery, principal surgeon (including aftercare) Y 30543 01DEC1991 APPENDICECTOMY, when performed in conjunction with any other intraabdominal procedure through the same incision Y 30544 01NOV1992 OESOPHAGECTOMY, by trans-hiatal oesophagectomy (cervical and abdominal mobilisation, anastomosis) with posterior or anterior mediastinal placement - conjoint surgery, co-surgeon Y 30545 01NOV1992 OESOPHAGECTOMY with colon or jejunal anastomosis, (abdominal and thoracic mobilisation with thoracic anastomosis) - 1 surgeon Y 30546 01DEC1991 SMALL BOWEL INTUBATION with biopsy Y 30547 01NOV1992 OESOPHAGECTOMY with colon or jejunal anastomosis, (abdominal and thoracic mobilisation with thoracic anastomosis) - conjoint surgery, principal surgeon (including aftercare) Y 30548 01NOV1992 OESOPHAGECTOMY with colon or jejunal anastomosis, (abdominal and thoracic mobilisation with thoracic anastomosis) - conjoint surgery, co-surgeon Y 30549 01DEC1991 SMALL BOWEL INTUBATIONas an independent procedure Y 30550 01NOV1992 OESOPHAGECTOMY with colon or jejunal replacement (abdominal and thoracic mobilisation with anastomosis of pedicle in the neck) - 1 surgeon Y 30551 01NOV1992 OESOPHAGECTOMY with colon or jejunal replacement (abdominal and thoracic mobilisation with anastomosis of pedicle in the neck) - conjoint surgery, principal surgeon (including aftercare) Y 30552 01DEC1991 PANCREATECTOMY, PARTIAL Y 30553 01NOV1992 OESOPHAGECTOMY with colon or jejunal replacement (abdominal and thoracic mobilisation with anastomosis of pedicle in the neck) - conjoint surgery, co-surgeon Y 30554 01NOV1992 OESOPHAGECTOMY with reconstruction by free jejunal graft - 1 surgeon Y 30555 01DEC1991 PANCREATICODUODENECTOMY, WHIPPLE'S OPERATION Y 30556 01NOV1992 OESOPHAGECTOMY with reconstruction by free jejunal graft - conjoint surgery, principal surgeon (including aftercare) Y 30557 01NOV1992 OESOPHAGECTOMY with reconstruction by free jejunal graft - conjoint surgery, co-surgeon Y 30558 01DEC1991 PANCREATIC ABSCESS, drainage of, excluding aftercare Y 30559 01NOV1992 OESOPHAGUS, local excision for tumour of Y 30560 01NOV1992 OESOPHAGEAL PERFORATION, repair of, by thoracotomy Y 30561 01DEC1991 ANASTOMOSIS OF PANCREATIC DUCT TO BOWEL Y 30562 01NOV1992 ENTEROSTOMY or COLOSTOMY, closure ofnot involving resection of bowel N 30562 01SEP2015 ENTEROSTOMY or COLOSTOMY, closure of (not involving resection of bowel), on a person 10 years of age or over Y 30563 01NOV1992 COLOSTOMY OR ILEOSTOMY, refashioning of N 30563 01SEP2015 COLOSTOMY OR ILEOSTOMY, refashioning of, on a person 10 years of age or over Y 30564 01DEC1991 SPLENORRHAPHY OR PARTIAL SPLENECTOMY FOR TRAUMA N 30564 01MAY1994 SMALL BOWEL STRICTUREPLASTY for chronic inflammatory bowel disease Y 30565 01NOV1992 SMALL INTESTINE, resection of, without anastomosis (including formation of stoma) Y 30566 01NOV1992 SMALL INTESTINE, resection of, with anastomosis N 30566 01SEP2015 SMALL INTESTINE, resection of, with anastomosis, on a person 10 years of age or over Y 30567 01DEC1991 SPLENECTOMY FOR TRAUMA Y 30568 01NOV1992 INTRAOPERATIVE ENTEROTOMY for visualisation of the small intestine by endoscopy Y 30569 01NOV1992 ENDOSCOPIC EXAMINATION of SMALL BOWEL with flexible endoscope passed at laparotomy, with or without biopsies Y 30570 01DEC1991 SPLENECTOMY, OTHER THAN FOR TRAUMA Y 30571 01NOV1992 APPENDICECTOMY, not being a service to which item 30574 applies N 30571 01SEP2015 APPENDICECTOMY, not being a service to which item 30574 applies on a person 10 years of age or over Y 30572 01NOV1992 LAPAROSCOPIC APPENDICECTOMY N 30572 01SEP2015 LAPAROSCOPIC APPENDICECTOMY, on a person 10 years of age or over Y 30573 01DEC1991 RETROPERITONEAL TUMOUR, removal of Y 30574 01NOV1992 NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item APPENDICECTOMY, when performed in conjunction with any other intraabdominal procedure through the same incision Y 30575 01NOV1992 PANCREATIC ABSCESS, laparotomy and external drainage of, not requiring retro-pancreatic dissection Y 30576 01DEC1991 RETROPERITONEAL ABSCESS, drainage of, not involving laparotomy Y 30577 01NOV1992 PANCREATIC NECROSECTOMY for PANCREATIC NECROSIS or ABSCESS FORMATION requiring major pancreatic or retro-pancreatic dissection, excluding aftercare Y 30578 01NOV1992 ENDOCRINE TUMOUR, exploration of pancreas or duodenum, followed by local excision of pancreatic tumour Y 30579 01DEC1991 LAPAROSCOPY, diagnostic Y 30580 01NOV1992 ENDOCRINE TUMOUR, exploration of pancreas or duodenum, followed by local excision of duodenal tumour Y 30581 01NOV1992 ENDOCRINE TUMOUR, exploration of pancreas or duodenum for, but no tumour found Y 30582 01DEC1991 LAPAROSCOPY with biopsy Y 30583 01NOV1992 DISTAL PANCREATECTOMY Y 30584 01NOV1992 PANCREATICO-DUODENECTOMY, WHIPPLE'S OPERATION, with or without preservation of pylorus Y 30585 01DEC1991 LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other procedureone or more procedures with or without biopsynot associated with Item 30582, 35687 or 35688 Y 30586 01NOV1992 PANCREATIC CYSTANASTOMOSIS TO STOMACH OR DUODENUM N 30586 01NOV1996 PANCREATIC CYSTANASTOMOSIS TO STOMACH OR DUODENUM - by open or endoscopic means Y 30587 01NOV1992 PANCREATIC CYST, anastomosis to Roux loop of jejunum Y 30588 01DEC1991 PARACENTESIS ABDOMINIS Y 30589 01NOV1992 PANCREATICO-JEJUNOSTOMY for pancreatitis or trauma Y 30590 01NOV1992 PANCREATICO-JEJUNOSTOMY following previous pancreatic surgery Y 30591 01DEC1991 FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not covered by Items 30595, 30624 or 30625 Y 30592 01DEC1991 FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not covered by Items 30595, 30624 or 30625 Y 30593 01NOV1992 PANCREATECTOMY, near total or total (including duodenum), with or without splenectomy Y 30594 01NOV1992 PANCREATECTOMY for pancreatitis following previously attempted drainage procedure or partial resection Y 30595 01DEC1991 STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection Y 30596 01NOV1992 SPLENORRHAPHY OR PARTIAL SPLENECTOMY FOR TRAUMA N 30596 01NOV2000 SPLENORRHAPHY OR PARTIAL SPLENECTOMY Y 30597 01NOV1992 SPLENECTOMY Y 30598 01DEC1991 DIAPHRAGMATIC HERNIA, TRAUMATIC, repair of Y 30599 01NOV1992 SPLENECTOMY, for massive spleen (weighing more than 1500 grams) or involving thoraco-abdominal incision Y 30600 01NOV1992 DIAPHRAGMATIC HERNIA, TRAUMATIC, repair of Y 30601 01DEC1991 DIAPHRAGMATIC HERNIA, CONGENITAL repair of, by thoracic or abdominal approach N 30601 01JUL2013 Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply N 30601 01SEP2015 Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply, on a person 10 years of age or over Y 30602 01NOV1992 PORTAL HYPERTENSION, porto-caval shunt for Y 30603 01NOV1992 PORTAL HYPERTENSION, meso-caval shunt for Y 30604 01DEC1991 ANTIREFLUX OPERATION involving insertion of prosthetic device - not associated with Item 30601, 30607, 30610 or 30613 Y 30605 01NOV1992 PORTAL HYPERTENSION, selective spleno-renal shunt for Y 30606 01NOV1992 PORTAL HYPERTENSION, oesophageal transection via stapler or oversew of gastric varices with or without devascularisation Y 30607 01DEC1991 ANTIREFLUX OPERATION by fundoplasty, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatusnot covered by Item 30601 or 30604 Y 30608 01SEP2015 SMALL INTESTINE, resection of, with anastomosis, on a person under 10 years of age Y 30609 01NOV1993 FEMORAL OR INGUINAL HERNIA, laparoscopic repair of, not being a service associated with a service to which item 30612 or 30614 applies N 30609 01SEP2015 FEMORAL OR INGUINAL HERNIA, laparoscopic repair of, not being a service associated with a service to which item 30614 applies Y 30610 01DEC1991 OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus Y 30611 01SEP2015 BENIGN TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage, and bone, simple lipomas covered by item 31345 and lipomata - removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, on a person under 10 years of age , not being a service to which another item in this Group applies Y 30612 01NOV1992 FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which item 30403 or 30615 applies Y 30613 01DEC1991 OESOPHAGOGASTRIC MYOTOMY (Heller's operation) via abdominal or thoracic approach, WITH FUNDOPLASTY, with or without closure of the diaphragmatic hiatus Y 30614 01NOV1992 FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which items 30403 or 30615 applies N 30614 01SEP2015 FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which item 30403 or 30615 applies, on a person 10 years of age or over Y 30615 01NOV1992 STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection N 30615 01SEP2015 STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection, on a person 10 years of age or over Y 30616 01DEC1991 UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person under 10 years of age Y 30617 01DEC1991 UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person under 10 years of age Y 30618 01SEP2015 LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck,on a person under 10 years of age Y 30619 01SEP2015 LAPAROSCOPIC SPLENECTOMY, on a person under 10 years of age Y 30620 01DEC1991 UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person 10 years of age or over N 30620 01MAY2016 Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other formal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies (G) Y 30621 01DEC1991 UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, in a person 10 years of age or over N 30621 01MAY2016 Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other fromal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies (S) N 30621 01NOV2017 Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other fromal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies N 30621 01DEC2018 Repair of symptomatic umbilical, epigastric or linea alba hernia requiring mesh or other formal repair of, in a person 10 years of age or over, other than a service to which item 30403 or 30405 applies Y 30622 01SEP2015 Caecostomy, Enterostomy, Colostomy, Enterotomy, Colotomy, Cholecystostomy, Gastrostomy, Gastrotomy, Reduction of intussusception, Removal of Meckel's diverticulum, Suture of perforated peptic ulcer, Simple repair of ruptured viscus, Reduction of volvulus, Pyloroplasty or Drainage of pancreas on a person under 10 years of age Y 30623 01SEP2015 LAPAROTOMY INVOLVING DIVISION OF PERITONEAL ADHESIONS (where no other intraabdominal procedure is performed) on a person under 10 years of age Y 30624 01DEC1991 VENTRAL, INCISIONAL, LUMBAR OR RECURRENT HERNIA OR BURST ABDOMEN, repair of Y 30625 01DEC1991 VENTRAL, INCISIONAL, LUMBAR OR RECURRENT HERNIA OR BURST ABDOMEN, repair of Y 30626 01SEP2015 LAPAROTOMY involving division of adhesions in conjunction with another intraabdominal procedure where the time taken to divide the adhesions is between 45 minutes and 2 hours, on a person under 10 years of age Y 30627 01SEP2015 LAPAROSCOPY, diagnostic, not being a service associated with any other laparoscopic procedure, on a person under 10 years of age Y 30628 01DEC1991 HYDROCELE, tapping of Y 30631 01DEC1991 HYDROCELE, removal of, not being a service associated with a service to which items 30638, 30641 and 30644 apply N 30631 01MAY2017 Hydrocele, removal of, other than a service associated with a service to which item 30638, 30641, 30642 or 30644 applies N 30631 01NOV2017 Hydrocele, removal of, other than a service associated with a service to which item 30641, 30642 or 30644 applies Y 30632 01NOV1992 PYLOROPLASTY, INFANT, OR PYLOROMYOTOMY (RAMSTEDT'S operation) Y 30633 01NOV1992 INTUSSUSCEPTION, reduction of, by fluid Y 30634 01DEC1991 VARICOCELE, surgical correction of, not being a service associated with a service to which items 30638, 30641 and 30644 apply, 1 procedure N 30634 01MAY2017 Varicocele, surgical correction of, other than a service associated with a service to which item 30638, 30641, 30642 or 30644 applies - one procedure Y 30635 01DEC1991 VARICOCELE, surgical correction of, not being a service associated with a service to which items 30638, 30641 and 30644 apply, 1 procedure N 30635 01MAY2017 Varicocele, surgical correction of, other than a service associated with a service to which item 30638, 30641, 30642 or 30644 applies - one procedure N 30635 01NOV2017 Varicocele, surgical correction of, other than a service associated with a service to which item 30641, 30642 or 30644 applies - one procedure Y 30636 01SEP2015 GASTROSTOMY BUTTON, caecostomy antegrade enema device (chait etc) and/or stomal indwelling device, non-endoscopic insertion of, or non-endoscopic replacement of, on a person under 10 years of age Y 30637 01SEP2015 ENTEROSTOMY or COLOSTOMY, closure of not involving resection of bowel, on a person under 10 years of age Y 30638 01DEC1991 ORCHIDECTOMY, simple or subscapsular, unilateral with or without insertion of testicular prosthesis Y 30639 01SEP2015 COLOSTOMY OR ILEOSTOMY, refashioning of, on a person under 10 years of age Y 30640 01MAY2016 Repair of large and irreducible scrotal hernia, where duration of surgery exceeds 2 hours, in a person 10 years of age or over, other than a service to which item 30403, 30405, 30614, 30615, 30620 or 30621 applies N 30640 01NOV2017 Repair of large and irreducible scrotal hernia, where duration of surgery exceeds 2 hours, in a person 10 years of age or over, other than a service to which item 30403, 30405, 30614, 30615 or 30621 applies Y 30641 01DEC1991 ORCHIDECTOMY, simple or subscapsular, unilateral with or without insertion of testicular prosthesis Y 30642 01MAY2017 Orchidectomy, radical, unilateral, with or without insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30634, 30635, 30638, 30641, 30643 or 30644 applies N 30642 01NOV2017 Orchidectomy, radical, unilateral, with or without insertion of testicular prosthesis, other than a service associated with a service to which item 30631, 30635,30641, 30643 or 30644 applies Y 30643 01SEP2015 EXPLORATION OF SPERMATIC CORD, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis on a person under 10 years of age Y 30644 01DEC1991 EXPLORATION OF SPERMATIC CORD, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis N 30644 01SEP2015 EXPLORATION OF SPERMATIC CORD, inguinal approach, with or without testicular biopsy and with or without excision of spermatic cord and testis on a person 10 years of age or over Y 30645 01SEP2015 APPENDICECTOMY, not being a service to which item 30574 applies, on a person under 10 years of age Y 30646 01SEP2015 LAPAROSCOPIC APPENDICECTOMY, on a person under 10 years of age Y 30647 01DEC1991 UNDESCENDED TESTIS, orchidopexy or transplantation of, with or without associated hernial repair Y 30649 01SEP2015 HAEMORRHAGE, arrest of, following circumcision requiring general anaesthesia on a person under 10 years of age Y 30650 01DEC1991 SECONDARY DETACHMENT OF TESTIS FROM THIGH Y 30653 01DEC1991 CIRCUMCISION of person UNDER 6 MONTHS of age N 30653 01JUL1995 CIRCUMCISION of person UNDER 6 MONTHS of age N 30653 01JUL2013 Circumcision of the penis, on a person under 6 months of age Y 30654 01NOV2016 Circumcision of the penis (other than a service to which item 30658 applies) Y 30656 01DEC1991 CIRCUMCISION of person UNDER 10 YEARS of age but not less than 6 months of age N 30656 01JUL1995 CIRCUMCISION of a male UNDER 10 YEARS of age but not less than 6 months of age N 30656 01JUL2013 Circumcision of the penis, on a person under 10 years of age but not less than 6 months of age Y 30658 01NOV2016 Circumcision of the penis, when performed in conjunction with a service to which an item in Group T7 or Group T10 applies Y 30659 01DEC1991 CIRCUMCISION of person 10 YEARS OF AGE OR OVER N 30659 01JUL1995 CIRCUMCISION of a male 10 YEARS OF AGE OR OVER N 30659 01JUL2013 Circumcision of the penis, on a person 10 years of age or over Y 30660 01DEC1991 CIRCUMCISION of person 10 YEARS OF AGE OR OVER N 30660 01JUL1995 CIRCUMCISION of a male 10 YEARS OF AGE OR OVER N 30660 01JUL2013 Circumcision of the penis, on a person 10 years of age or over. Y 30663 01DEC1991 HAEMORRHAGE, arrest of, following circumcision requiring general anaesthesia N 30663 01SEP2015 HAEMORRHAGE, arrest of, following circumcision requiring general anaesthesia on a person 10 years of age or over Y 30666 01DEC1991 PARAPHIMOSIS, reduction of, under general anaesthesia, with or without dorsal incision, not being a service associated with a service to which another item in this Group applies N 30666 01SEP2015 PARAPHIMOSIS or PHIMOSIS, reduction of, under general anaesthesia, with or without dorsal incision, not being a service associated with a service to which another item in this Group applies Y 30669 01DEC1991 FAECAL FISTULA, repair of Y 30672 01DEC1991 COCCYX, excision of Y 30675 01DEC1991 PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of, in a person ten years of age or over N 30675 01APR1992 PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of Y 30676 01DEC1991 PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of, in a person ten years of age or over N 30676 01APR1992 PILONIDAL SINUS OR CYST, OR SACRAL SINUS OR CYST, excision of Y 30679 01DEC1991 PILONIDAL SINUS, injection of sclerosant fluid under anaesthesia Y 30680 01JUL2007 DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (oral approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: (i)have recurrent or persistent bleeding; and (ii)be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. N 30680 01MAR2014 Balloon enteroscopy, examination of the small bowel (oral approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup(with the exception of item 30682 or 30686) The patient to whom the service is provided must: (i)have recurrent or persistent bleeding; and (ii)be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. Y 30682 01JUL2007 DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (anal approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: () have recurrent or persistent bleeding; and () be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. N 30682 01MAR2014 Balloon enteroscopy, examination of the small bowel (anal approach), with or without biopsy, WITHOUT intraprocedural therapy, for diagnosis of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: (i)have recurrent or persistent bleeding; and (ii)be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause ofthe bleeding. Y 30684 01JUL2007 DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (oral approach), with or without biopsy, WITH 1 or more of the following procedures (polypectomy, snares, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: () have recurrent or persistent bleeding; and () be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. N 30684 01JUL2009 DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (oral approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: lhave recurrent or persistent bleeding; and lbe anaemic or have active bleeding; and lhave had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. N 30684 01MAR2014 Balloon enteroscopy, examination of the small bowel (oral approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe, laser coagulation or argon plasma coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30682 or 30686) The patient to whom the service is provided must: (i)have recurrent or persistent bleeding; and (ii)be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. Y 30686 01JUL2007 DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (anal approach), with or without biopsy, WITH1 or more of the following procedures (polypectomy, snares, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: () have recurrent or persistent bleeding; and () be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. N 30686 01JUL2009 DOUBLE BALLOON ENTEROSCOPY, examination of the small bowel (anal approach), with or without biopsy, WITH1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe or laser coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: (i) have recurrent or persistent bleeding; and (ii) be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. N 30686 01MAR2014 Balloon enteroscopy, examination of the small bowel (anal approach), with or without biopsy, WITH 1 or more of the following procedures (snare polypectomy, removal of foreign body, diathermy, heater probe, laser coagulation or argon plasma coagulation), for diagnosis and management of patients with obscure gastrointestinal bleeding, not in association with another item in this subgroup (with the exception of item 30680 or 30684) The patient to whom the service is provided must: (i)have recurrent or persistent bleeding; and (ii)be anaemic or have active bleeding; and (iii)have had an upper gastrointestinal endoscopy and a colonoscopy performed which did not identify the cause of the bleeding. Y 30687 01NOV2012 ENDOSCOPY with RADIOFREQUENCY ABLATION of mucosal metaplasia for the treatment of Barrett's Oesophagus in a single course of treatment, following diagnosis of high grade dysplasia confirmed by histological examination Y 30688 01JUL2007 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. N 30688 01NOV2017 Endoscopicultrasound(endoscopy with ultrasound imaging), with or without biopsy, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup (other thanitem30484, 30485, 30491 or 30494) andother thana service associated with the routine monitoring of chronic pancreatitis. Y 30690 01JUL2007 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy,WITH FINE NEEDLE ASPIRATION, including aspiration of the locoregional lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. N 30690 01NOV2017 Endoscopic ultrasound(endoscopy with ultrasound imaging), with or without biopsy,with fine needle aspiration, including aspiration of the locoregional lymph nodes if performed, for the staging of 1 or more of oesophageal, gastric or pancreatic cancer, not in association with another item in this Subgroup (other than item30484, 30485, 30491 or 30494)and other thana service associated with the routine monitoring of chronic pancreatitis. Y 30692 01JUL2007 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. N 30692 01NOV2017 Endoscopic ultrasound(endoscopy with ultrasound imaging), with or without biopsy, for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours, not in association with another item in this Subgroup (other than item30484, 30485, 30491 or 30494)and other thana service associated with the routine monitoring of chronic pancreatitis. Y 30694 01JUL2007 ENDOSCOPIC ULTRASOUND (endoscopy with ultrasound imaging), with or without biopsy,WITH FINE NEEDLE ASPIRATION for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours,not in association with another item in this Subgroup and not being a service associated with the routine monitoring of chronic pancreatitis. N 30694 01NOV2017 Endoscopic ultrasound(endoscopy with ultrasound imaging), with or without biopsy,with fine needle aspiration,for the diagnosis of 1 or more of pancreatic, biliary or gastric submucosal tumours,not in association with another item in this Subgroup (other than item30484, 30485, 30491 or 30494)and other thana service associated with the routine monitoring of chronic pancreatitis. Y 30696 01JUL2009 ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION BIOPSY(S) (endoscopy with ultrasound imaging) to obtain one or more specimens from either: (a)mediastinal mass(es) or (b) locoregional nodes to stage non-small cell lung carcinoma not being a service associated with another item in this subgroup or to which items 30710 and 55054 apply Y 30710 01JUL2009 ENDOBRONCHIAL ULTRASOUND GUIDED BIOPSY(S) (bronchoscopy with ultrasound imaging, with or without associated fluoroscopic imaging) to obtain one or more specimens by either: (a) transbronchial biopsy(s) of peripheral lung lesions; or (b) fine needle aspiration(s) of a mediastinal mass(es);or (c) fine needle aspiration(s) of locoregional nodes to stage non-small cell lung carcinoma not being a service associated with another item in this subgroup or to which items 30696, 41892, 41898, and 60500 to 60509 applies Y 31000 01MAR1992 MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 6 or fewer sections (Ministerial Determination) N 31000 01JUL1995 MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 6 or fewer sections N 31000 01NOV2018 Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon - 6 or fewer sections Y 31001 01MAR1992 MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 7 to 12 sections (Ministerial Determination) N 31001 01JUL1995 MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 7 to 12 sections (inclusive) N 31001 01NOV2018 Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon - 7 to 12 sections (inclusive) Y 31002 01MAR1992 MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 13 or more sections (Ministerial Determination) N 31002 01JUL1995 MICROGRAPHICALLY CONTROLLED SERIAL EXCISION of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure - 13 or more sections N 31002 01NOV2018 Mohs surgery of skin tumour located on the head, neck, genitalia, hand, digits, leg (below knee) or foot, utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon - 13 or more sections Y 31003 01NOV2018 Mohs surgery of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon - 6 or fewer sections Not applicable to a service performed in association with a service to which item31000 applies Y 31004 01NOV2018 Mohs surgery of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon - 7 to 12 sections (inclusive) Not applicable to a service performed in association with a service to which item31001 applies Y 31005 01NOV2018 Mohs surgery of skin tumour utilising horizontal frozen sections with mapping of all excised tissue, and histological examination of all excised tissue by the specialist performing the procedure, if the specialist is recognised by the Australasian College of Dermatologists as an approved Mohs surgeon - 13 or more sections Not applicable to a service performed in association with a service to which item31002 applies Y 31200 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach to an operation), removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, not being a service to which another item in this Group applies N 31200 01MAY2004 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach to an operation), removal by surgical excision (other than shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, not being a service to which another item in this Group applies N 31200 01MAY2006 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach to an operation), removal by surgical excision (other than shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, not being a service associated with a service to which item 45200, 45203 or 45206 applies and not being a service to which another item in this Group applies Y 31205 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies) N 31205 01MAY2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31205 01NOV2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31205 01NOV2005 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size up to and including 10mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) Y 31206 01NOV2016 Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of and suture, if: (a) the lesion size is not more than 10 mm in diameter; and (b) the removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) the specimen excised is sent for histological examination Y 31210 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies) N 31210 01MAY2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31210 01NOV2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to 20mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31210 01NOV2005 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 10mm and up to and including 20mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) Y 31211 01NOV2016 Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of and suture, if: (a) the lesion size is more than 10 mm, but not more than 20 mm, in diameter; and (b) the removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) the specimen excised is sent for histological examination Y 31215 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies) N 31215 01MAY2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31215 01NOV2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), lesion size more than 20mm in diameter, removal by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) Y 31216 01NOV2016 Tumour, cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), removal of and suture, if: (a) the lesion size is more than 20 mm in diameter; and (b) the removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) the specimen excised is sent for histological examination Y 31220 01MAY1997 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where specimen sent for histological examination (not being a service to which item 30195 applies) N 31220 01MAY2003 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335, where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31220 01NOV2003 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of 4 to 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies) N 31220 01NOV2005 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to and including 10mm in diameter, removal of 4 to 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies) N 31220 01NOV2016 Tumours (other than viral verrucae (common warts) and seborrheic keratoses), cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of 4 to 10 lesions and suture, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from cutaneous or subcutaneous tissue by surgical excision (other than by shave excision); and (c) all of the specimens excised are sent for histological examination Y 31221 01NOV2016 Tumours, cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of 4 to 10 lesions, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from a mucous membrane by surgical excision (other than by shave excision); and (c) each site of excision is closed by suture; and (d) all of the specimens excised are sent for histological examination Y 31225 01MAY1997 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where specimen sent for histological examination (not being a service to which item 30195 applies) N 31225 01MAY2003 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions by surgical excision and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31225 01NOV2003 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to 10mm in diameter, removal of more than 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies) N 31225 01NOV2005 TUMOURS (other than viral verrucae [common warts] and seborrheic keratoses), CYSTS, ULCERS OR SCARS (other than scars removed during the surgical approach at an operation), lesion size up to and including 10mm in diameter, removal of more than 10 lesions by surgical excision (other than by shave excision) and suture from cutaneous or subcutaneous tissue or from mucous membrane, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimens excised are sent for histological examination (not being a service to which item 30195 applies) N 31225 01NOV2016 Tumours (other than viral verrucae (common warts) and seborrheic keratoses), cysts, ulcers or scars (other than scars removed during the surgical approach at an operation), removal of more than 10 lesions, if: (a) the size of each lesion is not more than 10 mm in diameter; and (b) each removal is from cutaneous or subcutaneous tissue or mucous membrane by surgical excision (other than by shave excision); and (c) each site of excision is closed by suture; and (d) all of the specimens excised are sent for histological examination Y 31230 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from nose, eyelid, lip, ear, digit or genitalia, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where specimen sent for histological examination (not being a service to which item 30195 applies) N 31230 01MAY2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision and suture from nose, eyelid, lip, ear, digit or genitalia, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31230 01NOV2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal by surgical excision (other than by shave excision) and suture from nose, eyelid, lip, ear, digit or genitalia, including excision to establish the diagnosis of tumours covered by items 31300 to 31335 - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) Y 31235 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to 10mm in diameter - where specimen sent for histological examination (not being a service to which item 30195 applies) N 31235 01MAY2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31235 01NOV2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision (other than by shave excision) and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31235 01NOV2005 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision (other than by shave excision) and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size up to and including 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) Y 31240 01MAY1997 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size more than 10mm in diameter - where specimen sent for histological examination (not being a service to which item 30195 applies) N 31240 01MAY2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size more than 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) N 31240 01NOV2003 TUMOUR (other than viral verrucae [common warts] and seborrheic keratoses), CYST, ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removalby surgical excision (other than by shave excision) and suture from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), including excision to establish the diagnosis of tumours covered by items 31300 to 31335, lesion size more than 10mm in diameter - where the specimen excised is sent for histological examination (not being a service to which item 30195 applies) Y 31245 01MAY1997 SKIN AND SUBCUTANEOUS TISSUE, extensive excision of, in the treatment of SUPPURATIVE HIDRADENITIS (excision from axilla, groin or natal cleft) or SYCOSIS BARBAE or NUCHAE (excision from face or neck) Y 31250 01MAY1997 GIANT HAIRY or COMPOUND NAEVUS, excision of an area at least 1 percent of body surface where the specimen is sent for histological confirmation of diagnosis N 31250 01MAY2003 GIANT HAIRY or COMPOUND NAEVUS, excision of an area at least 1 percent of body surface where the specimen excised is sent for histological confirmation of diagnosis Y 31255 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31255 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31255 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31255 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by surgical excision (other than shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31255 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to and including 10mm in diameter - where removal is by therapeutic surgical excision (other than by shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31256 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where previous excision was performed by the same practitioner, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31257 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31258 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from nose, eyelid, lip, ear, digit or genitalia, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies Y 31260 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31260 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31260 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31260 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by surgical excision (other than shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31260 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by therapeutic surgical excision (other than shave excision) and suture and where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31261 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where previous excision was performed by the same practitioner, where the original tumour size was more than 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31262 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from nose, eyelid, lip, ear, digit or genitalia, where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31263 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from nose, eyelid, lip, ear, digit or genitalia, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies Y 31265 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31265 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31265 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31265 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to 10mm in diameter and where removal is by surgical excision (other than shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31265 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck, (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), tumour size up to and including 10mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31266 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where previous excision was performed by the same practitioner, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31267 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31268 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies Y 31270 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mmin diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31270 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mmin diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31270 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mmin diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31270 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to 20mmin diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31270 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck, (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 10mm and up to and including 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31271 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where previous excision was performed by the same practitioner, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31272 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31273 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies Y 31275 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31275 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31275 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31275 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31275 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), tumour size more than 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31276 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where previous excision was performed by the same practitioner, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31277 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), where performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31278 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from face, neck (anterior to the sternomastoid muscles) or lower leg (mid calf to ankle), whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained - not being a service to which item 31295 applies Y 31280 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31280 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31280 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31280 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31280 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31255 and 31265, tumour size up to and including 10mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31281 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31255 and 31265, where previous excision was performed by the same practitioner, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31282 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31255 and 31265, performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31283 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from areas of the body not covered by items 31255 and 31265, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is up to and including 10mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31285 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31285 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31285 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31285 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31285 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31270, tumour size more than 10mm and up to and including 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31286 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31270, where previous excision was performed by the same practitioner, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31287 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31270, performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31288 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from areas of the body not covered by items 31260 and 31270, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 10mm and up to and including 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31290 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter - where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31290 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter - where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31290 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter and where removal is by surgical excision and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31290 01NOV2004 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination N 31290 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA (including keratocanthoma), removal from areas of the body not covered by items 31260 and 31275, tumour size more than 20mm in diameter and where removal is by therapeutic surgical excision (other than by shave excision) and suture, where the initial specimen removed is sent for histological examination and malignancy confirmed, and any subsequently excised specimen is sent for histological examination Y 31291 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31275, where previous excision was performed by the same practitioner, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31292 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RESIDUAL, removal of, from areas of the body not covered by items 31260 and 31275, performed by a practitioner other than the practitioner who provided the previous treatment, where the original tumour size was more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination Y 31293 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT, removal of, from areas of the body not covered by items 31260 and 31275, whether previous excision was performed by the same practitioner OR performed by a practitioner other than the practitioner who provided the previous treatment, where the tumour size is more than 20mm in diameter and where removal is by surgical excision (other than by shave excision) and suture and where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31295 01MAY1997 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, residual or recurrent ( where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture and histological confirmation of malignancy has been obtained N 31295 01MAY2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, residual or recurrent ( where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31295 01NOV2003 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, residual or recurrent (where lesion treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained N 31295 01MAY2005 BASAL CELL CARCINOMA OR SQUAMOUS CELL CARCINOMA, RECURRENT (where lesion was treated by previous surgery, serial cautery and curettage, radiotherapy or two prolonged freeze/thaw cycles of liquid nitrogen therapy), performed by a specialist in the practice of his or her specialty or by a practitioner other than the practitioner who provided the previous treatment, removal from the head or neck (anterior to the sternomastoid muscles), where removal is by surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31300 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31300 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31300 01NOV2003 "TREATMENT OF MALIGNANT MELANOMA AND LOCALLY AGGRESSIVE SKIN TUMOURS Definitive surgical excision for items 31300-31335 is defined as ""surgical removal with an adequate margin and as a result, no further surgery is indicated at the site of the primary tumour"". MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to 10mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained" N 31300 01NOV2005 "TREATMENT OF MALIGNANT MELANOMA AND LOCALLY AGGRESSIVE SKIN TUMOURS Definitive surgical excision for items 31300-31335 is defined as ""surgical removal with an adequate margin and as a result, no further surgery is indicated at the site of the primary tumour"". MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained" N 31300 01MAY2007 "TREATMENT OF MALIGNANT MELANOMA AND LOCALLY AGGRESSIVE SKIN TUMOURS Definitive surgical excision for items 31300-31335 is defined as ""surgical removal with an adequate margin and as a result, no further surgery is indicated at that site of excision"". MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained" Y 31305 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31305 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31305 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE and removal from nose, eyelid, lip, ear, digit or genitalia, tumour size more than 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31310 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31310 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31310 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to 10mm in diameter and where removal is by definitive surgical excision (as defined above in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained N 31310 01NOV2005 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31315 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31315 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31315 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to 20mm in diameter and where removal is by definitive surgical excision (as defined above in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained N 31315 01NOV2005 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 10mm and up to and including 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31320 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31320 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31320 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from face, neck (anterior to sternomastoid muscles) or lower leg (mid calf to ankle) tumour size more than 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31325 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31325 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to 10mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31325 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to 10mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained N 31325 01NOV2005 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31300 and 31310 - tumour size up to and including 10mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31330 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31330 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31330 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to 20mm in diameter and where removal is by definitive surgical excision (as defined above and in para T8.21.7 of the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained N 31330 01NOV2005 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31310 - tumour size more than 10mm and up to and including 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31335 01MAY1997 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31320 - tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture and histological confirmation of malignancy has been obtained N 31335 01MAY2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31320 - tumour size more than 20mm in diameter - where removal is by definitive surgical excision and suture, where the specimen excised is sent for histological examination and confirmation of malignancy obtained N 31335 01NOV2003 MALIGNANT MELANOMA, APPENDAGEAL CARCINOMA, MALIGNANT FIBROUS TUMOUR OF SKIN, MERKEL CELL CARCINOMA OF SKIN or HUTCHINSON'S MELANOTIC FRECKLE - removal from areas of the body not covered by items 31305 and 31320 - tumour size more than 20mm in diameter and where removal is by definitive surgical excision (as defined above and in the explanatory notes to this category) and suture, where the specimen excised is sent for histological examination and confirmation of malignancy has been obtained Y 31340 01MAY1997 NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, performed in association with excision of malignant tumour of skin covered by item 31255, 31260, 31265, 31270, 31275, 31280, 31285, 31290, 31295, 31300, 31305, 31310, 31315, 31320, 31325, 31330 or 31335 N 31340 01MAY2004 NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, where the specimen excised is sent for histological confirmation, performed in association with excision of malignant tumour of skin covered by item 31255, 31260, 31265, 31270, 31275, 31280, 31285, 31290, 31295, 31300, 31305, 31310, 31315, 31320, 31325, 31330 or 31335 N 31340 01NOV2005 NOTE: Multiple Operation and Multiple Anaesthetic rules apply to this item. MUSCLE, BONE OR CARTILAGE, excision of one or more of, where clinically indicated, where the specimen excised is sent for histological confirmation, performed in association with excision of malignant tumour of skin covered by item 31255, 31256, 31257, 31258, 31260, 31261, 31262, 31263, 31265, 31266, 31267, 31268, 31270, 31271, 31272, 31273, 31275, 31276, 31277, 31278, 31280, 31281, 31282, 31283, 31285, 31286, 31287, 31288, 31290, 31291, 31292, 31293, 31295, 31300, 31305, 31310, 31315, 31320, 31325, 31330 or 31335 N 31340 01NOV2016 Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if: (a) the specimen excised is sent for histological confirmation; and (b) a malignant tumour of skin covered by item 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371, 31372, 31373, 31374, 31375 or 31376 is excised N 31340 01MAY2017 Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if:(a) the specimen excised is sent for histological confirmation; and (b) a malignant tumour of skin covered by item 31000, 31001, 31002, 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371, 31372, 31373, 31374, 31375 or 31376 is excised N 31340 01NOV2018 Muscle, bone or cartilage, excision of one or more of, if clinically indicated, and if: (a) the specimen excised is sent for histological confirmation; and (b)a malignant tumour of skin covered by item 31000, 31001, 31002, 31003, 31004, 31005, 31356, 31358, 31359, 31361, 31363, 31365, 31367, 31369, 31371,31372, 31373, 31374, 31375 or 31376 is excised Y 31345 01MAY1997 LIPOMA, excision of, where lesion is subcutaneous and greater than 50mm in diameter, or is sub-fascial N 31345 01NOV1997 LIPOMA, removal of by surgical excision or liposuction, where lesion is subcutaneous and greater than 50mm in diameter, or is sub-fascial, where specimen is sent for histological confirmation of diagnosis N 31345 01MAY2003 LIPOMA, removal of by surgical excision or liposuction, where lesion is subcutaneous and greater than 50mm in diameter, or is sub-fascial, where the specimen is sent for histological confirmation of diagnosis N 31345 01NOV2005 LIPOMA, removal of by surgical excision or liposuction, where lesion is subcutaneous and 50mm or more in diameter, or is sub-fascial, where the specimen is sent for histological confirmation of diagnosis Y 31346 01MAY2003 LIPOSUCTION (suction assisted lipolysis) to 1 regional area for treatment of contour problems of abdominal fat due to repeated insulin injections, where the lesion is subcutaneous and greater than 50mm in diameter N 31346 01NOV2004 LIPOSUCTION (suction assisted lipolysis) to 1 regional area for treatment of contour problems of abdominal or upper arm or thigh fat due to repeated insulin injections, where the lesion is subcutaneous and greater than 50mm in diameter N 31346 01NOV2005 LIPOSUCTION (suction assisted lipolysis) to 1 regional area for treatment of contour problems of abdominal or upper arm or thigh fat due to repeated insulin injections, where the lesion is subcutaneous and 50mm or more in diameter N 31346 01NOV2018 Liposuction (suction assisted lipolysis) to one regional area for contour problems of abdominal, upper arm or thigh fat because of repeated insulin injections, if: (a) the lesion is subcutaneous; and (b) the lesion is 50 mm or more in diameter; and (c) photographic and/or diagnostic imaging evidence demonstrating the need for this service is documented in the patient notes Y 31350 01MAY1997 BENIGN TUMOUR of SOFT TISSUE, removal of by surgical excision, where specimen is sent for histological confirmation of diagnosis, not being a service to which another item in this Group applies N 31350 01MAY2003 BENIGN TUMOUR of SOFT TISSUE, removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, not being a service to which another item in this Group applies N 31350 01NOV2005 BENIGN TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage, and bone, simple lipomas covered by item 31345 and lipomata, removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, not being a service to which another item in this Group applies N 31350 01SEP2015 BENIGN TUMOUR of SOFT TISSUE, excluding tumours of skin, cartilage, and bone, simple lipomas covered by item 31345 and lipomata, removal of by surgical excision, where the specimen excised is sent for histological confirmation of diagnosis, on a person 10 years of age or over, not being a service to which another item in this Group applies Y 31355 01MAY1997 MALIGNANT TUMOURof SOFT TISSUE, removal of by surgical excision, where histological proof of malignancy has been obtained, not being a service to which another item in this Group applies N 31355 01NOV2005 MALIGNANT TUMOURof SOFT TISSUE, excluding tumours of skin, cartilage and bone, removal of by surgical excision, where histological proof of malignancy has been obtained, not being a service to which another item in this Group applies Y 31356 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is less than 6 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31357 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is less than 6 mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201 Y 31358 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy Y 31359 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision), if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia (the applicable site); and (b) the necessary excision area is at least one third of the surface area of the applicable site; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy (H) Y 31360 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination Y 31361 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31362 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201 Y 31363 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy Y 31364 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination Y 31365 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31369, 31370, 31371, 31372 or 31373), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31366 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31357, 31360, 31362 or 31364; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201 Y 31367 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31368 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31357, 31360, 31362 or 31364; and (b) the necessary excision diameter is at least 15 mm but not more than 30mm; and (c) the excised specimen is sent for histological examination; not in association with item 45201 Y 31369 01NOV2016 Malignant skin lesion (other than a malignant skin lesion covered by item 31371, 31372, 31373, 31374, 31375 or 31376), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31356, 31358, 31359, 31361 or 31363; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy Y 31370 01NOV2016 Non-malignant skin lesion (other than viral verrucae (common warts) and seborrheic keratoses), including a cyst, ulcer or scar (other than a scar removed during the surgical approach at an operation), surgical excision (other than by shave excision) and repair of, if: (a) the lesion is excised from any part of the body not covered by item 31357, 31360, 31362 or 31364; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination Y 31371 01NOV2016 Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from nose, eyelid, eyebrow, lip, ear, digit or genitalia, or from a contiguous area; and (b) the necessary excision diameter is 6 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy Y 31372 01NOV2016 Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is less than 14 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31373 01NOV2016 Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from face, neck, scalp, nipple-areola complex, distal lower limb (distal to, and including, the knee) or distal upper limb (distal to, and including, the ulnar styloid); and (b) the necessary excision diameter is 14 mm or more; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy Y 31374 01NOV2016 Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is less than 15 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31375 01NOV2016 Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is at least 15 mm but not more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy; not in association with item 45201 Y 31376 01NOV2016 Malignant melanoma, appendageal carcinoma, malignant connective tissue tumour of skin or merkel cell carcinoma of skin, definitive surgical excision (other than by shave excision) and repair of, if: (a) the tumour is excised from any part of the body not covered by item 31371, 31372 or 31373; and (b) the necessary excision diameter is more than 30 mm; and (c) the excised specimen is sent for histological examination; and (d) malignancy is confirmed from the excised specimen or previous biopsy Y 31400 01JUL1998 MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR up to 20mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained N 31400 01NOV2005 MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR up to and including 20mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained Y 31403 01JUL1998 MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 20mm and up to 40mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained N 31403 01NOV2005 MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 20mm and up to and including 40mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained Y 31406 01JUL1998 MALIGNANT UPPER AERODIGESTIVE TRACT TUMOUR more than 40mm in diameter (excluding tumour of the lip), excision of, where histological confirmation of malignancy has been obtained Y 31409 01JUL1998 PARAPHARYNGEAL TUMOUR, excision of, by cervical approach Y 31412 01JUL1998 RECURRENT OR PERSISTENT PARAPHARYNGEAL TUMOUR, excision of, by cervical approach Y 31420 01JUL1998 LYMPH NODE OF NECK, biopsy of Y 31423 01JUL1998 LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck N 31423 01SEP2015 LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck, on a person 10 years of age or over Y 31426 01JUL1998 LYMPH NODES OF NECK, selective dissection of 3 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck Y 31429 01JUL1998 LYMPH NODES OF NECK, selective dissection of 4 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve Y 31432 01JUL1998 LYMPH NODES OF NECK, bilateral selective dissection of levels I, II and III (bilateral supraomohyoid dissections) Y 31435 01JUL1998 LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck Y 31438 01JUL1998 LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve Y 31441 01MAR1999 (see Item 14215 for adding or removing fluid via the implanted reservoir to adjust the tightness of the gastric band) LONG-TERM IMPLANTED RESERVOIR associated with the adjustable gastric band, repair, revision or replacement of Y 31450 01NOV1999 LAPAROSCOPIC DIVISION OF ADHESIONS, as an independent procedure, where the time taken is 1 hour or less Y 31452 01NOV1999 LAPAROSCOPIC DIVISION OF ADHESIONS, as an independent procedure, where the time taken in more than 1 hour Y 31454 01NOV2000 LAPAROSCOPY with drainage of pus, bile or blood, as an independent procedure Y 31456 01NOV2000 GASTROSCOPY and insertion of nasogastric or nasoenteral feeding tube, where blind insertion of the feeding tube has failed or is inappropriate due to the patient's medical condition Y 31458 01NOV2000 GASTROSCOPY and insertion of nasogastric or nasoenteral feeding tube, where blind insertion of the feeding tube has failed or is inappropriate due to the patient's medical condition, and where the use of imaging intensification is clinically indicated Y 31460 01NOV2000 PERCUTANEOUS GASTROSTOMY TUBE, jejunal extension to, including any associated imaging services Y 31462 01NOV2000 OPERATIVE FEEDING JEJUNOSTOMY performed in conjunction with major upper gastro-intestinal resection Y 31464 01NOV2000 ANTIREFLUX OPERATION BY FUNDOPLASTY, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus, by laparoscopic technique - not being a service to which item 30601 applies Y 31466 01NOV2000 ANTIREFLUX OPERATION BY FUNDOPLASTY, via abdominal or thoracic approach, with or without closure of the diaphragmatic hiatus, revision procedure, by laparoscopy or open operation Y 31468 01NOV2000 PARA-OESOPHAGEAL HIATUS HERNIA, repair of, with complete reduction of hernia, resection of sac and repair of hiatus, with or without fundoplication Y 31470 01NOV2000 LAPAROSCOPIC SPLENECTOMY N 31470 01SEP2015 LAPAROSCOPIC SPLENECTOMY, on a person 10 years of age or over Y 31472 01NOV2000 CHOLECYSTODUODENOSTOMY, CHOLECYSTOENTEROSTOMY, CHOLEDOCHOJEJUNOSTOMY OR ROUX-EN-Y as a bypass procedure where prior biliary surgery has been performed Y 31500 01NOV2002 BREAST, BENIGN LESION up to and including 50mm in diameter, including simple cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision of, with or without frozen section histolog, not being a service to which items 31539, 31542 or 31545 apply N 31500 01MAY2003 BREAST, BENIGN LESION up to and including 50mm in diameter, including simple cyst, fibroadenoma or fibrocystic disease, open surgical biopsy or excision of, with or without frozen section histology Y 31503 01NOV2002 BREAST, BENIGN LESION more than 50mm in diameter, excision of, not being a service to which items 31539, 31542 or 31545 apply N 31503 01MAY2003 BREAST, BENIGN LESION more than 50mm in diameter, excision of Y 31506 01NOV2002 BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or other localisation procedure is performed, excision biopsy of, not being a service to which items 31539, 31542 or 31545 apply N 31506 01MAY2003 BREAST, ABNORMALITY detected by mammography or ultrasound where guidewire or other localisation procedure is performed, excision biopsy of Y 31509 01NOV2002 BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen section histology, not being a service to which items 31539, 31542 or 31545 apply N 31509 01MAY2003 BREAST, MALIGNANT TUMOUR, open surgical biopsy of, with or without frozen section histology Y 31512 01NOV2002 BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology, not being a service to which items 31539, 31542 or 31545 apply N 31512 01MAY2003 BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology Y 31515 01NOV2002 BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete excision of malignant tumour, not being a service to which items 31539, 31542 or 31545 apply N 31515 01MAY2003 BREAST, TUMOUR SITE, re-excision of following open biopsy or incomplete excision of malignant tumour Y 31516 01SEP2015 BREAST, MALIGNANT TUMOUR, complete local excision of, with or without frozen section histology when targeted intraoperative radiotherapy (using an Intrabeam(r) device) is performed concurrently, if the requirements of item 15900 are met for the patient Y 31518 01NOV2002 BREAST (female), total mastectomy Y 31519 01JUL2014 BREAST, total mastectomy (H) Y 31521 01NOV2002 BREAST (male), total mastectomy N 31521 01NOV2003 BREAST (male), total mastectomy, not being a service associated with a service to which item 45585 applies Y 31524 01NOV2002 BREAST (female), subcutaneous mastectomy N 31524 01JUL2014 BREAST, subcutaneous mastectomy (H) Y 31525 01JUL2014 BREAST, mastectomy for gynecomastia, with or without liposuction (suction assisted lipolysis), not being a service associated with a service to which item 45585 applies (H) Y 31527 01NOV2002 BREAST (male), subcutaneous mastectomy N 31527 01NOV2003 BREAST (male), subcutaneous mastectomy, not being a service associated with a service to which item 45585 applies N 31527 01NOV2012 BREAST (male), SUBCUTANEOUS MASTECTOMY, with or without liposuction (suction assisted lipolysis), not being a service associated with a service to which 45585 applies Y 31530 01NOV2002 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a vacuum-assisted breast biopsy device under imaging guidance, for histological examination, where imaging has demonstrated: (a)microcalcification of lesion; or (b)impalpable lesion less than 1cm in diameter -including pre-operative localisation of lesion where performed, not being a service to which items 31539, 31545 or 31548 apply Y 31533 01NOV2002 FINE NEEDLE ASPIRATION of an impalpable breast lesion detected by mammography or ultrasound, imaging guided - but not including imaging Y 31536 01NOV2002 BREAST, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques - but not including imaging, not being a service to which item 31542 applies N 31536 01MAY2003 BREAST, preoperative localisation of lesion of, by hookwire or similar device, using interventional imaging techniques - but not including imaging, not being a service to which item 31539, 31542 or 31545 applies Y 31539 01NOV2002 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using Advanced Breast Biopsy Instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, not being a service to which items 31530 or 31536 apply N 31539 01MAY2003 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using advanced breast biopsy instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, not being a service to which item 31530, 31536 or 31548 applies N 31539 01JAN2014 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a bore-enbloc stereotactic biopsy, for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, not being a service to which item 31530, 31536 or 31548 applies Y 31542 01NOV2002 BREAST, initial guidewire localisation of lesion, by hookwire, when conducted by a radiologist as determined by the Royal Australian and New Zealand College of Radiologists, using interventional imaging techniques prior to Advanced Breast Biopsy Instrumentation (ABBI), - including imaging not being a service to which item 31536 applies N 31542 01MAY2003 BREAST, initial guidewire localisation of lesion, by hookwire or similar device, when conducted by a radiologist as determined by the Royal Australian and New Zealand College of Radiologists, using interventional imaging techniques prior to advanced breast biopsy instrumentation (ABBI), - including imaging not being a service associated with a service to which item 31536 applies N 31542 01JAN2014 BREAST, initial guidewire localisation of lesion, by hookwire or similar device, when conducted by a radiologist as determined by the Royal Australian and New Zealand College of Radiologists, using interventional imaging techniques prior to using a bore-enbloc stereotactic biopsy - including imaging not being a service associated with a service to which item 31536 applies Y 31545 01NOV2002 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using Advanced Breast Biopsy Instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons, and where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, including initial guidewire localisation of lesion, by hookwire, using interventional imaging techniques and including imaging not being a service to which item 31530, 31536 or 31548 apply N 31545 01MAY2003 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using advanced breast biopsy instrumentation (ABBI), for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons; where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, including initial guidewire localisation of lesion, by hookwire or similar device, using interventional imaging techniques and including imaging not being a service associated with a service to which item 31530, 31536 or 31548 applies N 31545 01JAN2014 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using a bore-enbloc stereotactic biopsy, for histological examination, when conducted by a surgeon as determined by the Royal Australasian College of Surgeons; where imaging has demonstrated an impalpable lesion of less than 15mm in diameter, including initial guidewire localisation of lesion, by hookwire or similar device, using interventional imaging techniques and including imaging not being a service associated with a service to which item 31530, 31536 or 31548 applies Y 31548 01NOV2002 BREAST, BIOPSY OF SOLID TUMOUR OR TISSUE OF, using mechanical biopsy device, for histological examination, not being a service to which items 31530, 31539 or 31545 apply Y 31551 01NOV2002 BREAST, HAEMATOMA, SEROMA OR INFLAMMATORY CONDITION including abscess, granulomatous mastitis or similar, exploration and drainage of when undertaken in the operating theatre of a hospital, excluding aftercare Y 31554 01NOV2002 BREAST, microdochotomy of, for benign or malignant condition Y 31557 01NOV2002 BREAST CENTRAL DUCTS, excision of, for benign condition Y 31560 01NOV2002 ACCESSORY BREAST TISSUE, excision of Y 31563 01NOV2002 INVERTED NIPPLE, surgical eversion of Y 31566 01NOV2002 ACCESSORY NIPPLE, excision of Y 31569 01JUL2013 Adjustable gastric band, placement of, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity Y 31572 01JUL2013 Gastric bypass by Roux-en-Y including associated anastomoses, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity not being associated with a service to which item 30515 applies Y 31575 01JUL2013 Sleeve gastrectomy, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity Y 31578 01JUL2013 Gastroplasty (excluding by gastric plication), with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity Y 31581 01JUL2013 Gastric bypass by biliopancreatic diversion with or without duodenal switch including gastric resection and anastomoses, with or without crural repair taking 45 minutes or less, for a patient with clinically severe obesity Y 31584 01JUL2013 Surgical reversal of adjustable gastric banding (removal or replacement of gastric band), gastric bypass, gastroplasty (excluding by gastric plication) or biliopancreatic diversion being services to which items 31569 to 31581 apply Y 31587 01JUL2013 Adjustment of gastric band as an independent procedure including any associated consultation Y 31590 01JUL2013 Adjustment of gastric band reservoir, repair, revision or replacement of Y 31591 16NOV2017 Surgical reversal of an existing bariatric procedure performed in association with a service to which items 31569 to 31581 apply. Y 32000 01DEC1991 LARGE INTESTINE, resection of, without anastomosis, including right hemicolectomy (including formation of stoma) Y 32003 01DEC1991 LARGE INTESTINE, resection of, with anastomosis, including right hemicolectomy Y 32004 01NOV1992 LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) without anastomosis, not being a service associated with a service to which another item in this Group applies N 32004 01NOV1993 LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) without anastomosis, not being a service associated with a service to which item 32000, 32003, 32005 or 32006 applies Y 32005 01NOV1992 LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) with anastomosis, not being a service associated with a service to which another item in this Group applies N 32005 01NOV1993 LARGE INTESTINE, subtotal colectomy (resection of right colon, transverse colon and splenic flexure) with anastomosis, not being a service associated with a service to which item 32000, 32003, 32004 or 32006 applies Y 32006 01DEC1991 LEFT HEMICOLECTOMY, including the descending and sigmoid colon (including formation of stoma) Y 32009 01DEC1991 TOTAL COLECTOMY AND ILEOSTOMY Y 32012 01DEC1991 TOTAL COLECTOMY AND ILEORECTAL ANASTOMOSIS Y 32015 01DEC1991 TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY1 surgeon Y 32018 01DEC1991 TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY, COMBINED SYNCHRONOUS OPERATION; ABDOMINAL RESECTION (including aftercare) Y 32021 01DEC1991 TOTAL COLECTOMY WITH EXCISION OF RECTUM AND ILEOSTOMY, COMBINED SYNCHRONOUS OPERATION; PERINEAL RESECTION Y 32023 01MAR2013 Endoscopic insertion of stent or stents for large bowel obstruction, stricture or stenosis, including colonoscopy and any image intensification, where the obstruction is due to: a) a pre-diagnosed colorectal cancer, or cancer of an organ adjacent to the bowel; or b) an unknown diagnosis Y 32024 01DEC1991 RECTUM, HIGH RESTORATIVE ANTERIOR RESECTION WITH INTRAPERITONEAL ANASTOMOSIS (of the rectum) greater than 10 centimetres from the anal vergeexcluding resection of sigmoid colon alone N 32024 01MAY2004 RECTUM, HIGH RESTORATIVE ANTERIOR RESECTION WITH INTRAPERITONEAL ANASTOMOSIS (of the rectum) greater than 10 centimetres from the anal vergeexcluding resection of sigmoid colon alone not being a service associated with a service to which item 32103, 32104 or 32106 applies Y 32025 01MAY1994 RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge, with or without covering stoma N 32025 01MAY2004 RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge, with or without covering stoma not being a service associated with a service to which item 32103, 32104 or 32106 applies Y 32026 01MAY1994 RECTUM, ULTRA LOW RESTORATIVE RESECTION, with or without covering stoma, where the anastomosis is sited in the anorectal region and is 6cm or less from the anal verge Y 32027 01DEC1991 RECTUM, LOW RESTORATIVE ANTERIOR RESECTION WITH EXTRAPERITONEAL ANASTOMOSIS (of the rectum) less than 10 centimetres from the anal verge Y 32028 01MAY1994 RECTUM, LOW OR ULTRA LOW RESTORATIVE RESECTION, with peranal sutured coloanal anastomosis, with or without covering stoma Y 32029 01MAY1994 COLONIC RESERVOIR, construction of, being a service associated with a service to which any other item in this Subgroup applies Y 32030 01DEC1991 RECTOSIGMOIDECTOMY(Hartmann's operation) Y 32033 01DEC1991 RESTORATION OF BOWEL continuity following Hartmann's operation including dismantling of colostomy N 32033 01NOV1992 RESTORATION OF BOWEL following Hartmann's or similar operation, including dismantling of the stoma Y 32036 01DEC1991 SACROCOCCYGEAL AND PRESACRAL TUMOURexcision of Y 32039 01DEC1991 RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF1 surgeon Y 32042 01DEC1991 RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF, COMBINED SYNCHRONOUS OPERATIONabdominal resection Y 32045 01DEC1991 RECTUM AND ANUS, ABDOMINOPERINEAL RESECTION OF, COMBINED SYNCHRONOUS OPERATIONperineal resection Y 32046 01NOV1992 RECTUM and ANUS, abdomino-perineal resection of, combined synchronous operation - perineal resection where the perineal surgeon also provides assistance to the abdominal surgeon Y 32047 01NOV1992 PERINEAL PROCTECTOMY Y 32048 01DEC1991 ABDOMINOPERINEAL PULL-THROUGH RESECTION with coloanal anastomosis (1 or 2 stages), including associated colostomy Y 32051 01DEC1991 TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomy1 surgeon Y 32054 01DEC1991 TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with formation of ileal reservoir, with or without creation of temporary ileostomyconjoint surgery, abdominal surgeon (including aftercare) Y 32057 01DEC1991 TOTAL COLECTOMY with excision of rectum and ileoanal anastomosis with formation of ileal reservoirconjoint surgery, perineal surgeon Y 32060 01DEC1991 ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomy1 surgeon Y 32063 01DEC1991 ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomyconjoint surgery, abdominal surgeon (including aftercare) Y 32066 01DEC1991 ILEOSTOMY CLOSURE with rectal resection and mucosectomy and ileoanal anastomosis with formation of ileal reservoir, with or without temporary loop ileostomyconjoint surgery, perineal surgeon Y 32069 01DEC1991 ILEOSTOMY RESERVOIR, continent type, creation of, including conversion of existing ileostomy where appropriate Y 32072 01DEC1991 SIGMOIDOSCOPIC EXAMINATION (with rigid sigmoidoscope), with or without biopsy Y 32075 01DEC1991 SIGMOIDOSCOPIC EXAMINATION (with rigid sigmoidoscope), UNDER GENERAL ANAESTHESIA, with or without biopsy, not being a service associated with a service to which another item in this Group applies Y 32078 01DEC1991 SIGMOIDOSCOPIC EXAMINATION with diathermy OR resection of 1 or more polyps where the time taken is less than or equal to 45 minutes Y 32081 01DEC1991 SIGMOIDOSCOPIC EXAMINATION with diathermy OR resection of 1 or more polyps where the time taken is greater than 45 minutes Y 32084 01DEC1991 FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY up to the hepatic flexure, WITH or WITHOUT BIOPSY N 32084 01NOV2017 Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to the hepatic flexure, with or without biopsy,other thana service associated with a service to which item 32090 or 32093 applies. N 32084 01NOV2019 Flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy up to the hepatic flexure, with or without biopsy,other thana service associated with a service to whichany of items 32222 to 32228applies. Y 32087 01DEC1991 FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY up to the hepatic flexure WITH REMOVAL OF 1 OR MORE POLYPSnot being a service to which item 32078 applies N 32087 01MAY2010 Endoscopic examination of the colon up to the hepatic flexure by FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by ARGON PLASMA COAGULATION, 1 or more of, not being a service to which item 32078 applies N 32087 01JUL2016 Endoscopic examination of the colon up to the hepatic flexure by FLEXIBLE FIBREOPTIC SIGMOIDOSCOPY or FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by ARGON PLASMA COAGULATION, 1 or more of N 32087 01NOV2017 Endoscopic examination of the colon up to the hepatic flexure by flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy for the removal of 1 or more polyps or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by argon plasma coagulation, one or more of, other than a service associated with a service to which item 32090 or 32093 applies N 32087 01NOV2019 Endoscopic examination of the colon up to the hepatic flexure by flexible fibreoptic sigmoidoscopy or fibreoptic colonoscopy for the removal of 1 or more polyps or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by argon plasma coagulation, one or more of, other than a service associated with a service to which any of items 32222 to 32228 applies Y 32088 01MAY2016 FIBREOPTIC COLONOSCOPY examination of the colon beyond the hepatic flexure WITH or WITHOUT BIOPSY, following a positive faecal occult blood test for a participant registered on the National Bowel Cancer Screening Program. Y 32089 01MAY2016 Endoscopic examination of the colon beyond the hepatic flexure by FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS, following a positive faecal occult blood test for a participant registered on the National Bowel Cancer Screening Program. Y 32090 01DEC1991 FIBREOPTIC COLONOSCOPYexamination of colon beyond the hepatic flexure WITH or WITHOUT BIOPSY Y 32093 01DEC1991 FIBREOPTIC COLONOSCOPYexamination of colon beyond the hepatic flexure WITH REMOVAL OF 1 OR MORE POLYPS N 32093 01MAY2010 Endoscopic examination of the colon beyond the hepatic flexure by FIBREOPTIC COLONOSCOPY for the REMOVAL OF 1 OR MORE POLYPS, or the treatment of radiation proctitis, angiodysplasia or post-polypectomy bleeding by ARGON PLASMA COAGULATION, 1 or more of Y 32094 01NOV1992 ENDOSCOPIC DILATATION OF COLORECTAL STRICTURES including colonoscopy Y 32095 01NOV1992 ENDOSCOPIC EXAMINATION of SMALL BOWEL with flexible endoscope passed by stoma, with or without biopsies Y 32096 01DEC1991 RECTAL BIOPSY, full thickness, under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital Y 32099 01DEC1991 RECTAL TUMOUR of five centimetres or less in diameter, per anal submucosal excision of (excluding snare diathermy) N 32099 01NOV1992 RECTAL TUMOUR of 5 centimetres or less in diameter, per anal submucosal excision of Y 32102 01DEC1991 RECTAL TUMOUR of greater than five centimetres in diameter, per anal submucosal excision of N 32102 01NOV1992 RECTAL TUMOUR of greater than 5 centimetres in diameter, indicated by pathological examination, per anal submucosal excision of Y 32103 01MAY2004 RECTAL TUMOUR, of less than 4cm in diameter, per anal excision of, using stereoscopic rectoscopy (incorporating stereoscopic and optic systems), where removal is unable to be performed during colonoscopy or by local excision not being a service associated with a service to which item 32024, 32025, 32104 or 32106 applies N 32103 01NOV2012 RECTAL TUMOUR, of less than 4 cm in diameter, per anal excision of, using rectoscopy incorporating either 3 dimensional or 2 dimensional optic viewing systems, if removal is unable to be performed during colonoscopy or by local excision, other than a service associated with a service to which item 32024, 32025, 32104 or 32106 applies Y 32104 01MAY2004 RECTAL TUMOUR, of 4cm or greater in diameter, per anal excision of, using stereoscopic rectoscopy (incorporating stereoscopic and optic systems), where removal is unable to be performed during colonoscopy or by local excision not being a service associated with a service to which item 32024, 32025, 32103 or 32106 applies N 32104 01NOV2012 RECTAL TUMOUR, of 4 cm or greater in diameter, per anal excision of, using rectoscopy incorporating either 3 dimensional or 2 dimensional optic viewing systems, if removal is unable to be performed during colonoscopy or by local excision, other than a service associated with a service to which item 32024, 32025, 32103 or 32106 applies Y 32105 01DEC1991 ANORECTAL CARCINOMAper anal full thickness excision of Y 32106 01MAY2004 ANTEROLATERAL INTRAPERITONEAL RECTAL TUMOUR, per anal excision of, using stereoscopic rectoscopy (incorporating stereoscopic and optic systems), where removal is unable to be performed during colonoscopy and where removal requires dissection within the peritoneal cavity not being a service associated with a service to which item 32024, 32025, 32103 or 32104 applies N 32106 01NOV2012 ANTEROLATERAL INTRAPERITONEAL RECTAL TUMOUR, per anal excision of, using rectoscopy incorporating either 3 dimensional or 2 dimensional optic viewing systems, if removal is unable to be performed during colonoscopy and if removal requires dissection within the peritoneal cavity, other than a service associated with a service to which item 32024, 32025, 32103 or 32104 applies Y 32108 01DEC1991 RECTAL TUMOUR, transsphincteric excision of (Kraske or similar operation) Y 32111 01DEC1991 RECTAL PROLAPSEDelorme procedure for Y 32112 01MAY1994 RECTAL PROLAPSE, perineal recto-sigmoidectomy for Y 32114 01DEC1991 RECTAL STRICTURE, per anal release of Y 32115 01MAY1997 RECTAL STRICTURE, dilatation of Y 32117 01DEC1991 RECTAL PROLAPSE, abdominal repair of N 32117 01MAY1994 RECTAL PROLAPSE, abdominal rectopexy of Y 32120 01DEC1991 RECTAL PROLAPSE, perineal repair of Y 32123 01DEC1991 ANAL STRICTURE, anoplasty for Y 32126 01DEC1991 ANAL INCONTINENCE, Parks' intersphincteric procedure for Y 32129 01DEC1991 ANAL SPHINCTER, direct repair of Y 32131 01MAY1994 RECTOCELE, perineal repair of N 32131 01MAY2001 RECTOCELE, transanal repair of rectocele Y 32132 01DEC1991 HAEMORRHOIDS OR RECTAL PROLAPSEsclerotherapy for Y 32135 01DEC1991 HAEMORRHOIDS OR RECTAL PROLAPSErubber band ligation of, with or without sclerotherapy, cryosurgery or infra red therapy for N 32135 01NOV2003 HAEMORRHOIDS OR RECTAL PROLAPSErubber band ligation of, with or without sclerotherapy, cryotherapy or infra red therapy for Y 32138 01DEC1991 HAEMORRHOIDECTOMY N 32138 01JUL1995 HAEMORRHOIDECTOMY including excision of anal skin tags when performed Y 32139 01MAY1997 HAEMORRHOIDECTOMY involving third or fourth degree haemorrhoids, including excision of anal skin tags when performed Y 32141 01DEC1991 ANAL POLYPS, excision of one or more of Y 32142 01NOV1992 ANAL SKIN TAGS or ANAL POLYPS, excision of 1 or more of Y 32144 01DEC1991 ANAL SKIN TAGS, excision of one or more of Y 32145 01NOV1992 ANAL SKIN TAGS or ANAL POLYPS, excision of 1 or more of, undertaken in the operating theatre of a hospital Y 32147 01DEC1991 PERIANAL THROMBOSIS, incision of Y 32150 01DEC1991 OPERATION FOR FISSUREINANO, including excision or sphincterotomy, but excluding dilatation only Y 32153 01DEC1991 ANUS, DILATATION OF, under general anaesthesia, with or without disimpaction of faeces, not being a service associated with a service to which another item in this Group applies Y 32156 01DEC1991 FISTULA-IN-ANO, SUBCUTANEOUS, excision of Y 32159 01DEC1991 ANAL FISTULA, excision of, involving lower half of the anal sphincter mechanism N 32159 01MAY2004 ANAL FISTULA, treatment of, by excision or by insertion of a Seton, or by a combination of both procedures, involving the lower half of the anal sphincter mechanism Y 32162 01DEC1991 ANAL FISTULA, excision of, involving the upper half of the anal sphincter mechanism N 32162 01MAY2004 ANAL FISTULA, treatment of, by excision or by insertion of a Seton, or by a combination of both procedures, involving the upper half of the anal sphincter mechanism Y 32165 01DEC1991 ANAL FISTULA, repair of, by mucosal flap advancement Y 32166 01NOV1992 ANAL FISTULA - readjustment of Seton Y 32168 01DEC1991 FISTULA WOUND, review of, under general anaesthetic N 32168 01NOV1992 FISTULA WOUND, review of, under general or regional anaesthetic, as an independent procedure N 32168 01MAY1994 FISTULA WOUND, review of, under general or regional anaesthetic, as an independent procedure Y 32171 01DEC1991 ANORECTAL EXAMINATION, with or without biopsy, under general anaesthetic, not being a service associated with a service to which another item in this Group applies Y 32174 01DEC1991 INTR-AANAL, perianal or ischiorectal abscess, drainage of (excluding aftercare) Y 32175 01NOV1992 INTRA-ANAL, PERIANAL or ISCHIO-RECTAL ABSCESS, draining of, undertaken in the operating theatre of a hospital (excluding aftercare) Y 32177 01DEC1991 ANAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved dayhospital facility, where the time taken is less than or equal to 45 minutes N 32177 01APR1992 ANAL WARTS, removal of, under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is less than or equal to 45 minutes - not being a service associated with a service to which item 35507 or 35508 applies Y 32180 01DEC1991 ANAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital or approved dayhospital facility, where the time taken is greater than 45 minutes N 32180 01APR1992 ANAL WARTS, removal of, under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is greater than 45 minutes - not being a service associated with a service to which item 35507 or 35508 applies Y 32183 01DEC1991 INTESTINAL SLING PROCEDURE prior to radiotherapy Y 32186 01DEC1991 COLONIC LAVAGE, total, intra operative Y 32200 01MAY1997 DISTAL MUSCLE, devascularisation of Y 32203 01MAY1997 ANAL OR PERINEAL GRACILOPLASTY Y 32206 01MAY1997 STIMULATOR AND ELECTRODES, insertion of, following previous graciloplasty Y 32209 01MAY1997 ANAL OR PERINEAL GRACILOPLASTY with insertion of stimulator and electrodes Y 32210 19JUN1997 GRACILIS NEOSPHINCTER PACEMAKER, replacement of N 32210 01NOV1997 GRACILIS NEOSPHINCTER PACEMAKER, replacement of Y 32212 01MAY1997 ANO-RECTAL APPLICATION OF FORMALIN in the treatment of radiation proctitis, where performed in the operating theatre of a hospital, excluding aftercare Y 32213 01NOV2005 SACRAL NERVE LEAD(S), placement of, percutaneous using fluoroscopic guidance, or open, and intraoperative test stimulation, for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment N 32213 01JAN2015 SACRAL NERVE LEAD(S), placement of, percutaneous using fluoroscopic guidance, or open, and intraoperative test stimulation, for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment. Contraindicated in: (a)patients under 18 years of age; and (b)patients 18 years of age or older who: (i)are medically unfit for surgery; or (ii)are pregnant or planning pregnancy; or (iii)have irritable bowel syndrome; or (iv)have congenital anorectal malformations; or (v)have active anal abscesses or fistulas; or (vi)have anorectal organic bowel disease, including cancer; or (vii)have functional effects of previous pelvic irradiation; or (viii)have congenital or acquired malformations of the sacrum; or (ix)have had rectal or anal surgery within the previous 12 months. N 32213 01MAY2017 Sacral nerve lead or leads, percutaneous placement using fluoroscopic guidance (or open placement) and intraoperative test stimulation, to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non?surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months Y 32214 01NOV2005 NEUROSTIMULATOR or RECEIVER, subcutaneous placement of, and placement and connection of extension wire(s) to sacral nerve electrode(s), for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, using fluoroscopic guidance N 32214 01SEP2015 NEUROSTIMULATOR or RECEIVER, subcutaneous placement of, and placement and connection of extension wire(s) to sacral nerve electrode(s), for the management of faecal incontinence in a patient who has an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, using fluoroscopic guidance.Contraindicated in: (a)patients under 18 years of age; and (b)patients 18 years of age or older who: (i)are medically unfit for surgery; or (ii)are pregnant or planning pregnancy; or (iii)have irritable bowel syndrome; or (iv)have congenital anorectal malformations; or (v)have active anal abscesses or fistulas; or (vi)have anorectal organic bowel disease, including cancer; or (vii)have functional effects of previous pelvic irradiation; or (viii)have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months. N 32214 01MAY2017 Neurostimulator or receiver, subcutaneous placement of, involving placement and connection of an extension wire to a sacral nerve electrode using fluoroscopic guidance, to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non?surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months   Y 32215 01NOV2005 SACRAL NERVE ELECTRODE(S), management, adjustment, and electronic programming of neurostimulator by a medical practitioner, for the management of faecal incontinence - each day N 32215 01SEP2015 SACRAL NERVE ELECTRODE(S), management, adjustment, and electronic programming of neurostimulator by a medical practitioner, for the management of faecal incontinence - each day.Contraindicated in: (a)patients under 18 years of age; and (b)patients 18 years of age or older who: (i)are medically unfit for surgery; or (ii)are pregnant or planning pregnancy; or (iii)have irritable bowel syndrome; or (iv)have congenital anorectal malformations; or (v)have active anal abscesses or fistulas; or (vi)have anorectal organic bowel disease, including cancer; or (vii)have functional effects of previous pelvic irradiation; or (viii)have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months. N 32215 01MAY2017 Sacral nerve electrode or electrodes, management, adjustment and electronic programming of the neurostimulator by a medical practitioner, to manage faecal incontinence, other than in a patient who: a) is medically unfit for surgery; or b) is pregnant or planning pregnancy; or c) has irritable bowel syndrome; or d) has congenital anorectal malformations; or e) has active anal abscesses or fistulas; or f) has anorectal organic bowel disease, including cancer; or g) has functional effects of previous pelvic irradiation; or h) has congenital or acquired malformations of the sacrum; or i) has had rectal or anal surgery within the previous 12 months –each day Y 32216 01NOV2005 SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, surgical repositioning of, percutaneous using fluoroscopic guidance, or open, to correct displacement or unsatisfactory positioning, and intraoperative test stimulation, not being a service to which item 32213 applies N 32216 01SEP2015 SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, surgical repositioning of, percutaneous using fluoroscopic guidance, or open, to correct displacement or unsatisfactory positioning, and intraoperative test simulation, not being a service to which item 32213 applies.Contraindicated in: (a)patients under 18 years of age; and (b)patients 18 years of age or older who: (i)are medically unfit for surgery; or (ii)are pregnant or planning pregnancy; or (iii)have irritable bowel syndrome; or (iv)have congenital anorectal malformations; or (v)have active anal abscesses or fistulas; or (vi)have anorectal organic bowel disease, including cancer; or (vii)have functional effects of previous pelvic irradiation; or (viii)have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months. N 32216 01MAY2017 Sacral nerve lead or leads, percutaneous surgical repositioning of, using fluoroscopic guidance (or open surgical repositioning of) and interoperative test stimulation, to correct displacement or unsatisfactory positioning, if the lead was inserted to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non?surgical treatment for at least 12 months;  other than a patient who:  c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months other than a service to which item 32213 applies   Y 32217 01NOV2005 NEUROSTIMULATOR or RECEIVER, inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of N 32217 01SEP2015 NEUROSTIMULATOR or RECEIVER, inserted for the management of faecal incontinence in a patient who had an anatomically intact but funcionaly deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of.Contraindicated in: (a)patients under 18 years of age; and (b)patients 18 years of age or older who: (i)are medically unfit for surgery; or (ii)are pregnant or planning pregnancy; or (iii)have irritable bowel syndrome; or (iv)have congenital anorectal malformations; or (v)have active anal abscesses or fistulas; or (vi)have anorectal organic bowel disease, including cancer; or (vii)have functional effects of previous pelvic irradiation; or (viii)have congenital or acquired malformations of the sacrum; or (ix) have had rectal or anal surgery within the previous 12 months. N 32217 01MAY2017 Neurostimulator or receiver, removal of, if the neurostimulator or receiver was inserted to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non?surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months   Y 32218 01NOV2005 SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of N 32218 01JAN2015 SACRAL NERVE LEAD(S), inserted for the management of faecal incontinence in a patient who had an anatomically intact but functionally deficient anal sphincter with faecal incontinence refractory to at least 12 months of conservative non-surgical treatment, removal of Contraindicated in: (a)patients under 18 years of age; and (b)patients 18 years of age or older who: (i)are medically unfit for surgery; or (ii)are pregnant or planning pregnancy; or (iii)have irritable bowel syndrome; or (iv)have congenital anorectal malformations; or (v)have active anal abscesses or fistulas; or (vi)have anorectal organic bowel disease, including cancer; or (vii)have functional effects of previous pelvic irradiation; or (viii)have congenital or acquired malformations of the sacrum; or (ix)have had rectal or anal surgery within the previous 12 months. N 32218 01MAY2017 Sacral nerve lead or leads, removal of, if the lead was inserted to manage faecal incontinence in a patient who:a) has an anatomically intact but functionally deficient anal sphincter; and b) has faecal incontinence that has been refractory to conservative non?surgical treatment for at least 12 months; other than a patient who: c) is medically unfit for surgery; or d) is pregnant or planning pregnancy; or e) has irritable bowel syndrome; or f) has congenital anorectal malformations; or g) has active anal abscesses or fistulas; or h) has anorectal organic bowel disease, including cancer; or i) has functional effects of previous pelvic irradiation; or j) has congenital or acquired malformations of the sacrum; or k) has had rectal or anal surgery within the previous 12 months   Y 32220 01MAR2009 Insertion of an artificial bowel sphincter for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed N 32220 01JAN2015 Insertion of an artificial bowel sphincter for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed.Contraindicated in: (a)patients with inflammatory bowel disease, pelvic sepsis, pregnancy, progressive degenerative diseases or a scarred or fragile perineum; and (b)patients who have had an adverse reaction or radiopaque solution; and (c)patients who enage in receptive anal intercourse Y 32221 01MAR2009 Removal or revision of an artificial bowel sphincter (with or without replacement) for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed N 32221 01JAN2015 Removal or revision of an artificial bowel sphincter (with or without replacement) for severe faecal incontinence in the treatment of a patient for whom conservative and other less invasive forms of treatment are contraindicated or have failed.Contraindicated in: (a)patients with inflammatory bowel disease, pelvic sepsis, pregnancy, progressive degenerative diseases or a scarred or fragile perineum; and (b)patients who have had an adverse reaction to radiopaque solution; and (c)patients who engage in receptive anal intercourse Y 32222 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) following a positive faecal occult blood test; or (b) who has symptoms consistent with pathology of the colonic mucosa; or (c) with anaemia or iron deficiency; or (d) for whom diagnostic imaging has shown an abnormality of the colon; or (e) who is undergoing the first examination following surgery for colorectal cancer; or (f) who is undergoing pre?operative evaluation; or (g) for whom a repeat colonoscopy is required due to inadequate bowel preparation for the patient's previous colonoscopy; or (h) for the management of inflammatory bowel disease Applicable only once on a day under a single episode of anaesthesia or other sedation Y 32223 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy, for a patient: (a) who has had a colonoscopy that revealed 1 to 4 adenomas, each of which were less than 10mm in diameter, had no villous features and had no high grade dysplasia; or (b) with a moderate risk of colorectal cancer due to family history; or (c) with a history of colorectal cancer, who has had an initial post?operative colonoscopy that did not reveal any adenomas or colorectal cancer Applicable only once in any 5 year period Y 32224 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a moderate risk of colorectal cancer due to: (a) a history of adenomas, including an adenoma that: (i) was greater than 10mm in diameter; or (ii) had villous features; or (iii) had high grade dysplasia; or (iv) was an advanced serrated adenoma; or (b) having had a previous colonoscopy that revealed 5 to 9 adenomas, each of which was less than 10mm in diameter, had no villous features and had no high grade dysplasia Applicable only once in any 3 year period Y 32225 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a high risk of colorectal cancer due to having had a previous colonoscopy that: (a) revealed 10 or more adenomas; or (b) included a piecemeal, or possibly incomplete, excision of a large, sessile polyp Applicable not more than 4 times in any 12 month period Y 32226 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy, for a patient with a high risk of colorectal cancer due to: (a) a known or suspected familial condition, such as familial adenomatous polyposis, Lynch syndrome or serrated polyposis syndrome; or (b) a genetic mutation associated with hereditary colorectal cancer Applicable only once in any 12 month period Y 32227 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy: (a) for the treatment of bleeding, including one or more of the following: (i) radiation proctitis; (ii) angioectasia; (iii) post?polypectomy bleeding; or (b) for the treatment of colonic strictures with balloon dilatation Applicable only once on a day under a single episode of anaesthesia or other sedation Y 32228 01NOV2019 Endoscopic examination of the colon to the caecum by colonoscopy, other that a service to which item 32222, 32223, 32224, 32225, or 32226 applies. Applicable only once Y 32229 01NOV2019 Removal of one or more polyps during colonoscopy, in association with a service to which item 32222, 32223, 32224, 32225, 32226, or 32228 applies Y 32500 01DEC1991 VARICOSE VEINS VARICOSE VEINS, multiple simultaneous injections by continuous compression techniques including associated consultation - 1 OR BOTH LEGS - not being a service associated with any other varicose veins operation on the same leg (excluding after-care) N 32500 01MAY1994 VARICOSE VEINS VARICOSE VEINS, (excluding telangiectases, starburst vessels, spider nevi or similar), multiple injections using continuous compression techniques including associated consultation - 1 or both legs - not being a service associated with any other varicose veins operation on the same leg (excluding after-care) N 32500 01NOV1994 VARICOSE VEINS VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg (excluding after-care) - to a maximum of 6 treatments in a 12 month period N 32500 01MAY2003 VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections of sclerosant using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg (excluding after-care) - to a maximum of 6 treatments in a 12 month period Y 32501 19JUN1997 VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg, (excluding after-care) - where it can be demonstrated that a 7th or subsequent treatment (including any treatments to which item 32500 applies) is indicated in a 12 month period N 32501 01NOV1997 VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg, (excluding after-care) - where it can be demonstrated that a 7th or subsequent treatment (including any treatments to which item 32500 applies) is indicated in a 12 month period N 32501 01MAY2003 VARICOSE VEINS where varicosity measures 2.5mm or greater in diameter, multiple injections of sclerosant using continuous compression techniques, including associated consultation - 1 or both legs - not being a service associated with any other varicose vein operation on the same leg, (excluding after-care) where it can be demonstrated that truncal reflux in the long or short saphenous veins has been excluded by duplex examination - and that a 7th or subsequent treatment (including any treatments to which item 32500 applies) is indicated in a 12 month period Y 32503 01DEC1991 VARICOSE VEINS, multiple ligations, with or without local stripping or excision, including sub-fascial ligation of 1 or more deep perforating veins through separate incisions - 1 LEG - not being a service associated with a service to which item 32506, 32509 or 32530 applies on the same leg Y 32504 01NOV1994 VARICOSE VEINS, multiple excision of tributaries, with or without division of 1 or more perforating veins - 1 leg - not being a service associated with a service to which item 32507, 32508, 32511, 32514 or 32517 applies N 32504 01NOV2002 VARICOSE VEINS, multiple excision of tributaries, with or without division of 1 or more perforating veins - 1 leg - not being a service associated with a service to which item 32507, 32508, 32511, 32514 or 32517 applies on the same leg Y 32505 01NOV1994 VARICOSE VEINS, sub-fascial ligation of 1 or more incompetent perforating veins - 1 leg - not being a service associated with a service to which item 32508, 32511, 32514 or 32517 applies Y 32506 01DEC1991 VARICOSE VEINS, high ligation and complete or partial stripping or excision of long or short saphenous vein or its major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - 1 leg Y 32507 01JUL1998 VARICOSE VEINS, sub-fascial surgical exploration of one or more incompetent perforating veins - 1 leg - not being a service associated with a service to which item 32508, 32511, 32514 or 32517 applies N 32507 01NOV2002 VARICOSE VEINS, sub-fascial surgical exploration of one or more incompetent perforating veins - 1 leg - not being a service associated with a service to which item 32508, 32511, 32514 or 32517 applies on the same leg Y 32508 01NOV1994 VARICOSE VEINS, complete dissection at the sapheno-femoral OR sapheno-popliteal junction, with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time, including excision or injection of either tributaries or incompetent perforating veins, or both N 32508 01NOV2002 VARICOSE VEINS, complete dissection at the sapheno-femoral OR sapheno-popliteal junction - 1 leg - with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time on the same leg, including excision or injection of either tributaries or incompetent perforating veins, or both Y 32509 01DEC1991 VARICOSE VEINS, high ligation and stripping or excision of both long and short saphenous veins or their major tributaries, with multiple ligations, local stripping or excision of minor veins, with or without sclerotherapy of minor veins - 1 leg - Y 32511 01NOV1994 VARICOSE VEINS, complete dissection at the sapheno-femoral AND sapheno-popliteal junction, with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time, including excision or injection of either tributaries or incompetent perforating veins, or both N 32511 01NOV2002 VARICOSE VEINS, complete dissection at the sapheno-femoral AND sapheno-popliteal junction - 1 leg - with or without either ligation or stripping, or both, of the long or short saphenous veins, for the first time on the same leg, including excision or injection of either tributaries or incompetent perforating veins, or both Y 32512 01DEC1991 LONG SAPHENOUS VEIN, complete dissection and ligation of, at the sapheno-femoral junction, for migrating thrombosis of long saphenous vein Y 32514 01NOV1994 VARICOSE VEINS, ligation of the long or short saphenous vein, with or without stripping, by re-operation for recurrent veins in the same territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both N 32514 01NOV2002 VARICOSE VEINS, ligation of the long or short saphenous vein on the same leg, with or without stripping, by re-operation for recurrent veins in the same territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both Y 32515 01DEC1991 VARICOSE VEINS, complete dissection at SAPHENO-FEMORAL JUNCTION, with or without ligation of long saphenous vein, with or without ligation of the major tributaries at sapheno-femoral junction - 1 leg Y 32517 01NOV1994 VARICOSE VEINS, ligation of the long and short saphenous vein, with or without stripping, by re-operation for recurrent veins in either territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both N 32517 01NOV2002 VARICOSE VEINS, ligation of the long and short saphenous vein on the same leg, with or without stripping, by re-operation for recurrent veins in either territory - 1 leg - including excision or injection of either tributaries or incompetent perforating veins, or both Y 32518 01DEC1991 VARICOSE VEINS, complete dissection at sapheno-popliteal junction, with or without ligation of the short saphenous vein, with or without ligation of the major tributaries at the sapheno-popliteal junction - 1 leg Y 32520 01NOV2011 VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare but not including radiofrequency diathermy or radiofrequency ablation. N 32520 01JUL2012 VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) OR small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 of the general medical services table. N 32520 01MAY2013 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 N 32520 01MAY2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507 N 32520 01NOV2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507 Y 32521 01DEC1991 VARICOSE VEINS, sub-fascial ligation of single deep perforating vein not being a service associated with any other varicose vein operation on the same leg - 1 leg Y 32522 01NOV2011 VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare but not including radiofrequency diathermy or radiofrequency ablation. N 32522 01JUL2012 VARICOSE VEINS, abolition of venous reflux by occlusion of a primary or recurrent great (long) AND small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 of the general medical services table. N 32522 01MAY2013 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both) but not including radiofrequency diathermy or radiofrequency ablation, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 N 32522 01MAY2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507 N 32522 01NOV2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a laser probe introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or cyanoacrylate embolisation, and not provided on the same occasion as a service described in any of items 32500, 32504 and 32507 Y 32523 01MAY2013 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both), but not including endovenous laser therapy, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 N 32523 01MAY2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504and 32507 N 32523 01NOV2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32504and 32507 Y 32524 01DEC1991 VARICOSE VEINS, sub-fascial ligation of multiple deep perforating veins - 1 leg (Cockett's operation, Linton's operation or similar procedure) Y 32526 01MAY2013 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, where it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer, including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both), but not including endovenous laser therapy, and not provided on the same occasion as a service described in any of items 32500, 32501, 32504 or 32507 N 32526 01MAY2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a)including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32501, 32504 and 32507 N 32526 01NOV2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using a radiofrequency catheter introduced by an endovenous catheter, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including endovenous laser therapy or cyanoacrylate embolisation; and (c) not provided on the same occasion as a service described in any of items 32500, 32504 and 32507 Y 32527 01DEC1991 GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-popliteal incompetence - 1 leg Y 32528 01MAY2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items32500, 32501, 32504 and 32507 N 32528 01NOV2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) or small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great or small saphenous vein (whichever is to be treated) demonstrates reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items32500, 32504 and 32507 Y 32529 01MAY2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items32500, 32501, 32504 and 32507 N 32529 01NOV2018 Varicose veins, abolition of venous reflux by occlusion of a primary or recurrent great (long) and small (short) saphenous vein of one leg (and major tributaries of saphenous veins as necessary), using cyanoacrylate adhesive, if it is documented by duplex ultrasound that the great and small saphenous veins demonstrate reflux of 0.5 seconds or longer: (a) including all preparation and immediate clinical aftercare (including excision or injection of either tributaries or incompetent perforating veins, or both); and (b) not including radiofrequency diathermy, radiofrequency ablation or endovenous laser therapy; and (c) not provided on the same occasion as a service described in any of items32500, 32504 and 32507 Y 32530 01DEC1991 GROIN OR POPLITEAL FOSSA, reoperation in, for recurrent sapheno-femoral incompetence or recurrent sapheno-popliteal incompetence with 1 or more of the following - multiple ligations, local stripping or excision of minor veins or sclerotherapy of minor veins - 1 leg Y 32700 01DEC1991 ARTERY OF NECK, bypass using vein or synthetic material Y 32703 01DEC1991 INTERNAL CAROTID ARTERY, transection and reanastomosis of, or resection of small length and reanastomosis of - with or without endarterectomy Y 32706 01DEC1991 INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with bypass by graft of vein or synthetic material Y 32708 01JUL1996 AORTIC BYPASS for occlusive disease using a straight non-bifurcated graft Y 32709 01DEC1991 AORTO-ILIAC OR AORTO-FEMORAL GRAFTING, straight or bifurcated Y 32710 01JUL1996 AORTIC BYPASS for occlusive disease using a bifurcated graft with 1 or both anastomoses to the iliac arteries Y 32711 01JUL1996 AORTIC BYPASS for occlusive disease using a bifurcated graft with 1 or both anastomoses to the common femoral or profunda femoris arteries Y 32712 01DEC1991 ILIO-FEMORAL BYPASS GRAFTING Y 32715 01DEC1991 AXILLARY or SUBCLAVIAN TO FEMORAL BYPASS GRAFTING to 1 or both FEMORAL ARTERIES Y 32718 01DEC1991 FEMORO-FEMORAL OR ILIO-FEMORAL CROSS-OVER BYPASS GRAFTING Y 32721 01DEC1991 RENAL ARTERY, bypass grafting to Y 32724 01DEC1991 RENAL ARTERIES (both), bypass grafting to Y 32727 01DEC1991 SPLENO-RENAL ARTERIAL BYPASS GRAFTING Y 32730 01DEC1991 MESENTERIC VESSEL (single), bypass grafting to Y 32733 01DEC1991 MESENTERIC VESSELS (multiple), bypass grafting to Y 32736 01DEC1991 INFERIOR MESENTERIC ARTERY, operation on, when performed in conjunction with another intra-abdominal vascular operation Y 32739 01DEC1991 FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with above knee anastomosis Y 32742 01DEC1991 FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to below knee popliteal artery Y 32745 01DEC1991 FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis to tibio peroneal trunk or tibial or peroneal artery Y 32748 01DEC1991 FEMORAL ARTERY BYPASS GRAFTING using vein, including harvesting of vein (when it is the ipsilateral long saphenous vein) with distal anastomosis within 5cms of the ankle joint Y 32751 01DEC1991 FEMORAL ARTERY BYPASS GRAFTING using synthetic graft, with lower anastomosis above or below the knee Y 32754 01DEC1991 FEMORAL ARTERY BYPASS GRAFTING, using a composite graft (synthetic material and vein) with lower anastomosis above or below the knee, including use of a cuff or sleeve of vein at 1 or both anastomoses Y 32757 01DEC1991 FEMORAL ARTERY SEQUENTIAL BYPASS GRAFTING, (using a vein or synthetic material) where an additional anastomosis is made to separately revascularise more than 1 artery - each additional artery revascularised beyond a femoral bypass Y 32760 01DEC1991 VEIN, harvesting of from leg or arm for bypass or replacement graft when not performed through same incision as operation - each vein N 32760 01JUL1993 VEIN, HARVESTING OF, FROM LEG OR ARM for bypass or replacement graft when not performed on the limb which is the subject of the bypass or graft - each vein Y 32763 01DEC1991 ARTERIAL BYPASS GRAFTING, using vein or synthetic material, not being a service to which another item in this Sub-group applies Y 32766 01DEC1991 ARTERIAL OR VENOUS ANASTOMOSIS, not being a service to which another item in this Sub-group applies, as an independent procedure Y 32769 01DEC1991 ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item in this Sub-group applies, when performed in combination with another vascular operation (including graft to graft anastomosis) Y 33050 01JUL1996 BYPASS GRAFTING to replace a popliteal aneurysm using vein, including harvesting vein (when it is the ipsilateral long saphenous vein) Y 33055 01JUL1996 BYPASS GRAFTING to replace a popliteal aneurysm using a synthetic graft Y 33070 01JUL1996 ANEURYSM IN THE EXTREMITIES, ligation, suture closure or excision of, without bypass grafting Y 33075 01JUL1996 ANEURYSM IN THE NECK, ligation, suture closure or excision of, without bypass grafting Y 33080 01JUL1996 INTRA-ABDOMINAL OR PELVIC ANEURYSM, ligation, suture closure or excision of, without bypass grafting Y 33100 01DEC1991 ANEURYSM OF COMMON OR INTERNAL CAROTID ARTERY, OR BOTH, replacement by graft of vein or synthetic material Y 33103 01DEC1991 THORACIC ANEURYSM, replacement by graft Y 33106 01DEC1991 ARTERY OR VEIN BYPASS GRAFT, patch grafting to using vein or synthetic material, not being a service associated with any other vascular operation Y 33109 01DEC1991 THORACO-ABDOMINAL ANEURYSM, replacement by graft including re-implantation of arteries Y 33112 01DEC1991 SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft including re-implantation of arteries Y 33115 01DEC1991 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft N 33115 01NOV1999 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft, not being a service associated with a service to which item 33116 applies Y 33116 01NOV1999 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft using endovascular repair procedure, excluding associated radiological services (Ministerial Determination) N 33116 01NOV2007 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft using endovascular repair procedure, excluding associated radiological services Y 33118 01DEC1991 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision of common iliac aneurysms) N 33118 01NOV1999 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision of common iliac aneurysms) not being a service associated with a service to which item 33119 applies Y 33119 01NOV1999 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both iliac arteries using endovascular repair procedure, excluding associated radiological services (Ministerial Determination) N 33119 01NOV2007 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to one or both iliac arteries using endovascular repair procedure, excluding associated radiological services Y 33121 01DEC1991 INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to 1 or both femoral arteries (with or without excision or bypass of common iliac aneurysms) Y 33124 01DEC1991 ANEURYSM OF ILIAC ARTERY (common, external or internal), replacement by graft - unilateral Y 33127 01DEC1991 ANEURYSMS OF ILIAC ARTERIES (common, external or internal), replacement by graft - bilateral Y 33130 01DEC1991 ANEURYSM OF VISCERAL ARTERY, excision and repair by direct anastomosis or replacement by graft Y 33133 01DEC1991 ANEURYSM OF VISCERAL ARTERY, dissection and ligation of arteries without restoration of continuity Y 33136 01DEC1991 FALSE ANEURYSM, repair of, at aortic anastomosis following previous aortic surgery Y 33139 01DEC1991 FALSE ANEURYSM, repair of, in iliac artery and restoration of arterial continuity Y 33142 01DEC1991 FALSE ANEURYSM, repair of, in femoral artery and restoration of arterial continuity Y 33145 01DEC1991 RUPTURED THORACIC AORTIC ANEURYSM, replacement by graft Y 33148 01DEC1991 RUPTURED THORACO-ABDOMINAL AORTIC ANEURYSM, replacement by graft Y 33151 01DEC1991 RUPTURED SUPRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by graft Y 33154 01DEC1991 RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by tube graft Y 33157 01DEC1991 RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to iliac arteries (with or without excision or bypass of common iliac aneurysms) Y 33160 01DEC1991 RUPTURED INFRARENAL ABDOMINAL AORTIC ANEURYSM, replacement by bifurcation graft to 1 or both femoral arteries Y 33163 01DEC1991 RUPTURED ILIAC ARTERY ANEURYSM, replacement by graft Y 33166 01DEC1991 RUPTURED ANEURYSM OF VISCERAL ARTERY, replacement by anastomosis or graft Y 33169 01DEC1991 RUPTURED ANEURYSM OF VISCERAL ARTERY, simple ligation of Y 33172 01DEC1991 ANEURYSM OF MAJOR ARTERY, replacement by graft, not being a service to which another item in this Sub-group applies Y 33175 01JUL1996 RUPTURED ANEURYSM IN THE EXTREMITIES, ligation, suture closure or excision of, without bypass grafting Y 33178 01JUL1996 RUPTURED ANEURYSM IN THE NECK, ligation, suture closure or excision of, without bypass grafting Y 33181 01JUL1996 RUPTURED INTRA-ABDOMINAL OR PELVIC ANEURYSM, ligation, suture closure or excision of, without bypass grafting Y 33500 01DEC1991 ARTERY OR ARTERIES OF NECK, endarterectomy of, including closure by suture (where endarterectomy of 1 or more arteries is undertaken through 1 arteriotomy incision) Y 33503 01DEC1991 INTERNAL CAROTID ARTERY, re-operation for recurrent stenosis with endarterectomy and closure by suture Y 33506 01DEC1991 INNOMINATE OR SUBCLAVIAN ARTERY, endarterectomy of, including closure by suture Y 33509 01DEC1991 AORTIC ENDARTERECTOMY, including closure by suture, not being a service associated with another procedure on the aorta Y 33512 01DEC1991 AORTO-ILIAC ENDARTERECTOMY (1 or both iliac arteries), including closure by suture not being a service associated with a service to which item 33515 applies Y 33515 01DEC1991 AORTO-FEMORAL ENDARTERECTOMY (1 or both femoral arteries) or BILATERAL ILIO-FEMORAL ENDARTERECTOMY, including closure by suture, not being a service associated with a service to which item 33512 applies Y 33518 01DEC1991 ILIAC ENDARTERECTOMY, including closure by suture, not being a service associated with another procedure on the iliac artery Y 33521 01DEC1991 ILIO-FEMORAL ENDARTERECTOMY (1 side), including closure by suture Y 33524 01DEC1991 RENAL ARTERY, endarterectomy of Y 33527 01DEC1991 RENAL ARTERIES (both), endarterectomy of Y 33530 01DEC1991 COELIAC OR SUPERIOR MESENTERIC ARTERY, endarterectomy of Y 33533 01DEC1991 COELIAC AND SUPERIOR MESENTERIC ARTERY, endarterectomy of Y 33536 01DEC1991 INFERIOR MESENTERIC ARTERY, endarterectomy of, not being a service associated with a service to which another item in this Sub-group applies Y 33539 01DEC1991 ARTERY OF EXTREMITIES, endarterectomy of, including closure by suture Y 33542 01DEC1991 EXTENDED DEEP FEMORAL ENDARTERECTOMY where the endarterectomy is at least 7cms long Y 33545 01DEC1991 ARTERY OR VEIN, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is less than 3cm long N 33545 01NOV1997 ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material in association with another arterial or venous operation where patch is less than 3cm long N 33545 01MAR1999 ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material where patch is less than 3cm long Y 33548 01DEC1991 ARTERY OR VEIN, patch grafting to by vein or synthetic material in conjunction with another arterial or venous operation where patch is 3cm long or greater N 33548 01NOV1997 ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material in conjunction with another arterial or venous operation where patch is 3cm long or greater N 33548 01MAR1999 ARTERY, VEIN OR BYPASS GRAFT, patch grafting to by vein or synthetic material where patch is 3cm long or greater Y 33551 01DEC1991 VEIN, harvesting of from leg or arm for patch when not performed through same incision as operation Y 33554 01DEC1991 ENDARTERECTOMY, in conjunction with an arterial bypass operation to prepare the site for anastomosis - each site Y 33800 01DEC1991 EMBOLUS, removal of, from artery of neck Y 33803 01DEC1991 EMBOLECTOMY or THROMBECTOMY, by abdominal approach, of an artery or bypass graft of trunk Y 33806 01DEC1991 EMBOLECTOMY OR THROMBECTOMY, from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery N 33806 01NOV2002 EMBOLECTOMY OR THROMBECTOMY, including the infusion of thrombolytic or other agents, from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery N 33806 01MAR2013 Embolectomy or thrombectomy (including the infusion of thrombolytic or other agents) from an artery or bypass graft of extremities, or embolectomy of abdominal artery via the femoral artery, item to be claimed once per extremity, regardless of the number of incisions required to access the artery or bypass graft Y 33809 01DEC1991 INFERIOR VENA CAVA OR ILIAC VEIN, thrombectomy of Y 33810 01JUL1996 INFERIOR VENA CAVA OR ILIAC VEIN, closed thrombectomy by catheter via the femoral vein Y 33811 01JUL1996 INFERIOR VENA CAVA OR ILIAC VEIN, open removal of thrombus or tumour Y 33812 01DEC1991 THROMBUS, removal of, from femoral or other similar large vein Y 33815 01DEC1991 MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by lateral suture Y 33818 01DEC1991 MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by direct anastomosis Y 33821 01DEC1991 MAJOR ARTERY OR VEIN OF EXTREMITY, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein Y 33824 01DEC1991 MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by lateral suture Y 33827 01DEC1991 MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by direct anastomosis Y 33830 01DEC1991 MAJOR ARTERY OR VEIN OF NECK, repair of wound of, with restoration of continuity, by interposition graft of synthetic material or vein Y 33833 01DEC1991 MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by lateral suture Y 33836 01DEC1991 MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by direct anastomosis Y 33839 01DEC1991 MAJOR ARTERY OR VEIN OF ABDOMEN, repair of wound of, with restoration of continuity by means of interposition graft Y 33842 01DEC1991 ARTERY OF NECK, re-operation for bleeding or thrombosis after carotid or vertebral artery surgery Y 33845 01DEC1991 LAPAROTOMY for control of post operative bleeding or thrombosis after intra-abdominal vascular procedure, where no other procedure is performed Y 33848 01DEC1991 EXTREMITY, re-operation on, for control of bleeding or thrombosis after vascular procedure, where no other procedure is performed Y 34100 01DEC1991 MAJOR ARTERY OF NECK, elective ligation or exploration of, not being a service associated with any other vascular procedure Y 34103 01DEC1991 GREAT ARTERY OR GREAT VEIN (including subclavian, axillary, iliac, femoral or popliteal), ligation of, or exploration of, not being a service associated with any other vascular procedure N 34103 01JUL1998 GREAT ARTERY OR GREAT VEIN (including subclavian, axillary, iliac, femoral or popliteal), ligation of, or exploration of, not being a service associated with any other vascular procedure except those services to which items 32508, 32511, 32514 or 32517 apply N 34103 01NOV2016 Great artery (aorta or pulmonary artery) or great vein (superior or inferior vena cava), ligation or exploration of immediate branches or tributaries, or ligation or exploration of the subclavian, axillary, iliac, femoral or popliteal arteries or veins, if the service is not associated with item 32508, 32511, 32520, 32522, 32523 or 32526-for a maximum of 2 services provided to the same patient on the same occasion (H) N 34103 01MAY2018 Great artery (aorta or pulmonary artery) or great vein (superior or inferior vena cava), ligation or exploration of immediate branches or tributaries, or ligation or exploration of the subclavian, axillary, iliac, femoral or popliteal arteries or veins, if the service is not associated with item 32508, 32511, 32520, 32522, 32523, 32526, 32528 or 32529 - for a maximum of 2 services provided to the same patient on the same occasion (H) Y 34106 01DEC1991 ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by elective operation, or exploration of, not being a service associated with any other vascular procedure N 34106 01JUL1998 ARTERY OR VEIN (including brachial, radial, ulnar or tibial), ligation of, by elective operation, or exploration of, not being a service associated with any other vascular procedure except those services to which items 32508, 32511, 32514 or 32517 apply Y 34109 01DEC1991 TEMPORAL ARTERY, biopsy of Y 34112 01DEC1991 ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and ligation Y 34115 01DEC1991 ARTERIO-VENOUS FISTULA OF THE NECK, dissection and ligation Y 34118 01DEC1991 ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and ligation Y 34121 01DEC1991 ARTERIO-VENOUS FISTULA OF AN EXTREMITY, dissection and repair of, with restoration of continuity Y 34124 01DEC1991 ARTERIO-VENOUS FISTULA OF THE NECK, dissection and repair of, with restoration of continuity Y 34127 01DEC1991 ARTERIO-VENOUS FISTULA OF THE ABDOMEN, dissection and repair of, with restoration of continuity Y 34130 01DEC1991 SURGICALLY CREATED ARTERIO-VENOUS FISTULA OF AN EXTREMITY, closure of Y 34133 01DEC1991 SCALENOTOMY Y 34136 01DEC1991 FIRST RIB, resection of portion of Y 34139 01DEC1991 CERVICAL RIB, removal of, or other operation for removal of thoracic outlet compression, not being a service to which another item in this Sub-group applies Y 34142 01DEC1991 COELIAC ARTERY, decompression of, for coeliac artery compression syndrome, as an independent procedure Y 34145 01DEC1991 POPLITEAL ARTERY, exploration of, for popliteal entrapment, with or without division of fibrous tissue and muscle Y 34148 01DEC1991 CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is less that 4cm in maximum diameter N 34148 01JUL1998 CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is 4cm or less in maximum diameter Y 34151 01DEC1991 CAROTID BODY TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is greater than 4cm in maximum diameter N 34151 01JUL1998 CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or reconstruction of internal or common carotid arteries, when tumour is greater than 4cm in maximum diameter Y 34154 01DEC1991 RECURRENT CAROTID BODY TUMOUR, resection of, with or without repair or replacement of portion of common or internal carotid arteries N 34154 01JUL1998 RECURRENT CAROTID ASSOCIATED TUMOUR, resection of, with or without repair or replacement of portion of internal or common carotid arteries Y 34157 01DEC1991 NECK, excision of infected bypass graft, including closure of vessel or vessels Y 34160 01DEC1991 AORTO-DUODENAL FISTULA, repair of, by suture of aorta and repair of duodenum Y 34163 01DEC1991 AORTO-DUODENAL FISTULA, repair of, by insertion of aortic graft and repair of duodenum Y 34166 01DEC1991 AORTO-DUODENAL FISTULA, repair of, by oversewing of abdominal aorta, repair of duodenum and axillo-bifemoral grafting Y 34169 01DEC1991 INFECTED BYPASS GRAFT FROM TRUNK, excision of, including closure of arteries Y 34172 01DEC1991 INFECTED AXILLO-FEMORAL OR FEMORO-FEMORAL GRAFT, excision of, including closure of arteries Y 34175 01DEC1991 INFECTED BYPASS GRAFT FROM EXTREMITIES, excision of including closure of arteries Y 34500 01DEC1991 ARTERIOVENOUS SHUNT, EXTERNAL, insertion of Y 34503 01DEC1991 ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, in conjunction with another venous or arterial operation Y 34506 01DEC1991 ARTERIOVENOUS SHUNT, EXTERNAL, removal of Y 34509 01DEC1991 ARTERIOVENOUS ANASTOMOSIS OF UPPER OR LOWER LIMB, not in conjunctionwith another venous or arterial operation Y 34512 01DEC1991 ARTERIOVENOUS ACCESS DEVICE, insertion of Y 34515 01DEC1991 ARTERIOVENOUS ACCESS DEVICE, thrombectomy of Y 34518 01DEC1991 STENOSIS OF ARTERIOVENOUS FISTULA OR PROSTHETIC ARTERIOVENOUS ACCESS DEVICE, correction of Y 34521 01DEC1991 INTRA-ABDOMINAL ARTERY OR VEIN, cannulation of, for infusion chemotherapy, by open operation (excluding aftercare) Y 34524 01DEC1991 ARTERIAL CANNULATION for infusion chemotherapy by open operation, not being a service to which item 34521 applies (excluding after-care) Y 34527 01DEC1991 CENTRAL VEIN CATHETERISATION by open exposure, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device N 34527 01JUL1996 CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterisation N 34527 01JAN2014 CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterisation N 34527 01SEP2015 CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterization, on a person 10 years of age or over Y 34528 01JUL1996 CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with Hickman or Broviac catheter or other chemotherapy delivery device N 34528 01JAN2014 CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous linecatheter or other chemotherapy delivery device N 34528 01SEP2015 CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, on a person 10 years of age or over Y 34529 01SEP2015 CENTRAL VEIN CATHETERISATION by open technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, including any associated percutaneous central vein catheterization, on a person under 10 years of age Y 34530 01DEC1991 HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of N 34530 01JUL1995 HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of by open surgical procedure N 34530 01JUL1996 HICKMAN OR BROVIAC CATHETER, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital or approved day-hospital N 34530 01JAN2014 CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital or approved day-hospital N 34530 01SEP2015 CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital on a person 10 years of age or over Y 34533 01DEC1991 ISOLATED LIMB PERFUSION, including cannulation of artery and vein at commencement of procedure, regional perfusion for chemotherapy, or other therapy, repair of arteriotomy and venotomy at conclusion of procedure (excluding aftercare) Y 34534 01SEP2015 CENTRAL VEIN CATHETERISATION by percutaneous technique, using subcutaneous tunnel with pump or access port as with central venous line catheter or other chemotherapy delivery device, on a person under 10 years of age Y 34538 01MAY2004 CENTRAL VEIN CATHERTERISATION by percutaneous technique, using subcutaneous tunnelled cuffed catheter or similar device, for the administration of haemodialysis or parenteral nutrition Y 34539 01MAY2004 TUNNELLED CUFFED CATHETER, OR SIMILAR DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital N 34539 01MAY2016 TUNNELLED CUFFED CATHETER, OR SIMILAR DEVICE, removal of, by open surgical procedure Y 34540 01SEP2015 CENTRAL VENOUS LINE, OR OTHER CHEMOTHERAPY DEVICE, removal of, by open surgical procedure in the operating theatre of a hospital, on a person under 10 years of age Y 34700 01DEC1991 ENDOVASCULAR INTERVENTION PROCEDURES INFERIOR VENA CAVAL FILTER, insertion of, by percutaneous method using interventional imaging techniques Y 34703 01DEC1991 INFERIOR VENA CAVAL FILTER, insertion of, by open operation Y 34800 01DEC1991 INFERIOR VENA CAVA, plication, ligation, or application of caval clip Y 34803 01DEC1991 INFERIOR VENA CAVA, reconstruction of or bypass by vein or synthetic material Y 34806 01DEC1991 CROSS LEG BYPASS GRAFTING, saphenous to iliac or femoral vein Y 34809 01DEC1991 SAPHENOUS VEIN ANASTOMOSIS to femoral or popliteal vein for femoral vein bypass Y 34812 01DEC1991 VENOUS STENOSIS OR OCCLUSION, vein bypass for, using vein or synthetic material, not being a service associated with a service to which item 34806 or 34809 applies Y 34815 01DEC1991 VEIN STENOSIS, patch angioplasty for, (excluding vein graft stenosis)-using vein or synthetic material Y 34818 01DEC1991 VENOUS VALVE, plication or repair to restore valve competency Y 34821 01DEC1991 VEIN TRANSPLANT to restore valvular function Y 34824 01DEC1991 EXTERNAL STENT, application of, to restore venous valve competency to superficial vein - 1 stent Y 34827 01DEC1991 EXTERNAL STENTS, application of, to restore venous valve competency to superficial vein or veins - more than 1 stent Y 34830 01DEC1991 EXTERNAL STENT, application of, to restore venous valve competency to deep vein (1 stent) Y 34833 01DEC1991 EXTERNAL STENTS, application of, to restore venous valve competency to deep vein or veins (more than 1 stent) Y 34836 01DEC1991 PORTAL HYPERTENSION, vascular decompression operation for (including spleno-renal, porto-caval and mesenterico-caval anastomosis) Y 35000 01DEC1991 LUMBAR SYMPATHECTOMY Y 35003 01DEC1991 CERVICAL OR UPPER THORACIC SYMPATHECTOMY by any surgical approach Y 35006 01DEC1991 CERVICAL OR UPPER THORACIC SYMPATHECTOMY, where operation is a reoperation for previous incomplete sympathectomy by any surgical approach Y 35009 01DEC1991 LUMBAR SYMPATHECTOMY, where operation is following chemical sympathectomy or for previous incomplete surgical sympathectomy Y 35012 01MAY1994 SACRAL or PRE-SACRAL SYMPATHECTOMY Y 35100 01DEC1991 ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough in, in the operating theatre of a hospital, when debridement includes muscle, tendon or bone Y 35103 01DEC1991 ISCHAEMIC LIMB, debridement of necrotic material, gangrenous tissue, or slough in, in the operating theatre of a hospital, superficial tissue only Y 35200 01DEC1991 OPERATIVE ARTERIOGRAPHY OR VENOGRAPHY, 1 or more of, performed during the course of an operative procedure on an artery or vein, 1 site Y 35202 01JUL1996 MAJOR ARTERIES OR VEINS IN THE NECK, ABDOMEN OR EXTREMITIES, access to, as part of RE-OPERATION after prior surgery on these vessels Y 35203 01DEC1991 TRANSLUMINAL BALLOON ANGIOPLASTY OF CORONARY ARTERY AND DILATATION OF VESSEL, using interventional imaging techniques Y 35206 01DEC1991 TRANSLUMINAL BALLOON ANGIOPLASTY OF PERIPHERAL VESSEL AND DILATATION OF VESSEL, using interventional imaging techniques Y 35300 01APR1992 ENDOVASCULAR INTERVENTIONAL PROCEDURES TRANSLUMINAL BALLOON ANGIOPLASTY of 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35300 01NOV1993 TRANSLUMINAL BALLOON ANGIOPLASTY of 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 35303 01APR1992 TRANSLUMINAL BALLOON ANGIOPLASTY of aortic arch branches, aortic visceral branches, or more than 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35303 01NOV1993 TRANSLUMINAL BALLOON ANGIOPLASTY of aortic arch branches, aortic visceral branches, or more than 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 35304 01NOV1992 TRANSLUMINAL BALLOON ANGIOPLASTY of 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 35305 01NOV1992 TRANSLUMINAL BALLOON ANGIOPLASTY of more than 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation and excluding aftercare Y 35306 01APR1992 TRANSLUMINAL STENT INSERTION including associated balloon dilatation for 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35306 01NOV1993 TRANSLUMINAL STENT INSERTION including associated balloon dilatation for 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35306 01MAY2016 TRANSLUMINAL STENT INSERTION, 1 or more stents, including associated balloon dilatation for 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare. Y 35307 01NOV2005 TRANSLUMINAL STENT INSERTION, 1 or more stents (not drug-eluting), with or without associated balloon dilatation, for 1 carotid artery, percutaneous (not direct), with or without the use of an embolic protection device, in patients who: -meet the indications for carotid endarterectomy; and -have medical or surgical comorbidities that would make them at high risk of perioperative complications from carotid endarterectomy, excluding associated radiological services or preparation, and excluding aftercare Y 35309 01APR1992 TRANSLUMINAL STENT INSERTION including associated balloon dilatation for visceral arteries or veins, or more than 1 peripheral artery or vein, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35309 01NOV1993 TRANSLUMINAL STENT INSERTION including associated balloon dilatation for visceral arteries or veins, or more than 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35309 01MAY2016 TRANSLUMINAL STENT INSERTION, 1 or more stents, including associated balloon dilatation for visceral arteries or veins, or more than 1 peripheral artery or vein of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare. Y 35310 01NOV1992 TRANSLUMINAL STENT INSERTION including associated balloon dilatation for coronary artery, percutaneous or by open exposure, excluding associated radiological services and preparation, and excluding aftercare Y 35312 01APR1992 PERIPHERAL ARTERIAL ATHERECTOMY including associated balloon dilatation, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35312 01NOV1993 PERIPHERAL ARTERIAL ATHERECTOMY including associated balloon dilatation of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 35315 01APR1992 PERIPHERAL LASER ANGIOPLASTY including associated balloon dilatation, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35315 01NOV1993 PERIPHERAL LASER ANGIOPLASTY including associated balloon dilatation of 1 limb, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 35317 01JUL1996 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY CONTINUOUS INFUSION, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35319 or 35320 applies) N 35317 01NOV2002 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY CONTINUOUS INFUSION, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35319 or 35320 applies and not being a service associated with photodynamic therapy with verteporfin) Y 35318 01APR1992 PERIPHERAL ARTERIAL or VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which item 13915 applies) Y 35319 01JUL1996 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY PULSE SPRAY TECHNIQUE, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35320 applies) N 35319 01NOV2002 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY PULSE SPRAY TECHNIQUE, using percutaneous approach, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35320 applies and not being a service associated with photodynamic therapy with verteporfin) Y 35320 01JUL1996 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY OPEN EXPOSURE, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35319 applies) N 35320 01NOV2002 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION with administration of thrombolytic or chemotherapeutic agents, BY OPEN EXPOSURE, excluding associated radiological services or preparation, and excluding aftercare (not being a service associated with a service to which another item in Subgroup 11 of Group T1 or items 35317 or 35319 applies and not being a service associated with photodynamic therapy with verteporfin) Y 35321 01APR1992 PERIPHERAL ARTERIAL CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35321 01NOV1999 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare N 35321 01NOV2002 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare, not being a service associated with photodynamic therapy with verteporfin N 35321 01MAY2004 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, (but not for the treatment of uterine fibroids) percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare, not being a service associated with photodynamic therapy with verteporfin N 35321 01MAY2009 PERIPHERAL ARTERIAL OR VENOUS CATHETERISATION to administer agents to occlude arteries, veins or arterio-venous fistulae or to arrest haemorrhage, (but not for the treatment of uterine fibroids or varicose veins) percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare, not being a service associated with photodynamic therapy with verteporfin Y 35324 01APR1992 ANGIOSCOPY not combined with any other procedure, excluding associated radiological services or preparation, and excluding aftercare Y 35327 01APR1992 ANGIOSCOPY combined with any other procedure, excluding associated radiological services or preparation, and excluding aftercare Y 35330 01APR1992 INSERTION of INFERIOR VENA CAVAL FILTER, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 35331 01MAY2005 RETRIEVAL OF INFERIOR VENA CAVAL FILTER, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare Y 35335 01MAY2003 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with no stent insertion, where: -no lesion of the coronary artery has been stented; and -each lesion of the coronary artery is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare Y 35338 01MAY2003 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with insertion of 1 or more stents, where: -no lesion of the coronary artery has been stented; and -each lesion of the coronary artery is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare Y 35341 01MAY2003 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty with no stent insertion, where: -no lesion of the coronary arteries has been stented; and -each lesion of the coronary arteries is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare Y 35344 01MAY2003 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty, with insertion of 1 or more stents, where: -no lesion of the coronary arteries has been stented; and -each lesion of the coronary arteries is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable, excluding associated radiological services or preparation, and excluding aftercare Y 35347 01NOV2003 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 35350 01NOV2003 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty -intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 35353 01NOV2003 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty -percutaneous transluminal rotational artherectomy using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 35356 01NOV2003 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty -percutaneous transluminal rotational artherectomy -intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 35360 01MAY2005 Retrieval of foreign body in PULMONARY ARTERY, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered) Y 35361 01MAY2005 Retrieval of foreign body in RIGHT ATRIUM, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered) Y 35362 01MAY2005 Retrieval of foreign body in INFERIOR VENA CAVA or AORTA, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered) Y 35363 01MAY2005 Retrieval of foreign body in PERIPHERAL VEIN or PERIPHERAL ARTERY, percutaneous or by open exposure, not including associated radiological services or preparation, and not including aftercare (foreign body does not include an instrument inserted for the purpose of a service being rendered) Y 35400 01NOV2005 Vertebroplasty, for the treatment of a painful osteoporotic vertebral compression fracture, where: (a) the patient to whom the service is provided has not had the pain arising from the vertebral compression fracture controlled by conservative medical therapy; and (b) diagnostic imaging has confirmed that vertebroplasty will be of benefit; in association with item 61109, 57341 or 57345, performed on an admitted patient in a hospital or day hospital facility. N 35400 01MAY2006 VERTEBROPLASTY, for the treatment of a painful osteoporotic vertebral compression fracture, where: (a) the patient to whom the service is provided has not had the pain arising from the vertebral compression fracture controlled by conservative medical therapy; and (b) diagnostic imaging has confirmed that vertebroplasty will be of benefit; in association with item 61109, 57341 or 57345 performed on an admitted patient in a hospital or day hospital facility. N 35400 01NOV2006 VERTEBROPLASTY, for the treatment of a painful osteoporotic vertebral compression fracture, where: (a) the patient to whom the service is provided has not had the pain arising from the vertebral compression fracture controlled by conservative medical therapy; and (b) diagnostic imaging has confirmed that vertebroplasty will be of benefit; in association with item 61109, 57341 or 57345. Y 35402 01NOV2005 Vertebroplasty, for the treatment of a painful metastatic deposit or multiple myeloma in a vertebral body, in association with item 61109, 57341 or 57345, performed on an admitted patient in a hospital or day hospital facility. N 35402 01MAY2006 VERTEBROPLASTY, for the treatment of a painful metastatic deposit or multiple myeloma in a vertebral body, in association with item 61109, 57341 or 57345 performed on an admitted patient in a hospital or day hospital facility.. N 35402 01NOV2006 VERTEBROPLASTY, for the treatment of a painful metastatic deposit or multiple myeloma in a vertebral body, in association with item 61109, 57341 or 57345. Y 35404 01MAY2006 DOSIMETRY, HANDLING AND INJECTION OF SIR-SPHERES for selective internal radiation therapy of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies The procedure must be performed by a specialist or consultant physician recognised in the specialties of nuclear medicine or radiation oncology on an admitted patient in a hospital. To be claimed once in the patient's lifetime only. Y 35406 01MAY2006 Trans-femoral catheterisation of the hepatic artery to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies excluding associated radiological services or preparation, and excluding aftercare Y 35408 01MAY2006 Catheterisation of the hepatic artery via a permanently implanted hepatic artery port to administer SIR-Spheres to embolise the microvasculature of hepatic metastases which are secondary to colorectal cancer and are not suitable for resection or ablation, for selective internal radiation therapy used in combination with systemic chemotherapy using 5-fluorouracil (5FU) and leucovorin, not being a service to which item 35317, 35319, 35320 or 35321 applies excluding associated radiological services or preparation, and excluding aftercare Y 35410 01NOV2006 UTERINE ARTERY CATHETERISATION with percutaneous administration of occlusive agents, for the treatment of symptomatic uterine fibroids in a patient who has been referred for uterine artery embolisation by a specialist gynaecologist, excluding associated radiological services or preparation, and excluding aftercare Y 35412 01NOV2006 Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with detachable coils, and assisted coiling if performed, with parent artery preservation, not for use with liquid embolics only, including intra-operative imaging, but in association with pre-operative diagnostic imaging items 60009 and either 60072, 60075 or 60078, including aftercare N 35412 01JAN2015 Intracranial aneurysm, ruptured or unruptured, endovascular occlusion with detachable coils, and assisted coiling if performed, with parent artery preservation, not for use with liquid embolics only, including aftercare, including intra-operative imaging, but in association with the following pre-operative diagnostic imaging items: - either 60009 or 60010; and - either 60072, 60073, 60075, 60076, 60078 or 60079 Y 35414 01NOV2017 Mechanical thrombectomy, in a patient with a diagnosis of acute ischaemic stroke caused by occlusion of a large vessel of the anterior cerebral circulation, including intra-operative imaging and aftercare, if: (a) the diagnosis is confirmed by an appropriate imaging modality such as computed tomography, magnetic resonance imaging or angiography; and (b) the service is performed by a specialist or consultant physician with appropriate training that is recognised by the Conjoint Committee for Recognition of Training in Interventional Neuroradiology; and (c) the service is provided in an eligible stroke centre. For any particular patient - applicable once per presentation by the patient at an eligible stroke centre, regardless of the number of times mechanical thrombectomy is attempted during that presentation Y 35500 01DEC1991 GYNAECOLOGICAL EXAMINATION UNDER ANAESTHESIA, not being a service associated with a service to which another item in this Group applies Y 35502 01NOV2004 INTRAUTERINE DEVICE, INTRODUCTION OF, for the control of idiopathic menorrhagia, AND ENDOMETRIAL BIOPSY to exclude endometrial pathology, not being a service associated with a service to which another item in this Group applies Y 35503 01DEC1991 INTRAUTERINE CONTRACEPTIVE DEVICE, INTRODUCTION OF, not being a service associated with a service to which another item in this Group applies N 35503 01NOV2014 Intra uterine contraceptive device, introduction of, if the service is not associated with a service to which another item in this Group applies (other than a service mentioned in item 30062) Y 35506 01DEC1991 INTRAUTERINE CONTRACEPTIVE DEVICE, REMOVAL OF UNDER GENERAL ANAESTHESIA, not being a service associated with a service to which another item in this Group applies Y 35507 01APR1992 VULVAL OR VAGINAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is less than or equal to 45 minutes - not being a service associated with a service to which item 32177 or 32180 applies Y 35508 01APR1992 VULVAL OR VAGINAL WARTS, removal of under general anaesthesia, or under regional or field nerve block (excluding pudendal block) requiring admission to a hospital, where the time taken is greater than 45 minutes - not being a service associated with a service to which item 32177 or 32180 applies Y 35509 01DEC1991 HYMENECTOMY Y 35512 01DEC1991 BARTHOLIN'S CYST, excision of Y 35513 01DEC1991 BARTHOLIN'S CYST, excision of Y 35516 01DEC1991 BARTHOLIN'S CYST OR GLAND, marsupialisation of Y 35517 01DEC1991 BARTHOLIN'S CYST OR GLAND, marsupialisation of Y 35518 01JUL1995 OVARIAN CYST ASPIRATION, for cysts of at least 4cm in diameter in premenopausal women and at least 2cm in diameter in postmenopausal women, by abdominal or vaginal route, using interventional imaging techniques and not associated with services provided for assisted reproductive techniques N 35518 01JAN2014 OVARIAN CYST ASPIRATION, for cysts of at least 4cm in diameter in a premenopausal person and at least 2cm in diameter in a postmenopausal person, by abdominal or vaginal route, using interventional imaging techniques and not associated with services provided for assisted reproductive techniques Y 35520 01DEC1991 BARTHOLIN'S ABSCESS, incision of Y 35523 01DEC1991 URETHRA OR URETHRAL CARUNCLE, cauterisation of Y 35526 01DEC1991 URETHRAL CARUNCLE, excision of Y 35527 01DEC1991 URETHRAL CARUNCLE, excision of Y 35530 01DEC1991 CLITORIS, amputation of, where medically indicated Y 35533 01DEC1991 VULVOPLASTY or LABIOPLASTY, where medically indicated, not being a service associated with a service to which item 35536 applies N 35533 01NOV2014 VULVOPLASTY or LABIOPLASTY, for repair of: (a)female genital mutilation; or (b)anomalies associated with major congenital anomalies of the uro-gynaecological tract other than a service associated with a service to which item 35536, 37050, 37836, 37842, 37851 or 43882 applies (H) N 35533 01NOV2018 Vulvoplasty or labioplasty, for repair of: (a) female genital mutilation; or (b) an anomaly associated with a major congenital anomaly of the uro-gynaecological tract other than a service associated with a service to which item35536, 37836, 37050, 37842, 37851 or 43882 applies Y 35534 01NOV2014 VULVOPLASTY or LABIOPLASTY, for localised gigantism if it can be demonstrated that: (a)the structural abnormality is causing significant functional impairment; and (b)non-surgical treatments have failed (H) N 35534 01NOV2018 Vulvoplasty or labioplasty, in a patient aged 18 years or more, performed by a specialist in the practice of the specialist's specialty, for a structural abnormality that is causing significant functional impairment, if the patient's labium extends more than 8 cm below the vaginal introitus while the patient is in a standing resting position Y 35536 01DEC1991 VULVA, wide local excision of suspected malignancy; or hemivulvectomy; or superficial vulvectomy, (including colposcopically directed CO2 laser), one or more procedures N 35536 01APR1992 VULVA, wide local excision of suspected malignancy or hemivulvectomy, 1 or both procedures Y 35539 01DEC1991 COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsiesone anatomical site N 35539 01APR1992 COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for previously confirmed intraepithelial neoplastic changes of the cervix, vagina, vulva, urethra or anal canal, including any associated biopsies1 anatomical site Y 35542 01DEC1991 COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for intraepithelial neoplasia of the cervix, vagina, vulva, urethra or anal canal, including associated biopsiestwo or more anatomical sites N 35542 01APR1992 COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for previously confirmed intraepithelial neoplasticchanges of the cervix, vagina, vulva, urethra or anal canal, including any associated biopsies2 or more anatomical sites Y 35545 01DEC1991 COLPOSCOPICALLY DIRECTED CO2 LASER THERAPY for condylomata, unsuccessfully treated by other methods Y 35548 01DEC1991 VULVECTOMY (RADICAL) for malignancy N 35548 01NOV1992 VULVECTOMY, radical, for malignancy Y 35551 01DEC1991 PELVIC LYMPH GLANDS, excision of (radical) N 35551 01NOV2019 PELVIC LYMPH NODES, excision of (radical) Y 35554 01DEC1991 VAGINA, DILATATION OF, as an independent procedure including any associated consultation Y 35557 01DEC1991 VAGINA, removal of simple tumour (including Gartner duct cyst) Y 35560 01DEC1991 VAGINA, partial or complete removal of Y 35561 01NOV1992 VAGINECTOMY, radical, for proven invasive malignancy - 1 surgeon Y 35562 01NOV1992 VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - abdominal surgeon (including aftercare) Y 35563 01DEC1991 VAGINAL RECONSTRUCTION for congenital absence, gynatresia or urogenital sinus Y 35564 01NOV1992 VAGINECTOMY, radical, for proven invasive malignancy, conjoint surgery - perineal surgeon Y 35565 01NOV1992 VAGINAL RECONSTRUCTION for congenital absence, gynatresia or urogenital sinus Y 35566 01DEC1991 VAGINAL SEPTUM, excision of, for correction of double vagina Y 35567 01NOV1992 VAGINAL REPAIR (involving repair of enterocele) with transvaginal sacrospinus ligament colposuspension N 35567 01MAY1994 VAGINAL REPAIR including 1 or more of anterior, posterior or entrocele repair, with sacrospinous colpopexy Y 35568 01MAY2005 SACROSPINOUS COLPOPEXY FOR MANAGEMENT OF UPPER VAGINAL PROLAPSE Y 35569 01DEC1991 PLASTIC REPAIR TO ENLARGE VAGINAL ORIFICE Y 35570 01MAY2005 ANTERIOR VAGINAL COMPARTMENT REPAIR by vaginal approach (involving repair of urethrocoele and cystocoele) with or without mesh, not being a service associated with a service to which item 35573, 35577 or 35578 applies N 35570 01JUL2018 Anterior vaginal compartment repair by vaginal approach for pelvic organ prolapse (involving repair of urethrocele and cystocele), using native tissue without graft, other than a service associated with a service to which item 35573, 35577 or 35578 applies. Y 35571 01MAY2005 POSTERIOR VAGINAL COMPARTMENT REPAIR by vaginal approach (involving one or more of the following; repair of perineum, rectocoele or enterocoele) with or without mesh, not being a service associated with a service to which item 35573, 35577 or 35578 applies N 35571 01JUL2018 Posterior vaginal compartment repair by vaginal approach for pelvic organ prolapse involving repair of one or more of the following: (a) perineum; (b) rectocoele; (c) enterocoele; using native tissue without graft, other than a service associated with a service to which item 35573, 35577 or 35578 applies. Y 35572 01DEC1991 COLPOTOMYnot being a service to which another item in this Group applies Y 35573 01MAY2005 ANTERIOR AND POSTERIOR VAGINAL COMPARTMENT REPAIR by vaginal approach (involving both anterior and posterior compartment defects) with or without mesh, not being a service associated with a service to which item35577 or 35578 applies N 35573 01JUL2018 Anterior and posterior vaginal compartment repair by vaginal approach for pelvic organ prolapse (involving anterior and posterior compartment defects), using native tissue without graft, other than a service associated with a service to which item 35577 or 35578 applies. Y 35575 01DEC1991 ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35579, 35580, 35583 or 35584 applies Y 35576 01DEC1991 ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35579, 35580, 35583 or 35584 applies N 35576 01NOV1998 ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35580 or 35584 applies N 35576 01MAY2004 ANTERIOR VAGINAL REPAIR OR POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) with or without mesh, not being a service associated with a service to which item 30405, 35580 or 35584 applies Y 35577 01MAY2005 MANCHESTER (DONALD FOTHERGILL) OPERATION for genital prolapse, with or without mesh N 35577 01JUL2018 Manchester (Donald Fothergill) operation for pelvic organ prolapse (includes cervical amputation, anterior and posterior native tissue vaginal wall repairs without graft). Y 35578 01MAY2005 LE FORT OPERATION for genital prolapse, not being a service associated with a service to which another item in this Subgroup applies Y 35579 01DEC1991 ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35583 or 35584 applies Y 35580 01DEC1991 ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35584 applies N 35580 01NOV1998 ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) not being a service to which item 35584 applies N 35580 01MAY2004 ANTERIOR VAGINAL REPAIR AND POSTERIOR VAGINAL REPAIR (involving repair of rectocele or enterocele or both) with or without mesh, not being a service associated with a service to which item 30405 or 35584 applies Y 35581 01JUL2018 Vaginal procedure for excision of graft material in symptomatic patients with graft related complications, including graft related pain or discharge and bleeding related to graft exposure, less than 2cm2 in its maximum area, either singly or in multiple pieces, other than a service associated with a service to which item 35582 or 35585 applies. Y 35582 01JUL2018 Vaginal procedure for excision of graft material in symptomatic patients with graft related complications, including graft related pain or discharge and bleeding related to graft exposure, more than 2cm2 in its maximum area, either singly or in multiple pieces, other than a service associated with a service to which item 35581 or 35585 applies. Y 35583 01DEC1991 DONALDFOTHERGILL OR MANCHESTER OPERATION FOR GENITAL PROLAPSE N 35583 01NOV1997 Manchester (DonaldFothergill) operation or le fort opeartion for genital prolapse (Anaes.) (Assist.) Y 35584 01DEC1991 DONALDFOTHERGILL OR MANCHESTER OPERATION FOR GENITAL PROLAPSE N 35584 01NOV1997 MANCHESTER (DONALDFOTHERGILL) OPERATION OR LE FORT OPERATION for genital prolapse N 35584 01MAY2004 MANCHESTER (DONALDFOTHERGILL) OPERATION OR LE FORT OPERATION for genital prolapse, with or without mesh, not being a service associated with a service to which item 30405 applies Y 35585 01JUL2018 Abdominal procedure either open, laparoscopic or robotic, for removal of graft material in patients symptomatic with graft related complications, including graft related pain or discharge and bleeding related to graft exposure or where the graft has penetrated adjacent organs such as the bladder (including urethra) or bowel, including retroperitoneal dissection and mobilisation of bladder and/or bowel, other than a service associated with a service to which item 35581 or 35582 applies. Y 35587 01DEC1991 URETHROCELE, operation for Y 35590 01DEC1991 Operation involving ABDOMINAL APPROACH for repair of ENTEROCELE OR SUSPENSION OF VAGINAL VAULT OR ENTEROCELE AND SUSPENSION OF VAGINAL VAULT N 35590 01MAY2004 Operation involving ABDOMINAL APPROACH for repair of ENTEROCELE OR SUSPENSION OF VAGINAL VAULT OR ENTEROCELE AND SUSPENSION OF VAGINAL VAULT, with or without mesh, not being a service associated with a service to which item 30405 applies Y 35593 01DEC1991 VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, not being a service associated with a service to which item 35575, 35576, 35579, 35580, 35583, 35584, 35590,35657 or 35673 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35575, 35576, 35579, 35580, 35583, 35584, 35590, 35657 or 35673 applies N 35593 01MAY1997 VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, not being a service associated with a service to which item 35576, 35580, 35584, 35590,35657, 35673, 35750 or 35753 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35576, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies N 35593 01NOV1998 VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, not being a service associated with a service to which item 35576, 35580, 35584, 35590,35657, 35673, 35750 or 35753 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35576, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies N 35593 01MAY2004 VAGINAL REPAIR OF ENTEROCELE with or without repair of rectocele, with or without mesh, not being a service associated with a service to which item 30405, 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies, and where on a previous occasion there has been performed surgery reflected by a procedure to which item 35580, 35584, 35590, 35657, 35673, 35750 or 35753 applies Y 35595 01MAY2005 LAPAROSCOPIC OR ABDOMINAL PELVIC FLOOR REPAIR INCORPORATING THE FIXATION OF THE UTEROSACRAL AND CARDINAL LIGAMENTS TO RECTOVAGINAL AND PUBOCERVICAL FASCIA for symptomatic upper vaginal vault prolapse Y 35596 01DEC1991 FISTULA BETWEEN GENITAL AND URINARY OR ALIMENTARY TRACTS, repair of, not being a service to which item 37029, 37333 or 37336 applies Y 35597 01MAY2005 SACRAL COLPOPEXY, laparoscopic or open procedure where graft or mesh secured to vault, anterior and posterior compartment and to sacrum for correction of symptomatic upper vaginal vault prolapse Y 35599 01DEC1991 STRESS INCONTINENCE, sling operation for N 35599 01MAY2004 STRESS INCONTINENCE, sling operation for, with or without mesh, not being a service associated with a service to which item 30405 applies N 35599 01NOV2004 STRESS INCONTINENCE, sling operation for, with or without mesh or tape, not being a service associated with a service to which item 30405 applies Y 35600 01MAY1997 STRESS INCONTINENCE, VAGINAL PROCEDURE FOR N 35600 01MAY2004 STRESS INCONTINENCE, VAGINAL PROCEDURE FOR, with or without mesh, not being a service associated with a service to which item 30405 applies Y 35602 01DEC1991 STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; abdominal procedure (including aftercare) N 35602 01MAY2004 STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; abdominal procedure, with or without mesh, (including aftercare), not being a service associated with a service to which item 30405 applies Y 35605 01DEC1991 STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; vaginal procedure (including aftercare) N 35605 01MAY2004 STRESS INCONTINENCE, combined synchronous ABDOMINOVAGINAL operation for; vaginal procedure, with or without mesh, (including aftercare), not being a service associated with a service to which item 30405 applies Y 35608 01DEC1991 CERVIX, cauterisation (other than by chemical means), ionisation, diathermy or biopsy of, with or without dilatation of cervix Y 35611 01DEC1991 CERVIX, removal of polyp or polypi, with or without dilatation of cervix, not being a service associated with a service to which item 35608 applies Y 35612 01MAY1997 CERVIX, RESIDUAL STUMP, removal of, by abdominal approach Y 35613 01MAY1997 CERVIX, RESIDUAL STUMP, removal of, by vaginal approach Y 35614 01DEC1991 EXAMINATION OF LOWER FEMALE GENITAL TRACT by a Hinselmanntype colposcope in a patient with a previous abnormal cervical smear or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner N 35614 01JAN2014 EXAMINATION OF LOWER TRACT by a Hinselmanntype colposcope in a patient with a previous abnormal cervical smear or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner N 35614 01DEC2017 EXAMINATION OF LOWER TRACT by a Hinselmanntype colposcope in a patient with a previous abnormal cervical smear screen result or a history of maternal ingestion of oestrogen or where a patient, because of suspicious signs of cancer, has been referred by another medical practitioner Y 35615 01APR1992 VULVA, biopsy of, when performed in conjunction with a service to which item 35614 applies Y 35616 01MAY2001 ENDOMETRIUM, endoscopic examination of and ablation of, by microwave, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage N 35616 01NOV2003 ENDOMETRIUM, endoscopic examination of and ablation of, by microwave or thermal balloon, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage N 35616 01MAY2006 ENDOMETRIUM, endoscopic examination of and ablation of, by microwave or thermal balloon or radiofrequency electrosurgery, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage Y 35617 01DEC1991 CERVIX, cone biopsy, amputation or repair of, not being a service to which item 35584 applies N 35617 01MAY2005 CERVIX, cone biopsy, amputation or repair of, not being a service to which item 35577 or 35578 applies Y 35618 01DEC1991 CERVIX, cone biopsy, amputation or repair of, not being a service to which item 35584 applies N 35618 01NOV2017 CERVIX, cone biopsy, amputation or repair of, other than a service to which item35577 or 35578 applies Y 35619 01MAY1994 CERVIX, dilatation of, under general anaesthesia, not being a service to which item 35639, 35640 or 35643 applies Y 35620 01MAY1994 ENDOMETRIAL BIOPSY where malignancy is suspected in patients with abnormal uterine bleeding or post menopausal bleeding Y 35621 01DEC1991 CERVIX, dilatation of, under general anaesthesia, not being a service to which item 35639, 35640 or 35643 applies Y 35622 01MAY1994 ENDOMETRIUM, endoscopic ablation of, by laser or diathermy, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage, not being a service associated with a service to which item 30390 applies Y 35623 01MAY1994 HYSTEROSCOPIC RESECTION of myoma or uterine septum followed by endometrial ablation by laser or diathermy N 35623 01NOV2000 HYSTEROSCOPIC RESECTION of myoma, or myoma and uterine septum resection (where both are performed), followed by endometrial ablation by laser or diathermy Y 35624 01DEC1991 ENDOMETRIAL BIOPSY where malignancy is suspected in patients with abnormal uterine bleeding or post menopausal bleeding Y 35625 01APR1992 ENDOMETRIUM, endoscopic ablation of, by laser or diathermy resection, for chronic refractory menorrhagia including any hysteroscopy or laparoscopy performed on the same day but excluding services covered by Item 30582 or 35637 N 35625 01NOV1992 ENDOMETRIUM, endoscopic ablation of, by laser or diathermy, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, not being a service associated with a service to which item 30390 applies N 35625 01JUL1993 ENDOMETRIUM, endoscopic ablation of, by laser or diathermy, for chronic refractory menorrhagia including any hysteroscopy performed on the same day, with or without uterine curettage, not being a service associated with a service to which item 30390 applies Y 35626 01APR1992 HYSTEROSCOPY, including biopsy, for the investigation of suspected intrauterine pathology (with or without local anaesthetic), where the patient is referred by a medical practitioner who is not a member of a group of practitioners of which the practitioner who ordered the service is a member - not in association with Item 35630 N 35626 01NOV1992 HYSTEROSCOPY, including biopsy, performed by a specialist in the practice of his or her specialty where the patient is referred to him or her for the investigation of suspected intrauterine pathology (with or without local anaesthetic), not being a service associated with a service to which item 35627 or 35630 applies and including procedures to which item 35639, 35640 or 35643 applies, where performed N 35626 01NOV1994 HYSTEROSCOPY, including biopsy, performed by a specialist in the practice of his or her specialty where the patient is referred to him or her for the investigation of suspected intrauterine pathology (with or without local anaesthetic), not being a service associated with a service to which item 35627 or 35630 applies Y 35627 01DEC1991 HYSTEROSCOPY with dilatation of cervix under general anaesthesia N 35627 01APR1992 HYSTEROSCOPY with dilatation of cervix performed in the operating theatre of a hospital or approved day-hospital facility N 35627 01NOV1992 HYSTEROSCOPY with dilatation of the cervix performed in the operating theatre of a hospital or approved day-hospital facility - not being a service associated with a service to which item 35626 or 35630 applies, and including procedures to which item 35639, 35640 or 35643 applies, where performed N 35627 01NOV1994 HYSTEROSCOPY with dilatation of the cervix performed in the operating theatre of a hospital - not being a service associated with a service to which item 35626 or 35630 applies Y 35630 01DEC1991 HYSTEROSCOPY with endometrial biopsy or suction curettage, or both N 35630 01APR1992 HYSTEROSCOPY, with or without endometrial biopsy, performed in the operating theatre of a hospital or approved day-hospital facility - not covered by Item 35626 and including procedures covered by Item 35639, 35640 or 35643 where performed N 35630 01NOV1992 HYSTEROSCOPY, with endometrial biopsy, performed in the operating theatre of a hospital or approved day-hospital facility - not being a service associated with a service to which item 35626 or 35627 applies, and including procedures to which item 35639, 35640 or 35643 applies, where performed N 35630 01NOV1994 HYSTEROSCOPY, with endometrial biopsy, performed in the operating theatre of a hospital - not being a service associated with a service to which item 35626 or 35627 applies Y 35633 01DEC1991 HYSTEROSCOPY with uterine adhesiolysis or polypectomy or tubal catheterisation or removal of IUD which cannot be removed by other means, 1 or more of N 35633 01MAY2002 HYSTEROSCOPY with uterine adhesiolysis or polypectomy or tubal catheterisation (including for insertion of device for sterilisation) or removal of IUD which cannot be removed by other means, 1 or more of Y 35634 01NOV2000 HYSTEROSCOPIC RESECTION of uterine septum followed by endometrial ablation by laser or diathermy Y 35635 01NOV2000 HYSTEROSCOPY involving resection of the uterine septum Y 35636 01DEC1991 HYSTEROSCOPY AND LAPAROSCOPY under general anaesthesia involving either myomectomy or resection of uterine septum, or both N 35636 01MAY1994 HYSTEROSCOPY, and laparoscopy where performed, under general anaesthesia involving either myomectomy or resection of uterine septum or both N 35636 01NOV2000 HYSTEROSCOPY, involving resection of myoma, or resection of myoma and uterine septum (where both are performed) Y 35637 01APR1992 LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or any other gynaecological procedure - one or more procedures with or without biopsy - not associated with Item 30582, 35687 or 35688 N 35637 01NOV1992 LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or similar procedure - 1 or more procedures with or without biopsy - not being a service associated with any other laparoscopic procedure N 35637 01NOV1993 LAPAROSCOPY, involving puncture of cysts, diathermy of endometriosis, ventrosuspension, division of adhesions or similar procedure - 1 or more procedures with or without biopsy - not being a service associated with any other laparoscopic procedure or hysterectomy Y 35638 01APR1992 COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, division of adhesions requiring more than 1 hours operating time or division of utero-sacral ligaments for significant dysmenorrhoea N 35638 01MAY1994 COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, division of adhesions requiring more than 1 hours operating time or division of utero-sacral ligaments for significant dysmenorrhoea - not being a service associated with any other intraperitoneal procedure N 35638 01NOV2000 COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, or division of utero-sacral ligaments for significant dysmenorrhoea - not being a service associated with any other intraperitoneal procedure except item 30393 N 35638 01MAY2001 COMPLICATED OPERATIVE LAPAROSCOPY, including use of laser when required, for 1 or more of the following procedures; oophorectomy, ovarian cystectomy, myomectomy, salpingectomy or salpingostomy, ablation of moderate or severe endometriosis requiring more than 1 hours operating time, or division of utero-sacral ligaments for significant dysmenorrhoea - not being a service associated with any other intraperitoneal or retroperitoneal procedure except item 30393 Y 35639 01DEC1991 UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day hospital facility N 35639 01NOV1994 UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital, including procedures to which item 35626, 35627 or 35630 applies, where performed Y 35640 01DEC1991 UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital or approved day hospital facility N 35640 01NOV1994 UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block where undertaken in a hospital, including procedures to which item 35626, 35627 or 35630 applies, where performed N 35640 01NOV2017 UTERUS, CURETTAGE OF, with or without dilatation (including curettage for incomplete miscarriage) under general anaesthesia, or under epidural or spinal (intrathecal) nerve block, including procedures to which item 35626, 35627 or 35630 applies,if performed Y 35641 01NOV2000 ENDOMETRIOSIS LEVEL 4 OR 5, LAPAROSCOPIC RESECTION OF, involving any two of the following procedures, resection of the pelvic side wall with ureterolysis, resection of the Pouch of Douglas, resection of an ovarian endometrioma greater than 2 cms in diameter, dissection of bowel from uterus from the level of the endocervical junction or above: where the operating time exceeds 90 minutes N 35641 01MAY2001 ENDOMETRIOSIS LEVEL 4 OR 5, LAPAROSCOPIC RESECTION OF, involving any two of the following procedures, resection of the pelvic side wall including dissection of endometriosis or scar tissue from the ureter, resection of the Pouch of Douglas, resection of an ovarian endometrioma greater than 2 cms in diameter, dissection of bowel from uterus from the level of the endocervical junction or above: where the operating time exceeds 90 minutes Y 35643 01DEC1991 EVACUATION OF THE CONTENTS OF THE GRAVID UTERUS BY CURETTAGE OR SUCTION CURETTAGE not being a service to which item 35639/35640 applies N 35643 01NOV1994 EVACUATION OF THE CONTENTS OF THE GRAVID UTERUS BY CURETTAGE OR SUCTION CURETTAGE not being a service to which item 35639/35640 applies, including procedures to which item 35626, 35627 or 35630 applies, where performed N 35643 01NOV2017 EVACUATION OF THE CONTENTS OF THE GRAVID UTERUS BY CURETTAGE OR SUCTION CURETTAGE other than a service to which item 35640 applies, including procedures to which item 35626, 35627 or 35630 applies, if performed Y 35644 01APR1992 CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, not associated with Item 35647 N 35644 01NOV1992 CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, not being a service associated with a service to which item 35639, 35640 or 35647 applies N 35644 01NOV2017 CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, other than a service associated with a service to which item 35640 or 35647 applies Y 35645 01APR1992 CERVIX, electrocoagulation diathermy with colposcopy, for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, in conjunction with ablative therapy of additional areas of intraepithelial change in 1 or more sites of vagina, vulva, urethra or anus, not being a service associated with a service to which item 35648 applies Y 35646 01DEC1991 UTERUSCOLPOSCOPY with cervical biopsy and radical diathermy of cervix N 35646 01APR1992 CERVIX, colposcopy with radical diathermy of, with or without cervical biopsy, for previously confirmed intraepithelial neoplastic changes of the cervix N 35646 01NOV1992 CERVIX, colposcopy with radical diathermy of, with or without cervical biopsy, for previously confirmed intraepithelial neoplastic changes of the cervix, where performed in the operating theatre of a hospital N 35646 01MAY2016 CERVIX, colposcopy with radical diathermy of, with or without cervical biopsy, for previously confirmed intraepithelial neoplastic changes of the cervix Y 35647 01APR1992 CERVIX, large loop excision of transformation zone together with colposcopy for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, not being a service associated with a service to which item 35644 applies Y 35648 01APR1992 CERVIX, large loop excision diathermy for previously confirmed intraepithelial neoplastic changes of the cervix, including any local anaesthesia and biopsies, in conjunction with ablative treatment of additional areas of intraepithelial change of 1 or more sites of vagina, vulva, urethra or anus, not being a service associated with a service to which item 35645 applies Y 35649 01DEC1991 HYSTEROTOMY or UTERINE MYOMECTOMY, abdominal Y 35652 01DEC1991 HYSTERECTOMY, ABDOMINAL, SUBTOTAL or TOTAL, with or without removal of uterine adnexae Y 35653 01DEC1991 HYSTERECTOMY, ABDOMINAL, SUBTOTAL or TOTAL, with or without removal of uterine adnexae Y 35656 01DEC1991 HYSTERECTOMY, VAGINAL, with or without uterine curettage, not covered by Item 35673 Y 35657 01DEC1991 HYSTERECTOMY, VAGINAL, with or without uterine curettage, not being a service to which item 35673 applies N 35657 01MAY2002 HYSTERECTOMY, VAGINAL, with or without uterine curettage, not being a service to which item 35673 applies NOTE:Strict legal requirements apply in relation to sterilisation procedures on minors.Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law.Observe the explanatory note before submitting a claim. Y 35658 01NOV1995 UTERUS (at least equivalent in size to a 10 week gravid uterus), debulking of, prior to vaginal removal at hysterectomy Y 35660 01DEC1991 HYSTERECTOMY, ABDOMINAL, with excision of ovarian, paraovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries Y 35661 01DEC1991 HYSTERECTOMY, ABDOMINAL, with excision of ovarian, paraovarian, broad ligament or other adnexal cyst or mass, one or more, with conservation of the ovaries N 35661 01NOV1992 HYSTERECTOMY, ABDOMINAL, requiring extensive retroperitoneal dissection, with or without exposure of 1 or both ureters, for the management of severe endometriosis, pelvic inflammatory disease or benign pelvic tumours, with or without conservation of the ovaries Y 35664 01DEC1991 RADICAL HYSTERECTOMY with radical excision of pelvic lymph glands (with or without excision of uterine adnexae) for proven malignancy including excision of any one or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum N 35664 01NOV1992 RADICAL HYSTERECTOMY with radical excision of pelvic lymph glands (with or without excision of uterine adnexae) for proven malignancy including excision of any 1 or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum and involving ureterolysis where performed N 35664 01NOV2019 RADICAL HYSTERECTOMY with radical excision of pelvic lymph nodes (with or without excision of uterine adnexae) for proven malignancy including excision of any 1 or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum and involving ureterolysis where performed Y 35667 01DEC1991 RADICAL HYSTERECTOMY without gland dissection (with or without excision of uterine adnexae) for proven malignancy including excision of any one or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum N 35667 01NOV1992 RADICAL HYSTERECTOMY without gland dissection (with or without excision of uterine adnexae) for proven malignancy including excision of any 1 or more of parametrium, paracolpos, upper vagina or contiguous pelvic peritoneum and involving ureterolysis where performed Y 35670 01DEC1991 HYSTERECTOMY, abdominal, with radical excision of pelvic lymph glands, with or without removal of uterine adnexae N 35670 01NOV2019 HYSTERECTOMY, abdominal, with radical excision of pelvic lymph nodes, with or without removal of uterine adnexae Y 35673 01DEC1991 HYSTERECTOMY, VAGINAL (with or without uterine curettage) with salpingectomy, oophorectomy or excision of ovarian cyst, 1 or more, 1 or both sides Y 35674 01JUL1995 ULTRASOUND GUIDED NEEDLING and injection of ectopic pregnancy Y 35676 01DEC1991 ECTOPIC PREGNANCY, removal of Y 35677 01DEC1991 ECTOPIC PREGNANCY, removal of Y 35678 01APR1992 ECTOPIC PREGNANCY, laparoscopic removal of Y 35680 01DEC1991 BICORNUATE UTERUS, plastic reconstruction for Y 35683 01DEC1991 UTERUS, SUSPENSION OR FIXATION OF, as an independent procedure Y 35684 01DEC1991 UTERUS, SUSPENSION OR FIXATION OF, as an independent procedure Y 35687 01DEC1991 STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method. N 35687 01MAY2002 STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method. NOTE:Strict legal requirements apply in relation to sterilisation procedures on minors.Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law.Observe the explanatory note before submitting a claim. Y 35688 01DEC1991 STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method N 35688 01MAY2002 STERILISATION BY TRANSECTION OR RESECTION OF FALLOPIAN TUBES, via abdominal or vaginal routes or via laparoscopy using diathermy or any other method NOTE:Strict legal requirements apply in relation to sterilisation procedures on minors.Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law.Observe the explanatory note before submitting a claim. Y 35691 01DEC1991 STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in conjunction with Caesarean section N 35691 01MAY2002 STERILISATION BY INTERRUPTION OF FALLOPIAN TUBES, when performed in conjunction with Caesarean section NOTE:Strict legal requirements apply in relation to sterilisation procedures on minors.Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law.Observe the explantory note before submitting a claim. Y 35694 01DEC1991 TUBOPLASTY (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, 1 or more procedures Y 35697 01DEC1991 MICROSURGICAL TUBOPLASTY (salpingostomy, salpingolysis or tubal implantation into uterus), UNILATERAL or BILATERAL, 1 or more procedures Y 35700 01DEC1991 FALLOPIAN TUBES, unilateral microsurgical anastomosis of, using operating microscope N 35700 01NOV1996 FALLOPIAN TUBES, unilateral microsurgical anastomosis of, using operating microscope for other than reversal of previous sterilisation N 35700 01JUL2008 FALLOPIAN TUBES, unilateral microsurgical anastomosis of, using operating microscope Y 35703 01DEC1991 HYDROTUBATION OF FALLOPIAN TUBES as a nonrepetitive procedure not being a service associated with a service to which another item in this Sub-group applies Y 35706 01DEC1991 RUBIN TEST FOR PATENCY OF FALLOPIAN TUBES Y 35709 01DEC1991 FALLOPIAN TUBES, hydrotubation of, as a repetitive postoperative procedure Y 35710 01MAY1997 FALLOPOSCOPY, unilateral or bilateral, including hysteroscopy and tubal catheterization Y 35712 01DEC1991 LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - 1 such procedure, not being a service associated with hysterectomy Y 35713 01DEC1991 LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYSTone such procedure, not associated with hysterectomy N 35713 01NOV2017 LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGO-OOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - one such procedure,other than a serviceassociated with hysterectomy Y 35716 01DEC1991 LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - 2 or more such procedures, unilateral or bilateral, not being a service associated with hysterectomy Y 35717 01DEC1991 LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGOOOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST2 or more such procedures, unilateral or bilateral, not being a service associated with hysterectomy N 35717 01NOV2017 LAPAROTOMY, involving OOPHORECTOMY, SALPINGECTOMY, SALPINGO-OOPHORECTOMY, removal of OVARIAN, PARAOVARIAN, FIMBRIAL or BROAD LIGAMENT CYST - 2 or more such procedures, unilateral or bilateral,other thana service associated with hysterectomy Y 35720 01DEC1991 RADICAL OR DEBULKING OPERATION for advanced gynaecological malignancy, with or without omentectomy Y 35723 01DEC1991 RETROPERITONEAL LYMPH NODE BIOPSIES from above the level of the aortic bifurcation, for staging or restaging of gynaecological malignancy Y 35726 01DEC1991 INFRACOLIC OMENTECTOMY with multiple peritoneal biopsies for staging or restaging of gynaecological malignancy Y 35729 01NOV1992 OVARIAN TRANSPOSITION out of the pelvis, in conjunction with radical hysterectomy for invasive malignancy Y 35730 01MAY2017 Ovarian repositioning for one or both ovaries to preserve ovarian function, prior to gonadotoxic radiotherapy when the treatment volume and dose of radiation have a high probability of causing infertility Y 35750 01MAY1997 LAPAROSCOPICALLY ASSISTED HYSTERECTOMY, including any associated laparoscopy Y 35753 01MAY1997 LAPAROSCOPICALLY ASSISTED HYSTERECTOMY with one or more of the following procedures:salpingectomy, oophorectomy, excision of ovarian cyst or treatment of moderate endometriosis, one or both sides, including any associated laparoscopy N 35753 01MAY2001 LAPAROSCOPICALLY ASSISTED HYSTERECTOMY with one or more of the following procedures:salpingectomy, oophorectomy, excision of ovarian cyst or treatment of moderate endometriosis, one or both sides, including any associated laparoscopy Y 35754 01MAY2001 LAPAROSCOPICALLY ASSISTED HYSTERECTOMY which requires dissection of endometriosis, or other pathology, from the ureter, one or both sides, including any associated laparoscopy, including when performed with one or more of the following procedures:salpingectomy, oophorectomy, excision of ovarian cyst, or treatment of endometriosis, not being a service to which item 35641 applies Y 35756 01MAY1997 LAPAROSCOPICALLY ASSISTED HYSTERECTOMY, when procedure is completed by open hysterectomy, including any associated laparoscopy Y 35759 01NOV2000 Procedure for the control of POST OPERATIVE HAEMORRHAGE following gynaecological surgery, under general anaesthesia, utilising a vaginal or abdominal and vaginal approach where no other procedure is performed N 35759 01NOV2013 Procedure for the control of POST OPERATIVE HAEMORRHAGE following gynaecological surgery, under general anaesthesia, utilising a vaginal or abdominal and vaginal approach where no other procedure is performed Y 36500 01DEC1991 ADRENAL GLAND, excision ofpartial or total Y 36502 01NOV1997 PELVIC LYMPHADENECTOMY, open or laparoscopic, or both, unilateral or bilateral Y 36503 01DEC1991 RENAL TRANSPLANT (not being a service to which item 36506 or 36509 applies) Y 36504 01MAY2019 RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with biopsy of bladder, not being a service associated with a service to which item 36505, 36507, 36508, 36812, 36830, 36836, 36840, 36845, 36848, 36854, 37203, 37206, 37215, 37230 or 37233 applies. Y 36505 01MAY2019 RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with urethroscopy with or without urethral dilatation, not being a service associated with any other urological endoscopic procedure on the lower urinary tract except a service to which item 37327 applies. Y 36506 01DEC1991 RENAL TRANSPLANT, performed by vascular surgeon and urologist operating togethervascular anastomosis including aftercare Y 36507 01MAY2019 RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with resection, diathermy or visual laser destruction of bladder tumour or other lesion of the bladder, not being a service to which item 36840 or 36845 applies. Y 36508 01MAY2019 RIGID CYSTOSCOPY using blue light with hexaminolevulinate as an adjunct to white light, including catheterisation, with diathermy, resection or visual laser destruction of multiple tumours in more than 2 quadrants of the bladder or solitary tumour greater than 2cm in diameter, not being a service to which item 36845 applies. Y 36509 01DEC1991 RENAL TRANSPLANT, performed by vascular surgeon and urologist operating togetherureterovesical anastomosis including aftercare Y 36512 01DEC1991 DONOR NEPHRECTOMY (cadaver) one or both kidneys Y 36515 01DEC1991 NEPHRECTOMY, complete Y 36516 01DEC1991 NEPHRECTOMY, complete Y 36519 01DEC1991 NEPHRECTOMY, complete, complicated by previous surgery on the same kidney Y 36522 01DEC1991 NEPHRECTOMY, partial Y 36525 01DEC1991 NEPHRECTOMY, partial, complicated by previous surgery on the same kidney Y 36526 01MAY2004 NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour less than 10cms in diameter, where performed if malignancy is clinically suspected but not confirmed by histopathological examination Y 36527 01MAY2004 NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour 10cms or more in diameter, or complicated by previous open or laparoscopic surgery on the same kidney, where performed if malignancy is clinically suspected but not confirmed by histopathological examination Y 36528 01DEC1991 NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy N 36528 01MAY2001 NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour less than 10 cms in diameter Y 36529 01MAY2001 NEPHRECTOMY, radical with en bloc dissection of lymph nodes, with or without adrenalectomy, for a tumour 10 cms or more in diameter, or complicated by previous open or laparoscopic surgery on the same kidney Y 36531 01DEC1991 NEPHROURETERECTOMY, complete, including associated bladder repair and any associated endoscopic procedures Y 36532 01MAY2001 NEPHRO-URETERECTOMY, for tumour, with or without en bloc dissection of lymph nodes, including associated bladder repair and any associated endoscopic procedures Y 36533 01MAY2001 NEPHRO-URETERECTOMY, for tumour, with or without en bloc dissection of lymph nodes, including associated bladder repair and any associated endoscopic procedures, complicated by previous open or laparoscopic surgery on the same kidney or ureter Y 36534 01DEC1991 KIDNEY, FUSED, renal symphysiotomy for Y 36537 01DEC1991 KIDNEY OR PERINEPHRIC AREA, EXPLORATION OF, with or without drainage of, by open exposure, not being a service to which another item in this Sub-group applies Y 36540 01DEC1991 NEPHROLITHOTOMY OR PYELOLITHOTOMY, or both, through the same skin incision, for 1 or 2 stones Y 36543 01DEC1991 NEPHROLITHOTOMY OR PYELOLITHOTOMY, or both, extended, for staghorn stone or 3 or more stones, including 1 or more of the following: nephrostomy, pyelostomy, pedicle control with or without freezing, calyorrhaphy or pyeloplasty Y 36546 01DEC1991 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) to urinary tract and posttreatment care for 3 days, including pretreatment consultation, unilateral Y 36549 01DEC1991 URETEROLITHOTOMY Y 36552 01DEC1991 NEPHROSTOMY or pyelostomy, open, as an independent procedure Y 36555 01DEC1991 NEPHROPEXY, as an independent procedure Y 36558 01DEC1991 RENAL CYST OR CYSTS, excision or unroofing of Y 36561 01DEC1991 RENAL BIOPSY (closed) Y 36564 01DEC1991 PYELOPLASTY, by open exposure N 36564 01MAY2004 PYELOPLASTY, (plastic reconstruction of the pelvi-ureteric junction) by open exposure, laparoscopy or laparoscopic assisted techniques Y 36567 01DEC1991 PYELOPLASTY in congenitally abnormal kidney or solitary kidney, by openexposure N 36567 01MAY2001 PYELOPLASTY in a kidney that is congenitally abnormal in addition to the presence of PUJ obstruction, or in a solitary kidney, by open exposure Y 36570 01DEC1991 PYELOPLASTY, complicated by previous surgery on the same kidney, by open exposure Y 36573 01DEC1991 DIVIDED URETER, repair of Y 36576 01DEC1991 KIDNEY, exposure and exploration of, including repair or nephrectomy, for trauma, not being a service associated with any other procedure performed on the kidney, renal pelvis or renal pedicle Y 36579 01DEC1991 URETERECTOMY, COMPLETE OR PARTIAL, with or without associated bladder repair, not being a service associated with a service to which item 37000 applies Y 36582 01DEC1991 URETER, replacement of, by bowel Y 36585 01DEC1991 URETER, transplantation of, into skin Y 36588 01DEC1991 URETER, reimplantation into bladder Y 36591 01DEC1991 URETER, reimplantation into bladder with psoas hitch or Boari flap or both Y 36594 01DEC1991 URETER, transplantation of, into intestine Y 36597 01DEC1991 URETER, transplantation of, into another ureter Y 36600 01DEC1991 URETER, transplantation of, into isolated intestinal segment, unilateral Y 36603 01DEC1991 URETERS, transplantation of, into isolated intestinal segment, bilateral Y 36604 01MAY1997 URETERIC STENT, passage of through percutaneous nephrostomy tube, using interventional imaging techniques Y 36605 01MAY2005 URETERIC STENT, insertion of, with removal of calculus from: (a) the pelvicalyceal system; or (b) ureter; or (c) the pelvicalyceal system and ureter; through a nephrostomy tube using interventional imaging techniques Y 36606 01DEC1991 INTESTINAL URINARY RESERVOIR, continent, formation of, including formation of nonreturn valves and implantation of ureters (1 or both) into reservoir Y 36607 01MAY2005 URETERIC STENT insertion of, with baloon dilatation of: (a) the pelvicalyceal system; or (b) ureter; or (c) the pelvicalyceal system and ureter; through a nephrostomy tube using interventional imaging techniques Y 36608 01MAY2005 URETERIC STENT, exchange of, percutaneously through either the ileal conduit or bladder, using interventional imaging techniques, not being a service associated with a service to which items 36811 to 36854 apply Y 36609 01DEC1991 INTESTINAL URINARY CONDUIT OR URETEROSTOMY, revision of Y 36612 01DEC1991 URETER, exploration of, with or without drainage of, as an independent procedure Y 36615 01DEC1991 URETEROLYSIS, with or without repositioning of ureter, for retroperitoneal fibrosis, ovarian vein syndrome or similar condition N 36615 01MAY2001 URETEROLYSIS, with or without repositioning of the ureter, for obstruction of the ureter, evident either radiologically or by proximal ureteric dilatation at operation, secondary to retroperitoneal fibrosis, or similar condition Y 36618 01DEC1991 REDUCTION URETEROPLASTY Y 36621 01DEC1991 CLOSURE OF CUTANEOUS URETEROSTOMY Y 36624 01DEC1991 NEPHROSTOMY, percutaneous, including associated imaging N 36624 01MAY1994 NEPHROSTOMY, percutaneous, using interventional imaging techniques Y 36627 01DEC1991 NEPHROSCOPY, percutaneous, with or without any 1 or more of; stone extraction, biopsy or diathermy, not being a service to which item 36639, 36642, 36645 or 36648 applies Y 36630 01DEC1991 NEPHROSCOPY, BEING A SERVICE TO WHICH ITEM 36627 APPLIES, WHERE, after a substantial portion of the procedure has been performed, IT IS NECESSARY TO DISCONTINUE THE OPERATION DUE TO BLEEDING Y 36633 01DEC1991 NEPHROSCOPY, percutaneous, with incision of any 1 or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, not being a service associated with a service to which item 36627, 36639, 36642, 36645 or 36648 applies Y 36636 01DEC1991 NEPHROSCOPY, percutaneous, with incision of any 1 or more of; renal pelvis, calyx or calyces or ureter and including antegrade insertion of ureteric stent, being a service associated with a service to which item 36627, 36639, 36642, 36645 or 36648 applies Y 36639 01DEC1991 NEPHROSCOPY, percutaneous, with destruction and extraction of 1 or 2 stones using ultrasound or electrohydraulic shock waves or lasers (not being a service to which item 36645 or 36648 applies) Y 36642 01DEC1991 NEPHROSCOPY, BEING A SERVICE TO WHICH ITEM 36639 APPLIES, WHERE, after a substantial portion of the procedure has been performed, IT IS NECESSARY TO DISCONTINUE THE OPERATION DUE TO BLEEDING Y 36645 01DEC1991 NEPHROSCOPY, percutaneous, with removal or destruction of a stone greater than 3 cm in any dimension, or for 3 or more stones Y 36648 01DEC1991 NEPHROSCOPY, being a service to which item 36645 applies, WHERE, after a substantial portion of the procedure has been performed, IT IS NECESSARY TO DISCONTINUE THE OPERATION Y 36649 01APR1992 NEPHROSTOMY DRAINAGE TUBE, exchange of - but not including imaging Y 36650 01MAY2005 NEPHROSTOMY TUBE, removal of, if the ureter has been stented with a double J ureteric stent and that stent is left in place, using interventional imaging techniques Y 36652 01MAY2001 PYELOSCOPY, retrograde, of one collecting system, with or without any one or more of, cystoscopy, ureteric meatotomy, ureteric dilatation, not being a service associated with a service to which item 36803, 36812 or 36824 applies Y 36654 01MAY2001 PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus 1 or more of extraction of stone from the renal pelvis or calyces, or biopsy or diathermy of the renal pelvis or calyces N 36654 01NOV2001 PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus 1 or more of extraction of stone from the renal pelvis or calyces, or biopsy or diathermy of the renal pelvis or calyces, not being a service associated with a service to which item 36656 applies to a procedure performed in the same collecting system Y 36656 01MAY2001 PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus extraction of 2 or more stones in the renal pelvis or calyces or destruction of stone with ultrasound, electrohydraulic or kinetic lithotripsy, or laser in the renal pelvis or calyces, with or without extraction of fragments N 36656 01NOV2001 PYELOSCOPY, retrograde, of one collecting system, being a service to which item 36652 applies, plus extraction of 2 or more stones in the renal pelvis or calyces or destruction of stone with ultrasound, electrohydraulic or kinetic lithotripsy, or laser in the renal pelvis or calyces, with or without extraction of fragments, not being a service associated with a service to which item 36654 applies to a procedure performed in the same collecting system Y 36657 01APR2002 This is a dummy item used for statistical item mapping purposes Y 36658 01APR2002 SACRAL NERVE STIMULATION for refractory urinary incontinence or urge retention, removal of pulse generator and leads Y 36660 01APR2002 SACRAL NERVE STIMULATION for refractory urinary incontinence or urge retention, removal and replacement of pulse generator Y 36662 01APR2002 SACRAL NERVE STIMULATION for refractory urinary incontinence or urge retention, removal and replacement of leads Y 36663 01MAY2010 Sacral nerve lead(s), percutaneous placement using fluoroscopic guidance (or open placement) and intraoperative test stimulation, to manage: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older. N 36663 01MAY2017 Both:(a) percutaneous placement of sacral nerve lead or leads using fluoroscopic guidance, or open placement of sacral nerve lead or leads; and (b) intra?operative test stimulation, to manage: (i) detrusor over?activity that has been refractory to at least 12 months conservative non?surgical treatment; or (ii) non?obstructive urinary retention that has been refractory to at least 12 months conservative non?surgical treatment   Y 36664 01MAY2010 Sacral nerve lead(s), percutaneous surgical repositioning of, using fluoroscopic guidance (or open surgical repositioning) and intraoperative test stimulation, to correct displacement or unsatisfactory positioning, if inserted for the management of: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older, not being a service to which item 36663 applies N 36664 01MAY2017 Both:(a) percutaneous repositioning of sacral nerve lead or leads using fluoroscopic guidance, or open repositioning of sacral nerve lead or leads; and (b) intra?operative test stimulation, to correct displacement or unsatisfactory positioning, if inserted for the management of: (i) detrusor over?activity that has been refractory to at least 12 months conservative non?surgical treatment; or (ii) non?obstructive urinary retention that has been refractory to at least 12 months conservative non?surgical treatment - other than a service to which item 36663 applies Y 36665 01MAY2010 Sacral nerve electrode or electrodes, management and adjustment of the pulse generator by a medical practitioner, to manage detrusor overactivity or non obstructive urinary retention - each day Y 36666 01MAY2010 Pulse generator, subcutaneous placement of, and placement and connection of extension wire(s) to sacral nerve electrode(s), for the management of a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older. N 36666 01MAY2017 Pulse generator, subcutaneous placement of, and placement and connection of extension wire or wires to sacral nerve electrode or electrodes, for the management of:(a) detrusor over?activity that has been refractory to at least 12 months conservative non?surgical treatment; or (b) non?obstructive urinary retention that has been refractory to at least 12 months conservative non?surgical treatment Y 36667 01MAY2010 Sacral nerve lead(s), removal of, if the lead was inserted to manage: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older. N 36667 01MAY2017 Sacral nerve lead or leads, removal of, if the lead was inserted to manage:(a) detrusor over?activity that has been refractory to at least 12 months conservative non?surgical treatment; or (b) non?obstructive urinary retention that has been refractory to at least 12 months conservative non?surgical treatment   Y 36668 01MAY2010 Pulse generator, removal of, if the pulse generator was inserted to manage: a) detrusor overactivity; or b) non obstructive urinary retention that has been refractory to at least 12 months medical and conservative treatment in a patient 18 years of age or older. N 36668 01MAY2017 Pulse generator, removal of, if the pulse generator was inserted to manage:(a) detrusor over?activity that has been refractory to at least 12 months conservative non?surgical treatment; or (b) non?obstructive urinary retention that has been refractory to at least 12 months conservative non?surgical treatment     Y 36671 01NOV2018 Percutaneous tibial nerve stimulation, initial treatment protocol, for the treatment of overactive bladder, by a specialist urologist, gynaecologist or urogynaecologist, if: (a) the patient has been diagnosed with idiopathic overactive bladder; and (b) the patient has been refractory to, is contraindicated or otherwise not suitable for conservative treatments (including anti?cholinergic agents); and (c) the patient is contraindicated or otherwise not a suitable candidate for botulinum toxin type A therapy; and (d) the patient is contraindicated or otherwise not a suitable candidate for sacral nerve stimulation; and (e) the patient is willing and able to comply with the treatment protocol; and (f) the initial treatment protocol comprises 12 sessions, delivered over a 3 month period; and (g) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes. For each patient - applicable only once, unless the patient achieves at least a 50% reduction in overactive bladder symptoms from baseline at any time during the 3 month treatment period. Not applicable for a service associated with a service to which item36672 or 36673 applies Y 36672 01NOV2018 Percutaneous tibial nerve stimulation, tapering treatment protocol, for the treatment of overactive bladder, including any associated consultation at the time the percutaneous tibial nerve stimulation treatment is administered, if: (a) the patient responded to the percutaneous tibial nerve stimulation initial treatment protocol and has achieved at least a 50% reduction in overactive bladder symptoms from baseline at any time during the treatment period for the initial treatment protocol; and (b) the tapering treatment protocol comprises no more than 5 sessions, delivered over a 3 month period, and the interval between sessions is adjusted with the aim of sustaining therapeutic benefit of the treatment; and (c) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes. Not applicable for a service associated with a service to which item36671 or 36673 applies Y 36673 01NOV2018 Percutaneous tibial nerve stimulation, maintenance treatment protocol, for the treatment of overactive bladder, including any associated consultation at the time the percutaneous tibial nerve stimulation treatment is administered, if: (a) the patient responded to the percutaneous tibial nerve stimulation initial treatment protocol and to the tapering treatment protocol, and has achieved at least a 50% reduction in overactive bladder symptoms from baseline at any time during the treatment period for the initial treatment protocol; and (b) the maintenance treatment protocol comprises no more than 12 sessions, delivered over a 12 month period, and the interval between sessions is adjusted with the aim of sustaining therapeutic benefit of the treatment; and (c) each session lasts for a minimum of 45 minutes, of which neurostimulation lasts for 30 minutes. Not applicable for service associated with a service to which item36671 or 36672 applies Y 36800 01DEC1991 BLADDER, catheterisation of, where no other procedure is performed Y 36803 01DEC1991 URETEROSCOPY, of one ureter, with or without any one or more of; cystoscopy, ureteric meatotomy or ureteric dilatation, not being a service associated with a service to which item 36652, 36654, 36656,36806, 36809, 36812, 36824, 36848 or 36857 applies N 36803 01MAY2001 URETEROSCOPY, of one ureter, with or without any one or more of; cystoscopy, ureteric meatotomy or ureteric dilatation, not being a service associated with a service to which item 36652, 36654, 36656,36806, 36809, 36812, 36824, 36848 or 36857 applies Y 36806 01DEC1991 URETEROSCOPY, BEING A SERVICE TO WHICH ITEM 36803 APPLIES, PLUS 1 or more of extraction of stone, biopsy or diathermy N 36806 01MAY2001 URETEROSCOPY, of one ureter, with or without any one or more of, cystoscopy, ureteric meatotomy or ureteric dilatation, plus one or more of extraction of stone from the ureter, or biopsy or diathermy of the ureter, not being a service associated with a service to which item 36803 or 36812 applies, or a service associated with a service to which item 36809, 36824, 36848 or 36857 applies to a procedure performed on the same ureter Y 36809 01DEC1991 URETEROSCOPY, BEING A SERVICE TO WHICH ITEM 36803 APPLIES, PLUS destruction of stone with ultrasound, electrohydraulic shock waves, or laser, with extraction of fragments N 36809 01MAY2001 URETEROSCOPY, of one ureter, with or without any one or more of, cystoscopy, ureteric meatotomy or ureteric dilatation, PLUS destruction of stone in the ureter with ultrasound, electrohydraulic or kinetic lithotripsy, or laser, with or without extraction of fragments, not being a service associated with a service to which item 36803 or 36812 applies, or a service associated with a service to which item 36806, 36824, 36848 or 36857 applies to a procedure performed on the same ureter Y 36811 01MAY1997 CYSTOSCOPY with insertion of urethral prosthesis Y 36812 01DEC1991 CYSTOSCOPY with urethroscopy with or without urethral dilatation, not being a service associated with any other urological endoscopic procedure on the lower urinary tract except a service to which item 37327 applies Y 36815 01DEC1991 CYSTOSCOPY, with or without urethroscopy, for the treatment of penile warts or uretheral warts, not being a service associated with a service to which item 30189 applies Y 36818 01DEC1991 CYSTOSCOPY with ureteric catheterisation including fluoroscopic imaging of the upper urinary tract, unilateral or bilateral, not being a service associated with a service to which item 36824 or 36830 applies Y 36821 01DEC1991 CYSTOSCOPY with 1 or more of; ureteric dilatation, insertion of ureteric stent, or brush biopsy of ureter or renal pelvis, unilateral, not being a service associated with a service to which item 36824 or 36830 applies Y 36824 01DEC1991 CYSTOSCOPY, with ureteric catheterisation, unilateral or bilateral, not being a service associated with a service to which item 36818 or 36821 applies Y 36825 01NOV1997 CYSTOSCOPY, with endoscopic incision of pelviureteric junction or ureteric stricture, including removal or replacement of ureteric stent, not being a service associated with a service to which item 36818, 36821, 36824, 36830 or 36833 applies Y 36827 01DEC1991 CYSTOSCOPY, with controlled hydrodilatation of the bladder Y 36830 01DEC1991 CYSTOSCOPY, with ureteric meatotomy Y 36833 01DEC1991 CYSTOSCOPY WITH REMOVAL OF FOREIGN BODY N 36833 01NOV1997 CYSTOSCOPY, with removal of ureteric stent or other foreign body Y 36836 01DEC1991 CYSTOSCOPY, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36839, 36845, 36848, 36854, 37203, 37206 or 37215 applies N 36836 01MAY2003 CYSTOSCOPY, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36840, 36845, 36848, 36854, 37203, 37206 or 37215 applies N 36836 01FEB2019 CYSTOSCOPY, with biopsy of bladder, not being a service associated with a service to which item 36812, 36830, 36840, 36845, 36848, 36854, 37203, 37206, 37215, 37230 or 37233applies Y 36839 01DEC1991 CYSTOSCOPY, with resection or diathermy of bladder tumour or other lesion of the bladder or prostate, not being a service associated with a service to which item 36845 applies N 36839 01JUL1995 CYSTOSCOPY, with resection, diathermy or visual laser destruction of bladder tumour or other lesion of the bladder or prostate, not being a service associated with a service to which item 36845 applies Y 36840 01MAY2003 CYSTOSCOPY, with resection, diathermy or visual laser destruction of bladder tumour or other lesion of the bladder, not being a service to which item 36845 applies Y 36842 01DEC1991 CYSTOSCOPY, with lavage of blood clots from bladder including any associated diathermy of prostate or bladder and not being a service associated with a service to which item 36812, 36827 to 36863, 37203 or 37206 apply Y 36845 01DEC1991 CYSTOSCOPY, with diathermy or resection of multiple bladder tumours in more than 2 quadrants of the bladder or solitary tumour greater than 2cm in diameter N 36845 01JUL1995 CYSTOSCOPY, with diathermy, resection or visual laser destruction of multiple tumours in more than 2 quadrants of the bladder or solitary tumour greater than 2cm in diameter Y 36848 01DEC1991 CYSTOSCOPY, with resection of ureterocele Y 36851 01DEC1991 CYSTOSCOPY, with injection into bladder wall N 36851 27NOV2013 CYSTOSCOPY, with injection into bladder wall, other than a service associated with a service to which item 18375 applies N 36851 01NOV2014 Cystoscopy, with injection into bladder wall, other than a service associated with a service to which item 18375 or 18379 applies (H) Y 36854 01DEC1991 CYSTOSCOPY, with endoscopic incision or resection of external sphincter, bladder neck or both Y 36857 01DEC1991 ENDOSCOPIC MANIPULATION OR EXTRACTION of ureteric calculus Y 36860 01DEC1991 ENDOSCOPIC EXAMINATION of intestinal conduit or reservoir Y 36863 01DEC1991 LITHOLAPAXY, with or without cystoscopy Y 37000 01DEC1991 BLADDER, partial excision of Y 37003 01DEC1991 BLADDER, repair of rupture Y 37004 01DEC1991 BLADDER, repair of rupture Y 37007 01DEC1991 CYSTOSTOMY OR CYSTOTOMY, suprapubic, not being a service to which item 37011 applies and not being a service associated with other open bladder procedure Y 37008 01DEC1991 CYSTOSTOMY OR CYSTOTOMY, suprapubic, not being a service to which item 37011 applies and not being a service associated with other open bladder procedure Y 37011 01DEC1991 SUPRAPUBIC STAB CYSTOTOMY N 37011 01NOV1995 SUPRAPUBIC STAB CYSTOTOMY, not being a service associated with a service to which items 37200 to 37221 apply Y 37014 01DEC1991 BLADDER, total excision of Y 37017 01DEC1991 BLADDER TUMOURS, suprapubic diathermy of Y 37020 01DEC1991 BLADDER DIVERTICULUM, excision or obliteration of Y 37023 01DEC1991 VESICAL FISTULA, cutaneous, operation for Y 37026 01DEC1991 CUTANEOUS VESICOSTOMY, establishment of Y 37029 01DEC1991 VESICOVAGINAL FISTULA, closure of, by abdominal approach Y 37032 01DEC1991 VESICOVAGINAL FISTULA, closure of, synchronous combined approach, abdominal component, including aftercare Y 37035 01DEC1991 VESICOVAGINAL FISTULA, closure of, synchronous combined approach, vaginal component, including aftercare Y 37038 01DEC1991 VESICOINTESTINAL FISTULA, closure of, excluding bowel resection Y 37040 01MAY2016 Bladder stress incontinence, sling procedure for, using a non-adjustable synthetic male sling system, with or without mesh, other than a service associated with a service to which item 30405, 35599 or 37042 applies Y 37041 01DEC1991 BLADDER ASPIRATION by needle Y 37042 01MAY2001 BLADDER STRESS INCONTINENCE, sling procedure for, using autologous fascial sling, including harvesting of sling, not being a service to which item 35599 applies N 37042 01MAY2004 BLADDER STRESS INCONTINENCE, sling procedure for, using autologous fascial sling, including harvesting of sling, with or without mesh, not being a service associated with a service to which item 30405 or 35599 applies Y 37043 01MAY2001 BLADDER STRESS INCONTINENCE, Stamey or similar type needle colposuspension, not being a service to which item 35599 applies N 37043 01MAY2004 BLADDER STRESS INCONTINENCE, Stamey or similar type needle colposuspension, with or without mesh, not being a service associated with a service to which item 30405 or 35599 applies Y 37044 01DEC1991 BLADDER STRESS INCONTINENCE, suprapubic procedure for, e.g. Burch colposuspension, not being a service to which item 35599 applies N 37044 01MAY2001 BLADDER STRESS INCONTINENCE, suprapubic procedure for, e.g. Burch colposuspension, not being a service to which item 35599 applies N 37044 01MAY2004 BLADDER STRESS INCONTINENCE, suprapubic procedure for, eg Burch colposuspension, with or without mesh, not being a service associated with a service to which item 30405 or 35599 applies Y 37045 01MAY1997 MITROFANOFF CONTINENT VALVE, formation of N 37045 01SEP2015 CONTINENT CATHETERISATION BLADDER STOMAS (eg. Mitrofanoff), formation of Y 37047 01DEC1991 BLADDER ENLARGEMENT using intestine Y 37050 01DEC1991 BLADDER EXSTROPHY CLOSURE, not involving sphincter reconstruction Y 37053 01DEC1991 BLADDER TRANSECTION AND RE-ANASTOMOSIS TO TRIGONE Y 37200 01DEC1991 PROSTATECTOMY, open Y 37201 01NOV2002 PROSTATE, transurethral radio-frequency needle ablation of the, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies (Ministerial Determination) N 37201 01NOV2003 PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies N 37201 01MAY2013 PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is, prostatectomy using diathermy or cold punch) and including services to which item 36854, 37203, 37206, 37207, 37208, 37245, 37303, 37321 or 37324 applies Y 37202 01NOV2002 PROSTATE, transurethral radio-frequency needle ablation of the, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is prostatectomy using diathermy or cold punch) and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37203,37207, 37201 which had to be discontinued for medical reasons (Ministerial Determination) N 37202 01NOV2003 PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is prostatectomy using diathermy or cold punch) and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203 or 37207 which had to be discontinued for medical reasons N 37202 01MAY2013 PROSTATE, transurethral radio-frequency needle ablation of, with or without cystoscopy and with or without urethroscopy, in patients with moderate to severe lower urinary tract symptoms who are not medically fit for transurethral resection of the prostate (that is prostatectomy using diathermy or cold punch) and including services to which item 36854, 37245, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203 or 37207 which had to be discontinued for medical reasons Y 37203 01DEC1991 PROSTATECTOMY (endoscopic), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies N 37203 01JUL1995 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37207, 37208, 37303, 37321 or 37324 applies N 37203 01NOV2002 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37201, 37202, 37207, 37208, 37303, 37321 or 37324 applies N 37203 01MAY2013 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37201, 37202, 37207, 37208, 37245, 37303, 37321 or 37324 applies Y 37206 01DEC1991 PROSTATECTOMY (endoscopic), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of initial procedure which had to be discontinued for medical reasons N 37206 01JUL1995 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37203 or 37208 which had to be discontinued for medical reasons N 37206 01NOV2002 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203, 37208 or which had to be discontinued for medical reasons N 37206 01MAY2006 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203 or 37207 or which had to be discontinued for medical reasons N 37206 01MAY2013 PROSTATECTOMY (endoscopic, using diathermy or cold punch), with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203, 37207 or 37245 which had to be discontinued for medical reasons Y 37207 01JUL1995 PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37203, 37206, 37321 or 37324 applies N 37207 01NOV2002 PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854,37201, 37202, 37203, 37206, 37321 or 37324 applies N 37207 01MAY2013 PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854,37201, 37202, 37203, 37206, 37245, 37321 or 37324 applies Y 37208 01JUL1995 PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which items 36854, 37203, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by items 37203 or 37207, which had to be discontinued for medical reasons N 37208 01NOV2002 PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by items 37201, 37203 or 37207 or which had to be discontinued for medical reasons N 37208 01MAY2013 PROSTATE, endoscopic non-contact (side firing) visual laser ablation, with or without cystoscopy and with or without urethroscopy, and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by items 37201, 37203, 37207 or 37245 which had to be discontinued for medical reasons Y 37209 01DEC1991 PROSTATE, total excision of N 37209 01MAY2001 PROSTATE, and/or SEMINAL VESICLE/AMPULLA OF VAS, unilateral or bilateral, total excision of, not being a service associated with a service to which item number 37210 or 37211 applies Y 37210 01NOV1997 PROSTATECTOMY, radical, involving total excision of the prostate, sparing of nerves around the bladder and bladder neck reconstruction, not being a service associated with a service to which item 35551, 36502 or 37375 applies Y 37211 01NOV1997 PROSTATECTOMY, radical, involving total excision of the prostate, sparing of nerves around the bladder and bladder neck reconstruction, with pelvic lymphadenectomy, not being a service associated with a service to which item 35551, 36502 or 37375 applies Y 37212 01DEC1991 PROSTATE, open perineal biopsy or open drainage of abscess Y 37215 01DEC1991 PROSTATE, biopsy of, endoscopic, with or without cystoscopy Y 37217 01JUL2011 Prostate, implantation of gold fiducial markers into the prostate gland or prostate surgical bed N 37217 01JAN2014 Prostate, implantation of radio-opaque fiducial markers into the prostate gland or prostate surgical bed Y 37218 01DEC1991 PROSTATE, needle biopsy of, or injection into N 37218 01JUL2011 PROSTATE, needle biopsy of, or injection into, excluding for insertion of radiopaque markers Y 37219 01MAY1994 PROSTATE, transrectal needle biopsy of, using transrectal prostatic ultrasound techniques and obtaining 1 or more prostatic specimens, being a service associated with a service to which item 55600 or 55603 applies N 37219 01JUL2012 PROSTATE, needle biopsy of, using prostatic ultrasound techniques and obtaining 1 or more prostatic specimens, being a service associated with a service to which item 55600 or 55603 applies Y 37220 01NOV2001 PROSTATE, radioactive seed implantation of, urological component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1, T2A or T2B, with a Gleason score of less than or equal to 6 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis.The procedure must be performed by a urologist at an approved site in association with a radiation oncologist, and be associated with a service to which item 55603 applies. N 37220 01NOV2005 PROSTATE, radioactive seed implantation of, urological component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate), with a Gleason score of less than or equal to 6 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis.The procedure must be performed by a urologist at an approved site in association with a radiation oncologist, and be associated with a service to which item 55603 applies. N 37220 01JUL2007 PROSTATE, radioactive seed implantation of, urological component, using transrectal ultrasound guidance, for localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate), with a Gleason score of less than or equal to 7 and a prostate specific antigen (PSA) of less than or equal to 10ng/ml at the time of diagnosis.The procedure must be performed by a urologist at an approved site in association with a radiation oncologist, and be associated with a service to which item 55603 applies. Y 37221 01DEC1991 PROSTATIC ABSCESS, endoscopic drainage of Y 37222 01NOV2001 This dummy item created on 5 March 2010 to facilitate the payment of benefits for item 37220 which should have had an (Anaes.) attributed to it from 1 Nov 2001 Y 37223 01MAY1997 PROSTATIC COIL, insertion of, under ultrasound control Y 37224 01MAY2003 PROSTATE, diathermy or visual laser destruction of lesion of, not being a service associated with a service to which item 37201, 37202, 37203, 37206, 37207, 37208 or 37215 applies Y 37225 01NOV2001 This dummy item created on 5 March 2010 to facilitate the payment of benefits for item 37220 which should have had an (Anaes.) attributed to it from 1 Nov 2001 Y 37227 01NOV2006 PROSTATE, transperineal insertion of catheters into, for high dose rate brachytherapy using ultrasound guidance including any associated cystoscopy. The procedure must be performed at an approved site in association with a radiation oncologist, and be associated with a service to which item 15327 or 15328 applies. N 37227 01MAY2007 PROSTATE, transperineal insertion of catheters into, for high dose rate brachytherapy using ultrasound guidance including any associated cystoscopy. The procedure must be performed at an approved site in association with a radiation oncologist, and be associated with a service to which item 15331 or 15332 applies. Y 37230 01MAY2006 PROSTATE, high-energy transurethral microwave thermotherapy of, with or without cystoscopy and with or without urethroscopy and including services to which item 36854, 37203, 37206, 37207, 37208, 37303, 37321 or 37324 applies Y 37233 01MAY2006 PROSTATE, high-energy transurethral microwave thermotherapy of, with or without cystoscopy and with or without urethroscopy and including services to which item 36854, 37303, 37321 or 37324 applies, continuation of, within 10 days of the procedure described by item 37201, 37203, 37207, 37230 which had to be discontinued for medical reasons Y 37245 01MAR2013 Prostate, endoscopic enucleation of, using high powered Holmium:YAG laser and an end-firing, non-contact fibre, with or without tissue morcellation, with or without cystoscopy and with or without urethroscopy, for the treatment of benign prostatic hyperplasia, other than a service associated with a service to which item 36854, 37201, 37202, 37203, 37206, 37207, 37208, 37303, 37321, or 37324 applies. N 37245 01MAY2013 Prostate, endoscopic enucleation of, using high powered Holmium:YAG laser and an end-firing, non-contact fibre, with or without tissue morcellation, cystoscopy or urethroscopy, for the treatment of benign prostatic hyperplasia, and other than a service associated with a service to which item 36854, 37201, 37202, 37203, 37206, 37207, 37208, 37303, 37321, or 37324 applies. Y 37300 01DEC1991 URETHRAL SOUNDS, passage of, as an independent procedure Y 37303 01DEC1991 URETHRAL STRICTURE, dilatation of Y 37306 01DEC1991 URETHRA, repair of rupture of distal section Y 37309 01DEC1991 URETHRA, repair of rupture of prostatic or membranous segment Y 37312 01DEC1991 URETHRAL FISTULA, closure of Y 37315 01DEC1991 URETHROSCOPY, as an independent procedure Y 37318 01DEC1991 URETHROSCOPY with any 1 or more of; biopsy, diathermy or removal of foreign body or stone N 37318 01JUL1995 URETHROSCOPY with any 1 or more of - biopsy, diathermy, visual laser destruction of stone or removal of foreign body or stone Y 37321 01DEC1991 URETHRAL MEATOTOMY, EXTERNAL Y 37324 01DEC1991 URETHROTOMY OR URETHROSTOMY, internal or external Y 37327 01DEC1991 URETHROTOMY, optical, for urethral stricture Y 37330 01DEC1991 URETHRECTOMY, partial or complete, for removal of tumour Y 37333 01DEC1991 URETHROVAGINAL FISTULA, closure of Y 37336 01DEC1991 URETHRORECTAL FISTULA, closure of Y 37338 01MAY2016 Urethral synthetic male sling system, division or removal of, for urethral obstruction or erosion, following previous surgery for urinary incontinence, other than a service associated with a service to which item 37340 or 37341 applies Y 37339 01DEC1991 PERIURETHRAL INJECTION of Teflon, including urethroscopy and cystoscopy N 37339 01JUL1995 PERIURETHRAL OR TRANSURETHRAL INJECTION of materials for the treatment of urinary incontinence, including cystoscopy and urethroscopy N 37339 27NOV2013 PERIURETHRAL OR TRANSURETHRAL INJECTION of materials for the treatment of urinary incontinence, including cystoscopy and urethroscopy, other than a service associated with a service to which item 18375 applies N 37339 01NOV2014 Periurethral or transurethral injection of materials for the treatment of urinary incontinence, including cystoscopy and urethroscopy, other than a service associated with a service to which item 18375 or 18379 applies Y 37340 01MAY2001 URETHRAL SLING, division or removal of, for urethral obstruction or erosion, following previous surgery for urinary incontinence, vaginal approach, not being a service associated with a service to which item number 37341 applies Y 37341 01MAY2001 URETHRAL SLING, division or removal of, for urethral obstruction or erosion, following previous surgery for urinary incontinence, suprapubic or combined suprapubic/vaginal approach, not being a service associated with a service to which item number 37340 applies Y 37342 01DEC1991 URETHROPLASTYsingle stage operation Y 37343 01MAY2001 URETHROPLASTY, single stage operation, transpubic approach via separate incisions above and below the symphysis pubis, excluding laparotomy, symphysectomy and suprapubic cystotomy, with or without re-routing of the urethra around the crura Y 37345 01DEC1991 URETHROPLASTY2 stage operationfirst stage Y 37348 01DEC1991 URETHROPLASTY2 stage operationsecond stage Y 37351 01DEC1991 URETHROPLASTY, not being a service to which another item in this Group applies Y 37354 01DEC1991 HYPOSPADIAS, meatotomy and hemicircumcision Y 37357 01DEC1991 HYPOSPADIAS, glanuloplasty incorporating meatal advancement Y 37360 01DEC1991 HYPOSPADIAS OR EPISPADIAS, with or without chordee, correction of, as a staged procedure, first stage Y 37363 01DEC1991 HYPOSPADIAS OR EPISPADIAS, with or without chordee, correction of, as a staged procedure, second stage Y 37366 01DEC1991 HYPOSPADIAS OR EPISPADIAS, with or without chordee, correction of, as 1 stage procedure, not being a service to which item 37357 applies Y 37369 01DEC1991 URETHRA, excision of prolapse of Y 37372 01DEC1991 URETHRAL DIVERTICULUM, excision of Y 37375 01DEC1991 URETHRAL SPHINCTER, reconstruction by bladder tubularisation technique or similar procedure Y 37378 01DEC1991 URETHRA, operation for correction of male urinary incontinence, not being a service to which item 37381 or 37390 applies Y 37381 01DEC1991 ARTIFICIAL URINARY SPHINCTER, insertion of cuff, perineal approach Y 37384 01DEC1991 ARTIFICIAL URINARY SPHINCTER, insertion of cuff, abdominal approach Y 37387 01DEC1991 ARTIFICIAL URINARY SPHINCTER, insertion of pressure regulating balloon and pump Y 37390 01DEC1991 ARTIFICIAL URINARY SPHINCTER, revision or removal of, with or without replacement Y 37393 01DEC1991 PRIAPISM, decompression by glanular stab cavernosospongiosum shunt or penile aspiration with or without lavage Y 37396 01DEC1991 PRIAPISM, shunt operation for, not being a service to which item 37393 applies Y 37399 01DEC1991 URETHRAL VALVE, destruction of, including cystoscopy and urethroscopy Y 37402 01DEC1991 PENIS, partial amputation of Y 37405 01DEC1991 PENIS, complete or radical amputation of Y 37408 01DEC1991 PENIS, repair of laceration of cavernous tissue, or fracture involving cavernous tissue Y 37411 01DEC1991 PENIS, repair of avulsion Y 37414 01DEC1991 PENIS, injection of, for investigation or treatment of impotence, priapism or Peyronie's plaque Y 37415 01JUL1996 PENIS, injection of, for the investigation and treatment of impotence - 2 services only in a period of 36 consecutive months Y 37417 01DEC1991 PENIS, correction of chordee, with or without excision of fibrous plaque or plaques and with or without grafting Y 37418 01MAY2001 PENIS, correction of chordee, with or without excision of fibrous plaque or plaques and with or without grafting, involving mobilization of the urethra Y 37420 01DEC1991 PENIS, surgery to inhibit rapid penile drainage causing impotence, by ligation of veins deep to Buck's fascia including 1 or more deep cavernosal veins with or without pharmacological erection test Y 37423 01DEC1991 PENIS, lengthening by translocation of corpora Y 37426 01DEC1991 PENIS, artificial erection device, insertion of, into 1 or both corpora Y 37429 01DEC1991 PENIS, artificial erection device, insertion of pump and pressure regulating reservoir Y 37432 01DEC1991 PENIS, artificial erection device, complete or partial revision or removal of components, with or without replacement Y 37435 01DEC1991 PENIS, frenuloplasty as an independent procedure Y 37438 01DEC1991 SCROTUM, partial excision of Y 37441 01DEC1991 PENIS ERECTION TEST FOR HYPOSPADIAS AND CHORDEE when performed under general anaesthesia, as an independent procedure Y 37444 01DEC1991 URETEROLITHOTOMY COMPLICATED BY PREVIOUS SURGERY at the same site of the same ureter Y 37600 01DEC1991 OPERATIONS ON TESTES, VASA OR SEMINAL VESICLES SPERMATOCELE OR EPIDIDYMAL CYST, excision of, 1 or more of, on 1 side Y 37601 01DEC1991 SPERMATOCELE OR EPIDIDYMAL CYST, excision of, 1 or more of, on 1 side Y 37604 01DEC1991 EXPLORATION OF SCROTAL CONTENTS, with or without fixation and with or without biopsy, unilateral N 37604 01MAY2002 EXPLORATION OF SCROTAL CONTENTS, with or without fixation and with or without biopsy, unilateral, not being a service associated with sperm harvesting for IVF Y 37605 01MAY2007 TRANSCUTANEOUS SPERM RETRIEVAL, unilateral, from either the testis or the epididymis, for the purposes ofINTRACYTOPLASMIC SPERM INJECTION, in a man with male factor infertility, excluding a service to which item 13218 applies. N 37605 01JUL2013 Transcutaneous sperm retrieval, unilateral, from either the testis or the epididymis, for the purposes ofintracytoplasmic sperm injection, for male factor infertility, excluding a service to which item 13218 applies. Y 37606 01MAY2007 OPEN SURGICAL SPERM RETRIEVAL, unilateral, including the exploration of scrotal contents, with our without biopsy, for the purposes ofINTRACYTOPLASMIC SPERM INJECTION, in a man with male factor infertility, performed in a hospital, excluding a service to which item13218 or 37604 applies. N 37606 01JUL2013 Open surgical sperm retrieval, unilateral, including the exploration of scrotal contents, with our without biopsy, for the purposes of intracytoplasmic sperm injection, for male factor infertility, performed in a hospital, excluding a service to which item13218 or 37604 applies. Y 37607 01DEC1991 RETROPERITONEAL LYMPH NODE DISSECTION, unilateral, not being a service associated with a service to which item 36528 applies Y 37610 01DEC1991 RETROPERITONEAL LYMPH NODE DISSECTION, unilateral, not being a service associated with a service to which item 36528 applies, following previous similar retroperitoneal dissection, retroperitoneal irradiation or chemotherapy Y 37613 01DEC1991 EPIDIDYMECTOMY Y 37616 01DEC1991 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope N 37616 01NOV1996 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, for other than reversal of previous sterilisation N 37616 01MAY2001 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, for other than reversal of previous elective sterilisation N 37616 01MAY2002 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, for other than reversal of previous elective sterilisation, not being a service associated with sperm harvesting for IVF N 37616 01JUL2008 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, using operating microscope, not being a service associated with sperm harvesting for IVF Y 37619 01DEC1991 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral N 37619 01NOV1996 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, for other than reversal of previous sterilisation N 37619 01MAY2001 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, for other than reversal of previous elective sterilisation N 37619 01MAY2002 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, for other than reversal of previous elective sterilisation, not being a service associated with sperm harvesting for IVF N 37619 01JUL2008 VASOVASOSTOMY or VASOEPIDIDYMOSTOMY, unilateral, not being a service associated with sperm harvesting for IVF Y 37622 01DEC1991 VASOTOMY OR VASECTOMY, unilateral or bilateral N 37622 01MAY2002 VASOTOMY OR VASECTOMY, unilateral or bilateral NOTE:Strict legal requirements apply in relation to sterilisation procedures on minors.Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law.Observe the explanatory note before submitting a claim. Y 37623 01DEC1991 VASOTOMY OR VASECTOMY, unilateral or bilateral N 37623 01MAY2002 VASOTOMY OR VASECTOMY, unilateral or bilateral NOTE:Strict legal requirements apply in relation to sterilisation procedures on minors.Medicare benefits are not payable for services not rendered in accordance with relevant Commonwealth and State and Territory law.Observe the explanatory note before submitting a claim. Y 37800 01NOV1994 PATENT URACHUS, excision of N 37800 01SEP2015 PATENT URACHUS, excision of, on a person 10 years of age or over. Y 37801 01SEP2015 PATENT URACHUS, excision of, when performed on a person under 10 years of age Y 37803 01NOV1994 UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37806 applies N 37803 01SEP2015 UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37806 applies, on a person 10 years of age or over. Y 37804 01SEP2015 UNDESCENDED TESTIS, orchidopexy for, not being a service to which item 37807 applies, on a person under 10 years of age Y 37806 01NOV1994 UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for N 37806 01SEP2015 UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for, on a person 10 years of age or over Y 37807 01SEP2015 UNDESCENDED TESTIS in inguinal canal close to deep inguinal ring or within abdominal cavity, orchidopexy for, on a person under 10 years of age Y 37809 01NOV1994 UNDESCENDED TESTIS, revision orchidopexy for N 37809 01SEP2015 UNDESCENDED TESTIS, revision orchidopexy for, on a person 10 years of age or over. Y 37810 01SEP2015 UNDESCENDED TESTIS, revision orchidopexy for, on a person under 10 years of age Y 37812 01NOV1994 IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37803 to 37809 applies N 37812 01SEP2015 IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37803, 37806 and 37809 applies, on a person 10 years of age or over. Y 37813 01SEP2015 IMPALPABLE TESTIS, exploration of groin for, not being a service associated with a service to which items 37804, 37807 and 37810 applies, on a person under 10 years of age Y 37815 01NOV1994 HYPOSPADIAS, examination under anaesthesia with erection test N 37815 01SEP2015 HYPOSPADIAS, examination under anaesthesia with erection test on a person 10 years of age or over. Y 37816 01SEP2015 HYPOSPADIAS, examination under anaesthesia with erection test, on a person under 10 years of age Y 37818 01NOV1994 HYPOSPADIAS, glanuloplasty incorporating meatal advancement N 37818 01SEP2015 HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a person 10 years of age or over Y 37819 01SEP2015 HYPOSPADIAS, glanuloplasty incorporating meatal advancement, on a person under 10 years of age Y 37821 01NOV1994 HYPOSPADIAS, distal, 1 stage repair N 37821 01SEP2015 HYPOSPADIAS, distal, 1 stage repair, on a person 10 years of age or over. Y 37822 01SEP2015 HYPOSPADIAS, distal, 1 stage repair, on a person under 10 years of age Y 37824 01NOV1994 HYPOSPADIAS, proximal, 1 stage repair N 37824 01SEP2015 HYPOSPADIAS, proximal, 1 stage repair on a person 10 years of age or over. Y 37825 01SEP2015 HYPOSPADIAS, proximal, 1 stage repair, on a person under 10 years of age Y 37827 01NOV1994 HYPOSPADIAS, staged repair, first stage N 37827 01SEP2015 HYPOSPADIAS, staged repair, first stage, on a person 10 years of age or over. Y 37828 01SEP2015 HYPOSPADIAS, staged repair, first stage, on a person under 10 years of age Y 37830 01NOV1994 HYPOSPADIAS, staged repair, second stage N 37830 01NOV2015 HYPOSPADIAS, staged repair, second stage, on a person 10 years of age or over. Y 37831 01NOV2015 HYPOSPADIAS, staged repair, second stage, on a person under 10 years of age. Y 37833 01NOV1994 HYPOSPADIAS, repair of post operative urethral fistula N 37833 01SEP2015 HYPOSPADIAS, repair of post-operative urethral fistula, on a person 10 years of age or over. Y 37834 01SEP2015 HYPOSPADIAS, repair of post-operative urethral fistula, on a person under 10 years of age Y 37836 01NOV1994 EPISPADIAS, staged repair, first stage Y 37839 01NOV1994 EPISPADIAS, staged repair, second stage Y 37842 01NOV1994 EXSTROPHY OF BLADDER OR EPISPADIAS, secondary repair with bladder neck tightening, with or without ureteric reimplantation Y 37845 01NOV1994 AMBIGUOUS GENITALIA WITH UROGENITAL SINUS, reduction clitoroplasty, with or without endoscopy Y 37848 01NOV1994 AMBIGUOUS GENITALIA WITH UROGENITAL SINUS, reduction clitoroplasty with endoscopy and vaginoplasty Y 37851 01NOV1994 CONGENITAL ADRENAL HYPERPLASIA, mixed gonadal dysgenesis or similar condition, vaginoplasty for, with or without endoscopy Y 37854 01NOV1994 URETHRAL VALVE, destruction of, including cystoscopy and urethroscopy Y 38200 01DEC1991 CARDIOLOGY PROCEDURES RIGHT HEART CATHETERISATION, including fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection and exercise stress test N 38200 01MAY2007 RIGHT HEART CATHETERISATION, with any one or more of the following: fluoroscopy, oximetry, dye dilution curves, cardiac output measurement by any method, shunt detection or exercise stress test Y 38203 01DEC1991 LEFT HEART CATHETERISATION by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular punctureincluding fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test N 38203 01MAY2007 LEFT HEART CATHETERISATION by percutaneous arterial puncture, arteriotomy or percutaneous left ventricular puncture with any one or more of the following: fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection or exercise stress test Y 38206 01DEC1991 RIGHT HEART CATHETERISATION WITH LEFT HEART CATHETERISATION via the right heart or by any other procedureincluding fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection and exercise stress test N 38206 01MAY2007 RIGHT HEART CATHETERISATION WITH LEFT HEART CATHETERISATION via the right heart or by any other procedure with any one or more of the following: fluoroscopy, oximetry, dye dilution curves, cardiac output measurements by any method, shunt detection or exercise stress test Y 38209 01DEC1991 CARDIAC ELECTROPHYSIOLOGICAL STUDYup to and including 3 catheter investigation of any 1 or more ofsyncope, atrioventricular conduction, sinus node function or simple ventricular tachycardia studies, not being a service associated with a service to which item 38212 applies N 38209 01NOV1996 CARDIAC ELECTROPHYSIOLOGICAL STUDYup to and including 3 catheter investigation of any 1 or more ofsyncope, atrioventricular conduction, sinus node function or simple ventricular tachycardia studies, not being a service associated with a service to which item 38212 or 38213 applies Y 38212 01DEC1991 CARDIAC ELECTROPHYSIOLOGICAL STUDY4 or more catheter supraventricular tachycardia investigation; or complex ventricular tachycardia investigation involving multiple ventricular tachycardia inductions, or multiple catheter mapping, or acute intravenous antiarrhythmic drug testing with pre and post drug inductions; or catheter ablation; or intraoperative mapping; or electrophysiological services during defibrillator implantation or testingnot being a service associated with a service to which item 38209 applies N 38212 01JUL1995 CARDIAC ELECTROPHYSIOLOGICAL STUDY4 or more catheter supraventricular tachycardia investigation; or complex ventricular tachycardia investigation involving multiple ventricular tachycardia inductions, or multiple catheter mapping, or acute intravenous antiarrhythmic drug testing with pre and post drug inductions; or catheter ablation to intentionally induce complete AV block; or intraoperative mapping; or electrophysiological services during defibrillator implantation or testingnot being a service associated with a service to which item 38209 applies N 38212 01NOV1996 CARDIAC ELECTROPHYSIOLOGICAL STUDY4 or more catheter supraventricular tachycardia investigation; or complex tachycardia inductions, or multiple catheter mapping, or acute intravenous antiarrhythmic drug testing with pre and post drug inductions; or catheter ablation to intentionally induce complete AV block; or intraoperative mapping; or electrophysiological services during defibrillator implantationnot being a service associated with a service to which item 38209 or 38213 applies Y 38213 01NOV1996 CARDIAC ELECTROPHYSIOLOGICAL STUDY, for follow-up testing of implanted defibrillator - not being a service associated with a service to which item 38209 or 38212 applies Y 38215 01DEC1991 SELECTIVE CORONARY ARTERIOGRAPHY placement of catheters and injection of opaque material N 38215 01NOV2001 SELECTIVE CORONARY ANGIOGRAPHY placement of catheters and injection of opaque material N 38215 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries, not being a service associated with a service to which item 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies Y 38218 01DEC1991 SELECTIVE CORONARY ARTERIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both N 38218 01NOV2001 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography N 38218 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography, not being a service associated with a service to which item 38215, 38220, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies Y 38220 01NOV2001 PLACEMENT OF CATHETER(S) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts) (Anaes.) N 38220 01MAY2002 SELECTIVE CORONARY GRAFT ANGIOGRAPHY placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.) Y 38221 01DEC1991 INTRA-AORTIC BALLOON FOR COUNTERPULSATION, operation for insertion by arteriotomy, or removal and arterioplasty (excluding repair by patch graft) Y 38222 01NOV2001 PLACEMENT OF CATHETER(S) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts) (Anaes.) N 38222 01MAY2002 SELECTIVE CORONARY GRAFT ANGIOGRAPHY, placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38225, 38228, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.) Y 38224 01DEC1991 PERMANENT INTERNAL PACEMAKER AND MYOCARDIAL ELECTRODES, insertion or replacement of by thoracotomy Y 38225 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries and placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38228, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.) Y 38227 01DEC1991 PERMANENT TRANSVENOUS ELECTRODE, insertion or replacement of Y 38228 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38231, 38234, 38237, 38240 or 38246 applies (Anaes.) Y 38230 01DEC1991 PERMANENT PACEMAKER, insertion or replacement of Y 38231 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material into the native coronary arteries and placement of catheter(s) and injection of opaque material into the free coronary graft(s) attached to the aorta (irrespective of the number of grafts), and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38234, 38237, 38240 or 38246 applies (Anaes.) Y 38233 01DEC1991 TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of Y 38234 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography and placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38237, 38240 or 38246 applies (Anaes.) Y 38236 01DEC1991 OPEN HEART SURGERY for congenital heart disease in children up to two years, excluding patent ductus arteriosus Y 38237 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38240 or 38246 applies (Anaes.) Y 38239 01DEC1991 OPEN HEART SURGERY for single valve replacement, atrial septal defect, pulmonary valvotomy, congenital heart disease (not covered by Item 38236) or any other open heart operation not covered by any other item in this Group Y 38240 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography and placement of catheter(s) and injection of opaque material into free coronary graft(s) attached to the aorta (irrespective of the number of grafts) and placement of catheter(s) and injection of opaque material into direct internal mammary artery graft(s) to one or more coronary arteries (irrespective of the number of grafts), not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38237 or 38246 applies (Anaes.) Y 38241 01NOV2006 USE OF A CORONARY PRESSURE WIRE during selective coronary angiography to measure fractional flow reserve (FFR) and coronary flow reserve (CFR) in one or more intermediate coronary artery or graft lesions (stenosis of 30-70%), to determine whether revascularisation should be performed where previous stress testing has either not been performed or the results are inconclusive Y 38242 01DEC1991 OPEN HEART SURGERY on more than one valve or involving more than one chamber Y 38243 01MAY2002 PLACEMENT OF CATHETER(S) and injection of opaque material into any coronary vessel(s) or graft(s) prior to any coronary interventional procedure, not being a service associated with a service to which item 38246 applies (Anaes.) Y 38245 01DEC1991 CORONARY ARTERY OR ARTERIES, direct surgery to, employing cardiopulmonary bypass Y 38246 01MAY2002 SELECTIVE CORONARY ANGIOGRAPHY, placement of catheters and injection of opaque material with right or left heart catheterisation or both, or aortography followed by placement of catheters prior to any coronary interventional procedure, not being a service associated with a service to which item 38215, 38218, 38220, 38222, 38225, 38228, 38231, 38234, 38237, 38240 or 38243 applies (Anaes.) Y 38250 01JUL1993 SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion of Y 38253 01JUL1993 PERMANENT PACEMAKER, insertion or replacement of N 38253 01MAY1997 PERMANENT PACEMAKER, insertion, removal or replacement of Y 38256 01JUL1993 TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of Y 38259 01JUL1993 PERMANENT DUAL CHAMBER TRANSVENOUS ELECTRODES, insertion of N 38259 01MAY1997 PERMANENT DUAL CHAMBER TRANSVENOUS ELECTRODES, insertion, removal, or replacement of Y 38270 01MAY1997 BALLOON VALVULOPLASTY OR SEPTOSTOMY, including cardiac catheterisations before and after balloon dilatation N 38270 01NOV2004 BALLOON VALVULOPLASTY OR ISOLATED ATRIAL SEPTOSTOMY, including cardiac catheterisations before and after balloon dilatation Y 38272 01NOV2005 ATRIAL SEPTAL DEFECT closure, with septal occluder or other similar device, by transcatheter approach Y 38273 01JUL2014 Patent ductus arteriosus, transcatheter closure of, including cardiac catheterisation and any imaging associated with the service Y 38274 01JUL2014 Ventricular septal defect, transcatheter closure of, with imaging and cardiac catheterisation Y 38275 01MAY1997 MYOCARDIAL BIOPSY, by cardiac catheterisation Y 38276 01NOV2017 Transcatheter occlusion of left atrial appendage, and cardiac catheterisation performed by the same practitioner, for stroke prevention in a patient who has non?valvular atrial fibrillation and a contraindication to life?long oral anticoagulation therapy, and is at increased risk of thromboembolism demonstrated by: (a) a prior stroke (whether of an ischaemic or unknown type), transient ischaemic attack or non?central nervous system systemic embolism; or (b) at least 2 of the following risk factors: (i) an age of 65 years or more; (ii) hypertension; (iii) diabetes mellitus; (iv) heart failure or left ventricular ejection fraction of 35% or less (or both); (v) vascular disease (prior myocardial infarction, peripheral artery disease or aortic plaque) Y 38278 01JUL1998 SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or replacement of Y 38281 01JUL1998 PERMANENT PACEMAKER, insertion, removal or replacement of N 38281 01MAY2002 PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of Y 38284 01JUL1998 DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or replacement of Y 38285 01NOV2004 IMPLANTABLE ECG LOOP RECORDER, insertion of, for diagnosis of primary disorder in patients with recurrent unexplained syncope where: -a diagnosis has not been achieved through all other available cardiac investigations; and -a neurogenic cause is not suspected; and -it has been determined that the patient does not have structural heart disease associated with a high risk of sudden cardiac death. including initial programming and testing, as an admitted patient in an approved hospital Y 38286 01NOV2004 IMPLANTABLE ECG LOOP RECORDER, removal of, as an admitted patient in an approved hospital Y 38287 01JUL1998 ABLATION OF ARRHYTHMIA CIRCUIT OR FOCUS or isolation procedure involving 1 atrial chamber Y 38288 01MAY2018 Implantable loop recorder, insertion of, for diagnosis of atrial fibrillation, if: (a) the patient to whom the service is provided has been diagnosed as having had an embolic stroke of undetermined source; and (b) the bases of the diagnosis included the following: (i) the medical history of the patient; (ii) physical examination; (iii) brain and carotid imaging; (iv) cardiac imaging; (v) surface ECG testing including 24?hour Holter monitoring; and (c) atrial fibrillation is suspected; and (d) the patient: (i) does not have a permanent indication for oral anticoagulants; or (ii) does not have a permanent oral anticoagulants contraindication; including initial programming and testing Y 38290 01JUL1998 ABLATION OF ARRHYTHMIA CIRCUITS OR FOCI, or isolation procedure involving both atrial chambers and including curative procedures for atrial fibrillation Y 38293 01JUL1998 VENTRICULAR ARRHYTHMIA with mapping and ablation, including all associated electrophysiological studies performed on the same day Y 38300 01NOV2005 TRANSLUMINAL BALLOON ANGIOPLASTY of 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation, and excluding aftercare Y 38303 01NOV2005 TRANSLUMINAL BALLOON ANGIOPLASTY of more than 1 coronary artery, percutaneous or by open exposure, excluding associated radiological services or preparation and excluding aftercare Y 38306 01NOV2005 TRANSLUMINAL STENT INSERTION including associated balloon dilatation for coronary artery, percutaneous or by open exposure, excluding associated radiological services and preparation, and excluding aftercare N 38306 01NOV2006 TRANSLUMINAL INSERTION OF STENT OR STENTS into 1 occlusional site, including associated balloon dilatation for coronary artery, percutaneous or by open exposure, excluding associated radiological services and preparation, and excluding aftercare N 38306 24MAY2017 Transluminal insertion of stent or stents into one occlusional site, including associated balloon dilatation of coronary artery, percutaneous or by open exposure, excluding associated radiological services, radiological preparation and after?care Y 38309 01NOV2005 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with no stent insertion, where: -no lesion of the coronary artery has been stented; and -each lesion of the coronary artery is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare Y 38312 01NOV2005 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of 1 coronary artery, including balloon angioplasty with insertion of 1 or more stents, where: -no lesion of the coronary artery has been stented; and -each lesion of the coronary artery is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare Y 38315 01NOV2005 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty with no stent insertion, where: -no lesion of the coronary arteries has been stented; and -each lesion of the coronary arteries is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable; excluding associated radiological services or preparation, and excluding aftercare Y 38318 01NOV2005 PERCUTANEOUS TRANSLUMINAL ROTATIONAL ATHERECTOMY of more than 1 coronary artery, including balloon angioplasty, with insertion of 1 or more stents, where: -no lesion of the coronary arteries has been stented; and -each lesion of the coronary arteries is complex and heavily calcified; and -balloon angioplasty with or without stenting is not suitable, excluding associated radiological services or preparation, and excluding aftercare Y 38321 01NOV2005 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 38324 01NOV2005 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty -intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 38327 01NOV2005 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty -percutaneous transluminal rotational artherectomy using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 38330 01NOV2005 CATHETER BASED INTRAVASCULAR BRACHYTHERAPY treatment of in-stent restenoses in 1 coronary artery, catheterisation for, including in the same artery; -balloon angioplasty -percutaneous transluminal rotational artherectomy -intravascular ultrasound using automated intravascular brachytherapy systems approved by the Therapeutic Goods Administration, excluding associated radiological services or preparation, and excluding aftercare. The procedure must be performed by a cardiologist in association with a radiation oncologist, and be associated with a service to which item 15360, 15363 or 15541 applies. Y 38350 01NOV2005 SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or replacement of, N 38350 01NOV2010 SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion, removal or replacement of, including cardiac electrophysiological services where used for pacemaker implantation Y 38353 01NOV2005 PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of N 38353 01MAY2006 PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of, not for cardiac resynchronisation therapy N 38353 01NOV2010 PERMANENT CARDIAC PACEMAKER, insertion, removal or replacement of, not for cardiac resynchronisation therapy, including cardiac electrophysiological services where used for pacemaker implantation Y 38356 01NOV2005 DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or replacement of N 38356 01NOV2010 DUAL CHAMBER PERMANENT TRANSVENOUS ELECTRODES, insertion, removal or replacement of, including cardiac electrophysiological services where used for pacemaker implantation Y 38358 01NOV2005 Extraction of chronically implanted transvenous pacing or defibrillator lead or leads, by percutaneous method where the leads have been in situ for greater than six months and require removal with locking stylets, snares and/or extraction sheaths in a facility where cardiac surgery is available, in association with item 61109 or 60509 Y 38359 01NOV2005 PERICARDIUM, paracentesis of (excluding aftercare) Y 38362 01NOV2005 INTRA-AORTIC BALLOON PUMP, percutaneous insertion of Y 38365 01MAY2006 PERMANENT CARDIAC SYNCRONISATION DEVICE, insertion, removal or replacement of, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria: -sinus rhythm -a left ventricular ejection fraction of less than or equal to 35% -a QRS duration greater than or equal to 120ms. N 38365 01JUL2014 Permanent cardiac synchronisation device (including a cardiac synchronisation device that is capable of defibrillation), insertion, removal or replacement of, for a patient who: (a)has: (i)moderate to severe chronic heart failure (New York Heart Association (NYHA) class III or IV) despite optimised medical therapy; and (ii) sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 120 ms; or (b)satisfied the requirements mentioned in paragraph (a) immediately before the insertion of a cardiac resynchronisation therapy device and transvenous left ventricle electrode Y 38368 01MAY2006 PERMANENT TRANSVENOUS LEFT VENTRICULAR ELECTRODE, insertion, removal or replacement of through the coronary sinus, for the purpose of cardiac resynchronisation therapy, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria: -sinus rhythm -a left ventricular ejection fraction of less than or equal to 35% -a QRS duration greater than or equal to 120ms. Where the service includes right heart catheterisation and any associated venogram of left ventricular veins. Not being a service associated with a service to which items 38200 and 35200 apply N 38368 01JUL2014 Permanent transvenous left ventricular electrode, insertion, removal or replacement of through the coronary sinus, for the purpose of cardiac resynchronisation therapy, including right heart catheterisation and any associated venogram of left ventricular veins, other than a service associated with a service to which item 35200 or 38200 applies, for a patient who: (a)has: (i)moderate to severe chronic heart failure (New York Heart Association (NYHA) class III or IV) despite optimised medical therapy; and (ii) sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 120 ms; or (b)has: (i)mild chronic heart failure (New York Heart Association (NYHA) class II) despite optimised medical therapy; and (ii)sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 150 ms; or (c)satisfied the requirements mentioned in paragraph (a) or (b) immediately before the insertion of a cardiac resynchronisation therapy device and transvenous left ventricle electrode Y 38371 01NOV2006 PERMANENT CARDIAC SYNCHRONISATION DEVICE CAPABLE OF DEFIBRILLATION, insertion, removal or replacement of, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy who meet all of the following criteria: - sinus rhythm - a left ventricular ejection fraction of less than or equal to 35% - a QRS duration greater than or equal to 120ms. N 38371 01JUL2014 Permanent cardiac synchronisation device capable of defibrillation, insertion, removal or replacement of, for a patient who: (a)has: (i)moderate to severe chronic heart failure (New York Heart Association ((NYHA) class III or IV) despite optimised medical therapy; and (ii)sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 120 ms; or (b)has: (i)mild chronic heart failure (New York Heart Association (NYHA) class II) despite optimised medical therapy; and (ii)sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 150 ms Y 38384 01NOV2006 AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrodes for, primary prevention of sudden cardiac death in: - patients with a left ventricular ejection fraction of less than or equal to 30% at least one month after a myocardial infarct when the patient has received optimised medical therapy; or - patients with chronic heart failure associated with mild to moderate symptoms (NYHA II and III) and a left ventricular ejection fraction less than or equal to 35% when the patient has received optimised medical therapy. Not being a service associatedwith a service to which item 38213 applies Y 38387 01NOV2006 AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of for, primary prevention of sudden cardiac death in: - patients with a left ventricular ejection fraction of less than or equal to 30% at least one month after a myocardial infarct when the patient has received optimised medical therapy; or - patients with chronic heart failure associated with mild to moderate symptoms (NYHA II and III) and a left ventricular ejection fraction less than or equal to 35% when the patient has received optimised medical therapy. Not being a service associatedwith a service to which item 38213 applies, not for defibrillators capable of cardiac resynchronisation therapy Y 38390 01NOV2005 AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrodes for - not being a service associatedwith a service to which item 38213 applies N 38390 01NOV2006 AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrodes for - not for patients with heart failure or as primary prevention for tachycardia arrhythmias. Not being a service associatedwith a service to which item 38213 applies Y 38393 01NOV2005 AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of - not being a service associated with a service to which item 38213 applies N 38393 01MAY2006 AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of - not being a service associated with a service to which item 38213 applies, not for defibrillators capable of cardiac resynchronisation therapy N 38393 01NOV2006 AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of for - not for patients with heart failure or as primaryprevention for tachycardia arrhythmias. Not being a service associated with a service to which item 38213 applies. Y 38400 01DEC1991 THORACIC SURGERY THORACIC CAVITY, aspiration of, for diagnostic purposes, not being a service associated with a service to which item 38403 applies Y 38403 01DEC1991 THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with or without diagnostic sample Y 38406 01DEC1991 THORACIC SURGERY PERICARDIUM, paracentesis of (excluding aftercare) Y 38409 01DEC1991 INTERCOSTAL DRAIN, insertion of, not involving resection of rib (excluding aftercare) Y 38410 01JUL1993 INTERCOSTAL DRAIN, insertion of, with pleurodesis and not involving resection of rib (excluding aftercare) Y 38412 01DEC1991 PERCUTANEOUS NEEDLE BIOPSY of lung Y 38415 01DEC1991 EMPYEMA, radical operation for, involving resection of rib Y 38418 01DEC1991 THORACOTOMY, exploratory, with or without biopsy Y 38421 01DEC1991 THORACOTOMY, with pulmonary decortication Y 38424 01DEC1991 THORACOTOMY, with pleurectomy or pleurodesis, OR ENUCLEATION OF HYDATID cysts Y 38427 01DEC1991 THORACOPLASTY (COMPLETE) N 38427 01NOV1992 THORACOPLASTY (complete) - 3 or more ribs Y 38430 01DEC1991 THORACOPLASTY (in stages)each stage Y 38432 01NOV1992 PECTUS EXCAVATUM or PECTUS CARINATUM, repair or radical correction of Y 38433 01DEC1991 PECTUS EXCAVATUM OR PECTUS CARINATUM, radical correction of Y 38434 01NOV1992 PECTUS EXCAVATUM or PECTUS CARINATUM, repair with implantation of subcutaneous prosthesis of Y 38436 01DEC1991 THORACOSCOPY, with or without division of pleural adhesions N 38436 01NOV1992 THORACOSCOPY, with or without division of pleural adhesions, including insertion of intercostal catheter, with or without biopsy N 38436 01MAY2004 THORACOSCOPY, with or without division of pleural adhesions, including insertion of intercostal catheter where necessary, with or without biopsy Y 38438 01NOV1992 PNEUMONECTOMY or LOBECTOMY or SEGMENTECTOMY N 38438 01MAY1997 PNEUMONECTOMY or LOBECTOMY or SEGMENTECTOMY not being a service associated with a service to which Item 38418 applies Y 38439 01DEC1991 PNEUMONECTOMY or lobectomy Y 38440 01NOV1992 LUNG, wedge resection of Y 38441 01NOV1992 RADICAL LOBECTOMY or PNEUMONECTOMY including resection of chest wall, diaphragm, pericardium, or formal mediastinal node dissection Y 38442 01DEC1991 OESOPHAGECTOMY, with direct anastomosis OR WITH STOMACH TRANSPOSITION N 38442 01NOV1992 Oesophagectomy with gastric reconstruction Y 38445 01DEC1991 OESOPHAGECTOMY, with interposition of small or large bowel Y 38446 01NOV1992 THORACOTOMY or STERNOTOMY, for removal of thymus or mediastinal tumour Y 38447 01JUL1993 PERICARDIECTOMY via sternotomy or anterolateral thoracotomy without cardiopulmonary bypass Y 38448 01DEC1991 MEDIASTINUM, cervical exploration of, with or without biopsy Y 38449 01JUL1993 PERICARDIECTOMY via sternotomy or anterolateral thoracotomy with cardiopulmonary bypass Y 38450 01NOV1992 PERICARDIUM, transthoracic drainage of N 38450 01NOV2005 PERICARDIUM, transthoracic open surgical drainage of Y 38451 01DEC1991 PERICARDIUM, TRANSTHORACIC DRAINAGE OF (other than for treatment of constrictive pericarditis) Y 38452 01NOV1992 PERICARDIUM, sub-xyphoid drainage of N 38452 01JUN2017 PERICARDIUM, subxiphoid open surgical drainage of Y 38453 01NOV1992 TRACHEAL excision and repair without cardiopulmonary bypass Y 38454 01DEC1991 INTRATHORACIC OPERATION on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum, or on more than 1 of those organs, not being a service to which another item in this Group applies Y 38455 01JUL1993 TRACHEAL EXCISION AND REPAIR OF, with cardiopulmonary bypass Y 38456 01JUL1993 INTRATHORACIC OPERATION on heart, lungs, great vessels, bronchial tree, oesophagus or mediastinum, or on more than 1 of those organs, not being a service to which another item in this Group applies Y 38457 01JUL1993 PECTUS EXCAVATUM or PECTUS CARINATUM, repair or radical correction of Y 38458 01JUL1993 PECTUS EXCAVATUM, repair of, with implantation of subcutaneous prosthesis Y 38460 01JUL1993 STERNAL WIRE OR WIRES, removal of Y 38462 01JUL1993 STERNOTOMY WOUND, debridement of, not involving reopening of the mediastinum Y 38464 01JUL1993 STERNOTOMY WOUND, debridement of, involving curettage of infected bone with or without removal of wires but not involving reopening of the mediastinum Y 38466 01JUL1993 STERNUM, reoperation on, for dehiscence or infection involving reopening of the mediastinum, with or without rewiring Y 38468 01JUL1993 STERNUM AND MEDIASTINUM, reoperation for infection of, involving muscle advancement flaps or greater omentum Y 38469 01JUL1993 STERNUM AND MEDIASTINUM, reoperation for infection of, involving muscle advancement flaps and greater omentum Y 38470 01NOV1992 PACEMAKER PROCEDURES PERMANENT MYOCARDIAL ELECTRODE, insertion of, by thoracotomy N 38470 01MAY1997 PERMANENT MYOCARDIAL ELECTRODE, insertion of, by thoracotomy or sternotomy Y 38473 01NOV1992 PERMANENT PACEMAKER ELECTRODE, insertion by sub-xyphoid approach N 38473 01NOV2005 PERMANENT PACEMAKER ELECTRODE, insertion by open surgical approach Y 38475 01NOV1995 VALVE ANNULOPLASTY without insertion of ring, not being a service associated with a service to which item 38480 or 38481 applies Y 38476 01NOV1992 SINGLE CHAMBER PERMANENT TRANSVENOUS ELECTRODE, insertion of Y 38477 01NOV1995 VALVE ANNULOPLASTY with insertion of ring not being a service to which item 38478 applies Y 38478 01NOV1995 VALVE ANNULOPLASTY with insertion of ring performed in conjunction with item 38480 or 38481 Y 38479 01NOV1992 PERMANENT PACEMAKER, insertion or replacement of Y 38480 01NOV1995 VALVE REPAIR, 1 leaflet Y 38481 01NOV1995 VALVE REPAIR, 2 or more leaflets Y 38482 01NOV1992 TEMPORARY TRANSVENOUS PACEMAKING ELECTRODE, insertion of Y 38483 01NOV1995 AORTIC VALVE LEAFLET OR LEAFLETS, decalcification of, not being a service to which item 38475, 38477, 38480, 38481, 38488 or 38489 applies Y 38485 01NOV1992 PERMANENT DUAL CHAMBER TRANSVENOUS ELECTRODES, insertion of N 38485 01NOV1995 MITRAL ANNULUS, reconstruction of, after decalcification, when performed in association with valve surgery Y 38486 01JUL1993 AORTIC VALVE, decalcification of Y 38487 01JUL1993 MITRAL VALVE, open valvotomy of Y 38488 01NOV1992 VALVULAR PROCEDURES VALVE REPLACEMENT with BIOPROSTHESIS or MECHANICAL PROSTHESIS N 38488 01JUL1993 VALVE REPLACEMENT with BIOPROSTHESIS, MECHANICAL PROSTHESIS or UNSTENTED XENOGRAFT N 38488 01NOV1995 VALVE REPLACEMENT with BIOPROSTHESIS OR MECHANICAL PROSTHESIS Y 38489 01NOV1995 VALVE REPLACEMENT with allograft (subcoronary or cylindrical implant), or unstented xenograft Y 38490 01NOV1995 SUB-VALVULAR STRUCTURES, reconstruction and re-implantation of, associated with mitral and tricuspid valve replacement Y 38491 01NOV1992 VALVE REPLACEMENT with ALLOGRAFT or UNSTENTED XENOGRAFT Y 38492 01JUL1993 VALVE REPLACEMENT WITH ALLOGRAFT, subcoronary or cylindrical implant Y 38493 01NOV1998 OPERATIVE MANAGEMENT of acute infective endocarditis, in association with heart valve surgery Y 38494 01NOV1992 VALVE, repair of Y 38495 01NOV2017 TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, in a TAVI Hospital on a TAVI Patient by a TAVI Practitioner -includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient. (Not payable more than once per patient in a five year period.) Y 38496 01NOV1995 ARTERY HARVESTING (other than internal mammary), for coronary artery bypass Y 38497 01NOV1992 SURGERY FOR ISCHAEMIC HEART DISEASE CORONARY ARTERY BYPASS using saphenous vein graft or grafts only N 38497 01NOV1993 SURGERY FOR ISCHAEMIC HEART DISEASE CORONARY ARTERY BYPASS using saphenous vein graft or grafts only, including harvesting of graft material where performed N 38497 01NOV1995 CORONARY ARTERY BYPASS using saphenous vein graft or grafts only, including harvesting of vein graft material where performed N 38497 01NOV2002 CORONARY ARTERY BYPASS with cardiopulmonary bypass, using saphenous vein graft or grafts only, including harvesting of vein graft material where performed, not being a service asociated with a service to which items 38498, 38500, 38501, 38503 or 38504 apply Y 38498 01NOV2002 CORONARY ARTERY BYPASS with the aid of tissue stabilisers, performed without cardiopulmonary bypass, using saphenous vein graft or grafts only, including harvesting of vein graft material where performed, either via a median sternotomy or other minimally invasive technique and where a stand-by perfusionist is present, not being a service associated with a service to which items 38497, 38500, 38501, 38503, 38504 or 38600 apply Y 38500 01NOV1992 CORONARY ARTERY BYPASS using single arterial graft, with or without vein graft or grafts N 38500 01NOV1993 CORONARY ARTERY BYPASS using single arterial graft, with or without vein graft or grafts, including harvesting of graft material where performed N 38500 01NOV1995 CORONARY ARTERY BYPASS using single arterial graft, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed N 38500 01NOV2002 CORONARY ARTERY BYPASS with cardiopulmonary bypass, using single arterial graft, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, not being a service associated with a service to which items 38497, 38498, 38501, 38503 or 38504 apply Y 38501 01NOV2002 CORONARY ARTERY BYPASS with the aid of tissue stabilisers, performed without cardiopulmonary bypass, using single arterial graft, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, either via a median sternotomy or other minimally invasive technique and where a stand-by perfusionist is present, not being a service associated with a service to which items 38497, 38498, 38500, 38503,38504 or 38600 apply Y 38503 01NOV1992 CORONARY ARTERY BYPASS using 2 or more arterial grafts, with or without vein graft or grafts N 38503 01NOV1993 CORONARY ARTERY BYPASS using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of graft material where performed N 38503 01NOV1995 CORONARY ARTERY BYPASS using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed N 38503 01NOV2002 CORONARY ARTERY BYPASS with cardiopulmonary bypass, using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, not being a service associated with a service to which items 38497, 38498, 38500, 38501 or 38504 apply Y 38504 01NOV2002 CORONARY ARTERY BYPASS with the aid of tissue stabilisers, performed without cardiopulmonary bypass, using 2 or more arterial grafts, with or without vein graft or grafts, including harvesting of internal mammary artery or vein graft material where performed, either via a median sternotomy or other minimally invasive technique and where a stand-by perfusionist is present, not being a service associated with a service to which items 38497, 38498, 38500, 38501, 38503 or 38600 apply Y 38505 01NOV1995 CORONARY ENDARTERECTOMY, by open operation, including repair with 1 or more patch grafts, each vessel Y 38506 01NOV1992 LEFT VENTRICULAR ANEURYSMECTOMY N 38506 01NOV1995 LEFT VENTRICULAR ANEURYSM, plication of Y 38507 01NOV1995 LEFT VENTRICULAR ANEURYSM resection with primary repair Y 38508 01NOV1995 LEFT VENTRICULAR ANEURYSM resection with patch reconstruction of the left ventricle Y 38509 01NOV1992 ISCHAEMIC VENTRICULAR SEPTAL RUPTURE, repair of Y 38512 01NOV1992 DIVISION OF ACCESSORY PATHWAY, isolation procedure, procedure on atrioventricular node or perinodal tissues involving 1 atrial chamber only Y 38515 01NOV1992 DIVISION OF ACCESSORY PATHWAY, isolation procedure, procedure on atrioventricular node or perinodal tissues involving both atrial chambers and including curative surgery for atrial fibrillation Y 38518 01NOV1992 VENTRICULAR ARRHYTHMIA with mapping and muscle ablation, with or without aneurysmeotomy Y 38521 01NOV1992 AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrode for - not being a service associatedwith a service to which item 38213 applies N 38521 01JUL1998 AUTOMATIC DEFIBRILLATOR, insertion of patches for, or insertion of transvenous endocardial defibrillation electrode for - not being a service associatedwith a service to which item 38213 applies Y 38524 01NOV1992 AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of N 38524 01JUL1998 AUTOMATIC DEFIBRILLATOR GENERATOR, insertion or replacement of - not being a service associated with a service to which item 38213 applies Y 38530 01JUL1995 ARRHYTHMIA ABLATION ABLATION OF ARRHYTHMIA CIRCUIT OR FOCUS or isolation procedure involving 1 atrial chamber Y 38533 01JUL1995 ABLATION OF ARRHYTHMIA CIRCUITS OR FOCI, or isolation procedure involving both atrial chambers and including curative procedures for atrial fibrillation Y 38536 01JUL1995 VENTRICULAR ARRHYTHMIA with mapping and ablation, including all associated electrophysiological studies performed on the same day Y 38550 01NOV1992 ASCENDING THORACIC AORTA, repair or replacement of, not involving valve replacement or repair or coronary artery implantation Y 38553 01NOV1992 ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, without implantation of coronary arteries Y 38556 01NOV1992 ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, and implantation of coronary arteries Y 38559 01NOV1992 AORTIC ARCH and ASCENDING THORACIC AORTA, repair or replacement of, not involving valve replacement or repair or coronary artery implantation Y 38562 01NOV1992 AORTIC ARCH and ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, without implantation of coronary arteries Y 38565 01NOV1992 AORTIC ARCH and ASCENDING THORACIC AORTA, repair or replacement of, with aortic valve replacement or repair, and implantation of coronary arteries Y 38568 01NOV1992 DESCENDING THORACIC AORTA, repair or replacement of, without shunt or cardiopulmonary bypass N 38568 01NOV2006 DESCENDING THORACIC AORTA, repair or replacement of, without shunt or cardiopulmonary bypass, by open exposure, percutaneous or endovascular means Y 38571 01NOV1992 DESCENDING THORACIC AORTA, repair or replacement of, using shunt or cardiopulmonary bypass Y 38572 01JUL1993 OPERATIVE MANAGEMENT OF ACUTE RUPTURE OR DISSECTION, in conjunction with procedures on the thoracic aorta Y 38573 01JUL1998 OPERATIVE MANAGEMENT of acute infective endocarditis, in association with heart valve surgery Y 38574 01NOV1992 DEEP HYPOTHERMIA with cardiac arrest, in conjunction with OPEN HEART SURGERY N 38574 01JUL1998 Deep hypothermia with circulatory arrest, in conjunction with open heart surgery (Assist.) Y 38577 01NOV1995 CANNULATION FOR, and supervision and monitoring of, the administration of retrograde cerebral perfusion during deep hypothermic arrest Y 38588 01NOV1995 CANNULATION of the coronary sinus for, and supervision of, the retrograde administration of blood or crystalloid for cardioplegia, including pressure monitoring Y 38600 01NOV1992 CIRCULATORY SUPPORT PROCEDURES CENTRAL CANNULATION for cardiopulmonary bypass excluding post-operative management, not being a service associated with a service to which another item in this Subgroup applies N 38600 01JUL1993 CENTRAL CANNULATION for cardiopulmonary bypass excluding post-operative management, not being a service associated with a service to which another item in this Subgroup applies Y 38603 01NOV1992 PERIPHERAL CANNULATION for cardiopulmonary artery bypass excluding post-operative management, not being a service associated with a service to which another item in this Subgroup applies N 38603 01JUL1993 PERIPHERAL CANNULATION for cardiopulmonary bypass excluding post-operative management Y 38606 01NOV1992 INTRA-AORTIC BALLOON PUMP, percutaneous insertion of Y 38609 01NOV1992 INTRA-AORTIC BALLOON PUMP, insertion by femoral arteriotomy N 38609 01JUL1993 INTRA-AORTIC BALLOON PUMP, insertion of, by arteriotomy Y 38612 01NOV1992 INTRA-AORTIC BALLOON PUMP, removal with closure of femoral artery by direct suture N 38612 01JUL1993 INTRA-AORTIC BALLOON PUMP, removal of, with closure of artery by direct suture Y 38613 01JUL1993 INTRA-AORTIC BALLOON PUMP, removal of, with closure of artery by patch graft Y 38615 01NOV1992 LEFT OR RIGHT VENTRICULAR ASSIST DEVICE, insertion of N 38615 01NOV2015 Insertion of a left or right ventricular assist device, for use as: (a)a bridge to cardiac transplantation in patients with refractory heart failure who are: (i)currently on a heart transplant waiting list, or (ii)expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b)acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c)cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; not being a service associated with the use of a ventricular assist device as destination therapy in the management of patients with heart failure who are not expected to be suitable candidates for cardiac transplantation Y 38618 01NOV1992 LEFT AND RIGHT VENTRICULAR ASSIST DEVICE, insertion of N 38618 01NOV2015 Insertion of a left and right ventricular assist device, for use as: (a)a bridge to cardiac transplantation in patients with refractory heart failure who are: (i)currently on a heart transplant waiting list, or (ii)expected to be suitable candidates for cardiac transplantation following a period of support on the ventricular assist device; or (b)acute post cardiotomy support for failure to wean from cardiopulmonary transplantation; or (c)cardio-respiratory support for acute cardiac failure which is likely to recover with short term support of less than 6 weeks; not being a service associated with the use of a ventricular assist device as destination therapy in the management of patients with heart failure who are not expected to be suitable candidates for cardiac transplantation Y 38621 01NOV1992 LEFT OR RIGHT VENTRICULAR ASSIST DEVICE, removal of, as an independent procedure Y 38624 01NOV1992 LEFT AND RIGHT VENTRICULAR ASSIST DEVICE, removal of, as an independent procedure Y 38627 01JUL1998 EXTRA-CORPOREAL MEMBRANE OXYGENATION, BYPASS OR VENTRICULAR ASSIST DEVICE CANNULAE, adjustment and re-positioning of, by open operation, in patients supported by these devices Y 38637 01NOV1995 PATENT DISEASED coronary artery bypass vein graft or grafts, dissection, disconnection and oversewing of Y 38640 01NOV1992 RE-OPERATION RE-OPERATION via median sternotomy, for any procedure N 38640 01NOV1993 RE-OPERATION via median sternotomy, for any procedure, including any divisions of adhesions where the time taken to divide the adhesions is 45 minutes or less Y 38643 01NOV1995 THORACOTOMY OR STERNOTOMY involving division of adhesions where the time taken to divide the adhesions exceeds 45 minutes Y 38647 01NOV1995 THORACOTOMY OR STERNOTOMY involving division of extensive adhesions where the time taken to divide the adhesions exceeds 2 hours Y 38650 01NOV1992 MYOMECTOMY or MYOTOMY for hypertrophic obstructive cardiomyopathy Y 38653 01NOV1992 OPEN HEART SURGERY, not being a service to which another item in this Group applies Y 38654 01MAY2006 PERMANENT LEFT VENTRICULAR ELECTRODE, insertion, removal or replacement of via open thoracotomy, for the purpose of cardiac resynchronisation therapy, for patients who have moderate to severe chronic heart failure (NYHA class III or IV) despite optimised medical therapy and who meet all of the following criteria: -sinus rhythm -a left ventricular ejection fraction of less than or equal to 35% -a QRS duration greater than or equal to 120ms. N 38654 01JUL2014 Permanent left ventricular electrode, insertion, removal or replacement of via open thoracotomy, for the purpose of cardiac resynchronisation therapy, for a patient who: (a)has: (i)moderate to severe chronic heart failure (New York Heart Association (NYHA) class III or IV) despite optimised medical therapy; and (ii)sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 120 ms; or (b)has: (i)mild chronic heart failure (New York Heart Association (NYHA) class II) despite optimised medical therapy; and (ii)sinus rhythm; and (iii)a left ventricular ejection fraction of less than or equal to 35%; and (iv)a QRS duration greater than or equal to 150 ms; or (c)satisfied the requirements mentioned in paragraph (a) or (b) immediately before the insertion of a cardiac resynchronisation therapy device and transvenous left ventricle electrode Y 38656 01NOV1992 THORACOTOMY or median sternotomy for post-operative bleeding Y 38659 01NOV1992 THORACOTOMY or STERNOTOMY involving division of adhesions where the time taken to divide the adhesions exceeds 45 minutes Y 38662 01NOV1992 CARDIAC TUMOURS THORACOTOMY or STERNOTOMY involving division of extensive adhesions where the time taken to divide the adhesions exceeds 2 hours Y 38670 01NOV1995 CARDIAC TUMOUR, excision of, involving the wall of the atrium or inter-atrial septum, without patch or conduit reconstruction Y 38673 01NOV1995 CARDIAC TUMOUR, excision of, involving the wall of the atrium or inter-atrial septum, requiring reconstruction with patch or conduit Y 38677 01NOV1995 CARDIAC TUMOUR arising from ventricular myocardium, partial thickness excision of Y 38680 01NOV1995 CARDIAC TUMOUR arising from ventricular myocardium, full thickness excision of including repair or reconstruction Y 38700 01NOV1992 CONGENITAL CARDIAC SURGERY PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38700 01JUL1995 PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, without cardiopulmonary bypass, for congenital heart disease Y 38703 01NOV1992 PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38703 01JUL1995 PATENT DUCTUS ARTERIOSUS, shunt, collateral or other single large vessel, division or ligation of, with cardiopulmonary bypass, for congenital heart disease Y 38706 01NOV1992 AORTA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38706 01JUL1995 AORTA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease Y 38709 01NOV1992 AORTA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38709 01JUL1995 AORTA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease Y 38712 01NOV1992 AORTIC INTERRUPTION, repair of, for congenital heart disease (Ministerial Determination) N 38712 01JUL1995 AORTIC INTERRUPTION, repair of, for congenital heart disease Y 38715 01NOV1992 MAIN PULMONARY ARTERY, banding, debanding or repair of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38715 01JUL1995 MAIN PULMONARY ARTERY, banding, debanding or repair of, without cardiopulmonary bypass, for congenital heart disease Y 38718 01NOV1992 MAIN PULMONARY ARTERY, banding, debanding or repair of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38718 01JUL1995 MAIN PULMONARY ARTERY, banding, debanding or repair of, with cardiopulmonary bypass, for congenital heart disease Y 38721 01NOV1992 VENA CAVA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38721 01JUL1995 VENA CAVA, anastomosis or repair of, without cardiopulmonary bypass, for congenital heart disease Y 38724 01NOV1992 VENA CAVA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38724 01JUL1995 VENA CAVA, anastomosis or repair of, with cardiopulmonary bypass, for congenital heart disease Y 38727 01NOV1992 INTRATHORACIC VESSELS, anastomosis or repair of, without cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease (Ministerial Determination) N 38727 01JUL1995 INTRATHORACIC VESSELS, anastomosis or repair of, without cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease Y 38730 01NOV1992 INTRATHORACIC VESSELS, anastomosis or repair of, with cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease (Ministerial Determination) N 38730 01JUL1995 INTRATHORACIC VESSELS, anastomosis or repair of, with cardiopulmonary bypass, not being a service to which item 38700, 38703, 38706, 38709, 38712, 38715, 38718, 38721 or 38724 applies, for congenital heart disease Y 38733 01NOV1992 SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38733 01JUL1995 SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, without cardiopulmonary bypass, for congenital heart disease Y 38736 01NOV1992 SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, with cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38736 01JUL1995 SYSTEMIC PULMONARY or CAVO-PULMONARY SHUNT, creation of, with cardiopulmonary bypass, for congenital heart disease Y 38739 01NOV1992 ATRIAL SEPTECTOMY, with or without cardiopulmonary bypass, for congenital heart disease (Ministerial Determination) N 38739 01JUL1995 ATRIAL SEPTECTOMY, with or without cardiopulmonary bypass, for congenital heart disease Y 38742 01NOV1992 ATRIAL SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease (Ministerial Determination) N 38742 01JUL1995 ATRIAL SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease N 38742 01MAY2002 ATRIAL SEPTAL DEFECT, closure by open exposure direct suture or patch, for congenital heart disease Y 38743 01NOV2004 ATRIAL SEPTAL DEFECT closure, with septal occluder or other similar device, by transcatheter approach Y 38745 01NOV1992 INTRA-ATRIAL BAFFLE, insertion of, for congenital heart disease (Ministerial Determination) N 38745 01JUL1995 INTRA-ATRIAL BAFFLE, insertion of, for congenital heart disease Y 38748 01NOV1992 VENTRICULAR SEPTECTOMY, for congenital heart disease (Ministerial Determination) N 38748 01JUL1995 VENTRICULAR SEPTECTOMY, for congenital heart disease Y 38751 01NOV1992 VENTRICULAR SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease (Ministerial Determination) N 38751 01JUL1995 VENTRICULAR SEPTAL DEFECT, closure by direct suture or patch, for congenital heart disease N 38751 01JUL2014 Ventricular septal defect, closure by direct suture or patch Y 38754 01NOV1992 INTRAVENTRICULAR BAFFLE OR CONDUIT, insertion of, for congenital heart disease (Ministerial Determination) N 38754 01JUL1995 INTRAVENTRICULAR BAFFLE OR CONDUIT, insertion of, for congenital heart disease Y 38757 01NOV1992 EXTRACARDIAC CONDUIT, insertion of, for congenital heart disease (Ministerial Determination) N 38757 01JUL1995 EXTRACARDIAC CONDUIT, insertion of, for congenital heart disease Y 38760 01NOV1992 EXTRACARDIAC CONDUIT, replacement of, for congenital heart disease (Ministerial Determination) N 38760 01JUL1995 EXTRACARDIAC CONDUIT, replacement of, for congenital heart disease Y 38763 01NOV1992 VENTRICULAR MYECTOMY, for relief of ventricular obstruction, right or left, for congenital heart disease (Ministerial Determination) N 38763 01JUL1995 VENTRICULAR MYECTOMY, for relief of ventricular obstruction, right or left, for congenital heart disease Y 38766 01NOV1992 VENTRICULAR AUGMENTATION, right or left, for congenital heart disease (Ministerial Determination) N 38766 01JUL1995 VENTRICULAR AUGMENTATION, right or left, for congenital heart disease Y 38800 01NOV2005 THORACIC CAVITY, aspiration of, for diagnostic purposes, not being a service associated with a service to which item 38803 applies Y 38803 01NOV2005 THORACIC CAVITY, aspiration of, with therapeutic drainage (paracentesis), with or without diagnostic sample Y 38806 01NOV2005 INTERCOSTAL DRAIN, insertion of, not involving resection of rib (excluding aftercare) Y 38809 01NOV2005 INTERCOSTAL DRAIN, insertion of, with pleurodesis and not involving resection of rib (excluding aftercare) Y 38812 01NOV2005 PERCUTANEOUS NEEDLE BIOPSY of lung Y 39000 01DEC1991 GENERAL LUMBAR PUNCTURE, or spinal or epidural injection, not being a service to which item 18200 applies N 39000 01NOV1993 LUMBAR PUNCTURE Y 39003 01DEC1991 CISTERNAL PUNCTURE Y 39006 01DEC1991 VENTRICULAR PUNCTURE (not including burr-hole) Y 39009 01DEC1991 SUBDURAL HAEMORRHAGE, tap for, each tap Y 39012 01DEC1991 BURR-HOLE, single, preparatory to ventricular puncture or for inspection purpose - not being a service to which another item applies Y 39013 01JUL1993 INJECTION UNDER IMAGE INTENSIFICATION with 1 or more of contrast media, local anaesthetic or corticosteroid into 1 or more zygo-apophyseal or costo-transverse joints or 1 or more primary posterior rami of spinal nerves Y 39015 01DEC1991 VENTRICULAR RESERVOIR or intracranial pressure monitoring device, insertion of -including burr-hole (excluding after-care) N 39015 01JUL1993 VENTRICULAR RESERVOIR, EXTERNAL VENTRICULAR DRAIN or INTRACRANIAL PRESSURE MONITORING DEVICE, insertion of - including burr-hole (excluding after-care) Y 39018 01DEC1991 CEREBROSPINAL FLUID reservoir, insertion of Y 39100 01DEC1991 INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, phenol, or similar substance Y 39103 01DEC1991 INTRATHECAL INJECTION of alcohol or phenol Y 39106 01DEC1991 NEURECTOMY, INTRACRANIAL, for trigeminal neuralgia Y 39109 01DEC1991 TRIGEMINAL GANGLIOTOMY by radiofrequency, balloon or glycerol Y 39112 01DEC1991 CRANIAL NERVE, intracranial decompression of, using microsurgical techniques Y 39115 01DEC1991 PERCUTANEOUS NEUROTOMY of posterior divisions of spinal nerves by any method on 1 or more occasions within a 30 day period, including any spinal, epidural or regional nerve block given at the time of such neurotomy N 39115 01JUL1993 PERCUTANEOUS NEUROTOMY of posterior divisions (or rami) of spinal nerves by any method, including any associated spinal, epidural or regional nerve block (payable once only in a 30 day period) Y 39118 01DEC1991 PERCUTANEOUS NEUROTOMY for facet joint denervation by radio-frequency probe or cryoprobe using radiological imaging control Y 39121 01DEC1991 PERCUTANEOUS CORDOTOMY Y 39124 01DEC1991 CORDOTOMY OR MYELOTOMY, laminectomy for, or operation for dorsal root entry zone (Drez) lesion N 39124 01NOV2006 CORDOTOMY OR MYELOTOMY, partial or total laminectomy for, or operation for dorsal root entry zone (Drez) lesion Y 39125 01JUL1993 SPINAL CATHETER, insertion of - for an automated infusion device N 39125 01MAY2005 Intrathecal or epidural SPINAL CATHETER insertion or replacement of, and connection to a subcutaneous implanted infusion pump, for the management of chronic intractable pain Y 39126 01JUL1993 AUTOMATED SUBCUTANEOUS INFUSION DEVICE, insertion of N 39126 01MAY2005 INFUSION PUMP, subcutaneous implantation or replacement of, and connection of the pump to an intrathecal or epidural catheter, and filling of reservoir with a therapeutic agent or agents, with or without programming the pump, for the management of chronic intractable pain Y 39127 01DEC1991 SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER FOR PAIN, insertion of N 39127 01MAY2005 SUBCUTANEOUS RESERVOIR AND SPINAL CATHETER, insertion of, for the management of chronic intractable pain Y 39128 01JUL1993 AUTOMATED SUBCUTANEOUS INFUSION DEVICE AND SPINAL CATHETER, insertion of N 39128 01MAY2005 INFUSION PUMP, subcutaneous implantation of, AND intrathecal or epidural SPINAL CATHETER insertion of, and connection of pump to catheter, and filling of reservoir with a therapeutic agent or agents, with or without programming the pump, for the management of chronic intractable pain Y 39130 01DEC1991 PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, insertion of (1 or 2 stages), not involving laminectomy N 39130 01JUL1993 PERCUTANEOUS EPIDURAL ELECTRODE, insertion of 1 or more of - for spinal stimulation N 39130 01NOV2004 EPIDURAL LEAD, percutaneous placement of, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, to a maximum of 4 leads Y 39131 01JUL1993 PERCUTANEOUS EPIDURAL ELECTRODES, management, adjustment, electronic programming and trial of stimulation of, by a medical practitioner - each day N 39131 01NOV2004 ELECTRODES, epidural or peripheral nerve, management of patient and adjustment or reprogramming of neurostimulator by a medical practitioner, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris - each day Y 39133 01DEC1991 EPIDURAL STIMULATOR or INTRATHECAL INFUSION DEVICE, revision of N 39133 01NOV2004 SPINAL INFUSION DEVICE, revision of N 39133 01MAY2005 Removal of subcutaneously IMPLANTED INFUSION PUMP OR removal or repositioning of intrathecal or epidural SPINAL CATHETER, for the management of chronic intractable pain Y 39134 01JUL1993 SPINAL NEUROSTIMULATOR RECEIVER or pulse generator, subcutaneous placement of N 39134 01NOV2002 SPINAL NEUROSTIMULATOR RECEIVER or pulse generator, subcutaneous placement of, not being a service associated with deep brain stimulation for Parkinson's disease N 39134 01NOV2004 NEUROSTIMULATOR or RECEIVER, subcutaneous placement of, including placement and connection of extension wires to epidural or peripheral nerve electrodes, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris Y 39135 01NOV2004 NEUROSTIMULATOR or RECEIVER, that was inserted for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, removal of, performed in the operating theatre of a hospital Y 39136 01DEC1991 PERCUTANEOUS EPIDURAL IMPLANT FOR PAIN, removal of N 39136 01JUL1993 PERCUTANEOUS EPIDURAL IMPLANT for management of pain, removal of N 39136 01NOV2004 LEAD, epidural or peripheral nerve that was inserted for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, removal of, performed in the operating theatre of a hospital Y 39137 01NOV2004 LEAD, epidural or peripheral nerve that was inserted for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, surgical repositioning to correct displacement or unsatisfactory positioning, including intraoperative test stimulation, not being a service to which item 39130, 39138 or 39139 applies Y 39138 01NOV2004 PERIPHERAL NERVE LEAD, surgical placement of one or more, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris N 39138 01NOV2005 PERIPHERAL NERVE LEAD, surgical placement of, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris, to a maximum of 4 leads Y 39139 01DEC1991 EPIDURAL IMPLANT FOR PAIN, laminectomy and insertion of, including implantation of pulse generator (1 or 2 stages) N 39139 01JUL1993 EPIDURAL ELECTRODE for management of pain, insertion of 1 or more of by laminectomy, including implantation of pulse generator (1 or 2 stages) N 39139 01NOV2004 EPIDURAL LEAD, surgical placement of one or more by laminectomy, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris N 39139 01NOV2006 Epidural lead, surgical placement of one or more by partial or total laminectomy, including intraoperative test stimulation, for the management of chronic intractable neuropathic pain or pain from refractory angina pectoris - to a maximum of 4 leads (H) Y 39140 01MAY1997 EPIDURAL CATHETER, insertion of, under imaging control, with epidurogram and epidural therapeutic injection for lysis of adhesions Y 39300 01DEC1991 CUTANEOUS NERVE (including digital nerve), primary repair of, using microsurgical techniques Y 39303 01DEC1991 CUTANEOUS NERVE (including digital nerve), secondary repair of, using microsurgical techniques Y 39306 01DEC1991 NERVE TRUNK, primary repair of, using microsurgical techniques Y 39309 01DEC1991 NERVE TRUNK, secondary repair of, using microsurgical techniques Y 39312 01DEC1991 NERVE TRUNK, (interfascicular), neurolysis of, using microsurgical techniques Y 39315 01DEC1991 NERVE TRUNK, nerve graft to, (cable graft) including harvesting of nerve graft using microsurgical techniques Y 39318 01DEC1991 CUTANEOUS NERVE (including digital nerve), nerve graft to, using microsurgical techniques Y 39321 01DEC1991 NERVE, transposition of Y 39323 01JUL1993 PERCUTANEOUS NEUROTOMY by cryoneurotomy or radiofrequency lesion generator, not being a service to which another item applies N 39323 01NOV2003 PERCUTANEOUS NEUROTOMY by cryotherapy or radiofrequency lesion generator, not being a service to which another item applies Y 39324 01DEC1991 NEURECTOMY, NEUROTOMY or removal of tumour from superficial peripheral nerve N 39324 01JUL1993 NEURECTOMY, NEUROTOMY or removal of tumour from superficial peripheral nerve, by open operation Y 39327 01DEC1991 NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral nerve N 39327 01JUL1993 NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral nerve, by open operation N 39327 01NOV2006 NEURECTOMY, NEUROTOMY or removal of tumour from deep peripheral or cranial nerve, by open operation, not being a service to which item 41575, 41576, 41578 or 41579 applies Y 39330 01DEC1991 NEUROLYSIS by open operation without transposition, not being a service associated with a service to which item 39312 applies Y 39331 01JUL1993 CARPAL TUNNEL RELEASE (division of transverse carpal ligament), by any method Y 39333 01DEC1991 BRACHIAL PLEXUS, exploration of, not being a service to which another item in this Group applies Y 39500 01DEC1991 VESTIBULAR NERVE, section of, via posterior fossa Y 39503 01DEC1991 FACIO-HYPOGLOSSAL nerve or FACIO-ACCESSORY nerve, anastomosis of Y 39600 01DEC1991 INTRACRANIAL HAEMORRHAGE, burr-hole craniotomy for - including burr-holes Y 39603 01DEC1991 INTRACRANIAL HAEMORRHAGE, osteoplastic craniotomy or extensive craniectomy and removal of haematoma Y 39606 01DEC1991 FRACTURED SKULL, depressed or comminuted, operation for Y 39609 01DEC1991 FRACTURED SKULL, compound, without dural penetration, operation for Y 39612 01DEC1991 FRACTURED SKULL, compound or complicated, with dural penetration and brain laceration, operation for N 39612 01JUL1993 FRACTURED SKULL, compound, depressed or complicated, with dural penetration and brain laceration, operation for Y 39615 01DEC1991 FRACTURED SKULL with rhinorrhoea or otorrhoea, cranioplasty and repair of N 39615 01NOV2015 FRACTURED SKULL with rhinorrhoea or otorrhoea, repair of by cranioplasty or endoscopic approach Y 39640 01JUL1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving craniotomy, radical excision of the skull base, and dural repair Y 39642 01JUL1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy for clearance of paranasal sinus extension (intracranial procedure), conjoint surgery, principal surgeon N 39642 01NOV1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy for clearance of paranasal sinus extension (intracranial procedure) Y 39644 01JUL1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy for clearance of paranasal sinus extension (intracranial procedure), conjoint surgery, co-surgeon Y 39646 01JUL1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy and radical clearance of paranasal sinus and orbital fossa extensions, with intracranial decompression of the optic nerve (intracranial procedure), conjoint surgery, principal surgeon N 39646 01NOV1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy and radical clearance of paranasal sinus and orbital fossa extensions, with intracranial decompression of the optic nerve, (intracranial procedure) Y 39648 01JUL1995 TUMOUR INVOLVING ANTERIOR CRANIAL FOSSA, removal of, involving frontal craniotomy with lateral rhinotomy and radical clearance of paranasal sinus and orbital fossa extensions, with intracranial decompression of the optic nerve (intracranial procedure), conjoint surgery, co-surgeon Y 39650 01JUL1995 TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and radical excision, with division and reconstruction of zygomatic arch, and disarticulation of temporo-mandibular joint and complete facial nerve mobilisation (intracranial procedure), conjoint surgery, principal surgeon N 39650 01NOV1995 TUMOUR INVOLVING MIDDLE CRANIAL FOSSA AND INFRA-TEMPORAL FOSSA, removal of, craniotomy and radical or sub-total radical excision, with division and reconstruction of zygomatic arch, (intracranial procedure) Y 39652 01JUL1995 TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and radical excision, with division and reconstruction of zygomatic arch, and disarticulation of temporo-mandibular joint and complete facial nerve mobilisation (intra cranial procedure), conjoint surgery, co-surgeon Y 39653 01NOV1995 PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical or sub-total radical excision (intracranial procedure), not being a service to which item 39654 or 39656 applies Y 39654 01JUL1995 PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical excision (intracranial procedure), conjoint surgery, principal surgeon N 39654 01NOV1995 PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical or sub-total radical excision, (intracranial procedure), conjoint surgery, principal surgeon Y 39656 01JUL1995 PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical excision, (intracranial procedure) conjoint surgery, co-surgeon N 39656 01NOV1995 PETRO-CLIVAL AND CLIVAL TUMOUR, removal of, by supra and infratentorial approaches for radical or sub-total radical excision, (intracranial procedure) conjoint surgery, co-surgeon Y 39658 01JUL1995 TUMOUR INVOLVING THE CLIVUS, radical excision of, involving transoral approach and division of palate N 39658 01NOV1995 TUMOUR INVOLVING THE CLIVUS, radical or sub-total radical excision of, involving transoral or transmaxillary approach Y 39660 01JUL1995 TUMOUR OR VASCULAR LESION OF CAVERNOUS SINUS, radical excision of, involving craniotomy with or without carotid artery exposure N 39660 01NOV1995 TUMOUR OR VASCULAR LESION OF CAVERNOUS SINUS, radical excision of, involving craniotomy with or without intracranial carotid artery exposure Y 39662 01JUL1995 TUMOUR OR VASCULAR LESION OF FORAMEN MAGNUM, radical excision of, via transcondylar or far lateral suboccipital approach Y 39700 01DEC1991 SKULL TUMOUR, benign or malignant, excision of, excluding cranioplasty Y 39703 01DEC1991 INTRACRANIAL tumour or cyst, burr-hole and biopsy of, or drainage of, or both N 39703 01JUL1993 INTRACRANIAL tumour, cyst or other brain tissue, burr-hole and biopsy of, or drainage of, or both Y 39706 01DEC1991 INTRACRANIAL tumour, biopsy or decompression of via osteoplastic flap OR biopsy and decompression of via osteoplastic flap Y 39709 01DEC1991 CRANIOTOMY for removal of glioma, metastatic carcinoma or any other tumour in cerebrum, cerebellum or brain stem - not being a service to which another item in this Sub-group applies Y 39712 01DEC1991 CRANIOTOMY FOR REMOVAL OF MENINGIOMA, pinealoma, cranio-pharyngioma, intraventricular tumour or any other intracranial tumour, not being a service to which another item in this Sub-group applies Y 39715 01DEC1991 PITUITARY TUMOUR, hypophysectomy or removal of by transcranial or transphenoidal approach N 39715 01JUL1993 PITUITARY TUMOUR, removal of, by transcranial or transphenoidal approach Y 39718 01DEC1991 ARACHNOIDAL CYST, craniotomy for Y 39721 01DEC1991 CRANIOTOMY, involving osteoplastic flap, for re-opening post-operatively for haemorrhage, swelling, etc Y 39800 01DEC1991 ANEURYSM, clipping or reinforcement of sac Y 39803 01DEC1991 INTRACRANIAL ARTERIOVENOUS MALFORMATION, excision of Y 39806 01DEC1991 ANEURYSM, or arteriovenous malformation, intracranial proximal artery clipping of Y 39809 01DEC1991 ARTERIOVENOUS MALFORMATION, craniotomy and direct embolisation of Y 39812 01DEC1991 INTRACRANIAL ANEURYSM or arteriovenous fistula, ligation of cervical vessel or vessels Y 39815 01DEC1991 CAROTID-CAVERNOUS FISTULA, obliteration of - combined cervical and intracranial procedure Y 39818 01DEC1991 EXTRACRANIAL TO INTRACRANIAL BYPASS using superficial temporal artery or saphenous vein graft N 39818 01JUL1995 EXTRACRANIAL TO INTRACRANIAL BYPASS using superficial temporal artery Y 39821 01JUL1995 EXTRACRANIAL TO INTRACRANIAL BYPASS using saphenous vein graft Y 39900 01DEC1991 INTRACRANIAL INFECTION, drainage of, via burr-hole - including burr-hole Y 39903 01DEC1991 INTRACRANIAL ABSCESS, excision of Y 39906 01DEC1991 OSTEOMYELITIS OF SKULL or removal of infected bone flap, craniectomy for Y 40000 01DEC1991 VENTRICULO-CISTERNOSTOMY (Torkildsen's operation) Y 40003 01DEC1991 CRANIAL OR CISTERNAL SHUNT DIVERSION, insertion of Y 40006 01DEC1991 LUMBAR SHUNT DIVERSION, insertion of Y 40009 01DEC1991 CRANIAL, CISTERNAL OR LUMBAR SHUNT, revision or removal of Y 40012 01DEC1991 THIRD VENTRICULOSTOMY N 40012 01JUL1995 THIRD VENTRICULOSTOMY (open or endoscopic) with or without endoscopic septum pellucidotomy Y 40015 01DEC1991 SUBTEMPORAL DECOMPRESSION Y 40018 01DEC1991 LUMBAR CEREBROSPINAL FLUID DRAIN, insertion of Y 40100 01DEC1991 MENINGOCELE, excision and closure of Y 40103 01DEC1991 MYELOMENINGOCELE, excision and closure of, including skin flaps or Z plasty where performed Y 40106 01DEC1991 ARNOLD-CHIARI MALFORMATION, decompression of Y 40109 01DEC1991 ENCEPHALOCOELE, excision and closure of Y 40112 01DEC1991 TETHERED CORD, release of, including lipomeningocele or diastematomyelia Y 40115 01DEC1991 CRANIOSTENOSIS, operation for - single suture Y 40118 01DEC1991 CRANIOSTENOSIS, operation for - more than 1 suture Y 40300 01DEC1991 SPINAL DISORDERS INTERVERTEBRAL DISC OR DISCS, laminectomy for exploration or removal of N 40300 01JUL1993 SPINAL DISORDERS INTERVERTEBRAL DISC OR DISCS, laminectomy for removal of N 40300 01NOV2006 INTERVERTEBRAL DISC OR DISCS, partial or total laminectomy for removal of Y 40301 01JUL1993 INTERVERTEBRAL DISC OR DISCS, microsurgical discectomy of N 40301 01NOV2006 INTERVERTEBRAL DISC OR DISCS, microsurgical partial or total discectomy of Y 40303 01DEC1991 RECURRENT DISC LESION OR SPINAL STENOSIS, laminectomy for - 1 level N 40303 01JUL1993 RECURRENT DISC LESION OR SPINAL STENOSIS, or both, laminectomy for - 1 level N 40303 01NOV2006 RECURRENT DISC LESION OR SPINAL STENOSIS, or both, partial or total laminectomy for - 1 level Y 40306 01DEC1991 SPINAL CANAL STENOSIS, laminectomy (multi-level), for treatment of N 40306 01JUL1993 SPINAL STENOSIS, laminectomy for, involving more than 1 vertebral interspace (disc level) N 40306 01NOV2006 SPINAL STENOSIS, partial or total laminectomy for, involving more than 1 vertebral interspace (disc level) Y 40309 01DEC1991 EXTRADURAL TUMOUR OR ABSCESS, laminectomy for N 40309 01NOV2006 EEXTRADURAL TUMOUR OR ABSCESS, partial or total laminectomy for Y 40312 01DEC1991 INTRADURAL LESION, laminectomy for, not being a service to which another item in this Group applies N 40312 01NOV2006 INTRADURAL LESION, partial or total laminectomy for, not being a service to which another item in this Group applies Y 40315 01DEC1991 CRANIOCERVICAL JUNCTION LESION, transoral approach for Y 40316 01JUL1995 ODONTOID screw fixation Y 40318 01DEC1991 INTRAMEDULLARY TUMOUR OR ARTERIOVENOUS MALFORMATION, laminectomy and radical excision of N 40318 01NOV2006 INTRAMEDULLARY TUMOUR OR ARTERIOVENOUS MALFORMATION, partial or total laminectomy and radical excision of Y 40321 01DEC1991 POSTERIOR SPINAL FUSION, not being a service to which items 40324 and 40327 apply Y 40324 01DEC1991 LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - laminectomy, including aftercare N 40324 01NOV2006 PARTIAL OR TOTAL LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - laminectomy, including aftercare Y 40327 01DEC1991 LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - posterior fusion, including aftercare N 40327 01NOV2006 PARTIAL OR TOTAL LAMINECTOMY FOLLOWED BY POSTERIOR FUSION, performed by neurosurgeon and orthopaedic surgeon operating together - posterior fusion, including aftercare Y 40330 01DEC1991 SPINAL RHIZOLYSIS involving exposure of spinal nerve roots, with or without laminectomy N 40330 01JUL1995 SPINAL RHIZOLYSIS involving exposure of spinal nerve roots - for lateral recess, exit foraminal stenosis, adhesive radiculopathy or extensive epidural fibrosis, at 1 or more levels - with or without laminectomy N 40330 01NOV2006 SPINAL RHIZOLYSIS involving exposure of spinal nerve roots - for lateral recess, exit foraminal stenosis, adhesive radiculopathy or extensive epidural fibrosis, at 1 or more levels - with or without partial or total laminectomy Y 40331 01JUL1995 CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, without fusion, 1 level, by any approach, not being a service to which item 40330 applies Y 40332 01JUL1995 CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, including anterior fusion, 1 level, not being a service to which item 40330 applies Y 40333 01DEC1991 CERVICAL DISCECTOMY (ANTERIOR), without fusion N 40333 01NOV2006 CERVICAL PARTIAL OR TOTAL DISCECTOMY (ANTERIOR), without fusion Y 40334 01JUL1995 CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, without fusion, more than 1 level, by any approach, not being a service to which item 40330 applies Y 40335 01JUL1995 CERVICAL DECOMPRESSION of spinal cord with or without involvement of nerve roots, including anterior fusion, more than 1 level, by any approach, not being a service to which item 40330 applies Y 40336 01DEC1991 INTRADISCAL INJECTION OF CHYMOPAPAIN (DISCASE) - 1 disc Y 40339 01DEC1991 HYDROMYELIA, plugging of obex for, with or without duroplasty Y 40342 01DEC1991 HYDROMYELIA, craniotomy and laminectomy for, with cavity packing and CSF shunt N 40342 01NOV2006 HYDROMYELIA, craniotomy and partial or total laminectomy for, with cavity packing and CSF shunt Y 40345 01JUL1995 THORACIC DECOMPRESSION of spinal cord with or without involvement of nerve roots, via pedicle or costotransversectomy Y 40348 01JUL1995 THORACIC DECOMPRESSION of spinal cord via thoracotomy with vertebrectomy, not including stabilisation procedure Y 40351 01JUL1995 THORACO-LUMBAR or high lumbar anterior decompression of spinal cord, not including stabilisation procedure Y 40600 01DEC1991 CRANIOPLASTY, reconstructive Y 40700 01DEC1991 CORPUS CALLOSUM, anterior section of, for epilepsy Y 40701 01NOV2017 Vagus nerve stimulation therapy through stimulation of the left vagus nerve, subcutaneous placement of electrical pulse generator, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery Y 40702 01NOV2017 Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical repositioning or removal of electrical pulse generator inserted for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery Y 40703 01DEC1991 CORTICECTOMY, TOPECTOMY or PARTIAL LOBECTOMY for epilepsy Y 40704 01NOV2017 Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical placement of lead, including connection of lead to left vagus nerve and intra-operative test stimulation, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery Y 40705 01NOV2017 Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical repositioning or removal of lead attached to left vagus nerve for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery Y 40706 01DEC1991 HEMISPHERECTOMY for intractable epilepsy Y 40707 01NOV2017 Vagus nerve stimulation therapy through stimulation of the left vagus nerve, electrical analysis and programming of vagus nerve stimulation therapy device using external wand, for: (a) management of refractory generalised epilepsy; or (b) treatment of refractory focal epilepsy not suitable for resective epilepsy surgery Y 40708 01NOV2017 Vagus nerve stimulation therapy through stimulation of the left vagus nerve, surgical replacement of battery in electrical pulse generator inserted for: (a) management of refractory generalised epilepsy; or (b) treating refractory focal epilepsy not suitable for resective epilepsy surgery Y 40709 01DEC1991 BURR-HOLE PLACEMENT of intracranial depth or surface electrodes Y 40712 01DEC1991 INTRACRANIAL ELECTRODE PLACEMENT via craniotomy Y 40800 01DEC1991 STEREOTACTIC PROCEDURES STEREOTACTIC ANATOMICAL LOCALISATION in association with an intracranial operative procedure N 40800 01JUL1993 STEREOTACTIC ANATOMICAL LOCALISATION, as an independent procedure Y 40801 01JUL1993 FUNCTIONAL STEREOTACTIC procedure including computer assisted anatomical localisation, physiological localisation, and lesion production in the basal ganglia, brain stem or deep white matter tracts N 40801 01NOV2002 FUNCTIONAL STEREOTACTIC procedure including computer assisted anatomical localisation, physiological localisation, and lesion production in the basal ganglia, brain stem or deep white matter tracts, not being a service associated with deep brain stimulation for Parkinson's disease N 40801 01JUL2009 FUNCTIONAL STEREOTACTIC procedure including computer assisted anatomical localisation, physiological localisation, and lesion production in the basal ganglia, brain stem or deep white matter tracts, not being a service associated with deep brain stimulation for Parkinson's disease, essential tremor or dystonia Y 40803 01DEC1991 INTRACRANIAL STEREOTACTIC PROCEDURE BY ANY METHOD, not being a service to which another item in this Group applies N 40803 01MAY1994 INTRACRANIAL STEREOTACTIC PROCEDURE BY ANY METHOD, not being a service to which item 40800 or 40801 applies Y 40850 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes N 40850 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes N 40850 01JUL2009 DEEP BRAIN STIMULATION (unilateral) functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability Y 40851 05MAY2003 DEEP BRAIN STIMULATION for Parkinson's disease (bilateral), functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes N 40851 01NOV2006 DEEP BRAIN STIMULATION (bilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unnaccepatable motor fluctuations functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes N 40851 01JUL2009 DEEP BRAIN STIMULATION (bilateral) functional stereotactic procedure including computer assisted anatomical localisation, physiological localisation including twist drill, burr hole craniotomy or craniectomy and insertion of electrodes for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40852 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), subcutaneous placement of neurostimulator receiver or pulse generator N 40852 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, subcutaneous placement of neurostimulator receiver or pulse generator N 40852 01JUL2009 DEEP BRAIN STIMULATION (unilateral) subcutaneous placement of neurostimulator receiver or pulse generator for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40854 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), revision or removal of brain electrode N 40854 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, revision or removal of brain electrode N 40854 01JUL2009 DEEP BRAIN STIMULATION (unilateral) revision or removal of brain electrode for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40856 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), removal or replacement of neurostimulator receiver or pulse generator N 40856 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, removal or replacement of neurostimulator receiver or pulse generator N 40856 01JUL2009 DEEP BRAIN STIMULATION (unilateral) removal or replacement of neurostimulator receiver or pulse generator for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40858 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), removal or replacement of extension lead N 40858 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, placement, removal or replacement of extension lead N 40858 01JUL2009 DEEP BRAIN STIMULATION (unilateral) placement, removal or replacement of extension leadfor the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40860 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease (unilateral), target localisation incorporating anatomical and physiological techniques, including intra-operative clinical evaluation, for the insertion of a single neurostimulation wire N 40860 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, target localisation incorporating anatomical and physiological techniques, including intra-operative clinical evaluation, for the insertion of a single neurostimulation wire N 40860 01JUL2009 DEEP BRAIN STIMULATION (unilateral) target localisation incorporating anatomical and physiological techniques, including intra-operative clinical evaluation, for the insertion of a single neurostimulation wire for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40862 01FEB2002 DEEP BRAIN STIMULATION for Parkinson's disease, electronic analysis and programming of neaurostimulator pulse generator N 40862 01NOV2006 DEEP BRAIN STIMULATION (unilateral) for Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations, electronic analysis and programming of neurostimulator pulse generator N 40862 01JUL2009 DEEP BRAIN STIMULATION (unilateral) electronic analysis and programming of neurostimulator pulse generator for the treatment of: Parkinson's disease where the patient's response to medical therapy is not sustained and is accompanied by unacceptable motor fluctuations; or Essential tremor or dystonia where the patient's symptoms cause severe disability. Y 40900 01DEC1991 MISCELLANEOUS LEUCOTOMY for psychiatric disorder Y 40903 01JUL1995 NEUROENDOSCOPY, for inspection of an intraventricular lesion, with or without biopsy including burr hole Y 40905 01MAY2004 CRANIOTOMY, performed in association with items 45767, 45776, 45782 and 45785 for the correction of craniofacial abnormalities Y 41500 01DEC1991 EAR, foreign body in, removal of, otherwise than by simple syringing N 41500 01JUL1996 EAR, foreign body (other than ventilating tube) in, removal of, other than by simple syringing Y 41501 01NOV2019 Examination of glottal cycles and vibratory characteristics of the vocal folds by a specialist in the practice of the specialist's specialty of otolaryngology using videostroboscopy, including capturing audio, video, frequency and intensity, for confirmation of diagnosis , or for confirmation of treatment effectiveness where there is failure to progress or respond as expected, for: dysphonia where non stroboscopic techniques of the visualising the larynx have failed to identify any frank abnormality of the vocal folds; or benign vocal fold lesions; or premalignant or malignant laryngeal lesions; or vocal fold motion impairment or glottal insufficiency; or evaluation of vocal fold function after treatment or phonosurgery other than a service associated with a service to which item 41764 applies or with a services associated with the administration of a general anaesthetic Y 41503 01DEC1991 EAR, foreign body in, removal of, involving incision of external auditory canal Y 41506 01DEC1991 AURAL POLYP, removal of Y 41509 01DEC1991 EXTERNAL AUDITORY MEATUS, surgical removal of keratosis obturans from, not being a service to which another item in this Group applies Y 41512 01DEC1991 MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone, not being a service to which item 41515 applies Y 41515 01DEC1991 MEATOPLASTY involving removal of cartilage or bone or both cartilage and bone, being a service associated with a service to which item 41530, 41548, 41557, 41560 or 41563 applies Y 41518 01DEC1991 EXTERNAL AUDITORY MEATUS, removal of EXOSTOSES IN Y 41521 01DEC1991 Correction of AUDITORY CANAL STENOSIS, including meatoplasty, with or without grafting Y 41524 01DEC1991 RECONSTRUCTION OF EXTERNAL AUDITORY CANAL, being a service associated with a service to which items 41557, 41560 and 41563 apply Y 41527 01DEC1991 MYRINGOPLASTY, transcanal approach (Rosen incision) Y 41530 01DEC1991 MYRINGOPLASTY, postaural or endaural approach with or without mastoid inspection Y 41533 01DEC1991 ATTICOTOMY without reconstruction of the bony defect, with or without myringoplasty Y 41536 01DEC1991 ATTICOTOMY with reconstruction of the bony defect, with or without myringoplasty Y 41539 01DEC1991 OSSICULAR CHAIN RECONSTRUCTION Y 41542 01DEC1991 OSSICULAR CHAIN RECONSTRUCTION AND MYRINGOPLASTY Y 41545 01DEC1991 MASTOIDECTOMY (CORTICAL) Y 41548 01DEC1991 OBLITERATION OF THE MASTOID CAVITY Y 41551 01DEC1991 MASTOIDECTOMY, intact wall technique, with myringoplasty Y 41554 01DEC1991 MASTOIDECTOMY, intact wall technique, with myringoplasty and ossicular chain reconstruction Y 41557 01DEC1991 MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL) Y 41560 01DEC1991 MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL) AND MYRINGOPLASTY Y 41563 01DEC1991 MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL), MYRINGOPLASTY AND OSSICULAR CHAIN RECONSTRUCTION Y 41564 01MAY1997 MASTOIDECTOMY (RADICAL OR MODIFIED RADICAL), OBLITERATION OF THE MASTOID CAVITY, BLIND SAC CLOSURE OF EXTERNAL AUDITORY CANAL AND OBLITERATION OF EUSTACHIAN TUBE Y 41566 01DEC1991 REVISION OF MASTOIDECTOMY (radical, modified radical or intact wall), including myringoplasty Y 41569 01DEC1991 DECOMPRESSION OF FACIAL NERVE in its mastoid portion Y 41572 01DEC1991 LABYRINTHOTOMY OR DESTRUCTION OF LABYRINTH Y 41575 01DEC1991 CEREBELLOPONTINE ANGLE TUMOUR, removal of by 2 surgeons operating conjointly, by transmastoid, translabyrinthine or retromastoid approachtransmastoid, translabyrinthine or retromastoid procedure (including aftercare) Y 41576 01NOV1995 CEREBELLO - PONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine or retromastoid approach - intracranial procedure (including aftercare) not being a service to which item 41578 or 41579 applies Y 41578 01DEC1991 CEREBELLOPONTINE ANGLE TUMOUR, removal of by 2 surgeons operating conjointly, by transmastoid, translabyrinthine or retromastoid approachintracranial procedure (including aftercare) N 41578 01JUL1995 CEREBELLOPONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine or retromastoid approach, (intracranial procedure) - conjoint surgery, principal surgeon Y 41579 01JUL1995 CEREBELLO-PONTINE ANGLE TUMOUR, removal of, by transmastoid, translabyrinthine or retromastoid approach, (intracranial procedure) - conjoint surgery, co-surgeon Y 41581 01DEC1991 SKULL BASE TUMOUR, removal of by infratemporal approach N 41581 01JUL1995 TUMOUR INVOLVING INFRA-TEMPORAL FOSSA, removal of, involving craniotomy and radical excision of Y 41584 01DEC1991 PARTIAL TEMPORAL BONE RESECTION for removal of tumour involving mastoidectomy with or without decompression of facial nerve Y 41587 01DEC1991 TOTAL TEMPORAL BONE RESECTION for removal of tumour Y 41590 01DEC1991 ENDOLYMPHATIC SAC, TRANSMASTOID DECOMPRESSION with or without drainage of Y 41593 01DEC1991 TRANSLABYRINTHINE VESTIBULAR NERVE SECTION Y 41596 01DEC1991 RETROLABYRINTHINE VESTIBULAR NERVE SECTION or COCHLEAR NERVE SECTION, or BOTH Y 41599 01DEC1991 INTERNAL AUDITORY MEATUS, exploration by middle cranial fossa approach with cranial nerve decompression Y 41602 01DEC1991 FENESTRATION OPERATIONeach ear Y 41603 01NOV2006 OSSEO-INTEGRATION PROCEDURE - implantation of titanium fixture for use with implantable bone conduction hearing system device, in patients: -With a permanent or long term hearing loss; and -Unable to utilise conventional air or bone conduction hearing aid for medical or audiological reasons; and -With bone conduction thresholds that accord to recognised criteria for the implantable bone conduction hearing device being inserted. Not being a service associated with a service to which items 41554, 45794 or 45797 Y 41604 01NOV2006 OSSEO-INTEGRATION PROCEDURE - fixation of transcutaneous abutment implantation of titanium fixture for use with implantable bone conduction hearing system device, in patients: -With a permanent or long term hearing loss; and -Unable to utilise conventional air or bone conduction hearing aid for medical or audiological reasons; and -With bone conduction thresholds that accord to recognised criteria for the implantable bone conduction hearing device being inserted. Not being a service associated with a service to which items 41554, 45794 or 45797 Y 41605 01DEC1991 VENOUS GRAFT TO FENESTRATION CAVITY Y 41608 01DEC1991 STAPEDECTOMY Y 41611 01DEC1991 STAPES MOBILISATION Y 41614 01DEC1991 ROUND WINDOW SURGERY including repair of cochleotomy Y 41615 01MAY1994 OVAL WINDOW SURGERY, including repair of fistula, not being a service associated with a service to which any other item in this Group applies Y 41617 01DEC1991 COCHLEAR IMPLANT, insertion of, including mastoidectomy Y 41618 01MAY2017 Middle ear implant, partially implantable, insertion of, via mastoidectomy, for patients with: (a) stable sensorineural hearing loss; and (b) outer ear pathology that prevents the use of a conventional hearing aid; and (c) a PTA4 of less than 80 dBHL; and (d) bilateral, symmetrical hearing loss with PTA thresholds in both ears within 20 dBHL (0.5?4kHz) of each other; and (e) speech perception discrimination of at least 65% correct for word lists with appropriately amplified sound; and (f) a normal middle ear; and (g) normal tympanometry; and (h) on audiometry, an air?bone gap of less than 10 dBHL (0.5?4kHz) across all frequencies; and (i) no other inner ear disorders   Y 41620 01DEC1991 GLOMUS TUMOUR, transtympanic removal of Y 41623 01DEC1991 GLOMUS TUMOUR, transmastoid removal of, including mastoidectomy Y 41626 01DEC1991 ABSCESS OR INFLAMMATION OF MIDDLE EAR, operation for (excluding aftercare) Y 41629 01DEC1991 MIDDLE EAR, EXPLORATION OF Y 41632 01DEC1991 MIDDLE EAR, insertion of tube for DRAINAGE OF (including myringotomy) Y 41635 01DEC1991 CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, 1 or more, with or without myringoplasty Y 41638 01DEC1991 CLEARANCE OF MIDDLE EAR FOR GRANULOMA, CHOLESTEATOMA and POLYP, 1 or more, with or without myringoplasty with ossicular chain reconstruction Y 41641 01DEC1991 PERFORATION OF TYMPANUM, cauterisation or diathermy of Y 41644 01DEC1991 EXCISION OF RIM OF EARDRUM PERFORATION, not being a service associated with myringoplasty Y 41647 01DEC1991 EAR TOILET requiring use of operating microscope and microinspection of tympanic membrane with or without general anaesthesia Y 41650 01DEC1991 TYMPANIC MEMBRANE, microinspection of 1 or both ears under general anaesthesia, not being a service associated with a service to which another item in this Group applies Y 41653 01DEC1991 EXAMINATION OF NASAL CAVITY or POSTNASAL SPACE, or NASAL CAVITY AND POSTNASAL SPACE, UNDER GENERAL ANAESTHESIA, not being a service associated with a service to which another item in this Group applies Y 41656 01DEC1991 NASAL HAEMORRHAGE, POSTERIOR, ARREST OF, with posterior nasal packing with or without cauterisation and with or without anterior pack (excluding aftercare) Y 41659 01DEC1991 NOSE, removal of FOREIGN BODY IN, other than by simple probing Y 41662 01DEC1991 NASAL POLYP OR POLYPI (SIMPLE), removal of Y 41665 01DEC1991 NASAL POLYP OR POLYPI (requiring admission to hospital), removal of Y 41668 01DEC1991 NASAL POLYP OR POLYPI (requiring admission to hospital), removal of N 41668 01NOV2017 NASAL POLYP OR POLYPI, removal of Y 41671 01DEC1991 NASAL SEPTUM, SEPTOPLASTY, SUBMUCOUS RESECTION or closure of septal perforation Y 41672 01MAY1997 NASAL SEPTUM, reconstruction of Y 41674 01DEC1991 CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, TURBINATES OR PHARYNX - 1 or more of these procedures (including any consultation on the same occasion) not being a service associated with any other operation on the nose N 41674 01NOV2017 Cauterisation (other than by chemical means) or cauterisation by chemical means when performed under general anaesthesia or diathermy of septum or turbinates - one or more of these procedures (including any consultation on the same occasion) other than a service associated with another operation on the nose Y 41677 01DEC1991 NASAL HAEMORRHAGE, arrest of during an episode of epistaxis by cauterisation or nasal cavity packing or both Y 41680 01DEC1991 CRYOTHERAPY TO NOSE in the treatment of nasal haemorrhage Y 41683 01DEC1991 DIVISION OF NASAL ADHESIONS, with or without stenting not being a service associated with any other operation on the nose and not performed during the postoperative period of a nasal operation Y 41686 01DEC1991 DISLOCATION OF TURBINATE OR TURBINATES, 1 or both sides, not being a service associated with a service to which another item in this Group applies Y 41689 01DEC1991 TURBINECTOMY or turbinectomies, partial or total, unilateral Y 41692 01DEC1991 TURBINATES, submucous resection of, unilateral Y 41695 01DEC1991 TURBINATES, cryotherapy to Y 41698 01DEC1991 MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF Y 41701 01DEC1991 MAXILLARY ANTRUM, proof puncture and lavage of, under general anaesthesia (requiring admission to hospital) not being a service associated with a service to which another item in this Group applies Y 41704 01DEC1991 MAXILLARY ANTRUM, LAVAGE OFeach attendance at which the procedure is performed, including any associated consultation Y 41707 01DEC1991 MAXILLARY ARTERY, transantral ligation of Y 41710 01DEC1991 ANTROSTOMY (RADICAL) Y 41713 01DEC1991 ANTROSTOMY (RADICAL) with transantral ethmoidectomy or transantral vidian neurectomy Y 41716 01DEC1991 ANTRUM, intranasal operation on, or removal of foreign body from Y 41719 01DEC1991 ANTRUM, drainage of, through tooth socket Y 41722 01DEC1991 OROANTRAL FISTULA, plastic closure of Y 41725 01DEC1991 ETHMOIDAL ARTERY OR ARTERIES, transorbital ligation of (unilateral) Y 41728 01DEC1991 LATERAL RHINOTOMY with removal of tumour Y 41729 01NOV1994 DERMOID OF NOSE, excision of, with intranasal extension Y 41731 01DEC1991 FRONTONASAL ETHMOIDECTOMY with or without sphenoidectomy N 41731 01NOV1993 FRONTONASAL ETHMOIDECTOMY by external approach with or without sphenoidectomy Y 41734 01DEC1991 RADICAL FRONTOETHMOIDECTOMY with osteoplastic flap Y 41737 01DEC1991 FRONTAL SINUS OR ETHMOIDAL SINUSES, intranasal operation on N 41737 01NOV1999 FRONTAL SINUS, OR ETHMOIDAL SINUSES ON THE ONE SIDE, intranasal operation on Y 41740 01DEC1991 FRONTAL SINUS, catheterisation of Y 41743 01DEC1991 FRONTAL SINUS, trephine of Y 41746 01DEC1991 FRONTAL SINUS, radical obliteration of Y 41749 01DEC1991 ETHMOIDAL SINUSES, external operation on Y 41752 01DEC1991 SPHENOIDAL SINUS, intranasal operation on Y 41755 01DEC1991 EUSTACHIAN TUBE, catheterisation of Y 41758 01DEC1991 DIVISION OF PHARYNGEAL ADHESIONS Y 41761 01DEC1991 POSTNASAL SPACE, direct examination of, with or without biopsy Y 41764 01DEC1991 NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX N 41764 01NOV1993 NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX, one or more of these procedures N 41764 01NOV2006 NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX, one or more of these procedures, unilateral or bilateral examination Y 41767 01DEC1991 NASOPHARYNGEAL ANGIOFIBROMA, transpalatal removal N 41767 01JUL2011 NASOPHARYNGEAL ANGIOFIBROMA, removal of Y 41770 01DEC1991 PHARYNGEAL POUCH, removal of, with or without cricopharyngeal myotomy Y 41773 01DEC1991 PHARYNGEAL POUCH, ENDOSCOPIC RESECTION OF (Dohlman's operation) Y 41776 01DEC1991 CRICOPHARYNGEAL MYOTOMY with or without inversion of pharyngeal pouch Y 41779 01DEC1991 PHARYNGOTOMY (lateral), with or without total excision of tongue Y 41782 01DEC1991 PARTIAL PHARYNGECTOMY via PHARYNGOTOMY Y 41785 01DEC1991 PARTIAL PHARYNGECTOMY via PHARYNGOTOMY with partial or total glossectomy Y 41786 01DEC1991 PHARYNGEAL FLAP or PHARYNGOPLASTY, with or without tonsillectomy N 41786 01NOV1994 UVULOPALATOPHARYNGOPLASTY, with or without tonsillectomy, by any means Y 41787 01NOV1994 UVULECTOMY AND PARTIAL PALATECTOMY WITH LASER INCISION OF THE PALATE, with or without tonsillectomy, 1 or more stages, including any revision procedures within 12 months Y 41788 01DEC1991 TONSILS OR TONSILS AND ADENOIDS, removal of, in a person aged LESS THAN 12 YEARS Y 41789 01DEC1991 TONSILS OR TONSILS AND ADENOIDS, removal of, in a person aged LESS THAN 12 YEARS N 41789 01NOV2017 Tonsils or tonsils and adenoids, removal of, in a person aged less than 12 years(including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies Y 41792 01DEC1991 TONSILS OR TONSILS AND ADENOIDS, removal of, in a person 12 YEARS OF AGE OR OVER Y 41793 01DEC1991 TONSILS OR TONSILS AND ADENOIDS, removal of, in a person 12 YEARS OF AGE OR OVER N 41793 01NOV2017 Tonsils or tonsils and adenoids, removal of, in a person 12 years of age or over (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies Y 41796 01DEC1991 TONSILS OR TONSILS AND ADENOIDS, ARREST OF HAEMORRHAGE requiring general anaesthesia, following removal of Y 41797 01DEC1991 TONSILS OR TONSILS AND ADENOIDS, ARREST OF HAEMORRHAGE requiring general anaesthesia, following removal of Y 41800 01DEC1991 ADENOIDS, removal of Y 41801 01DEC1991 ADENOIDS, removal of N 41801 01NOV2017 Adenoids, removal of (including any examination of the postnasal space and nasopharynx and the infiltration of local anaesthetic), not being a service to which item 41764 applies Y 41804 01DEC1991 LINGUAL TONSIL OR LATERAL PHARYNGEAL BANDS, removal of Y 41807 01DEC1991 PERITONSILLAR ABSCESS (quinsy), incision of Y 41810 01DEC1991 UVULOTOMY or UVULECTOMY Y 41813 01DEC1991 VALLECULAR OR PHARYNGEAL CYSTS, removal of Y 41816 01DEC1991 OESOPHAGOSCOPY (with rigid oesophagoscope) Y 41819 01DEC1991 OESOPHAGEAL AND ANASTOMOTIC STRICTURE, endoscopic dilatation of N 41819 01NOV2000 DILATATION OF STRICTURE OF UPPER GASTRO-INTESTINAL TRACT using bougie or balloon over endoscopically inserted guidewire, including endoscopy with flexible or rigid endoscope Y 41820 01NOV2000 DILATATION OF STRICTURE OF UPPER GASTRO-INTESTINAL TRACT using bougie or balloon over endoscopically inserted guidewire, including endoscopy with flexible or rigid endoscope, where the use of imaging intensification is clinically indicated Y 41822 01DEC1991 OESOPHAGOSCOPY (with rigid oesophagoscope), with biopsy Y 41825 01DEC1991 OESOPHAGOSCOPY (with rigid oesophagoscope), with removal of foreign body Y 41828 01DEC1991 OESOPHAGEAL STRICTURE, dilatation of, without oesophagoscopy Y 41831 01DEC1991 OESOPHAGUS, endoscopic pneumatic dilatation of N 41831 01NOV2017 Oesophagus, endoscopic pneumatic dilatation of,for treatment of achalasia Y 41832 01MAY1997 OESOPHAGUS, balloon dilatation of, using interventional imaging techniques Y 41834 01DEC1991 LARYNGECTOMY (TOTAL) Y 41837 01DEC1991 VERTICAL HEMILARYNGECTOMY including tracheostomy Y 41840 01DEC1991 SUPRAGLOTTIC LARYNGECTOMY including tracheostomy Y 41843 01DEC1991 LARYNGOPHARYNGECTOMY or PRIMARY RESTORATION OF ALIMENTARY CONTINUITY after laryngopharyngectomy USING STOMACH OR BOWEL Y 41846 01DEC1991 LARYNX, direct examination of the supraglottic, glottic and subglottic regions, not being a service associated with any other procedure on the larynx or with the administration of a general anaesthetic Y 41849 01DEC1991 LARYNX, direct examination of, with biopsy Y 41852 01DEC1991 LARYNX, direct examination of, WITH REMOVAL OF TUMOUR Y 41855 01DEC1991 MICROLARYNGOSCOPY Y 41858 01DEC1991 MICROLARYNGOSCOPY with removal of juvenile papillomata Y 41861 01DEC1991 MICROLARYNGOSCOPY with removal of papillomata by laser surgery N 41861 01JUL2011 MICROLARYNGOSCOPY with removal of benign lesions of the larynx by laser surgery Y 41864 01DEC1991 MICROLARYNGOSCOPY WITH REMOVAL OF TUMOUR Y 41867 01DEC1991 MICROLARYNGOSCOPY with arytenoidectomy Y 41868 01MAY1997 LARYNGEAL WEB, division of, using microlarygoscopic techniques Y 41869 01MAY1997 BOTULINUM TOXIN INJECTION INTO VOCAL CORDS, including associated consultation Y 41870 01DEC1991 INJECTION OF VOCAL CORD BY TEFLON, FAT, COLLAGEN OR GELFOAM N 41870 01NOV1997 INJECTION OF VOCAL CORD BY TEFLON, FAT, COLLAGEN OR GELFOAM Y 41873 01DEC1991 LARYNX, FRACTURED, operation for Y 41876 01DEC1991 LARYNX, external operation on, OR LARYNGOFISSURE with or without cordectomy Y 41879 01DEC1991 LARYNGOPLASTY or TRACHEOPLASTY, including tracheostomy Y 41880 23NOV1998 TRACHEOSTOMY by a percutaneous technique using sequential dilatation or partial splitting method to allow insertion of a cuffed tracheostomy tube N 41880 01MAR1999 TRACHEOSTOMY by a percutaneous technique using sequential dilatation or partial splitting method to allow insertion of a cuffed tracheostomy tube Y 41881 01JUL1998 TRACHEOSTOMY by open exposure of the trachea as an independent procedure N 41881 01MAR1999 TRACHEOSTOMY by open exposure of the trachea, including separation of the strap muscles or division of the thyroid isthmus, where performed Y 41882 01DEC1991 TRACHEOSTOMY Y 41883 01DEC1991 TRACHEOSTOMY N 41883 01JUL1998 TRACHEOSTOMY by open exposure of the trachea in association with another procedure Y 41884 01JUL1995 CRICOTHYROSTOMY, by direct stab or Seldinger technique, using Minitrach or similar device, for tracheobronchial toilet N 41884 01JUL1998 CRICOTHYROSTOMY OR TRACHEOSTOMY, by direct stab or dilation technique, using Minitrach or similar device N 41884 01MAR1999 CRICOTHYROSTOMY by direct stab or Seldinger technique, using Minitrach or similar device N 41884 01JAN2014 CRICOTHYROSTOMY by direct stab or Seldinger technique, using mini tracheostomy device Y 41885 01JUL1998 TRACHE-OESOPHAGEAL FISTULA, formation of, as a secondary procedure following laryngectomy, including associated endoscopic procedures Y 41886 01DEC1991 TRACHEA, removal of foreign body in Y 41889 01DEC1991 BRONCHOSCOPY, as an independent procedure Y 41892 01DEC1991 BRONCHOSCOPY with 1 or more endobronchial biopsies or other diagnostic or therapeutic procedures Y 41895 01DEC1991 BRONCHUS, removal of foreign body in Y 41898 01DEC1991 FIBREOPTIC BRONCHOSCOPY with 1 or more transbronchial lung biopsies, with or without bronchial or bronchoalveolar lavage, with or without the use of interventional imaging Y 41901 01DEC1991 ENDOSCOPIC LASER RESECTION OF ENDOBRONCHIAL TUMOURS for relief of obstruction including any associated endoscopic procedures Y 41904 01DEC1991 BRONCHOSCOPY with dilatation of tracheal stricture Y 41905 01NOV1995 TRACHEA OR BRONCHUS, dilatation of stricture and endoscopic insertion of stent Y 41907 01DEC1991 NASAL SEPTUM BUTTON, insertion of Y 41910 01JUL1993 DUCT OF MAJOR SALIVARY GLAND, transposition of Y 42503 01DEC1991 OPHTHALMOLOGICAL EXAMINATION under general anaesthesia, not being a service associated with a service to which another item in this Group applies Y 42505 01NOV2018 Complete removal from the eye of a trans-trabecular drainage device or devices, with or without replacement, following device related medical complications necessitating complete removal.    N 42505 01FEB2019 Complete removal from the eye of a trans-trabecular drainage device or devices, with or without replacement, following device related medical complications necessitating complete removal.   Y 42506 01DEC1991 EYE, ENUCLEATION OF, with or without sphere implant Y 42509 01DEC1991 EYE, ENUCLEATION OF, with insertion of integrated implant Y 42510 01MAY1994 EYE, enucleation of, with insertion of hydroxy apatite implant (coral implant), by 1 or more stages N 42510 01JUL1998 EYE, enucleation of, with insertion of hydroxy apatite implant or similar coralline implant Y 42512 01DEC1991 GLOBE, EVISCERATION OF Y 42515 01DEC1991 GLOBE, EVISCERATION OF, AND INSERTION OF INTRASCLERAL BALL OR CARTILAGE Y 42518 01DEC1991 ANOPHTHALMIC ORBIT, INSERTION OF CARTILAGE OR ARTIFICIAL IMPLANT as a delayed procedure, or REMOVAL OF IMPLANT FROM SOCKET N 42518 01NOV1996 ANOPHTHALMIC ORBIT, INSERTION OF CARTILAGE OR ARTIFICIAL IMPLANT as a delayed procedure, or REMOVAL OF IMPLANT FROM SOCKET, or PLACEMENT OF A MOTILITY INTEGRATING PEG by drilling into an existing orbital implant Y 42521 01DEC1991 ANOPHTHALMIC SOCKET, treatment of, by insertion of a wired-in conformer, integrated implant or dermofat graft, as a secondary procedure Y 42524 01DEC1991 ORBIT, SKIN GRAFT TO, as a delayed procedure Y 42527 01DEC1991 CONTRACTED SOCKET, RECONSTRUCTION INCLUDING MUCOUS MEMBRANE GRAFTING AND STENT MOULD Y 42530 01DEC1991 ORBIT, EXPLORATION with or without biopsy, requiring REMOVAL OF BONE Y 42533 01DEC1991 ORBIT, EXPLORATION OF, with drainage or biopsy not requiring removal of bone Y 42536 01DEC1991 ORBIT, EXENTERATION OF, with or without skin graft and with or without temporalis muscle transplant Y 42539 01DEC1991 ORBIT, EXPLORATION OF, with removal of tumour or foreign body, requiring removal of bone Y 42542 01DEC1991 ORBIT, EXPLORATION OF, with removal of tumour or of foreign body N 42542 01JUL1998 ORBIT, exploration of anterior aspect with removal of tumour or foreign body Y 42543 01JUL1998 ORBIT, exploration of retrobulbar aspect with removal of tumour or foreign body Y 42545 01DEC1991 ORBIT, decompression of, for dysthyroid eye disease, 2 or more walls, 1 eye N 42545 01JUL1998 ORBIT, decompression of, for dysthyroid eye disease, by fenestrationof 2 or more walls, or by the removal of intraorbital peribulbar and retrobulbar fat from each quadrant of the orbit, 1 eye Y 42548 01DEC1991 OPTIC NERVE MENINGES, incision of Y 42551 01DEC1991 EYEBALL, PERFORATING WOUND OF, not involving intraocular structuresrepair involving suture of cornea or sclera, or both, not being a service to which item 42632 applies N 42551 01NOV2012 EYE, PENETRATING WOUND OR RUPTURE OF, not involving intraocular structures repair involving suture of cornea or sclera, or both, not being a service to which item 42632 applies Y 42554 01DEC1991 EYEBALL, PERFORATING WOUND OF, with incarceration or prolapse of uveal tissuerepair N 42554 01NOV2012 EYE, PENETRATING WOUND OR RUPTURE OF, with incarceration or prolapse of uveal tissue repair Y 42557 01DEC1991 EYEBALL, PERFORATING WOUND OF, with incarceration of lens or vitreousrepair N 42557 01NOV2012 EYE, PENETRATING WOUND OR RUPTURE OF, with incarceration of lens or vitreous repair Y 42560 01DEC1991 INTRAOCULAR FOREIGN BODY, magnetic removal from anterior segment Y 42561 01JUL1998 Historical item included for item mapping purposes Y 42563 01DEC1991 INTRAOCULAR FOREIGN BODY, nonmagnetic removal from anterior segment N 42563 01NOV2012 INTRAOCULAR FOREIGN BODY, removal from anterior segment Y 42566 01DEC1991 INTRAOCULAR FOREIGN BODY, magnetic removal from posterior segment Y 42569 01DEC1991 INTRAOCULAR FOREIGN BODY, nonmagnetic removal from posterior segment N 42569 01NOV2012 INTRAOCULAR FOREIGN BODY, removal from posterior segment Y 42572 01DEC1991 ORBITAL ABSCESS OR CYST, drainage of Y 42573 01NOV1994 DERMOID, periorbital, excision of N 42573 01SEP2015 DERMOID, periorbital, excision of, on a person 10 years of age or over Y 42574 01NOV1994 DERMOID, orbital, excision of Y 42575 01DEC1991 TARSAL CYST, extirpation of Y 42576 01SEP2015 DERMOID, periorbital, excision of, on a person under 10 years of age Y 42578 01DEC1991 TARSAL CARTILAGE, excision of Y 42581 01DEC1991 ECTROPION OR ENTROPION, tarsal cauterisation of Y 42584 01DEC1991 TARSORRHAPHY Y 42587 01DEC1991 CRYOTHERAPY or ELECTROLYSIS EPILATION for trichiasis - each eyelid N 42587 01MAY1994 TRICHIASIS, treatment of by cryotherapy, laser or electrolysis - each eyelid N 42587 01NOV2018 TRICHIASIS (due to causes other than trachoma), treatment of by cryotherapy, laser or electrolysis - each eyelid Y 42588 01NOV2018 TRICHIASIS (due to trachoma), treatment of by cryotherapy, laser or electrolysis - each eyelid Y 42590 01DEC1991 CANTHOPLASTY, medial or lateral Y 42593 01DEC1991 LACRIMAL GLAND, excision of palpebral lobe Y 42596 01DEC1991 LACRIMAL SAC, excision of, or operation on Y 42599 01DEC1991 LACRIMAL CANALICULAR SYSTEM, establishment of patency by closed operation using silicone tubes or similar, 1 eye Y 42602 01DEC1991 LACRIMAL CANALICULAR SYSTEM, establishment of patency by open operation, 1 eye Y 42605 01DEC1991 LACRIMAL CANALICULUS, immediate repair of Y 42608 01DEC1991 LACRIMAL DRAINAGE by insertion of glass tube, as an independent procedure Y 42610 01MAY1994 NASOLACRIMAL TUBE (unilateral) replacement of, or lacrimal passages, probing for obstruction, unilateral, with or without lavage - under general anaesthesia N 42610 01JUL1998 NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL PASSAGES, probing for obstruction, unilateral, with or without lavage - under general anaesthesia Y 42611 01DEC1991 NASOLACRIMAL TUBE (unilateral) replacement of, under general anaesthesia, or lacrimal passages, probing for obstruction, unilateral or bilateral, with or without lavage N 42611 01MAY1994 NASOLACRIMAL TUBE (bilateral) replacement of, or lacrimal passages, probing for obstruction, bilateral, with or without lavage - under general anaesthesia N 42611 01JUL1998 NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL PASSAGES, probing for obstruction, bilateral, with or without lavage - under general anaesthesia Y 42614 01DEC1991 LACRIMAL PASSAGES, lavage of, unilateral, not being a service associated with a service to which item 42611 applies (excluding aftercare) N 42614 01MAY1994 NASOLACRIMAL TUBE (unilateral) replacement of, or lacrimal passages, probing for obstruction, unilateral, with or without lavage, not being a service associated with a service to which item 42610 applies (excluding aftercare) N 42614 01JUL1998 NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or site of obstruction, unilateral, including lavage, with or without lavage, not being a service associated with a service to which item 42610 applies (excluding aftercare) N 42614 01NOV2001 NASOLACRIMAL TUBE (unilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or site of obstruction, unilateral, including lavage, not being a service associated with a service to which item 42610 applies (excluding aftercare) Y 42615 01MAY1994 NASOLACRIMAL TUBE (bilateral) replacement of, or lacrimal passages, probing for obstruction, bilateral, with or without lavage, not being a service associated with a service to which item 42611 applies (excluding aftercare) N 42615 01JUL1998 NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or sit of obstruction, bilateral, including lavage, not being a service associated with a service to which item 42611 applies (excluding aftercare) N 42615 01NOV2001 NASOLACRIMAL TUBE (bilateral), removal or replacement of, or LACRIMAL PASSAGES, probing to establish patency of the lacrimal passage and/or site of obstruction, bilateral, including lavage, not being a service associated with a service to which item 42611 applies (excluding aftercare) Y 42617 01DEC1991 PUNCTUM SNIP operation Y 42620 01DEC1991 PUNCTUM, occlusion of, by use of a plug Y 42621 01NOV1996 PUNCTUM, temporary occlusion of, by use of electrical cautery Y 42622 01NOV1996 PUNCTUM, permanent occlusion of, by use of electrical cautery Y 42623 01DEC1991 DACRYOCYSTORHINOSTOMY Y 42626 01DEC1991 DACRYOCYSTORHINOSTOMY where a previous dacryocystorhinostomy has been performed Y 42629 01DEC1991 CONJUNCTIVORHINOSTOMY including dacryocystorhinostomy and fashioning of conjunctival flaps Y 42632 01DEC1991 CONJUNCTIVAL PERITOMY OR REPAIR OF CORNEAL LACERATION by conjunctival flap Y 42635 01DEC1991 CORNEAL PERFORATIONS, sealing of, with tissue adhesive Y 42638 01DEC1991 CONJUNCTIVAL GRAFT OVER CORNEA Y 42641 01DEC1991 AUTOCONJUNCTIVAL TRANSPLANT, or mucous membrane graft Y 42644 01DEC1991 CORNEA OR SCLERA, removal of imbedded foreign body from (excluding aftercare) N 42644 01JUL2008 CORNEA OR SCLERA, removal of imbedded foreign body from - not more than once on the same day by the same practitioner (excluding aftercare) N 42644 01NOV2012 CORNEA OR SCLERA, complete removal of embedded foreign body from - not more than once on the same day by the same practitioner (excluding aftercare) Y 42647 01DEC1991 CORNEAL SCARS, removal of, by partial keratectomy, not being a service associated with a service to which item 42686 applies Y 42650 01DEC1991 CORNEA, epithelial debridement for corneal ulcer or corneal erosion (excluding aftercare) Y 42651 01JUL1998 CORNEA, epithelial debridement for eliminating band keratopathy Y 42652 01MAY2018 Corneal collagen cross linking, on a person with a corneal ectatic disorder, with evidence of progression - per eye. Y 42653 01DEC1991 CORNEA, transplantation of, full thickness, including collection of donor material N 42653 01NOV1993 CORNEA, transplantation of, full thickness N 42653 01JUL2014 CORNEA transplantation of Y 42656 01DEC1991 CORNEA, transplantation of, full thickness, including collection of donor material where there have been 2 previous graft operations N 42656 01NOV1993 CORNEA, transplantation of, where there have been 2 previous graft operations N 42656 01NOV2003 CORNEA, transplantation of, second and subsequent procedures Y 42659 01DEC1991 CORNEA, transplantation of, superficial or lamellar, including collection of donor material N 42659 01NOV1993 CORNEA, transplantation of, superficial or lamellar Y 42662 01DEC1991 SCLERA, transplantation of, full thickness, including collection of donor material Y 42665 01DEC1991 SCLERA, transplantation of, superficial or lamellar, including collection of donor material Y 42667 01MAY1997 RUNNING CORNEAL SUTURE, manipulation of, performed within 4 months of corneal grafting, to reduce astigmatism where a reduction of 2 dioptres of astigmatism is obtained, including any associated consultation Y 42668 01DEC1991 CORNEAL SUTURES, removal of, not earlier than 6 weeks after operation requiring use of slit lamp or operating microscope Y 42670 01MAY1997 PHOTOTHERAPEUTIC KERATECTOMY by excimer laser Y 42671 01DEC1991 REFRACTIVE KERATOPLASTY with penetrating incisions (excluding radial keratotomy) following corneal grafting or intraocular operation INCLUDING ANY MEASUREMENTS AND CALCULATIONS associated with the procedure Y 42672 01NOV2003 CORNEAL INCISONS, to correct corneal astigmatism of more than 11/2 dioptres following anterior segment surgery, including appropriate measurements and calculations, performed as an independent procedure Y 42673 01NOV2003 ADDITIONAL CORNEAL INCISIONS, to correct corneal astigmatism of more than 11/2 dioptres, including appropriate measurements and calculations, performed in conjunction with other anterior segment surgery Y 42674 01DEC1991 CORNEAL INCISIONS, non penetrating, for the correction of astigmatism following surgery of anterior chamber or corneal grafting, and including associated ultrasound pachymetry of corneal thickness, with or without compression sutures Y 42676 01MAY1997 CONJUNCTIVA, biopsy of, as an independent procedure Y 42677 01DEC1991 CONJUNCTIVA, CAUTERY OF, INCLUDING TREATMENT OF PANNUSeach attendance at which treatment is given including any associated consultation Y 42680 01DEC1991 CONJUNCTIVA, cryotherapy to, for melanotic lesions or similar using CO2 or N20 Y 42683 01DEC1991 CONJUNCTIVAL CYSTS, removal of, requiring admission to hospital or approved day-hospital facility Y 42686 01DEC1991 PTERYGIUM, removal of Y 42689 01DEC1991 PINGUECULA, removal of, not being a service associated with the fitting of contact lenses Y 42692 01DEC1991 LIMBIC TUMOUR, removal of N 42692 01NOV1998 LIMBIC TUMOUR, removal of, excluding Pterygium Y 42695 01DEC1991 LIMBIC TUMOUR, excision of, requiring keratectomy or sclerectomy N 42695 01NOV1998 LIMBIC TUMOUR, excision of, requiring keratectomy or sclerectomy, excluding Pterygium Y 42698 01DEC1991 LENS EXTRACTION N 42698 01NOV2000 LENS EXTRACTION, excluding surgery performed for the correction of refractive error only N 42698 01NOV2001 LENS EXTRACTION, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye Y 42701 01DEC1991 ARTIFICIAL LENS, insertion of N 42701 01NOV2000 ARTIFICIAL LENS, insertion of, excluding surgery performed for the correction of refractive errorexcept for anisometropia greater than 3 dioptres following the removal of cataract in the first eye N 42701 01NOV2001 ARTIFICIAL LENS, insertion of, excluding surgery performed for the correction of refractive errorexcept for anisometropia greater than 3 dioptres following the removal of cataract in the first eye N 42701 01NOV2012 INTRAOCULAR LENS, insertion of, excluding surgery performed for the correction of refractive errorexcept for anisometropia greater than 3 dioptres following the removal of cataract in the first eye Y 42702 01NOV1996 LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS N 42702 01NOV2000 LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS, excluding surgery performed for the correction of refractive error only N 42702 01NOV2001 LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS, excluding surgery performed for the correction of refractive errorexcept for anisometropia greater than 3 dioptres following the removal of cataract in the first eye N 42702 01NOV2012 LENS EXTRACTION AND INSERTION OF INTRAOCULAR LENS, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye Y 42703 01NOV1996 ARTIFICIAL LENS, insertion of, into the posterior chamber and suture to the iris and sclera N 42703 01NOV2012 INTRAOCULAR LENS or IRIS PROSTHESIS insertion of, into the posterior chamber with fixation to the iris or sclera Y 42704 01DEC1991 ARTIFICIAL LENS, REMOVAL or REPOSITIONING of by open operation, not being a service associated with a service to which item 42701 applies N 42704 01NOV2012 INTRAOCULAR LENS, REMOVAL or REPOSITIONING of by open operation, not being a service associated with a service to which item 42701 applies Y 42705 01MAY2017 LENS EXTRACTION AND INSERTION OF INTRAOCULAR LENS, excluding surgery performed for the correction of refractive errorexcept for anisometropia greater than 3 dioptres following the removal of cataract in the first eye, performed in association with insertion of a trans-trabecular drainage device or devices, in a patient diagnosed with open angle glaucoma who is not adequately responsive to topical anti-glaucoma medications or who is intolerant of anti-glaucoma medication. Y 42707 01DEC1991 ARTIFICIAL LENS, REMOVAL of and REPLACEMENT with a different lens N 42707 01NOV2005 ARTIFICIAL LENS, REMOVAL of and REPLACEMENT with a different lens, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye N 42707 01NOV2012 INTRAOCULAR LENS, REMOVAL of and REPLACEMENT with a different lens, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 dioptres following the removal of cataract in the first eye Y 42710 01DEC1991 ARTIFICIAL LENS, removal of, and replacement with a lens inserted into the posterior chamber and sutured to the iris or sclera N 42710 01NOV2012 INTRAOCULAR LENS, removal of, and replacement with a lens inserted into the posterior chamber and fixated to the iris or sclera Y 42713 01DEC1991 INTRAOCULAR LENSES, repositioning of, by the use of a McCannell suture or similar N 42713 01NOV2012 IRIS SUTURING, McCannell technique or similar, for fixation of intraocular lens or repair of iris defect Y 42716 01DEC1991 CATARACT, JUVENILE, removal of, including subsequent needlings Y 42718 01NOV2009 COMPLEX LENS EXTRACTION AND INSERTION OF ARTIFICIAL LENS, with a surgical procedure time of 40 minutes or more, excluding surgery performed for the correction of refractive error except for anisometropia greater than 3 diopres following the removal of cataract in the first eye. Y 42719 01DEC1991 CAPSULECTOMY OR REMOVAL OF VITREOUS via the anterior chamber by any method, not being a service associated with any other intraocular operation on that eye N 42719 01JUL1998 CAPSULECTOMY OR REMOVAL OF VITREOUS via the anterior chamber by any method, not being a service associated with a service to which item 42698, 42702 or 42716 applies N 42719 01NOV2005 CAPSULECTOMY OR REMOVAL OF VITREOUS, or both, via the anterior chamber by any method, not being a service associated with a service to which item 42698, 42702 or 42716 applies N 42719 01NOV2012 REMOVAL OF VITREOUS, and/or CAPSULAR or LENS MATERIAL, via a limbal approach,not being a service associated with a service to which item 42698, 42702, 42716, 42725 or 42731 applies Y 42722 01DEC1991 CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with any other intraocular operation on that eye1 or both procedures N 42722 01JUL1998 CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with a service to which item 42698, 42702 or 42716 applies - 1 or both procedures N 42722 01NOV2005 CAPSULECTOMY by posterior chamber sclerotomy OR REMOVAL OF VITREOUS or VITREOUS BANDS, or both, from the anterior chamber by posterior chamber sclerotomy, by cutting and suction and infusion, not being a service associated with a service to which item 42698, 42702 or 42716 applies - 1 or both procedures Y 42725 01DEC1991 VITRECTOMY by posterior chamber sclerotomyincluding the removal of vitreous, division of bands or removal of preretinal membranes by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with any other intraocular operation on that eye, other than a service to which item 42728 applies N 42725 01JUL1998 VITRECTOMY by posterior chamber sclerotomyincluding the removal of vitreous, division of bands or removal of preretinal membranes by cutting and suction and replacement by saline, Hartmann's or similar solution N 42725 01NOV2005 VITRECTOMY by posterior chamber sclerotomyincluding the removal of vitreous, division of bands or removal of preretinal membranes where performed, by cutting and suction and infusion N 42725 01NOV2012 VITRECTOMY via pars plana sclerotomies including the removal of vitreous, division of bands or removal of epiretinal membranes N 42725 01MAY2017 Vitrectomy via pars plana sclerotomy, including one or more of the following:(a) removal of vitreous; (b) division of vitreous bands; (c) removal of epiretinal membranes; (d) capsulotomy Y 42728 01DEC1991 CRYOTHERAPY OF RETINA or other intraocular structures with an internal probe, being a service associated with a service to which item 42725 applies Y 42731 01DEC1991 CAPSULECTOMY or LENSECTOMY by posterior chamber sclerotomy in conjunction with the removal of vitreous or division of vitreous bands or removal of preretinal membrane from the posterior chamber by cutting and suction and replacement by saline, Hartmann's or similar solution, not being a service associated with any other intraocular operation N 42731 01NOV2005 CAPSULECTOMY or LENSECTOMY, or both, by posterior chamber sclerotomy in conjunction with the removal of vitreous or division of vitreous bands or removal of preretinal membrane from the posterior chamber by cutting and suction and infusion, not being a service associated with any other intraocular operation N 42731 01NOV2012 LIMBAL OR PARS PLANA LENSECTOMY combined with vitrectomy, not being a service associated with items 42698, 42702, 42719, or 42725 Y 42734 01DEC1991 CAPSULOTOMY, other than by laser N 42734 01MAY2017 Capsulotomy, other than by laser, and other than a service associated with a service to which item 42725 or 42731 applies Y 42737 01DEC1991 NEEDLING OF POSTERIOR CAPSULE Y 42738 01MAR2012 PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the injection of therapeutic substances, or the removal of aqueous or vitreous humours for diagnostic or therapeutic purposes, 1 or more of, as an independent procedure. Y 42739 01MAR2012 PARACENTESIS OF ANTERIOR CHAMBER OR VITREOUS CAVITY, or both, for the injection of therapeutic substances, or the removal of aqueous or vitreous humours for diagnostic or therapeutic purposes, 1 or more of, as an independent procedure, for a patient requiring anaesthetic services. Y 42740 01DEC1991 PARACENTESIS OF ANTERIOR OR POSTERIOR CHAMBER OR BOTH, for the injection of therapeutic substances, or the removal of aqueous or vitreous for diagnostic purposes, 1 or more of N 42740 01NOV2006 PARACENTESIS OF ANTERIOR OR POSTERIOR SEGMENT (including the vitreous) OR BOTH, for the injection of therapeutic substances, or the removal of aqueous or vitreous for diagnostic purposes, 1 or more of N 42740 01MAR2012 INTRAVITREAL INJECTION OF THERAPEUTIC SUBSTANCES, or the removal of vitreous humour for diagnostic purposes, 1 or more of, as a procedure associated with other intraocular surgery. Y 42741 01JUL2008 Posterior juxtascleral depot injection of a therapeutic substance, for the treatment of subfoveal choroidal neovascularisation due to age-related macular degeneration, 1 or more of Y 42743 01DEC1991 ANTERIOR CHAMBER, IRRIGATION OF BLOOD FROM, as an independent procedure Y 42744 01NOV2005 NEEDLING FOR DRAINAGE OF ENCYSTED BLEB, following trabeculectomy N 42744 01JUL2014 Needle revision of glaucoma filtration bleb, following glaucoma filtering procedure Y 42746 01DEC1991 GLAUCOMA, filtering operation for N 42746 01NOV2012 GLAUCOMA, filtering operation for, where conservative therapies have failed, are likely to fail, or are contraindicated Y 42749 01DEC1991 GLAUCOMA, filtering operation for, where previous filtering operation has been performed Y 42752 01DEC1991 GLAUCOMA, insertion of Molteno valve for, 1 or more stages N 42752 01NOV2012 GLAUCOMA, insertion of drainage device incorporating an extraocular reservoir for, such as a Molteno device Y 42755 01DEC1991 GLAUCOMA, removal of Molteno valve N 42755 01NOV2012 GLAUCOMA, removal of drainage device incorporating an extraocular reservoir for, such as a Molteno device Y 42758 01DEC1991 GONIOTOMY N 42758 01MAY2017 Goniotomy for the treatment of primary congenital glaucoma, excluding the minimally invasive implantation of glaucoma drainage devices Y 42761 01DEC1991 DIVISION OF ANTERIOR OR POSTERIOR SYNECHIAE, as an independent procedure, other than by laser Y 42764 01DEC1991 IRIDECTOMY (including excision of tumour of iris) OR IRIDOTOMY, as an independent procedure, other than by laser Y 42767 01DEC1991 TUMOUR, INVOLVING CILIARY BODY OR CILIARY BODY AND IRIS, excision of Y 42770 01DEC1991 CYCLODIATHERMY OR CYCLOCRYOTHERAPY N 42770 01NOV1996 CYCLODESTRUCTIVE procedures for the treatment of intractable glaucoma, treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period Y 42771 01NOV2001 CYCLODESTRUCTIVE PROCEDURES for the treatment of intractable glaucoma, treatment to one eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which 42770 applies) is indicated in a 2 year period (Anaes.) Y 42773 01DEC1991 DETACHED RETINA, diathermy or cryotherapy for, not being a service associated with a service to which item 42776 applies N 42773 01NOV2012 DETACHED RETINA, pneumatic retinopexy for, not being a service associated with a service to which item 42776 applies Y 42776 01DEC1991 DETACHED RETINA, buckling or resection operation for Y 42779 01DEC1991 DETACHED RETINA, revision operation for N 42779 01NOV2012 DETACHED RETINA, revision of scleral buckling operation for Y 42782 01DEC1991 LASER TRABECULOPLASTY - each treatment to 1 eye, to a maximum of 4 treatments to that eye in a 2 year period N 42782 01NOV2012 LASER TRABECULOPLASTY, for the treatment of glaucoma. Each treatment to 1 eye, to a maximum of 4 treatments to that eye in a 2 year period Y 42783 19JUN1997 LASER TRABECULOPLASTY - each treatment to 1 eye - where it can be demonstrated that a 5th or subsequent treatment to that eye (including any treatments to which item 42782 applies) is indicated in a 2 year period N 42783 01NOV1997 LASER TRABECULOPLASTY - each treatment to 1 eye - where it can be demonstrated that a 5th or subsequent treatment to that eye (including any treatments to which item 42782 applies) is indicated in a 2 year period N 42783 01NOV2012 LASER TRABECULOPLASTY, for the treatment of glaucoma. Each treatment to 1 eye - where it can be demonstrated that a 5th or subsequent treatment to that eye (including any treatments to which item 42782 applies) is indicated in a 2 year period Y 42785 01DEC1991 LASER IRIDOTOMY - each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42785 01NOV2006 LASER IRIDOTOMY - each treatment episode to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42785 01NOV2018 LASER IRIDOTOMY - each treatment episode to 1 eye, to a maximum of 3 treatments to that eye in a 2 year period Y 42786 19JUN1997 LASER IRIDOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42785 applies) is indicated in a 2 year period N 42786 01NOV1997 LASER IRIDOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42785 applies) is indicated in a 2 year period N 42786 01NOV2006 LASER IRIDOTOMY - each treatment episode to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42785 applies) is indicated in a 2 year period Y 42788 01DEC1991 LASER CAPSULOTOMY - each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42788 01NOV2006 LASER CAPSULOTOMY - each treatment episode to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42788 01MAY2017 Laser capsulotomy - each treatment episode to one eye, to a maximum of 2 treatments to that eye in a 2 year period - other than a service associated with a service to which item 42702 applies Y 42789 19JUN1997 LASER CAPSULOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period N 42789 01NOV1997 LASER CAPSULOTOMY - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period N 42789 01NOV2006 LASER CAPSULOTOMY - each treatment episode to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period N 42789 01MAY2017 Laser capsulotomy - each treatment episode to one eye - if it can be demonstrated that a third or subsequent treatment to that eye (including any treatments to which item 42788 applies) is indicated in a 2 year period - other than a service associated with a service to which item 42702 applies Y 42791 01DEC1991 LASER VITREOLYSIS OR CORTICOLYSIS OF LENS MATERIAL OR FIBRINOLYSIS -each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42791 01MAY2017 Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding vitreolysis in the posterior vitreous cavity - each treatment to one eye, to a maximum of 2 treatments to that eye in a 2 year period N 42791 01NOV2018 Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding vitreolysis in the posterior vitreous cavity - each treatment to one eye, to a maximum of 3 treatments to that eye in a 2 year period Y 42792 19JUN1997 LASER VITREOLYSIS OR CORTICOLYSIS OF LENS MATERIAL OR FIBRINOLYSIS - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42791 applies) is indicated in a 2 year period N 42792 01NOV1997 LASER VITREOLYSIS OR CORTICOLYSIS OF LENS MATERIAL OR FIBRINOLYSIS - each treatment to 1 eye - where it can be demonstrated that a 3rd or subsequent treatment to that eye (including any treatments to which item 42791 applies) is indicated in a 2 year period N 42792 01MAY2017 Laser vitreolysis or corticolysis of lens material or fibrinolysis, excluding vitreolysis in the posterior vitreous cavity - each treatment to one eye - if it can be demonstrated that a third or subsequent treatment to that eye (including any treatments to which item 42791 applies) is indicated in a 2 year period Y 42794 01DEC1991 DIVISION OF SUTURE BY LASER - each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42794 01NOV1994 DIVISION OF SUTURE BY LASER following trabeculoplasty, each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period N 42794 01JUL2014 DIVISION OF SUTURE BY LASER following glaucoma filtration surgery, each treatment to 1 eye, to a maximum of 2 treatments to that eye in a 2 year period Y 42797 01DEC1991 LASER COAGULATION OF CORNEAL OR SCLERAL BLOOD VESSELS - each treatment to 1 eye, to a maximum of 4 treatments to that eye in a 2 year period Y 42800 01DEC1991 PTERYGIUM, removal by laser in 1 or more stages Y 42801 01NOV2006 EPISCLERAL RADIOACTIVE PLAQUE (Ruthenium 106 or Iodine 125), for the treatment of choroidal melanomas, insertion of Y 42802 01NOV2006 EPISCLERAL RADIOACTIVE PLAQUE (Ruthenium 106 or Iodine 125), for the treatment of choroidal melanomas, removal of Y 42803 01DEC1991 PINGUECULA, removal of by laser in 1 or more stages (not for contact lenses) Y 42805 01NOV2005 TANTALUM MARKERS, surgical insertion to the sclera to localise the tumour base to assist in planning of radiotherapy of choroidal melanomas, 1 or more Y 42806 01DEC1991 IRIS TUMOUR, laser photocoagulation of Y 42807 01MAY1997 PHOTOMYDRIASIS, laser Y 42808 01MAY1997 PHOTOIRIDOSYNERESIS, laser N 42808 01JUL2014 Laser peripheral iridoplasty Y 42809 01DEC1991 RETINA, photocoagulation of N 42809 01NOV2002 RETINA, photocoagulation of, not being a service associated with photodynamic therapy with verteporfin Y 42810 01NOV1996 PHOTOTHERAPEUTIC KERATECTOMY, by laser, for corneal scarring or disease, excluding surgery for refractive error Y 42811 01NOV2005 TRANSPUPILLARY THERMOTHERAPY, for treatment of choroidal and retinal tumours or vascular malformations Y 42812 01DEC1991 DETACHED RETINA, removal of encircling silicone band from N 42812 01NOV2012 Removal of scleral buckling material, from an eye having undergone previous scleral buckling surgery Y 42815 01DEC1991 POSTERIOR CHAMBER, removal of silicone oil from N 42815 01NOV2012 VITREOUS CAVITY, removal of silicone oil or other liquid vitreous substitutes from, during a procedure other than that in which the vitreous substitute is inserted Y 42818 01DEC1991 RETINA, CRYOTHERAPY TO, as an independent procedure, with external probe N 42818 01NOV2012 RETINA, CRYOTHERAPY TO, as an independent procedure, or when performed in conjunction with item 42809 or 42770 Y 42821 01DEC1991 RETROBULBAR TRANSILLUMINATION, as an independent procedure N 42821 01NOV2003 OCULAR TRANSILLUMINATION, for the diagnosis and measurement of intraocular tumours, as independent procedure N 42821 01NOV2005 OCULAR TRANSILLUMINATION, for the diagnosis and measurement of intraocular tumours Y 42824 01DEC1991 RETROBULBAR INJECTION OF ALCOHOL OR OTHER DRUG, as an independent procedure Y 42827 01DEC1991 BOTULINUS TOXIN, injection of, for blepharospasm, including all such injections on any 1 day Y 42830 01DEC1991 BOTULINUS TOXIN, injection of, for strabismus including all such injections on any 1 day and associated electromyography Y 42833 01DEC1991 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES N 42833 01NOV2006 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES on a patient aged 15 years or over Y 42836 01DEC1991 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES where there have been 2 or more previous squint operations on the eye or eyes N 42836 01NOV2006 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 1 OR 2 MUSCLES, on a patient aged 14 years or under, or where the patient has had previous squint, retinal or extra ocular operations on the eye or eyes, or on a patient with concurrent thyroid eye disease Y 42839 01DEC1991 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 OR MORE MUSCLES N 42839 01NOV2006 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 OR MORE MUSCLES on a patient aged 15 years or over Y 42842 01DEC1991 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 OR MORE MUSCLES where there have been 2 or more previous squint operations on the eye or eyes N 42842 01NOV2006 SQUINT, OPERATION FOR, ON 1 OR BOTH EYES, the operation involving a total of 3 or MORE MUSCLES, on a patient aged 14 years or under, or where the patient has had previous squint, retinal or extra ocular operations on the eye or eyes, or on a patient with concurrent thyroid eye disease Y 42845 01DEC1991 READJUSTMENT OF ADJUSTABLE SUTURES, 1 or both eyes, as an independent procedure following an operation for correction of squint Y 42848 01DEC1991 SQUINT, muscle transplant for (Hummelsheim type, or similar operation) N 42848 01NOV2006 SQUINT, muscle transplant for (Hummelsheim type, or similar operation) on a patient aged 15 years or over Y 42851 01DEC1991 SQUINT, muscle transplant for (Hummelsheim type, or similar operation) where there have been 2 or more previous squint operations on the eye or eyes N 42851 01NOV2006 SQUINT, muscle transplant for (Hummelsheim type, or similar operation) on a patient aged 14 years or under, or where the patient has had previous squint, retinal or extra ocular operations on the eye or eyes, or on a patient with concurrent thyroid eye disease Y 42854 01DEC1991 RUPTURED MEDIAL PALPEBRAL LIGAMENT or ruptured EXTRAOCULAR MUSCLE, repair of Y 42857 01DEC1991 RESUTURING OF WOUND FOLLOWING INTRAOCULAR PROCEDURES with or without excision of prolapsed iris Y 42860 01DEC1991 LID, upper or lower, scleral graft to, with recession of the lid retractors N 42860 01JUL1998 EYELID (upper or lower), scleral or Goretex or other non-autogenous graft to, with recession of the lid retractors Y 42863 01DEC1991 EYELID UPPER, recession of N 42863 01JUL1998 EYELID, recession of Y 42866 01DEC1991 ENTROPION, repair of, by tightening, shortening or repair of inferior retractors by open operation N 42866 01JUL1998 ENTROPION or TARSAL ECTROPION, repair of, by tightening, shortening or repair of inferior retractors by open operation across the entire width of the eyelid Y 42869 01DEC1991 EYELID closure in facial nerve paralysis, insertion of foreign implant for Y 42872 01DEC1991 EYEBROW, elevation of, for paretic states N 42872 01NOV2018 EYEBROW, elevation of, by skin excision, to correct for a reduced field of vision caused by paretic, involutional, or traumatic eyebrow descent/ptosis to a position below the superior orbital rim Y 42875 01JUN2002 Photodynamic therapy, first treatment on or after 1 June 2002, one eye, for patients having commenced therapy prior to 1 June 2002, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wavelength of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) other than a service to which item 42887 applies. Y 42878 01JUN2002 Photodynamic therapy, first treatment on or after 1 June 2002, both eyes, for patients having commenced therapy prior to 1 June 2002, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wavelength of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) other than a service to which item 42996 applies. Y 42881 01JUN2002 Photodynamic therapy, initial treatment, one eye, for patients commencing therapy after 1 June 2002, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wavelength of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; -and with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200). Y 42884 01JUN2002 Photodynamic therapy, 2nd to 4th treatments on the same eye where it has been demonstrated that the patient is eligible for further treatments subsequent to item 42875 or 42878 or 42881, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) Y 42887 01JUN2002 Photodynamic therapy, 5th treatment on the same eye (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) Y 42990 01JUN2002 Photodynamic therapy, 6th to 10th treatment on the same eye, where it has been demonstrated that the patient is eligible for further treatments subsequent to item 42875 or 42887, as the case may be, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) Y 42991 01NOV2005 Photodynamic therapy, 11th to 15th treatment on the same eye, subsequent to item 42990 (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) Y 42993 01JUN2002 Photodynamic therapy, 2nd to 4th treatments on both eyes where it has been demonstrated that the patient is eligible for further treatments on both eyes subsequent to item 42875 or 42878 or 42881, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200). Y 42996 01JUN2002 Photodynamic therapy, 5th treatment on both eyes (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration and has received treatment under; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200). Y 42999 01JUN2002 Photodynamic therapy, 6th to 10th treatment on both eyes where it has been demonstrated that the patient is eligible for further treatments on both eyes subsequent to item 42878 or item 42996, as the case may be, (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) Y 43000 01NOV2005 Photodynamic therapy, 11th to 15th treatment on both eyes, subsequent to item 42999 (including the infusion of verteporfin continuously through a peripheral vein) using a non-thermal laser at a wave length of 689nm, for the treatment of patients: -diagnosed at baseline with predominantly classic (>50%) subfoveal choroidal neovascularisation secondary to macular degeneration; and -with a baseline best-corrected visual acuity equal to or better than 6/60 (20/200) Y 43002 01JUN2002 Infusion of verteporfin for discontinued photodynamic therapy, where a session of therapy which would have been provided under item 42875, 42878, 42881, 42884, 42887, 42990, 42993, 42996 or 42999 has been discontinued on medical grounds Y 43005 01NOV2002 Photodynamic therapy, one eye, for patients who commenced photodynamic therapy on that eye prior to 1 November 2002, initial treatment after 1 November 2002, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive Y 43008 01NOV2002 Photodynamic therapy, one eye, for patients who commenced photodynamic therapy on that eye prior to 1 November 2002, ongoing treatment following item 43005 or 43011, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive Y 43011 01NOV2002 Photodynamic therapy, both eyes, for patients who commenced photodynamic therapy prior to 1 November 2002, initial treatment after 1 November 2002, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive Y 43014 01NOV2002 Photodynamic therapy, both eyes, for patients who commenced photodynamic therapy prior to 1 November 2002, ongoing treatment following item 43005 or 43011, including the infusion of verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation resulting from an ocular disease or condition, not being a service covered by items 42875 through to 42999 inclusive Y 43017 01NOV2002 Infusion of verteporfin for discontinued photodynamic therapy, where a session of therapy which would have been provided under item 43005, 43008, 43011 or 43014 has been discontinued on medical grounds Y 43021 01AUG2007 Photodynamic therapy, one eye, including the infusion of Verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation. Y 43022 01AUG2007 Photodynamic therapy, both eyes, including the infusion of Verteporfin continuously through a peripheral vein, using a non-thermal laser at a wavelength of 689nm, for the treatment of choroidal neovascularisation. Y 43023 01AUG2007 Infusion of Verteporfin for discontinued photodynamic therapy, where a session of therapy which would have been provided under item 43021 or 43022 has been discontinued on medical grounds. Y 43500 01DEC1991 OPERATION ON PHALANX Y 43503 01DEC1991 OPERATION ON STERNUM, CLAVICLE, RIB, ULNA, RADIUS, CARPUS, TIBIA, FIBULA, TARSUS, SKULL, MANDIBLE OR MAXILLA (other than alveolar margins)1 BONE Y 43506 01DEC1991 OPERATION ON HUMERUS OR FEMUR1 BONE Y 43509 01DEC1991 OPERATION ON SPINE OR PELVIC BONES1 BONE Y 43512 01DEC1991 OPERATION ON SCAPULA, STERNUM, CLAVICLE, RIB, ULNA, RADIUS, METACARPUS, CARPUS, PHALANX, TIBIA, FIBULA, METATARSUS, TARSUS, MANDIBLE OR MAXILLA (other than alveolar margins)1 BONE or ANY COMBINATION OF ADJOINING BONES Y 43515 01DEC1991 OPERATION ON HUMERUS OR FEMUR1 BONE Y 43518 01DEC1991 OPERATION ON SPINE OR PELVIC BONES1 BONE Y 43521 01DEC1991 OPERATION ON SKULL Y 43524 01DEC1991 OPERATION ON ANY COMBINATION OF ADJOINING BONES, being bones referred to in item 43515, 43518 or 43521 Y 43800 01DEC1991 OPERATIONS FOR CORRECTION OF CONGENITAL ABNORMALITIES HYPERTELORISM, correction of Y 43801 01NOV1994 INTESTINAL MALROTATION with or without volvulus, laparotomy for, not involving bowel resection Y 43803 01DEC1991 CHOANAL ATRESIA, plastic repair of Y 43804 01NOV1994 INTESTINAL MALROTATION with or without volvulus, laparotomy for, with bowel resection and anastomosis, with or without formation of stoma Y 43805 01SEP2015 UMBILICAL, EPIGASTRIC OR LINEA ALBA HERNIA, repair of, on a person under 10 years of age Y 43806 01DEC1991 CHOANAL ATRESIA, repair of by puncture and dilatation Y 43807 01NOV1994 DUODENAL ATRESIA or STENOSIS, duodenoduodenostomy or duodenojejunostomy for Y 43809 01DEC1991 MACROCHEILIA, MACROGLOSSIA OR MACROSTOMIA, operation for Y 43810 01NOV1994 JEJUNAL ATRESIA, bowel resection and anastomosis for, with or without tapering Y 43812 01DEC1991 TORTICOLLIS, operation for Y 43813 01NOV1994 MECONIUM ILEUS, laparotomy for, complicated by 1 or more of associated volvulus, atresia, intesinal perforation with or without meconium peritonitis Y 43815 01DEC1991 OESOPHAGUS, correction of congenital stenosis by oesophagectomy and anastomosis Y 43816 01NOV1994 ILEAL ATRESIA, COLONIC ATRESIA OR MECONIUM ILEUS not being a service associated with a service to which item 43813 applies, laparotomy for Y 43818 01DEC1991 TRACHEOOESOPHAGEAL FISTULA (with or without atresia), ligation and division of Y 43819 01NOV1994 HIRSCHSPRUNG'S DISEASE, laparotomy for, with or without frozen section biopsies and formation of stoma N 43819 01SEP2015 Agangliosis Coli, laparotomy for, with or without frozen section biopsies and formation of stoma Y 43821 01DEC1991 OESOPHAGEAL ATRESIA, with or without fistula, correction of Y 43822 01NOV1994 ANORECTAL MALFORMATION, laparotomy and colostomy for Y 43824 01DEC1991 NEONATAL ALIMENTARY OBSTRUCTION, laparotomy for, with or without resection, including reduction of volvulus Y 43825 01NOV1994 NEONATAL ALIMENTARY OBSTRUCTION, laparotomy for, not being a service to which any other item in this Subgroup applies Y 43827 01DEC1991 ANAL SPHINCTEROTOMY as an independent procedure for Hirschsprung's disease Y 43828 01NOV1994 ACUTE NEONATAL NECROTISING ENTEROCOLITIS, laparotomy for, with resection, including any anastomoses or stoma formation Y 43830 01DEC1991 RECTOSIGMOIDECTOMY for Hirschsprung's disease Y 43831 01NOV1994 ACUTE NEONATAL NECROTISING ENTEROCOLITIS where no definitive procedure is possible, laparotomy for Y 43832 01SEP2015 BRANCHIAL FISTULA, on a person under 10 years of age.Removal of, Y 43833 01DEC1991 EXOMPHALOS OR GASTROSCHISIS, operation for Y 43834 01NOV1994 BOWEL RESECTION for necrotising enterocolitis stricture or strictures, including any anastomoses or stoma formation Y 43835 01SEP2015 STRANGULATED, INCARCERATED OR OBSTRUCTED HERNIA, repair of, without bowel resection, on a person under 10 years of age Y 43836 01DEC1991 EXOMPHALOS OR GASTROSCHISIS, operation for, by plastic flap Y 43837 01NOV1994 CONGENITAL DIAPHRAGMATIC HERNIA, repair by thoracic or abdominal approach, with diagnosis confirmed in the first 24 hours of life Y 43838 01SEP2015 Diaphragmatic hernia, congential repair of, by thoracic or abdominal approach, not being a service to which any of items 31569 to 31581 apply, on a person under 10 years of age Y 43839 01DEC1991 ANORECTAL MALFORMATION, perineal anoplasty, primary or secondary repair Y 43840 01NOV1994 CONGENITAL DIAPHRAGMATIC HERNIA, repair by thoracic or abdominal approach, diagnosed after the first day of life and before 20 days of age Y 43841 01SEP2015 FEMORAL OR INGUINAL HERNIA OR INFANTILE HYDROCELE, repair of, not being a service to which item 30403 or 43835 applies, on a person under 10 years of age Y 43842 01DEC1991 ANORECTAL MALFORMATION, rectoplasty, primary or secondary repair, not being a service to which item 43839 applies Y 43843 01NOV1994 OESOPHAGEAL ATRESIA (with or without repair of tracheo-oesophageal fistula), complete correction of, not being a service to which item 43846 applies Y 43845 01DEC1991 CONTRACTED BLADDER NECK (congenital), wedge excision or perurethral resection of Y 43846 01NOV1994 OESOPHAGEAL ATRESIA (with or without repair of tracheo-oesophageal fistula), complete correction of, in infant of birth weight less than 1500 grams Y 43848 01DEC1991 URACHAL FISTULA, operation for Y 43849 01NOV1994 OESOPHAGEAL ATRESIA, gastrostomy for Y 43851 01DEC1991 SPHINCTER RECONSTRUCTION for ectopia vesicae, ectopia cloacae or congenital incontinence Y 43852 01NOV1994 OESOPHAGEAL ATRESIA, thoracotomy for, and division of tracheo-oesophageal fistula without anastomosis N 43852 01SEP2015 OESOPHAGEAL ATRESIA, thoracotomy for, and division of tracheo-oesophageal fistula without anastomosis Y 43854 01DEC1991 URETHRAL VALVES OR URETHRAL MEMBRANE, open removal of Y 43855 01NOV1994 OESOPHAGEAL ATRESIA, delayed primary anastomosis for Y 43857 01DEC1991 LYMPHANGIECTASIS OF LIMB (Milroy's disease)limited excision of Y 43858 01NOV1994 OESOPHAGEAL ATRESIA, cervical oesophagostomy for N 43858 01SEP2015 OESOPHAGEAL ATRESIA, cervical oesophagostomy for Y 43860 01DEC1991 LYMPHANGIECTASIS OF LIMB (Milroy's disease) - radical excision of Y 43861 01NOV1994 CONGENITAL CYSTADENOMATOID MALFORMATION OR CONGENITAL LOBAR EMPHYSEMA, thoracotomy and lung resection for Y 43864 01NOV1994 GASTROSCHISIS, operation for Y 43867 01NOV1994 GASTROSCHISIS, secondary operation for, with removal of silo and closure of abdominal wall N 43867 01SEP2015 GASTROSCHISIS or Exomphalos, secondary operation for, with removal of silo Y 43870 01NOV1994 EXOMPHALOS containing small bowel only, operation for Y 43873 01NOV1994 EXOMPHALOS containing small bowel and other viscera, operation for Y 43876 01NOV1994 SACROCOCCYGEAL TERATOMA, excision of, by posterior approach Y 43879 01NOV1994 SACROCOCCYGEAL TERATOMA, excision of, by combined posterior and abdominal approach Y 43882 01NOV1994 CLOACAL EXSTROPHY, operation for Y 43900 01NOV1994 TRACHEO-OESOPHAGEAL FISTULA without atresia, division and repair of Y 43903 01NOV1994 OESOPHAGEAL ATRESIA or CORROSIVE OESOPHAGEAL STRICTURE, oesophageal replacement for, utilizing gastric tube, jejunum or colon Y 43906 01NOV1994 OESOPHAGUS, resection of congenital, anastomic or corrosive stricture and anastomosis, not being a service to which item 43903 applies Y 43909 01NOV1994 TRACHEOMALACIA, aortopexy for Y 43912 01NOV1994 THORACOTOMY and excision of 1 or more of bronchogenic or enterogenous cyst or mediastinal teratoma Y 43915 01NOV1994 EVENTRATION, plication of diaphragm for N 43915 01SEP2015 EVENTRATION, plication of diaphragm for Y 43930 01NOV1994 HYPERTROPHIC PYLORIC STENOSIS, pyloromyotomy for Y 43933 01NOV1994 IDIOPATHIC INTUSSUSCEPTION, laparotomy and manipulative reduction of Y 43936 01NOV1994 INTUSSUSCEPTION, laparotomy and resection with anastomosis Y 43939 01NOV1994 VENTRAL HERNIA following neonatal closure of exomphalos or gastroschisis, repair of Y 43942 01NOV1994 ABDOMINAL WALL VITELLO INTESTINAL REMNANT, excision of N 43942 01SEP2015 ABDOMINAL WALL VITELLO INTESTINAL REMNANT, excision of Y 43945 01NOV1994 PATENT VITELLO INTESTINAL DUCT, excision of Y 43948 01NOV1994 UMBILICAL GRANULOMA, excision of, under general anaesthesia N 43948 01SEP2015 UMBILICAL GRANULOMA, excision of, under general anaesthesia Y 43951 01NOV1994 GASTRO-OESOPHAGEAL REFLUX with or without hiatus hernia, laparotomy and fundoplication for, without gastrostomy Y 43954 01NOV1994 GASTRO-OESOPHAGEAL REFLUX with or without hiatus hernia, laparotomy and fundoplication for, with gastrostomy Y 43957 01NOV1994 GASTRO-OESOPHAGEAL REFLUX, LAPAROTOMY AND FUNDOPLICATION for, with or without hiatus hernia, in child with neurological disease, with gastrostomy Y 43960 01NOV1994 ANORECTAL MALFORMATION, perineal anoplasty of Y 43963 01NOV1994 ANORECTAL MALFORMATION, posterior sagittal anorectoplasty of Y 43966 01NOV1994 ANORECTAL MALFORMATION, posterior sagittal anorectoplasty of, with laparotomy Y 43969 01NOV1994 PERSISTENT CLOACA, total correction of, with genital repair using posterior sagittal approach, with or without laparotomy Y 43972 01NOV1994 CHOLEDOCHAL CYST, resection of, with 1 duct anastomosis Y 43975 01NOV1994 CHOLEDOCHAL CYST, resection of, with 2 duct anastomoses Y 43978 01NOV1994 BILIARY ATRESIA, portoenterostomy for Y 43981 01NOV1994 NEPHROBLASTOMA, NEUROBLASTOMA OR OTHER MALIGNANT TUMOUR, laparotomy (exploratory), including associated biopsies, where no other intra-abdominal procedure is performed Y 43984 01NOV1994 NEPHROBLASTOMA, radical nephrectomy for Y 43987 01NOV1994 NEUROBLASTOMA, radical excision of Y 43990 01NOV1994 HIRSCHSPRUNG'S DISEASE, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends to sigmoid colon N 43990 01SEP2015 Aganglionosis Coli, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends to sigmoid colon Y 43993 01NOV1994 HIRSCHSPRUNG'S DISEASE, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends into descending or transverse colon with or without resiting of stoma N 43993 01SEP2015 Aganglionosis Coli, definitive resection with pull-through anastomosis, with or without frozen section biopsies, when aganglionic segment extends into descending or transverse colon with or without resiting of stoma Y 43996 01NOV1994 HIRSCHSPRUNG'S DISEASE, total colectomy for total colonic aganglionosis with ileoanal pull-through, with or without side to side ileocolic anastomosis N 43996 01SEP2015 Aganglionosis Coli, total colectomy for total colonic aganglionosis with ileoanal pull-through, with or without side to side ileocolic anastomosis Y 43999 01NOV1994 HIRSCHSPRUNG'S DISEASE, anal sphincterotomy as an independent procedure for N 43999 01SEP2015 Aganglionosis Coli, anal sphincterotomy as an independent procedure for Y 44100 01DEC1991 OPERATIONS FOR EXCISION OF CONGENITAL ABNORMALITIES EXTRA DIGIT, ligation of pedicle Y 44101 01SEP2015 RECTUM, examination of, on a person under 2 years of age, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion Y 44102 01NOV1994 RECTUM, examination of, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion N 44102 01SEP2015 RECTUM, examination of, on a person 2 years of age or over, under general anaesthesia with full thickness biopsy or removal of polyp or similar lesion Y 44103 01DEC1991 EXTRA DIGIT, amputation of Y 44104 01SEP2015 RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a person under 2 years of age, under general anaesthesia Y 44105 01NOV1994 RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, under general anaesthesia N 44105 01SEP2015 RECTAL PROLAPSE, SUBMUCOSAL or perirectal injection for, on a person 2 years of age or over, under general anaesthesia Y 44106 01DEC1991 DERMOID, periorbital or superficial nasal, excision of Y 44107 01DEC1991 DERMOID, periorbital or superficial nasal, excision of Y 44108 01NOV1994 INGUINAL HERNIA repair at age less than 3 months N 44108 01SEP2015 INGUINAL HERNIA repair at age less than 12 months Y 44110 01DEC1991 DERMOID, ORBITAL, excision of Y 44111 01NOV1994 OBSTRUCTED OR STRANGULATED INGUINAL HERNIA, repair of, at age less than 3 months, including orchidopexy when performed N 44111 01SEP2015 OBSTRUCTED OR STRANGULATED INGUINAL HERNIA, repair, at age, less than 12 months including orchidopexy when performed Y 44113 01DEC1991 DERMOID OF NOSE, excision of, with intranasal extension Y 44114 01NOV1994 INGUINAL HERNIA repair at age less than 3 months when orchidopexy also required N 44114 01SEP2015 INGUINAL HERNIA repair at age less than 12 months when orchidopexy also required Y 44130 01NOV1994 LYMPHADENECTOMY, for atypical mycobacterial infection or other granulomatous disease Y 44133 01NOV1994 TORTICOLLIS, open division of sternomastoid muscle for Y 44136 01NOV1994 INGROWN TOE NAIL, operation for, under general anaesthesia Y 44300 01DEC1991 Historical item included for item mapping purposes Y 44301 01DEC1991 Historical item included for item mapping purposes Y 44304 01DEC1991 Historical item included for item mapping purposes Y 44305 01DEC1991 Historical item included for item mapping purposes Y 44308 01DEC1991 Historical item included for item mapping purposes Y 44309 01DEC1991 Historical item included for item mapping purposes Y 44312 01DEC1991 Historical item included for item mapping purposes Y 44313 01DEC1991 Historical item included for item mapping purposes Y 44316 01DEC1991 Historical item included for item mapping purposes Y 44317 01DEC1991 Historical item included for item mapping purposes Y 44320 01DEC1991 Historical item included for item mapping purposes Y 44321 01DEC1991 Historical item included for item mapping purposes Y 44324 01DEC1991 HAND, MIDCARPAL OR TRANSMETACARPAL Y 44325 01DEC1991 HAND, MIDCARPAL OR TRANSMETACARPAL N 44325 01NOV1999 HAND, MIDCARPAL OR TRANSMETACARPAL, amputation of Y 44328 01DEC1991 HAND, FOREARM OR THROUGH ARM N 44328 01NOV1999 HAND, FOREARM OR THROUGH ARM, amputation of Y 44331 01DEC1991 AT SHOULDER N 44331 01NOV1999 AMPUTATION AT SHOULDER Y 44334 01DEC1991 INTERSCAPULOTHORACIC N 44334 01NOV1999 INTERSCAPULOTHORACIC AMPUTATION Y 44337 01DEC1991 1 DIGIT of foot Y 44338 01DEC1991 1 DIGIT of foot N 44338 01NOV1999 1 DIGIT of foot, amputation of Y 44341 01DEC1991 2 DIGITS of 1 foot Y 44342 01DEC1991 2 DIGITS of 1 foot N 44342 01NOV1999 2 DIGITS of 1 foot, amputation of Y 44345 01DEC1991 3 DIGITS of 1 foot Y 44346 01DEC1991 3 DIGITS of 1 foot N 44346 01NOV1999 3 DIGITS of 1 foot, amputation of Y 44349 01DEC1991 4 DIGITS of 1 foot Y 44350 01DEC1991 4 DIGITS of 1 foot N 44350 01NOV1999 4 DIGITS of 1 foot, amputation of Y 44353 01DEC1991 5 DIGITS of 1 foot Y 44354 01DEC1991 5 DIGITS of 1 foot N 44354 01NOV1999 5 DIGITS of 1 foot, amputation of Y 44357 01DEC1991 TOE, including metatarsal or part of metatarsaleach toe Y 44358 01DEC1991 TOE, including metatarsal or part of metatarsaleach toe N 44358 01NOV1999 TOE, including metatarsal or part of metatarsaleach toe , amputation of Y 44359 01NOV1999 ONE OR MORE TOES OF ONE FOOT, amputation of, including if performed, excision of 1 or more metatarsal bones of the foot, performed for diabetic or other microvascular disease, excluding aftercare Y 44361 01DEC1991 FOOT AT ANKLE (Syme, Pirogoff types) N 44361 01NOV1999 FOOT AT ANKLE (Syme, Pirogoff types), amputation of Y 44364 01DEC1991 FOOT, MIDTARSAL OR TRANSMETATARSAL N 44364 01NOV1999 FOOT, MIDTARSAL OR TRANSMETATARSAL, amputation of Y 44367 01DEC1991 THROUGH THIGH, AT KNEE OR BELOW KNEE N 44367 01NOV1999 AMPUTATION THROUGH THIGH, AT KNEE OR BELOW KNEE Y 44370 01DEC1991 AT HIP N 44370 01NOV1999 AMPUTATION AT HIP Y 44373 01DEC1991 HINDQUARTER N 44373 01NOV1999 HINDQUARTER, amputation of Y 44376 01DEC1991 AMPUTATION STUMP, reamputation of, to provide adequate skin and muscle cover Y 45000 01DEC1991 "METICULOUS REPAIR DESIGNED TO OBTAIN MAXIMUM FUNCTIONAL RESULTS INCLUDING THE PREPARATION OF THE DEFECT REQUIRING REPAIR (Note: See Explanatory notes to this Category for definition of ""Local skin flap"") SINGLE STAGE LOCAL MUSCLE FLAP REPAIR, on eyelid, nose, lip, neck, hand, thumb, finger or genitals" N 45000 01NOV2016 Single stage local muscle flap repair, on eyelid, nose, lip, neck, hand, thumb, finger or genitals not in association with any of items 31356 to 31376 Y 45003 01DEC1991 SINGLE STAGE LOCAL MYOCUTANEOUS FLAP REPAIR to 1 defect, simple and small N 45003 01NOV2016 Single stage local myocutaneous flap repair to one defect, simple and small not in association with any of items 31356 to 31376 Y 45006 01DEC1991 SINGLE STAGE LARGE MYOCUTANEOUS FLAP REPAIR to 1 defect, (pectoralis major, latissimus dorsi, or similar large muscle) Y 45009 01DEC1991 SINGLE STAGE LOCAL muscle flap repair to 1 defect, simple and small Y 45012 01DEC1991 SINGLE STAGE LARGE MUSCLE FLAP REPAIR to 1 defect, (pectoralis major, gastrocnemius, gracilis or similar large muscle) Y 45015 01DEC1991 MUSCLE OR MYOCUTANEOUS FLAP, delay of Y 45018 01DEC1991 DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) N 45018 01NOV2016 Dermis, dermofat or fascia graft (excluding transfer of fat by injection), if the service is not associated with neurosurgical services for spinal disorders mentioned in any of items 40300 to 40351 N 45018 01NOV2018 Dermis, dermofat or fascia graft (excluding transfer of fat by injection), if the service is not associated with neurosurgical services for spinal disorders mentioned in any of items51011 to 51171 Y 45019 19JUN1997 FULL FACE CHEMICAL PEEL for severely sun-damaged skin, where it can be demonstrated that the damage affects 75% of the facial skin surface area involving photodamage (dermatoheliosis) typically consisting of solar keratoses, solar lentigines, freckling, yellowing and leathering of the skin, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital or approved day-hospital facility by a specialist in the practice of his or her specialty - 1 session only in a 12 month period N 45019 01NOV1997 FULL FACE CHEMICAL PEEL for severely sun-damaged skin, where it can be demonstrated that the damage affects 75% of the facial skin surface area involving photodamage (dermatoheliosis) typically consisting of solar keratoses, solar lentigines, freckling, yellowing and leathering of the skin, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital by a specialist in the practice of his or her specialty - 1 session only in a 12 month period N 45019 01NOV2018 Full face chemical peel for severely sun?damaged skin, if: (a) the damage affects at least 75% of the facial skin surface area; and (b) the damage involves photo-damage (dermatoheliosis); and (c) the photo-damage involves: (i) a solar keratosis load exceeding 30 individual lesions; or (ii) solar lentigines; or (iii) freckling, yellowing or leathering of the skin; or (iv) solar kertoses which have proven refractory to, or recurred following, medical therapies; and (d) at least medium depth peeling agents are used; and (e) the chemical peel is performed in the operating theatre of a hospital by a medical practitioner recognised as a specialist in the specialty of dermatology or plastic surgery. Applicable once only in any 12 month period Y 45020 19JUN1997 FULL FACE CHEMICAL PEEL for severe chloasma or melasma refractory to all other treatments, where it can be demonstrated that the chloasma or melasma affects 75% of the facial skin surface area involving diffuse pigmentation visible at a distance of 4 metres, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital or approved day-hospital facility by a specialist in the practice of his or her specialty - 1 session only in a 12 month period N 45020 01NOV1997 FULL FACE CHEMICAL PEEL for severe chloasma or melasma refractory to all other treatments, where it can be demonstrated that the chloasma or melasma affects 75% of the facial skin surface area involving diffuse pigmentation visible at a distance of 4 metres, where at least medium depth peeling agents are used, performed in the operating theatre of a hospital by a specialist in the practice of his or her specialty - 1 session only in a 12 month period Y 45021 01DEC1991 ABRASIVE THERAPY, limited to 1 aesthetic area N 45021 01MAR1999 ABRASIVE THERAPY for serverely scarring resulting from trauma, burns or cystic acne - limited to 1 aesthetic area N 45021 01NOV1999 ABRASIVE THERAPY for severely disfiguring scarring resulting from trauma, burns or acne - limited to 1 aesthetic area Y 45024 01DEC1991 ABRASIVE THERAPY to more than 1 aesthetic area N 45024 01MAR1999 ABRASIVE THERAPY for severey disfiguring scarring resulting from trauma, burns or cystic acne - more than 1 aesthetic area N 45024 01NOV1999 ABRASIVE THERAPY for severely disfiguring scarring resulting from trauma, burns or acne - more than 1 aesthetic area Y 45025 01NOV1995 CARBON DIOXIDE LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or cystic acne - limited to 1 aesthetic area N 45025 01NOV1999 CARBON DIOXIDE LASER OR ERBIUM LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - limited to 1 aesthetic area N 45025 01NOV2007 CARBON DIOXIDE LASER OR ERBIUM LASER (not including fractional laser therapy) resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - limited to 1 aesthetic area Y 45026 01NOV1995 CARBON DIOXIDE LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or cystic acne - more than 1 aesthetic area N 45026 01NOV1999 CARBON DIOXIDE LASER OR ERBIUM LASER resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - more than 1 aesthetic area N 45026 01NOV2007 CARBON DIOXIDE LASER OR ERBIUM LASER (not including fractional laser therapy) resurfacing of the face or neck for severely disfiguring scarring resulting from trauma, burns or acne - more than 1 aesthetic area Y 45027 01DEC1991 ANGIOMA, cauterisation of or injection into, where undertaken in the operating theatre of a hospital Y 45030 01DEC1991 ANGIOMA OF SKIN and subcutaneous tissue (excluding facial muscle or breast) or mucous surface, small, excision and suture of N 45030 01NOV1994 ANGIOMA (haemangioma or lymphangioma or both) of skin and subcutaneous tissue (excluding facial muscle or breast) or mucous surface, small, excision and suture of Y 45033 01DEC1991 ANGIOMA OF FACIAL MUSCLE OR BREAST, large or involving deeper tissue, excision and suture of N 45033 01JUL1993 ANGIOMA, large or involving deeper tissue including facial muscle or breast, excision and suture of N 45033 01NOV1994 ANGIOMA, (haemangioma or lymphangioma or both), large or involving deeper tissue including facial muscle or breast, excision and suture of Y 45035 01NOV1994 ANGIOMA (haemangioma or lymphangioma or both), large and deep, involving muscles or nerves, excision of Y 45036 01DEC1991 ANGIOMA OF NECK, deep, excision of N 45036 01NOV1994 ANGIOMA (haemangioma or lymphangioma or both) of neck, deep, excision of Y 45039 01DEC1991 ARTERIOVENOUS MALFORMATION (3 centimetres or less) of superficial tissue, excision of Y 45042 01DEC1991 ARTERIOVENOUS MALFORMATION, (greater than 3 centimetres), excision of Y 45045 01DEC1991 ARTERIOVENOUS MALFORMATION on eyelid, nose, lip, neck, hand, thumb, finger or genitals, excision of N 45045 01JUL1993 ARTERIOVENOUS MALFORMATION on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, excision of Y 45048 01DEC1991 LYMPHOEDEMATOUS TISSUE of lower leg and foot, or thigh, or upper arm, or forearm and hand, major excision of N 45048 01NOV1994 LYMPHOEDEMATOUS tissue or lymphangiectasis, of lower leg and foot, or thigh, or upper arm, or forearm and hand, major excision of Y 45051 01DEC1991 FOREIGN IMPLANT, (non biological), insertion of, for contour reconstruction for pathological deformity N 45051 01JUL1993 CONTOUR RECONSTRUCTION for pathological deformity, insertion of foreign implant (non biological but excluding injection of liquid or semisolid material) by open operation N 45051 01NOV2015 Contour reconstruction for open repair of contour defects, due to deformity, requiring insertion of a non-biological implant, if it can be demonstrated that contour reconstructive surgery is indicated because the deformity is secondary to congenital absence of tissue or has arisen from trauma (other than trauma from previous cosmetic surgery), excluding the following: (a) insertion of a non-biological implant that is a component of another service listed in Group T8; (b) injection of liquid or semisolid material; (c) oral and maxillofacial implant services provided under item 52321; (d) services to insert mesh N 45051 01NOV2018 Contour reconstruction by open repair of contour defects, due to deformity, if: (a) contour reconstructive surgery is indicated because the deformity is secondary to congenital absence of tissue or has arisen from trauma (other than trauma from previous cosmetic surgery); and (b) insertion of a non-biological implant is required, other than one or more of the following: (i) insertion of a non-biological implant that is a component of another service specified in Group T8; (ii) injection of liquid or semisolid material; (iii) an oral and maxillofacial implant service to which item52321 applies; (iv) a service to insert mesh; and (c) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45054 01NOV1999 LIMB OR CHEST, decompression escharotomy of (including all incisions), for acute compartment syndrome secondary to burn Y 45060 01NOV2018 Developmental breast abnormality, single stage correction of, if: (a) the correction involves either: (i) bilateral mastopexy for symmetrical tubular breasts; or (ii) surgery on both breasts with a combination of insertion of one or more implants (which must have at least a 10% volume difference), mastopexy or reduction mammaplasty, if there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least 20% in normally shaped breasts, or 10% in tubular breasts or in breasts with abnormally high inframammary folds; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Applicable only once per occasion on which the service is provided Y 45061 01NOV2018 Developmental breast abnormality, 2 stage correction of, first stage, involving surgery on both breasts with a combination of insertion of one or more tissue expanders, mastopexy or reduction mammaplasty, if: (a) there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes. Applicable only once per occasion on which the service is provided Y 45062 01NOV2018 Developmental breast abnormality, 2 stage correction of, second stage, involving surgery on both breasts with a combination of exchange of one or more tissue expanders for one or more implants (which must have at least a 10% volume difference), mastopexy or reduction mammaplasty, if: (a) there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes. Applicable only once per occasion on which the service is provided Y 45200 01DEC1991 "SKIN FLAP SURGERY (Note: See Explanatory notes to this Category for definition of ""Local skin flap"") SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, simple and small, excluding flap for male pattern baldness" N 45200 01NOV2006 "(Note: See Explanatory notes to this Category for definition of ""Local skin flap"") SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, simple and small, excluding flap for male pattern baldness and excluding H-flap or double advancement flap" N 45200 01NOV2016 Single stage local flap, if indicated to repair one defect, simple and small, excluding flap for male pattern baldness and excluding H-flap or double advancement flap not in association with any of items 31356 to 31376 Y 45201 01NOV2016 Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion (only in association with items 31000, 31001, 31002, 31358, 31359, 31360, 31363, 31364, 31369, 31370, 31371, 31373 or 31376)-may be claimed only once per defect N 45201 01NOV2018 Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion (only in association with items 31000, 31001, 31002, 31003, 31004, 31005, 31358, 31359, 31360, 31363, 31364, 31369, 31370, 31371, 31373 or 31376)-may be claimed only once per defect Y 45202 01NOV2016 Muscle, myocutaneous or skin flap, where clinically indicated to repair one surgical excision made in the removal of a malignant or non-malignant skin lesion in a patient, if the clinical relevance of the procedure is clearly annotated in the patient's record and either: (a) item 45201 applies and additional flap repair is required for the same defect; or (b) item 45201 does not apply and either: (i) the patient has severe pre-existing scarring, severe skin atrophy or sclerodermoid changes; or (ii) the repair is contiguous with a free margin Y 45203 01DEC1991 SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, complicated or large, excluding flap for male pattern baldness N 45203 01NOV2006 SINGLE STAGE LOCAL FLAP, where indicated to repair 1 defect, complicated or large, excluding flap for male pattern baldness and excluding H-flap or double advancement flap N 45203 01NOV2016 Single stage local flap, if indicated to repair one defect, complicated or large, excluding flap for male pattern baldness and excluding H-flap or double advancement flap not in association with any of items 31356 to 31376 Y 45206 01DEC1991 SINGLE STAGE LOCAL FLAP where indicated to repair 1 defect, on eyelid, nose, lip, neck, hand, thumb, finger or genitals N 45206 01JUL1993 SINGLE STAGE LOCAL FLAP where indicated to repair 1 defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals N 45206 01NOV2006 SINGLE STAGE LOCAL FLAP where indicated to repair 1 defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, and excluding H-flap or double advancement flap N 45206 01NOV2016 Single stage local flap if indicated to repair one defect, on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals and excluding H-flap or double advancement flap not in association with any of items 31356 to 31376 Y 45207 01NOV2006 H-FLAP OR DOUBLE ADVANCEMENT FLAP where indicated to repair 1 defect, on eyelid, eyebrow or forehead N 45207 01NOV2016 H-flap or double advancement flap if indicated to repair one defect, on eyelid, eyebrow or forehead not in association with any of items 31356 to 31376 Y 45209 01DEC1991 DIRECT FLAP REPAIR (cross arm, abdominal or similar), first stage Y 45212 01DEC1991 DIRECT FLAP REPAIR (cross arm, abdominal or similar), second stage Y 45215 01DEC1991 DIRECT FLAP REPAIR, cross leg, first stage Y 45218 01DEC1991 DIRECT FLAP REPAIR, cross leg, second stage Y 45221 01DEC1991 DIRECT FLAP REPAIR, small (cross finger or similar), first stage Y 45224 01DEC1991 DIRECT FLAP REPAIR, small (cross finger or similar), second stage Y 45227 01DEC1991 INDIRECT FLAP OR TUBED PEDICLE, formation of Y 45230 01DEC1991 DIRECT OR INDIRECT FLAP OR TUBED PEDICLE, delay of Y 45233 01DEC1991 INDIRECT FLAP OR TUBED PEDICLE, preparation of intermediate or final site and attachment to the site Y 45236 01DEC1991 INDIRECT FLAP OR TUBED PEDICLE, spreading of pedicle, as a separate procedure Y 45239 01DEC1991 DIRECT, INDIRECT OR LOCAL FLAP, revision of N 45239 01NOV2006 DIRECT, INDIRECT OR LOCAL FLAP, revision of, by incision and suture, not being a service to which item 45240 applies Y 45240 01NOV2006 DIRECT, INDIRECT OR LOCAL FLAP, revision of, by liposuction, not being a service to which item 45239, 45497, 45498 or 45499 applies Y 45400 01DEC1991 FREE GRAFTING (split skin) of a granulating area, small Y 45403 01DEC1991 FREE GRAFTING (split skin) of a granulating area, extensive Y 45406 01DEC1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving not more than 3 per cent of total body surface Y 45409 01DEC1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent of total body surface Y 45412 01DEC1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface Y 45415 01DEC1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface Y 45418 01DEC1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 12 per cent or more of total body surface N 45418 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 12 per cent or more but less than 15 per cent of total body surface Y 45419 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more of total body surface Y 45421 01DEC1991 FREE GRAFTING (split skin) to burns, including excision of burnt tissue, on eyelid, nose, lip, neck, hand, thumb, finger or genitals Y 45424 01DEC1991 FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving not more than 3 per cent of total body surface Y 45427 01DEC1991 FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 3 per cent or more but less than 6 per cent of total body surface Y 45430 01DEC1991 FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 6 per cent or more but less than 9 per cent of total body surface Y 45433 01DEC1991 FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 9 per cent or more but less than 12 per cent of total body surface Y 45436 01DEC1991 FREE GRAFTING (xenograft or homograft split skin) to burns including excision of burnt tissue - involving 12 per cent or more of total body surface Y 45439 01DEC1991 FREE GRAFTING (split skin) to 1 defect, including elective dissection, small Y 45442 01DEC1991 FREE GRAFTING (split skin) to 1 defect, including elective dissection, extensive Y 45445 01DEC1991 FREE GRAFTING (split skin) as inlay graft to 1 defect including elective dissection using a mould (including insertion of, and removal of mould) Y 45448 01DEC1991 FREE GRAFTING (split skin) to 1 defect, including elective dissection on eyelid, nose, lip, ear, neck, hand, thumb, finger or genitals, not being a service to which item 45442 or 45445 applies Y 45451 01DEC1991 FREE GRAFTING (full thickness), to 1 defect, excluding grafts for male pattern baldness Y 45460 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more but less than 20 percent of total body surface - one surgeon Y 45461 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more but less than 20 percent of total body surface - conjoint surgery, principal surgeon Y 45462 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 15 percent or more but less than 20 percent of total body surface - conjoint surgery, co- surgeon Y 45464 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 20 percent or more but less than 30 percent of total body surface - one surgeon Y 45465 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 20 percent or more but less than 30 percent of total body surface - conjoint surgery, principal surgeon Y 45466 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 20 percent or more but less than 30 percent of total body surface - conjoint surgery, co-surgeon Y 45468 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 30 percent or more but less than 40 percent of total body surface - conjoint surgery, principal surgeon Y 45469 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 30 percent or more but less than 40 percent of total body surface - conjoint surgery, co-surgeon Y 45471 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 40 percent or more but less than 50 percent of total body surface - conjoint surgery, principal surgeon Y 45472 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 40 percent or more but less than 50 percent of total body surface - conjoint surgery, co-surgeon Y 45474 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 50 percent or more but less than 60 percent of total body surface - conjoint surgery, principal surgeon Y 45475 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 50 percent or more but less than 60 percent of total body surface - conjoint surgery, co-surgeon Y 45477 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 60 percent or more but less than 70 percent of total body surface - conjoint surgery, principal surgeon Y 45478 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 60 percent or more but less than 70 percent of total body surface - conjoint surgery, co-surgeon Y 45480 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 70 percent or more but less than 80 percent of total body surface - conjoint surgery, principal surgeon Y 45481 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 70 percent or more but less than 80 percent of total body surface - conjoint surgery, co-surgeon Y 45483 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 80 percent or more of total body surface - conjoint surgery, principal surgeon Y 45484 01MAY2000 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - involving 80 percent or more of total body surface - conjoint surgery, co-surgeon Y 45485 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - upper eyelid, nose, lip, ear or palm of the hand Y 45486 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - forehead, cheek, anterior aspect of the neck, chin, plantar aspect of the foot, heel or genitalia Y 45487 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - whole of toe Y 45488 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 1 digit of the hand Y 45489 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 2 digits of the hand Y 45490 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 3 digits of the hand Y 45491 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 4 digits of the hand Y 45492 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - the whole of 5 digits of the hand Y 45493 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - portion of digit of hand Y 45494 01NOV1999 FREE GRAFTING (split skin) to burns, including excision of burnt tissue - whole of face (excluding ears) Y 45496 01MAY2000 FLAP, free tissue transfer using microvascular techniques - revision of, by open operation Y 45497 01MAY2000 FLAP, free tissue transfer using microvascular techniques - complete revision of, by liposuction N 45497 01NOV2006 FLAP, free tissue transfer using microvascular techniques, or any autogenous breast reconstruction - complete revision of, by liposuction Y 45498 01MAY2000 FLAP, free tissue transfer using microvascular techniques - staged revision of, by liposuction - first stage N 45498 01NOV2006 FLAP, free tissue transfer using microvascular techniques, or any autogenous breast reconstruction - staged revision of, by liposuction - first stage Y 45499 01MAY2000 FLAP, free tissue transfer using microvascular techniques - staged revision of, by liposuction - second stage N 45499 01NOV2006 FLAP, free tissue transfer using microvascular techniques, or any autogenous breast reconstruction - staged revision of, by liposuction - second stage Y 45500 01DEC1991 MICROVASCULAR REPAIR using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit Y 45501 01MAR1999 MICROVASCULAR ANASTOMOSIS of artery using microsurgical techniques, for re-implantation of limb or digit Y 45502 01JUL1993 MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for reimplantation of limb or digit or free transfer of tissue N 45502 01MAR1999 MICROVASCULAR ANASTOMOSIS of vein using microsurgical techniques, for re-implantation of limb or digit Y 45503 01DEC1991 MICRO-ARTERIAL OR MICRO-VENOUS GRAFT using microsurgical techniques Y 45504 01MAR1999 MICROVASCULAR ANASTOMOSIS of artery using microsurgical techniques, for free transfer of tissue including setting in of free flap Y 45505 01MAR1999 MICROVASCULAR ANASTOMOSIS of vein using microsurgical techniques, for free transfer of tissue including setting in of free flap Y 45506 01DEC1991 SCAR, of face or neck, revision of, NOT MORE THAN 3 cms IN LENGTH, where undertaken in the operating theatre of a hospital or approved day-hospital facility N 45506 01JUL1993 SCAR, of face or neck, not more than 3 cm in length, revision of, where undertaken in the operating theatre of a hospital, or where performed by a specialist in the practice of his or her specialty Y 45509 01DEC1991 MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for reimplantation of limb or digit or free transfer of tissue Y 45512 01DEC1991 SCAR, of face or neck, revision of, MORE THAN 3 cms IN LENGTH, where undertaken in the operating theatre of a hospital or approved day-hospital facility N 45512 01JUL1993 SCAR, of face or neck, more than 3 cm in length, revision of, where undertaken in the operating theatre of a hospital, or where performed by a specialist in the practice of his or her specialty Y 45515 01DEC1991 SCAR, other than on face or neck, not more than 7 cms in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure N 45515 01JUL1993 SCAR, other than on face or neck, not more than 7 cms in length, revision of, as an independent procedure, where undertaken in the operating theatre of a hospital or where performed by a specialist in the practice of his or her specialty Y 45518 01DEC1991 SCAR, other than on face or neck, more than 7 cms in length, revision of, where undertaken in the operating theatre of a hospital or approved day-hospital facility, as an independent procedure N 45518 01JUL1993 SCAR, other than on face or neck, more than 7 cms in length, revision of, as an independent procedure, where undertaken in the operating theatre of a hospital, or where performed by a specialist in the practice of his or her speciality Y 45519 01NOV1996 EXTENSIVE BURN SCARS OF SKIN (more than 1 percent of body surface area), excision of, for correction of scar contracture Y 45520 01JUL1998 REDUCTION MAMMAPLASTY (unilateral) with surgical repositioning of nipple N 45520 01NOV2018 Reduction mammaplasty (unilateral) with surgical repositioning of nipple,in the context of breast cancer or developmental abnormality of the breast Y 45521 01DEC1991 MAMMAPLASTY, reduction (unilateral), with or without repositioning of nipple Y 45522 01JUL1998 REDUCTION MAMMAPLASTY (unilateral) without surgical repositioning of nipple N 45522 01NOV2006 REDUCTION MAMMAPLASTY (unilateral) without surgical repositioning of nipple, excluding the treatment of gynaecomastia N 45522 01JAN2015 REDUCTION MAMMAPLASTY (unilateral) without surgical repositioning of nipple, excluding the treatment of gynaecomastia (H) N 45522 01NOV2018 Reduction mammaplasty (unilateral) without surgical repositioning of the nipple: (a) excluding the treatment of gynaecomastia; and (b) not with insertion of any prosthesis Y 45523 01NOV2018 Reduction mammaplasty (bilateral) with surgical repositioning of the nipple: (a) for patients with macromastia and experiencing pain in the neck or shoulder region; and (b) not with insertion of any prosthesis Y 45524 01DEC1991 MAMMAPLASTY, AUGMENTATION, for significant breast asymmetry where the augmentation is limited to 1 breast N 45524 01NOV2018 Mammaplasty, augmentation (unilateral) in the context of: (a) breast cancer; or (b) developmental abnormality of the breast, if there is a difference in breast volume, as demonstrated by an appropriate volumetric measurement technique, of at least: (i) 20% in normally shaped breasts; or (ii) 10% in tubular breasts or in breasts with abnormally high inframammary folds. Applicable only once per occasion on which the service is provided Y 45527 01DEC1991 MAMMAPLASTY, AUGMENTATION, (unilateral), following mastectomy N 45527 01NOV2018 Breast reconstruction (unilateral), following mastectomy, using a permanent prosthesis Y 45528 19JUN1997 MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45524 or 45527 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital malformation N 45528 01NOV1997 MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45524 or 45527 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital malformation N 45528 01MAY2001 MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45524 or 45527 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital malformation of the breast N 45528 01MAY2003 MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45527 applies, where it can be demonstrated that surgery is indicated because of congenital malformation, disease or trauma of the breast (other than trauma resulting from previous elective cosmetic surgery) N 45528 01NOV2004 MAMMAPLASTY, AUGMENTATION, bilateral, not being a service to which Item 45527 applies, where it can be demonstrated that surgery is indicated because of malformation of breast tissue (excluding hypomastia), disease or trauma of the breast (other than trauma resulting from previous elective cosmetic surgery) N 45528 01NOV2018 Mammaplasty, augmentation, bilateral (other than a service to which item45527 applies), if: (a) reconstructive surgery is indicated because of: (i) developmental malformation of breast tissue (excluding hypomastia); or (ii) disease of or trauma to the breast (other than trauma resulting from previous elective cosmetic surgery); or (iii) amastia secondary to a congenital endocrine disorder; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45530 01DEC1991 BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large myocutaneous flap, including repair of secondary skin defect, excluding repair of muscular aponeurotic layer N 45530 01NOV1995 BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer N 45530 01NOV2004 BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer, being a service associated with item 30178 N 45530 01NOV2006 BREAST RECONSTRUCTION (unilateral) using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer, not being a service associated with a service to which items 30165, 30168, 30171, 30174 or 30177 applies N 45530 01JAN2016 Breast reconstruction (unilateral), using a latissimus dorsi or other large muscle or myocutaneous flap, including repair of secondary skin defect, if required, excluding repair of muscular aponeurotic layer, other than a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177 or 30179 applies (H) Y 45533 01DEC1991 BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure N 45533 01NOV2003 BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177 applies N 45533 01NOV2004 BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177 and 30178 applies N 45533 01NOV2005 BREAST RECONSTRUCTION using breast sharing technique (first stage) including breast reduction, transfer of complex skin and breast tissue flap, split skin graft to pedicle of flap or other similar procedure Y 45536 01DEC1991 BREAST RECONSTRUCTION using breast sharing technique (second stage) including division of pedicle, insetting of breast flap, with closure of donor site or other similar procedure Y 45539 01DEC1991 BREAST RECONSTRUCTION (unilateral), following mastectomy, using tissue expansion - insertion of tissue expansion unit and all attendances for subsequent expansion injections Y 45542 01DEC1991 BREAST RECONSTRUCTION (unilateral), following mastectomy, using tissue expansion - removal of tissue expansion unit and insertion of permanent prosthesis Y 45543 01NOV1999 BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast N 45543 01MAY2001 BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast Y 45544 01NOV1999 BREAST PTOSIS, correction of (unilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove N 45544 01MAY2001 BREAST PTOSIS, correction of (bilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove Y 45545 01DEC1991 NIPPLE OR AREOLA or both, reconstruction of by any technique N 45545 01JUL1998 NIPPLE OR AREOLA or both, reconstruction of, by any surgical technique Y 45546 01NOV1998 NIPPLE OR AREOLA or both, intradermal colouration of, following breast reconstruction after mastectomy or for congenital absence of nipple Y 45548 01DEC1991 BREAST PROSTHESIS, removal of, as an independent procedure Y 45551 01DEC1991 FIBROUS CAPSULE SURROUNDING BREAST PROSTHESIS, excision or multiple incisions to, as an independent procedure N 45551 01JUL1993 BREAST PROSTHESIS, removal of, with complete excision of fibrous capsule, as an independent procedure N 45551 01NOV1995 BREAST PROSTHESIS, removal of, with complete excision of fibrous capsule N 45551 01NOV2006 BREAST PROSTHESIS, removal of, with excision of fibrous capsule N 45551 01NOV2018 Breast prosthesis, removal of, with excision of at least half of the fibrous capsule, not with insertion of any prosthesis. The excised specimen must be sent for histopathology and the volume removed must be documented in the histopathology report Y 45552 01JUL1993 BREAST PROSTHESIS, removal of, with complete excision of fibrous capsule and replacement of prosthesis N 45552 01NOV2006 BREAST PROSTHESIS, removal of, with excision of fibrous capsule and replacement of prosthesis Y 45553 01NOV2006 BREAST PROSTHESIS, removal and replacement with another prosthesis, following medical complications (such as rupture, migration of prosthetic material, or capsule formation). N 45553 01NOV2018 Breast prosthesis, removal of and replacement with another prosthesis, following medical complications (for rupture, migration of prosthetic material or symptomatic capsular contracture), if: (a) either: (i) it is demonstrated by intra-operative photographs post-removal that removal alone would cause unacceptable deformity; or (ii) the original implant was inserted in the context of breast cancer or developmental abnormality; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45554 01DEC1991 BREAST PROSTHESIS, replacement of, following medical complications, (including rupture, migration, or capsule formation) where new pocket is formed N 45554 01JUL1993 BREAST PROSTHESIS, replacement of, following medical complications (such as rupture, migration of prosthetic material, or capsule formation), where new pocket is formed, including excision of fibrous capsule N 45554 01NOV2006 BREAST PROSTHESIS, removal and replacement with another prosthesis, following medical complications (such as rupture, migration of prosthetic material, or capsule formation), where new pocket is formed, including excision of fibrous capsule N 45554 01NOV2018 Breast prosthesis, removal and replacement with another prosthesis, following medical complications (for rupture, migration of prosthetic material or symptomatic capsular contracture), including excision of at least half of the fibrous capsule or formation of a new pocket, or both, if: (a) either: (i) it is demonstrated by intra-operative photographs post-removal that removal alone would cause unacceptable deformity; or (ii) the original implant was inserted in the context of breast cancer or developmental abnormality; and (b) the excised specimen is sent for histopathology and the volume removed is documented in the histopathology report; and (c) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45555 01MAY1997 SILICONE BREAST PROSTHESIS, removal of and replacement with prosthesis other than silicone gel prosthesis Y 45556 01NOV2001 BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast N 45556 01JAN2015 BREAST PTOSIS, correction of (unilateral), to match the position of the contralateral breast (H) N 45556 01NOV2018 Breast ptosis, correction of (unilateral), in the context of breast cancer or developmental abnormality, if photographic evidence (including anterior, left lateral and right lateral views) and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Applicable only once per occasion on which the service is provided Y 45557 01NOV2001 BREAST PTOSIS, correction of (unilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove N 45557 01MAY2003 BREAST PTOSIS, correction of by mastopexy of (unilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove N 45557 01JUL2009 BREAST PTOSIS, correction of by mastopexy by any means (unilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove, not being a service associated with a service to which item 45522 applies Y 45558 01NOV2001 BREAST PTOSIS, correction of (bilateral), following pregnancy and lactation, when performed within 6 years of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove N 45558 01MAY2003 BREAST PTOSIS, correction of by mastopexy of (bilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove N 45558 01JUL2009 BREAST PTOSIS, correction of by mastopexy by any means (bilateral), following pregnancy and lactation, when performed not less than 1 year, and not more than 7 years after the end of the most recent pregnancy, and where it can be demonstrated that the nipple is inferior to the infra-mammary groove, not being a service associated with a service to which item 45522 applies N 45558 01NOV2018 Breast ptosis, correction by mastopexy of (bilateral), if: (a) at least two-thirds of the breast tissue, including the nipple, lies inferior to the infra-mammary fold where the nipple is located at the most dependent, inferior part of the breast contour; and (b) if the patient has been pregnant - the correction is performed not less than 1 year, or more than 7 years, after completion of the most recent pregnancy of the patient; and (c) photographic evidence (including anterior, left lateral and right lateral views), with a marker at the level of the inframammary fold, demonstrating the clinical need for this service, is documented in the patient notes Applicable only once per lifetime Y 45559 01NOV2006 TUBEROUS, TUBULAR OR CONSTRICTED BREAST, where it can be demonstrated, correction of by simultaneous mastopexy and augmentation of (unilateral) Y 45560 01DEC1991 HAIR TRANSPLANTATION for the treatment of alopecia of congenital or traumatic origin or due to disease, excluding male pattern baldness, not being a service to which another item in this Group applies Y 45561 01MAY2007 MICROVASCULAR ANASTOMOSIS of artery or vein using microsurgical techniques, for supercharging of pedicled flaps Y 45562 01MAR1999 FREE TRANSFER OF TISSUE involving raising of tissue on vascular or neurovascular pedicle, including direct repair of secondary cutaneous defect if performed, excluding flap for male pattern baldness Y 45563 01DEC1991 NEUROVASCULAR ISLAND FLAP, or free transfer of tissue with vascular or neurovascular pedicle, including repair of secondary defect excluding flap for male pattern baldness N 45563 01MAR1999 NEUROVASCULAR ISLAND FLAP, including direct repair of secondary cutaneous defect if performed, excluding flap for male pattern baldness Y 45564 01NOV1999 FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, principal specialist surgeon N 45564 01NOV2003 FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, principal specialist surgeon N 45564 01MAY2007 FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, principal specialist surgeon N 45564 01JAN2016 Free transfer of tissue reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, other than a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 applies-conjoint surgery, principal specialist surgeon (H) Y 45565 01NOV1999 FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, conjoint specialist surgeon N 45565 01NOV2003 FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, conjoint specialist surgeon N 45565 01MAY2007 FREE TRANSFER OF TISSUE reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 of vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, not being a service associated with a service to which item 30165, 30168, 30171, 30174, 30177, 45501, 45502, 45504, 45505 or 45562 applies - conjoint surgery, conjoint specialist surgeon N 45565 01JAN2016 Free transfer of tissue reconstructive surgery for the repair of major tissue defect due to congenital deformity, surgery or trauma, involving anastomoses of up to 2 vessels using microvascular techniques and including raising of tissue on a vascular or neurovascular pedicle, preparation of recipient vessels, transfer of tissue, insetting of tissue at recipient site and direct repair of secondary cutaneous defect if performed, other than a service associated with a service to which item 30165, 30168, 30171, 30172, 30176, 30177, 30179, 45501, 45502, 45504, 45505 or 45562 applies-conjoint surgery, conjoint specialist surgeon (H) Y 45566 01DEC1991 TISSUE EXPANSION not being a service to which item 45539 or 45542 applies - insertion of tissue expansion unit and all attendances for subsequent expansion injections Y 45568 01NOV2003 TISSUE EXPANDER, removal of, with complete excision of fibrous capsule Y 45569 01NOV2006 CLOSURE OF ABDOMEN WITH RECONSTRUCTION OF UMBILICUS, with or without lipectomy, being a service associated with items 45562, 45564, 45565 or 45530 Y 45570 01NOV2006 CLOSURE OF ABDOMEN, repair of musculoaponeurotic layer, being a service associated with item 45569 Y 45572 01DEC1991 INTRA OPERATIVE TISSUE EXPANSION performed during an operation when combined with a service to which another item in Group T8 applies including expansion injections and excluding treatment of male pattern baldness Y 45575 01DEC1991 FACIAL NERVE PARALYSIS, free fascia graft for Y 45578 01DEC1991 FACIAL NERVE PARALYSIS, muscle transfer for Y 45581 01DEC1991 FACIAL NERVE PALSY, excision of tissue for Y 45584 01DEC1991 LIPOSUCTION (suction assisted lipolysis) to 1 regional area (thigh, buttock, or similar), for treatment of post-traumatic pseudolipoma N 45584 01NOV2018 Liposuction (suction assisted lipolysis) to one regional area (one limb or trunk), for treatment of post traumatic pseudolipoma, if photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45585 19JUN1997 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs (excluding knees), gynaecomastia, lymphoedema or similar conditions N 45585 01NOV1997 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs (excluding knees), gynaecomastia, lymphoedema or similar conditions N 45585 01NOV1999 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs (including knees), gynaecomastia, lymphoedema or similar conditions N 45585 01MAY2003 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service to which item 45584 or 45586 apply, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs and lower legs, including knees (Barraquer-Simon's Syndrome), gynaecomastia, or lymphoedema N 45585 01NOV2003 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service associated with a service to which item 31521 or 31527 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs(Barraquer-Simon's Syndrome), gynaecomastia, or lymphoedema N 45585 01NOV2006 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service associated with a service to which item 31521 or 31527 applies, where it can be demonstrated that the treatment is for pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs(Barraquer-Simon's Syndrome), gynaecomastia, lymphoedema or macrodystrophia lipomatosa N 45585 01NOV2012 LIPOSUCTION (suction assisted lipolysis) to 1 regional area, not being a service associated with a service to which item 31521 or 31527 applies, where it can be demonstrated that the treatment is for Barraquer-Simon's Syndrome (pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs), lymphoedema or macrodystrophia lipomatosa N 45585 01JUL2014 Liposuction (suction assisted lipolysis) to one regional area, other than a service associated with a service to which item 31525 applies, if it can be demonstrated that the treatment is for Barraquer-Simon's syndrome (pathological lipodystrophy of hips, buttocks, thighs, knees or lower legs), lymphoedema or macrodystrophia lipomatosa N 45585 01NOV2018 Liposuction (suction assisted lipolysis) to one regional area (one limb or trunk), other than a service associated with a service to which item31525 applies, if: (a) the liposuction is for: (i) the treatment of Barraquer-Simons syndrome, lymphoedema or macrodystrophia lipomatosa; or (ii) the reduction of a buffalo hump that is secondary to an endocrine disorder or pharmacological treatment of a medical condition; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45586 01MAY2003 LIPOSUCTION (suction assisted lipolysis) for reduction of a buffalo hump, where it can be demonstrated that the buffalo hump is secondary to an endocrine disorder or pharmacological treatment of a medical condition Y 45587 01DEC1991 MELOPLASTY for correction of facial asymmetry due to soft tissue abnormality where the meloplasty is limited to 1 side of the face N 45587 01NOV2018 Meloplasty for correction of facial asymmetry if: (a) the asymmetry is secondary to trauma (including previous surgery), a congenital condition or a medical condition (such as facial nerve palsy); and (b) the meloplasty is limited to one side of the face Y 45588 19JUN1997 MELOPLASTY, bilateral, not being a service to which Item 45587 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital conditions N 45588 01NOV1997 MELOPLASTY, bilateral, not being a service to which Item 45587 applies, where it can be demonstrated that surgery is indicated because of disease, trauma or congenital conditions N 45588 01MAY2003 MELOPLASTY, (excluding browlifts and chinlift platysmaplasties), bilateral where it can be demonstrated that surgery is indicated because of congenital conditions, disease or trauma (other than trauma resulting from previous elective cosmetic surgery) N 45588 01NOV2018 Meloplasty (excluding browlifts and chinlift platysmaplasties), bilateral, if: (a) surgery is indicated to correct a functional impairment due to a congenital condition, disease (excluding post-acne scarring) or trauma (other than trauma resulting from previous elective cosmetic surgery); and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45590 01DEC1991 ORBITAL CAVITY, reconstruction of a wall or floor, with or without foreign implant Y 45593 01DEC1991 ORBITAL CAVITY, bone or cartilage graft to orbital wall or floor including reduction of prolapsed or entrapped orbital contents Y 45596 01DEC1991 MAXILLA, total resection of Y 45597 01APR1992 MAXILLA, total resection of both maxillae Y 45599 01DEC1991 MANDIBLE, total resection of both sides, including condylectomies where performed Y 45602 01DEC1991 MANDIBLE, including lower border, OR MAXILLA, sub-total resection of Y 45605 01DEC1991 MANDIBLE OR MAXILLA, segmental resection of, for tumours or cysts Y 45608 01DEC1991 MANDIBLE, hemimandibular reconstruction with bone graft, not being a service associated with a service to which item 45599 applies Y 45611 01DEC1991 MANDIBLE, condylectomy Y 45614 01DEC1991 EYELID, WHOLE THICKNESS RECONSTRUCTION OF other than by direct suture only Y 45617 01DEC1991 UPPER EYELID, REDUCTION OF, for skin redundancy obscuring vision, herniation of orbital fat in exophthalmos, facial nerve palsy or posttraumatic scarring, or, in respect of 1 of these conditions, the restoration of symmetry of the contralateral upper eyelid N 45617 01JUL1998 UPPER EYELID, REDUCTION OF, for skin redundancy obscuring vision (as evidenced by upper eyelid skin resting on lashes on straight ahead gaze), herniation of orbital fat in exophthalmos, facial nerve palsy or posttraumatic scarring, or the restoration of symmetry of contralateral upper eyelid in respect of 1 of these conditions N 45617 01NOV2018 Upper eyelid, reduction of, if: (a) the reduction is for any of the following: (i) skin redundancy that causes a visual field defect (confirmed by an optometrist or ophthalmologist) or intertriginous inflammation of the eyelid; (ii) herniation of orbital fat in exophthalmos; (iii) facial nerve palsy; (iv) post-traumatic scarring; (v) the restoration of symmetry of contralateral upper eyelid in respect of one of the conditions mentioned in subparagraphs (i) to (iv); and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45620 01DEC1991 LOWER EYELID, REDUCTION OF, for herniation of orbital fat in exophthalmos, facial nerve palsy or posttraumatic scarring, or, in respect of 1 of these conditions, the restoration of symmetry of the contralateral lower eyelid N 45620 01NOV2018 Lower eyelid, reduction of, if: (a) the reduction is for: (i) herniation of orbital fat in exophthalmos, facial nerve palsy or post-traumatic scarring; or (ii) the restoration of symmetry of the contralateral lower eyelid in respect of one of these conditions; and (b) photographic and/or diagnostic imaging evidence demonstrating the clinical need for this service is documented in the patient notes Y 45623 01DEC1991 PTOSIS (unilateral), correction of N 45623 01JUL1993 PTOSIS of eyelid (unilateral), correction of N 45623 01NOV2018 Ptosis of upper eyelid (unilateral), correction of, by: (a) sutured elevation of the tarsal plate on the eyelid retractors (Muller's or levator muscle or levator aponeurosis); or (b) sutured suspension to the brow/frontalis muscle; Not applicable to a service for repair of mechanical ptosis to which item45617 applies Y 45624 01JUL1998 PTOSIS of eyelid, correction of, where previous ptosis surgery has been performed on that side N 45624 01NOV2018 Ptosis of upper eyelid, correction of, by: (a) sutured elevation of the tarsal plate on the eyelid retractors (Muller's or levator muscle or levator aponeurosis); or (b) sutured suspension to the brow/frontalis muscle; if a previous ptosis surgery has been performed on that side Y 45625 01JUL1998 PTOSIS of eyelid, correction of eyelid height by revision of levator sutures within one week of primary repair by levator resection or advancement, performed in the operating theatre of a hospital Y 45626 01DEC1991 ECTROPION OR ENTROPION, correction of (unilateral) N 45626 01NOV2019 Ectropion or entropion, not caused by trachoma, correction of (unilateral) Y 45627 01NOV2019 Ectropion or entropion, caused by trachoma, correction of (unilateral) Y 45629 01DEC1991 SYMBLEPHARON, grafting for Y 45632 01DEC1991 RHINOPLASTY, correction of lateral or alar cartilages N 45632 01NOV2014 RHINOPLASTY, correction of lateral or alar cartilages for correction of nasal obstruction N 45632 01NOV2018 Rhinoplasty, partial, involving correction of lateral or alar cartilages, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self?reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes Y 45635 01DEC1991 RHINOPLASTY, correction of bony vault only N 45635 01NOV2014 RHINOPLASTY, correction of vault only, for correction of nasal obstruction or post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery), or both N 45635 01NOV2018 Rhinoplasty, partial, involving correction of bony vault only, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self?reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes Y 45638 01DEC1991 RHINOPLASTYTOTAL, including correction of all bony and cartilaginous elements of the external nose N 45638 01JUL1998 RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, for correction of post-traumatic deformity or nasal obstruction, or both N 45638 01MAY2003 RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, for correction of nasal obstruction or post-traumatic deformity (but not as a result of previous elective cosmetic surgery), or both N 45638 01JAN2015 RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, for correction of nasal obstruction or post-traumatic deformity (but not as a result of previous elective cosmetic surgery), or both (H) Y 45639 01JUL1998 RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, where it can be demonstrated that there is a need for correction of significant developmental deformity N 45639 01JAN2015 RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose, where it can be demonstrated that there is a need for correction of significant developmental deformity (H) Y 45641 01DEC1991 RHINOPLASTY involving nasal or septal cartilage graft N 45641 01JUL1998 RHINOPLASTY involving nasal or septal cartilage graft, or nasal bone graft, or nasal bone and nasal cartilage graft N 45641 01NOV2014 RHINOPLASTY involving nasal or septal cartilage graft, or nasal bone graft, or nasal bone and nasal cartilage graft for correction of nasal obstruction or post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery), or both. (H) N 45641 01NOV2018 Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose, with or without autogenous cartilage or bone graft from a local site (nasal), if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self?reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes Y 45644 01DEC1991 RHINOPLASTY involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft N 45644 01NOV2014 RHINOPLASTY, TOTAL, including correction of all bony and cartilaginous elements of the external nose involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft For correction of nasal obstruction or post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery), or both. (H) N 45644 01NOV2018 Rhinoplasty, total, including correction of all bony and cartilaginous elements of the external nose involving autogenous bone or cartilage graft obtained from distant donor site, including obtaining of graft, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self?reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes Y 45645 01NOV1994 CHOANAL ATRESIA, repair of by puncture and dilatation Y 45646 01NOV1994 CHOANAL ATRESIA - correction by open operation with bone removal Y 45647 01DEC1991 FACE, contour restoration of 1 region, using autogenous bone or cartilage graft (not being a service to which item 45644 applies) N 45647 01NOV2003 FACE, contour restoration of 1 region, using autogenous bone or cartilage graft (not being a service to which item 45644 applies) Y 45650 01DEC1991 RHINOPLASTY, secondary revision of N 45650 01NOV2014 RHINOPLASTY, secondary revision of, for correction of nasal obstruction, post-traumatic deformity (other than deformity resulting from previous elective cosmetic surgery) or significant developmental deformity N 45650 01NOV2018 Rhinoplasty, revision of, if: (a) the indication for surgery is: (i) airway obstruction and the patient has a self-reported NOSE Scale score of greater than 45; or (ii) significant acquired, congenital or developmental deformity; and (b) photographic and/or NOSE Scale evidence demonstrating the clinical need for this service is documented in the patient notes Y 45652 01NOV1995 RHINOPHYMA, carbon dioxide laser excision-ablation of N 45652 01MAY2001 RHINOPHYMA, carbon dioxide laser or erbium laser excision-ablation of N 45652 01NOV2018 Rhinophyma of a moderate or severe degree, carbon dioxide laser or erbium laser excision - ablation of Y 45653 01DEC1991 RHINOPHYMA, shaving of Y 45656 01DEC1991 COMPOSITE GRAFT (Chondrocutaneous or chondromucosal) to nose, ear or eyelid Y 45659 01DEC1991 LOP EAR, BAT EAR OR SIMILAR DEFORMITY, correction of N 45659 01NOV2018 Correction of a congenital deformity of the ear if: (a) the patient is less than 18 years of age; and (b) the deformity is characterised by an absence of the antihelical fold and/or large scapha and/or large concha; and (c) photographic evidence demonstrating the clinical need for this service is documented in the patient notes Y 45660 01NOV2000 EXTERNAL EAR, COMPLEX TOTAL RECONSTRUCTION OF, using multiple costal cartilage grafts to form a framework, including the harvesting and sculpturing of the cartilage and its insertion, for congenital absence, microtia or post-traumatic loss of entire or substantial portion of pinna (first stage) - performed by a specialist in the practice of his or her specialty Y 45661 01NOV2000 EXTERNAL EAR, COMPLEX TOTAL RECONSTRUCTION OF, elevation of costal cartilage framework using cartilage previously stored in abdominal wall, including the use of local skin and fascia flaps and full thickness skin graft to cover cartilage (second stage) - performed by a specialist in the practice of his or her specialty Y 45662 01DEC1991 CONGENITAL ATRESIA, reconstruction of external auditory canal Y 45665 01DEC1991 LIP, EYELID OR EAR, FULL THICKNESS WEDGE EXCISION OF, with repair by direct sutures Y 45668 01DEC1991 VERMILIONECTOMY N 45668 01NOV1995 VERMILIONECTOMY, by surgical excision Y 45669 01NOV1995 VERMILIONECTOMY, using carbon dioxide laser excision-ablation N 45669 01MAY2001 VERMILIONECTOMY, using carbon dioxide laser or erbium laser excision-ablation N 45669 01NOV2018 Vermilionectomy for biopsy-confirmed cellular atypia, using carbon dioxide laser or erbium laser excision - ablation Y 45671 01DEC1991 LIP OR EYELID RECONSTRUCTION using full thickness flap (Abbe or similar), first stage Y 45674 01DEC1991 LIP OR EYELID RECONSTRUCTION using full thickness flap (Abbe or similar), second stage Y 45675 01NOV1994 MACROCHEILIA or macroglossia, operation for Y 45676 01NOV1994 MACROSTOMIA, operation for Y 45677 01DEC1991 CLEFT LIP, unilateralprimary repair, 1 stage, without anterior palate repair Y 45680 01DEC1991 CLEFT LIP, unilateral - primary repair, 1 stage, with anterior palate repair Y 45683 01DEC1991 CLEFT LIP, bilateral - primary repair, 1 stage, without anterior palate repair Y 45686 01DEC1991 CLEFT LIP, bilateral - primary repair, 1 stage, with anterior palate repair Y 45689 01DEC1991 CLEFT LIP, lip adhesion procedure, unilateral or bilateral Y 45692 01DEC1991 CLEFT LIP, partial revision, including minor flap revision alignment and adjustment, including revision of minor whistle deformity if performed Y 45695 01DEC1991 CLEFT LIP, total revision, including major flap revision, muscle reconstruction and revision of major whistle deformity Y 45698 01DEC1991 CLEFT LIP, primary columella lengthening procedure, bilateral Y 45701 01DEC1991 CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), first stage Y 45704 01DEC1991 CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), second stage Y 45707 01DEC1991 CLEFT PALATE, primary repair Y 45710 01DEC1991 CLEFT PALATE, secondary repair, closure of fistula using local flaps Y 45713 01DEC1991 CLEFT PALATE, secondary repair, lengthening procedure Y 45714 01NOV1995 ORO-NASAL FISTULA, plastic closure of, including services to which item 45200, 45203 or 45239 applies Y 45716 01DEC1991 VELO-PHARYNGEAL INCOMPETENCE, pharyngeal flap for, or pharyngoplasty for Y 45719 01DEC1991 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both Y 45720 01JUL1998 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site N 45720 01MAY2009 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and excluding services to which item 47933or 47936 apply Y 45722 01DEC1991 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both Y 45723 01JUL1998 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45723 01NOV2000 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 45723 01MAY2009 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply Y 45725 01DEC1991 MANDIBLE OR MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site Y 45726 01JUL1998 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site N 45726 01MAY2009 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply Y 45728 01DEC1991 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site Y 45729 01JUL1998 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45729 01NOV2000 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 45729 01MAY2009 MANDIBLE OR MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply Y 45731 01DEC1991 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site N 45731 01MAY2009 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply Y 45732 01JUL1998 MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45732 01NOV2000 MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 45732 01MAY2009 MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply Y 45734 01DEC1991 MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site Y 45735 01JUL1998 MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site N 45735 01MAY2009 MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply Y 45737 01DEC1991 MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site Y 45738 01JUL1998 MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45738 01NOV2000 MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 45738 01MAY2009 MANDIBLE AND MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply Y 45740 01DEC1991 MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site Y 45741 01JUL1998 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site N 45741 01MAY2009 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply Y 45743 01DEC1991 MANDIBLE OR MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both Y 45744 01JUL1998 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45744 01NOV2000 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 45744 01MAY2009 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply Y 45746 01DEC1991 MANDIBLE OR MAXILLA, osteotomies or oteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both Y 45747 01JUL1998 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site N 45747 01MAY2009 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site, and excluding services to which item 47933 or 47936 apply Y 45749 01DEC1991 MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both Y 45752 01DEC1991 MANDIBLE OR MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty (when performed) and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45752 01JUL1998 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45752 01NOV2000 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 45752 01MAY2009 MANDIBLE AND MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination, and excluding services to which item 47933 or 47936 apply Y 45753 01JUL1993 MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III(Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site Y 45754 01JUL1993 MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 45754 01NOV2000 MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 45755 01DEC1991 TEMPOROMANDIBULAR MENISCECTOMY N 45755 01NOV2006 TEMPOROMANDIBULAR PARTIAL OR TOTAL MENISCECTOMY Y 45758 01DEC1991 TEMPORO-MANDIBULAR JOINT, arthroplasty Y 45761 01DEC1991 GENIOPLASTY, including transposition of nerves and bone grafts taken from the same site N 45761 01JUL1998 GENIOPLASTY, including transposition of nerves and vessels and bone grafts taken from the same site Y 45764 01DEC1991 GENIOPLASTY being a service associated with a service to which item 45719, 45722, 45725, 45728, 45731, 45734, 45743 or 45746 applies N 45764 01JUL1998 GENIOPLASTY being a service associated with a service to which item 45720, 45723, 45726, 45729, 45731, 45732, 45735 or 45738 applies Y 45767 01DEC1991 HYPERTELORISM, correction of, intracranial Y 45770 01DEC1991 HYPERTELORISM, correction of, subcranial Y 45773 01DEC1991 TREACHER COLLINS SYNDROME, PERIORBITAL CORRECTION OF, with rib and iliac bone grafts Y 45776 01DEC1991 ORBITAL DYSTOPIA (UNILATERAL), CORRECTION OF, with total repositioning of 1 orbit, intracranial Y 45779 01DEC1991 ORBITAL DYSTOPIA (UNILATERAL), CORRECTION OF, with total repositioning of 1 orbit, extracranial Y 45782 01DEC1991 FRONTOORBITAL ADVANCEMENT, UNILATERAL Y 45785 01DEC1991 CRANIAL VAULT RECONSTRUCTION for oxycephaly, brachycephaly, turricephaly or similar condition(bilateral frontoorbital advancement) Y 45788 01DEC1991 GLENOID FOSSA, ZYGOMATIC ARCH AND TEMPORAL BONE, RECONSTRUCTION OF, (Obwegeser technique) Y 45791 01DEC1991 ABSENT CONDYLE AND ASCENDING RAMUS in hemifacial microsomia, CONSTRUCTION OF, not including harvesting of graft material Y 45794 01DEC1991 OSSEO-INTEGRATION PROCEDURE - extra-oral, implantation of titanium fixture N 45794 01NOV2006 OSSEO-INTEGRATION PROCEDURE - extra-oral, implantation of titanium fixture, not for implantable bone conduction hearing system device Y 45797 01DEC1991 OSSEO-INTEGRATION PROCEDURE, fixation of transcutaneous abutment N 45797 01NOV2006 OSSEO-INTEGRATION PROCEDURE, fixation of transcutaneous abutment, not for implantable bone conduction hearing system device Y 45799 01NOV2004 ASPIRATION BIOPSY of 1 or MORE JAW CYSTS as an independent procedure to obtain material for diagnostic purposes and not being a service associated with an operative procedure on the same day Y 45801 01NOV2004 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation),in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 45803 applies Y 45803 01NOV2004 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions Y 45805 01NOV2004 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane Y 45807 01NOV2004 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, removal of, not being a service to which another item in this Subgroup applies, involving muscle, bone, or other deep tissue Y 45809 01NOV2004 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), in the oral and maxillofacial region, removal of, requiring wide excision, not being a service to which another item in this Subgroup applies Y 45811 01NOV2004 TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft Y 45813 01NOV2004 TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft Y 45815 01NOV2004 OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for chronic osteomyelitis - 1 bone or in combination with adjoining bones Y 45817 01NOV2004 OPERATION on SKULL for OSTEOMYELITIS Y 45819 01NOV2004 OPERATION ON ANY COMBINATION OF ADJOINING BONES IN THE ORAL AND MAXILLOFACIAL REGION, being bones referred to in item 45817 Y 45821 01NOV2004 BONE GROWTH STIMULATOR IN THE ORAL AND MAXILLOFACIAL REGION, insertion of Y 45823 01NOV2004 ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia where undertaken in the operating theatre of a hospital Y 45825 01NOV2004 MANDIBULAR OR PALATAL EXOSTOSIS, excision of Y 45827 01NOV2004 MYLOHYOID RIDGE, reduction of Y 45829 01NOV2004 MAXILLARY TUBEROSITY, reduction of Y 45831 01NOV2004 PAPILLARY HYPERPLASIA OF THE PALATE, removal of - less than 5 lesions Y 45833 01NOV2004 PAPILLARY HYPERPLASIA OF THE PALATE, removal of - 5 to 20 lesions Y 45835 01NOV2004 PAPILLARY HYPERPLASIA OF THE PALATE, removal of - more than 20 lesions Y 45837 01NOV2004 VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or mucosal graft when performed - unilateral or bilateral Y 45839 01NOV2004 FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision of muscle and skin or mucosal graft when performed - unilateral Y 45841 01NOV2004 ALVEOLAR RIDGE AUGMENTATION with bone or alloplast or both - unilateral Y 45843 01NOV2004 ALVEOLAR RIDGE AUGMENTATION - unilateral, insertion of tissue expanding device into maxillary or mandibular alveolar ridge region for Y 45845 01NOV2004 OSSEO-INTEGRATION PROCEDURE - intra-oral implantation of titanium fixture to facilitate restoration of the dentition following resection of part of the maxilla or mandible for benign or malignant tumours Y 45847 01NOV2004 OSSEO-INTEGRATION PROCEDURE - fixation of transmucosal abutment to fixtures placed following resection of part of the maxilla or mandible for benign or malignant tumours Y 45849 01NOV2004 MAXILLARY SINUS, BONE GRAFT to floor of maxillary sinus following elevation of mucosal lining (sinus lift procedure), (unilateral) Y 45851 01NOV2004 TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre of a hospital, not being a service associated with a service to which another item in this Subgroup applies Y 45853 01NOV2004 ABSENT CONDYLE and ASCENDING RAMUS in hemifacial microsomia, construction of, not including harvesting of graft material Y 45855 01NOV2004 TEMPOROMANDIBULAR JOINT, arthroscopy of, with or without biopsy, not being a service associated with any other arthroscopic procedure of that joint Y 45857 01NOV2004 TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, or treatment of adhesions - 1 or more such procedures N 45857 01MAY2009 TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, or treatment of adhesions - 1 or more such procedure of that joint, not being a service associated with any other arthroscopic procedure of the temporomandibular joint Y 45859 01NOV2004 TEMPOROMANDIBULAR JOINT, arthrotomy of, not being a service to which another item in this Subgroup applies Y 45861 01NOV2004 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without microsurgical techniques Y 45863 01NOV2004 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with condylectomy or condylotomy, with or without microsurgical techniques Y 45865 01NOV2004 ARTHROCENTESIS, irrigation of temporomandibular joint after insertion of 2 cannuli into the appropriate joint space(s) Y 45867 01NOV2004 TEMPOROMANDIBULAR JOINT, synovectomy of, not being a service to which another item in this Subgroup applies Y 45869 01NOV2004 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without meniscus or capsular surgery, including meniscectomy when performed, with or without microsurgical techniques N 45869 01NOV2006 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without meniscus or capsular surgery, including partial or total meniscectomy when performed, with or without microsurgical techniques Y 45871 01NOV2004 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with meniscus, capsular and condylar head surgery, with or without microsurgical techniques Y 45873 01NOV2004 TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 45863, 45867, 45869 and 45871 apply and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques Y 45875 01NOV2004 TEMPOROMANDIBULAR JOINT, stabilisation of, involving 1 or more of: repair of capsule, repair of ligament or internal fixation, not being a service to which another item in this Subgroup applies Y 45877 01NOV2004 TEMPOROMANDIBULAR JOINT, arthrodesis of, not being a service to which another item in this Subgroup applies N 45877 01MAY2009 TEMPOROMANDIBULAR JOINT, arthrodesis of, with synovectomy if performed, not being a service to which another item in this Subgroup applies Y 45879 01NOV2004 TEMPOROMANDIBULAR JOINT OR JOINTS, application of external fixator to, other than for treatment of fractures Y 45882 01NOV2007 The treatment of a premalignant lesion of the oral mucosa by a treatment using cryotherapy, diathermy or carbon dioxide laser. Y 45885 01NOV2007 Facial, mandibular or lingual artery or vein or artery and vein, ligation of, not being a service to which item 41707 applies Y 45888 01NOV2007 FOREIGN BODY, in the oral and maxillofacial region, deep, removal of using interventional imaging techniques Y 45891 01NOV2007 SINGLE-STAGE LOCAL FLAP where indicated, repair to 1 defect, using temporalis muscle Y 45894 01NOV2007 FREE GRAFTING, in the oral and maxillofacial region, (mucosa or split skin) of a granulating area Y 45897 01NOV2007 ALVEOLAR CLEFT (congenital) unilateral, grafting of, including plastic closure of associated oro-nasal fistulae and ridge augmentation Y 45900 01NOV2007 MANDIBLE, fixation by intermaxillary wiring, excluding wiring for obesity Y 45903 01NOV2007 MANDIBULAR OR PALATAL EXOSTOSIS, excision of Y 45906 01NOV2007 MYLOHYOID RIDGE, reduction of Y 45909 01NOV2007 MAXILLARY TUBEROSITY, reduction of Y 45912 01NOV2007 PAPILLARY HYPERPLASIA OF THE PALATE, removal of less than 5 lesions Y 45915 01NOV2007 PAPILLARY HYPERPLASIA OF THE PALATE, removal of 5 to 20 lesions Y 45918 01NOV2007 PAPILLARY HYPERPLASIA OF THE PALATE, removal of more than 20 lesions Y 45921 01NOV2007 VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or mucosal graft when performed - unilateral or bilateral Y 45924 01NOV2007 FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision of muscle and skin or mucosal graft when performed - unilateral Y 45939 01NOV2007 PERIPHERAL BRANCHES OF THE TRIGEMINAL NERVE, cryosurgery of, for pain relief Y 45945 01NOV2007 MANDIBLE, treatment of a dislocation of, requiring open reduction Y 45975 01NOV2007 MAXILLA, unilateral or bilateral, treatment of fracture of, not requiring splinting Y 45978 01NOV2007 MANDIBLE, treatment of fracture of, not requiring splinting Y 45981 01NOV2007 ZYGOMATIC BONE, treatment of fracture of, not requiring surgical reduction Y 45984 01NOV2007 MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves requiring open reduction not involving plate(s) Y 45987 01NOV2007 MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction not involving plate(s) Y 45990 01NOV2007 MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves requiring open reduction involving the use of plate(s) Y 45993 01NOV2007 MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction involving the use of plate(s) Y 45996 01NOV2007 MANDIBLE, treatment of a closed fracture of, involving a joint surface Y 46300 01DEC1991 Note: Items 46300 to 46534 are restricted to surgery on the hand/s. INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrodesis of N 46300 01MAY2009 Note: Items 46300 to 46534 are restricted to surgery on the hand/s. INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrodesis of, with synovectomy if performed Y 46303 01DEC1991 CARPOMETACARPAL JOINT, arthrodesis of N 46303 01MAY2009 CARPOMETACARPAL JOINT, arthrodesis of, with synovectomy if performed Y 46306 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, interposition arthroplasty of (including volar plate arthroplasty), and including tendon transfers or realignment on the 1 ray N 46306 01NOV1994 INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, interposition arthroplasty of and including tendon transfers or realignment on the 1 ray Y 46307 01NOV1994 INTERPHALANGEAL JOINT OR METACARPOPHALANGEAL JOINT - volar plate arthroplasty for traumatic deformity including tendon transfers or realignment on the 1 ray Y 46309 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 1 joint N 46309 01NOV1996 INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 1 joint Y 46312 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 2 joints N 46312 01NOV1996 INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 2 joints Y 46315 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 3 joints N 46315 01NOV1996 INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 3 joints Y 46318 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 4 joints N 46318 01NOV1996 INTERPHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 4 joints Y 46321 01DEC1991 INTER-PHALANGEAL JOINT OR METACARPOPHALANGEAL JOINT, total replacement arthroplasty of, including associated synovectomy, tendon transfer or realignment - 5 or more joints N 46321 01NOV1996 INTERPHALANGEAL JOINT OR METACARPOPHALANGEAL JOINT, total replacement arthroplasty or hemiarthroplasty of, including associated synovectomy, tendon transfer or realignment - 5 or more joints Y 46324 01DEC1991 CARPAL BONE replacement arthroplasty including associated tendon transfer or realignment when performed N 46324 01NOV1994 CARPAL BONE REPLACEMENT ARTHROPLASTY including associated tendon transfer or realignment when performed Y 46325 01NOV1994 CARPAL BONE REPLACEMENT ARTHROPLASTY using adjacent tendon or other soft tissue including associated tendon transfer or realignment when performed N 46325 01NOV1996 CARPAL BONE REPLACEMENT OR RESECTION ARTHROPLASTY using adjacent tendon or other soft tissue including associated tendon transfer or realignment when performed Y 46327 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrotomy of Y 46330 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, arthrotomy of, with ligamentous or capsular repair N 46330 01NOV2006 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, ligamentous or capsular repair with or without arthrotomy Y 46333 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, ligamentous repair of, using free tissue graft or implant Y 46336 01DEC1991 INTER-PHALANGEAL JOINT or METACARPOPHALANGEAL JOINT, synovectomy, capsulectomy or debridement of, not being a service associated with any procedure related to that joint Y 46339 01DEC1991 EXTENSOR TENDONS or FLEXOR TENDONS of hand or wrist, synovectomy of Y 46342 01DEC1991 DISTAL RADIOULNAR JOINT or CARPOMETACARPAL JOINT OR JOINTS, synovectomy of Y 46345 01DEC1991 RECONSTRUCTION of DISTAL RADIOULNAR JOINT N 46345 01NOV1996 DISTAL RADIOULNAR JOINT, reconstruction or stabilisation of, including fusion, or ligamentous arthroplasty and excision of distal ulna, when performed Y 46348 01DEC1991 DIGIT, synovectomy of flexor tendon or tendons - 1 digit Y 46351 01DEC1991 DIGIT, synovectomy of flexor tendon or tendons - 2 digits Y 46354 01DEC1991 DIGIT, synovectomy of flexor tendon or tendons - 3 digits Y 46357 01DEC1991 DIGIT, synovectomy of flexor tendon or tendons - 4 digits Y 46360 01DEC1991 DIGIT, synovectomy of flexor tendon or tendons - 5 digits Y 46363 01DEC1991 TENDON SHEATH OF HAND OR WRIST, open operation on, for STENOSING TENOVAGINITIS Y 46366 01DEC1991 DUPUYTREN'S CONTRACTURE, subcutaneous fasciotomy for - 1 hand N 46366 01NOV1994 DUPUYTREN'S CONTRACTURE, subcutaneous fasciotomy for - each hand Y 46369 01DEC1991 DUPUYTREN'S CONTRACTURE, palmar fasciectomy for - 1 hand Y 46372 01DEC1991 DUPUYTREN'S CONTRACTURE, fasciectomy for, from 1 ray, including dissection of nerves - 1 hand Y 46375 01DEC1991 DUPUYTREN'S CONTRACTURE, fasciectomy for, from 2 rays, including dissection of nerves - 1 hand Y 46378 01DEC1991 DUPUYTREN'S CONTRACTURE, fasciectomy for, from 3 or more rays, including dissection of nerves - 1 hand Y 46381 01DEC1991 INTER-PHALANGEAL JOINT, joint capsule release when performed in conjunction with operation for Dupuytren's Contracture - each procedure Y 46384 01DEC1991 Z PLASTY (or similar local flap procedure) when performed in conjunction with operation for Dupuytren's Contracture - 1 such procedure Y 46387 01DEC1991 DUPUYTREN'S CONTRACTURE, fasciectomy for, from 1 ray, including dissection of nerves - operation for recurrence in that ray Y 46390 01DEC1991 DUPUYTREN'S CONTRACTURE, fasciectomy for, from 2 rays, including dissection of nerves - operation for recurrence in those rays Y 46393 01DEC1991 DUPUYTREN'S CONTRACTURE, fasciectomy for, from 3 or more rays, including dissection of nerves - operation for recurrence in those rays Y 46396 01DEC1991 PHALANX OR METACARPAL OF THE HAND, osteotomy or osteectomy of N 46396 01MAY2009 PHALANX OR METACARPAL OF THE HAND, osteotomy or osteectomy of, and excluding services to which item 47933 or 47936 apply Y 46399 01DEC1991 PHALANX OR METACARPAL OF THE HAND, osteotomy of, with internal fixation Y 46402 01DEC1991 PHALANX or METACARPAL, bone grafting of, for pseudarthrosis (non-union), including obtaining of graft material Y 46405 01DEC1991 PHALANX or METACARPAL, bone grafting of, for pseudarthrosis (non-union), involving internal fixation and including obtaining of graft material Y 46408 01DEC1991 TENDON, reconstruction of, by tendon graft Y 46411 01DEC1991 FLEXOR TENDON PULLEY, reconstruction of, by graft Y 46414 01DEC1991 ARTIFICIAL TENDON PROSTHESIS, INSERTION OF, in preparation for tendon grafting Y 46417 01DEC1991 TENDON transfer for restoration of hand function, each transfer Y 46420 01DEC1991 EXTENSOR TENDON OF HAND OR WRIST, primary repair of, each tendon Y 46423 01DEC1991 EXTENSOR TENDON OF HAND OR WRIST, secondary repair of, each tendon Y 46426 01DEC1991 FLEXOR TENDON OF HAND OR WRIST, primary repair of, proximal to A1 pulley, each tendon Y 46429 01DEC1991 FLEXOR TENDON OF HAND OR WRIST, secondary repair of, proximal to A1 pulley, each tendon Y 46432 01DEC1991 FLEXOR TENDON OF HAND, primary repair of, distal to A1 pulley, each tendon Y 46435 01DEC1991 FLEXOR TENDON OF HAND, secondary repair of, distal to A1 pulley, each tendon Y 46438 01DEC1991 MALLET FINGER, closed pin fixation of Y 46441 01DEC1991 MALLET FINGER, open repair of, including pin fixation when performed Y 46442 01NOV1994 MALLET FINGER with intra articular fracture involving more than one third of base of terminal phalanx - open reduction Y 46444 01DEC1991 BOUTONNIERE DEFORMITY without joint contracture, reconstruction of Y 46447 01DEC1991 BOUTONNIERE DEFORMITY with joint contracture, reconstruction of Y 46450 01DEC1991 EXTENSOR TENDON, TENOLYSIS OF, following tendon injury, repair or graft Y 46453 01DEC1991 FLEXOR TENDON, TENOLYSIS OF, following tendon injury, repair or graft Y 46456 01DEC1991 FINGER, percutaneous tenotomy of Y 46459 01DEC1991 OPERATION for OSTEOMYELITIS on distal phalanx Y 46462 01DEC1991 OPERATION for OSTEOMYELITIS on middle or proximal phalanx, metacarpal or carpus Y 46464 01NOV1994 AMPUTATION of a supernumerary complete digit Y 46465 01DEC1991 AMPUTATION of SINGLE DIGIT, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover Y 46468 01DEC1991 AMPUTATION of 2 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover Y 46471 01DEC1991 AMPUTATION of 3 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover Y 46474 01DEC1991 AMPUTATION of 4 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover Y 46477 01DEC1991 AMPUTATION of 5 DIGITS, proximal to nail bed, involving section of bone or joint and requiring soft tissue cover Y 46480 01DEC1991 AMPUTATION of SINGLE DIGIT,proximal to nail bed, involving section of bone or joint and requiring soft tissue cover, including metacarpal Y 46483 01DEC1991 REVISION of AMPUTATION STUMP to provide adequate soft tissue cover Y 46486 01DEC1991 NAIL BED, accurate reconstruction of nail bed laceration using magnification, undertaken in the operating theatre of a hospital Y 46489 01DEC1991 NAIL BED, secondary exploration and accurate repair of nail bed deformity using magnification, undertaken in the operating theatre of a hospital Y 46492 01DEC1991 FLEXION CONTRACTURE of HAND OR DIGIT, correction of, involving tissues deeper than skin and subcutaneous tissue N 46492 01NOV1996 CONTRACTURE OF DIGITS OF HAND, flexor or extensor, correction of, involving tissues deeper than skin and subcutaneous tissue Y 46494 01NOV1995 GANGLION OF HAND, excision of, not being a service associated with a service to which another item in this Group applies Y 46495 01DEC1991 GANGLION OR MUCOUS CYST OF DISTAL DIGIT, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46495 01NOV2017 GANGLION OR MUCOUS CYST OF DISTAL DIGIT, excision of,other thana service associated with a service to which item 30107 applies Y 46498 01DEC1991 GANGLION OF FLEXOR TENDON SHEATH, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46498 01NOV2017 GANGLION OF FLEXOR TENDON SHEATH, excision of,other thana service associated with a service to which item 30107 applies Y 46500 01NOV1994 GANGLION OF DORSAL WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46500 01NOV2017 GANGLION OF DORSAL WRIST JOINT, excision of,other thana service associated with a service to which item 30107 applies Y 46501 01DEC1991 GANGLION OF VOLAR OR DORSAL WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46501 01NOV1994 GANGLION OF VOLAR WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46501 01NOV2017 GANGLION OF VOLAR WRIST JOINT, excision of,other thana service associated with a service to which item 30107 applies Y 46502 01NOV1994 RECURRENT GANGLION OF DORSAL WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46502 01NOV2017 RECURRENT GANGLION OF DORSAL WRIST JOINT, excision of,other thana service associated with a service to which item30107 applies Y 46503 01NOV1994 RECURRENT GANGLION OF VOLAR WRIST JOINT, excision of, not being a service associated with a service to which item 30106 or 30107 applies N 46503 01NOV2017 RECURRENT GANGLION OF VOLAR WRIST JOINT, excision of,other thana service associated with a service to which item30107 applies Y 46504 01DEC1991 NEUROVASCULAR ISLAND FLAP, for pulp innervation Y 46507 01DEC1991 DIGIT, transposition of, complete procedure N 46507 01NOV1995 DIGIT OR RAY, transposition or transfer of, on vascular pedicle, complete procedure Y 46510 01DEC1991 MACRODACTYLY, surgical reduction of enlarged elements - each digit Y 46513 01NOV1994 DIGITAL NAIL OF FINGER OR THUMB, removal of, not being a service to which item 46516 applies Y 46516 01NOV1994 DIGITAL NAIL OF FINGER OR THUMB, removal of, in the operating theatre of a hospital Y 46519 01NOV1994 MIDDLE PALMAR, THENAR OR HYPOTHENAR SPACES OF HAND, drainage of (excluding aftercare) Y 46522 01NOV1994 FLEXOR TENDON SHEATH OF FINGER OR THUMB, open operation and drainage for infection Y 46525 01NOV1994 PULP SPACE INFECTION, PARONYCHIA OF HAND, incision for, not being a service to which another item in this Group applies (excluding after-care) N 46525 01NOV1996 PULP SPACE INFECTION, PARONYCHIA OF HAND, incision for, when performed in an operating theatre of a hospital, not being a service to which another item in this Group applies (excluding after-care) Y 46528 01NOV1994 INGROWING NAIL OF FINGER OR THUMB, wedge resection for, including removal of segment of nail, ungual fold and portion of the nail bed Y 46531 01NOV1994 INGROWING NAIL OF FINGER OR THUMB, partial resection of nail, including phenolisation but not including excision of nail bed Y 46534 01NOV1994 NAIL PLATE INJURY OR DEFORMITY, radical excision of nail germinal matrix Y 47000 01DEC1991 MANDIBLE, treatment of dislocation of, by closed reduction Y 47003 01DEC1991 CLAVICLE, treatment of dislocation of, by closed reduction Y 47006 01DEC1991 CLAVICLE, treatment of dislocation of, by open reduction Y 47009 01DEC1991 SHOULDER, treatment of dislocation of, requiring general anaesthesia, not being a service to which item 47012 applies Y 47012 01DEC1991 SHOULDER, treatment of dislocation of, requiring general anaesthesia, open reduction Y 47015 01DEC1991 SHOULDER, treatment of dislocation of, not requiring general anaesthesia Y 47018 01DEC1991 ELBOW, treatment of dislocation of, by closed reduction Y 47021 01DEC1991 ELBOW, treatment of dislocation of, by open reduction Y 47024 01DEC1991 RADIOULNAR JOINT, DISTAL or PROXIMAL, treatment of dislocation of, by closed reduction, not being a service associated with fracture or dislocation in the same region Y 47027 01DEC1991 RADIOULNAR JOINT, DISTAL or PROXIMAL, treatment of dislocation of, by open reduction, not being a service associated with fracture or dislocation in the same region Y 47030 01DEC1991 CARPUS, or CARPUS on RADIUS and ULNA, or CARPOMETACARPAL JOINT, treatment of dislocation of, by closed reduction Y 47033 01DEC1991 CARPUS, or CARPUS on RADIUS and ULNA, or CARPOMETACARPAL JOINT, treatment of dislocation of, by open reduction Y 47036 01DEC1991 INTERPHALANGEAL JOINT, treatment of dislocation of, by closed reduction Y 47039 01DEC1991 INTERPHALANGEAL JOINT, treatment of dislocation of, by open reduction Y 47042 01DEC1991 METACARPOPHALANGEAL JOINT, treatment of dislocation of, by closed reduction Y 47045 01DEC1991 METACARPOPHALANGEAL JOINT, treatment of dislocation of, by open reduction Y 47048 01DEC1991 HIP, treatment of dislocation of, by closed reduction Y 47051 01DEC1991 HIP, treatment of dislocation of, by open reduction Y 47054 01DEC1991 KNEE, treatment of dislocation of, by closed reduction Y 47057 01DEC1991 PATELLA, treatment of dislocation of, by closed reduction Y 47060 01DEC1991 PATELLA, treatment of dislocation of, by open reduction Y 47063 01DEC1991 ANKLE or TARSUS, treatment of dislocation of, by closed reduction Y 47066 01DEC1991 ANKLE or TARSUS, treatment of dislocation of, by open reduction Y 47069 01DEC1991 TOE, treatment of dislocation of, by closed reduction Y 47072 01DEC1991 TOE, treatment of dislocation of, by open reduction Y 47300 01DEC1991 DISTAL PHALANX of FINGER or THUMB, treatment of fracture of, by closed reduction, including percutaneous fixation where used Y 47301 01MAY2016 Phalanx, middle or proximal, treatment of fracture of, by closed reduction, requiring anaesthesia, not provided on the same occasion as a service described in item 47304, 47307, 47310, 47313, 47316 or 47319 Y 47303 01DEC1991 DISTAL PHALANX of FINGER or THUMB, treatment of intra-articular fracture of, by closed reduction Y 47304 01MAY2016 Metacarpal, treatment of fracture of, by closed reduction, requiring anaesthesia, not provided on the same occasion as a service described in item 47301, 47307, 47310, 47313, 47316 or 47319 Y 47306 01DEC1991 DISTAL PHALANX of FINGER or THUMB, treatment of fracture of, by open reduction Y 47307 01MAY2016 Phalanx or metacarpal, treatment of fracture of, by closed reduction with percutaneous K wire fixation Y 47309 01DEC1991 DISTAL PHALANX of FINGER or THUMB, treatment of intra-articular fracture of, by open reduction Y 47310 01MAY2016 Phalanx or metacarpal, treatment of fracture of, by open reduction with fixation Y 47312 01DEC1991 MIDDLE PHALANX of FINGER, treatment of fracture of, by closed reduction Y 47313 01MAY2016 Phalanx or metacarpal, treatment of intra articular fracture of, by closed reduction with percutaneous K wire fixation Y 47315 01DEC1991 MIDDLE PHALANX of FINGER, treatment of intra-articular fracture of, by closed reduction Y 47316 01MAY2016 Phalanx or metacarpal, treatment of intra articular fracture of, by open reduction with fixation, not provided on the same occasion as a service to which item 47319 applies Y 47318 01DEC1991 MIDDLE PHALANX OF FINGER, treatment of fracture of, by open reduction Y 47319 01MAY2016 Middle phalanx, proximal end, treatment of intra articular fracture of, by open reduction with fixation, not provided on the same occasion as a service to which item 47316 applies Y 47321 01DEC1991 MIDDLE PHALANX OF FINGER, treatment of intra-articular fracture of, by open reduction Y 47324 01DEC1991 PROXIMAL PHALANX OF FINGER OR THUMB, treatment of fracture of, by closed reduction Y 47327 01DEC1991 PROXIMAL PHALANX OF FINGER OR THUMB, treatment of intra-articular fracture of, by closed reduction Y 47330 01DEC1991 PROXIMAL PHALANX OF FINGER OR THUMB, treatment of fracture of, by open reduction Y 47333 01DEC1991 PROXIMAL PHALANX OF FINGER OR THUMB, treatment of intra-articular fracture of, by open operation Y 47336 01DEC1991 METACARPAL, treatment of fracture of, by closed reduction Y 47339 01DEC1991 METACARPAL, treatment of intra-articular fracture of, by closed reduction Y 47342 01DEC1991 METACARPAL, treatment of fracture of, by open reduction Y 47345 01DEC1991 METACARPAL, treatment of intra-articular fracture of, by open reduction Y 47348 01DEC1991 CARPUS (excluding scaphoid), treatment of fracture of, not being a service to which item 47351 applies Y 47351 01DEC1991 CARPUS (excluding scaphoid), treatment of fracture of, by open reduction Y 47354 01DEC1991 CARPAL SCAPHOID, treatment of fracture of, not being a service to which item 47357 applies Y 47357 01DEC1991 CARPAL SCAPHOID, treatment of fracture of, by open reduction Y 47360 01DEC1991 RADIUS OR ULNA, distal end of, treatment of fracture of, not being a service to which item 47363 or 47366 applies N 47360 01JUL1993 RADIUS OR ULNA, distal end of, treatment of fracture of, by cast immobilisation, not being a service to which item 47363 or 47366 applies Y 47361 01MAY2016 Radius or ulna, or radius and ulna, distal end of, treatment of fracture of, by cast immobilisation, other than a service associated with a service to which item 47362, 47364, 47367, 47370 or 47373 applies Y 47362 01MAY2016 Radius or ulna, or radius and ulna, distal end of, treatment of fracture of, by closed reduction, requiring general or major regional anaesthesia, but excluding local infiltration, other than a service associated with a service to which item 47361, 47364, 47367, 47370 or 47373 applies Y 47363 01DEC1991 RADIUS OR ULNA, distal end of, treatment of fracture of, by closed reduction Y 47364 01MAY2016 Radius or ulna, distal end of, not involving joint surface, treatment of fracture of, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies Y 47366 01DEC1991 RADIUS OR ULNA, distal end of, treatment of fracture of, by open reduction Y 47367 01MAY2016 Radius, distal end of, treatment of fracture of, by closed reduction with percutaneous fixation, other than a service associated with a service to which item 47361 or 47362 applies Y 47369 01DEC1991 RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture, not being a service to which item 47372 or 47375 applies N 47369 01JUL1993 RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture of, by cast immobilisation, not being a service to which item 47372 or 47375 applies Y 47370 01MAY2016 Radius, distal end of, treatment of intra articular fracture of, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies Y 47372 01DEC1991 RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture, by closed reduction Y 47373 01MAY2016 Ulna, distal end of, treatment of intra articular fracture of, by open reduction with fixation, other than a service associated with a service to which item 47361 or 47362 applies Y 47375 01DEC1991 RADIUS, distal end of, treatment of Colles', Smith's or Barton's fracture of, by open reduction Y 47378 01DEC1991 RADIUS OR ULNA, shaft of, treatment of fracture of, not being a service to which item 47381, 47384, 47385 or 47386 applies N 47378 01JUL1993 RADIUS OR ULNA, shaft of, treatment of fracture of, by cast immobilisation, not being a service to which item 47381, 47384, 47385 or 47386 applies Y 47381 01DEC1991 RADIUS OR ULNA, shaft of, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital Y 47384 01DEC1991 RADIUS OR ULNA, shaft of, treatment of fracture of, by open reduction Y 47385 01DEC1991 RADIUS OR ULNA, shaft of, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by closed reduction undertaken in the operating theatre of a hospital Y 47386 01DEC1991 RADIUS OR ULNA, shaft of, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by open reduction or internal fixation Y 47387 01DEC1991 RADIUS AND ULNA, shafts of, treatment of fracture of, not being a service to which item 47390 or 47393 applies N 47387 01JUL1993 RADIUS AND ULNA, shafts of, treatment of fracture of, by cast immobilisation, not being a service to which item 47390 or 47393 applies Y 47390 01DEC1991 RADIUS AND ULNA, shafts of, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital Y 47393 01DEC1991 RADIUS AND ULNA, shafts of, treatment of fracture of, by open reduction Y 47396 01DEC1991 OLECRANON, treatmentof fracture of, not being a service to which item 47399 applies Y 47399 01DEC1991 OLECRANON, treatment of fracture of, by open reduction Y 47402 01DEC1991 OLECRANON, treatment of fracture of, involving excision of olecranon fragment and reimplantation of tendon Y 47405 01DEC1991 RADIUS, treatment of fracture of head or neck of, closed management of N 47405 01NOV2006 RADIUS, treatment of fracture of head or neck of, closed reduction of Y 47408 01DEC1991 RADIUS, treatment of fracture of head or neck of, open management of, including internal fixation and excision where performed N 47408 01NOV2006 RADIUS, treatment of fracture of head or neck of, open reduction of, including internal fixation and excision where performed Y 47411 01DEC1991 HUMERUS, treatment of fracture of tuberosity of, not being a service to which item 47417 applies Y 47414 01DEC1991 HUMERUS, treatment of fracture of tuberosity of, by open reduction Y 47417 01DEC1991 HUMERUS, treatment of fracture of tuberosity of, and associated dislocation of shoulder, by closed reduction Y 47420 01DEC1991 HUMERUS, treatment of fracture of tuberosity of, and associated dislocation of shoulder, by open reduction Y 47423 01DEC1991 HUMERUS, proximal, treatment of fracture of, not being a service to which item 47426, 47429 or 47432 applies Y 47426 01DEC1991 HUMERUS, proximal, treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital Y 47429 01DEC1991 HUMERUS, proximal, treatment of fracture of, by open reduction Y 47432 01DEC1991 HUMERUS, proximal, treatment of intra-articular fracture of, by open reduction Y 47435 01DEC1991 HUMERUS, proximal, treatment of fracture of, and associated dislocation of shoulder, by closed reduction Y 47438 01DEC1991 HUMERUS, proximal, treatment of fracture of, and associated dislocation of shoulder, by open reduction Y 47441 01DEC1991 HUMERUS, proximal, treatment of intra-articular fracture of, and associated dislocation of shoulder, by open reduction Y 47444 01DEC1991 HUMERUS, shaft of, treatment of fracture of, not being a service to which item 47447 or 47450 applies Y 47447 01DEC1991 HUMERUS, shaft of, treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital Y 47450 01DEC1991 HUMERUS, shaft of, treatment of fracture of, by open reduction N 47450 01NOV1996 HUMERUS, shaft of, treatment of fracture of, by internal or external fixation Y 47451 01NOV1996 HUMERUS, shaft of, treatment of fracture of, by intramedullary fixation Y 47453 01DEC1991 HUMERUS, distal, (supracondylar or condylar), treatment of fracture of, not being a service to which item 47456 or 47459 applies Y 47456 01DEC1991 HUMERUS, distal (supracondylar or condylar), treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital Y 47459 01DEC1991 HUMERUS, distal (supracondylar or condylar), treatment of fracture of, by open reduction, undertaken in the operating theatre of a hospital Y 47462 01DEC1991 CLAVICLE, treatment of fracture of, not being a service to which item 47465 applies Y 47465 01DEC1991 CLAVICLE, treatment of fracture of, by open reduction Y 47466 01DEC1991 STERNUM, treatment of fracture of, not being a service to which item 47467 applies Y 47467 01DEC1991 STERNUM, treatment of fracture of, by open reduction Y 47468 01DEC1991 SCAPULA, neck or glenoid region of, treatment of fracture of, by open reduction Y 47471 01DEC1991 RIBS (1 or more), treatment of fracture of - each attendance Y 47474 01DEC1991 PELVIC RING, treatment of fracture of, not involving disrupting pelvic ring or acetabulum N 47474 01NOV1994 PELVIC RING, treatment of fracture of, not involving disruption of pelvic ring or acetabulum Y 47477 01DEC1991 PELVIC RING, treatment of fracture of, with disrupting pelvic ring or acetabulum N 47477 01NOV1994 PELVIC RING, treatment of fracture of, with disruption of pelvic ring or acetabulum Y 47480 01DEC1991 PELVIC RING, treatment of fracture of, requiring traction Y 47483 01DEC1991 PELVIC RING, treatment of fracture of, requiring control by external fixation Y 47486 01DEC1991 PELVIC RING, treatment of fracture of, by open reduction and involving internal fixation of anterior segment, including diastasis of pubic symphysis Y 47489 01DEC1991 PELVIC RING, treatment of fracture of, by open reduction and involving internal fixation of posterior segment (including sacro-iliac joint), with or without fixation of anterior segment Y 47492 01DEC1991 ACETABULUM, treatment of fracture of, and associated dislocation of hip Y 47495 01DEC1991 ACETABULUM, treatment of fracture of, and associated dislocation of hip, requiring traction Y 47498 01DEC1991 ACETABULUM, treatment of fracture of, and associated dislocation of hip, requiring internal fixation, with or without traction Y 47501 01DEC1991 ACETABULUM, treatment of single column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair N 47501 01MAY2009 ACETABULUM, treatment of single column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply Y 47504 01DEC1991 ACETABULUM, treatment of T-shape fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair N 47504 01MAY2009 ACETABULUM, treatment of T-shape fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply Y 47507 01DEC1991 ACETABULUM, treatment of transverse fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair N 47507 01MAY2009 ACETABULUM, treatment of transverse fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply Y 47510 01DEC1991 ACETABULUM, treatment of double column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair N 47510 01MAY2009 ACETABULUM, treatment of double column fracture of, by open reduction and internal fixation, including any osteotomy, osteectomy or capsulotomy required for exposure and subsequent repair, and excluding services to which item 47933 or 47936 apply Y 47513 01DEC1991 SACRO-ILIAC JOINT DISRUPTION, treatment of, requiring internal fixation, being a service associated with a service to which items 47501 to 47510 apply Y 47516 01DEC1991 FEMUR, treatment of fracture of, by closed reduction or traction Y 47519 01DEC1991 FEMUR, treatment of trochanteric or subcapital fracture of, by internal fixation Y 47522 01DEC1991 FEMUR, treatment of subcapital fracture of, by hemi-arthroplasty Y 47525 01DEC1991 FEMUR, treatment of fracture of, for slipped capital femoral epiphysis Y 47528 01DEC1991 FEMUR, treatment of fracture of, by internal fixation or external fixation Y 47531 01DEC1991 FEMUR, treatment of fracture of shaft, by internal fixation and cross fixation N 47531 01MAY1994 FEMUR, treatment of fracture of shaft, by intramedullary fixation and cross fixation Y 47534 01DEC1991 FEMUR, condylar region of, treatment of intra-articular (T-shaped condylar) fracture of, requiring internal fixation, with or without internal fixation of 1 or more osteochondral fragments Y 47537 01DEC1991 FEMUR, condylar region of, treatment of fracture of, requiring internal fixation of 1 or more osteochondral fragments, not being a service associated with a service to which item 47534 applies Y 47540 01DEC1991 HIP SPICA, application of, as an independent procedure N 47540 01JUL1993 HIP SPICA OR SHOULDER SPICA, application of, as an independent procedure Y 47543 01DEC1991 TIBIA, plateau of, treatment of medial or lateral fracture of, not being a service to which item 47546 or 47549 applies Y 47546 01DEC1991 TIBIA, plateau of, treatment of medial or lateral fracture of, by closed reduction Y 47549 01DEC1991 TIBIA, plateau of, treatment of medial or lateral fracture of, by open reduction Y 47552 01DEC1991 TIBIA, plateau of, treatment of both medial and lateral fractures of, not being a service to which item 47555 or 47558 applies Y 47555 01DEC1991 TIBIA, plateau of, treatment of both medial and lateral fractures of, by closed reduction Y 47558 01DEC1991 TIBIA, plateau of, treatment of both medial and lateral fractures of, by open reduction Y 47561 01DEC1991 TIBIA, shaft of, treatment of fracture of, not being a service to which item 47564, 47567, 47570 or 47573 applies, with or without treatment of fibular fracture N 47561 01JUL1993 TIBIA, shaft of, treatment of fracture of, by cast immobilisation, not being a service to which item 47564, 47567, 47570 or 47573 applies Y 47564 01DEC1991 TIBIA, shaft of, treatment of fracture of, by closed reduction, with or without treatment of fibular fracture Y 47565 01MAY1994 TIBIA, shaft of, treatment of fracture of, by internal fixation or external fixation Y 47566 01MAY1994 TIBIA, shaft of, treatment of fracture of, by intramedullary fixation and cross fixation Y 47567 01DEC1991 TIBIA, shaft of, treatment of intra-articular fracture of, by closed reduction, with or without treatment of fibular fracture Y 47570 01DEC1991 TIBIA, shaft of, treatment of fracture of, by open reduction, with or without treatment of fibular fracture Y 47573 01DEC1991 TIBIA, shaft of, treatment of intra-articular fracture of, by open reduction, with or without treatment of fibula fracture Y 47576 01DEC1991 FIBULA, treatment of fracture of Y 47579 01DEC1991 PATELLA, treatment of fracture of, not being a service to which item 47582 or 47585 applies Y 47582 01DEC1991 PATELLA, treatment of fracture of, by excision of patella or pole with reattachment of tendon Y 47585 01DEC1991 PATELLA, treatment of fracture of, by internal fixation Y 47588 01DEC1991 KNEE JOINT, treatment of fracture of, by internal fixation of intra-articular fractures of femoral condylar or tibial articular surfaces and requiring repair or reconstruction of 1 or more ligaments Y 47591 01DEC1991 KNEE JOINT, treatment of fracture of, by internal fixation of intra-articular fractures of femoral condylar and tibial articular surfaces and requiring repair or reconstruction of 1 or more ligaments Y 47594 01DEC1991 ANKLE JOINT, treatment of fracture of, not being a service to which item 47597 applies Y 47597 01DEC1991 ANKLE JOINT, treatment of fracture of, by closed reduction Y 47600 01DEC1991 ANKLE JOINT, treatment of fracture of, by internal fixation of 1 of malleolus, fibula or diastasis Y 47603 01DEC1991 ANKLE JOINT, treatment of fracture of, by internal fixation of more than 1 of malleolus, fibula or diastasis Y 47606 01DEC1991 CALCANEUM OR TALUS, treatment of fracture of, not being a service to which item 47609, 47612, 47615 or 47618 applies, with or without dislocation Y 47609 01DEC1991 CALCANEUM OR TALUS, treatment of fracture of, by closed reduction, with or without dislocation Y 47612 01DEC1991 CALCANEUM OR TALUS, treatment of intra-articular fracture of, by closed reduction, with or without dislocation Y 47615 01DEC1991 CALCANEUM OR TALUS, treatment of fracture of, by open reduction, with or without dislocation Y 47618 01DEC1991 CALCANEUM OR TALUS, treatment of intra-articular fracture of, by open reduction, with or without dislocation Y 47621 01DEC1991 TARSO-METATARSAL, treatment of intra-articular fracture of, by closed reduction, with or without dislocation Y 47624 01DEC1991 TARSO-METATARSAL, treatment of fracture of, by open reduction, with or without dislocation Y 47627 01DEC1991 TARSUS (excluding calcaneum or talus), treatment of fracture of Y 47630 01DEC1991 TARSUS (excluding calcaneum or talus), treatment of fracture of, by open reduction, with or without dislocation Y 47633 01DEC1991 METATARSAL, 1 of, treatment of fracture of Y 47636 01DEC1991 METATARSAL, 1 of, treatment of fracture of, by closed reduction Y 47639 01DEC1991 METATARSAL, 1 of, treatment of fracture of, by open reduction Y 47642 01DEC1991 METATARSALS, 2 of, treatment of fracture of Y 47645 01DEC1991 METATARSALS, 2 of, treatment of fracture of, by closed reduction Y 47648 01DEC1991 METATARSALS, 2 of, treatment of fracture of, by open reduction Y 47651 01DEC1991 METATARSALS, 3 or more of, treatment of fracture of Y 47654 01DEC1991 METATARSALS, 3 or more of, treatment of fracture of, by closed reduction Y 47657 01DEC1991 METATARSALS, 3 or more of, treatment of fracture of, by open reduction Y 47660 01DEC1991 PHALANX OF GREAT TOE, treatment of fracture of Y 47663 01DEC1991 PHALANX OF GREAT TOE, treatment of fracture of, by closed reduction Y 47666 01DEC1991 PHALANX OF GREAT TOE, treatment of fracture of, by open reduction Y 47669 01DEC1991 PHALANX OF TOE (other than great toe), 1 of, treatment of fracture of Y 47672 01DEC1991 PHALANX OF TOE (other than great toe), 1 of, treatment of fracture of, by open reduction Y 47675 01DEC1991 PHALANX OF TOE (other than great toe), more than 1 of, treatment of fracture of Y 47678 01DEC1991 PHALANX OF TOE (other than great toe), more than 1 of, treatment of fracture of, by open reduction Y 47681 01DEC1991 SPINE (excluding sacrum), treatment of fracture of transverse process, vertebral body, or posterior elements - each attendance Y 47684 01DEC1991 SPINE, treatment of fracture, dislocation or fracture-dislocation, without spinal cord involvement, including immobilisation by calipers N 47684 01NOV2005 SPINE, treatment of fracture, dislocation or fracture-dislocation, without spinal cord involvement, with immobilisation by calipers N 47684 01MAY2006 SPINE, treatment of fracture, dislocation or fracture-dislocation, without spinal cord involvement, with immobilisation by calipers or halo Y 47687 01DEC1991 SPINE, treatment of fracture, dislocation or fracture-dislocation, with spinal cord involvement, including immobilisation by calipers, and including up to 14 days post-operative care N 47687 01NOV2005 SPINE, treatment of fracture, dislocation or fracture-dislocation, with spinal cord involvement, with immobilisation by calipers, and including up to 14 days post-operative care N 47687 01MAY2006 SPINE, treatment of fracture, dislocation or fracture-dislocation, with spinal cord involvement, with immobilisation by calipers or halo, and including up to 14 days post-operative care Y 47690 01DEC1991 SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, including immobilisation by calipers, requiring reduction by closed manipulation N 47690 01NOV2005 SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, with immobilisation by calipers, requiring reduction by closed manipulation N 47690 01MAY2006 SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, with immobilisation by calipers or halo, requiring reduction by closed manipulation Y 47693 01DEC1991 SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, including immobilisation by calipers, requiring reduction by closed manipulation, including up to 14 days post-operative care N 47693 01NOV2005 SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, with immobilisation by calipers, requiring reduction by closed manipulation, including up to 14 days post-operative care N 47693 01MAY2006 SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, with immobilisation by calipers or halo, requiring reduction by closed manipulation, including up to 14 days post-operative care Y 47696 01DEC1991 SPINE, reduction of fracture or dislocation of, without cord involvement, undertaken in the operating theatre of a hospital Y 47699 01DEC1991 SPINE, treatment of fracture, dislocation or fracture-dislocation, without cord involvement, requiring open reduction with or without internal fixation Y 47702 01DEC1991 SPINE, treatment of fracture, dislocation or fracture-dislocation, with cord involvement, requiring open reduction with or without internal fixation, including up to 14 days post-operative care Y 47703 01DEC1991 SKULL, treatment of fracture of, each attendance Y 47705 01DEC1991 SKULL CALIPERS, insertion of, as an independent procedure Y 47708 01DEC1991 PLASTER JACKET, application of, as an independent procedure Y 47711 01DEC1991 HALO, application of, as an independent procedure Y 47714 01DEC1991 HALO, application of, in addition to spinal fusion for scoliosis, or other conditions Y 47717 01DEC1991 HALO-THORACIC TRACTION - application of both halo and thoracic jacket Y 47720 01DEC1991 HALO-FEMORAL TRACTION, as an independent procedure Y 47723 01DEC1991 HALO-FEMORAL TRACTION, in conjunction with a major spine operation Y 47726 01DEC1991 BONE GRAFT, harvesting of, via separate incision, associated with any item in this Group - Autogenous - small quantity N 47726 01NOV1992 BONE GRAFT, harvesting of, via separate incision, in conjunction with another service - autogenous - small quantity Y 47729 01DEC1991 BONE GRAFT, harvesting of, via separate incision, associated with any item in this Group - Autogenous - large quantity N 47729 01NOV1992 BONE GRAFT, harvesting of, via separate incision, in conjunction with another service - autogenous - large quantity Y 47732 01DEC1991 VASCULARISED PEDICLE BONE GRAFT, harvesting of, associated with any item in this Group N 47732 01NOV1992 VASCULARISED PEDICLE BONE GRAFT, harvesting of, in conjunction with another service Y 47735 01DEC1991 NASAL BONES, treatment of fracture of, not being a service to which item 47738 or 47741 applies N 47735 01NOV1994 NASAL BONES, treatment of fracture of, not being a service to which item 47738 or 47741 applies - each attendance Y 47738 01DEC1991 NASAL BONES, treatment of fracture of, by open reduction N 47738 01APR1992 NASAL BONES, treatment of fracture of, by reduction Y 47741 01DEC1991 NASAL BONES, treatment of fracture of, by open reduction involving osteotomies Y 47744 01DEC1991 ZYGOMA, treatment of fracture of Y 47753 01APR1992 MAXILLA, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation Y 47756 01APR1992 MANDIBLE, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation Y 47762 01APR1992 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction by a temporal, intra-oral or other approach Y 47765 01APR1992 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at 1 site Y 47768 01APR1992 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 2 sites Y 47771 01APR1992 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 3 sites Y 47774 01APR1992 MAXILLA, treatment of fracture of, requiring open operation Y 47777 01APR1992 MANDIBLE, treatment of fracture of, requiring open reduction Y 47780 01APR1992 MAXILLA, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s) Y 47783 01APR1992 MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s) Y 47786 01APR1992 MAXILLA, treatment of fracture of, requiring open reduction and internal fixation involving plate(s) Y 47789 01APR1992 MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation involving plate(s) Y 47804 01APR1992 Historical item included for item mapping purposes Y 47900 01DEC1991 BONE CYST, injection into or aspiration of Y 47903 01DEC1991 EPICONDYLITIS, open operation for Y 47904 01DEC1991 DIGITAL NAIL, removal of, not being a service to which item 47906 applies N 47904 01NOV1994 DIGITAL NAIL OF TOE, removal of, not being a service to which item 47906 applies Y 47906 01DEC1991 DIGITAL NAIL, removal of, in the operating theatre of a hospital or approved day hospital facility N 47906 01NOV1994 DIGITAL NAIL OF TOE, removal of, in the operating theatre of a hospital Y 47909 01DEC1991 MIDDLE PALMAR, THENAR OR HYPOTHENAR SPACES, drainage of (excluding aftercare) Y 47912 01DEC1991 PULP SPACE INFECTION, PARONYCHIA of HANDS or FEET, incision for, not being a service to which another item in this Group applies (excluding aftercare) N 47912 01NOV1994 PULP SPACE INFECTION, PARONYCHIA of FOOT, incision for, not being a service to which another item in this Group applies (excluding aftercare) Y 47915 01DEC1991 INGROWING TOENAIL, wedge resection for, not being a service associated with a service to which item 47918 applies N 47915 01JUL1993 INGROWING nail of finger or toe, wedge resection for, including removal of segment of nail, ungual fold and portion of the nail bed N 47915 01NOV1994 INGROWING NAIL OF TOE, wedge resection for, including removal of segment of nail, ungual fold and portion of the nail bed N 47915 01JUL2011 INGROWING NAIL OF TOE, wedge resection for, with removal of segment of nail, ungual fold and portion of the nail bed Y 47916 01JUL1993 INGROWING nail of finger or toe, partial resection of nail, including phenolisation but not including excision of nail bed N 47916 01NOV1994 INGROWING NAIL OF TOE, partial resection of nail, including phenolisation but not including excision of nail bed N 47916 01JUL2011 INGROWING NAIL OF TOE, partial resection of nail, with destruction of nail matrix by phenolisation, electrocautery, laser, sodium hydroxide or acid but not including excision of nail bed Y 47918 01DEC1991 INGROWING TOENAIL, radical excision of nailbed Y 47920 01MAY1997 BONE GROWTH STIMULATOR, insertion of Y 47921 01DEC1991 ORTHOPAEDIC PIN OR WIRE, insertion of, as an independent procedure Y 47924 01DEC1991 BURIED WIRE, PIN OR SCREW, 1 or more of, which were inserted for internal fixation purposes, removal of requiring incision and suture, not being a service to which item 47927 or 47930 applies - per bone Y 47927 01DEC1991 BURIED WIRE, PIN OR SCREW, 1 or more of, which were inserted for internal fixation purposes, removal of, in the operating theatre of a hospital- per bone Y 47930 01DEC1991 PLATE, ROD OR NAIL AND ASSOCIATED WIRES, PINS OR SCREWS, 1 or more of, all of which were inserted for internal fixation purposes, removal of, not being a service associated with a service to which item 47924 or 47927 applies - per bone Y 47933 01DEC1991 EXOSTOSIS OF SMALL BONE, excision of, including simple removal of bunion and any associated bursa N 47933 01MAY2009 SMALL EXOSTOSIS (NOT MORE THAN 20MM OF GROWTH ABOVE BONE), excision of, or simple removal of bunion and any associated bursa, not being a service associated with a service for removal of bursa Y 47936 01DEC1991 EXOSTOSIS OF LARGE BONE, excision of N 47936 01MAY2009 LARGE EXOSTOSIS (GREATER THAN 20MM GROWTH ABOVE BONE), excision of Y 47939 01DEC1991 LIMB LENGTHENING (single or first stage) osteotomy for, including application of distracting apparatus N 47939 01JUL1993 LIMB LENGTHENING (first stage), osteotomy for, including application of distracting apparatus Y 47942 01DEC1991 LIMB LENGTHENING (second stage) internal fixation with bone grafting, including removal of distracting apparatus Y 47943 01JUL1993 LIMB LENGTHENING requiring slow distraction and application of ring fixator, not being a service to which item 47939 applies Y 47945 01DEC1991 DISTRACTING APPARATUS, removal of, without internal fixation Y 47948 01DEC1991 EXTERNAL FIXATION, removal of, in the operating theatre of a hospital Y 47951 01DEC1991 EXTERNAL FIXATION, removal of, in conjunction with operations involving internal fixation or bone grafting or both Y 47954 01DEC1991 TENDON, large rupture, repair of, not being a service to which another item in this Group applies N 47954 01NOV1996 TENDON, repair of, not being a service to which another item in this Group applies N 47954 01MAY2009 TENDON, repair of, as an independent procedure Y 47957 01DEC1991 TENDON, large, lengthening of, not being a service to which another item in this Group applies N 47957 01MAY2009 TENDON, large, lengthening of, as an independent procedure Y 47960 01DEC1991 TENOTOMY, SUBCUTANEOUS, not being a service to which another item in this Group applies Y 47963 01DEC1991 TENOTOMY, OPEN, with or without tenoplasty, not being a service to which another item in this Group applies Y 47966 01DEC1991 TENDON OR LIGAMENT, TRANSFER, not being a service to which another item in this Group applies N 47966 01MAY2009 TENDON OR LIGAMENT, TRANSFER, as an independent procedure Y 47969 01DEC1991 TENOSYNOVECTOMY, not being a service to which another item in this Group applies Y 47972 01DEC1991 TENDON SHEATH, open operation for teno-vaginitis, not being a service to which another item in this Group applies Y 47975 01JUL1993 FOREARM OR CALF, decompression fasciotomy of, for acute compartment syndrome, requiring excision of muscle and deep tissue Y 47978 01JUL1993 FOREARM OR CALF, decompression fasciotomy of, for chronic compartment syndrome, requiring excision of muscle and deep tissue Y 47981 01JUL1993 FOREARM, CALF OR INTEROSSEOUS MUSCLE SPACE OF HAND, decompression fasciotomy of, not being a service to which another item applies Y 47982 01MAY1997 FORAGE (Drill decompression), of NECK OR HEAD of FEMUR, or BOTH Y 48200 01DEC1991 FEMUR, bone graft to Y 48203 01DEC1991 FEMUR, bone graft to, with internal fixation Y 48206 01DEC1991 TIBIA, bone graft to Y 48209 01DEC1991 TIBIA, bone graft to, with internal fixation Y 48212 01DEC1991 HUMERUS, bone graft to Y 48215 01DEC1991 HUMERUS, bone graft to, with internal fixation Y 48218 01DEC1991 RADIUS AND ULNA, bone graft to Y 48221 01DEC1991 RADIUS AND ULNA, bone graft to, with internal fixation of 1 or both bones Y 48224 01DEC1991 RADIUS OR ULNA, bone graft to Y 48227 01DEC1991 RADIUS OR ULNA, bone graft to, with internal fixation of 1 or both bones Y 48230 01DEC1991 SCAPHOID, bone graft to, for non-union Y 48233 01DEC1991 SCAPHOID, bone graft to, for non-union, with internal fixation Y 48236 01DEC1991 SCAPHOID, bone graft to, for mal-union, including osteotomy, bone graft and internal fixation Y 48239 01DEC1991 BONE GRAFT, not being a service to which another item in this Group applies Y 48242 01DEC1991 BONE GRAFT, with internal fixation, not being a service to which another item in this Group applies Y 48400 01DEC1991 PHALANX, METATARSAL, ACCESSORY BONE OR SESAMOID BONE, osteotomy or osteectomy of, excluding services to which item 49848 or 49851 applies N 48400 01MAY2009 PHALANX, METATARSAL, ACCESSORY BONE OR SESAMOID BONE, osteotomy or osteectomy of, excluding services to which item 49848 or 49851 applies, any of items 49848, 49851, 47933 or 47936 apply Y 48403 01DEC1991 PHALANX OR METATARSAL, osteotomy or osteectomy of, with internal fixation N 48403 01MAY2009 PHALANX OR METATARSAL, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply Y 48406 01DEC1991 FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of N 48406 01MAY2009 FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply Y 48409 01DEC1991 FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than Acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of, with internal fixation N 48409 01MAY2009 FIBULA, RADIUS, ULNA, CLAVICLE, SCAPULA (other than Acromion), RIB, TARSUS OR CARPUS, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply Y 48412 01DEC1991 HUMERUS, osteotomy or osteectomy of N 48412 01MAY2009 HUMERUS, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply Y 48415 01DEC1991 HUMERUS, osteotomy or osteectomy of, with internal fixation N 48415 01MAY2009 HUMERUS, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply Y 48418 01DEC1991 TIBIA, osteotomy or osteectomy of N 48418 01MAY2009 TIBIA, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply Y 48421 01DEC1991 TIBIA, osteotomy or osteectomy of, with internal fixation N 48421 01MAY2009 TIBIA, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply Y 48424 01DEC1991 FEMUR OR PELVIS, osteotomy or osteectomy of N 48424 01MAY2009 FEMUR OR PELVIS, osteotomy or osteectomy of, excluding services to which items 47933 or 47936 apply N 48424 01NOV2016 Femur or pelvis, osteotomy or osteectomy of, other than a service associated with surgery for femoroacetabular impingement, or to which item 47933 or 47936 applies (H) Y 48427 01DEC1991 FEMUR OR PELVIS, osteotomy or osteectomy of, with internal fixation N 48427 01MAY2009 FEMUR OR PELVIS, osteotomy or osteectomy of, with internal fixation, and excluding services to which items 47933 or 47936 apply Y 48500 01DEC1991 FEMUR, epiphysiodesis of Y 48503 01DEC1991 TIBIA AND FIBULA, epiphysiodesis of Y 48506 01DEC1991 FEMUR, TIBIA AND FIBULA, epiphysiodesis of Y 48509 01DEC1991 EPIPHYSIODESIS, staple arrest of hemiepiphysis Y 48512 01DEC1991 EPIPHYSIODESIS, operation to prevent closure of plate N 48512 01NOV1992 EPIPHYSIOLYSIS, operation to prevent closure of plate Y 48600 01DEC1991 SPINE, MANIPULATION OF, performed in the operating theatre of a hospital Y 48603 01DEC1991 SPINE, manipulation of, under epidural anaesthesia, with or without steroid injection, where the manipulation and the administration of the epidural anaesthetic are performed by the same medical practitioner in the operating theatre of a hospital, not being a service associated with a service to which item 48600 or 50115 applies Y 48606 01DEC1991 SCOLIOSIS or KYPHOSIS, spinal fusion for (without instrumentation) Y 48609 01DEC1991 SCOLIOSIS or KYPHOSIS, spinal fusion for, using Harrington or other nonsegmental fixation Y 48612 01DEC1991 SCOLIOSIS, spinal fusion for, using segmental instrumentation (C D, Zielke, Luque, or similar) Y 48613 01JUL1998 SCOLIOSIS OR KYPHOSIS, spinal fusion for, using segmental instrumentation, reconstruction utilising separate anterior and posterior approaches Y 48615 01DEC1991 SCOLIOSIS, re-exploration for, involving adjustment or removal of instrumentation or simple bone grafting procedure Y 48618 01DEC1991 SCOLIOSIS, revision of failed scoliosis surgery, involving more than 1 of multiple osteotomy, fusion or instrumentation Y 48621 01DEC1991 SCOLIOSIS, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke, or similar) - not more than 4 levels Y 48624 01DEC1991 SCOLIOSIS, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - more than 4 levels Y 48627 01DEC1991 SCOLIOSIS, spinal fusion for, combined with segmental instrumentation (C D, Zielke or similar) down to and including pelvis Y 48630 01DEC1991 SCOLIOSIS, requiring anterior decompression of spinal cord with resection of vertebrae including bone graft and instrumentation in the presence of spinal cord involvement Y 48632 01JUL1993 SCOLIOSIS, congenital, vertebral resection and fusion for Y 48636 01DEC1991 PERCUTANEOUS LUMBAR DISCECTOMY, 1 or more levels N 48636 01MAY2003 PERCUTANEOUS LUMBAR DISCECTOMY, 1 or more levels not being a service associated with intradiscal electrothermal annuloplasty N 48636 01NOV2006 PERCUTANEOUS LUMBAR PARTIAL OR TOTAL DISCECTOMY, 1 or more levels, not being a service associated with intradiscal electrothermal annuloplasty Y 48639 01DEC1991 VERTEBRAL BODY, total or subtotal excision of, including bone grafting or other form of fixation Y 48640 01JUL1998 VERTEBRAL BODY, disease of, excision and spinal fusion for, using segmental instrumentation, reconstruction utilising separate anterior and posterior approaches Y 48642 01DEC1991 SPINE, posterior, bone graft to, not being a service to which item 48648 or 48651 applies - 1 or 2 levels Y 48645 01DEC1991 SPINE, posterior, bone graft to, not being a service to which item 48648 or 48651 applies - more than 2 levels Y 48648 01DEC1991 SPINE, bone graft to, (postero-lateral fusion) - 1 or 2 levels Y 48651 01DEC1991 SPINE, bone graft to, (postero-lateral fusion) - more than 2 levels Y 48654 01DEC1991 SPINAL FUSION (posterior interbody), with laminectomy, 1 level N 48654 01NOV2006 SPINAL FUSION (posterior interbody), with partial or total laminectomy, 1 level Y 48657 01DEC1991 SPINAL FUSION (posterior interbody), with laminectomy, more than 1 level N 48657 01NOV2006 SPINAL FUSION (posterior interbody), with partial or total laminectomy, more than 1 level Y 48660 01DEC1991 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level N 48660 01NOV2006 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level, not being a service associated with artificial intervertebral total disc replacement N 48660 01JAN2014 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level Y 48663 01DEC1991 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level (where an assisting surgeon performs the approach) - principal surgeon N 48663 01JAN2014 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level - principal surgeon Y 48666 01DEC1991 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level (where an assisting surgeon performs the approach) - assisting surgeon N 48666 01JAN2014 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - 1 level - assisting surgeon Y 48669 01DEC1991 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level N 48669 01NOV2006 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level, not being a service associated with artificial intervertebral total disc replacement N 48669 01JAN2014 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level Y 48672 01DEC1991 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level (where an assisting surgeon performs the approach) - principal surgeon N 48672 01JAN2014 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level - principal surgeon Y 48675 01DEC1991 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level (where an assisting surgeon performs the approach) - assisting surgeon N 48675 01JAN2014 SPINAL FUSION (anterior interbody) to cervical, thoracic or lumbar regions - more than 1 level - assisting surgeon Y 48678 01DEC1991 SPINE, simple internal fixation of, involving 1 or more of facetal screw, wire loop or similar, being a service associated with a service to which items 48642 to 48675 apply Y 48681 01DEC1991 SPINE, non-segmental internal fixation of (Harrington or similar), other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies Y 48684 01DEC1991 SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies - 1 or 2 levels N 48684 01NOV2006 SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies - 1 or 2 levels,not being a service associated with artificial intervertebral total disc replacement N 48684 01JAN2014 SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which any one of items 48642 to 48675 applies - 1 or 2 levels Y 48687 01DEC1991 SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which items 48642 to 48675 apply - 3 or 4 levels Y 48690 01DEC1991 SPINE, segmental internal fixation of, other than for scoliosis, being a service associated with a service to which items 48642 to 48675 apply - more than 4 levels Y 48691 01NOV2006 LUMBAR ARTIFICIAL INTERVERTEBRALTOTAL DISC REPLACEMENT including removal of disc, 1 level, in patients with single-level intralumbar disc disease in the absence of vertebral osteoporosis and prior spinal fusion at the same lumbar level who have failed conservative therapy, with fluoroscopy N 48691 01JAN2014 Lumbar artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal fusion surgery at the same lumbar level; and (b) does not have vertebral osteoporosis; and (c) has failed conservative therapy; other than a service associated with item 40300 or 40301 Y 48692 01NOV2006 LUMBAR ARTIFICIAL INTERVERTEBRALTOTAL DISC REPLACEMENT including removal of disc, 1 level, in patients with single-level intralumbar disc disease in the absence of vertebral osteoporosis and prior spinal fusion at the same lumbar level who have failed conservative therapy, with fluoroscopy (where an assisting surgeon performs the approach) - principal surgeon N 48692 01JAN2014 Lumbar artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal fusion surgery at the same lumbar level; and (b) does not have vertebral osteoporosis; and (c) has failed conservative therapy; other than a service associated with item 40300 or 40301-principal surgeon Y 48693 01NOV2006 LUMBAR ARTIFICIAL INTERVERTEBRALTOTAL DISC REPLACEMENT including removal of disc, 1 level, in patients with single-level intralumbar disc disease in the absence of vertebral osteoporosis and prior spinal fusion at the same lumbar level who have failed conservative therapy, (where an assisting surgeon performs the approach) - assisting surgeon N 48693 01JAN2014 Lumbar artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal fusion surgery at the same lumbar level; and (b) does not have vertebral osteoporosis; and (c) has failed conservative therapy; other than a service associated with item 40300 or 40301-assisting surgeon Y 48694 01NOV2012 Cervical artificial intervertebral total disc replacement, at one level only, including removal of disc, for a patient who: (a) has not had prior spinal surgery at the same cervical level; and (b) is skeletally mature; and (c) has symptomatic degenerative disc disease with radiculopathy; and (d) does not have vertebral osteoporosis; and (e) has failed conservative therapy; other than a service associated with item 40300 or 40301 Y 48900 01DEC1991 SHOULDER, excision of coraco-acromial ligament or removal of calcium deposit from cuff or both Y 48903 01DEC1991 SHOULDER, decompression of subacromial space by acromionectomy, excision of coraco-acromial ligament and distal clavicle, or any combination N 48903 01NOV1996 SHOULDER, decompression of subacromial space by acromioplasty, excision of coraco-acromial ligament and distal clavicle, or any combination Y 48906 01DEC1991 SHOULDER, repair of rotator cuff, including excision of coraco-acromial ligament or removal of calcium deposit from cuff, or both - not being a service associated with a service to which item 48900 applies Y 48909 01DEC1991 SHOULDER, repairof rotator cuff, including decompression of subacromial space by acromionectomy, excision of coraco-acromial ligament and distal clavicle, or any combination, not being a service associated with a service to which item 48903 applies N 48909 01NOV1996 SHOULDER, repairof rotator cuff, including decompression of subacromial space by acromioplasty, excision of coraco-acromial ligament and distal clavicle, or any combination, not being a service associated with a service to which item 48903 applies Y 48912 01DEC1991 SHOULDER, arthrotomy of Y 48915 01DEC1991 SHOULDER, hemi-arthroplasty of Y 48918 01DEC1991 SHOULDER, total replacement arthroplasty of, including any associated rotator cuff repair Y 48921 01DEC1991 SHOULDER, total replacement arthroplasty, revision of Y 48924 01DEC1991 SHOULDER, total replacement arthroplasty, revision of, requiring bone graft to scapula or humerus, or both Y 48927 01DEC1991 SHOULDER prosthesis, removal of Y 48930 01DEC1991 SHOULDER, anterior stabilisation procedure for recurrent dislocation N 48930 01NOV1996 SHOULDER, stabilisation procedure for recurrent anterior or posterior dislocation Y 48933 01DEC1991 SHOULDER, stabilisation procedure for multi-directional instability N 48933 01NOV1996 SHOULDER, stabilisation procedure for multi-directional instability, including anterior or posterior (or both) repair when performed Y 48936 01DEC1991 SHOULDER, synovectomy of, as an independent procedure Y 48939 01DEC1991 SHOULDER, arthrodesis of N 48939 01MAY2009 SHOULDER, arthrodesis of, with synovectomy if performed Y 48942 01DEC1991 SHOULDER, arthrodesis of, including removal of prosthesis, requiring bone grafting or internal fixation N 48942 01MAY2009 SHOULDER, arthrodesis of, with synovectomy if performed, with removal of prosthesis, requiring bone grafting or internal fixation Y 48945 01DEC1991 SHOULDER, diagnostic arthroscopy of (including biopsy) - not being a service associated with any other arthroscopic procedure of the shoulder region Y 48948 01DEC1991 SHOULDER, arthroscopic surgery of, involving any 1 or more of: removal of loose bodies; debridement of labrum, synovium or rotator cuff; or chondroplasty - not being a service associated with any other arthroscopic procedure of the shoulder region N 48948 01NOV1996 SHOULDER, arthroscopic surgery of, involving any 1 or more of: removal of loose bodies; decompression of calcium deposit; debridement of labrum, synovium or rotator cuff; or chondroplasty - not being a service associated with any other arthroscopic procedure of the shoulder region Y 48951 01DEC1991 SHOULDER, arthroscopic division of coraco-acromial ligament including acromioplasty - not being a service associated with any other arthroscopic procedure of the shoulder region Y 48954 01DEC1991 SHOULDER, arthroscopic total synovectomy of - not being a service associated with any other arthroscopic procedure of the shoulder region N 48954 01NOV1996 SHOULDER, arthroscopic total synovectomy of, including release of contracture when performed - not being a service associated with any other arthroscopic procedure of the shoulder region Y 48957 01DEC1991 SHOULDER, arthroscopic stabilisation of, for recurrent instability - not being a service associated with any other arthroscopic procedure of the shoulder region N 48957 01NOV1996 SHOULDER, arthroscopic stabilisation of, for recurrent instability including labral repair or reattachment when performed - not being a service associated with any other arthroscopic procedure of the shoulder region Y 48960 01DEC1991 SHOULDER, arthroscopic reconstruction of, including repair of rotator cuff - not being a service associated with any other arthroscopic procedure of the shoulder region N 48960 01NOV1996 SHOULDER, reconstruction or repair of, including repair of rotator cuff by arthroscopic, arthroscopic assisted or mini open means; arthroscopic acromioplasty; or resection of acromioclavicular joint by separate approach when performed - not being a service associated with any other procedure of the shoulder region Y 49100 01DEC1991 ELBOW, arthrotomy of, involving 1 or more of lavage, removal of loose body or division of contracture Y 49103 01DEC1991 ELBOW, ligamentous stabilisation of Y 49106 01DEC1991 ELBOW, arthrodesis of N 49106 01MAY2009 ELBOW, arthrodesis of, with synovectomy if performed Y 49109 01DEC1991 ELBOW, total synovectomy of Y 49112 01DEC1991 ELBOW, silastic or other replacement of radial head Y 49115 01DEC1991 ELBOW, total joint replacement of Y 49116 01NOV2006 ELBOW, total replacement arthroplasty of, revision procedure, including removal of prosthesis Y 49117 01NOV2006 ELBOW, total replacement arthroplasty of, revision procedure, requiring bone grafting, including removal of prosthesis Y 49118 01DEC1991 ELBOW, diagnostic arthroscopy of, including biopsy N 49118 01MAY2009 ELBOW, diagnostic arthroscopy of, including biopsy and lavage, not being a service associated with any other arthroscopic procedure of the elbow Y 49121 01DEC1991 ELBOW, arthroscopic surgery involving any 1 or more of drilling of defect, removal of loose body or chondroplasty - not being a service associated with any other arthroscopic procedure of the elbow joint N 49121 01NOV1996 ELBOW, arthroscopic surgery involving any 1 or more of: drilling of defect, removal of loose body; release of contracture or adhesions; chondroplasty; or osteoplasty - not being a service associated with any other arthroscopic procedure of the elbow Y 49200 01DEC1991 WRIST, arthrodesis of, including bone graft, with or without internal fixation of the radiocarpal joint N 49200 01MAY2009 WRIST, arthrodesis of, with synovectomy if performed, with or without bone graft and internal fixation of the radiocarpal joint Y 49203 01DEC1991 WRIST, limited arthrodesis of the intercarpal joint, including bone graft N 49203 01MAY2009 WRIST, limited arthrodesis of the intercarpal joint, with synovectomy if performed, with or without bone graft Y 49206 01DEC1991 WRIST, excision arthroplasty of, with radial styloidectomy and proximal carpectomy N 49206 01NOV1996 WRIST, proximal carpectomy of, including styloidectomy when performed Y 49209 01DEC1991 WRIST, total replacement arthroplasty of Y 49210 01NOV2006 WRIST, total replacement arthroplasty of, revision procedure, including removal of prosthesis Y 49211 01NOV2006 WRIST, total replacement arthroplasty of, revision procedure, requiring bone grafting, including removal of prosthesis Y 49212 01DEC1991 WRIST, arthrotomy of Y 49215 01DEC1991 WRIST, reconstruction of, including repair of single or multiple ligaments or capsules, including associated arthrotomy Y 49218 01DEC1991 WRIST, diagnostic arthroscopy of, including radiocarpal or midcarpal joints, or both (including biopsy) - not being a service associated with any other arthroscopic procedure of the wrist joint Y 49221 01DEC1991 WRIST, arthroscopic surgery of, involving any 1 or more of drilling of defect, removal of loose body, local synovectomy or debridement - not being a service associated with any other arthroscopic procedure of the wrist joint N 49221 01NOV1996 WRIST, arthroscopic surgery of, involving any 1 or more of: drilling of defect; removal of loose body; release of adhesions; local synovectomy; or debridement of one area - not being a service associated with any other arthroscopic procedure of the wrist joint Y 49224 01DEC1991 WRIST, arthroscopic debridement of or total synovectomy of - not being a service associated with any other arthroscopic procedure of the wrist joint N 49224 01NOV1996 WRIST, arthroscopic debridement of 2 or more distinct areas; or osteoplasty including excision of the distal ulna; or total synovectomy N 49224 01MAY2009 WRIST, arthroscopic debridement of 2 or more distinct areas; or osteoplasty including excision of the distal ulna; or total synovectomy, not being a service associated with any other arthroscopic procedure of the wrist Y 49227 01DEC1991 WRIST, arthroscopic pinning of osteochondral fragment - not being a service associated with any other arthroscopic procedure of the wrist joint N 49227 01NOV1996 WRIST, arthroscopic pinning of osteochondral fragment or stabilisation procedure for ligamentous disruption - not being a service associated with any other arthroscopic procedure of the wrist joint Y 49300 01DEC1991 SACROILIAC JOINTarthrodesis of Y 49303 01DEC1991 HIP, arthrotomy of, including lavage, drainage or biopsy when performed N 49303 01NOV2016 Hip, arthrotomy of, including lavage, drainage or biopsy when performed, other than a service associated with surgery for femoroacetabular impingement (H) Y 49306 01DEC1991 HIParthrodesis of N 49306 01MAY2009 HIParthrodesis of, with synovectomy if performed Y 49309 01DEC1991 HIP, arthrectomy or excision arthroplasty of, including removal of prosthesis (Austin Moore or similar (non cement )) Y 49312 01DEC1991 HIP, arthrectomy or excision arthroplasty of, including removal of prosthesis (cemented, porous coated or similar) Y 49315 01DEC1991 HIP, arthroplasty of, unipolar or bipolar Y 49318 01DEC1991 HIP, total replacement arthroplasty of, including minor bone grafting Y 49319 01NOV1996 HIP, total replacement arthroplasty of, including associated minor grafting, if performed - bilateral Y 49321 01DEC1991 HIP, total replacement arthroplasty of, including major bone grafting, including obtaining of graft Y 49324 01DEC1991 HIP, total replacement arthroplasty of, revision procedure including removal of prosthesis Y 49327 01DEC1991 HIP, total replacement arthroplasty of, revision procedure requiring bone grafting to acetabulum, including obtaining of graft Y 49330 01DEC1991 HIP, total replacement arthroplasty of, revision procedure requiring bone grafting to femur, including obtaining of graft Y 49333 01DEC1991 HIP, total replacement arthroplasty of, revision procedure requiring bone grafting to both acetabulum and femur, including obtaining of graft Y 49336 01DEC1991 HIP, treatment of a fracture of the femur where revision total hip replacement is required as part of the treatment of the fracture (not including intra-operative fracture), being a service associated with a service to which items 49324 to 49333 apply Y 49339 01DEC1991 HIP, revision total replacement of, requiring anatomic specific allograft of proximal femur greater than 5 cm in length Y 49342 01DEC1991 HIP, revision total replacement of, requiring anatomic specific allograft of acetabulum Y 49345 01DEC1991 HIP, revision total replacement of, requiring anatomic specific allograft of both femur and acetabulum Y 49346 01MAY1994 HIP, revision arthroplasty with replacement of acetabular liner or ceramic head, not requiring removal of femoral component or acetabular shell Y 49348 01DEC1991 HIP, congenital dislocation of, manipulation of, with application of cast (excluding aftercare) N 49348 01JUL1993 HIP, congenital dislocation of, treatment of, by closed reduction Y 49351 01DEC1991 HIP, congenital dislocation of, treatment of, involving supervision of splint, harness or cast - each attendance Y 49354 01DEC1991 HIP, congenital dislocation of, open reduction of Y 49357 01JUL1993 HIP SPICA, initial application of, for congenital dislocation of hip (excluding aftercare) Y 49360 01MAY1994 HIP, diagnostic arthroscopy of N 49360 01MAY2009 HIP, diagnostic arthroscopy of, not being a service associated with any other arthroscopic procedure of the hip Y 49363 01MAY1994 HIP, diagnostic arthroscopy of, with synovial biopsy N 49363 01MAY2009 HIP, diagnostic arthroscopy of, with synovial biopsy, not being a service associated with any other arthroscopic procedure of the hip Y 49366 01MAY1994 HIP, arthroscopic surgery of N 49366 01MAY2009 HIP, arthroscopic surgery of, not being a service associated with any other arthroscopic procedure of the hip N 49366 01NOV2016 Hip, arthroscopic surgery of, other than a service associated with another arthroscopic procedure of the hip, or a service associated with surgery for femoroacetabular impingement(H) Y 49369 01MAY1994 Historical item included for item mapping purposes Y 49500 01DEC1991 KNEE, arthrotomy of, involving 1 or more of; capsular release, biopsy or lavage, or removal of loose body or foreign body Y 49503 01DEC1991 KNEE, meniscectomy of, repair of collateral ligament, patellectomy of, chondroplasty of, osteoplasty of, or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Group applies) - any 1 procedure N 49503 01JUL1993 KNEE, meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patello-femoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Group applies) - any 1 procedure N 49503 01NOV2006 KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Groups applies) - any 1 procedure N 49503 01JUL2008 KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon (not being a service to which another item in this Group applies) - any 1 procedure Y 49506 01DEC1991 KNEE, meniscectomy of, repair of collateral ligament, patellectomy of, chondroplasty of, osteoplasty of, or single transfer of ligament or tendon or any other procedure (not being a service to which another item in this Group applies) - any 2 or more procedures N 49506 01JUL1993 KNEE, meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patello-femoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Group applies) - any 2 or more procedures N 49506 01NOV2006 KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon or any other single procedure (not being a service to which another item in this Groups applies) - any 2 or more procedures (Anaes.) (Assist.) N 49506 01JUL2008 KNEE, partial or total meniscectomy of, repair of collateral or cruciate ligament, patellectomy of, chondroplasty of, osteoplasty of, patellofemoral stabilisation or single transfer of ligament or tendon (not being a service to which another item in this Group applies) - any 2 or more procedures Y 49509 01DEC1991 KNEE, total synovectomy of, arthrodesis of, patello-femoral stabilisation or repair of cruciate ligament - any 1 procedure N 49509 01JUL1993 KNEE, total synovectomy or arthrodesis of N 49509 01MAY2009 KNEE, total synovectomy or arthrodesis with synovectomy if performed Y 49512 01DEC1991 KNEE, arthrodesis of, with removal of prosthesis N 49512 01MAY2009 KNEE, arthrodesis of, with synovectomy if performed, with removal of prosthesis Y 49515 01DEC1991 KNEE, removal of prosthesis, cemented or uncemented, including associated cement, as the first stage of a 2 stage procedure Y 49517 01JUL1993 KNEE, hemiarthroplasty of Y 49518 01DEC1991 KNEE, total replacement arthroplasty of Y 49519 01NOV1996 KNEE, total replacement arthroplasty of, including associated minor grafting, if performed - bilateral Y 49521 01DEC1991 KNEE, total replacement arthroplasty of, requiring major bone grafting to femur or tibia, including obtaining of graft Y 49524 01DEC1991 KNEE, total replacement arthroplasty of, requiring major bone grafting to femur and tibia, including obtaining of graft Y 49527 01DEC1991 KNEE, total replacement arthroplasty of, revision procedure, including removal of prosthesis Y 49530 01DEC1991 KNEE, total replacement arthroplasty of, revision procedure, requiring bone grafting to femur or tibia, including obtaining of graft and including removal of prosthesis Y 49533 01DEC1991 KNEE, total replacement arthroplasty of, revision procedure, requiring bone grafting to both femur and tibia, including obtaining of graft and including removal of prosthesis Y 49534 01NOV1996 KNEE, patello-femoral joint of, total replacement arthroplasty as a primary procedure Y 49536 01DEC1991 KNEE, repair or reconstruction of, for chronic instability involving either cruciate or collateral ligaments N 49536 01NOV1996 KNEE, repair or reconstruction of, for chronic instability (open or arthroscopic, or both) involving either cruciate or collateral ligaments, including notchplasty when performed N 49536 01MAY2009 KNEE, repair or reconstruction of, for chronic instability (open or arthroscopic, or both) involving either cruciate or collateral ligaments, including notchplasty when performed, not being a service associated with any other arthroscopic procedure of the knee Y 49539 01DEC1991 KNEE, reconstructive surgery of cruciate ligaments (open or arthroscopic, or both), including surgery to other internal derangements, not being a service to which another item in this Group applies N 49539 01NOV1996 KNEE, reconstructive surgery of cruciate ligaments (open or arthroscopic, or both), including notchplasty when performed and surgery to other internal derangements, not being a service to which another item in this Group applies N 49539 01NOV2006 KNEE, reconstructive surgery of cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty when performed and surgery to other internal derangements, not being a service to which another item in this Group applies N 49539 01MAY2009 KNEE, reconstructive surgery of cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty when performed and surgery to other internal derangements, not being a service to which another item in this Group applies or a service associated with any other arthroscopic procedure of the knee Y 49542 01DEC1991 KNEE, reconstructive surgery to cruciate ligaments (open or arthroscopic, or both), including meniscus repair, extracapsular procedure and debridement when performed N 49542 01NOV1996 KNEE, reconstructive surgery to cruciate ligaments (open or arthroscopic, or both), including notchplasty, meniscus repair, extracapsular procedure and debridement when performed N 49542 01NOV2006 KNEE, reconstructive surgery to cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty, meniscus repair, extracapsular procedure and debridement when performed N 49542 01MAY2009 KNEE, reconstructive surgery to cruciate ligament or ligaments (open or arthroscopic, or both), including notchplasty, meniscus repair, extracapsular procedure and debridement when performed, not being a service associated with any other arthroscopic procedure of the knee Y 49545 01DEC1991 KNEE, revision arthrodesis of N 49545 01MAY2009 KNEE, revision arthrodesis of, with synovectomy if performed Y 49548 01DEC1991 KNEE, revision of patello-femoral stabilisation Y 49551 01DEC1991 KNEE, revision of procedures to which item 49536, 49539 or 49542 applies Y 49554 01DEC1991 KNEE, revision of total replacement of, by anatomic specific allograft of tibia or femur Y 49557 01DEC1991 KNEE, diagnostic arthroscopy of (including biopsy, simple trimming of meniscal margin or plica) - not being a service associated with any other arthroscopic procedure of the knee region N 49557 01NOV2011 KNEE, diagnostic arthroscopy of (including biopsy, simple trimming of meniscal margin or plica) - not being a service associated with autologous chondrocyte implantation or matrix-induced autologous chondrocyte implantation or any other arthroscopic procedure of the knee region Y 49558 01NOV1996 KNEE, arthroscopic surgery of, involving 1 or more of: debridement, osteoplasty or chondroplasty - not associated with any other arthroscopic procedure of the knee region Y 49559 01NOV1996 KNEE, arthroscopic surgery of, involving chondroplasty requiring multiple drilling or carbon fibre (or similar) implant; including any associated debridement or oestoplasty - not associated with any other arthroscopic procedure of the knee region Y 49560 01DEC1991 KNEE, arthroscopic surgery of, involving any 1 or more of: meniscectomy, removal of loose body, lateral release, or chondroplasty - not being a service associated with any other arthroscopic procedure of the knee region N 49560 01NOV1996 KNEE, arthroscopic surgery of, involving 1 or more of: meniscectomy, removal of loose body or lateral release - not being a service associated with any other arthroscopic procedure of the knee region N 49560 01NOV2006 KNEE, arthroscopic surgery of, involving 1 or more of: partial or total meniscectomy, removal of loose body or lateral release - not being a service associated with any other arthroscopic procedure of the knee region Y 49561 01NOV1996 KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: meniscectomy, removal of loose body or lateral release; where the procedure includes associated debridement, osteoplasty or chrondoplasty - not associated with any other arthroscopic procedure of the knee region N 49561 01NOV2006 KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: partial or total meniscectomy, removal of loose body or lateral release; where the procedure includes associated debridement, osteoplasty or chondroplasty - not associated with any other arthroscopic procedure of the knee region Y 49562 01NOV1996 KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: meniscectomy, removal of loose body or lateral release; where the procedure includes chondroplasty requiring multiple drilling or carbon fibre (or similar) implant and associated debridement or osteoplasty - not associated with any other arthroscopic procedure of the knee region N 49562 01NOV2006 KNEE, ARTHROSCOPIC SURGERY OF, involving 1 or more of: partial or total meniscectomy, removal of loose body or lateral release; where the procedure includes chondroplasty requiring multiple drilling or carbon fibre (or similar) implant and associated debridement or osteoplasty - not associated with any other arthroscopic procedure of the knee region Y 49563 01DEC1991 KNEE, arthroscopic surgery of, involving meniscus repair or osteoplasty, or both N 49563 01NOV1996 KNEE, arthroscopic surgery of, involving 1 or more of: meniscus repair; osteochondral graft; or chondral graft - not associated with any other arthroscopic procedure of the knee region N 49563 01NOV2011 KNEE, arthroscopic surgery of, involving 1 or more of: meniscus repair; osteochondral graft; or chondral graft (excluding autologous chondrocyte implantation or matrix-induced autologous chondrocyte implantation) -not associated with any other arthroscopic procedure of the knee region Y 49564 01MAY2000 KNEE, patello-femoral stabilisation of, combined arthroscopic and open procedure, including lateral release, medial capsulorrhaphy and tendon transfer N 49564 01MAY2009 KNEE, patello-femoral stabilisation of, combined arthroscopic and open procedure, including lateral release, medial capsulorrhaphy and tendon transfer, not being a service associated with any other arthroscopic procedure of the knee Y 49566 01DEC1991 KNEE, arthroscopic total synovectomy of N 49566 01MAY2009 KNEE, arthroscopic total synovectomy of, not being a service associated with any other arthroscopic procedure of the knee Y 49569 01MAY1994 KNEE, mobilisation for post-traumatic stiffness, by multiple muscle or tendon release (quadricepsplasty) Y 49700 01DEC1991 ANKLE, diagnostic arthroscopy of, including biopsy Y 49703 01DEC1991 ANKLE, arthroscopic surgery of N 49703 01MAY2009 ANKLE, arthroscopic surgery of, not being a service associated with any other arthroscopic procedure of the ankle Y 49706 01DEC1991 ANKLE, arthrotomy of, involving 1 or more of: lavage, removal of loose body or division of contracture Y 49709 01DEC1991 ANKLE, ligamentous stabilisation of Y 49712 01DEC1991 ANKLE, arthrodesis of N 49712 01MAY2009 ANKLE, arthrodesis of, with synovectomy if performed Y 49715 01DEC1991 ANKLE, total joint replacement of Y 49716 01NOV2006 ANKLE, total replacement arthroplasty of, revision procedure, including removal of prosthesis Y 49717 01NOV2006 ANKLE, total replacement arthroplasty of, revision procedure, requiring bone grafting, including removal of prosthesis Y 49718 01DEC1991 ANKLE, Achilles' tendon or other major tendon, repair of Y 49721 01DEC1991 ANKLE, Achilles' tendon rupture managed by non-operative treatment Y 49724 01DEC1991 ANKLE, Achilles' tendon, secondary repair or reconstruction of Y 49727 01DEC1991 ANKLE, Achilles' tendon, operation for lengthening Y 49728 01NOV2006 ANKLE, lengthening of the gastrocnemius aponeurosis and soleus fascia, for the correction of equinus deformity in children with cerebral palsy Y 49800 01DEC1991 FOOT, flexor or extensor tendon, primary repair of Y 49803 01DEC1991 FOOT, flexor or extensor tendon, secondary repair of Y 49806 01DEC1991 FOOT, subcutaneous tenotomy of, 1 or more tendons Y 49809 01DEC1991 FOOT, open tenotomy of, with or without tenoplasty Y 49812 01DEC1991 FOOT, tendon or ligament transplantation of, not being a service to which another item in this Group applies Y 49815 01DEC1991 FOOT, triple arthrodesis of N 49815 01MAY2009 FOOT, triple arthrodesis of, with synovectomy if performed Y 49818 01DEC1991 FOOT, excision of calcaneal spur Y 49821 01DEC1991 FOOT, correction of hallux valgus or hallux rigidus by excision arthroplasty (Keller's or similar procedure) - unilateral Y 49824 01DEC1991 FOOT, correction of hallux valgus or hallux rigidus by excision arthroplasty (Keller's or similar procedure) - bilateral Y 49827 01DEC1991 FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - unilateral N 49827 01MAY2000 FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - unilateral Y 49830 01DEC1991 FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - bilateral N 49830 01MAY2000 FOOT, correction of hallux valgus by transfer of adductor hallucis tendon - bilateral Y 49833 01DEC1991 FOOT, correction of hallux valgus by osteotomy of first metatarsal including internal fixation where performed - unilateral N 49833 01JUL2011 FOOT, correction of hallux valgus by osteotomy of first metatarsal with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - unilateral Y 49836 01DEC1991 FOOT, correction of hallux valgus by osteotomy of first metatarsal including internal fixation where performed - bilateral N 49836 01JUL2011 FOOT, correction of hallux valgus by osteotomy of first metatarsal with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - bilateral Y 49837 01MAY2000 FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, including internal fixation where performed - unilateral N 49837 01JUL2011 FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - unilateral Y 49838 01MAY2000 FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, including internal fixation where performed - bilateral N 49838 01JUL2011 FOOT, correction of hallux valgus by osteotomy of first metatarsal and transfer of adductor hallicus tendon, with or without internal fixation and with or without excision of exostoses associated with the first metatarsophalangeal joint - bilateral Y 49839 01DEC1991 FOOT, correction of hallux rigidus or hallux valgus by prosthetic arthroplasty - unilateral Y 49842 01DEC1991 FOOT, correction of hallux rigidus or hallux valgus by prosthetic arthroplasty - bilateral Y 49845 01DEC1991 FOOT, arthrodesis of, first metatarso-phalangeal joint N 49845 01MAY2009 FOOT, arthrodesis of, first metatarso-phalangeal joint, with synovectomy if performed Y 49848 01DEC1991 FOOT, correction of claw or hammer toe Y 49851 01DEC1991 FOOT, correction of claw or hammer toe with internal fixation Y 49854 01DEC1991 FOOT, radical plantar fasciotomy or fasciectomy of Y 49857 01DEC1991 FOOT, metatarso-phalangeal joint replacement Y 49860 01DEC1991 FOOT, synovectomy of metatarso-phalangeal joint, single joint Y 49863 01DEC1991 FOOT, synovectomy of metatarso-phalangeal joint, 2 or more joints Y 49866 01DEC1991 FOOT, neurectomy for plantar or digital neuritis (Morton's or Bett's syndrome) Y 49869 01DEC1991 TALIPES EQUINOVARUS, posterior release of Y 49872 01DEC1991 TALIPES EQUINOVARUS, medial release of Y 49875 01DEC1991 TALIPES EQUINOVARUS, combined postero-medial release of Y 49878 01DEC1991 TALIPES EQUINOVARUS, calcaneo valgus or metatarus varus, treatment by cast, splint or manipulation - each attendance Y 50100 01DEC1991 JOINT, diagnostic arthroscopy of (including biopsy), not being a service to which another item in this Group applies and not being a service associated with any other arthroscopic procedure Y 50102 01NOV1996 JOINT, arthroscopic surgery of, not being a service to which another item in this Group applies Y 50103 01DEC1991 JOINT, arthrotomy of, not being a service to which another item in this Group applies Y 50104 01JUL1993 JOINT, synovectomy of, not being a service to which another item in this Group applies Y 50106 01DEC1991 JOINT, stabilisation of, involving 1 or more of: repair of capsule, repair of ligament or internal fixation, not being a service to which another item in this Group applies Y 50109 01DEC1991 JOINT, arthrodesis of, not being a service to which another item in this Group applies N 50109 01MAY2009 JOINT, arthrodesis of, not being a service to which another item in this Group applies, with synovectomy if performed Y 50112 01DEC1991 CICATRICIAL FLEXION CONTRACTURE OF JOINT, correction of, involving tissues deeper than skin and subcutaneous tissue N 50112 01NOV1996 CICATRICIAL FLEXION OR EXTENSION CONTRACTION OF JOINT, correction of, involving tissues deeper than skin and subcutaneous tissue, not being a service to which another item in this Group applies Y 50115 01DEC1991 JOINT or JOINTS, manipulation of, performed in the operating theatre of a hospital, not being a service associated with a service to which another item in this Group applies Y 50118 01DEC1991 SUBTALAR JOINT, arthrodesis of N 50118 01MAY2009 SUBTALAR JOINT, arthrodesis of, with synovectomy if performed Y 50121 01DEC1991 GREATER TROCHANTER, transplantation of ileopsoas tendon to Y 50124 01DEC1991 JOINT or other SYNOVIAL CAVITY, aspiration of, injection into, or both of these procedures; payable on not more than 25 occasions in any 12 month period Y 50125 19JUN1997 JOINT OR OTHER SYNOVIAL CAVITY, aspiration of, or injection into, or both of these procedures - where it can be demonstrated that a 26th or subsequent treatment (including any treatments to which item 50124 applies) is indicated in a 12 month period N 50125 01NOV1997 JOINT OR OTHER SYNOVIAL CAVITY, aspiration of, or injection into, or both of these procedures - where it can be demonstrated that a 26th or subsequent treatment (including any treatments to which item 50124 applies) is indicated in a 12 month period Y 50127 01JUL1993 JOINT OR JOINTS, arthroplasty of, by any technique not being a service to which another item applies Y 50130 01JUL1993 JOINT OR JOINTS, application of external fixator to, other than for treatment of fractures Y 50200 01DEC1991 AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR, biopsy of (not including aftercare) Y 50201 01NOV2004 AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR, involving neurovascular structures, open biopsy of (not including aftercare) Y 50203 01DEC1991 BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR, lesional or marginal excision of Y 50206 01DEC1991 BONE TUMOUR, lesional or marginal excision of, combined with any 1 of: liquid nitrogen freezing, autograft, allograft or cementation Y 50209 01DEC1991 BONE TUMOUR, lesional or marginal excision of, combined with any 2 or more of: liquid nitrogen freezing, autograft, allograft or cementation Y 50212 01DEC1991 MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR affecting the long bones of leg or arm, enbloc resection of, with compartmental or wide excision of soft tissue, without reconstruction Y 50215 01DEC1991 MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR affecting the long bones of leg or arm, enbloc resection of, with compartmental or wide excision of soft tissue, with intercalary reconstruction (prosthesis, allograft or autograft) Y 50218 01DEC1991 MALIGNANT TUMOUR of LONG BONE, enbloc resection of, with replacement or arthrodesis of adjacent joint N 50218 01MAY2009 MALIGNANT TUMOUR of LONG BONE, enbloc resection of, with replacement or arthrodesis of adjacent joint, with synovectomy if performed Y 50221 01DEC1991 MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR of PELVIS, SACRUM or SPINE; or SCAPULA and SHOULDER, enbloc resection of Y 50224 01DEC1991 MALIGNANT or AGGRESSIVE SOFT TISSUE TUMOUR of PELVIS, SACRUM or SPINE; or SCAPULA and SHOULDER, enbloc resection of, with reconstruction by prosthesis, allograft or autograft Y 50227 01DEC1991 MALIGNANT BONE TUMOUR, enbloc resection of, with massive anatomic specific allograft or autograft, with or without prosthetic replacement Y 50230 01DEC1991 BENIGN TUMOUR, resection of, requiring anatomic specific allograft, with or without internal fixation Y 50233 01DEC1991 MALIGNANT TUMOUR, amputation for, hemipelvectomy or interscapulo-thoracic Y 50236 01DEC1991 MALIGNANT TUMOUR, amputation for, hip disarticulation, shoulder disarticulation or proximal third femur Y 50239 01DEC1991 MALIGNANT TUMOUR, amputation for, not being a service to which another item in this Group applies Y 50300 01JUL1995 JOINT DEFORMITY, slow correction of, using ring fixator or similar device, including all associated attendances - payable only once in any 12 month period Y 50303 01JUL1995 LIMB LENGTHENING, up to and including 5cm, requiring slow distraction under general anaesthesia in the operating theatre of a hospital or approved day-hospital facility, with or without application of a ring fixator or similar device, including all associated attendances - payable only once in any 12 month period N 50303 01NOV2005 LIMB LENGTHENING, 5cm or less, by gradual distraction, with application of an external fixator or intra-medullary device, in the operating theatre of a hospital - payable only once per limb in any 12 month period Y 50306 01JUL1995 LIMB LENGTHENING , where the lengthening is bipolar, or bone transport is performed or where the fixator is extended to correct an adjacent joint deformity N 50306 01NOV2005 LIMB LENGTHENING , where the lengthening is bipolar, or bone transport is performed or where the fixator is extended to correct an adjacent joint deformity, or where the lengthening is greater than 5cm Y 50309 01JUL1995 RING FIXATOR OR SIMILAR DEVICE, adjustment of, with or without insertion or removal of fixation pins, performed under general anaesthesia in the operating theatre of a hospital, not being a service to which item 50303 or 50306 applies Y 50312 01JUL1995 ANKLE, synovectomy of N 50312 01MAY2009 ANKLE, synovectomy of, by arthroscopic or open means - not associated with any other arthroscopic procedure of the ankle Y 50315 01JUL1995 TALIPES EQUINOVARUS, posterior release of Y 50318 01JUL1995 TALIPES EQUINOVARUS, medial release of Y 50321 01JUL1995 TALIPES EQUINOVARUS, combined postero-medial release of Y 50324 01JUL1995 TALIPES EQUINOVARUS, combined postero-medial release of, revision procedure Y 50327 01JUL1995 TALIPES EQUINOVARUS, bilateral procedures Y 50330 01JUL1995 TALIPES EQUINOVARUS, or talus, vertical congenital - post operative manipulation and change of plaster, performed under general anaesthesia in the operating theatre of a hospital, not being a service to which item 50315, 50318, 50321, 50324 or 50327 applies Y 50333 01JUL1995 TARSAL COALITION, excision of, with interposition of muscle, fat graft or similar graft Y 50336 01JUL1995 TALUS, VERTICAL, CONGENITAL, combined anterior and posterior reconstruction Y 50339 01JUL1995 FOOT AND ANKLE, tibialis anterior tendon (split or whole) transfer to lateral column Y 50342 01JUL1995 FOOT AND ANKLE, tibialis or tibialis posterior tendon transfer, through the interosseous membrane to anterior or posterior aspect of foot Y 50345 01JUL1995 HYPEREXTENSION DEFORMITY OF TOE, release incorporating V-Y plasty of skin, lengthening of extensor tendons and release of capsule contracture Y 50348 01JUL1995 HIP, KNEE AND LEG PROCEDURES KNEE, deformity of, post-operative manipulation and change of plaster, performed under general anaesthesiain the operating theatre of a hospital Y 50349 01MAY2001 HIP, congenital dislocation of, treatment of, by closed reduction Y 50350 01MAY2001 HIP, congenital dislocation of, open reduction of Y 50351 01JUL1995 HIP, congenital or developmental dislocation of, open reduction of N 50351 01MAY2001 HIP, developmental dislocation of, open reduction of Y 50352 01MAY2001 HIP, congenital dislocation of, treatment of, involving supervision of splint, harness or cast - each attendance Y 50353 01MAY2001 HIP SPICA, initial application of, for congenital dislocation of hip (excluding aftercare) Y 50354 01JUL1995 TIBIA, pseudarthrosis of, congenital, resection and internal fixation Y 50357 01JUL1995 KNEE, LEG OR THIGH, rectus femoris tendon transfer, or medial or lateral hamstring tendon transfer Y 50360 01JUL1995 KNEE, LEG OR THIGH, combined medial and lateral hamstring tendon transfer Y 50363 01JUL1995 KNEE, contracture of, posterior releaseinvolving multiple tendon lengthening or tenotomies, unilateral Y 50366 01JUL1995 KNEE, contracture of, posterior release involving multiple tendon lengthening or tenotomies, bilateral Y 50369 01JUL1995 KNEE, contracture of, posterior release involving multiple tendon lengthening with or without tenotomies and release of joint capsule with or without cruciate ligaments, unilateral Y 50372 01JUL1995 KNEE, contracture of, posterior release involving multiple tendon lengthening with or without tenotomies and release of joint capsule with or without cruciate ligaments, bilateral Y 50375 01JUL1995 HIP, contracture of, medial release, involving lengthening of, or division of the adductors and psoas with or without division of the obturator nerve, unilateral Y 50378 01JUL1995 HIP, contracture of, medial release, involving lengthening of, or division of the adductors and psoas with or without division of the obturator nerve, bilateral Y 50381 01JUL1995 HIP, contracture of, anterior release, involving lengthening of, or division of the hip flexors and psoas with or without division of the joint capsule, unilateral Y 50384 01JUL1995 HIP, contracture of, anterior release, involving lengthening of, or division of the hip flexors and psoas with or without division of the joint capsule, bilateral Y 50387 01JUL1995 HIP, iliopsoas tendon transfer to greater trochanter, or transfer of abdominal musculature to greater trochanter, or transfer of adductors to ischium Y 50390 01JUL1995 PERTHES, CEREBRAL PALSY, or other neuromuscular conditions, affecting hips or knees, application of cast under general anaesthesia, performed in the operating theatre of a hospital Y 50393 01JUL1995 PELVIS, bone graft or shelf procedures for acetabular dysplasia Y 50394 01JUL1998 ACETABULAR DYSPLASIA, treatment of, by multiple peri-acetabular osteotomy, including internal fixation where performed Y 50396 01JUL1995 SHOULDER, ARM AND FOREARM PROCEDURES HAND, congenital abnormalities or duplication of digits, amputation or splitting of phalanx or phalanges, with ligament or joint reconstruction Y 50399 01JUL1995 FOREARM, RADIAL APLASIA OR DYSPLASIA (radial club hand), centralisation or radialisation of Y 50402 01JUL1995 TORTICOLLIS, bipolar release of sternocleidomastoid muscle and associated soft tissue Y 50405 01JUL1995 ELBOW, flexorplasty, or tendon transfer to restore elbow function Y 50408 01JUL1995 SHOULDER, congenital or developmental dislocation, open reduction of Y 50411 01JUL1995 AMPUTATIONS OR RECONSTRUCTIONS FOR CONGENITAL DEFORMITIES LOWER LIMB DEFICIENCY, treatment of congenital deficiency of the femur by resection of the distal femur and proximal tibia followed by knee fusion Y 50414 01JUL1995 LOWER LIMB DEFICIENCY, treatment of congenital deficiency of the femur by resection of the distal femur and proximal tibia followed by knee fusion and rotationplasty Y 50417 01JUL1995 LOWER LIMB DEFICIENCY, treatment of congenital deficiency of the tibia by reconstruction of the knee, involving transfer of fibula or tibia, and repair of quadriceps mechanism Y 50420 01JUL1995 PATELLA, congenital dislocation of, reconstruction of the quadriceps Y 50423 01JUL1995 TIBIA, FIBULA OR BOTH, congenital deficiency of, transfer of the fibula to tibia, with internal fixation Y 50426 01JUL1995 TUMOROUS CONDITIONS DIAPHYSEAL ACLASIA, removal of lesion or lesions from bone - 1 approach Y 50450 01NOV2006 UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (`)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (`)Correction of muscle imbalance by tendon transfer/transfers. (`)Correction of femoral torsion by rotational osteotomy of the femur. (`)Correction of tibial torsion by rotational osteotomy of the tibia. (`)Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis or os calcis lengthening. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare N 50450 01MAY2009 UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of femoral torsion by rotational osteotomy of the femur. (d)Correction of tibial torsion by rotational osteotomy of the tibia. (e)Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis, with synovectomy if performed, or os calcis lengthening. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare Y 50451 01NOV2006 UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of femoral torsion by rotational osteotomy of the femur. (d)Correction of tibial torsion by rotational osteotomy of the tibia. (e)Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis or os calcis lengthening. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare N 50451 01MAY2009 UNILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with hemiplegic cerebral palsy comprising three or more of the following: (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of femoral torsion by rotational osteotomy of the femur. (d)Correction of tibial torsion by rotational osteotomy of the tibia. (e)Correction of joint instability by varus derotation osteotomy of the femur, subtalar arthrodesis, with synovectomy if performed, or os calcis lengthening. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare Y 50455 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises: (`)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (`)Correction of muscle imbalance by tendon transfer/transfers. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare Y 50456 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises: (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare Y 50460 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery and bilateral femoral osteotomies. (`)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (`)Correction of muscle imbalance by tendon transfer/transfers. (`)Correction of torsional abnormality of the femur by rotational osteotomy and internal fixation. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare Y 50461 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery and bilateral femoral osteotomies. (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of torsional abnormality of the femur by rotational osteotomy and internal fixation. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare Y 50465 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies and bilateral tibial osteotomies. (`)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (`)Correction of muscle imbalance by tendon transfer/transfers. (`)Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. (`)Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare Y 50466 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies and bilateral tibial osteotomies. (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. (d)Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare Y 50470 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot stabilisation. (`)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (`)Correction of muscle imbalance by tendon transfer/transfers. (`)Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. (`)Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. (`)Correction of bilateral pes valgus by os calcis lengthening or subtalar fusion. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare Y 50471 01NOV2006 BILATERAL SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with cerebral palsy that comprises bilateral soft tissue surgery, bilateral femoral osteotomies, bilateral tibial osteotomies and bilateral foot stabilisation. (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of abnormal torsion of the femur by rotational osteotomy with internal fixation. (d)Correction of abnormal torsion of the tibia by rotational osteotomy with internal fixation. (e)Correction of bilateral pes valgus by os calcis lengthening or subtalar fusion. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare Y 50475 01NOV2006 SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy for the correction of crouch gait including: (`)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (`)Correction of muscle imbalance by tendon transfer/transfers. (`)Correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation. (`)Correction of patella alta and quadriceps insufficiency by patella tendon shortening/reconstruction. (`)Correction of tibial torsion by rotational osteotomy of the tibia with internal fixation. (`)Correction of foot instability by os calcis lengthening or subtalar fusion. Conjoint surgery, principal specialist surgeon, including fluoroscopy and aftercare Y 50476 01NOV2006 SINGLE EVENT MULTILEVEL SURGERY for patients less than 18 years of age with diplegic cerebral palsy for the correction of crouch gait including: (a)Lengthening of one or more contracted muscle tendon units by tendon lengthening, muscle recession, fractional lengthening or intramuscular lengthening. (b)Correction of muscle imbalance by tendon transfer/transfers. (c)Correction of flexion deformity at the knee by extension osteotomy of the distal femur including internal fixation. (d)Correction of patella alta and quadriceps insufficiency by patella tendon shortening/reconstruction. (e)Correction of tibial torsion by rotational osteotomy of the tibia with internal fixation. (f)Correction of foot instability by os calcis lengthening or subtalar fusion. Conjoint surgery, conjoint specialist surgeon, including fluoroscopy and excluding aftercare Y 50500 01NOV2006 RADIUS OR ULNA, distal end of, with open growth plate, treatment of fracture of, by closed reduction Y 50504 01NOV2006 RADIUS OR ULNA, distal end of, with open growth plate, treatment of fracture of, by open reduction Y 50508 01NOV2006 RADIUS, distal end of, with open growth plate, treatment of Colles', Smith's or Barton's fracture, by closed reduction Y 50512 01NOV2006 RADIUS, distal end of, with open growth plate, treatment of Colles', Smith's or Barton's fracture of, by open reduction Y 50516 01NOV2006 RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital Y 50520 01NOV2006 RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, by open reduction Y 50524 01NOV2006 RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by closed reduction undertaken in the operating theatre of a hospital Y 50528 01NOV2006 RADIUS OR ULNA, shaft of, with open growth plate, treatment of fracture of, in conjunction with dislocation of distal radio-ulnar joint or proximal radio-humeral joint (Galeazzi or Monteggia injury), by reduction with or without internal fixation by open or percutaneous means Y 50532 01NOV2006 RADIUS AND ULNA, shafts of, with open growth plates, treatment of fracture of, by closed reduction undertaken in the operating theatre of a hospital Y 50536 01NOV2006 RADIUS AND ULNA, shafts of, with open growth plates, treatment of fracture of, by open reduction Y 50540 01NOV2006 OLECRANON, with open growth plate, treatment of fracture of, by open reduction Y 50544 01NOV2006 RADIUS, with open growth plate, treatment of fracture of head or neck of, by closed reduction of Y 50548 01NOV2006 RADIUS, with open growth plate, treatment of fracture of head or neck of, by reduction with or without internal fixation by open or percutaneous means Y 50552 01NOV2006 HUMERUS, proximal, with open growth plate, treatment of fracture of, by closed reduction, undertaken in the operating theatre, neonatal unit or nursery of a hospital Y 50556 01NOV2006 HUMERUS, proximal, with open growth plate, treatment of fracture of, by open reduction Y 50560 01NOV2006 HUMERUS, shaft of, with open growth plate, treatment of fracture of, by closed reduction, undertaken in the operating theatre, neonatal unit or nursery of a hospital Y 50564 01NOV2006 HUMERUS, shaft of, with open growth plate, treatment of fracture of, by internal or external fixation Y 50568 01NOV2006 HUMERUS, with open growth plate, supracondylar or condylar, treatment of fracture of, by closed reduction, undertaken in the operating theatre of a hospital Y 50572 01NOV2006 HUMERUS, with open growth plate, supracondylar or condylar, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means, undertaken in the operating theatre of a hospital Y 50576 01NOV2006 FEMUR, with open growth plate, treatment of fracture of, by closed reduction or traction Y 50580 01NOV2006 TIBIA, with open growth plate, plateau or condyles, medial or lateral, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means Y 50584 01NOV2006 TIBIA, distal, with open growth plate, treatment of fracture of, by reduction with or without internal fixation by open or percutaneous means Y 50588 01NOV2006 TIBIA AND FIBULA, with open growth plates, treatment of fracture of, by internal fixation Y 50600 01NOV2006 SCOLIOSIS OR KYPHOSIS, in a growing child, manipulation of deformity and application of a localiser cast, under general anaesthesia, in a hospital Y 50604 01NOV2006 SCOLIOSIS or KYPHOSIS, in a child or adolescent, spinal fusion for (without instrumentation) Y 50608 01NOV2006 SCOLIOSIS OR KYPHOSIS, in a child or adolescent, treatment by segmental instrumentation and fusion of the spine, not being a service to which item 48642 to 48675 applies N 50608 01NOV2018 SCOLIOSIS OR KYPHOSIS, in a child or adolescent, treatment by segmental instrumentation and fusion of the spine, not being a service to which item51011 to 51171 applies Y 50612 01NOV2006 SCOLIOSIS OR KYPHOSIS, in a child or adolescent, with spinal deformity, treatment by segmental instrumentation, utilising separate anterior and posterior approaches, not being a service to which item 48642 to 48675 applies N 50612 01NOV2018 SCOLIOSIS OR KYPHOSIS, in a child or adolescent, with spinal deformity, treatment by segmental instrumentation, utilising separate anterior and posterior approaches, not being a service to which item51011 to 51171 applies Y 50616 01NOV2006 SCOLIOSIS, in a child or adolescent, re-exploration for adjustment or removal of segmental instrumentation used for correction of spine deformity Y 50620 01NOV2006 SCOLIOSIS, in a child or adolescent, revision of failed scoliosis surgery, involving more than 1 of osteotomy, fusion, removal of instrumentation or instrumentation, not being a service to which item 48642 to 48675 applies N 50620 01NOV2018 SCOLIOSIS, in a child or adolescent, revision of failed scoliosis surgery, involving more than 1 of osteotomy, fusion, removal of instrumentation or instrumentation, not being a service to which item 51011 to 51171 applies Y 50624 01NOV2006 SCOLIOSIS, in a child or adolescent, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - not more than 4 levels Y 50628 01NOV2006 SCOLIOSIS, in a child or adolescent, anterior correction of, with fusion and segmental fixation (Dwyer, Zielke or similar) - more than 4 levels Y 50632 01NOV2006 SCOLIOSIS OR KYPHOSIS, in a child or adolescent, requiring segmental instrumentation and fusion of the spine down to and including the pelvis or sacrum, not being a service to which item 48642 to 48675 applies N 50632 01NOV2018 SCOLIOSIS OR KYPHOSIS, in a child or adolescent, requiring segmental instrumentation and fusion of the spine down to and including the pelvis or sacrum, not being a service to which item 51011 to 51171 applies Y 50636 01NOV2006 SCOLIOSIS, in a child or adolescent, requiring anterior decompression of the spinal cord with vertebral resection and instrumentation in the presence of spinal cord involvement, not being a service to which item 48642 to 48675 applies N 50636 01NOV2018 SCOLIOSIS, in a child or adolescent, requiring anterior decompression of the spinal cord with vertebral resection and instrumentation in the presence of spinal cord involvement, not being a service to which item 51011 to 51171 applies Y 50640 01NOV2006 SCOLIOSIS, in a child or adolescent, congenital, resection and fusion of abnormal vertebra via an anterior or posterior approach, not being a service to which item 48642 to 48675 applies N 50640 01NOV2018 SCOLIOSIS, in a child or adolescent, congenital, resection and fusion of abnormal vertebra via an anterior or posterior approach, not being a service to which item51011 to 51171 applies Y 50644 01NOV2006 SPINE, bone graft to, for a child or adolescent, associated with surgery for correction of scoliosis or kyphosis or both Y 50650 01NOV2006 HIP DYSPLASIA or DISLOCATION, in a child, examination, manipulation and arthrography of the hip under anaesthesia Y 50654 01NOV2006 HIP DYSPLASIA or DISLOCATION, in a child, application or reapplication of a hip spica, including examination of the hip Y 50658 01NOV2006 HIP DYSPLASIA or DISLOCATION, in a child, examination and manipulation of the hip under anaesthesia Y 50950 01MAY2004 NONRESECTABLE HEPATOCELLULAR CARCINOMA, destruction of, by percutaneous radiofrequency ablation, including any associated imaging services, not being a service associated with a service to which item 30419 or 50952 applies N 50950 01NOV2017 Unresectable primary malignant tumour of the liver, destruction of, by percutaneous radiofrequency ablation or percutaneous microwave tissue ablation (including any associated imaging services), other than a service associated with a service to which item 30419 or 50952 applies Y 50952 01MAY2004 NONRESECTABLE HEPATOCELLULAR CARCINOMA, destruction of, by open or laparoscopic radiofrequency ablation, where a multi-disciplinary team has assessed that percutaneous radiofrequency ablation cannot be performed or is not practical because of one or more of the following clinical circumstances: -percutaneous access cannot be achieved; -vital organs/tissues are at risk of damage from the percutaneous RFA procedure; or -resection of one part of the liver is possible however there is at least one primary liver tumour in a non-resectable region of the liver which is suitable for radiofrequency ablation, including any associated imaging services, not being a service associated with a service to which item 30419 or 50950 applies N 50952 01NOV2017 Unresectable primary malignant tumour of the liver, destruction of, by open or laparoscopic radiofrequency ablation or open or laparoscopic microwave tissue ablation (including any associated imaging services), if a multi?disciplinary team has assessed that percutaneous radiofrequency ablation or percutaneous microwave tissue ablation cannot be performed or is not practical because of one or more of the following clinical circumstances: (a) percutaneous access cannot be achieved; (b) vital organs or tissues are at risk of damage from the percutaneous radiofrequency ablation or percutaneous microwave tissue ablation procedure; (c) resection of one part of the liver is possible, however there is at least one primary liver tumour in an unresectable portion of the liver that is suitable for radiofrequency ablation or microwave tissue ablation; other than a service associated with a service to which item30419 or 50950 applies. Y 51011 01NOV2018 Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, one motion segment, not being a service associated with a service to which item 51012, 51013, 51014 or 51015 applies Y 51012 01NOV2018 Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, 2 motion segments, not being a service associated with a service to which item 51011, 51013, 51014 or 51015 applies Y 51013 01NOV2018 Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, 3 motion segments, not being a service associated with a service to which item 51011, 51012, 51014 or 51015 applies Y 51014 01NOV2018 Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, 4 motion segments, not being a service associated with a service to which item 51011, 51012, 51013 or 51015 applies Y 51015 01NOV2018 Spinal decompression or exposure via partial or total laminectomy, partial vertebrectomy or posterior spinal release, more than 4 motion segments, not being a service associated with a service to which item 51011, 51012, 51013 or 51014 applies Y 51020 01NOV2018 Simple fixation of part of one vertebra (not motion segment) including pars interarticularis, spinous process or pedicle, or simple interspinous wiring between 2 adjacent vertebral levels, not being a service associated with: (a) interspinous dynamic stabilisation devices; or (b) a service to which item51021, 51022, 51023, 51024, 51025 or 51026 applies Y 51021 01NOV2018 Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, one motion segment, not being a service associated with a service to which item 51020, 51022, 51023, 51024, 51025 or 51026 applies Y 51022 01NOV2018 Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 2 motion segments, not being a service associated with a service to which item 51020, 51021, 51023, 51024, 51025 or 51026 applies Y 51023 01NOV2018 Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 3 or 4 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51024, 51025 or 51026 applies Y 51024 01NOV2018 Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 5 or 6 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51025 or 51026 applies Y 51025 01NOV2018 Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, 7 to 12 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51024 or 51026 applies Y 51026 01NOV2018 Fixation of motion segment with vertebral body screw, pedicle screw or hook instrumentation including sublaminar tapes or wires, more than 12 motion segments, not being a service associated with a service to which item 51020, 51021, 51022, 51023, 51024 or 51025 applies Y 51031 01NOV2018 Spine, posterior and/or posterolateral bone graft to, one motion segment, not being a service associated with a service to which item 51032, 51033, 51034, 51035 or 51036 applies Y 51032 01NOV2018 Spine, posterior and/or posterolateral bone graft to, 2 motion segments, not being a service associated with a service to which item 51031, 51033, 51034, 51035 or 51036 applies Y 51033 01NOV2018 Spine, posterior and/or posterolateral bone graft to, 3 motion segments, not being a service associated with a service to which item 51031, 51032, 51034, 51035 or 51036 applies Y 51034 01NOV2018 Spine, posterior and/or posterolateral bone graft to, 4 to 7 motion segments, not being a service associated with a service to which item 51031, 51032, 51033, 51035 or 51036 applies Y 51035 01NOV2018 Spine, posterior and/or posterolateral bone graft to, 8 to 11 motion segments, not being a service associated with a service to which item 51031, 51032, 51033, 51034 or 51036 applies Y 51036 01NOV2018 Spine, posterior and/or posterolateral bone graft to, 12 or more motion segments, not being a service associated with a service to which item 51031, 51032, 51033, 51034 or 51035 applies Y 51041 01NOV2018 Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), one motion segment, not being a service associated with a service to which item 51042, 51043, 51044 or 51045 applies Y 51042 01NOV2018 Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 2 motion segments, not being a service associated with a service to which item 51041, 51043, 51044 or 51045 applies Y 51043 01NOV2018 Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 3 motion segments, not being a service associated with a service to which item 51041, 51042, 51044 or 51045 applies Y 51044 01NOV2018 Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 4 motion segments, not being a service associated with a service to which item 51041, 51042, 51043 or 51045 applies Y 51045 01NOV2018 Spinal fusion, anterior column (anterior, direct lateral or posterior interbody), 5 or more motion segments, not being a service associated with a service to which item 51041, 51042, 51043 or 51044 applies Y 51051 01NOV2018 Pedicle subtraction osteotomy, one motion segment, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51052, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies N 51051 01NOV2019 Pedicle subtraction osteotomy, one vertebra, not being a service associated with a service to which item51052, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies Y 51052 01NOV2018 Pedicle subtraction osteotomy, 2 motion segments, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies N 51052 01NOV2019 Pedicle subtraction osteotomy, 2 vertebrae, not being a service associated with a service to which item51051, 51053, 51054, 51055, 51056, 51057, 51058 or 51059 applies Y 51053 01NOV2018 Vertebral column resection osteotomy performed through single posterior approach, one motion segment, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51054, 51055, 51056, 51057, 51058 or 51059 applies N 51053 01NOV2019 Vertebral column resection osteotomy performed through single posterior approach, one vertebra, not being a service associated with a service to which item51051, 51052, 51054, 51055, 51056, 51057, 51058 or 51059 applies Y 51054 01NOV2018 Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal excision is defined as removal of more than 50% of the vertebral body), one vertebra, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51053, 51055, 51056, 51057, 51058 or 51059 applies Y 51055 01NOV2018 Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal excision is defined as removal of more than 50% of the vertebral body), 2 vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51053, 51054, 51056, 51057, 51058 or 51059 applies Y 51056 01NOV2018 Vertebral body, piecemeal or subtotal excision of (where piecemeal or subtotal excision is defined as removal of more than 50% of the vertebral body), 3 or more vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51053, 51054, 51055, 51057, 51058 or 51059 applies Y 51057 01NOV2018 Vertebral body, en bloc excision of (complete spondylectomy), one vertebra, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51053, 51054, 51055, 51056, 51058 or 51059 applies Y 51058 01NOV2018 Vertebral body, en bloc excision of (complete spondylectomy), 2 vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51053, 51054, 51055, 51056, 51057 or 51059 applies Y 51059 01NOV2018 Vertebral body, en bloc excision of (complete spondylectomy), 3 or more vertebrae, not being a service associated with: (a) anterior column fusion when at the same motion segment; or (b) a service to which item51051, 51052, 51053, 51054, 51055, 51056, 51057 or 51058 applies Y 51061 01NOV2018 Spine fusion, anterior and posterior, including spinal instrumentation at one motion segment, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51062, 51063, 51064, 51065 or 51066 applies N 51061 01NOV2019 Spinal fusion, anterior and posterior, including spinal instrumentation at one motion segment, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51062, 51063, 51064, 51065 or 51066 applies Y 51062 01NOV2018 Spine fusion, anterior and posterior, including spinal instrumentation at 2 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51063, 51064, 51065 or 51066 applies N 51062 01NOV2019 Spinal fusion, anterior and posterior, including spinal instrumentation at 2 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51063, 51064, 51065 or 51066 applies Y 51063 01NOV2018 Spine fusion, anterior and posterior, including spinal instrumentation at 3 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51064, 51065 or 51066 applies N 51063 01NOV2019 Spinal fusion, anterior and posterior, including spinal instrumentation at 3 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51064, 51065 or 51066 applies Y 51064 01NOV2018 Spine fusion, anterior and posterior, including spinal instrumentation at 4 to 7 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51065 or 51066 applies N 51064 01NOV2019 Spinal fusion, anterior and posterior, including spinal instrumentation at 4 to 7 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51065 or 51066 applies Y 51065 01NOV2018 Spine fusion, anterior and posterior, including spinal instrumentation at 8 to 11 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51066 applies N 51065 01NOV2019 Spinal fusion, anterior and posterior, including spinal instrumentation at 8 to 11 motion segments, posterior and/or posterolateral bone graft, and anterior column fusion, not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51066 applies Y 51066 01NOV2018 Spine fusion, anterior and posterior, including spinal instrumentation at 12 or more motion segments, posterior and/or posterolateral bone graft, and anterior column fusion not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51065 applies N 51066 01NOV2019 Spinal fusion, anterior and posterior, including spinal instrumentation at 12 or more motion segments, posterior and/or posterolateral bone graft, and anterior column fusion not being a service associated with a service to which item 51061, 51062, 51063, 51064 or 51065 applies Y 51071 01NOV2018 Removal of intradural lesion, not being a service associated with a service to which item 51072 or 51073 applies Y 51072 01NOV2018 Craniocervical junction lesion, transoral approach for, not being a service associated with a service to which item 51071 or 51073 applies Y 51073 01NOV2018 Removal of intramedullary tumour or arteriovenous malformation, not being a service associated with a service to which item 51071 or 51072 applies Y 51102 01NOV2018 Thoracoplasty in combination with thoracic scoliosis correction - 3 or more ribs Y 51103 01NOV2018 Odontoid screw fixation Y 51110 01NOV2018 Spine, treatment of fracture, dislocation or fracture dislocation, with immobilisation by calipers or halo, not including application of skull tongs or calipers as part of operative positioning Y 51111 01NOV2018 Skull calipers or halo, insertion of, as an independent procedure Y 51112 01NOV2018 Plaster jacket, application of, as an independent procedure Y 51113 01NOV2018 Halo, application of, in addition to spinal fusion for scoliosis, or other conditions Y 51114 01NOV2018 Halo thoracic orthosis - application of both halo and thoracic jacket Y 51115 01NOV2018 Halo femoral traction, as an independent procedure Y 51120 01NOV2018 Bone graft, harvesting of autogenous graft, via separate incision or via subcutaneous approach, in conjunction with spinal fusion, other than for the purposes of bone graft obtained from the cervical, thoracic, lumbar or sacral spine Y 51130 01NOV2018 Lumbar artificial intervertebral total disc replacement, at one motion segment only, including removal of disc and marginal osteophytes: (a) for a patient who: (i) has not had prior spinal fusion surgery at the same lumbar level; and (ii) does not have vertebral osteoporosis; and (iii) has failed conservative therapy; and (b) not being a service associated with a service to which item51011, 51012, 51013, 51014 or 51015 applies Y 51131 01NOV2018 Cervical artificial intervertebral total disc replacement, at one motion segment only, including removal of disc and marginal osteophytes, for a patient who: (a) has not had prior spinal surgery at the same cervical level; and (b) is skeletally mature; and (c) has symptomatic degenerative disc disease with radiculopathy; and (d) does not have vertebral osteoporosis; and (e) has failed conservative therapy Y 51140 01NOV2018 Previous spinal fusion, re-exploration for, involving adjustment or removal of instrumentation up to 3 motion segments, not being a service associated with a service to which item 51141 applies Y 51141 01NOV2018 Previous spinal fusion, re-exploration for, involving adjustment or removal of instrumentation more than 3 motion segments, not being a service associated with a service to which item 51140 applies Y 51145 01NOV2018 Wound debridement or excision for post operative infection or haematoma following spinal surgery Y 51150 01NOV2018 Coccyx, excision of Y 51160 01NOV2018 Anterior exposure of thoracic or lumbar spine, one motion segment, not being a service to which item 51165 applies Y 51165 01NOV2018 Anterior exposure of thoracic or lumbar spine, more than one motion segment, not being a service to which item 51160 applies Y 51170 01NOV2018 Syringomyelia or hydromyelia, craniotomy for, with or without duraplasty, intradural dissection, plugging of obex or local cerebrospinal fluid shunt Y 51171 01NOV2018 Syringomyelia or hydromyelia, treatment by direct cerebrospinal fluid shunt (for example, syringosubarachnoid shunt, syringopleural shunt or syringoperitoneal shunt) Y 51300 01DEC1991 NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45 N 51300 01NOV1994 NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45 N 51300 01JUL1995 NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies N 51300 01NOV1995 NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation for which the fee exceeds $186.50 but does not exceed $331.30 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $186.50 but where the fee for the series or combination of operations does not exceed $331.30 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies N 51300 01NOV1996 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $331.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $331.30" N 51300 01MAY1997 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $410.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $410.00" N 51300 01NOV1997 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $416.95 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $416.95" N 51300 01NOV1998 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $423.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $423.20" N 51300 01NOV1999 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $429.55 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $429.55" N 51300 01NOV2000 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65" N 51300 01NOV2001 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65" N 51300 01NOV2002 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $452.70 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $452.70" N 51300 01NOV2003 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $464.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $464.00" N 51300 01NOV2004 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $473.75 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $473.75" N 51300 01NOV2005 "NOTE: Benefit in respect of assistance at an operation is not payable unless the assistance is rendered by a medical practitioner other than the anaesthetist or assistant anaesthetist. The amount specified is the amount payable whether the assistance is rendered by one or more than one medical practitioner. Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $483.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $483.20" N 51300 01NOV2006 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $493.35 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $493.35" N 51300 01NOV2008 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $515.80 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $515.80" N 51300 01NOV2009 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $527.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $527.65" N 51300 01NOV2010 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $537.15 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $537.15" N 51300 01NOV2011 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $547.90 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $547.90" N 51300 01NOV2012 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $558.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $558.30" N 51300 01JUL2019 "Assistance at any operation identified by the word ""Assist."" for which the fee does not exceed $567.25 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $567.25" Y 51303 01DEC1991 Assistance at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20 N 51303 01NOV1994 Assistance at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20 N 51303 01JUL1995 Assistance at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies N 51303 01NOV1995 Assistance at any operation for which the fee exceeds $331.30 or at a combination of operations for which the aggregate fee exceeds $331.30 provided that the fee for at least 1 of the operations exceeds $186.50 not being a service associated with a service to which item 30473, 30475, 30476, 30478, 32072, 32075, 32078, 32081, 32084, 32087, 32090 or 32093 applies N 51303 01NOV1996 "Assistance at any operation identified by the word ""Assist."" for which the fees exceeds $331.30 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $331.30." N 51303 01MAY1997 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $410.00 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $410.00." N 51303 01NOV1997 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $416.95 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $416.95" N 51303 01NOV1998 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $423.20 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $423.20" N 51303 01NOV1999 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $429.55 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $429.55" N 51303 01NOV2000 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $441.65 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $441.65" N 51303 01NOV2001 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $441.65 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $441.65" N 51303 01NOV2002 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $452.70 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $452.70" N 51303 01NOV2003 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $464.00 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $464.00" N 51303 01NOV2004 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $473.75 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $473.75" N 51303 01NOV2005 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $483.20 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $483.20" N 51303 01NOV2006 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $493.35 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $493.35" N 51303 01NOV2008 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $515.80 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $515.80" N 51303 01NOV2009 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $527.65 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $527.65" N 51303 01NOV2010 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $537.15 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $537.15" N 51303 01NOV2011 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $547.90 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $547.90" N 51303 01NOV2012 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $558.30 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $558.30." N 51303 01JUL2019 "Assistance at any operation identified by the word ""Assist."" for which the fee exceeds $567.25 or at a series of operations identified by the word ""Assist."" for which the aggregate fee exceeds $567.25." Y 51306 01DEC1991 Assistance at a delivery involving Caesarean section N 51306 01NOV2017 Assistance at a birth involving Caesarean section Y 51309 01DEC1991 Assistance at a series or combination of operations, 1 of which is a delivery involving Caesarean section N 51309 01NOV1996 "Assistance at a series or combination of operations which have been identified by the word ""Assist."" and assistance at a delivery involving Caesarean section" N 51309 01NOV2017 Assistance at a series or combination of operations that include “(Assist.)” and assistance at a birth involving Caesarean section Y 51312 01JUL1995 Assistance at any interventional obstetric procedure described in items 16609, 16612, 16615 and 16633 N 51312 01NOV1995 Assistance at any interventional obstetric procedure covered by items 16606, 16609, 16612, 16615, 16627 and 16633 N 51312 01NOV2017 Assistance at any interventional obstetric procedure covered by items 16606, 16609, 16612, 16615 and 16627 Y 51315 01MAY1997 Assistance at cataract and intraocular lens surgery covered by item 42698,42701, 42702, 42704 or 42707, when performed in association with services covered by item 42551 to 42569, 42653, 42656, 42746, 42749, 42752, 42776 or 42779 N 51315 01NOV2012 Assistance at cataract and intraocular lens surgery covered by item 42698, 42701, 42702, 42704 or 42707, when performed in association with services covered by item 42551 to 42569, 42653, 42656, 42725, 42746, 42749, 42752, 42776 or 42779 Y 51318 01MAY1997 Assistance at cataract and intraocular lens surgery where patient has: -total loss of vision, including no potential for central vision, in the fellow eye; or -previous significant surgical complication in the fellow eye; or -pseudo exfoliation, subluxed lens, iridodonesis, phacodonesis, retinal detachment, corneal scarring, pre-existing uveitis, bound down miosed pupil, nanophthalmos, spherophakia, Marfan's syndrome, homocysteinuria or previous blunt trauma causing intraocular damage Y 51700 01DEC1991 PROFESSIONAL ATTENDANCE (other than a second or subsequent attendance in a single course of treatment) BY AN APPROVED DENTAL PRACTITIONER where the patient is referred to the approved dental practitioner - an attendance related to a subsequent operative procedure described in an item in Groups O3 to O9 where that attendance is at consulting rooms, hospital or nursing home (The referral must be from a registered dental practitioner or a medical practitioner) N 51700 01NOV1999 APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR NURSING HOME (Professional attendance at consulting rooms, hospital or nursing home by an approved dental practitioner in the practice of oral and maxillofacial surgery where the patient is referred to him or her) (The referral must be from a registered dental practitioner or a medical practitioner) - INITIAL attendance in a single course of treatment N 51700 01NOV2000 APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY (Professional attendance at consulting rooms, hospital or residential aged care facility by an approved dental practitioner in the practice of oral and maxillofacial surgery where the patient is referred to him or her) (The referral must be from a registered dental practitioner or a medical practitioner) - INITIAL attendance in a single course of treatment N 51700 01NOV2007 APPROVED DENTAL PRACTITIONER, REFERRED CONSULTATION - SURGERY, HOSPITAL OR RESIDENTIAL AGED CARE FACILITY Professional attendance (other than a second or subsequent attendance in a single course of treatment) by an approved dental practitioner, at consulting rooms, hospital or residential aged care facility where the patient is referred to him or her Y 51703 01DEC1991 PROFESSIONAL ATTENDANCE BY AN APPROVED DENTAL PRACTITIONER where the patient is referred to the approved dental practitioner - each attendance related to an operative procedure described in an item in Groups O3 to O9 subsequent to the first in a single course of treatment where that attendance is at consulting rooms, hospital or nursing home (The referral must be from a registered dental practitioner or a medical practitioner) N 51703 01NOV1999 - Each attendance SUBSEQUENT to the first in a single course of treatment N 51703 01NOV2007 Professional attendance by an approved dental practitioner, each attendance subsequent to the first in a single course of treatment at consulting rooms, hospital or residential aged care facility where the patient is referred to him or her Y 51800 01DEC1991 ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45 N 51800 01NOV1994 ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $183.20 but does not exceed $325.45 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $183.20 but where the fee for the series or combination of operations does not exceed $325.45 N 51800 01NOV1995 ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $186.50 but does not exceed $331.30 or at a series or a combination of operations where the fee for at least 1 of the operations exceeds $186.50 but where the fee for the series or combination of operations does not exceed $331.30 N 51800 01NOV1996 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $331.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $331.30" N 51800 01MAY1997 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $410.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $410.00" N 51800 01NOV1997 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $416.95 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $416.95" N 51800 01NOV1998 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee does not exceed $423.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $423.20" N 51800 01NOV1999 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $429.55 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $429.55" N 51800 01NOV2000 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65" N 51800 01NOV2001 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $441.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $441.65" N 51800 01NOV2002 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $452.70 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $452.70" N 51800 01NOV2003 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $464.00 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $464.00" N 51800 01NOV2004 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $473.75 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $473.75" N 51800 01NOV2005 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $483.20 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $483.20" N 51800 01NOV2006 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $493.35 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $493.35" N 51800 01NOV2008 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $515.80 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $515.80" N 51800 01NOV2009 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $527.65 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $527.65" N 51800 01NOV2010 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $537.15 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $537.15" N 51800 01NOV2011 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $547.90 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $547.90" N 51800 01NOV2012 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee does not exceed $558.30 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $558.30" N 51800 01JUL2019 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operationidentified by the word ""Assist.""for which the fee does not exceed$567.25 or at a series or combination of operations identified by the word ""Assist."" where the fee for the series or combination of operations identified by the word ""Assist."" does not exceed $567.25" Y 51803 01DEC1991 ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20 N 51803 01NOV1994 ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $325.45 or at a combination of operations for which the aggregate fee exceeds $325.45 provided that the fee for at least 1 of the operations exceeds $183.20 N 51803 01NOV1995 ASSISTANCE by an APPROVED DENTAL PRACTITIONER at any operation for which the fee exceeds $331.30 or at a combination of operations for which the aggregate fee exceeds $331.30 provided that the fee for at least 1 of the operations exceeds $186.50 N 51803 01NOV1996 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $331.30 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $331.30" N 51803 01MAY1997 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $410.00 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $410.00" N 51803 01NOV1997 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $416.95 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $416.95" N 51803 01NOV1998 "Assistance by an approved dental practitioner at any operation under an item in groups O3 to O9 identified by the word ""Assist."" for which the fee exceeds $423.20 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $423.20" N 51803 01NOV1999 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $429.55 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $429.55" N 51803 01NOV2000 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $434.70 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $434.70" N 51803 01NOV2001 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $441.65 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $441.65" N 51803 01NOV2002 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $452.70 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $452.70" N 51803 01NOV2003 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $464.00 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $464.00" N 51803 01NOV2004 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $473.75 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $473.75" N 51803 01NOV2005 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $483.20 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $483.20" N 51803 01NOV2006 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $493.35 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $493.35" N 51803 01NOV2008 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $515.80 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $515.80" N 51803 01NOV2009 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $527.65 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $527.65" N 51803 01NOV2010 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $537.15 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $537.15" N 51803 01NOV2011 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $547.90 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $547.90" N 51803 01NOV2012 "Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation identified by the word ""Assist."" for which the fee exceeds $558.30 or at a series or combination of operations identified by the word ""Assist."" where the aggregate fee exceeds $558.30" N 51803 01JUL2019 Assistance by an approved dental practitioner in the practice of oral and maxillofacial surgery at any operation specified in an item that includes '(Assist.)' for which the fee exceeds $567.25 or at a series or combination of operations specified in items that include '(Assist)' if the aggregate fee exceeds $567.25 Y 51900 01NOV2000 WOUND OF SOFT TISSUE IN THE ORAL AND MAXILLOFACIAL REGION, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed N 51900 01NOV2007 WOUND OF SOFT TISSUE, deep or extensively contaminated, debridement of, under general anaesthesia or regional or field nerve block, including suturing of that wound when performed Y 51902 01NOV2000 WOUNDS, OF THE ORAL AND MAXILLOFACIAL REGION, DRESSING OF, under general anaesthesia, with or without removal of sutures, not being a service associated with a service to which another item in Groups O3 to O9 applies N 51902 01NOV2007 WOUNDS, DRESSING OF, under general anaesthesia, with or without removal of sutures, not being a service associated with a service to which another item in Groups O3 to O9 applies Y 51904 01NOV2000 LIPECTOMY - wedge excision of skin or fat - 1 EXCISION N 51904 01MAY2001 LIPECTOMY - in the oral and maxillofacial region - wedge excision of skin or fat - 1 EXCISION N 51904 01NOV2007 LIPECTOMY - wedge excision of skin or fat - 1 EXCISION Y 51906 01NOV2000 LIPECTOMY - in the oral and maxillofacial region - wedge excision of skin or fat - 2 OR MORE EXCISIONS N 51906 01MAY2001 LIPECTOMY - in the oral and maxillofacial region - wedge excision of skin or fat - 2 OR MORE EXCISIONS N 51906 01NOV2007 LIPECTOMY- wedge excision of skin or fat - 2 OR MORE EXCISIONS Y 52000 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CM LONG), superficial Y 52001 01NOV1992 OPERATIVE PROCEDURE ON TISSUE, ORGAN OR REGION not being a service to which another item in Groups O3 to O9 applies, including any consultation on the same occasion Y 52003 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, small (NOT MORE THAN 7 CM LONG), involving deeper tissue Y 52006 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CM LONG), superficial Y 52009 01DEC1991 SKIN AND SUBCUTANEOUS TISSUE OR MUCOUS MEMBRANE, REPAIR OF RECENT WOUND OF, on face or neck, large (MORE THAN 7 CM LONG), involving deeper tissue Y 52010 01NOV2000 FULL THICKNESS LACERATION OF EAR, EYELID, NOSE OR LIP, repair of, with accurate apposition of each layer of tissue Y 52012 01DEC1991 SUPERFICIAL FOREIGN BODY,removal of, as an independent procedure N 52012 01MAY2001 SUPERFICIAL FOREIGN BODY,in the oral and maxillofacial region,removal of, as an independent procedure N 52012 01NOV2007 SUPERFICIAL FOREIGN BODY,removal of, as an independent procedure Y 52015 01DEC1991 SUBCUTANEOUS FOREIGN BODY, removal of, requiring incision and suture, as an independent procedure N 52015 01MAY2001 SUBCUTANEOUS FOREIGN BODY, in the oral and maxillofacial region,removal of, requiring incision and suture, as an independent procedure N 52015 01NOV2007 SUBCUTANEOUS FOREIGN BODY,removal of, requiring incision and suture, as an independent procedure Y 52018 01DEC1991 FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, removal of, as an independent procedure N 52018 01MAY2001 FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE, in the oral and maxillofacial region,removal of, as an independent procedure N 52018 01NOV2007 FOREIGN BODY IN MUSCLE, TENDON OR OTHER DEEP TISSUE,removal of, as an independent procedure Y 52021 01DEC1991 ASPIRATION BIOPSY of 1 or MORE JAW CYSTS as an independent procedure to obtain material for diagnostic purposes and not being a service associated with an operative procedure on the same day Y 52024 01DEC1991 BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure N 52024 01MAY2001 BIOPSY OF SKIN OR MUCOUS MEMBRANE, in the oral and maxillofacial region, as an independent procedure N 52024 01NOV2007 BIOPSY OF SKIN OR MUCOUS MEMBRANE, as an independent procedure Y 52025 01NOV2000 LYMPH NODE OF NECK, biopsy of Y 52027 01DEC1991 BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure N 52027 01NOV2000 BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure and not being a service to which item 52025 applies N 52027 01MAY2001 BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, in the oral and maxillofacial region, as an independent procedure and not being a service to which item 52025 applies N 52027 01NOV2007 BIOPSY OF LYMPH GLAND, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure and not being a service to which item 52025 applies N 52027 01NOV2019 BIOPSY OF LYMPH NODE, MUSCLE OR OTHER DEEP TISSUE OR ORGAN, as an independent procedure and not being a service to which item 52025 applies Y 52030 01DEC1991 SINUS, excision of, involving superficial tissue only N 52030 01MAY2001 SINUS, in the oral and maxillofacial region, excision of, involving superficial tissue only N 52030 01NOV2007 SINUS, excision of, involving superficial tissue only Y 52031 01NOV2000 PRE-AURICULAR SINUS, excision of Y 52033 01DEC1991 SINUS, excision of, involving muscle and deep tissue N 52033 01MAY2001 SINUS, in the oral and maxillofacial region, excision of, involving muscle and deep tissue N 52033 01NOV2007 SINUS, excision of, involving muscle and deep tissue Y 52034 01MAY1997 PREMALIGNANT LESIONS of the oral mucous, treatment by liquid nitrogen cryotherapy N 52034 01NOV2000 PREMALIGNANT LESIONS of the oral mucous, treatment by cryotherapy, diathermy or carbon dioxide laser Y 52035 01NOV2000 ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions or strictures of the upper aerodigestive tract N 52035 01MAY2001 ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions or strictures of the upper aerodigestive tract in the practice of oral and maxillofacial surgery N 52035 01NOV2001 ENDOSCOPIC LASER THERAPY for neoplasia and benign vascular lesions of the oral cavity Y 52036 01DEC1991 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 52039 applies N 52036 01MAY2001 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation),in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 52039 applies N 52036 01NOV2007 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, not being a service to which item 52039 applies Y 52039 01DEC1991 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions N 52039 01MAY2001 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions N 52039 01NOV2007 TUMOURS, CYSTS, ULCERS OR SCARS, (other than a scar removed during the surgical approach at an operation), up to 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane, where the removal is by surgical excision and suture, and the procedure is performed on more than 3 but not more than 10 lesions Y 52042 01DEC1991 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane N 52042 01MAY2001 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane N 52042 01NOV2007 TUMOUR, CYST, ULCER OR SCAR, (other than a scar removed during the surgical approach at an operation), more than 3 cm in diameter, removal from cutaneous or subcutaneous tissue or from mucous membrane Y 52045 01DEC1991 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5 mm separation between the cyst lining and tooth structure), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not covered by any other item in Groups O3 to O9, involving muscle, bone, or other deep tissue N 52045 01NOV1992 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in Groups O3 to O9 applies, involving muscle, bone, or other deep tissue N 52045 01MAY2001 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), in the oral and maxillofacial region, removal of, not being a service to which another item in Groups O3 to O9 applies, involving muscle, bone, or other deep tissue N 52045 01NOV2007 TUMOUR, CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), ULCER OR SCAR (other than a scar removed during the surgical approach at an operation), removal of, not being a service to which another item in Groups O3 to O9 applies, involving muscle, bone, or other deep tissue Y 52048 01DEC1991 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment), removal of, requiring wide excision, not covered by any other item in Groups O3 to O9 N 52048 01NOV1992 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), removal of, requiring wide excision, not being a service to which another item in Groups O3 to O9 applies N 52048 01MAY2001 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), in the oral and maxillofacial region, removal of, requiring wide excision, not being a service to which another item in Groups O3 to O9 applies N 52048 01NOV2007 TUMOUR OR DEEP CYST (other than a cyst associated with a tooth or tooth fragment unless it has been established by radiological examination that there is a minimum of 5mm separation between the cyst lining and tooth structure or where a tumour or cyst has been proven by positive histopathology), removal of, requiring wide excision, not being a service to which another item in Groups O3 to O9 applies Y 52051 01DEC1991 TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft N 52051 01MAY2001 TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft N 52051 01NOV2007 TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, without skin or mucosal graft Y 52054 01DEC1991 TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft N 52054 01MAY2001 TUMOUR, in the oral and maxillofacial region, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft N 52054 01NOV2007 TUMOUR, removal of, from soft tissue (including muscle, fascia and connective tissue), extensive excision of, with skin or mucosal graft Y 52055 01NOV1992 HAEMATOMA, SMALL ABSCESS OR CELLULITIS IN THE ORAL AND MAXILLOFACIAL REGION, not requiring admission to a hospital or day-hospital facility, INCISION WITH DRAINAGE OF (excluding after care) N 52055 01NOV2000 HAEMATOMA, SMALL ABSCESS OR CELLULITIS IN THE ORAL AND MAXILLOFACIAL REGION, not requiring admission to a hospital or day-hospital facility, INCISION WITH DRAINAGE OF (excluding after care) N 52055 01NOV2007 HAEMATOMA, SMALL ABSCESS OR CELLULITIS, not requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding after care) Y 52056 01NOV2000 HAEMATOMA IN THE ORAL AND MAXILLOFACIAL REGION, aspiration of N 52056 01NOV2007 HAEMATOMA, aspiration of Y 52057 01DEC1991 LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, INCISION WITH DRAINAGE OF (excluding aftercare), where undertaken in the operating theatre of a hospital or approved day-hospital facility N 52057 01NOV2000 LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion IN THE ORAL AND MAXILLOFACIAL REGION, requiring admission to a hospital or day-hospital facility, INCISION WITH DRAINAGE OF (excluding aftercare) N 52057 01NOV2007 LARGE HAEMATOMA, LARGE ABSCESS, CARBUNCLE, CELLULITIS or similar lesion, requiring admission to a hospital, INCISION WITH DRAINAGE OF (excluding aftercare) Y 52058 01NOV2000 PERCUTANEOUS DRAINAGE OF DEEP ABSCESS IN THE ORAL AND MAXILLOFACIAL REGION, usinginterventional imaging techniques - but not including imaging N 52058 01NOV2007 PERCUTANEOUS DRAINAGE OF DEEP ABSCESS, usinginterventional imaging techniques - but not including imaging Y 52059 01NOV2000 ABSCESS IN THE ORAL AND MAXILLOFACIAL REGION DRAINAGE TUBE, exchange of using interventional imaging techniques - but not including imaging N 52059 01NOV2007 ABSCESS, DRAINAGE TUBE, exchange of using interventional imaging techniques - but not including imaging Y 52060 01DEC1991 MUSCLE, excision of N 52060 01NOV2000 MUSCLE IN THE ORAL AND MAXILLOFACIAL REGION, excision of N 52060 01NOV2007 MUSCLE, excision of Y 52061 01NOV2000 MUSCLE, IN THE ORAL AND MAXILLOFACIAL REGION, RUPTURED, repair of (limited), not associated with external wound N 52061 01NOV2007 MUSCLE, RUPTURED, repair of (limited), not associated with external wound Y 52062 01NOV2000 MUSCLE, IN THE ORAL AND MAXILLOFACIAL REGION, RUPTURED, repair of (extensive), not associated with external wound N 52062 01NOV2007 MUSCLE, RUPTURED, repair of (extensive), not associated with external wound Y 52063 01DEC1991 BONE TUMOUR, INNOCENT, excision of, not being a service to which another item in Groups O3 to O9 applies N 52063 01NOV2000 BONE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, INNOCENT, excision of, not being a service to which another item in Groups O3 to O9 applies N 52063 01NOV2007 BONE TUMOUR, INNOCENT, excision of, not being a service to which another item in Groups O3 to O9 applies Y 52064 01NOV2000 BONE CYST IN THE ORAL AND MAXILLOFACIAL REGION, injection into or aspiration of N 52064 01NOV2007 BONE CYST, injection into or aspiration of Y 52066 01DEC1991 SUBMANDIBULAR GLAND, extirpation of Y 52069 01DEC1991 SUBLINGUAL GLAND, extirpation of Y 52072 01DEC1991 SALIVARY GLAND, DILATATION OR DIATHERMY of duct Y 52073 01NOV2000 SALIVARY GLAND, repair of CUTANEOUS FISTULA OF Y 52075 01DEC1991 SALIVARY GLAND, removal of CALCULUS from duct or meatotomy or marsupialisation, 1 or more such procedures Y 52078 01DEC1991 TONGUE, partial excision of Y 52081 01DEC1991 TONGUE TIE, division or excision of frenulum Y 52084 01DEC1991 TONGUE TIE, MANDIBULAR FRENULUM OR MAXILLARY FRENULUM, division or excision of frenulum, in a person aged not less than 2 years Y 52087 01DEC1991 RANULA OR MUCOUS CYST OF MOUTH, removal of Y 52090 01DEC1991 OPERATION (FOR ACUTE OSTEOMYLITIS) ON MANDIBLE OR MAXILLA (other than alveolar margins)ONE BONE N 52090 01NOV1992 OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for osteomyelitis - 1 bone N 52090 01NOV2000 OPERATION ON MANDIBLE OR MAXILLA (other than alveolar margins) for chronic osteomyelitis - 1 bone or in combination with adjoining bones Y 52092 01NOV1992 OPERATION on SKULL for OSTEOMYELITIS Y 52093 01DEC1991 OPERATION (FOR CHRONIC OSTEOMYELITIS) ON MANDIBLE OR MAXILLA OR MANDIBLE AND MAXILLA (other than alveolar margins) Y 52094 01NOV2000 OPERATION ON ANY COMBINATION OF ADJOINING BONES IN THE ORAL AND MAXILLOFACIAL REGION, being bones referred to in item 52092 N 52094 01NOV2007 OPERATION ON ANY COMBINATION OF ADJOINING BONES, being bones referred to in item 52092 Y 52095 01NOV2000 BONE GROWTH STIMULATOR IN THE ORAL AND MAXILLOFACIAL REGION, insertion of N 52095 01NOV2007 BONE GROWTH STIMULATOR, insertion of Y 52096 01DEC1991 ORTHOPAEDIC PIN OR WIRE, insertion of, into maxilla or mandible or zygoma, as an independent procedure Y 52097 01NOV2000 EXTERNAL FIXATION IN THE ORAL AND MAXILLOFACIAL REGION, removal of, in the operating theatre of a hospital or approved day-hospital facility N 52097 01NOV2007 EXTERNAL FIXATION, removal of, in the operating theatre of a hospital Y 52098 01NOV2000 EXTERNAL FIXATION IN THE ORAL AND MAXILLOFACIAL REGION, removal of, in conjunction with operations involving internal fixation or bone grafting or both N 52098 01NOV2007 EXTERNAL FIXATION, removal of, in conjunction with operations involving internal fixation or bone grafting or both Y 52099 01DEC1991 BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, per bone, not being a service associated with a service to which item 52102 or 52105 applies Y 52102 01DEC1991 BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, where undertaken in the operating theatre of a hospital or approved day-hospital facility, per bone N 52102 01NOV2007 BURIED WIRE, PIN or SCREW, 1 or more, which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, where undertaken in the operating theatre of a hospital, per bone Y 52105 01DEC1991 PLATE, 1 or more of, and associated screw and wire which were inserted for internal fixation purposes into maxilla or mandible or zygoma, removal of, requiring anaesthesia, incision, dissection and suturing, per bone, not being a service associated with a service to which item 52099 or 52102 applies Y 52106 01MAY1997 ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia where undertaken in the operating theatre of a hospital or approved day-hospital facility N 52106 01NOV2007 ARCH BARS, 1 or more, which were inserted for dental fixation purposes to the maxilla or mandible, removal of, requiring general anaesthesia where undertaken in the operating theatre of a hospital Y 52108 01DEC1991 LIP, full thickness wedge excision of, with repair by direct sutures Y 52111 01DEC1991 VERMILIONECTOMY Y 52114 01DEC1991 MANDIBLE or MAXILLA, segmental resection of, for tumours or cysts Y 52117 01DEC1991 MANDIBLE, including lower border, or MAXILLA, sub-total resection of Y 52120 01DEC1991 MANDIBLE, hemimandiblectomy of, including condylectomy where performed Y 52122 01NOV1992 MANDIBLE, HEMI-MANDIBULAR RECONSTRUCTION with BONE GRAFT, not being a service associated with a service to which item 52123 applies N 52122 01MAY1997 MANDIBLE, hemi-mandibular reconstruction of, OR MAXILLA, reconstruction of, with BONE GRAFT, PLATE, TRAY OR ALLOPLAST, not being a service associated with a service to which item 52123 applies Y 52123 01DEC1991 MANDIBLE, total resection of both sides, including condylectomies where performed Y 52126 01DEC1991 MAXILLA, total resection of Y 52129 01DEC1991 MAXILLA, total resection of both maxillae Y 52130 01NOV2000 BONE GRAFT IN THE ORAL AND MAXILLOFACIAL REGION, not being a service to which another item in Groups O3 to O9 applies N 52130 01NOV2007 BONE GRAFT, not being a service to which another item in Groups O3 to O9 applies Y 52131 01NOV2000 BONE GRAFT WITH INTERNAL FIXATION, IN THE ORAL AND MAXILLOFACIAL REGION, not being a service to which another item in Groups O3 to O9 applies N 52131 01NOV2007 BONE GRAFT WITH INTERNAL FIXATION, not being a service to which an item in the range 51900 to 53070 or the range 53203 to 53460 applies N 52131 01NOV2008 BONE GRAFT WITH INTERNAL FIXATION, not being a service to which an item in the range (a)51900 to 52186; or (b)52303 to 53460 applies Y 52132 01DEC1991 TRACHEOSTOMY Y 52133 01NOV2000 CRICOTHYROSTOMY by direct stab or Seldinger technique, using Minitrach or similar device Y 52135 01DEC1991 POST-OPERATIVE or POST-NASAL HAEMORRHAGE, or both, control of, where undertaken in the operating theatre of a hospital or approved day-hospital facility N 52135 01NOV2007 POST-OPERATIVE or POST-NASAL HAEMORRHAGE, or both, control of, where undertaken in the operating theatre of a hospital Y 52136 01NOV2000 ARTERIAL OR VENOUS ANASTOMOSIS, as an independent procedure N 52136 01MAY2001 ARTERIAL OR VENOUS ANASTOMOSIS, as an independent procedure in the practice of oral and maxillofacial surgery Y 52137 01NOV2000 ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item applies, when performed in combination with another vascular operation (including graft to graft anastomosis) N 52137 01MAY2001 ARTERIAL OR VENOUS ANASTOMOSIS not being a service to which another item applies, when performed in combination with another vascular operation (including graft to graft anastomosis) in the practice of oral and maxillofacial surgery Y 52138 01DEC1991 MAXILLARY ARTERY, ligation of Y 52141 01DEC1991 FACIAL, MANDIBULAR or LINGUAL ARTERY or VEIN or ARTERY and VEIN, ligation of, not being a service to which item 52138 applies Y 52144 01DEC1991 FOREIGN BODY, deep, removal of using interventional imaging techniques N 52144 01MAY2001 FOREIGN BODY, in the oral and maxillofacial region, deep, removal of using interventional imaging techniques N 52144 01NOV2007 FOREIGN BODY, deep, removal of using interventional imaging techniques Y 52147 01DEC1991 DUCT OF MAJOR SALIVARY GLAND, transposition of Y 52148 01NOV1992 PAROTID DUCT, repair of, using micro-surgical techniques Y 52150 01NOV2000 PAROTID GLAND, total extirpation of Y 52152 01NOV2000 PAROTID GLAND, total extirpation of, with preservation of facial nerve Y 52154 01NOV2000 RECURRENT PAROTID TUMOUR, excision of, withpreservation of facial nerve Y 52156 01NOV2000 PAROTID GLAND, SUPERFICIAL LOBECTOMY OF, with exposure of facial nerve Y 52158 01NOV2000 SUBMANDIBULAR DUCTS, relocation of, for surgical control of drooling Y 52160 01NOV2000 RADICAL EXCISION OF INTRA-ORAL TUMOUR INVOLVING RESECTION OF MANDIBLE AND LYMPH GLANDS OF NECK (commando-type operation) Y 52166 01NOV2000 LYMPH NODES OF NECK, selective dissection of 1 or 2 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck Y 52168 01NOV2000 LYMPH NODES OF NECK, selective dissection of 3 lymph node levels involving removal of soft tissue and lymph nodes from one side of the neck Y 52170 01NOV2000 LYMPH NODES OF NECK, selective dissection of 4 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve Y 52172 01NOV2000 LYMPH NODES OF NECK, bilateral dissection of levels I, II and III (bilateral supraomohyoid dissections) Y 52174 01NOV2000 LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck Y 52176 01NOV2000 LYMPH NODES OF NECK, comprehensive dissection of all 5 lymph node levels on one side of the neck with preservation of one or more of: internal jugular vein, sternocleido-mastoid muscle, or spinal accessory nerve Y 52180 01NOV2000 MALIGNANT DISEASE AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, biopsy of (not including aftercare) N 52180 01NOV2007 MALIGNANT DISEASE AGGRESSIVE OR POTENTIALLY MALIGNANT BONE OR DEEP SOFT TISSUE TUMOUR, biopsy of (not including aftercare) Y 52182 01NOV2000 BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, lesional or marginal excision of N 52182 01NOV2007 BONE OR MALIGNANT DEEP SOFT TISSUE TUMOUR, lesional or marginal excision of Y 52184 01NOV2000 BONE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, lesional or marginal excision of, combined with any 1 of: liquid nitrogen freezing, autograft, allograft or cementation N 52184 01NOV2007 BONE TUMOUR, lesional or marginal excision of, combined with any 1 of: liquid nitrogen freezing, autograft, allograft or cementation Y 52186 01NOV2000 BONE TUMOUR IN THE ORAL AND MAXILLOFACIAL REGION, lesional or marginal excision of, combined with any 2 or more of: liquid nitrogen freezing, autograft, allograft or cementation N 52186 01NOV2007 BONE TUMOUR, lesional or marginal excision of, combined with any 2 or more of: liquid nitrogen freezing, autograft, allograft or cementation Y 52300 01DEC1991 SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with skin or mucosa N 52300 01MAY2001 SINGLE-STAGE LOCAL FLAP, in the oral and maxillofacial region, where indicated, repair to 1 defect, with skin or mucosa N 52300 01NOV2007 SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with skin or mucosa Y 52303 01DEC1991 SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with buccal pad of fat N 52303 01MAY2001 SINGLE-STAGE LOCAL FLAP, in the oral and maxillofacial region, where indicated, repair to 1 defect, with buccal pad of fat N 52303 01NOV2007 SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, with buccal pad of fat Y 52306 01DEC1991 SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, using temporalis muscle N 52306 01MAY2001 SINGLE-STAGE LOCAL FLAP, in the oral and maxillofacial region, where indicated, repair to 1 defect, using temporalis muscle N 52306 01NOV2007 SINGLE-STAGE LOCAL FLAP, where indicated, repair to 1 defect, using temporalis muscle Y 52309 01DEC1991 FREE GRAFTING (mucosa or split skin) of a granulating area N 52309 01MAY2001 FREE GRAFTING (mucosa or split skin) of a granulating area in the oral and maxillofacial region, N 52309 01NOV2007 FREE GRAFTING (mucosa or split skin) of a granulating area Y 52312 01DEC1991 FREE GRAFTING (mucosa or split skin) to 1 defect, including elective dissection N 52312 01NOV1995 FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect including elective dissection N 52312 01MAY2001 FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect in the oral and maxillofacial region, including elective dissection N 52312 01NOV2007 FREE GRAFTING (mucosa, split skin or connective tissue) to 1 defect, including elective dissection Y 52315 01DEC1991 FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin) N 52315 01MAY2001 FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin) in the oral and maxillofacial region N 52315 01NOV2007 FREE GRAFTING, FULL THICKNESS, to 1 defect (mucosa or skin) Y 52318 01DEC1991 HARVESTING OF BONE GRAFT via separate incision, associated with any other item in Groups O3 to O9 - autogenous N 52318 01APR1992 BONE GRAFT, harvesting of, via separate incision, being a service associated with a service to which another item in Groups O3 to O9 applies - Autogenous - small quantity Y 52319 01APR1992 BONE GRAFT, harvesting of, via separate incision, being a service associated with a service to which another item in Groups O3 to O9 applies - Autogenous - large quantity Y 52320 01NOV2000 VASCULARISED PEDICLE BONE GRAFT TO BE USED IN THE ORAL AND MAXILLOFACIAL REGION, harvesting of, in conjunction with another service Y 52321 01DEC1991 FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of, for CONTOUR RECONSTRUCTION of pathological deformity, not being a service associated with a service to which item 52624 applies N 52321 01MAY2001 FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of in the oral and maxillofacial region, for CONTOUR RECONSTRUCTION of pathological deformity, not being a service associated with a service to which item 52624 applies N 52321 01NOV2007 FOREIGN IMPLANT (NON-BIOLOGICAL), insertion of, for CONTOUR RECONSTRUCTION of pathological deformity, not being a service associated with a service to which item 52624 applies Y 52324 01DEC1991 DIRECT FLAP REPAIR, using tongue, first stage Y 52327 01DEC1991 DIRECT FLAP REPAIR, using tongue, second stage Y 52330 01DEC1991 PALATAL DEFECT (oro-nasal fistula), plastic closure of, including services to which item 52300, 52303, 52306 or 52324 applies Y 52333 01DEC1991 CLEFT PALATE, primary repair Y 52336 01DEC1991 CLEFT PALATE, secondary repair, closure of fistula using local flaps Y 52337 01MAY1997 ALVEOLAR CLEFT (congenital) unilateral, grafting of, including plastic closure of associated oro-nasal fistulae and ridge augmentation Y 52339 01DEC1991 CLEFT PALATE, secondary repair, lengthening procedure Y 52342 01DEC1991 MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site Y 52345 01DEC1991 MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52345 01NOV2000 MANDIBLE or MAXILLA, unilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 52348 01DEC1991 MANDIBLE or MAXILLA, bilateral osteotomy or osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site Y 52351 01DEC1991 MANDIBLE or MAXILLA, bilateral osteotomy of osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52351 01NOV2000 MANDIBLE or MAXILLA, bilateral osteotomy of osteectomy of, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 52354 01DEC1991 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site Y 52357 01DEC1991 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52357 01NOV2000 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 3 or more such procedures on the 1 jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 52360 01DEC1991 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site N 52360 01JUL1998 MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site Y 52363 01DEC1991 MANDIBLE or MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52363 01JUL1998 MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52363 01NOV2000 MANDIBLE and MAXILLA, osteotomies or osteectomies of, involving 2 such procedures of each jaw, including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 52366 01DEC1991 MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site N 52366 01JUL1998 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site Y 52369 01DEC1991 MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52369 01JUL1998 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52369 01NOV2000 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of 1 jaw and 2 such procedures of the other jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 52372 01DEC1991 MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site N 52372 01JUL1998 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site Y 52375 01DEC1991 MANDIBLE or MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52375 01JUL1998 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52375 01NOV2000 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination N 52375 01JAN2015 MANDIBLE and MAXILLA, complex bilateral osteotomies or osteectomies of, involving 3 or more such procedures of each jaw, including genioplasty when performed and transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination (H) Y 52378 01DEC1991 GENIOPLASTY including transposition of nerves and vessels and bone grafts taken from the same site Y 52379 01NOV1992 FACE, contour reconstruction of 1 region, using autogenous bone or cartilage graft Y 52380 01NOV1992 MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site Y 52382 01NOV1992 MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and rigid fixation by bone plates, screws or both N 52382 01NOV2000 MIDFACIAL OSTEOTOMIES - Le Fort II, Modified Le Fort III (Nasomalar), Modified Le Fort III (Malar-Maxillary), Le Fort III involving 3 or more osteotomies of the midface including transposition of nerves and vessels and bone grafts taken from the same site and stabilisation with fixation by wires, screws, plates or pins, or any combination Y 52420 01NOV1992 MANDIBLE, fixation by intermaxillary wiring, excluding wiring for obesity Y 52424 01NOV2000 DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) IN THE ORAL AND MAXILLOFACIAL REGION N 52424 01NOV2007 DERMIS, DERMOFAT OR FASCIA GRAFT (excluding transfer of fat by injection) Y 52430 01NOV2000 MICROVASCULAR REPAIR OF THE ORAL AND MAXILLOFACIAL REGION using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit N 52430 01NOV2007 MICROVASCULAR REPAIR OF, using microsurgical techniques, with restoration of continuity of artery or vein of distal extremity or digit Y 52432 01NOV2000 MICROVASCULAR ANASTOMOSIS of artery or vein IN THE ORAL AND MAXILLOFACIAL REGION using microsurgical techniques, for free transfer of tissue including setting in of free flap Y 52434 01NOV2000 MICRO-ARTERIAL OR MICRO-VENOUS GRAFT IN THE ORAL AND MAXILLOFACIAL REGION using microsurgical techniques Y 52440 01NOV2000 CLEFT LIP, unilateral - primary repair, 1 stage, without anterior palate repair Y 52442 01NOV2000 CLEFT LIP, unilateral - primary repair, 1 stage, with anterior palate repair Y 52444 01NOV2000 CLEFT LIP, bilateral - primary repair, 1 stage, without anterior palate repair Y 52446 01NOV2000 CLEFT LIP, bilateral - primary repair, 1 stage, with anterior palate repair Y 52448 01NOV2000 CLEFT LIP, lip adhesion procedure, unilateral or bilateral Y 52450 01NOV2000 CLEFT LIP, partial revision, including minor flap revision alignment and adjustment, including revision of minor whistle deformity if performed Y 52452 01NOV2000 CLEFT LIP, total revision, including major flap revision, muscle reconstruction and revision of major whistle deformity Y 52454 01NOV2000 CLEFT LIP, primary columella lengthening procedure, bilateral Y 52456 01NOV2000 CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), first stage Y 52458 01NOV2000 CLEFT LIP RECONSTRUCTION using full thickness flap (Abbe or similar), second stage Y 52460 01NOV2000 VELO-PHARYNGEAL INCOMPETENCE, pharyngeal flap for, or pharyngoplasty for Y 52470 01NOV2000 FACIAL NERVE PALSY, excision of tissue for Y 52476 01NOV2000 EYELID closure in facial nerve paralysis, insertion of foreign implant for Y 52478 01NOV2000 EYELID, WHOLE THICKNESS RECONSTRUCTION OF other than by direct suture only Y 52480 01NOV2000 COMPOSITE GRAFT (Chondro-cutaneous or chondro-mucosal) to nose, ear or eyelid Y 52482 01NOV2000 MACROCHEILIA or macroglossia, operation for Y 52484 01NOV2000 MACROSTOMIA, operation for Y 52600 01DEC1991 MANDIBULAR OR PALATAL EXOSTOSIS, excision of Y 52603 01DEC1991 MYLOHYOID RIDGE, reduction of Y 52606 01DEC1991 MAXILLARY TUBEROSITY, reduction of Y 52609 01DEC1991 PAPILLARY HYPERPLASIA OF THE PALATE, removal of - less than 5 lesions Y 52612 01DEC1991 PAPILLARY HYPERPLASIA OF THE PALATE, removal of - 5 to 20 lesions Y 52615 01DEC1991 PAPILLARY HYPERPLASIA OF THE PALATE, removal of - more than 20 lesions Y 52618 01DEC1991 VESTIBULOPLASTY, submucosal or open, including excision of muscle and skin or mucosal graft when performed - unilateral or bilateral Y 52621 01DEC1991 FLOOR OF MOUTH LOWERING (Obwegeser or similar procedure), including excision of muscle and skin or mucosal graft when performed - unilateral Y 52624 01DEC1991 ALVEOLAR RIDGE AUGMENTATION with bone or alloplast or both - unilateral Y 52626 01NOV1992 ALVEOLAR RIDGE AUGMENTATION - unilateral, insertion of tissue expanding device into maxillary or mandibular alveolar ridge region for Y 52627 01DEC1991 OSSEO-INTEGRATION PROCEDURE - extra oral implantation of titanium fixture N 52627 01MAY2001 OSSEO-INTEGRATION PROCEDURE - in the practice of oral and maxillofacial surgery, extra oral implantation of titanium fixture Y 52630 01DEC1991 OSSEO-INTEGRATION PROCEDURE - fixation of transcutaneous abutment N 52630 01MAY2001 OSSEO-INTEGRATION PROCEDURE - in the practice of oral and maxillofacial surgery, fixation of transcutaneous abutment Y 52633 01MAY1997 OSSEO-INTEGRATION PROCEDURE - intra-oral implantation of titanium fixture to facilitate restoration of the dentition following resection of part of the maxilla or mandible for benign or malignant tumours Y 52636 01MAY1997 OSSEO-INTEGRATION PROCEDURE - fixation of transmucosal abutment to fixtures placed following resection of part of the maxilla or mandible for benign or malignant tumours Y 52800 01DEC1991 NEUROLYSIS BY OPEN OPERATION, without transposition, not being a service associated with a service to which item 52803 applies N 52800 01MAY2001 NEUROLYSIS BY OPEN OPERATION, in the oral and maxillofacial region, without transposition, not being a service associated with a service to which item 52803 applies N 52800 01NOV2007 NEUROLYSIS BY OPEN OPERATION, without transposition, not being a service associated with a service to which item 52803 applies Y 52803 01DEC1991 NERVE TRUNK, internal (interfascicular), NEUROLYSIS of, using microsurgical techniques N 52803 01MAY2001 NERVE TRUNK, internal (interfascicular), in the oral and maxillofacial region, NEUROLYSIS of, using microsurgical techniques N 52803 01NOV2007 NERVE TRUNK, internal (interfascicular), NEUROLYSIS of, using microsurgical techniques Y 52806 01DEC1991 NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve N 52806 01MAY2001 NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve in the oral and maxillofacial region N 52806 01NOV2007 NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from superficial peripheral nerve Y 52809 01DEC1991 NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve N 52809 01MAY2001 NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve in the oral and maxillofacial region N 52809 01NOV2007 NEURECTOMY, NEUROTOMY or REMOVAL OF TUMOUR from deep peripheral nerve Y 52812 01DEC1991 NERVE TRUNK, PRIMARY repair of, using microsurgical techniques N 52812 01MAY2001 NERVE TRUNK, in the oral and maxillofacial region, PRIMARY repair of, using microsurgical techniques N 52812 01NOV2007 NERVE TRUNK, PRIMARY repair of, using microsurgical techniques Y 52815 01DEC1991 NERVE TRUNK, SECONDARY repair of, using microsurgical techniques N 52815 01MAY2001 NERVE TRUNK, in the oral and maxillofacial region, SECONDARY repair of, using microsurgical techniques N 52815 01NOV2007 NERVE TRUNK, SECONDARY repair of, using microsurgical techniques Y 52818 01DEC1991 NERVE, TRANSPOSITION OF N 52818 01MAY2001 NERVE, in the oral and maxillofacial region, TRANSPOSITION OF N 52818 01NOV2007 NERVE, TRANSPOSITION OF Y 52821 01DEC1991 NERVE GRAFT TO NERVE TRUNK (cable graft) including harvesting of nerve graft using microsurgical techniques N 52821 01MAY2001 NERVE GRAFT TO NERVE TRUNK in the oral and maxillofacial region (cable graft) including harvesting of nerve graft using microsurgical techniques N 52821 01NOV2007 NERVE GRAFT TO NERVE TRUNK, (cable graft) including harvesting of nerve graft using microsurgical techniques Y 52824 01DEC1991 PERIPHERAL BRANCHES OF THE TRIGEMINAL NERVE, cryosurgery of, for pain relief Y 52826 01NOV2000 INJECTION OF PRIMARY BRANCH OF TRIGEMINAL NERVE with alcohol, cortisone, phenol, or similar substance Y 52828 01NOV2000 CUTANEOUS NERVE, primary repair of, using microsurgical techniques N 52828 01MAY2001 CUTANEOUS NERVE, in the oral and maxillofacial region, primary repair of, using microsurgical techniques N 52828 01NOV2007 CUTANEOUS NERVE,primary repair of, using microsurgical techniques Y 52830 01NOV2000 CUTANEOUS NERVE, secondary repair of, using microsurgical techniques N 52830 01MAY2001 CUTANEOUS NERVE, in the oral and maxillofacial region, secondary repair of, using microsurgical techniques N 52830 01NOV2007 CUTANEOUS NERVE,secondary repair of, using microsurgical techniques Y 52832 01NOV2000 CUTANEOUS NERVE, nerve graft to, using microsurgical techniques N 52832 01MAY2001 CUTANEOUS NERVE, in the oral and maxillofacial region, nerve graft to, using microsurgical techniques N 52832 01NOV2007 CUTANEOUS NERVE, nerve graft to, using microsurgical techniques Y 53000 01DEC1991 MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF Y 53003 01DEC1991 MAXILLARY ANTRUM, PROOF PUNCTURE AND LAVAGE OF, where undertaken in the operating theatre of a hospital or approved day-hospital facility - not being a service associated with a service to which another item in Groups O3 to O9 applies N 53003 01NOV2000 MAXILLARY ANTRUM, proof puncture and lavage of, under general anaesthesia (requiring admission to hospital) not being a service associated with a service to which another item in Groups O3 to O9 applies Y 53004 01NOV2000 MAXILLARY ANTRUM, LAVAGE OF - each attendance at which the procedure is performed, including any associated consultation Y 53006 01DEC1991 ANTROSTOMY (RADICAL) Y 53007 01NOV2000 ANTROSTOMY (RADICAL) with transantral ethmoidectomy or transantral vidian neurectomy Y 53009 01DEC1991 ANTRUM, intranasal operation on, or removal of foreign body from Y 53012 01DEC1991 ANTRUM, drainage of, through tooth socket Y 53015 01DEC1991 ORO-ANTRAL FISTULA, plastic closure of Y 53016 01MAY1997 NASAL SEPTUM, septoplasty, submucous resection or closure of septal perforation Y 53017 01NOV2000 NASAL SEPTUM, reconstruction of Y 53018 01DEC1991 TURBINECTOMY or TURBINECTOMIES, partial or total, unilateral Y 53019 01NOV1992 MAXILLARY SINUS, BONE GRAFT to floor of maxillary sinus following elevation of mucosal lining (sinus lift procedure), (unilateral) Y 53050 01NOV2000 LATERAL RHINOTOMY with removal of tumour Y 53052 01NOV2000 POST-NASAL SPACE, direct examination of, with or without biopsy Y 53054 01NOV2000 NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX and LARYNX, one or more of these procedures N 53054 01NOV2001 NASENDOSCOPY or SINOSCOPY or FIBREOPTIC EXAMINATION of NASOPHARYNX one or more of these procedures Y 53056 01NOV2000 EXAMINATION OF NASAL CAVITY or POST-NASAL SPACE, or NASAL CAVITY AND POST-NASAL SPACE, UNDER GENERAL ANAESTHESIA, not being a service associated with a service to which another item in this Group applies Y 53058 01NOV2000 NASAL HAEMORRHAGE, POSTERIOR, ARREST OF, with posterior nasal packing with or without cauterisation and with or without anterior pack (excluding aftercare) Y 53060 01NOV2000 CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, TURBINATES OR PHARYNX FOR OBSTRUCTION OR HAEMORRHAGE SECONDARY TO SURGERY (OR TRAUMA) - 1 or more of these procedures (including any consultation on the same occasion) not being a service associated with any other operation on the nose N 53060 01NOV2001 CAUTERISATION (other than by chemical means) OR CAUTERISATION by chemical means when performed under general anaesthesia OR DIATHERMY OF SEPTUM, TURBINATES FOR OBSTRUCTION OR HAEMORRHAGE SECONDARY TO SURGERY (OR TRAUMA) - 1 or more of these procedures (including any consultation on the same occasion) not being a service associated with any other operation on the nose Y 53062 01NOV2000 POST SURGICAL NASAL HAEMORRHAGE, arrest of during an episode of epistaxis by cauterisation or nasal cavity packing or both Y 53064 01NOV2000 CRYOTHERAPY TO NOSE in the treatment of nasal haemorrhage Y 53066 01NOV2000 DISLOCATION OF TURBINATE OR TURBINATES, 1 or both sides, not being a service associated with a service to which another item in this Group applies Y 53068 01NOV2000 TURBINECTOMY or TURBINECTOMIES, partial or total, unilateral Y 53070 01NOV2000 TURBINATES, submucous resection of, unilateral Y 53200 01DEC1991 MANDIBLE, treatment of a dislocation of, not requiring open reduction Y 53203 01DEC1991 MANDIBLE, treatment of a dislocation of, requiring open reduction Y 53206 01DEC1991 TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre of a hospital or approved day-hospital facility, not being a service associated with a service to which another item in Groups O3 to O9 applies N 53206 01NOV2007 TEMPOROMANDIBULAR JOINT, manipulation of, performed in the operating theatre of a hospital, not being a service associated with a service to which another item in Groups O3 to O9 applies Y 53209 01DEC1991 GLENOID FOSSA, ZYGOMATIC ARCH and TEMPORAL BONE, reconstruction of (Obwegeser technique) Y 53212 01DEC1991 ABSENT CONDYLE and ASCENDING RAMUS in hemifacial microsomia, construction of, not including harvesting of graft material Y 53215 01DEC1991 TEMPOROMANDIBULAR JOINT, arthroscopy of, with or without biopsy, not being a service associated with any other arthroscopic procedure of that joint Y 53218 01DEC1991 TEMPOROMANDIBULAR JOINT, arthroscopy of, removal of loose bodies, debridement, or treatment of adhesions - 1 or more such procedures Y 53220 01NOV2000 TEMPOROMANDIBULAR JOINT, arthrotomy of, not being a service to which another item in this Group applies Y 53221 01DEC1991 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without microsurgical techniques Y 53224 01DEC1991 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with condylectomy or condylotomy, with or without microsurgical techniques Y 53225 01NOV1992 ARTHROCENTESIS, irrigation of temporomandibular joint after insertion of 2 cannuli into the appropriate joint space(s) Y 53226 01NOV2000 TEMPOROMANDIBULAR JOINT, synovectomy of, not being a service to which another item in this Group applies Y 53227 01DEC1991 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with or without meniscus or capsular surgery, including meniscectomy when performed, with or without microsurgical techniques Y 53230 01DEC1991 TEMPOROMANDIBULAR JOINT, open surgical exploration of, with meniscus, capsular and condylar head surgery, with or without microsurgical techniques Y 53233 01DEC1991 TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 53224, 53227 and 53230 apply and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques N 53233 01NOV2000 TEMPOROMANDIBULAR JOINT, surgery of, involving procedures to which items 53224, 53226, 53227 and 53230 apply and also involving the use of tissue flaps, or cartilage graft, or allograft implants, with or without microsurgical techniques Y 53236 01NOV2000 TEMPOROMANDIBULAR JOINT, stabilisation of, involving 1 or more of: repair of capsule, repair of ligament or internal fixation, not being a service to which another item in this Group applies Y 53239 01NOV2000 TEMPOROMANDIBULAR JOINT, arthrodesis of, not being a service to which another item in this Group applies Y 53242 01NOV2000 TEMPOROMANDIBULAR JOINT OR JOINTS, application of external fixator to, other than for treatment of fractures Y 53400 01DEC1991 MAXILLA, unilateral or bilateral, treatment of fracture of, not requiring splinting Y 53403 01DEC1991 MANDIBLE, treatment of fracture of, not requiring splinting Y 53406 01DEC1991 MAXILLA, treatment of fracture of, requiring splinting, wiring of teeth, circumosseous fixation or external fixation Y 53409 01DEC1991 MANDIBLE, treatment of fracture of, requiringsplinting, wiring of teeth, circumosseous fixation or external fixation Y 53410 01DEC1991 ZYGOMATIC BONE, treatment of fracture of, not requiring surgical reduction Y 53411 01DEC1991 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction by a temporal, intra-oral or other approach Y 53412 01DEC1991 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation at 1 site Y 53413 01DEC1991 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 2 sites Y 53414 01DEC1991 ZYGOMATIC BONE, treatment of fracture of, requiring surgical reduction and involving internal or external fixation or both at 3 sites Y 53415 01DEC1991 MAXILLA, treatment of fracture of, requiring open operation N 53415 01APR1992 MAXILLA, treatment of fracture of, requiring open reduction Y 53416 01DEC1991 MANDIBLE, treatment of fracture of, requiring open reduction Y 53418 01DEC1991 MAXILLA, treatment of fracture of, requiring internal fixation not involving plate(s) N 53418 01APR1992 MAXILLA, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s) Y 53419 01DEC1991 MANDIBLE, treatment of fracture of, requiring internal fixation not involving plate(s) N 53419 01APR1992 MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation not involving plate(s) Y 53422 01DEC1991 MAXILLA, treatment of fracture of, requiring internal fixation involving plate(s) N 53422 01APR1992 MAXILLA, treatment of fracture of, requiring open reduction and internal fixation involving plate(s) Y 53423 01DEC1991 MANDIBLE, treatment of fracture of, requiring internal fixation involving plate(s) N 53423 01APR1992 MANDIBLE, treatment of fracture of, requiring open reduction and internal fixation involving plate(s) Y 53424 01DEC1991 MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction not involving plate(s) Y 53425 01DEC1991 MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction not involving plate(s) Y 53427 01DEC1991 MAXILLA, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction involving the use of plate(s) Y 53429 01DEC1991 MANDIBLE, treatment of a complicated fracture of, involving viscera, blood vessels or nerves, requiring open reduction involving the use of plate(s) Y 53439 01DEC1991 MANDIBLE, treatment of a closed fracture of, involving a joint surface Y 53453 01NOV1992 ORBITAL CAVITY, reconstruction of a wall or floor with or without foreign implant Y 53455 01NOV1992 ORBITAL CAVITY, bone or cartilage graft to orbital wall or floor including reduction of prolapsed or entrapped orbital contents Y 53458 01MAY1997 NASAL BONES, treatment of fracture of, not being a service to which item 53459 or 53460 applies Y 53459 01MAY1997 NASAL BONES, treatment of fracture of, by reduction Y 53460 01MAY1997 NASAL BONES, treatment of fractures of, by open reduction involving osteotomies Y 53600 01NOV2000 SKIN SENSITIVITY TESTING for allergens to anaesthetics and materials used in OMS surgery, USING 1 TO 20 ALLERGENS Y 53700 01NOV2000 (Note. Where an anaesthetic combines a regional nerve block with a general anaesthetic for an operative procedure, benefits will be paid only under the anaesthetic item relevant to the operation. The items in this Group are to be used in the practice of oral and maxillofacial surgery and are not to be used for dental procedures (eg. restorative dentistry or dental extraction.)) TRIGEMINAL NERVE, primary division of, injection of an anaesthetic agent Y 53702 01NOV2000 TRIGEMINAL NERVE, peripheral branch of, injection of an anaesthetic agent Y 53704 01NOV2000 FACIAL NERVE, injection of an anaesthetic agent Y 53706 01NOV2000 NERVE BRANCH IN THE ORAL AND MAXILLOFACIAL REGION, destruction by a neurolytic agent, not being a service to which any other item in this Group applies N 53706 01NOV2007 NERVE BRANCH, destruction by a neurolytic agent, not being a service to which any other item in this Group applies Y 55000 01DEC1991 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, not associated with Item 55003, 55006 or 55009 where the patient is not referred by a medical practitioner for ultrasonic examinationeach ultrasonic examination not exceeding two examinations in any one pregnancy (NR) N 55000 01NOV1992 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, not being a service associated with a service to which item 55003, 55004, 55006, 55102, 55105, 55112, 55118, 55124, 55130, 55201, 55204, 55225, 55231, 55234 or 55237 applies, if the patient is not referred by a medical practitioner for ultrasonic examinationeach ultrasonic examination not exceeding 2 examinations in 1 pregnancy (NR) Y 55003 01DEC1991 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not associated with Item 55000, 55006 or 55009 and where the referring medical practitioner is not a member of a group of practitioners of which the firstmentioned practitioner is a member (R) N 55003 01NOV1992 Ultrasonic crosssectional echography, performed by, or on behalf of, a medical practitioner, if: (a)the patient is referred by a medical practitioner for ultrasonic examination, not being a service associated with a service to which item 55004, 55006, 55102, 55105, 55112, 55118, 55124, 55130, 55201, 55204, 55225, 55231, 55234 or 55237 applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member (R) Y 55004 01NOV1992 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this category applies (R) Y 55005 01JUL2011 HEAD, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55006 01DEC1991 ULTRASONIC ECHOGRAPHY, UNIDIMENSIONAL, not associated with Item 55000, 55003 or 55009 (NR) N 55006 01NOV1992 ULTRASONIC ECHOGRAPHY, UNIDIMENSIONAL, not being a service associated with a service to which item 55003, 55004, 55102, 55105, 55112, 55201, 55204, 55225, 55231, 55234 or 55237 applies (NR) Y 55007 01JUL2011 HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55008 01JUL2011 ORBITAL CONTENTS, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55009 01DEC1991 ECHOCARDIOGRAPHY, not covered by Item 55000 or 55003 (R) Y 55010 01JUL2011 ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55011 01JUL2011 NECK, 1 or more structures of, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55012 01DEC1991 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries), peripheral vessels or intrathoracic or intraabdominal vascular structures (excluding cardiac and pregnancy related studies), (not associated with Item 55003)one examination and report (R) Y 55013 01JUL2011 NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55014 01JUL2011 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service to which an item in Subgroup 4,applies,where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55017, 55020, 55038, 55044, 55731 or 55732 on the same patient within 24 hours (R) (NK) N 55014 01JUL2014 Abdomen, ultrasound scan of (including scan of urinary tract when performed), if: (a)the patient is referred by a medical practitioner or participating nurse practitioner; and (b)if the patient is referred by a medical practitioner-the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)if the patient is referred by a participating nurse practitioner-the nurse practitioner does not have a business or financial arrangement with the providing practitioner; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (e) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (f)within 24 hours of the service, a service mentioned in item 55017, 55038, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (NK) Y 55015 01DEC1991 two or more examinations of the kind referred to in Item 55012 and report (not associated with Item 55003) (R) Y 55016 01JUL2011 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service to which an item in Subgroup 4,applieswhere the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55017 01JUL2011 URINARY TRACT, ultrasound scan of but not being a service associated with the service to which an item in Subgroup 4,applies,,where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55041, 55020, 55036, 55044, 55731 or 55732 on the same patient within 24 hours (R) (NK) N 55017 01JUL2014 Urinary tract, ultrasound scan of, if: (a)the patient is referred by a medical practitioner; and (b)the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d)the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (e)within 24 hours of the service, a service mentioned in item 55014, 55038, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (NK) Y 55018 01DEC1991 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography (not associated with Item 55003)examination and report (R) Y 55019 01JUL2011 URINARY TRACT, ultrasound scan of, but not being a service associated with the service to which an item in Subgroup 4,applies, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55020 01JUL2011 PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service to which an item in Subgroup 4,applies, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55014, 55017, 55036 or 55038 on the same patient within 24 hours (R) (NK) Y 55021 01DEC1991 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels and carotid vessels, with oculoplethysmography (not associated with Item 55003)examination and report (R) Y 55022 01JUL2011 PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service to which an item in Subgroup 4,applies, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55023 01JUL2011 SCROTUM, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55024 01DEC1991 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including any of the investigations covered by Item 11603, 11606 or 11609 (not associated with Item 55003)examination and report (R) Y 55025 01JUL2011 SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) (NK) Y 55026 01JUL2011 ULTRASONIC CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this Group applies (R) (NK) Y 55027 01DEC1991 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including any of the investigations covered by Item 11612 (not associated with Item 55003)examination and report (R) Y 55028 01JUL1993 HEAD, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55028 01NOV1993 HEAD, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55028 01FEB2000 HEAD, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55028 01NOV2001 HEAD, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55029 01JUL1993 HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55029 01NOV1993 HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55029 01FEB2000 HEAD, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55030 01JUL1993 ORBITAL CONTENTS, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55030 01NOV1993 ORBITAL CONTENTS, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55030 01FEB2000 ORBITAL CONTENTS, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55030 01NOV2001 ORBITAL CONTENTS, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55031 01JUL1993 ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55031 01NOV1993 ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55031 01FEB2000 ORBITAL CONTENTS, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55032 01JUL1993 NECK, 1 or more structures of, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55032 01NOV1993 NECK, 1 or more structures of, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55032 01FEB2000 NECK, 1 or more structures of, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55032 01NOV2001 NECK, 1 or more structures of, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55033 01JUL1993 NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55033 01NOV1993 NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55033 01FEB2000 NECK, 1 or more structures of, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55034 01JUL1993 BREAST, 1 or both, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55034 01NOV1993 BREAST, 1 or both, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) Y 55035 01JUL1993 BREAST, 1 or both, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55035 01NOV1993 BREAST, 1 or both, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) Y 55036 01JUL1993 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55036 01NOV1993 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55036 01SEP1999 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55042 or 55044 on the same patient within 24 hours (R) N 55036 01FEB2000 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R) N 55036 01NOV2000 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R) N 55036 01NOV2001 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R) N 55036 01NOV2011 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, where: (a)the patient is referred by a referring practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55038, 55044 or 55731 on the same patient within 24 hours (R) N 55036 01JUL2014 Abdomen, ultrasound scan of (including scan of urinary tract when performed), if: (a)the patient is referred by a medical practitioner or participating nurse practitioner for ultrasonic examination; and (b)if the patient is referred by a medical practitioner-the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)if the patient is referred by a participating nurse practitioner-the nurse practitioner does not have a business or financial arrangement with the providing practitioner; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (e)the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (f)within 24 hours of the service, a service mentioned in item 55017, 55038, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (K) Y 55037 01JUL1993 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55037 01NOV1993 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55037 01FEB2000 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) N 55037 01NOV2000 ABDOMEN, ultrasound scan of, including scan of urinary tract when undertaken but not being a service associated with the service described in item 55600 or item 55603, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55038 01JUL1993 URINARY TRACT, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55038 01NOV1993 URINARY TRACT, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55038 01FEB2000 URINARY TRACT, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55036, 55044 or 55731 on the same patient within 24 hours (R) N 55038 01NOV2000 URINARY TRACT, ultrasound scan of but not being a service associated with the service described in item 55600 or item 55603, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55036, 55044 or 55731 on the same patient within 24 hours (R) N 55038 01NOV2001 URINARY TRACT, ultrasound scan of but not being a service associated with the service described in item 55600 or item 55603, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55036, 55044 or 55731 on the same patient within 24 hours (R) N 55038 01JUL2014 Urinary tract, ultrasound scan of, if: (a)the patient is referred by a medical practitioner for ultrasonic examination; and (b)the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d)the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and (e)within 24 hours of the service, a service mentioned in item 55017, 55036, 55067 or 55065is not performed on the same patient by the providing practitioner (R) (K) Y 55039 01JUL1993 URINARY TRACT, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55039 01NOV1993 URINARY TRACT, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55039 01FEB2000 URINARY TRACT, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) N 55039 01NOV2000 URINARY TRACT, ultrasound scan of, but not being a service associated with the service described in item 55600 or item 55603, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55040 01JUL1993 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55040 01NOV1993 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) Y 55041 01JUL1993 TWO DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION including real time colour flow mapping or power doppler and report when indicated in the assessment of a known fetal anomaly where the service is performed by, or on behalf of, a medical; practitioner: (a)with recordings on videotape; and (b)not being a service associated with a service to which an item in this Groupo applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the first-mentioned practitioner is a member, payable once in any one pregnancy (R) N 55041 01NOV1993 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner for ultrasonic examination - each ultrasonic examination, not exceeding 2 examinations in any 1 pregnancy, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) Y 55042 01JUL1993 PELVIS, female, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55042 01NOV1993 PELVIS, female, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55042 01SEP1999 PELVIS, female, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55036 on the same patient within 24 hours (R) Y 55043 01JUL1993 PELVIS, female, ultrasound scan of, by any or all approaches,where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55043 01NOV1993 PELVIS, female, ultrasound scan of, by any or all approaches,where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) Y 55044 01JUL1993 PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55044 01NOV1993 PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55044 01SEP1999 PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55036 on the same patient within 24 hours (R) N 55044 01FEB2000 PELVIS, male, ultrasound scan of, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R) N 55044 01NOV2000 PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service described in item 55600 or item 55603, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R) N 55044 01NOV2001 PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service described in item 55600 or item 55603, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R) Y 55045 01JUL1993 PELVIS, male, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55045 01NOV1993 PELVIS, male, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55045 01FEB2000 PELVIS, male, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) N 55045 01NOV2000 PELVIS, male, ultrasound scan of, by any or all approaches, but not being a service associated with the service described in item 55600 or item 55603, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55046 01SEP1999 PELVIS, female, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasound examination not being a service associated with a service to which an item in subgroup 2 or 3 of this group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (c)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R). Y 55047 01SEP1999 PELVIS, female, ultrasound scan of, in association with saline infusion of the endometrial cavity by any or all approaches, where: (a)the patient is not referred by a medical practitioner and the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and (b)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR). Y 55048 01JUL1993 SCROTUM, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55048 01NOV1993 SCROTUM, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55048 01FEB2000 SCROTUM, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55048 01NOV2001 SCROTUM, ultrasound scan of, where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55049 01JUL1993 SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55049 01NOV1993 SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55049 01FEB2000 SCROTUM, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55050 01JUL1993 MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55050 01NOV1993 MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55050 01FEB2000 MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) Y 55051 01JUL1993 MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55051 01NOV1993 MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55051 01FEB2000 MUSCULO - SKELETAL, 1 or more regions, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55052 01JUL1993 JOINT, 1 or more, ultrasound scan of, performed by, or on behalf of, a medical practitioner where the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which another item in this Group applies and where the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55052 01NOV1993 JOINT, 1 or more, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55052 01FEB2000 JOINT, 1 or more, ultrasound scan of, performed by, or on behalf of, a medical practitioner where: (a)the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) Y 55053 01JUL1993 JOINT, 1 or more, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which another item in this Group applies (NR) N 55053 01NOV1993 JOINT, 1 or more, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which item 11240 or an item in Subgroups 2 or 3 of this Group applies (NR) N 55053 01FEB2000 JOINT, 1 or more, ultrasound scan of, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 of this Group applies (NR) Y 55054 01JUL1993 ULTRASONIC CROSSSECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this Group applies (R) N 55054 01NOV1993 ULTRASONIC CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this Group applies (R) Y 55055 01JUL1993 ORBITAL CONTENTS, ultrasonic echography of, unidimensional, not being a service associated with a service to which another item in this Group applies (NR) Y 55056 01JUL1993 ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which another item in this Group applies (R) N 55056 01NOV1993 ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which item 55055 or an item in Subgroups 2 or 3 of this Group applies (R) Y 55057 01JUL1993 ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which another item in this Group applies (NR) N 55057 01NOV1993 ULTRASOUND SCAN not otherwise specified, not being a service associated with a service to which item 55055 or an item in Subgroups 2 or 3 of this Group applies (NR) Y 55058 01JUL1995 MEASUREMENT OF UMBILICAL BLOOD FLOW using pulsed wave or continuous wave Doppler techniques after the 26th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - examination and report (R) Y 55059 01JUL2011 BREAST, one, ultrasound scan of, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55060 01JUL2011 BREAST, one, ultrasound scan of, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) (NK) Y 55061 01JUL2011 BREASTS, both, ultrasound scan of, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55062 01JUL2011 BREASTS, both, ultrasound scan of, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) (NK) Y 55063 01JUL2011 URINARY BLADDER, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of the Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55600, 55601, 55603, 55604, 55014, 55017, 55020, 55036, 55038, 55044, 55731, 55732 or 11917 on the same date of service (R) (NK) N 55063 01JUL2014 Urinary bladder, ultrasound scan of, by any or all approaches, if: (a)the patient is referred by a medical practitioner for ultrasonic examination; and (b)the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d)within 24 hours of the service, a service mentioned in item 11917, 55014, 55017, 55036, 55038, 55600, 55601, 55603, 55604, 55067 or 55065 is not performed on the same patient by the providing practitioner (R) (NK) Y 55064 01JUL2011 URINARY BLADDER, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 applies; and the service is not performed with item 55600, 55601, 55603, 55604, 55016, 55019, 55022, 55037, 55039, 55045, 55733, 55734 or 11917 on the same date of service (NR) (NK) N 55064 01JUL2014 Urinary bladder, ultrasound scan of, by any or all approaches, if: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c)within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55022, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (NK) N 55064 01JAN2015 Urinary bladder, ultrasound scan of, by any or all approaches, if: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c)within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (NK) Y 55065 01JUL2014 PELVIS, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2, or 3, applies; and (c)the referring practitioner is not a member of a group ofpractitioners of which the providing practitioner is a member; and (d)the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs;and (e)the service is not performed with item 55014, 55017, 55036 or 55038 on the same patient within 24 hours (R)(K) Y 55067 01JUL2014 PELVIS, ultrasound scan of, by any or all approaches, where: a)the patient is referred by a medical practitioner; and b)the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and c)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and d)the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs; and e)within 24 hours of the service, a service mentioned in item 55014, 55017, 55036 or 55038 is not performed on the same patient by the providing practitioner (R) (NK) Y 55068 01JUL2014 PELVIS, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this Group applies; and (c)the service is not solely atransrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs(NR)(K) Y 55069 01JUL2014 PELVIS, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item inSubgroup 2 or 3 of this Group applies; and (c) the service is not solely a transrectal ultrasonic examination of the prostate gland, bladder base and urethra, or any of those organs (NR) (NK) Y 55070 01FEB2000 BREAST, one, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55070 01NOV2001 BREAST, one, ultrasound scan of, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) N 55070 01NOV2011 BREAST, one, ultrasound scan of, where: (a)the patient is referred by a referring practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55073 01FEB2000 BREAST, one, ultrasound scan of, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) Y 55076 01FEB2000 BREASTS, both, ultrasound scan of, performed by or on behalf of a medical practitioner where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55076 01NOV2001 BREASTS, both, ultrasound scan of, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) N 55076 01NOV2011 BREASTS, both, ultrasound scan of, where: (a)the patient is referred by a referring practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55079 01FEB2000 BREASTS, both, ultrasound scan of, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) Y 55084 01MAY2004 URINARY BLADDER, ultrasound scan of, by any or all approaches, where: (a) the patient is referred by a medical practitioner for ultrasonic examination not being a service associated with a service to which an item in Subgroups 2 or 3 of the Group applies; and (b) the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c) the service is not performed with item 55600, 55603, 55036, 55038, 55044, 55731 or 11917 on the same date of service (R) N 55084 01JUL2014 Urinary bladder, ultrasound scan of, by any or all approaches, if: (a)the patient is referred by a medical practitioner; and (b)the medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d)within 24 hours of the service, a service mentioned in item 11917, 55014, 55017, 55036, 55038, 55600, 55601, 55603, 55604, 55067 or 55065is not performed on the same patient by the providing practitioner (R) (K) Y 55085 01MAY2004 URINARY BLADDER, ultrasound scan of, by any or all approaches, where the patient is not referred by a medical practitioner, not being a service associated with a service to which an item in Subgroups 2 or 3 applies; and the service is not performed with item 55600, 55603, 55037, 55039, 55045, 55733 or 11917 on the same date of service (NR) N 55085 01JUL2014 Urinary bladder, ultrasound scan of, by any or all approaches, if: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c)within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55022, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (K) N 55085 01JAN2015 Urinary bladder, ultrasound scan of, by any or all approaches, if: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (c)within 24 hours of the service, a service mentioned in item 11917, 55016, 55019, 55037, 55039, 55600, 55601, 55603, 55604, 55068 or 55069 is not performed on the same patient by the providing practitioner (NR) (K) Y 55100 01DEC1991 TWO DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, not associated with any other echocardiographic examination (R) Y 55102 01NOV1992 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST 2 THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R) N 55102 01JUL1993 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST 2 THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R) Y 55103 01DEC1991 TWO DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, associated with another echocardiographic examination (R) Y 55105 01NOV1992 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of cardiac dimensions, with recordings on video tape, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R) N 55105 01JUL1993 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of cardiac dimensions, with recordings on video tape, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R) Y 55106 01DEC1991 M-MODE AND TWO DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION OF THE HEART FROM AT LEAST TWO THORACIC WINDOWS, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, with recordings on video tape, not associated with Items 55000, 55003, or 55009 (R) Y 55112 01NOV1992 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, together with real time colour flow mapping from at least 2 thoracic windows, with recordings on video tape, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R) N 55112 01JUL1993 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 thoracic windows, performed using a mechanical sector scanner or phased array transducer, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 thoracic windows, with recordings on video tape, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R) N 55112 01NOV2000 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3 of this Group applies (R) Y 55113 01JUL2001 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies, for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain (R) N 55113 01MAY2002 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup (with the exception of items 55118 and 55130), applies, for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain (R) Y 55114 01JUL2001 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies, for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic, or embolic disease, or heart tumour (R) N 55114 01MAY2002 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup (with the exception of items 55118 and 55130), applies, for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic, or embolic disease, or heart tumour (R) Y 55115 01JUL2001 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies, for the investigation of symptoms or signs of congenital heart disease (R) N 55115 01MAY2002 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup (with the exception of items 55118 and 55130), applies, for the investigation of symptoms or signs of congenital heart disease (R) Y 55116 01NOV2000 EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) N 55116 01JUL2001 EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) N 55116 01MAY2002 EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup applies (with the exception of items 55118 and 55130). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) Y 55117 01NOV2000 PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose or immediately after, peak exercise. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) N 55117 01JUL2001 PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies. Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) N 55117 01MAY2002 PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies (with the exception of items 55118 and 55130). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) Y 55118 01NOV1992 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, not being a service associated with another echocardiographic examination (R) N 55118 01JUL1993 HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least 2 oesophageal windows: (i)performed using a mechanical sector scanner or phased array transducer; with (a)measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous Doppler techniques; (b)real time colour flow mapping from at least 2 oesophageal windows; and (c)recordings on video tape; and (ii)not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R) N 55118 01NOV2000 HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level, with: (a)pulsed wave Doppler examination; (b)real time colour flow mapping; and (c)recordings on video tape or digital medium; and not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, or another item in this Subgroup, applies (R) N 55118 01MAY2002 HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level, with: (a)pulsed wave Doppler examination; (b)real time colour flow mapping; and (c)recordings on video tape or digital medium; and not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, applies (R) N 55118 01JUN2003 HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level, with: (a)pulsed wave Doppler examination; (b)real time colour flow mapping; and (c)recordings on video tape or digital medium; and not being an intra-operative service or a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, applies (R) N 55118 01MAY2004 HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level: (a)with: (i)real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and (ii)recordings on video tape or digital medium; and (b)not being an intra-operative service or a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 3, applies (R) Y 55119 01JUL2011 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup (with the exception of items 55118, 55125, 55130 and 55131), applies, for the investigation of symptoms or signs of cardiac failure, or suspected or known ventricular hypertrophy or dysfunction, or chest pain (R) (NK) Y 55120 01JUL2011 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup (with the exception of items 55118, 55125, 55130 and 55131), applies, for the investigation of suspected or known acquired valvular, aortic, pericardial, thrombotic, or embolic disease, or heart tumour (R) (NK) Y 55121 01JUL2011 M-MODE and 2 DIMENSIONAL REAL TIME ECHOCARDIOGRAPHIC EXAMINATION of the heart from at least 2 acoustic windows, with measurement of blood flow velocities across the cardiac valves using pulsed wave and continuous wave Doppler techniques, and real time colour flow mapping from at least 2 acoustic windows, with recordings on video tape or digital medium, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup (with the exception of items 55118, 55125, 55130 and 55131), applies, for the investigation of symptoms or signs of congenital heart disease (R) (NK) Y 55122 01JUL2011 EXERCISE STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before exercise (baseline) from at least three acoustic windows and matching recordings from the same windows at, or immediately after, peak exercise, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup applies (with the exception of items 55118, 55125, 55130 and 55131). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) (NK) Y 55123 01JUL2011 PHARMACOLOGICAL STRESS ECHOCARDIOGRAPHY performed in conjunction with item 11712, with two-dimensional recordings before drug infusion (baseline) from at least three acoustic windows and matching recordings from the same windows at least twice during drug infusion, including a recording at the peak drug dose not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, or another item in this Subgroup, applies (with the exception of items 55118, 55125, 55130 and 55131). Recordings must be made on digital media with equipment permitting display of baseline and matching peak images on the same screen (R) (NK) Y 55124 01NOV1992 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION of the heart, being a service associated with another echocardiographic examination (R) Y 55125 01JUL2011 HEART, 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL EXAMINATION of, from at least two levels, and in more than one plane at each level: (a)with: (i)real time colour flow mapping and, if indicated, pulsed wave Doppler examination; and (ii)recordings on video tape or digital medium; and (b)not being an intra-operative service or a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 3, applies (R) (NK) Y 55130 01NOV1992 INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure (R) N 55130 01NOV2000 INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure (R) N 55130 01MAY2004 INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure - not associated with item 55135 (R) Y 55131 01JUL2011 INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac surgery incorporating sequential assessment of cardiac function before and after the surgical procedure - not associated with items 55135 and 55136 (R) (NK) Y 55135 01MAY2004 INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac valve surgery (repair or replacement) incorporating sequential assessment of cardiac function and valve competence before and after the surgical procedure - not associated with item 55130 (R) Y 55136 01JUL2011 INTRA-OPERATIVE 2 DIMENSIONAL REAL TIME TRANSOESOPHAGEAL ECHOCARDIOGRAPHY incorporating Doppler techniques with colour flow mapping and recording onto video tape or digital medium, performed during cardiac valve surgery (repair or replacement) incorporating sequential assessment of cardiac function and valve competence before and after the surgical procedure - not associated with items 55130 and 55131 (R) (NK) Y 55201 01NOV1992 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which item 55000, 55003 or 55006 applies - 1 examination and report (R) N 55201 01DEC1992 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which item 55000, 55003 or 55006 applies - 1 examination and report (R) N 55201 01JUL1993 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55201 01JUL1996 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels (with or without vertebral arteries) or peripheral vessels (excluding the cavernosal artery and dorsal artery of the penis) (with or without intra-abdominal studies necessary for views of the lower aorta) or intra-thoracic or intra-abdominal vascular structures (excluding cardiac and pregnancy related studies), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55204 01NOV1992 - 2 or more examinations of the kind referred to in item 55201 and report, not being a service associated with a service to which item 55000, 55003 or 55006 applies (R) N 55204 01JUL1993 - 2 or more examinations of the kind referred to in item 55201 and report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R) N 55204 01JUL1996 - 2 or more examinations of the kind referred to in item 55201 and report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies (R) Y 55207 01JUL1996 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence, where a specialist in diagnostic radiology, urology or general surgery (sub-specialising in vascular surgery) attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R) N 55207 01NOV1996 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence, where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R) Y 55208 01JAN1997 Confidential Item mapped to 55238 Y 55210 01JUL1996 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a)priapism; or (b)fibrosis of any type; or (c)fracture of the tunica; or (d)arteriovenous malformations; where a specialist in diagnostic radiology, urology or general surgery (sub-specialising in vascular surgery) attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and report is prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R). N 55210 01NOV1996 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a)priapism; or (b)fibrosis of any type; or (c)fracture of the tunica; or (d)arteriovenous malformations; where a specialist in diagnostic radiology, nuclearmedicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R). Y 55220 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies(R) (NK) Y 55221 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) N 55221 01JUL2019 Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which item 55222 or 55246 or an item in Subgroup 1 (with the exception of items55026 and 55054) or 4 applies (R) (NK) Y 55222 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) N 55222 01JUL2019 Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to whichitem 55221 or 55244 or an itemin Subgroup 1 (with the exception of items55026 and 55054) or 4 applies (R) (NK) Y 55223 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55224 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55225 01NOV1992 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography (not being a service associated with a service to which item 55000, 55003 or 55006 applies) - examination and report (R) N 55225 01JUL1993 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of carotid vessels, with oculoplethysmography, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R) Y 55226 01JUL2011 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra-cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri-orbital Doppler examination, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Groups applies (R) (NK) Y 55227 01JUL2011 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55228 01JUL2011 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55229 01JUL2011 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-cranial vessels, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55230 01JUL2011 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence, where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55231 01NOV1992 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels and carotid vessels, with oculoplethysmography (not being a service associated with a service to which item 55000, 55003 or 55006 applies)examination and report (R) N 55231 01JUL1993 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels and carotid vessels, with oculoplethysmography, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group appliesexamination and report (R) N 55231 01JUL1996 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels (excluding the cavernosal artery and dorsal artery of the penis) and carotid vessels, with oculoplethysmography, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group appliesexamination and report (R) Y 55232 01JUL2011 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Groups applies (R) (NK) Y 55233 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of surgically created arteriovenous fistula or surgically created arteriovenous access graft in the upper or lower limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) (NK) Y 55234 01NOV1992 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including a service referred to in item 11603, 11606 or 11609 (not being a service associated with a service to which item 55000, 55003 or 55006 applies)examination and report (R) N 55234 01JUL1993 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group appliesexamination and report (R) N 55234 01JUL1996 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis, of peripheral vessels (excluding the cavernosal artery and dorsal artery of the penis), including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group appliesexamination and report (R) Y 55235 01JUL2011 DUPLEX SCANNING, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or veins OR arteries and veins, for mapping of bypass conduit prior to vascular surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R) (NK) Y 55236 01JUL2011 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow spectral analysis and marking of veins in the lower limb below the inguinal ligament prior to varicose vein surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R) (NK) Y 55237 01NOV1992 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels before measured exercise using treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral), (not being a service associated with a service to which item 55000, 55003 or 55006 applies)examination and report (R) N 55237 01JUL1993 DUPLEX SCANNING (unilateral or bilateral) involving B mode ultrasound imaging and integrated Doppler flow measurement by spectral analysis of peripheral vessels before measured exercise using treadmill or bicycle ergometer, and measurement of pressure after exercise for 10 minutes or until pressure is normal (unilateral or bilateral), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group appliesexamination and report (R) Y 55238 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55238 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R) Y 55240 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, including a service referred to in item 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this group applies - 1 examination and report (R) Y 55242 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limb OR of arteries and bypass grafts in the lower limb, below the inguinal ligament, including a service referred to in item 11612, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55244 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) N 55244 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) N 55244 01JUL2019 Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which item 55222, 55246 or an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R) (K) Y 55245 01NOV1998 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55246 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55246 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) N 55246 01JUL2019 Duplex scanning, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which item 55221 or 55244 or an itemin Subgroup 1 (with the exception of items55026 and 55054) or 4 applies (R) (K) Y 55247 01NOV1998 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55248 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55248 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) N 55248 01JUL2019 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, not being a service associated with a service to which an item in Subgroup 1 (with the exception of items 55026 and55054) or 4 of this Group applies - (R) (K) Y 55250 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limb OR of arteries and bypass grafts in the upper limb, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55252 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroups 1 ( with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55252 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R) Y 55254 01NOV1997 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limb, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55256 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this group applies - 1 examination and report (R) N 55256 01NOV2001 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this group applies - (R) Y 55258 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55260 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the lower limbs OR of arteries and bypass grafts in the lower limbs, below the inguinal ligament, including a service referred to in item 11612, not being a service associated with a service to which an item in Subgroups 1 (with exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55262 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55262 01NOV2001 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for acute venous thrombosis, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55263 01NOV1998 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for acute venous thrombosis, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55264 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55264 01NOV2001 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limbs, below the inguinal ligament, for chronic venous disease, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55265 01NOV1998 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the lower limb, below the inguinal ligament, for chronic venous disease, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55266 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limbs OR of arteries and bypass grafts in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55266 01NOV2001 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limbs OR of arteries and bypass grafts in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55268 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or bypass grafts in the upper limbs OR of arteries and bypass grafts in the upper limbs, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55270 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55270 01NOV2001 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limbs, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55272 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of veins in the upper limbs, including a service referred to in item 11603, 11606 or 11609, not being a service associated with a service to which an item in Subgroups 1 (with the exception o f item 55054) or 4 of this Group applies - 1 examination and report (R) Y 55274 01NOV1997 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra-cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri-orbital Doppler examination, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Groups applies - 1 examination and report (R) N 55274 01NOV2001 DUPLEX SCANNING, bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of extra-cranial bilateral carotid and vertebral vessels, with or without subclavian and innominate vessels, with or without oculoplethysmography or peri-orbital Doppler examination, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Groups applies - (R) Y 55276 01NOV1997 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55276 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) N 55276 01MAY2002 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries or inferior vena cava and iliac veins OR of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55277 01NOV1998 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55277 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-abdominal, aorta and iliac arteries and inferior vena cava and iliac veins, excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55278 01NOV1997 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55278 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of not less than 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) N 55278 01MAY2002 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies - (R) Y 55279 01NOV1998 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55279 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of renal or visceral vessels OR of renal and visceral vessels, including aorta, inferior vena cava and iliac vessels as required excluding pregnancy related studies, for an examination of between 25 and 45 minutes duration, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55280 01NOV1997 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-cranial vessels, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - 1 examination and report (R) N 55280 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of intra-cranial vessels, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - (R) Y 55282 01NOV1997 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent, performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vasular aetiology for impotence, where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Group applies - examination and report (R) N 55282 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated doppler flow measurements: (a) by spectral analysis of cavernosal artery of the penis following intracavernosal administration of a vasoactive agent; and (b) performed during the period of pharmacological activity of the injected agent, to confirm a diagnosis of vascular aetiology for impotence; and (c) where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at thepractice location where the service is performed, immediately before or for a period during the performance of the service; and (d) where that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroup 1 (with the exception of items 55026 and 55054) or 4 applies (R) Y 55284 01NOV1997 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054) or 4 of this Groups applies - 1 examination and report (R) N 55284 01NOV2001 DUPLEX SCANNING involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of cavernosal tissue of the penis to confirm a diagnosis and, where indicated, assess the progress and management of: (a) priapism; or (b) fibrosis of any type; or (c) fracture of the tunica; or (d) arteriovenous malformations; where a specialist in diagnostic radiology, nuclear medicine, urology, general surgery (sub-specialising in vascular surgery) or a consultant physician in nuclear medicine attends the patient in person at the practice location where the service is rendered, immediately prior to or for a period during the rendering of the service, and that specialist or consultant physician interprets the results and prepares a report, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Groups applies - (R) Y 55286 01NOV1997 Note: For this item, the scanned area must be specified on the account or patient assignment form. DUPLEX SCANNING, unilateral or bilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of vessels not otherwise specified (excluding the cavernosal artery and the dorsal artery of the penis), not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), 3 or 4 of this Group applies - 1 examination and report (R) Y 55288 01NOV1997 NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. - TWO examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240,55242,55256,55258 and 55260; block (b) - item 55244, 55246, 55262 and 55264; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276 and 55278, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R) N 55288 01NOV1998 NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. - TWO examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240,55242,55256,55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279; not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R) N 55288 01SEP1999 NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. - TWO examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240,55242,55256,55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279; not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R) N 55288 01NOV2001 NOTE: An account issued or a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. - TWO examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238 and 55256; block (b) - item 55244, 55246, 55262, and 55264; block (c) - item 55248, and 55266; block (d) - item 55252 and 55270; block (e) - item 55276, 55277, 55278 and 55279; not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - (R) Y 55290 01NOV1997 NOTE: An account issuedor a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. THREE examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240, 55242,55256, 55258 and 55260; block (b) - item 55244, 55246, 55262 and 55264; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276 and 55278, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R) N 55290 01NOV1998 NOTE: An account issuedor a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55286) under this item. THREE examinations of the kind referred to in items 55238 to 55286 inclusive (excluding items 55282 and 55284) except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240, 55242,55256, 55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R) N 55290 01SEP1999 NOTE: An account issuedor a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. THREE examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238, 55240, 55242,55256, 55258 and 55260; block (b) - item 55244, 55245, 55246, 55247, 55262, 55263, 55264 and 55265; block (c) - item 55248, 55250, 55266 and 55268; block (d) - item 55252, 55254, 55270 and 55272; block (e) - item 55276, 55277, 55278 and 55279, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - examination and report (R) N 55290 01NOV2001 NOTE: An account issuedor a patient assignment form must show the item numbers of the examinations performed (and the area scanned where one of the examinations was of the kind referred to in item 55280) under this item. THREE examinations of the kind referred to in items 55238 to 55280 inclusive except for an examination of the kind referred to in the items shown in the blocks below, where only one examination can be provided from the items in any one block:- block (a) - item 55238 and 55256, block (b) - item 55244, 55246, 55262 and 55264; block (c) - item 55248 and 55266; block (d) - item 55252 and 55270; block (e) - item 55276, 55277, 55278 and 55279, not being a service associated with a service to which an item in Subgroups 1 (with the exception of item 55054), or 4 of this Group applies - (R) Y 55292 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of surgically created arteriovenous fistula or surgically created arteriovenous access graft in the upper or lower limb, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054) or 4 of this Group applies (R) Y 55294 01NOV2001 DUPLEX SCANNING, involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of arteries or veins OR arteries and veins, for mapping of bypass conduit prior to vascular surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R) Y 55296 01NOV2001 DUPLEX SCANNING, unilateral, involving B mode ultrasound imaging and integrated Doppler flow spectral analysis and marking of veins in the lower limb below the inguinal ligament prior to varicose vein surgery, not being a service associated with a service to which an item in Subgroups 1 (with the exception of items 55026 and 55054), 3 or 4 of this Group applies - including any associated skin marking (R) Y 55300 01JUL1993 PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a)personally by a medical practitioner using a transducer probe or probes able to operate within a frequency range of 7 to 7.5 megahertz and able to obtain both transverse and longitudinal scans; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist surgeon or consultant physician who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) N 55300 01NOV1993 PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a)personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) Y 55303 01NOV1993 PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a)personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequecies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) Y 55600 01NOV1998 PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a)personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) N 55600 01JUL2011 PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a)personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K) N 55600 01NOV2011 PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a)personally by a referring practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K) N 55600 01JUL2014 Prostate, bladder base and urethra, l ultrasound scan of, if performed: (a)personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that: (i)have a nominal frequency of 7 to 7.5 MHz or a nominal frequency range that includes frequencies of 7 to 7.5 MHz; and (ii)can obtain both axial and sagittal scans in 2 planes at right angles; and (b)after a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology, a consultant physician in medical oncology, who has: (i)examined the patient in the 60 days before the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K) N 55600 01JUL2018 Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patient's current prostatic disease (R) (K) Y 55601 01JUL2011 PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in (c)) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i) examined the patient in the 60 days prior to the scan; and (ii) recommended the scan for the management of the patient's current prostatic disease (R) (NK) N 55601 01JUL2018 Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner (not being the medical practitioner who assessed the patient as specified in paragraph (c)) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patient's current prostatic disease (R) (NK) Y 55603 01NOV1998 PROSTATE, bladder base and urethra, transrectal ultrasound scan of, where performed: (a)personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) N 55603 01JUL2011 PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a)personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b)following a digital rectal examination of the prostate by that medical practitioner; and (c)on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i)examined the patient in the 60 days prior to the scan; and (ii)recommended the scan for the management of the patient's current prostatic disease (R) (K) N 55603 01JUL2018 Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner who made the assessment mentioned in paragraph (c) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patient's current prostatic disease (R) (K) Y 55604 01JUL2011 PROSTATE, bladder base and urethra, ultrasound scan of, where performed: (a) personally by a medical practitioner who undertook the assessment referred to in (c) using a transducer probe or probes that: (i) have a nominal frequency of 7 to 7.5 megahertz or a nominal frequency range which includes frequencies of 7 to 7.5 megahertz; and (ii) can obtain both axial and sagittal scans in 2 planes at right angles; and (b) following a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by a specialist in urology, radiation oncology or medical oncology or a consultant physician in medical oncology who has: (i) examined the patient in the 60 days prior to the scan; and (ii) recommended the scan for the management of the patient's current prostatic disease (R) (NK) N 55604 01JUL2018 Prostate, bladder base and urethra, ultrasound scan of, if performed: (a) personally by a medical practitioner who made the assessment mentioned in paragraph (c) using one or more transducer probes that can obtain both axial and sagittal scans in 2 planes at right angles; and (b) after a digital rectal examination of the prostate by that medical practitioner; and (c) on a patient who has been assessed by: (i) a specialist in urology, radiation oncology or medical oncology; or (ii) a consultant physician in medical oncology; who has: (iii) examined the patient in the 60 days before the scan; and (iv) recommended the scan for the management of the patient's current prostatic disease (R) (NK) Y 55700 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)gross maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) N 55700 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) N 55700 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) N 55700 01NOV2005 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55707 (R). Fee is payable only for item 55700 or item 55707, not both items. N 55700 01NOV2007 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, if: (a)the patient is referred by a medical practitioner or participating midwife; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner -- the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife - the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f)1 or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55707 (R). Fee is payable only for item 55700 or item 55707, not both items. Y 55701 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55707 or 55714 (R) (NK). Fee is payable only for item 55700 or 55701, or, or item 55707 or 55714, not both items Y 55702 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55708 or 55716 (R) (NK). Fee is payable only for item 55702 or 55703, or, item 55707 or 55714, not both items Y 55703 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)gross maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical imcompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) N 55703 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) N 55703 01NOV2005 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55708 (R). Fee is payable only for item 55703 or item 55707, not both items. N 55703 01NOV2007 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is less than 12 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55708 (R). Fee is payable only for item 55703 or item 55707, not both items. Y 55704 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)gross maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) N 55704 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) N 55704 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) N 55704 01NOV2005 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (R) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55707 (R). Fee is payable only for item 55704 or item 55707, not both items. N 55704 01NOV2007 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, if: (a)the patient is referred by a medical practitioner or participating midwife; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner -- the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife -- the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) one or more of the following conditions are present: (i)hyperemesis gravidarum; (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormalityFootnote: for nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item number 55707 (r). fee is payable only for item 55704 or item 55707, not both items. Y 55705 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)gross maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical imcompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) N 55705 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) N 55705 01NOV2005 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the following conditions are present: (i)hyperemesis gravidarum (ii)diabetes mellitus; (iii)hypertension; (iv)toxaemia of pregnancy; (v)liver or renal disease; (vi)autoimmune disease; (vii)cardiac disease; (viii)alloimmunisation; (ix)maternal infection; (x)inflammatory bowel disease; (xi)bowel stoma; (xii)abdominal wall scarring; (xiii)previous spinal or pelvic trauma or disease; (xiv)drug dependency; (xv)thrombophilia; (xvi)significant maternal obesity; (xvii)advanced maternal age; (xviii)abdominal pain or mass; (xix)uncertain dates; (xx)high risk pregnancy; (xxi)previous post dates delivery; (xxii)previous caesarean section; (xxiii)poor obstetric history; (xxiv)suspicion of ectopic pregnancy; (xxv)risk of miscarriage; (xxvi)diminished symptoms of pregnancy; (xxvii)suspected or known cervical incompetence; (xxviii)suspected or known uterine abnormality; (xxix)pregnancy after assisted reproduction; (xxx)risk of fetal abnormality (NR) Footnote: For nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 80mm, refer to item number 55708 (R). Fee is payable only for item 55705 or item 55708, not both items. N 55705 01NOV2007 PELVIS OR ABDOMEN, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner;and (b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and (c) the service is not associated with a service to which an item in Subgroup 2 or 3 applies; and (d) one or more of the following conditions are present: (i) hyperemesis gravidarum;(ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (NR) Y 55706 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)the service is not performed in the same pregnancy as item 55709 (R) N 55706 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, if: (a)the patient is referred by a medical practitioner or participating midwife; and (b)the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner - the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife - the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f)the service is not performed in the same pregnancy as item 55709 (R) Y 55707 01NOV2005 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a)the patient is referred by a medical practitioner; and (b)the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 80mm; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)one or more of the conditions mentioned in subparagraphs (e) (i) to (xxx) of item 55704 are present; and (f)nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (g)the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (R) N 55707 01NOV2007 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, if; (a)the patient is referred by a medical practitioner or participating midwife; and (b)the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84mm; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d) if the patient is referred by a medical practitioner - the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife - the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f)at least 1 condition mentioned in paragraph (f) of item 55704 is present; and (g)nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (h)the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (R) Y 55708 01NOV2005 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a)the patient is not referred by a medical practitioner; and (b)the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 80mm; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the conditions in subparagraphs (e) (i) to (xxx) of item 55704 are present; and (e)nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (f)the service is not performed in conjunction with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (NR) N 55708 01NOV2007 PELVIS OR ABDOMEN, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84 mm; and (c) the service is not associated with a service to which an item in subgroup 2 or 3 applies; and (d) at least 1 condition mentioned in paragraph (e) of item 55704 is present; and (e) nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (f) the service is not performed with item 55700, 55703, 55704 or 55705 on the same patient within 24 hours (nr) (item is subject to subrule 11 (2)) Y 55709 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the service is not performed in the same pregnancy as item 55706 or 55713 (NR) Y 55710 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where:(a) the patient is referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and (d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and(e) one or more of the following conditions are present: (i) hyperemesis gravidarum; (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (r)Footnote: for nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item 55704 or 55707 (r) (nk). Fee is payable only for item 55704 or 55710, or, item 55707 or 55714, not both items Y 55711 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where:(a) the patient is not referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is 12 to 16 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) one or more of the following conditions are present: (i) hyperemesis gravidarum (ii) diabetes mellitus; (iii) hypertension; (iv) toxaemia of pregnancy; (v) liver or renal disease; (vi) autoimmune disease; (vii) cardiac disease; (viii) alloimmunisation; (ix) maternal infection; (x) inflammatory bowel disease; (xi) bowel stoma; (xii) abdominal wall scarring; (xiii) previous spinal or pelvic trauma or disease; (xiv) drug dependency; (xv) thrombophilia; (xvi) significant maternal obesity; (xvii) advanced maternal age; (xviii) abdominal pain or mass; (xix) uncertain dates; (xx) high risk pregnancy; (xxi) previous post dates delivery; (xxii) previous caesarean section; (xxiii) poor obstetric history; (xxiv) suspicion of ectopic pregnancy; (xxv) risk of miscarriage; (xxvi) diminished symptoms of pregnancy; (xxvii) suspected or known cervical incompetence; (xxviii) suspected or known uterine abnormality; (xxix) pregnancy after assisted reproduction; (xxx) risk of fetal abnormality (nr)Footnote: for nuchal translucency measurements performed when the pregnancy is dated by a crown rump length of 45 to 84mm, refer to item 55708 or 55716 (r) (nk). Fee is payable only for item 55705 or 55711, or, item 55708 or 55716, not both items Y 55712 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (R) N 55712 01MAY2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (R) N 55712 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as beingequivalent to a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (R) Y 55713 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner; and (b)the dating for the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member;and (e)the service is not performed in the same pregnancy as item 55709 or 55717 (R) (NK) Y 55714 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a)the patient is referred by a medical practitioner; and (b)the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84mm; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member;and (e)one or more of the conditions mentioned in subparagraphs (e) (i) to (xxx) of item 55704 or 55710 are present; and (f)nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (g)the service is not performed with item 55700, 55701, 55702, 55703, 55704, 55705, 55710 or 55711 on the same patient within 24 hours (R) (NK) Y 55715 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (NR) N 55715 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)further examination is clinically indicated in the same pregnancy to which item 55706 or 55709 applies (NR) Y 55716 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where; (a)the patient is not referred by a medical practitioner; and (b)the pregnancy (as confirmed by ultrasound) is dated by a crown rump length of 45 to 84mm; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)one or more of the conditions in subparagraphs (e) (i) to (xxx) of item 55704 or 55710 are present; and (e)nuchal translucency measurement is performed to assess the risk of fetal abnormality; and (f)the service is not performed in conjunction with item 55700, 55701, 55702, 55703, 55704, 55705, 55710 or 55711 on the same patient within 24 hours (NR) (NK) Y 55717 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the service is not performed in the same pregnancy as item 55706 or 55713 (NR) (NK) Y 55718 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, performed by or on behalf of a medical practitioner where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)the service is not performed in the same pregnancy as item 55723; and (f)one or more of the following conditions are present: (i)known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii)fetal anatomy (late booking or incomplete mid-trimester scan); (iii)malpresentation; (iv)cervical assessment; (v)clinical suspicion of amniotic fluid abnormality; (vi)clinical suspicion of placental or umbilical cord abnormality; (vii)previous complicated delivery; (viii)uterine scar assessment; (ix)uterine fibroid; (x)previous fetal death in utero or neonatal death; (xi)antepartum haemorrhage; (xii)clinical suspicion of intrauterine growth retardation; (xiii)clinical suspicion of macrosomia; (xiv)reduced fetal movements; (xv)suspected fetal death; (xvi)abnormal cardiotocography; (xvii)prolonged pregnancy; (xviii)premature labour; (xix)multiple pregnancy; (xx)fetal infection; (xxi)pregnancy after assisted reproduction; (xxii)trauma; (xxiii)diabetes mellitus; (xxiv)hypertension; (xxv)toxaemia of pregnancy; (xxvi)liver or renal disease; (xxvii)autoimmune disease; (xxviii)cardiac disease; (xxix)alloimmunisation; (xxx)maternal infection; (xxxi)inflammatory bowel disease; (xxxii)bowel stoma; (xxxiii)abdominal wall scarring; (xxxiv)previous spinal or pelvic trauma or disease; (xxxv)drug dependency; (xxxvi)thrombophilia; (xxxvii)gross maternal obesity; (xxxviii)advanced maternal age; (xxxix)abdominal pain or mass (R) N 55718 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, performed by or on behalf of a medical practitioner where: (a)the patient is referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)the service is not performed in the same pregnancy as item 55723; and (f)one or more of the following conditions are present: (i)known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii)fetal anatomy (late booking or incomplete mid-trimester scan); (iii)malpresentation; (iv)cervical assessment; (v)clinical suspicion of amniotic fluid abnormality; (vi)clinical suspicion of placental or umbilical cord abnormality; (vii)previous complicated delivery; (viii)uterine scar assessment; (ix)uterine fibroid; (x)previous fetal death in utero or neonatal death; (xi)antepartum haemorrhage; (xii)clinical suspicion of intrauterine growth retardation; (xiii)clinical suspicion of macrosomia; (xiv)reduced fetal movements; (xv)suspected fetal death; (xvi)abnormal cardiotocography; (xvii)prolonged pregnancy; (xviii)premature labour; (xix)fetal infection; (xx)pregnancy after assisted reproduction; (xxi)trauma; (xxii)diabetes mellitus; (xxiii)hypertension; (xxiv)toxaemia of pregnancy; (xxv)liver or renal disease; (xxvi)autoimmune disease; (xxvii)cardiac disease; (xxviii)alloimmunisation; (xxix)maternal infection; (xxx)inflammatory bowel disease; (xxxi)bowel stoma; (xxxii)abdominal wall scarring; (xxxiii)previous spinal or pelvic trauma or disease; (xxxiv)drug dependency; (xxxv)thrombophilia; (xxxvi)significant maternal obesity; (xxxvii)advanced maternal age; (xxxviii)abdominal pain or mass (R) N 55718 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, if:(a) the patient is referred by a medical practitioner or participating midwife; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) if the patient is referred by a medical practitioner -- the referring medical practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e) if the patient is referred by a participating midwife -- the referring midwife does not have a business or financial arrangement with the providing practitioner; and (f) the service is not performed in the same pregnancy as item 55723; and (g) 1 or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (r) Y 55719 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as beingequivalent to a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member;and (e)further examination is clinically indicated in the same pregnancy to which item 55706, 55709, 55713 or 55717 applies (R) (NK) Y 55720 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)further examination is clinically indicated in the same pregnancy to which item 55706, 55709, 55713 or 55717 applies (NR) (NK) Y 55721 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (R) N 55721 01MAY2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (R) N 55721 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has qualifications recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (R) Y 55722 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where:(a) the patient is referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member;and(e) the service is not performed in the same pregnancy as item 55723 or 55726; and(f) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (r) (nk) Y 55723 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the service is not performed in the same pregnancy as item 55718; and (e)one or more of the following conditions are present: (i)known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii)fetal anatomy (late booking or incomplete mid-trimester scan); (iii)malpresentation; (iv)cervical assessment; (v)clinical suspicion of amniotic fluid abnormality; (vi)clinical suspicion of placental or umbilical cord abnormality; (vii)previous complicated delivery; (viii)uterine scar assessment; (ix)uterine fibroid; (x)previous fetal death in utero or neonatal death; (xi)antepartum haemorrhage; (xii)clinical suspicion of intrauterine growth retardation; (xiii)clinical suspicion of macrosomia; (xiv)reduced fetal movements; (xv)suspected fetal death; (xvi)abnormal cardiotocography; (xvii)prolonged pregnancy; (xviii)premature labour; (xix)multiple pregnancy; (xx)fetal infection; (xxi)pregnancy after assisted reproduction; (xxii)trauma; (xxiii)diabetes mellitus; (xxiv)hypertension; (xxv)toxaemia of pregnancy; (xxvi)liver or renal disease; (xxvii)autoimmune disease; (xxviii)cardiac disease; (xxix)alloimmunisation; (xxx)maternal infection; (xxxi)inflammatory bowel disease; (xxxii)bowel stoma; (xxxiii)abdominal wall scarring; (xxxiv)previous spinal or pelvic trauma or disease; (xxxv)drug dependency; (xxxvi)thrombophilia; (xxxvii)gross maternal obesity; (xxxviii)advanced maternal age; (xxxix)abdominal pain or mass (NR) N 55723 01NOV2000 PELVIS OR ABDOMEN, pregnancy-related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a) the patient is not referred by a medical practitioner; and (b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c) the service is not associated with a service to which an item in subgroup 2 or 3 applies; and (d) the service is not performed in the same pregnancy as item 55718; and (e) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetalcardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy;(xviii) premature labour;(xix) fetal infection;(xx) pregnancy after assisted reproduction;(xxi) trauma;(xxii) diabetes mellitus;(xxiii) hypertension;(xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) gross maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (nr)(item is subject to subrule 11 (2)) Y 55724 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of by any or all approaches, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has qualifications recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)further examination is clinically indicated in the same pregnancy to which item 55718, 55722, 55723 or 55726 applies (R) NK) Y 55725 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricans and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (NR) N 55725 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)further examination is clinically indicated in the same pregnancy to which item 55718 or 55723 applies (NR) Y 55726 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where:(a) the patient is not referred by a medical practitioner; and(b) the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and(c) the service is not associated with a service to which an item in subgroup 2 or 3 of this group applies; and(d) the service is not performed in the same pregnancy as item 55718 or 55722; and(e) one or more of the following conditions are present: (i) known or suspected fetal abnormality or fetal cardiac arrhythmia; (ii) fetal anatomy (late booking or incomplete mid-trimester scan); (iii) malpresentation; (iv) cervical assessment; (v) clinical suspicion of amniotic fluid abnormality; (vi) clinical suspicion of placental or umbilical cord abnormality; (vii) previous complicated delivery; (viii) uterine scar assessment; (ix) uterine fibroid; (x) previous fetal death in utero or neonatal death; (xi) antepartum haemorrhage; (xii) clinical suspicion of intrauterine growth retardation; (xiii) clinical suspicion of macrosomia; (xiv) reduced fetal movements; (xv) suspected fetal death; (xvi) abnormal cardiotocography; (xvii) prolonged pregnancy; (xviii) premature labour; (xix) fetal infection; (xx) pregnancy after assisted reproduction; (xxi) trauma; (xxii) diabetes mellitus; (xxiii) hypertension; (xxiv) toxaemia of pregnancy; (xxv) liver or renal disease; (xxvi) autoimmune disease; (xxvii) cardiac disease; (xxviii) alloimmunisation; (xxix) maternal infection; (xxx) inflammatory bowel disease; (xxxi) bowel stoma; (xxxii) abdominal wall scarring; (xxxiii) previous spinal or pelvic trauma or disease; (xxxiv) drug dependency; (xxxv) thrombophilia; (xxxvi) significant maternal obesity; (xxxvii) advanced maternal age; (xxxviii) abdominal pain or mass (nr) (nk) Y 55727 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)further examination is clinically indicated in the same pregnancy to which item 55718, 55722, 55723 or 55726 applies (NR) (NK) Y 55728 01FEB2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)it can be demonstrated that a clinical condition other than a condition mentioned in paragraph (f) of item 55718 or paragraph (e) of item 55723 is present (R) N 55728 01MAY2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (e)it can be demonstrated that a clinical condition other than a condition mentioned in paragraph (f) of item 55718 or paragraph (e) of item 55723 is present (R) N 55728 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has qualifications recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as being equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)the dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (c)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (e)it can be demonstrated that a clinical condition other than a condition mentioned in paragraph (f) of item 55718 or paragraph (e) of item 55723 is present (R) Y 55729 01NOV2000 MEASUREMENT OF UMBILICAL BLOOD FLOW using pulsed wave or continuous wave Doppler techniques after the 26th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - examination and report (R) N 55729 01NOV2001 MEASUREMENT OF UMBILICAL BLOOD FLOW using pulsed wave or continuous wave Doppler techniques after the 26th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - (R) N 55729 01NOV2004 Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of the umbilical artery, and measured assessment of amniotic fluid volume after the 24th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies - (R) Y 55730 01JUL2011 Duplex scanning involving B mode ultrasound imaging and integrated Doppler flow measurements by spectral analysis of the umbilical artery, and measured assessment of amniotic fluid volume after the 24th week of gestation where the patient is referred by a medical practitioner for this procedure and where there is reason to suspect intrauterine growth retardation or a significant risk of foetal death, not being a service associated with a service to which an item in this Group applies(R) (NK) Y 55731 01FEB2000 PELVIS, FEMALE, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (d)the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R) N 55731 01NOV2001 PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (d)the service is not performed with item 55036 or 55038 on the same patient within 24 hours (R) Y 55732 01JUL2011 PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (d)the service is not performed with item 55014, 55017, 55036 or 55038 on the same patient within 24 hours (R) (NK) Y 55733 01FEB2000 PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) Y 55734 01JUL2011 PELVIS, FEMALE, ultrasound scan of, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies (NR) (NK) Y 55735 01JUL2011 PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) (NK) N 55735 01JAN2014 PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) (NK) Y 55736 01FEB2000 PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, performed by or on behalf of a medical practitioner where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of medical practitioners of which the first mentioned practitioner is a member; and (d)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) N 55736 01NOV2001 PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) N 55736 01JAN2014 PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)the referring medical practitioner is not a member of a group of medical practitioners of which the providing practitioner is a member; and (d)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (R) Y 55737 01JUL2011 PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) (NK) N 55737 01JAN2014 PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) (NK) Y 55739 01FEB2000 PELVIS, FEMALE, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) N 55739 01JAN2014 PELVIS, ultrasound scan of, in association with saline infusion of the endometrial cavity, by any or all approaches, where: (a)the patient is not referred by a medical practitioner; and (b)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (c)a previous transvaginal ultrasound has revealed an abnormality of the uterus or fallopian tube (NR) Y 55759 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e)the referring practitioner is not a member of a group of practitioners to which the first mentioned practitioner is a member; and (f)the service is not performed in conjunction with item 55706, 55709, 55712, or 55715 during the same pregnancy (R) N 55759 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e)the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f)the service is not performed in conjunction with item 55706, 55709, 55712, 55715 or 55762 during the same pregnancy (R) Y 55760 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e)the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f)the service is not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719, 57721, 55762 or 55763 during the same pregnancy (R) (NK) Y 55762 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is not referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not performed in conjunction with item 55706, 55709, 55712, 55715 or 55759during the same pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies (NR) Y 55763 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is not referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719, 55720, 55759 or 55760 during the same pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies (NR) (NK) Y 55764 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, where: (a)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e)the referring practitioner is not a member of a group of practitioners to which the first mentioned practitioner is a member; and (f)further examination is clinically indicated in the same pregnancy to which item 55759 or 55762 has been performed; and (g)not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (R) N 55764 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e)the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f)further examination is clinically indicated in the same pregnancy to which item 55759 or 55762 has been performed; and (g)not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (R) Y 55765 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, where: (a)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; and (e)the referring practitioner is not a member of a group of practitioners to which the providing practitioner is a member; and (f)further examination is clinically indicated in the same pregnancy to which item 55759, 55760, 55762 or 55763 has been performed; and (g)not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719 during the same pregnancy (R) (NK) Y 55766 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner, who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; (e)further examination is clinically indicated in the same pregnancy to which item 55759, or 55762 has been performed; and (f)not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (NR) N 55766 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; (e)further examination is clinically indicated in the same pregnancy to which item 55759, or 55762 has been performed; and (f)not performed in conjunction with item 55706, 55709, 55712 or 55715 during the same pregnancy (NR) Y 55767 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, with measurement of all parameters for dating purposes, performed by or on behalf of a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)the patient is not referred by a medical practitioner; and (b)ultrasound of the same pregnancy confirms a multiple pregnancy; and (c)the dating of the pregnancy (as confirmed by ultrasound) is 17 to 22 weeks of gestation; and (d)the service is not associated with a service to which an item in Subgroup 2 or 3 of this group applies; (e)further examination is clinically indicated in the same pregnancy to which item 55759, 55760, 55762 or 55763 has been performed; and (f)not performed in conjunction with item 55706, 55709, 55712, 55713, 55715, 55717, 55719 or 55720 during the same pregnancy (NR) (NK) Y 55768 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b)the ultrasound confirms a multiple pregnancy; and (c)the patient is referred by a medical practitioner; and (d)the service is not performed in the same pregnancy as item 55770; and (e) the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R) N 55768 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a)dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b)the ultrasound confirms a multiple pregnancy; and (c)the patient is referred by a medical practitioner; and (d)the service is not performed in the same pregnancy as item 55770; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R) N 55768 01NOV2006 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a)dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b)the ultrasound confirms a multiple pregnancy; and (c)the patient is referred by a medical practitioner; and (d)the service is not performed in the same pregnancy as item 55770 or 55771; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, or 55725, 55726 or 55727 during the same pregnancy (R) Y 55769 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a)dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b)the ultrasound confirms a multiple pregnancy; and (c)the patient is referred by a medical practitioner or participating nurse practitioner; and (d)the service is not performed in the same pregnancy as item 55770 or 55771; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (R) (NK) N 55769 01NOV2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy) of, by any or all approaches, where: (a)dating of the pregnancy (as confirmed by ultrasound) is after 22 weeks of gestation; and (b)the ultrasound confirms a multiple pregnancy; and (c)the patient is referred by a medical practitioner; and (d)the service is not performed in the same pregnancy as item 55770 or 55771; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (R) (NK) Y 55770 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy), by any or all approaches, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)the service is not performed in the same pregnancy as item 55768; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (NR) N 55770 01NOV2006 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy), by any or all approaches, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)the service is not performed in the same pregnancy as item 55768; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721, 55723 or 55725 during the same pregnancy (NR) Y 55771 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan (not exceeding 1 service in any 1 pregnancy), by any or all approaches, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)the service is not performed in the same pregnancy as item 55768 or 55759; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721, 55723, 55724,,55725, 55726 or 55727 during the same pregnancy (NR) (NK) Y 55772 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c)further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R) N 55772 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstericians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c)further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55723, 55725 or 55728 during the same pregnancy (R) N 55772 01NOV2006 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c)further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55723 or 55725 during the same pregnancy (R) Y 55773 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is referred by a medical practitioner who is a Member or Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists or who has a Diploma of Obstetrics or has a qualification recognised by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists as equivalent to a Diploma of obstetrics or has obstetric privileges at a non-metropolitan hospital; and (c)further examination is clinically indicated in the same pregnancy to which item 55768, 55769, 55770 or 55771 has been performed; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member; and (g)the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (R) (NK) Y 55774 01NOV2000 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721 55723, 55725 or 55728 during the same pregnancy (NR) N 55774 01NOV2001 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed ;and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721 55723, 55725 or 55728 during the same pregnancy (NR) N 55774 01NOV2006 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)further examination is clinically indicated in the same pregnancy to which item 55768 or 55770 has been performed ;and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721 55723 or 55725 during the same pregnancy (NR) Y 55775 01JUL2011 PELVIS OR ABDOMEN, pregnancy related or pregnancy complication, fetal development and anatomy, ultrasound scan of, by any or all approaches, performed by or on behalf of a medical practitioner who is a Member or a Fellow of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, where: (a)dating of the pregnancy as confirmed by ultrasound is after 22 weeks of gestation; and (b)the patient is not referred by a medical practitioner; and (c)further examination is clinically indicated in the same pregnancy to which item 55768, 55769, 55770 or 5571 has been performed; and (d)the pregnancy as confirmed by ultrasound is a multiple pregnancy; and (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this group applies; and (f)the service is not performed in conjunction with item 55718, 55721, 55722, 55723, 55724, 55725, 55726 or 55727 during the same pregnancy (NR) (NK) Y 55800 01NOV2000 HAND OR WRIST, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55800 01NOV2001 HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55801 01JUL2011 HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55802 01NOV2000 HAND OR WRIST, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55802 01NOV2001 HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55803 01JUL2011 HAND OR WRIST, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55804 01NOV2000 FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55804 01NOV2001 FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55805 01JUL2011 FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55806 01NOV2000 FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55806 01NOV2001 FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55807 01JUL2011 FOREARM OR ELBOW, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55808 01NOV2000 SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member. (R) N 55808 01NOV2001 SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member. (R) N 55808 01MAY2003 SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: -evaluation of injury to tendon, muscle or muscle/tendon junction; or -rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or -biceps subluxation; or -capsulitis and bursitis; or -evaluation of mass including ganglion; or -occult fracture; or -acromioclavicular joint pathology.(R) Y 55809 01JUL2011 Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific shoulder pain alone. SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: -evaluation of injury to tendon, muscle or muscle/tendon junction; or -rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or -biceps subluxation; or -capsulitis and bursitis; or -evaluation of mass including ganglion; or -occult fracture; or -acromioclavicular joint pathology (R) (NK) Y 55810 01NOV2000 SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55810 01NOV2001 SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55810 01MAY2003 SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: -evaluation of injury to tendon, muscle or muscle/tendon junction; or -rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or -biceps subluxation; or -capsulitis and bursitis; or -evaluation of mass including ganglion; or -occult fracture; or -acromioclavicular joint pathology.(NR) Y 55811 01JUL2011 Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific shoulder pain alone. SHOULDER OR UPPER ARM, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner, and where the service is provided, for the assessment of one or more of the following conditions or suspected conditions: -evaluation of injury to tendon, muscle or muscle/tendon junction; or -rotator cuff tear/calcification/tendinosis (biceps, subscapular, suspraspinatus, infraspinatus); or -biceps subluxation; or -capsulitis and bursitis; or -evaluation of mass including ganglion; or -occult fracture; or -acromioclavicular joint pathology (NR) (NK) Y 55812 01NOV2000 CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55812 01NOV2001 CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55813 01JUL2011 CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55814 01NOV2000 CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55814 01NOV2001 CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55815 01JUL2011 CHEST OR ABDOMINAL WALL, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55816 01NOV2000 HIP OR GROIN, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55816 01NOV2001 HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55817 01JUL2011 HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55818 01NOV2000 HIP OR GROIN, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (c)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies: and (d)the patient is not referred by a medical practitioner (NR) N 55818 01NOV2001 HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies: and (b)the patient is not referred by a medical practitioner (NR) Y 55819 01JUL2011 HIP OR GROIN, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies: and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55820 01NOV2000 PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (c)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (d)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55820 01NOV2001 PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providingpractitioner is a member (R) Y 55821 01JUL2011 PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providingpractitioner is a member (R) (NK) Y 55822 01NOV2000 PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (e)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (f)the patient is not referred by a medical practitioner (NR) N 55822 01NOV2001 PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55823 01JUL2011 PAEDIATRIC HIP EXAMINATION FOR DYSPLASIA, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55824 01NOV2000 BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55825 01JUL2011 BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55826 01NOV2000 BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55826 01NOV2001 BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55827 01JUL2011 BUTTOCK OR THIGH, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55828 01NOV2000 KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) N 55828 01NOV2001 KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) N 55828 01MAY2003 Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: -meniscal and cruciate ligament tears -assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: -abnormality of tendons or bursae about the knee; or -meniscal cyst, popliteal fossa cyst, mass or pseudomass; or -nerve entrapment, nerve or nerve sheath tumour; or -injury of collateral ligaments.(R) Y 55829 01JUL2011 Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: -meniscal and cruciate ligament tears -assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member, and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: -abnormality of tendons or bursae about the knee; or -meniscal cyst, popliteal fossa cyst, mass or pseudomass; or -nerve entrapment, nerve or nerve sheath tumour; or -injury of collateral ligaments (R) (NK) Y 55830 01NOV2000 KNEE, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55830 01NOV2001 KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55830 01MAY2003 Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: -meniscal and cruciate ligament tears -assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: -abnormality of tendons or bursae about the knee; or -meniscal cyst, popliteal fossa cyst, mass or pseudomass; or -nerve entrapment, nerve or nerve sheath tumour; or -injury of collateral ligaments.(NR) Y 55831 01JUL2011 Note: Benefits are only payable when referred based on the clinical indicators outlined in the item descriptions. Benefits are not payable when referred for non-specific knee pain alone or other knee condition including: -meniscal and cruciate ligament tears -assessment of chondral surfaces KNEE, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner and where the service is provided for the assessment of one or more of the following conditions or suspected conditions: -abnormality of tendons or bursae about the knee; or -meniscal cyst, popliteal fossa cyst, mass or pseudomass; or -nerve entrapment, nerve or nerve sheath tumour; or -injury of collateral ligaments (NR) (NK) Y 55832 01NOV2000 LOWER LEG, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55832 01NOV2001 LOWER LEG, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55833 01JUL2011 LOWER LEG, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55834 01NOV2000 LOWER LEG, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55834 01NOV2001 LOWER LEG, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55835 01JUL2011 LOWER LEG, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55836 01NOV2000 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where (a) the services is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b) the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55836 01NOV2001 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) N 55836 01NOV2001 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a)the services is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55836 01NOV2013 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55837 01JUL2011 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a)the services is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55838 01NOV2000 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55838 01NOV2001 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55839 01JUL2011 ANKLE OR HIND FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55840 01NOV2000 MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55840 01NOV2001 MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55841 01JUL2011 MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55842 01NOV2000 MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55842 01NOV2001 MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55843 01JUL2011 MID FOOT OR FORE FOOT, 1 or both sides, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55844 01NOV2000 ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55844 01NOV2001 ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55845 01JUL2011 ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55846 01NOV2000 ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, performed by or on behalf of a medical practitioner, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) N 55846 01NOV2001 ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) Y 55847 01JUL2011 ASSESSMENT OF A MASS ASSOCIATED WITH THE SKIN OR SUBCUTANEOUS STRUCTURES, NOT BEING A PART OF THE MUSCULOSKELETAL SYSTEM, 1 or more areas, ultrasound scan of, where: (a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and (b)the patient is not referred by a medical practitioner (NR) (NK) Y 55848 01NOV2000 MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this group applies, and not performed in conjunction with item 55054 (R) Y 55849 01JUL2011 MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which any other item in this group applies, and not performed in conjunction with item 55054 or 55026 (R) (NK) Y 55850 01NOV2000 MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, where: (a)the referring practitioner has indicated on a referral for a musculoskeletal ultrasound that a ultrasound guided intervention be performed if clinically indicated; (b)the service is not performed in conjunction with items 55054, or 55800 to 55848, and (c)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55850 01NOV2001 MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, where: (a)the referring practitioner has indicated on a referral for a musculoskeletal ultrasound that a ultrasound guided intervention be performed if clinically indicated; (b)the service is not performed in conjunction with items 55054, or 55800 to 55848, and (c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55851 01JUL2011 MUSCULOSKELETAL CROSS-SECTIONAL ECHOGRAPHY, in conjunction with a surgical procedure using interventional techniques, inclusive of a diagnostic musculoskeletal ultrasound service, where: (a)the referring practitioner has indicated on a referral for a musculoskeletal ultrasound that a ultrasound guided intervention be performed if clinically indicated; (b)the service is not performed in conjunction with items 55026, 55054, or 55800 to 55849, and (c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55852 01MAY2001 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, performed by or on behalf of a medical practitioner, where: a)the patient is referred by a medical practitioner b)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c)the referring practitioner is not a member of a group of practitioners of which the first mentioned practitioner is a member (R) N 55852 01NOV2001 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a)the patient is referred by a medical practitioner b)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) N 55852 01NOV2011 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a)the patient is referred by a referring practitioner b)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) Y 55853 01JUL2011 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a)the patient is referred by a medical practitioner b)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and c)the referring practitioner is not a member of a group of practitioners of which the providing practitioner is a member (R) (NK) Y 55854 01MAY2001 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, performed by or on behalf of a medical practitioner, where: a)the service is not associated with a service to whichan item in Subgroups 2 or 3 of this Group applies; and b)the patient is not referred by a medical practitioner (NR) N 55854 01NOV2001 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and b)the patient is not referred by a medical practitioner (NR) Y 55855 01JUL2011 PAEDIATRIC SPINE, SPINAL CORD AND OVERLYING SUBCUTANEOUS TISSUES, Ultrasound scan of, where: a)the service is not associated with a service to which an item in Subgroups 2 or 3 of this Group applies; and b)the patient is not referred by a medical practitioner (NR) (NK) Y 56000 01DEC1991 Computerised tomography - scan of brain with or without scan of internal auditory meatus without intravenous contrast medium (not covered by item 57000 or 57100) (R) (A) Y 56001 01NOV1996 HEAD COMPUTERISED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R) N 56001 01MAR1999 HEAD COMPUTED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R) (K) (Anaes.) N 56001 01JUL2018 COMPUTED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57001 applies (R) (K) (Anaes.) Y 56003 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF BRAIN with or without scan of internal auditory meatus with intravenous contrast medium (not being a service to which item 57003 or 57103 applies) (R) Y 56006 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF BRAIN with or without scan of internal auditory meatus without intravenous contrast medium (minimum of 8 slices) with intravenous contrast medium (not being a service to which item 57006 or 57106 applies) (R) Y 56007 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57007 applies (R) N 56007 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57007 applies (R) N 56007 01MAR1999 COMPUTED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57007 applies (R) (K) (Anaes.) Y 56009 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF PITUITARY FOSSA by multiple thin slices (including reconstructions) with or without intravenous contrast medium or brain scan (R) Y 56010 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when undertaken (R) N 56010 01MAR1999 COMPUTED TOMOGRAPHY - scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when undertaken (R) (K) (Anaes.) Y 56012 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF ORBITS by multiple thin slices (including reconstructions) with or without intravenous contrast medium or brain scan (R) Y 56013 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R) N 56013 01MAR1999 COMPUTED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R) (K) (Anaes.) Y 56015 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF MIDDLE EAR AND TEMPORAL BONE, unilateral or bilateral, detailed study by multiple thin slices (including reconstructions) with or without intravenous contrast medium or brain scan (R) Y 56016 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of middle ear and temporal bone, unilateral or bilateral, with or without intravenous contrast medium and with or without brain scan when undertaken (R) N 56016 01MAR1999 COMPUTED TOMOGRAPHY - scan of middle ear and temporal bone, unilateral or bilateral, with or without intravenous contrast medium and with or without brain scan when undertaken (R) (K) N 56016 01FEB2000 COMPUTED TOMOGRAPHY - scan of petrous bones in axial and coronal planes in 1 mm or 2 mm sections, with or without intravenous contrast medium, with or without scan of brain (R) (K) (Anaes.) Y 56018 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF TEMPORAL BONES WITH AIR STUDY (including reconstructions), including intrathecal injection, but not including an associated brain scan (R) Y 56019 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of temporal bones with air study (including reconstructions), with intrathecal injection but not including an associated brain scan (R) N 56019 01MAR1999 COMPUTED TOMOGRAPHY - scan of temporal bones with air study (including reconstructions), with intrathecal injection but not including an associated brain scan (R) (K) Y 56021 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF FACIAL BONES, sinuses and salivary glandsscan of 1 or more regions without intravenous contrast medium (R) Y 56022 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R) N 56022 01MAR1999 COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R) (K) (Anaes.) Y 56024 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF FACIAL BONES, sinuses and salivary glandsscan of 1 or more regions with intravenous contrast medium (R) Y 56025 01JUL2011 CONE BEAM COMPUTED TOMOGRAPHY of teeth and supporting bone structures (R) (K) Y 56026 01JUL2011 CONE BEAM COMPUTED TOMOGRAPHY of teeth and supporting bone structures (R) (NK) Y 56027 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF FACIAL BONES, sinuses and salivary glandsscan of 1 or more regions without and with intravenous contrast medium (R) Y 56028 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken (R) N 56028 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) N 56028 01MAR1999 COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) (K) N 56028 01NOV2001 COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) (K) (Anaes.) Y 56030 01FEB2000 COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (K) (Anaes.) Y 56033 01FEB2000 COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (NK) Y 56036 01FEB2000 COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, with intravenous contrast medium, where: (a)a scan without intravenous contrast medium has been undertaken; and (b)the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (K) (Anaes.) Y 56039 01FEB2000 COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, with intravenous contrast medium, where: (a)a scan without intravenous contrast medium has been undertaken; and (b)the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (NK) Y 56041 01MAR1999 COMPUTED TOMOGRAPHY - scan of brain without intravenous contrast medium, not being a service to which item 57041 applies (R) (NK) (Anaes.) Y 56047 01MAR1999 COMPUTED TOMOGRAPHY - scan of brain with intravenous contrast medium and with any scans of the brain prior to intravenous contrast injection, when undertaken, not being a service to which item 57047 applies (R) (NK) (Anaes.) Y 56050 01MAR1999 COMPUTED TOMOGRAPHY - scan of pituitary fossa with or without intravenous contrast medium and with or without brain scan when undertaken (R) (NK) (Anaes.) Y 56053 01MAR1999 COMPUTED TOMOGRAPHY - scan of orbits with or without intravenous contrast medium and with or without brain scan when undertaken (R) (NK) (Anaes.) Y 56056 01MAR1999 COMPUTED TOMOGRAPHY - scan of middle ear and temporal bone, unilateral or bilateral, with or without intravenous contrast medium and with or without brain scan when undertaken (R) (NK) N 56056 01FEB2000 COMPUTED TOMOGRAPHY - scan of petrous bones in axial and coronal planes in 1 mm or 2 mm sections, with or without intravenous contrast medium, with or without scan of brain (R) (NK) (Anaes.) Y 56059 01MAR1999 COMPUTED TOMOGRAPHY - scan of temporal bone, with air study (including reconstructions) with intrathecal injection but not including an associated brain scan (R) (NK) Y 56062 01MAR1999 COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both without intravenous contrast medium (R) (NK) (Anaes.) Y 56068 01MAR1999 COMPUTED TOMOGRAPHY - scan of facial bones, para nasal sinuses or both with intravenous contrast medium and with any scans of the facial bones, para nasal sinuses or both prior to intravenous contrast injection, when undertaken (R) (NK) (Anaes.) Y 56070 01MAY2000 COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, without intravenous contrast medium (R) (NK) (Anaes.) Y 56076 01MAY2000 COMPUTED TOMOGRAPHY - scan of facial bones, paranasal sinuses or both, with scan of brain, with intravenous contrast medium, where: (a)a scan without intravenous contrast medium has been undertaken; and (b)the service is required because the result of the scan mentioned in paragraph (a) is abnormal (R) (NK) (Anaes.) Y 56100 01DEC1991 NECK COMPUTERISED TOMOGRAPHYSCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine)scan of 1 or more regions without intravenous contrast medium (not being a service to which item 56900 applies) (R) Y 56101 01NOV1996 NECK COMPUTERISED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R) N 56101 01MAR1999 NECK COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R) (K) (Anaes.) N 56101 01JUL2018 COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56801 applies (R) (K) (Anaes.) Y 56103 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine)scan of 1 or more regions with intravenous contrast medium (not being a service to which item 56903 applies) (R) Y 56106 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SOFT TISSUES OF NECK, including larynx, pharynx and upper oesophagus (not associated with cervical spine)scan of 1 or more regions without and with intravenous contrast medium (not being a service to which item 56906 applies) (R) Y 56107 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken, not being a service to which item 56807 applies (R) N 56107 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans of soft tissues of neck including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) prior to intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56807 applies (R) N 56107 01MAR1999 COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans of soft tissues of neck including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) prior to intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56807 applies (R) (K) (Anaes.) Y 56141 01MAR1999 COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) without intravenous contrast medium, not being a service to which item 56841 applies (R) (NK) (Anaes.) Y 56147 01MAR1999 COMPUTED TOMOGRAPHY - scan of soft tissues of neck, including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) - with intravenous contrast medium and with any scans of soft tissues of neck including larynx, pharynx, upper oesophagus and salivary glands (not associated with cervical spine) prior to intravenous contrast injection, when undertaken, not being a service associated with a service to which item 56847 applies (R) (NK) (Anaes.) Y 56200 01DEC1991 SPINE COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions, 25 slices or less without intravenous contrast medium (R) Y 56203 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions, 25 slices or less with intravenous contrast medium (R) Y 56206 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions, 25 slices or less without and with intravenous contrast medium (R) Y 56209 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions, 26 or more slices without intravenous contrast medium (R) Y 56210 01NOV1996 SPINE COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) N 56210 01NOV1997 SPINE COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) N 56210 01MAR1999 SPINE COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56212 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions, 26 or more slices with intravenous contrast medium (R) Y 56215 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions, 26 or more slices without and with intravenous contrast medium (R) Y 56216 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) N 56216 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) N 56216 01MAR1999 COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56218 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF SPINE, 1 or more regions with intrathecal contrast medium, not including the preparation by intrathecal injection of contrast medium (R) Y 56219 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724, 59727 or 59730 applies and not in association with item 60957 (R) N 56219 01MAR1999 SPINE COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724 applies (R) (K) (Anaes.) N 56219 01JUL2018 COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724 applies (R) (K) (Anaes.) Y 56220 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, cervical region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56221 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, thoracic region, without intravenous contrast medium payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56223 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56224 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, cervical region, with intravenous contrast medium and with any scans of the cervical region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56225 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, thoracic region, with intravenous contrast medium and with any scans of the thoracic region of the spine prior to intravenous contrast injection when undertaken, only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56226 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, with intravenous contrast medium and with any scans of the lumbosacral region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56227 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, cervical region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56228 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, thoracic region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56229 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56230 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, cervical region, with intravenous contrast medium, and with any scans to the cerival region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56231 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, thoracic region, with intravenous contrast medium and with any scans of the thoracic region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56232 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, lumbosacral region, with intravenous contrast medium and with any scans of the lumbosacral region of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56233 01NOV2001 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56220, 56221 and 56223 without intravenous contrast medium payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56234 01NOV2001 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56224, 56225 and 56226 with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56235 01NOV2001 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56227, 56228 and 56229 without intravenous contrast medium payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56236 01NOV2001 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item COMPUTED TOMOGRAPHY - scan of spine, two examinations of the kind referred to in items 56230, 56231 and 56232 with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56237 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56238 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit, payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) Y 56239 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56240 01NOV2001 COMPUTED TOMOGRAPHY - scan of spine, three regions cervical, thoracic and lumbosacral, with intravenous contrast medium and with any scans of these regions of the spine prior to intravenous contrast injection when undertaken; only 1 benefit, payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56250 01MAR1999 COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, without intravenous contrast medium, payable once only, whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56256 01MAR1999 COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions, with intravenous contrast medium and with any scans of the spine prior to intravenous contrast injection when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) Y 56259 01MAR1999 COMPUTED TOMOGRAPHY - scan of spine, 1 or more regions with intrathecal contrast medium, including the preparation for intrathecal injection of contrast medium and any associated plain X-rays, not being a service to which item 59724 applies (R) (NK) (Anaes.) Y 56300 01DEC1991 CHEST COMPUTERISED TOMOGRAPHYSCAN OF CHEST, including lungs, mediastinum and pleura, without intravenous contrast medium (not being a service to which item 56700, 56800, 56900, 57000 or 57100 applies) (R) Y 56301 01NOV1996 CHEST AND UPPER ABDOMEN COMPUTERISED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies (R) N 56301 01MAR1999 CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.) N 56301 01MAY2006 CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) N 56301 01JUL2018 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56801 or 57001 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) Y 56303 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST, including lungs, mediastinum and pleura, with intravenous contrast medium (not being a service to which item 56703, 56803, 56903, 57003 or 57103 applies) (R) Y 56306 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST, including lungs, mediastinum and pleura, without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not being a service to which item 56706, 56806, 56906, 57006 or 57106 applies) (R) Y 56307 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken, not being a service to which item 56807 or 57007 applies (R) N 56307 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R) N 56307 01MAR1999 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies and not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.) N 56307 01MAY2006 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) Y 56341 01MAR1999 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56841 or 57041 applies and not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.) N 56341 01MAY2006 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, without intravenous contrast medium, not being a service to which item 56841 or 57041 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.) Y 56347 01MAR1999 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56847 or 57047 applies and not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.) N 56347 01MAY2006 COMPUTED TOMOGRAPHY - scan of chest, including lungs, mediastinum, chest wall and pleura, with or without scans of the upper abdomen, with intravenous contrast medium and with any scans of the chest including lungs, mediastinum, chest wall or pleura and upper abdomen prior to intravenous contrast injection, when undertaken, not being a service to which item 56847 or 57047 applies and not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.) Y 56400 01DEC1991 UPPER ABDOMEN COMPUTERISED TOMOGRAPHYSCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS without intravenous contrast medium (not being a service to which item 56700, 56800, 56900 or 57100 applies) (R) Y 56401 01NOV1996 UPPER ABDOMEN COMPUTERISED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R) N 56401 01MAR1999 UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R) (K) (Anaes.) N 56401 01JUL2018 COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) without intravenous contrast medium, not being a service to which item 56301, 56501, 56801 or 57001 applies (R) (K) (Anaes.) Y 56403 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS with intravenous contrast medium (not being a service to which item 56703, 56803, 56903 or 57103 applies) (R) Y 56406 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF UPPER ABDOMEN (diaphragm to iliac crest) or PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not being a service to which item 56706, 56806, 56906 or 57106 applies) (R) Y 56407 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest), with intravenous contrast medium and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R) N 56407 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest), with intravenous contrast medium and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R) N 56407 01MAR1999 COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) with intravenous contrast medium and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56307, 56507, 56807 or 57007 applies (R) (K) (Anaes.) Y 56409 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium not being a service associated with a service to which item 56401 applies (R) N 56409 01MAR1999 COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium not being a service associated with a service to which item 56401 applies (R) (K) (Anaes.) Y 56412 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis), with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R) N 56412 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis), with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R) N 56412 01MAR1999 COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) with intravenous contrast medium and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56407 applies (R) (K) (Anaes.) Y 56441 01MAR1999 COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest), without intravenous contrast medium, not being a service to which item 56341, 56541, 56841 or 57041 applies (R) (NK) (Anaes.) Y 56447 01MAR1999 COMPUTED TOMOGRAPHY - scan of upper abdomen only (diaphragm to iliac crest) with intravenous contrast medium, and with any scans of upper abdomen (diaphragm to iliac crest) prior to intravenous contrast injection, when undertaken, not being a service to which item 56347, 56547, 56847 or 57047 applies (R) (NK) (Anaes.) Y 56449 01MAR1999 COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) without intravenous contrast medium, not being a service to which item 56441 applies (R) (NK) (Anaes.) Y 56452 01MAR1999 COMPUTED TOMOGRAPHY - scan of pelvis only (iliac crest to pubic symphysis) with intravenous contrast medium, and with any scans of pelvis (iliac crest to pubic symphysis) prior to intravenous contrast injection, when undertaken, not being a service to which item 56447 applies (R) (NK) (Anaes.) Y 56500 01DEC1991 UPPER ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHYSCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (not being a service to which item 56700, 56800, 56900 or 57100 applies) (R) Y 56501 01NOV1996 UPPER ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not being a service to which item 56801 or 57001 applies (R) N 56501 01MAR1999 UPPER ABDOMEN AND PELVIS COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not being a service to which item 56801 or 57001 applies (R) (K) (Anaes.) N 56501 01MAY2004 UPPER ABDOMEN AND PELVIS COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy, not being a service to which item 56801 or 57001 applies (R) (K) (Anaes.) N 56501 01JUL2018 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy, not being a service to which item 56801 or 57001 applies (R) (K) (Anaes.) Y 56503 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF UPPER ABDOMEN AND PELVIS with intravenous contrast medium (not being a service to which item 56703, 56803, 56903 or 57103 applies) (R) Y 56506 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF UPPER ABDOMEN AND PELVIS without intravenous contrast medium (minimum of 8 slices) and with intravenous contrast medium (not being a service to which item 56706, 56806, 56906 or 57106 applies) (R) Y 56507 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R) N 56507 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R) N 56507 01MAR1999 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not being a service to which item 56807 or 57007 applies (R) (K) (Anaes.) N 56507 01MAY2004 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not for the purposes of virtual colonoscopy, not being a service to which item 56807 or 57007 applies (R) (K) (Anaes.) Y 56541 01MAR1999 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not being a service to which item 56841 or 57041 applies (R) (NK) (Anaes.) N 56541 01MAY2004 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis without intravenous contrast medium, not for the purposes of virtual colonoscopy, not being a service to which item 56841 or 57041 applies (R) (NK) (Anaes.) Y 56547 01MAR1999 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium, and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not being a service to which item 56847 or 57047 applies (R) (NK) (Anaes.) N 56547 01MAY2004 COMPUTED TOMOGRAPHY - scan of upper abdomen and pelvis with intravenous contrast medium, and with any scans of upper abdomen and pelvis prior to intravenous contrast injection, when undertaken, not for the purposes of virtual colonoscopy, not being a service to which item 56847 or 57047 applies (R) (NK) (Anaes.) Y 56549 01MAY2005 COMPUTED TOMOGRAPHY OF COLON, following incomplete colonoscopy in the preceding 3 months, where the patient is referred by the specialist or consultant physician who performed the incomplete colonoscopy, not being a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K) Y 56551 01MAY2005 COMPUTED TOMOGRAPHY OF COLON, where the patient is referred by a specialist or consultant physician and where (a)one of the following conditions is present: (i)fistulous disease (ii)obstructed colon (iii)megacolon and where (b)the request specifies the condition; not being a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K) Y 56552 01JUL2007 COMPUTED TOMOGRAPHY OF COLONfor exclusion of colorectal neoplasia in symptomatic or high risk patients if: (a) the patient has had an incomplete colonoscopy in the 3 months before the scan; and (b) the date of incomplete colonoscopy is set out on the request for scan; and (c) the service is not a service to which items 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K) Y 56553 01SEP2015 Computed tomography-scan of colon for exclusion or diagnosis of colorectal neoplasia in a symptomatic or high risk patient if: (a) one [or more] of the following applies: (i)the patient has had an incomplete colonoscopy in the 3 months before the scan; (ii) there is a high-grade colonic obstruction; (iii)the patient is referred by a specialist or consultant physician who performs colonoscopies [in the practice of his or her speciality]; and (b) the service is not a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies; and (c)the service has not been performed on the patient in the 36 months before the scan (R) (K) (Anaes.) Y 56554 01JUL2007 COMPUTED TOMOGRAPHY OF COLON for exclusion of colorectal neoplasia in symptomatic or high risk patients if: (a) the request for scan states that one of the following contraindications to colonoscopy is present: (i) suspected perforation of the colon; (ii) complete or high-grade obstruction that will not allow passage of the scope; and (b) the service must not be a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies (R) (K) Y 56555 01SEP2015 Computed tomography-scan of colon for exclusion or diagnosis of colorectal neoplasia in a symptomatic or high risk patient if: (a)one [or more] of the following applies: (i) the patient has had an incomplete colonoscopy in the 3 months before the scan; (ii)there is a high-grade colonic obstruction; (iii)the patient is referred by a specialist or consultant physician who performs colonoscopies [in the practice of his or her speciality]; and (b)the service is not a service to which item 56301, 56307, 56401, 56407, 56409, 56412, 56501, 56507, 56801, 56807 or 57001 applies; and (c)the service has not been performed on the patient in the 36 months before the scan (R) (NK) (Anaes.) Y 56600 01DEC1991 EXTREMITIES COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving up to 20 slices without intravenous contrast medium (R) Y 56603 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving up to 20 slices with intravenous contrast medium (R) Y 56606 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving up to 20 slices without and with intravenous contrast medium (R) Y 56609 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 20 slices but not more than 40 slices without intravenous contrast medium (R) Y 56612 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 20 slices but not more than 40 slices with intravenous contrast medium (R) Y 56615 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 20 slices but not more than 40 slices without and with intravenous contrast medium (R) Y 56618 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 40 slices without intravenous contrast medium (R) Y 56619 01NOV1996 EXTREMITIES COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) N 56619 01NOV1997 EXTREMITIES COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete the service (R) N 56619 01MAR1999 EXTREMITIES COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) N 56619 01JUL2018 COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) N 56619 01NOV2018 COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), without intravenous contrast medium. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56620, 56626, 56660 or 56666 apply(R) (K) (Anaes.) Y 56620 01NOV2018 COMPUTED TOMOGRAPHY - scan of knee, without intravenous contrast medium. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56619, 56625, 56659 or 56665 apply(R) (K) (Anaes.) Y 56621 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 40 slices with intravenous contrast medium (R) Y 56624 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF EXTREMITIES, 1 OR MORE REGIONS involving more than 40 slices without and with intravenous contrast medium (R) Y 56625 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium and with any scans prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) N 56625 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium and with any scans of extremities prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) N 56625 01MAR1999 COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium and with any scans of extremities prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (K) (Anaes.) N 56625 01NOV2018 COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), with intravenous contrast medium and with any scans of extremities before intravenous contrast injection, when performed. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56620, 56626, 56660 or 56666 apply. (R) (K) (Anaes.) Y 56626 01NOV2018 COMPUTED TOMOGRAPHY - scan of the knee, with intravenous contrast medium and with any scans of the knee prior to intravenous contrast injection, when undertaken. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items 56619, 56625, 56659 or 56665 apply(R) (K) (Anaes.). Y 56659 01MAR1999 COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions without intravenous contrast medium, payable once only whether 1 or more attendances are required to complete (R) (NK) (Anaes.) N 56659 01NOV2018 COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), without intravenous contrast medium. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56620, 56626, 56660 or 56666 apply(R) (NK) (Anaes.). Y 56660 01NOV2018 COMPUTED TOMOGRAPHY - scan of the knee, without intravenous contrast medium. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56619, 56625, 56659 or 56665 apply (R) (NK) (Anaes.) Y 56665 01MAR1999 COMPUTED TOMOGRAPHY - scan of extremities, 1 or more regions with intravenous contrast medium, and with any scans of extremities prior to intravenous contrast injection, when undertaken; only 1 benefit is payable whether 1 or more attendances are required to complete the service (R) (NK) (Anaes.) N 56665 01NOV2018 COMPUTED TOMOGRAPHY - scan of extremities, one region (other than knee), or more than one region (which may include knee), with intravenous contrast medium and with any scans of extremities before intravenous contrast injection, when performed. Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56620, 56626, 56660 or 56666 apply(R) (NK) (Anaes.). Y 56666 01NOV2018 COMPUTED TOMOGRAPHY - scan of knee, with intravenous contrast medium, and with any scans of the knee prior to intravenous contrast injection, when performed.Payable once only whetherone or more attendances are required to complete the service, not being a service to which any of items56619, 56625, 56659 or 56665 apply(R) (NK) (Anaes.) Y 56700 01DEC1991 CHEST AND UPPER ABDOMEN COMPUTERISED TOMOGRAPHYSCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without intravenous contrast medium (not being a service to which item 56800, 56900 or 57100 applies) (R) Y 56703 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) with intravenous contrast medium (not being a service to which item 56803, 56903 or 57103 applies) (R) Y 56706 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) without and with intravenous contrast medium (not being a service to which item 56806, 56906 or 57106 applies) (R) Y 56800 01DEC1991 CHEST, ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHYSCAN OF CHEST, ABDOMEN AND PELVIS without intravenous contrast medium (not being a service to which item 56900 applies) (R) Y 56801 01NOV1996 CHEST, ABDOMEN, PELVIS AND NECK COMPUTERISED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium (R) N 56801 01MAR1999 CHEST, ABDOMEN, PELVIS AND NECK COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.) N 56801 01MAY2006 CHEST, ABDOMEN, PELVIS AND NECK COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) N 56801 01JUL2018 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) Y 56803 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST, ABDOMEN AND PELVIS with intravenous contrast medium (not being a service to which item 56903 applies) (R) Y 56806 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST, ABDOMEN AND PELVIS without and with intravenous contrast medium (not being a service to which item 56906 applies) (R) Y 56807 01NOV1996 COMPUTERISED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans prior to intravenous contrast injection, when undertaken (R) N 56807 01NOV1997 COMPUTERISED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken (R) N 56807 01MAR1999 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.) N 56807 01MAY2006 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) Y 56841 01MAR1999 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.) N 56841 01MAY2006 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck without intravenous contrast medium not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.) Y 56847 01MAR1999 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification (R) (NK) (Anaes.) N 56847 01MAY2006 COMPUTED TOMOGRAPHY - scan of chest, abdomen and pelvis with or without scans of soft tissues of neck with intravenous contrast medium and with any scans of chest, abdomen and pelvis with or without scans of soft tissue of neck prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.) Y 56900 01DEC1991 NECK, CHEST, ABDOMEN AND PELVIS COMPUTERISED TOMOGRAPHYSCAN OF NECK, CHEST, ABDOMEN AND PELVIS without intravenous contrast medium (R) Y 56903 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF NECK, CHEST, ABDOMEN AND PELVIS with intravenous contrast medium (R) Y 56906 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF NECK, CHEST, ABDOMEN AND PELVIS without and with intravenous contrast medium (R) Y 57000 01DEC1991 BRAIN AND CHEST COMPUTERISED TOMOGRAPHYSCAN OF BRAIN AND CHEST without intravenous contrast medium (R) Y 57001 01NOV1996 BRAIN, CHEST AND UPPER ABDOMEN COMPUTERISED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium (R) N 57001 01MAR1999 BRAIN, CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification (R) (K) (Anaes.) N 57001 01MAY2006 BRAIN, CHEST AND UPPER ABDOMEN COMPUTED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) N 57001 01JUL2018 COMPUTED TOMOGRAPHY - scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) Y 57003 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF BRAIN AND CHEST with intravenous contrast medium (R) Y 57006 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF BRAIN AND CHEST without and with intravenous contrast medium (R) Y 57007 01NOV1996 COMPUTERISED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans prior to intravenous contrast injwection, when undertaken (R) N 57007 01NOV1997 COMPUTERISED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken (R) N 57007 01MAR1999 COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification(R) (K) (Anaes.) N 57007 01MAY2006 COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (K) (Anaes.) Y 57041 01MAR1999 COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification(R) (NK) (Anaes.) N 57041 01MAY2006 COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen without intravenous contrast medium, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.) Y 57047 01MAR1999 COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification(R) (NK) (Anaes.) N 57047 01MAY2006 COMPUTED TOMOGRAPHY- scan of brain and chest with or without scans of upper abdomen with intravenous contrast medium and with any scans of brain and chest and upper abdomen prior to intravenous contrast injection, when undertaken, not including a study performed to exclude coronary artery calcification or image the coronary arteries (R) (NK) (Anaes.) Y 57100 01DEC1991 CHEST AND UPPER ABDOMEN AND BRAIN COMPUTERISED TOMOGRAPHYSCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without intravenous contrast medium (R) Y 57103 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN with intravenous contrast medium (R) Y 57106 01DEC1991 COMPUTERISED TOMOGRAPHYSCAN OF CHEST AND UPPER ABDOMEN (from lung apices to iliac crest) and SCAN OF BRAIN without and with intravenous contrast medium (R) Y 57200 01DEC1991 PELVIMETRY COMPUTERISED TOMOGRAPHYPELVIMETRY (R) Y 57201 01NOV1996 PELVIMETRY COMPUTERISED TOMOGRAPHY - PELVIMETRY (R) N 57201 01MAR1999 PELVIMETRY COMPUTED TOMOGRAPHY - PELVIMETRY (R) (K) (Anaes.) N 57201 01JUL2018 COMPUTED TOMOGRAPHY - PELVIMETRY (R) (K) (Anaes.) Y 57247 01MAR1999 COMPUTED TOMOGRAPHY - PELVIMETRY (R) (NK) (Anaes.) Y 57300 01DEC1991 DYNAMIC SCAN OF REGION COMPUTERISED TOMOGRAPHYDYNAMIC SCAN OF REGION not being a service associated with a service to which another item in this Group applies (R) Y 57303 01DEC1991 COMPUTERISED TOMOGRAPHYDYNAMIC SCAN OF REGION being a service associated with a service to which another item in this Group applies (R) Y 57340 01NOV1992 INTERVENTIONAL TECHNIQUES COMPUTERISED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) Y 57341 01NOV1996 INTERVENTIONAL TECHNIQUES COMPUTERISED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) N 57341 01MAR1999 INTERVENTIONAL TECHNIQUES COMPUTED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) (K) (Anaes.) N 57341 01JUL2018 COMPUTED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) (K) (Anaes.) Y 57345 01MAR1999 COMPUTED TOMOGRAPHY, in conjunction with a surgical procedure using interventional techniques, not being a service associated with a service to which another item in this table applies (R) (NK) (Anaes.) Y 57350 01NOV1996 SPIRAL ANGIOGRAPHY COMPUTERISED TOMOGRAPHY - spiral angiography with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, including multiple projections, not being a service to which another item in this group applies (R) N 57350 01MAR1999 SPIRAL ANGIOGRAPHY COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c)the service is not performed on the same patient within 12 months (R) (K) N 57350 01NOV2000 SPIRAL ANGIOGRAPHY COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c)the service has not been performed on the same patient within the previous 12 months (R) (K) (Anaes.) N 57350 01MAY2006 SPIRAL ANGIOGRAPHY COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c)the service has not been performed on the same patient within the previous 12 months; and (d)the service is not a study performed to image the coronary arteries (R) (K) (Anaes.) N 57350 01JUL2018 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a) the service is not a service to which another item in this group applies; and (b) the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c) the service has not been performed on the same patient within the previous 12 months; and (d) the service is not a study performed to image the coronary arteries (R) (K) (Anaes.) Y 57351 01NOV2001 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; acute ruptured aneurysm; or acute dissection of the aorta, carotid or vertebral artery; and (c)the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months. (R) (K) (Anaes.) N 57351 01MAY2006 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; acute ruptured aneurysm; or acute dissection of the aorta, carotid or vertebral artery; and (c)the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months; and (d)the service is not a study performed to image the coronary arteries (R) (K) (Anaes.) Y 57355 01MAR1999 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium and with any scans prior to intravenous contrast injection when undertaken - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, including multiple projections, not being a service to which another item in this group applies (R) (NK) N 57355 01NOV2000 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c)the service has not been performed on the same patient within the previous 12 months (R) (NK) (Anaes.) N 57355 01MAY2006 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: (a)the service is not a service to which another item in this group applies; and (b)the service is performed for the exclusion of arterial stenosis, occlusion, aneurysm or embolism; and (c)the service has not been performed on the same patient within the previous 12 months; and (d)the service is not a study performed to image the coronary arteries (R) (NK) (Anaes.) Y 57356 01NOV2001 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: a)the service is not a service to which another item in this group applies; and b)the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; or acute ruptured aneurysm; acute dissection of the aorta, carotid or vertebral artery; and c)the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months. (R) (NK) (Anaes.) N 57356 01MAY2006 COMPUTED TOMOGRAPHY - spiral angiography with intravenous contrast medium, including any scans performed before intravenous contrast injection - 1 or more spiral data acquisitions, including image editing, and maximum intensity projections or 3 dimensional surface shaded display, with hardcopy recording of multiple projections, where: a)the service is not a service to which another item in this group applies; and b)the service is performed for the exclusion of acute or recurrent pulmonary embolism; acute symptomatic arterial occlusion; post operative complication of arterial surgery; or acute ruptured aneurysm; acute dissection of the aorta, carotid or vertebral artery; and (c)the services to which 57350 or 57355 apply have been performed on the same patient within the previous 12 months; and (d)the service is not a study performed to image the coronary arteries (R) (NK) (Anaes.) Y 57360 01JUL2011 COMPUTED TOMOGRAPHY OF THE CORONARY ARTERIES performed on a minimum of a 64 slice (or equivalent) scanner, where the request is made by a specialist or consultant physician, and: a)the patient has stable symptoms consistent with coronary ischaemia, is at low to intermediate risk of coronary artery disease and would have been considered for coronary angiography; or b)the patient requires exclusion of coronary artery anomaly or fistula; or c)the patient will be undergoing non-coronary cardiac surgery (R) (K) Y 57361 01JUL2011 COMPUTED TOMOGRAPHY OF THE CORONARY ARTERIES performed on a minimum of a 64 slice (or equivalent) scanner, where the request is made by a specialist or consultant physician, and: a)the patient has stable symptoms consistent with coronary ischaemia, is at low to intermediate risk of coronary artery disease and would have been considered for coronary angiography; or b)the patient requires exclusion of coronary artery anomaly or fistula; or c)the patient will be undergoing non-coronary cardiac surgery (R) (NK) Y 57362 01NOV2014 Dental & temporo-mandibular joint imaging for diagnosis and management of mandibular and dento-alveolar fractures, dental implant planning, orthodontics, endodontic, periodontal and temporo-mandibular joint conditions: without contrast medium. Restricted to requesting by dental specialists and medical practitioners and must be performed on equipment located in practices accredited under the Diagnostic Imaging Accreditation Scheme using dedicated (rather than hybrid) CBCT units. Claims for more than one CBCT per patient per day are excluded. Claiming with two-dimensional imaging in the same episode (items 57959-57969) and with CT in the same episode (items 56001-57361) are also excluded. (K) Y 57363 01NOV2014 Dental & temporo-mandibular joint imaging for diagnosis and management of mandibular and dento-alveolar fractures, dental implant planning, orthodontics, endodontic, periodontal and temporo-mandibular joint conditions: without contrast medium. Restricted to requesting by dental specialists and medical practitioners and must be performed on equipment located in practices accredited under the Diagnostic Imaging Accreditation Scheme using dedicated (rather than hybrid) CBCT units. Claims for more than one CBCT per patient per day are excluded. Claiming with two-dimensional imaging in the same episode (items 57959-57969) and with CT in the same episode (items 56001-57361) are also excluded. (NK) Y 57400 01DEC1991 Computerised tomography - scan of brain without intravenous contrast medium (R) (A) Y 57403 01DEC1991 THORACIC CAVITY, aspiration of, for diagnostic purposes, not associated with Item 6941 intravenous contrast medium (R) (A) Y 57406 01DEC1991 Computerised tomography - scan of brain without and with intravenous contrast medium (R) (A) Y 57500 01DEC1991 DIGITS OR PHALANGES - all or any of either hand or either foot (NR) Y 57503 01DEC1991 DIGITS OR PHALANGES - all or any of either hand or either foot (R) Y 57506 01DEC1991 HAND, WRIST, FOREARM, ELBOW OR ARM (elbow to shoulder) (NR) N 57506 01NOV1996 HAND, WRIST, FOREARM, ELBOW OR HUMERUS (NR) N 57506 01NOV1997 HAND, WRIST, FOREARM, ELBOW OR HUMERUS (NR) Y 57509 01DEC1991 HAND, WRIST, FOREARM, ELBOW OR ARM (elbow to shoulder) (R) N 57509 01NOV1996 HAND, WRIST, FOREARM, ELBOW OR HUMERUS (R) N 57509 01NOV1997 HAND, WRIST, FOREARM, ELBOW OR HUMERUS (R) Y 57512 01DEC1991 HAND, WRIST AND LOWER FOREARM OR UPPER FOREARM AND ELBOW OR ELBOW AND ARM (elbow to shoulder) (NR) N 57512 01NOV1996 HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (NR) N 57512 01NOV1997 HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (NR) N 57512 01MAY2005 HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (NR) Y 57515 01DEC1991 HAND, WRIST AND LOWER FOREARM OR UPPER FOREARM AND ELBOW OR ELBOW AND ARM (elbow to shoulder) (R) N 57515 01NOV1996 HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (R) N 57515 01NOV1997 HAND, WRIST AND FOREARM, OR FOREARM AND ELBOW, OR ELBOW AND HUMERUS (R) N 57515 01MAY2005 HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (R) Y 57518 01DEC1991 FOOT, ANKLE, LOWER LEG, UPPER LEG, KNEE OR THIGH (femur) (NR) N 57518 01NOV1996 FOOT, ANKLE, LEG, KNEE OR FEMUR (NR) N 57518 01NOV1997 FOOT, ANKLE, LEG, KNEE OR FEMUR (NR) N 57518 01NOV2018 FOOT, ANKLE, LEG, OR FEMUR (NR)(K) Y 57521 01DEC1991 FOOT, ANKLE, LOWER LEG, UPPER LEG, KNEE OR THIGH (femur) (R) N 57521 01NOV1996 FOOT, ANKLE, LEG, KNEE OR FEMUR (R) N 57521 01NOV1997 FOOT, ANKLE, LEG, KNEE OR FEMUR (R) N 57521 01NOV2018 FOOT, ANKLE, LEG, OR FEMUR (R)(K) Y 57522 01NOV2018 Knee (NR)(K) Y 57523 01NOV2018 Knee (R)(K) Y 57524 01DEC1991 FOOT, ANKLE AND LOWER LEG OR UPPER LEG AND KNEE (NR) N 57524 01NOV1996 FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (NR) N 57524 01NOV1997 FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (NR) Y 57527 01DEC1991 FOOT, ANKLE AND LOWER LEG OR UPPER LEG AND KNEE (R) N 57527 01NOV1996 FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (R) N 57527 01NOV1997 FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (R) Y 57529 01JUL2011 HAND, WRIST, FOREARM, ELBOW OR HUMERUS (NR) (NK) Y 57530 01JUL2011 HAND, WRIST, FOREARM, ELBOW OR HUMERUS (R) (NK) Y 57532 01JUL2011 HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (NR) (NK) Y 57533 01JUL2011 HAND AND WRIST OR HAND, WRIST AND FOREARM OR FOREARM AND ELBOW OR ELBOW AND HUMERUS (R) (NK) Y 57535 01JUL2011 FOOT, ANKLE, LEG, KNEE OR FEMUR (NR) (NK) N 57535 01NOV2018 FOOT, ANKLE, LEG, OR FEMUR (NR) (NK) Y 57536 01JUL2011 FOOT, ANKLE, LEG, KNEE OR FEMUR (R) (NK) N 57536 01NOV2018 FOOT, ANKLE, LEG, OR FEMUR (R) (NK) Y 57537 01NOV2018 Knee (NR)(NK) Y 57538 01JUL2011 FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (NR) (NK) Y 57539 01JUL2011 FOOT AND ANKLE, OR ANKLE AND LEG, OR LEG AND KNEE, OR KNEE AND FEMUR (R) (NK) Y 57540 01NOV2018 Knee (R)(NK) Y 57541 01NOV2019 Fee for a service rendered using first eligible x-ray procedure carried out during attendance at residential aged care facility, where the service has been requested by a medical practitioner who has attended the patient in person and the request identifies one or more of the following indications: the patient has experienced a fall and one or more of the following items apply to the service 57509, 57515, 57521, 57527, 57530, 57533, 57539, 57703, 57705, 57709, 57711, 57712, 57714, 57715, 57717, 58521, 58523, 58524, 58526, 58527, 58529, 57536; or pneumonia or heart failure is suspected and item 58503 or 58505 applies to the service; or acute abdomen or bowel obstruction is suspected and item 58903 or 58905 applies to the service. This call-out fee can be claimed once only per visit at a residential aged care facility irrespective of the number of patients attended. NOTE: If the service is bulked billed 95% of the fee is payable. The multiple services rule does not apply to this item. (R) Y 57700 01DEC1991 SHOULDER OR SCAPULA (NR) Y 57702 01JUL2011 SHOULDER OR SCAPULA (NR) (NK) Y 57703 01DEC1991 SHOULDER OR SCAPULA (R) Y 57705 01JUL2011 SHOULDER OR SCAPULA (R) (NK) Y 57706 01DEC1991 CLAVICLE (NR) Y 57708 01JUL2011 CLAVICLE (NR) (NK) Y 57709 01DEC1991 CLAVICLE (R) Y 57711 01JUL2011 CLAVICLE (R) (NK) Y 57712 01DEC1991 HIP JOINT (R) Y 57714 01JUL2011 HIP JOINT (R) (NK) Y 57715 01DEC1991 PELVIC GIRDLE (R) Y 57717 01JUL2011 PELVIC GIRDLE (R) (NK) Y 57718 01DEC1991 SACROILIAC JOINTS (R) Y 57721 01DEC1991 FEMUR, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (R) Y 57723 01JUL2011 FEMUR, internal fixation of neck or intertrochanteric (pertrochanteric) fracture (R) (NK) Y 57900 01DEC1991 SKULL (calvarium) (R) N 57900 01NOV1996 SKULL OR CEPHALOMETRY (R) Y 57901 01NOV1998 SKULL, not in association with item 57902 (R) Y 57902 01NOV1998 CEPHALOMETRY, not in association with item 57901 (R) Y 57903 01DEC1991 SINUSES (R) Y 57906 01DEC1991 MASTOIDS (R) Y 57909 01DEC1991 PETROUS TEMPORAL BONES (R) Y 57911 01JUL2011 SKULL, not in association with item 57902 or 57914 (R) (NK) Y 57912 01DEC1991 FACIAL BONESorbit, maxilla or malar, any or all (R) Y 57914 01JUL2011 CEPHALOMETRY, not in association with item 57901 or 57911 (R) (NK) Y 57915 01DEC1991 MANDIBLE (R) N 57915 01NOV1996 MANDIBLE, not by orthopantomography technique (R) Y 57917 01JUL2011 SINUSES (R) (NK) Y 57918 01DEC1991 SALIVARY CALCULUS (R) N 57918 01NOV1996 SALIVARY CALCULUS (R) Y 57920 01JUL2011 MASTOIDS (R) (NK) Y 57921 01DEC1991 NOSE (R) Y 57923 01JUL2011 PETROUS TEMPORAL BONES (R) (NK) Y 57924 01DEC1991 EYE (R) Y 57926 01JUL2011 FACIAL BONESorbit, maxilla or malar, any or all (R) (NK) Y 57927 01DEC1991 TEMPOROMANDIBULAR JOINTS (R) Y 57929 01JUL2011 MANDIBLE, not by orthopantomography technique (R) (NK) Y 57930 01DEC1991 TEETHSINGLE AREA (R) Y 57932 01JUL2011 SALIVARY CALCULUS (R) (NK) Y 57933 01DEC1991 TEETHFULL MOUTH (R) Y 57935 01JUL2011 NOSE (R) (NK) Y 57936 01DEC1991 TEETH, ORTHOPANTOMOGRAPHY (R) Y 57938 01JUL2011 EYE (R) (NK) Y 57939 01DEC1991 PALATOPHARYNGEAL STUDIES with fluoroscopic screening (R) Y 57941 01JUL2011 TEMPOROMANDIBULAR JOINTS (R) (NK) Y 57942 01DEC1991 PALATOPHARYNGEAL STUDIES without fluoroscopic screening (R) Y 57944 01JUL2011 TEETHSINGLE AREA (R) (NK) Y 57945 01DEC1991 LARYNX (R) N 57945 01NOV1996 LARYNX, LATERAL AIRWAYS AND SOFT TISSUES OF THE NECK, not being a service associated with a service to which item 57939 or 57942 applies (R) Y 57947 01JUL2011 TEETHFULL MOUTH (R) (NK) Y 57948 01NOV2001 Teeth, Orthopantomography, for diagnostic survey of the mandible OR of the maxilla OR of the mandible and the maxilla, and the associated dental structures (R) Y 57950 01JUL2011 PALATOPHARYNGEAL STUDIES with fluoroscopic screening (R) (NK) Y 57951 01NOV2001 Teeth, Orthopantomography, for exclusion of a fracture following significant trauma, infection or tumour of the mandible OR of the maxilla OR of the mandible and the maxilla (R) Y 57953 01JUL2011 PALATOPHARYNGEAL STUDIES without fluoroscopic screening (R) (NK) Y 57954 01NOV2001 Teeth, Orthopantomography, for further investigation or monitoring of a fracture, infection, or tumour of the mandible OR of the maxilla OR of the mandible and the maxilla (R) Y 57956 01JUL2011 LARYNX, LATERAL AIRWAYS AND SOFT TISSUES OF THE NECK, not being a service associated with a service to which item 57939, 57942, 57950 or 57953 applies (R) (NK) Y 57957 01NOV2001 Teeth, Orthopantomography, for monitoring following surgery to the mandible OR of the maxilla OR of the mandible and the maxilla OR to associated dental structures(R) Y 57959 01JUL2011 Orthopantomography, for diagnosis and/or management of trauma, infection, tumours, congenital conditions or surgical conditions of the teeth or maxillofacial region (R) (NK) Y 57960 01NOV2002 Orthopantomography, for diagnosis and/or management of trauma, infection, tumours, congenital conditions or surgical conditions of the teeth or maxillofacial region (R) Y 57962 01JUL2011 Orthopantomography, for diagnosis and/or management of impacted teeth, caries, periodontal or peripical pathology where signs or symptoms of those conditions are evident (R) (NK) Y 57963 01NOV2002 Orthopantomography, for diagnosis and/or management of impacted teeth, caries, periodontal or peripical pathology where signs or symptoms of those conditions are evident (R) Y 57965 01JUL2011 Orthopantomography, for diagnosis and/or management of missing or crowded teeth, or developmental anomalies of the teeth or jaws (R) (NK) Y 57966 01NOV2002 Orthopantomography, for diagnosis and/or management of missing or crowded teeth, or developmental anomalies of the teeth or jaws (R) Y 57968 01JUL2011 Orthopantomography, for diagnosis and/or management of temporomandibular joint arthroses or dysfunction (R) (NK) Y 57969 01NOV2002 Orthopantomography, for diagnosis and/or management of temporomandibular joint arthroses or dysfunction (R) Y 58100 01DEC1991 SPINECERVICAL (R) Y 58102 01JUL2011 SPINECERVICAL (R) (NK) Y 58103 01DEC1991 SPINETHORACIC (R) Y 58105 01JUL2011 SPINETHORACIC (R) (NK) Y 58106 01DEC1991 SPINELUMBOSACRAL (R) Y 58108 01NOV2001 Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal (R) Y 58109 01DEC1991 SPINESACROCOCCYGEAL (R) Y 58111 01JUL2011 SPINELUMBOSACRAL (R) (NK) Y 58112 01DEC1991 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, two examinations of the kind referred to in items 58100, 58103, 58106 and 58109 (R) Y 58114 01JUL2011 Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal (R) (NK) Y 58115 01DEC1991 NOTE:An account issued or a patient assignment form must show the item numbers of the examiniations performed under this item SPINE3 OR MORE REGIONS (R) N 58115 01NOV2002 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58103, 58106 and 58109 (R) Y 58117 01JUL2011 SPINESACROCOCCYGEAL (R) (NK) Y 58118 01DEC1991 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind referred to in items 58100, 58103, 58106 and 58109 (R) Y 58120 01JAN2010 Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal (R), if the service to which item 58120 or 58121 applies has not been performed on the same patient within the same calendar year Y 58121 01JAN2010 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58103, 58106 and 58109 (R), if the service to which item 58120 or 58121 applies has not been performed on the same patient within the same calendar year Y 58123 01JUL2011 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, two examinations of the kind referred to in items 58100, 58102, 58103, 58105, 58106, 58109, 58111 and 58117 (R) (NK) Y 58124 01JUL2011 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58102, 58103, 58105, 58106, 58109, 58111 and 58117 (R) (NK) Y 58126 01JUL2011 Spine, four regions, cervical, thoracic, lumbosacral and sacrococcygeal, if the service to which item 58120, 58121, 58126 or 58127 applies has not been performed on the same patient within the same calendar year (R) (NK) Y 58127 01JUL2011 NOTE:An account issued or a patient assignment form must show the item numbers of the examinations performed under this item Spine, three examinations of the kind mentioned in items 58100, 58102, 58103, 58105, 58106 and 58109, 58111 and 58117 if the service to which item 58120, 58121, 58126 or 58127 applies has not been performed on the same patient within the same calendar year (R) (NK) Y 58300 01DEC1991 BONE AGE STUDY, WRIST AND KNEE (R) N 58300 20JAN1997 BONE AGE STUDY (R) Y 58302 01JUL2011 BONE AGE STUDY (R) (NK) Y 58303 01DEC1991 BONE AGE STUDY, WRIST (R) Y 58306 01DEC1991 SKELETAL SURVEY INVOLVING 4 OR MORE REGIONS (R) N 58306 01NOV1996 SKELETAL SURVEY (R) Y 58308 01JUL2011 SKELETAL SURVEY (R) (NK) Y 58500 01DEC1991 CHEST (lung fields) by direct radiography (NR) Y 58502 01JUL2011 CHEST (lung fields) by direct radiography (NR) (NK) Y 58503 01DEC1991 CHEST (lung fields) by direct radiography (R) Y 58505 01JUL2011 CHEST (lung fields) by direct radiography (R) (NK) Y 58506 01DEC1991 CHEST (lung fields) by direct radiography with fluoroscopic screening (R) Y 58508 01JUL2011 CHEST (lung fields) by direct radiography with fluoroscopic screening (R) (NK) Y 58509 01DEC1991 THORACIC INLET OR TRACHEA (R) Y 58511 01JUL2011 THORACIC INLET OR TRACHEA (R) (NK) Y 58512 01DEC1991 CHEST, BY MINIATURE RADIOGRAPHY (R) Y 58515 01DEC1991 CARDIAC EXAMINATION (including barium swallow) (NR) Y 58518 01DEC1991 CARDIAC EXAMINATION (including barium swallow) (R) Y 58521 01DEC1991 STERNUM OR RIBS ON 1 SIDE (R) N 58521 01NOV1996 LEFT RIBS, RIGHT RIBS OR STERNUM (R) Y 58523 01JUL2011 LEFT RIBS, RIGHT RIBS OR STERNUM (R) (NK) Y 58524 01DEC1991 STERNUM AND RIBS ON 1 SIDE OR RIBS ON BOTH SIDES (R) N 58524 01NOV1996 LEFT AND RIGHT RIBS, LEFT RIBS AND STERNUM, OR RIGHT RIBS AND STERNUM (R) Y 58526 01JUL2011 LEFT AND RIGHT RIBS, LEFT RIBS AND STERNUM, OR RIGHT RIBS AND STERNUM (R) (NK) Y 58527 01DEC1991 STERNUM AND RIBS ON BOTH SIDES (R) N 58527 01NOV1996 LEFT RIBS, RIGHT RIBS AND STERNUM (R) Y 58529 01JUL2011 LEFT RIBS, RIGHT RIBS AND STERNUM (R) (NK) Y 58700 01DEC1991 PLAIN RENAL ONLY (R) Y 58702 01JUL2011 PLAIN RENAL ONLY (R) (NK) Y 58703 01DEC1991 DRIPINFUSION PYELOGRAPHY (R) Y 58706 01DEC1991 INTRAVENOUS PYELOGRAPHY, including preliminary plain film (R) N 58706 01NOV1997 INTRAVENOUS PYELOGRAPHY, with or without preliminary plain films and with or without tomography - (R) N 58706 01NOV2001 INTRAVENOUS PYELOGRAPHY, with or without preliminary plain films and with or without tomography - (R) Y 58708 01JUL2011 INTRAVENOUS PYELOGRAPHY, with or without preliminary plain films and with or without tomography - (R) (NK) Y 58709 01DEC1991 INTRAVENOUS PYELOGRAPHY, including preliminary plain film and limited tomography, involving up to 3 tomographic cuts (R) Y 58712 01DEC1991 INTRAVENOUS PYELOGRAPHY, including preliminary plain film with delayed examination for the CYSTOURETERIC REFLUX (R) Y 58715 01DEC1991 ANTEGRADE OR RETROGRADE PYELOGRAPHYincluding preliminary plain film (R) N 58715 01NOV1997 ANTEGRADE OR RETROGRADE PYELOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - 1 side - (R) N 58715 01NOV2001 ANTEGRADE OR RETROGRADE PYELOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - 1 side - (R) Y 58717 01JUL2011 ANTEGRADE OR RETROGRADE PYELOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - 1 side - (R) (NK) Y 58718 01DEC1991 RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY (R) N 58718 01NOV1997 RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY with or without preliminary plain films and with preparation and contrast injection - (R) N 58718 01NOV2001 RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY with or without preliminary plain films and with preparation and contrast injection - (R) Y 58720 01JUL2011 RETROGRADE CYSTOGRAPHY OR RETROGRADE URETHROGRAPHY with or without preliminary plain films and with preparation and contrast injection - (R) (NK) Y 58721 01DEC1991 RETROGRADE MICTURATING CYSTOURETHROGRAPHY (R) N 58721 01NOV1997 RETROGRADE MICTURATING CYSTOURETHROGRAPHY, with preparation and contrast injection - (R) N 58721 01NOV2001 RETROGRADE MICTURATING CYSTOURETHROGRAPHY, with preparation and contrast injection - (R) Y 58723 01JUL2011 RETROGRADE MICTURATING CYSTOURETHROGRAPHY, with preparation and contrast injection - (R) (NK) Y 58724 01DEC1991 RETROPERITONEAL PNEUMOGRAM (R) Y 58900 01DEC1991 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (NR) N 58900 01NOV1996 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (NR) N 58900 01JUL2016 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912 or 58915 applies (NR) Y 58902 01JUL2011 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915, 58917, 58924 or 58926 applies (NR) (NK) N 58902 01JUL2016 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915 or 58917 applies (NR) (NK) Y 58903 01DEC1991 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (R) N 58903 01NOV1996 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912, 58915 or 58924 applies (R) N 58903 01JUL2016 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58912 or 58915 applies (R) Y 58905 01JUL2011 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915, 58917, 58924 or 58926 applies (R) (NK) N 58905 01JUL2016 PLAIN ABDOMINAL ONLY, not being a service associated with a service to which item 58909, 58911, 58912, 58914, 58915 or 58917 applies (R) (NK) Y 58906 01DEC1991 OESOPHAGUS, with or without examination for foreign body or barium swallow (R) Y 58909 01DEC1991 BARIUM or other opaque meal OF OESOPHAGUS, STOMACH AND DUODENUM, with or without screening of chest, with or without preliminary plain film (R) N 58909 01NOV1997 BARIUM or other opaque meal of 1 or more of PHARYNX, OESOPHAGUS, STOMACH OR ABDOMEN, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939 or 57942 or 57945 applies - (R) N 58909 01NOV2001 BARIUM or other opaque meal of 1 or more of PHARYNX, OESOPHAGUS, STOMACH OR DUODENUM, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939 or 57942 or 57945 applies - (R) Y 58911 01JUL2011 BARIUM or other opaque meal of 1 or more of PHARYNX, OESOPHAGUS, STOMACH OR DUODENUM, with or without preliminary plain films of pharynx, chest or duodenum, not being a service associated with a service to which item 57939, 57942, 57945, 57950, 57953 or 57956 applies - (R) (NK) Y 58912 01DEC1991 BARIUM or other opaque meal OF OESOPHAGUS, STOMACH, DUODENUM AND FOLLOW THROUGH TO COLON, with or without screening of chest, with or without preliminary plain film (R) Y 58914 01JUL2011 BARIUM or other opaque meal OF OESOPHAGUS, STOMACH, DUODENUM AND FOLLOW THROUGH TO COLON, with or without screening of chest, with or without preliminary plain film (R) (NK) Y 58915 01DEC1991 BARIUM or other opaque meal, SMALL BOWEL SERIES ONLY, with or without preliminary plain film (R) Y 58916 01NOV1997 SMALL BOWEL ENEMA, barium or other opaque study of the small bowel, including DUODENAL INTUBATION, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies - (R) N 58916 01NOV2001 SMALL BOWEL ENEMA, barium or other opaque study of the small bowel, including DUODENAL INTUBATION, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies - (R) Y 58917 01JUL2011 BARIUM or other opaque meal, SMALL BOWEL SERIES ONLY, with or without preliminary plain film (R) (NK) Y 58918 01DEC1991 OPAQUE ENEMA (R) Y 58920 01JUL2011 SMALL BOWEL ENEMA, barium or other opaque study of the small bowel, including DUODENAL INTUBATION, with or without preliminary plain films, not being a service associated with a service to which item 30488 applies - (R) (NK) Y 58921 01DEC1991 OPAQUE ENEMA, including air contrast study (R) N 58921 01NOV1997 OPAQUE ENEMA, with or without air contrast study and with or without preliminary plain films - examination and report (R) N 58921 01NOV2001 OPAQUE ENEMA, with or without air contrast study and with or without preliminary plain films - (R) Y 58923 01JUL2011 OPAQUE ENEMA, with or without air contrast study and with or without preliminary plain films - (R) (NK) Y 58924 01DEC1991 GRAHAM'S TEST (cholecystography), including preliminary abdominal radiography (R) N 58924 01NOV1997 GRAHAM'S TEST (cholecystography), with preliminary plain films and with or without tomography - examination and report (R) N 58924 01NOV2001 GRAHAM'S TEST (cholecystography), with preliminary plain films and with or without tomography - (R) Y 58926 01JUL2011 GRAHAM'S TEST (cholecystography), with preliminary plain films and with or without tomography - (R) (NK) Y 58927 01DEC1991 CHOLEGRAPHY DIRECToperative or postoperative (R) N 58927 01NOV1997 CHOLEGRAPHY DIRECT, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies - examination and report (R) N 58927 01NOV2001 CHOLEGRAPHY DIRECT, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies - (R) Y 58929 01JUL2011 CHOLEGRAPHY DIRECT, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 30439 applies - (R) (NK) Y 58930 01DEC1991 CHOLEGRAPHYintravenous (R) Y 58933 01DEC1991 CHOLEGRAPHYpercutaneous transhepatic (R) N 58933 01NOV1997 CHOLEGRAPHY, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection - (R) N 58933 01NOV2001 CHOLEGRAPHY, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection - (R) Y 58935 01JUL2011 CHOLEGRAPHY, percutaneous transhepatic, with or without preliminary plain films and with preparation and contrast injection - (R) (NK) Y 58936 01DEC1991 CHOLEGRAPHYdrip infusion (R) N 58936 01NOV1997 CHOLEGRAPHY, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography - (R) N 58936 01NOV2001 CHOLEGRAPHY, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography - (R) Y 58938 01JUL2011 CHOLEGRAPHY, drip infusion, with or without preliminary plain films, with preparation and contrast injection and with or without tomography - (R) (NK) Y 58939 01NOV1996 DEFAECOGRAM, paediatric (R) N 58939 19FEB1997 DEFAECOGRAM (R) Y 58941 01JUL2011 DEFAECOGRAM (R) (NK) Y 59100 01DEC1991 FOREIGN BODY IN EYE (special method, Sweet's or other) (R) Y 59103 01DEC1991 FOREIGN BODY, LOCALISATION OF AND REPORT, not being a service to which another item in this Group applies (R) N 59103 01NOV2009 Localisation of foreign body, if provided in conjunction with a service described in Subgroups 1 to 12 of Group I3 (R) Y 59104 01JUL2011 Localisation of foreign body, if provided in conjunction with a service described in Subgroups 1 to 12 of Group I3 (R) (NK) Y 59300 01DEC1991 (Note: These items are intended for use in the investigation of a clinical abnormalityof the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, (with or without thermography) and report if: (a)the patient is referred with a specific request for this procedure; and (b)there is reason to suspect the presence of malignancy in the breasts because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) N 59300 01NOV2001 (Note: These items are intended for use in the investigation of a clinical abnormalityof the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, (with or without thermography) if: (a)the patient is referred with a specific request for this procedure; and (b)there is reason to suspect the presence of malignancy in the breasts because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) N 59300 01NOV2003 (Note: These items are intended for use in the investigation of a clinical abnormalityof the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, if: (a)the patient is referred with a specific request for this procedure; and (b)there is reason to suspect the presence of malignancy in the breasts because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) N 59300 01MAY2004 (Note: These items are intended for use in the investigation of a clinical abnormalityof the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) MAMMOGRAPHY OF BOTH BREASTS, if there is a reason to suspect the presence of malignancy because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner.Unless otherwise indicated, mammography includes both breasts (R) Y 59301 01JUL2011 (Note: These items are intended for use in the investigation of a clinical abnormalityof the breast/s and NOT for individual, group or opportunistic screening of asymptomatic patients) MAMMOGRAPHY OF BOTH BREASTS, if there is a reason to suspect the presence of malignancy because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner.Unless otherwise indicated, mammography includes both breasts (R) (NK) Y 59302 01NOV2018 Three dimensional tomosynthesis of both breasts, not being a service associated with item 59300 or 59301, if there is reason to suspect the presence of malignancy because of: the past occurrence of breast malignancy in the patient or members of the patient's family; or symptoms or indications of malignancy found on examination of the patient by a medical practitioner (R) (K) Y 59303 01DEC1991 RADIOGRAPHIC EXAMINATION OF 1 BREAST, (with or without thermography) and report if: (a)the patient is referred with a specific request for this procedure; and (b)there is reason to suspect the presence of malignancy in the breasts because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) N 59303 01NOV2001 RADIOGRAPHIC EXAMINATION OF 1 BREAST, (with or without thermography) if: (a)the patient is referred with a specific request for this procedure; and (b)there is reason to suspect the presence of malignancy in the breasts because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) N 59303 01NOV2003 RADIOGRAPHIC EXAMINATION OF 1 BREAST,if: (a)the patient is referred with a specific request for this procedure; and (b)there is reason to suspect the presence of malignancy in the breasts because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) N 59303 01MAY2004 MAMMOGRAPHY OF ONE BREAST,if: (a)the patient is referred with a specific request for a unilateral mammogram; and (b)there is reason to suspect the presence of malignancy because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii)symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) Y 59304 01JUL2011 MAMMOGRAPHY OF ONE BREAST,if: (a)the patient is referred with a specific request for a unilateral mammogram; and (b)there is reason to suspect the presence of malignancy because of: (i)the past occurrence of breast malignancy in the patient or members of the patient's family; or (ii) symptoms or indications of malignancy found on an examination of the patient by a medical practitioner (R) (NK) Y 59305 01NOV2018 Three dimensional tomosynthesis of one breast, not being a service associated with item 59303 or 59304, if there is reason to suspect the presence of malignancy because of: the past occurrence of breast malignancy in the patient or members of the patient's family; or symptoms or indications of malignancy found on examination of the patient by a medical practitioner (R) (K) Y 59306 01DEC1991 MAMMARY DUCTOGRAM (galactography) - 1 breast (R) Y 59307 01JUL2011 MAMMARY DUCTOGRAM (galactography) - 1 breast (R) (NK) Y 59309 01DEC1991 MAMMARY DUCTOGRAM (galactography) - 2 breasts (R) Y 59310 01JUL2011 MAMMARY DUCTOGRAM (galactography) - 2 breasts (R) (NK) Y 59312 01NOV1997 RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, in conjunction with a surgical procedure on each breast, using interventional techniques - examination and report (R) N 59312 01NOV2001 RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, in conjunction with a surgical procedure on each breast, using interventional techniques - (R) Y 59313 01JUL2011 RADIOGRAPHIC EXAMINATION OF BOTH BREASTS, in conjunction with a surgical procedure on each breast, using interventional techniques - (R) (NK) Y 59314 01NOV1997 RADIOGRAPHIC EXAMINATION OF 1 BREAST, in conjunction with a surgical procedure using interventional techniques - examination and report (R) N 59314 01NOV2001 RADIOGRAPHIC EXAMINATION OF 1 BREAST, in conjunction with a surgical procedure using interventional techniques - (R) Y 59315 01JUL2011 RADIOGRAPHIC EXAMINATION OF 1 BREAST, in conjunction with a surgical procedure using interventional techniques - (R) (NK) Y 59318 01NOV1997 RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 30361 - examination and report (R) N 59318 01NOV2001 RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 30361 - (R) N 59318 01NOV2003 RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 31536 - (R) Y 59319 01JUL2011 RADIOGRAPHIC EXAMINATION OF EXCISED BREAST TISSUE to confirm satisfactory excision of 1 or more lesions in 1 breast or both following pre-operative localisation in conjunction with a service under item 31536 - (R) (NK) Y 59500 01DEC1991 PREGNANT UTERUS (R) Y 59503 01DEC1991 PELVIMETRY OR PLACENTOGRAPHY (R) N 59503 01NOV1996 PELVIMETRY, not being a service associated with a service to which item 57201 applies (R) N 59503 01MAR1999 PELVIMETRY, not being a service associated with a service to which item 57201 applies (R) Y 59504 01JUL2011 PELVIMETRY, not being a service associated with a service to which item 57201 or 57247 applies (R) (NK) Y 59506 01DEC1991 CONTROL XRAYS IN CONJUNCTION WITH INTRAUTERINE FOETAL BLOOD TRANSFUSION (R) Y 59700 01DEC1991 DISCOGRAPHY1 disc (R) N 59700 01NOV1997 DISCOGRAPHY, each disc, with or without preliminary plain films and with preparation and contrast injection - examination and report (R) N 59700 01NOV2001 DISCOGRAPHY, each disc, with or without preliminary plain films and with preparation and contrast injection - (R) Y 59701 01JUL2011 DISCOGRAPHY, each disc, with or without preliminary plain films and with preparation and contrast injection - (R) (NK) Y 59703 01DEC1991 DACRYOCYSTOGRAPHY1 side (R) N 59703 01NOV1997 DACRYOCYSTOGRAPHY, 1 side, with or without preliminary plain film and with preparation and contrast injection - examination and report (R) N 59703 01NOV2001 DACRYOCYSTOGRAPHY, 1 side, with or without preliminary plain film and with preparation and contrast injection - (R) Y 59704 01JUL2011 DACRYOCYSTOGRAPHY, 1 side, with or without preliminary plain film and with preparation and contrast injection - (R)(NK) Y 59706 01DEC1991 ENCEPHALOGRAPHY (R) Y 59709 01DEC1991 CEREBRAL VENTRICULOGRAPHY (R) Y 59712 01DEC1991 HYSTEROSALPINGOGRAPHY (R) N 59712 01NOV1997 HYSTEROSALPINGOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - examination and report (R) N 59712 01NOV2001 HYSTEROSALPINGOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - (R) Y 59713 01JUL2011 HYSTEROSALPINGOGRAPHY, with or without preliminary plain films and with preparation and contrast injection - (R)(NK) Y 59715 01DEC1991 BRONCHOGRAPHY1 side (R) N 59715 01NOV1997 BRONCHOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - examination and report (R) N 59715 01NOV2001 BRONCHOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R) N 59715 01JUL2016 BRONCHOGRAPHY, one side, with or without preliminary plain films and with preparation and contrast injection, on a person under 16 years of age- (R) (K) Y 59716 01JUL2011 BRONCHOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R) (NK) N 59716 01JUL2016 BRONCHOGRAPHY, one side, with or without preliminary plain films and with preparation and contrast injection, on a person under 16 years of age- (R) (NK) Y 59718 01DEC1991 PHLEBOGRAPHY1 side (R) N 59718 01NOV1997 PHLEBOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - examination and report (R) N 59718 01NOV2001 PHLEBOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R) Y 59719 01JUL2011 PHLEBOGRAPHY, 1 side, with or without preliminary plain films and with preparation and contrast injection - (R) (NK) Y 59721 01DEC1991 SPLENOGRAPHY (R) Y 59724 01DEC1991 MYELOGRAPHY, 1 region (R) N 59724 01NOV1996 MYELOGRAPHY, 1 region, not being a service associated with a service to which item 56219 applies (R) N 59724 01NOV1997 MYELOGRAPHY, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 applies - examination and report (R) N 59724 01NOV2001 MYELOGRAPHY, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 applies - (R) Y 59725 01JUL2011 MYELOGRAPHY, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection, not being a service associated with a service to which item 56219 or 56259 applies - (R) (NK) Y 59727 01DEC1991 MYELOGRAPHY, 2 regions (R) N 59727 01NOV1996 MYELOGRAPHY, 2 regions, not being a service associated with a service to which item 56219 applies (R) Y 59730 01DEC1991 MYELOGRAPHY, 3 regions (R) N 59730 01NOV1996 MYELOGRAPHY, 3 regions, not being a service associated with a service to which item 56219 applies (R) Y 59733 01DEC1991 SIALOGRAPHY1 side (R) N 59733 01NOV1997 SIALOGRAPHY, 1 side, with preparation and contrast injection, not being a service associated with a service to which item 57918 applies - examination and report (R) N 59733 01NOV2001 SIALOGRAPHY, 1 side, with preparation and contrast injection, not being a service associated with a service to which item 57918 applies - (R) Y 59734 01JUL2011 SIALOGRAPHY, 1 side, with preparation and contrast injection, not being a service associated with a service to which item 57918 or 57932 applies - (R) (NK) Y 59736 01DEC1991 VASOEPIDIDYMOGRAPHY1 side (R) N 59736 01NOV1997 VASOEPIDIDYMOGRAPHY, 1 side, for other than an investigation for reversal of previous sterilisation - examination and report (R) N 59736 01NOV2001 VASOEPIDIDYMOGRAPHY, 1 side, for other than an investigation for reversal of previous sterilisation -(R) N 59736 01JUL2008 VASOEPIDIDYMOGRAPHY, 1 side, -(R) Y 59737 01JUL2011 VASOEPIDIDYMOGRAPHY, 1 side, -(R) (NK) Y 59739 01DEC1991 SINUSES AND FISTULAE (R) N 59739 01NOV1997 SINOGRAM OR FISTULOGRAM, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection - examination and report (R) N 59739 01NOV2001 SINOGRAM OR FISTULOGRAM, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection - (R) Y 59740 01JUL2011 SINOGRAM OR FISTULOGRAM, 1 or more regions, with or without preliminary plain films and with preparation and contrast injection - (R) (NK) Y 59742 01DEC1991 LARYNGOGRAPHY with contrast media (R) Y 59745 01DEC1991 PNEUMOARTHROGRAPHY (R) Y 59748 01DEC1991 ARTHROGRAPHYcontrast (R) Y 59751 01DEC1991 ARTHROGRAPHYdouble contrast (R) N 59751 20JAN1997 ARTHROGRAPHYdouble contrast (R) N 59751 01NOV1997 ARTHROGRAPHY, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection - examination and report (R) N 59751 01NOV2001 ARTHROGRAPHY, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection - (R) Y 59752 01JUL2011 ARTHROGRAPHY, each joint, excluding the facet (zygapophyseal) joints of the spine, single or double contrast study, with or without preliminary plain films and with preparation and contrast injection - (R) (NK) Y 59754 01DEC1991 LYMPHANGIOGRAPHY, including follow up radiography (R) N 59754 01NOV1997 LYMPHANGIOGRAPHY, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection - examination and report(R) N 59754 01NOV2001 LYMPHANGIOGRAPHY, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection - (R) Y 59755 01JUL2011 LYMPHANGIOGRAPHY, one or both sides, with preliminary plain films and follow-up radiography and with preparation and contrast injection - (R) (NK) Y 59757 01DEC1991 PNEUMOMEDIASTINUM (R) Y 59760 01NOV1996 PERITONEOGRAM (herniography) with or without contrast medium including preparation - performed on a person over 14 years of age (R) Y 59761 01JUL2011 PERITONEOGRAM (herniography) with or without contrast medium including preparation - performed on a person over 14 years of age (R) (NK) Y 59763 01NOV1996 AIR INSUFFLATION during video - fluoroscopic imaging including associated consultation (R) Y 59764 01JUL2011 AIR INSUFFLATION during video - fluoroscopic imaging including associated consultation (R) (NK) Y 59900 01DEC1991 BY FILM OR OTHER TECHNIQUE SERIAL ANGIOCARDIOGRAPHY (rapid cassette changing)each series (R) Y 59903 01DEC1991 SERIAL ANGIOCARDIOGRAPHY (SINGLE PLAIN, direct rollfilm method)each series (R) N 59903 01JUL1993 SERIAL ANGIOCARDIOGRAPHY (SINGLE PLANE)each series (R) N 59903 01JUL2001 ANGIOCARDIOGRAPHY including the service described in item 59970, 59974 or 61109, not being a service to which item 59912 or 59925 applies (R) (K) N 59903 01DEC2015 Angiocardiography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59912 or 59925 applies(R) (K) (Anaes.) Y 59906 01DEC1991 SERIAL ANGIOCARDIOGRAPHY (BIPLANE, direct rollfilm method)each series (R) N 59906 01JUL1993 SERIAL ANGIOCARDIOGRAPHY (BIPLANE)each series (R) Y 59909 01DEC1991 SERIAL ANGIOCARDIOGRAPHY (indirect rollfilm method)each series (R) Y 59912 01DEC1991 SELECTIVE CORONARY ARTERIOGRAPHY (R) N 59912 01JUL2001 SELECTIVE CORONARY ARTERIOGRAPHY (R) (K), including the services described in item 59970, 59974 or 61109, not being a service to which item 59903 or 59925 applies (Anaes.) N 59912 01DEC2015 Selective coronary arteriography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59903 or 59925 applies (R) (K) (Anaes.) Y 59915 01DEC1991 CEREBRAL ANGIOGRAPHY1 side (R) Y 59918 01DEC1991 ARTERIOGRAPHY, PERIPHERAL1 side (R) Y 59921 01DEC1991 AORTOGRAPHY (R) Y 59924 01DEC1991 SELECTIVE ARTERIOGRAPHYeach injection and film run (R) N 59924 01JUL1993 SELECTIVE ARTERIOGRAPHYper injection and film or data acquisition run (R) Y 59925 01JUL2001 SELECTIVE CORONARY ARTERIOGRAPHY AND ANGIOCARDIOGRAPHY, including the services described in items 59903, 59912, 59970, 59974 or 61109 (R) (K) N 59925 01DEC2015 Selective coronary arteriography and angiocardiography, including a service mentioned in item 59903, 59912, 59970, 59974, 61109 or 61110 (R) (K) (Anaes.) Y 59970 01NOV1996 ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, one or more regions including any preliminary plain films, preparation and contrast injection (R) N 59970 01NOV1998 ANGIOGRAPHY AND/OR DIGITAL SUBTRACTION ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, 1 or more regions including any preliminary plain films, preparation and contrast injection (R) N 59970 01JUL2001 ANGIOGRAPHY AND/OR DIGITAL SUBTRACTION ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, 1 or more regions including any preliminary plain films, preparation and contrast injection (R) (K) (Anaes.) Y 59971 01JUL2001 ANGIOCARDIOGRAPHY including the service described in item 59970, 59974 or 61109, not being a service to which item 59972 or 59973 applies (R) (NK) N 59971 01DEC2015 Angiocardiography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59972 or 59973applies (R) (NK) (Anaes.) Y 59972 01JUL2001 SELECTIVE CORONARY ARTERIOGRAPHY (R) (NK), including the service described in item 59970, 59974 or 61109, not being a service to which item 59971 or 59973 applies (Anaes.) N 59972 01DEC2015 Selective coronary arteriography, including the service mentioned in item 59970, 59974, 61109 or 61110, not being a service to which item 59971 or 59973 applies (R) (NK) (Anaes.) Y 59973 01JUL2001 SELECTIVE CORONARY ARTERIOGRAPHY AND ANGIOCARDIOGRAPHY, including the services described in items 59970, 59971, 59972, 59974 or 61109 (R) (NK) N 59973 01DEC2015 Selective coronary arteriography and angiocardiography, including a service mentioned in item 59970, 59971, 59972, 59974, 61109 or 61110 (R) (NK) (Anaes.) Y 59974 01JUL2001 ANGIOGRAPHY AND/OR DIGITAL SUBTRACTION ANGIOGRAPHY with fluoroscopy and image acquisition using a mobile image intensifier, 1 or more regions including any preliminary plain films, preparation and contrast injection (R) (NK) (Anaes.) Y 60000 01NOV1992 BY DIGITAL SUBTRACTION TECHNIQUE DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 1 to 3 data acquisition runs (R) (Anaes.) N 60000 01JAN2015 BY DIGITAL SUBTRACTION TECHNIQUE DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 1 to 3 data acquisition runs (R) (K) (Anaes.) Y 60001 01JAN2015 Digital subtraction angiography, examination of head and neck with or without arch aortography - 1 to 3 data acquisition runs (R) (NK) (Anaes.) Y 60003 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 4 to 6 data acquisition runs (R) (Anaes.) N 60003 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 4 to 6 data acquisition runs (R) (K) (Anaes.) Y 60004 01JAN2015 Digital subtraction angiography, examination of head and neck with or without arch aortography - 4 to 6 data acquisition runs (R) (NK) (Anaes.) Y 60006 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 7 to 9 data acquisition runs (R) (Anaes.) N 60006 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 7 to 9 data acquisition runs (R) (K) (Anaes.) Y 60007 01JAN2015 Digital subtraction angiography, examination of head and neck with or without arch aortography - 7 to 9 data acquisition runs (R) (NK) (Anaes.) Y 60009 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 10 or more data acquisition runs (R) (Anaes.) N 60009 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of head and neck with or without arch aortography - 10 or more data acquisition runs (R) (K) (Anaes.) Y 60010 01JAN2015 Digital subtraction angiography, examination of head and neck with or without arch aortography - 10 or more data acquisition runs (R) (NK) (Anaes.) Y 60012 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 1 to 3 data acquisition runs (R) (Anaes.) N 60012 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 1 to 3 data acquisition runs (R) (K) (Anaes.) Y 60013 01JAN2015 Digital subtraction angiography, examination of thorax - 1 to 3 data acquisition runs (R) (NK) (Anaes.) Y 60015 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 4 to 6 data acquisition runs (R) (Anaes.) N 60015 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 4 to 6 data acquisition runs (R) (K) (Anaes.) Y 60016 01JAN2015 Digital subtraction angiography, examination of thorax - 4 to 6 data acquisition runs (R) (NK) (Anaes.) Y 60018 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 7 to 9 data acquisition runs (R) (Anaes.) N 60018 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 7 to 9 data acquisition runs (R) (K) (Anaes.) Y 60019 01JAN2015 Digital subtraction angiography, examination of thorax - 7 to 9 data acquisition runs (R) (NK) (Anaes.) Y 60021 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 10 or more data acquisition runs (R) (Anaes.) N 60021 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of thorax - 10 or more data acquisition runs (R) (K) (Anaes.) Y 60022 01JAN2015 Digital subtraction angiography, examination of thorax - 10 or more data acquisition runs (R) (NK) (Anaes.) Y 60024 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 1 to 3 data acquisition runs (R) (Anaes.) N 60024 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 1 to 3 data acquisition runs (R) (K) (Anaes.) Y 60025 01JAN2015 Digital subtraction angiography, examination of abdomen - 1 to 3 data acquisition runs (R) (NK) (Anaes.) Y 60027 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 4 to 6 data acquisition runs (R) (Anaes.) N 60027 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 4 to 6 data acquisition runs (R) (K) (Anaes.) Y 60028 01JAN2015 Digital subtraction angiography, examination of abdomen - 4 to 6 data acquisition runs (R) (NK) (Anaes.) Y 60030 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 7 to 9 data acquisition runs (R) (Anaes.) N 60030 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 7 to 9 data acquisition runs (R) (K) (Anaes.) Y 60031 01JAN2015 Digital subtraction angiography, examination of abdomen - 7 to 9 data acquisition runs (R) (NK) (Anaes.) Y 60033 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 10 or more data acquisition runs (R) (Anaes.) N 60033 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of abdomen - 10 or more data acquisition runs (R) (K) (Anaes.) Y 60034 01JAN2015 Digital subtraction angiography, examination of abdomen - 10 or more data acquisition runs (R) (NK) (Anaes.) Y 60036 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 1 to 3 data acquisition runs (R) (Anaes.) N 60036 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 1 to 3 data acquisition runs (R) (K) (Anaes.) Y 60037 01JAN2015 Digital subtraction angiography, examination of upper limb or limbs - 1 to 3 data acquisition runs (R) (NK) (Anaes.) Y 60039 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 4 to 6 data acquisition runs (R) (Anaes.) N 60039 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 4 to 6 data acquisition runs (R) (K) (Anaes.) Y 60040 01JAN2015 Digital subtraction angiography, examination of upper limb or limbs - 4 to 6 data acquisition runs (R) (NK) (Anaes.) Y 60042 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 7 to 9 data acquisition runs (R) (Anaes.) N 60042 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 7 to 9 data acquisition runs (R) (K) (Anaes.) Y 60043 01JAN2015 Digital subtraction angiography, examination of upper limb or limbs - 7 to 9 data acquisition runs (R) (NK) (Anaes.) Y 60045 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 10 or more data acquisition runs (R) (Anaes.) N 60045 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of upper limb or limbs - 10 or more data acquisition runs (R) (K) (Anaes.) Y 60046 01JAN2015 Digital subtraction angiography, examination of upper limb or limbs - 10 or more data acquisition runs (R) (NK) (Anaes.) Y 60048 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 1 to 3 data acquisition runs (R) (Anaes.) N 60048 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 1 to 3 data acquisition runs (R) (K) (Anaes.) Y 60049 01JAN2015 Digital subtraction angiography, examination of lower limb or limbs - 1 to 3 data acquisition runs (R) (NK) (Anaes.) Y 60051 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 4 to 6 data acquisition runs (R) (Anaes.) N 60051 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 4 to 6 data acquisition runs (R) (K) (Anaes.) Y 60052 01JAN2015 Digital subtraction angiography, examination of lower limb or limbs - 4 to 6 data acquisition runs (R) (NK) (Anaes.) Y 60054 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 7 to 9 data acquisition runs (R) (Anaes.) N 60054 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 7 to 9 data acquisition runs (R) (K) (Anaes.) Y 60055 01JAN2015 Digital subtraction angiography, examination of lower limb or limbs - 7 to 9 data acquisition runs (R) (NK) (Anaes.) Y 60057 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 10 or more data acquisition runs (R) (Anaes.) N 60057 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of lower limb or limbs - 10 or more data acquisition runs (R) (K) (Anaes.) Y 60058 01JAN2015 Digital subtraction angiography, examination of lower limb or limbs - 10 or more data acquisition runs (R) (NK) (Anaes.) Y 60060 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 1 to 3 data acquisition runs (R) (Anaes.) N 60060 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 1 to 3 data acquisition runs (R) (K) (Anaes.) Y 60061 01JAN2015 Digital subtraction angiography, examination of aorta and lower limb or limbs - 1 to 3 data acquisition runs (R) (NK) (Anaes.) Y 60063 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 4 to 6 data acquisition runs (R) (Anaes.) N 60063 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 4 to 6 data acquisition runs (R) (K) (Anaes.) Y 60064 01JAN2015 Digital subtraction angiography, examination of aorta and lower limb or limbs - 4 to 6 data acquisition runs (R) (NK) (Anaes.) Y 60066 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 7 to 9 data acquisition runs (R) (Anaes.) N 60066 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 7 to 9 data acquisition runs (R) (K) (Anaes.) Y 60067 01JAN2015 Digital subtraction angiography, examination of aorta and lower limb or limbs - 7 to 9 data acquisition runs (R) (NK) (Anaes.) Y 60069 01NOV1992 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 10 or more data acquisition runs (R) (Anaes.) N 60069 01JAN2015 DIGITAL SUBTRACTION ANGIOGRAPHY, examination of aorta and lower limb or limbs - 10 or more data acquisition runs (R) (K) (Anaes.) Y 60070 01JAN2015 Digital subtraction angiography, examination of aorta and lower limb or limbs - 10 or more data acquisition runs (R) (NK) (Anaes.) Y 60072 01NOV1992 SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 1 vessel (NR) (Anaes.) N 60072 01JAN2015 SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 1 vessel (NR) (K) (Anaes.) Y 60073 01JAN2015 Selective arteriography or selective venography by digital subtraction angiography technique - one vessel (NR) (NK) (Anaes.) Y 60075 01NOV1992 SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 2 vessels (NR) (Anaes.) N 60075 01JAN2015 SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 2 vessels (NR) (K) (Anaes.) Y 60076 01JAN2015 Selective arteriography or selective venography by digital subtraction angiography technique - 2 vessels (NR) (NK) (Anaes.) Y 60078 01NOV1992 SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 3 or more vessels (NR) (Anaes.) N 60078 01JAN2015 SELECTIVE ARTERIOGRAPHY or SELECTIVE VENOGRAPHY by digital subtraction angiography technique - 3 or more vessels (NR) (K) (Anaes.) Y 60079 01JAN2015 Selective arteriography or selective venography by digital subtraction angiography technique - 3 or more vessels (NR) (NK) (Anaes.) Y 60100 01DEC1991 TOMOGRAPHY OF ANY REGION AND REPORT (R) N 60100 01NOV2001 TOMOGRAPHY OF ANY REGION (R) (Anaes.) Y 60101 01JUL2011 TOMOGRAPHY OF ANY REGION (R) (NK) Y 60300 01DEC1991 STEREOSCOPIC EXAMINATION AND REPORT (R) Y 60500 01DEC1991 FLUOROSCOPY, with general anaesthesia (R) N 60500 19FEB1997 FLUOROSCOPY, with general anaesthesia (not being a service associated with a radiographic examination) (R) Y 60501 01JUL2011 FLUOROSCOPY, with general anaesthesia (not being a service associated with a radiographic examination) (R) (NK) Y 60503 01DEC1991 FLUOROSCOPY, without general anaesthesia (R) N 60503 19FEB1997 FLUOROSCOPY, without general anaesthesia (not being a service associated with a radiographic examination) (R) Y 60504 01JUL2011 FLUOROSCOPY, without general anaesthesia (not being a service associated with a radiographic examination) (R) (NK) Y 60506 01NOV1992 FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Category applies (R) N 60506 01NOV1997 FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Table applies (R) Y 60507 01JUL2011 FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting less than 1 hour, not being a service associated with a service to which another item in this Table applies (R) (NK) Y 60509 01NOV1992 FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Category applies (R) N 60509 01NOV1997 FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Table applies (R) Y 60510 01JUL2011 FLUOROSCOPY using a mobile image intensifier, in conjunction with a surgical procedure lasting 1 hour or more, not being a service associated with a service to which another item in this Table applies (R) (NK) Y 60700 01DEC1991 Radiographic examination of any part and report not covered by another item in this Group (R) Y 60900 01DEC1991 "Note: In this Subgroup, ""preparation"" means the injection of opaque or contrast media or the removal of fluid and its replacement by air, oxygen or other similar preparation ENCEPHALOGRAPHY (NR)" Y 60903 01DEC1991 CEREBRAL ANGIOGRAPHY (one side)percutaneous, catheter or open exposure (NR) N 60903 01NOV1997 CEREBRAL ANGIOGRAPHY, 1 sidepercutaneous, catheter or open exposure, when used in association with a service to which items 59900, 59903,59906, 59912, 59915, 59918, 59921, 59924 or 59970 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR) Y 60906 01DEC1991 CEREBRAL VENTRICULOGRAPHY (NR) Y 60909 01DEC1991 DACRYOCYSTOGRAPHY1 side (NR) Y 60912 01DEC1991 BRONCHOGRAPHY1 or both sides (NR) Y 60915 01DEC1991 AORTOGRAPHY (NR) N 60915 01NOV1997 AORTOGRAPHY, when used in association with a service to which items 59900, 59903, 59906, 59912, 59915, 59918 59921, 59924 or 59970 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR) Y 60918 01DEC1991 ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY1 vessel (NR) N 60918 01NOV1997 ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY1 vessel, when used in association with a service to which items 59900, 59903, 59906, 59912, 59915, 59918, 59921 or 59924applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR) N 60918 01JUL2001 ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY1 vessel, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR) N 60918 01JAN2015 ARTERIOGRAPHY (peripheral) or PHLEBOGRAPHY1 vessel, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60079 inclusive apply (NR) Y 60921 01DEC1991 SPLENOGRAPHY (NR) Y 60924 01DEC1991 RETROPERITONEAL PNEUMOGRAM (NR) Y 60927 01DEC1991 SELECTIVE ARTERIOGRAM or PHLEBOGRAM (NR) N 60927 01NOV1997 SELECTIVE ARTERIOGRAM or PHLEBOGRAM, when used in association with a service to which items 59900, 59903, 59906, 59912, 59915, 59918, 59921 or 59924 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR) N 60927 01JUL2001 SELECTIVE ARTERIOGRAM or PHLEBOGRAM, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60078 inclusive apply (NR) N 60927 01JAN2015 SELECTIVE ARTERIOGRAM or PHLEBOGRAM, when used in association with a service to which items 59903, 59912, 59925, 59970, 59971 59972, 59973 or 59974 applies, not being a service associated with a service to which items 60000 to 60079 inclusive apply (NR) Y 60930 01DEC1991 PERCUTANEOUS INJECTION of radioopaque material into RENAL CYST (including aspiration) or RENAL PELVIS for antegrade pyelography (NR) Y 60933 01DEC1991 PNEUMOARTHROGRAPHY or PNEUMOPERITONEUM (NR) Y 60936 01DEC1991 ARTHROGRAPHY, single or double contrast, excluding arthrography of the joints between articular processes of the vertebrae (NR) Y 60939 01DEC1991 DRIPINFUSION PYELOGRAPHY OR CHOLEGRAPHY (NR) N 60939 01NOV1996 DRIPINFUSION CHOLEGRAPHY (NR) Y 60942 01DEC1991 RETROGRADE MICTURATING CYSTOURETHROGRAPHY (NR) Y 60945 01DEC1991 HYSTEROSALPINGOGRAPHY (NR) Y 60948 01DEC1991 DISCOGRAPHY1 disc (NR) Y 60951 01DEC1991 DISCOGRAPHY using Metrizamide contrast medium (NR) Y 60954 01DEC1991 INTRAOSSEOUS VENOGRAPHY (NR) Y 60957 01DEC1991 MYELOGRAPHY not being a service to which item 60960 applies (NR) N 60957 01JUL1995 MYELOGRAPHY (NR) Y 60960 01DEC1991 MYELOGRAPHY, using Metrizamide contrast medium (NR) Y 60963 01DEC1991 CISTERNAL PUNCTURE (NR) Y 60966 01DEC1991 SINUS OR FISTULA, INJECTION INTO (NR) Y 60969 01DEC1991 SIALOGRAPHY (NR) Y 60972 01DEC1991 LYMPHANGIOGRAPHY1 side (NR) Y 60975 01DEC1991 LARYNGOGRAPHY (NR) Y 60978 01DEC1991 PNEUMOMEDIASTINUM (NR) Y 60981 01DEC1991 CHOLEGRAM (CHOLANGIOGRAM)percutaneous transhepatic (NR) Y 61109 01NOV1992 FLUOROSCOPY in an ANGIOGRAPHY SUITE with image intensification, in conjunction with a surgical procedure, using interventional techniques, not being a service associated with a service to which another item in this Table applies (R) N 61109 01NOV1997 FLUOROSCOPY in an ANGIOGRAPHY SUITE with image intensification, in conjunction with a surgical procedure, using interventional techniques, not being a service associated with a service to which another item in this Table applies (R) Y 61110 01JUL2011 FLUOROSCOPY in an ANGIOGRAPHY SUITE with image intensification, in conjunction with a surgical procedure, using interventional techniques, not being a service associated with a service to which another item in this Table applies (R) (NK) Y 61200 01DEC1991 Magnetic resonance imaging - examination of any part or parts of the body (R) (HR) Y 61300 01DEC1991 NOTE (This note should be read in conjunction with explanatory notes for this Category).Benefits for a nuclear scanning service are only payable when the preliminary examination of the patient, estimation and administration of the dosage and the performance of the scan, are undertaken by a medical practitioner, or on behalf of a medical practitioner in the practitioner's presence, and the compilation of the final report is undertaken by the medical practitioner.Additional benefits will only be attracted for a specialist physician or consultant physician attendance under Category 1 of the Schedule where there is a request for a full medical examination accompanied by a letter or note of referral. MYOCARDIAL PERFUSION STUDY USING THALLIUMsingle study for stress or reperfusion (R) Y 61301 01DEC1991 MYOCARDIAL PERFUSION STUDY USING THALLIUMsingle study for stress or reperfusion (R) Y 61302 01NOV1996 NOTE Benefits for a nuclear medicine scanning service are only payable when the preliminary examination of the patient, estimation and administration of the dosage and the performance of the scan, are undertaken by a medical specialist, or on behalf of the medical specialist in the specialist's presence, and the compilation of the report is undertaken by the medical specialist.Additional benefits will only be attracted for a specialist or consultant physician attendance under Category 1 of the Schedule where there is a request for a full medical examination accompanied by a letter or note of referral. SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY with thallium or sestamibi - planar imaging (R) N 61302 01NOV1997 SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - planar imaging (R) Y 61303 01NOV1996 SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY with thallium or sestamibi - with single photon emission tomography and with planar imaging when undertaken (R) N 61303 01NOV1997 SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - with single photon emission tomography and with planar imaging when undertaken (R) Y 61304 01DEC1991 MYOCARDIAL PERFUSION STUDY USING THALLIUMcombined study for stress and reperfusion (R) Y 61305 01DEC1991 MYOCARDIAL PERFUSION STUDY USING THALLIUMcombined study for stress and reperfusion (R) Y 61306 01NOV1996 COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study with thallium or sestamibi, or thallium and sestamibi, including delayed imaging or re-injection protocol on a subsequent occasion - planar imaging (R) N 61306 01NOV1997 COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - planar imaging (R) Y 61307 01NOV1996 COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study with thallium or sestamibi, or thallium and sestamibi, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging when undertaken (R) N 61307 01NOV1997 COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging when undertaken (R) Y 61308 01DEC1991 MYOCARDIAL INFARCTAVID IMAGING STUDY (R) Y 61309 01DEC1991 MYOCARDIAL INFARCTAVID IMAGING STUDY (R) Y 61310 01NOV1996 MYOCARDIAL INFARCT-AVID-STUDY, with planar imaging and single photon emission tomography, OR planar imaging or single photon emission tomography (R) Y 61311 14SEP2019 Single stress or rest myocardial perfusion study - with PET (R) N 61311 10JAN2020 Single stress or rest myocardial perfusion study - with PET (R) Item 61311 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61312 01DEC1991 GATED CARDIAC BLOOD POOL (equilibrium) STUDY (R) Y 61313 01NOV1996 GATED CARDIAC BLOOD POOL STUDY, (equilibrium), with planar imaging and single photon emission tomography ORplanar imaging or single photon emission tomography (R) Y 61314 01NOV1996 GATED CARDIAC BLOOD POOL STUDY, and first pass blood flow or cardiac shunt study, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) Y 61315 01DEC1991 GATED CARDIAC BLOOD POOL STUDY with intervention (R) Y 61316 01NOV1996 GATED CARDIAC BLOOD POOL STUDY, with intervention, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) Y 61317 01NOV1996 GATED CARDIAC BLOOD POOL STUDY, with intervention and first pass blood flow study or cardiac shunt study, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R) Y 61318 01DEC1991 CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY (not being a service associated with a service to which another item in this Group applies (R) Y 61319 01DEC1991 CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY (not being a service associated with a service to which another item in this Group applies (R) Y 61320 01NOV1996 CARDIAC FIRST PASS BLOOD FLOW STUDY OR CARDIAC SHUNT STUDY, not being a service to which another item in this Group applies (R) Y 61322 01DEC1991 CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY being a serviceassociated with a service to which another item in this Group applies (R) Y 61323 01DEC1991 CARDIAC FIRST PASS BLOOD FLOW STUDY, CARDIAC SHUNT STUDY OR CARDIAC OUTPUT STUDY being a service associated with a service to which another item in this Group applies (R) Y 61326 01DEC1991 LUNG PERFUSION STUDY (R) Y 61327 01DEC1991 LUNG PERFUSION STUDY (R) Y 61328 01NOV1996 LUNG PERFUSION STUDY, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R) Y 61330 01DEC1991 LUNG VENTILATION STUDY using Xe127 gas (R) Y 61331 01DEC1991 LUNG VENTILATION STUDY using Xe127 gas (R) Y 61332 14SEP2019 Combined stress and rest, stress and re?injection or rest and redistribution myocardial perfusion study, including delayed imaging or re?injection protocol on a subsequent occasion - with PET (R) N 61332 10JAN2020 Combined stress and rest, stress and re?injection or rest and redistribution myocardial perfusion study, including delayed imaging or re?injection protocol on a subsequent occasion - with PET (R) Item 61332 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61333 14SEP2019 Lung perfusion study and lung ventilation study using galligas or 68Ga-MAA, with PET (R) N 61333 10JAN2020 Lung perfusion study and lung ventilation study using galligas or 68Ga-MAA, with PET (R) Item 61333 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61334 01DEC1991 LUNG VENTILATION STUDY using Xe133 gas (R) Y 61335 01DEC1991 LUNG VENTILATION STUDY using Xe133 gas (R) Y 61336 14SEP2019 Cerebral perfusion study, with PET (R) N 61336 10JAN2020 Cerebral perfusion study, with PET (R) Item 61336 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61337 14SEP2019 Bone study - whole body, with PET, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) N 61337 10JAN2020 Bone study - whole body, with PET, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Item 61337 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61338 01DEC1991 LUNG VENTILATION STUDY using aerosol (R) Y 61339 01DEC1991 LUNG VENTILATION STUDY using aerosol (R) Y 61340 01NOV1996 LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography OR planar imaging or single photon emission tomography (R) Y 61341 14SEP2019 Bone study - whole body and PET, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) N 61341 10JAN2020 Bone study - whole body and PET, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Item 61341 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61342 01DEC1991 LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using either Xe127 or Xe133 gas (R) Y 61343 01DEC1991 LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using either Xe127 or Xe133 gas (R) Y 61344 14SEP2019 Computed tomography performed at the same time and covering the same body area as positron emission tomography covered by items 61311, 61332, 61333, 61336, 61337and 61341, for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued (R) N 61344 10JAN2020 Computed tomography performed at the same time and covering the same body area as positron emission tomography covered by items 61311, 61332, 61333, 61336, 61337and 61341, for the purpose of anatomic localisation or attenuation correction if no separate diagnostic CT report is issued (R) Item 61344 was only available from 14 September 2019 until 20 December 2019, during a national shortage of technetium. See the Health Insurance (Section 3C Diagnostic Imaging - Nuclear Medicine Services) Amendment (No. 2) Determination 2019 on the Federal Register of Legislation for further information. Y 61346 01DEC1991 LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol (R) Y 61347 01DEC1991 LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol (R) Y 61348 01NOV1996 LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) Y 61350 01DEC1991 LIVER AND SPLEEN STUDY (colloid) (R) Y 61351 01DEC1991 LIVER AND SPLEEN STUDY (colloid) (R) Y 61352 01NOV1996 LIVER AND SPLEEN STUDY (colloid) - planar imaging (R) Y 61353 01NOV1996 LIVER AND SPLEEN STUDY (colloid), with single photon emission tomography and with planar imaging when undertaken (R) Y 61354 01DEC1991 RED BLOOD CELL SPLEEN OR LIVER STUDY (R) Y 61355 01DEC1991 RED BLOOD CELL SPLEEN OR LIVER STUDY (R) Y 61356 01NOV1996 RED BLOOD CELL SPLEEN OR LIVER STUDY, including single photon emission tomography when undertaken (R) Y 61358 01DEC1991 HEPATOBILIARY STUDY (R) Y 61359 01DEC1991 HEPATOBILIARY STUDY (R) Y 61360 01NOV1996 HEPATOBILIARY STUDY, including morphine administration or pre-treatment with cholecystokinin (CCK) when undertaken (R) N 61360 27NOV2013 HEPATOBILIARY STUDY, including morphine administration or pre-treatment with a cholagogue when performed (R) (K) Y 61361 01NOV1996 HEPATOBILIARY STUDY with formal quantification following baseline imaging, using an infusion of cholecystokinin (CCK) (R) N 61361 27NOV2013 HEPATOBILIARY STUDY with formal quantification following baseline imaging, using a cholagogue (R) (K) Y 61362 01DEC1991 BOWEL HAEMORRHAGE STUDY (R) Y 61363 01DEC1991 BOWEL HAEMORRHAGE STUDY (R) Y 61364 01NOV1996 BOWEL HAEMORRHAGE STUDY (R) Y 61366 01DEC1991 MECKEL'S DIVERTICULUM STUDY (R) Y 61367 01DEC1991 MECKEL'S DIVERTICULUM STUDY (R) Y 61368 01NOV1996 MECKEL'S DIVERTICULUM STUDY (R) Y 61369 01NOV1999 INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a)there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b)a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (Ministerial Determination)(R) N 61369 01NOV2004 INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a)there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b)a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (Ministerial Determination) (R) N 61369 01JUL2010 INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a)there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b)a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (R) Y 61370 01DEC1991 SALIVARY STUDY (R) Y 61371 01DEC1991 SALIVARY STUDY (R) Y 61372 01NOV1996 SALIVARY STUDY (R) Y 61373 01NOV1996 GASTRO-OESOPHAGEAL REFLUX STUDY, including delayed imaging on a separate occasion when undertaken (R) Y 61374 01DEC1991 GASTROOESOPHAGEAL REFLUX STUDY (R) Y 61375 01DEC1991 GASTROOESOPHAGEAL REFLUX STUDY (R) Y 61376 01NOV1996 OESOPHAGEAL CLEARANCE STUDY (R) Y 61378 01DEC1991 OESOPHAGEAL CLEARANCE STUDY (R) Y 61379 01DEC1991 OESOPHAGEAL CLEARANCE STUDY (R) Y 61381 01NOV1996 GASTRIC EMPTYING STUDY, using single tracer (R) Y 61382 01DEC1991 GASTRIC EMPTYING STUDY using single tracer (R) Y 61383 01NOV1996 COMBINED SOLID AND LIQUID GASTRIC EMPTYING STUDY using dual isotope technique or the same isotope on separate days (R) Y 61384 01NOV1996 RADIONUCLIDE COLONIC TRANSIT STUDY (R) Y 61385 01DEC1991 GASTRIC EMPTYING STUDY using dual tracer (R) Y 61386 01NOV1996 RENAL STUDY, including perfusion and renogram images and computer analysis OR cortical study with planar imaging (R) Y 61387 01NOV1996 RENAL CORTICAL STUDY, with single photon emission tomography and planar quantification (R) Y 61388 01DEC1991 RENAL STUDY WITH OR WITHOUT DYNAMIC FLOW STUDY AND WITH OR WITHOUT COMPUTER EXTRACTION OF functional parameters (R) Y 61389 01NOV1996 SINGLE RENAL STUDY with pre-procedural administration of a diuretic or angiotensin converting enzyme (ACE) inhibitor (R) Y 61390 01NOV1996 RENAL STUDY with diuretic administration following a baseline study (R) Y 61391 01DEC1991 RENAL STUDY WITH INTERVENTION (R) Y 61392 01DEC1991 RENAL STUDY WITH INTERVENTION (R) Y 61393 01NOV1996 COMBINED EXAMINATION INVOLVING A RENAL STUDY following angiotensin converting enzyme (ACE) inhibitor provocation and a baseline study, in either order and related to a single referral episode (R) Y 61395 01DEC1991 CYSTOURETEROGRAM (R) Y 61396 01DEC1991 CYSTOURETEROGRAM (R) Y 61397 01NOV1996 CYSTOURETEROGRAM (R) Y 61399 01DEC1991 TESTICULAR STUDY (R) Y 61400 01DEC1991 TESTICULAR STUDY (R) Y 61401 01NOV1996 TESTICULAR STUDY (R) Y 61402 01NOV1996 BRAIN STUDY USING TC-EXAMETAZINE, with single photon emission tomogrophy and with planar imaging when undertaken (R) N 61402 01NOV1998 CEREBRAL PERFUSION STUDY, with single photon emission tomography and with planar imaging when undertaken (R) Y 61403 01DEC1991 BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT (R) Y 61404 01DEC1991 BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT (R) Y 61405 01NOV1996 BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) Y 61407 01DEC1991 CEREBROSPINAL FLUID TRANSPORT STUDY (R) Y 61408 01DEC1991 CEREBROSPINAL FLUID TRANSPORT STUDY (R) Y 61409 01NOV1996 CEREBRO-SPINAL FLUID TRANSPORT STUDY, with imaging on 2 or more separate occasions (R) Y 61411 01DEC1991 CEREBROSPINAL FLUID SHUNT PATENCY STUDY (R) Y 61412 01DEC1991 CEREBROSPINAL FLUID SHUNT PATENCY STUDY (R) Y 61413 01NOV1996 CEREBRO-SPINAL FLUID SHUNT PATENCY STUDY (R) Y 61415 01DEC1991 DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (not being a service associated with a service to which another item in this Group applies) (R) Y 61416 01DEC1991 DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (not being a service associated with a service to which another item in this Group applies) (R) (NC) Y 61417 01NOV1996 DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY, not being a service associated with a service to which another item in this Group applies (R) Y 61419 01DEC1991 BONE STUDYwhole body (R) Y 61420 01DEC1991 BONE STUDYwhole body (R) Y 61421 01NOV1996 BONE STUDY - whole body, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Y 61423 01DEC1991 BONE STUDYwhole body and DYNAMIC BLOOD FLOW OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (R) Y 61424 01DEC1991 BONE STUDYwhole body and DYNAMIC BLOOD FLOW OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY (R) Y 61425 01NOV1996 BONE STUDY - whole body and single photon emission tomography, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) Y 61426 01NOV1996 WHOLE BODY STUDY using iodine (R) Y 61427 01DEC1991 WHOLE BODY STUDY USING IODINE (R) Y 61428 01DEC1991 WHOLE BODY STUDY USING IODINE (R) Y 61429 01NOV1996 WHOLE BODY STUDY using gallium (R) Y 61430 01NOV1996 WHOLE BODY STUDY using gallium, with single photon emission tomography (R) Y 61431 01DEC1991 WHOLE BODY STUDY USING GALLIUM (R) Y 61432 01DEC1991 WHOLE BODY STUDY USING GALLIUM (R) Y 61433 01NOV1996 WHOLE BODY STUDY using cells labelled with technetium (R) Y 61434 01NOV1996 WHOLE BODY STUDY using cells labelled with technetium, with single photon emission tomography (R) Y 61435 01DEC1991 WHOLE BODY STUDY USING CELLS LABELLED WITH TECHNETIUM (R) Y 61436 01DEC1991 WHOLE BODY STUDY USING CELLS LABELLED WITH TECHNETIUM (R) Y 61437 01NOV1996 WHOLE BODY STUDY using thallium (R) Y 61438 01NOV1996 WHOLE BODY STUDY using thallium, with single photon emission tomography (R) Y 61439 01DEC1991 BONE MARROW STUDYwhole body (R) Y 61440 01DEC1991 BONE MARROW STUDYwhole body (R) Y 61441 01NOV1996 BONE MARROW STUDY - whole body (R) N 61441 01NOV1999 BONE MARROW STUDY - whole body using technetium labelled bone marrow agents (R) Y 61442 01NOV1997 WHOLE BODY STUDY, using gallium - with single photon emission tomography of 2 or more body regions acquired separately (R) Y 61443 01DEC1991 REPEAT OF A WHOLE BODY STUDY on a different occasion using the same administration of radiopharmaceutical (R) Y 61444 01DEC1991 REPEAT OF A WHOLE BODY STUDY on a different occasion using the same administration of radiopharmaceutical (R) (NC) Y 61445 01NOV1999 BONE MARROW STUDY - localised using technetium labelled agent (R) Y 61446 01NOV1996 LOCALISED BONE OR JOINT STUDY, including when undertaken, blood flow, blood pool and repeat imaging on a separate occasion (R) Y 61447 01DEC1991 LOCALISED BONE OR JOINT STUDY including FLOW AND BLOOD POOL STUDIES (R) Y 61448 01DEC1991 LOCALISED BONE OR JOINT STUDY including FLOW AND BLOOD POOL STUDIES (R) Y 61449 01NOV1996 LOCALISED BONE OR JOINT STUDY and single photon emission tomography, including when undertaken, blood flow, blood pool and imaging on a separate occasion (R) Y 61450 01NOV1996 LOCALISED STUDY using gallium (R) Y 61451 01DEC1991 LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using gallium (R) Y 61452 01DEC1991 LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using gallium (R) Y 61453 01NOV1996 LOCALISED STUDY using gallium, with single photon emission tomography (R) Y 61454 01NOV1996 LOCALISED STUDY using cells labelled with technetium (R) Y 61455 01DEC1991 LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using cells labelled with technetium (R) Y 61456 01DEC1991 LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY using cells labelled with technetium (R) Y 61457 01NOV1996 LOCALISED STUDY using cells labelled with technetium, with single photon emission tomography (R) Y 61458 01NOV1996 LOCALISED STUDY using thallium (R) Y 61459 01DEC1991 REPEAT OF A LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY on a different occasion using the same administration of radiopharmaceutical (R) Y 61460 01DEC1991 REPEAT OF A LOCALISED BONE, JOINT, TUMOUR, INFECTION OR INFLAMMATION SEEKING STUDY on a different occasion using the same administration of radiopharmaceutical (R) (NC) Y 61461 01NOV1996 LOCALISED STUDY using thallium, with single photon emission tomography (R) Y 61462 01NOV1996 REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING OR REPEAT PLANAR OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on a separate occasion using the same administration of radiopharmaceutical, not being a service associated with items 61373, 61409, 61421, 61425, 61446, 61449, 61484 or 61485 (R) N 61462 20JAN1997 REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING, OR REPEAT PLANAR IMAGING OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on an occasion subsequent to the performance of any one of items 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469, where there is no additional administration of radiopharmaceutical and where the previous radionuclide scan was abnormal or equivocal. (R) N 61462 01FEB2009 REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING, OR REPEAT PLANAR IMAGING OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on an occasion subsequent to the performance of any one of items 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469, 61484 or 61485 where there is no additional administration of radiopharmaceutical and where the previous radionuclide scan was abnormal or equivocal. (R) Y 61463 01DEC1991 VENOGRAPHY (including blood pool study, active uptake study or dynamic blood flow study) (R) Y 61464 01DEC1991 VENOGRAPHY (including blood pool study, active uptake study or dynamic blood flow study) (R) Y 61465 01NOV1996 VENOGRAPHY (R) Y 61467 01DEC1991 LYMPHOSCINTIGRAPHY (R) Y 61468 01DEC1991 LYMPHOSCINTIGRAPHY (R) Y 61469 01NOV1996 LYMPHOSCINTIGRAPHY (R) Y 61471 01DEC1991 THYROID STUDY (R) Y 61472 01DEC1991 THYROID STUDY (R) Y 61473 01NOV1996 THYROID STUDY including uptake measurement when undertaken (R) Y 61475 01DEC1991 THYROID UPTAKE STUDY PERFORMED ON GAMMA CAMERA (R) Y 61476 01DEC1991 THYROID UPTAKE STUDY PERFORMED ON GAMMA CAMERA (R) Y 61479 01DEC1991 PARATHYROID (R) Y 61480 01NOV1996 PARATHYROID STUDY, planar imaging and single photon emission tomography when undertaken (R) Y 61482 01DEC1991 ADRENAL STUDY USING SELENOCHOLESTEROL (R) Y 61483 01DEC1991 ADRENAL STUDY USING SELENOCHOLESTEROL (R) (NC) Y 61484 01NOV1996 ADRENAL STUDY, with imaging on 2 or more separate occasions (R) N 61484 01FEB2009 ADRENAL STUDY (R) Y 61485 01NOV1996 ADRENAL STUDY, with imaging on 2 or more occasions and renal localisation and single photon emission tomography when undertaken (R) N 61485 01FEB2009 ADRENAL STUDY, with single photon emission tomography(R) Y 61486 01DEC1991 ADRENAL STUDY (not being a service to which item 61482 or 61483 applies) (R) Y 61487 01DEC1991 ADRENAL STUDY (not being a service to which item 61482 or 61483 applies) (R) (NC) Y 61490 01DEC1991 SINGLE PHOTON EMISSION TOMOGRAPHY being a service associated with a service to which another item in this Group applies (R) Y 61493 01DEC1991 TEAR DUCT STUDY (R) Y 61494 01DEC1991 TEAR DUCT STUDY (R) Y 61495 01NOV1996 TEAR DUCT STUDY (R) Y 61497 01DEC1991 PARTICLE PERFUSION STUDY (INTRAARTERIAL) OR LE VEEN SHUNT STUDY (R) Y 61498 01DEC1991 PARTICLE PERFUSION STUDY (INTRAARTERIAL) OR LE VEEN SHUNT STUDY (R) Y 61499 01NOV1996 PARTICLE PERFUSION STUDY (intra-arterial) or Le Veen shunt study (R) Y 61501 01DEC1991 STUDY OF REGION OR ORGAN not being a service to which another item in this Group applies (R) Y 61502 01DEC1991 Study of region or organ not being a service to which another item in this Group applies (R) (NC) Y 61503 01NOV1996 STUDY OF REGION OR ORGAN not being a service to which another item in this Group applies (R) Y 61505 01MAY2007 CT scan performed at the same time and covering the same body area as single photon emission tomography for the purpose of anatomic localisation or attenuation correction where no separate diagnostic CT report is issued and only in association with items 61302 - 61650 (R) Y 61506 04DEC1999 Test item reserved for ITEM FEE MAP - DO NOT USE FOR ANY PROCEDURE Y 61507 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61508 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61509 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61510 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61511 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61512 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61513 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61514 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61515 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61516 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61517 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61518 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61519 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61520 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61521 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61522 01OCT1997 POSITRON EMISSION TOMOGRAPHY - location specific Y 61523 01OCT2001 Whole body FDG PET study, performed for evaluation of a solitary pulmonary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration, or for which an attempt at pathological characterisation has failed. N 61523 22DEC2005 Whole body FDG PET study, performed for evaluation of a solitary pulmonary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration biopsy, or for which an attempt at pathological characterisation has failed.(R) Y 61524 01NOV2019 Whole body FDG PET study, performed for the staging of locally advanced (Stage III) breast cancer, for a patient who is considered suitable for active therapy (R) Y 61525 01NOV2019 Whole body FDG PET study, performed for the evaluation of suspected metastatic or suspected locally or regionally recurrent breast carcinoma, for a patient who is considered suitable for active therapy (R) Y 61526 01OCT2001 Whole body FDG PET study, performed for evaluation of a solitary nodule where the lesion is considered unsuitable for transthoracic fine needle aspiration, or for which an attempt at pathological characterisation has failed, with catheterisation of the bladder Y 61529 01OCT2001 Whole body FDG PET study, performed for the primary staging of proven non-small cell lung cancer, where curative surgery or radiotherapy is planned N 61529 22DEC2005 Whole body FDG PET study, performed for the staging of proven non-small cell lung cancer, where curative surgery or radiotherapy is planned (R) Y 61532 01OCT2001 Whole body FDG PET study, performed for the primary staging of proven non-small cell lung cancer, where curative surgery or radiotherapy is planned, with catheterisation of the bladder Y 61535 01OCT2001 FDG PET study of the brain performed for the evaluation of a suspected primary brain tumour to guide surgical biopsy of the lesion and to assist in treatment planning Y 61538 01OCT2001 FDG PET study of the brain performed for the evaluation of a residual structural brain lesion based on anatomical imaging findings, after definitive therapy for glioma N 61538 01JUL2011 FDG PET study of the brain for evaluation of suspected residual or recurrent malignant brain tumour based on anatomical imaging findings, after definitive therapy (or during ongoing chemotherapy) in patients who are considered suitable for further active therapy. (R) Y 61541 01OCT2001 Whole body FDG PET study, performed in a symptomatic patient for the evaluation of a residual structural lesion, after definitive therapy for colorectal cancer N 61541 01DEC2008 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent colorectal carcinoma in patients considered suitable for active therapy N 61541 01JUL2011 Whole body FDG PET study, following initial therapy, for the evaluation of suspected residual, metastatic or recurrent colorectal carcinoma in patients considered suitable for active therapy (R) Y 61544 01OCT2001 Whole body FDG PET study, performed in a symptomatic patient for the evaluation of a residual structural lesion after definitive therapy for colorectal cancer, with catheterisation of the bladder N 61544 01DEC2008 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent colorectal carcinoma in patients considered suitable for active therapy, with catheterisation of the bladder. Y 61547 01OCT2001 Whole body FDG PET study, performed for the evaluation of apparently isolated liver or pulmonary metastases, following previous therapy for colorectal carcinoma, where surgical resection is planned Y 61550 01OCT2001 Whole body FDG PET study, performed for the evaluation of apparently isolated liver or pulmonary metastases, following previous therapy for colorectal carcinoma, where surgical resection is planned, with catheterisation of the bladder Y 61553 01OCT2001 Whole body FDG PET study, performed for the evaluation of apparently limited metastatic disease from malignant melanoma, where surgical resection is planned N 61553 01DEC2008 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected metastatic or recurrent malignant melanoma in patients considered suitable for active therapy N 61553 01JUL2011 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected metastatic or recurrent malignant melanoma in patients considered suitable for active therapy (R) Y 61556 01OCT2001 Whole body FDG PET study, performed for the evaluation of apparently limited metastatic disease from malignant melanoma, where surgical resection is planned, with catheterisation of the bladder N 61556 01DEC2008 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected metastatic or recurrent malignant melanoma in patients considered suitable for active therapy, with catheterisation of the bladder Y 61559 01OCT2001 FDG PET study of the brain, performed for the evaluation of refractory epilepsy which is being evaluated for surgery, where results of standard assessment are inconclusive for localisation of the epileptogenic focus N 61559 22DEC2005 FDG PET study of the brain, performed for the evaluation of refractory epilepsy which is being evaluated for surgery (R) Y 61562 01OCT2001 FDG PET study of the heart, performed for the evaluation of ischaemic heart disease and impaired left ventricular function, where revascularisation surgery is being considered and standard myocardial viability tests are negative or equivocal for ischaemia Y 61565 01OCT2001 Whole body FDG PET study, performed for the evaluation of epithelial ovarian carcinoma with suspected tumour recurrence following initial therapy, based on equivocal anatomical imaging findings or an elevation of CA-125 N 61565 01DEC2008 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy. N 61565 01JUL2011 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy. (R) Y 61568 01OCT2001 Whole body FDG PET study, performed for the evaluation of epithelial ovarian carcinoma with suspected tumour recurrence following initial therapy, based on equivocal anatomical imaging findings or an elevation of CA-125, with catheterisation of the bladder N 61568 01DEC2008 Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent ovarian carcinoma in patients considered suitable for active therapy with curative intent, with catheterisation of the bladder. Y 61571 01OCT2001 Whole body FDG PET study, performed for the primary staging of proven carcinoma of the uterine cervix, prior to planned radical radiation therapy or combined modality therapy N 61571 01JUL2011 Whole body FDG PET study, for the further primary staging ofpatients with histologically proven carcinoma of the uterine cervix, at FIGO stage IB2 or greater by conventional staging, prior to planned radical radiation therapy or combined modality therapy with curative intent. (R) Y 61574 01OCT2001 Whole body FDG PET study, performed for the primary staging of proven carcinoma of the uterine cervix, prior to planned radical radiation therapy or combined modality therapy, with catheterisation of the bladder Y 61575 01JUL2011 Whole body FDG PET study, for the further staging of patients with confirmed local recurrence of carcinoma of the uterine cervix considered suitable for salvage pelvic chemoradiotherapy or pelvic exenteration with curative intent. (R) Y 61577 01OCT2001 Whole body FDG PET study, performed for the staging of proven oesophageal carcinoma, where curative surgery or chemoradiation is planned N 61577 01SEP2009 Whole body FDG PET study, performed for the staging of proven oesophageal or GEJ carcinoma, in patients considered suitable for active therapy (R). Y 61580 01OCT2001 Whole body FDG PET study, performed for the staging of proven oesophageal carcinoma, where curative surgery or chemoradiation is planned, with catheterisation of the bladder N 61580 01SEP2009 Whole body FDG PET study, performed for the staging of proven oesophageal or GEJ carcinoma, in patients considered suitable for active therapy, with catheterisation of the bladder (R). Y 61583 01OCT2001 Whole body FDG PET study, performed for the staging of proven gastric carcinoma, where curative surgery is planned Y 61586 01OCT2001 Whole body FDG PET study, performed for the staging of proven gastric carcinoma, where curative surgery is planned, with catheterisation of the bladder Y 61589 01OCT2001 FDG PET study for follow-up of a cancer shown to be positive by an earlier FDG PET service (the earlier service), if (a) the earlier service was eligible for Medicare benefit because of Health Insurance Determination HS/3/1997, (B) the service is not eligible for Medicare benefit otherwise than because of Health Insurance Determination HS/02/2001, and (c) the service is required to assess response to treatment or possible tumour recurrence Y 61592 01OCT2001 FDG PET study, with catheterisation of the bladder, for follow-up of a cancer shown to be positive by an earlier FDG PET service (the earlier service), if (a) the earlier service was eligible for Medicare benefit because of Health Insurance Determination HS/3/1997, (B) the service is not eligible for Medicare benefit otherwise than because of Health Insurance Determination HS/02/2001, and (c) the service is required to assess response to treatment or possible tumour recurrence Y 61595 14JAN2002 FDG PET study for the primary staging of carcinoma of the head and neck Y 61598 14JAN2002 Whole body FDG PET study for the primary staging of carcinoma of the head and neck N 61598 01SEP2009 Whole body FDG PET study performed for the staging of biopsy-proven newly diagnosed or recurrent head and neck cancer (R). Y 61601 14JAN2002 FDG PET study for the further investigation of suspected residual or recurrent carcinoma of the head and neck Y 61604 14JAN2002 Whole body FDG PET study for the further investigation of suspected residual or recurrent carcinoma of the head and neck N 61604 01SEP2009 Whole body FDG PET study performed for the evaluation of patients with suspected residual head and neck cancer after definitive treatment, and who are suitable for active therapy (R). Y 61607 14JAN2002 FDG PET study for the evaluation of metastatic squamous cell carcinoma involving cervical nodes from an unknown primary site Y 61610 14JAN2002 Whole body FDG PET study for the evaluation of metastatic squamous cell carcinoma involving cervical nodes from an unknown primary site N 61610 01SEP2009 Whole body FDG PET study performed for the evaluation of metastatic squamous cell carcinoma of unknown primary site involving cervical nodes (R). Y 61613 14JAN2002 Whole body FDG PET study for the evaluation of metastatic squamous cell carcinoma involving cervical nodes from an unknown primary site, with catherterisation of the bladder N 61613 01SEP2009 Whole body FDG PET study performed for the evaluation of metastatic squamous cell carcinoma from an unknown primary site involving cervical nodes, with catherterisation of the bladder (R). Y 61616 14JAN2002 Whole body FDG PET study for staging of newly diagnosed or previously untreated Hodgkin's or non-Hodgkin's lymphoma N 61616 01JUL2011 Whole body FDG PET study for the initial staging of indolent non-Hodgkin's lymphoma where clinical, pathological and imaging findings indicate that the stage is I or IIA and the proposed management is definitive radiotherapy with curative intent. (R) Y 61619 14JAN2002 Whole body FDG PET study for staging of newly diagnosed or previously untreated Hodgkin's or non-Hodgkin's lymphoma, with catherterisation of the bladder Y 61620 01JUL2011 Whole body FDG PET study for the initial staging of newly diagnosed or previously untreated Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma. (R) N 61620 01NOV2017 Whole body FDG PET study for the initial staging of newly diagnosed or previously untreated Hodgkin or non-Hodgkin lymphoma (R) Y 61622 14JAN2002 Whole body FDG PET study for evaluation of a residual mass after treatment of Hodgkin's or non-Hodgkin's lymphoma N 61622 01JUL2011 Whole body FDG PET study to assess response to first line therapy either during treatment or within three months of completing definitive first line treatment for Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma), (R) N 61622 01NOV2017 Whole body FDG PET study to assess response to first line therapy either during treatment or within three months of completing definitive first line treatment for Hodgkin or non-Hodgkin lymphoma (R) Y 61625 14JAN2002 Whole body FDG PET study for evaluation of a residual mass after treatment of Hodgkin's or non-Hodgkin's lymphoma, with catherterisation of the bladder Y 61628 14JAN2002 Whole body FDG PET study for restaging of suspected recurrent or residual Hodgkin's or non-Hodgkin's lymphoma N 61628 01JUL2011 Whole body FDG PET study for restaging following confirmation of recurrence of Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma). (R) N 61628 01NOV2017 Whole body FDG PET study for restaging following confirmation of recurrence of Hodgkin or non-Hodgkin lymphoma (R) Y 61631 14JAN2002 Whole body FDG PET study for restaging of suspected recurrent or residual Hodgkin's or non-Hodgkin's lymphoma, with catherterisation of the bladder Y 61632 01JUL2011 Whole body FDG PET study to assess response to second-line chemotherapy when stem cell transplantation is being considered, for Hodgkin's or non-Hodgkin's lymphoma (excluding indolent non-Hodgkin's lymphoma). (R) N 61632 01NOV2017 Whole body FDG PET study to assess response to second-line chemotherapy ifhaemopoietic stem cell transplantation is being considered for Hodgkin or non-Hodgkin lymphoma (R) Y 61634 14JAN2002 Whole body FDG PET study to guide biopsy of a suspected bone or soft tissue sarcoma, where structural imaging suggests lesional heterogeneity Y 61637 14JAN2002 Whole body FDG PET study to guide biopsy of a suspected bone or soft tissue sarcoma, where structural imaging suggests lesional heterogeneity, with catheterisation of the bladder Y 61640 14JAN2002 Whole body FDG PET study for staging of biopsy-proven bone or soft tissue sarcoma being considered for resection of the primary or limited metastatic disease N 61640 01JUL2011 Whole body FDG PET study for initial staging of patients with biopsy-proven bone or soft tissue sarcoma (excluding gastrointestinal stromal tumour) considered by conventional staging to be potentially curable. (R) Y 61643 14JAN2002 Whole body FDG PET study for staging of biopsy-proven bone or soft tissue sarcoma being considered for resection of the primary or limited metastatic disease, with catheterisation of the bladder Y 61646 14JAN2002 Whole body FDG PET study for the evaluation of suspected residual or recurrent sarcoma on structural imaging after definitive therapy N 61646 01JUL2011 Whole body FDG PET study for the evaluation of patients with suspected residual or recurrent sarcoma (excluding gastrointestinal stromal tumour) after the initial course of definitive therapy to determine suitability for subsequent therapy with curative intent. (R) Y 61647 01MAY2018 Whole body 68Ga?DOTA?peptide PET study (including any associated computed tomography scans for anatomic localisation and attenuation correction), if: (a) a gastro?entero?pancreatic neuroendocrine tumour is suspected on the basis of biochemical evidence with negative or equivocal conventional imaging; or (b) both: (i) a surgically amenable gastro?entero?pancreatic neuroendocrine tumour has been identified on the basis of conventional techniques; and (ii) the study is for excluding additional disease sites (R) Y 61649 14JAN2002 Whole body FDG PET study for the evaluation of suspected residual or recurrent sarcoma on structural imaging after definitive therapy, with catheterisation of the bladder Y 61650 01JUN2004 LEUKOSCAN STUDY, for use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, and where patients do not have access to ex-vivo WBC scanning. (Ministerial Determination) Note LeukoScan is only indicated for diagnostic imaging in patients suspected of infection in the long bones and feet, including those with diabetic ulcers. The descriptor does not cover patients who are being investigated for other sites of infection N 61650 01JUL2010 LEUKOSCAN STUDY, for use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, and where patients do not have access to ex-vivo WBC scanning. (R) Note LeukoScan is only indicated for diagnostic imaging in patients suspected of infection in the long bones and feet, including those with diabetic ulcers. The descriptor does not cover patients who are being investigated for other sites of infection Y 61651 01JUL2011 SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - planar imaging (R) (NK) Y 61652 01JUL2011 SINGLE STRESS OR REST MYOCARDIAL PERFUSION STUDY - with single photon emission tomography and with planar imaging when undertaken (R) (NK) Y 61653 01JUL2011 COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - planar imaging (R) (NK) Y 61654 01JUL2011 COMBINED STRESS AND REST, stress and re-injection or rest and redistribution myocardial perfusion study, including delayed imaging or re-injection protocol on a subsequent occasion - with single photon emission tomography and with planar imaging when undertaken (R) (NK) Y 61655 01JUL2011 MYOCARDIAL INFARCT-AVID-STUDY, with planar imaging and single photon emission tomography, OR planar imaging or single photon emission tomography (R) (NK) Y 61656 01JUL2011 GATED CARDIAC BLOOD POOL STUDY, (equilibrium), with planar imaging and single photon emission tomography ORplanar imaging or single photon emission tomography (R) (NK) Y 61657 01JUL2011 GATED CARDIAC BLOOD POOL STUDY, and first pass blood flow or cardiac shunt study, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK) Y 61658 01JUL2011 GATED CARDIAC BLOOD POOL STUDY, with intervention, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK) Y 61659 01JUL2011 GATED CARDIAC BLOOD POOL STUDY, with intervention and first pass blood flow study or cardiac shunt study, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R) (NK) Y 61660 01JUL2011 CARDIAC FIRST PASS BLOOD FLOW STUDY OR CARDIAC SHUNT STUDY, not being a service to which another item in this Group applies (R) (NK) Y 61661 01JUL2011 LUNG PERFUSION STUDY, with planar imaging and single photon emission tomography OR planar imaging, or single photon emission tomography (R) (NK) Y 61662 01JUL2011 LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography OR planar imaging or single photon emission tomography (R) (NK) Y 61663 01JUL2011 LUNG PERFUSION STUDY AND LUNG VENTILATION STUDY using aerosol, technegas or xenon gas, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK) Y 61664 01JUL2011 LIVER AND SPLEEN STUDY (colloid) - planar imaging (R) (NK) Y 61665 01JUL2011 LIVER AND SPLEEN STUDY (colloid), with single photon emission tomography and with planar imaging when undertaken (R) (NK) Y 61666 01JUL2011 RED BLOOD CELL SPLEEN OR LIVER STUDY, including single photon emission tomography when undertaken (R) (NK) Y 61667 01JUL2011 HEPATOBILIARY STUDY, including morphine administration or pre-treatment with cholecystokinin (CCK) when undertaken (R) (NK) N 61667 27NOV2013 HEPATOBILIARY STUDY, including morphine administration or pre-treatment with a cholagogue when performed (R) (NK) Y 61668 01JUL2011 HEPATOBILIARY STUDY with formal quantification following baseline imaging, using an infusion of cholecystokinin (CCK) (R) (NK) N 61668 27NOV2013 HEPATOBILIARY STUDY with formal quantification following baseline imaging, using a cholagogue (R) (NK) Y 61669 01JUL2011 BOWEL HAEMORRHAGE STUDY (R) (NK) Y 61670 01JUL2011 MECKEL'S DIVERTICULUM STUDY (R) (NK) Y 61671 01JUL2011 INDIUM-LABELLED OCTREOTIDE STUDY - including single photon emission tomography when undertaken, where: (a)there is a suspected gastro-entero-pancreatic endocrine tumour, based on biochemical evidence, with negative or equivocal conventional imaging; or (b)a surgically amenable gastro-entero-pancreatic endocrine tumour has been identified based on conventional techniques, in order to exclude additional disease sites. (Ministerial Determination) (R) (NK) Y 61672 01JUL2011 SALIVARY STUDY (R) (NK) Y 61673 01JUL2011 GASTRO-OESOPHAGEAL REFLUX STUDY, including delayed imaging on a separate occasion when undertaken (R) (NK) Y 61674 01JUL2011 OESOPHAGEAL CLEARANCE STUDY (R) (NK) Y 61675 01JUL2011 GASTRIC EMPTYING STUDY, using single tracer (R) (NK) Y 61676 01JUL2011 COMBINED SOLID AND LIQUID GASTRIC EMPTYING STUDY using dual isotope technique or the same isotope on separate days (R) (NK) Y 61677 01JUL2011 RADIONUCLIDE COLONIC TRANSIT STUDY (R) (NK) Y 61678 01JUL2011 RENAL STUDY, including perfusion and renogram images and computer analysis OR cortical study with planar imaging (R) (NK) Y 61679 01JUL2011 RENAL CORTICAL STUDY, with single photon emission tomography and planar quantification (R) (NK) Y 61680 01JUL2011 SINGLE RENAL STUDY with pre-procedural administration of a diuretic or angiotensin converting enzyme (ACE) inhibitor (R) (NK) Y 61681 01JUL2011 RENAL STUDY with diuretic administration following a baseline study (R) (NK) Y 61682 01JUL2011 COMBINED EXAMINATION INVOLVING A RENAL STUDY following angiotensin converting enzyme (ACE) inhibitor provocation and a baseline study, in either order and related to a single referral episode (R) (NK) Y 61683 01JUL2011 CYSTOURETEROGRAM (R) (NK) Y 61684 01JUL2011 TESTICULAR STUDY (R) (NK) Y 61685 01JUL2011 CEREBRAL PERFUSION STUDY, with single photon emission tomography and with planar imaging when undertaken (R) (NK) Y 61686 01JUL2011 BRAIN STUDY WITH BLOOD BRAIN BARRIER AGENT, with planar imaging and single photon emission tomography, OR planar imaging, or single photon emission tomography (R) (NK) Y 61687 01JUL2011 CEREBRO-SPINAL FLUID TRANSPORT STUDY, with imaging on 2 or more separate occasions (R) (NK) Y 61688 01JUL2011 CEREBRO-SPINAL FLUID SHUNT PATENCY STUDY (R) (NK) Y 61689 01JUL2011 DYNAMIC BLOOD FLOW STUDY OR REGIONAL BLOOD VOLUME QUANTITATIVE STUDY, not being a service associated with a service to which another item in this Group applies (R) (NK) Y 61690 01JUL2011 BONE STUDY - whole body, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) (NK) Y 61691 01JUL2011 BONE STUDY - whole body and single photon emission tomography, with, when undertaken, blood flow, blood pool and delayed imaging on a separate occasion (R) (NK) Y 61692 01JUL2011 WHOLE BODY STUDY using iodine (R) (NK) Y 61693 01JUL2011 WHOLE BODY STUDY using gallium (R) (NK) Y 61694 01JUL2011 WHOLE BODY STUDY using gallium, with single photon emission tomography (R) (NK) Y 61695 01JUL2011 WHOLE BODY STUDY using cells labelled with technetium (R) (NK) Y 61696 01JUL2011 WHOLE BODY STUDY using cells labelled with technetium, with single photon emission tomography (R) (NK) Y 61697 01JUL2011 WHOLE BODY STUDY using thallium (R) (NK) Y 61698 01JUL2011 WHOLE BODY STUDY using thallium, with single photon emission tomography (R) (NK) Y 61699 01JUL2011 BONE MARROW STUDY - whole body using technetium labelled bone marrow agents (R) (NK) Y 61700 01JUL2011 WHOLE BODY STUDY, using gallium - with single photon emission tomography of 2 or more body regions acquired separately (R) (NK) Y 61701 01JUL2011 BONE MARROW STUDY - localised using technetium labelled agent (R) (NK) Y 61702 01JUL2011 LOCALISED BONE OR JOINT STUDY, including when undertaken, blood flow, blood pool and repeat imaging on a separate occasion (R) (NK) Y 61703 01JUL2011 LOCALISED BONE OR JOINT STUDY and single photon emission tomography, including when undertaken, blood flow, blood pool and imaging on a separate occasion (R) (NK) Y 61704 01JUL2011 LOCALISED STUDY using gallium (R) (NK) Y 61705 01JUL2011 LOCALISED STUDY using gallium, with single photon emission tomography (R) (NK) Y 61706 01JUL2011 LOCALISED STUDY using cells labelled with technetium (R) (NK) Y 61707 01JUL2011 LOCALISED STUDY using cells labelled with technetium, with single photon emission tomography (R) (NK) Y 61708 01JUL2011 LOCALISED STUDY using thallium (R) (NK) Y 61709 01JUL2011 LOCALISED STUDY using thallium, with single photon emission tomography (R) (NK) Y 61710 01JUL2011 REPEAT PLANAR AND SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING, OR REPEAT PLANAR IMAGING OR SINGLE PHOTON EMISSION TOMOGRAPHY IMAGING on an occasion subsequent to the performance of any one of items 61364, 61426, 61429, 61430, 61442, 61450, 61453, 61469, 61484, 61485, 61669, 61692, 61693, 61694, 61700, 61704, 61705, 61712, 61715 or 61716 where there is no additional administration of radiopharmaceutical and where the previous radionuclide scan was abnormal or equivocal. (R) (NK) Y 61711 01JUL2011 VENOGRAPHY (R) (NK) Y 61712 01JUL2011 LYMPHOSCINTIGRAPHY (R) (NK) Y 61713 01JUL2011 THYROID STUDY including uptake measurement when undertaken (R) (NK) Y 61714 01JUL2011 PARATHYROID STUDY, planar imaging and single photon emission tomography when undertaken (R) (NK) Y 61715 01JUL2011 ADRENAL STUDY (R) (NK) Y 61716 01JUL2011 ADRENAL STUDY, with single photon emission tomography(R) (NK) Y 61717 01JUL2011 TEAR DUCT STUDY (R) (NK) Y 61718 01JUL2011 PARTICLE PERFUSION STUDY (intra-arterial) or Le Veen shunt study (R) (NK) Y 61719 01JUL2011 CT scan performed at the same time and covering the same body area as single photon emission tomography for the purpose of anatomic localisation or attenuation correction where no separate diagnostic CT report is issued and only in association with items 61302 - 61729 (R) (NK) Y 61729 01JUL2011 LEUKOSCAN STUDY, for use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, and where patients do not have access to ex-vivo WBC scanning. (Ministerial Determination) (NK) Note LeukoScan is only indicated for diagnostic imaging in patients suspected of infection in the long bones and feet, including those with diabetic ulcers. The descriptor does not cover patients who are being investigated for other sites of infection Y 63000 01SEP1998 NOTE: Benefits are payable for each service included in Subgroup 1 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for the exclusion of: - tumour of the brain or meninges (R) (Anaes.) Y 63001 01AUG2004 MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - tumour of the brain or meninges (R) (Contrast) Y 63002 01JUL2006 MRI - scan of head (including MRA, if performed) for tumour of the brain or meninges (R) (Contrast) Y 63003 01SEP1998 - skull base or orbital tumour (R) (Anaes.) Y 63004 01AUG2004 - inflammation of the brain or meninges (R) (Contrast) Y 63005 01JUL2006 MRI - scan of head (including MRA, if performed) for inflammation of brain or meninges (R) (Contrast) Y 63006 01SEP1998 - acoustic neuroma (R) (Anaes.) Y 63007 01AUG2004 - skull base or orbital tumour (R) (Contrast) Y 63008 01JUL2006 MRI - scan of head (including MRA, if performed) for skull base or orbital tumour (R) (Contrast) Y 63009 01SEP1998 - pituitary tumour (R) (Anaes.) Y 63010 01AUG2004 - stereotactic scan of brain, with Fiducials in place, for the sole purpose to allow planning for stereotactic neurosurgery (R) (Contrast) Y 63011 01JUL2006 MRI - scan of head (including MRA, if performed) for stereotactic scan of brain, with fiducials in place, for the sole purpose of allowing planning for stereotactic neurosurgery (R) (Contrast) Y 63012 01SEP1998 - inflammation of brain or meninges (R) (Anaes.) Y 63013 01JUL2011 MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - tumour of the brain or meninges (R) (NK) (Contrast) Y 63014 01JUL2011 - inflammation of the brain or meninges (R) (NK) (Contrast) Y 63015 01SEP1998 - toxic or metabolic or ischaemic encephalopathy (R) (Anaes.) Y 63016 01JUL2011 - skull base or orbital tumour (R) (NK) (Contrast) Y 63017 01JUL2011 - stereotactic scan of brain, with Fiducials in place, for the sole purpose to allow planning for stereotactic neurosurgery (R) (NK) (Contrast) Y 63018 01SEP1998 - demyelinating disease of the brain (R) (Anaes.) Y 63021 01SEP1998 - congenital malformation of brain or meninges (R) Y 63024 01SEP1998 - venous sinus thrombosis (R) (Anaes.) Y 63040 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 2 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - acoustic neuroma (R) (Contrast) Y 63041 01JUL2006 MRI - scan of head (including MRA, if performed) for acoustic neuroma (R) (Contrast) Y 63042 01JUL2006 MRI - scan of head (including MRA, if performed) for pituitary tumour (R) (Contrast) Y 63043 01AUG2004 - pituitary tumour (R) (Contrast) Y 63044 01JUL2006 MRI - scan of head (including MRA, if performed) for toxic or metabolic or ischaemic encephalopathy (R) (Contrast) Y 63045 01JUL2006 MRI - scan of head (including MRA, if performed) for demyelinating disease of the brain (R) (Contrast) Y 63046 01AUG2004 - toxic or metabolic or ischaemic encephalopathy (R) (Contrast) Y 63047 01JUL2006 MRI - scan of head (including MRA, if performed) for congenital malformation of the brain or meninges (R) (Contrast) Y 63048 01JUL2006 MRI - scan of head (including MRA, if performed) for venous sinus thrombosis (R) (Contrast) Y 63049 01AUG2004 - demyelinating disease of the brain (R) (Contrast) Y 63050 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 2 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for the exclusion of: - tumour of the central nervous system or meninges (R) (Anaes.) Y 63051 01JUL2006 MRI - scan of head (including MRA, if performed) for head trauma (R) (Contrast) Y 63052 01AUG2004 - congenital malformation of the brain or meninges (R) (Contrast) Y 63053 01SEP1998 - inflammation of the central nervous system or meninges (R) (Anaes.) Y 63054 01JUL2006 MRI - scan of head (including MRA, if performed) for epilepsy (R) (Contrast) Y 63055 01AUG2004 - venous sinus thrombosis (R) (Contrast) Y 63056 01SEP1998 - demyelinating disease of the central nervous system (R) (Anaes.) Y 63057 01JUL2006 MRI - scan of head (including MRA, if performed) for stroke (R) (Contrast) Y 63058 01AUG2004 - head trauma (R) (Contrast) Y 63059 01SEP1998 - congenital malformation of the central nervous system or meninges (R) (Anaes.) Y 63060 01JUL2006 MRI - scan of head (including MRA, if performed) for carotid or vertebral artery dissection (R) (Contrast) Y 63061 01AUG2004 - epilepsy (R) (Contrast) Y 63062 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63063 01JUL2006 MRI - scan of head (including MRA, if performed) for intracranial aneurysm (R) (Contrast) Y 63064 01AUG2004 - stroke (R) (Contrast) Y 63065 01JUL2006 MRI - scan of head (including MRA, if performed) for intracranial arteriovenous malformation (R) (Contrast) Y 63067 01AUG2004 - carotid or vertebral artery desection (R) (Contrast) Y 63070 01AUG2004 - intracranial aneurysm (R) (Contrast) Y 63073 01AUG2004 - intracranial arteriovenous malformation (R) (Contrast) Y 63074 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 2 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head for: - acoustic neuroma (R) (NK) (Contrast) Y 63075 01JUL2011 - pituitary tumour (R) (NK) (Contrast) Y 63076 01JUL2011 - toxic or metabolic or ischaemic encephalopathy (R) (NK) (Contrast) Y 63077 01JUL2011 - demyelinating disease of the brain (R) (NK) (Contrast) Y 63078 01JUL2011 - congenital malformation of the brain or meninges (R) (NK) (Contrast) Y 63079 01JUL2011 - venous sinus thrombosis (R) (NK) (Contrast) Y 63080 01JUL2011 - head trauma (R) (NK) (Contrast) Y 63081 01JUL2011 - epilepsy (R) (NK) (Contrast) Y 63082 01JUL2011 - stroke (R) (NK) (Contrast) Y 63083 01JUL2011 - carotid or vertebral artery desection (R) (NK) (Contrast) Y 63084 01JUL2011 - intracranial aneurysm (R) (NK) (Contrast) Y 63085 01JUL2011 - intracranial arteriovenous malformation (R) (NK) (Contrast) Y 63100 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 3 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for further investigation of: - tumour of the brain or meninges (R) (Anaes.) Y 63101 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 3 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE ANGIOGRAPHY of extra and/or intracranial circulation, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and neck vessels for: - stroke (R) (Contrast) Y 63102 01JUL2006 MRI and MRA of extracranial or intracranial circulation (or both) - scan of head and neck vessels for stroke (R) (Contrast) Y 63103 01SEP1998 - skull base or orbital tumour (R) (Anaes.) Y 63104 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 3 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING AND MAGNETIC RESONANCE ANGIOGRAPHY of extra and/or intracranial circulation, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and neck vessels for: - stroke (R) (NK) (Contrast) Y 63106 01SEP1998 - acoustic neuroma (R) (Anaes.) Y 63109 01SEP1998 - pituitary tumour (R) (Anaes.) Y 63111 01AUG2004 MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - tumour of the central nervous system or meninges (R) (Contrast) Y 63112 01SEP1998 - inflammation of the brain or meninges (R) (Anaes.) Y 63113 01JUL2006 MRI - scan of head and cervical spine (including MRA, if performed) for tumour of the central nervous system or meninges (R) (Contrast) Y 63114 01AUG2004 - inflammation of the central nervous system or meninges (R) (Contrast) Y 63115 01SEP1998 - toxic or metabolic or ischaemic encephalopathy (R) (Anaes.) Y 63116 01JUL2006 MRI - scan of head and cervical spine (including MRA, if performed) for inflammation of the central nervous system or meninges (R) (Contrast) Y 63117 01JUL2011 MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - tumour of the central nervous system or meninges (R) (NK) (Contrast) Y 63118 01SEP1998 - demyelinating disease of the brain (R) (Anaes.) Y 63119 01JUL2011 - inflammation of the central nervous system or meninges (R) (NK) (Contrast) Y 63121 01SEP1998 - congenital malformation of the brain or meninges (R) (Anaes.) Y 63124 01SEP1998 - head trauma (R) (Anaes.) Y 63125 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 5 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - demyelinating disease of the central nervous system (R) (Contrast) Y 63126 01JUL2006 MRI - scan of head and cervical spine (including MRA, if performed) for demyelinating disease of the central nervous system (R) (Contrast) Y 63127 01SEP1998 - epilepsy (R) (Anaes.) Y 63128 01AUG2004 - congenital malformation of the central nervous system or meninges (R) (Contrast) Y 63129 01JUL2006 MRI - scan of head and cervical spine (including MRA, if performed) for congenital malformation of the central nervous system or meninges (R) (Contrast) Y 63130 01SEP1998 - stroke (R) (Anaes.) Y 63131 01AUG2004 - syrinx (congenital or acquired) (R) (Contrast) Y 63132 01JUL2006 MRI - scan of head and cervical spine (including MRA, if performed) for syrinx (congenital or acquired) (R) (Contrast) Y 63133 01SEP1998 - venous sinus thrombosis (R) (Anaes.) Y 63134 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 5 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of head and cervical spine for: - demyelinating disease of the central nervous system (R) (NK) (Contrast) Y 63135 01JUL2011 - congenital malformation of the central nervous system or meninges (R) (NK) (Contrast) Y 63136 01JUL2011 - syrinx (congenital or acquired) (R) (NK) (Contrast) Y 63150 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 4 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for further investigation of: - tumour of the central nervous system or meninges (R) (Anaes.) Y 63151 01AUG2004 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - infection (R) (Contrast) Y 63152 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for infection (R) (Contrast) Y 63153 01SEP1998 - inflammation of the central nervous system or meninges (R) (Anaes.) Y 63154 01AUG2004 - tumour (R) (Contrast) Y 63155 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for tumour (R) (Contrast) Y 63156 01SEP1998 - demyelinating disease of the central nervous system (R) (Anaes.) Y 63157 01JUL2011 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - infection (R) (NK) (Contrast) Y 63158 01JUL2011 - tumour (R) (NK) (Contrast) Y 63159 01SEP1998 - congenital malformation of the central nervous system or meninges (R) (Anaes.) Y 63161 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 7 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - demyelinating (R) (Contrast) Y 63162 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63163 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for demyelinating disease (R) (Contrast) Y 63164 01AUG2004 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Contrast) Y 63165 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for congenital malformation of the spinal cord or the cauda equina or th emeninges (R) (Contrast) Y 63167 01AUG2004 myelopathy (R) (Contrast) Y 63168 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for myelopathy (R) (Contrast) Y 63169 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for syrinx (congenital or acquired) (R) (Contrast) Y 63170 01AUG2004 - syrinx (congenital or acquired) (R) (Contrast) Y 63171 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for cervical radiculopathy (R) (Contrast) Y 63172 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for sciatica (R) (Contrast) Y 63173 01AUG2004 - cervical radiculopathy (R) (Contrast) Y 63174 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for spinal canal stenosis (R) (Contrast) Y 63175 01JUL2006 MRI - scan or 1 region or 2 contiguous regions of the spine for previous spinal surgery (R) (Contrast) Y 63176 01AUG2004 - sciatica (R) (Contrast) Y 63177 01JUL2006 MRI - scan of 1 region or 2 contiguous regions of the spine for trauma (R) Y 63179 01AUG2004 - spinal canal stenosis (R) (Contrast) Y 63182 01AUG2004 - previous spinal surgery (R) (Contrast) Y 63185 01AUG2004 - trauma (R) Y 63186 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 7 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of one region or two contiguous regions of the spine for: - demyelinating (R) (NK) (Contrast) Y 63187 01JUL2011 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (NK) (Contrast) Y 63188 01JUL2011 - myelopathy (R) (NK) (Contrast) Y 63189 01JUL2011 - syrinx (congenital or acquired) (R) (NK) (Contrast) Y 63190 01JUL2011 - cervical radiculopathy (R) (NK) (Contrast) Y 63191 01JUL2011 - sciatica (R) (NK) (Contrast) Y 63192 01JUL2011 - spinal canal stenosis (R) (NK) (Contrast) Y 63193 01JUL2011 - previous spinal surgery (R) (NK) (Contrast) Y 63194 01JUL2011 - trauma (R) (NK) Y 63200 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 5 on two occasions only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for monitoring of: - acoustic neuroma (R) (Anaes.) Y 63201 01AUG2004 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two non contiguous regions of the spine for: - infection (R) (Contrast) Y 63202 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for infection (R) (Contrast) Y 63203 01SEP1998 - pituitary tumour (R) (Anaes.) Y 63204 01AUG2004 - tumour (R) (Contrast) Y 63205 01JUL2006 MRI - scan of 3 contiguous of 2 non-contiguous regions of the spine for tumour (R) (Contrast) Y 63206 01SEP1998 - demyelinating disease of the brain (R) (Anaes.) Y 63207 01JUL2011 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two non contiguous regions of the spine for: - infection (R) (NK) (Contrast) Y 63208 01JUL2011 - tumour (R) (NK) (Contrast) Y 63209 01SEP1998 - congenital malformation of brain or meninges (R) (Anaes.) Y 63212 01SEP1998 - head trauma (R) (Anaes.) Y 63215 01SEP1998 - epilepsy (R) (Anaes.) Y 63218 01SEP1998 - stroke (R) (Anaes.) Y 63219 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 9 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two noncontiguous regions of the spine for: - demyelinating disease (R) (Contrast) Y 63220 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine of rdemyelinating disease (R) (Contrast) Y 63221 01SEP1998 - toxic or metabolic or ischaemic encephalopathy (R) (Anaes.) Y 63222 01AUG2004 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Contrast) Y 63223 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Contrast) Y 63224 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for myelopathy (R) (Contrast) Y 63225 01AUG2004 - myelopathy (R) (Contrast) Y 63226 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for syrinx (congenital or acquired) (R) (Contrast) Y 63227 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for cervial radiculopathy (R) (Contrast) Y 63228 01AUG2004 - syrinx (congenital or acquired ) (R) (Contrast) Y 63229 27JUN2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for sciatica (R) (Contrast) Y 63230 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for spinal canal stenosis (R) (Contrast) Y 63231 01AUG2004 - cervical radiculopathy (R) (Contrast) Y 63232 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for previous spinal surgery (R) (Contrast) Y 63234 01AUG2004 - sciatica (R) (Contrast) Y 63237 01AUG2004 - spinal canal stenosis (R) (Contrast) Y 63240 01AUG2004 - previous spinal surgery (R) (Contrast) Y 63243 01AUG2004 - trauma (R) Y 63244 01JUL2006 MRI - scan of 3 contiguous or 2 non-contiguous regions of the spine for trauma (R) Y 63250 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 6 on two occasions only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for monitoring of: - demyelinating disease of the central nervous system (R) (Anaes.) Y 63253 01SEP1998 - congenital malformation of the central nervous system or meninges (R) (Anaes.) Y 63256 01SEP1998 -syrinx (congenital or acquired) (R) (Anaes.) Y 63257 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 9 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of three contiguous regions or two noncontiguous regions of the spine for: - demyelinating disease (R) (NK) (Contrast) Y 63258 01JUL2011 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (NK) (Contrast) Y 63259 01JUL2011 - myelopathy (R) (NK) (Contrast) Y 63260 01JUL2011 - syrinx (congenital or acquired ) (R) (NK) (Contrast) Y 63261 01JUL2011 - cervical radiculopathy (R) (NK) (Contrast) Y 63262 01JUL2011 - sciatica (R) (NK) (Contrast) Y 63263 01JUL2011 - spinal canal stenosis (R) (NK) (Contrast) Y 63264 01JUL2011 - previous spinal surgery (R) (NK) (Contrast) Y 63265 01JUL2011 - trauma (R) (NK) Y 63270 01SEP1998 MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head for monitoring of: - tumour of the brain or meninges (R) (Anaes.) Y 63271 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 10 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cervical spine and brachial plexus for: - tumour (R) (Contrast) Y 63272 01JUL2006 MRI - scan of cervial spine and brachial plexus for tumour (R) (Contrast) Y 63273 01SEP1998 - skull base or orbital tumour (R) (Anaes.) Y 63274 01AUG2004 - trauma (R) (Contrast) Y 63275 01JUL2006 MRI - scan of cervical spine and brachial plexus for trauma (R) (Contrast) Y 63276 01SEP1998 - inflammation of brain or meninges (R) (Anaes.) Y 63277 01AUG2004 - cervical radiculopathy (R) (Contrast) Y 63278 01JUL2006 MRI - scan of cervical spine and brachial plexus for cervical radiculopathy (R) (Contrast) Y 63279 01SEP1998 - venous sinus thrombosis (R) (Anaes.) Y 63280 01AUG2004 - previous surgery (R) (Contrast) Y 63281 01JUL2006 MRI - scan of cervical spine and brachial plexus for previous surgery (R) (Contrast) Y 63282 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 10 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cervical spine and brachial plexus for: - tumour (R) (NK) (Contrast) Y 63283 01JUL2011 - trauma (R) (NK) (Contrast) Y 63284 01JUL2011 - cervical radiculopathy (R) (NK) (Contrast) Y 63285 01JUL2011 - previous surgery (R) (NK) (Contrast) Y 63290 01SEP1998 MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of head and cervical spine for monitoring of: - tumour of the central nervous system or meninges (R) (Anaes.) Y 63293 01SEP1998 - inflammation of the central nervous system or meninges (R) (Anaes.) Y 63300 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 9 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for the exclusion of: - infection (R) (Anaes.) Y 63301 01AUG2004 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - tumour arising in bone or musculoskeletal system, this excludes tumours arising in breast, prostate or rectum (R) (Contrast) Y 63302 01JUL2006 MRI - scan of musculoskeletal system for tumour arising, in bone or musculoskeletal system, excluding tumours arising in breast, prostate or rectum (R) (Contrast) Y 63303 01SEP1998 - tumour (R) (Anaes.) Y 63304 01AUG2004 - infection arising in bone or musculoskeletal system, this excludes infection arising in breast, prostate or rectum (R) (Contrast) Y 63305 01JUL2006 MRI - scan of musculoskeletal system for infection arising in bone or musculoskeletal system, excluding infection arising in breast, prostate or rectum (R) (Contrast) Y 63306 01SEP1998 - demyelinating disease (R) (Anaes.) Y 63307 01AUG2004 - osteonecrosis (R) (Contrast) Y 63308 01JUL2006 MRI - scan of musculoskeletal system for osteonecrosis (R) (Contrast) Y 63309 01SEP1998 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) Y 63310 01JUL2011 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - tumour arising in bone or musculoskeletal system, this excludes tumours arising in breast, prostate or rectum (R) (NK) (Contrast) Y 63311 01JUL2011 - infection arising in bone or musculoskeletal system, this excludes infection arising in breast, prostate or rectum (R) (NK)(Contrast) Y 63312 01SEP1998 - myelopathy (R) (Anaes.) Y 63313 01JUL2011 - osteonecrosis (R) (NK) (Contrast) Y 63315 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63322 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 12 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - derangement of hip or its supporting structures (R) (Contrast) Y 63323 01JUL2006 MRI - scan of musculoskeletal system for derangement of hip or its supporting structures (R) (Contrast) Y 63324 01JUL2006 MRI - scan of musculoskeletal system for derangement of shoulder its supporting structures (R) (Contrast) Y 63325 01AUG2004 - derangment of shoulder or its supporting structures (R) (Contrast) Y 63326 01JUL2006 MRI - scan of musculoskeletal system for derangement of knee or its supporting structures (R) (Contrast) Y 63327 01JUL2006 MRI - scan of musculoskeletal system for derangement of ankle or foot (or both) or its supporting structures (R) (Contrast) Y 63328 01AUG2004 - derangment of knee or its supporting structures (R) (Contrast) Y 63329 01JUL2006 MRI - scan of musculoskeletal system for derangement of 1 or both temporomandibular joints or their supporting structures (R) (Contrast) Y 63330 01JUL2006 MRI - scan of musculoskeletal system for derangement of wrist or hand (or both) or its supporting structures (R) (Contrast) Y 63331 01AUG2004 - derangment of ankle and/or foot or its supporting structures (R) (Contrast) Y 63332 01JUL2006 MRI - scan of musculoskeletal system for derangement of elbow or its supporting structures (R) (Contrast) Y 63334 01AUG2004 - derangment of one or both temporomandibular joints or their supporting structures (R) (Contrast) Y 63337 01AUG2004 - derangment of wrist and/or hand or its supporting structures (R) (Contrast) Y 63340 01AUG2004 - derangment of elbow or its supporting structures (R) (Contrast) Y 63341 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 12 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - derangement of hip or its supporting structures (R) (NK) (Contrast) Y 63342 01JUL2011 - derangement of shoulder or its supporting structures (R) (NK) (Contrast) Y 63343 01JUL2011 - derangement of knee or its supporting structures (R) (NK) (Contrast) Y 63345 01JUL2011 - derangement of ankle and/or foot or its supporting structures (R) (NK) (Contrast) Y 63346 01JUL2011 - derangement of one or both temporomandibular joints or their supporting structures (R) (NK) (Contrast) Y 63347 01JUL2011 - derangement of wrist and/or hand or its supporting structures (R) (NK) (Contrast) Y 63348 01JUL2011 - derangement of elbow or its supporting structures (R) (NK) (Contrast) Y 63350 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 10 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for the exclusion of: - infection (R) (Anaes.) Y 63353 01SEP1998 - tumour (R) (Anaes.) Y 63356 01SEP1998 - demyelinating disease (R) (Anaes.) Y 63359 01SEP1998 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) Y 63361 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 13 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - Gaucher disease (R) Y 63362 01SEP1998 - myelopathy (R) (Anaes.) Y 63363 01JUL2006 MRI - scan of musculoskeletal system for Gaucher disease (R) Y 63364 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 13 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of musculoskeletal system for: - Gaucher disease (R) (NK) Y 63365 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63385 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 14 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cardiovascular system for: - congenital disease of the heart or a great vessel (R) (Contrast) Y 63386 01JUL2006 MRI - scan of cardiovascular system for congenital disease of the heart or a great vessel (R) (Contrast) Y 63387 01JUL2006 MRI - scan of cardiovascular system for tumour of the heart or a great vessel (R) (Contrast) Y 63388 01AUG2004 - tumour of the heart or a great vessel (R) (Contrast) Y 63389 01JUL2006 MRI - scan of cardiovascular system for abnormality of thoracic aorta (R) (Contrast) Y 63391 01AUG2004 - abnormality of thoracic aorta (R) (Contrast) Y 63392 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 14 on two occasions only in any 12 month period MAGNETIC RESONANCE IMAGING (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of cardiovascular system for: - congenital disease of the heart or a great vessel (R) (NK) (Contrast) Y 63393 01JUL2011 - tumour of the heart or a great vessel (R) (NK) (Contrast) Y 63394 01JUL2011 - abnormality of thoracic aorta (R) (NK) (Contrast) Y 63395 01MAY2018 MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable oncein 12 months (R) (K) (Contrast) N 63395 03AUG2018 MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI, for the assessment of myocardial structure and functioninvolving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable oncein 12 months (R) (K) (Contrast) N 63395 10AUG2018 MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and functioninvolving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable oncein 12 months (R) (K) (Contrast) Y 63396 01MAY2018 MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable oncein 12 months (R) (NK) (Contrast) N 63396 03AUG2018 MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI,for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable oncein 12 months (R) (NK) (Contrast) N 63396 10AUG2018 MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that: (d) the patient presented with symptoms consistent with arrhythmogenic right ventricular cardiomyopathy (ARVC); or (e) investigative findings in relation to the patient are consistent with ARVC NOTE: benefits are payable oncein 12 months (R) (NK) (Contrast) Y 63397 01MAY2018 MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable oncein 36 months (R) (K) (Contrast) N 63397 03AUG2018 MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI,for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable oncein 36 months (R) (K) (Contrast) N 63397 10AUG2018 MRI scan of the cardiovascular system, performed by a person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable oncein 36 months (R) (K) (Contrast) Y 63398 01MAY2018 MRI scan of the cardiovascular system for assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable oncein 36 months (R) (NK) (Contrast) N 63398 03AUG2018 MRI scan of the cardiovascular system, performed by a specialist in diagnostic radiology or a consultant physician who is recognised by the Conjoint Committee for Certification in Cardiac MRI,for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable oncein 36 months (R) (NK) (Contrast) N 63398 10AUG2018 MRI scan of the cardiovascular system, performed bya person who is: (a) a specialist in diagnostic radiology or a consultant physician; and (b) recognised by the Conjoint Committee for Certification in Cardiac MRI for the assessment of myocardial structure and function involving: (a) dedicated right ventricular views; and (b) 3D volumetric assessment of the right ventricle; and (c) reporting of end?diastolic and end?systolic volumes, ejection fraction and BSA?indexed values; if the request for the scan indicates that the patient: (d) is asymptomatic; and (e) has one or more first degree relatives diagnosed with confirmed arrhythmogenic right ventricular cardiomyopathy (ARVC) NOTE: benefits are payable oncein 36 months (R) (NK) (Contrast) Y 63400 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 11 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for further investigation of: - infection (R) (Anaes.) Y 63401 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 15 on three occasions only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for: - vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Contrast) Y 63402 01JUL2006 MRA - if the request for the scan specifically identifies the clinical identification for the scan - scan of cardiovascular system for vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Contrast) Y 63403 01SEP1998 - tumour (R) (Anaes.) Y 63404 01AUG2004 - obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Contrast) Y 63405 01JUL2006 MRA - if the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Contrast) Y 63406 01SEP1998 - demyelinating disease (R) (Anaes.) Y 63407 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 15 on three occasions only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for: - vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (NK) (Contrast) Y 63408 01JUL2011 - obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (NK) (Contrast) Y 63409 01SEP1998 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) Y 63412 01SEP1998 - myelopathy (R) (Anaes.) Y 63415 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63416 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 16 on one occasion only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Contrast) Y 63417 01JUL2006 MRA - scan of person under the age of 16 for the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Contrast) Y 63418 01SEP1998 - cervical radiculopathy (R) (Anaes.) Y 63419 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 16 on one occasion only in any 12 month period MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) NK) (Contrast) Y 63421 01SEP1998 - sciatica (R) (Anaes.) Y 63424 01SEP1998 - spinal canal stenosis (R) (Anaes.) Y 63425 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 17 on two occasions only in any 12 month period, for previously diagnosed conditions MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - post-inflammatory or post-traumatic physeal fusion (R) Y 63426 01JUL2006 MRI - scan of person under the age of 16 for post-inflammatory or post-traumatic physeal fusion (R) Y 63427 01SEP1998 - previous spinal surgery (R) (Anaes.) Y 63428 01AUG2004 - Gaucher disease (R) Y 63429 01JUL2006 MRI - scan of person under the age of 16 for Gaucher disease (R) Y 63430 01SEP1998 - trauma (R) (Anaes.) Y 63432 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 17 on two occasions only in any 12 month period, for previously diagnosed conditions MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - post-inflammatory or post-traumatic physeal fusion (R) (NK) Y 63433 01JUL2011 - Gaucher disease (R) (NK) Y 63440 01AUG2004 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - pelvic or abdominal mass (R) (Contrast) Y 63441 01JUL2006 MRI - scan of person under the age of 16 for pelvic or abdominal mass (R) (Contrast) Y 63442 01JUL2006 MRI - scan of person under the age of 16 for mediastinal mass (R) (Contrast) Y 63443 01AUG2004 - mediastinal mass (R) (Contrast) Y 63444 01JUL2006 MRI - scan of person under the age of 16 for congenital uterine or anorectal abnormality (R) (Contrast) Y 63446 01AUG2004 - congenital uterine or anorectal abnormality (R) (Contrast) Y 63447 01JUL2011 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of person under the age of 16 for: - pelvic or abdominal mass (R) (NK) (Contrast) Y 63448 01JUL2011 - mediastinal mass (R) (NK) (Contrast) Y 63449 01JUL2011 - congenital uterine or anorectal abnormality (R) (NK) (Contrast) Y 63450 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 12 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for further investigation of: - infection (R) (Anaes.) Y 63453 01SEP1998 - tumour (R) (Anaes.) Y 63454 01MAY2019 MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where: (a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected and diagnosis is indeterminate; and(d) further examination is clinically indicated in the same pregnancy to which item 55712 or 55715 or 55719 or 55720 or 55721 or 55724 or 55725 or 55727 applies. (R) (K) (Anaes.) (Contrast) N 63454 01AUG2019 MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where:(a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected; and (d) an ultrasound provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics, has been performed and diagnosis is indeterminate or requires further examination.  (R) (K) (Contrast) Y 63455 01JUL2011 NOTE: Benefits are payable for each service included by Subgroup 19 on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of body for: - adrenal mass in a patient with malignancy which is otherwise resectable (R) (NK) Y 63456 01SEP1998 - demyelinating disease (R) (Anaes.) Y 63457 01JUL2011 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer,if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period (NK) N 63457 01JAN2014 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the person is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer,if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period (NK) Y 63458 01JUL2011 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the woman has had an abnormality detected as a result of a service described in item 63464 or 63457 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1:Benefits are payable on one occasion only in any 12 month period NOTE 2:This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464 or 63457 (NK) N 63458 01JAN2014 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the person has had an abnormality detected as a result of a service described in item 63464 or 63457 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1:Benefits are payable on one occasion only in any 12 month period NOTE 2:This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464 or 63457 (NK) Y 63459 01SEP1998 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) Y 63460 01MAY2019 MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where: (a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected and diagnosis is indeterminate; and(d) further examination is clinically indicated in the same pregnancy to which item 55712 or 55715 or 55719 or 55720 or 55721 or 55724 or 55725 or 55727 applies. (R) (NK) (Anaes.) (Contrast) N 63460 01AUG2019 MAGNETIC RESONANCE IMAGING scan of the pelvis or abdomen, where:(a) the patient is referred by a specialist obstetrician; and(b) the patient is pregnant at 18 weeks gestation or greater; and(c) a fetal central nervous system (CNS) abnormality is suspected; and (d) an ultrasound provided by, or on behalf of, or at the request of, a specialist who is practising in the specialty of obstetrics, has been performed and diagnosis is indeterminate or requires further examination.  (R) (NK) (Contrast)   Y 63461 01AUG2004 NOTE: Benefits are payable for each service included by Subgroup 19 on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of body for: - adrenal mass in a patient with malignancy which is otherwise resecetable (R) Y 63462 01SEP1998 - myelopathy (R) (Anaes.) Y 63463 01JUL2006 MRI - scan of the body for adrenal mass in a patient with a malignancy that is otherwise resectable (R) Y 63464 01FEB2009 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, including any of the following features: - bilateral breast cancer; - onset of breast cancer before the age of 40 years; - onset of ovarian cancer before the age of 50 years; - breast and ovarian cancer in one relative; - Ashkenazi Jewish ancestry; - breast cancer in a male relative; (C)1 first or second degree relative diagnosed with breastcancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period N 63464 17APR2009 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, including any of the following features: - bilateral breast cancer; - onset of breast cancer before the age of 40 years; - onset of ovarian cancer before the age of 50 years; - breast and ovarian cancer in one relative; - Ashkenazi Jewish ancestry; - breast cancer in a male relative; (C)1 first or second degree relative diagnosed with breastcancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period N 63464 01JAN2010 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer,if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period N 63464 01JAN2014 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the person is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer,if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period Y 63465 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63466 01FEB2009 NOTE: benefits are payable on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the request for scan identifies that the woman is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, including any of the following features: - bilateral breast cancer; - onset of breast cancer before the age of 40 years; - onset of ovarian cancer before the age of 50 years; - breast and ovarian cancer in one relative; - Ashkenazi Jewish ancestry; - breast cancer in a male relative; (C)1 first or second degree relative diagnosed with breastcancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) N 63466 17APR2009 NOTE: benefits are payable on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b)the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C)1 first or second degree relative diagnosed with breastcancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period N 63466 01JAN2010 NOTE: benefits are payable on one occasion only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b)the request for scan identifies that the woman is asymptomatic and is less than 50 years of age; and (c) the request for scan identifies either: (i) that the patient is at high risk of developing breast cancer, due to 1 of the following: (A) 3 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer; (B) 2 or more first or second degree relatives on the same side of the family diagnosed with breast or ovarian cancer, if any of the following applies to at least 1 of the relatives: - has been diagnosed with bilateral breast cancer; - had onset of breast cancer before the age of 40 years; - had onset of ovarian cancer before the age of 50 years; - has been diagnosed with breast and ovarian cancer, at the same time or at different times; - has Ashkenazi Jewish ancestry; - is a male relative who has been diagnosed with breast cancer; (C) 1 first or second degree relative diagnosed with breast cancer at age 45 years or younger, plus another first or second degree relative on the same side of the family with bone or soft tissue sarcoma at age 45 years or younger; or (ii)that genetic testing has identified the presence of a high risk breast cancer gene mutation. Scan of both breasts for: - detection of cancer (R) NOTE: Benefits are payable on one occasion only in any 12 month period Y 63467 01FEB2009 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the woman has had an abnormality detected as a result of a service described in item 63464 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1:Benefits are payable on one occasion only in any 12 month period NOTE 2:This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464 N 63467 01JAN2014 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the person has had an abnormality detected as a result of a service described in item 63464 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1:Benefits are payable on one occasion only in any 12 month period NOTE 2:This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63464 Y 63468 01SEP1998 - cervical radiculopathy (R) (Anaes.) Y 63469 01FEB2009 MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a dedicated breast coil is used; and (b) the woman has had an abnormality detected as a result of a service described in item 63464 performed in the previous 12 months Scan of both breasts for: - detection of cancer (R) NOTE 1:Benefits are payable on one occasion only in any 12 month period NOTE 2:This item is intended for follow-up imaging of abnormalities diagnosed on a scan described by item 63466 Y 63470 01AUG2004 NOTE: Benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where: (a)the patient is referred by a specialist or by a consultant physician and (b)the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater Scan of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast) N 63470 01NOV2010 NOTE: Benefits are payable for a service under items 63470 and 63473 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where: (a)the patient is referred by a specialist or by a consultant physician and (b)the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater Scan of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast) Y 63471 01SEP1998 - sciatica (R) (Anaes.) Y 63472 01JUL2006 MRI - if: (a)the patient is referred by a specialist or by a consultant physician; and (b)the request for scan identifies that: (i)a histological diagnosis of carcinoma of the cervix has been made; and (ii)the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater - scan of pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast) Y 63473 01AUG2004 - Pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast) Y 63474 01SEP1998 - spinal canal stenosis (R) (Anaes.) Y 63475 01JUL2006 MRI - if: (a)the patient is referred by a specialist or by a consultant physician; and (b)the request for scan identifies that: (i)a histological diagnosis of carcinoma of the cervix has been made; and (ii)the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater - scan of pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (Contrast) Y 63476 01JUL2009 NOTE: benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (contrast) N 63476 01NOV2010 NOTE: benefits are payable for a service under item 63476 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (contrast) Y 63477 01SEP1998 - previous spinal surgery (R) (Anaes.) Y 63478 01JUL2009 NOTE: benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b)the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (contrast) Y 63479 01JUL2011 NOTE: Benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where: (a)the patient is referred by a specialist or by a consultant physician and (b)the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater Scan of: - Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (NK) (Contrast) Y 63480 01SEP1998 - trauma (R) (Anaes.) Y 63481 01JUL2011 - Pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) (NK) (Contrast) Y 63482 01JAN2006 NOTE: Benefits are only payable for each service included by Subgroup 21 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of pancreas and biliary tree for: - suspected biliary or pancreatic pathology (R) (Contrast) N 63482 01NOV2012 NOTE: Benefits are only payable for each service included by Subgroup 21 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of pancreas and biliary tree for: - suspected biliary or pancreatic pathology (R) Y 63483 01JUL2006 MRI - scan of pancreas and biliary tree for suspected biliary or pancreatic pathology (R) Y 63484 01JUL2011 NOTE: benefits are payable for a service included by Subgroup 20 on one occasion only. MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where: (a) a phased array body coil is used, and (b) the request for scan identifies that the indication is for the initial staging of rectal cancer (including cancer of the rectosigmoid and anorectum). Scan of: - Pelvis for the initial staging of rectal cancer (R) (NK) (contrast) Y 63486 01JUL2011 NOTE: Benefits are only payable for each service included by Subgroup 21 on three occasions only in any 12 month period MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician - scan of pancreas and biliary tree for: - suspected biliary or pancreatic pathology (R) (NK) Y 63487 01NOV2016 MRI-performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has been diagnosed with metastatic cancer restricted to the regional lymph nodes; and (ii) clinical examination and conventional imaging have failed to identify the primary cancer (R) (K) (Anaes) Y 63488 01NOV2016 MRI-performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has been diagnosed with metastatic cancer restricted to the regional lymph nodes; and (ii) clinical examination and conventional imaging have failed to identify the primary cancer (R) (NK) (Anaes) Y 63489 01NOV2016 MRI-guided biopsy, performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b)a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has a suspicious lesion seen on MRI but not on conventional imaging; and (ii) the lesion is not amenable to biopsy guided by conventional imaging; and (d) a repeat ultrasound scan of the affected breast is performed: (i) before the guided biopsy is performed; and (ii) as part of the service under this item (R) (K) (Anaes.) Y 63490 01NOV2016 MRI-guided biopsy performed under the professional supervision of an eligible provider at an eligible location, if: (a) the patient is referred by a specialist or a consultant physician; and (b) a dedicated breast coil is used; and (c) the request for the scan identifies that: (i) the patient has a suspicious lesion seen on MRI but not on conventional imaging; and (ii) the lesion is not amenable to biopsy guided by conventional imaging; and (d) a repeat ultrasound scan of the affected breast is performed: (i) before the guided biopsy is performed; and (ii) as part of the service under this item (R) (NK) (Anaes.) Y 63491 01AUG2004 NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying items for use with MAGNETIC RESONANCE IMAGING or MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician. Scan performed: - involves the use of contrast agent for eligible Magnetic Resonance Imaging items (Note: (Contrast) denotes an item eligible for use with this item) N 63491 01NOV2012 NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying items for use with MAGNETIC RESONANCE IMAGING or MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the service requested by a medical practitioner. Scan performed: - involves the use of contrast agent for eligible Magnetic Resonance Imaging items (Note: (Contrast) denotes an item eligible for use with this item) Y 63492 01JUL2006 MRI or MRA service to which an item in the Group (other than an item in this Subgroup) applies if: (a)the item for the service includes in its description '(Contrast)'; and (b)the service is performed using a contrast agent N 63492 01NOV2012 NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying items for use with MAGNETIC RESONANCE IMAGING or MAGNETIC RESONANCE ANGIOGRAPHY performed under the professional supervision of an eligible provider at an eligible location where the service is requested by a medical practitioner. Scan performed: - involves the use of contrast agent for eligible Magnetic Resonance Imaging items (Note: (Contrast) denotes an item eligible for use with this item) Y 63493 01JUL2006 MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if the service is performed on a person using intravenous or intra muscular sedation N 63493 01NOV2012 - involves use of intravenous or intramuscular sedation on a patient Y 63494 01AUG2004 - involves use of intravenous or intramuscular sedation on a patient Y 63495 01JUL2006 MRI or MRA service to which an item in this Group (other than an item in this Subgroup) applies if the service is performed on a person under anaesthetic in the presence of a medical practitioner who is qualified to perform an anaesthetic N 63495 01NOV2012 - on a patient under anaesthetic in the presence of a medical practitioner qualified to perform an anaesthetic Y 63496 01MAY2019 NOTE: Benefits in Subgroup 22 are only payable for modifying items where claimed simultaneously with MRI services. Modifiers for sedation and anaesthesia may not be claimed for the same service. Modifying item for use with MAGNETIC RESONANCE IMAGING performed under the professional supervision of an eligible provider at an eligible location where the service requested by a specialist or by a consultant and the scan performedinvolves the use of HEPATOBILIARY SPECIFICcontrast agent, as clinically indicated for eligible MRI items 64545 and 64546. Y 63497 01AUG2004 - on a patient under anaesthetic in the presence of a medical practitioner qualified to perform an anaesthetic Y 63498 12MAR2012 MRI service to which item 63501, 63502, 63504 or 63505 applies if: (a) the service is performed in accordance with the determination; and (b) the service is performed on a person using intravenous or intra muscular sedation Y 63499 12MAR2012 MRI service to which item 63501, 63502, 63504 or 63505 applies if: (a) the service is performed in accordance with the determination; and (b) the service is performed on a person under anaesthetic in the presence of a medical practitioner who is qualified to perform an anaesthetic. Y 63500 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 13 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for monitoring of: - demyelinating disease (R) (Anaes.) Y 63501 12MAR2012 MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan confirms a loss of integrity of the implant (R) Note: Benefits are payable on one occasion only in any 12 Month Period Y 63502 12MAR2012 MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) the result of the scan does not demonstrate a loss of integrity of the implant (R) Note: Benefits are payable on one occasion only in any 12 Month Period Y 63503 01SEP1998 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) Y 63504 12MAR2012 MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) presents with symptoms where implant rupture is suspected; and (iii) the result of the scan confirms a loss of integrity of the implant (R) Y 63505 12MAR2012 MRI - scan of one or both breasts for the evaluation of implant integrity where: (a) a dedicated breast coil is used; and (b) the request for the scan identifies that the patient: (i) has or is suspected of having a silicone breast implant manufactured by Poly Implant Prosthese (PIP); and (ii) presents with symptoms where implant rupture is suspected; and (iii) the result of the scan does not demonstrate a loss of integrity of the implant (R) Y 63506 01SEP1998 - myelopathy (R) (Anaes.) Y 63507 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for any of the following: -unexplained seizure(s) (R) (Contrast) (Anaes.); or -unexplained headache where significant pathology is suspected (R) (Contrast) (Anaes.); or -paranasal sinus pathology which has not responded to conservative therapy (R) (Contrast) (Anaes.) N 63507 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient under 16 years for any of the following: -unexplained seizure(s) (R) (Contrast) (Anaes.); or -unexplained headache where significant pathology is suspected (R) (Contrast) (Anaes.); or -paranasal sinus pathology which has not responded to conservative therapy (R) (Contrast) (Anaes.) Y 63508 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for any of the following: -unexplained seizure(s) (R) (NK) (Contrast) (Anaes.); or -unexplained headache where significant pathology is suspected (R) (NK) (Contrast) (Anaes.); or -paranasal sinus pathology which has not responded to conservative therapy (R) (NK) (Contrast) (Anaes.) N 63508 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient under 16 years for any of the following: -unexplained seizure(s) (R) (NK) (Contrast) (Anaes.); or -unexplained headache where significant pathology is suspected (R) (NK) (Contrast) (Anaes.); or -paranasal sinus pathology which has not responded to conservative therapy (R) (NK) (Contrast) (Anaes.) Y 63509 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63510 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine following radiographic examination for any of the following: -significant trauma (R) (Contrast) (Anaes.); or -unexplained neck or back pain with associated neurological signs (R) (Contrast) (Anaes.); or -unexplained back pain where significant pathology is suspected (R) (Contrast) (Anaes.) N 63510 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient under 16 years following radiographic examination for: -significant trauma (R) (Contrast) (Anaes.); or -unexplained neck or back pain with associated neurological signs (R) (Contrast) (Anaes.); or -unexplained back pain where significant pathology is suspected (R) (Contrast) (Anaes.) Y 63511 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine following radiographic examination for any of the following: -significant trauma (R) (NK) (Contrast) (Anaes.); or -unexplained neck or back pain with associated neurological signs (R) (NK) (Contrast) (Anaes.); or -unexplained back pain where significant pathology is suspected (R) (NK) (Contrast) (Anaes.) N 63511 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient under 16 years following radiographic examination for: -significant trauma (R) (NK) (Contrast) (Anaes.); or -unexplained neck or back pain with associated neurological signs (R) (NK) (Contrast) (Anaes.); or -unexplained back pain where significant pathology is suspected (R) (NK) (Contrast) (Anaes.) Y 63512 01SEP1998 - cervical radiculopathy (R) (Anaes.) Y 63513 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following radiographic examination for internal joint derangement. (R) (Contrast) (Anaes.) N 63513 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient under 16 years following radiographic examination for internal joint derangement (R) (Contrast) (Anaes.) N 63513 01NOV2018 MRI - referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient aged under16 years for internal joint derangement (R) (K)(Contrast) (Anaes.) Y 63514 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following radiographic examination for internal joint derangement. (R) (NK) (Contrast) (Anaes.) N 63514 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient under 16 years following radiographic examination for internal joint derangement (R) (NK) (Contrast) (Anaes.) N 63514 01NOV2018 MRI - referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee for a patient agedunder 16 years for internal joint derangement (R) (NK) (Contrast) (Anaes.) Y 63515 01SEP1998 - sciatica (R) (Anaes.) Y 63516 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip following radiographic examination for any of the following: -suspected septic arthritis (R) (Contrast) (Anaes.); or -suspected slipped capital femoral epiphysis (R) (Contrast) (Anaes.); or -suspected Perthes disease (R) (Contrast) (Anaes.) N 63516 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip for a patient under 16 years following radiographic examination for: -suspected septic arthritis (R) (Contrast) (Anaes.); or -suspected slipped capital femoral epiphysis (R) (Contrast) (Anaes.); or -suspected Perthes disease (R) (Contrast) (Anaes.) Y 63517 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip following radiographic examination for any of the following: -suspected septic arthritis (R) (NK) (Contrast) (Anaes.); or -suspected slipped capital femoral epiphysis (R) (NK) (Contrast) (Anaes.); or -suspected Perthes disease (R) (NK) (Contrast) (Anaes.) N 63517 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip for a patient under 16 years following radiographic examination for: -suspected septic arthritis (R) (NK) (Contrast) (Anaes.); or -suspected slipped capital femoral epiphysis (R) (NK) (Contrast) (Anaes.); or -suspected Perthes disease (R) (NK) (Contrast) (Anaes.) Y 63518 01SEP1998 - spinal canal stenosis (R) (Anaes.) Y 63519 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow following radiographic examination where a significant fracture or avulsion injury is suspected that would change the way in which the patient is managed. (R) (Contrast) (Anaes.) N 63519 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow for a patient under 16 years following radiographic examination where a significant fracture or avulsion injury is suspected that will change management (R) (Contrast) (Anaes.) Y 63520 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow following radiographic examination where a significant fracture or avulsion injury is suspected that would change the way in which the patient is managed. (R) (NK) (Contrast) (Anaes.) N 63520 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow for a patient under 16 years following radiographic examination where a significant fracture or avulsion injury is suspected that will change management (R) (NK) (Contrast) (Anaes.) Y 63521 01SEP1998 - previous spinal surgery (R) (Anaes.) Y 63522 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist following radiographic examination where scaphoid fracture is suspected (R) (Contrast) (Anaes.) N 63522 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist for a patient under 16 years following radiographic examination where scaphoid fracture is suspected (R) (Contrast) (Anaes.) Y 63523 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist following radiographic examination where scaphoid fracture is suspected (R) (NK) (Contrast) (Anaes.) N 63523 01OCT2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist for a patient under 16 years following radiographic examination where scaphoid fracture is suspected (R) (NK) (Contrast) (Anaes.) Y 63524 01SEP1998 - trauma (R) (Anaes.) Y 63525 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for any of the following: -unexplained seizure(s) (R) (Contrast) (Anaes.); or -unexplained headache where significant pathology is suspected (R) (Contrast) (Anaes.); or -paranasal sinus pathology which has not responded to conservative therapy (R) (Contrast) (Anaes.) Y 63526 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine following radiographic examination for any or the following: -significant trauma (R) (Contrast) (Anaes.); or -unexplained neck or back pain with associated neurological signs (R) (Contrast) (Anaes.); or -unexplained back pain where significant pathology is suspected (R) (Contrast) (Anaes.) Y 63527 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following radiographic examination for internal joint derangement. (R) (Contrast) (Anaes.) Y 63528 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of hip following radiographic examination for any of the following: -suspected septic arthritis (R) (Contrast) (Anaes.); -suspected slipped capital femoral epiphysis (R) (Contrast) (Anaes.); -suspected Perthes disease (R) (Contrast) (Anaes.) Y 63529 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of elbow following radiographic examination where a significant fracture or avulsion injury is suspected that would change the way in which the patient is managed. (R) (Contrast) (Anaes.) Y 63530 01NOV2012 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of wrist following radiographic examination where scaphoid fracture is suspected (R) (Contrast) (Anaes.) Y 63531 01NOV2019 MRI -scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has a breast lesion; and the results of conventional imaging are inconclusive for the presence of breast cancer; and biopsy has not been possible. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (K) (Anaes.) (Contrast) Y 63532 01NOV2019 MRI -scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has a breast lesion; and the results of conventional imaging are inconclusive for the presence of breast cancer; and biopsy has not been possible. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (NK) (Anaes.) (Contrast) Y 63533 01NOV2019 MRI -scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has been diagnosed with a breast cancer; and there is a discrepancy between the clinical assessment and the conventional imaging assessment of the extent of the malignancy; and the results of breast MRI imaging may alter treatment planning. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (K) (Anaes.) (Contrast) Y 63534 01NOV2019 MRI -scan of both breasts, performed under the supervision of a specialist in diagnostic radiology who is a participant of the Royal Australian and New Zealand College of Radiologists' (RANZCR) Quality and Accreditation Program at an eligible location, if: a dedicated breast coil is used; and the service has been requested by a specialist or consultant physician; and the request for the scan identifies that: the patient has been diagnosed with a breast cancer;and there is a discrepancy between the clinical assessment and the conventional imaging assessment of the extent of the malignancy; and the results of breast MRI imaging may alter treatment planning. NOTE: This service can be provided on both full and partial MRI eligible equipment. There are no frequency restrictions for this item. (R) (NK) (Anaes.) (Contrast) Y 63541 01JUL2018 Multiparametric Magnetic Resonance Imaging scan of the prostate for the detection of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and the request for the scan identifies:that the patient is suspected of  developing prostate cancer, due to one of the following: (i) a digital rectal examination which is suspicious for prostate cancer; or (ii) in a person under 70 years, at least two prostate specific antigen (PSA) tests performed within an interval of 1- 3 months are greater than 3.0 ng/ml, and the free/total PSA ratio is less than 25% or the repeat PSA exceeds 5.5 ng/ml; or (iii) in a person under 70 years, whose risk of developing prostate cancer based on relevant family history is at least double the average risk, at least two PSA tests performed within an interval of 1- 3 months are greater than 2.0 ng/ml, and the free/total PSA  ratio is less than 25%; or (iv) in a person 70 years or older, at least two PSA tests performed within an interval of 1- 3 months are greater than 5.5ng/ml and the free/total PSA ratio is less than 25%.using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)  (R) (K)  Note: Benefits are payable on one occasion only in any 12 month period. Relevant family history is a first degree relative with prostate cancer, or suspected of carrying a BRCA 1 or BRCA 2 mutation.   Y 63542 01JUL2018 Multiparametric Magnetic Resonance Imaging scan of the prostate for the detection of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and the request for the scan identifies:that the patient is suspected of  developing prostate cancer, due to one of the following: (i) a digital rectal examination which is suspicious for prostate cancer; or (ii) in a person under 70 years, at least two prostate specific antigen (PSA) tests performed within an interval of 1- 3 months are greater than 3.0 ng/ml, and the free/total PSA ratio is less than 25% or the repeat PSA exceeds 5.5 ng/ml; or (iii) in a person under 70 years, whose risk of developing prostate cancer based on relevant family history is at least double the average risk, at least two PSA tests performed within an interval of 1- 3 months are greater than 2.0 ng/ml, and the free/total PSA  ratio is less than 25%; or (iv) in a person 70 years or older, at least two PSA tests performed within an interval of 1- 3 months are greater than 5.5ng/ml and the free/total PSA ratio is less than 25%.using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)  (R) (NK)  Note: Benefits are payable on one occasion only in any 12 month period. Relevant family history is a first degree relative with prostate cancer, or suspected of carrying a BRCA 1 or BRCA 2 mutation. Y 63543 01JUL2018 Multiparametric Magnetic Resonance Imaging scan of the prostate for the assessment of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and: the request for the scan identifies:  (i) the patient is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and (ii) the patient is not planning or undergoing treatment for prostate cancer. using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)(R) (K) Note: Benefits are payable at the time of diagnosis of prostate cancer, 12 months following diagnosis and then every 3rd year thereafter or at any time, if there is a clinical concern, including PSA progression.  This item is not to be used for the purposes of treatment planning or for monitoring after treatment.   Y 63544 01JUL2018 Multiparametric Magnetic Resonance Imaging scan of the prostate for the assessment of cancer, if the patient is referred by an urologist, radiation oncologist, or medical oncologist and: the request for the scan identifies:  (i) the patient is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and (ii) the patient is not planning or undergoing treatment for prostate cancer. using a standardised image acquisition protocol involving T2 Weighted Imaging, Diffusion Weighted Imaging, and Dynamic Contrast Enhancement (unless contraindicated)(R) (NK) Note: Benefits are payable at the time of diagnosis of prostate cancer, 12 months following diagnosis and then every 3rd year thereafter or at any time, if there is a clinical concern, including PSA progression.  This item is not to be used for the purposes of treatment planning or for monitoring after treatment Y 63545 01MAY2019 Note: Benefits are payable on only one occasion in any 12-month period MAGNETIC RESONANCE IMAGING with a contrast agent-multiphase scans of the liver (including delayed imaging,when performed) - performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or consultant physician- for characterisation or intervention planning, in a patient with: known colorectal carcinoma; and known, suspected, or possible liver metastasis; and previous computed tomography or ultrasound imaging has identified a mass lesion in the liver. For use with HEPATOBILIARY-SPECIFIC CONTRAST AGENT (item 63496). If a patient has known or suspectedclinical indication/s considered by a specialist or consultant physician to indicate the need for imaging with an extracellular contrast agent, the modifying MRI item 63491 can be used with this item. Fee: $550 Benefit: 75% = $412.50 85% = $467.50 (R) (K) (Anaes.) (See IN.0.18, IN.0.19 of explanatory notes to this category) Y 63546 01MAY2019 Note: Benefits are payable on only one occasion in any 12-month period MAGNETIC RESONANCE IMAGING with a contrast agent -multiphase scans of the liver (including delayed imaging, when performed) - performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or consultant physician -for diagnosis or staging, in a patient with known or suspected hepatocellular carcinoma, and: chronic liver disease, that has been confirmed by a specialist or consultant physician; and liver function identified as Child-Pugh class A or B; and an identified hepatic lesion over 10 mm in diameter. For use with HEPATOBILIARY-SPECIFIC CONTRAST AGENT (item 63496). If a patient has known or suspectedclinical indication/s considered by a specialist or consultant physician to indicate the need for imaging with anextracellular contrast agent, the modifying MRI item 63491 can be used with this item. Fee: $550 Benefit: 75% = $412.50 85% = $467.50 (R) (K) (Anaes.) (See IN.0.18, IN.0.19 of explanatory notes to this category) Y 63547 01MAY2018 MRI scan of both breasts for the detection of cancer, if (a) a dedicated breast coil is used; and (b) the request for the scan identifies that: (i)the patient has a breast implant in situ; and (ii) anaplastic large cell lymphoma has been diagnosed NOTE: benefits are payable once in a patient's lifetime (R) (K) (Contrast) Y 63548 01MAY2018 MRI scan of both breasts for the detection of cancer, if (a) a dedicated breast coil is used; and (b) the request for the scan identifies that: (i)the patient has a breast implant in situ; and (ii) anaplastic large cell lymphoma has been diagnosed NOTE: benefits are payable once in a patient's lifetime (R) (NK) (Contrast) Y 63550 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 14 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for monitoring of: - demyelinating disease (R) (Anaes.) Y 63551 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient16 years or older for any of the following: - unexplained seizure(s) (R) (Contrast) (Anaes.) - unexplained chronic headache with suspected intracranial pathology (R) (Contrast) (Anaes.) Y 63552 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient16 years or older for any of the following: - unexplained seizure(s) (R) (NK) (Contrast) (Anaes.) - unexplained chronic headache with suspected intracranial pathology (R) (NK) (Contrast) (Anaes.) Y 63553 01SEP1998 - congenital malformation of the spinal cord or the cauda equina or the meninges (R) (Anaes.) Y 63554 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical radiculopathy (R) (Contrast) (Anaes.) Y 63555 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical radiculopathy (R) (NK) (Contrast) (Anaes.) Y 63556 01SEP1998 - myelopathy (R) (Anaes.) Y 63557 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical spine trauma (R) (Contrast) (Anaes.) Y 63558 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: - cervical spine trauma (R) (NK) (Contrast) (Anaes.) Y 63559 01SEP1998 - syrinx (congenital or acquired) (R) (Anaes.) Y 63560 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following acute knee trauma for a patient 16 years or older with: - inability to extend the knee suggesting the possibility of acute meniscal tear (R) (Contrast) (Anaes.); or - clinical findings suggesting acute anterior cruciate ligament tear. (R) (Contrast) (Anaes.) N 63560 01NOV2018 MRI - scan of knee following acute knee trauma, after referral by a medical practitioner (other than a specialist or consultant physician), for a patient aged 16 to 49 years with: inability to extend the knee suggesting the possibility of acute meniscal tear; or clinical findings suggesting acute anterior cruciate ligament tear. (R) (K)(Contrast) (Anaes.) Y 63561 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following acute knee trauma for a patient 16 years or older with: - inability to extend the knee suggesting the possibility of acute meniscal tear (R) (NK) (Contrast) (Anaes.); or - clinical findings suggesting acute anterior cruciate ligament tear. (R) (NK) (Contrast) (Anaes.) N 63561 01NOV2018 MRI - scan of knee following acute knee trauma, after referral by a medical practitioner (other than a specialist or consultant physician), for a patient aged 16to 49 yearswith: inability to extend the knee suggesting the possibility of acute meniscal tear; or clinical findings suggesting acute anterior cruciate ligament tear. (R) (NK) (Contrast) (Anaes.) Y 63562 01SEP1998 - cervical radiculopathy (R) (Anaes.) Y 63565 01SEP1998 - sciatica (R) (Anaes.) Y 63568 01SEP1998 - spinal canal stenosis (R) (Anaes.) Y 63571 01SEP1998 - previous spinal surgery (R) (Anaes.) Y 63574 01SEP1998 - trauma (R) (Anaes.) Y 63580 01SEP1998 MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of one region or two contiguous regions of the spine for monitoring of: - infection (R) (Anaes.) Y 63583 01SEP1998 - tumour (R) (Anaes.) Y 63584 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of head for a patient16 years or older for any of the following: -unexplained seizure(s) (R) (Contrast) (Anaes.) -unexplained chronic headache with suspected intracranial pathology (R) (Contrast) (Anaes.) Y 63585 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: -cervical radiculopathy (R) (Contrast) (Anaes.) Y 63586 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of spine for a patient 16 years or older for suspected: -cervical spine trauma (R) (Contrast) (Anaes.) Y 63587 01NOV2013 referral by a medical practitioner (excluding a specialist or consultant physician) for a scan of knee following acute knee trauma for a patient 16 years or older with: -inability to extend the knee suggesting the possibility of acute meniscal tear (R) (Contrast) (Anaes.); or -clinical findings suggesting acute anterior cruciate ligament tear (R) (Contrast) (Anaes.) Y 63590 01SEP1998 MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of three contiguous regions or two non contiguous regions of the spine for monitoring of: - infection (R) (Anaes.) Y 63593 01SEP1998 - tumour (R) (Anaes.) Y 63600 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 17 on one occasion only in a 12 month period for one service per item per episode MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for the exclusion of: - tumour arising in bone or other connective tissue (R) (Anaes.) Y 63603 01SEP1998 - infection arising in bone or other connective tissue (R) (Anaes.) Y 63606 01SEP1998 - osteonecrosis (R) (Anaes.) Y 63609 01SEP1998 - derangement of hip or its supporting structures (R) (Anaes.) Y 63612 01SEP1998 - derangement of shoulder or its supporting structures (R) (Anaes.) Y 63615 01SEP1998 - derangement of knee or its supporting structures (R) (Anaes.) Y 63618 01SEP1998 - derangement of ankle or its supporting structures (R) (Anaes.) Y 63621 01SEP1998 - derangement of temporomandibular joint or its supporting structures (R) (Anaes.) Y 63624 01SEP1998 - derangement of wrist or its supporting structures (R) (Anaes.) Y 63627 01SEP1998 - derangement of elbow or its supporting structures (R) (Anaes.) Y 63650 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 18 on one occasion only in a 12 month period, for one service per item per episode. MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for further investigation of: - tumour arising in bone or other connective tissue (R) (Anaes.) Y 63653 01SEP1998 - infection arising in bone or other connective tissue (R) (Anaes.) Y 63656 01SEP1998 - osteonecrosis (R) (Anaes.)) Y 63659 01SEP1998 - derangement of hip or its supporting structures (R) (Anaes.) Y 63662 01SEP1998 - derangement of shoulder or its supporting structures (R) (Anaes.) Y 63665 01SEP1998 - derangement of knee or its supporting structures (R) (Anaes.) Y 63668 01SEP1998 - derangement of ankle or its supporting structures (R) (Anaes.) Y 63671 01SEP1998 - derangement of temporomandibular joint or its supporting structures (R) (Anaes.) Y 63674 01SEP1998 - derangement of wrist or its supporting structures (R) (Anaes.) Y 63677 01SEP1998 - derangement of elbow or its supporting structures (R) (Anaes.) Y 63680 01SEP1998 - post-inflammatory or post-traumatic physeal fusion in a person under 16 years of age (R) (Anaes.) Y 63700 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 19 on one occasion only in a 12 month period, for one service per item per episode. MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for monitoring of: - derangement of hip or its supporting structures (R) (Anaes.) Y 63703 01SEP1998 - derangement of shoulder or its supporting structures (R) (Anaes.) Y 63706 01SEP1998 - derangement of knee or its supporting structures (R) (Anaes.) Y 63709 01SEP1998 - derangement of ankle or its supporting structures (R) (Anaes.) Y 63712 01SEP1998 - derangement of temporomandibular joint or its supporting structures (R) (Anaes.) Y 63715 01SEP1998 - derangement of wrist or its supporting structures (R) (Anaes.) Y 63718 01SEP1998 - derangement of elbow or its supporting structures (R) (Anaes.) Y 63721 01SEP1998 - post-inflammatory or post-traumatic physeal fusion in a person under 16 years of age (R) (Anaes.) Y 63736 01SEP1998 MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for monitoring of: - osteonecrosis (R) (Anaes.) Y 63739 01SEP1998 - tumour arising in bone or other connective tissue (R) (Anaes.) Y 63740 01NOV2014 MRI to evaluate small bowel Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients: (a) Evaluation of disease extent at time of initial diagnosis of Crohn's disease (b) Evaluation of exacerbation/suspected complications of known Crohn's disease (c) Evaluation of known or suspected Crohn's disease in pregnancy (d) Assessment of change to therapyin patients with small bowel Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (K) (Contrast) Y 63741 01NOV2014 MRI enteroclysis for Crohn's disease. Medicare benefits are only payable for this item if the service is related to item 63740. (R) (K) Y 63742 01SEP1998 - infection arising in bone or other connective tissue (R) (Anaes.) Y 63743 01NOV2014 MRI for fistulising perianal Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients for: - Evaluation of pelvic sepsis and fistulas associated with established or suspected Crohn's disease - Assessment of change to therapy of pelvis sepsis and fistulas from Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (K) (Contrast) Y 63744 01NOV2014 MRI to evaluate small bowel Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients: (a) Evaluation of disease extent at time of initial diagnosis of Crohn's disease (b) Evaluation of exacerbation/suspected complications of known Crohn's disease (c) Evaluation of known or suspected Crohn's disease in pregnancy (d) Assessment of change to therapyin patients with small bowel Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (NK) (Contrast) Y 63745 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 21 on two occasions only in a 12 month period, and for a maximum of one service per item per episode of care. MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of musculoskeletal system for further investigation or monitoring of: - Gaucher disease (R) (Anaes.) Y 63746 01NOV2014 MRI enteroclysis for Crohn's disease. Medicare benefits are only payable for this item if the service is related to item 63744. (R) (NK) Y 63747 01NOV2014 MRI for fistulising perianal Crohn's disease. Medicare benefits are only payable for this item if the service is provided to patients for: - Evaluation of pelvic sepsis and fistulas associated with established or suspected Crohn's disease - Assessment of change to therapy of pelvis sepsis and fistulas from Crohn's disease Assessment of change to therapy can only be claimed once in a 12 month period. (R) (NK) (Contrast) Y 63750 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 22 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for further investigation of: - congenital disease of the heart or a great vessel (R) (Anaes.) Y 63753 01SEP1998 - tumour of the heart or a great vessel (R) (Anaes.) Y 63756 01SEP1998 - abnormality of thoracic aorta (R) (Anaes.) Y 63800 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 23 on two occasions only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast (including Magnetic Resonance Angiography if performed), performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for monitoring of: - congenital disease of the heart or a great vessel (R) (Anaes.) Y 63803 01SEP1998 - tumour of the heart or a great vessel (R) (Anaes.) Y 63806 01SEP1998 - abnormality of the thoracic aorta (R) (Anaes.) Y 63850 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 24 on two occasions only in a 12 month period MAGNETIC RESONANCE ANGIOGRAPHY with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for exclusion of or further investigation of: - stroke (R) (Anaes.) Y 63853 01SEP1998 - carotid or vertebral artery dissection (R) (Anaes.) Y 63856 01SEP1998 - intracranial aneurysm (R) (Anaes.) Y 63859 01SEP1998 - intracranial arteriovenous malformation (R) (Anaes.) Y 63862 01SEP1998 - venous sinus thrombosis (R) (Anaes.) Y 63865 01SEP1998 - vascular abnormality in a patient with a previous anaphylactic reaction to an iodinated contrast medium (R) (Anaes.) Y 63868 01SEP1998 - obstruction of the superior vena cava, inferior vena cava or a major pelvic vein (R) (Anaes.) Y 63870 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 25 on one occasion only in a 12 month period MAGNETIC RESONANCE ANGIOGRAPHY with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system of a person under the age of 16 years for further investigation of: - the vasculature of limbs prior to limb or digit transfer surgery in congenital limb deficiency syndrome (R) (Anaes.) Y 63880 01SEP1998 MAGNETIC RESONANCE ANGIOGRAPHY with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of cardiovascular system for monitoring of: - carotid or vertebral artery dissection (R) (Anaes.) Y 63883 01SEP1998 - venous sinus thrombosis (R) (Anaes.) Y 63900 01SEP1998 NOTE: Benefits are payable for each service included by Subgroup 27 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body of a person under the age of 16 years for further investigation of: - pelvic or abdominal mass (R) (Anaes.) Y 63903 01SEP1998 - mediastinal mass (R) (Anaes.) Y 63906 01SEP1998 - congenital uterine or anorectal abnormality (R) (Anaes.) Y 63909 01SEP1998 - Gaucher disease (R) (Anaes.) Y 63920 01SEP1998 NOTE: Benefits are payable for the each service included by item 63920 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body for further investigation of: - adrenal mass in a patient with a malignancy which is otherwise resectable (R) (Anaes.) Y 63930 01SEP1998 NOTE: Benefits are payable for the each service included by item 63930 on one occasion only in a 12 month period MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body of a person under the age of 16 years for monitoring of: - congenital uterine or anorectal abnormality (R) (Anaes.) Y 63940 01SEP1998 MAGNETIC RESONANCE IMAGING with or without intravenous contrast, performed under the professional supervision of an eligible provider at an eligible location where the patient is referred by a specialist or by a consultant physician and where the request for the scan specifically identifies the clinical indication for the scan - scan of the body of a person under the age of 16 years for monitoring of: - mediastinal mass (R) (Anaes.) Y 63943 01SEP1998 - pelvic or abdominal mass (R) (Anaes.) Y 63946 01SEP1998 - Gaucher disease (R) (Anaes.) Y 63960 01MAY2004 Note: Benefits are payable for each service included by Subgroup 31 on one occasion only. Magnetic Resonance Imaging, performed under the professional supervision of an eligible provider at an eligible location where: (a)the patient is referred by a specialist or by a consultant physician; and (b)the request for scan identifies that (i) a histological diagnosis of carcinoma of the cervix has been made and (ii) the patient has been diagnosed with cervical cancer at FIGO stage 1B or greater. Scan for the further investigation of: -Pelvis for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) Y 63963 01MAY2004 - Pelvis and upper abdomen, in a single examination, for the staging of histologically diagnosed cervical cancer at FIGO stages 1B or greater (R) Y 64990 01FEB2004 A diagnostic imaging service to which an item in this table (other than this item or item 64991) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c)the person is not an admitted patient of a hospital; and (d)the service is bulk-billed in respect of the fees for: (i)this item; and (ii)the other item in this table applying to the service Y 64991 01MAY2004 A diagnostic imaging service to which an item in this table (other than this item or item 64990) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c)the person is not an admitted patient of a hospital or day-hospital facility: and (d)the service is bulk-billed in respect of the fees for: (i)this item: and (ii)the other item in this table applying to the service (e)the service is provided at, or from, a practice location in: (i)a regional, rural or remote area; or (ii)Tasmania N 64991 01SEP2004 A diagnostic imaging service to which an item in this table (other than this item or item 64990) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c)the person is not an admitted patient of a hospital; and (d)the service is bulk-billed in respect of the fees for: (i)this item; and (ii)the other item in this table applying to the service; and (e)the service is provided at, or from, a practice location in: (i)a regional, rural or remote area; or (ii)Tasmania; or (iii)A geographical area included in any of the following SSD spatial units: (A)Beaudesert Shire Part A (B)Belconnen (C)Darwin City (D)Eastern Outer Melbourne (E)East Metropolitan, Perth (F)Frankston City (G)Gosford-Wyong (H)Greater Geelong City Part A (I)Gungahlin-Hall (J)Ipswich City (part in BSD) (K)Litchfield Shire (L)Melton-Wyndham (M)Mornington Peninsula Shire (N)Newcastle (O)North Canberra (P)Palmerston-East Arm (Q)Pine Rivers Shire (R)Queanbeyan (S)South Canberra (T)South Eastern Outer Melbourne (U)Southern Adelaide (V)South West Metropolitan, Perth (W)Thuringowa City Part A (X)Townsville City Part A (Y)Tuggeranong (Z)Weston Creek-Stromlo (ZA)Woden Valley (ZB)Yarra Ranges Shire Part A; or (iv)the geographical area included in the SLA spatial unit of Palm Island (AC) N 64991 01JAN2020 A diagnostic imaging service to which an item in this table (other than this item or item 64990) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c)the person is not an admitted patient of a hospital; and (d)the service is bulk-billed in respect of the fees for: (i)this item; and (ii)the other item in this table applying to the service; and (e)the service is provided at, or from, a practice location within Modified Monash areas 2 to 7. Y 65001 01DEC1991 Blood count consisting of erythrocyte count, Creactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte count1 or 2 procedures N 65001 01JUL1994 Erythrocyte count, Creactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, or reticulocyte count1 or 2 tests Y 65002 01DEC1991 Blood count consisting of erythrocyte count, Creactive protein, erythrocyte sedimentation rate, blood viscosity, haematocrit, haemoglobin, platelet count, leucocyte count, reticulocyte countone or two procedures. Y 65003 01DEC1991 3 or more procedures to which item 65001 applies, including any calculation or measurement of erythrocyte or other indices N 65003 01JUL1994 3 or more tests described in 65001, and calculation or measurement of cell index or indices Y 65004 01DEC1991 Three or more procedures to which item 65001/65002 applies, including any calculation or measurement of erythrocyte or other indices Y 65005 01DEC1991 Examination of blood film, with or without 5 part differential cell count, or 5 part differential cell count with or without examination of blood film, and if performed, any of these additional servicesDirect Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alphanaphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027 N 65005 01JUL1994 Examination of blood film, or 5 part differential cell count, or both 5 part differential cell count and examination of blood film, including (if performed): (a)a service described in item 65027; and (b)any of the following services: (i)examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron; (ii)examination of a blood film with alphanaphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitroblue tetrazolium, periodic acid Schiff or Sudan Black stains; (iii)Kleihauer test for HbF on blood film N 65005 20MAR1997 Examination of: (a)a blood film by special stains to demonstrate Heinz bodies, parasites or iron; or (b)a blood film by enzyme cytochemistry for neutrophil alkaline phosphatese, alphanaphthyl acetate esterase or chloroacetate esterase; or (c)a blood film using any other special staining methods including periodic acid Schiff and Sudan black; or (d)a urinary sediment for haemosiderin including a service described in item 65072 Y 65006 01DEC1991 Examination of blood film, with or without five part differential cell count, or five part differential cell count with or without examination of blood film, and if performed, any of these additional servicesDirect Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alphanaphthylacetate esterase, choloroacetate esterase, neutrophil alkaline phosphatase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 65027/65028 Y 65007 01DEC1991 Full blood examination consisting of items 65003 and 65005 N 65007 01JUL1994 Full blood examination (consisting of the services described in items 65003 and 65005) Y 65008 01DEC1991 Full blood examination consisting of items 65003/65004 and 65005/65006 Y 65009 01DEC1991 Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes byerythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine1 or more procedures N 65009 01JUL1994 Haemolysis or metabolic enzymes - assessment by: (a) erythrocyte autohaemolysis test; (b) erythrocyte fragility test; (c) sugar water test; (d) erythrocyte metabolic enzyme test; (e) heat denaturation test; (f) isopropanol precipitation test; (g) acid haemolysis test;and (h) quantitation of muramidase in serum or urine; 1 or more tests Y 65010 01DEC1991 Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes byerythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urineone or more procedures Y 65011 01DEC1991 Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and 2 of the followingexamination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001, 65003, 65005, and 65007 N 65011 01JUL1994 Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and instrument generated differential countincluding any services in item 65060 or 65072 2 or more instrument generated results from a single sample Y 65012 01DEC1991 Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and two of the followingexamination for HbH, quantitation of HbA2 or HbF, including any services specified in items 65001/65002, 65003/65004, 65005/65006 and 65007/65008 Y 65013 01DEC1991 Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001, 65003, 65005, 65007 and 65015 N 65013 01JUL1994 Bone marrow trephine biopsy - histopathological examination of sections of bone marrow, including (if performed): (a)examination of aspirated material; and (b)special stains or immunochemical techniques (if any); and (c)a service described in item 65001, 65003, 65005, 65007 or 65015 Y 65014 01DEC1991 Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immunochemical techniques, including any services specified in items 65001/65002, 65003/65004, 65005/65006, 65007/65008 and 65015/65016 Y 65015 01DEC1991 Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001, 65003, 65005 and 65007 N 65015 01JUL1994 Bone marrow - examination of aspirated material (including clot sections where necessary), including (if performed): (a)special stains or immunochemical techniques (if any); and (b)a service described in item 65001, 65003, 65005 or 65007 Y 65016 01DEC1991 Bone marrow examination of aspirated material including any special stains, immunochemical techniques and clot sections where necessary, including any services specified in items 65001/65002, 65003/65004, 65005/65006 and 65007/65008 Y 65017 01DEC1991 Blood grouping, including backgrouping when performedABO and Rh (D antigen) N 65017 01JUL1994 Blood grouping (including backgrouping if performed)ABO and Rh (D antigen) Y 65018 01DEC1991 Blood grouping, including backgrouping when performedABO and Rh (D antigen). Y 65019 01DEC1991 Blood groupingRh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system1 or more systems, including any services specified in item 65017 N 65019 01JUL1994 Blood groupingRh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system1 or more systems, including a service described in item 65017 (if performed) Y 65020 01DEC1991 Blood groupingRh phenotypes, Kell system, Duffy system, M and N factors or any other blood group systemone or more systems, including any services specified in item 65017/65018 Y 65021 01DEC1991 Blood grouping, including backgrouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001, 65003, 65005 and 65007 N 65021 01JUL1994 Blood grouping (including backgrouping if performed), and examination of serum for Rh and other blood group antibodies, including: (a)identification and quantitation of any antibodies detected; and (b)(if performed) a service described in item 65001, 65003, 65005 or 65007 Y 65022 01DEC1991 Blood grouping, including backgrouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 65001/65002, 65003/65004, 65005/65006 and 65007/65008 Y 65023 01DEC1991 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001, 65003, 65005, 65007, 65017 and 65021 including all testing performed on any 1 day N 65023 01JUL1994 Compatibility tests - all tests performed on any 1 day, including: (a)all grouping checks of patient and donor; and (b)examination for antibodies, and, if necessary, quantitation of any antibodies detected; and (c)a service described in item 65001, 65003, 65005, 65007, 65017 or 65021 (if performed) Y 65024 01DEC1991 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 65001/65002, 65003/65004, 65005/65006, 65007/65008, 65017/65018 and 65021/65022 including all testing performed on any one day Y 65025 01DEC1991 Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected N 65025 01JUL1994 Examination of serum for blood group antibodies (including identification and, if necessary, quantitation of any antibodies detected) Y 65026 01DEC1991 Examination of serum for blood group antibodies including identification and, if necessary, quantative estimation of any antibodies detected Y 65027 01DEC1991 Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) including those services specified in items 65005 and 650071 or more tests N 65027 01JUL1994 1 or more of the following tests (a)direct Coombs test; (b)qualitative or quantitative test for cold agglutinins or heterophile antibodies; (c)qualitative spectroscopic examination of blood for abnormal haemoglobins; (d)qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) Y 65028 01DEC1991 Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examinations of blood for abnormal haemoglobins, qua;itative test for red cell porphyrins and detected of metalbumin (Schumm's test) including those services specified in items 65005/65006 and 65007/65008 - one or more tests Y 65029 01DEC1991 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 offibrinogen degradation products, fibrin monomer or Ddimer1 estimation N 65029 01JUL1994 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or 1 of: fibrinogen degradation products, fibrin monomer or Ddimer 1 test Y 65030 01DEC1991 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or one offibrinogen degradation products, fibrin monomer or Ddimerone estimation Y 65031 01DEC1991 2 estimations specified in item 65029 N 65031 01JUL1994 2 tests described in item 65029 Y 65032 01DEC1991 Two estimations specified in item 65029/65030 Y 65033 01DEC1991 3 estimations specified in item 65029 N 65033 01JUL1994 3 tests described in item 65029 Y 65034 01DEC1991 Three estimations specified in item 65029/65030 Y 65035 01DEC1991 4 or more estimations specified in item 65029 N 65035 01JUL1994 4 or more tests described in item 65029 Y 65036 01DEC1991 Four or more estimations specified in item 65029/65030 Y 65037 01DEC1991 Quantitative assay, by 1 or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant1 estimation N 65037 01JUL1994 Quantitation, by 1 or more techniques, of: plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, euglobulin clot lysis time and test for lupus anticoagulant1 to 3 tests Y 65038 01DEC1991 Quantitative assay, by one or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin cofactor II, Euglobulin clot lysis time and test for lupus anticoagulantone estimation. Y 65039 01DEC1991 4 or more estimations specified in item 65037 N 65039 01JUL1994 4 or more tests described in item 65037 Y 65040 01DEC1991 Four or more estimations specified in item 65037/65038 Y 65041 01DEC1991 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance1 or more estimations N 65041 01JUL1994 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance1 or more tests Y 65042 01DEC1991 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substanceone or more estimations Y 65043 01DEC1991 Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin1 or more estimations N 65043 01JUL1994 Heparin quantitation when monitoring a patient on subcutaneous heparin or low molecular weight heparin1 or more tests Y 65044 01DEC1991 Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparinone or more estimations Y 65045 01DEC1991 Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor1 estimation N 65045 01JUL1994 Quantitation of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, or Passovy factor1 test Y 65046 01DEC1991 Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factorone estimation Y 65047 01DEC1991 2 estimations specified in item 65045 N 65047 01JUL1994 2 tests described in item 65045 Y 65048 01DEC1991 Two estimations as specified in item 65045/65046 Y 65049 01DEC1991 3 or more estimations specified in item 65045 N 65049 01JUL1994 3 or more tests described in item 65045 Y 65050 01DEC1991 Three or more estimations as specified in item 65045/65046 Y 65052 20MAR1997 Examination of a maternal blood film for the presence of fetal red blood cells (Kleihauer test) including any service described in item 65005 (if performed) Y 65053 20MAR1997 Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell surface antigens using flow cytometric methods including any service described in item 65007 or 65052 (if performed) Y 65060 01NOV1998 Haemoglobin, erythrocyte sedimentation rate, blood viscosity - 1 or more tests Y 65063 01NOV1998 Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and instrument generated differential countincluding any services in item 65060 or 65072 2 or more instrument generated results from a single sample N 65063 01NOV1999 Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and instrument generated differential count - not being a service where haemoglobin only is requested including any services in item 65060 or 65072 - 1 or more instrument generated results from a single sample Y 65066 01NOV1998 Examination of: (a)a blood film by special stains to demonstrate Heinz bodies, parasites or iron; or (b)a blood film by enzyme cytochemistry for neutrophil alkaline phosphatase, alpha-naphthyl acetate esterase or chloroacetate esterase; or (c)a blood film using any other special staining methods including periodic acid Schiff and Sudan Black; or (d)a urinary sediment for haemosiderin including a service described in item 65072 Y 65069 01NOV1998 Full blood examination consisting of: (a)a morphological assessment of a blood film; (b)item 65063; and (c)(if performed) any test in item 65060 or 65072 Y 65070 01NOV2000 Erythrocyte count, haematocrit, haemoglobin, calculation or measurement of red cell index or indices, platelet count, leucocyte count and manual or instrument generated differential count - not being a service where haemoglobin only is requested - one or more instrument generated set of results from a single sample; and (if performed) (a) a morphological assessment of a blood film; (b) any service in item 65060 or 65072 Y 65072 01NOV1998 Examination for reticulocytes including a reticulocyte count by any method - 1 or more tests in any episode N 65072 01MAY2005 Examination for reticulocytes including a reticulocyte count by any method - 1 or more tests Y 65075 01NOV1998 Haemolysis or metabolic enzymes - assessment by: (a)erythrocyte autohaemolysis test; or (b)erythrocyte osmotic fragility test; or (c)sugar water test; or (d)G-6-P D (qualitative or quantitative) test; or (e)pyruvate kinase (qualitative or quantitative) test; or (f)acid haemolysis test; or (g) quantitation of muramidase in serum or urine; or (h) Donath Landsteiner antibody test; or (i) other erythrocyte metabolic enzyme tests 1 or more tests Y 65078 01NOV1998 Tests for the diagnosis of thalassaemia when indicated on the basis of an abnormal full blood examination or by the clinical need for family studies, consisting of haemoglobin electrophoresis or chromatography and at least 2 of: (a)examination for HbH; or (b)quantitation of HbA2; or (c)quantitation of HbF; including (if performed) any service described in item 65060 or 65070 N 65078 01MAY2008 Tests for the diagnosis of thalassaemia consisting of haemoglobin electrophoresis or chromatography and at least 2 of: (a)examination for HbH; or (b)quantitation of HbA2; or (c)quantitation of HbF; including (if performed) any service described in item 65060 or 65070 Y 65079 01MAY2007 Tests described in item 65078 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 65081 01NOV1998 Tests for the investigation of haemoglobinopathy (including S, C, D, E), other than thalassaemia, when indicated on the basis of an abnormal full blood examination or by the clinical need for family studies, consisting of haemoglobin electrophoresis or chromatography and at least 1 of: (a)heat denaturation test; or (b)isopropanol precipitation test; or (c)tests for the presence of haemoglobin S; or (d)quantitation of any haemoglobin fraction (including S, C, D, E); including (if performed) any service described in item 65060, 65070 or 65078 N 65081 01MAY2008 Tests for the investigation of haemoglobinopathy consisting of haemoglobin electrophoresis or chromatography and at least 1 of: (a)heat denaturation test; or (b)isopropanol precipitation test; or (c)tests for the presence of haemoglobin S; or (d)quantitation of any haemoglobin fraction (including S, C, D, E); including (if performed) any service described in item 65060, 65070 or 65078 Y 65082 01MAY2007 Tests described in item 65081 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 65084 01NOV1998 Bone marrow trephine biopsy - histopathological examination of sections of bone marrow and examination of aspirated material (including clot sections where necessary), including (if performed): (a)special stains or immunohistochemical techniques (if any); and (b)any test described in item 65060, 65066 or 65070 N 65084 01MAY2008 Bone marrow trephine biopsy - histopathological examination of sections of bone marrow and examination of aspirated material (including clot sections where necessary), including (if performed): any test described in item 65060, 65066 or 65070 Y 65087 01NOV1998 Bone marrow - examination of aspirated material (including clot sections where necessary), including (if performed): (a)special stains or immunohistochemical techniques (if any); and (b)any test described in item 65060, 65066 or 65070 N 65087 01MAY2008 Bone marrow - examination of aspirated material (including clot sections where necessary), including (if performed): any test described in item 65060, 65066 or 65070 Y 65090 01NOV1998 Blood grouping (including back-grouping if performed) - ABO and Rh (D antigen) Y 65093 01NOV1998 Blood grouping - Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system - 1 or more systems, including item 65090 (if performed) Y 65096 01NOV1998 Blood grouping (including back-grouping if performed), and examination of serum for Rh and other blood group antibodies, including: (a)identification and quantitation of any antibodies detected; and (b)(if performed) any test described in item 65060 or 65070 Y 65099 01NOV1998 Compatibility tests by crossmatch all tests performed on any one day for up to 6 units, including: (a)all grouping checks of the patient and donor; and (b)examination for antibodies, and if necessary identification of any antibodies detected; and (c)any tests described in item 65060, 65063, 65069, 65090 or 65096 (if performed) N 65099 01NOV1999 Compatibility tests by crossmatch - all tests performed on any one day for up to 6 units, including: (a)all grouping checks of the patient and donor; and (b)examination for antibodies, and if necessary identification of any antibodies detected; and (c)(if performed) any tests described in item 65060, 65070, 65090 or 65096 (Item is subject to rule 5) Y 65102 01NOV1998 Compatibility tests by crossmatch - all tests performed on any one day in excess of 6 units, including: (a)all grouping checks of the patient and donor; and (b)examination for antibodies, and if necessary identification of any antibodies detected; and (c)(if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105 (Item is subject to rule 5) Y 65105 01NOV1998 Compatibility testing using at least a 3 cell panel and issue of red cells for transfusionall tests performed on any one day for up to 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies, and if necessary identification of any antibodies detected; and (c) any tests described in item 65060, 65063, 65069, 65090 or 65096 (if performed) N 65105 01NOV1999 Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion - all tests performed on any one day for up to 6 units, including: (a) all grouping checks of the patient and donor; and (b) examination for antibodies and, if necessary, identification of any antibodies detected; and (c) (if performed) any tests described in item 65060, 65070, 65090 or 65096 (Item is subject to rule 5) Y 65108 01NOV1998 Compatibility testing using at least a 3 cell panel and issue of red cells for transfusion - all tests performed on any one day in excess of 6 units, including: (a)all grouping checks of the patient and donor; and (b)examination for antibodies and, if necessary, identification of any antibodies detected; and (c) (if performed) any tests described in item 65060, 65070, 65090, 65096, 65099 or 65105 (Item is subject to rule 5) Y 65109 01MAY2007 Release of fresh frozen plasma or cryoprecipitate for the use in a patient for the correction of a coagulopathy - 1 release. Y 65110 01MAY2007 Release of compatible fresh platelets for the use in a patient for platelet support as prophylaxis to minimize bleeding or during active bleeding - 1 release. Y 65111 01NOV1998 Examination of serum for blood group antibodies (including identification and, if necessary, quantitation of any antibodies detected) Y 65114 01NOV1998 1 or more of the following tests: (a)direct Coombs (antiglobulin) test; (b)qualitative or quantitative test for cold agglutinins or heterophil antibodies Y 65117 01NOV1998 1 or more of the following tests: (a)qualitative spectroscopic examination of blood for chemically altered haemoglobins; (b)detection of methaemalbumin (Schumm's test) N 65117 01MAY2003 1 or more of the following tests: (a)Spectroscopic examination of blood for chemically altered haemoglobins; (b)detection of methaemalbumin (Schumm's test) Y 65120 01NOV1998 Prothrombin time (including INR where appropriate), activated partial thromboplastin time, thrombin time (including test for the presence of heparin), test for factor XIII deficiency (qualitative), Echis test, Stypven test, reptilase time, fibrinogen, or 1 of fibrinogen degradation products, fibrin monomer or D-dimer - 1 test Y 65123 01NOV1998 2 tests described in item 65120 Y 65126 01NOV1998 3 tests described in item 65120 Y 65129 01NOV1998 4 or more tests described in item 65120 Y 65132 01NOV1998 Quantitation, by 1 or more techniques, of antithrombin III, Protein C, Protein S, heparin cofactor II, plasminogen, euglobulin clot lysis time and test for lupus anticoagulant1 to 3 tests N 65132 01MAY2000 Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - where any request for the test by a medical practitioner specifically identifies in writing a history of venous thromboembolism or arterial thrombosis - quantitation by 1 or more techniques - 1 test N 65132 01NOV2000 Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - if the request for the test specifically identifies in writing a history of venous thromboembolism - quantitation by 1 or more techniques - 1 test N 65132 01NOV2003 Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - where the request for the test(s) specifically identifies that the patient has a history of venous thromboembolism - quantitation by 1 or more techniques - 1 test Y 65133 01MAY2000 2 tests described in item 65132 Y 65134 01MAY2000 3 tests described in item 65132 Y 65135 01MAY2000 4 tests described in item 65132 Y 65136 01MAY2000 5 tests described in item 65132 Y 65137 01MAY2000 Test for the presence of lupus anticoagulant not being a service associated with any service to which item 65132 applies N 65137 01NOV2000 Test for the presence of lupus anticoagulant not being a service associated with any service to which items 65132, 65133, 65134, 65135 and 65136 apply N 65137 01NOV2007 Test for the presence of lupus anticoagulant not being a service associated with any service to which items 65175, 65176, 65177, 65178 and 65179 apply Y 65138 01NOV1998 4 or more tests described in item 65132 Y 65139 01MAY2000 Quantitation of plasminogen - 1 test Y 65140 01MAY2000 Quantitation of euglobulin clot lysis time - 1 test Y 65141 01NOV1998 Test for Activated Protein C resistance for a patient with a history of venous thrombosis or pulmonary thromboembolism where any request for the test by a medical practitioner specifically identifies in writing a history of venous thrombosis or pulmonary thromboembolism Y 65142 01MAY2000 Confirmation or characterisation of an abnormal or indeterminate results using a separate specimen collected on a different day using tests described in item 65132 - 1 or more tests N 65142 01NOV2000 Confirmation or clarification of an abnormal or indeterminate result from a test described in item 65132, by testing a specimen collected on a different day - 1 or more tests N 65142 01NOV2007 Confirmation or clarification of an abnormal or indeterminate result from a test described in item 65175, by testing a specimen collected on a different day - 1 or more tests Y 65144 01NOV1998 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or other substances; or heparin, low molecular weight heparins, heparinoid or other drugs - 1 or more tests Y 65147 01NOV1998 Quantitation of anti-Xa activity when monitoring is required for a patient receiving a low molecular weight heparin or heparinoid - 1 test Y 65150 01NOV1998 Quantitation of von Willebrand factor antigen, von Willebrand factor activity (ristocetin cofactor assay), von Willebrand factor collagen binding activity, factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, circulating coagulation factor inhibitors other than by Bethesda assay - 1 test N 65150 01MAY2007 Quantitation of von Willebrand factor antigen, von Willebrand factor activity (ristocetin cofactor assay), von Willebrand factor collagen binding activity, factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, circulating coagulation factor inhibitors other than by Bethesda assay - 1 test (Item is subject to rule 6 ) Y 65153 01NOV1998 2 tests described in item 65150 N 65153 01MAY2007 2 tests described in item 65150 (Item is subject to rule 6 ) Y 65156 01NOV1998 3 or more tests described in item 65150 N 65156 01MAY2007 3 or more tests described in item 65150 (Item is subject to rule 6 ) Y 65157 01MAY2007 A test described in item 65150, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 65158 01MAY2007 Tests described in item 65150, other than that described in 65157, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6 and 18) Y 65159 01NOV1998 Quantitation of circulating coagulation factor inhibitors by Bethesda assay - 1 test Y 65162 01NOV1998 Examination of a maternal blood film for the presence of fetal red blood cells (Kleihauer test) Y 65165 01NOV1998 Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell surface antigens using flow cytometric methods including (if performed) any test described in item 65070 or 65162 N 65165 01NOV2003 Detection and quantitation of fetal red blood cells in the maternal circulation by detection of red cell antigens using flow cytometric methods including (if performed) any test described in item 65070 or 65162 Y 65166 01MAY2007 A test described in item 65165 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 65168 01MAY2000 Characterisation of the genotype of a patient for Factor V Leiden gene mutation, or detection of other relevant mutations in the investigation of proven venous thrombosis or pulmonary embolism - 1 or more tests Y 65171 01MAY2000 Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency or activated protein C resistance in a first degree relative of a person who has a proven defect of any of the above - 1 or more tests Y 65174 01MAY2000 Characterisation of the genotype of a person who is a first degree relative of a person who has been proven to have 1 or more abnormal genotypes under item 65168 - 1 or more tests Y 65175 01MAY2007 Test for the presence of antithrombin III deficiency, protein C deficiency, protein S deficiency, lupus anticoagulant, activated protein C resistance - where the request for the test(s) specifically identifies that the patient has a history of venous thromboembolism - quantitation by 1 or more techniques - 1 test (Item is subject to Rule 6) Y 65176 01MAY2007 2 tests described in item 65175 (Item is subject to rule 6) Y 65177 01MAY2007 3 tests described in item 65175 (Item is subject to rule 6) Y 65178 01MAY2007 4 tests described in item 65175 (Item is subject to rule 6) Y 65179 01MAY2007 5 tests described in item 65175 (Item is subject to rule 6) Y 65180 01MAY2007 A test described in item 65175, if rendered by a receiving APA, where no tests in the item have been rendered by the referring APA - 1 test (Item is subject to rule6 and 18) Y 65181 01MAY2007 Tests described in item 65175, other than that described in 65180, if rendered by a receiving APA - each test to a maximum of 4 tests(Item is subject to rule 6 and 18) Y 65200 09AUG2004 Characterisation of gene rearrangement by nucleic acid amplification in the diagnosis and monitoring of patients with laboratory evidence of: (a)acute myeloid leukaemia; or (b)acute promyelocytic leukaemia; or (c)acute lymphoid leukaemia; or (d)chronic myeloid leukaemia; each test to a maximum of 4 tests in a 12 month period Y 66201 01DEC1991 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis ofalanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea1 estimation N 66201 01JUL1993 Quantitative in serum, plasma, urine or other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis, when not performed as specified in item 66331, ofalanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, or urea1 estimation N 66201 01NOV1993 Quantitative estimation in serum, plasma, urine or other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis ofalanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, urea1 estimation N 66201 01JUL1994 Quantitation in serum, plasma, urine or other body fluid, by any method except reagent strip (with or without reflectance meter or electrophoresis) of: alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (if not performed as described in item 66249), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate, or urea1 test N 66201 01JUL1995 Quantitation in serum, plasma, urine or other body fluid, by any method except reagent strip (with or without reflectance meter or electrophoresis) of: alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total), bilirubin (any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (if not performed as described in item 66249), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate or urea1 test N 66201 01NOV1995 Quantitation in serum, plasma, urine or other body fluid, by any method except reagent tablet or reagent strip (with or without reflectance meter or electrophoresis) of: alanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total), bilirubin (any fractions), calcium (total, dialysed or ionised), chloride, creatine kinase, creatine kinase isoenzymes (if not performed as described in item 66249), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, urate or urea1 test Y 66202 01DEC1991 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis ofalanine aminotransferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 66245/66246), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, ureaone estimation Y 66203 01DEC1991 2 estimations specified in item 66201 N 66203 01JUL1994 2 tests described in item 66201 Y 66204 01DEC1991 Two estimations specified in item 66201/66202 Y 66205 01DEC1991 3 estimations specified in item 66201 N 66205 01JUL1994 3 tests described in item 66201 Y 66206 01DEC1991 Three estimations specified in item 66201/66202 Y 66207 01DEC1991 4 estimations specified in item 66201 N 66207 01JUL1994 4 tests described in item 66201 Y 66208 01DEC1991 Four estimations specified in item 66201/66202 Y 66209 01DEC1991 5 estimations specified in item 66201 N 66209 01JUL1994 5 tests described in item 66201 Y 66210 01DEC1991 Five estimations specified in item 66201/66202 Y 66211 01DEC1991 6 or more estimations specified in item 66201 N 66211 01JUL1994 6 or more tests described in item 66201 Y 66212 01DEC1991 Six or more estimations specified in item 66201/66202 Y 66213 01DEC1991 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma - 1 or more estimations N 66213 01JUL1994 Test by any method (except reagent strip or dip-stick): (a)for the presence of: (i)the following urine constituents - bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen; or (ii)cryoglobulins or cryofibrinogen in plasma; or (b)of pH of body fluids other than urine (not including urine acidification test); 1 or more tests Y 66214 01DEC1991 Qualitative estimation by any method, except by reagent strip or dipstick of the following urine constituentsbilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrin, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasmaone or more estimations Y 66215 01SEP1992 Quantitative estimation of cryoglobulins or cryofibrinogen after a positive result for cryoglobulin is obtained in any service specified in item 66213 (including provision of that service) - 1 or more estimations N 66215 01JUL1994 Quantitation of cryoglobulins or cryofibrinogen following their detection in a test described in item 66213, including that service - 1 or more tests Y 66217 01DEC1991 Qualitative estimation by any method except by reagent strip or dipstick of the following faecal constituentshaemoglobin, porphyrins, reducing substanceseach estimation, to a maximum of 3 estimations, taken on separate days N 66217 01JUL1994 Tests by any chemical method (except reagent strip or dipstick) for the following faecal constituentshaemoglobin, porphyrins, reducing substanceseach test, to a maximum of 3 tests taken on separate days Y 66218 01DEC1991 Qualitative estimation by any method except by reagent strip or dipstick of the following faecal constituentshaemoglobin, porphyrins, reducing substanceseach estimation, to a maximum of three estimations, taken on separate days Y 66219 01DEC1991 Immunological detection of human haemoglobin in faeces, including any additional services specified in items 66217 - 1 estimation in any 28 day period N 66219 01SEP1992 Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217 - 1 estimation in any 28 day period N 66219 01JUL1994 Identification of human haemoglobin in faeces, including a service (if performed) described in item 66217 - 1 test in a 28 - day period Y 66220 01DEC1991 Immunological detection of human haemoglobin in faeces, including any additional services specified in item 66217/66218 - one estimation in any twenty eight day period Y 66221 01NOV1994 Test for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces) by: (a)an immunological method; and (b)a chemical method (except reagent strip or dip-stick); each test, to a maximum of 3 tests taken on separate days in a 28 day period Y 66223 01DEC1991 Osmolality, estimation by osmometer, in serum or in urine1 or more estimations N 66223 01JUL1994 Osmolality, estimation by osmometer, in serum or in urine1 or more tests Y 66224 01DEC1991 Osmolality, estimation by osmometer, in serum or in urineone or more estimations Y 66225 01DEC1991 Quantitative estimation of blood gases including tests performed frompO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen1 or more estimations on 1 specimen N 66225 01JUL1994 Quantitation of: (a)blood gases (including pO2, oxygen saturation and pCO2; and (b)bicarbonate and pH; including any other measurement (eg., haemoglobin or potassium) or calculation performed on the same specimen1 or more tests on 1 specimen Y 66226 01DEC1991 Quantitative estimation of blood gases including tests performed frompO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimenone or more estimations on one specimen Y 66227 01DEC1991 Estimation of blood gases as specified in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day N 66227 01JUL1994 Quantitation of blood gases, bicarbonate and pH as described in item 66225 on each specimen in excess of 1 to a maximum of 6 specimens within any 1 day Y 66228 01DEC1991 Estimation of blood gases as specified in items 66225/66226 on each specimen in excess of 1 to a maximum of 6 specimens within any one day Y 66229 01DEC1991 Calculus, analysis of 1 or more N 66229 01JUL1994 Calculus, analysis of 1 or more Y 66230 01DEC1991 Calculus, analysis of one or more Y 66231 01DEC1991 Drug or chemical assaysincluding all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances1 or more assays N 66231 01NOV1993 Drug or chemical assaysincluding all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235, 66237 and 66239, but excluding the surveillance of sports people and athletes for performance improving substances or the monitoring of patients participating in a drug abuse treatment program N 66231 01JUL1994 All qualitative and quantitative tests on blood, urine or other body fluid for: (a)a drug or drugs of abuse (including illegal drugs and legally available drugs taken other than in appropriate dosage); or (b)ingested or absorbed toxic chemicals; including a service described in item 66235, 66237 or 66239 (if performed), but excluding: (c)the surveillance of sports people and athletes for performance improving substances; and (d)the monitoring of patients participating in a drug abuse treatment program Y 66232 01DEC1991 Drug or chemical assaysincluding all qualitative and quantitative tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 66235/66236, 66237/66238 and 66239/66240, but excluding the surveillance of sports people and athletes for performance improving substancesone or more assays. Y 66233 01DEC1991 Drug assaysincluding all qualitative and quantitative estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmeseach assay to a maximum of 4 assays within any 28 day period N 66233 01JUL1993 Drug assays including all qualitative and quantitative estimations on blood, urine or other body fluid for a drug, or drugs, of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment program, being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programs each assay to a maximum of 21 assays in any 12 month period Y 66234 01DEC1991 Drug assaysincluding all qualitative and quantitative estimations on blood, urine orother body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programmeseach assay to a maximum of four assays within any twenty eight day period Y 66235 01DEC1991 Drug assayquantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule1 estimation N 66235 01JUL1993 Drug assayquantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Schedule1 estimation (This fee applies where a laboratory performs the only drug assay specified on the request form or performs 1 assay and refers the rest to the laboratory of a separate APA) N 66235 01JUL1994 Quantitation, not elsewhere described in this Table by any method or methods, in blood or other body fluid, of a drug being used therapeutically by the patient from whom the specimen was taken - 1 test (This fee applies where a laboratory performs the only drug assay specified on the request form or performs 1 assay refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66236 01DEC1991 Drug assayquantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken and not elsewhere specified in the Scheduleone estimation Y 66237 01DEC1991 2 estimations specified in item 66235 N 66237 01JUL1993 2 estimations specified in item 66235 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the drug assays specified on the request form and refers the remainder to the laboratory of a separate APA.) N 66237 01JUL1994 2 tests described in item 66235 (This fee applies where 1 laboratory performs the only drug assay specified on the request form or performs 2 assay and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66238 01DEC1991 Two estimations specified in item 66235/66236 Y 66239 01DEC1991 3 or more estimations specified in item 66235 N 66239 01JUL1994 3 or more tests described in item 66235 Y 66240 01DEC1991 Three or more estimations specified in item 66235/66236 Y 66241 01SEP1992 Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3 - each estimation to a maximum of 2 estimations N 66241 01JUL1993 "Estimations specified in any of items 66235 to 66239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 3 - each estimation to a maximum of 2 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the drug assays specified on the request form.The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" N 66241 01JUL1994 "Tests described in any of items 66235 to 66237 (inclusive), if the number of tests relating to the same patient episode does not exceed 3 - each test to a maximum of 2 tests (Item is subject to Rule 6) (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the drug assays specified on the request form.The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" N 66241 01NOV1994 Tests described in item 66235, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 (Item is subject to Rule 6) N 66241 01NOV1995 Tests described in item 66235, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 2 tests (Item is subject to Rule 6) Y 66243 01DEC1991 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid1 or more examinations or estimations N 66243 01JUL1994 Amniotic fluid, spectrophotometric examination of, and quantitation of : (a)lecithin/sphingomyelin ratio; or (b)palmitic acid, phosphatidylglycerol or lamellar body phospholipid; 1 or more tests Y 66244 01DEC1991 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid, phosphatidylglycerol or lamellar body phospholipid - one or more examinations or estimations Y 66245 01DEC1991 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the cholesterol is >6.5 mmol/l and triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity1 examination to a maximum of 2 examinations in any 12 month period Y 66246 01DEC1991 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase or lipoprotein electrophoresis (only when the Cholesterol is >6.5 mmol/l and Triglyceride >3.0 mmol/l or in the diagnosis of types III and IV hyperlipidaemia), including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activityone examination to a maximum of two examinations in any twelve month period Y 66247 01DEC1991 Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a 28 day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin or of total rele'/ant enzyme activity - 2 or more examinations Y 66248 01DEC1991 Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a twenty eight day period, serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activitytwo or more examinations Y 66249 01JUL1994 Electrophoresis, quantitative or qualitative, of serum, urine or other body fluid to demonstrate: (a)protein classes; or (b)presence and amount of paraprotein; or (c)the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase; including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity Y 66250 01JUL1994 Electrophoresis, quantitation or qualitative, of serum, for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >3.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - each episode to a maximum of 2 episodes in a 12 month period Y 66251 01DEC1991 Alphafeto protein, Alpha1 antitrypsin, Alpha2 macroglobulin, beta2 microglobulin, C1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in items 66263), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphotase, Transferrin (unless specified in items 66263), and, in the follow up of proven malignancy, Mucinlike carcinoma associated antigen, CA125 antigen, CA19.9 antigen, CA15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specificenolase, Thyroglobulinquantitative estimation in serum, urine or other body fluid1 estimation Y 66252 01DEC1991 Alphafeto protein, Alpha1 antitrypsin, Alpha2 macroglobulin, beta2 microglobulin, C1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in items 66263/66264), Haptoglobins, Microalbumin (in proven diabetes mellitus), Prealbumin, Prostate Specific Antigen, Prostatic Acid Phosphotase, Transferrin (unless specified in items 66263/66264), and, in the follow up of proven malignancy, Mucinlike carcinoma associated antigen, CA125 antigen, CA19.9 antigen, CA15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, Thyroglobulinquantitative estimation in serum, urine or other body fluidone estimation Y 66253 01DEC1991 Two or more estimations specified in item 66251 Y 66254 01DEC1991 Two or more estimations specified in item 66251/66252 Y 66255 01SEP1992 Alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-2-macroglobulin, quantitative estimation in serum, urine or other body fluid - 1 or more estimations N 66255 01JUL1994 Alpha-1-acid glycoprotein, alpha-1-antitrypsin, or alpha-2-macroglobulin - quantitation in serum, urine or other body fluid - 1 or more tests Y 66257 01SEP1992 C-1 esterase inhibitor, quantitative estimation N 66257 01JUL1994 C-1 esterase inhibitor, quantitation Y 66258 01SEP1992 C-1 esterase inhibitor, functional assay Y 66259 01SEP1992 Alpha-fetoprotein, beta-2-microglobulin, caeruloplasmin, ferritin (except when part of item 66263), haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin, prostate specific antigen, prostatic acid phosphatase, transferrin (except when part of item 66263) - quantitative estimation in serum, urine or other body fluid - 1 estimation Y 66260 01SEP1992 2 or more estimations as specified in item 66259 Y 66261 01SEP1992 CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy, quantitative estimation - 1 estimation N 66261 01JUL1994 CA-125 antigen, CA-15.3 antigen, CA-19.9 antigen, carcinoembryonic antigen (CEA), mammary serum antigen, mucin-like carcinoma associated antigen (1 or more fractions), neuron-specific enolase, thyroglobulin in serum or other body fluid, in the monitoring or confirmation of malignancy - quantitation - 1 test Y 66262 01SEP1992 2 or more estimations specified in item 66261 N 66262 01JUL1994 2 or more tests described in item 66261 Y 66263 01DEC1991 Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin N 66263 01JUL1994 Iron studies consisting of quantitation of: (a)serum iron; (b)transferrin or iron binding capacity; and (c)ferritin Y 66264 01DEC1991 Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin Y 66265 01DEC1991 Serum B12, serum folate1 or more estimations within any 28 day period N 66265 01JUL1994 Serum B12 or serum folate1 or more tests within a 28 - day period Y 66266 01DEC1991 Serum B12, serum folateone or more estimations within any twenty eight day period Y 66267 01DEC1991 Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 estimations in any 12 month period N 66267 01JUL1994 Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 episodes in a 12 month period Y 66268 01DEC1991 Red cell folate and serum B12 add, if required, serum folate, to a maximum of three estimations in any twelve month period Y 66269 01DEC1991 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of vitamins A, B1, B2, B3, B6, C, and E1 or more estimations within any 6 month period N 66269 01JUL1994 Vitamins - quantitation of vitamins A, B1, B2, B3, B6, C, and E in blood, urine or other body fluid - 1 or more tests within a 6 month period Y 66270 01DEC1991 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and Eone or more estimations within any six month period Y 66271 01DEC1991 Vitamin D or D fractions1 or more estimations N 66271 01JUL1994 Vitamin D or D fractions1 or more tests Y 66272 01DEC1991 Vitamin D or D fractionsone or more estimations Y 66273 01DEC1991 Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (1 or more fractions), oxalate, pyruvate, serotonin, xylose, zinc1 quantitative estimation Y 66274 01DEC1991 Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (one or more fractions), oxalate, pyruvate, serotonin, xylose, zincone quantitative estimation Y 66275 01DEC1991 2 or more estimations specified in item 66273 Y 66276 01DEC1991 Two or more estimations specified in item 66273/66274 Y 66277 01DEC1991 Aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium, in blood, urine or other body fluid or tissue - 1 or more estimations in any 6 month period N 66277 01JUL1994 Quantitation of aluminium (except if item 66325 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, or strontium, in blood, urine or other body fluid or tissue - 1 or more tests in a 6 month period Y 66278 01DEC1991 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium - in blood, urine or other body fluid or tissue - one or more estimations within any six months Y 66279 01DEC1991 Blood lead estimation, other than for occupational health screening purposes, to a maximum of 3 estimations in any 6 month periodeach estimation N 66279 01JUL1994 Blood lead quantitation (other than for occupational health screening purposes) to a maximum of 3 tests in a 6 month periodeach test Y 66280 01DEC1991 Blood lead estimation, other than for occupational health screening purposes, to a maximum of three estimations in any six month periodeach estimation Y 66281 01DEC1991 Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA)quantitative including any qualitative estimations1 or more estimations N 66281 01JUL1994 Porphyrins (1 or more fractions), catecholamines (1 or more fractions), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), or phenylacetic acid (PAA)quantitation1 or more tests Y 66282 01DEC1991 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA)quantitative including any qualitative estimationsone or more estimations Y 66283 01DEC1991 Faecal fat, breath hydrogen measurements in response to loading with disaccharides1 or more quantitative estimations within any 28 day period N 66283 01JUL1994 Quantitation of: (a)faecal fat; or (b)breath hydrogen in response to loading with disaccharides; 1 or more tests within a 28 day period Y 66284 01DEC1991 Faecal Fat, Breath Hydrogen measurements in response to loading with disaccharidesone or more quantitative estimations within any twenty eight day period Y 66285 01DEC1991 Solid tissue or tissues excluding blood elementsassay of 1 or 2 enzymes N 66285 01JUL1994 Enzymes - quantitation of 1 or 2 in solid tissue or tissues other than blood elements Y 66286 01DEC1991 Solid tissue or tissues excluding blood elementsassay of one or two enzymes Y 66287 01DEC1991 Assay of 3 to 5 enzymes specified in item 66285 N 66287 01JUL1994 Quantitation of 3 to 5 enzymes as described in item 66285 Y 66288 01DEC1991 Assay of three to five enzymes as specified in item 66285/66286 Y 66289 01DEC1991 Assay of 6 or more enzymes specified in item 66285 N 66289 01JUL1994 Quantitation of 6 or more enzymes as described in item 66285 Y 66290 01DEC1991 Assay of six or more enzymes as specified in item 66285/66286 Y 66291 01DEC1991 Thyroid function tests, including thyrotrophin (TSH) and at least 1 or more of the following testsfree thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin N 66291 01JUL1994 Thyroid function tests, including thyrotrophin (TSH) and 1 or more of the following testsfree thyroxine index, free thyroxine, free T3, total T3, thyroxine-binding globulin Y 66292 01DEC1991 Thyroid function tests, including thyrotrophin (TSH) and at least one or more of the following testsfree thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin Y 66293 01DEC1991 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones N 66293 01JUL1994 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and quantitation of hormones Y 66294 01DEC1991 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones Y 66295 01DEC1991 Growth hormone suppression by glucose loading, growth hormone stimulation by exercise, dexamethasone suppression test, Ldopa stimulation of growth hormone, where physically performed by a recognised pathologist1 or more procedures N 66295 01JUL1994 Personal performance by a recognised pathologist of 1 or more of the following: (a)growth hormone suppression by glucose loading; (b)growth hormone stimulation by exercise; (c)dexamethasone suppression test; (d)Ldopa stimulation of growth hormone Y 66296 01DEC1991 Growth hormone suppression by glucose loading, Growth hormone stimulation by exercise, Dexamethasone suppression test, LDopa stimulation of growth hormone, where physically performed by a recognised pathologistone or more procedures Y 66297 01DEC1991 Gonadotrophin releasing hormone stimulation test, synacthen stimulation test, glucagon stimulation test with Cpeptide measurement, pentagastrin stimulation of thyrocalcitonin release, secretin stimulation of gastrin release, insulin hypoglycaemia, arginine infusion, where physically performed by a recognised pathologist1 procedure N 66297 01JUL1994 Personal performance by a recognised pathologist of 1 of the following: (a)gonadotrophin releasing hormone stimulation test; (b)synacthen stimulation test; (c)glucagon stimulation test with Cpeptide measurement; (d)pentagastrin stimulation of thyrocalcitonin release; (e)secretin stimulation of gastrin release; (f)insulin hypoglycaemia; (g)arginine infusion Y 66298 01DEC1991 Gonadotrophin releasing stimulation test, Synacthen stimulation test, Glucagon stimulation test with Cpeptide measurement, Pentagastrin stimulation of thyrocalcitonin release, Secretin stimulation of gastrin release, Insulin hypoglycaemia, Arginine infusion, where physically performed by a recognised pathologistone procedure Y 66299 01DEC1991 2 or more tests specified in item 66297 N 66299 01JUL1994 Personal performance by a recognised pathologist of 2 or more tests described in item 66297 Y 66300 01DEC1991 Two or more procedures specified in item 66297/66298 Y 66301 01DEC1991 Hormones and hormone binding proteins, quantitative estimation by any method ofACTH, aldosterone, androstenedione, Cpeptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, human placental lactogen, hydroxyprogesterone, insulin, LH, oestradiol, oestriol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, TSH (where not requested as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (anti diuretic hormone)1 estimation N 66301 01JUL1993 Hormones and hormone binding proteins, quantitative estimation by any method ofACTH, aldosterone, androstenedione, Cpeptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, human placental lactogen, hydroxyprogesterone, insulin, LH, oestradiol, oestriol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, TSH (where not requested as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone)1 estimation (This fee applies where a laboratory performs the only hormone estimation specified on the request form or performs 1 estimation and refers the rest to the laboratory of a separate APA) Y 66302 01DEC1991 Hormones and hormone binding proteins, quantitative estimation by any method ofACTH, Aldosterone, Androstenedione, Cpeptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth hormone, Human Placental Lactogen, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti diuretic hormone)one estimation Y 66303 01DEC1991 2 estimations specified in item 66301 N 66303 01JUL1993 2 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the hormone estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66304 01DEC1991 Two estimations specified in item 66301/66302 Y 66305 01DEC1991 3 estimations specified in item 66301 N 66305 01JUL1993 3 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the hormone estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66306 01DEC1991 Three estimations specified in item 66301/66302 Y 66307 01DEC1991 4 estimations specified in item 66301 N 66307 01JUL1993 4 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the hormone estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66308 01DEC1991 Four estimations specified in item 66301/66302 Y 66309 01DEC1991 5 estimations specified in item 66301 N 66309 01JUL1993 5 estimations specified in item 66301 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the hormone estimations specified on the request form refers the remainder to the laboratory of a separate APA.) Y 66310 01DEC1991 Five estimations specified in item 66301/66302 Y 66311 01DEC1991 6 or more estimations specified in item 66301 Y 66312 01DEC1991 Six or more estimations specified in item 66301/66302 Y 66313 01SEP1992 Estimations specified in any of items 66301 to 66311 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations N 66313 01JUL1993 "Estimations specified in any of items 66301 to 66311 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the hormone estimations specified on the request form.The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" Y 66315 01DEC1991 Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast1 or more assays N 66315 01JUL1994 Quantitation of hormone receptors on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast1 or more tests Y 66316 01DEC1991 Hormone receptor assay on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breastone or more assays Y 66317 01DEC1991 HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level > 2.0 mmol/1each estimation to a maximum of 4 estimations in any 12 month period N 66317 01NOV1993 HDL cholesterol or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugs or with a fasting serum triglyceride level > 2.0 mmol/1each episode to a maximum of 4 episodes in any 12 month period N 66317 01JUL1994 Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a)has a serum cholesterol level >5.5mmol/l; or (b)is on prescribed lipid lowering drugs; or (c)has a fasting serum triglyceride level > 2.0 mmol/1; each episode to a maximum of 4 episodes in a 12 - month period N 66317 01NOV1994 Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a)has a serum cholesterol level >5.5mmol/L; or (b)has a fasting serum triglyceride level > 2.0 mmol/L; or (c)is on a lipid lowering drug prescribed by a medical practitioner; each episode to a maximum of 4 episodes in a 12 month period (Item is subject to rule 9) Y 66318 01DEC1991 HDL cholesterol, or apolipoprotein B/A1 ratio, estimation of, in patients with serum cholesterol >5.5mmol/l or those on prescribed lipid lowering drugseach estimation to a maximum of four estimations in any twelve month period Y 66319 01DEC1991 Glycosylated haemoglobin only when performed in the management of established diabeteseach estimation to a maximum of 4 estimations in any 12 month period N 66319 01JUL1994 Quantitation of glycosylated haemoglobin performed in the management of established diabeteseach test to a maximum of 4 tests in a 12 month period Y 66320 01DEC1991 Glycosylated haemoglobin only when performed in the management of established diabeteseach estimation to a maximum of four estimations in any twelve month period Y 66321 01MAR1992 Quantitative estimation in the 2nd trimester of pregnancy of alpha-fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66353, 66373, 73527 or 73529 - 1 patient episode in that pregnancy N 66321 01NOV1993 Quantitative estimation in the 2nd trimester of pregnancy of alpha-fetoprotein, human chorionic gonadotrophin and oestriol and any other substance to detect foetal abnormality, including any service specified in 1 or more of items 66353, 66373, 73527 or 73529 - 1 patient episode in that pregnancy N 66321 01JUL1994 Quantitation in the 2nd trimester of pregnancy, of alpha-fetoprotein, human chorionic gonadotrophin, oestriol and any other substance to detect foetal abnormality, including a service described in 1 or more of items 66353, 66373, 73527 and 73529 (if performed) - 1 patient episode in a pregnancy Y 66322 20MAR1997 Quantitation of glycosylated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - each test to a maximum of 6 tests in a 12 month period which includes the whole pregnancy, including a service in item 66319 (if performed) Y 66323 01SEP1992 Estimation of tryptic activity in faeces for the investigation of diarrhoea of greater than 4 weeks duration in children less than 6 years of age N 66323 01JUL1994 Test for tryptic activity in faeces in the investigation of diarrhoea of longer than 4 weeks duration in children under 6 years old Y 66325 01SEP1992 Estimation of serum aluminium in a patient in a renal dialysis program - each estimation N 66325 01JUL1994 Quantitation of serum aluminium in a patient in a renal dialysis program - each test Y 66327 01NOV1994 TSH - quantitation, requested as a preliminary test to thyroid function testing N 66327 20MAR1997 TSH quantitation Y 66329 01NOV1994 Thyroid function tests (comprising the service described in item 66327 and 1 or more of the following tests - estimation of free thyroxine index, free thryoxine, free T3, total T3, thyroxine binding globulin) in respect of a patient, if at least one of the following conditions is satisfied: (a)the patient has an abnormal level of TSH; (b)the test are performed for the purpose of: (i)monitoring thyroid disease in the patient; or (ii)if the patient is in a hospital - investigating thyroid function in the patient; or (iii)investigating dementia or psychiatric illness of the patient; or (iv)investigating amenorrhoea or infertility of the patient (c)the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d)the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 7B) N 66329 01NOV1995 Thyroid function tests (comprising the service described in item 66327 and 1 or more of the following tests - estimation of free thyroxine index, free thryoxine, free T3, total T3, thyroxine binding globulin) in respect of a patient, if at least one of the following conditions is satisfied: (a)the patient has an abnormal level of TSH; (b)the tests are performed for the purpose of: (i)monitoring thyroid disease in the patient; or (ii)if the patient is an admitted patient -investigating the sick euthyroid syndrome; or (iii)investigating dementia or psychiatric illness of the patient; or (iv)investigating amenorrhoea or infertility of the patient (c)the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d)the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 10) Y 66331 01JUL1993 Quantitative estimation in serum, plasma, urine or other body fluid of cholesterol or triglycerides or both, except by reagent strip with or without reflectance meter or electrophoresis N 66331 01JUL1994 Quantitation (except by reagent strip with or without reflectance meter or electrophoresis) of cholesterol or triglycerides or both in serum, plasma, urine or other body fluid Y 66335 01JUL1993 Services specified in item 66331 and 1 estimation specified in item 66201 N 66335 01JUL1994 A service described in item 66331 and 1 test described in item 66201 Y 66337 01JUL1993 Services specified in item 66331 and 2 estimations specified in item 66201 N 66337 01JUL1994 A service described in item 66331 and 2 tests described in item 66201 Y 66339 01JUL1993 Services specified in item 66331 and 3 estimations specified in item 66201 N 66339 01JUL1994 A service described in item 66331 and 3 tests described in item 66201 Y 66341 01JUL1993 Services specified in item 66331 and 4 or more estimations specified in item 66201 N 66341 01JUL1994 A service described in item 66331 and 4 or more tests described in item 66201 Y 66343 01JUL1993 Drug assaysincluding all qualitative and quantitative estimations on blood, urine or other body fluid for a drug, or drugs, of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment program, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programseach assay to a maximum of 21 assays in any 12 month period N 66343 01JUL1994 Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient: (a)participating in a drug abuse treatment program; or (b)being treated for drug effects; including all tests on blood, urine or other body fluid - each episode, to a maximum of 21 episodes in a 12 month period Y 66353 01NOV1993 Alpha-fetoprotein (where not requested as part of item 66321) - quantitative estimation in serum or other body fluids N 66353 01JUL1994 Quantitation in serum or other body fluids of alpha fetoprotein, except if requested as part of item 66321 Y 66355 01NOV1993 Ferritin (where not requested as part of iron studies) - quantitative estimation N 66355 01JUL1994 Ferritin - quantitation, except if requested as part of iron studies Y 66357 01NOV1993 Prostate specific antigen, prostatic acid phosphatase, in the monitoring or confirmation of malignancy - quantitative estimation - 1 estimation N 66357 01JUL1994 Prostate specific antigen or prostatic acid phosphatase - quantitation in the confirmation or monitoring of malignancy - 1 test Y 66359 01NOV1993 2 estimations specified in item 66357 N 66359 01JUL1994 2 tests described in item 66357 Y 66361 01NOV1993 Beta-2-microglobulin, caeruloplasmin, haptoglobulins, microalbumin in proven diabetes mellitus, prealbumin - quantitative estimation in serum, urine or other body fluids - 1 estimation N 66361 01JUL1994 Beta-2-microglobulin, caeruloplasmin, haptoglobins, microalbumin in proven diabetes mellitus, or prealbumin - quantitation in serum, urine or other body fluids - 1 test Y 66363 01NOV1993 2 or more estimations specified in item 66361 N 66363 01JUL1994 2 or more tests described in item 66361 Y 66365 01NOV1993 Neonatal bilirubin (1 or more fractions) - quantitative estimation N 66365 01JUL1994 Neonatal bilirubin (1 or more fractions) - quantitation Y 66367 01NOV1993 Acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, oxalate, pyruvate, serotonin, xylose, zinc - 1 quantitative estimation N 66367 01JUL1994 Quantitation of acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, oxalate, pyruvate, serotonin, xylose, or zinc - 1 test N 66367 01NOV1996 Quantitation of acetoacetate, alcohol, amino acids, ammonia, angiotensin converting enzyme, beta-hydroxybutyrate, cholinesterase, cysteine, total free fatty acids, histamine, hydroxyindoleacetic acid, hydroxyproline (except if performed as part of item 66425 or 66426), lactate, oxalate, pyruvate, serotonin, xylose, or zinc - 1 test Y 66369 01NOV1993 2 or more estimations specified in item 66367 N 66369 01JUL1994 2 or more tests described in item 66367 Y 66371 01NOV1993 TSH (where not requested as part of thyroid function test or in association with other hormones or hormone binding proteins specified in item 66377) - quantitative estimation N 66371 01JUL1994 TSH - quantitation, except if requested as part of thyroid function test or in association with other hormones or hormone binding proteins described in item 66405 Y 66373 01NOV1993 Human placental lactogen, oestriol (where not requested as part of item 66321 - quantitative estimation by any method - 1 estimation N 66373 01JUL1994 Human placental lactogen or oestriol - quantitation, except if requested as part of item 66321 - 1 test Y 66375 01NOV1993 2 estimations specified in item 66373 N 66375 01JUL1994 2 tests described in item 66373 Y 66377 01NOV1993 Hormones and hormone binding proteins, quantitative estimation by any method of - androstenedione, DHEAS, dihydrotestosterone, FSH, hydroxyprogesterone, LH, oestradiol, oestrone, progesterone, prolactin, sex hormone binding globulin, free or total testosterone, TSH (where it is not requested on its own or as part of a thyroid function test) - 1 estimation Y 66379 01NOV1993 2 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66381 01NOV1993 3 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66383 01NOV1993 4 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66385 01NOV1993 5 estimations specified in item 66377 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66387 01NOV1993 6 or more estimations specified in item 66377 Y 66389 01NOV1993 "Estimations specified in any of items 66377 to 66387 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" Y 66391 01NOV1993 Hormones and hormone binding proteins, quantitative estimation by any method of - ACTH, aldosterone, C-peptide, calcitonin, cortisol, cyclic AMP, 11-deoxycortisol, gastrin, glucagon, growth hormone, insulin, PTH, renin, somatomedin C(IgF1), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (anti-diuretic hormone) - 1 estimation Y 66393 01NOV1993 2 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66395 01NOV1993 3 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66397 01NOV1993 4 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66399 01NOV1993 5 estimations specified in item 66391 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the tests specified on the request form and refers the remainder to the laboratory of a separate APA.) Y 66401 01NOV1993 6 or more estimations specified in item 66391 Y 66403 01NOV1993 "Estimations specified in any of items 66391 to 66401 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" Y 66405 01JUL1994 Quantitation of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(1gF1), free or total testosterone, TSH (where not requested on its own or as part of a thyroid function test), urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test (This fee applies where a laboratory performs the only hormone test specified on the request form or performs 1 test and refers the rest to a laboratory of a separate APA) (Item is subject to rule 6) N 66405 20MAR1997 Quantitation of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IgF1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test Y 66407 01JUL1994 2 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 2 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 66409 01JUL1994 3 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 3 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 66411 01JUL1994 4 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 4 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 66413 01JUL1994 5 tests described in item 66405 (This fee applies where 1 laboratory belonging to the same APA, performs 5 of the hormone tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 66415 01JUL1994 6 or more tests described in item 66405 Y 66417 01JUL1994 "Tests described in any of items 66405 to 66413 (inclusive), if the number of tests relating to the same patient episode does not exceed 6 - each test to a maximum of 5 tests (Item subject to Rule 6) (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the hormone tests specified on the request form. The PEI applicable to this item is 73921, the ""Specimen Referred Fee"")." N 66417 01NOV1994 Tests described in item 66405, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 (Item subject to Rule 6) N 66417 01NOV1995 Tests described in item 66405, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to Rule 6) Y 66419 01NOV1994 Oral glucose test that includes the following: (a)administration of glucose; (b)at least 3 estimations of blood glucose; (c)1 or more of the tests (other than those described in paragraph (a) or (b) described in item 66405 N 66419 01JUL1995 Oral glucose test for the diagnosis of diabetes mellitus that includes the following: (a)administration of glucose; (b)at least 3 estimations of blood glucose; (c)if performed, any test described in item 66405 Y 66421 01NOV1995 Tests for reducing substances in faeces by any method (except reagent strip or dipstick) Y 66422 01JUL1996 Examination for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces) by: (a)an immunological method; and (b)a chemical method (except reagent strip or dip stick); with a maximum of 3 examinations on specimens collected on separate days in a 28 day period - 1 examination by both methods Y 66423 01JUL1996 2 examinations by both methods described in item 66422 performed on separately collected and identified specimens Y 66424 01JUL1996 3 examinations by both methods described in item 66422 performed on separately collected and identified specimens Y 66425 01NOV1996 Quantitation of products of collagen breakdown for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66367 - 1 or more tests (Low bone densitometry is defined in paragraph D1.14 of explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule) Y 66426 01NOV1996 Quantitation of products of collagen breakdown for the monitoring of patients with metabolic bone disease, and if performed, a service described in item 66367 - 1 or more tests Y 66427 20MAR1997 TSH quantitation described in item 66327 and 1 test described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66428 20MAR1997 TSH quantitation described in item 66327 and 2 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 3 tests specified on the request form or performs 3 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66429 20MAR1997 TSH quantitation described in item 66327 and 3 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 tests specified on the request form or performs 4 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66430 20MAR1997 TSH quantitation described in item 66327 and 4 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 tests specified on the request form or performs 5 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66431 20MAR1997 TSH quantitation described in item 66327 and 5 tests described in item 66405 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 6 or more tests specified on the request form) (Item is subject to rule 6) Y 66432 20MAR1997 Tests described in items 66327 and 66405, if rendered under a request mentioned in subparagraph (2)(a)(iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to Rule 6) Y 66435 01JUL1998 Detection of the C282Y genetic mutation for haemochromatosis where: a)the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or b)the patient has a first degree relative with haemochromatosis or with homozygosity for the C282Y genetic mutation. Not exceeding 1 episode in a 3 year period. Y 66500 01NOV1998 Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter or electrophoresis) of: acetoacetate, acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, beta-hydroxybutyrate, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, pyruvate, sodium, total protein, total cholesterol, triglycerides, urate or urea1 test N 66500 01NOV2001 Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter or electrophoresis) of: acetoacetate, acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, beta-hydroxybutyrate, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, pyruvate, sodium, total protein, total cholesterol, triglycerides, urate or urea - 1 test N 66500 01MAY2002 Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter) of: acetoacetate, acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, beta-hydroxybutyrate, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, pyruvate, sodium, total protein, total cholesterol, triglycerides, urate or urea - 1 test N 66500 01NOV2008 Quantitation in serum, plasma, urine or other body fluid (except amniotic fluid), by any method except reagent tablet or reagent strip (with or without reflectance meter) of: acid phosphatase, alanine aminotransferase, albumin, alkaline phosphatase, ammonia, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total), bilirubin (any fractions), C-reactive protein, calcium (total or corrected for albumin), chloride, creatine kinase, creatinine, gamma glutamyl transferase, globulin, glucose, lactate dehydrogenase, lipase, magnesium, phosphate, potassium, sodium, total protein, total cholesterol, triglycerides, urate or urea - 1 test Y 66503 01NOV1998 2 tests described in item 66500 Y 66506 01NOV1998 3 tests described in item 66500 Y 66509 01NOV1998 4 tests described in item 66500 Y 66512 01NOV1998 5 tests described in item 66500 N 66512 01JUL2008 5 or more tests described in item 66500 Y 66515 01NOV1998 6 or more tests described in item 66500 Y 66517 01NOV2007 Quantitation of bile acids in blood in pregnancy.To a maximum of 3 tests in a pregnancy. Y 66518 01NOV1998 Investigation of cardiac or skeletal muscle damage by measurement of creatine kinase isoenzymes (by any method), troponin or myoglobin in plasma or serum - 1 or more tests in a 24 hour period N 66518 01NOV2001 Investigation of cardiac or skeletal muscle damage by measurement of creatine kinase isoenzymes (by any method), troponin or myoglobin in plasma or serum - testing on 1 specimen in a 24 hour period N 66518 01NOV2004 Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in plasma or serum - testing on 1 specimen in a 24 hour period N 66518 01MAY2005 Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in blood - testing on 1 specimen in a 24 hour period Y 66519 01NOV2001 Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in plasma or serum - testing on 2 or more specimens in a 24 hour period N 66519 01NOV2004 Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in plasma or serum - testing on 2 or more specimens in a 24 hour period N 66519 01MAY2005 Investigation of cardiac or skeletal muscle damage by quantitative measurement of creatine kinase isoenzymes, troponin or myoglobin in blood - testing on 2 or more specimens in a 24 hour period Y 66521 01NOV1998 Quantitation (except by reagent strip with or without reflectance meter or electrophoresis) of cholesterol or triglycerides or both in serum, plasma, urine or other body fluid Y 66524 01NOV1998 A service described in item 66521 and 1 test described in item 66500 Y 66527 01NOV1998 A service described in item 66521 and 2 tests described in item 66500 Y 66530 01NOV1998 A service described in item 66521 and 3 tests described in item 66500 Y 66533 01NOV1998 A service described in item 66521 and 4 or more tests described in item 66500 Y 66536 01NOV1998 Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a)has a serum cholesterol level >5.5mmol/L; or (b)has a fasting serum triglyceride level > 2.0 mmol/L; or (c)is on a lipid lowering drug prescribed by a medical practitioner; each episode to a maximum of 4 episodes in a 12 month period (Item is subject to rule 9) N 66536 01NOV2000 Quantitation of HDL cholesterol or apolipoprotein B/A1 ratio in a patient who: (a)has a serum cholesterol level >5.5mmol/L; or (b)has a fasting serum triglyceride level > 2.0 mmol/L; or (c)is on a lipid lowering drug prescribed by a medical practitioner; or (d)has a serum cholesterol level >4.0 mmol/L and has a history of ischaemic heart disease; each episode to a maximum of 4 episodes in a 12 month period (Item is subject to rule 9) N 66536 01NOV2001 Quantitation of HDL cholesterol Y 66539 01NOV1998 Electrophoresis of serum for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - each episode to a maximum of 2 episodes in a 12 month period N 66539 01MAY2005 Electrophoresis of serum for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - 1 of this item to a maximum of 2 in a 12 month period N 66539 01MAY2007 Electrophoresis of serum for demonstration of lipoprotein subclasses, if the cholesterol is >6.5 mmol/L and triglyceride >4.0 mmol/L or in the diagnosis of types III and IV hyperlipidaemia - (Item is subject to rule 25) Y 66542 01NOV1998 Oral glucose tolerence test for the diagnosis of diabetes mellitus that includes the following: (a)administration of glucose; (b)at least 3 estimations of blood glucose; and if performed (c)any test described in item 66695 N 66542 01MAY2000 Oral glucose tolerance test for the diagnosis of diabetes mellitus that includes: (a)administration of glucose; and (b)at least 2 measurements of blood glucose; and (c)(if performed) any test described in item 66695 Y 66545 01NOV1998 Oral glucose challenge test in pregnancy for the detection of gestational diabetes that includes: (a)administration of glucose; (b)1 or 2 measurements of blood glucose; and (c)any test in item 66695 (if performed) 1 patient episode in a pregnancy N 66545 01NOV1999 Oral glucose challenge test in pregnancy for the detection of gestational diabetes that includes: (a)administration of glucose; and (b)1 or 2 measurements of blood glucose; and (c)(if performed) any test in item 66695 Y 66548 01NOV1998 Oral glucose tolerance test in pregnancy for the diagnosis of gestational diabetes that includes: (a)administration of glucose; (b)at least 3 measurements of blood glucose; and (c)any test in item 66695 (if performed) 1 patient episode in a pregnancy N 66548 01NOV1999 Oral glucose tolerance test in pregnancy for the diagnosis of gestational diabetes that includes: (a)administration of glucose; and (b)at least 3 measurements of blood glucose; and (c)(if performed) any test in item 66695 N 66548 01NOV2001 Oral glucose tolerance test in pregnancy for the diagnosis of gestational diabetes that includes: (a)administration of glucose; and (b)at least 3 measurements of blood glucose; and (c)any test in item 66695 (if performed) Y 66551 01NOV1998 Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximumof 4 tests in a 12 month period N 66551 01MAY2007 Quantitation of glycosylated haemoglobin performed in the management of established diabetes - (Item is subject to rule 25) N 66551 01NOV2014 Quantitation of glycated haemoglobin performed in the management of established diabetes - (Item is subject to rule 25) Y 66554 01NOV1998 Quantitation of glycosylated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - each test to a maximum of 6 tests in a 12 month period which includes the whole pregnancy, including a service in item 66551 (if performed) N 66554 01MAY2007 Quantitation of glycosylated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - including a service in item 66551 (if performed) (Item is subject to rule 25) N 66554 01NOV2014 Quantitation of glycated haemoglobin performed in the management of pre-existing diabetes where the patient is pregnant - including a service in item 66551 (if performed) - (Item is subject to rule 25) Y 66557 01NOV1998 Quantitation of fructosamine performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period Y 66560 01NOV1998 Microalbumin in proven diabetes mellitus quantitation in urine1 or more tests N 66560 01NOV2000 Microalbumin - quantitation in urine Y 66563 01NOV1998 Osmolality, estimation by osmometer, in serum or in urine - 1 or more tests Y 66566 01NOV1998 Quantitation of: (a)blood gases (including pO2, oxygen saturation and pCO2) ; and (b)bicarbonate and pH; including any other measurement (eg. haemoglobin, potassium or ionised calcium) or calculation performed on the same specimen - 1 or more tests on 1 specimen N 66566 01NOV2008 Quantitation of: (a)blood gases (including pO2, oxygen saturation and pCO2) ; and (b)bicarbonate and pH; including any other measurement (eg. haemoglobin, lactate, potassium or ionised calcium) or calculation performed on the same specimen - 1 or more tests on 1 specimen Y 66569 01NOV1998 Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 2 specimens performed within any 1 day Y 66572 01NOV1998 Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 3 specimens performed within any 1 day Y 66575 01NOV1998 Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 4 specimens performed within any 1 day Y 66578 01NOV1998 Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 5 specimens performed within any 1 day Y 66581 01NOV1998 Quantitation of blood gases, bicarbonate and pH as described in item 66566 on 6 or more specimens performed within any 1 day Y 66584 01NOV1998 Quantitation of ionised calcium (except if performed as part of item 66566) - 1 test Y 66587 01NOV1998 Urine acidification test for the diagnosis of renal tubular acidosis including the administration of an acid load, and pH measurements on 4 or more urine specimens and at least 1 blood specimen Y 66590 01NOV1998 Calculus, analysis of 1 or more Y 66593 01NOV1998 Ferritin - quantitation, except if requested as part of iron studies Y 66596 01NOV1998 Iron studies, consisting of quantitation of: (a)serum iron; and (b)transferrin or iron binding capacity; and (c)ferritin Y 66599 01NOV1998 Serum B12 or red cell folate and, if required, serum folate (Item is subject to rule 23) N 66599 01MAR1999 Serum B12 or red cell folate and, if required, serum folate (Item is subject to Rule 21) Y 66602 01NOV1998 Red cell folate and serum B12 and, if required, serum folate, to a maximum of 3 episodes in a 12 month period N 66602 01MAR1999 Serum B12 and red cell folate and, if required, serum folate (Item is subject to rule 21) Y 66605 01NOV1998 Vitamins - quantitation of vitamins A, B1, B2, B3, B6, C and E in blood, urine or other body fluid - 1 or more tests withina6 month period N 66605 01MAY2009 Vitamins - quantitation of vitamins B1, B2, B3, B6 and Cin blood, urine or other body fluid - 1 or more tests withina6 month period N 66605 01JUL2011 Vitamins - quantitation of vitamins B1, B2, B3, B6 or Cin blood, urine or other body fluid - 1 or more tests Y 66606 01MAY2007 A test described in item 66605 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18 and 25) Y 66607 01MAY2009 Vitamins - quantitation of vitamins A and E in blood, urine or other body fluid - 1 or more tests within a 6 month period N 66607 01JUL2011 Vitamins - quantitation of vitamins A or E in blood, urine or other body fluid - 1 or more tests within a 6 month period Y 66608 01NOV1998 Vitamin D or D fractions - 1 or more tests Y 66609 01MAY2007 A test described in item 66608 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66610 01JUL2011 A test described in item 66607 if rendered by a receiving APP - 1 or more tests Y 66611 01NOV1998 Quantitation, not elsewhere described in this Table by any method or methods, in blood or other body fluid, of a drug being used therapeutically by the patient from whom the specimen was taken - 1 test (This fee applies where 1 laboratory performs the only test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66614 01NOV1998 2 tests described in item 66611 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66617 01NOV1998 3 or more tests described in item 66611 (Item is subject to rule 6) Y 66620 01NOV1998 Tests described in item 66611, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 2 tests (Item is subject to rule 6) Y 66623 01NOV1998 All qualitative and quantitative tests on blood, urine or other body fluid for: (a)a drug or drugs of abuse (including illegal drugs and legally available drugs taken other than in appropriate dosage); or (b)ingested or absorbed toxic chemicals; including a service described in item 66611, 66614 or 66617 (if performed), but excluding: (c)the surveillance of sports people and athletes for performance improving substances; and (d)the monitoring of patients participating in a drug abuse treatment program N 66623 01NOV2003 All qualitative and quantitative tests on blood, urine or other body fluid for: (a)a drug or drugs of abuse (including illegal drugs and legally available drugs taken other than in appropriate dosage); or (b)ingested or absorbed toxic chemicals; including a service described in item 66800, 66803, 66806, 66812 or 66815 (if performed), but excluding: (c)the surveillance of sports people and athletes for performance improving substances; and (d)the monitoring of patients participating in a drug abuse treatment program Y 66626 01NOV1998 Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient: (a)participating in a drug abuse treatment program; or (b)being monitored for drug effects; but excluding (c)the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid - each episode, to a maximum of 21 episodes in a 12 month period N 66626 01MAY2002 Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program; but excluding the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid - each episode, to a maximum of 36 episodes in a 12 month period N 66626 01MAY2005 Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program; but excluding the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid N 66626 01MAY2007 Detection or quantitation or both (not including the detection of nicotine and metabolites in smoking withdrawal programs) of a drug, or drugs, of abuse or a therapeutic drug, on a sample collected from a patient participating in a drug abuse treatment program; but excluding the surveillance of sports people and athletes for performance improving substances; including all tests on blood, urine or other body fluid (Item is subject to rule 25) Y 66629 01NOV1998 Beta-2-microglobulin - quantitation in serum, urine or other body fluids - 1 or more tests Y 66632 01NOV1998 Caeruloplasmin, haptoglobins, or prealbumin - quantitation in serum, urine or other body fluids - 1 or more tests Y 66635 01NOV1998 Alpha-1-antitrypsin - quantitation in serum, urine or other body fluid - 1 or more tests Y 66638 01NOV1998 Isoelectric focussing or similar methods for determination of alpha-1-antitrypsin phenotype in serum - 1 or more tests Y 66639 01MAY2007 A test described in item 66638 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66641 01NOV1998 Electrophoresis of serum or other body fluid to demonstrate: (a)the isoenzymes of lactate dehydrogenase; or (b)the isoenzymes of alkaline phosphatase; including the preliminary quantitation of total relevant enzyme activity - 1 or more tests Y 66642 01MAY2007 A test described in item 66641 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66644 01NOV1998 C-1 esterase inhibitor - quantitation Y 66647 01NOV1998 C-1 esterase inhibitor - functional assay Y 66650 01NOV1998 Alphafetoprotein, CA15.3 antigen (CA15.3), CA125 antigen (CA125), CA19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancyquantitation1 test N 66650 01NOV1999 Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of gestational trophoblastic disease - quantitation - 1 test N 66650 01MAY2003 Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour - quantitation - 1 test N 66650 01MAY2007 Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), mammary serum antigen (MSA), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour - quantitation - 1 test (Item is subject to rule 6) N 66650 01NOV2008 Alpha-fetoprotein, CA-15.3 antigen (CA15.3), CA-125 antigen (CA125), CA-19.9 antigen (CA19.9), cancer associated serum antigen (CASA), carcinoembryonic antigen (CEA), human chorionic gonadotrophin (HCG), neuron specific enolase (NSE), thyroglobulin in serum or other body fluid, in the monitoring of malignancy or in the detection or monitoring of hepatic tumours, gestational trophoblastic disease or germ cell tumour - quantitation - 1 test (Item is subject to rule 6) Y 66651 01MAY2007 A test described in item 66650 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 66652 01MAY2007 A test described in item 66650 if rendered by a receiving APP - other than that described in 66651, if rendered by a receiving APP, 1 test (Item is subject to rule 6 and 18) Y 66653 01NOV1998 2 or more tests described in item 66650 N 66653 01MAY2007 2 or more tests described in item 66650 (Item is subject to rule 6) Y 66655 01MAY2001 Prostate specific antigen - quantitation in the assessment of clinically suspected prostatic disease - 1 patient episode in a 12 month period N 66655 01MAY2002 Prostate specific antigen - quantitation - 1 patient episode in a 12 month period N 66655 01MAY2005 Prostate specific antigen - quantitation - 1 of this item in a 12 month period N 66655 01MAY2007 Prostate specific antigen - quantitation - 1 of this item in a 12 month period (Item is subject to rule 25) Y 66656 01NOV1998 Prostate specific antigen or prostate acid phosphatase - quantitation in the confirmation or monitoring of malignancy - 1 test N 66656 01MAY2001 Prostate specific antigen - quantitation in the monitoring of previously diagnosed prostatic disease (including a test described in item 66655) - each patient episode to a maximum of 4 patient episodes in a 12 month period N 66656 01NOV2002 Prostate specific antigen - quantitation in the monitoring of previously diagnosed prostatic disease (including a test described in item 66655) Y 66659 01NOV1998 2 tests described in item 66656 N 66659 01MAY2001 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies in the equivocal range of the particular method of assay used to determine the level - 1 patient episode in a 12 month period N 66659 01MAY2005 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies in the equivocal range of the particular method of assay used to determine the level - 1 of this item in a 12 month period N 66659 01MAY2007 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies in the equivocal range of the particular method of assay used to determine the level - 1 of this item in a 12 month period (Item is subject to rule 25) N 66659 01MAY2009 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the followup of a PSA result which lies above the age related median but below the age related, method specific 97.5% reference limit - 1 of this item in a 12 month period (Item is subject to rule 25) N 66659 01JUL2009 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the follow up of a PSA result that lies at or above the age related median but below the age related, method specific 97.5% reference limit - 1 of this item in a 12 month period (Item is subject to rule 25) Y 66660 01MAY2009 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the follow up of a PSA result which lies above the age related, method specific 97.5% reference limit, but below a value of 10 ug/L - 4 of this item in a 12 month period. (Item is subject to rule 25) N 66660 01JUL2009 Prostate specific antigen - quantitation of 2 or more fractions of PSA and any derived index including (if performed) a test described in item 66656, in the follow up of a PSA result that lies at or above the age related, method specific 97.5% reference limit, but below a value of 10 ug/L - 4 of this item in a 12 month period. (Item is subject to rule 25) Y 66662 01NOV1998 Quantitation of hormone receptors on proven primary breast or ovarian carcinoma or a metastasis from a breast or ovarian carcinoma or a subsequent lesion in the breast - 1 or more tests Y 66663 01MAY2007 A test described in item 66662 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66665 01NOV1998 Lead quantitation in blood or urine (other than for occupational health screening purposes) to a maximum of 3 tests in a 6 month period - each test Y 66666 01MAY2007 A test described in item 66665 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66667 01NOV2000 Quantitation of serum zinc in a patient receiving intravenous alimentation - each test Y 66668 01NOV1998 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium,strontium, or zinc, in blood, urine or other body fluid or tissue - 1 or more tests in a 6 month period Y 66669 01NOV2000 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 1 test to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22) N 66669 01MAY2005 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22) Y 66670 01NOV2000 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 2 or more tests to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22) N 66670 01MAY2005 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22) Y 66671 01NOV1998 Quantitation of serum aluminium in a patient in a renal dialysis program - each test Y 66672 01NOV2000 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 1 test to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22) N 66672 01MAY2005 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22) Y 66673 01NOV2000 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 2 or more tests to a maximum of 3 episodes in a 6 month period (Item is subject to rule 22) N 66673 01MAY2005 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 22) Y 66674 01NOV1998 Quantitation of: (a)faecal fat; or (b)breath hydrogen in response to loading with disaccharides; 1 or more tests within a 28 day period Y 66677 01NOV1998 Test for tryptic activity in faeces in the investigation of diarrhoea of longer than 4 weeks duration in children under 6 years old Y 66680 01NOV1998 Quantitation of disaccharidases and other enzymes in intestinal tissue - 1 or more tests Y 66683 01NOV1998 Enzymes - quantitation in solid tissue or tissues other than blood elements or intestinal tissue - 1 or more tests Y 66686 01NOV1998 Performance of 1 or more of the following procedures: (a)growth hormone suppression by glucose loading; (b)growth hormone stimulation by exercise; (c)dexamethasone suppression test; (d)sweat collection by iontophoresis for chloride analysis; (e)pharmacological stimulation of growth hormone Y 66689 01NOV1998 Personal performance by a recognised pathologist of 1 of the following procedures: (a)gonadotrophin releasing hormone stimulation test; (b)synacthen stimulation test; (c)glucagon stimulation test with C-peptide measurement; (d)pentagastrin or calcium stimulation of thyrocalcitonin release; (e)secretin or calcium stimulation of gastrin release; (f)insulin hypoglycaemia; (g)arginine infusion; (h)thyrotrophin releasing hormone (TRH) test Y 66692 01NOV1998 Personal performance by a recognised pathologist of 2 or more tests described in item 66689 Y 66695 01NOV1998 Quantitation of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test N 66695 01NOV2004 Quantitation in blood or urine of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test N 66695 01MAY2007 Quantitation in blood or urine of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, cyclic AMP, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide, vasopressin (antidiuretic hormone) - 1 test (Item is subject to rule 6) N 66695 01NOV2008 Quantitation in blood or urine of hormones and hormone binding proteins - ACTH, aldosterone, androstenedione, C-peptide, calcitonin, cortisol, DHEAS, 11-deoxycortisol, dihydrotestosterone, FSH, gastrin, glucagon, growth hormone, hydroxyprogesterone, insulin, LH, oestradiol, oestrone, progesterone, prolactin, PTH, renin, sex hormone binding globulin, somatomedin C(IGF-1), free or total testosterone, urine steroid fraction or fractions, vasoactive intestinal peptide,- 1 test (Item is subject to rule 6) Y 66696 01MAY2007 A test described in item 66695, if rendered by a receiving APP - where no tests in the item have been rendered by the referring APP (Item is subject to rule 6 and 18) Y 66697 01MAY2007 Tests described in item 66695, other than that described in 66696, if rendered by a receiving APP - each test to a maximum of 5 tests (Item is subject to rule 6 and 18) N 66697 01NOV2008 Tests described in item 66695, other than that described in 66696, if rendered by a receiving APP - each test to a maximum of 4 tests (Item is subject to rule 6 and 18) Y 66698 01NOV1998 2 tests described in item 66695 (Item is subject to rule 6) Y 66701 01NOV1998 3 tests described in item 66695 (Item is subject to rule 6) Y 66704 01NOV1998 4 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 tests specified on the request form or performs 4 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66707 01NOV1998 5 tests described in item 66695 (Item is subject to rule 6) N 66707 01JUL2008 5 or more tests described in item 66695 (Item is subject to rule 6) Y 66710 01NOV1998 6 or more tests described in item 66695 (Item is subject to rule 6) Y 66711 01NOV2005 Quantitation in saliva of cortisol in: (a)the investigation of Cushing's syndrome; or (b)the management of children with congenital adrenal hyperplasia N 66711 01MAY2007 Quantitation in saliva of cortisol in: (a)the investigation of Cushing's syndrome; or (b)the management of children with congenital adrenal hyperplasia (Item is subject to rule 6) Y 66712 01NOV2005 Two tests described in item 66711 N 66712 01MAY2007 Two tests described in item 66711 (Item is subject to rule 6) Y 66713 01NOV1998 Tests described in item 66695, if rendered under a request referred to in subparagraph (2)(a)(iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6) Y 66714 01MAY2007 A test described in item 66711, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP (Item is subject to rule 6 and 18) Y 66715 01MAY2007 Tests described in item 66711, other than that described in 66714, if rendered by a receiving APP, each test to a maximum of 1 test (Item is subject to rule 6 and 18) Y 66716 01NOV1998 TSH quantitation Y 66719 01NOV1998 Thyroid function tests (comprising the service described in item 66716 and 1 or more of the following tests - estimation of free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin) for a patient, if at least 1 of the following conditions is satisfied: (a)the patient has an abnormal level of TSH; (b)the tests are performed: (i)for the purpose of monitoring thyroid disease in the patient; or (ii)to investigate the sick euthyroid syndrome if the patient is an admitted patient; or (iii)to investigate dementia or psychiatric illness of the patient; or (iv)to investigate amenorrhoea or infertility of the patient; (c)the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d)the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 9) N 66719 01NOV2008 Thyroid function tests (comprising the service described in item 66716 and 1 or more of the following tests - free thyroxine, free T3, for a patient, if at least 1 of the following conditions is satisfied: (a)the patient has an abnormal level of TSH; (b)the tests are performed: (i)for the purpose of monitoring thyroid disease in the patient; or (ii)to investigate the sick euthyroid syndrome if the patient is an admitted patient; or (iii)to investigate dementia or psychiatric illness of the patient; or (iv)to investigate amenorrhoea or infertility of the patient; (c)the medical practitioner who requested the tests suspects the patient has a pituitary dysfunction; (d)the patient is on drugs that interfere with thyroid hormone metabolism or function (Item is subject to rule 9) Y 66722 01NOV1998 TSH quantitation described in item 66716 and 1 test described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66723 01MAY2007 Tests described in item 66722, that is, TSH quantitation and 1 test described in 66695, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 66724 01MAY2007 Tests described in item 66722, if rendered by a receiving APP, other than that described in 66723. It is to include a quantitation of TSH - each test to a maximum of 4 tests described in item 66695 (Item is subject to rule 6 and 18) Y 66725 01NOV1998 TSH quantitation described in item 66716 and 2 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 3 tests specified on the request form or performs 3 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66728 01NOV1998 TSH quantitation described in item 66716 and 3 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 tests specified on the request form or performs 4 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66731 01NOV1998 TSH quantitation described in item 66716 and 4 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 tests specified on the request form or performs 5 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66734 01NOV1998 TSH quantitation described in item 66716 and 5 tests described in item 66695 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 6 or more tests specified on the request form) (Item is subject to rule 6) Y 66737 01NOV1998 Tests described in items 66716 and 66695, if rendered under a request mentioned in subparagraph (2)(a)(iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6) Y 66740 01NOV1998 Quantitation, in pregnancy, of alpha-fetoprotein, human chorionic gonadotrophin, oestriol and any other substance to detect fetal abnormality, including a service described in 1 or more of items 66743, 66746, 73527 and 73529 (if performed) - 1 patient episode in a pregnancy Y 66743 01NOV1998 Quantitation of alpha-fetoprotein in serum or other body fluids during pregnancy except if requested as part of item 66740 N 66743 01MAY2003 Quantitation of alpha-fetoprotein in serum or other body fluids during pregnancy except if requested as part of items 66750 or 66751 Y 66746 01NOV1998 Human placental lactogen or oestriol - quantitation, except if requested as part of item 66740 - 1 test Y 66749 01NOV1998 Amniotic fluid, spectrophotometric examination of, and quantitation of: (a)lecithin/sphingomyelin ratio; or (b)palmitic acid, phosphatidylglycerol or lamellar body phospholipid; or (c)bilirubin, including correction for haemoglobin 1 or more tests Y 66750 01MAY2003 Quantitation, in pregnancy, of any two of the following - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - to detect foetal abnormality, including a service described in 1 or more of items 73527 and 73529 (if performed) - 1 patient episode in a pregnancy N 66750 01MAY2005 Quantitation, in pregnancy, of any two of the following - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - to detect foetal abnormality, including a service described in 1 or more of items 73527 and 73529 (if performed) - 1 of this item in a pregnancy N 66750 01MAY2007 Quantitation, in pregnancy, of any two of the following - total human chorionic gonadotrophin (total HCG), free alpha human chorionic gonadotrophin (free alpha HCG), free beta human chorionic gonadotrophin (free beta HCG), pregnancy associated plasma protein A (PAPP-A), unconjugated oestriol (uE3), alpha-fetoprotein (AFP) - to detect foetal abnormality, including a service described in 1 or more of items 73527 and 73529 (if performed) - (Item is subject to rule 25) Y 66751 01MAY2003 Quantitation, in pregnancy, of any three or more tests described in 66750 N 66751 01MAY2007 Quantitation, in pregnancy, of any three or more tests described in 66750 (Item is subject to rule 25) Y 66752 01NOV1998 Quantitation of citrate, oxalate, total free fatty acids or amino acids including cysteine, homocysteine, cystine and hydroxyproline (except if performed as part of item 66773 or 66776) - 1 test N 66752 01MAY2007 Quantitation of citrate, oxalate, total free fatty acids, cysteine, homocysteine, cystine or other amino acids and hydroxyproline (except if performed as part of item 66773 or 66776) - 1 test N 66752 01NOV2008 Quantitation of acetoacetate, beta-hydroxybutyrate, citrate, oxalate, total free fatty acids, cysteine, homocysteine, cystine, lactate, pyruvate or other amino acids and hydroxyproline (except if performed as part of item 66773 or 66776) - 1 test Y 66755 01NOV1998 2 or more tests described in item 66752 Y 66756 01MAY2007 Quantitation of 10 or more amino acids for the diagnosis of inborn errors of metabolism - up to 4 tests in a 12 month period on specimens of plasma, CSF and urine. Y 66757 01MAY2007 Quantitation of 10 or more amino acids for monitoring of previously diagnosed inborn errors of metabolism in 1 tissue type. Y 66758 01NOV1998 Quantitation of angiotensin converting enzyme, or cholinesterase - 1 or more tests Y 66761 01NOV1998 Test for reducing substances in faeces by any method (except reagent strip or dipstick) Y 66764 01NOV1998 Examination for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces) by: (a)an immunological method; and (b)a chemical method (except reagent strip or dip stick); with a maximum of 3 examinations on specimens collected on separate days in a 28 day period - 1 examination by both methods N 66764 01NOV2008 Examination for faecal occult blood (including tests for haemoglobin and its derivatives in the faeces except by reagent strip or dip stick methods) with a maximum of 3 examinations on specimens collected on separate days in a 28 day period Y 66767 01NOV1998 2 examinations by both methods described in item 66764 performed on separately collected and identified specimens N 66767 01NOV2008 2 examinations described in item 66764 performed on separately collected and identified specimens Y 66770 01NOV1998 3 examinations by both methods described in item 66764 performed on separately collected and identified specimens N 66770 01NOV2008 3 examinations described in item 66764 performed on separately collected and identified specimens Y 66773 01NOV1998 Quantitation of products of collagen breakdown for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66752 - 1 or more tests (Low bone densitometry is defined in paragraph D1.15 of explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule) N 66773 01NOV2001 Quantitation of products of collagen breakdown for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66752 - 1 or more tests (Low bone densitometry is defined in the explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule) N 66773 01NOV2007 Quantitation of products of collagen breakdown or formation for the monitoring of patients with proven low bone mineral density, and if performed, a service described in item 66752 - 1 or more tests (Low bone densitometry is defined in the explanatory notes to Category 2 - Diagnostic Procedures and Investigations of the Medicare Benefits Schedule) Y 66776 01NOV1998 Quantitation of products of collagen breakdown for the monitoring of patients with metabolic bone disease or Paget's disease of bone, and if performed, a service described in item 66752 - 1 or more tests N 66776 01NOV2007 Quantitation of products of collagen breakdown or formation for the monitoring of patients with metabolic bone disease or Paget's disease of bone, and if performed, a service described in item 66752 - 1 or more tests Y 66779 01NOV1998 Adrenaline, noradrenaline, dopamine, histamine, hydroxyindoleacetic acid (5HIAA), hydroxymethoxymandelic acid (HMMA), homovanillic acid (HVA), metanephrines, methoxyhydroxyphenylethylene glycol (MHPG), phenylacetic acid (PAA) or serotoninquantitation - 1 or more tests Y 66780 01MAY2007 A test described in item 66779 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66782 01NOV1998 Porphyrins or porphyrins precursors - detection in plasma, red cells, urine or faeces - 1 or more tests Y 66783 01MAY2007 A test described in item 66782 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66785 01NOV1998 Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 1 test N 66785 01MAY2007 Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 1 test (Item is subject to rule 6) Y 66788 01NOV1998 Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 2 or more tests N 66788 01MAY2007 Porphyrins or porphyrins precursors - quantitation in plasma, red cells, urine or faeces - 2 or more tests (Item is subject to rule 6) Y 66789 01MAY2007 A test described in item 66785 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 66790 01MAY2007 A test described in item 66785 other than that described in 66789, if rendered by a receiving APP - to a maximum of 1 test (Item is subject to rule 6 and 18) Y 66791 01NOV1998 Porphyrin biosynthetic enzymes - measurement of activity in blood cells or other tissues - 1 or more tests Y 66792 01MAY2007 A test described in item 66791 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 66794 01NOV1998 Detection of the C282Y genetic mutation for haemochromatosis where: (a)the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or (b) the patient has a first degree relative with haemochromatosis or with homozygosity for the C282Y genetic mutation; not exceeding 1 episode in a 3 year period (Item is subject to rule 22) N 66794 01NOV1999 Detection of the C282Y genetic mutation of the HFE gene and, if performed, detection of other mutations for haemochromatosis where: (a)the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or (b) the patient has a first degree relative with haemochromatosis; or (c) the patient has a first degree relative with homozygosity for the C282Y genetic mutation, or with compound heterozygosity for recognised genetic mutations for haemochromatosis (Item is subject to rule 20) Y 66800 01NOV2003 Quantitation in blood, urine or other body fluid by any method (except reagent tablet or reagent strip) of any of the following being used therapeutically by the patient from whom the specimen was taken: amikacin, carbamazepine, digoxin, disopyramide, ethanol, ethosuximide, gentamicin, lithium, lignocaine, netilmicin, paracetamol, phenobarbitone, primidone, phenytoin, procainamide, quinidine, salicylate, theophylline, tobramycin, valproate or vancomycin - 1 test (Item to be subject to rule 6) Y 66803 01NOV2003 2 tests described in item 66800 (Item is subject to rule 6) Y 66804 01MAY2007 A test described in item 66800 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 66805 01MAY2007 A test described in item 66800 other than that described in 66804, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6 and 18) Y 66806 01NOV2003 3 tests described in item 66800 (Item is subject to rule 6) Y 66809 01NOV2003 Tests described in item 66800, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 2 tests (Item is subject to rule 6) Y 66812 01NOV2003 Quantitation, not elsewhere described in this Table by any method or methods, in blood, urine or other body fluid, of a drug being used therapeutically by the patient from whom the specimen was taken - 1 test (This fee applies where 1 laboratory performs the only test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66815 01NOV2003 2 tests described in item 66812 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 tests specified on the request form or performs 2 tests and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 66816 01MAY2007 A test described in item 66812 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 66817 01MAY2007 A test described in item 66812, other than that described in 66816, if rendered by a receiving APP - to a maximum of 1 test (Item is subject to rule 6 and 18) Y 66818 01NOV2003 Tests described in item 66812, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 1 test (Item is subject to rule 6) Y 66819 01MAY2007 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25) N 66819 01NOV2008 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid - 1 test. (Item is subject to rule 6, 22 and 25) Y 66820 01MAY2007 A test described in item 66819 if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6, 18, 22 and 25) Y 66821 01MAY2007 A test described in item 66819 other than that described in 66820 if rendered by a receiving APP to a maximum of 1 test (Item is subject to rule 6, 18,22 and 25) Y 66822 01MAY2007 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25) N 66822 01NOV2008 Quantitation of copper, manganese, selenium, or zinc (except if item 66667 applies), in blood, urine or other body fluid - 2 or more tests. (Item is subject to rule 6, 22 and 25) Y 66825 01MAY2007 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 1 test. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25) Y 66826 01MAY2007 A test described in item 66825 if rendered by a receiving APP where no tests have been rendered by the referring APP - 1 test (Item is subject to rules 6, 18, 22 and 25 ) Y 66827 01MAY2007 A test described in item 66825, other than that described in 66826, if rendered by a receiving APP to a maximum of 1 test (Item is subject to rules 6, 18, 22 and 25) Y 66828 01MAY2007 Quantitation of aluminium (except if item 66671 applies), arsenic, beryllium, cadmium, chromium, gold, mercury, nickel, or strontium, in blood, urine or other body fluid or tissue - 2 or more tests. To a maximum of 3 of this item in a 6 month period (Item is subject to rule 6, 22 and 25) Y 66830 01JUL2008 Quantitation of BNP or NT-proBNP for the diagnosis of heart failure in patients presenting with dyspnoea to a hospital Emergency Department (Item is subject to rule 25) Y 66831 01NOV2008 Quantitation of copper or iron in liver tissue biopsy Y 66832 01NOV2008 A test described in item 66831 if rendered by a receiving APP (Item is subject to rule 18A and 22) Y 66833 01NOV2014 25-hydroxyvitamin D, quantification in serum, for the investigation of a patient who: (a)has signs or symptoms of osteoporosis or osteomalacia; or (b)has increased alkaline phosphatase and otherwise normal liver function tests; or (c)has hyperparathyroidism, hypo- or hypercalcaemia, or hypophosphataemia; or (d)is suffering from malabsorption (for example, because the patient has cystic fibrosis, short bowel syndrome, inflammatory bowel disease or untreated coeliac disease, or has had bariatric surgery); or (e) has deeply pigmented skin, or chronic and severe lack of sun exposure for cultural, medical, occupational or residential reasons; or (f)is taking medication known to decrease 25OH-D levels (for example, anticonvulsants); or (g)has chronic renal failure or is a renal transplant recipient; or (h)is less than 16 years of age and has signs or symptoms of rickets; or (i)is an infant whose mother has established vitamin D deficiency; or (j)is a exclusively breastfed baby and has at least one other risk factor mentioned in a paragraph in this item; or (k)has a sibling who is less than 16 years of age and has vitamin D deficiency Y 66834 01NOV2014 A test described in item 66833 if rendered by a receiving APP (Item is subject to Rule 18) Y 66835 01NOV2014 1, 25-dihydroxyvitamin D - quantification in serum, if the request for the test is made by, or on advice of, the specialist or consultant physician managing the treatment of the patient Y 66836 01NOV2014 1, 25-dihydroxyvitamin D-quantification in serum, if: (a)the patient has hypercalcaemia; and (b)the request for the test is made by a general practitioner managing the treatment of the patient Y 66837 01NOV2014 A test described in item 66835 or 66836 if rendered by a receiving APP (Item is subject to Rule 18) Y 66838 01NOV2014 Serum vitamin B12 test (Item is subject to Rule 25) Y 66839 01NOV2014 Quantification of vitamin B12 markers such as holoTranscobalamin or methylmalonic acid, where initial serum vitamin B12 result is low or equivocal Y 66840 01NOV2014 Serum folate test and, if required, red cell folate test for a patient at risk of folate deficiency, including patients with malabsorption conditions, macrocytic anaemia or coeliac disease Y 66841 01NOV2014 Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk.(Item is subject to rule 25) Y 66900 01MAY2009 CARBON-LABELLED UREA BREATH TEST using oral C-13 or C-14 urea, including the measurement of exhaled 13CO2 or 14CO2 (except if item 12533 applies) for either:- (a)the confirmation of Helicobacter pylori colonisation OR (b)the monitoring of the success of eradication of Helicobacter pylori. Y 69201 01DEC1991 Microscopic examination of material other than blood, from 1 or more sites, obtained directly from a patient and excluding material from cultureswet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stains1 or more examinations N 69201 01JUL1994 Microscopy of wet film material other than blood, from 1 or more sites, obtained directly from a patient (not cultures) including: (a)differential cell count (if performed); or (b)examination for dermatophytes; or (c)dark ground illumination; or (d)stained preparation or preparations using any relevant stain or stains; 1 or more tests Y 69202 01DEC1991 Microscopic examination of material other than blood, from one or more sites, obtained directly from a patient and excluding material from cultureswet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparations using any relevant stain or stainsone or more examinations Y 69203 01DEC1991 Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of 3 estimations taken on separate days including any services specified in item 69201each estimation N 69203 01JUL1994 Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) to a maximum of 3 tests taken on separate days, including a service (if performed) described in item 69201each test Y 69204 01DEC1991 Microscopic examination of faeces forparasites using concentration techniques including the use of appropriate stains, to a maximum of three estimations taken on separate days including any services specified in item 69201/69202each estimation Y 69205 01DEC1991 The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 692011 or more sites N 69205 01JUL1994 Culture and (if performed) microscopy to detect pathogenic micro-organisms (including fungi but excluding viruses), from nasal swabs, throat swabs, eye swabs and ear swabs, including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b)the detection of antigens not elsewhere described in this Table; or (c)a service described in item 69201; specimens from 1 or more sites Y 69206 01DEC1991 The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic microorganisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201one or more sites Y 69207 01DEC1991 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sitesskin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201 and 692051 or more examinations on 1 or more specimens N 69207 01NOV1993 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sitesskin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 738101 or more examinations on 1 or more specimens N 69207 01JUL1994 Microscopy and culture to detect pathogenic micro-organisms, including fungi but excluding viruses, from: (a)skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens); or (b)specimens of sputum (except when part of item 69213); including (if performed): (c)the detection of antigens not elsewhere specified in this Table; or (d)pathogenic identification and antibiotic susceptibility testing; or (e)a service described in item 69201, 69205 and 73810; 1 or more tests on 1 or more specimens Y 69208 01DEC1991 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic microorganisms, including fungi but excluding viruses, from the following sitesskin or other superficial sites, urethra, vagina, cervix, or rectum (except for faecal pathogens), or specimens of sputum (except when part of item 69213/69214), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 69201/69202, 69205/69206one or more examinations on one or more specimens Y 69209 01DEC1991 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201, 69205 and 692071 or more sites N 69209 01JUL1994 Microscopy and culture of postoperative wounds, aspirates of body cavities, synovial fluid, CSF or operative or biopsy specimens, for the presence of pathogenic micro-organisms (including fungi but excluding viruses) involving aerobic and anaerobic culture and the use of different culture media, and including (if performed); (a)pathogen identification and antibiotic susceptibility testing; (b)the detection of antigens not elsewhere specified in this Table; or (c)a service described in item 69201, 69205 or 69207; specimens from 1 or more sites Y 69210 01DEC1991 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic microorganisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 69201/69202, 69205/69206 and 69207/69208one or more sites Y 69211 01DEC1991 Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least 2 selective or enrichment media as well as culture in at least 2 different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201, to a maximum of 3 specimens in any 7 day periodeach examination N 69211 01JUL1994 Culture of faeces for faecal pathogens, involving the use of at least 2 selective or enrichment media and culture in at least 2 different atmospheres and including (if performed): (a)pathogen identification and antibiotic susceptibility testing; (b)the detection of clostridial toxins or antigens not elsewhere specified in this Table; or (c)a service described in item 69201; to a maximum of 3 specimens in any 7-day periodeach test Y 69212 01DEC1991 Cultural examination (including the detection of clostridial toxins or antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least two selective or enrichment media as well as culture in at least two different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 69201/69202, to a maximum of three specimens in any seven day periodeach examination Y 69213 01DEC1991 Microscopy with appropriate stains and cultural examinations of 3 specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201 N 69213 01JUL1994 Microscopy with appropriate stains and culture of 3 specimens of sputum, urine or other body fluids for mycobacteria including (if performed): (a)microscopy and culture of other bacterial pathogens; or (b)pathogen identification and antibiotic susceptibility testing; and (c)a service described in item 69201 Y 69214 01DEC1991 Microscopy with appropriate stains and cultural examinations of three specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 69201/69202 Y 69215 01DEC1991 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing - each set of cultures to a maximum of 3 sets N 69215 01JUL1994 Blood culture for pathogenic micro-organisms (other than viruses), including sub-cultures and (if performed): (a)identification of any cultured pathogen; and (b)necessary antibiotic susceptibility testing; each set of cultures to a maximum of 3 sets Y 69216 01DEC1991 Blood culture to determine the presence or absence of pathogenic microorganisms excluding viruses, including serial cultures and subcultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testingeach set of cultures to a maximum of three sets Y 69217 01DEC1991 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (simple culture by dip slide is excluded from this item) N 69217 01JUL1994 Urine examination (including serial examination) by any means other than simple culture by dip slide, including: (a)cell count; and (b)culture; and (c)colony count (if performed); and (d)stained preparations; and (e)identification of cultured pathogens; and (f)antibiotic susceptibility testing; and (g)any examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts Y 69218 01DEC1991 Urine examination including serial examination,with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts (Simple culture by dip slide is excluded from this item) Y 69219 01DEC1991 Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211 has been performed1 or more estimations N 69219 01JUL1994 Detection of: (a)the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus, respiratory syncytial virus, cryptococcal antigens or Varicella zoster; or (b)Clostridium difficile toxin (except if the service described in item 69211 has been performed); 1 or more tests N 69219 01NOV1996 Detection of: (a)the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus, respiratory syncytial virus, cryptococcal antigens or Varicella zoster; or (b)Clostridium difficile toxin (except if a service described in item 69289 to 69291 has been performed); 1 or more tests Y 69220 01DEC1991 Direct detection of the antigens of Heamophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF andurine specimens only), RSV, cryptococcal antigens and Varicella zoster or detection of Clostridium difficile toxin except where item 69211/69212 has been performedone or more estimations Y 69221 01DEC1991 Direct detection of Chlamydia from clinical material, not cultures1 or more estimations N 69221 01JUL1994 Detection of Chlamydia from material obtained directly from a patient (not cultures) - 1 or more tests Y 69222 01DEC1991 Direct detection of Chlamydia from clinical material, not culturesoneor more estimations Y 69223 01DEC1991 Direct detection of herpes simplex virus from clinical material, not cultures1 or more estimations N 69223 01JUL1994 Detection of herpes simplex virus from material obtained directly from a patient (not cultures)1 or more tests Y 69224 01DEC1991 Direct detection of Herpes simplex from clinical material, not cultures one or more estimations Y 69225 01DEC1991 Investigation for herpes simplex virus (1 or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by 1 or more cultural methods, including any services specified in items 69221 and 69223 Y 69226 01DEC1991 Investigation for Herpes simplex virus (one or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by one or more cultural methods, including any services specified in items 69221/69222 and 69223/69224 Y 69227 01DEC1991 All microbiological serology during pregnancy, which must include the determination of Rubella immune status, syphilis serology and Hepatitis B surface antigen and including all services in Items 69229, 69243 and 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy Y 69228 01DEC1991 All microbiological serology during pregnancy, which must include the determination of Rubella immune status, syphilis serology and Hepatitis B surface antigen and including all services in Items 69230, 69244 and 69246, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy Y 69229 01DEC1991 Antibodies to microbial or exogenous antigens not elsewhere specified in the Scheduleestimation of 1 antibody N 69229 01JUL1993 Antibodies to microbial or exogenous antigens not elsewhere specified in the Scheduleestimation of 1 antibody (This fee applies where a laboratory performs the only antibody estimation specified on the request form or performs 1 estimation and refers the rest to the laboratory of a separate APA) N 69229 01JUL1994 Quantitation of 1 antibody to microbial or exogenous antigens not elsewhere described in the Schedule - 1 test (This fee applies where a laboratory performs the only antibody test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 69230 01DEC1991 Antibodies to microbial or exogenous antigens not elsewhere specified in the Scheduleestimation of one antibody Y 69231 01DEC1991 2 estimations specified in item 69229 N 69231 01JUL1993 2 estimations specified in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.) N 69231 01JUL1994 2 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 2 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 69232 01DEC1991 Two estimations specified in item 69229/69230 Y 69233 01DEC1991 3 estimations specified in item 69229 N 69233 01JUL1993 3 estimations specified in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.) N 69233 01JUL1994 3 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 3 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 69234 01DEC1991 Three estimations specified in item 69229/69230 Y 69235 01DEC1991 4 estimations specified in item 69229 N 69235 01JUL1993 4 estimations specified in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.) N 69235 01JUL1994 4 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 4 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 69236 01DEC1991 Four estimations specified in item 69229/69230 Y 69237 01DEC1991 5 estimations specified in item 69229 N 69237 01JUL1993 5 tests described in item 69229 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs 5 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA.) (Item is subject to rule 6) Y 69238 01DEC1991 Five estimations specified in item 69229/69230 Y 69239 01DEC1991 6 or more estimations specified in item 69229 N 69239 01JUL1994 6 or more tests described in item 69229 Y 69240 01DEC1991 Six or more estimations specified in item 69229/69230 Y 69241 01SEP1992 Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations N 69241 01JUL1993 "Estimations specified in any of items 69229 to 69239 (inclusive), if the number of estimations relating to the same patient episode does not exceed 6 - each estimation to a maximum of 5 estimations (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the antibody estimations specified on the request form.The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" N 69241 01JUL1994 "Tests described in any of items 69229 to 69237, if the number of tests relating to the same patient episode does not exceed 6 - each tests to a maximum of 5 tests (Item is subject to rule 6) (This fee applies to the laboratory of a different APA to the first laboratory, which has referred to it the remainder of the antibody tests specified on the request form.The PEI applicable to this item is 73921, the ""Specimen Referred Fee"".)" N 69241 01NOV1994 Tests described in item 69229, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 (Item is subject to rule 6) N 69241 01NOV1995 Tests described in item 69229, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6) Y 69243 01DEC1991 Hepatitis B surface antigen test Y 69244 01DEC1991 Hepatitis B surface antigen test Y 69245 01DEC1991 Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody tests, including services specified in items 69243, 69247 and 69249 N 69245 01JUL1994 Hepatitis B serology to define the immune status of an individual, including at least hepatitis B surface antibody or hepatitis B core antibody test, and including a service described in item 69243, 69247 or 69249 (if performed) Y 69246 01DEC1991 Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including services specified in items 69243/69244, 69247/69248 and 69249/69250 Y 69247 01DEC1991 All serological tests performed for the identification of the agent causing acute hepatitis, which must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody tests and those services specified in items 69243, 69245 and 69249 N 69247 01JUL1994 Serological tests to identify the agent causing acute hepatitis (must include hepatitis B surface antigen, hepatitis B core antibody and hepatitis A IgM antibody test and the services described in item 69243, 69245 and 69249) Y 69248 01DEC1991 All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in items 69243/69244, 69245/69246 and 69249/69250 Y 69249 01DEC1991 All tests performed in the follow up of a patient with proven hepatitis B, including hepatitis B surface antigen and either hepatitis B antigen or hepatitis B surface antibody tests, including services specified in items 69243 and 69245 N 69249 01JUL1994 Tests performed in the follow-up of a patient with proven hepatitis B, including: (a)hepatitis B surface antigen test; and (b)either: (i)hepatitis Be antigen test; or (ii)hepatitis B surface antibody test, and (c)(if performed) services described in item 69243 and 69245 Y 69250 01DEC1991 All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in items 69243/69244 and 69245/69246 Y 69251 01DEC1991 Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent1 or more estimations N 69251 01JUL1994 Antibiotics or antimicrobial chemotherapeutic agents in serum, urine or other body fluid - quantitation1 or more tests Y 69252 01DEC1991 Antibiotics or antimicrobial chemotherapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agentone or more estimations Y 69253 01SEP1992 All microbiological serology during a pregnancy, which must include the determination of 1 of the following - rubella immune status, specific syphilis serology or hepatitis B surface antigen - including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy N 69253 01JUL1994 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of 1 of the following: rubella immune status, specific syphilis serology, hepatitis B surface antigen; and (b)a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed) N 69253 20MAR1997 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of 1 of the following: rubella immune status, specific syphilis serology,hepatitis B surface antigen; and (b)a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed) Y 69255 01SEP1992 All microbiological serology during a pregnancy, which must include the determination of 2 of the following - rubella immune status, specific syphilis serology or hepatitis B surface antigen and including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy N 69255 01JUL1994 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of 2 of the following: rubella immune status, specific syphilis serology or hepatitis B surface antigen; (b)a service described in 1 or more of items 69229, 69243 and 69245 (if performed) N 69255 01NOV1995 Microbiological serology during a pregnancy (except in the investigation of a clinically intercurrent microbial illness during that pregnancy) including: (a)the determination of 2 of the following: rubella immune status, specific syphilis serology or hepatitis B antigen; (b)a service described in 1 or more of items 69229, 69266 to 69281 (if performed) N 69255 20MAR1997 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of 2 of the following: rubella immune status, specific syphilis serology or hepatitis B surface antigen; and (b)a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed) Y 69257 01SEP1992 All microbiological serology during a pregnancy, which must include the determination of all 3 of the following - rubella immune status, specific syphilis serology and hepatitis B surface antigen - including any service specified in 1 or more of items 69229, 69243 or 69245, except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy N 69257 01JUL1994 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including : (a)the determination of all 3 of the following: rubella immune status, specific syphilis serology and hepatitis B surface antigen; and (b)a service described in 1 or more of items 69229, 69243 and 69245 (if performed) N 69257 01NOV1996 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including : (a)the determination of all 3 of the following: rubella immune status, specific syphilis serology and hepatitis B surface antigen; and (b)a service described in 1 or more of items 69229, 69266 to 69281 (if performed) N 69257 20MAR1997 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including : (a)the determination of all 3 of the following: rubella immune status, specific syphilis serology and hepatitis B surface antigen; and (b)a service described in 1 or more of items 69229, 69266 to 69273, 69275 to 69278, 69280 and 69281 (if performed) Y 69259 01JUL1998 Quantitation of HIV viral RNA load in plasma, serum or cerebrospinal fluid in the monitoring of a HIV sero-positive patient, who is not on antiretroviral therapy.1 or more assays on 1 or more specimens in any 1 episode to a maximum of 6 episodes in a 12 month period Y 69260 01JUL1998 Quantitation of HIV viral RNA load in plasma, serum or cerebrospinal fluid in the monitoring of antiretroviral therapy in a HIV sero-positive patient.1 or more assays on 1 or more specimens in any 1 episode to a maximum of 6 episodes in a 12 month period Y 69261 01JUL1993 Examination for chlamydia by culture or by the demonstration of chlamydial nucleic acid using a DNA probe in material collected directly from a patient, including a service specified in item 69221, 69223 or 69263 N 69261 01JUL1994 Examination for Chlamydia (by culture or by the demonstration of chlamydial nucleic acid using a DNA probe) in material obtained directly from a patient, including a service specified in item 69221, 69223 or 69263 (if performed) Y 69262 01JUL1996 Detection of chlamydia by any method in specimens from 1 or more sites Y 69263 01JUL1993 Examination for herpes simplex virus of 1 or more types in material collected directly from a patient by culture, including a service specified in item 69221, 69223 or 69261 N 69263 01JUL1994 Examination for herpes simplex virus of 1 or more types by culture in material obtained directly from a patient, including a service described in item 69221, 69223 or 69261 (if performed) Y 69264 01JUL1996 Examination for Herpes simplex virus of 1 or more types by culture in material obtained directly from a patient, including a service described in items 69223, 69262 or 69282 (if performed) Y 69265 01JUL1993 Determination of antibodies to hepatitis C N 69265 01JUL1994 Hepatitis C antibody test Y 69266 01JUL1996 Investigation for acute Hepatitis A - Hepatitis A IgM antibody test (Item is subject to rule 12) N 69266 20MAR1997 Investigation for acute Hepatitis A using: Hepatitis A IgM antibody test (Item is subject to rule 12) Y 69267 01JUL1996 Determination of immune status to Hepatitis A - Hepatitis A IgG antibody test (Item is subject to rule 12) N 69267 20MAR1997 Determination of immune status to Hepatitis A using: Hepatitis A IgG antibody test (Item is subject to rule 12) Y 69268 01JUL1996 Investigation for acute or resolving Hepatitis B, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis B core antibody test; and (c)Hepatitis B e antibody test (if the Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed) (Item is subject to rule 12) N 69268 20MAR1997 Investigation for acute or resolving Hepatitis B, or testing of close, recent contacts of proven Hepatitis B infection, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis B core antibody test; and (c)Hepatitis B e antibody test (if the Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed) (Item is subject to rule 12) Y 69269 01JUL1996 Investigation for resolving Hepatitis B if Hepatitis B core antibody test is positive and Hepatitis B surface antigen test is negative, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis B core antibody test; and (c)Hepatitis B surface antibody test (Item is subject to rule 12) N 69269 20MAR1997 Investigation for resolution of Hepatitis B if the Hepatitis B core antibody test is positive and the Hepatitis B surface antigen test is negative, including: (a)Hepatitis B core antibody test; and (b)Hepatitis B surface antigen test; and (c)Hepatitis B surface antibody test (Item is subject to rule 12) Y 69270 01JUL1996 Determination of immune status to Hepatitis B (post exposure) - Hepatitis B core antibody test (Item is subject to rule 12) N 69270 20MAR1997 Determination of immune status to Hepatitis B (post exposure) using: Hepatitis B core antibody test (Item is subject to rule 12) Y 69271 01JUL1996 Determination of immune status to Hepatitis B (post vaccination) - Hepatitis B surface antibody test (Item is subject to rule 12) N 69271 20MAR1997 Determination of immune status to Hepatitis B (post vaccination) using: Hepatitis B surface antibody test (Item is subject to rule 12) Y 69272 01JUL1996 Investigation for chronic Hepatitis B or determination of carriage of Hepatitis B antigen - Hepatitis B surface antigen test (Item is subject to rule 12) N 69272 20MAR1997 Investigation for chronic Hepatitis B or determination of carriage of Hepatitis B antigen using: Hepatitis B surface antigen test (Item is subject to rule 12) Y 69273 01JUL1996 Investigation for chronic Hepatitis B or carriage of Hepatitis B antigen if the Hepatitis B surface antigen test is positive, including: (a)Hepatitis B surface antigen test;and (b)Hepatitis B e antigen test (Item is subject to rule 12) Y 69274 01JUL1996 Investigation for Hepatitis C - Hepatitis C antibody test (Item is subject to rule 12) N 69274 20MAR1997 Testing for Hepatitis C using: Hepatitis C antibody test (Item is subject to rule 12) Y 69275 01JUL1996 Investigation for acute or chronic Hepatitis D in a patient with a positive Hepatitis B surface antigen test - Hepatitis D antibody test (Item is subject to rule 12) N 69275 20MAR1997 Investigation for acute or chronic Hepatitis D in a patient with a positive Hepatitis B surface antigen test using: Hepatitis D antibody test (Item is subject to rule 12) Y 69276 01JUL1996 Determination of immune status to Hepatitis A and Hepatitis B, including: (a)Hepatitis A IgG antibody test;and (b)Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 12) Y 69277 01JUL1996 Investigation for chronic viral hepatitis, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis C antibody test (Item is subject to rule 12) N 69277 20MAR1997 Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis C antibody test (Item is subject to rule 12) Y 69278 01JUL1996 Investigation for chronic viral hepatitis if Hepatitis B surface antigen test is positive, including: (a)Hepatitis C antibody test; and (b)Hepatitis B surface antigen test; and (c)Hepatitis B e antigen test (Item is subject to rule 12) N 69278 20MAR1997 Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, if Hepatitis B surface antigen test is positive, including: (a)Hepatitis C antibody test; and (b)Hepatitis B surface antigen test; and (c)Hepatitis B e antigen test (Item is subject to rule 12) Y 69279 01JUL1996 Investigation for acute Hepatitis A, Hepatitis B or Hepatitis C in a patient with a currently elevated transaminase level, including: (a)Hepatitis A IgM antibody test; and (b)Hepatitis C antibody test; and (c)Hepatitis B surface antigen test; and (d)Hepatitis B core antibody test; and (e)Hepatitis B e antibody test (if Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed) (Item is subject to rule 12) N 69279 20MAR1997 Investigation for acute Hepatitis A, Hepatitis B, Hepatitis C and Hepatitis D in a patient with a currently elevated transaminase level, including: (a)Hepatitis A IgM antibody test; and (b)Hepatitis C antibody test; and (c)Hepatitis B surface antigen test; and (d)Hepatitis B core antibody test; and (e)Hepatitis B e antibody test (if Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (if performed); and (f)Hepatitis D antibody test (if Hepatitis B surface antigen test is positive) (if performed) (Item is subject to rule 12) Y 69280 20MAR1997 Determination of immune status to Hepatitis B and testing for Hepatitis C, including: (a)Hepatitis C antibody test; and (b)Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 12) Y 69281 01JUL1996 Syphilis serology and any 1 of items 69273, 69274 or 69277 (Item is subject to rule 12) Y 69282 01JUL1996 Microscopy and culture to detect pathogenic micro-organisms, including the detection of chlamydia by any method from urethra, vagina, cervix or rectum and including (if performed): (a)the detection of microbial antigens; or (b)pathogen identification and antibiotic susceptibility testing; or (c)a service described in item 69201, 69205, 69207, 69223, 69262, 69264 or 73810; 1 or more tests on 1 or more specimens Y 69283 20MAR1997 Investigation for acute Hepatitis A and Hepatitis C in a patient with a currently elevated transaminase level, including: (a)Hepatitis A IgM antibody test; and (b)Hepatitis C antibody test (Item is subject to rule 12) Y 69284 01JUL1998 Detection of Hepatitis C viral RNA if at least one of the following criteria is satisfied: a)the patient is Hepatitis C sero-positive and has normal liver function tests on two occasions six months apart; b)the patient's serological status is uncertain after testing; c)the test is performed for the purpose of: (i)determining the Hepatitis C status in immunosuppressed in an immunocompromised patient; or (ii)the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient. Not exceeding 1 episode in a 12 month period. Y 69285 01JUL1996 Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) with a maximum of 3 examinations on specimens collected on separate days, including a service (if performed) described in item 69201 - 1 examination Y 69286 01JUL1996 2 examinations described in item 69285 performed on separately collected and identified specimens Y 69287 01JUL1996 3 examinations described in item 69285 performed on separately collected and identified specimens Y 69289 01JUL1996 Culture of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a)pathogen identification and antibiotic susceptibility testing;and (b)the detection of clostridial toxins or antigens not elsewhere specified in this Table;and (c)a service described in item 69201; with a maximum of 3 examinations performed on separately collected and identified specimens in any 7 day period - 1 examination Y 69290 01JUL1996 2 examinations described in item 69289 performed on separately collected and identified specimens Y 69291 01JUL1996 3 examinations described in item 69289 performed on separately collected and identified specimens Y 69293 01JUL1996 Blood culture for pathogenic micro-organisms (other than viruses), including sub-cultures and (if performed): (a)identification of any cultured pathogen;and (b)necessary antibiotic susceptibility testing; to a maximum of 3 sets of cultures - 1 set of cultures Y 69294 01JUL1996 2 sets of cultures described in item 69293 Y 69295 01JUL1996 3 sets of cultures described in item 69293 Y 69300 01NOV1998 Microscopy of wet film material other than blood, from 1 or more sites, obtained directly from a patient (not cultures) including: (a)differential cell count (if performed); or (b)examination for dermatophytes; or (c)dark ground illumination; or (d)stained preparation or preparations using any relevant stain or stains; 1 or more tests Y 69303 01NOV1998 Culture and (if performed) microscopy to detect pathogenic micro-organisms (including fungi but excluding viruses) from nasal swabs, throat swabs, eye swabs and ear swabs (excluding swabs taken for epidemiological surveillance), including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b)the detection of antigens not elsewhere described in this Table; or (c)a service described in item 69300; specimens from 1 or more sites N 69303 01NOV2005 Culture and (if performed) microscopy to detect pathogenic micro-organisms from nasal swabs, throat swabs, eye swabs and ear swabs (excluding swabs taken for epidemiological surveillance), including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b)a service described in item 69300; specimens from 1 or more sites Y 69306 01NOV1998 Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from skin or other superficial sites, including (if performed): (a)the detection of antigens not elsewhere specified in this Table; or (b)pathogen identification and antibiotic susceptibility testing; or (c)a service described in items 69300, 69303, 69312, 69318 and 73810; 1 or more tests on 1 or more specimens N 69306 01NOV2005 Microscopy and culture to detect pathogenic micro-organisms from skin or other superficial sites, including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b)a service described in items 69300, 69303, 69312, 69318; 1 or more tests on 1 or more specimens Y 69309 01NOV1998 Microscopy and culture to detect dermatophytes and other fungi causing cutaneous disease from skin scrapings, skin biopsies, hair and nails (excluding swab specimens) and including (if performed): (a)the detection of antigens not elsewhere specified in this Table; or (b)a service described in items 69300, 69303, 69306, 69312, 69318 and 73810; 1 or more tests on 1 or more specimens N 69309 01NOV2005 Microscopy and culture to detect dermatophytes and other fungi causing cutaneous disease from skin scrapings, skin biopsies, hair and nails (excluding swab specimens) and including (if performed): (a)the detection of antigens not elsewhere specified in this Table; or (b)a service described in items 69300, 69303, 69306, 69312, 69318; 1 or more tests on 1 or more specimens Y 69312 01NOV1998 Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from urethra, vagina, cervix or rectum (except for faecal pathogens), including (if performed): (a)the detection of antigens not elsewhere specified in this Table; or (b)pathogen identification and antibiotic susceptibility testing; or (c) a service described in items 69300, 69303, 69306 and 69318; 1 or more tests on 1 or more specimens N 69312 01NOV2005 Microscopy and culture to detect pathogenic micro-organisms from urethra, vagina, cervix or rectum (except for faecal pathogens), including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b) a service described in items 69300, 69303, 69306 and 69318; 1 or more tests on 1 or more specimens Y 69315 01NOV1998 Microscopy and culture to detect pathogenic microorganisms, including the detection of chlamydia by any method from urethra, vagina, cervix or rectum and including (if performed): (a) the detection of microbial antigens; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in item 69300, 69303, 69306, 69312, 69318, 69363, 69369, 69372, 69375 or 73810 1 or more tests on 1 or more specimens N 69315 01NOV1999 Microscopy and culture to detect pathogenic microorganisms, and the detection of chlamydia from urethra, vagina, cervix or rectum and including (if performed): (a) the detection of microbial antigens; or (b) pathogen identification and antibiotic susceptibility testing; or (c) a service described in item 69300, 69303, 69306, 69312, 69318, 69363, 69369, 69372, 69375 or 73810; 1 or more tests on 1 or more specimens N 69315 01NOV2000 Microscopy and culture to detect pathogenic micro-organisms, and the detection of chlamydia from urethra, vagina, cervix or rectum and including (if performed): (a)the detection of microbial antigens; or (b)pathogen identification and antibiotic susceptibility testing; or (c)a service described in items 69300, 69303, 69306, 69312, 69318, 69363, 69369, 69370, 69372, 69375 or 73810; 1 or more tests on 1 or more specimens Y 69316 01MAY2007 Detection of Chlamydia trachomatis by any method - 1 test (Item is subject to rule 26) Y 69317 01MAY2007 1 test described in item 69494 and a test described in 69316.(Item is subject to rule 26) Y 69318 01NOV1998 Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from specimens of sputum (except when part of items 69324, 69327 and 69330), including (if performed): (a)the detection of antigens not elsewhere specified in this Table; or (b) pathogen identification and antibiotic susceptibility testing; or (c)a service described in items 69300, 69303, 69306 and 69312; 1 or more tests on 1 or more specimens N 69318 01MAY2003 Microscopy and culture to detect pathogenic micro-organisms (including fungi but excluding viruses) from specimens of sputum (except when part of items 69324, 69327 and 69330), including (if performed): (a)the detection of antigens (from any type of specimen) not elsewhere specified in this Table including item 69372; or (b) pathogen identification and antibiotic susceptibility testing; or (c)a service described in items 69300, 69303, 69306 and 69312; 1 or more tests on 1 or more specimens N 69318 01NOV2005 Microscopy and culture to detect pathogenic micro-organisms from specimens of sputum (except when part of items 69324, 69327 and 69330), including (if performed): (a) pathogen identification and antibiotic susceptibility testing; or (b)a service described in items 69300, 69303, 69306 and 69312; 1 or more tests on 1 or more specimens Y 69319 01MAY2007 2 tests described in item 69494 and a test described in 69316. (Item is subject to rule 26) Y 69321 01NOV1998 Microscopy and culture of post-operative wounds, aspirates of body cavities, synovial fluid, CSF or operative or biopsy specimens, for the presence of pathogenic micro-organisms (including fungi but excluding viruses) involving aerobic and anaerobic cultures and the use of different culture media, and including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b)the detection of antigens not elsewhere specified in this Table; or (c)a service described in item 69300, 69303, 69306, 69312 or 69318; specimens from 1 or more sites N 69321 01NOV2005 Microscopy and culture of post-operative wounds, aspirates of body cavities, synovial fluid, CSF or operative or biopsy specimens, for the presence of pathogenic micro-organisms involving aerobic and anaerobic cultures and the use of different culture media, and including (if performed): (a)pathogen identification and antibiotic susceptibility testing; or (b)a service described in item 69300, 69303, 69306, 69312 or 69318; specimens from 1 or more sites Y 69324 01NOV1998 Microscopy with appropriate stains and culture of 1 specimen of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300 N 69324 01MAY2000 Microscopy with appropriate stains and culture of 1 specimen of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300 N 69324 01NOV2000 Microscopy (with appropriate stains) and culture for mycobacteria - 1 specimen of sputum, urine, or other body fluid or 1 operative or biopsy specimen, including (if performed): (a)microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b)pathogen identification and antibiotic susceptibility testing; including a service mentioned in item 69300 Y 69325 01MAY2007 A test described in item 69324 if rendered by a receiving APP (Item is subject to rule 18) Y 69327 01NOV1998 Microscopy with appropriate stains and culture of 2 specimens of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300 N 69327 01NOV2000 Microscopy (with appropriate stains) and culture for mycobacteria - 2 specimens of sputum, urine, or other body fluid or 2 operative or biopsy specimens, including (if performed): (a)microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b)pathogen identification and antibiotic susceptibility testing; including a service mentioned in item 69300 Y 69328 01MAY2007 A test described in item 69327 if rendered by a receiving APP (Item is subject to rule 18) Y 69330 01NOV1998 Microscopy with appropriate stains and culture of 3 specimens of sputum, urine, other body fluids or operative or biopsy specimens for mycobacteria including (if performed): (a) microscopy and culture of other bacterial pathogens; or (b) pathogen identification and antibiotic susceptibility testing; including a service described in item 69300 N 69330 01NOV2000 Microscopy (with appropriate stains) and culture for mycobacteria - 3 specimens of sputum, urine, or other body fluid or 3 operative or biopsy specimens, including (if performed): (a)microscopy and culture of other bacterial pathogens isolated as a result of this procedure; or (b)pathogen identification and antibiotic susceptibility testing; including a service mentioned in item 69300 Y 69331 01MAY2007 A test described in item 69330 if rendered by a receiving APP (Item is subject to rule 18) Y 69333 01NOV1998 Urine examination (including serial examination) by any means other than simple culture by dip slide, including: (a)cell count; and (b)culture; and (c)colony count; and (d)(if performed) stained preparations; and (e)(if performed) identification of cultured pathogens; and (f)(if performed) antibiotic suseptibility testing; and (g)(if performed) examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts N 69333 01JUL2011 Urine examination (including serial examination) by any means other than simple culture by dip slide, including: (a)cell count; and (b)culture; and (c)colony count; and (d)(if performed) stained preparations; and (e)(if performed) identification of cultured pathogens; and (f)(if performed) antibiotic susceptibility testing; and (g)(if performed) examination for pH, specific gravity, blood, protein, urobilinogen, sugar, acetone or bile salts Y 69336 01NOV1998 Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) with a maximum of 3 examinations on specimens collected on separate days, including (if performed) a service described in item 69300 - 1 examination N 69336 01MAY2000 Microscopy of faeces for parasites using concentration techniques (including the use of appropriate stains) with a maximum of 3 examinations on specimens collected on separate days in any 7 day period, including (if performed) a service described in item 69300 - 1 examination N 69336 01NOV2000 Microscopy of faeces for ova, cysts and parasites using concentration techniques (including the use of appropriate stains) with no more than 3 examinations on specimens collected on separate days in any 7 day period, including (if performed) a service mentioned in item 69300 - 1 examination N 69336 01MAY2003 Microscopy of faeces for ova, cysts and parasites using concentration techniques and including use of fixed stains for cryptosporidia and giardia - 1 examination in any 7 day period N 69336 01NOV2003 Microscopy of faeces for ova, cysts and parasites using concentration techniques including use of fixed stains or antigen detection for cryptosporidia and giardia - including (if performed) a service mentioned in item 69300 - 1 examination in any 7 day period N 69336 01MAY2005 Microscopy of faeces for ova, cysts and parasites that must include a concentration technique, and the use of fixed stains or antigen detection for cryptosporidia and giardia - including (if performed) a service mentioned in item 69300 - 1 of this item in any 7 day period Y 69339 01NOV1998 2 examinations described in item 69336 performed on separately collected and identified specimens N 69339 01MAY2003 Microscopy of faeces for ova, cysts and parasites using concentration techniques examined subsequent to item 69336 on a separately collected and identified specimen collected within 7 days of the examination described in 69336 - 1 examination in any 7 day period Y 69342 01NOV1998 3 examinations described in item 69336 performed on separately collected and identified specimens Y 69345 01NOV1998 Culture of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a)pathogen identification and antibiotic susceptibility testing;and (b)the detection of clostridial toxins or antigens not elsewhere specified in this Table;and (c)a service described in item 69300; with a maximum of 3 examinations performed on separately collected and identified specimens in any 7 day period - 1 examination N 69345 01NOV2000 Culture and (if performed) microscopy without concentration techniques of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a)pathogen identification and antibiotic susceptibility testing;and (b)the detection of clostridial toxins or antigens not elsewhere specified in this Table;and (c)a service described in item 69300; with no more than 3 examinations performed on separately collected and identified specimens in any 7 day period - 1 examination N 69345 01MAY2002 Culture and (if performed) microscopy without concentration techniques of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a)pathogen identification and antibiotic susceptibility testing;and (b)the detection of clostridial toxins or antigens not elsewhere specified in this Table;and (c)a service described in item 69300; with no more than 3 examinations performed on separately identified specimens, collected at different times in any 7 day period - 1 examination N 69345 01MAY2003 Culture and (if performed) microscopy without concentration techniques of faeces for faecal pathogens, using at least 2 selective or enrichment media and culture in at least 2 different atmospheres including (if performed): (a)pathogen identification and antibiotic susceptibility testing; and (b)the detection of clostridial toxins; and (c)a service described in item 69300; - 1 examination in any 7 day period Y 69348 01NOV1998 2 examinations described in item 69345 performed on separately collected and identified specimens Y 69351 01NOV1998 3 examinations described in item 69345 performed on separately collected and identified specimens Y 69354 01NOV1998 Blood culture for pathogenic micro-organisms (other than viruses), including sub-cultures and (if performed): (a)identification of any cultured pathogen;and (b)necessary antibiotic susceptibility testing; to a maximum of 3 sets of cultures - 1 set of cultures Y 69357 01NOV1998 2 sets of cultures described in item 69354 Y 69360 01NOV1998 3 sets of cultures described in item 69354 Y 69363 01NOV1998 Detection of clostridium difficile or clostridium difficile toxin (except if a service described in item 69345, 69348, 69351, 69369 or 69372 has been performed) - 1 or more tests N 69363 01NOV2001 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69348, 69351, 69369 or 69372 has been performed) - 1 or more tests N 69363 01NOV2002 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69348, 69351, 69369, 69370 or 69372 has been performed) - 1 or more tests N 69363 01MAY2003 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345, 69369, 69370 or 69372 has been performed) - 1 or more tests N 69363 01MAY2004 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in items 69345, 69369, 69370, 69372, 69373 or 69375 has been performed) - 1 or more tests N 69363 01NOV2005 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in items 69345, 69369, 69370, 69373 or 69375 has been performed) - 1 or more tests N 69363 01NOV2014 Detection of Clostridium difficile or Clostridium difficile toxin (except if a service described in item 69345 has been performed) - one or more tests Y 69364 01NOV2005 Detection of a virus or microbial antigen or microbial nucleic acid (not elsewhere specified) 1 test (Item is subjuect to rule 25) N 69364 01MAY2006 Detection of a virus or microbial antigen or microbial nucleic acid (not elsewhere specified) 1 test (Item is subject to rule 26) Y 69365 01NOV2005 2 or more tests described in 69364 (Item is subject to rule 25) N 69365 01MAY2006 2 or more tests described in 69364 (Item is subject to rule 26) N 69365 01NOV2006 2 tests described in 69364 (Item is subject to rule 26) Y 69366 01NOV1998 Test for Helicobacter pylori in faeces, for either: (a)the confirmation of Helicobacter pylori colonisation; where (i)suitable biopsy material for diagnosis cannot be obtained at endoscopy in patients with peptic ulcer disease, or where the diagnosis of peptic ulcer has been made on barium meal; or (ii)in patients with a history of peptic ulcer disease or gastric neoplasia, where endoscopy is not indicated; or (b)the monitoring of the success of eradication therapy for Helicobacter pylori in patients with peptic ulcer disease; where any request for the test by a medical practitioner specifically identifies in writing one or more of the clinical indications for the test Y 69367 01NOV2006 3 or more tests described in 69364 (Item is subject to rule 26) Y 69369 01NOV1998 Detection of chlamydia by any method in specimens from 1 or more sites Y 69370 01NOV1999 Detection of chlamydia by any method and Neisseria gonorrhoeae by nucleic acid amplification techniques in specimens from 1 or more sites Y 69372 01NOV1998 Detection of microbial antigens (except if the service described in item 69369 has been performed)1 or more tests N 69372 01NOV2000 Detection of microbial antigens (except if the service described in item 69369 or 69370 has been performed) - 1 or more tests N 69372 01NOV2002 Detection of microbial antigens or nucleic acids (except if the service described in item 69369 or 69370 has been performed) - 1 or more tests N 69372 01MAY2004 Detection of microbial antigens or nucleic acids (not elsewhere described in this table) - 1 or more tests Y 69373 01MAY2004 Detection of a virus or microbial antigen or nucleic acid from a respiratory tract specimen - 1 test Y 69374 01MAY2004 2 or more tests described in 69373 Y 69375 01NOV1998 Examination for Herpes simplex virus, varicella zoster virus and cytomegalovirus by culture, including a service described in item 69315, 69369 or 69372 (if performed) N 69375 01MAR1999 Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture, including a service described in item 69369 or 69372 (if performed) - 1 or more tests N 69375 01NOV2001 Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by nucleic acid amplification technique, including a service described in item 69369 or 69372 (if performed) - 1 or more tests N 69375 01NOV2002 Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by nucleic acid amplification technique, including a service described in item 69369, 69370 or 69372 (if performed) - 1 or more tests N 69375 01MAY2004 Examination for Herpes simplex virus, varicella zoster virus or cytomegalovirus by culture or by detection of microbial antigen or nucleic acid, including a service described in item 69363, 69369, 69370, 69372 or 69373 (if performed) - 1 test Y 69376 01MAY2004 2 or more tests described in 69375 Y 69378 01NOV1998 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV seropositive patient, who is not on antiretroviral therapy1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20) N 69378 01MAR1999 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV seropositive patient, who is not on antiretroviral therapy1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20) N 69378 01JUL1999 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV sero-positive patient not on antiretroviral therapy - 1 or more assays on 1 or more specimens in any 1 episode N 69378 01MAY2005 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV sero-positive patient not on antiretroviral therapy - 1 or more tests on 1 or more specimens N 69378 01MAY2008 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of a HIV sero-positive patient not on antiretroviral therapy - 1 or more tests Y 69379 01MAY2007 A test described in item 69378 if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 69380 01JUL2011 Genotypic testing for HIV antiretroviral resistance in a patient with confirmed HIV infection if the patient's viral load is greater than 1,000 copies per ml at any of the following times: (a)at presentation; or (b)before antiretroviral therapy: or (c)when treatment with combination antiretroviral agents fails; maximum of 2 tests in a 12 month period Y 69381 01NOV1998 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV seropositive patient1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20) N 69381 01MAR1999 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV seropositive patient1 or more assays on 1 or more specimens in any 1 episode to a maximum of 7 episodes in a 12 month period (Item is subject to rule 20) N 69381 01JUL1999 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV sero-positive patient - 1 or more assays on 1 or more specimens in any 1 episode N 69381 01MAY2005 Quantitation of HIV viral RNA load in plasma or serum in the monitoring of antiretroviral therapy in a HIV sero-positive patient - 1 or more tests on 1 or more specimens Y 69382 01MAR1999 Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV sero-positive patient - 1 or more assays on 1 or more specimens in any 1 episode (Item is not subject to rule 20) N 69382 01JUL1999 Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV sero-positive patient - 1 or more assays on 1 or more specimens in any 1 episode N 69382 01MAY2005 Quantitation of HIV viral RNA load in cerebrospinal fluid in a HIV sero-positive patient - 1 or more tests on 1 or more specimens Y 69383 01MAY2007 A test described in item 69381 if rendered by a receiving APP - 1 or more tests on 1 or more specimens (Item is subject to rule 18) Y 69384 01NOV1998 Quantitation of 1 antibody to microbial or exogenous antigens not elsewhere described in the Schedule - 1 test (This fee applies where a laboratory performs the only antibody test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) N 69384 01NOV2007 Quantitation of 1 antibody to microbial antigens not elsewhere described in the Schedule - 1 test (This fee applies where a laboratory performs the only antibody test specified on the request form or performs 1 test and refers the rest to the laboratory of a separate APA) (Item is subject to rule 6) Y 69387 01NOV1998 2 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 2 estimations specified on the request form or performs 2 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6) Y 69390 01NOV1998 3 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 3 estimations specified on the request form or performs 3 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6) Y 69393 01NOV1998 4 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 4 estimations specified on the request form or performs 4 of the antibody estimations specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6) Y 69396 01NOV1998 5 tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 estimations specified on the request form or performs 5 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6) N 69396 01JUL2008 5 or more tests described in item 69384 (This fee applies where 1 laboratory, or more than 1 laboratory belonging to the same APA, performs the only 5 estimations specified on the request form or performs 5 of the antibody tests specified on the request form and refers the remainder to the laboratory of a separate APA) (Item is subject to rule 6) Y 69399 01NOV1998 6 or more tests described in item 69384 N 69399 01MAY2007 6 or more tests described in item 69384 (Item is subject to rule 6) Y 69400 01MAY2007 A test described in item 69384, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rules 6 and 18) Y 69401 01MAY2007 A test described in item 69384, other than that described in 69400, if rendered by a receiving APP - each test to a maximum of 5 tests (Item is subject to rule 6 and 18) N 69401 01NOV2008 A test described in item 69384, other than that described in 69400, if rendered by a receiving APP - each test to a maximum of 4 tests (Item is subject to rule 6, 18 and 18A) Y 69402 01NOV1998 Tests described in item 69384, if rendered under a request referred to in subparagraph (2) (a) (iii) of rule 6 - each test to a maximum of 5 tests (Item is subject to rule 6) Y 69405 01NOV1998 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of 1 of the following - rubella immune status, specific syphilis serology, hepatitis B surface antigen; and (b)(if performed) a service described in 1 or more of items 69384, 69414 to 69435, 69447 to 69456, 69462 and 69465 N 69405 01NOV2002 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 1 of the following - rubella immune status, specific syphilis serology, Hepatitis B surface antigen; and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69484, 69487, 69490 and 69493 N 69405 01MAY2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 1 of the following - rubella immune status, specific syphilis serology, or carriage of Hepatitis B; and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69487, 69490 and 69493 N 69405 01NOV2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 1 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 N 69405 01NOV2005 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 1 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 Y 69408 01NOV1998 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of 2 of the following - rubella immune status, specific syphilis serology or,hepatitis B surface antigen; and (b)(if performed) a service described in 1 or more of items 69384, 69414 to 69435, 69447 to 69456, 69462 and 69465 N 69408 01NOV2002 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 2 of the following - rubella immune status, specific syphilis serology, Hepatitis B surface antigen; and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69484, 69487, 69490 and 69493 N 69408 01MAY2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 2 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody test; and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 N 69408 01NOV2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 2 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 N 69408 01NOV2005 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 2 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 Y 69411 01NOV1998 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness during that pregnancy) including: (a)the determination of all 3 of the following - rubella immune status, specific syphilis serology and,hepatitis B surface antigen; and (b)(if performed) a service described in 1 or more of items 69384, 69414 to 69435, 69447 to 69456, 69462 and 69465 N 69411 01NOV2002 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of all 3 of the following - rubella immune status, specific syphilis serology, Hepatitis B surface antigen; and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69484, 69487, 69490 and 69493 N 69411 01MAY2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of all 3 of the following - rubella immune status, specific syphilis serology, and carriage of Hepatitis B; and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478, 69481, 69487, 69490 and 69493 N 69411 01NOV2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 3 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 N 69411 01NOV2005 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 3 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 Y 69413 01NOV2003 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of all 4 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 N 69413 01NOV2005 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of 4 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 Y 69414 01NOV1998 Investigation for acute Hepatitis A using: Hepatitis A IgM antibody test (Item is subject to rule 11) Y 69415 01NOV2005 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of all 5 of the following - rubella immune status, specific syphillis serology, carriage of Hepatitus B, Hepatitus C antibody, HIV antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 N 69415 01MAY2008 Microbiological serology during a pregnancy (except in the investigation of a clinically apparent intercurrent microbial illness or close contact with a patient suffering from parvovirus infection or varicella during that pregnancy) including: (a)the determination of all 5 of the following - rubella immune status, specific syphilis serology, carriage of Hepatitis B, Hepatitis C antibody, HIV antibody and (b)(if performed) a service described in 1 or more of items 69384, 69475, 69478 and 69481 Y 69417 01NOV1998 Determination of immune status to Hepatitis A using: Hepatitis A IgG antibody test (Item is subject to rule 11) Y 69418 01MAY2007 A test for high risk human papillomaviruses (HPV) in a patient who: - has received excisional or ablative treatment for high grade squamous intraepithelial lesions (HSIL) of the cervix within the last two years; or - who within the last two years has had a positive HPV test after excisional or ablative treatment for HSIL of the cervix; or - is already undergoing annual cytological review for the follow-up of a previously treated HSIL. - to a maximum of 2 of this item in a 24 month period (Item is subject to rule 25) Y 69419 01MAY2007 A test described in item 69418 if rendered by a receiving APP - 1 test (Item is subject to rule 18 and 25 ) Y 69420 01NOV1998 Investigation for acute or resolving Hepatitis B, or testing of close, recent contacts of proven Hepatitis B infection, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis B core antibody test; and (c)(if performed,) Hepatitis B e antibody test (where the Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive) (Item is subject to rule 11) Y 69423 01NOV1998 Investigation for resolution of Hepatitis B if the Hepatitis B core antibody test is positive and the Hepatitis B surface antigen test is negative, including: (a)Hepatitis B core antibody test; and (b)Hepatitis B surface antigen test; and (c)Hepatitis B surface antibody test (Item is subject to rule 11) Y 69426 01NOV1998 Determination of immune status to Hepatitis B (post exposure) using: Hepatitis B core antibody test (Item is subject to rule 11) Y 69429 01NOV1998 Determination of immune status to Hepatitis B (post vaccination) using: Hepatitis B surface antibody test (Item is subject to rule 11) Y 69432 01NOV1998 Investigation for chronic Hepatitis B or determination of carriage of Hepatitis B antigen using: Hepatitis B surface antigen test (Item is subject to rule 11) Y 69435 01NOV1998 Investigation for chronic Hepatitis B or carriage of Hepatitis B antigen if the Hepatitis B surface antigen test is positive, including: (a)Hepatitis B surface antigen test;and (b)Hepatitis B e antigen test (Item is subject to rule 11) Y 69438 01NOV1998 Testing for Hepatitis C using: Hepatitis C antibody test (Item is subject to rule 11) Y 69441 01NOV1998 Supplementary testing for Hepatitis C antibodies using a different Hepatitis C antibody assay on the specimen which has a reactive result on the initial Hepatitis C antibody test. (Item is not subject to rule 11) Y 69442 01NOV2000 Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation for antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69444 or 69445) - not exceeding 1 episode in a 12 month period (Item is subject to rule 19) N 69442 08DEC2003 Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation or the assessment of efficacy of antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69444 or 69445) - not more than 2 tests in a 12 month period N 69442 01MAY2005 Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation or the assessment of efficacy of antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69444 or 69445) - To a maximum of 2 of this item in a 12 month period Y 69443 01NOV2000 Nucleic acid amplification and determination of hepatitis C virus (HCV) genotype provided: (a) the patient is HCV RNA positive; and (b)the patient is being evaluated for antiviral therapy of chronic HCV hepatitis; where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis - not exceeding 1 episode N 69443 01NOV2001 Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if: (a)the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis; and (b)the request for the test is made by, or on the advice of, the specialist or consultant physician managing the treatment of the patient; No more than 1 episode in a 12 month period N 69443 01MAY2005 Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if: (a)the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis; and (b)the request for the test is made by, or on the advice of, the specialist or consultant physician managing the treatment of the patient; To a maximum of 1 of this item in a 12 month period Y 69444 01NOV1998 Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a)the patient is Hepatitis C seropositive and has normal liver function tests on 2 occasions at least 6 months apart; (b)the patient's serological status is uncertain after testing; (c)the test is performed for the purpose of: (i)determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii)the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; Not exceeding 1 episode in a 12 month period (Item is subject to rule 19) N 69444 01MAY2004 Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a)the patient is Hepatitis C seropositive; (b)the patient's serological status is uncertain after testing; (c)the test is performed for the purpose of: (i)determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii)the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; Not exceeding 1 episode in a 12 month period (Item is subject to rule 19) N 69444 01MAY2005 Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a)the patient is Hepatitis C seropositive; (b)the patient's serological status is uncertain after testing; (c)the test is performed for the purpose of: (i)determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii)the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; To a maximum of 1 of this item in a 12 month period (Item is subject to rule 19) Y 69445 01NOV2000 Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69444) - not exceeding 4 episodes in a 12 month period (Item is subject to rule 19) N 69445 01MAY2005 Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69444) - 1 test. To a maximum of 4 of this item in a 12 month period (Item is subject to rule 19) N 69445 01MAY2007 Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69444) - 1 test. To a maximum of 4 of this item in a 12 month period (Item is subject to rule 25) N 69445 01NOV2007 Detection of Hepatitis C viral RNA in a patient undertaking antiviral therapy for chronic HCV hepatitis (including a service described in item 69499) - 1 test. To a maximum of 4 of this item in a 12 month period (Item is subject to rule 25) Y 69447 01NOV1998 Investigation for acute or chronic Hepatitis D in a patient with a positive Hepatitis B surface antigen test using: Hepatitis D antibody test (Item is subject to rule 11) Y 69450 01NOV1998 Determination of immune status to Hepatitis A and Hepatitis B, including: (a)Hepatitis A IgG antibody test;and (b)Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 11) Y 69451 01MAY2007 A test described in item 69445 if rendered by a receiving APP - 1 test. (Item is subject to rule 18 and 25) Y 69453 01NOV1998 Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, including: (a)Hepatitis B surface antigen test; and (b)Hepatitis C antibody test (Item is subject to rule 11) Y 69456 01NOV1998 Investigation for chronic viral hepatitis, or Hepatitis B or Hepatitis C carriage, if Hepatitis B surface antigen test is positive, including: (a)Hepatitis C antibody test; and (b)Hepatitis B surface antigen test; and (c)Hepatitis B e antigen test (Item is subject to rule 11) Y 69459 01NOV1998 Investigation for acute Hepatitis A, Hepatitis B, Hepatitis C and Hepatitis D in a patient with a currently elevated transaminase level, including: (a)Hepatitis A IgM antibody test; and (b)Hepatitis C antibody test; and (c)Hepatitis B surface antigen test; and (d)Hepatitis B core antibody test; and (e)(if performed) Hepatitis B e antibody test (if Hepatitis B surface antigen test is negative and Hepatitis B core antibody test is positive); and (f)( if performed) Hepatitis D antibody test (if Hepatitis B surface antigen test is positive) (Item is subject to rule 11) Y 69462 01NOV1998 Determination of immune status to Hepatitis B and testing for Hepatitis C, including: (a)Hepatitis C antibody test; and (b)Hepatitis B core antibody test or Hepatitis B surface antibody test (Item is subject to rule 12) N 69462 01NOV2000 Determination of Hepatitis B status and testing for Hepatitis C, including: (a)Hepatitis C antibody test; and (b)Hepatitis B core antibody test and if this is positive; (c)Hepatitis B surface antigen test (Item is subject to rule 11) Y 69465 01NOV1998 Syphilis serology and any 1 of items 69435, 69438 or 69453 (Item is subject to rule 11) Y 69468 01NOV1998 Investigation for acute Hepatitis A and Hepatitis C in a patient with a currently elevated transaminase level, including: (a)Hepatitis A IgM antibody test; and (b)Hepatitis C antibody test (Item subject to rule 11) Y 69471 01NOV1998 Test of cell-mediated immunity in blood for the detection of active tuberculosis or atypical mycobacterial infection in an immunosuppressed or immunocompromised patient - 1 test N 69471 01NOV2008 Test of cell-mediated immunity in blood for the detection of latent tuberculosis in an immunosuppressed or immunocompromised patient - 1 test N 69471 01MAY2017 Test of cell?mediated immune response in blood for the detection of latent tuberculosis by interferon gamma release assay (IGRA) in the following people: (a) a person who has been exposed to a confirmed case of active tuberculosis; (b) a person who is infected with human immunodeficiency virus; (c) a person who is to commence, or has commenced, tumour necrosis factor (TNF) inhibitor therapy; (d) a person who is to commence, or has commenced, renal dialysis; (e) a person with silicosis; (f) a person who is, or is about to become, immunosuppressed because of a disease, or a medical treatment, not mentioned in paragraphs(a) to (e) Y 69472 01NOV2001 Detection of antibodies to Epstein Barr Virus using specific serology - 1 test Y 69474 01NOV2001 Detection of antibodies to Epstein Barr Virus using specific serology - 2 or more tests Y 69475 01NOV2002 One test for hepatitis antigen or antibodies to determine immune status or viral carriage following exposure or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D including: (a)One test for antibodies to Hepatitis A; or (b)One test for antibodies to or antigens of Hepatitis B; or (c)One test for antibodies to Hepatitis C; or (d)One test for antibodies to Hepatitis D in a patient who is Hepatitis B surface antigen positive (Item subject to rule 11) N 69475 01MAY2008 One test for hepatitis antigen or antibodies to determine immune status or viral carriage following exposure or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D (Item subject to rule 11) Y 69478 01NOV2002 Two tests for hepatitis antigens or antibodies to determine immune status or viral carriage following exposure to, or vaccination to Hepatitis A, Hepatitis B, Hepatitis C or Hepatitis D including: (a)One test for antibodies to Hepatitis A; or (b)One test for surface or core antibodies to Hepatitis B; or (c)One test for surface antigen of Hepatitis B; or (d)One test for 'e' antibodies to or 'e' antigen of Hepatitis B; or (e)One test for antibodies to Hepatitis C; or (f)One test for antibodies to Hepatitis D in a patient who is Hepatitis B surface antigen positive (Item subject to rule 11) N 69478 01MAY2008 2 tests described in 69475 (Item subject to rule 11) Y 69481 01NOV2002 Three tests for the investigation of infectious causes of acute or chronic hepatitis including: (a)One test for antibodies to Hepatitis A; or (b)One test for core antibodies to Hepatitis B; or (c)One test for 'e' antibodies to or 'e' antigens of Hepatitis B; or (d)One test for surface antibodies to or surface antigen of Hepatitis B; or (e)One test for antibodies to Hepatitis C; or (f)One test for antibodies to Hepatitis D in a patient who is Hepatitis B surface antigen positive (Item subject to rule 11) N 69481 01MAY2008 Investigation of infectious causes of acute or chronic hepatitis - 3 tests for hepatitis antibodies or antigens, (Item subject to rule 11) Y 69482 01JUL2008 Quantitation of Hepatitis B viral DNA in patients who are Hepatitis B surface antigen positive and have chronic hepatitis B, but are not receiving antiviral therapy - 1 test (Item is subject to rule 25) Y 69483 01JUL2008 Quantitation of Hepatitis B viral DNA in patients who are Hepatitis B surface antigen positive and who have chronic hepatitis B and are receiving antiviral therapy - 1 test (Item is subject to rule 25) Y 69484 01NOV2002 Supplementary testing for Hepatitis B surface antigen or Hepatitis C antibody using a different assay on the specimen which yielded a reactive result on initial testing (Item is not subject to rule 11) N 69484 01MAY2008 Supplementary testing for Hepatitis B surface antigen or Hepatitis C antibody using a different assay on the specimen which yielded a reactive result on initial testing (Item is subject to rule 18) Y 69486 01NOV2005 A test for high risk human papillomaviruses (HPV) in a patient who: - has received excisional or ablative treatment for high grade intraepithelial abnormalities of the cervix within the last two years; or - who within the last two years has had a positive HPV test after excisional or ablative treatment for high grade intraepithelial abnormalities of the cervix -to a maximum of 2 of this item in a 24 month period N 69486 01MAY2006 A test for high risk human papillomaviruses (HPV) in a patient who: - has received excisional or ablative treatment for high grade squamous intraepithelial lesions (HSIL) of the cervix within the last two years; or - who within the last two years has had a positive HPV test after excisional or ablative treatment for HSIL of the cervix; or - is already undergoing annual cytological review for the follow-up of a previously treated HSIL. - to a maximum of 2 of this item in a 24 month period Y 69487 01NOV2002 One test referred to in 69475 and a supplementary test described in 69484 (Item subject to rule 11) Y 69488 01MAY2007 Quantitation of HCV RNA load in plasma or serum in the pretreatment evaluation or the assessment of efficacy of antiviral therapy of a patient with chronic HCV hepatitis - where any request for the test is made by or on the advice of the specialist or consultant physician who manages the treatment of the patient with chronic HCV hepatitis (including a service in item 69499 or 69445) (Item is subject to rule 18 and 25) N 69488 01DEC2017 Quantitation of HCV RNA load in plasma or serum in: (a) the pre-treatment evaluation,of a patient with chronic HCV hepatitis, for antiviral therapy;or (b) the assessment of efficacy of antiviral therapy for such a patient (including a service in item 69499 or 69445) (Item is subject to rule 18 and 25) Y 69489 01MAY2007 A test described in item 69488 if rendered by a receiving APP (Item is subject to rule 18 and 25) Y 69490 01NOV2002 Two tests referred to in 69478 and a supplementary test described in 69484 (Item subject to rule 11) Y 69491 01MAY2007 Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if: (a)the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis; and (b)the request for the test is made by, or on the advice of, the specialist or consultant physician managing the treatment of the patient; To a maximum of 1 of this item in a 12 month period N 69491 01DEC2017 Nucleic acid amplification and determination of Hepatitis C virus (HCV) genotype if the patient is HCV RNA positive and is being evaluated for antiviral therapy of chronic HCV hepatitis. To a maximum of 1 of this item in a 12 month period Y 69492 01MAY2007 A test described in item 69491 if rendered by a receiving APP - 1 test(Item is subject to rule 18 and 25) Y 69493 01NOV2002 Three tests referred to in 69481 and a supplementary test described in 69484 (Item subject to rule 11) Y 69494 01MAY2007 Detection of a virus or microbial antigen or microbial nucleic acid (not elsewhere specified) 1 test (Item is subject to rule 6 and 26) Y 69495 01MAY2007 2 tests described in 69494 (Item is subject to rule 6 and 26) Y 69496 01MAY2007 3 or more tests described in 69494 (Item is subject to rule 6 and 26) Y 69497 01MAY2007 A test described in item 69494, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6, 18 and 26) Y 69498 01MAY2007 A test described in item 69494, other than that described in 69497, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6, 18 and 26) Y 69499 01MAY2007 Detection of Hepatitis C viral RNA if at least 1 of the following criteria is satisfied: (a)the patient is Hepatitis C seropositive; (b)the patient's serological status is uncertain after testing; (c)the test is performed for the purpose of: (i)determining the Hepatitis C status of an immunosuppressed or immunocompromised patient; or (ii)the detection of acute Hepatitis C prior to seroconversion where considered necessary for the clinical management of the patient; To a maximum of 1 of this item in a 12 month period (Item is subject to rule 19 and 25) Y 69500 01MAY2007 A test described in item 69499 if rendered by a receiving APP - 1 test (Item is subject to rule 18,19 and 25) Y 71001 01DEC1991 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixation1 or more procedures Y 71002 01DEC1991 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245/66246, 66247/66248 or 71005/71006), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresis or immunofixationone or more procedures Y 71003 01DEC1991 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245, 66247 or 71005) on serum and urine concurrently collected2 or more procedures Y 71004 01DEC1991 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 66245/66246, 66247/66248 or 71005/71006) on serum and urine concurrently collectedtwo or more procedures Y 71005 01DEC1991 Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method estimation of 1 immunoglobin Y 71006 01DEC1991 Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any methodestimation of one immunoglobin Y 71007 01DEC1991 2 estimations specified in item 71005 Y 71008 01DEC1991 Two estimations specified in item 71005/71006 Y 71009 01DEC1991 3 or more estimations specified in item 71005 Y 71010 01DEC1991 Three or more estimations specified in item 71005/71006 Y 71011 01DEC1991 Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA1 or more estimations Y 71012 01DEC1991 Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgAone or more estimation Y 71013 01DEC1991 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of 2 estimations in any 12 month period Y 71014 01DEC1991 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period Y 71015 01DEC1991 Specific IgG or IgE antibodies to potential allergens1 or more tests for single or multiple allergens with a maximum of 4 estimations in any 12 month period Y 71016 01DEC1991 Specific IgG or IgE antibodies to potential allergensone or more tests for single or multiple allergens with a maximum of four estimations in any twelve month period Y 71017 01DEC1991 Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required Y 71018 01DEC1991 Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required Y 71019 01DEC1991 Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1 in 40 or greater has been obtained Y 71020 01DEC1991 Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method), performed only where a positive antinuclear antibody titre of 1 in 40 or greater has been obtained Y 71021 01DEC1991 Antibodies to extractable nuclear antigens, detection of in serum or other body fluids Y 71022 01DEC1991 Antibodies to extractable nuclear antigens, detection of in serum or other body fluids Y 71023 01DEC1991 Characterisation of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021 N 71023 01DEC1991 Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021 Y 71024 01DEC1991 Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 71021/71022 Y 71025 01DEC1991 Antibodies to tissue antigens which are not elsewhere specified in an item in the Scheduleestimation of 1 antibody Y 71026 01DEC1991 Antibodies to tissue antigens which are not elsewhere specified in an item in the Scheduleestimation of one antibody Y 71027 01DEC1991 2 estimations specified in item 71025 Y 71028 01DEC1991 Two estimations specified in item 71025/71026 Y 71029 01DEC1991 3 estimations specified in item 71025 Y 71030 01DEC1991 Three estimations specified in item 71025/71026 Y 71031 01DEC1991 4 or more estimations specified in item 71025 Y 71032 01DEC1991 Four or more estimations specified in item 71025/71026 Y 71033 01DEC1991 Rheumatoid factor, detection of by any technique Y 71034 01DEC1991 Rheumatoid factor, detection of by any technique. Y 71035 01DEC1991 Quantitation of Rheumatoid factor where detected, including services specified in item 71033 Y 71036 01DEC1991 Quantitation of Rheumatoid factor where detected, including services specified in item 71033/71034 Y 71037 01DEC1991 Complementtotal and components1 quantitative estimation Y 71038 01DEC1991 Complementtotal and componentsone quantitative estimation Y 71039 01DEC1991 2 estimations specified in item 71037 Y 71040 01DEC1991 2 estimations specified in item 71037/71038 Y 71041 01DEC1991 3 or more estimations specified in item 71037 Y 71042 01DEC1991 Three or more estimations specified in item 71037/71038 Y 71043 01DEC1991 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests Y 71044 01DEC1991 Leucocyte fractionation as a preliminary toleucocyte marker or leucocyte function tests Y 71045 01DEC1991 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in the HAEMATOLOGY GROUP of the Schedule Y 71046 01DEC1991 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in the HAEMATOLOGY DIVISION of the Schedule Y 71047 01DEC1991 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of 3 monoclonal antibodies, including any services in item 710491 or more estimations Y 71048 01DEC1991 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of three monoclonal antibodies, including any services in item 71049/71050one or more estimations Y 71049 01DEC1991 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techiques in the investigation of a probable haematological malignancy using a minimum of 7 monoclonal antibodies, including any services in item 710471 or more estimations Y 71050 01DEC1991 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techiques in the investigation of a probable haematological malignancy using a minimum of seven monoclonal antibodies, including any services in item 71047/71048one or more estimations Y 71051 01DEC1991 HLA typing comprising A, B, C and DR phenotypes Y 71052 01DEC1991 HLA typing comprising A, B, C and DR phenotypes Y 71053 01DEC1991 HLA typing, excluding any services specified in item 710511 or more antigens Y 71054 01DEC1991 HLA typing, excluding any services specified in item 71051/71052one or more antigens Y 71055 01DEC1991 Mantoux test Y 71056 01DEC1991 Mantoux test Y 71057 01NOV1998 Electrophoresis, quantitative and qualitative, of serum, urine or other body fluid all collected within a 28 day period, to demonstrate: (a)protein classes; or (b)presence and amount of paraprotein; including the preliminary quantitation of total protein, albumin and globulin - 1 specimen type Y 71058 01NOV1998 Examination as described in item 71057 of 2 or more specimen types Y 71059 01NOV1998 Electrophoresis and immunofixation or immuno electrophoresis or isoelectric focussing of: (a)urine for detection of Bence Jones proteins; and (b)serum, plasma or other body fluid; and characterisation, if detected, of a paraprotein or cryoglobulin not previously characterised - examination of 1 specimen type (eg. serum, urine or CSF) N 71059 01NOV2000 Electrophoresis and immunofixation or immunoelectrophoresis or isoelectric focussing of: (a)urine for detection of Bence Jones proteins; or (b)serum, plasma or other body fluid; and characterisation, if detected, of a paraprotein or cryoglobulin not previously characterised - examination of 1 specimen type (eg. serum, urine or CSF) N 71059 01JUL2011 Immunofixation or immunoelectrophoresis or isoelectric focusing of: (a)urine for detection of Bence Jones proteins; or (b)serum, plasma or other body fluid; and characterisation of a paraprotein or cryoglobulin- examination of 1 specimen type (eg. serum, urine or CSF) Y 71060 01NOV1998 Examination as described in item 71059 of 2 or more specimen types Y 71061 01SEP1992 Examination for, and characterisation of, a paraprotein or cryoglobulin not previously characterised on serum, urine or other body fluid by immunoelectrophoresis or immunofixation - 1 or more procedures N 71061 01JUL1994 Immunoelectrophoresis or immunofixation, of serum, urine or other body fluid, and characterisation of, a paraprotein or cryoglobulin not previously characterised, including a service described in 1 or both of items 66213 and 66215 (if performed ) - 1 or more tests Y 71062 01NOV1998 Electrophoresis and immunofixation or immunoelectrophoresis or isoelectric focussing of CSF for the detection of oligoclonal bands and including if required electrophoresis of the patient's serum for comparison purposes - 1 or more tests Y 71063 01SEP1992 Examination for, and characterisation of, a paraprotein not previously characterised, by immunoelectrophoresis or immunofixation on serum and urine collected concurrently - 2 or more procedures Y 71064 01NOV1998 Detection and quantitation of cryoglobulins or cryofibrinogen - 1 or more tests Y 71065 01SEP1992 Examination of CSF and serum concurrently for the presence of oligoclonal proteins - 2 or more procedures N 71065 01JUL1994 Examination of CSF and serum concurrently collected for the presence of oligoclonal proteins - 2 or more tests Y 71066 01NOV2002 Quantitation of total immunoglobulin A by any method in serum, urine or other body fluid - 1 test Y 71067 01SEP1992 Immunoglobulins A, G, M or D, quantitative estimation by any method in serum, urine or other body fluid - 1 estimation N 71067 01JUL1994 Quantitation of total immunoglobulins A, G, M or D by any method in serum, urine or other body fluid - 1 test Y 71068 01NOV2002 Quantitation of total immunoglobulin G by any method in serum, urine or other body fluid - 1 test Y 71069 01SEP1992 2 estimations specified in item 71067 N 71069 01JUL1994 2 tests described in item 71067 N 71069 01NOV2002 2 tests described in items 71066, 71068, 71072 or 71074 Y 71071 01SEP1992 3 or more estimations specified in item 71067 N 71071 01JUL1994 3 or more tests described in item 71067 N 71071 01NOV2002 3 or more tests described in items 71066, 71068, 71072 or 71074 Y 71072 01NOV2002 Quantitation of total immunoglobulin M by any method in serum, urine or other body fluid - 1 test Y 71073 01SEP1992 Immunoglobulin G subclasses, quantitative estimation of all 4 subclasses with a maximum of 2 patient episodes in any 12 month period - each patient episode N 71073 01JUL1994 Quantitation of all 4 immunoglobulin G subclasses, with a maximum of 2 patient episodes in a 12-month period - each patient episode N 71073 01NOV1997 Quantitation of all 4 immunoglobulin G subclasses - each patient episode N 71073 01MAY2005 Quantitation of all 4 immunoglobulin G subclasses Y 71074 01NOV2002 Quantitation of total immunoglobulin D by any method in serum, urine or other body fluid - 1 test Y 71075 01SEP1992 Immunoglobulin E (total), quantitative estimation with a maximum of 2 patient episodes in any 12 month period - each patient episode N 71075 01JUL1994 Quantitation of immunoglobulin E (total), with a maximum of 2 patient episodes in any 12 month period - each patient episode N 71075 01MAY2005 Quantitation of immunoglobulin E (total), 1 test. To a maximum of 2 of this item in a 12 month period N 71075 01MAY2007 Quantitation of immunoglobulin E (total), 1 test. (Item is subject to rule 25) Y 71076 01MAY2007 A test described in item 71073 if rendered by a receiving APP - 1 test (Item is subject to rule 18) Y 71077 01SEP1992 Immunoglobulin E (total), quantitative estimation in the follow up of a patient with proven immunoglobulin E secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in any 12 month period - each patient episode N 71077 01JUL1994 Quantitation of immunoglobulin E (total) in the follow up of a patient with proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, with a maximum of 6 patient episodes in a 12 month period - each patient episode N 71077 01MAY2005 Quantitation of immunoglobulin E (total) in the follow up of a patient with proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, 1 test. To a maximum of 6 of this item in a 12 month period N 71077 01MAY2007 Quantitation of immunoglobulin E (total) in the follow up of a patient with proven immunoglobulin-E-secreting myeloma, proven congenital immunodeficiency or proven allergic bronchopulmonary aspergillosis, 1 test. (Item is subject to rule 25) Y 71079 01SEP1992 Estimation of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in any 12 month period - each patient episode N 71079 01JUL1994 Detection of specific immunoglobulin G or E antibodies to single or multiple potential allergens, with a maximum of 4 patient episodes in a 12 month period - each patient episode N 71079 01MAY2005 Detection of specific immunoglobulin G or E antibodies to single or multiple potential allergens, 1 of this item to a maximum of 4 in a 12 month period N 71079 01MAY2007 Detection of specific immunoglobulin G or E antibodies to single or multiple potential allergens, 1 test (Item is subject to rule 25) N 71079 01NOV2007 Detection of specific immunoglobulin E antibodies to single or multiple potential allergens, 1 test (Item is subject to rule 25) Y 71081 01SEP1992 Total haemolytic complement, quantitative estimation N 71081 01JUL1994 Quantitation of total haemolytic complement Y 71083 01SEP1992 Complement components C3, C4 or properdin factor B, quantitative estimation - 1 estimation N 71083 01JUL1994 Quantitation of complement components C3 and C4 or properdin factor B - 1 test Y 71085 01SEP1992 2 estimations specified in item 71083 N 71085 01JUL1994 2 tests described in item 71083 Y 71087 01SEP1992 3 or more estimations specified in item 71083 N 71087 01JUL1994 3 or more tests described in item 71083 Y 71089 01SEP1992 Complement components or breakdown products of complement proteins not elsewhere specified in an item in this Schedule, quantitative estimation - 1 estimation N 71089 01JUL1994 Quantitation of complement components or breakdown products of complement proteins not elsewhere described in an item in this Schedule - 1 test N 71089 01MAY2007 Quantitation of complement components or breakdown products of complement proteins not elsewhere described in an item in this Schedule - 1 test (Item is subject to rule 6) Y 71090 01MAY2007 A test described in item 71089, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 71091 01SEP1992 2 estimations specified in item 71089 N 71091 01JUL1994 2 tests described in item 71089 N 71091 01MAY2007 2 tests described in item 71089 (Item is subject to rule 6) Y 71092 01MAY2007 Tests described in item 71089, other than that described in 71090, if rendered by a receiving APP - each test to a maximum of 2 tests (Item is subject to rule 6 and 18) Y 71093 01SEP1992 3 or more estimations specified in item 71089 N 71093 01JUL1994 3 or more tests described in item 71089 N 71093 01MAY2007 3 or more tests described in item 71089 (Item is subject to rule 6) Y 71095 01NOV1997 Quantitation of serum or plasma eosinophil cationic protein, or both, to a maximum of 3 assays in 1 year, for monitoring the response to therapy in corticosteroid treated asthma, in a child aged less than 12 years Y 71096 01MAY2007 A test described in item 71095 if rendered by a receiving APP. (Item is subject to rule 18) Y 71097 01SEP1992 Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required N 71097 01JUL1994 Antinuclear antibodies - detection in serum or other body fluids, including quantitation if required Y 71099 01SEP1992 Double-stranded DNA antibodies, quantitative estimation by 1 or more methods other than the Crithidia method N 71099 01JUL1994 Double-stranded DNA antibodies - quantitation by 1 or more methods other than the Crithidia method Y 71101 01SEP1992 Antibodies to 1 or more extractable nuclear antigens, detection in serum or other body fluids N 71101 01JUL1994 Antibodies to 1 or more extractable nuclear antigens - detection in serum or other body fluids Y 71103 01SEP1992 Antibodies to 1 or more extractable nuclear antigens, characterisation after a positive result is obtained by a service specified in item 71101, including that service N 71103 01JUL1994 Characterisation of an antibody detected in a service described in item 71101 (including that service) Y 71105 01SEP1992 Rheumatoid factor, detection by any technique Y 71106 01JUL1994 Rheumatoid factor - detection by any technique in serum or other body fluids, including quantitation if required Y 71107 01SEP1992 Quantitation of rheumatoid factor if detected, during a service specified in item 71105, including that service Y 71109 01SEP1992 Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, glomerular basement membrane, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, neutrophil cytoplasm, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome, thyroid stimulating hormone receptor), qualitative or quantitative - estimation of 1 antibody N 71109 01JUL1994 Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody N 71109 01MAY2001 Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody Y 71113 01SEP1992 Estimation of 2 antibodies specified in item 71109 N 71113 01JUL1994 Detection of 2 antibodies described in item 71109 Y 71115 01SEP1992 Estimation of 3 antibodies specified in item 71109 N 71115 01JUL1994 Detection of 3 antibodies described in item 71109 Y 71117 01SEP1992 Estimation of 4 antibodies specified in item 71109 N 71117 01JUL1994 Detection of 4 antibodies described in item 71109 N 71117 01NOV2001 Detection of 4 or more antibodies described in item 71109 Y 71119 01SEP1992 Antibodies to tissue antigens not elsewhere specified in an item in this Schedule, qualitative or quantitative - estimation of 1 antibody N 71119 01JUL1994 Antibodies to tissue antigens not elsewhere specified in this Table - detection, including quantitation if required, of 1 antibody Y 71121 01SEP1992 Estimation of 2 antibodies specified in item 71119 N 71121 01JUL1994 Detection of 2 antibodies specified in item 71119 Y 71123 01SEP1992 Estimation of 3 antibodies specified in item 71119 N 71123 01JUL1994 Detection of 3 antibodies specified in item 71119 Y 71125 01SEP1992 Estimation of 4 or more antibodies specified in item 71119 N 71125 01JUL1994 Detection of 4 or more antibodies specified in item 71119 Y 71127 01SEP1992 Functional tests for lymphocytes - estimation of proliferation induced by 1 or more mitogens, estimation of proliferation induced by 1 or more antigens or estimation of 1 or more mixed lymphocyte reactions, other than quantitation by microscopy - including a test specified in item 65005, with a maximum of 2 patient episodes in any 12 month period - each patient episode N 71127 01JUL1994 Functional tests for lymphocytes - quantitation other than by microscopy of: (a)proliferation induced by 1 or more mitogens; or (b)proliferation induced by 1 or more antigens; or (c)estimation of 1 or more mixed lymphocyte reactions; including a test described in item 65066 or 65070 (if performed), with a maximum of 2 patient episodes in a 12 month period - each patient episode N 71127 01MAY2005 Functional tests for lymphocytes - quantitation other than by microscopy of: (a)proliferation induced by 1 or more mitogens; or (b)proliferation induced by 1 or more antigens; or (c)estimation of 1 or more mixed lymphocyte reactions; including a test described in item 65066 or 65070 (if performed), 1 of this item to a maximum of 2 in a 12 month period Y 71129 01SEP1992 2 estimations specified in item 71127 N 71129 01JUL1994 2 tests described in item 71127 Y 71131 01SEP1992 3 or more estimations specified in item 71127 N 71131 01JUL1994 3 or more tests described in item 71127 Y 71133 01NOV2002 Investigation of recurrent infection by qualitative assessment for the presence of defects in oxidative pathways in neutrophils by the nitroblue tetrazolium (NBT) reduction test Y 71134 01NOV2002 Investigation of recurrent infection by quantitative assessment of oxidative pathways by flow cytometric techniques, including a test described in 71133 (if performed) Y 71135 01SEP1992 Determination of neutrophil function - comprising at least 2 of neutrophil chemotaxis, neutrophil phagocytosis, neutrophil oxidative metabolism, neutrophil bactericidal activity - including any test specified in item 65005 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in any 12 month period - each patient episode N 71135 01JUL1994 Quantitation of neutrophil function, comprising at least 2 of the following: (a)chemotaxis; (b)phagocytosis; (c)oxidative metabolism; (d)bactericidal activity; including any test described in item 65066 or 65070 (other than nitroblue tetrazolium reduction slide test), with a maximum of 2 patient episodes in a 12 month period - each patient episode N 71135 01NOV2002 Quantitation of neutrophil function, comprising at least 2 of the following: (a)chemotaxis; (b)phagocytosis; (c)oxidative metabolism; (d)bactericidal activity; including any test described in items 65066, 65070, 71133 or 71134 (if performed), with a maximum of 2 patient episodes in a 12 month period - each patient episode N 71135 01MAY2005 Quantitation of neutrophil function, comprising at least 2 of the following: (a)chemotaxis; (b)phagocytosis; (c)oxidative metabolism; (d)bactericidal activity; including any test described in items 65066, 65070, 71133 or 71134 (if performed), 1 of this item to a maximum of 2 in a 12 month period Y 71137 01SEP1992 Determination of cell mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in any 12 month period - each patient episode N 71137 01JUL1994 Quantitation of cell-mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, with a maximum of 2 patient episodes in a 12 month period - each patient episode N 71137 01MAY2005 Quantitation of cell-mediated immunity by multiple antigen delayed type hypersensitivity intradermal skin testing using a minimum of 7 antigens, 1 of this item to a maximum of 2 in a 12 month period Y 71139 01SEP1992 Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more specimens of blood, CSF or serous fluid N 71139 01JUL1994 Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations, including a total lymphocyte count by any method, on 1 or more specimens of blood, CSF or serous fluid N 71139 01MAY2004 Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations, including a total lymphocyte count or total leucocyte count by any method, on 1 or more specimens of blood, CSF or serous fluid Y 71141 01SEP1992 Characterisation of 3 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations on 1 or more disaggregated tissue specimens Y 71143 01SEP1992 Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139 or 71141, on a specimen of blood, CSF, serous fluid or disaggregated tissue N 71143 01JUL1994 Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis of an immunological or haematological malignancy, including a service described in 1 or both of items 71139 and 71141 (if performed), on a specimen of blood, CSF, serous fluid or disaggregated tissue N 71143 01NOV1999 Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis(but not monitoring) of an immunological or haematological malignancy, including a service described in 1 or both of items 71139 and 71141 (if performed), on a specimen of blood, CSF, serous fluid or disaggregated tissue Y 71145 01SEP1992 Characterisation (not monitoring) of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations in an immunological or haematological malignancy, including any service specified in 1 or more of items 71139, 71141 or 71143, on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF, serous fluid N 71145 01JUL1994 Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis of an immunological or haematological malignancy, including a service described in 1 or more of items 71139, 71141 and 71143 (if performed), on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid N 71145 01NOV1999 Characterisation of 6 or more leucocyte surface antigens by immunofluorescence or immunoenzyme techniques to assess lymphoid or myeloid cell populations for the diagnosis (but not monitoring) of an immunological or haematological malignancy, including a service described in 1 or more of items 71139, 71141 and 71143 (if performed), on 2 or more specimens of disaggregated tissues or 1 specimen of disaggregated tissue and 1 or more specimens of blood, CSF or serous fluid Y 71146 01MAY2004 Enumeration of CD34+ cells, only for the purposes of autologous or directed allogeneic haemopoietic stem cell transplantation, including a total white cell count N 71146 01MAY2006 Enumeration of CD34+ cells, only for the purposes of autologous or directed allogeneic haemopoietic stem cell transplantation, including a total white cell count on the pherisis collection Y 71147 01SEP1992 HLA-B27 typing N 71147 01MAY2007 HLA-B27 typing (Item is subject to rule 27) Y 71148 01MAY2007 A test described in item 71147 if rendered by a receiving APP. (Item is subject to rule 18 and 27) Y 71149 01SEP1992 Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including any service specified in item 71147 N 71149 01JUL1994 Complete tissue typing for 4 HLA-A and HLA-B Class I antigens (including any separation of leucocytes), including (if performed) a service described in item 71147 Y 71151 01SEP1992 Tissue typing for HLA-DR, HLA-DP and HLA-DQ Class II antigens (including any separation of leucocytes) - phenotyping or genotyping of 2 or more antigens Y 71153 01MAY2001 Investigations in the assessment or diagnosis of systemic inflammatory disease or vasculitis - antineutrophil cytoplasmic antibody immunofluorescence (ANCA test), antineutrophil proteinase 3 antibody (PR-3 ANCA test), antimyeloperoxidase antibody (MPO ANCA test) or antiglomerular basement membrane antibody (GBM test) - detection of 1 antibody (Item is subject to rule 23) N 71153 01MAY2007 Investigations in the assessment or diagnosis of systemic inflammatory disease or vasculitis - antineutrophil cytoplasmic antibody immunofluorescence (ANCA test), antineutrophil proteinase 3 antibody (PR-3 ANCA test), antimyeloperoxidase antibody (MPO ANCA test) or antiglomerular basement membrane antibody (GBM test) - detection of 1 antibody (Item is subject to rule 6 and 23) Y 71154 01MAY2007 A test described in item 71153, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test. (Item is subject to rule 6, 18 and 23) Y 71155 01MAY2001 Detection of 2 antibodies described in item 71153 (Item is subject to rule 23) N 71155 01MAY2007 Detection of 2 antibodies described in item 71153 (Item is subject to rule 6 and 23) Y 71156 01MAY2007 Tests described in item 71153, other than that described in 71154, if rendered by a receiving APP - each test to a maximum of 3 tests (Item is subject to rule 6, 18 and 23) Y 71157 01MAY2001 Detection of 3 antibodies described in item 71153 (Item is subject to rule 23) N 71157 01MAY2007 Detection of 3 antibodies described in item 71153 (Item is subject to rule 6 and 23) Y 71159 01MAY2001 Detection of 4 or more antibodies described in item 71153 (Item is subject to rule 23) N 71159 01MAY2007 Detection of 4 or more antibodies described in item 71153 (Item is subject to rule 6 and 23) Y 71160 01NOV2002 Detection of antibodies for the monitoring of established coeliac disease or other gluten hypersensitivity syndromes, including: a)IgA antibody to gliadin; or b)IgG antibody to gliadin; or c)Antibody to endomysium; or d)Antibody to tissue transglutaminase; or e)IgA antibody to tissue transglutaminase; or f)IgG antibody to tissue transglutaminase One test Y 71161 01NOV2002 Two or more tests described in 71160 for the monitoring of established coeliac disease or other gluten hypersensitivity syndrome Y 71162 01NOV2002 Three or more tests described in 71160 for the diagnosis of coeliac disease or other gluten hypersensitivity syndrome. To a maximum of 2 patient episodes in a 12 month period - each patient episode (Item subject to rule 24) Y 71163 01NOV2003 Detection of one of the following antibodies (of 1 or more class or isotype) in the assessment or diagnosis of coeliac disease or other gluten hypersensitivity syndromes and including a service described in item 71066 (if performed): a)Antibodies to gliadin; or b)Antibodies to endomysium; or c)Antibodies to tissue transglutaminase; - 1 test Y 71164 01NOV2003 Two or more tests described in 71163 and including a service described in 71066 (if performed) Y 71165 01MAY2007 Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, cardiolipin, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody (Item is subject to rule 6) N 71165 01NOV2007 Antibodies to tissue antigens (acetylcholine receptor, adrenal cortex, heart, histone, insulin, insulin receptor, intrinsic factor, islet cell, lymphocyte, neuron, ovary, parathyroid, platelet, salivary gland, skeletal muscle, skin basement membrane and intercellular substance, thyroglobulin, thyroid microsome or thyroid stimulating hormone receptor) - detection, including quantitation if required, of 1 antibody (Item is subject to rule 6) Y 71166 01MAY2007 Detection of 2 antibodies described in item 71165 (Item is subject to rule 6) Y 71167 01MAY2007 Detection of 3 antibodies described in item 71165 (Item is subject to rule 6) Y 71168 01MAY2007 Detection of 4 or more antibodies described in item 71165 (Item is subject to rule 6) Y 71169 01MAY2007 A test described in item 71165, if rendered by a receiving APP, where no tests in the item have been rendered by the referring APP - 1 test (Item is subject to rule 6 and 18) Y 71170 01MAY2007 Tests described in item 71165, other than that described in 71169, if rendered by a receiving APP - each test to a maximum of 3 tests (Item is subject to rule 6 and 18) Y 71180 01NOV2007 Antibody to cardiolipin or beta-2 glycoprotein I - detection, including quantitation if required; one antibody specificity (IgG or IgM) Y 71183 01NOV2007 Detection of two antibodies described in item 71180 Y 71186 01NOV2007 Detection of three or more antibodies described in item 71180 Y 71189 01NOV2007 Detection of specific IgG antibodies to 1 or more respiratory disease allergens not elsewhere specified. Y 71192 01NOV2007 2 items described in item 71189. Y 71195 01NOV2007 3 or more items described in item 71189. Y 71198 01NOV2007 Estimation of serum tryptase for the evaluation of unexplained acute hypotension or suspected anaphylactic event, assessment of risk in stinging insect anaphylaxis, exclusion of mastocytosis, monitoring of known mastocytosis. Y 71200 01NOV2007 Detection and quantitation, if present, of free kappa or lambda light chains in serum for the diagnosis or monitoring of amyloidosis, myeloma or plasma cell dyscrasias. N 71200 01MAY2009 Detection and quantitation, if present, of free kappa and lambda light chains in serum for the diagnosis or monitoring of amyloidosis, myeloma or plasma cell dyscrasias. Y 71203 01NOV2007 Determination of HLAB5701 status by flow cytometry or cytotoxity assay prior to the initiation of Abacavir therapy including item 73323 if performed. Y 72801 01DEC1991 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions N 72801 01JUL1994 Examination of biopsy material (gross and microscopic) including all tissue processing, staining, and except as provided for in 72805 and 72807 - all professional opinions Y 72802 01DEC1991 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions Y 72803 01DEC1991 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination N 72803 01JUL1994 Intraoperative frozen section diagnosis of biopsy material, including any other tissue pathology service in Group P5 Y 72804 01DEC1991 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination Y 72805 01DEC1991 Immunohistochemical investigation of biopsy material by 1 or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination N 72805 01JUL1994 Immunohistochemical staining of biopsy material by 1 or more labelled antibody techniques (including immunofluorescence and immunoperoxidase) and including any other tissue pathology service in Group P5 Y 72806 01DEC1991 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination Y 72807 01DEC1991 Electron microscopy of biopsy material including any other histopathology examination N 72807 01JUL1994 Electron microscopy of biopsy material including any other tissue pathology service in Group P5 Y 72808 01DEC1991 Electron microscopy of biopsy material including any other histopathology examination Y 72813 20MAR1997 Examination of complexity level 2 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens (Item is subject to rule 13) Y 72814 01NOV2018 Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with non-small cell lung cancer, to determine if the requirements relating to PD-L1 status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled. Y 72816 20MAR1997 Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 separately identified specimen (Item is subject to rule 13) Y 72817 20MAR1997 Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 2 or more separately identified specimens (Item is subject to rule 13) N 72817 01NOV2002 Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 2 to 4 separately identified specimens (Item is subject to rule 13) Y 72818 01NOV2002 Examination of complexity level 3 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 5 or more separately identified specimens (Item is subject to rule 13) Y 72823 20MAR1997 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 separately identified specimen (Item is subject to rule 13) Y 72824 20MAR1997 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 2 to 4 separately identified specimens (Item is subject to rule 13) Y 72825 20MAR1997 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 5 or more separately identified specimens (Item is subject to rule 13) N 72825 01NOV2002 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 5 to 7 separately identified specimens (Item is subject to rule 13) Y 72826 01NOV2002 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 8 or more separately identified specimens (Item is subject to rule 13) N 72826 01NOV2008 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 8 to 11 separately identified specimens (Item is subject to rule 13) Y 72827 01NOV2008 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 12 to 17 separately identified specimens (Item is subject to Rule 13) Y 72828 01NOV2008 Examination of complexity level 4 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions -18 or more separately identified specimens (Item is subject to Rule 13) Y 72830 20MAR1997 Examination of complexity level 5 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens (Item is subject to rule 13) Y 72836 20MAR1997 Examination of complexity level 6 biopsy material with 1 or more tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens (Item is subject to rule 13) Y 72838 01NOV2007 Examination of complexicity level 7 biopsy material with multiple tissue blocks, including specimen dissection, all tissue processing, staining, light microscopy and professional opinion or opinions - 1 or more separately identified specimens. (Item is subject to rule 13) Y 72844 01NOV1998 Enzyme histochemistry of skeletal muscle for investigation of primary degenerative or metabolic muscle diseases or of muscle abnormalities secondary to disease of the central or peripheral nervous system - 1 or more tests Y 72846 20MAR1997 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies (Item is subject to rule 13) N 72846 01NOV2003 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 72848 (Item is subject to rule 13) Y 72847 20MAR1997 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 or more antibodies (Item is subject to rule 13) N 72847 01NOV2008 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4-6 or more antibodies (Item is subject to rule 13) N 72847 01JUL2009 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4-6 antibodies (Item is subject to rule 13) Y 72848 01NOV2003 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13) Y 72849 01NOV2008 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7-10 antibodies (Item is subject to rule 13) Y 72850 01NOV2008 Immunohistochemical examination of biopsy material by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13) Y 72851 20MAR1997 Electron microscopic examination of biopsy material - 1 separately identified specimen (Item is subject to rule 13) Y 72852 20MAR1997 Electron microscopic examination of biopsy material - 2 or more separately identified specimens (Item is subject to rule 13) Y 72855 20MAR1997 Intraoperative frozen section diagnosis of biopsy material - 1 separately identified specimen (Item is subject to rule 14) N 72855 01NOV2001 Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 1 separately identified specimen (Item is subject to rule 13) Y 72856 20MAR1997 Intraoperative frozen section diagnosis of biopsy material - 2 or more separately identified specimens (Item is subject to rule 14) N 72856 01NOV2001 Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 2 or more separately identified specimens (Item is subject to rule 13) N 72856 01NOV2003 Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 2 to 4 separately identified specimens (Item is subject to rule 13) Y 72857 01NOV2003 Intraoperative consultation and examination of biopsy material by frozen section or tissue imprint or smear - 5 or more separately identified specimens (Item is subject to rule 13) Y 72858 01NOV2015 A second opinion, provided in a written report, where the opinion and report together require no more than 30 minutes to complete, on a patient specimen, requested by a treating practitioner, where further information is needed for accurate diagnosis and appropriate patient management. Y 72859 01NOV2015 A second opinion, provided in a written report, where the opinion and report together require more than 30 minutes to complete, on a patient specimen, requested by a treating practitioner, where further information is needed for accurate diagnosis and appropriate patient management. Y 72860 01MAY2019 Retrieval and review of archived formalin fixed paraffin embedded block(s) to determine the appropriate sample(s) for the purpose of conducting further genetic testing. For any particular patient, this item is applicable for a maximum of one retrieval per subsequent patient episode. Y 73043 01DEC1991 Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changes1 or more examinations N 73043 01JUL1994 Cytology (including serial examinations) of nipple discharge or smears from skin, lip, mouth, nose or anus for detection of precancerous or cancerous changes1 or more tests Y 73044 01DEC1991 Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of precancerous or cancerous changesone or more examinations Y 73045 01DEC1991 Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 73043 and any histopathological service performed on that cytology specimenone or more examinations N 73045 01MAR1992 Cytological examination, other than an examination mentioned in item 73053, for malignancy, including serial examinations and histological services performed on the resulting specimens from washings or brushings from sites not specified in item 73043, or performed on a single specimen of sputum or urine or on 1 or more specimens of other body fluids - 1 or more examinations N 73045 01JUL1994 Cytology (including serial examinations) for malignancy (other than an examination mentioned in item 73053); and including any Group P5 service, if performed on: (a)specimens resulting from washings or brushings from sites not specified in item 73043; or (b)a single specimen of sputum or urine; or (c)1 or more specimens of other body fluids; 1 or more tests N 73045 01DEC2017 Cytology (including serial examinations) for malignancy (other than an examination mentioned in item 73076); and including any Group P5 service, if performed on: (a)specimens resulting from washings or brushings from sites not specified in item 73043; or (b)a single specimen of sputum or urine; or (c)1 or more specimens of other body fluids; 1 or more tests Y 73046 01DEC1991 Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 73043/73044 and any histopathological service performed on that cytology specimenone or more examinations Y 73047 01DEC1991 Cytological examination including examination of a series of 3 sputum or urine specimens for malignant cells N 73047 01JUL1994 Cytology of a series of 3 sputum or urine specimens for malignant cells Y 73048 01DEC1991 Cytological examination including examination of a series of three sputum or urine specimens for malignant cells Y 73049 01DEC1991 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues N 73049 01JUL1994 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues N 73049 01MAY2000 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues N 73049 01MAY2009 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues - 1 identified site Y 73050 01DEC1991 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues Y 73051 01DEC1991 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance N 73051 01JUL1994 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues if: (a)the aspiration is performed by a recognised pathologist; or (b)a recognised pathologist attends the aspiration and performs cytological examination during the attendance N 73051 01MAY2000 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues if: (a)the aspiration is performed by a recognised pathologist; or (b)a recognised pathologist attends the aspiration and performs cytological examination during the attendance N 73051 01JUL2011 Cytology of material obtained directly from a patient at one identified site by fine needle aspiration of solid tissue or tissues if a recognized pathologist: (a)performs the aspiration; or (b)attends the aspiration and performs cytological examination during the attendance Y 73052 01DEC1991 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance Y 73053 01DEC1991 Routine cytological examination of smears from cervix for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear - each examination N 73053 01JUL1994 Cytology of smears from cervix: (a)for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia; or (b)due to an unsatisfactory smear taken in the circumstances defined in para (a) above; each examination N 73053 20MAR1997 Cytology of smears from cervix: (a)for detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia; or (b)due to an unsatisfactory smear taken in the circumstances defined in para (a) above; or (c)if there is inadequate information provided to use item 73055; each examination N 73053 01NOV2001 Cytology of a smear from cervix where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each examination (a)for the detection of precancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia, or (b)if a further specimen is taken due to an unsatisfactory smear taken for the purposes of paragraph (a); or (c)if there is inadequate information provided to use item 73055; Y 73054 01DEC1991 Routine cytological examination of smears from the cervix for detection of pre-cancerous or cancerous changes in women with no symptoms, signs or recent history suggestive of cervical neoplasia and smears repeated due to an unsatisfactory routine smear - each examination Y 73055 01DEC1991 Cytological examination of smears from cervix in association with the management of previously detected abnormalities including precancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with item 73053 - each examination N 73055 01JUL1994 Cytology not associated with item 73053, of smears from cervix in association with: (a)the management of previously detected abnormalities including precancerous or cancerous conditions; or (b)the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia; each test N 73055 01NOV2001 Cytology of a smear from cervix, not associated with item 73053, where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each test (a)for the management of previously detected abnormalities including precancerous or cancerous conditions; or (b)for the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia; N 73055 01MAY2017 Cytology of a smear from cervix, not associated with item 73053, where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each test: (a)for the management of previously detected abnormalities including precancerous or cancerous conditions; or (b)for the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia. Y 73056 01DEC1991 Cytological examination of smears from cervix in association with the management of previously detected abnormalities including pre-cancerous or cancerous conditions, or the investigation of women with symptoms, signs or recent history suggestive of cervical neoplasia, not associated with Item 73054 - each examination Y 73057 01DEC1991 Cytological examination of smears from vagina, not associated with items 73053 or 73055 - each examination N 73057 01JUL1994 Cytology of smears from vagina, not associated with item 73053 or 73055 nor to monitor hormone replacement therapy - each test N 73057 01NOV2001 Cytology of smears from vagina, not associated with item 73053 or 73055 and not to monitor hormone replacement therapy, where the smear is prepared by direct application of the specimen to a slide, excluding the use of liquid based slide preparation techniques, and the stained smear is microscopically examined by or on behalf of a pathologist - each test Y 73058 01DEC1991 Cytological examination of smears from vagina, not associated with Items 73054 or 73056 - each examination Y 73059 01NOV1997 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies N 73059 01NOV2003 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13) N 73059 01MAY2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13) N 73059 01JUL2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13) N 73059 01JAN2014 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 antibodies except those listed in 73061 (Item is subject to rule 13) Y 73060 01NOV1997 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 or more antibodies N 73060 01NOV2003 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 or more antibodies (Item is subject to rule 13) N 73060 01MAY2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6antibodies (Item is subject to rule 13) N 73060 01JUL2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, and 73063for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6antibodies (Item is subject to rule 13) N 73060 01JAN2014 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 4 to 6antibodies (Item is subject to rule 13) Y 73061 01NOV2003 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13) N 73061 01MAY2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13) N 73061 01JUL2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13) N 73061 01JAN2014 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 1 to 3 of the following antibodies - oestrogen, progesterone and c-erb-B2 (HER2) (Item is subject to rule 13) Y 73062 01MAY2009 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues - 2 or more separately identified sites. Y 73063 01MAY2009 Cytology of material obtained directly from a patient by fine needle aspiration of solid tissue or tissues, where an employee of the APA also attends the aspiration for confirmation of sample adequacy. N 73063 01JUL2011 Cytology of material obtained directly from a patient at one identified site by fine needle aspiration of solid tissue or tissues if an employee of an approved pathology authority attends the aspiration for confirmation of sample adequacy Y 73064 01MAY2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7 to 10 antibodies (Item is subject to rule 13) N 73064 01JUL2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7 to 10 antibodies (Item is subject to rule 13) N 73064 01JAN2014 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 7 to 10 antibodies (Item is subject to rule 13) Y 73065 01MAY2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73062 and 73051 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13) N 73065 01JUL2009 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062 and 73063 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13) N 73065 01JAN2014 Immunocytochemical examination of material obtained by procedures described in items 73045, 73047, 73049, 73051, 73062, 73063, 73066 and 73067 for the characterisation of a malignancy by immunofluorescence, immunoperoxidase or other labelled antibody techniques with multiple antigenic specificities per specimen - 11 or more antibodies (Item is subject to rule 13) Y 73066 01JUL2011 Cytology of material obtained directly from a patient at 2 or more separately identified sites by fine needle aspiration of solid tissue or tissues if a recognized pathologist: (a)performs the aspiration; or (b) attends the aspiration and performs cytological examination during the attendance Y 73067 01JUL2011 Cytology of material obtained directly from a patient at 2 or more separately identified sites by fine needle aspiration of solid tissue or tissues if an employee of an approved pathology authority attends the aspiration for confirmation of sample adequacy Y 73069 01MAY2017 Cytology of a specimen obtained from cervix or vagina, not associated with item 73053, 73055 or 73057, where the slide is prepared by liquid based preparation techniques, and the slide is microscopically examined by or on behalf of a pathologist using manual or semi-automated image analysis methods. Y 73070 01DEC2017 73070 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre?cancer or cancer: (a) performed on a liquid based cervical specimen; and (b) for an asymptomatic patient who is at least 24 years and 9 months of age For any particular patient, once only in a 57 month period Y 73071 01DEC2017 73071 A test, including partial genotyping, for oncogenic human papillomavirus that may be associated with cervical pre?cancer or cancer: (a) performed on a self?collected vaginal specimen; and (b) for an asymptomatic patient who is at least 30 years of age For any particular patient, once only in a 7 year period Y 73072 01DEC2017 A test, including partial genotyping, for oncogenic human papillomavirus, performed on a liquid based cervical specimen: (a) for the investigation of a patient in a specific population that appears to have a higher risk of cervical pre?cancer or cancer; or (b) for the follow?up management of a patient with a previously detected oncogenic human papillomavirus infection or cervical pre?cancer or cancer; or (c) for the investigation of a patient with symptoms suggestive of cervical cancer; or (d) for the follow?up management of a patient after treatment of high grade squamous intraepithelial lesions or adenocarcinoma in situ of the cervix; or (e) for the follow?up management of a patient with glandular abnormalities; or (f) for the follow?up management of a patient exposed to diethylstilboestrol in utero Y 73073 01DEC2017 A test, including partial genotyping, for oncogenic human papillomavirus: (a) performed on a self?collected vaginal specimen; and (b) for the follow?up management of a patient with oncogenic human papillomavirus infection or cervical pre?cancer or cancer that was detected by a test to which item73071 applies For any particular patient, once only in a 21 month period Y 73074 01DEC2017 A test, including partial genotyping, for oncogenic human papillomavirus: (a) performed on a liquid based vaginal vault specimen; and (b) for the investigation of a patient following a total hysterectomy Y 73075 01DEC2017 A test, including partial genotyping, for oncogenic human papillomavirus, if: (a) the test is a repeat of a test to which item73070, 73071, 73072, 73073, 73074 or this item applies; and (b) the specimen collected for the previous test is unsatisfactory Y 73076 01DEC2017 Cytology of a liquid?based cervical or vaginal vault specimen, where the stained cells are examined microscopically or by automated image analysis by or on behalf of a pathologist, if: (a) the cytology is associated with the detection of oncogenic human papillomavirus infection by: (i) a test to which item73070, 73071, 73073, 73074 or 73075 applies; or (ii) a test to which item73072 applies for a patient mentioned in paragraph(a) or (b) of that item; or (b) the cytology is associated with a test to which item73072 applies for a patient mentioned in paragraph(c), (d), (e) or (f) of that item; or (c) the cytology is associated with a test to which item73074 applies; or (d) the test is a repeat of a test to which this item applies, if the specimen collected for the previous test is unsatisfactory; or (e) the cytology is for the follow?up management of a patient treated for endometrial adenocarcinoma Y 73281 01DEC1991 Chromosome studies, including preparation, count and karyotyping of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood1 or more estimations Y 73282 01DEC1991 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding bloodone or more estimations Y 73283 01DEC1991 Chromosome studies, including preparation, count and karyotyping of blood Y 73284 01DEC1991 Chromosome studies, including preparation, count and karyotyping of blood Y 73285 01DEC1991 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile Xsite determination1 or more identifications Y 73286 01DEC1991 Chromosome identification by banding techniques (using fluorescein, Giemsa, or centromere staining or high resolution analysis); or by fragile Xsite determinationone or more identifications Y 73287 01JUL1993 Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or by fragile X-site determination of 1 or more of amniotic fluid, bone marrow, skin and any other tissue or fluid except blood - 1 or more estimations N 73287 01JUL1994 Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or fragile X-site determination of 1 or more of any tissue or fluid except blood - 1 or more tests N 73287 01MAY2003 Chromosome studies, including preparation, count, karyotyping and identification by banding techniques of 1 or more of any tissue or fluid except blood - 1 or more tests N 73287 01NOV2008 Chromosome studies, (karyotype), by cytogenetic or other comparable techniques, of 1 or more of any tissue or fluid except blood - 1 or more tests N 73287 01MAY2010 The study of the whole of every chromosome by cytogenetic or other techniques, performed on 1 or more of any tissue or fluid except blood (including a service mentioned in item 73293, if performed) - 1 or more tests Y 73288 01NOV2018 Immunohistochemical examination by immunoperoxidase or other labelled antibody techniques using the programmed cell death ligand 1 (PD-L1) antibody of tumour material from a patient diagnosed with non-small cell lung cancer, to determine if the requirements relating to PD-L1 status for access to pembrolizumab under the Pharmaceutical Benefits Scheme are fulfilled. Y 73289 01JUL1993 Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or by fragile X-site determination of blood - 1 or more estimations N 73289 01JUL1994 Chromosome studies, including preparation, count, karyotyping and identification by banding techniques or fragile X-site determination of blood - 1 or more tests N 73289 01MAY2003 Chromosome studies, including preparation, count, karyotyping and identification by banding techniques of blood - 1 or more tests N 73289 01NOV2008 Chromosome studies, (karyotype), by cytogenetic or other comparable techniques of blood - 1 or more tests N 73289 01MAY2010 The study of the whole of every chromosome by cytogenetic or other techniques, performed on blood (including a service mentioned in item 73293, if performed) - 1 or more tests Y 73290 01MAY2010 The study of the whole of each chromosome by cytogenetic or other techniques, performed on blood or bone marrow, in the diagnosis and monitoringof haematological malignancy (including a service in items 73287 or 73289, if performed). - 1 or more tests. Y 73291 01MAY2010 Analysis of one or more chromosome regions for specific constitutional genetic abnormalities of blood or fresh tissue in a)diagnostic studies of a person with developmental delay, intellectual disability, autism, or at least two congenital abnormalities, in whom cytogenetic studies (item 73287 or 73289) are either normal or have not been performed; or b)studies of a relative for an abnormality previously identified in such an affected person. - 1 or more tests. Y 73292 01MAY2010 Analysis of chromosomes by genome-wide micro-array including targeted assessment of specific regions for constitutional genetic abnormalities in diagnostic studies of a person with developmental delay, intellectual disability, autism, or at least two congenital abnormalities (including a service in items 73287, 73289 or 73291, if performed) - 1 or more tests. Y 73293 01MAY2010 Analysis of one or more regions on all chromosomes for specific constitutional genetic abnormalities of fresh tissue in diagnostic studies of the products of conception, including exclusion of maternal cell contamination. - 1 or more tests. Y 73294 01MAY2010 Analysis of the PMP22 gene for constitutional genetic abnormalities causing peripheral neuropathy, either as: a)diagnostic studies of an affected person; or b)studies of a relative for an abnormality previously identified in an affected person - 1 or more tests. Y 73295 01FEB2017 Detection of germline BRCA1 or BRCA2 gene mutations, in a patient with platinum-sensitive relapsed ovarian, fallopian tube or primary peritoneal cancer with high grade serous features or a high grade serous component, and who has responded to subsequent platinum-based chemotherapy, requested by a specialist or consultant physician, to determine whether the eligibility criteria for olaparib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. Maximum one test per lifetime Y 73296 01NOV2017 Characterisation of germline gene mutations, requested by a specialist or consultant physician, including copy number variation in BRCA1 and BRCA2 genes and one or more of the following genes STK11, PTEN, CDH1, PALB2, or TP53 in a patient with breast or ovarian cancer for whom clinical and family history criteria, as assessed by the specialist or consultant physician who requests the service using a quantitative algorithm, place the patient at >10% risk of having a pathogenic mutation identified in one or more of the genes specified above. Y 73297 01NOV2017 Characterisation of germline gene mutations, requested by a specialist or consultant physician, including copy number variation in BRCA1 and BRCA2 genes and one or more of the following genes STK11, PTEN, CDH1, PALB2, or TP53 in a patient who is a biological relative of a patient who has had a pathogenic mutation identified in one or more of the genes specified above, and has not previously received a service under item 73296. Y 73298 01MAY2019 Characterisation of germline gene variants in the following genes: (a) COL4A3; and (b) COL4A4; and (c) COL4A5; in a patient for whom clinical and relevant family history criteria have been assessed by a specialist or consultant physician, who requests the service to be strongly suggestive of Alport syndrome. Y 73299 01MAY2019 Characterisation of germline gene variants: (a) in the following genes: (i) COL4A3; and (ii) COL4A4; and (iii) COL4A5; (b) in a patient who: (i) is a first degree biological relative of a patient who has had a pathogenic mutation identified in one or more of the genes mentioned insubparagraphs(a)(i), (ii) and (iii); and (ii) has not previously received a service which item 73298 applies; requested by a specialist or consultant physician. Y 73300 01MAY2003 Detection of genetic mutation of the FMR1 gene by nucleic acid amplification (NAA) where: (a) the patient exhibits the specific clinical features of fragile X (A) syndrome, including intellectual disabilities; or (b) the patient has a first or second degree relative with a fragile X (A) mutation 1 or more tests N 73300 01NOV2003 Detection of genetic mutation of the FMR1 gene by nucleic acid amplification (NAA) where: (a) the patient exhibits one or more of the clinical features of fragile X (A) syndrome, including intellectual disabilities; or (b) the patient has a relative with a fragile X (A) mutation 1 or more tests N 73300 01NOV2008 Detection of mutation of the FMR1 gene where: (a) the patient exhibits one or more of the clinical features of fragile X (A) syndrome, including intellectual disabilities; or (b) the patient has a relative with a fragile X (A) mutation 1 or more tests N 73300 01MAY2009 Detection of mutation of the FMR1 gene where: (a) the patient exhibits intellectual disability, ataxia, neurodegeneration, or premature ovarian failure consistent with an FMRI mutation; or (b) the patient has a relative with a FMR1 mutation 1 or more tests Y 73305 01MAY2003 Detection of genetic mutation of the FMR1 gene by Southern Blot where the results in item 73300 are inconclusive N 73305 01NOV2008 Detection of mutation of the FMR1 gene by Southern Blot analysis where the results in item 73300 are inconclusive Y 73308 01MAY2006 Characterisation of the genotype of a patient for Factor V Leiden gene mutation, or detection of the other relevant mutations in the investigation of proven venous thrombosis or pulmonary embolism - 1 or more tests Y 73309 01MAY2007 A test described in item 73308, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 73311 01MAY2006 Characterisation of the genotype of a person who is a first degree relative of a person who has proven to have 1 or more abnormal genotypes under item 73308 - 1 or more tests Y 73312 01MAY2007 A test described in item 73311, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 73314 01MAY2006 Characterisation of gene rearrangement by nucleic acid amplification in the diagnosis and monitoring of patients with laboratory evidence of: (a)acute myeloid leukaemia; or (b)acute promyelocytic leukaemia; or (c)acute lymphoid leukaemia; or (d)chronic myeloid leukaemia; each test to a maximum of 4 tests in a 12 month period N 73314 01NOV2008 Characterisation of gene rearrangement or the identification of mutations within a known gene rearrangement, in the diagnosis and monitoring of patients with laboratory evidence of: (a)acute myeloid leukaemia; or (b)acute promyelocytic leukaemia; or (c)acute lymphoid leukaemia; or (d)chronic myeloid leukaemia; (Item is subject to Rule 25) N 73314 01MAY2009 Characterisation of gene rearrangement or the identification of mutations within a known gene rearrangement, in the diagnosis and monitoring of patients with laboratory evidence of: (a)acute myeloid leukaemia; or (b)acute promyelocytic leukaemia; or (c)acute lymphoid leukaemia; or (d)chronic myeloid leukaemia; Y 73315 01MAY2007 A test described in item 73314, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18 and 25) N 73315 01MAY2009 A test described in item 73314, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18) Y 73317 01MAY2006 Detection of the C282Y genetic mutation of the HFE gene and, if performed, detection of other mutations for haemochromatosis where: (a)the patient has an elevated transferrin saturation or elevated serum ferritin on testing of repeated specimens; or (b)the patient has a first degree relative with haemochromatosis; or (c)the patient has a first degree relative with homozygosity for the C282Y genetic mutation, or with compound heterozygosity for recognised genetic mutations for haemochromatosis (Item is subject to rule 20) Y 73318 01MAY2007 A test described in item 73317, if rendered by a receiving APP - 1 or more tests (Item is subject to rule 18 and 20) Y 73320 01MAY2006 Detection of HLA-B27 by nucleic acid amplification N 73320 01NOV2006 Detection of HLA-B27 by nucleic acid amplification includes a service described in 71147 unless the service in item 73320 is rendered as a pathologist determinable service. (Item is subject to rule 27) Y 73321 01MAY2007 A test described in item 73320, if rendered by a receiving APP - 1 or more tests. (Item is subject to rule 18 and 27) Y 73323 01NOV2007 Determination of HLAB5701 status by molecular techniques or cytotoxity assay prior to the initiation of Abacavir therapy including item 71203 if performed. N 73323 01NOV2008 Determination of HLAB5701 status by molecular techniques prior to the initiation of Abacavir therapy including item 71203 if performed. Y 73324 01NOV2008 A test described in item 73323 if rendered by a receiving APP 1 or more tests (Item is subject to Rule 18) Y 73325 01JUL2011 Characterisation of mutations in: (a) the JAK2 gene; or (b) the MPL gene; or (c) both genes; in the diagnostic work-up, by, or on behalf of, the specialist or consultant physician, of a patient with clinical and laboratory evidence of: a)polycythaemia vera; or b)essential thrombocythaemia; 1 or more tests Y 73326 01JUL2011 Characterisation of the gene rearrangement FIP1L1-PDGFRA in the diagnostic work-up and management of a patient with laboratory evidence of: a)mast cell disease; or b)idiopathic hypereosinophilic syndrome; or c)chronic eosinophilic leukaemia;. 1 or more tests Y 73327 01JUL2011 Detection of genetic polymorphisms in the Thiopurine S-methyltransferase gene for the prevention of dose-related toxicity during treatment with thiopurine drugs; including (if performed) any service described in item 65075. 1 or more tests Y 73328 01MAY2012 A test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to gefitinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. Y 73330 01MAY2012 A test of tumour tissue from a patient with metastatic colorectal cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to Kirsten ras (KRAS) gene mutation status for access to cetuximab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. Y 73332 01MAY2012 An in situ hybridization (ISH) test of tumour tissue from a patient with breast cancer (other than in the neoadjuvant setting) requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to human epidermal growth factor receptor 2 (HER2) gene mutation status for access to trastuzumab under the Pharmaceutical Benefits Scheme (PBS) or the Herceptin Program are fulfilled. N 73332 01DEC2012 An in situ hybridization (ISH) test of tumour tissue from a patient with breast cancer requested by, or on the advice of, a specialist or consultant physician who manages the treatment of the patient to determine if the requirements relating to human epidermal growth factor receptor 2 (HER2) gene amplification for access to trastuzumab under the Pharmaceutical Benefits Scheme (PBS) or the Herceptin Program are fulfilled. Y 73333 01NOV2012 Detection of germline mutations of the von Hippel-Lindau (VHL) gene: (a)in a patient who has a clinical diagnosis of VHL syndrome and: (i)a family history of VHL syndrome and one of the following: (A) haemangioblastoma (retinal or central nervous system); (B) phaeochromocytoma; (C) renal cell carcinoma; or (i)2 or more haemangioblastomas; or (ii)one haemangioblastoma and a tumour or a cyst of: (A) the adrenal gland; or (B) the kidney; or (C)the pancreas; or (D) the epididymis; or (E) a broad ligament (other than epididymal and single renal cysts, which are common in the general population); or (a)in a patient presenting with one or more of the following clinical features suggestive of VHL syndrome: (i)haemangioblastomas of the brain, spinal cord, or retina; (ii)phaeochromocytoma; (iii)functional extra-adrenal paraganglioma Y 73334 01NOV2012 Detection of germline mutations of the von Hippel-Lindau (VHL) gene in biological relatives of a patient with a known mutation in the VHL gene Y 73335 01NOV2012 Detection of somatic mutations of the von Hippel-Lindau (VHL) gene in a patient with: (a)2 or more tumours comprising: (i)2 or more haemangioblastomas, or (ii)one haemangioblastoma and a tumour of: (A)the adrenal gland; or (B)the kidney; or (C)the pancreas; or (D)the epididymis; and (b)no germline mutations of the VHL gene identified by genetic testing Y 73336 01DEC2013 A test of tumour tissue from a patient with unresectable stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib under Pharmaceutical Benefits Scheme (PBS) are fulfilled. N 73336 01MAY2017 A test of tumour tissue from a patient with unresectable stage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib or vemurafenib under the Pharmaceutical Benefits Scheme are fulfilled. N 73336 01NOV2019 A test of tumour tissue from a patient withstage III or stage IV metastatic cutaneous melanoma, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to BRAF V600 mutation status for access to dabrafenib or vemurafenib under the Pharmaceutical Benefits Scheme are fulfilled. Y 73337 01JAN2014 A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to erlotinib or gefitinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. N 73337 01JUL2018 A test of tumour tissue from a patient diagnosed with non-small cell lung cancer, shown to have non-squamous histology or histology not otherwise specified, requested by, or on behalf of, a specialist or consultant physician, to determine if the requirements relating to epidermal growth factor receptor (EGFR) gene status for access to erlotinib, gefitinib or afatinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. Y 73338 01APR2014 A test of tumour tissue from a patient with metastatic colorectal cancer requested by, or on behalf of, a specialist or consultant physician to determine if the requirements relating to Kirsten ras (KRAS) gene mutation status for access to cetuximab or panitumumab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. N 73338 01JAN2015 A test of tumour tissue from a patient with metastatic colorectal cancer (stage IV), requested by a specialist or consultant physician, to determine if the requirements relating to rat sarcoma oncogene (RAS) gene mutation status for access to cetuximab or panitumumab under the Pharmaceutical Benefits Scheme (PBS) are fulfilled, if: (a) the test is conducted for all clinically relevant mutations on KRAS exons 2, 3 and 4 and NRAS exons 2, 3, and 4; or (b) a RAS mutation is found. Y 73339 01NOV2014 Detection of germline mutations in the RET gene in patients with a suspected clinical diagnosis of multiple endocrine neoplasia type 2 (MEN2) requested by a specialist or consultant physician who manages the treatment of the patient. One test.(Item issubject to rule 25) Y 73340 01NOV2014 Detection of a known mutation in the RET gene in an asymptomatic relative of a patient with a documented pathogenic germline RET mutation requested by a specialist or consultant physician who manages the treatment of the patient. One test.(Item is subject to rule 25) Y 73341 01JUL2015 Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to crizotinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled. N 73341 01FEB2017 Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to crizotinib or ceritinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled N 73341 06FEB2018 Fluorescence in situ hybridisation (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small cell lung cancer, which is of non-squamous histology or histology not otherwise specified, with documented evidence of anaplastic lymphoma kinase (ALK) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score > 0, and with documented absence of activating mutations of the epidermal growth factor receptor (EGFR) gene, requested by a specialist or consultant physician to determine if requirements relating to ALK gene rearrangement status for access to crizotinib, ceritinib oralectinib under the Pharmaceutical Benefits Scheme (PBS) are fulfilled Y 73342 01JAN2016 An in situ hybridisation (ISH) test of tumour tissue from a patient with metastatic adenocarcinoma of the stomach or gastro-oesophageal junction, with documented evidence of human epidermal growth factor receptor 2 (HER2) overexpression by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+ on the same tumour tissue sample, requested by, or on the advice of, a specialist or consultant physician who manages the treatment of the patient to determine if the requirements relating to HER2 gene amplification for access to trastuzumab under the Pharmaceutical Benefits Scheme are fulfilled. Y 73343 01SEP2017 Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib on the Pharmaceutical Benefits Scheme are fulfilled. N 73343 01DEC2017 Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib or ibrutinib on the Pharmaceutical Benefits Scheme are fulfilled. N 73343 01MAR2019 Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib, ibrutinib or venetoclaxon the Pharmaceutical Benefits Scheme are fulfilled. Y 73344 01JAN2019 Fluorescence in situ hybridization (FISH) test of tumour tissue from a patient with locally advanced or metastatic non-small-cell lung cancer (NSCLC), which is of non-squamous histology or histology not otherwise specified, with documented evidence of ROS proto-oncogene 1 (ROS1) immunoreactivity by immunohistochemical (IHC) examination giving a staining intensity score of 2+ or 3+; and with documented absence of both activating mutations of the epidermal growth factor receptor (EGFR) gene and anaplastic lymphoma kinase (ALK) immunoreactivity by IHC, requested by a specialist or consultant physician to determine if requirements relating to ROS1 gene rearrangement status for access to crizotinib under the Pharmaceutical Benefits Scheme are fulfilled. Y 73345 01JUL2018 Testing of a patient for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of investigating, making or excluding a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73347, 73348, or 73349 applies. The patient must have clinical or laboratory findings suggesting there is a high probability suggestive of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder. Y 73346 01JUL2018 Testing of a pregnant patient whose carrier status for pathogenic cystic fibrosis transmembrane conductance regulator variants, as well as their reproductive partner carrier status is unknown, for the purpose of determining whether pathogenic cystic fibrosis transmembrane conductance regulator variants are present in the fetus, in order to make or exclude a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder in the fetus when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73350 applies. The fetus must have ultrasonic findings of echogenic gut, with unknown familial cystic fibrosis transmembrane conductance regulator variants. Y 73347 01JUL2018 Testing of a prospective parent for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining the risk of their fetus having pathogenic cystic fibrosis transmembrane conductance regulator variants. This is indicated when the fetus has ultrasonic evidence of echogenic gut when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73348, or 73349 applies. Y 73348 01JUL2018 Testing of a patient with a laboratory-established family history of pathogenic cystic fibrosis transmembrane conductance regulator variants, for the purpose of determining whether the patient is an asymptomatic genetic carrier of the pathogenic cystic fibrosis transmembrane conductance regulator variants that have been laboratory established in the family history when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73347, or 73349 applies. The patient must have a positive family history, confirmed by laboratory findings of pathogenic cystic fibrosis transmembrane conductance regulator variants, with a personal risk of being a heterozygous genetic carrier of at least 6%. (This includes family relatedness of: parents, children, full-siblings, half-siblings, grand-parents, grandchildren, aunts, uncles, first cousins, and first cousins once-removed, but excludes relatedness of second cousins or more distant relationships). N 73348 01JAN2020 Testing of a patient with a laboratory-established family history of pathogenic cystic fibrosis transmembrane conductance regulator variants, for the purpose of determining whether the patient is an asymptomatic genetic carrier of the pathogenic cystic fibrosis transmembrane conductance regulator variants that have been laboratory established in the family history, not being a service associated with a service to which item 73345, 73347, or 73349 applies. The patient must have a positive family history, confirmed by laboratory findings of pathogenic cystic fibrosis transmembrane conductance regulator variants, with a personal risk of being a heterozygous genetic carrier of at least 6%. (This includes family relatedness of: parents, children, full-siblings, half-siblings, grand-parents, grandchildren, aunts, uncles, first cousins, and first cousins once-removed, but excludes relatedness of second cousins or more distant relationships). Y 73349 01JUL2018 Testing of a patient for pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining the reproductive risk of the patient with their reproductive partner because their reproductive partner is already known to have pathogenic cystic fibrosis transmembrane conductance regulator variants requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73345, 73347, or 73348 applies. Y 73350 01JUL2018 Testing of a pregnant patient, where one or both prospective parents are known to be a genetic carrier of pathogenic cystic fibrosis transmembrane conductance regulator variants for the purpose of determining whether pathogenic cystic fibrosis transmembrane conductance regulator variants are present in the fetus in order to make or exclude a diagnosis of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder in the fetus, when requested by a specialist or consultant physician who manages the treatment of the patient, not being a service associated with a service to which item 73346 applies. The fetus must be at 25% or more risk of cystic fibrosis or a cystic fibrosis transmembrane conductance regulator related disorder because of known familial cystic fibrosis transmembrane conductance regulator variants. Y 73351 01FEB2019 A test of tumour tissue that is derived from a new sample from a patient with locally advanced (Stage IIIb) or metastatic (Stage IV) non-small cell lung cancer (NSCLC), who has progressed on or after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI). The test is to be requested by a specialist or consultant physician, to determine if the requirements relating to EGFR T790M gene status for access to osimertinib under the Pharmaceutical Benefits Scheme are fulfilled. Y 73521 01DEC1991 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) Y 73522 01DEC1991 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test) Y 73523 01DEC1991 Semen examination (excluding post vasectomy semen examination), involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and 1 or more chemical tests, with a maximum of 4 examinations in any 12 month period N 73523 01JUL1994 Semen examination (other than post-vasectomy semen examination), including: (a)measurement of volume, sperm count and motility; and (b)examination of stained preparations; and (c)morphology; and (if performed) (d)differential count and 1 or more chemical tests; with a maximum of 4 episodes in a 12 month period - each episode N 73523 01MAY2005 Semen examination (other than post-vasectomy semen examination), including: (a)measurement of volume, sperm count and motility; and (b)examination of stained preparations; and (c)morphology; and (if performed) (d)differential count and 1 or more chemical tests; 1 of this item to a maximum of 4 in a 12 month period N 73523 01MAY2007 Semen examination (other than post-vasectomy semen examination), including: (a)measurement of volume, sperm count and motility; and (b)examination of stained preparations; and (c)morphology; and (if performed) (d)differential count and 1 or more chemical tests; (Item is subject to rule 25) Y 73524 01DEC1991 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month period Y 73525 01DEC1991 Sperm antibodies, sperm penetrating ability1 or more tests N 73525 01JUL1994 Sperm antibodies - sperm-penetrating ability - 1 or more tests Y 73526 01DEC1991 Sperm antibodies, sperm penetrating abilityone or more tests Y 73527 01DEC1991 Chorionic gonadotrophin (betaHCG), qualitative estimation in serum or urine by 1 or more methods, including serial dilution if performed, for diagnosis of pregnancy1 or more estimations N 73527 01JUL1994 Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods, including serial dilution (if performed) for diagnosis of pregnancy1 or more tests N 73527 01MAY2002 Human chorionic gonadotrophin (HCG) - detection in serum or urine by 1 or more methods for diagnosis of pregnancy - 1 or more tests Y 73528 01DEC1991 Chorionic gonadotrophin (betaHCG), qualitative estimation in serum or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancyone or more estimations Y 73529 01DEC1991 Chorionic gonadotrophin (betaHCG), qualitative (if performed) and quantitative estimation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCGsecreting neoplasm, threatened abortion or followup of abortion N 73529 01JUL1994 Chorionic gonadotrophin (betaHCG), quantitation in serum by 1 or more methods for diagnosis of hydatidiform mole, HCGsecreting neoplasm, or threatened abortion, or followup of abortion or diagnosis of ectopic pregnancy, including any services performed in 73527 - 1 test N 73529 01NOV1995 Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or followup of abortion or diagnosis of ectopic pregnancy, including any services performed in 73527 - 1 test N 73529 01NOV1999 Human chorionic gonadotrophin (HCG), quantitation in serum by 1 or more methods (except by latex, membrane, strip or other pregnancy test kit) for diagnosis of threatened abortion, or follow up of abortion or diagnosis of ectopic pregnancy, including any services performed in item 73527 - 1 test Y 73530 01DEC1991 Chorionic gonadotrophin (betaHCG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCGsecreting neoplasm, threatened abortion or follow up of abortion Y 73801 01DEC1991 Seminal examination for presence of spermatozoa N 73801 01JUL1994 Semen examination for presence of spermatozoa Y 73802 01DEC1991 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count1 procedure N 73802 01JUL1993 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin estimation, haematocrit estimation or erythrocyte count1 procedure N 73802 01JUL1994 Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count - 1 test Y 73803 01DEC1991 2 procedures specified in item 73802 N 73803 01JUL1994 2 tests described in item 73802 Y 73804 01DEC1991 3 or more procedures specified in item 73802 N 73804 01JUL1994 3 or more tests described in item 73802 Y 73805 01DEC1991 Microscopical examination of urine N 73805 01JUL1993 Urine - microscopical examination of, or catalase test for, bacteria and cells, whether stained or not N 73805 01JUL1994 Microscopy of urine, whether stained or not, or catalase test N 73805 01NOV2018 Microscopy of urine, excluding dipstick testing. Y 73806 01DEC1991 Pregnancy test by 1 or more immunochemical methods N 73806 01JUL1994 Pregnancy test by 1 or more immunochemical methods Y 73807 01DEC1991 Microscopical examination of wet film other than urine N 73807 01JUL1993 Microscopical examination of wet film other than urine, including any relevant stain N 73807 01JUL1994 Microscopy for wet film other than urine, including any relevant stain Y 73808 01DEC1991 Microscopical examination of gram stained film N 73808 01JUL1993 Microscopical examination of Gram stained film, including any examination specified in items 73805 and 73807 N 73808 01JUL1994 Microscopy of Gram-stained film, including (if performed) a service described in item 73805 or 73807 Y 73809 01DEC1991 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method Y 73810 01DEC1991 Microscopical examination screening for fungi in skin, hair or nails1 or more sites N 73810 01JUL1994 Microscopy for fungi in skin, hair or nails - 1 or more sites Y 73811 01DEC1991 Mantoux test N 73811 01FEB1992 Mantoux test Y 73815 01MAY2003 Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period - where: (a)the health service is provided in a designated general practice participating in PoCT trials; and (b)the service is rendered as part of a consultation; and (c)the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes. Y 73818 01MAY2003 Quantitation of fasting HDL cholesterol, total cholesterol and triglyceride levels in patients undergoing lipid lowering therapy - each episode to a maximum of 4 episodes in a 12 month period - where: (a)the health service is provided in a designated general practice participating in PoCT trials; and (b)the service is rendered as part of a consultation; and (c)the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes. Y 73821 01MAY2003 Quantitation of urinary microalbumin as determined by urine albumin excretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in insulin dependent diabetic patients over 12 years of age and non-insulin dependent diabetic patients under 70 years of age - each test to a maximum of one test in a 12 month period - where: (a)the health service is provided in a designated general practice participating in PoCT trials; and (b)the service is rendered as part of a consultation; and (c)the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes. Y 73824 01MAY2003 Quantitation of urinary microalbumin as determined by urine albumin excretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in diabetic patients with established microalbuminuria - each test to a maximum of 4 tests in a 12 month period - where: (a)the health service is provided in a designated general practice participating in PoCT trials; and (b)the service is rendered as part of a consultation; and (c)the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes. Y 73827 01MAY2003 Determination of INR in patients undergoing anticoagulant therapy - where: (a)the health service is provided in a designated general practice participating in PoCT trials; and (b)the service is rendered as part of a consultation; and (c)the general practitioner participating in the PoCT trial will make available any information as requested by the HIC for audit purposes. Y 73828 01NOV2011 Semen examination for presence of spermatozoa by a participating nurse practitioner Y 73829 01NOV2011 Leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count), haemoglobin, haematocrit or erythrocyte count by a participating nurse practitioner- 1 test Y 73830 01NOV2011 2 tests described in item 73829 by a participating nurse practitioner Y 73831 01NOV2011 3 or more tests described in item 73829 by a participating nurse practitioner Y 73832 01NOV2011 Microscopy of urine, whether stained or not, or catalase test by a participating nurse practitioner N 73832 01NOV2019 Microscopy of urine,excluding dipstick testingby a participating nurse practitioner. Y 73833 01NOV2011 Pregnancy test by 1 or more immunochemical methods by a participating nurse practitioner Y 73834 01NOV2011 Microscopy for wet film other than urine, including any relevant stain by a participating nurse practitioner Y 73835 01NOV2011 Microscopy of Gram-stained film, including (if performed) a service described in item 73832 or 73834 by a participating nurse practitioner Y 73836 01NOV2011 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method by a participating nurse practitioner Y 73837 01NOV2011 Microscopy for fungi in skin, hair or nails by a participating nurse practitioner- 1 or more sites Y 73839 01DEC2015 Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a12 month period. N 73839 16MAR2018 Quantitation of HbA1c (glycated haemoglobin) performed for the diagnosis of diabetes in asymptomatic patients at high risk - not more than once in a 12 month period. (Item is subject to restrictions in rulePR.9.1 of explanatory notes to this category) Y 73840 01DEC2000 Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period - where: (a)the health service is provided in a Commonwealth funded aboriginal and Torres strait Islander health and medical service; and (b)the Aboriginal and Torres Strait Islander health and medical service participates in a recognised quality assurance program. N 73840 01JAN2006 Quantitation of glycosylated haemoglobin performed in the management of established diabetes - each test to a maximum of 4 tests in a 12 month period. N 73840 16MAR2018 Quantitation of glycosylated haemoglobin performed in the management of established diabetes -each test to a maximum of 4 tests in a 12 month period. (Item is subject to restrictions in rulePR.9.1 of explanatory notes to this category) Y 73844 01JAN2006 Quantitation of urinary microalbumin as determined by urine albumin extretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in the management of established diabetes. N 73844 16MAR2018 Quantitation of urinary microalbumin as determined by urine albumin excretion on a timed overnight urine sample or urine albumin/creatinine ratio as determined on a first morning urine sample in the management of established diabetes. (Item is subject to restrictions in rulePR.9.1 of explanatory notes to this category) Y 73899 01NOV2015 Initiation of a patient episode that consists of a service described in item 72858 or 72859 in circumstances other than those mentioned in item 73900 Y 73900 01NOV2015 Initiation of a patient episode that consists of a service described in item 72858 or 72859 if the service is rendered in a prescribed laboratory. Y 73901 01FEB1992 Initiation of a patient episode which consists only of a service specified in item 73053, 73055 or 73057from a person who is not in a recognised hospital or a prescribed laboratory N 73901 01JUL1994 Initiation of a patient episode that consists only of a service described in item 73053, 73055 or 73057from a person who is not in a recognised hospital or a prescribed laboratory Y 73902 01NOV2007 Initiation of a patient episode that consists of 1 or more services described in item 72838 (in circumstances other than those described in item 73904) from a person who is an in-patient of a hospital Y 73903 01FEB1992 Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital N 73903 01JUL1994 Initiation of a patient episode that consists only of a service described in item 72801 from a person who is an in-patient of a hospital other than a recognised hospital N 73903 20MAR1997 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72823, 72824, 72825, 72830 and 72836 from a person who is an in-patient of a hospital other than a recognised hospital N 73903 01NOV2003 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is an in-patient of a hospital other than a recognised hospital Y 73904 01NOV2007 Initiation of a patient episode that consists of 1 or more services described in item 72838 if the person is: (a) a private patient of a recognised hospital; or (b) a private patient of a hospital who receives the service or services from a prescribed laboratory Y 73905 01FEB1992 Initiation of a patient episode which consists only of a service specified in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital N 73905 01JUL1994 Initiation of a patient episode that consists only of a service described in item 72801 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital N 73905 20MAR1997 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72823, 72824, 72825, 72830 and 72836 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital N 73905 01NOV2003 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is not an in-patient of a private hospital and not a patient of a recognised hospital Y 73906 01NOV2007 Initiation of a patient episode that consists only of 1 or more services described in item 72838 (in circumstances other than those described in item 73908) from a person who is not a patient of a hospital Y 73907 01FEB1992 Initiation of a patient episode by collection of specimen for a service other than a service specified in Items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a licensed collection centre other than a temporary licensed collection centre N 73907 01JUL1994 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or in Group P9) if the specimen is collected in an approved collection centre Y 73908 01NOV2007 Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in item 72838 from a person who is not a patient of a hospital Y 73909 01FEB1992 Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital N 73909 01JUL1994 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital Y 73910 20MAR1997 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in the place where the person was residing Y 73911 01FEB1992 Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority, from a person in the place where the person was residing or in a nursing home or institution N 73911 01JUL1994 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in the place where the person was residing or in a nursing home or institution Y 73912 20MAR1997 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a nursing home or institution N 73912 01NOV2000 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a residential aged care facility or institution N 73912 01NOV2001 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903 or 73905 or in Group P9) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a residential aged care home or institution Y 73913 01FEB1992 Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905, 73907, 73917 and 73801 to 73811 (inclusive) where the specimen is collected from the person by the person N 73913 01JUL1994 Initiation of a patient episode by collection of a specimen for a service (other than a service described in item 73901, 73903, 73905 or 73907 or items in Group P9) if the specimen is collected from the person by the person Y 73914 01NOV2007 Initiation of a patient episode that consists of 1 or more services described in items 72827, 72828 and 72838 (in circumstances other than those described in item 73916) from a person who is an in-patient of a hospital N 73914 01NOV2008 Initiation of a patient episode that consists of 1 or more services described in items 72827, 72828 and 72838 (in circumstances other than those described in item 73916) from a person who is an in-patient of a hospital Y 73915 01FEB1992 Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected by or on behalf of the treating practitioner N 73915 01JUL1994 Initiation of a patient episode by collection of a specimen for a service (other than a service described in items 73901, 73903 or 73905 or items in Group P9) if the specimen is collected by or on behalf of the treating practitioner Y 73916 01NOV2008 Initiation of a patient episode that consists of 1 or more services described in items 72827, 72828 and 72838 if the person is: (a) a private patient of a recognised hospital; or (b) a private patient of a hospital who receives the service or services from a prescribed laboratory Y 73917 01FEB1992 Initiation of a patient episode by collection of specimen for a service other than a service specified in items 73901, 73903, 73905 and 73801 to 73811 (inclusive) where the specimen is collected in a temporary licensed collection centre Y 73918 01NOV2008 Initiation of a patient episode that consists only of 1 or more services described in items 72827, 72828 and 72838 (in circumstances other than those described in item 73919) from a person who is not a patient of a hospital Y 73919 01NOV2008 Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in items 72827, 72828 and 72838 from a person who is not a patient of a hospital Y 73920 01JUL2008 Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected in an approved collection centre that the APA operates in the same premises as it operates a category GX or GY pathology laboratory Y 73921 01FEB1992 Referral of specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority N 73921 01JUL1994 Referral of a specimen by an approved pathology practitioner of an approved pathology authority to another approved pathology practitioner of another approved pathology authority or to another approved pathology authority (Item is subject to subrule 11(9)) N 73921 01JUL1995 Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to subrule 15(9)) N 73921 01NOV1999 Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to subrule 14(9) and 16(3)) N 73921 01MAY2004 Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to rules 14, 15 and 16) Y 73922 01MAY2007 Initiation of a patient episode that consists only of a service described in item 73053, 73055 or 73057. Unless item 73923 applies N 73922 01MAY2012 Initiation of a patient episode that consists of a service described in item 73053, 73055 or 73057 (in circumstances other than those described in item 73923). N 73922 01MAY2017 Initiation of a patient episode that consists of a service described in item 73053, 73055, 73057 or 73069 (in circumstances other than those described in item 73923). N 73922 01DEC2017 Initiation of a patient episode that consists of a service described in item 73070, 73071, 73072, 73073, 73074, 73075 or 73076(in circumstances other than those described in item 73923). Y 73923 01MAY2007 Initiation of a patient episode that consists only of a service described in items 73053, 73055 or 73057 from a person who is a private patient in a recognised hospital or the service is renderedby a prescribed laboratory N 73923 01MAY2012 Initiation of a patient episode that consists of a service described in items 73053, 73055 or 73057 if: (a) the person who is a private patient in a recognised hospital: or (b) the person receives the service from a prescribed laboratory N 73923 01MAY2017 Initiation of a patient episode that consists of a service described in items 73053, 73055, 73057 or 73069 if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory N 73923 01DEC2017 Initiation of a patient episode that consists of a service described in items 73070, 73071, 73072, 73073, 73074, 73075 or 73076 if: (a) the person is a private patient in a recognised hospital; or (b) the person receives the service from a prescribed laboratory Y 73924 01MAY2007 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is an in-patient of a hospital. Unless item 73925 applies N 73924 01MAY2012 Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 (in circumstances other than those described in item 73925) from a person who is an in-patient of a hospital. Y 73925 01MAY2007 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is a private patient in a recognised hospital or the service is rendered to a private patient in a hospital by a prescribed laboratory N 73925 01MAY2012 Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 if the person is: (a)a private patient of a recognised hospital;or (b) a private patient of a hospital who receives the service or services from a prescribed laboratory. Y 73926 01MAY2007 Initiation of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is not an in-patient of a private hospital. Unless item 73927 applies. N 73926 01MAY2012 Initiation of a patient episode that consists of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 (in circumstances other than those described in item 73927) from a person who is not a patient of a hospital. Y 73927 01MAY2007 Initiation by a prescribed laboratory of a patient episode that consists only of 1 or more services described in items 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72830 and 72836 from a person who is not a private patient in a recognised hospital nor a patient in a private hospital N 73927 01MAY2012 Initiation of a patient episode by a prescribed laboratory that consists of 1 or more services described in items, 72813, 72816, 72817, 72818, 72823, 72824, 72825, 72826, 72827, 72828, 72830, 72836 and 72838 from a person who is not a patient of a hospital. Y 73928 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or moreservices (other than those services described in items 73922, 73924 or 73926) if the specimen is collected in an approved collection centre. Unless item 73929 applies N 73928 01JUL2008 Initiation of a patient episode by collection of a specimen for 1 or moreservices (other than those services described in items 73922, 73924 or 73926) if the specimen is collected in an approved collection centre. Unless item 73920 or 73929 applies Y 73929 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services(other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner for a prescribed laboratory or by an employee of an approved pathology authority, who conducts a prescribed laboratory, if the specimen is collected in an approved pathology collection centre Y 73930 01MAY2007 Initiation of a patient episode by collection of a specimen for a service for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person who is an in-patient of a hospital other than a recognised hospital. Unless item 73931 applies Y 73931 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services(other than those services described in items 73922, 73924 or 73926) if: ()the specimen is collected by an approved pathology practitioner for a prescribed laboratory or by an employee of an approved pathology authority, who conducts a prescribed laboratory, from a person who is a private patient in a hospital or () the person is a private patient in a recognised hospital and the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority Y 73932 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in the place where the person was residing. Unless item 73933 applies Y 73933 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services(other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner for a prescribed laboratory or by an employee of an approved pathology authority, who conducts a prescribed laboratory, from a person in the place where the person is residing Y 73934 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 and 73926) if the specimen is collected by an approved pathology practitioner or an employee of an approved pathology authority from a person in a residential aged care home or institution. Unless 73935 applies Y 73935 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services(other than those services described in items 73922, 73924 or 73926) if the specimen is collected by an approved pathology practitioner or by an employee of an approved pathology authority, who conducts a prescribed laboratory, from a person in a residential aged care home or institution Y 73936 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected from the person by the person. Y 73937 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services(other than those services described in items 73922, 73924 or 73926), if the specimen is collected from the person by the person and if: ()the service is performed in a prescribed laboratory or ()the person is a private patient in a recognised hospital Y 73938 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services (other than those services described in items 73922, 73924 or 73926) if the specimen is collected by or on behalf of the treating practitioner. Unless item 73939 applies Y 73939 01MAY2007 Initiation of a patient episode by collection of a specimen for 1 or more services(other than those services described in items 73922, 73924 or 73926), if the specimen is collected by or on behalf of the treating practitioner and if: ()the service is performed in a prescribed laboratory or ()the person is a private patient in a recognised hospital Y 73940 01MAY2007 Receipt of a specimen by an approved pathology practitioner of an approved pathology authority from another approved pathology practitioner of a different approved pathology authority or another approved pathology authority (Item is subject to rules 14, 15 and 16) Y 74990 01FEB2004 A pathology service to which an item in this table (other than this item or item 74991) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder;and (c)the person is not an admitted patient of a hospital; and (d)the service is bulk-billed in respect of the fees for: (i)this item; and (ii)the other item in this table applying to the service Y 74991 01MAY2004 A pathology service to which an item in this table (other than this item or item 74990) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder: and (c)the person is not an admitted patient of a hospital or day-hospital facility: and (d)the service is bulk-billed in respect of the fees for: (i)this item: and (ii)the other item in this table applying to the service; and (e)the service is provided at, or from, a practice location in: (i)a regional, rural or remote area; or (ii)Tasmania (iii)A geographical area included in any of the following SSD spatial units: `)Beaudesert Shire Part A `)Belconnen `)Darwin City `)Eastern Outer Melbourne `)East Metropolitan `)Frankston City `)Gosford-Wyong `)Greater Geelong City Part A `)Gungahlin-Hall `)Ipswich City (Part in BSD) `)Litchfield Shire `)Melton-Wyndham `)Mornington Peninsula Shire `)Newcastle `)North Canberra `)Palmerston-East Arm `)Pine Rivers Shire `)Queanbeyan `)South Canberra `)South Eastern Outer Melbourne `)Southern Adelaide `)South West Metropolitan `)Thuringowa City Part A `)Townsville City Part A `)Tuggeranong `)Weston Creek-Stromlo (ZA)Woden Valley (ZB)Yarra Ranges Shire Part A; or lthe geographical area included in the SLA spatial unit of Palm Island (AC) N 74991 01SEP2004 A pathology service to which an item in this table (other than this item or item 74990) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c)the person is not an admitted patient of a hospital; and (d)the service is bulk-billed in respect of the fees for: (i)this item; and (ii)the other item in this table applying to the service; and (e)the service is provided at, or from, a practice location in: (i)a regional, rural or remote area; or (ii)Tasmania; or (iii)A geographical area included in any of the following SSD spatial units: (A)Beaudesert Shire Part A (B)Belconnen (C)Darwin City (D)Eastern Outer Melbourne (E)East Metropolitan, Perth (F)Frankston City (G)Gosford-Wyong (H)Greater Geelong City Part A (I)Gungahlin-Hall (J)Ipswich City (part in BSD) (K)Litchfield Shire (L)Melton-Wyndham (M)Mornington Peninsula Shire (N)Newcastle (O)North Canberra (P)Palmerston-East Arm (Q)Pine Rivers Shire (R)Queanbeyan (S)South Canberra (T)South Eastern Outer Melbourne (U)Southern Adelaide (V)South West Metropolitan, Perth (W)Thuringowa City Part A (X)Townsville City Part A (Y)Tuggeranong (Z)Weston Creek-Stromlo (ZA)Woden Valley (ZB)Yarra Ranges Shire Part A; or (iv)the geographical area included in the SLA spatial unit of Palm Island (AC) N 74991 01JAN2020 A pathology service to which an item in this table (other than this item or item 74990) applies if: (a)the service is an unreferred service; and (b)the service is provided to a person who is under the age of 16 or is a Commonwealth concession card holder; and (c)the person is not an admitted patient of a hospital; and (d)the service is bulk-billed in respect of the fees for: (i)this item; and (ii)the other item in this table applying to the service; and (e) the service is provided at, or from, a practice location within Modified Monash areas 2 to 7. Y 74992 01NOV2009 A payment when the episode is bulk billed and includes item 73920. Y 74993 01NOV2009 A payment when the episode is bulk billed and includes item 73918, 73922 or 73926. N 74993 01MAY2012 A payment when the episode is bulk billed and includes item 73922 or 73926. Y 74994 01NOV2009 A payment when the episode is bulk billed and includes item 73914 or 73924. N 74994 01MAY2012 A payment when the episode is bulk billed and includes item 73924. Y 74995 01NOV2009 A payment when the episode is bulk billed and includes item 73928, 73930 or 73936. N 74995 01NOV2015 A payment when the episode is bulk billed and includes item 73899, 73900, 73928, 73930 or 73936. Y 74996 01NOV2009 A payment when the episode is bulk billed and includes item 73932 or 73940. Y 74997 01NOV2009 A payment when the episode is bulk billed and includes item 73934. Y 74998 01NOV2009 A payment when the episode is bulk billed and includes item 73938. Y 74999 01NOV2009 A payment when the episode is bulk billed and includes item 73916, 73919, 73923, 73925,73927, 73929, 73931, 73933, 73935, 73937 or 73939. N 74999 01MAY2012 A payment when the episode is bulk billed and includes item 73923, 73925, 73927, 73929, 73931, 73933, 73935, 73937 or 73939. Y 75000 01DEC1991 CONSULTATION BY AN ACCREDITED ORTHODONTIST not being a service to which item 75003 applies Y 75001 01JUL1995 Note: In this Group, benefit is only payable where the service has been rendered to a patient by a dental practitioner who has been accredited by the Minister to provide orthodontic services, except for the services covered by Items 75009-75023 which may also be rendered by a dental practitioner approved by the Minister to provide oral surgical services. CONSULTATIONS INITIAL PROFESSIONAL ATTENDANCE in a single course of treatment by an accredited orthodontist N 75001 01NOV2012 Note: In this Group, benefit is only payable where the service has been rendered to a patient by a dental practitioner who is registered in the specialty of orthodontics, except for the services covered by Items 75009-75023 which may also be rendered by a medical practitioner who is a specialist in the practice of his or her specialty of oral and maxillofacial surgery. CONSULTATIONS INITIAL PROFESSIONAL ATTENDANCE in a single course of treatment by an eligible orthodontist (AO) Y 75003 01DEC1991 CONSULTATION BY AN ACCREDITED ORTHODONTIST and treatment planning where treatment is deferred Y 75004 01JUL1995 PROFESSIONAL ATTENDANCE by an accredited orthodontist subsequent to the first professional attendance by the orthodontist in a single course of treatment N 75004 01NOV2012 PROFESSIONAL ATTENDANCE by an eligible orthodontist subsequent to the first professional attendance by the orthodontist in a single course of treatment (AO) Y 75006 01DEC1991 PRODUCTION OF DENTAL STUDY MODELS not being a service associated with a service to which item 75003 applies or not being a service to which item 75024, 75027, 75030, 75033, 75036, 75039, 75042, 75045, 75048 or 75051 applies N 75006 01JUL1995 PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a service to which item 75004 applies) prior to provision of a service to which: (a)item 75030, 75033, 75034, 75036, 75037, 75039, 75045 or 75051 applies; or (b)an item in Group T8 or Groups 03 to 09 applies; in a single course of treatment Y 75009 01DEC1991 ORTHODONTIC RADIOGRAPHYorthopantomography (panoramic radiography) N 75009 01JUL1995 RADIOGRAPHY ORTHODONTIC RADIOGRAPHY orthopantomography (panoramic radiography), including any consultation on the same occasion Y 75012 01DEC1991 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings OR LATERAL CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings N 75012 01JUL1995 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings OR LATERAL CEPHALOMETRIC RADIOGRAPHY with cephalometric tracings including any consultation on the same occasion Y 75015 01DEC1991 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings N 75015 01JUL1995 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings including any consultation on the same occasion Y 75018 01DEC1991 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings and orthopantomography N 75018 01JUL1995 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETRIC RADIOGRAPHY, with cephalometric tracings and orthopantomography including any consultation on the same occasion Y 75021 01DEC1991 ORTHODONTIC RADIOGRAPHYANTEROPOSTERIOR AND LATERAL CEPHALOMETIC RADIOGRAPHY, with cephalometric tracings, orthopantomography and hand-wrist studies (including growth prediction) N 75021 01JUL1995 ORTHODONTIC RADIOGRAPHYhand-wrist studies (including growth prediction) including any consultation on the same occasion Y 75023 01JUL1995 INTRAORAL RADIOGRAPHY - single area, periapical or bitewing film Y 75024 01DEC1991 PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all associated consultationsWHERE 1 APPLIANCE IS USED N 75024 01JUL1995 PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all adjustments of appliances and supervision - WHERE 1 APPLIANCE IS USED Y 75027 01DEC1991 PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all associated consultationsWHERE 2 APPLIANCES ARE USED N 75027 01JUL1995 PRESURGICAL INFANT MAXILLARY ARCH REPOSITIONING including supply of appliances and all adjustments of appliances and supervisionWHERE 2 APPLIANCES ARE USED Y 75030 01DEC1991 DECIDUOUS DENTITION TREATMENTMAXILLARY ARCH EXPANSION including supply of appliances and all associated consultations, treatment planning and retention services beyond the period of active treatment N 75030 01JUL1995 DENTITION TREATMENT MAXILLARY ARCH EXPANSION not being a service associated with a service to which item 75039, 75042, 75045 or 75048 applies, including supply of appliances, all adjustments of the appliances, removal of the appliances and retention Y 75033 01DEC1991 DECIDUOUS AND PERMANENT DENTITION TREATMENTINCISOR ALIGNMENT using fixed appliances in maxillary arch, including supply of appliances and all associated consultations, treatment planning and retention services beyond the period of active treatment N 75033 01JUL1995 MIXED DENTITION TREATMENT - incisor alignment using fixed appliances in maxillary arch, including supply of appliances, all adjustments of appliances, removal of the appliances and retention Y 75034 01JUL1995 MIXED DENTITION TREATMENT - incisor alignment with or without lateral arch expansion using a removable appliance in the maxillary arch, including supply of appliances, associated adjustments and retention Y 75036 01DEC1991 DECIDUOUS AND PERMANENT DENTITION TREATMENTLATERAL ARCH EXPANSION AND INCISOR ALIGNMENT using fixed appliances in maxillary arch, including supply of appliances and associated consultations, treatment planning and retention services beyond the period of active treatment; not being a service associated with a service to which item 75033 applies N 75036 01JUL1995 MIXED DENTITION TREATMENT - lateral arch expansion and incisor alignment using fixed appliances in maxillary arch, including supply of appliances, all adjustments of appliances, removal of appliances and retention Y 75037 01JUL1995 MIXED DENTITION TREATMENT - lateral arch expansion and incisor correction - 2 arch (maxillary and mandibular) using fixed appliances in both maxillary and mandibular arches, including supply of appliances, all adjustments of appliances, removal of appliances and retention Y 75039 01DEC1991 PERMANENT DENTITION TREATMENTSINGLE ARCH (mandibular or maxillary) TREATMENT (correction and/or alignment) using fixed appliances, including supply of appliances, and associated consultations, treatment planning and retention services beyond the period of active treatment; not being a service associated with a service to which item 75045 or 75048 applies INITIAL 3 MONTHS of active treatment N 75039 01JUL1995 PERMANENT DENTITION TREATMENTSINGLE ARCH (mandibular or maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - initial 3 months of active treatment Y 75042 01DEC1991 EACH SUBSEQUENT 3 MONTHS of active treatment for a maximum of a further 33 months N 75042 01JUL1995 PERMANENT DENTITION TREATMENT - SINGLE ARCH (mandibular or maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - each 3 months of active treatment (including all adjustments and maintenance and removal of the appliances) after the first for a maximum of a further 33 months Y 75045 01DEC1991 PERMANENT DENTITION TREATMENT2 ARCH (mandibular and maxillary) TREATMENT (correction and/or alignment) using fixed appliances, including supply of appliances and associated consultations, treatment planning and retention services beyond the period of active treatment; not being a service associated with a service to which item 75039 or 75042 applies INITIAL 3 MONTHS OF ACTIVE TREATMENT N 75045 01JUL1995 PERMANENT DENTITION TREATMENT2 ARCH (mandibular and maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - initial 3 months of active treatment Y 75048 01DEC1991 EACH SUBSEQUENT 3 MONTHS of active treatment fora maximum of a further 33 months N 75048 01JUL1995 PERMANENT DENTITION TREATMENT - 2 ARCH (mandibular and maxillary) TREATMENT (correction and alignment) using fixed appliances, including supply of appliances - each subsequent 3 months of active treatment (including all adjustments and maintenance, and removal of the appliances) after the first for a maximum of a further 33 months Y 75049 01JUL1995 RETENTION, FIXED OR REMOVABLE, single arch (mandibular or maxillary) - supply of retainer and supervision of retention Y 75050 01JUL1995 RETENTION, FIXED OR REMOVABLE, 2-arch (mandibular and maxillary) - supply of retainers and supervision of retention Y 75051 01DEC1991 PRESURGICAL OR POSTSURGICAL JAW GROWTH GUIDANCE using removable appliances, including supply of appliances, all associated consultations and treatment planning N 75051 01JUL1995 JAW GROWTH GUIDANCE JAW GROWTH guidance using removable or functional appliances, including supply of appliances and all adjustments to appliances Y 75150 01JUL1995 Note:(i) In this Group, benefit is only payable where the service has been rendered to a patient who has been referred by an accredited orthodontist. (ii)While benefit is payable for simple extractions performed by a registered dental practitioner, benefit is only payable for surgical extractions and other surgical procedures where the service is rendered by a dental practitioner who has been approved by the Minister to provide oral surgical services. (see para CB1.5) CONSULTATIONS INITIAL PROFESSIONAL attendance in a single course of treatment by an accredited oral and maxillofacial surgeon where the patient is referred to the surgeon by an accredited orthodontist N 75150 01NOV2012 Note:(i) In this Group, benefit is only payable where the service has been rendered to a patient who has been referred by an eligibleorthodontist. (ii)While benefit is payable for simple extractions performed by a registered dental practitioner, benefit is only payable for surgical extractions and other surgical procedures where the service is rendered by amedical practitioner who is a specialist in the practice of his or her speciality of oral and maxillofacial surgery. CONSULTATIONS INITIAL PROFESSIONAL attendance in a single course of treatment by an eligible oral and maxillofacial surgeon where the patient is referred to the surgeon by an eligible orthodontist (AOS) Y 75153 01JUL1995 PROFESSIONAL ATTENDANCE by an accredited oral and maxillofacial surgeon subsequent to the first professional attendance by the surgeon in a single course of treatment where the patient is referred to the surgeon by an accredited orthodontist N 75153 01NOV2012 PROFESSIONAL ATTENDANCE by an eligible oral and maxillofacial surgeon subsequent to the first professional attendance by the surgeon in a single course of treatment where the patient is referred to the surgeon by an eligible orthodontist Y 75156 01JUL1995 PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a service to which item 75153 applies) prior to provision of a service: (a)to which item 52321, 53212 or 75618 applies; or (b)to which an item in the series 52330 to 52382, 52600 to 52630, 53400 to 53409 or 53415 to 53429 applies; in a single course of treatment N 75156 01NOV2012 PRODUCTION OF DENTAL STUDY MODELS (not being a service associated with a service to which item 75153 applies) prior to provision of a service: (a)to which item 52321, 53212 or 75618 applies; or (b)to which an item in the series 52330 to 52382, 52600 to 52630, 53400 to 53409 or 53415 to 53429 applies; in a single course of treatment if the patient is referred by an eligible orthodontist (AOS) Y 75200 01DEC1991 SIMPLE EXTRACTIONS REMOVAL OF TOOTH OR TOOTH FRAGMENT not being treatment to which item 75400, 75403, 75406, 75409, 75412 or 75415 applies N 75200 01NOV2012 SIMPLE EXTRACTIONS Removal of tooth or tooth fragment (other than treatment to which item 75400, 75403, 75406, 75409, 75412 or 75415 applies), if the patient is referred by an eligible orthodontist (AD) Y 75203 01DEC1991 REMOVAL OF TOOTH OR TOOTH FRAGMENT under general anaesthesia N 75203 01NOV2012 REMOVAL OF TOOTH OR TOOTH FRAGMENT under general anaesthesia, if the patient is referred by an eligible orthodontist (AD) Y 75206 01DEC1991 REMOVAL OF EACH ADDITIONAL TOOTH OR TOOTH FRAGMENT at the same attendance at which a service to which item 75200 or 75203 applies is rendered N 75206 01NOV2012 Removal of each additional tooth or tooth fragment at the same attendance at which a service to which item 75200 or 75203 applies is rendered, if the patient is referred by an eligible orthodontist (AD) Y 75400 01DEC1991 SURGICAL EXTRACTIONS Surgical removal of erupted tooth, if the patient is referred by an eligible orthodontist (AOS) N 75400 01NOV2012 SURGICAL EXTRACTIONS Surgical removal of erupted tooth, if the patient is referred by an eligible orthodontist (AOS) Y 75403 01DEC1991 SURGICAL REMOVAL OF TOOTH with soft tissue impaction N 75403 01NOV2012 Surgical removal of tooth with soft tissue impaction, if the patient is referred by an eligible orthodontist (AOS) Y 75406 01DEC1991 SURGICAL REMOVAL OF TOOTH with partial bone impaction N 75406 01NOV2012 Surgical removal of tooth with partial bone impaction, if the patient is referred by an eligible orthodontist (AOS) Y 75409 01DEC1991 SURGICAL REMOVAL OF TOOTH with complete bone impaction N 75409 01NOV2012 Surgical removal of tooth with complete bone impaction, if the patient is referred by an eligible orthodontist (AOS) Y 75412 01DEC1991 SURGICAL REMOVAL OF TOOTH FRAGMENT involving soft tissueonly N 75412 01NOV2012 Surgical removal of tooth fragment requiring incision of soft tissue only, if the patient is referred by an eligible orthodontist (AOS) Y 75415 01DEC1991 SURGICAL REMOVAL OF TOOTH FRAGMENT involving bone N 75415 01NOV2012 Surgical removal of tooth fragment requiring removal of bone, if the patient is referred by an eligible orthodontist (AOS) Y 75600 01DEC1991 OTHER SURGICAL PROCEDURES Surgical exposure, stimulation and packing of unerupted tooth, if the patient is referred by an eligible orthodontist (AOS) N 75600 01NOV2012 OTHER SURGICAL PROCEDURES Surgical exposure, stimulation and packing of unerupted tooth, if the patient is referred by an eligible orthodontist (AOS) Y 75603 01DEC1991 SURGICAL EXPOSURE OF UNERUPTED TOOTH for the purpose of fitting a traction device N 75603 01NOV2012 Surgical exposure of unerupted tooth for the purpose of fitting a traction device, if the patient is referred by an eligible orthodontist (AOS) Y 75606 01DEC1991 SURGICAL REPOSITIONING OF UNERUPTED TOOTH N 75606 01NOV2012 Surgical repositioning of unerupted tooth, if the patient is referred by an eligible orthodontist (AOS) Y 75609 01DEC1991 TRANSPLANTATION OF TOOTH BUD N 75609 01NOV2012 Transplantation of tooth bud, if the patient is referred by an eligible orthodontist (AOS) Y 75612 01JUL1995 SURGICAL PROCEDURE for intra oral implantation of osseointegrated fixture (first stage) N 75612 01NOV2012 Surgical procedure for intra oral implantation of osseointegrated fixture (first stage), if the patient is referred by an eligible orthodontist (AOS) Y 75615 01JUL1995 SURGICAL PROCEDURE FOR FIXATION of trans-mucosal abutment (second stage of osseointegrated implant) N 75615 01NOV2012 Surgical procedure for fixation of trans mucosal abutment (second stage of osseointegrated implant), if the patient is referred by an eligible orthodontist (AOS) Y 75618 01JUL1995 PROVISION AND FITTING OF A BITE RISING APPLIANCE or DENTAL SPLINT for the management of temporomandibular joint dysfunction syndrome N 75618 01NOV2012 Provision and fitting of a bite rising appliance or dental splint for the management of temporomandibular joint dysfunction syndrome, if the patient is referred by an eligible orthodontist (AOS) Y 75621 01JUL1995 THE PROVISION AND FITTING OF SURGICAL TEMPLATE in conjuction with orthognathic surgical procedures in association with: (a)an item in the series 52342 to 52375; or (b)item 52380 or 52382 N 75621 01NOV2008 THE PROVISION AND FITTING OF SURGICAL TEMPLATE in conjuction with orthognathic surgical procedures in association with an item in the range: (a)45720 to 45754; or (b)52342 to 52375; or (c)52380 or 52382 N 75621 01NOV2012 The provision and fitting of surgical template in conjunction with orthognathic surgical procedures in association with: (a)an item in the series: (i)45720 to 45754; or (ii)52342 to 52375; or (b)item 52380 or 52382; if the patient is referred by an eligible orthodontist (AOS) Y 75800 01DEC1991 Note:Benefit is payable for services listed in this Group where they are rendered by a State registered dental practitioner CONSULTATIONS ATTENDANCE BY AN ELIGIBLE DENTAL PRACTITIONER involving consultation, preventive treatment and prophylaxis, of not less than 30 minutes' durationeach attendance to a maximum of 3 attendances in any period of 12 months N 75800 01NOV2012 Note:Benefit is payable for services listed in this Group where they are rendered by a registered dental practitioner CONSULTATIONS ATTENDANCE BY AN ELIGIBLE DENTAL PRACTITIONER involving consultation, preventive treatment and prophylaxis, of not less than 30 minutes' durationeach attendance to a maximum of 3 attendances in any period of 12 months Y 75803 01DEC1991 PROSTHODONTIC PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers1 TOOTH Y 75806 01DEC1991 2 TEETH N 75806 01NOV2010 PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 2 TEETH Y 75809 01DEC1991 3 TEETH N 75809 01NOV2010 PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE. including retainers 3 TEETH Y 75812 01DEC1991 4 TEETH N 75812 01NOV2010 PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 4 TEETH Y 75815 01DEC1991 5 TO 9 TEETH N 75815 01NOV2010 PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 5 TO 9 TEETH Y 75818 01DEC1991 10 TO 12 TEETH N 75818 01NOV2010 PROVISION AND FITTING OF ACRYLIC BASE PARTIAL DENTURE, including retainers 10 TO 12 TEETH Y 75821 01DEC1991 PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 1 TOOTH Y 75824 01DEC1991 2 TEETH N 75824 01NOV2010 PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers2 TEETH Y 75827 01DEC1991 3 TEETH N 75827 01NOV2010 PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 3 TEETH Y 75830 01DEC1991 4 TEETH N 75830 01NOV2010 PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 4 TEETH Y 75833 01DEC1991 5 TO 9 TEETH N 75833 01NOV2010 PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 5 TO 9 TEETH Y 75836 01DEC1991 10 TO 12 TEETH N 75836 01NOV2010 PROVISION AND FITTING OF CAST METAL BASE (cobalt chromium alloy) PARTIAL DENTURE including casting and retainers 10 TO 12 TEETH Y 75839 01DEC1991 PROVISION AND FITTING OF RETAINERS not being a service associated with a service to which item 75803, 75806, 75809, 75812, 75815, 75818, 75821, 75824, 75827, 75830, 75833 or 75836 applieseach retainer Y 75842 01DEC1991 ADJUSTMENT OF PARTIAL DENTURE not being a service associated with a service to which item 75803, 75806, 75809, 75812, 75815, 75818, 75821, 75824, 75827, 75830, 75833 or 75836 applies Y 75845 01DEC1991 RELINING OF PARTIAL DENTURE by laboratory process and associated fitting Y 75848 01DEC1991 REMODELLING AND FITTING OF PARTIAL DENTURE of more than 4 teeth Y 75851 01DEC1991 REPAIR TO CAST METAL BASE OF PARTIAL DENTURE1 or more points Y 75854 01DEC1991 ADDITION OF A TOOTH OR TEETH to a partial denture to replace extracted tooth or teeth including taking of necessary impression Y 80000 01NOV2006 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80000 01MAY2007 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80000 01NOV2007 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80000 01AUG2009 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80000 01NOV2011 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80000 01MAR2012 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80000 01OCT2017 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80000 01NOV2017 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80000 01SEP2018 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80001 01NOV2017 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80001 01SEP2018 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting more than 30 minutes but less than 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80005 01NOV2006 Professional attendance at a place other than consulting rooms. As per the service requirements outlined for item 80000. Y 80010 01NOV2006 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80010 01MAY2007 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80010 01NOV2007 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80010 01AUG2009 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80010 01NOV2011 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80010 01MAR2012 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80010 01OCT2017 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80010 01NOV2017 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80010 01SEP2018 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80011 01NOV2017 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance , at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80011 01SEP2018 Professional attendance for the purpose of providing psychological assessment and therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting at least 50 minutes, where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance , at least 15 kilometres by road from the clinical psychologist. Psychological therapy services delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80015 01NOV2006 Professional attendance at a place other than consulting rooms As per the service requirements outlined for item 80010. Y 80020 01NOV2006 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP PSYCHOTHERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01MAY2007 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP PSYCHOTHERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01NOV2007 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01AUG2009 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01NOV2011 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01OCT2017 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part ofa shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80120, 80145 and 80170 apply). - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01NOV2017 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80020 01SEP2018 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80021 01NOV2017 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Group psychological therapy services delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face?to?face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80021 01SEP2018 Professional attendance for the purpose of providing psychological therapy for a mental disorder by a clinical psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist. Group psychological therapy services delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group psychological therapy services delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. - GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80100 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80100 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80100 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80100 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80100 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80100 01MAR2012 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80100 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80100 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80100 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80101 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80101 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80105 01NOV2006 Professional attendance at a place other than consulting rooms. As per the psychologist service requirements outlined for item 80100. Y 80110 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80110 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80110 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80110 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80110 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80110 01MAR2012 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80110 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80110 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80110 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80111 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80111 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80115 01NOV2006 Professional attendance at a place other than consulting rooms. As per the psychologist service requirements outlined for item 80110. Y 80120 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80145 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80120 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80121 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face?to?face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80121 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a psychologist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80125 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80125 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80125 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional services at consulting rooms) N 80125 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional services at consulting rooms) N 80125 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms) N 80125 01MAR2012 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional services at consulting rooms) N 80125 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms) N 80125 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms) N 80125 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional services at consulting rooms) Y 80126 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80126 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80130 01NOV2006 Professional attendance at a place other than consulting rooms. As per the occupational therapist service requirements outlined for item 80125. Y 80135 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80135 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80135 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80135 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80135 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80135 01MAR2012 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80135 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80135 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80135 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80136 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80136 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80140 01NOV2006 Professional attendance at a place other than consulting rooms. As per the occupational therapist service requirements outlined for item 80135. Y 80145 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of ashared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80170 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80145 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80146 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face?to?face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80146 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by an occupational therapist registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the occupational therapist. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80150 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80150 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80150 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80150 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80150 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80150 01MAR2012 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80150 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverablein up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80150 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80150 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80151 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80151 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 20 minutes, but not more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80155 01NOV2006 Professional attendance at a place other than consulting rooms. As per the social worker service requirements outlined for item 80150. Y 80160 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80160 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. N 80160 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80160 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 and the Better Outcomes in Mental Health Care Program Access To Allied Psychological Services apply).Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply. (Professional attendance at consulting rooms) N 80160 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80160 01MAR2012 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). Claims for this service may exceed this maximum session limit, however, where exceptional circumstances apply (to a maximum total of 16 individual services per patient from 1 March 2012 to 31 December 2012). (Professional attendance at consulting rooms) N 80160 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These services are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80160 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) N 80160 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply). (Professional attendance at consulting rooms) Y 80161 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply), with at least one face-to-face consultation (to which items 2721, 2723, 2725, 2727, 80000, 80005, 80010, 80015, 80100, 80105, 80110, 80115, 80125, 80130, 80135, 80140, 80150, 80155, 80160 and 80165 apply) to be conducted within the first four sessions. Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. N 80161 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service - lasting more than 50 minutes - where the patient is referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80001, 80011, 80101, 80111, 80126, 80136, 80151 and 80161 apply). Focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 283 to 287; 2721 to 2727; 80000 to 80015; 80100 to 80115; 80125 to 80140; 80150 to 80165 apply. Y 80165 01NOV2006 Professional attendance at a place other than consulting rooms. As per the social worker service requirements outlined for item 80160. Y 80170 01NOV2006 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a consultant physician specialising in the practice of his or her field of psychiatry; or a consultant physician specialising in the practice of his or her field of paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01MAY2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; and/or a psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01NOV2007 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Care Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01AUG2009 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable, in general, in up to 12 planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01NOV2011 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01OCT2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80120 and 80145 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year, up to seven of which may be provided via video conference, (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80170 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics. These therapies are time limited, being deliverable in up to ten planned sessions in a calendar year (including services to which items 80020, 80021, 80120, 80121, 80145, 80146, 80170 and 80171 apply). GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 80171 01NOV2017 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up to seven planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply), with at least one face?to?face consultation (to which items 80020, 80120, 80145 and 80170 apply) to be conducted within the first four sessions. Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT N 80171 01SEP2018 Professional attendance for the purpose of providing focussed psychological strategies services for an assessed mental disorder by a social worker registered with Medicare Australia as meeting the credentialing requirements for provision of this service, lasting for at least 60 minutes duration where the patients are referred by a medical practitioner, as part of a GP Mental Health Treatment Plan or as part of a shared care plan; or referred by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) who is managing the patient under a referred psychiatrist assessment and management plan; or referred by a specialist or consultant physician in the practice of his or her field of psychiatry or paediatrics if: the attendance is by video conference; and the patient is not an admitted patient; and the patient is located within a telehealth eligible area; and the patient is, at the time of the attendance, at least 15 kilometres by road from the social worker. Group focussed psychological strategies delivered by video conference are time limited, being deliverable in up toten planned sessions in a calendar year (including services to which items 80021, 80121, 80146 and 80171 apply). Group focussed psychological strategies delivered by video conference time limits include the maximum ten planned sessions in a calendar year services to which items 80020, 80120, 80145 and 80170 apply. GROUP THERAPY with a group of 6 to 10 patients, EACH PATIENT Y 81000 01NOV2006 Provision of a non-directive pregnancy support counselling service to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by an eligible psychologist, where the patient is referred to the psychologist by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a psychologist who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service.It may not be provided by a psychologist who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001 N 81000 01JAN2014 Provision of a non-directive pregnancy support counselling service to a person who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible psychologist, where the patient is referred to the psychologist by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a psychologist who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service.It may not be provided by a psychologist who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001 Y 81005 01NOV2006 Provision of a non-directive pregnancy support counselling service to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by an eligible social worker, where the patient is referred to the social worker by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a social worker who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service.It may not be provided by a social worker who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001 N 81005 01JAN2014 Provision of a non-directive pregnancy support counselling service to a person who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible social worker, where the patient is referred to the social worker by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a social worker who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service.It may not be provided by a social worker who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items -81000, 81005, 81010 and 4001 Y 81010 01NOV2006 Provision of a non-directive pregnancy support counselling service to a woman who is concerned about a current pregnancy or a pregnancy that occurred in the preceding 12 months, by an eligible mental health nurse, where the patient is referred to the mental health nurse by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a mental health nurse who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service.It may not be provided by a mental health nurse who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items - 81000, 81005, 81010 and 4001 N 81010 01JAN2014 Provision of a non-directive pregnancy support counselling service to a person who is currently pregnant or who has been pregnant in the preceding 12 months, by an eligible mental health nurse, where the patient is referred to the mental health nurse by a medical practitioner (including a general practitioner, but not a specialist or consultant physician), and lasting at least 30 minutes. The service may be used to address any pregnancy related issues for which non-directive counselling is appropriate. This service may be provided by a mental health nurse who is registered with Medicare Australia as meeting the credentialling requirements for provision of this service.It may not be provided by a mental health nurse who has a direct pecuniary interest in a health service that has as its primary purpose the provision of services for pregnancy termination. To a maximum of three non-directive pregnancy support counselling services per patient, per pregnancy from any of the following items - 81000, 81005, 81010 and 4001 Y 81100 01MAY2007 DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that substantially complies with the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). N 81100 01NOV2009 DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that contains all the components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). N 81100 01MAY2010 DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). N 81100 01OCT2017 DIABETES EDUCATION SERVICE - ASSESSMENT FOR GROUP SERVICES Diabetes education health service provided to a person by an eligible diabetes educator for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible diabetes educator by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). Y 81105 01MAY2007 DIABETES EDUCATION SERVICE - GROUP SERVICE Diabetes education health service provided to a person by an eligible diabetes educator, as a GROUP SERVICE for the management of type 2 diabetes if: (a)the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c)the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible diabetes educator; and (e) the service is of at least 60 minutes duration; and (f)after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible diabetes educator prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible diabetes educator; and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eightGROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year. N 81105 01NOV2010 DIABETES EDUCATION SERVICE - GROUP SERVICE Diabetes education health service provided to a person by an eligible diabetes educator, as a GROUP SERVICE for the management of type 2 diabetes if: (a)the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c)the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible diabetes educator; and (e) the service is of at least 60 minutes duration; and (f)after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible diabetes educator prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible diabetes educator; and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eightGROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year. Y 81110 01MAY2007 EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUPSERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, theirmedical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that substantially complies with the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). N 81110 01NOV2009 EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUPSERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, theirmedical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that contains all the components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). N 81110 01MAY2010 EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUPSERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 732, or if the person is a resident of an aged care facility, theirmedical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). N 81110 01OCT2017 EXERCISE PHYSIOLOGY SERVICE - ASSESSMENT FOR GROUPSERVICES Exercise physiology health service provided to a person by an eligible exercise physiologist for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan [ie item 721 or 732, or if the person is a resident of an aged care facility, theirmedical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible exercise physiologist by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all the components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and 81120 apply). Y 81115 01MAY2007 EXERCISE PHYSIOLOGY SERVICE - GROUP SERVICE Exercise physiology health service provided to a person by an eligible exercise physiologist, as a GROUP SERVICE for the management of type 2 diabetes if: (a)the person has been assessed as suitable for a type 2 diabetes group service under assessment item 8100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c)the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible exercise physiologist; and (e) the service is of at least 60 minutes duration; and (f)after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible exercise physiologist prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible exercise physiologist; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eightGROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year. N 81115 01NOV2010 EXERCISE PHYSIOLOGY SERVICE - GROUP SERVICE Exercise physiology health service provided to a person by an eligible exercise physiologist, as a GROUP SERVICE for the management of type 2 diabetes if: (a)the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c)the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible exercise physiologist; and (e) the service is of at least 60 minutes duration; and (f)after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible exercise physiologist prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible exercise physiologist; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eightGROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year. Y 81120 01MAY2007 DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that substantially complies with the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply). N 81120 01NOV2009 DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 725], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health and Ageing, or a referral form that contains all components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply). N 81120 01MAY2010 DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply). N 81120 01OCT2017 DIETETICS SERVICE - ASSESSMENT FOR GROUP SERVICES Dietetics health service provided to a person by an eligible dietitian for the purposes of ASSESSING a person's suitability for group services for the management of type 2 diabetes, including taking a comprehensive patient history, identifying an appropriate group services program based on the patient's needs, and preparing the person for the group services, if: (a)the service is provided to a person who has type 2 diabetes; and (b)the person is being managed by a medical practitioner (including a general practitioner, but not a specialist or consultant physician) under a shared care plan or a GP Management Plan [ie item 721 or 732], or if the person is a resident of an aged care facility, their medical practitioner has contributed to a multidisciplinary care plan [ie item 731]; and (c)the person is referred to an eligible dietitian by the medical practitioner using a referral form that has been issued by the Department of Health, or a referral form that contains all components of the form issued by the Department; and (d)the person is not an admitted patient of a hospital; and (e)the service is provided to the person individually and in person; and (f)the service is of at least 45 minutes duration; and (g)after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (c); and (h)in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit. Benefits are payable once only in a calendar year for this or any other Assessment for Group Services item (including services to which items 81100, 81110 and item 81120 apply). Y 81125 01MAY2007 DIETETICS SERVICE - GROUP SERVICE Dietetics health service provided to a person by an eligible dietitian, as a GROUP SERVICE for the management of type 2 diabetes if: (a)the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients; and (c)the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible dietitian; and (e) the service is of at least 60 minutes duration; and (f)after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible dietitian prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible dietitian; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year. N 81125 01NOV2010 DIETETICS SERVICE - GROUP SERVICE Dietetics health service provided to a person by an eligible dietitian, as a GROUP SERVICE for the management of type 2 diabetes if: (a)the person has been assessed as suitable for a type 2 diabetes group service under assessment item 81100, 81110 or 81120; and (b) the service is provided to a person who is part of a group of between 2 and 12 patients inclusive; and (c)the person is not an admitted patient of a hospital; and (d) the service is provided to a person involving the personal attendance by an eligible dietitian; and (e) the service is of at least 60 minutes duration; and (f)after the last service in the group services program provided to the person under items 81105, 81115 or 81125, the eligible dietitian prepares, or contribute to, a written report to be provided to the referring medical practitioner; and (g) an attendance record for the group is maintained by the eligible dietitian; and (h) in the case of a service in respect of which a private health insurance benefit is payable - the person who incurred the medical expenses in respect of the service has elected to claim the Medicare benefit in respect of the service, and not the private health insurance benefit; - to a maximum of eight GROUP SERVICES (including services to which items 81105, 81115 and 81125 apply) in a calendar year. Y 81300 01NOV2008 ABORIGINAL OR TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible Aboriginal health worker if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible Aboriginal health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum of 5 services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81300 01MAY2010 ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible Aboriginal health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible Aboriginal health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81300 01JUL2012 ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81300 01OCT2017 ABORIGINAL AND TORRES STRAIT ISLANDER HEALTH SERVICE provided to a person who is of Aboriginal and Torres Strait Islander descent by an eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible Aboriginal health worker or eligible Aboriginal and Torres Strait Islander health practitioner gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81305 01NOV2008 DIABETES EDUCATION HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible diabetes educator if: (a)a medical practitioner has identified a need for follow-up allied health services; and (b)the person is referred to the eligible diabetes educator by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81305 01OCT2017 DIABETES EDUCATION HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible diabetes educator if: (a)either: a medical practitioner has identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible diabetes educator by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible diabetes educator gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81310 01NOV2008 AUDIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible audiologist if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medicalpractitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81310 01OCT2017 AUDIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible audiologist if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible audiologist by the medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible audiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medicalpractitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81315 01NOV2008 EXERCISE PHYSIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible exercise physiologist if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible exercise physiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81315 01OCT2017 EXERCISE PHYSIOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible exercise physiologist if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible exercise physiologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible exercise physiologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters; - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81320 01NOV2008 DIETETICS HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible dietitian if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible dietitian by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81320 01OCT2017 DIETETICS HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible dietitian if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible dietitian by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible dietitian gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81325 01NOV2008 MENTAL HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible mental health worker if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible mental health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81325 01OCT2017 MENTAL HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible mental health worker if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible mental health worker by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible mental health worker gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81330 01NOV2008 OCCUPATIONAL THERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible occupational therapist if (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible occupational therapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81330 01OCT2017 OCCUPATIONAL THERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible occupational therapist if (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible occupational therapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible occupational therapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81335 01NOV2008 PHYSIOTHERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible physiotherapist if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible physiotherapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81335 01OCT2017 PHYSIOTHERAPY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible physiotherapist if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible physiotherapist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible physiotherapist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81340 01NOV2008 PODIATRY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible podiatrist if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible podiatrist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81340 01OCT2017 PODIATRY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible podiatrist if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible podiatrist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible podiatrist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81345 01NOV2008 CHIROPRACTIC HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible chiropractor if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible chiropractor by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medicalpractitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81345 01OCT2017 CHIROPRACTIC HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible chiropractor if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible chiropractor by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible chiropractor gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medicalpractitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81350 01NOV2008 OSTEOPATHY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible osteopath if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible osteopath by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81350 01OCT2017 OSTEOPATHY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible osteopath if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible osteopath by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible osteopath gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81355 01NOV2008 PSYCHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible psychologist if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible psychologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81355 01OCT2017 PSYCHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible psychologist if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible psychologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible psychologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 81360 01NOV2008 SPEECH PATHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible speech pathologist if: (a)a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; and (b)the person is referred to the eligible speech pathologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year N 81360 01OCT2017 SPEECH PATHOLOGY HEALTH SERVICE provided to a person who is of Aboriginal or Torres Strait Islander descent by an eligible speech pathologist if: (a)either: a medical practitioner has undertaken a health assessment and identified a need for follow-up allied health services; or the person's shared care plan identifies the need for follow-up allied health services; and (b)the person is referred to the eligible speech pathologist by a medical practitioner using a referral form that has been issued by the Department or a referral form that substantially complies with the form issued by the Department; and (c)the person is not an admitted patient of a hospital; and (d)the service is provided to the person individually and in person; and (e)the service is of at least 20 minutes duration; and (f)after the service, the eligible speech pathologist gives a written report to the referring medical practitioner mentioned in paragraph (b): (i) if the service is the only service under the referral - in relation to that service; or (ii) if the service is the first or the last service under the referral - in relation to the service; or (iii) if neither subparagraph (i) nor (ii) applies but the service involves matters that the referring medical practitioner would reasonably be expected to be informed of - in relation to those matters - to a maximum offive services (including services to which items 81300 to 81360 inclusive apply) in a calendar year Y 82000 01JUL2008 PSYCHOLOGY Psychology health service provided to a child, aged under 13 years, by an eligible psychologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) treatment plan, developed by the practitioner; and (c) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (d) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005 and 82010 N 82000 01JUL2011 PSYCHOLOGY Psychology health service provided to a child, aged under 13 years, by an eligible psychologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 N 82000 01JAN2013 PSYCHOLOGY Psychology health service provided to a child, aged under 13 years, by an eligible psychologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 Y 82005 01JUL2008 SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 13 years, by an eligible speech pathologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) treatment plan, developed by the practitioner; and (c) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (d) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005 and 82010 N 82005 01JUL2011 SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 13 years, by an eligible speech pathologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner: and (d) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 N 82005 01JAN2013 SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 13 years, by an eligible speech pathologist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner: and (d) the speech pathologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 Y 82010 01JUL2008 OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 13 years, by an eligible occupational therapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) treatment plan, developed by the practitioner; and (c) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (d) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005 and 82010 N 82010 01JUL2011 OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 13 years, by an eligible occupational therapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 N 82010 01JAN2013 OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 13 years, by an eligible occupational therapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the occupational therapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 Y 82015 01JUL2008 PSYCHOLOGY Psychology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) by an eligible psychologist where: (a) the child has been diagnosed with PDD; and (b) the child has received a PDD treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD treatment plan; and (d) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (e) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020 and 82025 N 82015 01JUL2011 PSYCHOLOGY Psychology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible psychologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the psychologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 N 82015 01JAN2013 PSYCHOLOGY Psychology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible psychologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the psychologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 Y 82020 01JUL2008 SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) by an eligible speech pathologist where: (a) the child has been diagnosed with PDD; and (b) the child has received a PDD treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD treatment plan; and (d) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (e) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020 and 82025 N 82020 01JUL2011 SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible speech pathologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the speech pathologist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 N 82020 01JAN2013 SPEECH PATHOLOGY Speech pathology health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible speech pathologist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the speech pathologist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 Y 82025 01JUL2008 OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) by an eligible occupational therapist where: (a) the child has been diagnosed with PDD; and (b) the child has received a PDD treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD treatment plan; and (d) the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; and (e) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020 and 82025 N 82025 01JUL2011 OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible occupational therapist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the occupational therapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 N 82025 01JAN2013 OCCUPATIONAL THERAPY Occupational therapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or an eligible disability by an eligible occupational therapist where: (a) the child has been diagnosed with PDD or an eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD or disability treatment plan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the occupational therapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 Y 82030 01JUL2011 AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 13 years, by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 N 82030 01JAN2013 AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 13 years, by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child is referred by an eligible practitioner for the purpose of assisting the practitioner with their diagnosis of the child; or (b) the child is referred by an eligible practitioner for the purpose of contributing to the child's pervasive developmental disorder (PDD) or disability treatment plan, developed by the practitioner; and (c) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (d) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (e) the child is not an admitted patient of a hospital; and (f) the service is provided to the child individually and in person; and (g) the service lasts at least 50 minutes in duration. These items are limited to a maximum of four services per patient, consisting of any combination of the following items - 82000, 82005, 82010 and 82030 Y 82035 01JUL2011 AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child has been diagnosed with PDD or eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD ordisability treatmentplan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with Medicare Australia as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 N 82035 01JAN2013 AUDIOLOGY, OPTOMETRY, ORTHOPTIC OR PHYSIOTHERAPY Audiology, optometry, orthoptic or physiotherapy health service provided to a child, aged under 15 years, for treatment of a pervasive developmental disorder (PDD) or eligible disability by an eligible audiologist, optometrist, orthoptist or physiotherapist where: (a) the child has been diagnosed with PDD or eligible disability; and (b) the child has received a PDD or disability treatment plan (while aged under 13 years) as prepared by an eligible practitioner; and (c) the child has been referred by an eligible practitioner for the provision of services that are consistent with the PDD ordisability treatmentplan; and (d) for a child with PDD, the eligible practitioner is a consultant physician in the practice of his or her field of psychiatry or paediatrics; or for a child with disability, the eligible practitioner is a specialist, consultant physician or general practitioner; and (e) the audiologist, optometrist, orthoptist or physiotherapist attending the child is registered with the Department of Human Services as meeting the credentialing requirements for provision of these services; and (f) the child is not an admitted patient of a hospital; and (g) the service is provided to the child individually and in person; and (h) the service lasts at least 30 minutes in duration. These items are limited to a maximum of 20 services per patient, consisting of any combination of items - 82015, 82020, 82025 and 82035 Y 82100 01NOV2010 Initial antenatal professional attendance by a participating midwife, lasting at least 40 minutes, including all of the following: (a)taking a detailed patient history; (b)performing a comprehensive examination; (c)performing a risk assessment; (d)based on the risk assessment - arranging referral or transfer of the patient's care to an obstetrician; (e)requesting pathology and diagnostic imaging services, when necessary; (f)discussing with the patient the collaborative arrangements for her maternity care and recording the arrangements in the midwife's written records in accordance with section 2E of the Health Insurance Regulations 1975. Payable once only for any pregnancy. N 82100 01NOV2018 Initial antenatal professional attendance by a participating midwife, lasting at least 40 minutes, including all of the following: (a)taking a detailed patient history; (b)performing a comprehensive examination; (c)performing a risk assessment; (d)based on the risk assessment - arranging referral or transfer of the patient's care to an obstetrician; (e)requesting pathology and diagnostic imaging services, when necessary; (f)discussing with the patient the collaborative arrangements for her maternity care and recording the arrangements in the midwife's written records in accordance with section 6 of the Health Insurance Regulations 2018. Payable once only for any pregnancy. Y 82105 01NOV2010 Short antenatal professional attendance by a participating midwife, lasting up to 40 minutes. Y 82110 01NOV2010 Long antenatal professional attendance by a participating midwife, lasting at least 40 minutes. Y 82115 01NOV2010 Professional attendance by a participating midwife, lasting at least 90 minutes, for assessment and preparation of a maternity care plan for a patient whose pregnancy has progressed beyond 20 weeks, if: (a)the patient is not an admitted patient of a hospital; and (b)the participating midwife undertakes a comprehensive assessment of the patient; and (c) the participating midwife develops a written maternity care plan that contains: (*)outcomes of the assessment; and (*)details of agreed expectations for care during pregnancy, labour and delivery; and (*)details of any health problems or care needs; and (*)details of collaborative arrangements that apply for the patient; and (*)details of any medication taken by the patient during the pregnancy, and any additional medication that may be required by the patient; and (*)details of any referrals or requests for pathology services or diagnostic imaging services for the patient during the pregnancy, and any additional referrals or requests that may be required for the patient; and (d) the maternity care plan is explained and agreed with the patient; and (e) the fee does not include any amount for the management of the labour and delivery. (Includes any antenatal attendance provided on the same occasion). Payable once only for any pregnancy. Y 82120 01NOV2010 Management of confinement for up to 12 hours, including delivery (if undertaken), if: (a) the patient is an admitted patient of a hospital; and (b) the attendance is by a participating midwife who: (i)provided the patient's antenatal care; or (ii) is a member of a practice that provided the patient's antenatal care. (Includes all attendances related to the confinement by the participating midwife) Payable once only for any pregnancy Y 82125 01NOV2010 Management of confinement, including delivery (if undertaken) when care is transferred from 1 participating midwife to another participating midwife (the second participating midwife), if:(a) the patient is an admitted patient of a hospital; and (b) the patient's confinement is for longer than 12 hours; (c) the second participating midwife: (i)  has provided the patient's antenatal care; or (ii) is a member of a practice that has provided the patient's antenatal care.   (Includes all attendances related to the confinement by the second participating midwife)   Payable one only for any pregnancy. Y 82130 01NOV2010 Short Postnatal Attendance Short postnatal professional attendance by a participating midwife, lasting up to 40 minutes, within 6 weeks after delivery. Y 82135 01NOV2010 Long Postnatal Attendance Long postnatal professional attendance by a participating midwife, lasting at least 40 minutes, within 6 weeks after delivery. Y 82140 01NOV2010 Six Week Postnatal Attendance Postnatal professional attendance by a participating midwife on a patient not less than 6 weeks but not more than 7 weeks after delivery of a baby, including: (a)a comprehensive examination of patient and baby to ensure normal postnatal recovery; and (b)referral of the patient to a general practitioner for the ongoing care of the patient and baby Payable once only for any pregnancy. Y 82150 01JUL2011 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, not being an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist practising in their specialty of obstetrics or paediatrics. N 82150 01NOV2012 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A)an Aboriginal Medical Service; or (B)an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. N 82150 01JAN2013 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. Y 82151 01JUL2011 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, not being an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist practising in their specialty of obstetrics or paediatrics. N 82151 01NOV2012 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A)an Aboriginal Medical Service; or (B)an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. N 82151 01JAN2013 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. Y 82152 01JUL2011 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, not being an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist practising in their specialty of obstetrics or paediatrics. N 82152 01NOV2012 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A)an Aboriginal Medical Service; or (B)an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. N 82152 01JAN2013 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating midwife that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist practising in his or her speciality of obstetrics or a specialist or consultant physician practising in his or her speciality of paediatrics; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. Y 82200 01NOV2010 Professional attendance by a participating nurse practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management. Y 82205 01NOV2010 Professional attendance by a participating nurse practitioner lasting less than 20 minutes and including any of the following: a)taking a history; b)undertaking clinical examination; c)arranging any necessary investigation; d)implementing a management plan; e)providing appropriate preventive health care, for 1 or more health related issues, with appropriate documentation. Y 82210 01NOV2010 Professional attendance by a participating nurse practitioner lasting at least 20 minutes and including any of the following: a)taking a detailed history; b)undertaking clinical examination; c)arranging any necessary investigation; d)implementing a management plan; e)providing appropriate preventive health care, for 1 or more health related issues, with appropriate documentation. Y 82215 01NOV2010 Professional attendance by a participating nurse practitioner lasting at least 40 minutes and including any of the following: a)taking an extensive history; b)undertaking clinical examination; c)arranging any necessary investigation; d)implementing a management plan; e)providing appropriate preventive health care, for 1 or more health related issues, with appropriate documentation. Y 82220 01JUL2011 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, not being an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician. N 82220 01NOV2012 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located:(i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. N 82220 01JAN2013 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. Y 82221 01JUL2011 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, not being an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician. N 82221 01NOV2012 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. N 82221 01JAN2013 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. Y 82222 01JUL2011 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a)located outside an inner metropolitan area, not being an admitted patient; or b)at an Aboriginal Medical Service or Aboriginal Community Controlled Health Service in relation to which a direction made under subsection 19(2) of the Act applies; and who is participating in a video consultation with a specialist or consultant physician. N 82222 01NOV2012 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) outside an Inner metropolitan area; and (B) at the time of the attendance-at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A)an Aboriginal Medical Service; or (B)an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. N 82222 01JAN2013 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) is not an admitted patient; and c) is located: (i) both: (A) within a telehealth eligible area; and (B) at the time of the attendance - at least 15 kms by road from the specialist or consultant physician mentioned in paragraph (a); or (ii) in Australia if the patient is a patient of: (A) an Aboriginal Medical Service; or (B) an Aboriginal Community Controlled Health Service for which a direction made under subsection 19(2) of the Act applies. Y 82223 01JUL2011 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex if the patient is an approved care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician. N 82223 01NOV2012 A professional attendance lasting less than 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) either: (i)is a care recipient receiving care in a residential care service; or (ii)is at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service; and c) the professional attendance is not provided at a self-contained unit. Y 82224 01JUL2011 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex if the patient is an approved care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician. N 82224 01NOV2012 A professional attendance lasting at least 20 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) either: (i)is a care recipient receiving care in a residential care service; or (ii)is at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service; and c) the professional attendance is not provided at a self-contained unit Y 82225 01JUL2011 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who is: a)a care recipient receiving care in a residential aged care service (other than a professional attendance at a self-contained unit); or b)at consulting rooms situated within such a complex if the patient is an approved care recipient receiving care in a residential aged care service (excluding accommodation in a self-contained unit); and who is participating in a video consultation with a specialist or consultant physician N 82225 01NOV2012 A professional attendance lasting at least 40 minutes (whether or not continuous) by a participating nurse practitioner that requires the provision of clinical support to a patient who: a) is participating in a video consultation with a specialist or consultant physician; and b) either: (i)is a care recipient receiving care in a residential care service; or (ii)is at consulting rooms situated within such a complex if the patient is a care recipient receiving care in a residential aged care service; and c) the professional attendance is not provided at a self-contained unit Y 82300 01NOV2012 Audiology health service, consisting of BRAIN STEM EVOKED RESPONSE AUDIOMETRY, performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is a specialist in the specialty of otolaryngology head and neck surgery; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11300 applies has not been performed on the person on the same day. Y 82306 01NOV2012 Audiology health service, consisting of NON-DETERMINATE AUDIOMETRY performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is a specialist in the specialty of otolaryngology head and neck surgery; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11306 applies has not been performed on the person on the same day. Y 82309 01NOV2012 Audiology health service, consisting of an AIR CONDUCTION AUDIOGRAM performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i)a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11309 applies has not been performed on the person on the same day. Y 82312 01NOV2012 Audiology health service, consisting of an AIR AND BONE CONDUCTION AUDIOGRAM OR AIR CONDUCTION AND SPEECH DISCRIMINATION AUDIOGRAM performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i)a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11312 applies has not been performed on the person on the same day. Y 82315 01NOV2012 Audiology health service, consisting of an AIR AND BONE CONDUCTION AND SPEECH DISCRIMINATION AUDIOGRAM performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitionerto assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i)a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11315 applies has not been performed on the person on the same day. Y 82318 01NOV2012 Audiology health service, consisting of an AIR AND BONE CONDUCTION AND SPEECH DISCRIMINATION AUDIOGRAM WITH OTHER COCHLEAR TESTS performed on a person by an eligible audiologist if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i)a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11318 applies has not been performed on the person on the same day. Y 82324 01NOV2012 Audiology health service, consisting of an IMPEDANCE AUDIOGRAM involving tympanometry and measurement of static compliance and acoustic reflex performed on a person by an eligible audiologist (not being a service associated with a service to which item 82309, 82312, 82315 or 82318 applies) if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i) a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11324 applies has not been performed on the person on the same day. Y 82327 01NOV2012 Audiology health service, consisting of an IMPEDANCE AUDIOGRAM involving tympanometry and measurement of static compliance and acoustic reflex performed on a person by an eligible audiologist (being a service associated with a service to which item 82309, 82312, 82315 or 82318 applies) if: (a) the service is performed pursuant to a written request made by an eligible practitioner to assist the eligible practitioner in the diagnosis and/or treatment and/or management of ear disease or a related disorder in the person; and (b) the eligible practitioner is: (i)a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (c) the service is not performed for the purpose of a hearing screening; and (d) the person is not an admitted patient of a hospital; and (e) the service is performed on the person individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11327 applies has not been performed on the person on the same day. Y 82332 01NOV2012 Audiology health service, consisting of an OTO-ACOUSTIC EMISSION AUDIOMETRY for the detection of permanent congenital hearing impairment, performed by an eligible audiologist on an infant or child in circumstances in which: (a) the service is performed pursuant to a written request made by an eligible practitioner who is: (i)a specialist in the specialty of otolaryngology head and neck surgery; or (ii) a specialist or consultant physician in the specialty of neurology; and (b) the infant or child is at risk due to 1 or more of the following factors: (i) admission to a neonatal intensive care unit; (ii) family history of hearing impairment; (iii) intra-uterine or perinatal infection (either suspected or confirmed); (iv) birthweight less than 1.5kg; (v) craniofacial deformity; (vi) birth asphyxia; (vii) chromosomal abnormality, including Down Syndrome; (viii) exchange transfusion; and (c) middle ear pathology has been excluded by specialist opinion; and (d) the infant or child is not an admitted patient of a hospital; and (e) the service is performed on the infant or child individually and in person; and (f) after the service, the eligible audiologist provides a copy of the results of the service performed, together with relevant comments in writing that the eligible audiologist has on those results, to the eligible practitioner who requested the service; and (g) a service to which item 11332 applies has not been performed on the infant or child on the same day. Y 82350 01NOV2019 Dietetics health service provided to an eligible patient by an eligible dietitian if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is of at least 20 minutes in duration Y 82351 01NOV2019 Dietetics health service provided to an eligible patient by an eligible dietitian if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the dietitian; and (f) the service is of at least 20 minutes duration Y 82352 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 30 minutes but less than 50 minutes in duration. Y 82353 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 30 minutes but less than 50 minutes in duration. Y 82354 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and the service is at least 30 minutes but less than 50 minutes in duration. Y 82355 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration. Y 82356 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 50 minutes in duration. Y 82357 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration. Y 82358 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration. Y 82359 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible clinical psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration. Y 82360 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration. Y 82361 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 20 minutes but less than 50 minutes in duration. Y 82362 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration. Y 82363 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration. Y 82364 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 50 minutes in duration. Y 82365 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration. Y 82366 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration. Y 82367 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible psychologist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration. Y 82368 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration. Y 82369 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 20 minutes but less than 50 minutes in duration. Y 82370 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration. Y 82371 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration. Y 82372 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 50 minutes in duration. Y 82373 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration. Y 82374 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration Y 82375 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient as part of a group of 6 to 10 patients by an eligible occupational therapist if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration. Y 82376 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration Y 82377 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 20 minutes but less than 50 minutes in duration Y 82378 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 20 minutes but less than 50 minutes in duration. Y 82379 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient in consulting rooms by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d)the service is at least 50 minutes in duration. Y 82380 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the psychologist; and (f) the service is at least 50 minutes in duration. Y 82381 01NOV2019 Eating disorder psychological treatment service provided to an eligible patient at a place other than consulting rooms by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided to the person individually and in person; and (d) the service is at least 50 minutes in duration Y 82382 01NOV2019 Eating disorder psychological treatment service provided to a person as part of a group of 6 to 10 patients (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the service is provided in person; and (d) the service is at least 60 minutes in duration. Y 82383 01NOV2019 Eating disorder psychological treatment service provided to a person as part of a group of 6 to 10 patients (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the service is recommended in the patient's eating disorder treatment and management plan; and (b) the person is not an admitted patient of a hospital; and (c) the attendance is by video conference; and (d) the patient is located within a telehealth eligible area; and (e) the patient is, at the time of the attendance, at least 15 kilometres by road from the clinical psychologist; and (f) the service is at least 60 minutes in duration. Y 85011 01NOV2007 Comprehensive oral examination Evaluation of all teeth, their supporting tissues and the oral tissues in order to record the condition of these structures. This evaluation includes recording an appropriate medical history and any other relevant information. Limit of one (1) per provider every 2 years. Y 85012 01NOV2007 Periodic oral examination An evaluation performed on a patient of record to determine any changes in the patient's dental and medical health status since a previous comprehensive or periodic examination. Limit of one (1) per provider every 6 months. Y 85013 01NOV2007 Oral examination - limited A limited problem-focused oral evaluation carried out immediately prior to required treatment. This evaluation includes recording an appropriate medical history and any other relevant information. Limit of three (3) per 3 month period. Y 85022 01NOV2007 Intraoral periapical or bitewing radiograph - per exposure Limit of six (6) per day. Y 85025 01NOV2007 Intraoral radiograph - occlusal, maxillary or mandibular -per exposure Y 85031 01NOV2007 Extraoral radiograph - maxillary, mandibular - per exposure Y 85037 01NOV2007 Panoramic radiograph - per exposure Y 85039 01NOV2007 Tomography of the skull or parts thereof Limit of one (1) per 12 month period. Y 85047 01NOV2007 Caries activity screening test Limit one (1) per 12 month period. Y 85051 01NOV2007 Biopsy of tissue Y 85071 01NOV2007 Diagnostic model - per model Y 85111 01NOV2007 Removal of plaque and/or stain. Limit of one (1) per 6 month period. Y 85113 01NOV2007 Recontouring pre-existing restoration(s) Y 85114 01NOV2007 Removal of calculus - first visit Limit of one (1) per 6 month period. Y 85115 01NOV2007 Removal of calculus - subsequent visit Limit of two (2) per 12 month period. Y 85117 01NOV2007 Bleaching, internal - per tooth For non-vital discoloured tooth. Y 85121 01NOV2007 Topical application of remineralising agent - one treatment Limit of one (1) per 6 month period. Y 85123 01NOV2007 Concentrated remineralising agent, application - single tooth Limit of one (1) per day. Y 85131 01NOV2007 Dietary advice Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period. Y 85141 01NOV2007 Oral hygiene instruction Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period. Y 85161 01NOV2007 Fissure sealing - per tooth Y 85165 01NOV2007 Desensitizing procedure - per visit Y 85171 01NOV2007 Odontoplasty - per tooth Y 85213 01NOV2007 Treatment of acute periodontal infection - per visit Limit of two (2) per 12 month period. Y 85221 01NOV2007 Clinical periodontal analysis and recording Limit of one (1) per 12 month period. Y 85222 01NOV2007 Root planing and subgingival curettage - per eight teeth or less Limit of two (2) per day. Y 85225 01NOV2007 Non-surgical periodontal treatment where not otherwise specified - per visit Limit of one (1) per 12 month period. Y 85231 01NOV2007 Gingivectomy - per eight teeth or less Limit of four (4) per 12 month period. Y 85232 01NOV2007 Periodontal flap surgery - per eight teeth or less Limit of four (4) per 12 month period. Y 85233 01NOV2007 Osseous surgery - per eight teeth or less Limit of four (4) per 12 month period. Y 85234 01NOV2007 Osseous graft - per tooth or implant Limit of two (2) per 12 month period. Y 85238 01NOV2007 Periodontal flap surgery for crown lengthening - per tooth Y 85241 01NOV2007 Root resection - per root Y 85245 01NOV2007 Periodontal surgery involving one tooth or an implant Limit of one (1) per 12 month period. Y 85311 01NOV2007 Removal of a tooth or part(s) thereof 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 85316. Limit of one (1) per day. Y 85314 01NOV2007 Sectional removal of a tooth 1st sectional removal. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 85316. Limit of one (1) per day. Y 85316 01NOV2007 Additional extraction requiring removal of a tooth or part(s) thereof, or sectional removal of a tooth To be used for additional extractions on the same day in conjunction with items 85311 or 85314. Y 85322 01NOV2007 Surgical removal of a tooth or tooth fragment not requiring removal of bone or tooth division 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 85326. Limit of one (1) per day. Y 85323 01NOV2007 Surgical removal of a tooth or tooth fragment requiring removal of bone 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 85326. Limit of one (1) per day. Y 85324 01NOV2007 Surgical removal of a tooth or tooth fragment requiring both removal of bone and tooth division 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 85326. Limit of one (1) per day. Y 85326 01NOV2007 Additional extraction requiring surgical removal of a tooth or tooth fragment. To be used for additional surgical extractions on the same day in conjunction with items 85322, 85323 or 85324. Y 85331 01NOV2007 Alveolectomy - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 85337 01NOV2007 Reduction of fibrous tuberosity Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately Y 85338 01NOV2007 Reduction of flabby ridge - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately Y 85341 01NOV2007 Removal ofhyperplastic tissue Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 85377 01NOV2007 Removal or repair of soft tissue (not elsewhere defined) Includes insertion of sutures, normal post-operative care and suture removal. Y 85378 01NOV2007 Surgical removal of foreign body Includes insertion of sutures, normal post-operative care and suture removal. Y 85381 01NOV2007 Surgical exposure of unerupted tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 85384 01NOV2007 Repositioning of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 85386 01NOV2007 Splinting of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 85387 01NOV2007 Replantation and splinting of a tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 85391 01NOV2007 Frenectomy Includes insertion of sutures, normal post-operative care and suture removal Y 85392 01NOV2007 Incision and drainage of abscess or cyst Includes insertion of sutures, normal post-operative care and suture removal. Y 85411 01NOV2007 Direct pulp capping Y 85412 01NOV2007 Incomplete endodontic therapy (inoperable or fractured) Y 85414 01NOV2007 Pulpotomy Y 85415 01NOV2007 Complete chemo-mechanical preparation of root canal - one canal Y 85416 01NOV2007 Complete chemo-mechanical preparation of root canal - each additional canal on the same tooth. To be claimed in conjunction with item 85415. Y 85417 01NOV2007 Root canal obturation - one canal Y 85418 01NOV2007 Root canal obturation - each additional canal on the same tooth To be claimed in conjunction with item 85417. Y 85419 01NOV2007 Extirpation of pulp or debridement of root canal(s) - emergency or palliative Y 85431 01NOV2007 Periapical curettage - per root Y 85432 01NOV2007 Apicectomy - per root Includes curettage. Y 85433 01NOV2007 Exploratory periradicular surgery Limit of one (1) per 12 month period. Not claimable if services for the following items 85431, 85432, 85434, 85436, 85437 and 85438 are provided on the same day Y 85434 01NOV2007 Apical seal - per canal Includes apicectomy and periapical curettage. Y 85436 01NOV2007 Sealing of perforation Y 85437 01NOV2007 Surgical treatment and repair of an external root resorption - per tooth Y 85438 01NOV2007 Hemisection Y 85445 01NOV2007 Exploration for a calcified root canal - per canal Y 85451 01NOV2007 Removal of root filling - per canal Y 85452 01NOV2007 Removal of cemented root canal post or post crown Y 85453 01NOV2007 Removal or bypassing fractured endodontic instrument Y 85455 01NOV2007 Additional visit for irrigation and/or dressing of the root canal system - per tooth Cannot be paid with items 85415, 85416, 85417 or 85418 on the same day. Y 85457 01NOV2007 Obturation of resorption defect or perforation (non-surgical) Y 85458 01NOV2007 Interim therapeutic root filling - per tooth Limit of three (3) in a 12 month period. Y 85511 01NOV2007 Metallic restoration - one surface - direct Y 85512 01NOV2007 Metallicrestoration - two surfaces - direct Y 85513 01NOV2007 Metallic restoration - three surfaces - direct Y 85514 01NOV2007 Metallic restoration - four surfaces - direct Y 85515 01NOV2007 Metallic restoration - five surfaces - direct Y 85521 01NOV2007 Adhesive restoration - one surface - anterior tooth - direct Limit of five (5) single-surface adhesive restorations (85521 or 85531) per day. Y 85522 01NOV2007 Adhesive restoration - two surfaces - anterior tooth - direct Y 85523 01NOV2007 Adhesive restoration - three surfaces - anterior tooth - direct Y 85524 01NOV2007 Adhesive restoration - four surfaces - anterior tooth - direct Y 85525 01NOV2007 Adhesive restoration - five surfaces - anterior tooth - direct Y 85531 01NOV2007 Adhesive restoration - one surface - posterior tooth - direct Limit of five (5) single-surface adhesive restorations (85521 or 85531) per day. Y 85532 01NOV2007 Adhesive restoration - two surfaces - posterior tooth - direct Y 85533 01NOV2007 Adhesive restoration - three surfaces - posterior tooth - direct Y 85534 01NOV2007 Adhesive restoration - four surfaces - posterior tooth - direct Y 85535 01NOV2007 Adhesive restoration - five surfaces - posterior tooth - direct Y 85541 01NOV2007 Metallic restoration - one surface - indirect Y 85542 01NOV2007 Metallic restoration - two surfaces - indirect Y 85543 01NOV2007 Metallic restoration - three surfaces - indirect Y 85544 01NOV2007 Metallic restoration - four surfaces - indirect Y 85545 01NOV2007 Metallic restoration - five surfaces - indirect Y 85551 01NOV2007 Tooth-coloured restoration - one surface - indirect Y 85552 01NOV2007 Tooth-coloured restoration - two surfaces - indirect Y 85553 01NOV2007 Tooth-coloured restoration - three surfaces - indirect Y 85554 01NOV2007 Tooth-coloured restoration - four surfaces - indirect Y 85555 01NOV2007 Tooth-coloured restoration - five surfaces - indirect Y 85572 01NOV2007 Provisional (intermediate/ temporary) restoration Not claimable if services for endodontic items (85411 to 85458 inclusive) except 85419 are provided on the same day. Limit of three (3) per 3 month period. Y 85574 01NOV2007 Metal band The cementation of a metal band for diagnostic, protective purposes or for the placement of a provisional (intermediate) restoration. Y 85575 01NOV2007 Pin retention - per pin Y 85576 01NOV2007 Stainless steel crown Y 85577 01NOV2007 Cusp capping - per cusp Y 85578 01NOV2007 Restoration of an incisal corner - per corner Y 85595 01NOV2007 Removal of inlay/onlay Y 85596 01NOV2007 Recementing of inlay/onlay Y 85597 01NOV2007 Post - direct Insertion of a post into a prepared root canal to provide an anchor for an artificial crown or other restoration. Y 85613 01NOV2007 Full crown - non metallic - indirect Y 85615 01NOV2007 Full crown - veneered - indirect Y 85618 01NOV2007 Full crown - metallic - indirect Y 85625 01NOV2007 Core for crown including post - indirect Y 85627 01NOV2007 Preliminary restoration for crown - direct Y 85629 01NOV2007 Post and root cap - indirect Y 85631 01NOV2007 Provisional crown Y 85632 01NOV2007 Provisional bridge - per pontic Y 85642 01NOV2007 Bridge pontic - direct - per pontic Y 85643 01NOV2007 Bridge pontic - indirect - per pontic Y 85644 01NOV2007 Semi-fixed attachment Y 85645 01NOV2007 Precision or magnetic attachment Y 85649 01NOV2007 Retainer for bonded fixture - indirect - per tooth Y 85651 01NOV2007 Recementing crown or veneer Y 85652 01NOV2007 Recementing bridge or splint - per abutment Y 85653 01NOV2007 Rebonding of bridge or splint where retreatment of bridge surface is required Y 85655 01NOV2007 Removal of crown Y 85656 01NOV2007 Removal of bridge or splint Y 85658 01NOV2007 Repair of crown, bridge or splint - indirect. Inclusive of labour and laboratory costs. Y 85659 01NOV2007 Repair of crown, bridge or splint - direct. Y 85661 01NOV2007 Fitting of implant abutment - per abutment Y 85669 01NOV2007 Removal and reattachment of prosthesis fixed to implant(s) - per implant Y 85671 01NOV2007 Full crown attached to osseointegrated implant - non metallic - indirect Y 85672 01NOV2007 Full crown attached to osseointegrated implant - veneered - indirect Y 85673 01NOV2007 Full crown attached to osseointegrated implant - metallic - indirect Y 85711 01NOV2007 Complete maxillary denture Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 85712 01NOV2007 Complete mandibular denture Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 85716 01NOV2007 Metal palate or plate Additional to items 85711, 85712 or 85719. Y 85719 01NOV2007 Complete maxillary and mandibular dentures Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 85721 01NOV2007 Partial maxillary denture - resin base Base amount only. To be claimed in conjunction with item 85733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period Y 85722 01NOV2007 Partial mandibular denture - resin base Base amount only. To be claimed in conjunction with item 85733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 85727 01NOV2007 Partial maxillary denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 85733 for each additional tooth and item 85739 for each metal backing. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 85728 01NOV2007 Partial mandibular denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 85733 for each additional tooth and item 85739 for each metal backing. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 85731 01NOV2007 Retainer - per tooth Additional to items 85721 and 85722. Y 85732 01NOV2007 Occlusal rest - per rest Additional to items 85721 and 85722. Y 85733 01NOV2007 Tooth/Teeth (Partial denture) An item to describe each tooth added to the base of new partial denture. The number of teeth should be indicated. To be claimed with items 85721, 85722, 85727 or 85728. Limit of twelve (12) per base. Y 85735 01NOV2007 Precision or magnetic attachment Y 85736 01NOV2007 Immediate tooth replacement - per tooth Y 85737 01NOV2007 Resilient lining Y 85738 01NOV2007 Wrought bar A wrought bar joining sections of a partial prosthesis. Y 85739 01NOV2007 Metal Backing - per backing An extension of the casting of a cast metal partial denture to provide a backing for the denture tooth. The number of backings should be indicated.To be claimed with items 85727 or 85728. Y 85741 01NOV2007 Adjustment of a denture Adjustment of a denture to improve comfort and function. This item cannot be claimed for routine adjustments following the insertion of a new denture or maintenance or repair of an existing denture. Y 85743 01NOV2007 Relining - complete denture - processed For soft relines, use items 85743 and 85737. Y 85744 01NOV2007 Relining - partial denture - processed For soft relines, use items 85744 and 85737. Y 85745 01NOV2007 Remodelling - complete denture Y 85746 01NOV2007 Remodelling - partial denture Y 85751 01NOV2007 Relining - complete denture - direct Chair-side only.Either hard or soft material. Y 85752 01NOV2007 Relining - partial denture - direct Y 85753 01NOV2007 Cleaning and polishing of pre-existing denture Limit of one (1) per 2 year period. Y 85761 01NOV2007 Reattaching pre-existing tooth or clasp to denture. Inclusive of labour and laboratory costs Y 85762 01NOV2007 Replacing clasp on denture Y 85763 01NOV2007 Repairing broken base of a complete denture. Inclusive of labour and laboratory costs. Y 85764 01NOV2007 Repairing broken base of a partial denture. Inclusive of labour and laboratory costs. Y 85765 01NOV2007 Replacing first tooth on denture Y 85767 01NOV2007 Any repair or tooth replacement in addition to other repairs, alterations or other modifications for same denture on same day. Inclusive of labour and laboratory costs. Y 85768 01NOV2007 Adding tooth to partial denture to replace an extracted or decoronated tooth - per tooth Y 85769 01NOV2007 Repair or addition to metal casting Y 85771 01NOV2007 Tissue conditioning treatment prior to impressions Limit of five (5) per 3 month period. Y 85772 01NOV2007 Splint - resin - indirect Y 85773 01NOV2007 Splint - metal - indirect Y 85776 01NOV2007 Impression where required for denture repair/modification Y 85777 01NOV2007 Identification Marking a dental appliance with a patient's name or other form of enduring patient identification. Y 85811 01NOV2007 Passive removable appliance - per arch Y 85821 01NOV2007 Active removable appliance - per arch Y 85823 01NOV2007 Functional orthopaedic appliance Y 85829 01NOV2007 Partial banding - per arch Y 85831 01NOV2007 Full arch banding - per arch Y 85911 01NOV2007 Palliative care Interim care to relieve pain, infection, bleeding or other problems not associated with other treatment. Y 85926 01NOV2007 Individually made tray - medicaments A tray made for the application of medicaments to the teeth or supporting tissues. Not to be claimed for bleaching. Y 85927 01NOV2007 Provision of medication/ medicament The supply, prescription or administration of appropriate medications and medicaments required for dental treatment. Limit of one (1) per three month period. Y 85949 01NOV2007 Treatment under general anaesthesia A specialist anaesthetist must administer the anaesthetic. Y 85963 01NOV2007 Clinical occlusal analysis including muscle and joint palpation Limit of one (1) per three year period. Y 85964 01NOV2007 Registration and mounting of casts for occlusal analysis Limit of one (1) per three year period. Y 85965 01NOV2007 Occlusal splint Y 85966 01NOV2007 Adjustment of pre-existing occlusal splint - per visit Y 85968 01NOV2007 Occlusal adjustment following occlusal analysis - per visit Y 85971 01NOV2007 Adjunctive physical therapy for temporomandibular joint and associated structures Limit of four (4) per 12 month period Y 85972 01NOV2007 Repair/addition - occlusal splint Y 85981 01NOV2007 Splinting and stabilisation - direct - per tooth Y 85986 01NOV2007 Post-operative care where not otherwise included In normal circumstances, dentists provide post-operative care following dental treatment. However, where a patient requires unforeseen post-operative care or is seen by a dentist who did not provide the initial treatment, this item can be used. Limit of two (2) per 12 month period. Y 86012 01NOV2007 Periodic oral examination An evaluation performed on a patient of record to determine any changes in the patient's dental and medical health status since a previous periodic examination. Limit of one (1) per provider every 6 months. Y 86013 01NOV2007 Oral examination - limited A limited problem-focused oral evaluation carried out immediately prior to required treatment. This evaluation includes recording an appropriate medical history and any other relevant information. Limit of three (3) per 3 month period. Y 86014 01NOV2007 Consultation A consultation to seek advice or discuss treatment options regarding a specific dental or oral condition. This consultation includes recording an appropriate medical history and any other relevant information. Y 86015 01NOV2007 Consultation - extended (30 mins) An extended consultation to seek advice or discuss treatment options regarding a specific dental or oral complaint. This consultation includes recording an appropriate medical history and any other relevant information. Limit of one (1) per provider per 12 month period. Y 86022 01NOV2007 Intraoral periapical or bitewing radiograph - per exposure Limit of six (6) per day. Y 86025 01NOV2007 Intraoral radiograph - occlusal, maxillary or mandibular - per exposure Y 86031 01NOV2007 Extraoral radiograph - maxillary, mandibular - per exposure Y 86035 01NOV2007 Radiograph of temporomandibular joint - per exposure Y 86036 01NOV2007 Cephalometric radiograph - lateral, antero-posterior, postero-anterior or submento-vertex - per exposure Limit of one (1) per 12 month period. Y 86037 01NOV2007 Panoramic radiograph - per exposure Y 86038 01NOV2007 Hand-wrist radiograph for skeletal age assessment Limit of one (1) per provider per 12 month period. Y 86039 01NOV2007 Tomography of the skull or parts thereof Limit of one (1) per 12 month period. Y 86047 01NOV2007 Caries activity screening test Limit one (1) per 12 month period. Y 86051 01NOV2007 Biopsy of tissue Y 86071 01NOV2007 Diagnostic model - per model Y 86082 01NOV2007 Tooth-jaw size prediction analysis Limit of one (1) per provider per 12 month period. Y 86111 01NOV2007 Removal of plaque and/or stain Limit of one (1) per 6 month period. Y 86113 01NOV2007 Recontouring pre-existing restoration(s) Y 86114 01NOV2007 Removal of calculus - first visit Limit of one (1) per 6 month period. Y 86115 01NOV2007 Removal of calculus - subsequent visit Limit of two (2) per 12 month period. Y 86117 01NOV2007 Bleaching, internal - per tooth For non-vital discoloured tooth. Y 86121 01NOV2007 Topical application of remineralising agent - one treatment Limit of one (1) per 6 month period. Y 86123 01NOV2007 Concentrated remineralising agent, application - single tooth Limit of one (1) per day. Y 86131 01NOV2007 Dietary advice Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period. Y 86141 01NOV2007 Oral hygiene instruction Where a full appointment of at least 15 minutes is used. Limit of one (1) per 12 month period. Y 86161 01NOV2007 Fissure sealing - per tooth Y 86165 01NOV2007 Desensitizing procedure - per visit Y 86171 01NOV2007 Odontoplasty - per tooth Y 86213 01NOV2007 Treatment of acute periodontal infection - per visit Limit of two (2) per 12 month period. Y 86221 01NOV2007 Clinical periodontal analysis and recording Limit of one (1) per 12 month period. Y 86222 01NOV2007 Root planning and subgingival curettage - per eight teeth or less Limit of two (2) per day. Y 86225 01NOV2007 Non-surgical periodontal treatment where not otherwise specified - per visit Limit of one (1) per 12 month period. Y 86231 01NOV2007 Gingivectomy - pereight teeth or less Limit of four (4) per 12 month period. Y 86232 01NOV2007 Periodontal flap surgery - per eight teeth or less Limit of four (4) per 12 month period. Y 86233 01NOV2007 Osseous surgery - per eight teeth or less Limit of four (4) per 12 month period. Y 86234 01NOV2007 Osseous graft - per tooth or implant Limit of two (2) per 12 month period. Y 86235 01NOV2007 Gingival graft - per tooth or implant Limit of two (2) per 12 month period. Y 86236 01NOV2007 Guided tissue regeneration - per tooth or implant Y 86237 01NOV2007 Guided tissue regeneration - membrane removal Y 86238 01NOV2007 Periodontal flap surgery for crown lengthening - per tooth Y 86241 01NOV2007 Root resection - per root Y 86245 01NOV2007 Periodontal surgery involving one tooth or an implant Limit of one (1) per 12 month period. Y 86311 01NOV2007 Removal of a tooth or part(s) thereof 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 86316. Limit of one (1) per day. Y 86314 01NOV2007 Sectional removal of a tooth 1st sectional removal. Inclusive of local anaesthesia and routine post-operative care. For additional extractions on the same day, use item 86316. Limit of one (1) per day. Y 86316 01NOV2007 Additional extraction requiring removal of a tooth or part(s) thereof, or sectional removal of a tooth To be used for additional extractions on the same day in conjunction with items 86311 or 86314. Y 86322 01NOV2007 Surgical removal of a tooth or tooth fragment not requiring removal of bone or tooth division 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 86326. Limit of one (1) per day. Y 86323 01NOV2007 Surgical removal of a tooth or tooth fragment requiring removal of bone 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 86326. Limit of one (1) per day. Y 86324 01NOV2007 Surgical removal of a tooth or tooth fragment requiring both removal of bone and tooth division. 1st tooth extracted. Inclusive of local anaesthesia and routine post-operative care. For additional surgical extractions on the same day, use item 86326. Limit of one (1) per day. Y 86326 01NOV2007 Additional extraction requiring surgical removal of a tooth or tooth fragment. To be used for additional surgical extractions on the same day in conjunction with items 86322, 86323 or 86324. Y 86331 01NOV2007 Alveolectomy - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86332 01NOV2007 Ostectomy - per jaw Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86337 01NOV2007 Reduction of fibrous tuberosity Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86338 01NOV2007 Reduction of flabby ridge - per segment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86341 01NOV2007 Removal ofhyperplastic tissue Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86343 01NOV2007 Repositioning of muscle attachment Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86344 01NOV2007 Vestibuloplasty Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86345 01NOV2007 Vestibuloplasty with skin or mucosal graft Includes insertion of sutures, normal post-operative care and suture removal. Extraction items to be claimed separately. Y 86371 01NOV2007 Removal of tumour, cyst or scar - cutaneous, subcutaneous or in mucous membrane. Includes insertion of sutures, normal post-operative care and suture removal. Y 86373 01NOV2007 Removal of tumour, cyst or scar involving muscle, bone or other deep tissue. Includes insertion of sutures, normal post-operative care and suture removal. Y 86375 01NOV2007 Surgery to salivary duct Includes insertion of sutures, normal post-operative care and suture removal. Y 86376 01NOV2007 Surgery to salivary gland Includes insertion of sutures, normal post-operative care and suture removal. Y 86377 01NOV2007 Removal or repair of soft tissue (not elsewhere defined) Includes insertion of sutures, normal post-operative care and suture removal. Y 86378 01NOV2007 Surgical removal of foreign body Includes insertion of sutures, normal post-operative care and suture removal. Y 86379 01NOV2007 Marsupialisation of cyst Includes insertion of sutures, normal post-operative care and suture removal. Y 86381 01NOV2007 Surgical exposure of unerupted tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 86382 01NOV2007 Surgical exposure and attachment of device for orthodontic traction Includes insertion of sutures, normal post-operative care and suture removal. Y 86384 01NOV2007 Repositioning of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 86385 01NOV2007 Surgical repositioning of unerupted tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 86386 01NOV2007 Splinting of displaced tooth/teeth - per tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 86387 01NOV2007 Replantation and splinting of a tooth Includes insertion of sutures, normal post-operative care and suture removal. Y 86388 01NOV2007 Transplantation of tooth or tooth bud Includes insertion of sutures, normal post-operative care and suture removal. Y 86389 01NOV2007 Surgery to isolate and preserve neurovascular tissue Includes insertion of sutures, normal post-operative care and suture removal. Y 86391 01NOV2007 Frenectomy Includes insertion of sutures, normal post-operative care and suture removal. Y 86392 01NOV2007 Incision and drainage of abscess or cyst Includes insertion of sutures, normal post-operative care and suture removal. Y 86393 01NOV2007 Surgery involving the maxillary antrum Includes insertion of sutures, normal post-operative care and suture removal. Y 86394 01NOV2007 Surgery for osteomylitis Includes insertion of sutures, normal post-operative care and suture removal. Y 86395 01NOV2007 Repair of nerve trunk Includes insertion of sutures, normal post-operative care and suture removal. Y 86411 01NOV2007 Direct pulp capping Y 86412 01NOV2007 Incomplete endodontic therapy (inoperable or fractured) Y 86414 01NOV2007 Pulpotomy Y 86415 01NOV2007 Complete chemo-mechanical preparation of root canal - one canal Y 86416 01NOV2007 Complete chemo-mechanical preparation of root canal - each additional canal on the same tooth. To be claimed in conjunction with item 86415. Y 86417 01NOV2007 Root canal obturation - one canal Y 86418 01NOV2007 Root canal obturation - each additional canal on the same tooth To be claimed in conjunction with item 86417. Y 86419 01NOV2007 Extirpation of pulp or debridement of root canal(s) - emergency or palliative Y 86431 01NOV2007 Periapical curettage - per root Y 86432 01NOV2007 Apicectomy - per root Includes curettage. Y 86433 01NOV2007 Exploratory periradicular surgery Limit of one (1) per 12 month period. Not claimable if services for the following items 86431, 86432, 86434, 86436, 86437 and 86438 are provided on the same day. Y 86434 01NOV2007 Apical seal - per canal Included apicectomy and periapical curettage. Y 86436 01NOV2007 Sealing of perforation Y 86437 01NOV2007 Surgical treatment and repair of an external root resorption - per tooth Y 86438 01NOV2007 Hemisection Y 86445 01NOV2007 Exploration for a calcified root canal - per canal Y 86451 01NOV2007 Removal of root filling - per canal Y 86452 01NOV2007 Removal of cemented root canal post or post crown Y 86453 01NOV2007 Removal or bypassing fractured endodontic instrument Y 86455 01NOV2007 Additional visit for irrigation and/or dressing of the root canal system - per tooth Cannot be paid with items 86415, 86416, 86417 or 86418 on the same day. Y 86457 01NOV2007 Obturation of resorption defect or perforation (non-surgical) Y 86458 01NOV2007 Interim therapeutic root filling - per tooth Limit of three (3) in a 12 month period. Y 86511 01NOV2007 Metallic restoration - one surface - direct Y 86512 01NOV2007 Metallic restoration - two surfaces - direct Y 86513 01NOV2007 Metallic restoration - three surfaces - direct Y 86514 01NOV2007 Metallic restoration - four surfaces - direct Y 86515 01NOV2007 Metallic restoration - five surfaces - direct Y 86521 01NOV2007 Adhesive restoration - one surface - anterior tooth - direct Limit of five (5) single-surface adhesive restorations (86521 or 86531) per day. Y 86522 01NOV2007 Adhesive restoration - two surfaces - anterior tooth - direct Y 86523 01NOV2007 Adhesive restoration - three surfaces - anterior tooth - direct Y 86524 01NOV2007 Adhesive restoration - four surfaces - anterior tooth - direct Y 86525 01NOV2007 Adhesive restoration - five surfaces - anterior tooth - direct Y 86531 01NOV2007 Adhesive restoration - one surface - posterior tooth - direct Limit of five (5) single-surface adhesive restorations (86521 or 86531) per day. Y 86532 01NOV2007 Adhesive restoration - two surfaces - posterior tooth - direct Y 86533 01NOV2007 Adhesive restoration - three surfaces - posterior tooth - direct Y 86534 01NOV2007 Adhesive restoration - four surfaces - posterior tooth - direct Y 86535 01NOV2007 Adhesive restoration - five surfaces - posterior tooth - direct Y 86541 01NOV2007 Metallic restoration - one surface - indirect Y 86542 01NOV2007 Metallic restoration - two surfaces - indirect Y 86543 01NOV2007 Metallic restoration - three surfaces - indirect Y 86544 01NOV2007 Metallic restoration - four surfaces - indirect Y 86545 01NOV2007 Metallic restoration - five surfaces - indirect Y 86551 01NOV2007 Tooth-coloured restoration - one surface - indirect Y 86552 01NOV2007 Tooth-coloured restoration - two surfaces - indirect Y 86553 01NOV2007 Tooth-coloured restoration - three surfaces - indirect Y 86554 01NOV2007 Tooth-coloured restoration - four surfaces - indirect Y 86555 01NOV2007 Tooth-coloured restoration - five surfaces - indirect Y 86572 01NOV2007 Provisional (intermediate/ temporary) restoration Not claimable if services for endodontic items (86411 to 86458 inclusive) except 86419 are provided on the same day. Limit of three (3) per three month period. Y 86574 01NOV2007 Metal band The cementation of a metal band for diagnostic, protective purposes or for the placement of a provisional (intermediate) restoration. Y 86575 01NOV2007 Pin retention - per pin Y 86576 01NOV2007 Stainless steel crown Y 86577 01NOV2007 Cusp capping - per cusp Y 86578 01NOV2007 Restoration of an incisal corner - per corner Y 86595 01NOV2007 Removal of inlay/onlay Y 86596 01NOV2007 Recementing of inlay/onlay Y 86597 01NOV2007 Post - direct Insertion of a post into a prepared root canal to provide an anchor for an artificial crown or other restoration. Y 86613 01NOV2007 Full crown - non metallic - indirect Y 86615 01NOV2007 Full crown - veneered - indirect Y 86618 01NOV2007 Full crown - metallic - indirect Y 86625 01NOV2007 Core for crown including post - indirect Y 86627 01NOV2007 Preliminary restoration for crown - direct Y 86629 01NOV2007 Post and root cap - indirect Y 86631 01NOV2007 Provisional crown Y 86632 01NOV2007 Provisional bridge - per pontic Y 86642 01NOV2007 Bridge pontic - direct - per pontic Y 86643 01NOV2007 Bridge pontic - indirect - per pontic Y 86644 01NOV2007 Semi-fixed attachment Y 86645 01NOV2007 Precision or magnetic attachment Y 86649 01NOV2007 Retainer for bonded fixture - indirect - per tooth Y 86651 01NOV2007 Recementing crown or veneer Y 86652 01NOV2007 Recementing bridge or splint - per abutment Y 86653 01NOV2007 Rebonding of bridge or splint where retreatment of bridge surface is required Y 86655 01NOV2007 Removal of crown Y 86656 01NOV2007 Removal of bridge or splint Y 86658 01NOV2007 Repair of crown, bridge or splint - indirect Inclusive of labour and laboratory costs. Y 86659 01NOV2007 Repair of crown, bridge or splint - direct Y 86661 01NOV2007 Fitting of implant abutment - per abutment Y 86663 01NOV2007 Removal of implant Y 86664 01NOV2007 Fitting of bar for denture - per abutment Y 86666 01NOV2007 Prosthesis with metal frame attached to implants - per tooth Y 86669 01NOV2007 Removal and reattachment of prosthesis fixed to implant(s) - per implant Y 86671 01NOV2007 Full crown attached to osseointegrated implant - non metallic - indirect Y 86672 01NOV2007 Full crown attached to osseointegrated implant- veneered - indirect Y 86673 01NOV2007 Full crown attached to osseointegrated implant - metallic - indirect Y 86679 01NOV2007 Surgical implant guide Y 86684 01NOV2007 Insertion of first stage of two-stage endosseous implant - per implant Includes cost of hardware. Y 86688 01NOV2007 Insertion of one-stage endosseous implant - per implant Includes cost of hardware. Y 86691 01NOV2007 Second stage surgery of two stage endosseous implant - per implant Includes the cost of hardware. Y 86711 01NOV2007 Complete maxillary denture Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86712 01NOV2007 Complete mandibular denture Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86716 01NOV2007 Metal palate or plate Additional to items 86711, 86712 or 86719 Y 86719 01NOV2007 Complete maxillary and mandibular dentures Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86721 01NOV2007 Partial maxillary denture - resin base Base amount only. To be claimed in conjunction with items 86733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86722 01NOV2007 Partial mandibular denture - resin base Base amount only. To be claimed in conjunction with item 86733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86727 01NOV2007 Partial maxillary denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 86733 for each additional tooth and item 86739 for each metal backing Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86728 01NOV2007 Partial mandibular denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 86733 for each additional tooth and item 86739 for each metal backing Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 86731 01NOV2007 Retainer - per tooth Additional to items 86721 and 86722. Y 86732 01NOV2007 Occlusal rest - per rest Additional to items 86721 and 86722. Y 86733 01NOV2007 Tooth/Teeth (Partial denture) An item to describe each tooth added to the base of new partial denture. The number of teeth should be indicated. To be claimed with items 86721, 86722, 86727 or 86728. Limit of twelve (12) per base. Y 86735 01NOV2007 Precision or magnetic attachment Y 86736 01NOV2007 Immediate tooth replacement - per tooth Y 86737 01NOV2007 Resilient lining Y 86738 01NOV2007 Wrought bar A wrought bar joining sections of a partial prosthesis. Y 86739 01NOV2007 Metal Backing - per backing An extension of the casting of a cast metal partial denture to provide a backing for the denture tooth. The number of backings should be indicated.To be claimed with items 86727 or 86728. Y 86741 01NOV2007 Adjustment of a denture Adjustment of a denture to improve comfort and function. This item cannot be claimed for routine adjustments following the insertion of a new denture or maintenance or repair of an existing denture. Y 86743 01NOV2007 Relining - complete denture - processed For soft relines, use items 86743 and 86737. Y 86744 01NOV2007 Relining - partial denture - processed For soft relines, use items 86744 and 86737. Y 86745 01NOV2007 Remodelling- complete denture Y 86746 01NOV2007 Remodelling - partial denture Y 86751 01NOV2007 Relining - complete denture - direct Chair-side only.Either hard or soft material. Y 86752 01NOV2007 Relining - partial denture - direct Y 86753 01NOV2007 Cleaning and polishing of pre-existing denture Limit of one (1) per two year period. Y 86761 01NOV2007 Reattaching pre-existing tooth or clasp to denture Includes labour and laboratory costs. Y 86762 01NOV2007 Replacing clasp on denture Y 86763 01NOV2007 Repairing broken base of a complete denture Includes labour and laboratory costs. Y 86764 01NOV2007 Repairing broken base of a partial denture Includes labour and laboratory costs. Y 86765 01NOV2007 Replacing first tooth on denture Y 86767 01NOV2007 Any repair or tooth replacement in addition to other repairs, alterations or other modifications for same denture on same day Includes labour and laboratory costs. Y 86768 01NOV2007 Adding tooth to partial denture to replace an extracted or decoronated tooth- per tooth Y 86769 01NOV2007 Repair or addition to metal casting Y 86771 01NOV2007 Tissue conditioning treatment prior to impressions Limit of five (5) per 3 month period Y 86772 01NOV2007 Splint - resin - indirect Y 86773 01NOV2007 Splint - metal - indirect Y 86776 01NOV2007 Impression where required for denture repair/modification Y 86777 01NOV2007 Identification Marking a dental appliance with a patient's name or other form of enduring patient identification. Y 86811 01NOV2007 Passive removable appliance - per arch Y 86821 01NOV2007 Active removable appliance - per arch Y 86823 01NOV2007 Functional orthopaedic appliance Y 86829 01NOV2007 Partial banding - per arch Y 86831 01NOV2007 Full arch banding - per arch Y 86862 01NOV2007 Bonding of attachment for application of orthodontic force Y 86911 01NOV2007 Palliative care Interim care to relieve pain, infection, bleeding or other problems not associated with other treatment. Y 86926 01NOV2007 Individually made tray - medicaments A tray made for the application of medicaments to the teeth or supporting tissues. Not to be claimed for bleaching. Y 86927 01NOV2007 Provision of medication/ medicament The supply, prescription or administration of appropriate medications and medicaments required for dental treatment. Limit of one (1) per three month period. Y 86949 01NOV2007 Treatment under general anaesthesia A specialist anaesthetist must administer the anaesthetic. Y 86963 01NOV2007 Clinical occlusal analysis including muscle and joint palpation Limit of one (1) per three year period. Y 86964 01NOV2007 Registration and mounting of casts for occlusal analysis Limit of one (1) per three year period. Y 86965 01NOV2007 Occlusal splint Y 86966 01NOV2007 Adjustment of pre-existing occlusal splint - per visit Y 86968 01NOV2007 Occlusal adjustment following occlusal analysis - per visit Y 86971 01NOV2007 Adjunctive physical therapy for temporomandibular joint and associated structures Limit of four (4) per 12 month period. Y 86972 01NOV2007 Repair/addition - occlusal splint Y 86981 01NOV2007 Splinting and stabilisation - direct - per tooth Y 86986 01NOV2007 Post-operative care where not otherwise included In normal circumstances, dental specialists provide post-operative care following dental treatment. However, where a patient requires unforeseen post-operative care or is seen by a dental specialist who did not provide the initial treatment, this item can be used. Limit of two (2) per 12 month period Y 87011 01NOV2007 Initial denture examination Assessment of any existing dentures and any teeth, supporting tissues and oral tissues in order to construct a removable dental prosthesis or refer to an appropriate clinician. This assessment includes the recording an appropriate medical history and any other relevant information. Limit of one (1) per provider every 2 years. Y 87014 01NOV2007 Consultation A consultation to seek advice or discuss treatment options regarding removable dental prosthesis. This consultation includes the recording an appropriate medical history and any other relevant information. Y 87071 01NOV2007 Diagnostic model - per model Y 87711 01NOV2007 Complete maxillary denture Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87712 01NOV2007 Complete mandibular denture Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87716 01NOV2007 Metal palate or plate Additional to items 87711, 87712 or 87719. Y 87719 01NOV2007 Complete maxillary and mandibular dentures Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87721 01NOV2007 Partial maxillary denture - resin base Base amount only. To be claimed in conjunction with item 87733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87722 01NOV2007 Partial mandibular denture - resin base Base amount only. To be claimed in conjunction with item 87733 for each additional tooth. Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87727 01NOV2007 Partial maxillary denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 87733 for each additional tooth and item 87739 for each metal backing Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87728 01NOV2007 Partial mandibular denture - cast metal framework (includes provision of casting) Inclusive of clasps, retainers and occlusal rests. Base amount only. To be claimed in conjunction with item 87733 for each additional tooth and item 87739 for each metal backing Limit of one new set of dentures per patient every eight (8) years.In exceptional circumstances, a patient may receive a second set of new dentures during the eight year period. Y 87731 01NOV2007 Retainer - per tooth Additional to items 87721 and 87722 Y 87732 01NOV2007 Occlusal rest Additional to items 87721 and 87722 Y 87733 01NOV2007 Tooth/Teeth (Partial denture) An item to describe each tooth added to the base of new partial denture. The number of teeth should be indicated. To be claimed with items 87721, 87722, 87727 or 87728. Limit of twelve (12) per base Y 87736 01NOV2007 Immediate tooth replacement - per tooth Y 87737 01NOV2007 Resilient lining Y 87738 01NOV2007 Wrought bar A wrought bar joining sections of a partial prosthesis. Y 87739 01NOV2007 Metal Backing - per backing An extension of the casting of a cast metal partial denture to provide a backing for the denture tooth. The number of backings should be indicated.To be claimed with items 87727 or 87728. Y 87741 01NOV2007 Adjustment of pre-existing denture Adjustment of a denture to improve comfort and function. This item cannot be claimed for routine adjustments following the insertion of a new denture or maintenance or repair of an existing denture. Y 87743 01NOV2007 Relining - complete denture - processed For soft relines, use items 87743 and 87737. Y 87744 01NOV2007 Relining - partial denture - processed For soft relines, use items 87744 and 87737. Y 87745 01NOV2007 Remodelling - complete denture Y 87746 01NOV2007 Remodelling - partial denture Y 87751 01NOV2007 Relining - complete denture - direct Chair-side only.Either hard or soft material. Y 87752 01NOV2007 Relining - partial denture - direct Y 87753 01NOV2007 Cleaning and polishing of pre-existing denture Limit of one (1) per 2 year period. Y 87761 01NOV2007 Reattaching pre-existing tooth or clasp to denture Includes labour and laboratory costs. Y 87762 01NOV2007 Replacing clasp on denture Y 87763 01NOV2007 Repairing broken base of a complete denture Includes labour and laboratory costs. Y 87764 01NOV2007 Repairing broken base of a partial denture Includes labour and laboratory costs. Y 87765 01NOV2007 Replacing first tooth on denture Y 87767 01NOV2007 Any repair or tooth replacement in addition to other repairs, alterations or other modifications for same denture on same day Includes labour and laboratory costs. Y 87768 01NOV2007 Adding tooth to partial denture to replace an extracted or decoronated tooth - per tooth Y 87769 01NOV2007 Repair or addition to metal casting Y 87771 01NOV2007 Tissue conditioning treatment prior to impressions Limit of five (5) per 3 month period. Y 87776 01NOV2007 Impression where required for denture repair Y 87777 01NOV2007 Identification Marking a dental appliance with a patient's name or other form of enduring patient identification. Y 88000 01JUL2008 Preventative dental check (or preventative dental program) consisting of: `)an oral examination (minimum requirement); and, where clinically necessary, one or more of the following services: radiological examination and interpretation; `)removal of plaque and/or stain; `)removal of calculus; `)topical application of re-mineralising agent; `)dietary advice; `)oral hygiene instruction; and/or `)fissure sealing provided to an eligible dental patient by, or on behalf of, an eligible dentist. Limit of one (1) preventative dental program per eligible dental patient, per calendar year. Y 88011 01JAN2014 Comprehensive oral examination Evaluation of all teeth, their supporting tissues and the oral tissues in order to record the condition of these structures. This evaluation includes recording an appropriate medical history and any other relevant information. Y 88012 01JAN2014 Periodic oral examination An evaluation performed on a patient of record to determine any changes in the patient's dental and medical health status since a previous comprehensive or periodic examination. Y 88013 01JAN2014 Oral examination - limited A limited oral problem-focussed evaluation carried out immediately prior to required treatment. This evaluation includes recording an appropriate medical history and any other relevant information. Y 88022 01JAN2014 Intraoral periapical or bitewing radiograph - per exposure Taking and interpreting a radiograph made with the film inside the mouth. Y 88025 01JAN2014 Intraoral radiograph - occlusal, maxillary, mandibular - per exposure Taking and interpreting an occlusal, maxillary or mandibular intraoral radiograph. This radiograph shows a more extensive view of teeth and maxillary or mandibular bone. Y 88111 01JAN2014 Removal of plaque and/or stain Removal of dental plaque and/or stain from the surfaces of all teeth. N 88111 01JAN2018 Removal of plaque and/or stain Removal of dental plaque and/or stain from the surfaces of all teeth and/or implants. Y 88114 01JAN2014 Removal of calculus - first visit Removal of calculus from the surfaces of teeth. Y 88115 01JAN2014 Removal of calculus - subsequent visit This item describes procedures in item 88114 when, because of the extent or degree of calculus, an additional visit(s) is required to remove deposits from the teeth. Y 88121 01JAN2014 Topical application of remineralisation and/or cariostatic agents, one treatment Application of remineralisation and/or cariostatic agents to the surfaces of the teeth. This may include activation of the agent. Not to be used as an intrinsic part of the restoration. Y 88161 01JAN2014 Fissure and/or tooth surface sealing - per tooth (first four services) Sealing of non-carious pits, fissures, smooth surfaces or cracks in a tooth with an adhesive material. Any preparation prior to application of the sealant is included in this item number. N 88161 01JAN2015 Fissure and/or tooth surface sealing - per tooth (first four services on a day) Sealing of non-carious pits, fissures, smooth surfaces or cracks in a tooth with an adhesive material. Any preparation prior to application of the sealant is included in this item number. Y 88162 01JAN2014 Fissure and/or tooth surface sealing - per tooth (subsequent services) Sealing of non-carious pits, fissures, smooth surfaces or cracks in a tooth with an adhesive material. Any preparation prior to application of the sealant is included in this item number. Y 88213 01JAN2014 Treatment of acute periodontal infection - per visit This item describes the treatment of acute periodontal infection(s). It may include establishing drainage and the removal of calculus from the affected tooth (teeth). Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88221 01JAN2014 Clinical periodontal analysis and recording This is a special examination performed as part of the diagnosis and management of periodontal disease. The procedure consists of assessing and recording a patient's periodontal condition. All teeth and six sites per tooth must be recorded. Written documentation of these measurements must be retained. Y 88311 01JAN2014 Removal of a tooth or part(s) thereof - first tooth extracted on a day A procedure consisting of the removal of a tooth or part(s) thereof. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88314 01JAN2014 Sectional removal of a tooth or part(s) thereof - first tooth extracted on a day The removal of a tooth or part(s) thereof in sections. Bone removal may be necessary. Inclusive of the insertion of sutures, normal postoperative care and suture removal. Y 88316 01JAN2014 Additional extraction requiring removal of a tooth or part(s) thereof, or sectional removal of a tooth. Additional extraction provided on the same day as a service described in item 88311 or 88314 is provided to the patient. Y 88322 01JAN2014 Surgical removal of a tooth or tooth fragment not requiring removal of bone or tooth division - first tooth extracted on a day Removal of a tooth or tooth fragment where an incision and the raising of a mucoperiosteal flap is required, but where removal of bone or sectioning of the tooth is not necessary to remove the tooth. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88323 01JAN2014 Surgical removal of a tooth or tooth fragment requiring removal of bone - first tooth extracted on a day Removal of a tooth or tooth fragment where removal of bone is required after an incision and a mucoperiosteal flap raised. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88324 01JAN2014 Surgical removal of a tooth or tooth fragment requiring both removal of bone and tooth division - first tooth extracted on a day Removal of a tooth or tooth fragment where both removal of bone and sectioning of the tooth are required after an incision and a mucoperiosteal flap raised. The tooth will be removed in portions. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88326 01JAN2014 Additional extraction requiring surgical removal of a tooth or tooth fragment Additional surgical extraction provided on the same day as a service described in item 88322, 88323 or 88324 is provided to the patient. Y 88351 01JAN2014 Repair of skin and subcutaneous tissue or mucous membrane The surgical cleaning and repair of a facial skin wound in the region of the mouth or jaws, or the repair of oral mucous membrane, where the wounds involve the subcutaneous tissues. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88384 01JAN2014 Repositioning of displaced tooth/teeth - per tooth A procedure following trauma where the position of the displaced tooth/teeth is corrected by manipulation. Stabilising procedures are itemised separately. Inclusive of the insertion of sutures, normal postoperative care and suture removal. Y 88386 01JAN2014 Splinting of displaced tooth/teeth - per tooth A procedure following trauma where the position of the displaced tooth/teeth may be stabilized by splinting. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88387 01JAN2014 Replantation and splinting of a tooth Replantation of a tooth which has been avulsed or intentionally removed. It may be held in the correct position by splinting. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88392 01JAN2014 Drainage of abscess Drainage and/or irrigation of an abscess other than through a root canal or at the time of extraction. The drainage may be through an incision or inserted tube. Inclusive of the insertion of sutures, normal post-operative care and suture removal. Y 88411 01JAN2014 Direct pulp capping A procedure where an exposed pulp is directly covered with a protective dressing or cement. Y 88412 01JAN2015 Incomplete endodontic therapy (tooth not suitable for further treatment) A procedure where in assessing the suitability of a tooth for endodontic treatment a decision is made that the tooth is not suitable for restoration. Y 88414 01JAN2014 Pulpotomy Amputation within the pulp chamber of part of the vital pulp of a tooth. The pulp remaining in the canal(s) is then covered with a protective dressing or cement. Y 88415 01JAN2014 Complete chemo-mechanical preparation of root canal - one canal Complete chemo-mechanical preparation including removal of pulp or necrotic debris from a canal. Y 88416 01JAN2014 Complete chemo-mechanical preparation of root canal - each additional canal Complete chemo-mechanical preparation including removal of pulp or necrotic debris from each additional canal of a tooth with multiple canals. Y 88417 01JAN2014 Root canal obturation - one canal The filling of a root canal, following chemo-mechanical preparation. Y 88418 01JAN2014 Root canal obturation - each additional canal The filling, following chemo-mechanical preparation, of each additional canal in a tooth with multiple canals. Y 88419 01JAN2014 Extirpation of pulp or debridement of root canal(s) - emergency or palliative The partial or thorough removal of pulp and/or debris from the root canal system of a tooth. This is an emergency or palliative procedure distinct from visits for scheduled endodontic treatment. Y 88421 01JAN2014 Resorbable root canal filling - primary tooth The placement of resorbable root canal filling material in a primary tooth. Y 88455 01JAN2014 Additional visit for irrigation and/or dressing of the root canal system - per tooth Additional debridement irrigation and short-term dressing required where evidence of infection or inflammation persists following prior opening of the root canal and removal of its contents. Y 88458 01JAN2014 Interim therapeutic root filling - per tooth A procedure consisting of the insertion of a long-term provisional (temporary) root canal filling with therapeutic properties which facilitates healing/development of the root and periradicular tissues over an extended time. Y 88511 01JAN2014 Metallic restoration - one surface - direct Direct metallic restoration involving one surface of a tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88512 01JAN2014 Metallic restoration - two surfaces - direct Direct metallic restoration involving two surfaces of a tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88513 01JAN2014 Metallic restoration - three surfaces - direct Direct metallic restoration involving three surfaces of a tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88514 01JAN2014 Metallic restoration - four surfaces - direct Direct metallic restoration involving four surfaces of a tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88515 01JAN2014 Metallic restoration - five surfaces - direct Direct metallic restoration involving five surfaces of a tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88521 01JAN2014 Adhesive restoration - one surface - anterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving one surface of an anterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88522 01JAN2014 Adhesive restoration - two surfaces - anterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving two surfaces of an anterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88523 01JAN2014 Adhesive restoration - three surfaces - anterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving three surfaces of an anterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88524 01JAN2014 Adhesive restoration - four surfaces - anterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving four surfaces of an anterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88525 01JAN2014 Adhesive restoration - five surfaces - anterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving five surfaces of an anterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88531 01JAN2014 Adhesive restoration - one surface - posterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving one surface of an posterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88532 01JAN2014 Adhesive restoration - two surfaces - posterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving two surfaces of an posterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88533 01JAN2014 Adhesive restoration - three surfaces - posterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving three surfaces of an posterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88534 01JAN2014 Adhesive restoration - four surfaces - posterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving four surfaces of an posterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88535 01JAN2014 Adhesive restoration - five surfaces - posterior tooth - direct Direct restoration, using an adhesive technique and a tooth-coloured material, involving five surfaces of an posterior tooth. Inclusive of the preparation of the tooth, placement of a lining, contouring of the adjacent and opposing teeth, placement of the restoration and normal post-operative care. Y 88572 01JAN2014 Provisional (intermediate/temporary) restoration - per tooth The provisional (intermediate) restoration of a tooth designed to last until the definitive restoration can be constructed or the tooth is removed. This item should only be used where the provisional (intermediate) restoration is not an intrinsic part of treatment. It does not include provisional (temporary) sealing of the access cavity during endodontic treatment or during construction of indirect restorations. Y 88574 01JAN2014 Metal band The cementation of a metal band for diagnostic, protective purposes or for the placement of a provisional (intermediate) restoration. Y 88575 01JAN2014 Pin retention - per pin Use of a pin to aid the retention and support of direct or indirect restorations in a tooth. Y 88576 01JAN2014 Metallic crown - preformed Placing a preformed metallic crown as a coronal restoration for a tooth. Y 88579 01JAN2014 Bonding of tooth fragment The direct bonding of a tooth fragment as an alternative to placing a restoration. Y 88586 01JAN2018 Crown-metallic-with tooth preparation-preformed Placing a preformed metallic crown as a coronal restoration for a tooth. Y 88587 01JAN2018 Crown-metallic-minimal tooth preparation-preformed Placing a preformed metallic crown as a coronal restoration for a tooth and where minimal or no restoration of the tooth is required. Commonly referred to as a 'Hall' crown. Y 88597 01JAN2014 Post - direct Insertion of a post into a prepared root canal to provide an anchor for an artificial crown or other restoration. Y 88721 01JAN2014 Partial maxillary denture - resin, base only Provision of a resin base for a removable dental prosthesis for the maxilla where some natural teeth remain. Y 88722 01JAN2014 Partial mandibular denture - resin, base only Provision of a resin base for a removable dental prosthesis for the mandible where some natural teeth remain. Y 88723 01JAN2018 Provisional partial maxillary denture Provision of a patient removable partial dental prosthesis replacing the natural teeth and adjacent tissues in the maxilla which is designed to last until the definitive prosthesis can be constructed. This item should only be used where a provisional denture is not an intrinsic part of item 88721. Y 88724 01JAN2018 Provisional partial mandibular denture Provision of a patient removable partial dental prosthesis replacing the natural teeth and adjacent tissues in the mandible which is designed to last until the definitive prosthesis can be constructed. This item should only be used where a provisional denture is not an intrinsic part of item 88722. Y 88731 01JAN2014 Retainer - per tooth A retainer or attachment fitted to a tooth to aid retention of a partial denture. The number of retainers should be indicated. Y 88733 01JAN2014 Tooth/teeth (partial denture) An item to describe each tooth added to the base of a new partial denture. The number of teeth should be indicated. Y 88736 01JAN2014 Immediate tooth replacement - per tooth Provision within a denture to allow immediate replacement of an extracted tooth. The number of teeth so replaced should be indicated. Y 88741 01JAN2014 Adjustment of a denture Adjustment of a denture to improve comfort, function or aesthetics. This item does not apply to routine adjustments following the insertion of a new denture or the maintenance or repair of an existing denture. Y 88761 01JAN2014 Reattaching pre-existing clasp to denture Repair, insertion and adjustment of a denture involving re-attachment of a pre-existing clasp. Y 88762 01JAN2014 Replacing/adding clasp to denture - per clasp Repair, insertion and adjustment of a denture involving replacement or addition of a new clasp or clasps. Y 88764 01JAN2014 Repairing broken base of a partial denture Repair, insertion and adjustment of a broken resin partial denture base. Y 88765 01JAN2014 Replacing/adding new tooth on denture - per tooth Repair, insertion and adjustment of a denture involving replacement with or addition of a new tooth or teeth to a previously existing denture. Y 88766 01JAN2014 Reattaching existing tooth on denture - per tooth Repair, insertion and adjustment of a denture involving reattachment of a pre-existing denture tooth or teeth. Y 88768 01JAN2014 Adding tooth to partial denture to replace an extracted ordecoronated tooth - per tooth Modification, insertion and adjustment of a partial denture involving an addition to accommodate the loss of a natural tooth or its coronal section. Y 88776 01JAN2014 Impression - dental appliance repair/modification An item to describe taking an impression where required for the repair or modification of a dental appliance. Y 88911 01JAN2014 Palliative care An item to describe interim care to relieve pain, infection, bleeding or other problems not associated with other treatment. Y 88942 01JAN2014 Sedation - intravenous Sedative drug(s) administered intravenously, usually in increments.The incremental administration may continue while dental treatment is being provided. Y 88943 01JAN2014 Sedation - inhalation Nitrous oxide gas mixed with oxygen is inhaled by the patient while dental treatment is being provided. Y 90001 01MAR2019 A flag fall service to which item 90020, 90035, 90043 or 90051 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on. Y 90002 01MAR2019 A flag fall service to which item 90092, 90093, 90095, 90096, 90183, 90188, 90202 or 90212 applies. For the initial attendance at one residential aged care facility on one occasion, applicable to a maximum of one patient attended on. Y 90020 01MAR2019 Professional attendance (other than a service to which another item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex if the patient is accommodated in a residential aged care facility (other than accommodation in a self?contained unit) by a general practitioner for an obvious problem characterised by the straightforward nature of the task that requires a short patient history and, if required, limited examination and management - an attendance on one or more patients at one residential aged care facility on one occasion - each patient. Y 90035 01MAR2019 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting less than 20 minutes and including any of the following that are clinically relevant: (a) taking a patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health?related issues, with appropriate documentation - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 90043 01MAR2019 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 20 minutes and including any of the following that are clinically relevant: (a) taking a detailed patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health?related issues, with appropriate documentation - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 90051 01MAR2019 Professional attendance by a general practitioner at a residential aged care facility to residents of the facility (other than a service to which another item in the table applies), lasting at least 40 minutes and including any of the following that are clinically relevant: (a) taking an extensive patient history; (b) performing a clinical examination; (c) arranging any necessary investigation; (d) implementing a management plan; (e) providing appropriate preventive health care; for one or more health?related issues, with appropriate documentation - an attendance on one or more patients at one residential aged care facility on one occasion - each patient Y 90092 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of not more than 5 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause2.3.1 applies. N 90092 01NOV2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of not more than 5 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner who is not a general practitioner. Y 90093 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 5 minutes in duration but not more than 25 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause2.3.1 applies. N 90093 01NOV2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 5 minutes in duration but not more than 25 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner who is not a general practitioner. Y 90095 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 25 minutes in duration but not more than 45 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause2.3.1 applies. N 90095 01NOV2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 25 minutes in duration but not more than 45 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner who is not a general practitioner. Y 90096 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 45 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by: (a) a medical practitioner (who is not a general practitioner); or (b) a general practitioner to whom clause2.3.1 applies. N 90096 01NOV2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 45 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner who is not a general practitioner. Y 90183 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of not more than 5 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by medical practitioner in an eligible area. Y 90188 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 5 minutes in duration but not more than 25 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner in an eligible area. Y 90202 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 25 minutes in duration but not more than 45 minutes - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner in an eligible area. Y 90212 01MAR2019 Professional attendance (other than a service to which any other item applies) at a residential aged care facility (other than a professional attendance at a self?contained unit) or professional attendance at consulting rooms situated within such a complex where the patient is accommodated in the residential aged care facility (that is not accommodation in a self?contained unit) of more than 45 minutes in duration - an attendance on one or more patients at one residential aged care facility on one occasion - each patient, by a medical practitioner in an eligible area. Y 90250 01NOV2019 Professional attendance by a general practitioner who has not undertaken mental health skills training (not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b) the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90251 01NOV2019 Professional attendance by a general practitioner who has not undertaken mental health skills training (not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b) the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90252 01NOV2019 Professional attendance by a general practitioner who has undertaken mental health skills training (not including a specialist or consultant physician), of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b) the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c) the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the general practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90253 01NOV2019 Professional attendance by a general practitioner who has undertaken mental health skills training (not including a specialist or consultant physician), of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a)the plan includes an opinion on diagnosis of the patient's eating disorder; and (b)the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c)the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d)the general practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90254 01NOV2019 Professional attendance by a medical practitioner who has not undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b)the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c)the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d)the medical practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i)a copy of the plan; and (ii) suitable education about the eating disorder Y 90255 01NOV2019 Professional attendance by a medical practitioner who has not undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b)the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c)the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d)the medical practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90256 01NOV2019 Professional attendance by a medical practitioner who has undertaken mental health skills training, of at least 20 minutes but less than 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b)the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c)the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d)the medical practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90257 01NOV2019 Professional attendance by a medical practitioner who has undertaken mental health skills training, of at least 40 minutes in duration for the preparation of a written eating disorder treatment and management plan for an eligible patient, if: (a) the plan includes an opinion on diagnosis of the patient's eating disorder; and (b)the plan includes treatment options and recommendations to manage the patient's condition for the following 12 months; and (c)the plan includes an outline of the referral options to allied health professionals for mental health and dietetic services, and specialists, as appropriate; and (d) the medical practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90260 01NOV2019 Professional attendance of at least 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patient's diagnosis; and (C) comprehensively evaluates the patient's biological, psychological and social issues; and (D) addresses the patient's diagnostic psychiatric issues; and (E) makes management recommendations addressing the patient's biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees. Y 90261 01NOV2019 Professional attendance of at least 45 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees Y 90262 01NOV2019 Professional attendance of at least 45 minutes in duration by video conference by a consultant physician in the practice of the consultant physician's specialty of psychiatry for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a) the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (c) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that: (A) covers the next 12 months; and (B) is appropriate to the patient's diagnosis; and (C) comprehensively evaluates the patient's biological, psychological and social issues; and (D) addresses the patient's diagnostic psychiatric issues; and (E) makes management recommendations addressing the patient's biological, psychological and social issues; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees Y 90263 01NOV2019 Professional attendance of at least 45 minutes in duration by video conference by a consultant physician in the practice of the consultant physician's specialty of paediatrics for the preparation of an eating disorder treatment and management plan for an eligible patient, if: (a)the patient has been referred by a referring practitioner; and (b) during the attendance, the consultant paediatrician undertakes an assessment that covers: (i) a comprehensive history, including psychosocial history and medication review; and (ii) comprehensive multi or detailed single organ system assessment; and (iii) the formulation of diagnoses; and (c) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) prepares a written management plan for the patient that involves: (A) an opinion on diagnosis and risk assessment; and (B) treatment options and decisions; and (C) medication recommendations; and (iii) gives the referring practitioner a copy of the diagnosis and the management plan; and (iv) if clinically appropriate, explains the diagnosis and management plan, and a gives a copy, to: (A) the patient; and (B) the patient's carer (if any), if the patient agrees Y 90264 01NOV2019 Professional attendance by a general practitioner to review an eligible patient's eating disorder treatment and management plan prepared by the general practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a) the general practitioner reviews the treatment efficacyof services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patient's needs; and (b) modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i) recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c) initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d) the general practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder Y 90265 01NOV2019 Professional attendance by a medical practitioner to review an eligible patient's eating disorder treatment and management plan prepared by the medical practitioner, an associated medical practitioner working in general practice, or a consultant physician practising in the specialty of psychiatry or paediatrics, if: (a)the medical practitioner reviews the treatment efficacyof services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patient's needs; and (b)modifications are made to the eating disorder treatment and management plan, recorded in writing, including: (i)recommendations to continue with treatment options detailed in the plan; or (ii) recommendations to alter the treatment options detailed in the plan, with the new arrangements documented in the plan; and (c)initiates referrals for a review by a consultant physician practising in the specialty of psychiatry or paediatrics, where appropriate; and (d)the medical practitioner offers the patient and the patient's carer (if any, and if the practitioner considers it appropriate and the patient agrees): (i) a copy of the plan; and (ii) suitable education about the eating disorder. Y 90266 01NOV2019 Professional attendance of at least 30 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of psychiatry for an eligible patient, if: (a) the consultant psychiatrist reviews the treatment efficacyof services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patient's needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to:: (A) the patient; and (B) is the patient's carer (if any), if the patient agrees. Y 90267 01NOV2019 Professional attendance of at least 20 minutes in duration at consulting rooms by a consultant physician in the practice of the consultant physician's specialty of paediatrics for an eligible patient, if: (a) the consultant paediatrician reviews the treatment efficacyof services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patient's needs; and (b) the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv)review of original and differential diagnoses; and (d)within 2 weeks after the attendance, the consultant paediatrician: (i)prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) is the patient's carer (if any), if the patient agrees. Y 90268 01NOV2019 Professional attendance of at least 30 minutes in duration by video conference by a consultant physician in the practice of the consultant physician's specialty of psychiatry for an eligible patient, if: (a)the consultant psychiatrist reviews the treatment efficacyof services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patient's needs; and (b) the patient has been referred by a referring practitioner; and (c)during the attendance, the consultant psychiatrist: (i) uses an outcome tool (if clinically appropriate); and (ii) carries out a mental state examination; and (iii) makes a psychiatric diagnosis; and (iv) reviews the eating disorder treatment and management plan; and (d) within 2 weeks after the attendance, the consultant psychiatrist: (i)prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) is the patient's carer (if any), if the patient agrees. Y 90269 01NOV2019 Professional attendance of at least 20 minutes in duration by video conference by a consultant physician in the practice of the consultant physician's specialty of paediatrics for an eligible patient, if: (a)the consultant paediatrician reviews the treatment efficacyof services provided under the eating disorder treatment and management plan, including a discussion with the patient regarding whether the eating disorders psychological treatment and dietetic services are meeting the patient's needs; and (b)the patient has been referred by a referring practitioner; and (c) during the attendance, the consultant paediatrician reviews the eating disorder treatment and management plan, including a: (i) review of initial presenting problems and results of diagnostic investigations; and (ii) review of responses to treatment and medication plans initiated at time of initial consultation; and (iii) comprehensive multi or detailed single organ system assessment; and (iv)review of original and differential diagnoses; and (d) within 2 weeks after the attendance, the consultant paediatrician: (i) prepares a written diagnosis of the patient; and (ii) revises the eating disorder treatment and management; and (iii) gives the referring practitioner a copy of the diagnosis and the revised management plan; and (iv) if clinically appropriate, explains the diagnosis and the revised management plan, and gives a copy, to: (A) the patient; and (B) is the patient's carer (if any), if the patient agrees. Y 90271 01NOV2019 Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90272 01NOV2019 Professional attendance at a place other than consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan Y 90273 01NOV2019 Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90274 01NOV2019 Professional attendance at a place other than consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90275 01NOV2019 Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90276 01NOV2019 Professional attendance at a place other than consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90277 01NOV2019 Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90278 01NOV2019 Professional attendance at a place other than consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan. Y 90279 01NOV2019 Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if: (a)the attendance is by video conference; and (b)the patient is not an admitted patient; and (c)the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner. Y 90280 01NOV2019 Professional attendance at consulting rooms by a general practitioner, for providing eating disorder psychological treatment services by a general practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if: (a) the attendance is by video conference; and (b) the patient is not an admitted patient; and (c) the patient is located within a telehealth eligible area; and (d) the patient is, at the time of the attendance, at least 15 kilometres by road from the general practitioner Y 90281 01NOV2019 Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 30 minutes but less than 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if:(a)     the attendance is by video conference; and (b)     the patient is not an admitted patient; and (c)     the patient is located within a telehealth eligible area; and (d)     the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner. Y 90282 01NOV2019 Professional attendance at consulting rooms by a medical practitioner, for providing eating disorder psychological treatment services by a medical practitioner registered with the Chief Executive Medicare as meeting the credentialling requirements for provision of this service, and lasting at least 40 minutes in duration, for an eligible patient if treatment is clinically indicated under an eating disorder treatment and management plan, if:(a)     the attendance is by video conference; and (b)     the patient is not an admitted patient; and (c)     the patient is located within a telehealth eligible area; and (d)     the patient is, at the time of the attendance, at least 15 kilometres by road from the medical practitioner. Y 91000 17JAN2020 Psychological therapy health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c) the service is at least 30 minutes but less than 50 minutes duration Y 91001 17JAN2020 Psychological therapy health service provided to a patient (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c)the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 30 minutes but less than 50 minutes duration Y 91005 17JAN2020 Psychological therapy health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist in accordance with the requirements of item 91000 Y 91010 17JAN2020 Psychological therapy health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a) the patient is affected by bushfire; and (b) the service is provided to the patient individually and in person; and (c)the service is at least 50 minutes duration Y 91011 17JAN2020 Psychological therapy health service provided to a patient (but not as an admitted patient of a hospital) by an eligible clinical psychologist if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c) the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 50 minutes duration Y 91015 17JAN2020 Psychological therapy health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible clinical psychologist in accordance with the requirements of item 91010 Y 91100 17JAN2020 Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually and in person; and (c)the service is at least 20 minutes but less than 50 minutes duration Y 91101 17JAN2020 Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible psychologist if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c)the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 20 minutes but less than 50 minutes duration Y 91105 17JAN2020 Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist in accordance with the requirements of item 91100 Y 91110 17JAN2020 Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually and in person; and (c)the service is at least 50 minutes duration Y 91111 17JAN2020 Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible psychologist if: (a) the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c)the attendance is by video conference; and (d) the patient is not an admitted patient; and (e)the service is at least 50 minutes duration Y 91115 17JAN2020 Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible psychologist in accordance with the requirements of item 91110 Y 91125 17JAN2020 Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually and in person; and (c) the service is at least 20 minutes but less than 50 minutes duration Y 91126 17JAN2020 Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a)the patient is affected by bushfire; and (b) the service is provided to the patient individually; and (c)the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 20 minutes but less than 50 minutes duration Y 91130 17JAN2020 Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist in accordance with the requirements of item 91125 Y 91135 17JAN2020 Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a) the patient is affected by bushfire; and (b)the service is provided to the patient individually and in person; and (c)the service is at least 50 minutes duration Y 91136 17JAN2020 Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible occupational therapist if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c)the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 50 minutes duration Y 91140 17JAN2020 Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible occupational therapist in accordance with the requirements of item 91135 Y 91150 17JAN2020 Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually and in person; and (c)the service is at least 20 minutes but less than 50 minutes duration Y 91151 17JAN2020 Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible social worker if: (a)the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c) the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 20 minutes but less than 50 minutes duration Y 91155 17JAN2020 Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker in accordance with the requirements of item 91150 Y 91160 17JAN2020 Focussed psychological strategies health service provided to a patient in consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the patient is affected by bushfire; and (b)the service is provided to the patient individually and in person; and (c) the service is at least 50 minutes duration Y 91161 17JAN2020 Focussed psychological strategies health service provided to a patient (but not as an admitted patient of a hospital) by an eligible social worker if: (a) the patient is affected by bushfire; and (b)the service is provided to the patient individually; and (c)the attendance is by video conference; and (d)the patient is not an admitted patient; and (e)the service is at least 50 minutes duration Y 91165 17JAN2020 Focussed psychological strategies health service provided to a patient at a place other than consulting rooms (but not as an admitted patient of a hospital) by an eligible social worker in accordance with the requirements of item 91160 Y 91283 17JAN2020 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration Y 91285 17JAN2020 Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration Y 91286 17JAN2020 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration Y 91287 17JAN2020 Professional attendance at a place other than consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration Y 91371 17JAN2020 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the service is at least 30 minutes but less than 40 minutes duration Y 91372 17JAN2020 Professional attendance at consulting rooms by a medical practitioner, for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the patient is not an admitted patient; and (d) the service is at least 40 minutes duration Y 91721 17JAN2020 Professional attendance at consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration Y 91723 17JAN2020 Professional attendance at a place other than consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 30 minutes but less than 40 minutes duration Y 91725 17JAN2020 Professional attendance at consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration Y 91727 17JAN2020 Professional attendance at a place other than consulting rooms by a general practitioner (not including a specialist or a consultant physician), for providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the service is at least 40 minutes duration Y 91729 17JAN2020 Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the service is at least 30 minutes but less than 40 minutes duration Y 91731 17JAN2020 Professional attendance at consulting rooms by a general practitioner, for the purpose of providing focussed psychological strategies for mental health services to a patient with mental health issues, if: (a) the patient is affected by bushfire; and (b) the attendance is by video conference; and (c) the services is at least 40 minutes duration Y